PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Quoix, E; Zalcman, G; Oster, JP; Westeel, V; Pichon, E; Lavole, A; Dauba, J; Debieuvre, D; Souquet, PJ; Bigay-Game, L; Dansin, E; Poudenx, M; Molinier, O; Vaylet, F; Moro-Sibilot, D; Herman, D; Bennouna, J; Tredaniel, J; Ducolone, A; Lebitasy, MP; Baudrin, L; Laporte, S; Milleron, B				Quoix, Elisabeth; Zalcman, Gerard; Oster, Jean-Philippe; Westeel, Virginie; Pichon, Eric; Lavole, Armelle; Dauba, Jerome; Debieuvre, Didier; Souquet, Pierre-Jean; Bigay-Game, Laurence; Dansin, Eric; Poudenx, Michel; Molinier, Olivier; Vaylet, Fabien; Moro-Sibilot, Denis; Herman, Dominique; Bennouna, Jaafar; Tredaniel, Jean; Ducolone, Alain; Lebitasy, Marie-Paule; Baudrin, Laurence; Laporte, Silvy; Milleron, Bernard		Intergrp Francophone Cancerologie	Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial	LANCET			English	Article							INTERNATIONAL-SOCIETY; GERIATRIC ASSESSMENT; OLDER; AGE; COMBINATION; MANAGEMENT; COMORBIDITY; UNDERREPRESENTATION; SURVIVAL; OUTCOMES	Background Platinum-based doublet chemotherapy is recommended to treat advanced non-small-cell lung cancer (NSCLC) in fit, non-elderly adults, but monotherapy is recommended for patients older than 70 years. We compared a carboplatin and paclitaxel doublet chemotherapy regimen with monotherapy in elderly patients with advanced NSCLC. Methods In this multicentre, open-label, phase 3, randomised trial we recruited patients aged 70-89 years with locally advanced or metastatic NSCLC and WHO performance status scores of 0-2. Patients received either four cycles (3 weeks on treatment, 1 week off treatment) of carboplatin (on day 1) plus paclitaxel (on days 1,8, and 15) or five cycles (2 weeks on treatment, 1 week off treatment) of vinorelbine or gemcitabine monotherapy. Randomisation was done centrally with the minimisation method. The primary endpoint was overall survival, and analysis was done by intention to treat. This trial is registered, number NCT00298415. Findings 451 patients were enrolled. 226 were randomly assigned monotherapy and 225 doublet chemotherapy. Median age was 77 years and median follow-up was 30.3 months (range 8.6-45.2). Median overall survival was 10.3 months for doublet chemotherapy and 6.2 months for monotherapy (hazard ratio 0.64, 95% CI 0.52-0.78; p<0.0001); 1-year survival was 44.5% (95% CI 37.9-50.9) and 25.4% (19.9-31.3), respectively. Toxic effects were more frequent in the doublet chemotherapy group than in the monotherapy group (most frequent, decreased neutrophil count (108 [48.4%] vs 28 [12.4%]; asthenia 23 [10.3%] vs 13 [5.8%]). Interpretation Despite increased toxic effects, platinum-based doublet chemotherapy was associated with survival benefits compared with vinorelbine or gemcitabine monotherapy in elderly patients with NSCLC. We feel that the current treatment paradigm for these patients should be reconsidered.	[Quoix, Elisabeth] Univ Strasbourg, Hop Univ Strasbourg, Serv Pneumol, Dept Chest Dis, F-67091 Strasbourg, France; [Zalcman, Gerard] CHU Caen, Serv Pneumol, F-14000 Caen, France; [Zalcman, Gerard] Univ Caen Basse Normandie, Caen, France; [Oster, Jean-Philippe] Hop Colmar, Serv Pneumol, Colmar, France; [Westeel, Virginie] CHU Besancon, Serv Pneumol, F-25030 Besancon, France; [Pichon, Eric] CHRU Tours, Serv Pneumol, Tours, France; [Lavole, Armelle; Milleron, Bernard] Hop Tenon, Serv Pneumol, F-75970 Paris, France; [Dauba, Jerome] Hop Layne, Med Oncol Serv, Mont De Marsan, France; [Debieuvre, Didier] Ctr Hosp Paul Morel, Serv Pneumol, Vesoul, France; [Souquet, Pierre-Jean] Ctr Hosp Lyon Sud, Serv Pneumol, F-69310 Pierre Benite, France; [Bigay-Game, Laurence] Hop Larrey, Serv Pneumol, Toulouse, France; [Dansin, Eric] Ctr Oscar Lambret, Dept Med Oncol, F-59020 Lille, France; [Poudenx, Michel] Ctr Antoine Lacassagne, F-06054 Nice, France; [Molinier, Olivier] Ctr Hosp, Serv Malad Resp, Le Mans, France; [Vaylet, Fabien] Hop Instruct Armees Percy, Serv Malad Resp, Clamart, France; [Moro-Sibilot, Denis] CHU Grenoble, Serv Pneumol, F-38043 Grenoble, France; [Herman, Dominique] Ctr Hosp, Serv Pneumol, Nevers, France; [Bennouna, Jaafar] Ctr Rene Gauducheau, Med Oncol Serv, F-44035 Nantes, France; [Tredaniel, Jean] Grp Hosp Paris St Joseph, Serv Oncopneumol, Paris, France; [Ducolone, Alain] NHC, Serv Pneumol, Strasbourg, France; [Lebitasy, Marie-Paule; Baudrin, Laurence; Milleron, Bernard] Intergrp Francophone Cancerol Thorac, Paris, France; [Laporte, Silvy] CHU St Etienne, Unite Pharmacol Clin, St Etienne, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; Universite de Franche-Comte; CHU Besancon; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; CHU de Toulouse; UNICANCER; Centre Oscar Lambret; UNICANCER; Centre Antoine Lacassagne; Centre Hospitalier Le Mans; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne	Quoix, E (corresponding author), Univ Strasbourg, Hop Univ Strasbourg, Serv Pneumol, Dept Chest Dis, 1 Pl Hop, F-67091 Strasbourg, France.	elisabeth.quoix@chru-strasbourg.fr	ZALCMAN, Gérard/L-7809-2015; ZALCMAN, Gerard/P-4150-2015; MORO-SIBILOT, denis L/N-6493-2013; bennouna, jaafar/K-9350-2015; ZALCMAN, Gerard/M-8113-2019	ZALCMAN, Gérard/0000-0002-0343-9575; MORO-SIBILOT, Denis/0000-0001-6776-8610; Bennouna, Jaafar/0000-0002-5034-1108	Intergroupe Francophone de Cancerologie Thoracique, Institut National du Cancer; Lilly; Roche; BMS; Pierre Fabre	Intergroupe Francophone de Cancerologie Thoracique, Institut National du Cancer(Institut National du Cancer (INCA) France); Lilly(Eli Lilly); Roche(Roche Holding); BMS(Bristol-Myers Squibb); Pierre Fabre	Intergroupe Francophone de Cancerologie Thoracique, Institut National du Cancer.; EQ, GZ, J-PO, VW, J-PS, ED, FV, DM-S, (B, and BM have received consultancy fees or honoraria, participated on advisory boards, or both, for Roche and Lilly. GZ has also participated as an advisory board member for Bristol-Myers Squibb. EQ, GZ, VW, FV, DM-S, and BM have received travel grants from Lilly and Roche, and J-PO from Lilly. The other authors declare that they have no conflicts of interest.; We thank the IDMC members who were involved in the two preliminary analyses: Martine Extermann, Joseph Gligorov, Bruno Housset, and Marianne Paesmans. We thank also Franck Morin, Quail Tran, Elodie Amour, and Rebecca Rouveau, who provided substantial administrative help and did data quality checks during the study. We thank Gabrielle Cremer for helping us to improve the English language. This study was supported by grants from BMS, Roche, and Pierre Fabre.	Ansari RH, 2011, CRIT REV ONCOL HEMAT, V78, P162, DOI 10.1016/j.critrevonc.2010.03.003; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Baldini EH, 1997, CHEST, V112, pS229, DOI 10.1378/chest.112.4_Supplement.229S; Balducci L, 2000, CRIT REV ONCOL HEMAT, V35, P147, DOI 10.1016/S1040-8428(00)00089-5; Belani CP, 2008, J CLIN ONCOL, V26, P468, DOI 10.1200/JCO.2007.13.1912; Belani CP, 2005, CANCER, V104, P2766, DOI 10.1002/cncr.21495; Blanchard EM, 2011, J THORAC ONCOL, V6, P115, DOI 10.1097/JTO.0b013e3181fbebfd; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Davidoff AJ, 2010, J CLIN ONCOL, V28, P2191, DOI 10.1200/JCO.2009.25.4052; Extermann M, 2010, J CLIN ONCOL, V28; Extermann M, 1998, J CLIN ONCOL, V16, P1582, DOI 10.1200/JCO.1998.16.4.1582; Firat S, 2006, AM J CLIN ONCOL-CANC, V29, P252, DOI 10.1097/01.coc.0000217824.20290.ab; Firat S, 2010, INT J RADIAT ONCOL, V78, P1394, DOI 10.1016/j.ijrobp.2009.09.051; Foegle J, 2005, BRIT J CANCER, V92, P459, DOI 10.1038/sj.bjc.6602342; Gregor A, 2001, THORAX, V56, P212, DOI 10.1136/thorax.56.3.212; Gridelli C, 1999, JNCI-J NATL CANCER I, V91, P66; Gridelli C, 2003, JNCI-J NATL CANCER I, V95, P362, DOI 10.1093/jnci/95.5.362; Gronberg BH, 2010, EUR J CANCER, V46, P2225, DOI 10.1016/j.ejca.2010.04.009; HRYNIUK WM, 1990, J CLIN ONCOL, V8, P1935, DOI 10.1200/JCO.1990.8.12.1935; Hurria A, 2010, J CLIN ONCOL S, V28, p15s; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Jennens RR, 2006, INTERN MED J, V36, P216, DOI 10.1111/j.1445-5994.2006.01033.x; Lebitasy MP, 2001, BRIT J CANCER, V85, P808, DOI 10.1054/bjoc.2001.1955; Lichtman SM, 2003, CRIT REV ONCOL HEMAT, V46, P101, DOI 10.1016/S1040-8428(02)00120-8; Lichtman SM, 2007, EUR J CANCER, V43, P14, DOI 10.1016/j.ejca.2006.11.004; Lilenbaum RC, 2005, J CLIN ONCOL, V23, P190, DOI 10.1200/JCO.2005.07.172; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; National Cancer Institute National Institutes of Health, COMM TERM CRIT ADV E; Pallis AG, 2010, ANN ONCOL, V21, P692, DOI 10.1093/annonc/mdp360; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Pujol JL, 2006, J THORAC ONCOL, V1, P328; Ramalingam S, 2008, CANCER-AM CANCER SOC, V113, P542, DOI 10.1002/cncr.23583; Repetto L, 2002, J CLIN ONCOL, V20, P494, DOI 10.1200/JCO.20.2.494; Rodin MB, 2007, J CLIN ONCOL, V25, P1936, DOI 10.1200/JCO.2006.10.2954; Sakakibara T, 2010, ANN ONCOL, V21, P795, DOI 10.1093/annonc/mdp401; Scagliotti G, 2010, J CLIN ONCOL, V28, P1835, DOI 10.1200/JCO.2009.26.1321; Shepherd FA, 1997, SEMIN ONCOL S7, V24, pS7; Tsukada H, 2007, J CLIN ONCOL, V25; Yee KWL, 2003, J CLIN ONCOL, V21, P1618, DOI 10.1200/JCO.2003.12.044	42	404	418	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2011	378	9796					1079	1088		10.1016/S0140-6736(11)60780-0	http://dx.doi.org/10.1016/S0140-6736(11)60780-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829BE	21831418				2022-12-28	WOS:000295548900024
J	Togashi, H; Kominami, K; Waseda, M; Komura, H; Miyoshi, J; Takeichi, M; Takai, Y				Togashi, Hideru; Kominami, Kanoko; Waseda, Masazumi; Komura, Hitomi; Miyoshi, Jun; Takeichi, Masatoshi; Takai, Yoshimi			Nectins Establish a Checkerboard-Like Cellular Pattern in the Auditory Epithelium	SCIENCE			English	Article							INTERCELLULAR-JUNCTIONS; SIGNALING PATHWAY; MAMMALIAN COCHLEA; DROSOPHILA EYE; ADHESION; AFADIN; CORTI; MORPHOGENESIS; MOLECULES; PLANAR	In the auditory epithelium of the cochlea, the sensory hair cells and supporting cells are arranged in a checkerboard-like fashion, but the mechanism underlying this cellular patterning is unclear. We found that mouse hair cells and supporting cells express the immunoglobulin-like adhesion molecules nectin-1 and -3, respectively, and that their interaction mediates the heterotypic adhesion between these two cell types. Genetic removal of nectin-1 or -3 disrupted the checkerboard-like pattern, inducing aberrant attachment between hair cells. When cells expressing either nectin-1 or -3 were cocultured, they arranged themselves into a mosaic pattern. Thus, nectin-1 and -3 promote the formation of the checkerboard-like pattern of the auditory epithelia.	[Togashi, Hideru; Kominami, Kanoko; Waseda, Masazumi; Komura, Hitomi; Takai, Yoshimi] Kobe Univ, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Miyoshi, Jun] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka 5378511, Japan; [Takeichi, Masatoshi] RIKEN Ctr Dev Biol, Lab Cell Adhes & Tissue Patterning, Kobe, Hyogo 6500047, Japan	Kobe University; Osaka Medical Center for Cancer & Cardiovascular Diseases; RIKEN	Takai, Y (corresponding author), Kobe Univ, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; Togashi, Hideru/0000-0002-3967-5940; Waseda, Masazumi/0000-0001-7179-5945	Global Center for Education and Research in Integrative Membrane Biology; Ministry of Education, Culture, Sports, Science and Technology in Japan; Japan Society for the Promotion of Science; Japanese Science and Technology Agency	Global Center for Education and Research in Integrative Membrane Biology; Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by the Global Centers of Excellence Program "Global Center for Education and Research in Integrative Membrane Biology" and the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science and Technology in Japan; by Grants-in-Aid from the Japan Society for the Promotion of Science; and by the Core Research for Evolutional Science and Technology from the Japanese Science and Technology Agency.	Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; Bao SJ, 2010, DEV BIOL, V344, P948, DOI 10.1016/j.ydbio.2010.06.013; Chen P, 2002, DEVELOPMENT, V129, P2495; GULLEY RL, 1976, J NEUROCYTOL, V5, P479, DOI 10.1007/BF01181652; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; HONDA H, 1986, J EMBRYOL EXP MORPH, V98, P1; KELLEY MW, 1995, J NEUROSCI, V15, P3013; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; Kopan R, 1997, TRENDS GENET, V13, P465, DOI 10.1016/S0168-9525(97)01318-8; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; McKenzie E, 2004, DEV DYNAM, V229, P802, DOI 10.1002/dvdy.10500; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2003, J NEUROSCI, V23, P9469; Nunes FD, 2006, J CELL SCI, V119, P4819, DOI 10.1242/jcs.03233; Okabe N, 2004, DEV DYNAM, V230, P174, DOI 10.1002/dvdy.20033; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; YAMANAKA H I, 1990, International Journal of Developmental Biology, V34, P377	24	81	85	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1144	1147		10.1126/science.1208467	http://dx.doi.org/10.1126/science.1208467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21798896				2022-12-28	WOS:000294244300048
J	Domecq, JP; Prutsky, G; Montori, VM				Pablo Domecq, Juan; Prutsky, Gabriela; Montori, Victor M.			Review: Oral drugs for type 2 diabetes, alone or in combination, have different relative benefits and harms for surrogate endpoints	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Pablo Domecq, Juan; Prutsky, Gabriela] Univ Peruana Cayetano Heredia, Lima, Peru; [Montori, Victor M.] Mayo Clin, Rochester, MN USA	Universidad Peruana Cayetano Heredia; Mayo Clinic	Domecq, JP (corresponding author), Univ Peruana Cayetano Heredia, Lima, Peru.							Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Montori VM, 2009, ANN INTERN MED, V150, P803, DOI 10.7326/0003-4819-150-11-200906020-00008; Mullan RJ, 2009, ARCH INTERN MED, V169, P1560, DOI 10.1001/archinternmed.2009.293	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4							JC2-4	10.7326/0003-4819-155-4-201108160-02004	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LM	21844537				2022-12-28	WOS:000208885100003
J	Wang, TT; Palese, P				Wang, Taia T.; Palese, Peter			Catching a Moving Target	SCIENCE			English	Editorial Material							NEUTRALIZING EPITOPE; INFLUENZA; ANTIBODIES; INFECTION; GENE; PEPTIDE; BINDING; CELLS; H5N1		[Wang, Taia T.; Palese, Peter] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Wang, TT (corresponding author), Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA.	taia.wang@mssm.edu; peter.palese@mssm.edu		Palese, Peter/0000-0002-0337-5823	PHS HHS [HHSN266200700010C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Chan CH, 2001, BLOOD, V97, P1023, DOI 10.1182/blood.V97.4.1023; Chen GL, 2011, P NATL ACAD SCI USA, V108, P1140, DOI 10.1073/pnas.1009908108; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Hashem AM, 2010, BIOCHEM BIOPH RES CO, V403, P247, DOI 10.1016/j.bbrc.2010.11.030; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kostolansky F, 2002, ACTA VIROL, V46, P229; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; Kunert R, 2004, AIDS RES HUM RETROV, V20, P755, DOI 10.1089/0889222041524571; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Pos W, 2011, J THROMB HAEMOST, V9, P1285, DOI 10.1111/j.1538-7836.2011.04307.x; Sasso EH, 1996, J CLIN INVEST, V97, P2074, DOI 10.1172/JCI118644; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui J, 2011, CLIN INFECT DIS, V52, P1003, DOI 10.1093/cid/cir121; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; ZOUALI M, 1992, IMMUNOL REV, V128, P73, DOI 10.1111/j.1600-065X.1992.tb00833.x	25	19	35	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					834	835		10.1126/science.1210724	http://dx.doi.org/10.1126/science.1210724			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836007				2022-12-28	WOS:000293785400029
J	Alifrangis, C; Evans, R; Williams, J; Seckl, MJ				Alifrangis, C.; Evans, R.; Williams, J.; Seckl, M. J.			PICTURE QUIZ An unusual gum lesion with a positive pregnancy test	BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT; TUMORS		[Alifrangis, C.; Evans, R.; Williams, J.; Seckl, M. J.] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Med Oncol, London W6 8RF, England	Imperial College London	Seckl, MJ (corresponding author), Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Med Oncol, London W6 8RF, England.	m.seckl@imperial.ac.uk						Bower M, 1997, J CLIN ONCOL, V15, P2636, DOI 10.1200/JCO.1997.15.7.2636; Jose Ricardo Jorge, 2010, JRSM Short Rep, V1, P34, DOI 10.1258/shorts.2010.010043; Ngan S, 2007, CURR OPIN ONCOL, V19, P486, DOI 10.1097/CCO.0b013e3282dc94e5; Oladipo A, 2007, BJOG-INT J OBSTET GY, V114, P1298, DOI 10.1111/j.1471-0528.2007.01486.x; Savage P, 2008, J REPROD MED, V53, P774; Sebire NJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1193; Seckl MJ, 2010, LANCET, V376, P717, DOI 10.1016/S0140-6736(10)60280-2; Sun LM, 2002, BRIT J RADIOL, V75, P275, DOI 10.1259/bjr.75.891.750275; Wang J, 2008, ANN ONCOL, V19, P1578, DOI 10.1093/annonc/mdn181	9	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2011	343								d5009	10.1136/bmj.d5009	http://dx.doi.org/10.1136/bmj.d5009			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808DP	21835870				2022-12-28	WOS:000293956900004
J	Warriner, DR				Warriner, David R.			PERSONAL VIEW Patients who discharge themselves need further thought	BRITISH MEDICAL JOURNAL			English	Editorial Material												D.R.Warriner@sheffield.ac.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2011	343								d5054	10.1136/bmj.d5054	http://dx.doi.org/10.1136/bmj.d5054			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808DL	21831946				2022-12-28	WOS:000293956300015
J	Greenberg, ER; Anderson, GL; Morgan, DR; Torres, J; Chey, WD; Bravo, LE; Dominguez, RL; Ferreccio, C; Herrero, R; Lazcano-Ponce, EC; Meza-Montenegro, MM; Pena, R; Pena, EM; Salazar-Martinez, E; Correa, P; Martinez, ME; Valdivieso, M; Goodman, GE; Crowley, JJ; Baker, LH				Greenberg, E. Robert; Anderson, Garnet L.; Morgan, Douglas R.; Torres, Javier; Chey, William D.; Eduardo Bravo, Luis; Dominguez, Ricardo L.; Ferreccio, Catterina; Herrero, Rolando; Lazcano-Ponce, Eduardo C.; Mercedes Meza-Montenegro, Maria; Pena, Rodolfo; Pena, Edgar M.; Salazar-Martinez, Eduardo; Correa, Pelayo; Elena Martinez, Maria; Valdivieso, Manuel; Goodman, Gary E.; Crowley, John J.; Baker, Laurence H.			14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial	LANCET			English	Article							GASTRIC-CANCER; ANTIBIOTIC-RESISTANCE; COST-EFFECTIVENESS; METAANALYSIS; ERADICATION; CLARITHROMYCIN; PREVALENCE; MANAGEMENT; CHILDREN; BURDEN	Background Evidence from Europe, Asia, and North America suggests that standard three-drug regimens of a proton-pump inhibitor plus amoxicillin and clarithromycin are significantly less effective for eradication of Helicobacter pylori infection than are 5-day concomitant and 10-day sequential four-drug regimens that include a nitroimidazole. These four-drug regimens also entail fewer antibiotic doses than do three-drug regimens and thus could be suitable for eradication programmes in low-resource settings. Few studies in Latin America have been done, where the burden of H pylori-associated diseases is high. We therefore did a randomised trial in Latin America comparing the effectiveness of four-drug regimens given concomitantly or sequentially with that of a standard 14-day regimen of triple therapy. Methods Between September, 2009, and June, 2010, we did a randomised trial of empiric 14-day triple, 5-day concomitant, and 10-day sequential therapies for H pylori in seven Latin American sites: Chile, Colombia, Costa Rica, Honduras, Nicaragua, and Mexico (two sites). Participants aged 21-65 years who tested positive for H pylori by a urea breath test were randomly assigned by a central computer using a dynamic balancing procedure to: 14 days of lansoprazole, amoxicillin, and clarithromycin (standard therapy); 5 days of lansoprazole, amoxicillin, clarithromycin, and metronidazole (concomitant therapy); or 5 days of lansoprazole and amoxicillin followed by 5 days of lansoprazole, clarithromycin, and metronidazole (sequential therapy). Eradication was assessed by urea breath test 6-8 weeks after randomisation. The trial was not masked. Our primary outcome was probablity of H pylori eradication. Our analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, registration number NCT01061437. Findings 1463 participants aged 21-65 years were randomly allocated a treatment: 488 were treated with 14-day standard therapy, 489 with 5-day concomitant therapy, and 486 with 10-day sequential therapy. The probability of eradication with standard therapy was 82.2% (401 of 488), which was 8.6% higher (95% adjusted CI 2.6-14.5) than with concomitant therapy (73.6% [360 of 489]) and 5.6% higher (-0.04% to 11.6) than with sequential therapy (76.5% [372 of 486]). Neither four-drug regimen was significantly better than standard triple therapy in any of the seven sites. Interpretation Standard 14-day triple-drug therapy is preferable to 5-day concomitant or 10-day sequential four-drug regimens as empiric therapy for H pylori infection in diverse Latin American populations.	[Greenberg, E. Robert; Anderson, Garnet L.; Crowley, John J.] Canc Res & Biostat, SWOG Stat Ctr, Seattle, WA 98101 USA; [Greenberg, E. Robert; Anderson, Garnet L.; Goodman, Gary E.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Morgan, Douglas R.] Univ N Carolina, Div Gastroenterol, Chapel Hill, NC USA; [Torres, Javier] Inst Mexicano Seguro Social, Unidad Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Chey, William D.] Univ Michigan, Sch Med, Div Gastroenterol, Ann Arbor, MI USA; [Eduardo Bravo, Luis] Univ Valle, Dept Patol, Cali, Colombia; [Dominguez, Ricardo L.] Hosp Reg Occidente, Santa Rosa De Copan, Honduras; [Ferreccio, Catterina] Pontificia Univ Catolica Chile, Dept Salud Publ, Santiago, Chile; [Herrero, Rolando] Fdn INCIENSA, San Jose, Costa Rica; [Herrero, Rolando] World Hlth Org, Screening & Prevent Grp, Int Agcy Res Canc, Lyon, France; [Lazcano-Ponce, Eduardo C.; Elena Martinez, Maria] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Mercedes Meza-Montenegro, Maria] Inst Tecnol Sonora, Obregon, Mexico; [Pena, Rodolfo; Pena, Edgar M.] Ctr Invest Demog & Salud, Leon, Nicaragua; [Correa, Pelayo] Vanderbilt Univ Sch Med, Div Gastroenterol, Nashville, TN USA; [Elena Martinez, Maria] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Valdivieso, Manuel; Baker, Laurence H.] Univ Michigan, Sch Med, Div Hematol Oncol, Ann Arbor, MI USA; [Goodman, Gary E.] Swedish Canc Inst, Seattle, WA USA	Cancer Research & Biostatistics; Southwest Oncology Group; Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; Instituto Mexicano del Seguro Social; University of Michigan System; University of Michigan; Universidad del Valle; Pontificia Universidad Catolica de Chile; World Health Organization; International Agency for Research on Cancer (IARC); Instituto Nacional de Salud Publica; Vanderbilt University; University of Arizona; University of Michigan System; University of Michigan; Swedish Cancer Institute; Swedish Medical Center	Greenberg, ER (corresponding author), Canc Res & Biostat, SWOG Stat Ctr, 1730 Minor Ave,Suite 1900, Seattle, WA 98101 USA.	e.r.greenberg@dartmouth.edu	Chey, William/AAY-7766-2021; Bravo, Luis/K-9882-2014; Bravo, Luis Eduardo/AAB-7209-2019; Bravo, Luis Eduardo/G-9671-2013	Bravo, Luis/0000-0002-9708-0312; Bravo, Luis Eduardo/0000-0002-9708-0312; Meza-Montenegro, Maria Mercedes/0000-0002-1199-9310; ferreccio, catterina/0000-0001-6331-5534; Pena-Galo, Edgar/0000-0003-2858-3079	Bill & Melinda Gates Foundation; US National Institutes of Health; Axcan; AstraZeneca; National Institutes of Health [CA037429]; NATIONAL CANCER INSTITUTE [U10CA037429, P01CA028842] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Axcan; AstraZeneca(AstraZeneca); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding Bill & Melinda Gates Foundation, US National Institutes of Health.; DRM has submitted a patent application through the University of North Carolina for a technique using molecular endoscopy to detect cancer in the gastrointestinal tract, and has received fund; The Bill & Melinda Gates Foundation provided financial support for the trial, and the National Institutes of Health (Grant number CA037429) supported the SWOG administrative and statistical infrastructure. We thank the trial participants for making this study possible and recognise the many contributions of the investigative team members: SWOG Statistical Center, Seattle, WA, USA-Vanessa Bolejack, Susie Carlin, Dacia Christin, Evonne Lackey, and Rachael Sexton; Division of Gastroenterology, University of North Carolina, Chapel Hill, CA, USA Paris Heidt; Universidad del Valle, Cali, Colombia-Luz Stella Garcia, Yolanda Mora: Hospital Regional de Occidente, Santa Rosa de Copan, Honduras Jean Paul Higuero, Glenda Jeanette Euceda Wood, Lesby Maritza Castellanos; Pontificia Universidad Catolica de Chile, Santiago, Chile-Maria Paz Cook, Paul Harris, Antonio Rollin; Fundacion INCIENSA. San Jose, Costa Rica-Silvia Jimenez, Paula Gonzalez, Ana Cecilia Rodriguez, Lidiana Morera, Blanca Cruz Reyes; Instituto Nacional de Salad Publica, Cuernavaca, Mexico-Rogelio Danis, Erika Marlen Hurtado Salgado, Maria del Pilar Hernandez Nevares; Instituto Tecnologico de Sonora, Ciudad Obregon, Mexico-Myriam Bringas, Araceli Molina, Claudia Osorio, Maria de Jesus Lopez Valenzuela; Centro de Investigacion en Dernografia y Salad, Leon, Nicaragua-Yesenia Zapata; and also Charles A Coltman, David S Alberts, and Jesse Nodora for their help during the course of the study.ing from Axcan for his participation in a speakers' bureau; he has also received a research grant from AstraZeneca, for a proton-pump inhibitor study in Hispanic populations in the USA, and from Given Imaging, for ongoing efficacy studies of colon endocapsule efficacy. All other authors declare that they have no conflicts of interest.	Alvarez A, 2009, ANTIMICROB AGENTS CH, V53, P4022, DOI 10.1128/AAC.00145-09; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Coelho LGV, 2000, AM J GASTROENTEROL, V95, P2688, DOI 10.1111/j.1572-0241.2000.03174.x; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Essa AS, 2009, HELICOBACTER, V14, P109, DOI 10.1111/j.1523-5378.2009.00671.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fischbach L, 2007, ALIMENT PHARM THER, V26, P343, DOI 10.1111/j.1365-2036.2007.03386.x; Ford AC, 2005, GASTROENTEROLOGY, V129, P1910, DOI 10.1053/j.gastro.2005.09.016; Fuccio L, 2007, ANN INTERN MED, V147, P553, DOI 10.7326/0003-4819-147-8-200710160-00008; Fuccio L, 2009, ANN INTERN MED, V151, P121, DOI 10.7326/0003-4819-151-2-200907210-00009; Gatta L, 2009, AM J GASTROENTEROL, V104, P3069, DOI 10.1038/ajg.2009.555; Graham DY, 2008, NAT CLIN PRACT GASTR, V5, P321, DOI 10.1038/ncpgasthep1138; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Graham DY, 2005, GUT, V54, P735, DOI 10.1136/gut.2004.056549; IARC, 1994, IARC MON EV CARC RIS, V61, P177; Jafri NS, 2008, ANN INTERN MED, V148, P923, DOI 10.7326/0003-4819-148-12-200806170-00226; Lochhead P, 2008, BRIT MED BULL, V85, P87, DOI 10.1093/bmb/ldn007; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2010, CURR OPIN GASTROEN, V26, P618, DOI 10.1097/MOG.0b013e32833efede; Marugame T, 2007, JPN J CLIN ONCOL, V37, P242, DOI 10.1093/jjco/hym014; Mason J, 2002, ALIMENT PHARM THER, V16, P559, DOI 10.1046/j.1365-2036.2002.01204.x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Megraud F, 2004, GUT, V53, P1374, DOI 10.1136/gut.2003.022111; Morgan DR, 2010, GASTROENTEROLOGY, V138, pS386; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Parsonnet J, 2004, JAMA-J AM MED ASSOC, V291, P244, DOI 10.1001/jama.291.2.244; Parsonnet J, 1996, LANCET, V348, P150, DOI 10.1016/S0140-6736(96)01501-2; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Torres J, 2001, J CLIN MICROBIOL, V39, P2677, DOI 10.1128/JCM.39.7.2677-2680.2001; Vallejos C, 2007, REV MED CHILE, V135, P287; *WHO, WORLD HLTH REP 2003; Wu DC, 2010, CLIN GASTROENTEROL H, V8, P36, DOI 10.1016/j.cgh.2009.09.030; Zullo A, 2007, GUT, V56, P1353, DOI 10.1136/gut.2007.125658	34	186	203	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 6	2011	378	9790					507	514		10.1016/S0140-6736(11)60825-8	http://dx.doi.org/10.1016/S0140-6736(11)60825-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809SO	21777974	Green Accepted, Green Submitted			2022-12-28	WOS:000294077200030
J	van Durme, CMPG; Kisters, JMH; van Paassen, P; van Etten, RW; Tervaert, JWC				van Durme, Caroline M. P. G.; Kisters, Jerome M. H.; van Paassen, Pieter; van Etten, Ronald W.; Tervaert, Jan Willem Cohen			Multiple endocrine abnormalities	LANCET			English	Editorial Material							WEGENERS-GRANULOMATOSIS		[van Durme, Caroline M. P. G.; Kisters, Jerome M. H.; van Paassen, Pieter; Tervaert, Jan Willem Cohen] Maastricht Univ, Med Ctr, Dept Internal Med, NL-6229 HX Maastricht, Netherlands; [van Etten, Ronald W.] Amphia Hosp, Dept Internal Med, Breda, Netherlands	Maastricht University; Amphia Hospital	van Durme, CMPG (corresponding author), Maastricht Univ, Med Ctr, Dept Internal Med, P Debyelaan 25, NL-6229 HX Maastricht, Netherlands.	carolinevd@gmail.com	tervaert, jan willem cohen/AAB-1111-2019					Bosch X, 1997, MAYO CLIN PROC, V72, P440, DOI 10.4065/72.5.440; BOUDES P, 1990, SEMIN ARTHRITIS RHEU, V19, P365, DOI 10.1016/0049-0172(90)90073-O; Schuerwegh AJ, 2007, CLIN RHEUMATOL, V26, P454, DOI 10.1007/s10067-005-0165-2; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; YOUNG TY, 2008, PITUITARY, V11, P1177	5	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 6	2011	378	9790					540	540		10.1016/S0140-6736(11)60831-3	http://dx.doi.org/10.1016/S0140-6736(11)60831-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809SO	21821186				2022-12-28	WOS:000294077200034
J	Beaufort, L; Probert, I; de Garidel-Thoron, T; Bendif, EM; Ruiz-Pino, D; Metzl, N; Goyet, C; Buchet, N; Coupel, P; Grelaud, M; Rost, B; Rickaby, REM; de Vargas, C				Beaufort, L.; Probert, I.; de Garidel-Thoron, T.; Bendif, E. M.; Ruiz-Pino, D.; Metzl, N.; Goyet, C.; Buchet, N.; Coupel, P.; Grelaud, M.; Rost, B.; Rickaby, R. E. M.; de Vargas, C.			Sensitivity of coccolithophores to carbonate chemistry and ocean acidification	NATURE			English	Article							EMILIANIA-HUXLEYI PRYMNESIOPHYCEAE; ATMOSPHERIC CO2; REDUCED CALCIFICATION; CALCIUM-CARBONATE; SEA; PHOTOSYNTHESIS; PCO(2); LIGHT	About one-third of the carbon dioxide (CO(2)) released into the atmosphere as a result of human activity has been absorbed by the oceans(1), where it partitions into the constituent ions of carbonic acid. This leads to ocean acidification, one of the major threats to marine ecosystems(2) and particularly to calcifying organisms such as corals(3,4), foraminifera(5-7) and coccolithophores(8). Coccolithophores are abundant phytoplankton that are responsible for a large part of modern oceanic carbonate production. Culture experiments investigating the physiological response of coccolithophore calcification to increased CO(2) have yielded contradictory results between and even within species(8-11). Here we quantified the calcite mass of dominant coccolithophores in the present ocean and over the past forty thousand years, and found a marked pattern of decreasing calcification with increasing partial pressure of CO(2) and concomitant decreasing concentrations of CO(3)(2-). Our analyses revealed that differentially calcified species and morphotypes are distributed in the ocean according to carbonate chemistry. A substantial impact on the marine carbon cycle might be expected upon extrapolation of this correlation to predicted ocean acidification in the future. However, our discovery of a heavily calcified Emiliania huxleyi morphotype in modern waters with low pH highlights the complexity of assemblage-level responses to environmental forcing factors.	[Beaufort, L.; de Garidel-Thoron, T.; Buchet, N.; Grelaud, M.] Univ Aix Marseille, CNRS, CEREGE, F-13545 Aix En Provence 4, France; [Probert, I.; Bendif, E. M.; de Vargas, C.] Univ Paris 06, Stn Biol Roscoff, CNRS, F-29680 Roscoff, France; [Ruiz-Pino, D.; Metzl, N.; Coupel, P.] Univ Paris 06, LOCEAN IPSL, CNRS, F-75252 Paris 5, France; [Goyet, C.] Univ Perpignan, F-66860 Perpignan 9, France; [Rost, B.] Alfred Wegener Inst, D-27570 Bremerhaven, Germany; [Rickaby, R. E. M.] Univ Oxford, Dept Earth Sci, Oxford OX1 30R, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Perpignan Via Domitia; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Oxford	Beaufort, L (corresponding author), Univ Aix Marseille, CNRS, CEREGE, Ave L Philibert,BP80, F-13545 Aix En Provence 4, France.	beaufort@cerege.fr	Rost, Bjoern/B-4447-2015; Beaufort, Luc/ABG-2289-2021; Probert, Ian/M-9807-2019; de Garidel-Thoron, Thibault/B-1204-2008; Beaufort, Luc/AAH-5305-2021	Rost, Bjoern/0000-0001-5452-5505; Beaufort, Luc/0000-0001-6055-9373; de Garidel-Thoron, Thibault/0000-0001-8983-9571; metzl, nicolas/0000-0002-1165-1074; Rickaby, Rosalind/0000-0002-6095-8419; Grelaud, Michael/0000-0001-8649-9743	INSU (Institut National des Sciences de l'Univers); IPSL (Institut Pierre-Simon Laplace); IPEV (Institut Paul-Emile Victor); Agence National de la Recherche [ANR-06-JCJC-0142]; European Research Council [205150]; European Funding Agencies from the ERA-net program Biodiversa; Biomarks project; European Community [211384]	INSU (Institut National des Sciences de l'Univers); IPSL (Institut Pierre-Simon Laplace); IPEV (Institut Paul-Emile Victor); Agence National de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); European Funding Agencies from the ERA-net program Biodiversa; Biomarks project; European Community(European Commission)	We thank the crew from Puerto Deseado, Atalante, Suroit and Marion-Dufresne, and D. Vaulot, L. Garczarek, M.-A. Sicre and H. Claustre for their help in collecting material for this work. The long-term OISO observational programme is supported by INSU (Institut National des Sciences de l'Univers), IPSL (Institut Pierre-Simon Laplace) and IPEV (Institut Paul-Emile Victor). We thank F. C. Bassinot for help in estimating palaeosalinities. The IMAGES programme is acknowledged for collection and curation of the cores. This work was funded by the 'Agence National de la Recherche' project PALEO-CTD (grant ANR-06-JCJC-0142), by the European Research Council under grant agreement 205150, by the European Funding Agencies from the ERA-net program Biodiversa, under the Biomarks project, and by the European Community's Seventh Framework Program EPOCA (European Project on Ocean Acidification) under grant agreement 211384.	Anderson DM, 2002, NATURE, V416, P70, DOI 10.1038/416070a; Barker S, 2002, SCIENCE, V297, P833, DOI 10.1126/science.1072815; Berry L, 2002, FUNCT PLANT BIOL, V29, P289, DOI 10.1071/PP01218; Bollmann J, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000742; Bollmann J, 2007, EARTH PLANET SC LETT, V255, P273, DOI 10.1016/j.epsl.2006.12.029; Buitenhuis ET, 1999, J PHYCOL, V35, P949, DOI 10.1046/j.1529-8817.1999.3550949.x; Colmenero-Hidalgo E, 2002, MAR MICROPALEONTOL, V46, P247, DOI 10.1016/S0377-8398(02)00065-8; de Moel H, 2009, BIOGEOSCIENCES, V6, P1917, DOI 10.5194/bg-6-1917-2009; De Vargas Colomban, 2007, P251, DOI 10.1016/B978-012370518-1/50013-8; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feng Y, 2008, EUR J PHYCOL, V43, P87, DOI 10.1080/09670260701664674; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gibbs SJ, 2006, SCIENCE, V314, P1770, DOI 10.1126/science.1133902; HAGINO K, J PHYCOL IN PRESS, P97654; Honisch B, 2005, EARTH PLANET SC LETT, V236, P305, DOI 10.1016/j.epsl.2005.04.027; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Langer G., 2009, BIOGEOSCI DISCUSS, V6, P4361, DOI DOI 10.5194/BGD-6-4361-2009; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Lewis E., 1998, ORNLCDIAC105; Mackinder L, 2010, GEOMICROBIOL J, V27, P585, DOI 10.1080/01490451003703014; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Moy AD, 2009, NAT GEOSCI, V2, P276, DOI 10.1038/NGEO460; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Young J.R., 2003, J NANNOPLANKTON RES, V1, P1; Zondervan I, 2002, J EXP MAR BIOL ECOL, V272, P55, DOI 10.1016/S0022-0981(02)00037-0; Zondervan I, 2007, DEEP-SEA RES PT II, V54, P521, DOI 10.1016/j.dsr2.2006.12.004	30	318	338	13	413	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					80	83		10.1038/nature10295	http://dx.doi.org/10.1038/nature10295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21814280				2022-12-28	WOS:000293447300033
J	Cormican, M; Murphy, AW; Vellinga, A				Cormican, Martin; Murphy, Andrew W.; Vellinga, Akke			RATIONAL TESTING Interpreting asymptomatic bacteriuria	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							URINARY-TRACT-INFECTION; MANAGEMENT		[Cormican, Martin] NUI Galway, Antimicrobial Resistance & Microbial Ecol Lab, Sch Med, Inst Clin Sci, Galway, Ireland; [Cormican, Martin] NUI Galway, Ctr Hlth Environm, Ryan Inst, Galway, Ireland; [Murphy, Andrew W.; Vellinga, Akke] NUI Galway, Discipline Gen Practice, Sch Med, Inst Clin Sci, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Cormican, M (corresponding author), NUI Galway, Antimicrobial Resistance & Microbial Ecol Lab, Sch Med, Inst Clin Sci, Newcastle Rd, Galway, Ireland.	martin.cormican@hse.ie	Cormican, Martin/T-8323-2019; Vellinga, Akke/H-2130-2011	Cormican, Martin/0000-0002-8023-1882; Vellinga, Akke/0000-0002-6583-4300; Murphy, Andrew/0000-0001-5549-8246				Al-Hasan MN, 2010, J INFECTION, V60, P278, DOI 10.1016/j.jinf.2010.01.007; BAERHEIM A, 1990, Scandinavian Journal of Primary Health Care, V8, P207, DOI 10.3109/02813439008994960; Bent S, 2002, JAMA-J AM MED ASSOC, V287, P2701, DOI 10.1001/jama.287.20.2701; Costelloe C, 2010, BMJ-BRIT MED J, V340, P1; Ducharme James, 2007, CJEM, V9, P87; Fry AC, 2006, POSTGRAD MED J, V82, P106, DOI 10.1136/pgmj.2005.038588; Giesen LGM, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-78; Grabe M, 2010, GUIDELINE UROLOGICAL; John AS, 2006, AM J CLIN PATHOL, V126, P428, DOI DOI 10.1309/C69RW1BT7E4QAFPV; Lifshitz E, 2000, ARCH INTERN MED, V160, P2537, DOI 10.1001/archinte.160.16.2537; Little P, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13190; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V62; National Institute for Health and Clinical Excellence, 2007, CLIN GUID NAT I HLTH; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; NielWeise BS, 2009, URINARY CATHETER POL; Patrick DM, 2009, CAN MED ASSOC J, V180, P416, DOI 10.1503/cmaj.080626; Renko M, 2011, DIABETES CARE, V34, P230, DOI 10.2337/dc10-0421; Rodhe N, 2008, SCAND J INFECT DIS, V40, P804, DOI 10.1080/00365540802195242; Rodhe N, 2008, SCAND J PRIM HEALTH, V26, P35, DOI 10.1080/02813430701878250; SAVAGE DCL, 1973, ARCH DIS CHILD, V48, P8, DOI 10.1136/adc.48.1.8; Smaill FM, 2009, ANTIBIOTICS ASYMPTOM; Tenke P, 2008, INT J ANTIMICROB AG, V31, pS68, DOI 10.1016/j.ijantimicag.2007.07.033; Trautner BW, 2010, CURR OPIN INFECT DIS, V23, P76, DOI 10.1097/QCO.0b013e328334dda8; Whiting P, 2006, HEALTH TECHNOL ASSES, V10, P1; WHITING P, 2006, HEALTH TECHNOL ASSES, V10, pR11; WHITING P, 2006, HEALTH TECHNOL ASSES, V10, pR3	26	16	16	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2011	343								d4780	10.1136/bmj.d4780	http://dx.doi.org/10.1136/bmj.d4780			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NO	21816734	Green Submitted			2022-12-28	WOS:000293734800004
J	Seely, EW; Ecker, J				Seely, Ellen W.; Ecker, Jeffrey			Chronic Hypertension in Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; DEVELOPMENTAL TOXICITY; ALDOSTERONE SYSTEM; WOMEN; PREECLAMPSIA; MANAGEMENT; DISORDERS; PRESSURE; OUTCOMES; GROWTH	A 35-year-old woman who has never been pregnant and who has a 5-year history of hypertension wants to become pregnant. She has stopped using contraception. Her only medication is lisinopril at a dose of 10 mg per day. Her blood pressure is 124/68 mm Hg, and her body-mass index (the weight in kilograms divided by the square of the height in meters) is 27. What would you advise?	[Seely, Ellen W.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Seely, Ellen W.; Ecker, Jeffrey] Harvard Univ, Sch Med, Boston, MA USA; [Ecker, Jeffrey] Massachusetts Gen Hosp, Div Maternal Fetal Med, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Seely, EW (corresponding author), Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA.	eseely@partners.org			Bayer Healthcare	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals)	Dr. Seely reports receiving an investigator-initiated grant from Bayer Healthcare for a study involving postmenopausal women. No other potential conflict of interest relevant to this article was reported.	Abalos E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; Aleksandrov NA, 2008, J OBSTET GYNAECOL CA, V30, P1000, DOI 10.1016/S1701-2163(16)32992-9; American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V106, P671; Ananth CV, 2007, AM J OBSTET GYNECOL, V197, p273el; [Anonymous], 2001, OBSTET GYNECOL, V98, P177; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; AUGUST P, 1990, AM J OBSTET GYNECOL, V163, P1612, DOI 10.1016/0002-9378(90)90639-O; BARR M, 1994, TERATOLOGY, V50, P399, DOI 10.1002/tera.1420500606; Beardmore KS, 2002, HYPERTENS PREGNANCY, V21, P85, DOI 10.1081/PRG-120002912; Bodnar LM, 2005, ANN EPIDEMIOL, V15, P475, DOI 10.1016/j.annepidem.2004.12.008; BRENT RL, 1991, TERATOLOGY, V43, P543, DOI 10.1002/tera.1420430602; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P139, DOI 10.1111/j.1479-828X.2000.tb01137.x; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Catov JM, 2008, OBSTET GYNECOL, V112, P290, DOI 10.1097/AOG.0b013e31817f589b; Chappell LC, 2008, HYPERTENSION, V51, P1002, DOI 10.1161/HYPERTENSIONAHA.107.107565; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COCKBURN J, 1982, LANCET, V1, P647; COLLINS R, 1985, BMJ-BRIT MED J, V290, P17, DOI 10.1136/bmj.290.6461.17; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Gersak K, 2009, REPROD TOXICOL, V28, P109, DOI 10.1016/j.reprotox.2009.02.004; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hofmeyr GJ, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001059.pub2, 10.1002/14651858.CD001059.pub4, 10.1002/14651858.CD001059.pub5]; Levine RJ, 1997, NEW ENGL J MED, V337, P69, DOI 10.1056/NEJM199707103370201; Magee LA, 2011, BR J CLIN PHARM 0504; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; McCowan LME, 1996, BRIT J OBSTET GYNAEC, V103, P123, DOI 10.1111/j.1471-0528.1996.tb09662.x; National Library of Medicine Toxicology Data Network, DRUGS LACT DAT; Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8; Rey E, 1997, CAN MED ASSOC J, V157, P1245; REY E, 1994, AM J OBSTET GYNECOL, V171, P410, DOI 10.1016/0002-9378(94)90276-3; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; Serreau R, 2005, BJOG-INT J OBSTET GY, V112, P710, DOI 10.1111/j.1471-0528.2004.00525.x; Sherman DJ, 1998, OBSTET GYNECOL, V91, P212, DOI 10.1016/S0029-7844(97)00654-6; Sibai BM, 1998, NEW ENGL J MED, V339, P667, DOI 10.1056/NEJM199809033391004; Sibai BM, 2002, OBSTET GYNECOL, V100, P369, DOI 10.1016/S0029-7844(02)02128-2; Tabacova S, 2003, BIRTH DEFECTS RES A, V67, P181, DOI 10.1002/bdra.10011; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0; WILSON M, 1980, AM J MED, V68, P97, DOI 10.1016/0002-9343(80)90178-3; Woolcock J, 2008, AUST NZ J OBSTET GYN, V48, P64, DOI 10.1111/j.1479-828X.2007.00804.x	41	77	81	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					439	446		10.1056/NEJMcp0804872	http://dx.doi.org/10.1056/NEJMcp0804872			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801NW	21812673				2022-12-28	WOS:000293447800008
J	Kuhl, PK				Kuhl, Patricia K.			Who's Talking?	SCIENCE			English	Editorial Material							SOCIAL-INTERACTION; SPEECH; LANGUAGE		Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kuhl, PK (corresponding author), Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA.	pkkuhl@u.washington.edu			NICHD NIH HHS [HD37954, HD55782, HD02274] Funding Source: Medline; NIDCD NIH HHS [DC04661] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037954, P50HD055782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004661] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		[Anonymous], 2003, OVERCOMING DYSLEXIA; Brooks R, 2008, J CHILD LANG, V35, P207, DOI 10.1017/S030500090700829X; Gabrieli JDE, 2009, SCIENCE, V325, P280, DOI 10.1126/science.1171999; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Imada T, 2006, NEUROREPORT, V17, P957, DOI 10.1097/01.wnr.0000223387.51704.89; Johnson EK, 2011, DEVELOPMENTAL SCI, V14, P1002, DOI 10.1111/j.1467-7687.2011.01052.x; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Kuhl PK, 2010, NEURON, V67, P713, DOI 10.1016/j.neuron.2010.08.038; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Perrachione TK, 2011, SCIENCE, V333, P595, DOI 10.1126/science.1207327; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; SUNDARA M, 2006, J ACOUST SOC AM, V120, P3135	14	9	10	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					529	530		10.1126/science.1210277	http://dx.doi.org/10.1126/science.1210277			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	798PI	21798918				2022-12-28	WOS:000293222400028
J	Barth, WH; Kwolek, CJ; Abrams, JL; Ecker, JL; Roberts, DJ				Barth, William H., Jr.; Kwolek, Christopher J.; Abrams, Joshua L.; Ecker, Jeffrey L.; Roberts, Drucilla J.			Case 23-2011: A 40-Year-Old Pregnant Woman with Placenta Accreta Who Declined Blood Products	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Barth, William H., Jr.; Ecker, Jeffrey L.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA; [Kwolek, Christopher J.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Abrams, Joshua L.] Massachusetts Gen Hosp, Off Gen Counsel, Boston, MA 02114 USA; [Roberts, Drucilla J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Barth, William H., Jr.; Ecker, Jeffrey L.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Kwolek, Christopher J.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Roberts, Drucilla J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Barth, WH (corresponding author), Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA.		Roberts, Drucilla/AAB-6379-2022					Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Gyamfi C, 2003, OBSTET GYNECOL, V102, P173, DOI 10.1016/S0029-7844(03)00236-9; Rebarber A, 1998, AM J OBSTET GYNECOL, V179, P715, DOI 10.1016/S0002-9378(98)70070-5; Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84; Tan CH, 2007, AM J ROENTGENOL, V189, P1158, DOI 10.2214/AJR.07.2417; Tantbirojn P, 2008, PLACENTA, V29, P639, DOI 10.1016/j.placenta.2008.04.008; Warshak CR, 2006, OBSTET GYNECOL, V108, P573, DOI 10.1097/01.AOG.0000233155.62906.6d; 1991, MASSACHUSETTS L 0624	8	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					359	366		10.1056/NEJMcpc1103561	http://dx.doi.org/10.1056/NEJMcpc1103561			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21793748				2022-12-28	WOS:000293172200016
J	Heathcote, E				Heathcote, Edwin			OLDER PEOPLE Old age and the city	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Heathcote, E (corresponding author), Financial Times, London, England.	edwinheathcote@hotmail.com							0	2	2	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 25	2011	343								d4418	10.1136/bmj.d4418	http://dx.doi.org/10.1136/bmj.d4418			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801LM	21788259				2022-12-28	WOS:000293440400004
J	Baum, J; Cowman, AF				Baum, Jake; Cowman, Alan F.			Revealing a Parasite's Invasive Trick	SCIENCE			English	Editorial Material							MOVING JUNCTION; MEMBRANE-PROTEINS; HOST-CELL; ERYTHROCYTE; COMPLEX; ENTRY		[Baum, Jake] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic 3052, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne	Baum, J (corresponding author), Univ Melbourne, Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic 3052, Australia.	cowman@wehi.edu.au	Cowman, Alan F/C-7642-2013	Cowman, Alan F/0000-0001-5145-9004; Baum, Jake/0000-0002-0275-352X				AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Harris KS, 2005, INFECT IMMUN, V73, P6981, DOI 10.1128/IAI.73.10.6981-6989.2005; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Mordue DG, 1999, J EXP MED, V190, P1783, DOI 10.1084/jem.190.12.1783; Murphy SC, 2004, BLOOD, V103, P1920, DOI 10.1182/blood-2003-09-3165; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Straub KW, 2009, CELL MICROBIOL, V11, P590, DOI 10.1111/j.1462-5822.2008.01276.x; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282	16	10	10	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					410	411		10.1126/science.1209875	http://dx.doi.org/10.1126/science.1209875			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	795FR	21778386				2022-12-28	WOS:000292959600029
J	Sukhdeo, K; Hambardzumyan, D; Rich, JN				Sukhdeo, Kumar; Hambardzumyan, Dolores; Rich, Jeremy N.			Glioma Development: Where Did It All Go Wrong?	CELL			English	Editorial Material							CELLS; P53; ASTROCYTOMA; ORIGIN; BRAIN	Investigating the family tree of a tumor to identify its cellular origins is a daunting task. Liu et al. (2011) now use an elegant lineage tracing technique (MADM) to visualize glioma from its earliest stages. They show that mutations originally induced in neural stem cells lie dormant and only trigger malignant transformation following differentiation into oligodendrocyte precursor cells.	[Sukhdeo, Kumar; Hambardzumyan, Dolores; Rich, Jeremy N.] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Rich, JN (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA.	richj@ccf.org	Messier, Claude/A-2322-2008; Rich, Jeremy/AAM-1445-2021	Messier, Claude/0000-0002-4791-1763; Sukhdeo, Kumar/0000-0001-8725-6081				Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	11	16	17	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 22	2011	146	2					187	188		10.1016/j.cell.2011.06.047	http://dx.doi.org/10.1016/j.cell.2011.06.047			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784240	Bronze			2022-12-28	WOS:000293013000001
J	Xiao, CL; Xu, X; Liu, S; Wang, T; Dong, WR; Yang, TG; Sun, ZG; Dai, DX; Xu, X; Zhang, DH; Yang, XM				Xiao, Chunlei; Xu, Xin; Liu, Shu; Wang, Tao; Dong, Wenrui; Yang, Tiangang; Sun, Zhigang; Dai, Dongxu; Xu, Xin; Zhang, Dong H.; Yang, Xueming			Experimental and Theoretical Differential Cross Sections for a Four-Atom Reaction: HD+OH -> H2O+D	SCIENCE			English	Article							HYDROGEN-EXCHANGE REACTION; CHEMICAL-REACTIONS; SCATTERING CALCULATIONS; QUANTUM SCATTERING; REACTION DYNAMICS; 6 DIMENSIONS; CHEMISTRY; RESONANCES	Quantum dynamical theories have progressed to the stage in which state-to-state differential cross sections can now be routinely computed with high accuracy for three-atom systems since the first such calculation was carried out more than 30 years ago for the H + H-2 system. For reactions beyond three atoms, however, highly accurate quantum dynamical calculations of differential cross sections have not been feasible. We have recently developed a quantum wave packet method to compute full-dimensional differential cross sections for four-atom reactions. Here, we report benchmark calculations carried out for the prototypical HD + OH -> H2O + D reaction on an accurate potential energy surface that yield differential cross sections in excellent agreement with those from a high-resolution, crossed-molecular beam experiment.	[Xiao, Chunlei; Xu, Xin; Liu, Shu; Wang, Tao; Dong, Wenrui; Yang, Tiangang; Sun, Zhigang; Dai, Dongxu; Zhang, Dong H.; Yang, Xueming] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Liaoning, Peoples R China; [Xu, Xin] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China; [Yang, Tiangang] Dalian Univ Technol, Sch Phys & Optoelect Engn, Dalian 116024, Liaoning, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Fudan University; Dalian University of Technology	Zhang, DH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Liaoning, Peoples R China.	zhangdh@dicp.ac.cn; xmyang@dicp.ac.cn	Yang, Xueming/C-8764-2013; Yang, Tiangang/C-8788-2013; Yang, Tiangang/A-3962-2015; xiao, chunlei/D-1019-2014; Sun, Zhigang/B-5757-2011	Yang, Tiangang/0000-0002-8940-8875; xiao, chunlei/0000-0002-1549-5945; Xu, Xin/0000-0002-5247-2937	Chinese Academy of Sciences; National Natural Science Foundation of China; Ministry of Science and Technology	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Chinese Academy of Sciences, the National Natural Science Foundation of China, and the Ministry of Science and Technology.	Alagia M, 1996, CHEM PHYS, V207, P389, DOI 10.1016/0301-0104(95)00422-X; Althorpe SC, 2003, ANNU REV PHYS CHEM, V54, P493, DOI 10.1146/annurev.physchem.54.011002.103750; Althorpe SC, 2002, NATURE, V416, P67, DOI 10.1038/416067a; BOWMAN JM, 1995, ANNU REV PHYS CHEM, V46, P169, DOI 10.1146/annurev.pc.46.100195.001125; BRONIKOWSKI MJ, 1991, J CHEM PHYS, V95, P8647, DOI 10.1063/1.461243; Clary DC, 2008, SCIENCE, V321, P789, DOI 10.1126/science.1157718; CLARY DC, 1994, J PHYS CHEM-US, V98, P10678, DOI 10.1021/j100093a004; Crim FF, 1999, ACCOUNTS CHEM RES, V32, P877, DOI 10.1021/ar950046a; Cvitas MT, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3525541; Dong WR, 2010, SCIENCE, V327, P1501, DOI 10.1126/science.1185694; Harich SA, 2002, NATURE, V419, P281, DOI 10.1038/nature01068; Millar T. J., 1988, RATE COEFFICIENTS AT; Pogrebnya SK, 2000, PHYS CHEM CHEM PHYS, V2, P693, DOI 10.1039/a908080e; Qiu MH, 2006, SCIENCE, V311, P1440, DOI 10.1126/science.1123452; SCHATZ GC, 1988, ANNU REV PHYS CHEM, V39, P317, DOI 10.1146/annurev.physchem.39.1.317; SCHATZ GC, 1976, J CHEM PHYS, V65, P4668, DOI 10.1063/1.432919; SCHATZ GC, 1980, CHEM PHYS LETT, V73, P21, DOI 10.1016/0009-2614(80)85193-1; Schnieder L, 1997, J CHEM PHYS, V107, P6175, DOI 10.1063/1.474283; SINHA A, 1990, J CHEM PHYS, V92, P6333, DOI 10.1063/1.458312; Strazisar BR, 2000, SCIENCE, V290, P958, DOI 10.1126/science.290.5493.958; Sun ZG, 2010, P NATL ACAD SCI USA, V107, P555, DOI 10.1073/pnas.0911356107; Wang XG, 2008, SCIENCE, V322, P573, DOI 10.1126/science.1163195; Warnatz J., 1984, COMBUSTION CHEM; Zare RN, 1998, SCIENCE, V279, P1875, DOI 10.1126/science.279.5358.1875; Zhang DH, 2000, SCIENCE, V290, P961, DOI 10.1126/science.290.5493.961; Zhang DH, 1996, J CHEM PHYS, V105, P1291, DOI 10.1063/1.471994; Zhang DH, 1996, J CHEM PHYS, V104, P4544, DOI 10.1063/1.471203; ZHANG DH, 1994, J CHEM PHYS, V101, P1146, DOI 10.1063/1.467808; Zhang DH, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2217439; Zhu W, 1996, J CHEM PHYS, V105, P4881, DOI 10.1063/1.472324	30	145	147	9	278	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					440	442		10.1126/science.1205770	http://dx.doi.org/10.1126/science.1205770			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778397				2022-12-28	WOS:000292959600041
J	Hillhouse, E; Al Kuwari, H; Sheikh, J				Hillhouse, Edward; Al Kuwari, Hanan; Sheikh, Javaid			Establishment of a model academic health system in Qatar	LANCET			English	Editorial Material									[Hillhouse, Edward; Al Kuwari, Hanan] Hamad Med Corp, Doha, Qatar; [Sheikh, Javaid] Weill Cornell Med Coll, Doha, Qatar	Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Hillhouse, E (corresponding author), Hamad Med Corp, Doha, Qatar.	ehillhouse@hmc.org.qa		Sheikh, Javaid/0000-0002-5762-4186				Dzau VJ, 2010, LANCET, V375, P949, DOI 10.1016/S0140-6736(09)61082-5; General Secretariat for Development Planning, 2011, QAT NAT VIS 2030; Hunter-Zinck H, 2010, AM J HUM GENET, V87, P17, DOI 10.1016/j.ajhg.2010.05.018; Wartman SA, 2010, ACAD MED, V85, P1821, DOI 10.1097/ACM.0b013e3181fa0001	4	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 25	2012	379	9817					694	695		10.1016/S0140-6736(11)61026-X	http://dx.doi.org/10.1016/S0140-6736(11)61026-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	899CU	21820733				2022-12-28	WOS:000300792600008
J	Shi, WL; Zhang, XL; Jiang, X; Yuan, HM; Lee, JS; Barry, CE; Wang, HH; Zhang, WH; Zhang, Y				Shi, Wanliang; Zhang, Xuelian; Jiang, Xin; Yuan, Haiming; Lee, Jong Seok; Barry, Clifton E., III; Wang, Honghai; Zhang, Wenhong; Zhang, Ying			Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis	SCIENCE			English	Article							RIBOSOMAL-PROTEIN S1; ESCHERICHIA-COLI; PYRAZINOIC ACID; PNCA MUTATIONS; MESSENGER-RNA; BINDING; RESISTANCE; TMRNA; SUSCEPTIBILITY; SYNTHASE	Pyrazinamide (PZA) is a first-line tuberculosis drug that plays a unique role in shortening the duration of tuberculosis chemotherapy. PZA is hydrolyzed intracellularly to pyrazinoic acid (POA) by pyrazinamidase (PZase, encoded by pncA), an enzyme frequently lost in PZA-resistant strains, but the target of POA in Mycobacterium tuberculosis has remained elusive. Here, we identify a previously unknown target of POA as the ribosomal protein S1 (RpsA), a vital protein involved in protein translation and the ribosome-sparing process of trans-translation. Three PZA-resistant clinical isolates without pncA mutation harbored RpsA mutations. RpsA overexpression conferred increased PZA resistance, and we confirmed that POA bound to RpsA (but not a clinically identified DAla mutant) and subsequently inhibited trans-translation rather than canonical translation. Trans-translation is essential for freeing scarce ribosomes in nonreplicating organisms, and its inhibition may explain the ability of PZA to eradicate persisting organisms.	[Shi, Wanliang; Zhang, Ying] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Zhang, Xuelian; Yuan, Haiming; Wang, Honghai] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Jiang, Xin] Shanghai Univ Tradit Chinese Med, Dept Med Microbiol & Immunol, Shanghai 201203, Peoples R China; [Lee, Jong Seok] Int TB Res Ctr, Chang Won 4751, South Korea; [Barry, Clifton E., III] NIAID, TB Res Sect, NIH, Bethesda, MD 20892 USA; [Zhang, Wenhong; Zhang, Ying] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200040, Peoples R China	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Fudan University; Shanghai University of Traditional Chinese Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fudan University	Zhang, Y (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	yzhang@jhsph.edu	Barry, Clifton E/ABE-7992-2020; 吴, 晶/D-3782-2013; Barry, III, Clifton/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Barry, III, Clifton/0000-0002-2927-270X; Jiang, Xin/0000-0001-7007-0483	NIH [AI44063]; NIAID, NIH; National Key Technologies Research and Development Program of China [2008ZX10003003]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783, R01AI044063, ZIAAI001067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Key Technologies Research and Development Program of China(National Key Technology R&D Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grant AI44063, in part by the intramural research program of the NIAID, NIH, and by National Key Technologies Research and Development Program of China (2008ZX10003003). We thank D. E. Griffin and M. J. Klag for encouragement and support. Johns Hopkins University has filed a patent on detection of RpsA mutation as a marker for pyrazinamide resistance and use of trans-translation pathway as a target for development of new antibiotics against TB persister bacteria.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Barends S, 2001, J MOL BIOL, V314, P9, DOI 10.1006/jmbi.2001.5114; Boni IV, 2000, J BACTERIOL, V182, P5872, DOI 10.1128/JB.182.20.5872-5879.2000; Boshoff HI, 2002, J BACTERIOL, V184, P2167, DOI 10.1128/JB.184.8.2167-2172.2002; Bycroft M, 1997, CELL, V88, P235, DOI 10.1016/S0092-8674(00)81844-9; Cheng SJ, 2000, ANTIMICROB AGENTS CH, V44, P528, DOI 10.1128/AAC.44.3.528-532.2000; Ibrahim M, 2007, ANTIMICROB AGENTS CH, V51, P1011, DOI 10.1128/AAC.00898-06; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Keiler KC, 2008, ANNU REV MICROBIOL, V62, P133, DOI 10.1146/annurev.micro.62.081307.162948; LAMBERT JM, 1983, J BACTERIOL, V154, P1323, DOI 10.1128/JB.154.3.1323-1328.1983; Li X, 2006, RNA, V12, P248, DOI 10.1261/rna.2212606; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; MCDERMOTT W, 1954, AM REV TUBERC PULM, V70, P748; Mikulik K, 2008, PROTEOMICS, V8, P1429, DOI 10.1002/pmic.200700560; MITCHISON DA, 1985, TUBERCLE, V66, P219, DOI 10.1016/0041-3879(85)90040-6; Muto A, 2000, GENES CELLS, V5, P627, DOI 10.1046/j.1365-2443.2000.00356.x; Nuermberger E, 2008, ANTIMICROB AGENTS CH, V52, P1522, DOI 10.1128/AAC.00074-08; Saguy M, 2007, NUCLEIC ACIDS RES, V35, P2368, DOI 10.1093/nar/gkm100; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Scorpio A, 1997, ANTIMICROB AGENTS CH, V41, P540, DOI 10.1128/AAC.41.3.540; TARSHIS MS, 1953, AM REV TUBERC PULM, V67, P391; Thibonnier M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003810; World Health Organization, 2010, WHO REP 2010 GLOB TU; Wower IK, 2000, EMBO J, V19, P6612, DOI 10.1093/emboj/19.23.6612; Yew WW, 2011, EXPERT OPIN EMERG DR, V16, P1, DOI 10.1517/14728214.2011.521497; Zhang Y, 2003, J ANTIMICROB CHEMOTH, V52, P790, DOI 10.1093/jac/dkg446; Zhang Y, 2003, INT J TUBERC LUNG D, V7, P6; Zhang Y, 2002, J MED MICROBIOL, V51, P42, DOI 10.1099/0022-1317-51-1-42; Zhang Y, 1999, J BACTERIOL, V181, P2044, DOI 10.1128/JB.181.7.2044-2049.1999; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zimhony O, 2000, NAT MED, V6, P1043, DOI 10.1038/79558	31	367	391	2	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1630	1632		10.1126/science.1208813	http://dx.doi.org/10.1126/science.1208813			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21835980	Green Published, Green Accepted			2022-12-28	WOS:000294900900043
J	Wake, H; Lee, PR; Fields, D				Wake, Hiroaki; Lee, Philip R.; Fields, Douglas			Control of Local Protein Synthesis and Initial Events in Myelination by Action Potentials	SCIENCE			English	Article							WHITE-MATTER; OLIGODENDROCYTE LINEAGE; FYN KINASE; CELLS; DIFFERENTIATION; COMMUNICATION; PROGRESSION; ACTIVATION; RELEASE; NEURONS	Formation of myelin, the electrical insulation on axons produced by oligodendrocytes, is controlled by complex cell-cell signaling that regulates oligodendrocyte development and myelin formation on appropriate axons. If electrical activity could stimulate myelin induction, then neurodevelopment and the speed of information transmission through circuits could be modified by neural activity. We find that release of glutamate from synaptic vesicles along axons of mouse dorsal root ganglion neurons in culture promotes myelin induction by stimulating formation of cholesterol-rich signaling domains between oligodendrocytes and axons, and increasing local synthesis of the major protein in the myelin sheath, myelin basic protein, through Fyn kinase-dependent signaling. This axon-oligodendrocyte signaling would promote myelination of electrically active axons to regulate neural development and function according to environmental experience.	[Wake, Hiroaki; Lee, Philip R.; Fields, Douglas] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Nervous Syst Dev & Plast Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fields, D (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Nervous Syst Dev & Plast Sect, Bethesda, MD 20892 USA.	fieldsd@mail.nih.gov		WAKE, Hiroaki/0000-0002-8543-4590	National Institute of Child Health and Human Development; Japan Society for the Promotion of Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. D. Ehlers for the TfR construct; J. Lippincott-Schwartz for the photoactivatable GFP; E. A. Johnson for BnTX; D. Abebe for assistance with experimental animals; and J. Chan, R. Chittajallu, and J. Ou for critical comments on an earlier draft of this manuscript. This work was supported by the intramural research program at the National Institute of Child Health and Human Development and by a Japan Society for the Promotion of Science fellowship for H. Wake.	AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Back SA, 2002, J NEUROPATH EXP NEUR, V61, P197, DOI 10.1093/jnen/61.2.197; Bakiri Y, 2009, NEURON GLIA BIOL, V5, P3, DOI 10.1017/S1740925X09990202; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Fields RD, 2010, SCIENCE, V330, P768, DOI 10.1126/science.1199139; Fields RD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001128; FIELDS RD, 1992, PRACTICAL ELECTROPHY; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Kramer EM, 1999, J BIOL CHEM, V274, P29042, DOI 10.1074/jbc.274.41.29042; Kukley M, 2010, J NEUROSCI, V30, P8320, DOI 10.1523/JNEUROSCI.0854-10.2010; Laursen LS, 2011, J CELL BIOL, V192, P797, DOI 10.1083/jcb.201007014; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; Wacker SA, 2007, DEV DYNAM, V236, P473, DOI 10.1002/dvdy.20955; Welch MJ, 2000, TOXICON, V38, P245, DOI 10.1016/S0041-0101(99)00153-1; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164	25	421	430	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1647	1651		10.1126/science.1206998	http://dx.doi.org/10.1126/science.1206998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21817014	Green Accepted			2022-12-28	WOS:000294900900048
J	Frank, KT; Petrie, B; Fisher, JAD; Leggett, WC				Frank, Kenneth T.; Petrie, Brian; Fisher, Jonathan A. D.; Leggett, William C.			Transient dynamics of an altered large marine ecosystem	NATURE			English	Article							SCOTIAN-SHELF; TROPHIC CASCADES; CONTINENTAL-SHELF; REGIME SHIFTS; GADUS-MORHUA; ATLANTIC COD; FISH; CANADA; RECOVERY; COLLAPSE	Overfishing of large-bodied benthic fishes and their subsequent population collapses on the Scotian Shelf of Canada's east coast(1,2) and elsewhere(3,4) resulted in restructuring of entire food webs now dominated by planktivorous, forage fish species and macroinvertebrates. Despite the imposition of strict management measures in force since the early 1990s, the Scotian Shelf ecosystem has not reverted back to its former structure. Here we provide evidence of the transient nature of this ecosystem and its current return path towards benthic fish species domination. The prolonged duration of the altered food web, and its current recovery, was and is being governed by the oscillatory, runaway consumption dynamics of the forage fish complex. These erupting forage species, which reached biomass levels 900% greater than those prevalent during the pre-collapse years of large benthic predators, are now in decline, having outstripped their zooplankton food supply. This dampening, and the associated reduction in the intensity of predation, was accompanied by lagged increases in species abundances at both lower and higher trophic levels, first witnessed in zooplankton and then in large-bodied predators, all consistent with a return towards the earlier ecosystem structure. We conclude that the reversibility of perturbed ecosystems can occur and that this bodes well for other collapsed fisheries.	[Frank, Kenneth T.; Petrie, Brian] Bedford Inst Oceanog, Ocean Sci Div, Dartmouth, NS B2Y 4A2, Canada; [Fisher, Jonathan A. D.; Leggett, William C.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Queens University - Canada	Frank, KT (corresponding author), Bedford Inst Oceanog, Ocean Sci Div, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	kenneth.frank@dfo-mpo.gc.ca	Leggett, William C/F-6009-2011	Frank, Kenneth T/0000-0001-6939-9724	Fisheries and Oceans Canada; Natural Sciences and Engineering Research Council of Canada; Natural Environment Research Council [SAH01001] Funding Source: researchfish; NERC [SAH01001] Funding Source: UKRI	Fisheries and Oceans Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Department of Fisheries and Oceans staff who collected and maintained the multi-trophic level and biogeochemical monitoring data, J. Black for assistance with computing and database issues, and A. Bundy and D. R. Strong for helpful criticisms. Symbols for Fig. 2b are courtesy of the Integration and Application Network (http://www.ian.umces.edu/symbols). This research was supported by Fisheries and Oceans Canada and Discovery grants from the Natural Sciences and Engineering Research Council of Canada (to K.T.F. and W.C.L.).	Anderson SC, 2008, CAN J FISH AQUAT SCI, V65, P2553, DOI 10.1139/F08-156; Benoit H., 2008, AZMP B, V8, P19; Bundy A., 2004, Canadian Technical Report of Fisheries and Aquatic Sciences, V2520, P1; Bundy A, 2009, PROG OCEANOGR, V81, P188, DOI 10.1016/j.pocean.2009.04.010; Casini M, 2008, P ROY SOC B-BIOL SCI, V275, P1793, DOI 10.1098/rspb.2007.1752; Cauffope Genevieve, 2005, University of British Columbia Fisheries Centre Research Reports, V13, P225; Chadwick E.M.P., 2007, AZMP B, V6, P25; Choi JS, 2005, OCEANOGR MAR BIOL, V43, P47; COCHLAN WP, 1986, CONT SHELF RES, V5, P555, DOI 10.1016/0278-4343(86)90076-2; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Doubleday W.G., 1981, Canadian Special Publication of Fisheries and Aquatic Sciences, V58, P1; Doubleday W. G., 1981, STUDIES 2 MANUAL GRO; Fauchald P, 2010, ECOLOGY, V91, P2191, DOI 10.1890/09-1500.1; Fisher JAD, 2008, ECOL LETT, V11, P883, DOI 10.1111/j.1461-0248.2008.01216.x; Fisher JAD, 2010, ECOLOGY, V91, P2499, DOI 10.1890/09-1914.1; Forsyth DM, 2006, ECOLOGY, V87, P297, DOI 10.1890/05-0709; FOURNIER RO, 1977, J FISH RES BOARD CAN, V34, P1004, DOI 10.1139/f77-153; Fowler G. W., 2000, DFO CAN SCI ADVIS SE, V2000, P1; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Frank KT, 2000, ICES J MAR SCI, V57, P1023, DOI 10.1006/jmsc.2000.0587; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Harrison G., 2009, DFO CAN SCI ADVIS SE, V2009, P1; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Litzow MA, 2008, ECOL APPL, V18, P1331, DOI 10.1890/07-0998.1; MAYO R K, 1981, Journal of Northwest Atlantic Fishery Science, V2, P13; MILLS EL, 1979, MAR BIOL, V54, P101, DOI 10.1007/BF00386589; Mousseau L, 1998, ICES J MAR SCI, V55, P44, DOI 10.1006/jmsc.1997.0224; Murawski SA, 2010, ICES J MAR SCI, V67, P1830, DOI 10.1093/icesjms/fsq125; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Myers RA, 1997, FISH B-NOAA, V95, P762; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Persson L, 2007, SCIENCE, V316, P1743, DOI 10.1126/science.1141412; PETERSON RO, 1984, SCIENCE, V224, P1350, DOI 10.1126/science.224.4655.1350; Petrie B, 2007, ATMOS OCEAN, V45, P141, DOI 10.3137/ao.450302; Petrie B, 2009, FISH OCEANOGR, V18, P83, DOI 10.1111/j.1365-2419.2009.00500.x; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Savenkoff C, 2007, ECOL MODEL, V204, P115, DOI 10.1016/j.ecolmodel.2006.12.029; Shackell NL, 2010, P ROY SOC B-BIOL SCI, V277, P1353, DOI 10.1098/rspb.2009.1020; Shackell NL, 2003, AQUAT CONSERV, V13, P305, DOI 10.1002/aqc.554; Shelton PA, 2006, CAN J FISH AQUAT SCI, V63, P235, DOI 10.1139/F05-253; Smith Stephen J., 1996, Northwest Atlantic Fisheries Organization Scientific Council Studies, V28, P25; Steele J. H., 2004, GLOBAL COASTAL OCEAN, V13; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Terborgh J., 2010, TROPHIC CASCADES PRE; TREMBLAY MJ, 1983, CAN J FISH AQUAT SCI, V40, P749, DOI 10.1139/f83-097; Yodzis P, 2001, TRENDS ECOL EVOL, V16, P78, DOI 10.1016/S0169-5347(00)02062-0	50	195	203	0	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2011	477	7362					86	U98		10.1038/nature10285	http://dx.doi.org/10.1038/nature10285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21796120				2022-12-28	WOS:000294404300036
J	Rasko, DA; Webster, DR; Sahl, JW; Bashir, A; Boisen, N; Scheutz, F; Paxinos, EE; Sebra, R; Chin, CS; Iliopoulos, D; Klammer, A; Peluso, P; Lee, L; Kislyuk, AO; Bullard, J; Kasarskis, A; Wang, S; Eid, J; Rank, D; Redman, JC; Steyert, SR; Frimodt-Moller, J; Struve, C; Petersen, AM; Krogfelt, KA; Nataro, JP; Schadt, EE; Waldor, MK				Rasko, David A.; Webster, Dale R.; Sahl, Jason W.; Bashir, Ali; Boisen, Nadia; Scheutz, Flemming; Paxinos, Ellen E.; Sebra, Robert; Chin, Chen-Shan; Iliopoulos, Dimitris; Klammer, Aaron; Peluso, Paul; Lee, Lawrence; Kislyuk, Andrey O.; Bullard, James; Kasarskis, Andrew; Wang, Susanna; Eid, John; Rank, David; Redman, Julia C.; Steyert, Susan R.; Frimodt-Moller, Jakob; Struve, Carsten; Petersen, Andreas M.; Krogfelt, Karen A.; Nataro, James P.; Schadt, Eric E.; Waldor, Matthew K.			Origins of the E. coli Strain Causing an Outbreak of Hemolytic-Uremic Syndrome in Germany	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; AGGREGATIVE ADHERENCE; GENOMIC ANALYSIS; DIARRHEA; FIMBRIAE; CHILDREN; PROTEASE; AGENT; CELLS	Background A large outbreak of diarrhea and the hemolytic-uremic syndrome caused by an unusual serotype of Shiga-toxin-producing Escherichia coli (O104:H4) began in Germany in May 2011. As of July 22, a large number of cases of diarrhea caused by Shiga-toxinproducing E. coli have been reported - 3167 without the hemolytic-uremic syndrome (16 deaths) and 908 with the hemolytic-uremic syndrome (34 deaths) - indicating that this strain is notably more virulent than most of the Shiga-toxin-producing E. coli strains. Preliminary genetic characterization of the outbreak strain suggested that, unlike most of these strains, it should be classified within the enteroaggregative pathotype of E. coli. Methods We used third-generation, single-molecule, real-time DNA sequencing to determine the complete genome sequence of the German outbreak strain, as well as the genome sequences of seven diarrhea-associated enteroaggregative E. coli serotype O104: H4 strains from Africa and four enteroaggregative E. coli reference strains belonging to other serotypes. Genomewide comparisons were performed with the use of these enteroaggregative E. coli genomes, as well as those of 40 previously sequenced E. coli isolates. Results The enteroaggregative E. coli O104: H4 strains are closely related and form a distinct clade among E. coli and enteroaggregative E. coli strains. However, the genome of the German outbreak strain can be distinguished from those of other O104: H4 strains because it contains a prophage encoding Shiga toxin 2 and a distinct set of additional virulence and antibiotic-resistance factors. Conclusions Our findings suggest that horizontal genetic exchange allowed for the emergence of the highly virulent Shiga-toxin-producing enteroaggregative E. coli O104: H4 strain that caused the German outbreak. More broadly, these findings highlight the way in which the plasticity of bacterial genomes facilitates the emergence of new pathogens.	[Rasko, David A.; Sahl, Jason W.; Redman, Julia C.; Steyert, Susan R.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Rasko, David A.; Sahl, Jason W.; Redman, Julia C.; Steyert, Susan R.] Univ Maryland, Sch Dent, Dept Microbiol, Baltimore, MD 21201 USA; [Webster, Dale R.; Bashir, Ali; Paxinos, Ellen E.; Sebra, Robert; Chin, Chen-Shan; Iliopoulos, Dimitris; Klammer, Aaron; Peluso, Paul; Lee, Lawrence; Kislyuk, Andrey O.; Bullard, James; Kasarskis, Andrew; Wang, Susanna; Eid, John; Rank, David; Schadt, Eric E.] Pacific Biosci, Menlo Pk, CA USA; [Boisen, Nadia; Nataro, James P.] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA; [Boisen, Nadia; Scheutz, Flemming] World Hlth Org Collaborating Ctr Reference & Res, Copenhagen, Denmark; [Boisen, Nadia; Scheutz, Flemming; Frimodt-Moller, Jakob; Struve, Carsten; Petersen, Andreas M.; Krogfelt, Karen A.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Frimodt-Moller, Jakob] Hillerod Sygehus, Dept Clin Microbiol, Hillerod, Denmark; [Petersen, Andreas M.] Hvidovre Univ Hosp, Dept Gastroenterol, DK-2650 Hvidovre, Denmark; [Waldor, Matthew K.] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp, Boston, MA 02115 USA; [Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Virginia; World Health Organization; Statens Serum Institut; University of Copenhagen; University of Copenhagen; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Schadt, EE (corresponding author), 1380 Willow Rd, Menlo Pk, CA 94025 USA.	eschadt@pacificbiosciences.com	Paxinos, Ellen/AAG-2907-2019; Krogfelt, Karen Angeliki A/O-8145-2016; Krogfelt, Karen Angeliki/P-2430-2018	Paxinos, Ellen/0000-0002-1710-8064; Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Frimodt-Moller, Jakob/0000-0002-7585-636X; David, Rasko/0000-0002-7337-7154; Petersen, Andreas Munk/0000-0003-0531-0553; Rank, David/0000-0001-9213-6965; Scheutz, Flemming/0000-0002-3931-4846; , Jason/0000-0002-2497-0138; Eid, John/0000-0002-2099-8344; Waldor, Matthew/0000-0003-1843-7000	University of Maryland; National Institutes of Health (NIH) [AI090873, R37-AI-42347, AI-033096]; Howard Hughes Medical Institute; Danish Council for Strategic Research [09-063070]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI033096, R01AI033096, R37AI042347, U19AI090873] Funding Source: NIH RePORTER	University of Maryland; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the University of Maryland Internal Funds and by grants from the National Institutes of Health (NIH) (AI090873, to the University of Maryland School of Medicine), the Howard Hughes Medical Institute and the NIH (R37-AI-42347, to Dr. Waldor), the NIH (AI-033096, to Drs. Nataro and Boisen), and the Danish Council for Strategic Research (09-063070, to Dr. Krogfelt).	Adachi JA, 2001, CLIN INFECT DIS, V32, P1706, DOI 10.1086/320756; Al-Hasani K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008223; Bae WK, 2006, YONSEI MED J, V47, P437, DOI 10.3349/ymj.2006.47.3.437; Behrman R. E., 2002, NELSON ESSENTIALS PE; Bernier C, 2002, INFECT IMMUN, V70, P4302, DOI 10.1128/IAI.70.8.4302-4311.2002; Bielaszewska M, 2011, LANCET INFECT D 0622; Boisen N, 2008, INFECT IMMUN, V76, P3281, DOI 10.1128/IAI.01646-07; Boisen N, 2009, AM J TROP MED HYG, V80, P294, DOI 10.4269/ajtmh.2009.80.294; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Cobeljic M, 1996, EPIDEMIOL INFECT, V117, P11, DOI 10.1017/S0950268800001072; Czeczulin JR, 1997, INFECT IMMUN, V65, P4135, DOI 10.1128/IAI.65.10.4135-4145.1997; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Eslava C, 1993, 93 GEN M AM SOC MICR; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Harrington SM, 2005, CELL MICROBIOL, V7, P1565, DOI 10.1111/j.1462-5822.2005.00588.x; Harrington SM, 2009, INFECT IMMUN, V77, P2465, DOI 10.1128/IAI.01494-08; Huang DB, 2004, AM J GASTROENTEROL, V99, P383, DOI 10.1111/j.1572-0241.2004.04041.x; Itoh Y, 1997, J CLIN MICROBIOL, V35, P2546, DOI 10.1128/JCM.35.10.2546-2550.1997; Iyoda S, 2000, FEMS MICROBIOL LETT, V191, P7, DOI 10.1016/S0378-1097(00)00360-8; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kupferschmidt K, 2011, SCIENCE, V332, P1249, DOI 10.1126/science.332.6035.1249; MATHEWSON JJ, 1987, J CLIN MICROBIOL, V25, P1917, DOI 10.1128/JCM.25.10.1917-1919.1987; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Morabito S, 1998, J CLIN MICROBIOL, V36, P840, DOI 10.1128/JCM.36.3.840-842.1998; NATARO JP, 1985, J INFECT DIS, V152, P560, DOI 10.1093/infdis/152.3.560; NATARO JP, 1992, INFECT IMMUN, V60, P2297, DOI 10.1128/IAI.60.6.2297-2304.1992; Okeke IN, 2000, J INFECT DIS, V181, P252, DOI 10.1086/315204; Olesen B, 2005, J CLIN MICROBIOL, V43, P3636, DOI 10.1128/JCM.43.8.3636-3641.2005; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Ruiz-Perez F, P NATL ACAD IN PRESS; Sahl JW, 2011, INFECT IMMUN, V79, P950, DOI 10.1128/IAI.00932-10; Scheutz F, 2011, EURO SURVEILL, V16; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Tompkins D S, 1999, Commun Dis Public Health, V2, P108; TOMPKINS DS, 1999, COMMUN DIS PUBLIC HL, V2, P222; Torres AG, 2009, J CLIN MICROBIOL, V47, P2442, DOI 10.1128/JCM.00566-09; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; VIAL PA, 1988, J INFECT DIS, V158, P70, DOI 10.1093/infdis/158.1.70; Wanke CA, 1998, J INFECT DIS, V178, P185, DOI 10.1086/515595; Wieser A, 2010, INFECT IMMUN, V78, P3432, DOI 10.1128/IAI.00174-10; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239	46	601	632	4	121	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					709	717		10.1056/NEJMoa1106920	http://dx.doi.org/10.1056/NEJMoa1106920			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811JM	21793740	Bronze, Green Accepted			2022-12-28	WOS:000294205300006
J	Flather, M; Pepper, J				Flather, Marcus; Pepper, John			CABG added no benefit to medical therapy for preventing death in coronary artery disease with heart failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Flather, Marcus] Royal Brompton & Harefield NHS Fdn Trust, London, England; Univ London Imperial Coll Sci Technol & Med, London, England	Royal Brompton & Harefield NHS Foundation Trust; Imperial College London	Flather, M (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, London, England.							Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358; Jones RH, 2009, NEW ENGL J MED, V360, P1705, DOI 10.1056/NEJMoa0900559	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4							JC2-9	10.7326/0003-4819-155-4-201108160-02009	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LM	21844542				2022-12-28	WOS:000208885100008
J	Fosbol, EL; Granger, CB				Fosbol, Emil L.; Granger, Christopher B.			Meta-analysis: High-dose statin pretreatment prevents periprocedural cardiac events in patients having PCI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Fosbol, Emil L.; Granger, Christopher B.] Duke Clin Res Inst, Durham, NC 27705 USA	Duke University	Fosbol, EL (corresponding author), Duke Clin Res Inst, Durham, NC 27705 USA.			Fosbol, Emil/0000-0002-2048-4167					0	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4							JC2-8	10.7326/0003-4819-155-4-201108160-02008	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LM	21844541				2022-12-28	WOS:000208885100007
J	Kiers, ET; Duhamel, M; Beesetty, Y; Mensah, JA; Franken, O; Verbruggen, E; Fellbaum, CR; Kowalchuk, GA; Hart, MM; Bago, A; Palmer, TM; West, SA; Vandenkoornhuyse, P; Jansa, J; Bucking, H				Kiers, E. Toby; Duhamel, Marie; Beesetty, Yugandhar; Mensah, Jerry A.; Franken, Oscar; Verbruggen, Erik; Fellbaum, Carl R.; Kowalchuk, George A.; Hart, Miranda M.; Bago, Alberto; Palmer, Todd M.; West, Stuart A.; Vandenkoornhuyse, Philippe; Jansa, Jan; Buecking, Heike			Reciprocal Rewards Stabilize Cooperation in the Mycorrhizal Symbiosis	SCIENCE			English	Article							HOST SANCTIONS; MUTUALISM; EVOLUTION; CARBON; PERSISTENCE; HYPOTHESIS; ALLOCATION; CONFLICT; NETWORKS; TRADE	Plants and their arbuscular mycorrhizal fungal symbionts interact in complex underground networks involving multiple partners. This increases the potential for exploitation and defection by individuals, raising the question of how partners maintain a fair, two-way transfer of resources. We manipulated cooperation in plants and fungal partners to show that plants can detect, discriminate, and reward the best fungal partners with more carbohydrates. In turn, their fungal partners enforce cooperation by increasing nutrient transfer only to those roots providing more carbohydrates. On the basis of these observations we conclude that, unlike many other mutualisms, the symbiont cannot be "enslaved." Rather, the mutualism is evolutionarily stable because control is bidirectional, and partners offering the best rate of exchange are rewarded.	[Kiers, E. Toby; Duhamel, Marie; Franken, Oscar; Verbruggen, Erik; Kowalchuk, George A.] Vrije Univ Amsterdam, Inst Ecol Sci, NL-1081 HV Amsterdam, Netherlands; [Duhamel, Marie; Vandenkoornhuyse, Philippe] Univ Rennes 1, CNRS, EcoBio UMR6553, F-35042 Rennes, France; [Beesetty, Yugandhar] Rutgers State Univ, Dept Biol, Camden, NJ 08102 USA; [Beesetty, Yugandhar; Mensah, Jerry A.; Fellbaum, Carl R.; Buecking, Heike] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Kowalchuk, George A.] Netherlands Inst Ecol, Dept Microbial Ecol, NL-6708 PB Wageningen, Netherlands; [Hart, Miranda M.] Univ British Columbia, Kelowna, BC, Canada; [Bago, Alberto] CSIC, Estn Expt Zaidin, E-18008 Granada, Spain; [Palmer, Todd M.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [West, Stuart A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Jansa, Jan] Swiss Fed Inst Technol, Inst Agr Sci, CH-8315 Lindau, Switzerland	Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; Rutgers State University Camden; Rutgers State University New Brunswick; South Dakota State University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of British Columbia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); State University System of Florida; University of Florida; University of Oxford; Swiss Federal Institutes of Technology Domain; ETH Zurich	Kiers, ET (corresponding author), Vrije Univ Amsterdam, Inst Ecol Sci, NL-1081 HV Amsterdam, Netherlands.	toby.kiers@vu.nl	Toby, Kiers/H-4819-2017; Hart, Miranda m/D-1562-2011; Drigo, Barbara/AAJ-9484-2021; Verbruggen, Erik/AAF-1018-2019; Palmer, Todd/GRS-0639-2022; Verbruggen, Erik/A-5351-2012; West, Stuart A/M-3608-2014; Jansa, Jan/H-3161-2014; Kowalchuk, George A/C-4298-2011; Pijl, A/D-4220-2012	Toby, Kiers/0000-0002-0597-1653; Drigo, Barbara/0000-0002-3301-0470; Verbruggen, Erik/0000-0001-7015-1515; West, Stuart A/0000-0003-2152-3153; Jansa, Jan/0000-0002-0331-1774; Bucking, Heike/0000-0002-4040-0944; Palmer, Todd/0000-0001-5710-9750; Kowalchuk, George/0000-0003-3866-0832; Franken, Oscar/0000-0001-8361-3117	Netherlands Organisation for Scientific Research (NWO);  [NSF-IOS 0943338/1051397];  [NSF-DEB-0827610];  [ANR-10-STRA-002]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ; ; 	We thank R. F. Denison, J. Ellers, and N. M. van Straalen for useful discussion; Isolife, A. S. Pijl, and B. Drigo for technical assistance; B. Hause for seeds; and NSF-IOS 0943338/1051397, NSF-DEB-0827610, ANR-10-STRA-002, and the Netherlands Organisation for Scientific Research (NWO) for financial support. A. B. is one of the cofounders of Mycovitro S. L. (Granada, Spain), a company providing AM fungal inoculum for research and biotechnology purposes. Fungal cultures provided by Mycovitro are available for purchase. Plasmids containing mitochondrial DNA fragments of fungal species (provided by ETH Zurich, Switzerland) are freely available under a material transfer agreement for noncommercial use. AM fungal sequences were deposited in GenBank, accession nos. HQ706096 to HQ706103.	Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; Bshary R, 2003, DAHL WS ENV, P167; Cowden CC, 2009, ECOL MODEL, V220, P1522, DOI 10.1016/j.ecolmodel.2009.03.028; de Mazancourt C, 2010, ECOL LETT, V13, P349, DOI 10.1111/j.1461-0248.2009.01431.x; Douglas AE, 2008, NEW PHYTOL, V177, P849, DOI 10.1111/j.1469-8137.2007.02326.x; Fitter AH, 2006, NEW PHYTOL, V172, P3, DOI 10.1111/j.1469-8137.2006.01861.x; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; Goto R, 2010, ECOL LETT, V13, P321, DOI 10.1111/j.1461-0248.2009.01425.x; Hoeksema JD, 2003, AM NAT, V162, pS40, DOI 10.1086/378644; Jander KC, 2010, P ROY SOC B-BIOL SCI, V277, P1481, DOI 10.1098/rspb.2009.2157; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Kiers ET, 2006, ECOLOGY, V87, P1627, DOI 10.1890/0012-9658(2006)87[1627:MSITAM]2.0.CO;2; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Leigh EG, 2010, J EVOLUTION BIOL, V23, P2507, DOI 10.1111/j.1420-9101.2010.02114.x; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Mikkelsen BL, 2008, NEW PHYTOL, V180, P890, DOI 10.1111/j.1469-8137.2008.02623.x; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; PELLMYR O, 1994, NATURE, V372, P257, DOI 10.1038/372257a0; Pfeffer PE, 1999, PLANT PHYSIOL, V120, P587, DOI 10.1104/pp.120.2.587; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Powell JR, 2009, P ROY SOC B-BIOL SCI, V276, P4237, DOI 10.1098/rspb.2009.1015; Schwartz MW, 1998, ECOLOGY, V79, P1029, DOI 10.1890/0012-9658(1998)079[1029:SARTBM]2.0.CO;2; Selosse MA, 2006, TRENDS ECOL EVOL, V21, P621, DOI 10.1016/j.tree.2006.07.003; Smith SE, 2010, PLANT SOIL, V326, P3, DOI 10.1007/s11104-009-9981-5; Takanishi I, 2009, SOIL BIOL BIOCHEM, V41, P1571, DOI 10.1016/j.soilbio.2009.04.002; Vandenkoornhuyse P, 2007, P NATL ACAD SCI USA, V104, P16970, DOI 10.1073/pnas.0705902104; WEST SA, 1994, P ROY SOC B-BIOL SCI, V258, P67, DOI 10.1098/rspb.1994.0143	29	993	1058	38	1087	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					880	882		10.1126/science.1208473	http://dx.doi.org/10.1126/science.1208473			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836016				2022-12-28	WOS:000293785400041
J	Fearon, KCH				Fearon, Kenneth C. H.			Cancer Cachexia and Fat-Muscle Physiology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Edinburgh, Royal Infirm, Dept Clin Surg, Sch Clin Sci & Community Hlth, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Fearon, KCH (corresponding author), Univ Edinburgh, Royal Infirm, Dept Clin Surg, Sch Clin Sci & Community Hlth, Edinburgh EH3 9YW, Midlothian, Scotland.							DAS SK, 2011, SCIENCE         0616; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	5	95	100	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					565	567		10.1056/NEJMcibr1106880	http://dx.doi.org/10.1056/NEJMcibr1106880			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805MW	21830971				2022-12-28	WOS:000293732100015
J	Ospelkaus, C; Warring, U; Colombe, Y; Brown, KR; Amini, JM; Leibfried, D; Wineland, DJ				Ospelkaus, C.; Warring, U.; Colombe, Y.; Brown, K. R.; Amini, J. M.; Leibfried, D.; Wineland, D. J.			Microwave quantum logic gates for trapped ions	NATURE			English	Article							STATES	Control over physical systems at the quantum level is important in fields as diverse as metrology, information processing, simulation and chemistry. For trapped atomic ions, the quantized motional and internal degrees of freedom can be coherently manipulated with laser light(1,2). Similar control is difficult to achieve with radio-frequency or microwave radiation: the essential coupling between internal degrees of freedom and motion requires significant field changes over the extent of the atoms' motion(2,3), but such changes are negligible at these frequencies for freely propagating fields. An exception is in the near field of microwave currents in structures smaller than the free-space wavelength(4,5), where stronger gradients can be generated. Here we first manipulate coherently (on time-scales of 20 nanoseconds) the internal quantum states of ions held in a microfabricated trap. The controlling magnetic fields are generated by microwave currents in electrodes that are integrated into the trap structure. We also generate entanglement between the internal degrees of freedom of two atoms with a gate operation(4,6-8) suitable for general quantum computation(9); the entangled state has a fidelity of 0.76(3), where the uncertainty denotes standard error of the mean. Our approach, which involves integrating the quantum control mechanism into the trapping device in a scalable manner, could be applied to quantum information processing(4), simulation(5,10) and spectroscopy(3,11).	[Ospelkaus, C.; Warring, U.; Colombe, Y.; Brown, K. R.; Amini, J. M.; Leibfried, D.; Wineland, D. J.] Natl Inst Stand & Technol, Time & Frequency Div, Boulder, CO 80305 USA	National Institute of Standards & Technology (NIST) - USA	Ospelkaus, C (corresponding author), Leibniz Univ Hannover, Inst Quantum Opt, Welfengarten 1, D-30167 Hannover, Germany.	christian.ospelkaus@iqo.uni-hannover.de	Ospelkaus, Christian/C-3612-2009	Ospelkaus, Christian/0000-0002-4170-2936; Warring, Ulrich/0000-0001-8081-9718	IARPA; ONR; DARPA; NSA; Sandia National Laboratories; NIST	IARPA; ONR(Office of Naval Research); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSA(National Security Agency); Sandia National Laboratories(United States Department of Energy (DOE)); NIST(National Institute of Standards & Technology (NIST) - USA)	We thank M. J. Biercuk, J. J. Bollinger and A. P. VanDevender for experimental assistance, J. C. Bergquist, C. W. Chou and T. Rosenband for the loan of a fibre laser, R. Jordens and E. Knill for comments on the manuscript, and D. Hanneke and J. P. Home for discussions. We thank P. Treutlein for discussions on microfabrication techniques. This work was supported by IARPA, the ONR, DARPA, the NSA, Sandia National Laboratories and the NIST Quantum Information Program. This paper, a submission of NIST, is not subject to US copyright.	Amini JM, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033031; BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Brown KR, 2011, NATURE, V471, P196, DOI 10.1038/nature09721; Campbell WC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.090502; Chiaverini J, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.022324; Ciaramicoli G, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.017901; Forster L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.233001; Fortagh J, 2007, REV MOD PHYS, V79, P235, DOI 10.1103/RevModPhys.79.235; Friedenauer A, 2008, NAT PHYS, V4, P757, DOI 10.1038/nphys1032; Harlander M, 2011, NATURE, V471, P200, DOI 10.1038/nature09800; Hayes D., 2011, COHERENT ERROR SUPPR; HEINZEN DJ, 1990, PHYS REV A, V42, P2977, DOI 10.1103/PhysRevA.42.2977; Johanning M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.073004; Jost JD, 2009, NATURE, V459, P683, DOI 10.1038/nature08006; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; King BE, 1998, PHYS REV LETT, V81, P1525, DOI 10.1103/PhysRevLett.81.1525; Knoop M, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/15/150201; Langer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060502; Leibfried D, 2003, REV MOD PHYS, V75, P281, DOI 10.1103/RevModPhys.75.281; LEVITT MH, 1986, PROG NUCL MAG RES SP, V18, P61, DOI 10.1016/0079-6565(86)80005-X; Milburn GJ, 2000, FORTSCHR PHYS, V48, P801, DOI 10.1002/1521-3978(200009)48:9/11<801::AID-PROP801>3.0.CO;2-1; Mintert F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.257904; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schmied R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.233002; Seidelin S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.253003; Solano E, 1999, PHYS REV A, V59, pR2539, DOI 10.1103/PhysRevA.59.R2539; Wang SX, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3095520	33	232	235	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					181	U77		10.1038/nature10290	http://dx.doi.org/10.1038/nature10290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21833084	Green Submitted			2022-12-28	WOS:000293731900030
J	Levin, MH; O'Brien, JM				Levin, Marc H.; O'Brien, Joan M.			Adult Ovarian Retinoblastoma Genomic Profile	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TUMORS		[O'Brien, Joan M.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	O'Brien, JM (corresponding author), Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Sch Med, 51 N 39th St, Philadelphia, PA 19104 USA.	joan.obrien@uphs.upenn.edu						CAVENEE WK, 1985, SCIENCE, V228, P501, DOI 10.1126/science.3983638; Corson TW, 2007, GENE CHROMOSOME CANC, V46, P617, DOI 10.1002/gcc.20457; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; JAKOBIEC FA, 1977, CANCER-AM CANCER SOC, V39, P2048, DOI 10.1002/1097-0142(197705)39:5<2048::AID-CNCR2820390522>3.0.CO;2-9; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Navalkele P, 2011, PEDIATR BLOOD CANCER, V56, P50, DOI 10.1002/pbc.22559; Soh SY, 2011, ARCH OPHTHALMOL-CHIC, V129, P1101, DOI 10.1001/archophthalmol.2011.220; VOGEL F, 1979, HUM GENET, V52, P1; Woo KI, 2010, ARCH OPHTHALMOL-CHIC, V128, P865, DOI 10.1001/archophthalmol.2010.126	10	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2011	306	6					646	647		10.1001/jama.2011.1123	http://dx.doi.org/10.1001/jama.2011.1123			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804XD	21834141				2022-12-28	WOS:000293687300027
J	Lowney, AC; Ryan, SA; Ryan, A; Harney, S				Lowney, Aoife C.; Ryan, Stephen A.; Ryan, Andrea; Harney, Sinead			PICTURE QUIZ Waking up to darkness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GIANT-CELL ARTERITIS; TEMPORAL ARTERITIS; POLYMYALGIA-RHEUMATICA; DISEASE; THERAPY; VESSEL		[Lowney, Aoife C.; Ryan, Stephen A.; Harney, Sinead] Cork Univ Hosp, Dept Rheumatol, Cork, Ireland; [Ryan, Andrea] Mater Misericordiae Univ Hosp, Dept Ophthalmol, Dublin 7, Ireland	University College Cork; Mater Misericordiae University Hospital; University College Dublin	Lowney, AC (corresponding author), Cork Univ Hosp, Dept Rheumatol, Cork, Ireland.	aoifelowney@gmail.com						AIELLO PD, 1993, OPHTHALMOLOGY, V100, P550; Cantini F, 2000, SEMIN ARTHRITIS RHEU, V30, P17, DOI 10.1053/sarh.2000.8366; CASELLI RJ, 1994, SEMIN NEUROL, V14, P349, DOI 10.1055/s-2008-1041094; Chevalet P, 2000, J RHEUMATOL, V27, P1484; HALL S, 1983, LANCET, V2, P1217; Hayreh SS, 2002, ACTA OPHTHALMOL SCAN, V80, P355, DOI 10.1034/j.1600-0420.2002.800403.x; Hellmann DB, 2002, JAMA-J AM MED ASSOC, V287, P2996, DOI 10.1001/jama.287.22.2996; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Jacob A, 2004, BMJ-BRIT MED J, V328, P1552, DOI 10.1136/bmj.328.7455.1552; Lee MS, 2006, ARTHRITIS RHEUM, V54, P3306, DOI 10.1002/art.22141; LIE JT, 1995, SEMIN ARTHRITIS RHEU, V24, P422, DOI 10.1016/S0049-0172(95)80010-7; Liozon E, 2003, J AM GERIATR SOC, V51, P722; Nesher G, 2004, ARTHRITIS RHEUM, V50, P1332, DOI 10.1002/art.20171; Salvarani C, 1999, ARTHRITIS RHEUM-US, V42, P1259, DOI 10.1002/1529-0131(199906)42:6<1259::AID-ANR24>3.0.CO;2-I; Salvarani C, 2008, LANCET, V372, P234, DOI 10.1016/S0140-6736(08)61077-6; Scola CJ, 2008, MEDICINE, V87, P45, DOI 10.1097/MD.0b013e3181646118; Smetana GW, 2002, JAMA-J AM MED ASSOC, V287, P92, DOI 10.1001/jama.287.1.92; WEYAND CM, 1992, J CLIN INVEST, V90, P2355, DOI 10.1172/JCI116125; Weyand CM, 2003, NEW ENGL J MED, V349, P160, DOI 10.1056/NEJMra022694	19	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2011	343								d4783	10.1136/bmj.d4783	http://dx.doi.org/10.1136/bmj.d4783			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808CX	21828203				2022-12-28	WOS:000293954000002
J	Junge, W; Muller, DJ				Junge, Wolfgang; Mueller, Daniel J.			Seeing a Molecular Motor at Work	SCIENCE			English	Editorial Material							RESOLUTION; EVOLUTION		[Junge, Wolfgang] Univ Osnabruck, Div Biophys, D-49069 Osnabruck, Germany; [Mueller, Daniel J.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland	University Osnabruck; Swiss Federal Institutes of Technology Domain; ETH Zurich	Junge, W (corresponding author), Univ Osnabruck, Div Biophys, D-49069 Osnabruck, Germany.	junge@uos.de; daniel.mueller@bsse.ethz.ch	Müller, Daniel J./A-5967-2010; Junge, Wolfgang/F-6289-2012	Müller, Daniel J./0000-0003-3075-0665; 				Cabezon E, 2006, RES MICROBIOL, V157, P299, DOI 10.1016/j.resmic.2005.12.002; Gerber C, 2006, NAT NANOTECHNOL, V1, P3, DOI 10.1038/nnano.2006.70; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kodera N, 2003, ADV EXP MED BIOL, V538, P119; Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Puchner EM, 2009, CURR OPIN STRUC BIOL, V19, P605, DOI 10.1016/j.sbi.2009.09.005; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; WALKER JE, 1986, CHEM SCRIPTA, V26B, P263; Wintterlin J, 1997, SCIENCE, V278, P1931, DOI 10.1126/science.278.5345.1931	12	14	14	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					704	705		10.1126/science.1210238	http://dx.doi.org/10.1126/science.1210238			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817036				2022-12-28	WOS:000293512100025
J	O' Flynn, N; Timmis, A; Henderson, R; Rajesh, S; Fenu, E				O' Flynn, Norma; Timmis, Adam; Henderson, Robert; Rajesh, Sharangini; Fenu, Elisabetta		Guideline Dev Grp	GUIDELINES Management of stable angina: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-ARTERY-DISEASE; CARDIAC-CATHETERIZATION; INTERVENTION; REVASCULARIZATION; COMPLICATIONS; PROGNOSIS		[O' Flynn, Norma; Rajesh, Sharangini; Fenu, Elisabetta] Royal Coll Physicians, Natl Clin Guideline Ctr Acute & Chron Condit, London NW1 4LE, England; [Timmis, Adam] Barts & London Queen Marys Sch Med & Dent, London E1 2AD, England; [Henderson, Robert] Univ Nottingham Hosp, Trent Cardiac Ctr, Nottingham NG5 1PB, England	Royal College of Physicians; University of London; Queen Mary University London; University of Nottingham	O' Flynn, N (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr Acute & Chron Condit, London NW1 4LE, England.	norma.oflynn@rcplondon.ac.uk						Borden WB, 2011, JAMA-J AM MED ASSOC, V305, P1882, DOI 10.1001/jama.2011.601; Daly CA, 2005, EUR HEART J, V26, P1011, DOI 10.1093/eurheartj/ehi109; DEBONO D, 1993, BRIT HEART J, V70, P297; Hannan EL, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-35; Information Centre for Health and Social Care. Health Survey for England, 2006, HLTH SURV ENGL 2006, V1; Jones M, 2006, FAM PRACT, V23, P520, DOI 10.1093/fampra/cml038; KENNEDY JW, 1982, CATHETER CARDIO DIAG, V8, P5, DOI 10.1002/ccd.1810080103; Lin GA, 2007, ARCH INTERN MED, V167, P1604, DOI 10.1001/archinte.167.15.1604; *NAT I HLTH CLIN E, 2008, CART RISK ASS MOD BL; *NAT I HLTH CLIN E, 2011, MAN STAB ANG CLIN GU; National Institute for Health and Clinical Excellence, 2010, CHEST PAIN REC ONS C; National Institute for Health and Clinical Excellence, 2006, HYP MAN HYP AD PRIM; Poole-Wilson PA, 2004, LANCET, V364, P849, DOI 10.1016/S0140-6736(04)16980-8; Ragosta M, 2006, CATHETER CARDIO INTE, V68, P357, DOI 10.1002/ccd.20709; Rothberg MB, 2010, ANN INTERN MED, V153, P307, DOI 10.7326/0003-4819-153-5-201009070-00005; TAYLOR HA, 1989, CIRCULATION, V79, P1171, DOI 10.1161/01.CIR.79.6.1171; The Society for Cardiothoracic Surgery in Great Britain &amp Ireland, 2008, 6 NAT AD CARD SURG D; Timmis AD, 2007, HEART, V93, P786, DOI 10.1136/hrt.2006.103119	18	9	9	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 5	2011	343								d4147	10.1136/bmj.d4147	http://dx.doi.org/10.1136/bmj.d4147			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	805NQ	21821647				2022-12-28	WOS:000293735100001
J	Zhang, RD; So, BR; Li, PL; Yong, J; Glisovic, T; Wan, LL; Dreyfuss, G				Zhang, Rundong; So, Byung Ran; Li, Pilong; Yong, Jeongsik; Glisovic, Tina; Wan, Lili; Dreyfuss, Gideon			Structure of a Key Intermediate of the SMN Complex Reveals Gemin2's Crucial Function in snRNP Assembly	CELL			English	Article							SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON COMPLEX; CRYSTAL-STRUCTURE; RNA-BINDING; U1 SNRNP; X-RAY; SPLICEOSOMAL SNRNPS; ARGININE RESIDUES; PROTEIN COMPLEXES; GENE-PRODUCT	The SMN complex mediates the assembly of heptameric Sm protein rings on small nuclear RNAs (snRNAs), which are essential for snRNP function. Specific Sm core assembly depends on Sm proteins and snRNA recognition by SMN/Gemin2- and Gemin5-containing subunits, respectively. The mechanism by which the Sm proteins are gathered while preventing illicit Sm assembly on non-snRNAs is unknown. Here, we describe the 2.5 angstrom crystal structure of Gemin2 bound to SmD1/D2/F/E/G pentamer and SMN's Gemin2-binding domain, a key assembly intermediate. Remarkably, through its extended conformation, Gemin2 wraps around the crescent-shaped pentamer, interacting with all five Sm proteins, and gripping its bottom and top sides and outer perimeter. Gemin2 reaches into the RNA-binding pocket, preventing RNA binding. Interestingly, SMN-Gemin2 interaction is abrogated by a spinal muscular atrophy (SMA)-causing mutation in an SMN helix that mediates Gemin2 binding. These findings provide insight into SMN complex assembly and specificity, linking snRNP biogenesis and SMA pathogenesis.	[Zhang, Rundong; So, Byung Ran; Li, Pilong; Yong, Jeongsik; Glisovic, Tina; Wan, Lili; Dreyfuss, Gideon] Univ Penn, Howard Hughes Med Inst, Sch Med, Philadelphia, PA 19104 USA; [Zhang, Rundong; So, Byung Ran; Li, Pilong; Yong, Jeongsik; Glisovic, Tina; Wan, Lili; Dreyfuss, Gideon] Univ Penn, Dept Biochem & Biophys, Sch Med, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Dreyfuss, G (corresponding author), Univ Penn, Howard Hughes Med Inst, Sch Med, Philadelphia, PA 19104 USA.	gdreyfuss@hhmi.upenn.edu	Dreyfuss, Gideon/D-1218-2013; Zhang, Rundong/F-5946-2012; wan, li/GRY-7634-2022; ZHANG, RUNDONG/AAD-1161-2019	Dreyfuss, Gideon/0000-0001-8129-8774; ZHANG, RUNDONG/0000-0002-1719-1961	Association Francaise Contre les Myopathies	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies)	We thank Corie Ralston and Christy Bertoldo for their assistance with X-ray data collection at the Advanced Light Source (ALS, Berkeley, CA) synchrotron beamlines 8.2.1 and 8.2.2. We thank Emily Anna Bridges for help with bacterial cell culture. We are grateful to the members of our laboratory for helpful discussions and comments on this manuscript. This work was supported by the Association Francaise Contre les Myopathies. G. D. is an Investigator of the Howard Hughes Medical Institute.	Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Battle DJ, 2007, J BIOL CHEM, V282, P27953, DOI 10.1074/jbc.M702317200; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Carissimi C, 2005, FEBS LETT, V579, P2348, DOI 10.1016/j.febslet.2005.03.034; Cauchi RJ, 2010, BIOESSAYS, V32, P1077, DOI 10.1002/bies.201000088; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Collins BM, 2003, J BIOL CHEM, V278, P17291, DOI 10.1074/jbc.M211826200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Golembe TJ, 2005, MOL CELL BIOL, V25, P10989, DOI 10.1128/MCB.25.24.10989-11004.2005; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Jablonka S, 2002, P NATL ACAD SCI USA, V99, P10126, DOI 10.1073/pnas.152318699; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Ma YL, 2005, STRUCTURE, V13, P883, DOI 10.1016/j.str.2005.03.014; MATTAJ IW, 1993, MOL BIOL REP, V18, P79, DOI 10.1007/BF00986760; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Neuenkirchen N, 2008, FEBS LETT, V582, P1997, DOI 10.1016/j.febslet.2008.03.009; Newman AJ, 2010, CURR OPIN STRUC BIOL, V20, P82, DOI 10.1016/j.sbi.2009.12.003; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen N, 2000, HUM MOL GENET, V9, P675, DOI 10.1093/hmg/9.5.675; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Paushkin S, 2000, J BIOL CHEM, V275, P23841, DOI 10.1074/jbc.M001441200; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pesiridis GS, 2009, J BIOL CHEM, V284, P21347, DOI 10.1074/jbc.M109.015578; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Raker VA, 1999, MOL CELL BIOL, V19, P6554; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Sauter C, 2003, NUCLEIC ACIDS RES, V31, P4091, DOI 10.1093/nar/gkg480; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sun Y, 2005, HUM MUTAT, V25, P64, DOI 10.1002/humu.20111; Talbot K, 2001, SEMIN NEUROL, V21, P189, DOI 10.1055/s-2001-15264; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wan LL, 2008, MOL CELL, V31, P244, DOI 10.1016/j.molcel.2008.06.004; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Wang J, 2001, J BIOL CHEM, V276, P45387, DOI 10.1074/jbc.M105059200; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wirth Brunhilde, 2006, Semin Pediatr Neurol, V13, P121, DOI 10.1016/j.spen.2006.06.008; Yong J, 2004, MOL CELL BIOL, V24, P2747, DOI 10.1128/MCB.24.7.2747-2756.2004; Yong J, 2010, MOL CELL, V38, P551, DOI 10.1016/j.molcel.2010.03.014; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010	73	76	76	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					384	395		10.1016/j.cell.2011.06.043	http://dx.doi.org/10.1016/j.cell.2011.06.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816274	Green Accepted, Bronze			2022-12-28	WOS:000293570500013
J	Fenton, MB				Fenton, M. Brock			The World Through a Bat's Ear	SCIENCE			English	Editorial Material							PREY		Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada	Western University (University of Western Ontario)	Fenton, MB (corresponding author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.	bfenton@uwo.ca						Bates ME, 2011, SCIENCE, V333, P627, DOI 10.1126/science.1202065; Chadha M, 2011, J COMP PHYSIOL A, V197, P89, DOI 10.1007/s00359-010-0590-9; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; Griffin Donald R., 1944, SCIENCE, V100, P589, DOI 10.1126/science.100.2609.589; Jacobs DS, 2008, BEHAV ECOL, V19, P1333, DOI 10.1093/beheco/arn071; Jakobsen L, 2010, P NATL ACAD SCI USA, V107, P13930, DOI 10.1073/pnas.1006630107; KURTEN L, 1984, NATURWISSENSCHAFTEN, V71, P327, DOI 10.1007/BF00396621; Ma JG, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/2/026008; Simon R, 2011, SCIENCE, V333, P631, DOI 10.1126/science.1204210; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Teeling EC, 2009, TRENDS ECOL EVOL, V24, P351, DOI 10.1016/j.tree.2009.02.012; Thaler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020162; Voigt CC, 2008, J MAMMAL, V89, P1401, DOI 10.1644/08-MAMM-S-060.1; Voigt-Heucke SL, 2010, ANIM BEHAV, V80, P59, DOI 10.1016/j.anbehav.2010.03.025; von Helversen D, 1999, NATURE, V398, P759, DOI 10.1038/19648	15	3	3	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					528	529		10.1126/science.1209933	http://dx.doi.org/10.1126/science.1209933			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798917				2022-12-28	WOS:000293222400027
J	Relman, DA				Relman, David A.			Microbial Genomics and Infectious Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PATHOGENIC ESCHERICHIA-COLI; SEROGROUP-B MENINGOCOCCUS; TROPHERYMA-WHIPPLEI; YERSINIA-PESTIS; GUT MICROBIOME; GENE-TRANSFER; EVOLUTION; IDENTIFICATION; RESISTANCE; SEQUENCE		[Relman, David A.] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Relman, David A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Relman, DA (corresponding author), VA Palo Alto Hlth Care Syst, 154T,Bldg 101,Rm B4-185,3801 Miranda Ave, Palo Alto, CA 94304 USA.	relman@stanford.edu		Relman, David A./0000-0001-8331-1354	NIAID NIH HHS [T32 AI007502] Funding Source: Medline; NIH HHS [DP1 OD000964] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007502] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baker S, 2010, CURR OPIN MICROBIOL, V13, P640, DOI 10.1016/j.mib.2010.08.002; Bakkali N, 2008, J INFECT DIS, V198, P101, DOI 10.1086/588706; Bentley SD, 2003, LANCET, V361, P637, DOI 10.1016/S0140-6736(03)12597-4; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Chiu CY, 2008, J PEDIATR-US, V153, P76, DOI 10.1016/j.jpeds.2007.12.035; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Diard M, 2010, J BACTERIOL, V192, P4885, DOI 10.1128/JB.00804-10; Doolittle RF, 2002, NATURE, V416, P697, DOI 10.1038/416697a; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fenollar F, 2008, CLIN INFECT DIS, V47, P659, DOI 10.1086/590559; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Fischbach MA, 2009, CURR OPIN MICROBIOL, V12, P520, DOI 10.1016/j.mib.2009.07.002; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Fraser-Liggett CM, 2005, GENOME RES, V15, P1603, DOI 10.1101/gr.3724205; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gardy JL, 2011, NEW ENGL J MED, V364, P2174; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Han ZG, 2009, ANNU REV GENOM HUM G, V10, P211, DOI 10.1146/annurev-genom-082908-150036; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; LIPKIN WI, 1990, P NATL ACAD SCI USA, V87, P4184, DOI 10.1073/pnas.87.11.4184; Llibre JM, 2010, CLIN INFECT DIS, V50, P872, DOI 10.1086/650732; Los Alamos National Laboratory, 2011, LOS AL HIV SEQ DAT; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; McHardy AC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000566; Molmeret M, 2002, INFECT IMMUN, V70, P69, DOI 10.1128/IAI.70.1.69-78.2002; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; *NAT CTR BIOT INF, GEN; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; nternational Antiviral Society-USA, 2011, HIV DRUG RES MUT; Palacios G, 2008, NEW ENGL J MED, V358, P1204; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Preston A, 2004, NAT REV MICROBIOL, V2, P379, DOI 10.1038/nrmicro886; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Raoult D, 2003, GENOME RES, V13, P1800, DOI 10.1101/gr.1474603; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; Relman DA, 2001, TRENDS MICROBIOL, V9, P206, DOI 10.1016/S0966-842X(01)02041-8; Renesto P, 2003, LANCET, V362, P447, DOI 10.1016/S0140-6736(03)14071-8; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Scheutz F, 2011, EURO SURVEILL, V16; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Squires B, 2008, NUCLEIC ACIDS RES, V36, pD497, DOI 10.1093/nar/gkm905; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P16530, DOI 10.1073/pnas.0508532102; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2006, EXPERT REV VACCINES, V5, P687, DOI 10.1586/14760584.5.5.687; Tettelin H, 2009, METHODS MOL BIOL, V551, P231, DOI 10.1007/978-1-60327-999-4_18; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; US Department of Health and Human Services US Food and Drug Administration Center for Drug Evaluation and Research Center for Biologics Evaluation and Research Center for Devices and Radiological Health, 2009, PAN ANT GUID AD AD G, P1; Van Voorhis WC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000530; Venter JC, 2001, SCIENCE, V292, P1838; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wang RX, 2009, J CLIN MICROBIOL, V47, P3403, DOI 10.1128/JCM.01666-09; Wang RX, 2009, J CLIN MICROBIOL, V47, P2675, DOI 10.1128/JCM.01087-09; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Zimmermann M, 2010, CHEM BIOL, V17, P925, DOI 10.1016/j.chembiol.2010.08.006	87	113	123	0	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					347	357		10.1056/NEJMra1003071	http://dx.doi.org/10.1056/NEJMra1003071			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21793746	Green Accepted, Bronze			2022-12-28	WOS:000293172200013
J	Brook, RH				Brook, Robert H.			Facts, Facts, Facts: What Is a Physician to Do?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brook, Robert H.] RAND Corp, Santa Monica, CA 90401 USA; [Brook, Robert H.] David Geffen UCLA Sch Med, Santa Monica, CA 90401 USA	RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Brook, RH (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	robert_brook@rand.org						Organization for Economic Cooperation and Development, 2009, HLTH GLANC 2009, DOI [10.1787/health_glance-2009-en, DOI 10.1787/HEALTH_GLANCE-2009-EN]	1	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					432	433		10.1001/jama.2011.1021	http://dx.doi.org/10.1001/jama.2011.1021			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797KL	21791693				2022-12-28	WOS:000293125800031
J	Ferron, SR; Charalambous, M; Radford, E; McEwen, K; Wildner, H; Hind, E; Morante-Redolat, JM; Laborda, J; Guillemot, F; Bauer, SR; Farinas, I; Ferguson-Smith, AC				Ferron, Sacri R.; Charalambous, Marika; Radford, Elizabeth; McEwen, Kirsten; Wildner, Hendrik; Hind, Eleanor; Manuel Morante-Redolat, Jose; Laborda, Jorge; Guillemot, Francois; Bauer, Steven R.; Farinas, Isabel; Ferguson-Smith, Anne C.			Postnatal loss of Dlk1 imprinting in stem cells and niche astrocytes regulates neurogenesis	NATURE			English	Article							DIFFERENTIATION; EXPRESSION; GENES; ZONE; MOUSE-CHROMOSOME-12; PROLIFERATION; GTL2; GLIA	The gene for the atypical NOTCH ligand delta-like homologue 1 (Dlk1) encodes membrane-bound and secreted isoforms that function in several developmental processes in vitro and in vivo. Dlk1, a member of a cluster of imprinted genes, is expressed from the paternally inherited chromosome(1,2). Here we show that mice that are deficient in Dlk1 have defects in postnatal neurogenesis in the subventricular zone: a developmental continuum that results in depletion of mature neurons in the olfactory bulb. We show that DLK1 is secreted by niche astrocytes, whereas its membrane-bound isoform is present in neural stem cells (NSCs) and is required for the inductive effect of secreted DLK1 on self-renewal. Notably, we find that there is a requirement for Dlk1 to be expressed from both maternally and paternally inherited chromosomes. Selective absence of Dlk1 imprinting in both NSCs and niche astrocytes is associated with postnatal acquisition of DNA methylation at the germ-line-derived imprinting control region. The results emphasize molecular relationships between NSCs and the niche astrocyte cells of the microenvironment, identifying a signalling system encoded by a single gene that functions coordinately in both cell types. The modulation of genomic imprinting in a stem-cell environment adds a new level of epigenetic regulation to the establishment and maintenance of the niche, raising wider questions about the adaptability, function and evolution of imprinting in specific developmental contexts.	[Ferron, Sacri R.; Charalambous, Marika; Radford, Elizabeth; McEwen, Kirsten; Hind, Eleanor; Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Wildner, Hendrik; Guillemot, Francois] Natl Inst Med Res, MRC, Dept Mol Neurobiol, London NW7 1AA, England; [Manuel Morante-Redolat, Jose; Farinas, Isabel] Univ Valencia, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Biol Celular, E-46100 Burjassot, Spain; [Laborda, Jorge] Univ Castilla La Mancha, Reg Ctr Biomed Res, Sch Med, Dept Inorgan & Organ Chem & Biochem, Albacete 02006, Spain; [Bauer, Steven R.] US FDA, Cellular & Tissue Therapies Branch, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA	University of Cambridge; MRC National Institute for Medical Research; CIBERNED; University of Valencia; Universidad de Castilla-La Mancha; US Food & Drug Administration (FDA)	Ferguson-Smith, AC (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	afsmith@mole.bio.cam.ac.uk	Laborda, Jorge/L-5726-2014; Guillemot, Francois/AAV-1482-2021; Ferguson-Smith, Anne C/G-7534-2011; Ferrón, Sacri R./I-2958-2015; Bauer, Steven/G-5559-2012; Morante-Redolat, Jose Manuel/L-9397-2014; Farinas, Isabel/L-7118-2014	Laborda, Jorge/0000-0002-9210-838X; Ferrón, Sacri R./0000-0003-0854-8575; Morante-Redolat, Jose Manuel/0000-0003-0610-1665; McEwen, Kirsten/0000-0002-9173-5664; Charalambous, Marika/0000-0002-1684-5783; Farinas, Isabel/0000-0003-2903-4960; Bauer, Steven/0000-0003-2831-846X; Ferguson-Smith, Anne/0000-0002-7608-5894; Radford, Elizabeth/0000-0002-7829-5422	Medical Research Council; Wellcome Trust; Ministerio de Ciencia e Innovacion [SAF2008-01006, CB06/05/0086, RD06/0010/0010]; Generalitat Valenciana (Prometeo); University of Cambridge; MRC [G0800784, G0701196, MC_U117570528] Funding Source: UKRI; Medical Research Council [G0800784B, G0701196, G0800784, MC_U117570528] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana (Prometeo)(Center for Forestry Research & Experimentation (CIEF)); University of Cambridge(University of Cambridge); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to J. Herbert and E. B. Keverne for sharing expertise during the course of this work. We thank members of the Ferguson-Smith laboratory for discussions and B. Sun, D. Gray, S. Curran, I. Gutteridge, R. Rancourt and X. d'Anglemont de Tassigny for technical assistance. The work was funded by grants from the Medical Research Council and Wellcome Trust to A.C.F.-S. and by grants from Ministerio de Ciencia e Innovacion (SAF2008-01006, CB06/05/0086, RD06/0010/0010) and Generalitat Valenciana (Prometeo) to I. F. S. R. F. is a recipient of a University of Cambridge Herchel-Smith Fellowship.	Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Bauer M, 2008, J NEUROCHEM, V104, P1101, DOI 10.1111/j.1471-4159.2007.05037.x; Bray SJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-11; Christophersen NS, 2007, EXP NEUROL, V204, P791, DOI 10.1016/j.expneurol.2007.01.014; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Garcia-Marques J, 2010, GLIA, V58, P218, DOI 10.1002/glia.20918; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kornyei Z, 2005, GLIA, V49, P430, DOI 10.1002/glia.20123; Li L, 2005, ONCOGENE, V24, P4472, DOI 10.1038/sj.onc.1208637; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Mirzadeh Zaman, 2010, J Vis Exp, DOI 10.3791/1938; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Raghunandan R, 2008, STEM CELLS DEV, V17, P495, DOI 10.1089/scd.2007.0102; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Schmidt JV, 2000, GENE DEV, V14, P1997; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580	30	191	198	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					381	U136		10.1038/nature10229	http://dx.doi.org/10.1038/nature10229			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21776083	Green Submitted, Green Accepted			2022-12-28	WOS:000292911200043
J	Hoffman, BD; Grashoff, C; Schwartz, MA				Hoffman, Brenton D.; Grashoff, Carsten; Schwartz, Martin A.			Dynamic molecular processes mediate cellular mechanotransduction	NATURE			English	Review							MECHANICAL STRETCH; PHYSICAL RESPONSES; GENE-EXPRESSION; LIVING CELLS; ACTIN; FORCE; STRESS; INTEGRIN; TENSION; CYTOSKELETON	Cellular responses to mechanical forces are crucial in embryonic development and adult physiology, and are involved in numerous diseases, including atherosclerosis, hypertension, osteoporosis, muscular dystrophy, myopathies and cancer. These responses are mediated by load-bearing subcellular structures, such as the plasma membrane, cell-adhesion complexes and the cytoskeleton. Recent work has demonstrated that these structures are dynamic, undergoing assembly, disassembly and movement, even when ostensibly stable. An emerging insight is that transduction of forces into biochemical signals occurs within the context of these processes. This framework helps to explain how forces of varying strengths or dynamic characteristics regulate distinct signalling pathways.	[Hoffman, Brenton D.; Grashoff, Carsten; Schwartz, Martin A.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Schwartz, Martin A.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Schwartz, Martin A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Schwartz, MA (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.	maschwartz@virginia.edu		schwartz, martin/0000-0002-2071-1243	US Public Health Service [HL075092]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075092] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by R01 grant HL075092 from the US Public Health Service to M. A. S. and by a fellowship from the American Heart Association to B.D.H.	Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Asparuhova MB, 2009, SCAND J MED SCI SPOR, V19, P490, DOI 10.1111/j.1600-0838.2009.00928.x; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Bruinsma R, 2005, BIOPHYS J, V89, P87, DOI 10.1529/biophysj.104.048280; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chandrasekharan K, 2010, METHOD ENZYMOL, V479, P291, DOI 10.1016/S0076-6879(10)79017-0; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Chen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012035; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Dado D, 2009, SEMIN CELL DEV BIOL, V20, P656, DOI 10.1016/j.semcdb.2009.02.001; Dancu MB, 2006, J BIOMECH ENG-T ASME, V128, P329, DOI 10.1115/1.1824120; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; De RM, 2010, METHOD CELL BIOL, V98, P143, DOI 10.1016/S0091-679X(10)98007-2; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Ferrer JM, 2008, P NATL ACAD SCI USA, V105, P9221, DOI 10.1073/pnas.0706124105; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gardel ML, 2008, METHOD CELL BIOL, V89, P487, DOI 10.1016/S0091-679X(08)00619-5; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gelfand BD, 2006, J MAGN RESON IMAGING, V24, P1386, DOI 10.1002/jmri.20765; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Guo B, 2006, P NATL ACAD SCI USA, V103, P9844, DOI 10.1073/pnas.0601255103; Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053; Helmke BP, 2003, BIOPHYS J, V84, P2691, DOI 10.1016/S0006-3495(03)75074-7; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Hoffman BD, 2009, ANNU REV BIOMED ENG, V11, P259, DOI 10.1146/annurev.bioeng.10.061807.160511; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Hu Shaohua, 2006, Molecular & Cellular Biomechanics, V3, P49; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; KANDA K, 1993, CELL TRANSPLANT, V2, P475, DOI 10.1177/096368979300200606; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; Laurent S, 2005, HYPERTENSION, V45, P1050, DOI 10.1161/01.HYP.0000164580.39991.3d; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Lee H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011919; Lehoux S, 2005, CIRCULATION, V111, P643, DOI 10.1161/01.CIR.0000154548.16191.2F; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li Y, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194113; Liu B, 2008, BIOPHYS J, V94, P1497, DOI 10.1529/biophysj.106.098574; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Mack PJ, 2004, AM J PHYSIOL-CELL PH, V287, pC954, DOI 10.1152/ajpcell.00567.2003; Mallion JM, 1997, ADV EXP MED BIOL, V432, P123, DOI 10.1016/B978-012466615-3/50025-2; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; Maruthamuthu V, 2010, CURR OPIN CELL BIOL, V22, P583, DOI 10.1016/j.ceb.2010.07.010; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Miyata H, 1996, BBA-GEN SUBJECTS, V1290, P83, DOI 10.1016/0304-4165(96)00003-7; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Poh YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007886; Prezhdo OV, 2009, ACCOUNTS CHEM RES, V42, P693, DOI 10.1021/ar800202z; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Saratzis A, 2011, ANGIOLOGY, V62, P18, DOI 10.1177/0003319710373092; Sawada Y, 2001, J CELL SCI, V114, P1221; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Shafrir Y, 2002, AM J PHYSIOL-CELL PH, V282, pC479, DOI 10.1152/ajpcell.00394.2001; Smith MA, 2010, DEV CELL, V19, P365, DOI 10.1016/j.devcel.2010.08.008; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; Wang N, 2000, AM J PHYSIOL-CELL PH, V279, pC188, DOI 10.1152/ajpcell.2000.279.1.C188; Wehrle-Haller Bernhard, 2007, Methods Mol Biol, V370, P173; Wojtowicz A, 2010, CIRC RES, V107, P898, DOI 10.1161/CIRCRESAHA.110.227850; Yashiro K, 2007, NATURE, V450, P285, DOI 10.1038/nature06254; Yu HM, 2011, TRENDS CELL BIOL, V21, P47, DOI 10.1016/j.tcb.2010.08.015; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zheng W, 2008, AM J PHYSIOL-HEART C, V295, pH794, DOI 10.1152/ajpheart.00343.2008; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539; Ziegler WH, 2008, BIOCHEM SOC T, V36, P235, DOI 10.1042/BST0360235	95	649	660	13	414	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					316	323		10.1038/nature10316	http://dx.doi.org/10.1038/nature10316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21776077	Green Accepted			2022-12-28	WOS:000292911200032
J	Snyder, JS; Soumier, A; Brewer, M; Pickel, J; Cameron, HA				Snyder, Jason S.; Soumier, Amelie; Brewer, Michelle; Pickel, James; Cameron, Heather A.			Adult hippocampal neurogenesis buffers stress responses and depressive behaviour	NATURE			English	Article							GLUCOCORTICOID-RECEPTOR; TRANSGENIC MICE; ANIMAL-MODEL; ASTROCYTES; NEURONS; ANTIDEPRESSANTS; FOREBRAIN; LESIONS; BRAIN; RATS	Glucocorticoids are released in response to stressful experiences and serve many beneficial homeostatic functions. However, dysregulation of glucocorticoids is associated with cognitive impairments and depressive illness(1,2). In the hippocampus, a brain region densely populated with receptors for stress hormones, stress and glucocorticoids strongly inhibit adult neurogenesis(3). Decreased neurogenesis has been implicated in the pathogenesis of anxiety and depression, but direct evidence for this role is lacking(4,5). Here we show that adult-born hippocampal neurons are required for normal expression of the endocrine and behavioural components of the stress response. Using either transgenic or radiation methods to inhibit adult neurogenesis specifically, we find that glucocorticoid levels are slower to recover after moderate stress and are less suppressed by dexamethasone in neurogenesis-deficient mice than intact mice, consistent with a role for the hippocampus in regulation of the hypothalamic-pituitary-adrenal (HPA) axis(6,7). Relative to controls, neurogenesis-deficient mice also showed increased food avoidance in a novel environment after acute stress, increased behavioural despair in the forced swim test, and decreased sucrose preference, a measure of anhedonia. These findings identify a small subset of neurons within the dentate gyrus that are critical for hippocampal negative control of the HPA axis and support a direct role for adult neurogenesis in depressive illness.	[Snyder, Jason S.; Soumier, Amelie; Brewer, Michelle; Pickel, James; Cameron, Heather A.] NIMH, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Cameron, HA (corresponding author), NIMH, NIH, Bethesda, MD 20892 USA.	heathercameron@mail.nih.gov	Snyder, Jason/F-3435-2011; Cameron, Heather/E-6221-2011	Cameron, Heather/0000-0002-3245-5777; Snyder, Jason/0000-0002-5509-0272	National Institute of Mental Health, National Institutes of Health, USA [ZIA MH002784]; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002784, ZIAMH002784, ZICMH002901] Funding Source: NIH RePORTER	National Institute of Mental Health, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Sowers and J. Mitchell for help with irradiation, M. Brenner for providing the plasmid construct, GlaxoSmithKline for providing the antibody against HSV-TK, and K. Sanzone, F. Kamhi, L. Glover, S. Ferrante and L. Grigereit for assisting with mouse breeding and treatment. This research was supported by the Intramural Program of the National Institute of Mental Health, National Institutes of Health, USA, ZIA MH002784 (to H.A.C.).	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Anacker C, 2011, PSYCHONEUROENDOCRINO, V36, P415, DOI 10.1016/j.psyneuen.2010.03.007; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; BROWN TS, 1973, PHYSIOL BEHAV, V11, P833, DOI 10.1016/0031-9384(73)90278-3; Buccafusco JJ, 2009, METHODS BEHAV ANAL N; Burns KA, 2009, GLIA, V57, P1115, DOI 10.1002/glia.20835; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Delaney CL, 1996, J NEUROSCI, V16, P6908; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Drew Michael R., 2007, CNS & Neurological Disorders-Drug Targets, V6, P205, DOI 10.2174/187152707780619353; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; Furay AR, 2008, ENDOCRINOLOGY, V149, P5482, DOI 10.1210/en.2008-0642; Holsboer F, 2010, ANNU REV PSYCHOL, V61, P81, DOI 10.1146/annurev.psych.093008.100321; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; Roozendaal B, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn766; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2004, BIOL PSYCHIAT, V56, P137, DOI 10.1016/j.biopsych.2004.04.012; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158	30	972	1011	6	331	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2011	476	7361					458	U112		10.1038/nature10287	http://dx.doi.org/10.1038/nature10287			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21814201	Green Accepted			2022-12-28	WOS:000294209400038
J	Davis, MM; Walter, JK				Davis, Matthew M.; Walter, Jennifer K.			Equality-in-Quality in the Era of the Affordable Care Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH		[Davis, Matthew M.; Walter, Jennifer K.] Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res CHEAR Unit, Ann Arbor, MI 48109 USA; [Davis, Matthew M.; Walter, Jennifer K.] Univ Michigan, Robert Wood Johnson Fdn Clin Scholars Program, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Univ Michigan, Div Gen Med, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Davis, MM (corresponding author), Univ Michigan, Div Gen Pediat, Child Hlth Evaluat & Res CHEAR Unit, 300 NIB,6C23, Ann Arbor, MI 48109 USA.	mattdav@med.umich.edu						[Anonymous], THEORY JUSTICE; CDC, 1997, MMWR-MORBID MORTAL W, V46, P963; Daniels N, 1999, DAEDALUS, V128, P215; Institute of Medicine, 2009, HLTH EQ PAT CTR INT; Nussbaum M., 2001, WOMEN HUMAN DEV CAPA, V3; Sen A, 1992, INEQUALITY RE EXAMIN; *US AG HEALTHC RES, PUBL US AG HEALTHC R; Woolf SH, 2007, AM J PUBLIC HEALTH, V97, P679, DOI 10.2105/AJPH.2005.084848; Wooten K. G., 2010, Morbidity and Mortality Weekly Report, V59, P1171	9	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					872	873		10.1001/jama.2011.1208	http://dx.doi.org/10.1001/jama.2011.1208			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	810VY	21828310				2022-12-28	WOS:000294157300025
J	Struck, J; Olschlager, C; Le Targat, R; Soltan-Panahi, P; Eckardt, A; Lewenstein, M; Windpassinger, P; Sengstock, K				Struck, J.; Oelschlaeger, C.; Le Targat, R.; Soltan-Panahi, P.; Eckardt, A.; Lewenstein, M.; Windpassinger, P.; Sengstock, K.			Quantum Simulation of Frustrated Classical Magnetism in Triangular Optical Lattices	SCIENCE			English	Article							ULTRACOLD ATOMS; PHYSICS; ICE; GASES	Magnetism plays a key role in modern technology and stimulates research in several branches of condensed matter physics. Although the theory of classical magnetism is well developed, the demonstration of a widely tunable experimental system has remained an elusive goal. Here, we present the realization of a large-scale simulator for classical magnetism on a triangular lattice by exploiting the particular properties of a quantum system. We use the motional degrees of freedom of atoms trapped in an optical lattice to simulate a large variety of magnetic phases: ferromagnetic, antiferromagnetic, and even frustrated spin configurations. A rich phase diagram is revealed with different types of phase transitions. Our results provide a route to study highly debated phases like spin-liquids as well as the dynamics of quantum phase transitions.	[Struck, J.; Oelschlaeger, C.; Le Targat, R.; Soltan-Panahi, P.; Windpassinger, P.; Sengstock, K.] Univ Hamburg, Inst Laser Phys, D-22761 Hamburg, Germany; [Eckardt, A.; Lewenstein, M.] Inst Ciencies Foton, E-08860 Barcelona, Spain; [Lewenstein, M.] Inst Catalana Ric & Estudis Avancats, E-08010 Barcelona, Spain	University of Hamburg; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); ICREA	Sengstock, K (corresponding author), Univ Hamburg, Inst Laser Phys, D-22761 Hamburg, Germany.	klaus.sengstock@physnet.uni-hamburg.de	Struck, Julian/E-2297-2012; Lewenstein, Maciej/I-1337-2014; Le Targat, Rodolphe/AAC-1305-2019; Eckardt, André/C-9895-2009; Windpassinger, Patrick J/D-6169-2014	Lewenstein, Maciej/0000-0002-0210-7800; Le Targat, Rodolphe/0000-0002-8740-1709; Eckardt, André/0000-0002-5542-3516; Struck, Julian/0000-0002-9728-1632	Deutsche Forschungsgemeinschaft [FOR 801, GRK 1355]; Landesexzellenzinitiative Hamburg; Joachim Herz Stiftung; Spanish Ministerio de Ciencia y Innovacion; European Research Council; European Union; ICREA Funding Source: Custom	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesexzellenzinitiative Hamburg; Joachim Herz Stiftung; Spanish Ministerio de Ciencia y Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); ICREA(ICREA)	We thank A. Rosch, P. Hauke, and D.-S. Luhmann for stimulating discussions and the Deutsche Forschungsgemeinschaft (FOR 801, GRK 1355) and the Landesexzellenzinitiative Hamburg, which is supported by the Joachim Herz Stiftung, for funding. A. E. and M. L. are grateful for support through the Spanish Ministerio de Ciencia y Innovacion grant TOQATA, European Research Council grant QUAGATUA, and European Union grants AQUTE and NAMEQUAM.	Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Becker C, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065025; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Eckardt A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.260404; Eckardt A, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/10010; Fennell T, 2009, SCIENCE, V326, P415, DOI 10.1126/science.1177582; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Lignier H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.220403; Lin YJ, 2009, NATURE, V462, P628, DOI 10.1038/nature08609; Ma XS, 2011, NAT PHYS, V7, P399, DOI 10.1038/NPHYS1919; Moessner R, 2006, PHYS TODAY, V59, P24, DOI 10.1063/1.2186278; Morris DJP, 2009, SCIENCE, V326, P411, DOI 10.1126/science.1178868; Pauling L, 1935, J AM CHEM SOC, V57, P2680, DOI 10.1021/ja01315a102; Sachdev S, 2008, NAT PHYS, V4, P173, DOI 10.1038/nphys894; Schmied R, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/045017; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; WANNIER GH, 1950, PHYS REV, V79, P357, DOI 10.1103/PhysRev.79.357; Wirth G, 2011, NAT PHYS, V7, P147, DOI [10.1038/nphys1857, 10.1038/NPHYS1857]; Zwerger W, 2009, SCIENCE, V325, P1507, DOI 10.1126/science.1179767	22	487	490	1	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2011	333	6045					996	999		10.1126/science.1207239	http://dx.doi.org/10.1126/science.1207239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808TD	21778359	Green Submitted			2022-12-28	WOS:000294000400050
J	Polkinghorne, KR				Polkinghorne, Kevan R.			An antimicrobial, antithrombotic lock solution reduced catheter-related bloodstream infections in patients receiving dialysis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Monash Univ, Melbourne, Vic 3004, Australia	Monash University	Polkinghorne, KR (corresponding author), Monash Univ, Melbourne, Vic 3004, Australia.							[Anonymous], 2006, AM J KIDNEY DIS S, V48, pS176, DOI DOI 10.1053/J.AJKD.2006.04.029; James MT, 2008, ANN INTERN MED, V148, P596, DOI 10.7326/0003-4819-148-8-200804150-00004; Polkinghorne KR, 2009, AM J KIDNEY DIS, V53, P359, DOI 10.1053/j.ajkd.2009.01.010; Rabindranath KS, 2009, NEPHROL DIAL TRANSPL, V24, P3763, DOI 10.1093/ndt/gfp327	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4							JC2-11	10.7326/0003-4819-155-4-201108160-02011	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LM	21844544				2022-12-28	WOS:000208885100010
J	Boyce, N				Boyce, Niall			The Lancet Technology: August, 2011	LANCET			English	Editorial Material												niall.boyce@lancet.com							0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 6	2011	378	9790					475	475		10.1016/S0140-6736(11)61237-3	http://dx.doi.org/10.1016/S0140-6736(11)61237-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	809SO	21826807				2022-12-28	WOS:000294077200013
J	Sato, Y; Iketani, M; Kurihara, Y; Yamaguchi, M; Yamashita, N; Nakamura, F; Arie, Y; Kawasaki, T; Hirata, T; Abe, T; Kiyonari, H; Strittmatter, SM; Goshima, Y; Takei, K				Sato, Yasufumi; Iketani, Masumi; Kurihara, Yuji; Yamaguchi, Megumi; Yamashita, Naoya; Nakamura, Fumio; Arie, Yuko; Kawasaki, Takahiko; Hirata, Tatsumi; Abe, Takaya; Kiyonari, Hiroshi; Strittmatter, Stephen M.; Goshima, Yoshio; Takei, Kohtaro			Cartilage Acidic Protein-1B (LOTUS), an Endogenous Nogo Receptor Antagonist for Axon Tract Formation	SCIENCE			English	Article							LATERAL OLFACTORY TRACT; MITRAL CELL AXONS; NERVOUS-SYSTEM; IDENTIFICATION; REGENERATION; INHIBITION; EXPRESSION; GROWTH	Neural circuitry formation depends on the molecular control of axonal projection during development. By screening with fluorophore-assisted light inactivation in the developing mouse brain, we identified cartilage acidic protein-1B as a key molecule for lateral olfactory tract (LOT) formation and named it LOT usher substance (LOTUS). We further identified Nogo receptor-1 (NgR1) as a LOTUS-binding protein. NgR1 is a receptor of myelin-derived axon growth inhibitors, such as Nogo, which prevent neural regeneration in the adult. LOTUS suppressed Nogo-NgR1 binding and Nogo-induced growth cone collapse. A defasciculated LOT was present in lotus-deficient mice but not in mice lacking both lotus- and ngr1. These findings suggest that endogenous antagonism of NgR1 by LOTUS is crucial for normal LOT formation.	[Sato, Yasufumi; Iketani, Masumi; Kurihara, Yuji; Yamaguchi, Megumi; Yamashita, Naoya; Nakamura, Fumio; Arie, Yuko; Goshima, Yoshio; Takei, Kohtaro] Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan; [Kawasaki, Takahiko; Hirata, Tatsumi] Natl Inst Genet, Grad Sch Adv Studies, Div Brain Funct, Mishima, Shizuoka 4118540, Japan; [Abe, Takaya; Kiyonari, Hiroshi] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; [Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; [Strittmatter, Stephen M.] Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA; [Goshima, Yoshio; Takei, Kohtaro] Yokohama City Univ, Grad Sch Med, Adv Med Res Ctr, Yokohama, Kanagawa 2360004, Japan	Yokohama City University; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; RIKEN; Yale University; Yale University; Yokohama City University	Goshima, Y (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan.	goshima@med.yokohama-cu.ac.jp; kohtaro@med.yokohama-cu.ac.jp	Kiyonari, Hiroshi/N-7936-2015; Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092; Kawasaki, Takahiko/0000-0001-9939-8407	Core Research for Evolutionary Science Technology (CREST) of the Japan Science and Technology Agency; Ministry of Education, Culture, Sport, Science, and Technology of Japan; Dr. Ralph and Marion Falk Medical Research Trust; NIH; Yokohama City University, Japan [S2107]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033020] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23657151, 21700387, 23500452] Funding Source: KAKEN	Core Research for Evolutionary Science Technology (CREST) of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Dr. Ralph and Marion Falk Medical Research Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yokohama City University, Japan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by grants from the Core Research for Evolutionary Science Technology (CREST) of the Japan Science and Technology Agency (to Y.S., T.H., Y.G., and K.T.); grants-in-aid from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (to T.H. and K.T.); grants from the Dr. Ralph and Marion Falk Medical Research Trust and the NIH (to S.M.S.); and a grant for Research and Development Project II (No. S2107) of Yokohama City University, Japan (to Y.G. and K.T.). The authors thank T. Takeyama and Y. Saito at the Olympus Corporation (Tokyo, Japan) for technical assistance with FALI; H. Sekiguchi-Kaneko, T. Okada, M. Ogawara, and S. Chen for technical assistance; and Y. Sasaki, K. Ogura, K. Nishiyama, H. Ito, and T. Takahashi for helpful discussions and comments. K.T. and Y.S. designed the study, and K.T. and Y.G. supervised the experiments, data analysis, and interpretation. The experiments were carried out by Y.S., M.I., Y.K., M.Y., N.Y., F.N., Y.A., and K.T. T.K. and T.H. generated the mouse cDNA expression library of the olfactory bulb and collaborated on the production of monoclonal antibodies. T.A. and H.K. collaborated on the generation of crtac1B (lotus)-deficient mice. S.M.S. collaborated on experiments using ngr1-deficient mice and NgR2-3. K.T. wrote the paper, and Y.S., F.N., N.Y., and Y.G. edited the manuscript. S.M.S. is a cofounder and consultant of Axerion Therapeutics. Yale University holds a patent licensed to Axerion Therapeutics related to Ngr1 receptor blockers for recovery from central nervous system damage. Yokohama City University has a patent pending on Crtac 1B(LOTUS) function in neuronal cell growth. Materials transfer agreements restrict the use of Crtac1B(LOTUS) knockout mice and NgR1 knockout mice and expression constructs of NgR1, NgR2, and NgR3 proteins.	Beck S, 2002, PROTEOMICS, V2, P247, DOI 10.1002/1615-9861(200203)2:3<247::AID-PROT247>3.0.CO;2-K; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hirata T, 1999, J NEUROBIOL, V38, P93; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Kawakami A, 1996, J NEUROBIOL, V29, P1, DOI 10.1002/(SICI)1097-4695(199601)29:1<1::AID-NEU1>3.0.CO;2-F; Kawasaki T, 2005, J NEUROBIOL, V62, P330, DOI 10.1002/neu.20105; Liu BP, 2006, PHILOS T R SOC B, V361, P1593, DOI 10.1098/rstb.2006.1891; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; LOFTUS JC, 1994, J BIOL CHEM, V269, P25235; LopezMascaraque L, 1996, NEUROSCIENCE, V70, P255, DOI 10.1016/0306-4522(95)00360-U; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Sato Y, 1998, J NEUROSCI, V18, P7800; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; Shipley MT, 1996, J NEUROBIOL, V30, P123; Steck E, 2001, BIOCHEM J, V353, P169, DOI 10.1042/0264-6021:3530169; Steck E, 2007, MATRIX BIOL, V26, P30, DOI 10.1016/j.matbio.2006.09.006; Sugisaki N, 1996, J NEUROBIOL, V29, P127, DOI 10.1002/(SICI)1097-4695(199602)29:2<127::AID-NEU1>3.0.CO;2-C; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tozaki H, 2002, MOL BRAIN RES, V104, P111, DOI 10.1016/S0169-328X(02)00172-9; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	22	59	61	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					769	773		10.1126/science.1204144	http://dx.doi.org/10.1126/science.1204144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817055	Green Accepted			2022-12-28	WOS:000293512100047
J	Funk, C				Funk, Chris			We thought trouble was coming	NATURE			English	Editorial Material									Univ Calif Santa Barbara, Dept Geog, Climate Hazard Grp, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Funk, C (corresponding author), Univ Calif Santa Barbara, Dept Geog, Climate Hazard Grp, Santa Barbara, CA 93106 USA.	cfunk@usgs.gov		Funk, Chris/0000-0002-9254-6718					0	42	43	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					7	7		10.1038/476007a	http://dx.doi.org/10.1038/476007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	801NR	21814237	Bronze			2022-12-28	WOS:000293447300003
J	Jin, K; Butch, NP; Kirshenbaum, K; Paglione, J; Greene, RL				Jin, K.; Butch, N. P.; Kirshenbaum, K.; Paglione, J.; Greene, R. L.			Link between spin fluctuations and electron pairing in copper oxide superconductors	NATURE			English	Article							TEMPERATURE; TRANSITION	Although it is generally accepted that superconductivity is unconventional in the high-transition-temperature copper oxides, the relative importance of phenomena such as spin and charge (stripe) order, superconductivity fluctuations, proximity to a Mott insulator, a pseudogap phase and quantum criticality are still a matter of debate(1). In electron-doped copper oxides, the absence of an anomalous pseudogap phase in the underdoped region of the phase diagram(2) and weaker electron correlations(3,4) suggest that Mott physics and other unidentified competing orders are less relevant and that antiferromagnetic spin fluctuations are the dominant feature. Here we report a study of magnetotransport in thin films of the electron-doped copper oxide La2-xCexCuO4. We show that a scattering rate that is linearly dependent on temperature-a key feature of the anomalous normal state properties of the copper oxides-is correlated with the electron pairing. We also show that an envelope of such scattering surrounds the superconducting phase, surviving to zero temperature when superconductivity is suppressed by magnetic fields. Comparison with similar behaviour found in organic superconductors(5) strongly suggests that the linear dependence on temperature of the resistivity in the electron-doped copper oxides is caused by spin-fluctuation scattering.	[Jin, K.; Butch, N. P.; Kirshenbaum, K.; Paglione, J.; Greene, R. L.] Univ Maryland, Ctr Nanophys Adv Mat, College Pk, MD 20742 USA; [Jin, K.; Butch, N. P.; Kirshenbaum, K.; Paglione, J.; Greene, R. L.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Greene, RL (corresponding author), Univ Maryland, Ctr Nanophys Adv Mat, College Pk, MD 20742 USA.	rgreene@squid.umd.edu	Jin, Kui/D-8814-2018; Jin, Kui/B-1324-2011; Paglione, Johnpierre/B-4433-2018; Jin, Kui/AAT-4728-2021	Jin, Kui/0000-0003-2208-8501; Paglione, Johnpierre/0000-0001-7257-014X; Jin, Kui/0000-0003-2208-8501	NSF [DMR-0952716, DMR-0653535]; Maryland Center for Nanophysics and Advanced Materials	NSF(National Science Foundation (NSF)); Maryland Center for Nanophysics and Advanced Materials	We thank L. Taillefer for extensive discussions and N. Doiron-Leyraud for some preliminary analysis of our zero-field data. We also appreciate discussions with A. Chubukov, A. Millis and C. Varma. Some experimental help was provided by X. Zhang, P. Bach and G. Droulers. This research was supported by the NSF under DMR-0952716 (J.P. and K. K.) and DMR-0653535 (R. L. G.) and the Maryland Center for Nanophysics and Advanced Materials (K.J. and N.P.B.).	Armitage NP, 2010, REV MOD PHYS, V82, P2421, DOI 10.1103/RevModPhys.82.2421; Bourbonnais C, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.085105; Cooper RA, 2009, SCIENCE, V323, P603, DOI 10.1126/science.1165015; Dagan Y, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.167001; Daou R, 2009, NAT PHYS, V5, P31, DOI [10.1038/nphys1109, 10.1038/NPHYS1109]; Dhokarh D, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.064518; Doiron-Leyraud N, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.214531; Fournier P, 1998, PHYS REV LETT, V81, P4720, DOI 10.1103/PhysRevLett.81.4720; Fujita M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107003; Helm T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.157002; Jin K, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.172503; Jin K, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.012501; Jin K, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.174521; KUBO Y, 1991, PHYS REV B, V43, P7875, DOI 10.1103/PhysRevB.43.7875; Lin J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.214506; Matsui H, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.224514; Monthoux P, 2007, NATURE, V450, P1177, DOI 10.1038/nature06480; Moriya T, 2000, ADV PHYS, V49, P555, DOI 10.1080/000187300412248; Motoyama EM, 2007, NATURE, V445, P186, DOI 10.1038/nature05437; Nakamae S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.100502; Norman MR, 2011, SCIENCE, V332, P196, DOI 10.1126/science.1200181; Rosch A, 2000, PHYS REV B, V62, P4945, DOI 10.1103/PhysRevB.62.4945; Sachdev S, 2011, PHYS TODAY, V64, P29, DOI 10.1063/1.3554314; Sawa A, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.014531; SCALAPINO DJ, 1995, PHYS REP, V250, P330; Senechal D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126401; Taillefer L, 2010, ANNU REV CONDEN MA P, V1, P51, DOI 10.1146/annurev-conmatphys-070909-104117; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Weber C, 2010, NAT PHYS, V6, P574, DOI 10.1038/NPHYS1706	29	148	152	11	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					73	75		10.1038/nature10308	http://dx.doi.org/10.1038/nature10308			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21814279				2022-12-28	WOS:000293447300031
J	Krystal, JH; Rosenheck, RA; Cramer, JA; Vessicchio, JC; Jones, KM; Vertrees, JE; Horney, RA; Huang, GD; Stock, C				Krystal, John H.; Rosenheck, Robert A.; Cramer, Joyce A.; Vessicchio, Jennifer C.; Jones, Karen M.; Vertrees, Julia E.; Horney, Rebecca A.; Huang, Grant D.; Stock, Christopher		Vet Affairs Cooperative Study 504	Adjunctive Risperidone Treatment for Antidepressant-Resistant Symptoms of Chronic Military Service-Related PTSD A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; OF-VETERANS-AFFAIRS; MENTAL-HEALTH PROBLEMS; DOUBLE-BLIND; PLACEBO; SCALE; SERTRALINE; COMBAT; PRAZOSIN; PHARMACOTHERAPY	Context Serotonin reuptake-inhibiting (SRI) antidepressants are the only FDA-approved pharmacotherapies for the treatment of posttraumatic stress disorder (PTSD). Objective To determine efficacy of the second-generation antipsychotic risperidone as an adjunct to ongoing pharmacologic and psychosocial treatments for veterans with chronic military-related PTSD. Design, Setting, and Participants A 6-month, randomized, double-blind, placebo-controlled multicenter trial conducted between February 2007 and February 2010 at 23 Veterans Administration outpatient medical centers. Of the 367 patients screened, 296 were diagnosed with military-related PTSD and had ongoing symptoms despite at least 2 adequate SRI treatments, and 247 contributed to analysis of the primary outcome measure. Intervention Risperidone (up to 4 mg once daily) or placebo. Main Outcome Measures The Clinician-Administered PTSD Scale (CAPS) (range, 0-136). Other measures included the Montgomery-Asberg Depression Rating Scale (MADRS), Hamilton Anxiety Scale (HAMA), Clinical Global Impression scale (CGI), and Veterans RAND 36-Item Health Survey (SF-36V). Results Change in CAPS scores from baseline to 24 weeks in the risperidone group was -16.3(95% CI, -19.7 to -12.9) and in the placebo group, -12.5(95% CI, -15.7 to -9.4); the mean difference was 3.74(95% CI, -0.86 to 8.35; t=1.6; P=.11). Mixed model analysis of all time points also showed no significant difference in CAPS score (risperidone: mean, 64.43; 95% CI, 61.98 to 66.89, vs placebo: mean, 67.16; 95% CI, 64.71 to 69.62; mean difference, 2.73; 95% CI, -0.74 to 6.20; P=.12). Risperidone did not reduce symptoms of depression (MADRS mean difference, 1.19; 95% CI, -0.29 to 2.68; P=.11) or anxiety (HAMA mean difference, 1.16; 95% CI, -0.18 to 2.51; P=.09; patient-rated CGI mean difference, 0.20; 95% CI, -0.06 to 0.45; P=.14; observer-rated CGI mean difference, 0.18; 95% CI, 0.01 to 0.34; P=.04), or increase quality of life (SF-36V physical component mean difference, -1.13, 95% CI, -2.58 to 0.32; P=.13; SF-36V mental component mean difference, -0.26; 95% CI, -2.13 to 1.61; P=.79). Adverse events were more common with risperidone vs placebo, including self-reported weight gain(15.3% vs 2.3%), fatigue(13.7% vs 0.0%), somnolence (9.9% vs 1.5%), and hypersalivation (9.9% vs 0.8%), respectively. Conclusion Among patients with military-related PTSD with SRI-resistant symptoms, 6-month treatment with risperidone compared with placebo did not reduce PTSD symptoms.	[Krystal, John H.; Rosenheck, Robert A.; Cramer, Joyce A.; Vessicchio, Jennifer C.] VA Connecticut Healthcare Syst, Psychiat Serv, West Haven, CT USA; [Krystal, John H.; Rosenheck, Robert A.; Cramer, Joyce A.; Vessicchio, Jennifer C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Krystal, John H.] Yale Univ, New Haven Hosp, Psychiat Serv, New Haven, CT USA; [Rosenheck, Robert A.] VA New England Mental Illness Res Educ & Clin Ctr, West Haven, CT USA; [Jones, Karen M.; Horney, Rebecca A.] VA Cooperat Studies Program Coordinating Ctr, Perry Point, MD USA; [Vertrees, Julia E.] Clin Res Pharm Coordinating Ctr, VA Cooperat Studies Program, Albuquerque, NM USA; [Huang, Grant D.] VA Off Res & Dev, Cooperat Studies Program Cent Off, Washington, DC USA; [Stock, Christopher] VA Med Ctr, Mental Hlth Serv, Dept Pharm, Salt Lake City, UT USA; [Krystal, John H.] VA Connecticut Healthcare Syst, Clin Neurosci Div, Dept Vet Affairs, Natl Ctr PTSD, West Haven, CT USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Krystal, JH (corresponding author), VA Connecticut Healthcare Syst 151 D, 950 Campbell Ave, West Haven, CT USA.	john.krystal@yale.edu	Marmar, Charles R./O-1902-2017	Marmar, Charles R./0000-0001-8427-5607	Janssen Research Foundation; Eli Lilly; Janssen Pharmaceutica; Astra-Zeneca; Wyeth Pharmaceuticals; Department of Veterans Affairs Office of Research and Development	Janssen Research Foundation(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Eli Lilly(Eli Lilly); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Astra-Zeneca(AstraZeneca); Wyeth Pharmaceuticals(Wyeth); Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Krystal reported having received research support from Janssen Research Foundation; having been a consultant to Aisling Capital, AstraZeneca, Brintnall and Nicolini, Bristol-Myers Squibb, Easton and Associates, Eli Lilly, F. Hoffman LaRoche, Forest Laboratories, Gilead Sciences, GlaxoSmithKline, Janssen, Lundbeck Research USA, Medivation, Merz Pharmaceuticals, MK Medical Communications, Naurex, Pfizer, SK Holdings, Sunovion Pharmaceuticals, Takeda Industries, Tetragenex, and Teva Pharmaceutical Industries; having patents for glutamatergic treatment of neuropsychiatric disorders and intranasal administration of ketamine to treat depression (pending); having served on the scientific advisory boards for Abbott, Bristol-Myers Squibb, Eisai, Eli Lilly, Forest Laboratories, Lohocla Research Corporation, Mnemosyne Pharmaceuticals, Naurex, Pfizer, and Shire; and being the editor of Biological Psychiatry and president elect of the American College of Neuropsychopharmacology. Dr Rosenheck reported having received research support from Eli Lilly, Janssen Pharmaceutica, Astra-Zeneca, and Wyeth Pharmaceuticals; having been a consultant to GlaxoSmithKline, Bristol-Myers Squibb, Organon, Janssen Pharmaceutica, and Otsuka; having provided expert testimony for the plaintiffs in UFCW Local 1776 and Participating Employers Health and Welfare Fund, et al v Eli Lilly and Company; for the respondent in Eli Lilly Canada Inc v Novapharm Ltd and Minister of Health respondent; and for the Patent Medicine Prices Review Board of Canada in the matter of Janssen Ortho Inc and "Risperdal Consta"; and being a testifying expert in Jones ex rel the State of Texas v Janssen Pharmaceutica et al. No other conflicts were reported.; This study was supported by the Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development. Risperidone and matching placebo were donated to the VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center (Albuquerque, New Mexico) by Ortho-McNeil Janssen Scientific Affairs. Ortho-McNeil Janssen Scientific Affairs also contributed a total of $606 219 to the Baltimore Research and Education Foundation on behalf of the VA Cooperative Studies Program.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; Berger W, 2009, PROG NEURO-PSYCHOPH, V33, P169, DOI 10.1016/j.pnpbp.2008.12.004; Blake D. D., 1990, BEHAV THERAPIST, V18, P187, DOI DOI 10.1007/BF02105408; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brady K, 2000, JAMA-J AM MED ASSOC, V283, P1837, DOI 10.1001/jama.283.14.1837; Cramer JA, 1999, J NERV MENT DIS, V187, P53, DOI 10.1097/00005053-199901000-00009; Davidson JRT, 2004, INT CLIN PSYCHOPHARM, V19, P85, DOI 10.1097/00004850-200403000-00005; Davidson JRT, 2001, ARCH GEN PSYCHIAT, V58, P485, DOI 10.1001/archpsyc.58.5.485; First M.B., 2014, STRUCTURED CLIN INTE; Fontana A, 1997, AM J PSYCHIAT, V154, P758; Friedman MJ, 2007, J CLIN PSYCHIAT, V68, P711, DOI 10.4088/JCP.v68n0508; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Guy W., 1976, ECDEU ASSESSMENT MAN, P534; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hammer MB, 2003, INT CLIN PSYCHOPHARM, V18, P1, DOI 10.1097/01.yic.0000050744.67514.6d; Hamner Mark B, 2005, Expert Rev Neurother, V5, P267, DOI 10.1586/14737175.5.2.267; Harpaz-Rotem I, 2009, ARCH GEN PSYCHIAT, V66, P417, DOI 10.1001/archgenpsychiatry.2008.536; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hertzberg M A, 2000, Ann Clin Psychiatry, V12, P101, DOI 10.3109/10401230009147096; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; KAY SR, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P59, DOI 10.1192/S0007125000291514; Krystal JH, 2001, NEW ENGL J MED, V345, P1734, DOI 10.1056/NEJMoa011127; Kulka R.A., 1990, TRAUMA VIETNAM WAR G; Leslie DL, 2009, PSYCHIAT SERV, V60, P1174, DOI 10.1176/ps.2009.60.9.1175; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lunney CA, 2007, J TRAUMA STRESS, V20, P955, DOI 10.1002/jts.20269; Marshall RD, 2001, AM J PSYCHIAT, V158, P1982, DOI 10.1176/appi.ajp.158.12.1982; Mellman TA, 2003, PSYCHIAT SERV, V54, P1618, DOI 10.1176/appi.ps.54.12.1618; Mohamed S, 2008, J CLIN PSYCHIAT, V69, P959, DOI 10.4088/JCP.v69n0611; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Pae CU, 2008, INT CLIN PSYCHOPHARM, V23, P1, DOI 10.1097/YIC.0b013e32825ea324; Pivac N, 2006, CROAT MED J, V47, P440; Raskind MA, 2007, BIOL PSYCHIAT, V61, P928, DOI 10.1016/j.biopsych.2006.06.032; Rothbaum BO, 2008, J CLIN PSYCHIAT, V69, P520, DOI 10.4088/JCP.v69n0402; Schnurr PP, 2001, CONTROL CLIN TRIALS, V22, P74, DOI 10.1016/S0197-2456(00)00118-5; Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606; SIMPSON GM, 1970, ACTA PSYCHIAT SCAND, P11; Smith A. A., 2001, ANN M INT SOC TRAUM; SOBELL LC, 1988, BRIT J ADDICT, V83, P393; Taylor FB, 2006, BIOL PSYCHIAT, V59, P577, DOI 10.1016/j.biopsych.2005.09.023; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tucker P, 2001, J CLIN PSYCHIAT, V62, P860, DOI 10.4088/JCP.v62n1105; VANDERKOLK BA, 1994, J CLIN PSYCHIAT, V55, P517; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	47	172	176	2	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2011	306	5					493	502		10.1001/jama.2011.1080	http://dx.doi.org/10.1001/jama.2011.1080			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800SH	21813427	Bronze			2022-12-28	WOS:000293386500016
J	Abubakar, I; Lipman, M; Anderson, C; Davies, P; Zumla, A				Abubakar, Ibrahim; Lipman, Marc; Anderson, Charlotte; Davies, Peter; Zumla, Alimuddin			Tuberculosis in the UK-time to regain control	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEW-YORK-CITY; ASYLUM SEEKERS; IMMIGRATION; EPIDEMIOLOGY; POLITICS; ENGLAND; IMPACT; ENTRY; CARE		[Abubakar, Ibrahim] Hlth Protect Agcy, Hlth Protect Serv Colindale, TB Sect, London NW9 5EQ, England; [Abubakar, Ibrahim] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Lipman, Marc] UCL, Sch Med, Royal Free Hosp, Ctr Resp Med, London W1N 8AA, England; [Anderson, Charlotte] Hlth Protect Agcy, London Reg Epidemiol Unit, London, England; [Davies, Peter] Liverpool Heart & Chest Hosp, TB Unit, Liverpool, Merseyside, England; [Zumla, Alimuddin] UCL, Sch Med, Div Infect & Immun, London WC1E 6BT, England	Health Protection Agency; University of East Anglia; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Health Protection Agency; Liverpool Heart & Chest Hospital; University of London; University College London; UCL Medical School	Abubakar, I (corresponding author), Hlth Protect Agcy, Hlth Protect Serv Colindale, TB Sect, London NW9 5EQ, England.	ibrahim.abubakar@hpa.org.uk	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735; Abubakar, Ibrahim/0000-0002-0370-1430; Lipman, Marc/0000-0001-7501-4448				Abubakar I, 2010, COST EFFECTIVENESS F; Ahmed AB, 2007, THORAX, V62, P672, DOI 10.1136/thx.2006.072611; Anderson C, 2011, EVALUATION IMPLEMENT; Anderson C, 2010, J EPIDEMIOL COMMUN H, V64, P373, DOI 10.1136/jech.2009.094375; Borgdorff MW, 2010, EUR RESPIR J, V36, P339, DOI 10.1183/09031936.00155409; *BRIT THOR SOC ALL, 2008, PUTT TUB LOC AG; Erkens C, 2008, EUR RESPIR J, V32, P153, DOI 10.1183/09031936.00137907; [European Centre for Disease Prevention and Control WHO], 2003, TUB SURV REP; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; GEITER L, 2000, ENDING NEGLECT ELIMI; Gilbert RL, 2009, INT J TUBERC LUNG D, V13, P645; Griffiths C, 2007, LANCET, V369, P1528, DOI 10.1016/S0140-6736(07)60707-7; Harstad I, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-670; Hayward J, 2010, LONDON TB SERVICE RE; Health Protection Agency, ENH TB SURV; Health Protection Agency, 2010, TUB UK ANN REP TUB S; Hollo V, 2009, EUROSURVEILLANCE, V14; Love J, 2009, INT J TUBERC LUNG D, V13, P201; Lowenthal P, 2011, INT J TUBERC LUNG D, V15, P761, DOI 10.5588/ijtld.10.0370; Moore-Gillon J, 2010, THORAX, V65, P663, DOI 10.1136/thx.2009.132373; New York Health Department, 2008, CLIN POL PROT; NICE, 2011, TUB CG117 CLIN DIAGN; Paolo WF, 2004, LANCET INFECT DIS, V4, P287, DOI 10.1016/S1473-3099(04)01004-7; Pareek M, 2011, EUR RESPIR J, V37, P1175, DOI 10.1183/09031936.00105810; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; Story A, 2006, BRIT MED J, V333, P57, DOI 10.1136/bmj.333.7558.57; Taylor K, 2009, BRIT J GEN PRACT, V59, P765, DOI 10.3399/bjgp09X472539; Watson J, 2007, MOBILE TARGETED DIGI	29	42	42	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2011	343								d4281	10.1136/bmj.d4281	http://dx.doi.org/10.1136/bmj.d4281			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LY	21804155				2022-12-28	WOS:000293441600001
J	Kurotobi, K; Murata, Y				Kurotobi, Kei; Murata, Yasujiro			A Single Molecule of Water Encapsulated in Fullerene C-60	SCIENCE			English	Article							KR-AT-C-60	Water normally exists in hydrogen-bonded environments, but a single molecule of H2O without any hydrogen bonds can be completely isolated within the confined subnano space inside fullerene C-60. We isolated bulk quantities of such a molecule by first synthesizing an open-cage C-60 derivative whose opening can be enlarged in situ at 120 degrees C that quantitatively encapsulated one water molecule under the high-pressure conditions. The relatively simple method was developed to close the cage and encapsulate water. The structure of H2O@C-60 was determined by single-crystal x-ray analysis, along with its physical and spectroscopic properties.	[Kurotobi, Kei; Murata, Yasujiro] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan	Kyoto University	Murata, Y (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	yasujiro@scl.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT, Japan [B-09];  [20108003];  [23241032]; Grants-in-Aid for Scientific Research [20108003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) project on Integrated Research on Chemical Synthesis, Grants-in-Aid for Scientific Research on Innovative Areas (20108003, pi-Space) and for Scientific Research (A) (23241032), and the Global COE Program Integrated Materials Science (B-09) from MEXT, Japan. The structural coordinates have been deposited with the Cambridge Data Bank. The accession numbers for the three x-ray structures are as follows: 5a center dot (o-xylene)<INF>2.5</INF>, CCDC 828041; H<INF>2</INF>O@C<INF>60</INF> center dot (NiOEP)<INF>2</INF>, CCDC 828029; empty C<INF>60</INF> center dot (NiOEP)<INF>2</INF>, CCDC 828028.	Akasaka T., 2002, ENDOFULLERENES NEW F; ANDRES CJ, 1995, TETRAHEDRON LETT, V36, P1613, DOI 10.1016/0040-4039(95)00114-R; Aoyagi S, 2010, NAT CHEM, V2, P678, DOI [10.1038/NCHEM.698, 10.1038/nchem.698]; BOROWITZ IJ, 1971, J ORG CHEM, V36, P553, DOI 10.1021/jo00803a014; Donohoe TJ, 2001, ORG LETT, V3, P861, DOI 10.1021/ol007035o; Iwamatsu S, 2004, J AM CHEM SOC, V126, P2668, DOI 10.1021/ja038537a; JONES M, 1967, J AM CHEM SOC, V89, P150, DOI 10.1021/ja00977a031; JONES M, 1968, TETRAHEDRON LETT, P4881; Kohama Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.073001; Komatsu K, 2005, SCIENCE, V307, P238, DOI 10.1126/science.1106185; Lee HM, 2002, CHEM COMMUN, P1352, DOI 10.1039/b202925c; Ludwig R, 2001, ANGEW CHEM INT EDIT, V40, P1808, DOI 10.1002/1521-3773(20010518)40:10<1808::AID-ANIE1808>3.3.CO;2-T; Maniwa Y, 2007, NAT MATER, V6, P135, DOI 10.1038/nmat1823; Morinaka Y, 2010, CHEM COMMUN, V46, P4532, DOI 10.1039/c0cc00113a; Murata M, 2010, CHEM LETT, V39, P298, DOI 10.1246/cl.2010.298; Murata M, 2008, CHEM COMMUN, P6083, DOI 10.1039/b811738a; Murata M, 2008, J AM CHEM SOC, V130, P15800, DOI 10.1021/ja8076846; Murata Y, 2003, CHEM-EUR J, V9, P1600, DOI 10.1002/chem.200390184; Noh TH, 2011, J AM CHEM SOC, V133, P1236, DOI 10.1021/ja1093925; Rubin Y, 1997, CHEM-EUR J, V3, P1009, DOI 10.1002/chem.19970030705; Saunders M, 1996, SCIENCE, V271, P1693, DOI 10.1126/science.271.5256.1693; Syamala MS, 2002, J AM CHEM SOC, V124, P6216, DOI 10.1021/ja012676f; Takeda A, 2006, CHEM COMMUN, P912, DOI 10.1039/b514974f; Tikhonov VI, 2002, SCIENCE, V296, P2363, DOI 10.1126/science.1069513; Vougioukalakis GC, 2010, CHEM SOC REV, V39, P817, DOI 10.1039/b913766a; Xiao Z, 2007, J AM CHEM SOC, V129, P16149, DOI 10.1021/ja0763798; Yagi K, 2009, INT J QUANTUM CHEM, V109, P2080, DOI 10.1002/qua.22066; Yamamoto K, 1999, J AM CHEM SOC, V121, P1591, DOI 10.1021/ja9831498; Yoshizawa M, 2005, J AM CHEM SOC, V127, P2798, DOI 10.1021/ja043953w; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	30	372	375	10	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					613	616		10.1126/science.1206376	http://dx.doi.org/10.1126/science.1206376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798946				2022-12-28	WOS:000293222400057
J	Connors, M; Wiegert, P; Veillet, C				Connors, Martin; Wiegert, Paul; Veillet, Christian			Earth's Trojan asteroid	NATURE			English	Article							INFRARED-SURVEY-EXPLORER; CO-ORBITALS	It was realized in 1772 that small bodies can stably share the same orbit as a planet if they remain near 'triangular points' 60 degrees ahead of or behind it in the orbit(1). Such 'Trojan asteroids' have been found co-orbiting with Jupiter(2), Mars(3) and Neptune(4). They have not hitherto been found associated with Earth, where the viewing geometry poses difficulties for their detection(5), although other kinds of co-orbital asteroid (horseshoe orbiters(6) and quasi-satellites(7)) have been observed(8). Here we report an archival search of infrared data for possible Earth Trojans, producing the candidate 2010 TK7. We subsequently made optical observations which established that 2010 TK7 is a Trojan companion of Earth, librating around the leading Lagrange triangular point, L-4. Its orbit is stable over at least ten thousand years.	[Connors, Martin] Athabasca Univ, Athabasca, AB T9S 3A3, Canada; [Connors, Martin] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Wiegert, Paul] Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada; [Veillet, Christian] Canada France Hawaii Telescope Corp, Kamuela, HI 96743 USA	Athabasca University; University of California System; University of California Los Angeles; Western University (University of Western Ontario); Canada France Hawaii Telescope	Connors, M (corresponding author), Athabasca Univ, 1 Univ Dr, Athabasca, AB T9S 3A3, Canada.	martinc@athabascau.ca	Veillet, Christian/P-5301-2018	Veillet, Christian/0000-0003-0272-0418	Canada's Natural Sciences and Engineering Research Council; Canada's Research Chairs	Canada's Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada's Research Chairs	We thank the WISE team and JPL and NEODyS (University of Pisa) data services. Support came from Canada's Natural Sciences and Engineering Research Council and Research Chairs. Problems with some 2010 TK<INF>7</INF> positions reported in ref. 23 were pointed out by T. Spahr and D. Tholen. We are grateful to them for data reductions provided, and to D. Tholen, M. Micheli and G. T. Elliot for observations made in support of this study.	Almeida AJC, 2009, ASTRON ASTROPHYS, V508, P1021, DOI 10.1051/0004-6361/200911943; [Anonymous], 2011, 2011G37 MPEC IAU MIN; Boulade O, 2000, P SOC PHOTO-OPT INS, V4008, P657, DOI 10.1117/12.395524; Bowell E., 1989, ASTEROIDS, VII, P524; Brasser R, 2004, ICARUS, V171, P102, DOI 10.1016/j.icarus.2004.04.019; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; Christou AA, 2011, MON NOT R ASTRON SOC, V414, P2965, DOI 10.1111/j.1365-2966.2011.18595.x; Connors M, 2005, PLANET SPACE SCI, V53, P617, DOI 10.1016/j.pss.2004.12.004; Connors M, 2002, METEORIT PLANET SCI, V37, P1435, DOI 10.1111/j.1945-5100.2002.tb01039.x; Connors M., 2000, B AM ASTRON SOC, V32, P1019; Everhart E., 1985, DYNAMICS COMETS THEI, P185; Giorgini J.D., 1996, AAS DIV PLAN SCI M A; Mainzer A, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/53; MIKKOLA S, 1990, ASTRON J, V100, P290, DOI 10.1086/115514; MILANI A, 1992, NATURE, V357, P569, DOI 10.1038/357569a0; Moulton F. R., 1920, PERIODIC ORBITS, p[299, 151]; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC, P63; Stacey RG, 2008, PLANET SPACE SCI, V56, P358, DOI 10.1016/j.pss.2007.11.002; Stacey RG, 2009, PLANET SPACE SCI, V57, P822, DOI 10.1016/j.pss.2009.01.013; Standish E. M., 1998, 312F98048 IOM NASA J; Tsiganis K, 2000, ASTRON ASTROPHYS, V354, P1091; WHIPPLE AL, 1995, ICARUS, V115, P347, DOI 10.1006/icar.1995.1102; Whiteley RJ, 1998, ICARUS, V136, P154, DOI 10.1006/icar.1998.5995; Wiegert P, 2000, ICARUS, V145, P33, DOI 10.1006/icar.2000.6339; Wiegert PA, 1997, NATURE, V387, P685, DOI 10.1038/42662; Wilson C., 1995, PLANETARY ASTRONOMY, P108; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868	27	103	107	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					481	483		10.1038/nature10233	http://dx.doi.org/10.1038/nature10233			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796207				2022-12-28	WOS:000293167900036
J	Zhang, K; Ding, S				Zhang, Kang; Ding, Sheng			Stem Cells and Eye Development	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zhang, Kang] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu 610064, Peoples R China; [Zhang, Kang] Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Dept Ophthalmol, Chengdu 610064, Peoples R China; [Zhang, Kang] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Ding, Sheng] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [Ding, Sheng] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Sichuan University; Sichuan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Zhang, K (corresponding author), Sichuan Univ, W China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu 610064, Peoples R China.		Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697	NEI NIH HHS [R01 EY021374, R01 EY018660] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY021374, R01EY018660] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691	4	14	16	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					370	372		10.1056/NEJMcibr1105280	http://dx.doi.org/10.1056/NEJMcibr1105280			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21793749	Green Accepted			2022-12-28	WOS:000293172200018
J	Iedema, R; Allen, S; Britton, K; Piper, D; Baker, A; Grbich, C; Allan, A; Jones, L; Tuckett, A; Williams, A; Manias, E; Gallagher, TH				Iedema, Rick; Allen, Suellen; Britton, Kate; Piper, Donella; Baker, Andrew; Grbich, Carol; Allan, Alfred; Jones, Liz; Tuckett, Anthony; Williams, Allison; Manias, Elizabeth; Gallagher, Thomas H.			Patients' and family members' views on how clinicians enact and how they should enact incident disclosure: the "100 patient stories" qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICIANS ATTITUDES; MEDICAL ERRORS; ADVERSE EVENTS; HEALTH-CARE; COMMUNICATION; PROFESSIONALS; EXPERIENCES	Objectives To investigate patients' and family members' perceptions and experiences of disclosure of healthcare incidents and to derive principles of effective disclosure. Design Retrospective qualitative study based on 100 semi-structured, in depth interviews with patients and family members. Setting Nationwide multisite survey across Australia. Participants 39 patients and 80 family members who were involved in high severity healthcare incidents (leading to death, permanent disability, or long term harm) and incident disclosure. Recruitment was via national newspapers (43%), health services where the incidents occurred (28%), two internet marketing companies (27%), and consumer organisations (2%). Main outcome measures Participants' recurrent experiences and concerns expressed in interviews. Results Most patients and family members felt that the health service incident disclosure rarely met their needs and expectations. They expected better preparation for incident disclosure, more shared dialogue about what went wrong, more follow-up support, input into when the time was ripe for closure, and more information about subsequent improvement in process. This analysis provided the basis for the formulation of a set of principles of effective incident disclosure. Conclusions Despite growing prominence of open disclosure, discussion about healthcare incidents still falls short of patient and family member expectations. Healthcare organisations and providers should strengthen their efforts to meet patients' (and family members') needs and expectations.	[Iedema, Rick; Allen, Suellen; Britton, Kate; Piper, Donella; Baker, Andrew] Ctr Hlth Commun, Broadway, NSW 2007, Australia; [Iedema, Rick; Allen, Suellen; Britton, Kate; Piper, Donella; Baker, Andrew] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Grbich, Carol] Flinders Univ S Australia, Sch Med, Adelaide, SA, Australia; [Allan, Alfred] Edith Cowan Univ, Sch Psychol & Social Sci, Joondalup, WA 6027, Australia; [Jones, Liz] Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; [Tuckett, Anthony] Univ Queensland, Sch Nursing & Midwifery, Brisbane, Qld 4072, Australia; [Williams, Allison; Manias, Elizabeth] Univ Melbourne, Dept Nursing, Melbourne Sch Hlth Sci, Carlton, Vic 3010, Australia; [Gallagher, Thomas H.] Univ Washington, Med Ctr, Seattle, WA 98195 USA	University of Technology Sydney; Flinders University South Australia; Edith Cowan University; Griffith University; University of Queensland; University of Melbourne; University of Washington; University of Washington Seattle	Iedema, R (corresponding author), Ctr Hlth Commun, POB 123, Broadway, NSW 2007, Australia.	r.iedema@uts.edu.au	TUCKETT, Anthony G./B-2229-2009; Piper, Donella/S-1950-2019; Allan, Alfred/I-7332-2019; Manias, Elizabeth/D-2035-2009	TUCKETT, Anthony G./0000-0002-7578-4271; Allan, Alfred/0000-0001-7039-797X; Manias, Elizabeth/0000-0002-3747-0087; Piper, Donella/0000-0002-5802-6380; Iedema, Roderick/0000-0001-6792-1048; Jones, Liz/0000-0001-6566-5036	Australian Commission on Safety and Quality in Health Care	Australian Commission on Safety and Quality in Health Care	Funding for this study was awarded by the Australian Commission on Safety and Quality in Health Care.	Berlinger N., 2005, HARM MED ERROR ETHIC; Bon A, 2009, ALS MISGAAT; Boothman Richard C, 2009, J Health Life Sci Law, V2, P125; Canadian Patient Safety Institute, 2008, CAN DISCL GUID; Conway J, 2010, RESPECTFUL MANAGEMEN; Duclos CW, 2005, INT J QUAL HEALTH C, V17, P479, DOI 10.1093/intqhc/mzi065; Gallagher TH, 2003, JAMA-J AM MED ASSOC, V289, P1001, DOI 10.1001/jama.289.8.1001; Gallagher TH, 2006, ARCH INTERN MED, V166, P1585, DOI 10.1001/archinte.166.15.1585; Gallagher TH, 2006, ARCH INTERN MED, V166, P1605, DOI 10.1001/archinte.166.15.1605; Gallagher TH, 2009, JAMA-J AM MED ASSOC, V302, P669, DOI 10.1001/jama.2009.1011; Iedema R., 2008, FINAL REPORT EVALUAT; Iedema R, 2008, INT J QUAL HEALTH C, V20, P421, DOI 10.1093/intqhc/mzn043; Iedema R, 2009, SOCIOL HEALTH ILL, V31, P262, DOI 10.1111/j.1467-9566.2008.01131.x; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Kachalia A, 2010, ANN INTERN MED, V153, P213, DOI 10.7326/0003-4819-153-4-201008170-00002; Ledema RAM, 2008, MED J AUSTRALIA, V188, P397, DOI 10.5694/j.1326-5377.2008.tb01683.x; *MA COAL PREV MED, 2006, THINGS GO WRONG RESP; Manser T, 2005, ACTA ANAESTH SCAND, V49, P728, DOI 10.1111/j.1399-6576.2005.00746.x; NSW Health, 2007, OP DISCL GUID; NSW Health, 2006, POL DIR OP DISCL; NZ Health & Disability Commissioner, 2007, GUID OP DISCL POL; O'Connor E, 2010, INT J QUAL HEALTH C, V22, P371, DOI 10.1093/intqhc/mzq042; Rose D, 2004, WORKING DISCOURSE ME; Studdert DM, 2007, HEALTH AFFAIR, V26, P215, DOI 10.1377/hlthaff.26.1.215; Studdert DM, 2010, MED J AUSTRALIA, V193, P351, DOI 10.5694/j.1326-5377.2010.tb03948.x; U. K. National Patient Safety Agency, 2009, BEING OP COMM PAT SA; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x	27	77	77	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 25	2011	343								d4423	10.1136/bmj.d4423	http://dx.doi.org/10.1136/bmj.d4423			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801LM	21788260	Green Published, Green Submitted			2022-12-28	WOS:000293440400005
J	Woo, WM; Oro, AE				Woo, Wei-Meng; Oro, Anthony E.			SnapShot: Hair Follicle Stem Cells	CELL			English	Editorial Material							REGENERATION; NICHE; ACTIVATION; LINEAGES; SKIN		[Woo, Wei-Meng; Oro, Anthony E.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA	Stanford University	Woo, WM (corresponding author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.		Woo, Wei Meng/H-6594-2015; Woo, Wei Meng/M-5856-2013	Oro, Anthony/0000-0002-6261-138X	NIAMS NIH HHS [R01 AR054780, R01 AR052785] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054780, R01AR052785] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Fuchs E, 2008, COLD SH Q B, V73, P333, DOI 10.1101/sqb.2008.73.032; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Legue E, 2010, DEVELOPMENT, V137, P569, DOI 10.1242/dev.044123; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733	10	35	37	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 22	2011	146	2					334	U159		10.1016/j.cell.2011.07.001	http://dx.doi.org/10.1016/j.cell.2011.07.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784251	Green Accepted, Bronze			2022-12-28	WOS:000293013000015
J	Pincock, S				Pincock, Stephen			Lunch with The Lancet Samuel Shem	LANCET			English	Editorial Material												stephen.pincock@journalist.co.uk		Pincock, Stephen/0000-0003-1655-2902					0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2011	378	9789					392	392		10.1016/S0140-6736(11)61197-5	http://dx.doi.org/10.1016/S0140-6736(11)61197-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XM	21803194				2022-12-28	WOS:000293615900014
J	Reynolds, L; Mckee, M				Reynolds, Lucy; McKee, Martin			"Any qualified provider" in NHS reforms: but who will qualify?	LANCET			English	Editorial Material									[Reynolds, Lucy; McKee, Martin] London Sch Hyg & Trop Med, Fac Publ Hlth Policy, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Reynolds, L (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth Policy, London WC1H 9SH, England.	lucy.reynolds@lshtm.ac.uk	Mckee, Martin/E-6673-2018; Reynolds, Dr L/CAG-7830-2022; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X				Bubb S, 2011, DAILY TELEGRAPH 0113; Butler P., 2011, GUARDIAN        0622; Curry N., 2011, VOLUNTARY COMMUNITY; Ferguson N., 2008, THE ASCENT OF MONEY; Hancher L, 2009, 2009028 TILB LAW EC; Lansley A, 2011, COMMUNICATION   0330; Peedell C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2996; Reynolds L, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3760	8	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 24	2012	379	9821					1083	1084		10.1016/S0140-6736(11)61264-6	http://dx.doi.org/10.1016/S0140-6736(11)61264-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	916VR	21835458				2022-12-28	WOS:000302131800011
J	Strunk, BS; Loucks, CR; Su, M; Vashisth, H; Cheng, SS; Schilling, J; Brooks, CL; Karbstein, K; Skiniotis, G				Strunk, Bethany S.; Loucks, Cherisse R.; Su, Min; Vashisth, Harish; Cheng, Shanshan; Schilling, Justin; Brooks, Charles L., III; Karbstein, Katrin; Skiniotis, Georgios			Ribosome Assembly Factors Prevent Premature Translation Initiation by 40S Assembly Intermediates	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR-DYNAMICS; TRANSFER-RNA; 30S SUBUNIT; CRYOELECTRON MICROSCOPY; EUKARYOTIC RIBOSOME; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; 80S RIBOSOME; BIOGENESIS	Ribosome assembly in eukaryotes requires approximately 200 essential assembly factors (AFs) and occurs through ordered events that initiate in the nucleolus and culminate in the cytoplasm. Here, we present the electron cryo-microscopy (cryo-EM) structure of a late cytoplasmic 40S ribosome assembly intermediate from Saccharomyces cerevisiae at 18 angstrom resolution. We obtained cryo-EM reconstructions of preribosomal complexes lacking individual components to define the positions of all seven AFs bound to this intermediate. These late-binding AFs are positioned to prevent each step in the translation initiation pathway. Together, they obstruct the binding sites for initiation factors, prevent the opening of the messenger RNA channel, block 60S subunit joining, and disrupt the decoding site. These redundant mechanisms probably ensure that pre-40S particles do not enter the translation pathway, which would result in their rapid degradation.	[Strunk, Bethany S.; Karbstein, Katrin] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Strunk, Bethany S.] Univ Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA; [Loucks, Cherisse R.; Su, Min; Schilling, Justin; Skiniotis, Georgios] Univ Michigan, Inst Life Sci, Sch Med, Ann Arbor, MI 48109 USA; [Loucks, Cherisse R.; Su, Min; Schilling, Justin; Skiniotis, Georgios] Univ Michigan, Dept Biol Chem, Sch Med, Ann Arbor, MI 48109 USA; [Vashisth, Harish; Brooks, Charles L., III] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Vashisth, Harish; Brooks, Charles L., III; Skiniotis, Georgios] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Cheng, Shanshan; Brooks, Charles L., III] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	Scripps Research Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Karbstein, K (corresponding author), Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA.	kkarbst@scripps.edu; skinioti@umich.edu	Vashisth, Harish/E-5651-2011	Vashisth, Harish/0000-0002-2087-2880; Skiniotis, Georgios/0000-0003-0238-7846; Strunk, Bethany/0000-0003-2337-4614; Cheng, Shanshan/0000-0003-2676-7341; Karbstein, Katrin/0000-0002-4034-1331	NSF; NIH [R01-GM086451, RR12255]; Univ. of Michigan; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086451] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Univ. of Michigan; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Campbell for the gift of recombinant Tsr1 and (MBP)Tsr1; J. P. Gelugne for yeast strains; J. Doudna for making eIF3 maps available; H. Remmers (Univ. of Michigan) and M. Chalmers (The Scripps Research Institute-Florida) for performing mass spectrometry experiments; S. Ludtke, J. Zhang, and L. Passmore for EMAN scripts to generate variance maps; and J. Doudna, J. Cleveland, K. Nettles, T. Walz, and members of the Karbstein and Skiniotis labs for comments. B.S.S. is supported by a NSF predoctoral fellowship. This work is supported by NIH grant R01-GM086451 (to K.K.), the NIH-supported resource Multiscale Modeling Tools for Structural Biology (grant RR12255 to C.L.B.), and the Univ. of Michigan Biological Sciences Scholars Program (G.S.). EM maps have been deposited in the Electron Microscopy Data Bank with accession codes EMD-1922, -1923, -1924, -1925, -1926, and -1927.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Campbell MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016194; Carron C, 2011, NUCLEIC ACIDS RES, V39, P280, DOI 10.1093/nar/gkq734; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Datta PP, 2007, MOL CELL, V28, P434, DOI 10.1016/j.molcel.2007.08.026; Desai PM, 2006, ARCH BIOCHEM BIOPHYS, V449, P57, DOI 10.1016/j.abb.2006.02.028; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Granneman S, 2010, EMBO J, V29, P2026, DOI 10.1038/emboj.2010.86; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Ho JHN, 1999, MOL CELL BIOL, V19, P2389; Jakovljevic J, 2004, MOL CELL, V14, P331, DOI 10.1016/S1097-2765(04)00215-1; Lamanna AC, 2011, J MOL BIOL, V405, P3, DOI 10.1016/j.jmb.2010.09.064; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; Neueder A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010194; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Roy-Chaudhuri B, 2010, P NATL ACAD SCI USA, V107, P4567, DOI 10.1073/pnas.0912305107; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Sengupta J, 2010, J CELL BIOL, V189, P1079, DOI 10.1083/jcb.201001124; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Si K, 1999, MOL CELL BIOL, V19, P1416; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trabuco LG, 2011, J STRUCT BIOL, V173, P420, DOI 10.1016/j.jsb.2010.09.024; Trabuco LG, 2010, J MOL BIOL, V402, P741, DOI 10.1016/j.jmb.2010.07.056; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; VERSCHOOR A, 1989, J MOL BIOL, V209, P115, DOI 10.1016/0022-2836(89)90175-7; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Woolls HA, 2011, J BIOL CHEM, V286, P2578, DOI 10.1074/jbc.M110.191494; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P534, DOI 10.1038/nsmb.1408; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	46	160	160	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1449	1453		10.1126/science.1208245	http://dx.doi.org/10.1126/science.1208245			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21835981	Green Accepted			2022-12-28	WOS:000294672200043
J	Pomowski, A; Zumft, WG; Kroneck, PMH; Einsle, O				Pomowski, Anja; Zumft, Walter G.; Kroneck, Peter M. H.; Einsle, Oliver			N2O binding at a [4Cu:2S] copper-sulphur cluster in nitrous oxide reductase	NATURE			English	Article							CU-Z CLUSTER; ACHROMOBACTER-CYCLOCLASTES; PSEUDOMONAS-STUTZERI; ANGSTROM RESOLUTION; MULTICOPPER ENZYME; CUPRIC SITE; DENITRIFICATION; PURIFICATION; ACTIVATION; DINITROGEN	Nitrous oxide (N2O) is generated by natural and anthropogenic processes and has a critical role in environmental chemistry. It has an ozone-depleting potential similar to that of hydrochlorofluorocarbons as well as a global warming potential exceeding that of CO2 300-fold(1,2). In bacterial denitrification, N2O is reduced to N-2 by the copper-dependent nitrous oxide reductase (N2OR)(3). This enzyme carries the mixed-valent Cu-A centre and the unique, tetranuclear Cu-Z site. Previous structural data were obtained with enzyme isolated in the presence of air that is catalytically inactive without prior reduction. Its Cu-Z site was described as a [4Cu:S] centre, and the substrate-binding mode and reduction mechanism remained elusive. Here we report the structure of purple N2OR from Pseudomonas stutzeri, handled under the exclusion of dioxygen, and locate the substrate in N2O-pressurized crystals. The active Cu-Z cluster contains two sulphur atoms, yielding a [4Cu:2S] stoichiometry; and N2O bound side-on at Cu-Z, in close proximity to Cu-A. With the substrate located between the two clusters, electrons are transferred directly from Cu-A to N2O, which is activated by side-on binding in a specific binding pocket on the face of the [4Cu:2S] centre. These results reconcile a multitude of available biochemical data on N2OR that could not be explained by earlier structures, and outline a mechanistic pathway in which both metal centres and the intervening protein act in concert to achieve catalysis. This structure represents the first direct observation, to our knowledge, of N2O bound to its reductase, and sheds light on the functionality of metalloenzymes that activate inert small-molecule substrates. The principle of using distinct clusters for substrate activation and for reduction may be relevant for similar systems, in particular nitrogen-fixing nitrogenase(4).	[Pomowski, Anja; Einsle, Oliver] Univ Freiburg, Inst Organ Chem & Biochem, Lehrstuhl Biochem, D-79104 Freiburg, Germany; [Zumft, Walter G.] Karlsruher Inst Technol, Abt Mol Mikrobiol, Inst Angew Biowissensch, D-76187 Karlsruhe, Germany; [Kroneck, Peter M. H.] Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; [Einsle, Oliver] Univ Freiburg, Ctr Biol Signalling Studies Bioss, D-79104 Freiburg, Germany	University of Freiburg; Helmholtz Association; Karlsruhe Institute of Technology; University of Konstanz; University of Freiburg	Einsle, O (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Lehrstuhl Biochem, Albertstr 21, D-79104 Freiburg, Germany.	einsle@biochemie.uni-freiburg.de		Einsle, Oliver/0000-0001-8722-2893	Deutsche Forschungsgemeinschaft [IRTG 1422]; Center for Biological Signalling Studies [EXC 294]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Biological Signalling Studies	This work was supported by the Deutsche Forschungsgemeinschaft (IRTG 1422) and the Center for Biological Signalling Studies (bioss, EXC 294). We thank the beam line staff at the Swiss Light Source for their assistance with data collection, T. Spatzal, K. Dorner and T. Friedrich for recording EPR spectra and F. Neese for discussions.	Atkins, 2001, INORG CHEM, P227; Brown K, 2000, NAT STRUCT BIOL, V7, P191; Brown K, 2000, J BIOL CHEM, V275, P41133, DOI 10.1074/jbc.M008617200; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; COYLE CL, 1985, EUR J BIOCHEM, V153, P459, DOI 10.1111/j.1432-1033.1985.tb09324.x; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; DeLano W.L, PYMOL MOL GRAPHICS S; Dell'Acqua S, 2010, J BIOL INORG CHEM, V15, P967, DOI 10.1007/s00775-010-0658-6; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Einsle O, 2004, BIOL CHEM, V385, P875, DOI 10.1515/BC.2004.115; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujita K, 2007, J INORG BIOCHEM, V101, P1836, DOI 10.1016/j.jinorgbio.2007.06.029; Ghosh S, 2003, J AM CHEM SOC, V125, P15708, DOI 10.1021/ja038344n; Gorelsky SI, 2006, J AM CHEM SOC, V128, P278, DOI 10.1021/ja055856o; Haltia T, 2003, BIOCHEM J, V369, P77, DOI 10.1042/BJ20020782; KRONECK PMH, 1989, FEBS LETT, V248, P212, DOI 10.1016/0014-5793(89)80464-8; KRONECK PMH, 1988, FEBS LETT, V242, P70, DOI 10.1016/0014-5793(88)80987-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Paraskevopoulos K, 2006, J MOL BIOL, V362, P55, DOI 10.1016/j.jmb.2006.06.064; Paulat F, 2004, INORG CHEM, V43, P6979, DOI 10.1021/ic049302i; Pomowski A, 2010, ACTA CRYSTALLOGR F, V66, P1541, DOI 10.1107/S1744309110038832; Rasmussen T, 2005, DALTON T, P3501, DOI 10.1039/b501846c; Rasmussen T, 2000, BIOCHEMISTRY-US, V39, P12753, DOI 10.1021/bi001811i; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; RIESTER J, 1989, EUR J BIOCHEM, V178, P751, DOI 10.1111/j.1432-1033.1989.tb14506.x; Samarkin VA, 2010, NAT GEOSCI, V3, P341, DOI 10.1038/NGEO847; Savelieff MG, 2010, J BIOL INORG CHEM, V15, P461, DOI 10.1007/s00775-010-0625-2; Schmittner A, 2008, NATURE, V456, P373, DOI 10.1038/nature07531; Solomon EI, 2006, INORG CHEM, V45, P8012, DOI 10.1021/ic060450d; Tolman WB, 2010, ANGEW CHEM INT EDIT, V49, P1018, DOI 10.1002/anie.200905364; Zumft WG, 2007, ADV MICROB PHYSIOL, V52, P107, DOI 10.1016/S0065-2911(06)52003-X; ZUMFT WG, 1982, FEBS LETT, V148, P107, DOI 10.1016/0014-5793(82)81253-2; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	33	142	144	3	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					234	U143		10.1038/nature10332	http://dx.doi.org/10.1038/nature10332			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21841804				2022-12-28	WOS:000294603900041
J	Siracusa, MC; Saenz, SA; Hill, DA; Kim, BS; Headley, MB; Doering, TA; Wherry, EJ; Jessup, HK; Siegel, LA; Kambayashi, T; Dudek, EC; Kubo, M; Cianferoni, A; Spergel, JM; Ziegler, SF; Comeau, MR; Artis, D				Siracusa, Mark C.; Saenz, Steven A.; Hill, David A.; Kim, Brian S.; Headley, Mark B.; Doering, Travis A.; Wherry, E. John; Jessup, Heidi K.; Siegel, Lori A.; Kambayashi, Taku; Dudek, Emily C.; Kubo, Masato; Cianferoni, Antonella; Spergel, Jonathan M.; Ziegler, Steven F.; Comeau, Michael R.; Artis, David			TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation	NATURE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; CELL; EXPRESSION; IMMUNITY; SUFFICIENT; INDUCTION; INFECTION; ASSOCIATE; VARIANTS; ASTHMA	CD4(+) T-helper type 2 (T(H)2) cells, characterized by their expression of interleukin (IL)-4, IL-5, IL-9 and IL-13, are required for immunity to helminth parasites(1) and promote the pathological inflammation associated with asthma and allergic diseases(2). Polymorphisms in the gene encoding the cytokine thymic stromal lymphopoietin (TSLP) are associated with the development of multiple allergic disorders in humans, indicating that TSLP is a critical regulator of T(H)2 cytokine-associated inflammatory diseases(3-6). In support of genetic analyses, exaggerated TSLP production is associated with asthma, atopic dermatitis and food allergies in patients, and studies in murine systems demonstrated that TSLP promotes T(H)2 cytokine-mediated immunity and inflammation(5,7-12). However, the mechanisms through which TSLP induces T(H)2 cytokine responses remain poorly defined. Here we demonstrate that TSLP promotes systemic basophilia, that disruption of TSLP-TSLPR interactions results in defective basophil responses, and that TSLPR-sufficient basophils can restore T(H)2-cell-dependent immunity in vivo. TSLP acted directly on bone-marrow-resident progenitors to promote basophil responses selectively. Critically, TSLP could elicit basophil responses in both IL-3-IL-3R-sufficient and -deficient environments, and genome-wide transcriptional profiling and functional analyses identified heterogeneity between TSLP-elicited versus IL-3-elicited basophils. Furthermore, activated human basophils expressed TSLPR, and basophils isolated from eosinophilic oesophagitis patients were distinct from classical basophils. Collectively, these studies identify previously unrecognized heterogeneity within the basophil cell lineage and indicate that expression of TSLP may influence susceptibility to multiple allergic diseases by regulating basophil haematopoiesis and eliciting a population of functionally distinct basophils that promote T(H)2 cytokine-mediated inflammation.	[Siracusa, Mark C.; Saenz, Steven A.; Hill, David A.; Kim, Brian S.; Doering, Travis A.; Wherry, E. John; Artis, David] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Siracusa, Mark C.; Saenz, Steven A.; Hill, David A.; Kim, Brian S.; Doering, Travis A.; Wherry, E. John; Artis, David] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Headley, Mark B.; Ziegler, Steven F.] Benaroya Res Inst, Program Immunol, Seattle, WA 98101 USA; [Headley, Mark B.; Ziegler, Steven F.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Jessup, Heidi K.; Siegel, Lori A.; Comeau, Michael R.] Amgen Inc, Inflammat Res, Seattle, WA 98119 USA; [Kambayashi, Taku] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Dudek, Emily C.; Cianferoni, Antonella; Spergel, Jonathan M.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Allergy & Immunol,Dept Pediat, Philadelphia, PA 19104 USA; [Kubo, Masato] RIKEN, Yokohama Inst, Res Ctr Allergy & Immunol, Lab Signal Network, Yokohama, Kanagawa 2300045, Japan; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biol Sci, Div Mol Pathol, Chiba 2780022, Japan; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Benaroya Research Institute; University of Washington; University of Washington Seattle; Amgen; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; RIKEN; Tokyo University of Science; University of Pennsylvania	Artis, D (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu	Kim, Brian/GZK-6649-2022; Kubo, Masato/A-5918-2016; Wherry, John/ABI-1280-2020	Kim, Brian/0000-0002-8100-7161; Headley, Mark/0000-0002-0924-9326; Spergel, Jonathan/0000-0002-4658-5353; Hill, David/0000-0001-9286-4268; Artis, David/0000-0002-1753-4100	National Institutes of Health [AI61570, AI74878, AI87990, AI083480, AI085828, GM082187, AI060516]; Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095608, R01AI095466, R01AI074878, R21AI087990, R21AI083480, T32AI060516, F32AI085828, R01AI061570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM082187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Artis laboratory for critical reading of the manuscript, A. Budelsky, T. Martin, B.-R. Park Yoon, J. Bigler and M. Timour (Amgen) for assistance with experiments and microarrays and the University of Pennsylvania flow cytometry core for assistance with sorting. Work in the Artis laboratory is supported by the National Institutes of Health (AI61570, AI74878, AI87990 and AI083480 (to D. A.), F32 fellowship AI085828 (to M. C. S.), F31 training grant GM082187 (to S. A. S), T32 training grant AI060516 (to D. A. H.)) and the Burroughs Wellcome Fund (to D.A.).	Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Harada M, 2011, AM J RESP CELL MOL, V44, P787, DOI 10.1165/rcmb.2009-0418OC; Hunninghake GM, 2010, ALLERGY, V65, P1566, DOI 10.1111/j.1398-9995.2010.02415.x; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Lenox LE, 2009, J ALLERGY CLIN IMMUN, V124, P1088, DOI 10.1016/j.jaci.2009.08.038; Li M, 2009, J INVEST DERMATOL, V129, P498, DOI 10.1038/jid.2008.232; Mou ZL, 2009, ACTA OTO-LARYNGOL, V129, P297, DOI 10.1080/00016480802225884; Nair MG, 2008, J IMMUNOL, V181, P4709, DOI 10.4049/jimmunol.181.7.4709; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Sawaguchi M., 2011, INT C IMM; Scott CL, 2000, BLOOD, V96, P1588, DOI 10.1182/blood.V96.4.1588.h8001588_1588_1590; Sebestyen MG, 2006, J GENE MED, V8, P852, DOI 10.1002/jgm.921; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Siracusa MC, 2010, IMMUNOL CELL BIOL, V88, P275, DOI 10.1038/icb.2010.1; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	32	343	354	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2011	477	7363					229	U138		10.1038/nature10329	http://dx.doi.org/10.1038/nature10329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21841801	Green Accepted			2022-12-28	WOS:000294603900040
J	Yizhar, O; Fenno, LE; Prigge, M; Schneider, F; Davidson, TJ; O'Shea, DJ; Sohal, VS; Goshen, I; Finkelstein, J; Paz, JT; Stehfest, K; Fudim, R; Ramakrishnan, C; Huguenard, JR; Hegemann, P; Deisseroth, K				Yizhar, Ofer; Fenno, Lief E.; Prigge, Matthias; Schneider, Franziska; Davidson, Thomas J.; O'Shea, Daniel J.; Sohal, Vikaas S.; Goshen, Inbal; Finkelstein, Joel; Paz, Jeanne T.; Stehfest, Katja; Fudim, Roman; Ramakrishnan, Charu; Huguenard, John R.; Hegemann, Peter; Deisseroth, Karl			Neocortical excitation/inhibition balance in information processing and social dysfunction	NATURE			English	Article							RETT-SYNDROME; OPTOGENETIC CONTROL; PREFRONTAL CORTEX; NEURAL SYSTEMS; MOUSE MODEL; AUTISM; SCHIZOPHRENIA; NEURONS; CHILDREN; MEMORY	Severe behavioural deficits in psychiatric diseases such as autism and schizophrenia have been hypothesized to arise from elevations in the cellular balance of excitation and inhibition (E/I balance) within neural microcircuitry. This hypothesis could unify diverse streams of pathophysiological and genetic evidence, but has not been susceptible to direct testing. Here we design and use several novel optogenetic tools to causally investigate the cellular E/I balance hypothesis in freely moving mammals, and explore the associated circuit physiology. Elevation, but not reduction, of cellular E/I balance within the mouse medial prefrontal cortex was found to elicit a profound impairment in cellular information processing, associated with specific behavioural impairments and increased high-frequency power in the 30-80 Hz range, which have both been observed in clinical conditions in humans. Consistent with the E/I balance hypothesis, compensatory elevation of inhibitory cell excitability partially rescued social deficits caused by E/I balance elevation. These results provide support for the elevated cellular E/I balance hypothesis of severe neuropsychiatric disease-related symptoms.	[Yizhar, Ofer; Fenno, Lief E.; Davidson, Thomas J.; O'Shea, Daniel J.; Sohal, Vikaas S.; Goshen, Inbal; Finkelstein, Joel; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Clark Ctr W083, Stanford, CA 94305 USA; [Yizhar, Ofer] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Fenno, Lief E.; O'Shea, Daniel J.] Stanford Univ, Neurosci Program, Clark Ctr W083, Stanford, CA 94305 USA; [Prigge, Matthias; Schneider, Franziska; Stehfest, Katja; Fudim, Roman; Hegemann, Peter] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Sohal, Vikaas S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Paz, Jeanne T.; Huguenard, John R.] Stanford Univ, Dept Neurol & Neurol Sci, Clark Ctr W083, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Clark Ctr W083, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Clark Ctr W083, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Clark Ctr W083, Stanford, CA 94305 USA	Stanford University; Weizmann Institute of Science; Stanford University; Humboldt University of Berlin; University of California System; University of California San Francisco; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Yizhar, O (corresponding author), Stanford Univ, Dept Bioengn, Clark Ctr W083, 318 Campus Dr W, Stanford, CA 94305 USA.	ofer.yizhar@weizmann.ac.il; hegemape@rz.hu-berlin.de; deissero@stanford.edu	Goshen, Inbal/GQI-2230-2022; Fenno, Lief/AAK-2924-2020; Huguenard, John/I-5016-2012; Fenno, Lief/AAF-9638-2019; YIZHAR, OFER/AAV-8497-2021; Huguenard, John/K-6429-2019; O'Shea, Daniel J/AAK-6525-2020; Sohal, Vikaas/M-9327-2016	Goshen, Inbal/0000-0001-7578-2615; Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Sohal, Vikaas/0000-0002-2238-4186; O'Shea, Daniel/0000-0002-1366-1743; Yizhar, Ofer/0000-0003-4228-1448; Davidson, Thomas/0000-0003-0836-6333; Ramakrishnan, Charu/0000-0002-3474-6332	Human Frontier Science Program; Stanford MSTP program; DFG [HE3824/9-1, 17-1]; NIMH; NIDA; NINDS; DARPA; CIRM; Yu Foundation; Woo Foundation; Snyder Foundation; Keck Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957, R01MH086373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS006477, R01NS034774] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000616] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Stanford MSTP program; DFG(German Research Foundation (DFG)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); CIRM(California Institute for Regenerative Medicine); Yu Foundation; Woo Foundation; Snyder Foundation; Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the K. D., P. H. and J.R.H. laboratories for discussions on the manuscript. We are grateful to S. Pak, Z. Chen and C. Perry for technical assistance. O.Y. is supported by the Human Frontier Science Program. L. E. F. is supported by the Stanford MSTP program. P. H. is supported by the DFG (HE3824/9-1 and 17-1, Cluster of Excellence: Unifying Concepts in Catalysis), and K. D. by NIMH, NIDA, NINDS, the DARPA REPAIR program, CIRM and the Yu, Woo, Snyder and Keck Foundations.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Belmonte MK, 2010, J CHILD PSYCHOL PSYC, V51, P259, DOI 10.1111/j.1469-7610.2009.02153.x; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Blatt GJ, 2001, J AUTISM DEV DISORD, V31, P537, DOI 10.1023/A:1013238809666; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Canitano R, 2007, EUR CHILD ADOLES PSY, V16, P61, DOI 10.1007/s00787-006-0563-2; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; D'Argembeau A, 2008, J ABNORM PSYCHOL, V117, P247, DOI 10.1037/0021-843X.117.1.247; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Dichter GS, 2009, SOC COGN AFFECT NEUR, V4, P215, DOI 10.1093/scan/nsp017; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Gillberg C, 2000, ACTA PSYCHIAT SCAND, V102, P321, DOI 10.1034/j.1600-0447.2000.102005321.x; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gomot M, 2008, BRAIN, V131, P2479, DOI 10.1093/brain/awn172; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Kehrer C, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02/006.2008; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2004, PSYCHOPHARMACOLOGY, V174, P143, DOI 10.1007/s00213-003-1673-x; Lind SE, 2010, J ABNORM PSYCHOL, V119, P896, DOI 10.1037/a0020631; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Markram K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00224; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Ni AM, 2010, CURR BIOL, V20, P824, DOI 10.1016/j.cub.2010.02.065; O'Donovan MC, 2009, HUM GENET, V126, P3, DOI 10.1007/s00439-009-0703-0; Orekhova EV, 2007, BIOL PSYCHIAT, V62, P1022, DOI 10.1016/j.biopsych.2006.12.029; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Patterson PH, 2011, PEDIATR RES, V69, p34R, DOI 10.1203/PDR.0b013e318212b80f; Rinaldi T, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.004.2008; Rippon G, 2007, INT J PSYCHOPHYSIOL, V63, P164, DOI 10.1016/j.ijpsycho.2006.03.012; Rojas DC, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-66; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Vattikuti S, 2010, BIOL PSYCHIAT, V67, P672, DOI 10.1016/j.biopsych.2009.09.008; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893; Wilson TW, 2007, BIOL PSYCHIAT, V62, P192, DOI 10.1016/j.biopsych.2006.07.002; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120	50	1487	1548	6	276	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2011	477	7363					171	178		10.1038/nature10360	http://dx.doi.org/10.1038/nature10360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	816MC	21796121	Green Accepted			2022-12-28	WOS:000294603900027
J	Voss, TC; Schiltz, RL; Sung, MH; Yen, PM; Stamatoyannopoulos, JA; Biddie, SC; Johnson, TA; Miranda, TB; John, S; Hager, GL				Voss, Ty C.; Schiltz, R. Louis; Sung, Myong-Hee; Yen, Paul M.; Stamatoyannopoulos, John A.; Biddie, Simon C.; Johnson, Thomas A.; Miranda, Tina B.; John, Sam; Hager, Gordon L.			Dynamic Exchange at Regulatory Elements during Chromatin Remodeling Underlies Assisted Loading Mechanism	CELL			English	Article							TRANSCRIPTION-FACTOR-BINDING; PROTEIN-DNA INTERACTIONS; CHIP-SEQ DATA; GLUCOCORTICOID-RECEPTOR; IN-VIVO; LIVING CELLS; ESTROGEN-RECEPTOR; GENE-EXPRESSION; SITES; ASSOCIATION	The glucocorticoid receptor (GR), like other eukaryotic transcription factors, regulates gene expression by interacting with chromatinized DNA response elements. Photobleaching experiments in living cells indicate that receptors transiently interact with DNA on the time scale of seconds and predict that the response elements may be sparsely occupied on average. Here, we show that the binding of one receptor at the glucocorticoid response element (GRE) does not reduce the steady-state binding of another receptor variant to the same GRE. Mathematical simulations reproduce this noncompetitive state using short GR/GRE residency times and relatively long times between DNA binding events. At many genomic sites where GR binding causes increased chromatin accessibility, concurrent steady-state binding levels for the variant receptor are actually increased, a phenomenon termed assisted loading. Temporally sparse transcription factor-DNA interactions induce local chromatin reorganization, resulting in transient access for binding of secondary regulatory factors.	[Voss, Ty C.; Schiltz, R. Louis; Sung, Myong-Hee; Biddie, Simon C.; Johnson, Thomas A.; Miranda, Tina B.; John, Sam; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Yen, Paul M.] Duke Natl Univ Singapore, Cardiovasc & Metab Disorders Program, Lab Hormonal Regulat, Singapore 169857, Singapore; [Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National University of Singapore; University of Washington; University of Washington Seattle	Hager, GL (corresponding author), NCI, Lab Receptor Biol & Gene Express, NIH, Bldg 41,B602,41 Lib Dr, Bethesda, MD 20892 USA.	hagerg@exchange.nih.gov	Yen, Paul M/V-9857-2019; Sung, Myong-Hee/AAC-7316-2020	Sung, Myong-Hee/0000-0002-9739-8558; Biddie, Simon/0000-0002-8253-0253; Yen, Paul/0000-0002-3790-8114	NIH, National Cancer Institute, Center for Cancer Research; D.O.D.'s U.S. [W81XWH-06-1-0776]; NATIONAL CANCER INSTITUTE [ZIABC005450] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); D.O.D.'s U.S.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Anindya Indrawan for general technical support of these experiments. Tatiana Karpova, manager of the NCI Fluorescence Imaging Core Facility), provided expert assistance for epifluorescence microscopy experiments. The resources of the NCI High-Throughput Imaging Facility (HiTIF) were also essential for the rapid completion of this study. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, and by the D.O.D.'s U.S. Congressionally Directed Medical Research Programs Grant W81XWH-06-1-0776.	Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; BURGHAUS U, 2006, PRACTICAL GUIDE KINE, P1; CANN JR, 1989, J BIOL CHEM, V264, P17032; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Fletcher TM, 2002, MOL CELL BIOL, V22, P3255, DOI 10.1128/MCB.22.10.3255-3263.2002; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Hager GL, 2002, CURR OPIN GENET DEV, V12, P137, DOI 10.1016/S0959-437X(02)00278-2; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Kraus WL, 1995, P NATL ACAD SCI USA, V92, P12314, DOI 10.1073/pnas.92.26.12314; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li Q, 1997, METHODS, V12, P96, DOI 10.1006/meth.1997.0451; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; OSTROWSKI MC, 1984, EMBO J, V3, P1891, DOI 10.1002/j.1460-2075.1984.tb02064.x; PAYVAR F, 1983, CELL, V35, P381, DOI 10.1016/0092-8674(83)90171-X; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Voss TC, 2009, J CELL SCI, V122, P345, DOI 10.1242/jcs.035865; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; Wasson T, 2009, GENOME RES, V19, P2101, DOI 10.1101/gr.093450.109	38	237	238	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					544	554		10.1016/j.cell.2011.07.006	http://dx.doi.org/10.1016/j.cell.2011.07.006			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21835447	Green Accepted, Bronze			2022-12-28	WOS:000294043600010
J	Abou-Setta, AM; Beaupre, LA; Rashiq, S; Dryden, DM; Hamm, MP; Sadowski, CA; Menon, MRG; Majumdar, SR; Wilson, DM; Karkhaneh, M; Mousavi, SS; Wong, K; Tjosvold, L; Jones, CA				Abou-Setta, Ahmed M.; Beaupre, Lauren A.; Rashiq, Saifee; Dryden, Donna M.; Hamm, Michele P.; Sadowski, Cheryl A.; Menon, Matthew R. G.; Majumdar, Sumit R.; Wilson, Donna M.; Karkhaneh, Mohammad; Mousavi, Shima S.; Wong, Kai; Tjosvold, Lisa; Jones, C. Allyson			Comparative Effectiveness of Pain Management Interventions for Hip Fracture: A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							FEMORAL NERVE BLOCK; PREOPERATIVE SKIN TRACTION; PSOAS COMPARTMENT BLOCK; PERIOPERATIVE MYOCARDIAL-ISCHEMIA; SPINAL-ANESTHESIA; ELDERLY-PATIENTS; POSTOPERATIVE ANALGESIA; EMERGENCY-DEPARTMENT; ONSET TIME; DOSE BUPIVACAINE	Background: Pain management is integral to the management of hip fracture. Purpose: To review the benefits and harms of pharmacologic and nonpharmacologic interventions for managing pain after hip fracture. Data Sources: 25 electronic databases (January 1990 to December 2010), gray literature, trial registries, and reference lists, with no language restrictions. Study Selection: Multiple reviewers independently and in duplicate screened 9357 citations to identify randomized, controlled trials (RCTs); nonrandomized, controlled trials (non-RCTs); and cohort studies of pain management techniques in older adults after acute hip fracture. Data Extraction: Independent, duplicate data extraction and quality assessment were conducted, with discrepancies resolved by consensus or a third reviewer. Data extracted included study characteristics, inclusion and exclusion criteria, participant characteristics, interventions, and outcomes. Data Synthesis: 83 unique studies (64 RCTs, 5 non-RCTs, and 14 cohort studies) were included that addressed nerve blockade (n = 32), spinal anesthesia (n = 30), systemic analgesia (n = 3), traction (n = 11), multimodal pain management (n = 2), neurostimulation (n = 2), rehabilitation (n = 1), and complementary and alternative medicine (n = 2). Overall, moderate evidence suggests that nerve blockades are effective for relieving acute pain and reducing delirium. Low-level evidence suggests that preoperative traction does not reduce acute pain. Evidence was insufficient on the benefits and harms of most interventions, including spinal anesthesia, systemic analgesia, multimodal pain management, acupressure, relaxation therapy, transcutaneous electrical neurostimulation, and physical therapy regimens, in managing acute pain. Limitations: No studies evaluated outcomes of chronic pain or exclusively examined participants from nursing homes or with cognitive impairment. Systemic analgesics (narcotics, nonsteroidal anti-inflammatory drugs) were understudied during the search period. Conclusion: Nerve blockade seems to be effective in reducing acute pain after hip fracture. Sparse data preclude firm conclusions about the relative benefits or harms of many other pain management interventions for patients with hip fracture.	[Abou-Setta, Ahmed M.] Univ Alberta, Fac Med & Dent, Dept Pediat, Alberta Res Ctr Hlth Evidence,Univ Alberta Eviden, Edmonton, AB T6G 2J3, Canada	University of Alberta	Abou-Setta, AM (corresponding author), Univ Alberta, Fac Med & Dent, Dept Pediat, Alberta Res Ctr Hlth Evidence,Univ Alberta Eviden, Aberhart Ctr 1,Room 8412,11402 Univ Ave, Edmonton, AB T6G 2J3, Canada.	ahmedabou-setta@med.ualberta.ca	Sadowski, Cheryl/X-4663-2019	Tjosvold, Lisa/0000-0002-5667-6312	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [HHSA 290 2007 10021 I]; Alberta Innovates-Health Solutions (formerly Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research; Agency for Healthcare Research and Quality; University of Alberta Evidence-based Practice Center; Edmonton Civic Employees Charitable Fund	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Alberta Innovates-Health Solutions (formerly Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); University of Alberta Evidence-based Practice Center; Edmonton Civic Employees Charitable Fund	This project was funded under contract HHSA 290 2007 10021 I from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services. Drs. Beaupre, Jones, and Majumdar receive salary support from Alberta Innovates-Health Solutions (formerly Alberta Heritage Foundation for Medical Research), and Dr. Jones receives new investigator salary support from the Canadian Institutes of Health Research.r Drs. Abou-Setta, Rashiq, and Dryden: Grant (money to institution): Agency for Healthcare Research and Quality. Drs. Beaupre and Jones: Grant (money to institution): Agency for Healthcare Research and Quality; Other (money to institution): University of Alberta Evidence-based Practice Center. Dr. Sadowski: Grants/grants pending (money to institution): Pfizer Canada; Payment for lectures including service on speakers bureaus: Pfizer Canada. Dr. Menon: Employment: University of Alberta; Grants/grants pending: Edmonton Civic Employees Charitable Fund. Dr. Karkhaneh: Grant (money to institution): Agency for Healthcare Research and Quality. Mr. Wong: Grant (money to institution): Agency for Healthcare Research and Quality. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M11-0328.	Abbey Jennifer, 2004, Int J Palliat Nurs, V10, P6; Abou-Setta AM, 2011, AHRQ PUBLICATION; Adams H A, 1990, Anasth Intensivther Notfallmed, V25, P263, DOI 10.1055/s-2007-1001062; Alonso Chico A, 2003, Rev Esp Anestesiol Reanim, V50, P17; Amador LF, 2005, J AM COLL SURGEONS, V200, P767, DOI 10.1016/j.jamcollsurg.2004.08.031; ANDERSON GH, 1993, J BONE JOINT SURG BR, V75, P794, DOI 10.1302/0301-620X.75B5.8376442; Antonopoulo E, 2006, REGIONAL ANESTHES S1, V31, P92; Apostolopoulos A, 2006, J BONE JOINT SURG S1, p[88, 186]; Baker A, 2004, ANESTH ANALG, V99, P128, DOI 10.1213/01.ANE.0000114549.17864.36; Barker R, 2006, ACAD EMERG MED, V13, P19, DOI 10.1197/j.aem.2005.07.014; Beaupre LA, 2007, J GERONTOL A-BIOL, V62, P1127, DOI 10.1093/gerona/62.10.1127; Ben-David B, 2000, ANESTHESIOLOGY, V92, P6, DOI 10.1097/00000542-200001000-00007; Bitsch MS, 2004, ACTA ORTHOP SCAND, V75, P378, DOI 10.1080/00016470410001123; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; BREDAHL C, 1991, ACTA ANAESTH SCAND, V35, P548, DOI 10.1111/j.1399-6576.1991.tb03346.x; Casati A, 2003, EUR J ANAESTH, V20, P640, DOI 10.1097/00003643-200308000-00009; Chudinov A, 1999, REGION ANESTH PAIN M, V24, P563, DOI 10.1016/S1098-7339(99)90050-0; Cleeland CS, 1998, JAMA-J AM MED ASSOC, V279, P1914, DOI 10.1001/jama.279.23.1914; CLOSS SJ, 1990, J ADV NURS, V15, P42, DOI 10.1111/j.1365-2648.1990.tb01671.x; COAD NR, 1991, EUR J ANAESTH, V8, P287; Cuvillon P, 2007, ANN FR ANESTH, V26, P2, DOI 10.1016/j.annfar.2006.06.025; Danelli G, 2008, CAN J ANAESTH, V55, P501, DOI 10.1007/BF03016669; de Visme V, 2000, REGION ANESTH PAIN M, V25, P158, DOI 10.1053/rapm.2000.0250158; Del Rosario E., 2008, ACUTE PAIN, V10, P59, DOI [10.1016/j.acpain.2008.02.001, DOI 10.1016/J.ACPAIN.2008.02.001]; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Lorenzo L, 2007, Eura Medicophys, V43, P349; Ehret B, 2006, J EUROPEEN URGENCES, V19, P9; Eyrolle L, 1998, BRIT J ANAESTHESI S1, V80, P112; FavarelGarrigues JF, 1996, ANESTH ANALG, V82, P312, DOI 10.1097/00000539-199602000-00017; Ferrell BA, 1998, J AM GERIATR SOC, V46, P635, DOI 10.1111/j.1532-5415.1998.tb01084.x; FERRELL BA, 1991, J AM GERIATR SOC, V39, P64, DOI 10.1111/j.1532-5415.1991.tb05908.x; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; FINSEN V, 1992, INJURY, V23, P242, DOI 10.1016/S0020-1383(05)80007-5; Fletcher AK, 2003, ANN EMERG MED, V41, P227, DOI 10.1067/mem.2003.51; Foss NB, 2005, ANESTHESIOLOGY, V102, P1197, DOI 10.1097/00000542-200506000-00020; Foss NB, 2007, ANESTHESIOLOGY, V106, P773, DOI 10.1097/01.anes.0000264764.56544.d2; Fuchs-Lacelle S, 2004, PAIN MANAG NURS, V5, P37, DOI 10.1016/j.pmn.2003.10.001; Ghnaimat M, 2005, J BAHRAIN MED SOC, V17, P240; Gille J, 2006, ANAESTHESIST, V55, P414, DOI 10.1007/s00101-005-0949-4; Monzon DG, 2010, INT J EMERG MED, V3, P321, DOI 10.1007/s12245-010-0234-4; Gorodetskyi IG, 2007, J BONE JOINT SURG BR, V89B, P1488, DOI 10.1302/0301-620X.89B11.19352; Gotzsche PC, 2007, JAMA-J AM MED ASSOC, V298, P430, DOI 10.1001/jama.298.4.430; Graham CA, 2008, HONG KONG J EMERG ME, V15, P205, DOI 10.1177/102490790801500403; HADDAD FS, 1995, J BONE JOINT SURG BR, V77B, P922, DOI 10.1302/0301-620X.77B6.7593107; Henderson K, 2008, ANN EMERG MED, V52, pS164, DOI 10.1016/j.annemergmed.2008.06.426; Herrick C, 2004, J AM GERIATR SOC, V52, P2062, DOI 10.1111/j.1532-5415.2004.52566.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hoda Mohammad Qamarul, 2007, J Pak Med Assoc, V57, P245; HOOD G, 1991, ANAESTHESIA, V46, P138, DOI 10.1111/j.1365-2044.1991.tb09361.x; Hooda S, 2006, J ANAESTHESIOLOGY CL, V22, P267; Jerre R, 2000, CLIN ORTHOP RELAT R, P169; Juelsgaard P, 1998, EUR J ANAESTH, V15, P656, DOI 10.1097/00003643-199811000-00006; KLIMSCHA W, 1995, ANESTH ANALG, V80, P322, DOI 10.1097/00000539-199502000-00020; Kocum A, 2007, ANAESTH INTENS CARE, V35, P510, DOI 10.1177/0310057X0703500408; Koval KJ, 1999, ORTHOPEDICS, V22, P31; Krobot R, 2006, REG ANESTH PAIN M S1, V31, P33; Kwan A. S. K., 1997, Hong Kong Medical Journal, V3, P250; LABAILLE T, 1992, REGION ANESTH, V17, P193; Lane A, 2008, CAN J ANAESTH, V55, P190, DOI 10.1007/BF03016097; Lang T, 2007, J TRAUMA, V62, P184, DOI 10.1097/01.ta.0000197176.75598.fc; Mak JCS, 2010, MED J AUSTRALIA, V192, P37, DOI 10.5694/j.1326-5377.2010.tb03400.x; Malchow RJ, 2008, CRIT CARE MED, V36, pS346, DOI 10.1097/CCM.0b013e31817e2fc9; Malcolmson SE, 2009, CRITICAL CARE SHOCK, V12, P144; Malek J, 2004, ACUTE PAIN, V6, P53; Mannion S, 2005, ANESTH ANALG, V100, P873, DOI 10.1213/01.ANE.0000143950.13939.7A; Marhofer P, 1997, ANESTH ANALG, V85, P854, DOI 10.1097/00000539-199710000-00026; Marhofer P, 1998, REGION ANESTH PAIN M, V23, P584, DOI 10.1016/S1098-7339(98)90086-4; Marhofer P, 2000, ANESTH ANALG, V90, P125, DOI 10.1097/00000539-200001000-00028; Martin KR, 1991, RELAXATION POSTOPERA; Martyr JW, 2005, ANAESTH INTENS CARE, V33, P64, DOI 10.1177/0310057X0503300110; Martyr JW, 2001, ANAESTH INTENS CARE, V29, P501, DOI 10.1177/0310057X0102900509; Matot I, 2003, ANESTHESIOLOGY, V98, P156, DOI 10.1097/00000542-200301000-00025; MAURETTE P, 1993, REGION ANESTH, V18, P290; Milisen K, 2001, J AM GERIATR SOC, V49, P523, DOI 10.1046/j.1532-5415.2001.49109.x; MILLER K, 1990, ANAESTHESIST, V39, P83; Minville V, 2006, ANESTH ANALG, V102, P1559, DOI 10.1213/01.ane.0000218421.18723.cf; Minville V, 2008, MINERVA ANESTESIOL, V74, P691; Morrison RS, 2003, J GERONTOL A-BIOL, V58, P76; Morrison RS, 2003, PAIN, V103, P303, DOI 10.1016/S0304-3959(02)00458-X; Mouzopoulos G, 2009, J ORTHOP TRAUMATOL, V10, P127, DOI 10.1007/s10195-009-0062-6; Navas Martinez A, 2008, REG ANESTH PAIN M S1, V33, pe30; NEEDOFF M, 1993, INJURY, V24, P317, DOI 10.1016/0020-1383(93)90054-A; OGILVIEHARRIS DJ, 1993, J ORTHOP TRAUMA, V7, P428, DOI 10.1097/00005131-199310000-00005; Olofsson C, 2004, ACTA ANAESTH SCAND, V48, P1240, DOI 10.1111/j.1399-6576.2004.00504.x; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Parker MJ, 2006, COCHRANE DB SYST REV, V3; Pasero CL, 1997, AM J NURS, V97, P20; Pedersen SJ, 2008, J AM GERIATR SOC, V56, P1831, DOI 10.1111/j.1532-5415.2008.01945.x; Penrod JD, 2004, J AM GERIATR SOC, V52, P1114, DOI 10.1111/j.1532-5415.2004.52309.x; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Poitevin Luciano Augusto, 1999, Prensa Medica Argentina, V86, P913; Rais K, 2008, EUR 2008 EUR SOC AN; Resch S, 2005, DISABIL REHABIL, V27, P1191, DOI 10.1080/09638280500055800; Resch S, 1998, ACTA ORTHOP SCAND, V69, P277; Ronald LA, 2008, CAN J AGING, V27, P109, DOI 10.3138/cja.27.1.109; Roofthooft E, 2008, CURR OPIN ANESTHESIO, V21, P259, DOI 10.1097/ACO.0b013e3282ff5e41; Rosen JE, 2001, J ORTHOP TRAUMA, V15, P81, DOI 10.1097/00005131-200102000-00001; Said-Ahmed HA, 2006, ACTA ANAESTHESIOL IT, V57, P198; Saygi B, 2010, BULL HOSP JT DIS, V68, P15; Scheinin H, 2000, ACTA ANAESTH SCAND, V44, P1061, DOI 10.1034/j.1399-6576.2000.440905.x; Jimenez MIS, 2009, REV ESP ANEST REANIM, V56, P590, DOI 10.1016/S0034-9356(09)70474-8; Segado Jimnez MI., 2010, REV SOC ESPA OLA DOL, V17, P259; Sen Selda, 2007, J Clin Monit Comput, V21, P103, DOI 10.1007/s10877-006-9062-8; Shih YJ, 2010, INT J GERONTOL, V4, P37, DOI 10.1016/S1873-9598(10)70020-X; Spansberg NLM, 1996, EUR J ANAESTH, V13, P410, DOI 10.1046/j.1365-2346.1996.00958.x; SUTCLIFFE AJ, 1994, ANAESTHESIA, V49, P237; Tuncer S, 2003, ACUTE PAIN, V4, P105; Turker G, 2003, ACTA ANAESTH SCAND, V47, P30, DOI 10.1034/j.1399-6576.2003.470106.x; Van Balen R, 2003, DISABIL REHABIL, V25, P507, DOI 10.1080/0963828031000090443; Vermeiren J, 1995, Acta Orthop Belg, V61, P122; Warden Victoria, 2003, J Am Med Dir Assoc, V4, P9, DOI 10.1097/00130535-200301000-00002; Wells G.A., 2000, VIS COMMUN Q; Yip DKH, 2002, INT ORTHOP, V26, P361, DOI 10.1007/s00264-002-0387-8; Yun MJ, 2009, ACTA ANAESTH SCAND, V53, P1282, DOI 10.1111/j.1399-6576.2009.02052.x	115	125	134	5	55	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4					234	+		10.7326/0003-4819-155-4-201108160-00346	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-00346			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807KN	21844549				2022-12-28	WOS:000293896400004
J	Hippisley-Cox, J; Coupland, C				Hippisley-Cox, Julia; Coupland, Carol			Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEEP-VEIN THROMBOSIS; WALES PROSPECTIVE DERIVATION; PULMONARY-EMBOLISM; CARDIOVASCULAR RISK; HOSPITALIZED-PATIENTS; ORAL-CONTRACEPTIVES; GENERAL-PRACTICE; UNITED-KINGDOM; MISSING DATA; ENGLAND	Objectives To derive and validate a new clinical risk prediction algorithm (QThrombosis, www.qthrombosis.org) to estimate individual patients' risk of venous thromboembolism. Design Prospective open cohort study using routinely collected data from general practices. Cox proportional hazards models used in derivation cohort to derive risk equations evaluated at 1 and 5 years. Measures of calibration and discrimination undertaken in validation cohort. Setting 564 general practices in England and Wales contributing to the QResearch database. Participants Patients aged 25-84 years, with no record of pregnancy in the preceding 12 months or any previous venous thromboembolism, and not prescribed oral anticoagulation at baseline: 2 314 701 in derivation cohort and 1 240 602 in validation cohort. Outcomes Incident cases of venous thromboembolism, either deep vein thrombosis or pulmonary embolism, recorded in primary care records or linked cause of death records. Results The derivation cohort included 14 756 incident cases of venous thromboembolism from 10 095 199 person years of observation (rate of 14.6 per 10 000 person years). The validation cohort included 6913 incident cases from 4 632 694 person years of observation (14.9 per 10 000 person years). Independent predictors included in the final model for men and women were age, body mass index, smoking status, varicose veins, congestive cardiac failure, chronic renal disease, cancer, chronic obstructive pulmonary disease, inflammatory bowel disease, hospital admission in past six months, and current prescriptions for antipsychotic drugs. We also included oral contraceptives, tamoxifen, and hormone replacement therapy in the final model for women. The risk prediction equation explained 33% of the variation in women and 34% in men in the validation cohort evaluated at 5 years The D statistic was 1.43 for women and 1.45 for men. The receiver operating curve statistic was 0.75 for both sexes. The model was well calibrated. Conclusions We have developed and validated a new risk prediction model that quantifies absolute risk of thrombosis at 1 and 5 years. It can help identify patients at high risk of venous thromboembolism for prevention. The algorithm is based on simple clinical variables which the patient is likely to know or which are routinely recorded in general practice records. The algorithm could be integrated into general practice clinical computer systems and used to risk assess patients before hospital admission or starting medication which might increase the risk of venous thromboembolism.	[Hippisley-Cox, Julia; Coupland, Carol] Div Primary Care, Nottingham NG2 7RD, England		Hippisley-Cox, J (corresponding author), Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	juliahippisleycox@gmail.com	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306	EMIS	EMIS	There was no external funding for the majority of the work undertaken on this project, which JHC and CC undertook in their ClinRisk roles. This analysis arose from a study of risks and benefits of hormone replacement therapy which was originally funded by David Stables (medical director of EMIS) in 2008, since venous thromboembolism was one of the outcomes.	Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963; Canonico M, 2008, BMJ-BRIT MED J, V336, P1227, DOI 10.1136/bmj.39555.441944.BE; Collins GS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2584; Committee HoCH, 2005, PREV THROMB HOSP PAT, P112; Couturaud F, 2009, CHEST, V136, P1537, DOI 10.1378/chest.09-0757; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Galanter WL, 2010, AM J HEALTH-SYST PH, V67, P1265, DOI 10.2146/ajhp090575; Geerts WH, 2001, CHEST, V119, p132S, DOI 10.1378/chest.119.1_suppl.132S; Grainge MJ, 2010, LANCET, V375, P657, DOI 10.1016/S0140-6736(09)61963-2; Health NIf, 2010, VEN THROMB RED RISK, P50, DOI [DOI 10.1056/NEJMOA011327, 10.1056/NEJMoa011327]; Heinemann LAJ, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-5; Heinemann LAJ, 2007, CONTRACEPTION, V75, P328, DOI 10.1016/j.contraception.2006.12.018; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, pb880, DOI DOI 10.1136/bmj.b880; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; HOFFENBERG R, 1989, BRIT MED J, V298, P573; HOSMER DW, 1989, APPL LOGISTIC REGRES; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick SS, 2006, CONTRACEPTION, V73, P566, DOI 10.1016/j.contraception.2006.02.002; Khorana AA, 2008, BLOOD, V111, P4902, DOI 10.1182/blood-2007-10-116327; KOELEMAN BPC, 1994, BLOOD, V84, P1031; Kyrle PA, 2005, LANCET, V365, P1163, DOI 10.1016/S0140-6736(05)71880-8; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Lidegaard O, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2890; Lutsey PL, 2010, AM J PUBLIC HEALTH, V100, P1506, DOI 10.2105/AJPH.2008.157776; Majeed Azeem, 2004, Health Stat Q, P5; Miehsler W, 2004, GUT, V53, P542, DOI 10.1136/gut.2003.025411; Mohr DN, 2000, MAYO CLIN PROC, V75, P1249, DOI 10.4065/75.12.1249; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Ng TMH, 2010, CIRC-HEART FAIL, V3, P165, DOI 10.1161/CIRCHEARTFAILURE.109.892349; Parker C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4245; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Roberts H, 2008, BRIT MED J, V336, P1203, DOI 10.1136/bmj.39556.666944.80; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Samama MM, 2003, HAEMATOLOGICA, V88, P1410; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Smith NL, 2004, JAMA-J AM MED ASSOC, V292, P1581, DOI 10.1001/jama.292.13.1581; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; Vlieg AV, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2921	50	88	96	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2011	343								d4656	10.1136/bmj.d4656	http://dx.doi.org/10.1136/bmj.d4656			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811KU	21846713	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000294209500001
J	Rahman, NM; Maskell, NA; West, A; Teoh, R; Arnold, A; Mackinlay, C; Peckham, D; Davies, CWH; Ali, N; Kinnear, W; Bentley, A; Kahan, BC; Wrightson, JM; Davies, HE; Hooper, CE; Lee, YCG; Hedley, EL; Crosthwaite, N; Choo, L; Helm, EJ; Gleeson, FV; Nunn, AJ; Davies, RJO				Rahman, Najib M.; Maskell, Nicholas A.; West, Alex; Teoh, Richard; Arnold, Anthony; Mackinlay, Carolyn; Peckham, Daniel; Davies, Chris W. H.; Ali, Nabeel; Kinnear, William; Bentley, Andrew; Kahan, Brennan C.; Wrightson, John M.; Davies, Helen E.; Hooper, Clare E.; Lee, Y. C. Gary; Hedley, Emma L.; Crosthwaite, Nicky; Choo, Louise; Helm, Emma J.; Gleeson, Fergus V.; Nunn, Andrew J.; Davies, Robert J. O.			Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPLICATED PARAPNEUMONIC EFFUSIONS; HUMAN RECOMBINANT DEOXYRIBONUCLEASE; RANDOMIZED CONTROLLED TRIAL; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; PROGNOSTIC-FACTORS; CHILDHOOD EMPYEMA; EXTRACELLULAR DNA; RANDOM ALLOCATION; CLINICAL-TRIALS	Background More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve outcomes in an earlier, large, randomized trial. Methods We conducted a blinded, 2-by-2 factorial trial in which 210 patients with pleural infection were randomly assigned to receive one of four study treatments for 3 days: double placebo, intrapleural tissue plasminogen activator (t-PA) and DNase, t-PA and placebo, or DNase and placebo. The primary outcome was the change in pleural opacity, measured as the percentage of the hemithorax occupied by effusion, on chest radiography on day 7 as compared with day 1. Secondary outcomes included referral for surgery, duration of hospital stay, and adverse events. Results The mean (+/- SD) change in pleural opacity was greater in the t-PA-DNase group than in the placebo group (-29.5 +/- 23.3% vs. -17.2 +/- 19.6%; difference, -7.9%; 95% confidence interval [CI], -13.4 to -2.4; P = 0.005); the change observed with t-PA alone and with DNase alone (-17.2 +/- 24.3 and -14.7 +/- 16.4%, respectively) was not significantly different from that observed with placebo. The frequency of surgical referral at 3 months was lower in the t-PA-DNase group than in the placebo group (2 of 48 patients [4%] vs. 8 of 51 patients [16%]; odds ratio for surgical referral, 0.17; 95% CI, 0.03 to 0.87; P = 0.03) but was greater in the DNase group (18 of 46 patients [39%]) than in the placebo group (odds ratio, 3.56; 95% CI, 1.30 to 9.75; P = 0.01). Combined t-PA-DNase therapy was associated with a reduction in the hospital stay, as compared with placebo (difference, -6.7 days; 95% CI, -12.0 to -1.9; P = 0.006); the hospital stay with either agent alone was not significantly different from that with placebo. The frequency of adverse events did not differ significantly among the groups. Conclusions Intrapleural t-PA-DNase therapy improved fluid drainage in patients with pleural infection and reduced the frequency of surgical referral and the duration of the hospital stay. Treatment with DNase alone or t-PA alone was ineffective.	[Rahman, Najib M.; Wrightson, John M.; Davies, Helen E.; Hedley, Emma L.; Crosthwaite, Nicky; Davies, Robert J. O.] Churchill Hosp, United Kingdom Clin Res Collaborat Oxford Resp Tr, Oxford OX3 7LJ, England; [Rahman, Najib M.; Wrightson, John M.; Davies, Helen E.; Hedley, Emma L.; Crosthwaite, Nicky; Davies, Robert J. O.] Churchill Hosp, Oxford Pleural Dis Unit, Oxford OX3 7LJ, England; [Rahman, Najib M.; Gleeson, Fergus V.; Davies, Robert J. O.] Univ Oxford, Natl Inst Hlth Res Oxford, Biomed Res Ctr, Oxford OX3 7LJ, England; [Helm, Emma J.; Gleeson, Fergus V.] Oxford Radcliffe Natl Hlth Serv Trusts, Dept Radiol, Oxford, England; [Maskell, Nicholas A.; Hooper, Clare E.] Univ Bristol, Acad Resp Unit, Dept Clin Sci, Southmead Hosp, Bristol, Avon, England; [West, Alex] Medway Maritime Hosp, Gillingham, England; [Teoh, Richard; Arnold, Anthony] Castle Hill Hosp, Cottingham, England; [Mackinlay, Carolyn] Great Western Hosp, Swindon, Wilts, England; [Peckham, Daniel] St James Hosp, Leeds, W Yorkshire, England; [Davies, Chris W. H.] Royal Berkshire Hosp, Reading RG1 5AN, Berks, England; [Ali, Nabeel] Kings Mill Hosp, Nottingham, England; [Kinnear, William] Queens Med Ctr, Nottingham NG7 2UH, England; [Bentley, Andrew] Wythenshawe Hosp, Manchester M23 9LT, Lancs, England; [Kahan, Brennan C.; Choo, Louise; Nunn, Andrew J.] MRC, Clin Trials Unit, London, England; [Lee, Y. C. Gary] Univ Western Australia, Sch Med, Perth, WA 6009, Australia; [Lee, Y. C. Gary] Univ Western Australia, Ctr Asthma Allergy & Resp, Perth, WA 6009, Australia	University of Oxford; University of Oxford; University of Oxford; Southmead Hospital; University of Bristol; Medway Maritime Hospital; University of Hull; Saint James's University Hospital; Royal Berkshire Hospital; University of Nottingham; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Medical Research Council Clinical Trials Unit; University of Western Australia; University of Western Australia	Rahman, NM (corresponding author), Univ Oxford, UKCRC Oxford Resp Trials Unit, Oxford Ctr Resp Med, Nuffield Dept Med, Churchill Hosp Site, Oxford OX3 7LJ, England.	najib.rahman@ndm.ox.ac.uk	Lee, Y C Gary/H-5264-2014	Choo, Louise/0000-0003-4040-1522; Gleeson, Fergus/0000-0002-5121-3917; Bentley, Andrew/0000-0002-6883-9246; Peckham, Daniel/0000-0001-7723-1868; Nunn, Andrew/0000-0002-9158-4595; Wrightson, John Matthew/0000-0002-3036-9672; Rahman, Najib M/0000-0003-1195-1680; Davies, Helen/0000-0001-6102-256X; maskell, nick/0000-0002-1276-6500; Lee, Yun Chor Gary/0000-0002-0036-511X	Roche UK; Oxford Biomedical Research Centre through the United Kingdom National Institute for Health Research; United Kingdom Medical Research Council; ResMed UK; Boehringer Ingelheim UK; MRC [G0600475, MC_U122888468] Funding Source: UKRI; Medical Research Council [MC_U122888468, G0600475] Funding Source: researchfish; National Institute for Health Research [CL-2009-13-006] Funding Source: researchfish	Roche UK(Roche Holding); Oxford Biomedical Research Centre through the United Kingdom National Institute for Health Research; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ResMed UK; Boehringer Ingelheim UK(Boehringer Ingelheim); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by an unrestricted educational grant to the University of Oxford from Roche UK and by others; Current Controlled Trials number, ISRCTN57454527.; Supported by an unrestricted educational grant from Roche UK to the University of Oxford and by grants from the Oxford Biomedical Research Centre Programme, through the United Kingdom National Institute for Health Research (to Drs. R. Davies, Gleeson, and Rahman) and the United Kingdom Medical Research Council (to Dr. Rahman).; Dr. C. Davies reports receiving lecture fees from ResMed UK; and Dr. Wrightson, lecture fees from Boehringer Ingelheim UK. No other potential conflict of interest relevant to this article was reported.	Alipour M, 2009, J ANTIMICROB CHEMOTH, V64, P317, DOI 10.1093/jac/dkp165; Bishop NB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.2.e188; Bouros D, 1999, AM J RESP CRIT CARE, V159, P37, DOI 10.1164/ajrccm.159.1.9803094; Bouros D, 2005, NEW ENGL J MED, V352, P2244; Davies CWH, 1999, AM J RESP CRIT CARE, V160, P1682, DOI 10.1164/ajrccm.160.5.9903002; Davies RJO, 1997, THORAX, V52, P416, DOI 10.1136/thx.52.5.416; Desrumaux A, 2007, ARCH PEDIATRIE, V14, P1298, DOI 10.1016/j.arcped.2007.06.008; Diacon AH, 2005, NEW ENGL J MED, V352, P2243; Diacon AH, 2004, AM J RESP CRIT CARE, V170, P49, DOI 10.1164/rccm.200312-1740OC; Eckhart L, 2007, BRIT J DERMATOL, V156, P1342, DOI 10.1111/j.1365-2133.2007.07886.x; Farjah F, 2007, J THORAC CARDIOV SUR, V133, P346, DOI 10.1016/j.jtcvs.2006.09.038; Feola G Peter, 2003, Tech Vasc Interv Radiol, V6, P197, DOI 10.1053/j.tvir.2003.10.004; Ferguson AD, 1996, QJM-MON J ASSOC PHYS, V89, P285; Finley C, 2008, CAN RESPIR J, V15, P85, DOI 10.1155/2008/975312; FLOROVA G, 2010, AM J RESP CRIT CARE, V181; FORSYTHE AB, 1987, COMPUT STAT DATA AN, V5, P193, DOI 10.1016/0167-9473(87)90015-6; Fujiwara K, 2002, Kyobu Geka, V55, P1115; Gates RL, 2004, J PEDIATR SURG, V39, P1638, DOI 10.1016/j.jpedsurg.2004.07.015; Hagino A, 2004, CONTROL CLIN TRIALS, V25, P572, DOI 10.1016/j.cct.2004.08.004; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Heffner JE, 2005, NEW ENGL J MED, V352, P926, DOI 10.1056/NEJMe048352; IDELL S, 1992, AM J RESP CELL MOL, V7, P414, DOI 10.1165/ajrcmb/7.4.414; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Keenan Sean P, 2005, ACP J Club, V143, P40; Kroegel C, 1997, EUR RESPIR J, V10, P2411, DOI 10.1183/09031936.97.10102411; LIGHT RW, 1980, AM J MED, V69, P507, DOI 10.1016/0002-9343(80)90460-X; Light RW, 2000, LUNG, V178, P13, DOI 10.1007/s004080000002; Maskell NA, 2005, NEW ENGL J MED, V352, P865, DOI 10.1056/NEJMoa042473; Maskell NA, 2005, NEW ENGL J MED, V352, P2146; Misthos P, 2005, EUR J CARDIO-THORAC, V28, P599, DOI 10.1016/j.ejcts.2005.07.005; Montgomery Alan A, 2003, BMC Med Res Methodol, V3, P26, DOI 10.1186/1471-2288-3-26; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Nemoto K, 2003, CHEMOTHERAPY, V49, P121, DOI 10.1159/000070617; Netten A, 1999, UNIT COSTS HLTH SOCI; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; POULSEN J, 1983, ACTA CHIR SCAND, V149, P245; Ray Theresa L, 2004, J Intensive Care Med, V19, P44, DOI 10.1177/0885066603259942; Rosa UW, 2005, NEW ENGL J MED, V352, P2244; Rovers MM, 2000, EUR J EPIDEMIOL, V16, P1123, DOI 10.1023/A:1010907912024; Roxburgh C, 2007, SCOT MED J, V52, P25, DOI 10.1258/rsmsmj.52.4.25; Simpson G, 2000, CHEST, V117, P1728, DOI 10.1378/chest.117.6.1728; Simpson G, 2003, THORAX, V58, P365, DOI 10.1136/thorax.58.4.365; Skeete DA, 2004, J TRAUMA, V57, P1178, DOI 10.1097/01.TA.0000141879.67441.52; Sonnappa S, 2006, AM J RESP CRIT CARE, V174, P221, DOI 10.1164/rccm.200601-027OC; SUOMALAINEN O, 1983, ANN CHIR GYNAECOL FE, V72, P62; Talib S H, 2003, J Assoc Physicians India, V51, P464; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Tokuda Y, 2006, CHEST, V129, P783, DOI 10.1378/chest.129.3.783; Tuncozgur B, 2001, INT J CLIN PRACT, V55, P658; Walker CA, 2003, ANN PHARMACOTHER, V37, P376, DOI 10.1345/aph.1C248; Weinstein M, 2004, PEDIATRICS, V113, pE182, DOI 10.1542/peds.113.3.e182; Wells RG, 2003, RADIOLOGY, V228, P370, DOI 10.1148/radiol.2282020486; Zhu ZW, 2006, CHEST, V129, P1577, DOI 10.1378/chest.129.6.1577; 2005, N ENGL J MED, V352, P2243	55	411	426	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					518	526		10.1056/NEJMoa1012740	http://dx.doi.org/10.1056/NEJMoa1012740			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805MW	21830966				2022-12-28	WOS:000293732100007
J	Farge, D; Gluckman, E				Farge, Dominique; Gluckman, Eliane			Autologous HSCT in systemic sclerosis: a step forward	LANCET			English	Editorial Material							DOSE IMMUNOSUPPRESSIVE THERAPY; CELL TRANSPLANTATION; MARROW-TRANSPLANTATION; INVOLVEMENT; SCLERODERMA		[Farge, Dominique] Univ Paris 07, Hop St Louis, Internal Med & Vasc Dis Unit, INSERM,U796, F-75010 Paris, France; [Gluckman, Eliane] Hop St Louis, Clin Res Unit, APHP, Eurocord Off, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Farge, D (corresponding author), Univ Paris 07, Hop St Louis, Internal Med & Vasc Dis Unit, INSERM,U796, F-75010 Paris, France.	dominique.farge-bancel@sls.aphp.fr	eliane, Gluckman/AAA-5024-2021					Abrahamsson S, 2008, AUTOIMMUNITY, V41, P577, DOI 10.1080/08916930802197081; Burt RK, 2011, LANCET, V378, P498, DOI 10.1016/S0140-6736(11)60982-3; Domsic RT, 2011, ANN RHEUM DIS, V70, P104, DOI 10.1136/ard.2009.127621; Farge D, 2005, ARTHRITIS RHEUM, V52, P1555, DOI 10.1002/art.21036; Farge D, 2004, ANN RHEUM DIS, V63, P974, DOI 10.1136/ard.2003.011205; Farge D, 2010, HAEMATOL-HEMATOL J, V95, P284, DOI 10.3324/haematol.2009.013458; Launay D, 2009, J RHEUMATOL, V36, P1460, DOI 10.3899/jrheum.081212; McSweeney PA, 2002, BLOOD, V100, P1602, DOI 10.1182/blood.V100.5.1602.h81702001602_1602_1610; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Nannini C, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2534; Nash RA, 2007, BLOOD, V110, P1388, DOI 10.1182/blood-2007-02-072389; Oyama Y, 2007, BONE MARROW TRANSPL, V40, P549, DOI 10.1038/sj.bmt.1705782; Snowden J, BONE MARROW IN PRESS; Verrecchia F, 2007, RHEUMATOLOGY, V46, P833, DOI 10.1093/rheumatology/kel451	14	6	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2011	378	9790					460	462		10.1016/S0140-6736(11)61100-8	http://dx.doi.org/10.1016/S0140-6736(11)61100-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809SO	21777973				2022-12-28	WOS:000294077200005
J	Gracheva, EO; Cordero-Morales, JF; Gonzalez-Carcacia, JA; Ingolia, NT; Manno, C; Aranguren, CI; Weissman, JS; Julius, D				Gracheva, Elena O.; Cordero-Morales, Julio F.; Gonzalez-Carcacia, Jose A.; Ingolia, Nicholas T.; Manno, Carlo; Aranguren, Carla I.; Weissman, Jonathan S.; Julius, David			Ganglion-specific splicing of TRPV1 underlies infrared sensation in vampire bats	NATURE			English	Article							DESMODUS-ROTUNDUS; CAPSAICIN RECEPTOR; PHYLOGENETICS; SENSITIVITY; MAMMALS; CHANNEL; SNAKES; COLD; WARM	Vampire bats (Desmodus rotundus) are obligate blood feeders that have evolved specialized systems to suit their sanguinary lifestyle(1-3). Chief among such adaptations is the ability to detect infrared radiation as a means of locating hotspots on warm-blooded prey. Among vertebrates, only vampire bats, boas, pythons and pit vipers are capable of detecting infrared radiation(1,4). In each case, infrared signals are detected by trigeminal nerve fibres that innervate specialized pit organs on the animal's face(5-10). Thus, vampire bats and snakes have taken thermosensation to the extreme by developing specialized systems for detecting infrared radiation. As such, these creatures provide a window into the molecular and genetic mechanisms underlying evolutionary tuning of thermoreceptors in a species-specific or cell-type-specific manner. Previously, we have shown that snakes co-opt a non-heat-sensitive channel, vertebrate TRPA1 (transient receptor potential cation channel A1), to produce an infrared detector(6). Here we show that vampire bats tune a channel that is already heat-sensitive, TRPV1, by lowering its thermal activation threshold to about 30 degrees C. This is achieved through alternative splicing of TRPV1 transcripts to produce a channel with a truncated carboxy-terminal cytoplasmic domain. These splicing events occur exclusively in trigeminal ganglia, and not in dorsal root ganglia, thereby maintaining a role for TRPV1 as a detector of noxious heat in somatic afferents. This reflects a unique organization of the bat Trpv1 gene that we show to be characteristic of Laurasiatheria mammals (cows, dogs and moles), supporting a close phylogenetic relationship with bats. These findings reveal a novel molecular mechanism for physiological tuning of thermosensory nerve fibres.	[Gracheva, Elena O.; Cordero-Morales, Julio F.; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Gonzalez-Carcacia, Jose A.; Aranguren, Carla I.] Inst Venezolano Invest Cient, Ctr Ecol, Lab Biol Organismos, Caracas 1020A, Venezuela; [Ingolia, Nicholas T.] Carnegie Inst, Dept Embryol, Baltimore, MD 21218 USA; [Manno, Carlo] Inst Venezolano Invest Cient, Ctr Biofis & Bioquim, Lab Fisiol Celular, Caracas 1020A, Venezuela; [Weissman, Jonathan S.; Julius, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Venezuelan Institute Science Research; Carnegie Institution for Science; Venezuelan Institute Science Research; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	ingolia@ciwemb.edu; david.julius@ucsf.edu		Gracheva, Elena O/0000-0002-0846-3427; Cordero Morales, Julio/0000-0002-6505-5403; Weissman, Jonathan/0000-0003-2445-670X; Manno, Carlo/0000-0002-1120-9606	Ruth L. Kirschstein National Research Service Award [GM080853]; UCSF CVRI; Howard Hughes Medical Institute; NIH [P01 AG010770, NS047723, NS055299]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047723, R01NS055299, R01NS047723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF CVRI; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Y. Kelly and J. Poblete for technical assistance, C. Sehnert for help with bovine tissue collection, M. Suzawa and H. Ingraham for providing zebrafish mRNA, A. Walsh for providing megabat blood samples, the Centro Tecnico de Produccion Socialista Florentino for providing access to Hato Pinero (Cojedes, Venezuela) for animal collection and J. Nassar for providing access to laboratory material required for specimen collection. This work was supported by a Ruth L. Kirschstein National Research Service Award (GM080853; N.T.I.), a Pathway to Independence Fellowship from the UCSF CVRI (E.O.G.), the Howard Hughes Medical Institute (J. S. W.), and grants from NIH, including P01 AG010770 (J. S. W.) and NS047723 and NS055299 (D.J.).	Asher RJ, 2009, BIOESSAYS, V31, P853, DOI 10.1002/bies.200900053; Bakken GS, 2007, J EXP BIOL, V210, P2801, DOI 10.1242/jeb.006965; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BULLOCK TH, 1952, SCIENCE, V115, P541, DOI 10.1126/science.115.2994.541-a; Campbell AL, 2002, MICRON, V33, P211, DOI 10.1016/S0968-4328(01)00010-5; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; KISHIDA R, 1984, BRAIN RES, V322, P351, DOI 10.1016/0006-8993(84)90132-X; KURTEN L, 1984, NATURWISSENSCHAFTEN, V71, P327, DOI 10.1007/BF00396621; KURTEN L, 1982, J COMP PHYSIOL, V146, P223; MOLENAAR GJ, 1978, J COMP NEUROL, V179, P137, DOI 10.1002/cne.901790109; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PETTIGREW JD, 1989, PHILOS T ROY SOC B, V325, P489, DOI 10.1098/rstb.1989.0102; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Safer AB, 2004, BEHAV BRAIN RES, V154, P55, DOI 10.1016/j.bbr.2004.01.020; SCHAFER K, 1988, PFLUG ARCH EUR J PHY, V412, P188, DOI 10.1007/BF00583749; Schutt B., 2008, DARK BANQUET BLOOD C; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Tellgren-Roth A, 2009, NATURWISSENSCHAFTEN, V96, P39, DOI 10.1007/s00114-008-0446-0; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084	30	150	154	2	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					88	+		10.1038/nature10245	http://dx.doi.org/10.1038/nature10245			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21814281	Green Accepted, Green Submitted			2022-12-28	WOS:000293447300035
J	Bongaarts, J; Sinding, S				Bongaarts, John; Sinding, Steven			Population Policy in Transition in the Developing World	SCIENCE			English	Editorial Material							DEVELOPING-COUNTRIES	Population growth remains rapid in the poorest countries, particularly in sub-Saharan Africa, despite substantial AIDS mortality. Voluntary family-planning programs reduce unplanned pregnancies by providing access to and information about contraception and by reducing socioeconomic obstacles to use. With sufficient political will and resources, well-run voluntary programs have been shown to bring about sustained declines in fertility and population growth across much of Asia, the Middle East, and Latin America, simply by permitting people to realize their individual reproductive goals. Such programs represent a cost-effective approach to relieving population pressures, stimulating economic development, improving health, and enhancing human freedom.	[Bongaarts, John] Populat Council, New York, NY 10017 USA; [Sinding, Steven] Int Planned Parenthood Federat, London SE1 3UZ, England	Population Council	Bongaarts, J (corresponding author), Populat Council, New York, NY 10017 USA.	jbongaarts@popcouncil.org						[Anonymous], 1994, DETERMINANTS REPROD; [Anonymous], 2011, 4 UN C LEAST DEV COU; Birdsall N., 2001, POPULATION MATTERS; Bloom DE, 2008, POPUL DEV REV, V34, P17; BONGAARTS J, 2011, POP ASS AM M WASH DC; Bongaarts J, 2008, STUD FAMILY PLANN, V39, P105, DOI 10.1111/j.1728-4465.2008.00157.x; Brown L.R., 2011, FOREIGN POLICY; Campbell M, 2007, SCIENCE, V315, P1501, DOI 10.1126/science.1140057; Casterline JB, 2000, POPUL DEV REV, V26, P691, DOI 10.1111/j.1728-4457.2000.00691.x; Cates W, 2010, SCIENCE, V329, P1603, DOI 10.1126/science.1197080; Cincotta R.P, 2003, SECURITY DEMOGRAPHIC; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Coleman I, 2011, FAMILY PLANNING US F; *COMM POP DEV, 2009, INT C POP DEV NEW YO; JEEJEEBHOY S, 1995, WOMENS ED AUTONOMY R; Khuda B, 2001, FERTILITY TRANSITION, P364; Lutz W, 2009, PHILOS T R SOC B, V364, P3031, DOI 10.1098/rstb.2009.0156; POTTS M, 2011, FOREIGN POLICY  0509; Potts M, 2010, LANCET, V375, P1762, DOI 10.1016/S0140-6736(10)60750-7; SIMMONS R, 1988, STUD FAMILY PLANN, V19, P29, DOI 10.2307/1966737; Singh S, 2009, ADDING IT COSTS BENE; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Solo J, 2008, FAMILY PLANNING RWAN; United Nations, 2011, WORLD POP PROSP 2010; *USAID, 2009, BRIEF; 2006, SPEC SESS AFR UN C M; 2010, ECONOMIST       1122, P10; 2011, NATL GEOGRAPHIC SPEC	28	45	49	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					574	576		10.1126/science.1207558	http://dx.doi.org/10.1126/science.1207558			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	798PI	21798937				2022-12-28	WOS:000293222400047
J	Mack, MC; Bret-Harte, MS; Hollingsworth, TN; Jandt, RR; Schuur, EAG; Shaver, GR; Verbyla, DL				Mack, Michelle C.; Bret-Harte, M. Syndonia; Hollingsworth, Teresa N.; Jandt, Randi R.; Schuur, Edward A. G.; Shaver, Gaius R.; Verbyla, David L.			Carbon loss from an unprecedented Arctic tundra wildfire	NATURE			English	Article							CLIMATE-CHANGE; NORTH-AMERICA; FIRE; VEGETATION; SOILS; VULNERABILITY; ECOSYSTEMS; SEVERITY; STORAGE; FORESTS	Arctic tundra soils store large amounts of carbon (C) in organic soil layers hundreds to thousands of years old that insulate, and in some cases maintain, permafrost soils(1,2). Fire has been largely absent from most of this biome since the early Holocene epoch(3), but its frequency and extent are increasing, probably in response to climate warming(4). The effect of fires on the C balance of tundra landscapes, however, remains largely unknown. The Anaktuvuk River fire in 2007 burned 1,039 square kilometres of Alaska's Arctic slope, making it the largest fire on record for the tundra biome and doubling the cumulative area burned since 1950 (ref. 5). Here we report that tundra ecosystems lost 2,016 +/- 435 g C m(-2) in the fire, an amount two orders of magnitude larger than annual net C exchange in undisturbed tundra(6). Sixty per cent of this C loss was from soil organic matter, and radiocarbon dating of residual soil layers revealed that the maximum age of soil C lost was 50 years. Scaled to the entire burned area, the fire released approximately 2.1 teragrams of C to the atmosphere, an amount similar in magnitude to the annual net C sink for the entire Arctic tundra biome averaged over the last quarter of the twentieth century(7). The magnitude of ecosystem C lost by fire, relative to both ecosystem and biome-scale fluxes, demonstrates that a climate-driven increase in tundra fire disturbance may represent a positive feedback, potentially offsetting Arctic greening(8) and influencing the net C balance of the tundra biome.	[Mack, Michelle C.; Schuur, Edward A. G.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Bret-Harte, M. Syndonia] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Hollingsworth, Teresa N.] Univ Alaska Fairbanks, Boreal Ecol Cooperat Res Unit, PNW Res Stn USDA Forest Serv, Fairbanks, AK 99775 USA; [Jandt, Randi R.] Bur Land Management, Alaska Fire Serv, Ft Wainwright, AK 99703 USA; [Shaver, Gaius R.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Verbyla, David L.] Univ Alaska Fairbanks, Dept Forest Sci, Fairbanks, AK USA	State University System of Florida; University of Florida; University of Alaska System; University of Alaska Fairbanks; United States Department of Agriculture (USDA); United States Forest Service; University of Alaska System; University of Alaska Fairbanks; Marine Biological Laboratory - Woods Hole; University of Alaska System; University of Alaska Fairbanks	Mack, MC (corresponding author), Univ Florida, Dept Biol, POB 118525, Gainesville, FL 32611 USA.	mcmack@ufl.edu	Jandt, Randi/E-9018-2013	Jandt, Randi/0000-0001-8471-792X	US NSF Division of Environmental Biology; Division of Biological Infrastructure and Office of Polar Programs; US National Center for Ecological Analysis and Synthesis; US Bureau of Land Management Alaska Fire Service and Arctic Field Office	US NSF Division of Environmental Biology; Division of Biological Infrastructure and Office of Polar Programs; US National Center for Ecological Analysis and Synthesis; US Bureau of Land Management Alaska Fire Service and Arctic Field Office	We thank J. Ahgook Jr, L. Boby, M. Cahill, E. Miya, E. Miller, J. Oyler, C. Roberts, E. Suronen, C. Wachs, C. Wasykowski and D. Yokel for their contributions to fieldwork, C. Apodaca, G. Blohm, E. Brown, G. Crummer and D. Nossov for their contributions to laboratory work and sample analyses, H. Alexander for contributing to data analyses, and P. Ray for insights into tussock morphology. This research was supported by the US NSF Division of Environmental Biology, the Division of Biological Infrastructure and Office of Polar Programs, by the US National Center for Ecological Analysis and Synthesis and by the US Bureau of Land Management Alaska Fire Service and Arctic Field Office.	Balshi MS, 2009, GLOBAL CHANGE BIOL, V15, P1491, DOI 10.1111/j.1365-2486.2009.01877.x; Boby LA, 2010, ECOL APPL, V20, P1633, DOI 10.1890/08-2295.1; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; Chapin FS, 2000, GLOBAL CHANGE BIOL, V6, P211, DOI 10.1046/j.1365-2486.2000.06022.x; Field CB, 2007, ANNU REV ENV RESOUR, V32, P1, DOI 10.1146/annurev.energy.32.053006.141119; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; HARDEN JW, 1992, SCIENCE, V258, P1921, DOI 10.1126/science.258.5090.1921; Higuera PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001744; Hobara S, 2006, ARCT ANTARCT ALP RES, V38, P363, DOI 10.1657/1523-0430(2006)38[363:NFISSA]2.0.CO;2; Hu FS, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001270; Jones BM, 2009, ARCT ANTARCT ALP RES, V41, P309, DOI 10.1657/1938-4246-41.3.309; Kasischke ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025677; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; Oechel WC, 2000, GLOB CHANGE BIOL, V6, P160, DOI 10.1046/j.1365-2486.2000.06018.x; Ping CL, 2008, NAT GEOSCI, V1, P615, DOI 10.1038/ngeo284; Ping CL, 1998, J GEOPHYS RES-ATMOS, V103, P28917, DOI 10.1029/98JD02024; Randerson JT, 2006, SCIENCE, V314, P1130, DOI 10.1126/science.1132075; Rocha AV, 2009, AGR FOREST METEOROL, V149, P1560, DOI 10.1016/j.agrformet.2009.03.016; Schell D., 1989, PEAT CORES TOOLIK LA; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; The Intergovernmental Panel on Climate Change (IPCC), 2007, CHANG 2007 PHYS SCI; Trumbore SE, 1997, J GEOPHYS RES-ATMOS, V102, P28817, DOI 10.1029/97JD02231; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Zimov SA, 1999, SCIENCE, V284, P1973, DOI 10.1126/science.284.5422.1973	32	289	295	6	307	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					489	492		10.1038/nature10283	http://dx.doi.org/10.1038/nature10283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796209				2022-12-28	WOS:000293167900038
J	Maslin, M; Scott, J				Maslin, Mark; Scott, Joanne			Carbon trading needs a multi-level approach	NATURE			English	Editorial Material									[Maslin, Mark] UCL, Dept Geog, London WC1E 6BT, England; [Scott, Joanne] UCL, Fac Laws, London WC1H 0EG, England	University of London; University College London; University of London; University College London	Maslin, M (corresponding author), UCL, Dept Geog, Pearson Bldg,Gower St, London WC1E 6BT, England.	mmaslin@geog.ucl.ac.uk		Maslin, Mark/0000-0001-9957-3463				Eggleston S., 2006, 2006 IPCC GUIDELINES; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Levin K., 2010, COMPARABILITY ANNEX; Linacre N., 2011, STATE TRENDS CARBON; Phelps J, 2010, SCIENCE, V328, P312, DOI 10.1126/science.1187774; POESSINOUW M, 2010, KNOWLEDGE MATRIX LTD; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Wagner F., 2003, IPCC GOOD PRACTICE G; Wara M, 2007, NATURE, V445, P595, DOI 10.1038/445595a	9	17	18	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					445	447		10.1038/475445a	http://dx.doi.org/10.1038/475445a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	797ZA	21796183	Bronze			2022-12-28	WOS:000293167900014
J	Perner, J; Mauer, MC; Hildenbrand, M				Perner, Josef; Mauer, M. Christine; Hildenbrand, Monika			Identity: Key to Children's Understanding of Belief	SCIENCE			English	Article							FALSE-BELIEF; DOMAIN SPECIFICITY; INHIBITORY CONTROL; MIND; PRESCHOOLERS; IMPLICIT; METAANALYSIS; AUTISM	Is knowledge structured and acquired as independent facts and concepts, as parcels of independent domains, or as domains that share conceptual abilities? For an answer, we looked at the development of two concepts, belief and identity. These concepts are not part of the same domain, but the application of both depends on the common ability to separate sense from reference. We show that both capacities become functional between the ages of 3 and 5 years, which provides empirical support for the contention that deep conceptual structures play an important role in cognitive development.	[Perner, Josef; Mauer, M. Christine; Hildenbrand, Monika] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria; [Perner, Josef] Salzburg Univ, Ctr Neurocognit Res, A-5020 Salzburg, Austria	Salzburg University; Salzburg University	Perner, J (corresponding author), Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria.				Austrian Science Fund [I93-G15]	Austrian Science Fund(Austrian Science Fund (FWF))	Study 1 was part of the diploma thesis of C. M., and study 2 was that of M. H., who were financially supported as research assistants by the Austrian Science Fund (project I93-G15 "Metacognition of Perspective Differences," European Science Foundation-European Collaborative Research-Consciousness in a Natural and Cultural Context). The basic idea for the study was conceived in conversations with N. Goodman and B. Rendl.	Aichhorn M, 2009, J COGNITIVE NEUROSCI, V21, P1179, DOI 10.1162/jocn.2009.21082; Baillargeon R, 2010, TRENDS COGN SCI, V14, P110, DOI 10.1016/j.tics.2009.12.006; Bowler DM, 2005, J COGN DEV, V6, P259, DOI 10.1207/s15327647jcd0602_5; Carlson SM, 2002, INFANT CHILD DEV, V11, P73, DOI 10.1002/icd.298; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; CLEMENTS WA, 1994, COGNITIVE DEV, V9, P377, DOI 10.1016/0885-2014(94)90012-4; Flavell J.H., 1988, DEV CHILDRENS KNOWLE, P244; Forguson L., 1988, DEV THEORIES MIND, P226; Frege G., 1960, PHILOS WRITINGS, P56; Kamp Hans, 1990, PROPOSITIONAL ATTITU, P27; LEEKAM SR, 1991, COGNITION, V40, P203, DOI 10.1016/0010-0277(91)90025-Y; Leekam S, 2008, BRIT J DEV PSYCHOL, V26, P485, DOI 10.1348/026151007X260154; LESLIE AM, 1992, COGNITION, V43, P225, DOI 10.1016/0010-0277(92)90013-8; Low J, 2010, CHILD DEV, V81, P597, DOI 10.1111/j.1467-8624.2009.01418.x; May R, 2001, SEMANTIC INTERFACES, P1, DOI DOI 10.1017/S0022226702221970; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; PERNER J, 1988, DEV THEORIES MIND, P141; Perner J, 2008, Q J EXP PSYCHOL, V61, P76, DOI 10.1080/17470210701508756; Perner J, 2010, COGNITION AND NEUROPSYCHOLOGY: INTERNATIONAL PERSPECTIVES ON PSYCHOLOGICAL SCIENCE, VOL 1, P241; Povinelli DJ, 2004, MIND LANG, V19, P1, DOI 10.1111/j.1468-0017.2004.00244.x; Ruffman T, 2001, J EXP CHILD PSYCHOL, V80, P201, DOI 10.1006/jecp.2001.2633; Sabbagh MA, 2006, CHILD DEV, V77, P1034, DOI 10.1111/j.1467-8624.2006.00917.x; Southgate V, 2007, PSYCHOL SCI, V18, P587, DOI 10.1111/j.1467-9280.2007.01944.x; Wellman H. M, 1990, CHILDS THEORY MIND; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	28	51	51	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					474	477		10.1126/science.1201216	http://dx.doi.org/10.1126/science.1201216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	795FR	21778403				2022-12-28	WOS:000292959600052
J	Cirak, S; Arechavala-Gomeza, V; Guglieri, M; Feng, L; Torelli, S; Anthony, K; Abbs, S; Garralda, ME; Bourke, J; Wells, DJ; Dickson, G; Wood, MJA; Wilton, SD; Straub, V; Kole, R; Shrewsbury, SB; Sewry, C; Morgan, JE; Bushby, K; Muntoni, F				Cirak, Sebahattin; Arechavala-Gomeza, Virginia; Guglieri, Michela; Feng, Lucy; Torelli, Silvia; Anthony, Karen; Abbs, Stephen; Garralda, Maria Elena; Bourke, John; Wells, Dominic J.; Dickson, George; Wood, Matthew J. A.; Wilton, Steve D.; Straub, Volker; Kole, Ryszard; Shrewsbury, Stephen B.; Sewry, Caroline; Morgan, Jennifer E.; Bushby, Kate; Muntoni, Francesco			Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study	LANCET			English	Article							EXPRESSION; PROTEIN; SARCOLEMMA; EXERCISE; MUSCLE; ABNORMALITIES; PHENOTYPE; PRO051; MOUSE; NNOS	Background We report clinical safety and biochemical efficacy from a dose-ranging study of intravenously administered AVI-4658 phosphorodiamidate Morph lino oligomer (PMO) in patients with Duchenne muscular dystrophy. Method We undertook an open-label, phase 2, dose-escalation study (0.5, 1.0, 2.0, 4.0, 10.0, and 20.0 mg/kg bodyweight) in ambulant patients with Duchenne muscular dystrophy aged 5-15 years with amenable deletions in DMD. Participants had a muscle biopsy before starting treatment and after 12 weekly intravenous infusions of AVI-4658. The primary study objective was to assess safety and tolerability of AVI-4658. The secondary objectives were pharmacokinetic properties and the ability of AVI-4658 to induce exon 51 skipping and dystroph in restoration by RT-PCR, immunohistochemistry, and immunoblotting. The study is registered, number NCT00844597. Findings 19 patients took part in the study. AVI-4658 was well tolerated with no drug-related serious adverse events. AVI-4658 induced exon 51 skipping in all cohorts and new dystrophin protein expression in a significant dose-dependent (p=0.0203), but variable, manner in boys from cohort 3 (dose 2 mg/kg) onwards. Seven patients responded to treatment, in whom mean dystrophin fluorescence intensity increased from 89% (95% CI 7.1-10.6) to 16.4% (10.8-22.0) of normal control after treatment (p=0.0287). The three patients with the greatest responses to treatment had 21%, 15%, and 55% dystrophin-positive fibres after treatment and these findings were confirmed with western blot, which showed an increase after treatment of protein levels from 2% to 18%, from 0.9% to 17%, and from 0% to 7.7% of normal muscle, respectively. The dystrophin-associated proteins a-sarcoglycan and neuronal nitric oxide synthase were also restored at the sarcolemma. Analysis of the inflammatory infiltrate indicated a reduction of cytotoxic T cells in the post-treatment muscle biopsies in the two high-dose cohorts. Interpretation The safety and biochemical efficacy that we present show the potential of AVI-4658 to become a disease-modifying drug for Duchenne muscular dystrophy.	[Cirak, Sebahattin; Arechavala-Gomeza, Virginia; Feng, Lucy; Torelli, Silvia; Anthony, Karen; Sewry, Caroline; Morgan, Jennifer E.; Muntoni, Francesco] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Guglieri, Michela; Bourke, John; Straub, Volker; Bushby, Kate] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Abbs, Stephen] Guys Hosp, DNA Lab Genet Ctr, London SE1 9RT, England; [Garralda, Maria Elena] Imperial Coll St Marys Campus, Acad Unit Child & Adolescent Psychiat, London, England; [Wells, Dominic J.] Univ London Royal Vet Coll, London, England; [Dickson, George] Univ London Royal Holloway & Bedford New Coll, London NW1 4NS, England; [Wood, Matthew J. A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Wilton, Steve D.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; [Kole, Ryszard; Shrewsbury, Stephen B.] AVI BioPharma, Bothell, WA USA; [Sewry, Caroline] RJAH Orthopaed Hosp, Ctr Inherited Neuromuscular Disorders, Oswestry, Shrops, England	University of London; University College London; Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; Imperial College London; University of London; University of London Royal Veterinary College; University of London; Royal Holloway University London; University of Oxford; University of Western Australia; Keele University	Muntoni, F (corresponding author), UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England.	f.muntoni@ich.ucl.ac.uk	Cirak, Sebahattin/AAX-9593-2020; Anthony, Karen/H-6027-2019; anthony, karen/G-1172-2011; Arechavala-Gomeza, Virginia/C-1546-2008; Cirak, Sebahattin/AAZ-6829-2020; Wood, Matthew/HDN-1469-2022	Anthony, Karen/0000-0002-3638-2405; Arechavala-Gomeza, Virginia/0000-0001-7703-3255; Wilton, Steve/0000-0002-9400-893X; Wells, Dominic/0000-0002-1425-6344; Straub, Volker/0000-0001-9046-3540; Wood, Matthew/0000-0002-5436-6011; Bourke, John/0000-0001-7857-9073	AVI BioPharma; AVI; Trophos; PTC; GlaxoSmithKline; NIHR Biomedical Research Centre; Somers Clinical Research Facility at Great Ormond Street Hospital, UCL Institute of Child Health; Newcastle NIHR Clinical Research Facility; ICHT Comprehensive Biomedical Research Centre; MRC Centre for Neuromuscular Diseases at UCL; Newcastle including the MRC Neuromuscular Centre Biobank; Wellcome Trust; Great Ormond Street Hospital Children's Charity; AVI BioPharma (Bothell, WA, USA); British Heart Foundation [SP/05/001/18616] Funding Source: researchfish; Medical Research Council [G0502130, G0500822, G0601943, G0900887] Funding Source: researchfish; MRC [G0502130, G0601943, G0900887] Funding Source: UKRI	AVI BioPharma; AVI; Trophos; PTC; GlaxoSmithKline(GlaxoSmithKline); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Somers Clinical Research Facility at Great Ormond Street Hospital, UCL Institute of Child Health; Newcastle NIHR Clinical Research Facility; ICHT Comprehensive Biomedical Research Centre; MRC Centre for Neuromuscular Diseases at UCL(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newcastle including the MRC Neuromuscular Centre Biobank(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Great Ormond Street Hospital Children's Charity; AVI BioPharma (Bothell, WA, USA); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	FM serves on scientific advisory boards for Acceleron Pharma, Genzyme, AVI BioPharma, Debiopharma Group, GlaxoSmithKline, Prosensa, and Santhera Pharmaceutical, receives research support from AVI BioPharma, and has received funding for trials from AVI, Trophos, and PTC. KB has served on scientific advisory boards for Acceleron, AMT, AVI Biopharma, Debiopharm, Genzyme, GlaxoSmithKline, Prosensa, PTC, and Santhera and has received funding for trials from AVI and PTC. SBS is employed full time as Chief Medical Officer and Senior Vice President by AVI BioPharma and owns AVI stock. RK is employed full time as Senior Vice President and Distinguished Scientist by AVI BioPharma and owns AVI stock. VS has served on scientific advisory boards for Acceleron and Genzyme and has received funding for a trial from GlaxoSmithKline. GD and SDW hold patents in the area of exon skipping. MJAW serves as a scientific adviser for AVI BioPharma and Novartis. All other authors declare that they have no conflicts of interest.; We thank the participating patients and their families, the charities Muscular Dystrophy Campaign, Action Duchenne, and the Duchenne Family Support Group for participating in the UK MDEX consortium, which undertook this study. We also thank the members of the MDEX Scientific Advisory Board chaired by Kay Davies (see consortium website for full membership) for their constructive criticism. We thank Matt Rogan, Kathy Smith, and Jim Balsley for their participation in the data safety monitoring board. We thank Kanagasabai Ganeshaguru for study coordination in London, Maria Kinali for constructive discussion in early stages about the trial design and Geoff Bell for patient coordination in Newcastle upon Tyne, Darren Chambers, Rita Barresi, and Richard Charlton for their excellent technical assistance in processing muscle samples, and Rivka Steinberg for the in-vitro testing of patients' fibroblasts. We thank Valeria Ricotti for her technical assistance in the CD cell counts and Glenn Morris, Oswestry, and the MDA Monoclonal Antibody Resource for MANDYS106. We are grateful for the support of the NIHR Biomedical Research Centre Funding Scheme and the Somers Clinical Research Facility at Great Ormond Street Hospital, UCL Institute of Child Health, and in particular thank Anna Massey, Katie Rees, and Elizabeth Leads and the physiotherapists Marion Main, Maria Ash, Michelle Eagle, and Anna Mayhew for their expert assessment of the study participants. This work was supported by the Newcastle NIHR Clinical Research Facility, in particular the study nurses Linda Smith and Dorothy Carman. We are very grateful for Mariacristina Scoto's help in the clinical care of the patients. We also acknowledge the collaborations of the North Star Clinical network, which contributed to the recruitment of participants via the clinical colleagues Adnan Manzur, Stephanie Robb, Helen Roper, Rosaline Quinlivan, and Louise Hartley. We are grateful to the surgeons for obtaining the muscle biopsies (at the London site: Joe Curry and Paolo De Coppi; at the Newcastle site: Anne Lawson). We are grateful to Ann S Le Couteur, Helen McConachie, and Nil Chakrabarti at the Newcastle site and to Sriranjan Sucharita at the London site for psychiatric interviews of the patients and their families. MEG is grateful for support from the ICHT Comprehensive Biomedical Research Centre. The study was supported by the MRC Centre for Neuromuscular Diseases at UCL and Newcastle including the MRC Neuromuscular Centre Biobank. (EM is supported by a Wellcome Trust University Award. FM is supported by Great Ormond Street Hospital Children's Charity. Newcastle University, UCL, and Oxford are partners in TREAT-NMD (EC036825). The study was sponsored by AVI BioPharma (Bothell, WA, USA).	Aoki Y, 2010, MOL THER, V18, P1995, DOI 10.1038/mt.2010.186; ARAHATA K, 1984, ANN NEUROL, V16, P193, DOI 10.1002/ana.410160206; Arechavala-Gomeza V, 2007, HUM GENE THER, V18, P798, DOI 10.1089/hum.2006.061; Arechavala-Gomeza V, 2010, NEUROPATH APPL NEURO, V36, P265, DOI 10.1111/j.1365-2990.2009.01056.x; Arechavala-Gomeza V, 2010, NEUROMUSCULAR DISORD, V20, P295, DOI 10.1016/j.nmd.2010.03.007; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; BUSHBY KMD, 1993, J NEUROL, V240, P105, DOI 10.1007/BF00858726; Fletcher S, 2006, J GENE MED, V8, P207, DOI 10.1002/jgm.838; Garrood P, 2009, J MAGN RESON IMAGING, V30, P1130, DOI 10.1002/jmri.21941; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Helderman-van den Enden ATJM, 2010, NEUROMUSCULAR DISORD, V20, P251, DOI 10.1016/j.nmd.2010.01.013; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Kinali M, 2011, NEUROLOGY, V76, P346, DOI 10.1212/WNL.0b013e318208811f; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; Krieger CC, 2010, CYTOSKELETON, V67, P796, DOI 10.1002/cm.20489; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Malerba A, 2011, MOL THER, V19, P345, DOI 10.1038/mt.2010.261; MAN NT, 1993, AM J HUM GENET, V52, P1057; Mayhew JE, 2007, MUSCLE NERVE, V35, P36, DOI 10.1002/mus.20654; Mazzone ES, 2009, NEUROMUSCULAR DISORD, V19, P458, DOI 10.1016/j.nmd.2009.06.368; McDonald CM, 2005, ARCH PHYS MED REHAB, V86, P802, DOI 10.1016/j.apmr.2004.10.012; McDonald CM, 2010, MUSCLE NERVE, V42, P966, DOI 10.1002/mus.21808; MORANDI L, 1995, J NEUROL SCI, V132, P146, DOI 10.1016/0022-510X(95)00147-T; Muntoni F, 1997, HEART, V78, P608, DOI 10.1136/hrt.78.6.608; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; Saengpattrachai M, 2006, PEDIATR NEUROL, V35, P145, DOI 10.1016/j.pediatrneurol.2006.01.004; Sazani P., 2008, ANTISENSE DRUG TECHN, P89; Sazani P, 2010, INT J TOXICOL, V29, P143, DOI 10.1177/1091581809359206; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wu B, 2011, MOL THER, V19, P576, DOI 10.1038/mt.2010.288; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627	34	627	692	1	97	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2011	378	9791					595	605		10.1016/S0140-6736(11)60756-3	http://dx.doi.org/10.1016/S0140-6736(11)60756-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812UX	21784508	Green Published			2022-12-28	WOS:000294319500031
J	Gerrienne, P; Gensel, PG; Strullu-Derrien, C; Lardeux, H; Steemans, P; Prestianni, C				Gerrienne, Philippe; Gensel, Patricia G.; Strullu-Derrien, Christine; Lardeux, Hubert; Steemans, Philippe; Prestianni, Cyrille			A Simple Type of Wood in Two Early Devonian Plants	SCIENCE			English	Article									[Gerrienne, Philippe; Steemans, Philippe] Univ Liege U Lg, Dept Geol, B-4000 Liege 1, Belgium; [Gensel, Patricia G.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Strullu-Derrien, Christine] Univ Angers, Lab Mycorhizes, Fac Sci, F-49045 Angers, France; [Lardeux, Hubert] Univ Catholique Ouest, Inst Rech Fondamentale & Appl, Lab Geol, F-49008 Angers 1, France; [Prestianni, Cyrille] Inst Royal Sci Nat Belgique, B-1000 Brussels, Belgium	University of North Carolina; University of North Carolina Chapel Hill; Universite d'Angers	Gerrienne, P (corresponding author), Univ Liege U Lg, Dept Geol, B18 Sart Tilman, B-4000 Liege 1, Belgium.	P.Gerrienne@ulg.ac.be	Strullu-Derrien, Christine/P-4543-2019	Strullu-Derrien, Christine/0000-0003-1131-9546; Steemans, Philippe/0000-0003-1183-6324				Bannan MW, 1934, BOT GAZ, V96, P260, DOI 10.1086/334470; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Dannenhoffer JM, 2003, INT J PLANT SCI, V164, P429, DOI 10.1086/374198; Donoghue MJ, 2005, PALEOBIOLOGY, V31, P77, DOI 10.1666/0094-8373(2005)031[0077:KICASM]2.0.CO;2; ROWE NP, 2003, EVOLUTION PLANT PHYS, P297	5	68	72	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					837	837		10.1126/science.1208882	http://dx.doi.org/10.1126/science.1208882			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836008				2022-12-28	WOS:000293785400030
J	Rhodes, K				Rhodes, Karin			Taking the Mystery out of "Mystery Shopper" Studies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACCESS; CARE; INSURANCE		Univ Penn, Div Emergency Care Policy Res, Dept Emergency Med, Sch Social Policy & Practice, Philadelphia, PA 19104 USA	University of Pennsylvania	Rhodes, K (corresponding author), Univ Penn, Div Emergency Care Policy Res, Dept Emergency Med, Sch Social Policy & Practice, Philadelphia, PA 19104 USA.							Asplin BR, 2005, JAMA-J AM MED ASSOC, V294, P1248, DOI 10.1001/jama.294.10.1248; Bisgaier J, 2011, NEW ENGL J MED, V364, P2324, DOI 10.1056/NEJMsa1013285; Fix Michael E., 1993, CLEAR CONVINCING EVI; KELLERMANN AL, 1994, NEW ENGL J MED, V330, P1426; ROSENHAN DL, 1973, SCIENCE, V179, P250, DOI 10.1126/science.179.4070.250	5	28	28	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					484	486		10.1056/NEJMp1107779	http://dx.doi.org/10.1056/NEJMp1107779			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	805MW	21793739				2022-12-28	WOS:000293732100002
J	Altman, DG; Bland, JM				Altman, Douglas G.; Bland, J. Martin			How to obtain the confidence interval from a P value	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England; [Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of Oxford; University of York - UK	Altman, DG (corresponding author), Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England.	doug.altman@csm.ox.ac.uk						Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Bland JM, 1996, BRIT MED J, V312, P700; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; LIN JT, 1989, APPL STAT-J ROY ST C, V38, P69; LINDBLAD U, 1994, BRIT MED J, V308, P681, DOI 10.1136/bmj.308.6930.681; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Roy SK, 2008, BMJ-BRIT MED J, V336, P266, DOI 10.1136/bmj.39416.646250.AE	7	97	99	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 8	2011	343								d2090	10.1136/bmj.d2090	http://dx.doi.org/10.1136/bmj.d2090			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KQ	21824904	Green Submitted, Bronze			2022-12-28	WOS:000209545500001
J	Mattern, S				Mattern, Susan			The art of medicine Galen and his patients	LANCET			English	Editorial Material									[Mattern, Susan] Univ Georgia, Dept Hist, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Mattern, S (corresponding author), Univ Georgia, Dept Hist, Athens, GA 30602 USA.	smattern@uga.edu						Flemming R., 2000, MED MAKING ROMAN WOM; Hankinson RJ, 2008, CAMBR COMPANION PHIL, P1, DOI 10.1017/CCOL9780521819541; Littman R J, 1973, Am J Philol, V94, P243, DOI 10.2307/293979; Mattern S. P., 2008, GALEN RHETORIC HEALI; Nutton V., 2004, ANCIENT MED; Temkin Owsei, 1973, GALENISM RISE DECLIN	6	10	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 6	2011	378	9790					478	479		10.1016/S0140-6736(11)61240-3	http://dx.doi.org/10.1016/S0140-6736(11)61240-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	809SO	21826808				2022-12-28	WOS:000294077200015
J	Harrington, AW; St Hillaire, C; Zweifel, LS; Glebova, NO; Philippidou, P; Halegoua, S; Ginty, DD				Harrington, Anthony W.; St Hillaire, Coryse; Zweifel, Larry S.; Glebova, Natalia O.; Philippidou, Polyxeni; Halegoua, Simon; Ginty, David D.			Recruitment of Actin Modifiers to TrkA Endosomes Governs Retrograde NGF Signaling and Survival	CELL			English	Article							NERVE GROWTH-FACTOR; SYMPATHETIC NEURONS; RHO-GTPASES; VESICULAR TRAFFICKING; IN-VIVO; PATHWAYS; RECEPTOR; NEUROTROPHIN-3; ORGANIZATION; ENDOCYTOSIS	The neurotrophins NGF and NT3 collaborate to support development of sympathetic neurons. Although both promote axonal extension via the TrkA receptor, only NGF activates retrograde transport of TrkA endosomes to support neuronal survival. Here, we report that actin depolymerization is essential for initiation of NGF/TrkA endosome trafficking and that a Rac1-cofilin signaling module associated with TrkA early endosomes supports their maturation to retrograde transport-competent endosomes. These actin-regulatory endosomal components are absent from NT3/TrkA endosomes, explaining the failure of NT3 to support retrograde TrkA transport and survival. The inability of NT3 to activate Rac1-GTP-cofilin signaling is likely due to the labile nature of NT3/TrkA complexes within the acidic environment of TrkA early endosomes. Thus, TrkA endosomes associate with actin-modulatory proteins to promote F-actin disassembly, enabling their maturation into transport-competent signaling endosomes. Differential control of this process explains how NGF but not NT3 supports retrograde survival of sympathetic neurons.	[Harrington, Anthony W.; St Hillaire, Coryse; Zweifel, Larry S.; Glebova, Natalia O.; Ginty, David D.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Harrington, Anthony W.; St Hillaire, Coryse; Zweifel, Larry S.; Glebova, Natalia O.; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Philippidou, Polyxeni; Halegoua, Simon] SUNY Stony Brook, Ctr Nervous Syst Disorders, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Philippidou, Polyxeni; Halegoua, Simon] SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11794 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu	Zweifel, Larry/O-3284-2017	Zweifel, Larry/0000-0003-3465-5331; Philippidou, Polyxeni/0000-0002-0733-3591	NIH [NS34814, NS18218]; Silvio Conte Center for Neuroscience Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034814, R29NS034814, R01NS018218, R01NS034814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Silvio Conte Center for Neuroscience Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Alex Kolodkin, Christopher Deppmann, and members of the Ginty laboratory for comments on this manuscript. We thank William Mobley and Janice Valletta for advice about cell fractionation, Robert Cole and Marjan Gucek at the JHU Mass Spectroscopy and Proteomics Facility for performing the mass spectroscopy proteomic analysis, Ann Taylor and Huy Vo for advice and help with microfluidic chamber devices, and Douglas Robinson for advice on actin depolymerization assays. This work was supported by NIH grants NS34814 (D.D.G.), NS18218 (S.H.) and The Silvio Conte Center for Neuroscience Research (D. D. G.). D. D. G. is an investigator of the Howard Hughes Medical Institute.	Andres R, 2008, NEUROSCI LETT, V431, P241, DOI 10.1016/j.neulet.2007.11.045; Barker PA, 2002, TRENDS NEUROSCI, V25, P379, DOI 10.1016/S0166-2236(02)02199-9; Belliveau DJ, 1997, J CELL BIOL, V136, P375, DOI 10.1083/jcb.136.2.375; Cosker KE, 2008, CURR OPIN NEUROBIOL, V18, P270, DOI 10.1016/j.conb.2008.08.005; DAVIES AM, 1995, EMBO J, V14, P4482, DOI 10.1002/j.1460-2075.1995.tb00127.x; Deppmann CD, 2008, SCIENCE, V320, P369, DOI 10.1126/science.1152677; Devon RS, 2006, P NATL ACAD SCI USA, V103, P9595, DOI 10.1073/pnas.0510197103; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Glebova NO, 2004, J NEUROSCI, V24, P743, DOI 10.1523/JNEUROSCI.4523-03.2004; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Miller FD, 2001, CELL MOL LIFE SCI, V58, P1045, DOI 10.1007/PL00000919; Overly CC, 1996, J NEUROSCI, V16, P6056; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pandey D, 2009, BLOOD, V114, P415, DOI 10.1182/blood-2008-10-183582; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Robertson AS, 2009, CELL MOL LIFE SCI, V66, P2049, DOI 10.1007/s00018-009-0001-y; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sharma N, 2010, NEURON, V67, P422, DOI 10.1016/j.neuron.2010.07.018; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Sun YJ, 2006, MOL CELL BIOL, V26, P6923, DOI 10.1128/MCB.02474-05; Symons M, 2003, CURR BIOL, V13, pR409, DOI 10.1016/S0960-9822(03)00324-5; Valdez G, 2007, P NATL ACAD SCI USA, V104, P12270, DOI 10.1073/pnas.0702819104; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Wu CB, 2007, TRAFFIC, V8, P1503, DOI 10.1111/j.1600-0854.2007.00636.x	38	92	96	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 5	2011	146	3					421	434		10.1016/j.cell.2011.07.008	http://dx.doi.org/10.1016/j.cell.2011.07.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816277	Green Accepted, Bronze			2022-12-28	WOS:000293570500016
J	Giuliano, AE; Hawes, D; Ballman, KV; Whitworth, PW; Blumencranz, PW; Reintgen, DS; Morrow, M; Leitch, AM; Hunt, KK; McCall, LM; Abati, A; Cote, R				Giuliano, Armando E.; Hawes, Debra; Ballman, Karla V.; Whitworth, Pat W.; Blumencranz, Peter W.; Reintgen, Douglas S.; Morrow, Monica; Leitch, A. Marilyn; Hunt, Kelly K.; McCall, Linda M.; Abati, Andrea; Cote, Richard			Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CIRCULATING TUMOR-CELLS; PROGNOSTIC-SIGNIFICANCE; CLINICAL-TRIAL; MICROMETASTASES; DISSECTION; CARCINOMA	Context Immunochemical staining of sentinel lymph nodes (SLNs) and bone marrow identifies breast cancer metastases not seen with routine pathological or clinical examination. Objective To determine the association between survival and metastases detected by immunochemical staining of SLNs and bone marrow specimens from patients with early-stage breast cancer. Design, Setting, and Patients From May 1999 to May 2003, 126 sites in the American College of Surgeons Oncology Group Z0010 trial enrolled women with clinical T1 to T2N0M0 invasive breast carcinoma in a prospective observational study. Interventions All 5210 patients underwent breast-conserving surgery and SLN dissection. Bone marrow aspiration at the time of operation was initially optional and subsequently mandatory (March 2001). Sentinel lymph node specimens (hematoxylineosin negative) and bone marrow specimens were sent to a central laboratory for immunochemical staining; treating clinicians were blinded to results. Main Outcome Measures Overall survival (primary end point) and disease-free survival (a secondary end point). Results Of 5119 SLN specimens (98.3%), 3904 (76.3%) were tumor-negative by hematoxylin-eosin staining. Of 3326 SLN specimens examined by immunohistochemistry, 349 (10.5%) were positive for tumor. Of 3413 bone marrow specimens examined by immunocytochemistry, 104 (3.0%) were positive for tumors. At a median follow-up of 6.3 years (through April 2010), 435 patients had died and 376 had disease recurrence. Immunohistochemical evidence of SLN metastases was not significantly associated with overall survival (5-year rates: 95.7%; 95% confidence interval [CI], 95.0%-96.5% for immunohistochemical negative and 95.1%; 95% CI, 92.7%-97.5% for immunohistochemical positive disease; P=.64; unadjusted hazard ratio [HR], 0.90; 95% CI, 0.59-1.39; P=.64). Bone marrow metastases were associated with decreased overall survival (unadjusted HR for mortality, 1.94; 95% CI, 1.02-3.67; P=.04), but neither immunohistochemical evidence of tumor in SLNs (adjusted HR, 0.88; 95% CI, 0.45-1.71; P=.70) nor immunocytochemical evidence of tumor in bone marrow (adjusted HR, 1.83; 95% CI, 0.79-4.26; P=.15) was statistically significant on multivariable analysis. Conclusion Among women receiving breast-conserving therapy and SLN dissection, immunohistochemical evidence of SLN metastasis was not associated with overall survival over a median of 6.3 years, whereas occult bone marrow metastasis, although rare, was associated with decreased survival.	[Giuliano, Armando E.] St Johns Hlth Ctr, John Wayne Canc Inst, Div Surg Oncol, Santa Monica, CA USA; [Hawes, Debra] Univ So Calif, Dept Pathol, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Ballman, Karla V.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Whitworth, Pat W.] Nashville Breast Ctr, Nashville, TN USA; [Blumencranz, Peter W.] Morton Plant Hosp, Clearwater, FL USA; [Reintgen, Douglas S.] Lakeland Reg Canc Ctr, Lakeland, FL USA; [Morrow, Monica] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Leitch, A. Marilyn] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Hunt, Kelly K.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [McCall, Linda M.] Amer Coll Surg Oncol Grp, Durham, NC USA; [Abati, Andrea] NCI, Cytopathol Sect, Pathol Lab, Bethesda, MD 20892 USA; [Cote, Richard] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA	John Wayne Cancer Institute; University of Southern California; Mayo Clinic; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Miami	Giuliano, AE (corresponding author), Cedars Sinai Med Ctr, 310 N San Vicente Blvd,3rd Floor, Los Angeles, CA 90048 USA.	armando.giuliano@cshs.org		Ballman, Karla/0000-0002-4492-0357	NIH [NCI R01 CA 85840]; US Department of Defense; California Breast Cancer Research; Whittier Foundation; V-Force; American College of Surgeons Oncology Group [NCI U10 CA076001]; NATIONAL CANCER INSTITUTE [U10CA076001, P30CA016672, R01CA085840] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); California Breast Cancer Research; Whittier Foundation; V-Force; American College of Surgeons Oncology Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Giuliano reported that he has received support from ACOSOG for travel to ACOSOG meetings. Dr Hawes reported receiving grant support from the NIH and travel support from ACOSOG and has personal and institutional grants pending from the NIH, the US Department of Defense, California Breast Cancer Research, Whittier Foundation, and V-Force. Dr Ballman reported institutional support from the National Institute of Cancer and other support from AstraZeneca, Lilly, and Novartis. Dr Whitworth reported travel support from ACOSOG. Dr Blumencranz reported institutional support from Morton Plant Hospital, serving on the Florida Society of General Surgeons board of directors; and institutional payment for lectures from Hologic. Dr Morrow reported grant support from ACOSOG. Dr Leitch reported travel support from ACOSOG and institutional support from ACOSOG for capitation payments for patients enrolled in a study.; This study was supported by funds from the National Institutes of Health, under the grants entitled "Bone Marrow and Sentinel Node Micrometastases in Breast Cancer" (NCI R01 CA 85840; R. Cote, principal investigator) and American College of Surgeons Oncology Group (NCI U10 CA076001).	Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Chen SL, 2007, ANN SURG ONCOL, V14, P3378, DOI 10.1245/s10434-007-9513-6; COTE RJ, 1991, J CLIN ONCOL, V9, P1749, DOI 10.1200/JCO.1991.9.10.1749; Cote RJ, 1999, LANCET, V354, P896, DOI 10.1016/S0140-6736(98)11104-2; Cristofanilli M, 2010, JAMA-J AM MED ASSOC, V303, P1092, DOI 10.1001/jama.2010.292; de Boer M, 2009, NEW ENGL J MED, V361, P653, DOI 10.1056/NEJMoa0904832; DEMASCAREL I, 1992, BRIT J CANCER, V66, P523, DOI 10.1038/bjc.1992.306; Diel IJ, 1996, JNCI-J NATL CANCER I, V88, P1652, DOI 10.1093/jnci/88.22.1652; FISHER ER, 1978, CANCER, V42, P2025, DOI 10.1002/1097-0142(197810)42:4<2025::AID-CNCR2820420452>3.0.CO;2-J; GIULIANO AE, 1995, ANN SURG, V222, P394, DOI 10.1097/00000658-199509000-00016; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Hansen NM, 2009, J CLIN ONCOL, V27, P4679, DOI 10.1200/JCO.2008.19.0686; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; MOLINO A, 1991, CANCER, V67, P1033, DOI 10.1002/1097-0142(19910215)67:4<1033::AID-CNCR2820670428>3.0.CO;2-H; NASSER IA, 1993, HUM PATHOL, V24, P950, DOI 10.1016/0046-8177(93)90108-S; Oakman C, 2010, NAT REV CLIN ONCOL, V7, P725, DOI 10.1038/nrclinonc.2010.170; OSBORNE MP, 1991, CANCER RES, V51, P2706; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Posther KE, 2005, ANN SURG, V242, P593, DOI 10.1097/01.sla.0000184210.68646.77; TROJANI M, 1987, BRIT J CANCER, V55, P303, DOI 10.1038/bjc.1987.59; Tvedskov TF, 2011, EUR J CANCER, V47, P872, DOI 10.1016/j.ejca.2010.11.022; Weaver DL, 2011, NEW ENGL J MED, V364, P412, DOI 10.1056/NEJMoa1008108	24	185	188	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					385	393		10.1001/jama.2011.1034	http://dx.doi.org/10.1001/jama.2011.1034			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797KL	21791687	Green Accepted			2022-12-28	WOS:000293125800024
J	Harel, A; Gruenbaum, Y				Harel, Amnon; Gruenbaum, Yosef			Nuclear Pore Structure: Warming up theCore	CELL			English	Editorial Material							MEMBRANE; COMPLEX; NUCLEOPORIN	Structural determination of the nuclear pore complex has been limited by the complexity and size of this cellular megalith. By taking advantage of exceptionally stable nucleoporins from the thermophilic fungus Chaetomium thermophilum, Amlacher et al. (2011) provide new insight into a core element of the nuclear pore scaffold.	[Harel, Amnon] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Gruenbaum, Yosef] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Technion Israel Institute of Technology; Hebrew University of Jerusalem	Harel, A (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	amharel@tx.technion.ac.il		Harel, Amnon/0000-0003-4230-7468				Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Chiu W, 2006, TRENDS CELL BIOL, V16, P144, DOI 10.1016/j.tcb.2006.01.002; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Maimon T, 2010, NUCLEUS-PHILA, V1, P383, DOI 10.4161/nucl.1.5.12332; Onischenko E, 2011, CURR OPIN CELL BIOL, V23, P293, DOI 10.1016/j.ceb.2011.01.002; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Theerthagiri G, 2010, J CELL BIOL, V189, P1129, DOI 10.1083/jcb.200912045	10	3	3	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 22	2011	146	2					191	193		10.1016/j.cell.2011.06.045	http://dx.doi.org/10.1016/j.cell.2011.06.045			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784242	Bronze			2022-12-28	WOS:000293013000003
J	Pandolfi, JM; Connolly, SR; Marshall, DJ; Cohen, AL				Pandolfi, John M.; Connolly, Sean R.; Marshall, Dustin J.; Cohen, Anne L.			Projecting Coral Reef Futures Under Global Warming and Ocean Acidification	SCIENCE			English	Review							CARBONATE-ION CONCENTRATION; CLIMATE-CHANGE; SCLERACTINIAN CORALS; SATURATION STATE; BLEACHING EVENT; THERMAL-STRESS; RANGE SHIFTS; CALCIFICATION; GROWTH; EVOLUTION	Many physiological responses in present-day coral reefs to climate change are interpreted as consistent with the imminent disappearance of modern reefs globally because of annual mass bleaching events, carbonate dissolution, and insufficient time for substantial evolutionary responses. Emerging evidence for variability in the coral calcification response to acidification, geographical variation in bleaching susceptibility and recovery, responses to past climate change, and potential rates of adaptation to rapid warming supports an alternative scenario in which reef degradation occurs with greater temporal and spatial heterogeneity than current projections suggest. Reducing uncertainty in projecting coral reef futures requires improved understanding of past responses to rapid climate change; physiological responses to interacting factors, such as temperature, acidification, and nutrients; and the costs and constraints imposed by acclimation and adaptation.	[Pandolfi, John M.] ARC, Ctr Excellence Coral Reef Studies, St Lucia, Qld 4072, Australia; [Pandolfi, John M.; Marshall, Dustin J.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Connolly, Sean R.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4011, Australia; [Connolly, Sean R.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4011, Australia; [Cohen, Anne L.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	University of Queensland; James Cook University; James Cook University; Woods Hole Oceanographic Institution	Pandolfi, JM (corresponding author), ARC, Ctr Excellence Coral Reef Studies, St Lucia, Qld 4072, Australia.	j.pandolfi@uq.edu.au	Connolly, Sean R./E-7773-2011; Marshall, Dustin/A-4185-2008; Marshall, Dustin/C-3450-2016; Pandolfi, John M/A-3121-2009	Connolly, Sean R./0000-0003-1537-0859; Pandolfi, John M/0000-0003-3047-6694; Marshall, Dustin/0000-0001-6651-6219	Australian Research Council (ARC); ARC Centre of Excellence for Coral Reef Studies; U.S. NSF; Directorate For Geosciences [1041106] Funding Source: National Science Foundation	Australian Research Council (ARC)(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); U.S. NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Experimental data summarized in this paper can be found in the supporting online material. This review has benefited greatly from discussions with A. Baird, C. Duarte, M. Fine, B. Greenstein, C. Lovelock, P. Munday, C. Parmesan, M. Pratchett, R. Reef, and B. Sommer. Figures were drafted by M. Gomez, M. Hisano, and M. Lybolt. This work was supported by the Australian Research Council (ARC), the ARC Centre of Excellence for Coral Reef Studies, and the U.S. NSF.	Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Aronson RB, 2002, MAR BIOL, V141, P435, DOI 10.1007/s00227-002-0842-5; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Broecker WS, 2001, GLOBAL BIOGEOCHEM CY, V15, P589, DOI 10.1029/2000GB001350; Chevin LM, 2010, EVOLUTION, V64, P1143, DOI 10.1111/j.1558-5646.2009.00875.x; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Csaszar NBM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009751; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; de Putron SJ, 2011, CORAL REEFS, V30, P321, DOI 10.1007/s00338-010-0697-z; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Eakin CM, 2001, B MAR SCI, V69, P171; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Grandcourt EM, 2003, FISH RES, V60, P539, DOI 10.1016/S0165-7836(02)00173-X; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Holcomb M, 2010, J EXP MAR BIOL ECOL, V386, P27, DOI 10.1016/j.jembe.2010.02.007; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; Jury CP, 2010, GLOBAL CHANGE BIOL, V16, P1632, DOI 10.1111/j.1365-2486.2009.02057.x; Kiessling W, 2008, NAT GEOSCI, V1, P527, DOI 10.1038/ngeo251; Kiessling W, 2011, GLOBAL CHANGE BIOL, V17, P56, DOI 10.1111/j.1365-2486.2010.02204.x; Kleypas JA, 1999, AM ZOOL, V39, P146; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Kump LR, 2009, OCEANOGRAPHY, V22, P94, DOI 10.5670/oceanog.2009.100; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Lea DW, 2003, SCIENCE, V301, P1361, DOI 10.1126/science.1088470; Leclercq N, 2002, LIMNOL OCEANOGR, V47, P558, DOI 10.4319/lo.2002.47.2.0558; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Manzello DP, 2010, CORAL REEFS, V29, P749, DOI 10.1007/s00338-010-0623-4; Marubini F, 2003, P ROY SOC B-BIOL SCI, V270, P179, DOI 10.1098/rspb.2002.2212; Marubini F, 2001, MAR ECOL PROG SER, V220, P153, DOI 10.3354/meps220153; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; Mendes JM, 2002, MAR ECOL PROG SER, V235, P93, DOI 10.3354/meps235093; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Monro K, 2004, AM NAT, V163, P564, DOI 10.1086/382551; Montaggioni LF, 2005, EARTH-SCI REV, V71, P1, DOI 10.1016/j.earscirev.2005.01.002; Ohde S, 2004, GEOCHEM J, V38, P613, DOI 10.2343/geochemj.38.613; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pelejero C, 2010, TRENDS ECOL EVOL, V25, P332, DOI 10.1016/j.tree.2010.02.002; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Riegl B, 2002, MAR BIOL, V140, P29, DOI 10.1007/s002270100676; Riegl B, 2009, ANN NY ACAD SCI, V1162, P136, DOI 10.1111/j.1749-6632.2009.04493.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Robinson SA, 2011, GEOLOGY, V39, P51, DOI 10.1130/G31422.1; Rodolfo-Metalpa R, 2010, BIOGEOSCIENCES, V7, P289, DOI 10.5194/bg-7-289-2010; Rosenthal Y, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016612; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Ruhlemann C, 1999, NATURE, V402, P511, DOI 10.1038/990069; Scheibner C, 2008, EARTH-SCI REV, V90, P71, DOI 10.1016/j.earscirev.2008.07.002; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Silverman J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003770; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Somerfield PJ, 2008, CORAL REEFS, V27, P951, DOI 10.1007/s00338-008-0390-7; Steinacher M, 2010, BIOGEOSCIENCES, V7, P979, DOI 10.5194/bg-7-979-2010; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Strychar KB, 2009, J EXP MAR BIOL ECOL, V369, P31, DOI 10.1016/j.jembe.2008.10.021; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Tribollet A, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003286; Van Oppen MJH, 2006, MOL ECOL, V15, P3863, DOI 10.1111/j.1365-294X.2006.03026.x; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Wilkinson C, 2008, STATUS CORAL REEFS W; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474; Yee SH, 2008, ECOL MODEL, V218, P162, DOI 10.1016/j.ecolmodel.2008.06.037; Zeebe R.E., 2011, OCEAN ACIDIFICATION	92	760	772	137	2988	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					418	422		10.1126/science.1204794	http://dx.doi.org/10.1126/science.1204794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778392				2022-12-28	WOS:000292959600035
J	Bettegowda, C; Agrawal, N; Jiao, YC; Sausen, M; Wood, LD; Hruban, RH; Rodriguez, FJ; Cahill, DP; McLendon, R; Riggins, G; Velculescu, VE; Oba-Shinjo, SM; Marie, SKN; Vogelstein, B; Bigner, D; Yan, H; Papadopoulos, N; Kinzler, KW				Bettegowda, Chetan; Agrawal, Nishant; Jiao, Yuchen; Sausen, Mark; Wood, Laura D.; Hruban, Ralph H.; Rodriguez, Fausto J.; Cahill, Daniel P.; McLendon, Roger; Riggins, Gregory; Velculescu, Victor E.; Oba-Shinjo, Sueli Mieko; Marie, Suely Kazue Nagahashi; Vogelstein, Bert; Bigner, Darell; Yan, Hai; Papadopoulos, Nickolas; Kinzler, Kenneth W.			Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma	SCIENCE			English	Article							C-MYC; GLIOMAS; CAPICUA; CANCER; 19Q; 1P; OLIGOASTROCYTOMAS; REPRESSION; DELETIONS; GENES	Oligodendrogliomas are the second most common malignant brain tumor in adults and exhibit characteristic losses of chromosomes 1p and 19q. To identify the molecular genetic basis for this alteration, we performed exomic sequencing of seven tumors. Among other changes, we found that the CIC gene (homolog of the Drosophila gene capicua) on chromosome 19q was somatically mutated in six cases and that the FUBP1 gene [encoding far-upstream element (FUSE) binding protein] on chromosome 1p was somatically mutated in two tumors. Examination of 27 additional oligodendrogliomas revealed 12 and 3 more tumors with mutations of CIC and FUBP1, respectively, 58% of which were predicted to result in truncations of the encoded proteins. These results suggest a critical role for these genes in the biology and pathology of oligodendrocytes.	[Bettegowda, Chetan; Agrawal, Nishant; Jiao, Yuchen; Sausen, Mark; Riggins, Gregory; Velculescu, Victor E.; Vogelstein, Bert; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21287 USA; [Bettegowda, Chetan; Agrawal, Nishant; Jiao, Yuchen; Sausen, Mark; Riggins, Gregory; Velculescu, Victor E.; Vogelstein, Bert; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21287 USA; [Bettegowda, Chetan; Riggins, Gregory] Johns Hopkins Med Inst, Dept Neurosurg, Baltimore, MD 21287 USA; [Agrawal, Nishant] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Wood, Laura D.; Hruban, Ralph H.; Rodriguez, Fausto J.] Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21287 USA; [Cahill, Daniel P.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Cahill, Daniel P.] Baylor Coll Med, Houston, TX 77030 USA; [McLendon, Roger; Bigner, Darell; Yan, Hai] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr Duke, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; [McLendon, Roger; Bigner, Darell; Yan, Hai] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Oba-Shinjo, Sueli Mieko; Marie, Suely Kazue Nagahashi] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, Brazil	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Duke University; Duke University; Universidade de Sao Paulo	Vogelstein, B (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21287 USA.	vogelbe@jhmi.edu; yan00002@mc.duke.edu; npapado1@jhmi.edu; kinzlke@jhmi.edu	Marie, Suely Kazue Nagahashi/D-1870-2012; Oba-Shinjo, Sueli M./C-4017-2012; Papadopoulos, Nickolas/K-7272-2012; Velculescu, Victor/ABF-4846-2020; Wood, Laura/ABF-1531-2020; jiao, yuchen/H-6313-2011	Marie, Suely Kazue Nagahashi/0000-0003-4419-7928; Oba-Shinjo, Sueli M./0000-0002-1650-5973; Velculescu, Victor/0000-0003-1195-438X; Jiao, Yuchen/0000-0001-7917-8810; Cahill, Daniel/0000-0003-2552-6546; Sausen, Mark/0000-0002-2916-5269	Virginia; D. K. Ludwig Fund for Cancer Research; Pediatric Brain Tumor Foundation; Duke Comprehensive Cancer Center Core; Burroughs Wellcome Fund; James S. McDonnell Foundation; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/12433-6, 01/12898-4]; National Cancer Institute Division of Cancer Prevention [N01-CN-43302]; National Institutes of Health [CA43460, CA57345, CA11898, CA121113, CA62924, RC2DE020957, NS20023]; NIH/NCI Institutional National Research Service [T32 CA009574]; NATIONAL CANCER INSTITUTE [R01CA043460, R01CA121113, R37CA057345, R01CA140316, R01CA057345, T32CA009574, R01CA011898, P50CA062924, R37CA011898, R37CA043460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS020023] Funding Source: NIH RePORTER	Virginia; D. K. Ludwig Fund for Cancer Research; Pediatric Brain Tumor Foundation; Duke Comprehensive Cancer Center Core; Burroughs Wellcome Fund(Burroughs Wellcome Fund); James S. McDonnell Foundation; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Cancer Institute Division of Cancer Prevention(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI Institutional National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Whalen, N. Silliman, J. Ptak, L. Dobbyn, and J. Schaeffer for expert technical assistance. This work was supported by the Virginia and D. K. Ludwig Fund for Cancer Research, Pediatric Brain Tumor Foundation, Duke Comprehensive Cancer Center Core, Burroughs Wellcome Fund, James S. McDonnell Foundation, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grants 04/12433-6, 01/12898-4, the National Cancer Institute Division of Cancer Prevention contract N01-CN-43302, and National Institutes of Health grants CA43460, CA57345, CA11898, CA121113, CA62924, RC2DE020957, and NS20023. C.B. is a recipient of T32 CA009574 NIH/NCI Institutional National Research Service Award. Johns Hopkins University has filed a patent relating to the application of the mutations described in this work to the diagnosis and treatment of cancer. Under agreements between the Johns Hopkins University, Genzyme, Exact Sciences, Inostics, Qiagen, Invitrogen, and Personal Genome Diagnostics, N.P., B.V., K.W.K., and V.E.V are entitled to a share of the royalties received by the university on sales of products related to genes and technologies described in this manuscript. N.P., B.V., K.W.K., and V.E.V are co-founders of Inostics and Personal Genome Diagnostics, are members of their Scientific Advisory Boards, and own Inostics and Personal Genome Diagnostics stock, which is subject to certain restrictions under Johns Hopkins University policy. The sequence data reported in this manuscript are deposited in www.sanger.ac.uk/perl/genetics/CGP/cosmic.	Ajuria L, 2011, DEVELOPMENT, V138, P915, DOI 10.1242/dev.057729; Astigarraga S, 2007, EMBO J, V26, P668, DOI 10.1038/sj.emboj.7601532; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Bromberg JEC, 2009, ONCOLOGIST, V14, P155, DOI 10.1634/theoncologist.2008-0248; Cairncross G, 2008, CANCER J, V14, P352, DOI 10.1097/PPO.0b013e31818d8178; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Griffin CA, 2006, J NEUROPATH EXP NEUR, V65, P988, DOI 10.1097/01.jnen.0000235122.98052.8f; Hsiao HH, 2010, BIOCHEMISTRY-US, V49, P4620, DOI 10.1021/bi9021445; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jimenez G, 2000, GENE DEV, V14, P224; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Knudson AG, 1996, J CANCER RES CLIN, V122, P135, DOI 10.1007/BF01366952; KNUDSON AG, 1975, CANCER, V35, P1022, DOI 10.1002/1097-0142(197503)35:3+<1022::AID-CNCR2820350726>3.0.CO;2-A; Lee CJ, 2005, J NEURO-ONCOL, V73, P101, DOI 10.1007/s11060-004-4598-2; Maintz D, 1997, J NEUROPATH EXP NEUR, V56, P1098, DOI 10.1097/00005072-199710000-00003; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Parmigiani G, 2009, GENOMICS, V93, P17, DOI 10.1016/j.ygeno.2008.07.005; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Roch F, 2002, DEVELOPMENT, V129, P993; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	25	382	397	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2011	333	6048					1453	1455		10.1126/science.1210557	http://dx.doi.org/10.1126/science.1210557			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21817013	Green Accepted			2022-12-28	WOS:000294672200044
J	Reed, RD; Papa, R; Martin, A; Hines, HM; Counterman, BA; Pardo-Diaz, C; Jiggins, CD; Chamberlain, NL; Kronforst, MR; Chen, R; Halder, G; Nijhout, HF; McMillan, WO				Reed, Robert D.; Papa, Riccardo; Martin, Arnaud; Hines, Heather M.; Counterman, Brian A.; Pardo-Diaz, Carolina; Jiggins, Chris D.; Chamberlain, Nicola L.; Kronforst, Marcus R.; Chen, Rui; Halder, Georg; Nijhout, H. Frederik; McMillan, W. Owen			optix Drives the Repeated Convergent Evolution of Butterfly Wing Pattern Mimicry	SCIENCE			English	Article							GENETICS	Mimicry-whereby warning signals in different species evolve to look similar-has long served as a paradigm of convergent evolution. Little is known, however, about the genes that underlie the evolution of mimetic phenotypes or to what extent the same or different genes drive such convergence. Here, we characterize one of the major genes responsible for mimetic wing pattern evolution in Heliconius butterflies. Mapping, gene expression, and population genetic work all identify a single gene, optix, that controls extreme red wing pattern variation across multiple species of Heliconius. Our results show that the cis-regulatory evolution of a single transcription factor can repeatedly drive the convergent evolution of complex color patterns in distantly related species, thus blurring the distinction between convergence and homology.	[Reed, Robert D.; Papa, Riccardo; Martin, Arnaud] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Papa, Riccardo] Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA; [Papa, Riccardo] Univ Puerto Rico, Ctr Appl Trop Ecol & Conservat, Rio Piedras, PR 00931 USA; [Hines, Heather M.; McMillan, W. Owen] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Counterman, Brian A.] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA; [Pardo-Diaz, Carolina; Jiggins, Chris D.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Chamberlain, Nicola L.; Kronforst, Marcus R.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Chen, Rui] Baylor Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Halder, Georg] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Nijhout, H. Frederik] Duke Univ, Dept Biol, Durham, NC 27708 USA; [McMillan, W. Owen] Smithsonian Trop Res Inst, Panama City, Panama	University of California System; University of California Irvine; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Rio Piedras; University of North Carolina; North Carolina State University; Mississippi State University; University of Cambridge; Harvard University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Duke University; Smithsonian Institution; Smithsonian Tropical Research Institute	Reed, RD (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	rreed@uci.edu; rpapa.lab@gmail.com	Jiggins, Chris/T-4296-2019; Halder, Georg/F-2966-2015; Jiggins, Chris D/B-9960-2008; Pardo-Diaz, Carolina/C-7936-2016; Reed, Robert D/A-2419-2008	Jiggins, Chris/0000-0002-7809-062X; Halder, Georg/0000-0001-7580-3236; Jiggins, Chris D/0000-0002-7809-062X; Pardo-Diaz, Carolina/0000-0002-7259-1183; Reed, Robert/0000-0002-6065-6728; Counterman, Brian/0000-0003-2724-071X; McMillan, W. Owen/0000-0003-2805-2745; Martin, Arnaud/0000-0002-5980-2249	NSF; NIH; Centre National de la Recherche Scientifique-Guyane; Peruvian Ministerio de Agricultura and Instituto Nacional De Recursos Naturales [004-2008-INRENA-IFFS-DCB, 011756-AG-INRENA]; French Guiana Ministere de L'Ecologie, de L'Energie, du Developpemet Durable et de la Mar [BIODAD-2010-0433]; Ecuadorian Ministerio del Ambiente Ecuadorian [013-09 IC-FAU-DNB/MA]; Panamanian Autoridad Nacional del Ambiente [SC/A-7-11]	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National de la Recherche Scientifique-Guyane; Peruvian Ministerio de Agricultura and Instituto Nacional De Recursos Naturales; French Guiana Ministere de L'Ecologie, de L'Energie, du Developpemet Durable et de la Mar; Ecuadorian Ministerio del Ambiente Ecuadorian; Panamanian Autoridad Nacional del Ambiente	We thank M. A. Flores and A. Portugal for help rearing butterflies, M.-J. Sung for help with electron microscopy, J. Miller for help with microarray analysis, and J. Mallet for sharing samples. Supported by funding from NSF (R.D.R., W.O.M., M.R.K.), NIH (H.M.H., M.R.K.), and Centre National de la Recherche Scientifique-Guyane (B.A.C.) Sequences are available on GenBank (JN102349-JN102354). Microarray data are available on Gene Expression Omnibus (GSE30221). Permission to collect and export butterfly tissue was provided by the Peruvian Ministerio de Agricultura and Instituto Nacional De Recursos Naturales (004-2008-INRENA-IFFS-DCB and 011756-AG-INRENA); the French Guiana Ministere de L'Ecologie, de L'Energie, du Developpemet Durable et de la Mar (BIODAD-2010-0433); the Ecuadorian Ministerio del Ambiente Ecuadorian (013-09 IC-FAU-DNB/MA); and the Panamanian Autoridad Nacional del Ambiente (SC/A-7-11). W.O.M., F.N, and R.D.R. designed experiments and conducted initial work. R.P. produced butterfly crosses and generated and analyzed the microarray data with H.M.H. A.M. generated in situ hybridization data. B.A.C., C.P.-D., C.D.J., N.L.C, and M.R.K. contributed nucleotide association data. R.C. and G.H. assisted with positional cloning. R.P., A.M., B.A.C., and R.D.R. prepared figures and R.D.R. wrote the manuscript with support from R.P., A.M., and W.O.M. The authors declare that they have no competing financial interests.	Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Baxter SW, 2008, GENETICS, V180, P1567, DOI 10.1534/genetics.107.082982; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000794; BROWN K.S., 1979, THESIS U ESTADUAL CA; Chamberlain NL, 2011, HEREDITY, V107, P200, DOI 10.1038/hdy.2011.3; Counterman BA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000796; MALLET J, 1995, BIOL J LINN SOC, V55, P159, DOI 10.1111/j.1095-8312.1995.tb01057.x; Papa R, 2008, CURR OPIN GENET DEV, V18, P559, DOI 10.1016/j.gde.2008.11.007; Papa R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-345; Pohl N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-99; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Wagner GP, 2007, NAT REV GENET, V8, P473, DOI 10.1038/nrg2099; Werner T, 2010, NATURE, V464, P1143, DOI 10.1038/nature08896	15	283	287	5	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2011	333	6046					1137	1141		10.1126/science.1208227	http://dx.doi.org/10.1126/science.1208227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21778360				2022-12-28	WOS:000294244300046
J	Berger, AH; Knudson, AG; Pandolfi, PP				Berger, Alice H.; Knudson, Alfred G.; Pandolfi, Pier Paolo			A continuum model for tumour suppression	NATURE			English	Review							HEMATOPOIETIC STEM-CELLS; EMBRYONIC-DEVELOPMENT; EPITHELIAL-CELLS; CONDITIONAL LOSS; GENE-MUTATIONS; CANCER GENES; PTEN; RETINOBLASTOMA; IDENTIFICATION; P53	This year, 2011, marks the forty-year anniversary of the statistical analysis of retinoblastoma that provided the first evidence that tumorigenesis can be initiated by as few as two mutations. This work provided the foundation for the two-hit hypothesis that explained the role of recessive tumour suppressor genes (TSGs) in dominantly inherited cancer susceptibility syndromes. However, four decades later, it is now known that even partial inactivation of tumour suppressors can critically contribute to tumorigenesis. Here we analyse this evidence and propose a continuum model of TSG function to explain the full range of TSG mutations found in cancer.	[Berger, Alice H.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA; [Berger, Alice H.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Dept Pathol, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA; [Knudson, Alfred G.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Fox Chase Cancer Center	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu		Pandolfi, Pier Paolo/0000-0002-5352-5295	NIH [CA06927, R01CA142787]; NATIONAL CANCER INSTITUTE [P30CA006927, U01CA141496, R01CA142787] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Salmena, L. Poliseno and all Pandolfi laboratory members for advice and critical discussions. This work was supported in part by NIH core grant CA06927 and an appropriation from the Commonwealth of Pennsylvania to the Fox Chase Cancer Center to A. G. K. and NIH grant R01CA142787 to A.H.B. and P.P.P.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bellacosa A, 2010, CANCER PREV RES, V3, P48, DOI 10.1158/1940-6207.CAPR-09-0078; BENEDICT WF, 1983, SCIENCE, V219, P973, DOI 10.1126/science.6336308; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Burga LN, 2009, CANCER RES, V69, P1273, DOI 10.1158/0008-5472.CAN-08-2954; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CAVENEE WK, 1985, SCIENCE, V228, P501, DOI 10.1126/science.3983638; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; DRYJA TP, 1984, NEW ENGL J MED, V310, P550, DOI 10.1056/NEJM198403013100902; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FISHER E, 1994, NAT GENET, V7, P5, DOI 10.1038/ng0594-5; Fodde R, 2002, SCIENCE, V298, P761, DOI 10.1126/science.1077707; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; GUDMUNDSSON J, 1995, CANCER RES, V55, P4830; Hagstrom SA, 1999, P NATL ACAD SCI USA, V96, P2952, DOI 10.1073/pnas.96.6.2952; HARRIS H, 1988, CANCER RES, V48, P3302; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lambertz I, 2010, CELL DEATH DIFFER, V17, P633, DOI 10.1038/cdd.2009.202; Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEVY DB, 1994, CANCER RES, V54, P5953; Li G, 2002, DEVELOPMENT, V129, P4159; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Lynch CJ, 2006, ONCOGENE, V25, P3463, DOI 10.1038/sj.onc.1209387; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; OPPERMANN H, 1979, P NATL ACAD SCI USA, V76, P1804, DOI 10.1073/pnas.76.4.1804; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; Payne SR, 2005, CARCINOGENESIS, V26, P2031, DOI 10.1093/carcin/bgi223; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; ROWLEY JD, 1977, LANCET, V1, P549; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sancho R, 2010, GASTROENTEROLOGY, V139, P929, DOI 10.1053/j.gastro.2010.05.078; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; SPARKES RS, 1983, SCIENCE, V219, P971, DOI 10.1126/science.6823558; Sportoletti P, 2008, BLOOD, V111, P3859, DOI 10.1182/blood-2007-06-098251; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Teresi RE, 2008, HUM MOL GENET, V17, P919, DOI 10.1093/hmg/ddm364; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Varley JM, 1997, BRIT J CANCER, V76, P1, DOI 10.1038/bjc.1997.328; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Volinia S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003380; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhou XZ, 2011, J CLIN INVEST, V121, P1266, DOI 10.1172/JCI43452	71	323	331	2	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					163	169		10.1038/nature10275	http://dx.doi.org/10.1038/nature10275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21833082	Green Accepted			2022-12-28	WOS:000293731900027
J	Goldfine, AB; Kaul, S; Hiatt, WR				Goldfine, Allison B.; Kaul, Sanjay; Hiatt, William R.			Fibrates in the Treatment of Dyslipidemias - Time for a Reassessment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GEMFIBROZIL; PREVENTION; THERAPY; MEN		[Goldfine, Allison B.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Goldfine, Allison B.] Harvard Univ, Sch Med, Boston, MA USA; [Kaul, Sanjay] Univ Calif Los Angeles, Los Angeles, CA USA; [Kaul, Sanjay] Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA; [Hiatt, William R.] Univ Colorado, Div Cardiol, Sch Med, Aurora, CO USA; [Hiatt, William R.] CPC Clin Res, Aurora, CO USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Goldfine, AB (corresponding author), Joslin Diabet Ctr, Boston, MA 02215 USA.			Goldfine, Allison/0000-0002-0345-1048				FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1748; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Keech A, 2005, LANCET; Keech A, 2005, LANCET; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21	8	42	44	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					481	484		10.1056/NEJMp1106688	http://dx.doi.org/10.1056/NEJMp1106688			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805MW	21830963				2022-12-28	WOS:000293732100001
J	Barker, MK				Barker, Mary Kavanagh			A Great Case	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Vanguard Med Associates, Wellesley, MA 02481 USA	Harvard Vanguard Medical Associates	Barker, MK (corresponding author), Harvard Vanguard Med Associates, Wellesley, MA 02481 USA.	mary_barker@vmed.org							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2011	306	6					588	589		10.1001/jama.2011.905	http://dx.doi.org/10.1001/jama.2011.905			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804XD	21828314				2022-12-28	WOS:000293687300001
J	Spence, D				Spence, Des			FROM THE FRONTLINE Inactivity and obesity	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						2008, OBESITY, V16, P654, DOI DOI 10.1038/0BY.2007.103	1	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2011	343								d5093	10.1136/bmj.d5093	http://dx.doi.org/10.1136/bmj.d5093			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808DL	21831949				2022-12-28	WOS:000293956300020
J	Wallis, SP; Mistry, D; Coatesworth, AP; Porte, M				Wallis, Sebastian P.; Mistry, Dipan; Coatesworth, Andrew P.; Porte, Michael			PICTURE QUIZ A man with dilated veins on his upper chest	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VENA-CAVA SYNDROME; SUBSTERNAL GOITER; SURGICAL-MANAGEMENT; MULTINODULAR GOITER; OBSTRUCTION; MORBIDITY; THYROIDECTOMY; MORTALITY		[Wallis, Sebastian P.; Mistry, Dipan] York Hosp, Ear Nose & Throat Dept, York YO31 8HE, N Yorkshire, England; [Coatesworth, Andrew P.; Porte, Michael] York Hosp, Dept Radiol, York YO31 8HE, N Yorkshire, England		Wallis, SP (corresponding author), York Hosp, Ear Nose & Throat Dept, York YO31 8HE, N Yorkshire, England.	sebwallis@hotmail.com						ALBAZZAZ F, 1975, AM REV RESPIR DIS, V111, P631; Cubas ER, 2009, INT J CLIN PRACT, V63, P583, DOI 10.1111/j.1742-1241.2008.01904.x; GERAGHTY JG, 1992, ANN SURG, V215, P83, DOI 10.1097/00000658-199201000-00013; Gharib Hossein, 2006, Endocr Pract, V12, P63; Hardy RG, 2009, ANN ROY COLL SURG, V91, P8, DOI 10.1308/003588409X359196; Hashmi SM, 2006, J LARYNGOL OTOL, V120, P644, DOI 10.1017/S0022215106000995; Hyer SL, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-36; KAY TWH, 1988, AM J MED, V84, P19, DOI 10.1016/0002-9343(88)90003-4; MAHAJAN V, 1975, CHEST, V68, P32, DOI 10.1378/chest.68.1.32; Moran JC, 1998, AM SURGEON, V64, P889; NEWMAN E, 1995, J SURG ONCOL, V60, P207, DOI 10.1002/jso.2930600313; PARISH JM, 1981, MAYO CLIN PROC, V56, P407; Pieracci FM, 2007, J AM COLL SURGEONS, V205, P1, DOI 10.1016/j.jamcollsurg.2007.03.010; RIEU M, 1993, CLIN ENDOCRINOL, V39, P67, DOI 10.1111/j.1365-2265.1993.tb01752.x; Rugiu MG, 2009, ACTA OTORHINOLARYNGO, V29, P331; Sancho JJ, 2006, ARCH SURG-CHICAGO, V141, P82, DOI 10.1001/archsurg.141.1.82; Shai SE, 2000, J FORMOS MED ASSOC, V99, P827; TOLLE SW, 1981, WESTERN J MED, V135, P235; White ML, 2008, WORLD J SURG, V32, P1285, DOI 10.1007/s00268-008-9466-3	19	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2011	343								d4674	10.1136/bmj.d4674	http://dx.doi.org/10.1136/bmj.d4674			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NQ	21821648				2022-12-28	WOS:000293735100002
J	Rojas-Rueda, D; de Nazelle, A; Tainio, M; Nieuwenhuijsen, MJ				Rojas-Rueda, David; de Nazelle, Audrey; Tainio, Marko; Nieuwenhuijsen, Mark J.			The health risks and benefits of cycling in urban environments compared with car use: health impact assessment study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL-ACTIVITY; AIR-POLLUTION; MORTALITY; METAANALYSIS; EXPOSURE	Objective To estimate the risks and benefits to health of travel by bicycle, using a bicycle sharing scheme, compared with travel by car in an urban environment. Design Health impact assessment study. Setting Public bicycle sharing initiative, Bicing, in Barcelona, Spain. Participants 181 982 Bicing subscribers. Main outcomes measures The primary outcome measure was all cause mortality for the three domains of physical activity, air pollution (exposure to particulate matter <2.5 mu m), and road traffic incidents. The secondary outcome was change in levels of carbon dioxide emissions. Results Compared with car users the estimated annual change in mortality of the Barcelona residents using Bicing (n=181 982) was 0.03 deaths from road traffic incidents and 0.13 deaths from air pollution. As a result of physical activity, 12.46 deaths were avoided (benefit: risk ratio 77). The annual number of deaths avoided was 12.28. As a result of journeys by Bicing, annual carbon dioxide emissions were reduced by an estimated 9 062 344 kg. Conclusions Public bicycle sharing initiatives such as Bicing in Barcelona have greater benefits than risks to health and reduce carbon dioxide emissions.	[Rojas-Rueda, David; de Nazelle, Audrey; Nieuwenhuijsen, Mark J.] Ctr Res Environm Epidemiol, Barcelona 08003, Spain; [Rojas-Rueda, David; de Nazelle, Audrey; Nieuwenhuijsen, Mark J.] IMIM Hosp Mar, Municipal Inst Med Res, Barcelona, Spain; [Rojas-Rueda, David; de Nazelle, Audrey; Nieuwenhuijsen, Mark J.] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Tainio, Marko] Polish Acad Sci, Syst Res Inst, PL-01447 Warsaw, Poland; [Tainio, Marko] Natl Inst Hlth & Welf, Dept Environm Hlth, Kuopio, Finland	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Polish Academy of Sciences; Systems Research Institute of the Polish Academy of Sciences; Finland National Institute for Health & Welfare	Rojas-Rueda, D (corresponding author), Ctr Res Environm Epidemiol, C Doctor Aiguader 88, Barcelona 08003, Spain.	drojas@creal.cat	Nieuwenhuijsen, Mark J/C-3914-2017; Rojas-Rueda, David/AAK-2184-2020; Rojas-Rueda, David/E-4020-2012	Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Rojas-Rueda, David/0000-0001-5854-2484; de Nazelle, Audrey/0000-0002-1092-3971; Tainio, Marko/0000-0002-0973-2342	Coca-Cola Foundation; AGAUR; CREAL	Coca-Cola Foundation; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); CREAL	This work is part of the European wide project Transportation Air pollution and Physical ActivitieS: an integrated health risk assessment progamme of climate change and urban policies (TAPAS), which has partners in Barcelona, Basel, Copenhagen, Paris, Prague, and Warsaw. TAPAS is a four year project funded by the Coca-Cola Foundation, AGAUR, and CREAL.	Aertsens J, 2010, ACCIDENT ANAL PREV, V42, P2149, DOI 10.1016/j.aap.2010.07.008; Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Autoridad del Transporte Metropolitano, 2007, EMQ 2006 REG METR BA; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS347, DOI 10.1097/00005768-200106001-00002; *CDC, 1996, PHYS ACT HLTH REP SU; Centers for Disease Control and Prevention (CDCP), 2010, OB HALT EP MAK HLTH; Commission of the European Communities, 2005, PROM HLTH DIETS PHYS; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; de Nazelle A, 2008, EPIDEMIOLOGY, V19, pS130; de Nazelle A, 2009, SCI TOTAL ENVIRON, V407, P2525, DOI 10.1016/j.scitotenv.2009.01.006; de Nazelle A, 2011, ENVIRON INT, V37, P766, DOI 10.1016/j.envint.2011.02.003; de Nazelle A, 2010, OCCUP ENVIRON MED, V67, P76, DOI 10.1136/oem.2009.050054; Direccio de Serveis de Mobilitat, 2010, DAD BAS MOB 2009; Direccion General de Trafico, 2008, PARQ NAC AUT DISTR P; GESOP, 2009, BAR ANN BIC; *INT PAN CLIM CHAN, 2007, 4 IPCC; Krewski D., 2009, EXTENDED FOLLOW UP S, V140; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; Lopez A, 2009, BICING TRANSPORTE PU; Midgley P, 2011, COMMISSION SUSTAINAB; Oficina Catalana del Cambio Climatico, 2010, GUIA PRACT CALC EM G; Perez L, 2009, INT J PUBLIC HEALTH, V54, P45, DOI 10.1007/s00038-008-8025-x; Pope CA, 2007, INHAL TOXICOL, V19, P33, DOI 10.1080/08958370701492961; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Santamarina E, 2008, ACCIDENTS LESIONATS; Servicio de Informacion y Estudios, 2010, AN MORT CAT 2007; TUXWORTH W, 1986, BRIT J IND MED, V43, P733; Wichmann H, 2000, DAILY MORTALITY FINE; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Health Organization, 2008, HLTH EC ASS TOOL HEA; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yang L, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5293	35	322	327	3	118	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2011	343								d4521	10.1136/bmj.d4521	http://dx.doi.org/10.1136/bmj.d4521			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NO	21816732	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000293734800001
J	Mozaffarian, D; Lemaitre, RN; King, IB; Song, XL; Spiegelman, D; Sacks, FM; Rimm, EB; Siscovick, DS				Mozaffarian, Dariush; Lemaitre, Rozenn N.; King, Irena B.; Song, Xiaoling; Spiegelman, Donna; Sacks, Frank M.; Rimm, Eric B.; Siscovick, David S.			Circulating Long-Chain omega-3 Fatty Acids and Incidence of Congestive Heart Failure in Older Adults: The Cardiovascular Health Study A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							POLYUNSATURATED FATTY-ACIDS; LEFT-VENTRICULAR FUNCTION; NITRIC-OXIDE SYNTHASE; FISH-OIL; EICOSAPENTAENOIC ACID; BLOOD-PRESSURE; DOCOSAHEXAENOIC ACID; VASCULAR MORTALITY; INDIVIDUAL DATA; RISK	Background: Few previous studies have evaluated associations between long-chain omega-3 fatty acids and incidence of congestive heart failure (CHF), and those that have are typically based on diet questionnaires and yield conflicting results. Circulating fatty acid concentrations provide objective biomarkers of exposure. Objective: To determine whether plasma phospholipid concentrations of long-chain omega-3 fatty acids, including eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA), were associated with incident CHF. Design: Prospective cohort study. Setting: 4 U. S. communities. Patients: 2735 U. S. adults without prevalent heart disease who were enrolled in the Cardiovascular Health Study from 1992 to 2006. Measurements: Plasma phospholipid fatty acid concentrations and other cardiovascular risk factors were measured in 1992 by using standardized methods. Relationships with incident CHF (555 cases during 26 490 person-years, adjudicated by using medical records) were assessed by using Cox proportional hazards models. Results: After multivariate adjustment, plasma phospholipid EPA concentration was inversely associated with incident CHF; risk was approximately 50% lower in the highest versus the lowest quartile (hazard ratio [HR], 0.52 [95% CI, 0.38 to 0.72]; P for trend = 0.001). In similar analyses, trends toward lower risk were seen for DPA (HR, 0.76 [CI, 0.56 to 1.04]; P for trend = 0.057) and total long-chain omega-3 fatty acids (HR, 0.70 [CI, 0.49 to 0.99]; P for trend = 0.062) but not for DHA (HR, 0.84 [CI, 0.58 to 1.21]; P for trend = 0.38). In analyses censored to the middle of follow-up (7 years) to minimize exposure misclassification over time, multivariate-adjusted HRs were 0.48 for EPA (CI, 0.32 to 0.71; P for trend = 0.005), 0.61 for DPA (CI, 0.39 to 0.95; P for trend = 0.033), 0.64 for DHA (CI, 0.40 to 1.04; P for trend = 0.057), and 0.51 for total omega-3 fatty acids (CI, 0.32 to 0.80; P for trend = 0.003). Limitations: Temporal changes in fatty acid concentrations over time may have caused underestimation of associations. Unmeasured or imperfectly measured covariates may have caused residual confounding. Conclusion: Circulating individual and total omega-3 fatty acid concentrations are associated with lower incidence of CHF in older adults.	[Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Univ New Mexico, Albuquerque, NM 87131 USA; Univ Washington, Seattle, WA 98101 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of New Mexico; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Mozaffarian, D (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008		National Heart, Lung, and Blood Institute [R01-HL-085710-01, N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079, N01-HC-85086, N01-HC-15103, N01-HC-55222, U01-HL080295]; Office of Dietary Supplements; National Institutes of Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC075150, N01HC045133, N01HC015103, N01HC035129, N01HC055222, N01HC085086, N01HC085079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085710, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By grant R01-HL-085710-01 from the National Heart, Lung, and Blood Institute, with cofunding from the Office of Dietary Supplements. The National Heart, Lung, and Blood Institute provided further support for the CHS (contracts N01-HC-35129, N01-HC-45133, N01-HC-75150, N01-HC-85079 through N01-HC-85086, N01-HC-15103, N01-HC-55222, and U01-HL080295), with additional contributions from the National Institute of Neurological Disorders and Stroke.r National Institutes of Health.	Balk EM, 2006, ATHEROSCLEROSIS, V189, P19, DOI 10.1016/j.atherosclerosis.2006.02.012; Centers for Medicare & Medicaid Services US Department of Health and Human Services, 2010, MED MED STAT SUPPL; CHARNOCK JS, 1992, MOL CELL BIOCHEM, V116, P19, DOI 10.1007/BF01270564; CHIN JPF, 1993, HYPERTENSION, V21, P22, DOI 10.1161/01.HYP.21.1.22; De Caterina R, 2000, AM J CLIN NUTR, V71, p213S, DOI 10.1093/ajcn/71.1.213S; Demaison L, 2000, REPROD NUTR DEV, V40, P113, DOI 10.1051/rnd:2000124; Dijkstra SC, 2009, EUR J HEART FAIL, V11, P922, DOI 10.1093/eurjhf/hfp126; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010; Ghio S, 2010, EUR J HEART FAIL, V12, P1345, DOI 10.1093/eurjhf/hfq172; Gottdiener JS, 2002, ANN INTERN MED, V137, P631, DOI 10.7326/0003-4819-137-8-200210150-00006; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Grimsgaard S, 1998, AM J CLIN NUTR, V68, P52, DOI 10.1093/ajcn/68.1.52; Harris WS, 2004, CIRCULATION, V110, P1645, DOI 10.1161/01.CIR.0000142292.10048.B2; Harris WS, 1997, AM J CLIN NUTR, V65, P459, DOI 10.1093/ajcn/65.2.459; James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s; KENNY D, 1992, AM J CARDIOL, V70, P1347, DOI 10.1016/0002-9149(92)90773-R; King IB, 2006, AM J CLIN NUTR, V83, P227; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kumanyika SK, 1997, AM J CLIN NUTR, V65, P1123; Lemaitre RN, 2003, AM J CLIN NUTR, V77, P319, DOI 10.1093/ajcn/77.2.319; Lemaitre RN, 2006, CIRCULATION, V114, P209, DOI 10.1161/CIRCULATIONAHA.106.620336; LEPAGE G, 1986, J LIPID RES, V27, P114; Levitan EB, 2009, EUR HEART J, V30, P1495, DOI 10.1093/eurheartj/ehp111; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Li QR, 2007, ARCH BIOCHEM BIOPHYS, V466, P250, DOI 10.1016/j.abb.2007.06.023; Li QR, 2007, BIOCHIMIE, V89, P169, DOI 10.1016/j.biochi.2006.10.009; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; MCLENNAN PL, 1992, CARDIOVASC RES, V26, P871, DOI 10.1093/cvr/26.9.871; MCVEIGH GE, 1994, ARTERIOSCLER THROMB, V14, P1425, DOI 10.1161/01.ATV.14.9.1425; Mori TA, 2000, CIRCULATION, V102, P1264, DOI 10.1161/01.CIR.102.11.1264; Mozaffarian D, 2006, AM J CARDIOL, V97, P216, DOI 10.1016/j.amjcard.2005.08.025; Mozaffarian D, 2005, J AM COLL CARDIOL, V45, P2015, DOI 10.1016/j.jacc.2005.03.038; Mozaffarian D, 2005, CIRCULATION, V112, P1945, DOI 10.1161/CIRCULATIONAHA.105.556886; Mozaffarian D, 2011, CIRCULATION IN PRESS; Mozaffarian D, 2011, J AM COLL C IN PRESS; Mozaffarian D, 2007, J CARDIOVASC MED, V8, pS23, DOI 10.2459/01.JCM.0000289279.95427.e2; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Mozaffarian D, 2006, J AM COLL CARDIOL, V48, P478, DOI 10.1016/j.jacc.2006.03.048; National Institutes of Health, 2011, NUTR DIET CAUS PREV; Nodari S, 2011, J AM COLL CARDIOL, V57, P870, DOI 10.1016/j.jacc.2010.11.017; Omura M, 2001, FEBS LETT, V487, P361, DOI 10.1016/S0014-5793(00)02351-6; Peoples GE, 2008, J CARDIOVASC PHARM, V52, P540, DOI 10.1097/FJC.0b013e3181911913; Robinson JG, 2006, AM J CARDIOL, V98, p39I, DOI 10.1016/j.amjcard.2005.12.026; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; ROSNER B, 1977, AM J EPIDEMIOL, V106, P306, DOI 10.1093/oxfordjournals.aje.a112466; Sun Q, 2008, AM J CLIN NUTR, V88, P216, DOI 10.1093/ajcn/88.1.216; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; VONAU D, 1988, EUR J APPL PHYSIOL O, V58, P97, DOI 10.1007/BF00636610; Yamagishi K, 2008, AM HEART J, V156, P965, DOI 10.1016/j.ahj.2008.06.017; Yamagishi K, 2008, J AM COLL CARDIOL, V52, P988, DOI 10.1016/j.jacc.2008.06.018; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	55	132	139	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2011	155	3					160	+		10.7326/0003-4819-155-3-201108020-00006	http://dx.doi.org/10.7326/0003-4819-155-3-201108020-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800DJ	21810709	Green Accepted			2022-12-28	WOS:000293339600004
J	Wiener, RS; Schwartz, LM; Woloshin, S; Welch, HG				Wiener, Renda Soylemez; Schwartz, Lisa M.; Woloshin, Steven; Welch, H. Gilbert			Population-Based Risk for Complications After Transthoracic Needle Lung Biopsy of a Pulmonary Nodule: An Analysis of Discharge Records	ANNALS OF INTERNAL MEDICINE			English	Article							PNEUMOTHORAX; ASPIRATION; ICD-9-CM; LESIONS; HEMORRHAGE; CANCER	Background: Because pulmonary nodules are found in up to 25% of patients undergoing computed tomography of the chest, the question of whether to perform biopsy is becoming increasingly common. Data on complications after transthoracic needle lung biopsy are limited to case series from selected institutions. Objective: To determine population-based estimates of risks for complications after transthoracic needle biopsy of a pulmonary nodule. Design: Cross-sectional analysis. Setting: The 2006 State Ambulatory Surgery Databases and State Inpatient Databases for California, Florida, Michigan, and New York from the Healthcare Cost and Utilization Project. Patients: 15 865 adults who had transthoracic needle biopsy of a pulmonary nodule. Measurements: Percentage of biopsies complicated by hemorrhage, any pneumothorax, or pneumothorax requiring a chest tube, and adjusted odds ratios for these complications associated with various biopsy characteristics, calculated by using multivariate, population-averaged generalized estimating equations. Results: Although hemorrhage was rare, complicating 1.0% (95% CI, 0.9% to 1.2%) of biopsies, 17.8% (CI, 11.8% to 23.8%) of patients with hemorrhage required a blood transfusion. In contrast, the risk for any pneumothorax was 15.0% (CI, 14.0% to 16.0%), and 6.6% (CI, 6.0% to 7.2%) of all biopsies resulted in pneumothorax requiring a chest tube. Compared with patients without complications, those who experienced hemorrhage or pneumothorax requiring a chest tube had longer lengths of stay (P < 0.001) and were more likely to develop respiratory failure requiring mechanical ventilation (P = 0.020). Patients aged 60 to 69 years (as opposed to younger or older patients), smokers, and those with chronic obstructive pulmonary disease had higher risk for complications. Limitations: Estimated risks may be inaccurate if coding of complications is incomplete. The analyzed databases contain little clinical detail (such as information on nodule characteristics or biopsy pathology) and cannot indicate whether performing the biopsy produced useful information. Conclusion: Whereas hemorrhage is an infrequent complication of transthoracic needle lung biopsy, pneumothorax is common and often necessitates chest tube placement. These population-based data should help patients and physicians make more informed choices about whether to perform biopsy of a pulmonary nodule.	[Wiener, Renda Soylemez] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA; Edith Nourse Rogers Mem Vet Adm Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA 01730 USA; Dept Vet Affairs, Vet Affairs Outcomes Grp, White River Jct, VT USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA	Boston University; Dartmouth College	Wiener, RS (corresponding author), Boston Univ, Sch Med, Ctr Pulm, 72 E Concord St,R-304, Boston, MA 02118 USA.	rwiener@bu.edu	Wiener, Renda/AAO-1557-2020	Wiener, Renda/0000-0001-7712-2135	National Cancer Institute [K07 CA138772]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [K07CA138772] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By career development award K07 CA138772 from the National Cancer Institute (Dr. Wiener) and by the Department of Veterans Affairs.	[Anonymous], 2010, LUNG CANC TRIAL RES; Chakrabarti B, 2009, RESP MED, V103, P449, DOI 10.1016/j.rmed.2008.09.010; Covey AM, 2004, J VASC INTERV RADIOL, V15, P479; Croswell JM, 2010, ANN INTERN MED, V152, P505, DOI 10.7326/0003-4819-152-8-201004200-00007; De Coster C, 2008, MED CARE, V46, P627, DOI 10.1097/MLR.0b013e3181649439; Geraghty PR, 2003, RADIOLOGY, V229, P475, DOI 10.1148/radiol.2291020499; Gould MK, 2007, CHEST, V132, p108S, DOI 10.1378/chest.07-1353; Healthcare Cost and Utilization Project (HCUP), 2006, HCUP STAT AMB SURG D; Healthcare Cost and Utilization Project (HCUP), 2006, HCUP STAT INP DAT SI; Heyer CM, 2008, ACAD RADIOL, V15, P1017, DOI 10.1016/j.acra.2008.02.018; Hiraki T, 2010, AM J ROENTGENOL, V194, P809, DOI 10.2214/AJR.09.3224; Hodges A, 2009, CODING Q A ASK EXPER; Khan MF, 2008, EUR RADIOL, V18, P1356, DOI 10.1007/s00330-008-0893-1; Laspas F, 2008, J MED IMAG RADIAT ON, V52, P458, DOI 10.1111/j.1440-1673.2008.01990.x; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Mazza E, 2005, RADIOL MED, V110, P141; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; Ost D, 2003, NEW ENGL J MED, V348, P2535, DOI 10.1056/NEJMcp012290; Romano Maurizio, 2004, Radiol Med, V108, P275; Sadeghi B, 2010, AM J MED QUAL, V25, P218, DOI 10.1177/1062860609359534; U.S. Census Bureau, 2010, POP EST; Yamagami T, 2006, Australas Radiol, V50, P435, DOI 10.1111/j.1440-1673.2006.01619.x; Yeow KM, 2004, CHEST, V126, P748, DOI 10.1378/chest.126.3.748	23	327	349	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2011	155	3					137	+		10.7326/0003-4819-155-3-201108020-00003	http://dx.doi.org/10.7326/0003-4819-155-3-201108020-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800DJ	21810706	Green Accepted			2022-12-28	WOS:000293339600001
J	Landry, CR				Landry, Christian R.			A Cellular Roadmap for the Plant Kingdom	SCIENCE			English	Editorial Material							PROTEIN; SYSTEM		[Landry, Christian R.] Univ Laval, Inst Biol Integrat & Syst IBIS, Dept Biol, Quebec City, PQ G1V 0A6, Canada; [Landry, Christian R.] Univ Laval, Regrp Strateg Fonct Struct & Ingn Prot PROTEO, Quebec City, PQ G1V 0A6, Canada	Laval University; Laval University	Landry, CR (corresponding author), Univ Laval, Inst Biol Integrat & Syst IBIS, Dept Biol, Quebec City, PQ G1V 0A6, Canada.	christian.landry@bio.ulaval.ca	Landry, Christian R/F-3890-2011	Landry, Christian/0000-0003-3028-6866				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Boruc J, 2010, PLANT CELL, V22, P1264, DOI 10.1105/tpc.109.073635; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Van Leene J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.53	13	7	7	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					532	533		10.1126/science.1209753	http://dx.doi.org/10.1126/science.1209753			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798921				2022-12-28	WOS:000293222400031
J	Morrison, D; Aitchison, M; Connelly, DT; Mair, FS				Morrison, Deborah; Aitchison, Michael; Connelly, Derek T.; Mair, Frances S.			10-MINUTE CONSULTATION Sexual dysfunction in cardiovascular disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morrison, Deborah; Mair, Frances S.] Univ Glasgow, Inst Hlth & WellBeing, Acad Unit Gen Practice & Primary Care, Glasgow, Lanark, Scotland; [Aitchison, Michael] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland; [Connelly, Derek T.] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland; [Connelly, Derek T.] Golden Jubilee Natl Hosp, Glasgow, Lanark, Scotland	University of Glasgow; Gartnavel Royal Hospital; University of Glasgow; Golden Jubilee Hospital	Mair, FS (corresponding author), Univ Glasgow, Inst Hlth & WellBeing, Acad Unit Gen Practice & Primary Care, Glasgow, Lanark, Scotland.	Frances.Mair@glasgow.ac.uk		Mair, Frances/0000-0001-9780-1135				Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Hackett G., 2007, BRIT SOC SEXUAL MED; Hatzimouratidis K, 2010, EUR UROL, V57, P804, DOI 10.1016/j.eururo.2010.02.020; Kostis JB, 2005, AM J CARDIOL, V96, P313, DOI 10.1016/j.amjcard.2005.03.065	4	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2011	343								d4437	10.1136/bmj.d4437	http://dx.doi.org/10.1136/bmj.d4437			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801LP	21791492	Green Accepted			2022-12-28	WOS:000293440700005
J	MacDonald, ME				MacDonald, Margaret E.			The art of medicine The cultural evolution of natural birth	LANCET			English	Editorial Material							HOME BIRTH; BODIES		York Univ, Dept Anthropol, N York, ON M3J 1P3, Canada	York University - Canada	MacDonald, ME (corresponding author), York Univ, Dept Anthropol, N York, ON M3J 1P3, Canada.	maggie@yorku.ca						Bernike Pasveer, 2001, BIRTH DESIGN PREGNAN, P229; BOURGEAULT IL, 2002, CAN J MIDWIFERY RES, V1, P4; Klassen PE, 2001, SIGNS, V26, P775, DOI 10.1086/495628; MacDonald M., 2007, WORK FIELD BIRTH MID; Macdonald M, 2006, MED ANTHROPOL Q, V20, P235, DOI 10.1525/maq.2006.20.2.235; MICHIE H, 2000, GENDER HLTH, P44; Viisainen K, 2001, SOC SCI MED, V52, P1109, DOI 10.1016/S0277-9536(00)00206-9	7	5	5	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2011	378	9789					394	395		10.1016/S0140-6736(11)61200-2	http://dx.doi.org/10.1016/S0140-6736(11)61200-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XM	21809497	Bronze			2022-12-28	WOS:000293615900017
J	Zuber, J; Shi, JW; Wang, E; Rappaport, AR; Herrmann, H; Sison, EA; Magoon, D; Qi, J; Blatt, K; Wunderlich, M; Taylor, MJ; Johns, C; Chicas, A; Mulloy, JC; Kogan, SC; Brown, P; Valent, P; Bradner, JE; Lowe, SW; Vakoc, CR				Zuber, Johannes; Shi, Junwei; Wang, Eric; Rappaport, Amy R.; Herrmann, Harald; Sison, Edward A.; Magoon, Daniel; Qi, Jun; Blatt, Katharina; Wunderlich, Mark; Taylor, Meredith J.; Johns, Christopher; Chicas, Agustin; Mulloy, James C.; Kogan, Scott C.; Brown, Patrick; Valent, Peter; Bradner, James E.; Lowe, Scott W.; Vakoc, Christopher R.			RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia	NATURE			English	Article							TRANSCRIPTIONAL PROGRAM; H3K79 METHYLATION; STEM-CELLS; IN-VIVO; C-MYC; CLASSIFICATION; LEUKEMOGENESIS; EXPRESSION; MLL-AF9; INHIBITION	Epigenetic pathways can regulate gene expression by controlling and interpreting chromatin modifications. Cancer cells are characterized by altered epigenetic landscapes, and commonly exploit the chromatin regulatory machinery to enforce oncogenic gene expression programs(1). Although chromatin alterations are, in principle, reversible and often amenable to drug intervention, the promise of targeting such pathways therapeutically has been limited by an incomplete understanding of cancer-specific dependencies on epigenetic regulators. Here we describe a non-biased approach to probe epigenetic vulnerabilities in acute myeloid leukaemia (AML), an aggressive haematopoietic malignancy that is often associated with aberrant chromatin states(2). By screening a custom library of small hairpin RNAs (shRNAs) targeting known chromatin regulators in a genetically defined AML mouse model, we identify the protein bromodomain-containing 4 (Brd4) as being critically required for disease maintenance. Suppression of Brd4 using shRNAs or the small-molecule inhibitor JQ1 led to robust antileukaemic effects in vitro and in vivo, accompanied by terminal myeloid differentiation and elimination of leukaemia stem cells. Similar sensitivities were observed in a variety of human AML cell lines and primary patient samples, revealing that JQ1 has broad activity in diverse AML subtypes. The effects of Brd4 suppression are, at least in part, due to its role in sustaining Myc expression to promote aberrant self-renewal, which implicates JQ1 as a pharmacological means to suppress MYC in cancer. Our results establish small-molecule inhibition of Brd4 as a promising therapeutic strategy in AML and, potentially, other cancers, and highlight the utility of RNA interference (RNAi) screening for revealing epigenetic vulnerabilities that can be exploited for direct pharmacological intervention.	[Lowe, Scott W.; Vakoc, Christopher R.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Zuber, Johannes] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Shi, Junwei] SUNY Stony Brook, Mol & Cellular Biol Program, Stony Brook, NY 11794 USA; [Rappaport, Amy R.; Lowe, Scott W.] Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Sison, Edward A.; Magoon, Daniel; Brown, Patrick] Johns Hopkins Univ, Sch Med, Div Pediat Oncol, Baltimore, MD 21231 USA; [Qi, Jun; Bradner, James E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Blatt, Katharina; Valent, Peter] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, A-1090 Vienna, Austria; [Wunderlich, Mark; Mulloy, James C.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Kogan, Scott C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cold Spring Harbor Laboratory; Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Medical University of Vienna; Cincinnati Children's Hospital Medical Center; University of California System; University of California San Francisco	Vakoc, CR (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu; vakoc@cshl.edu	Clovis, Jeff/C-1020-2009; Test, PV/U-9451-2019; Gamperl, Susi/V-2715-2019; Hermann, Harald/E-7073-2018; Zuber, Johannes/E-7517-2011; Test, Test/Y-7921-2019; Valent, Peter/B-8533-2016	Gamperl, Susi/0000-0003-0456-5095; Hermann, Harald/0000-0002-5095-4641; Zuber, Johannes/0000-0001-8810-6835; Valent, Peter/0000-0003-0456-5095; Kogan, Scott/0000-0002-2395-8479; Wang, Eric/0000-0001-7865-6702; Vakoc, Christopher/0000-0002-1158-7180	Don Monti Memorial Research Foundation; Laurie Strauss Leukemia Foundation; German Research Foundation (DFG); CSHL; NIH; Barbara McClintock fellowship; Damon-Runyon Cancer Research Foundation; Smith Family Foundation; Damon Runyon-Lilly Clinical Investigator Award; Leukemia and Lymphoma Society (LLS); Leukemia and Lymphoma Society of America; National Cancer Institute; Howard Hughes Medical Institute; CSHL President's Council; SASS Foundation for Medical Research; NATIONAL CANCER INSTITUTE [K08CA128972] Funding Source: NIH RePORTER	Don Monti Memorial Research Foundation; Laurie Strauss Leukemia Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); CSHL; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barbara McClintock fellowship; Damon-Runyon Cancer Research Foundation; Smith Family Foundation; Damon Runyon-Lilly Clinical Investigator Award; Leukemia and Lymphoma Society (LLS)(Leukemia and Lymphoma Society); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); CSHL President's Council; SASS Foundation for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. Ma, S. Muller and M. Weissenboeck for technical assistance; J. Simon, E. Earl and L. Bianco for support with mouse work; C. dos Santos for assistance with LSK FACS analysis; S. Hearn for microscopy support; G. Hannon, K. Chang, and E. Hodges for shRNA technology support; A. Gordon and M. Hammell for bioinformatics support; L. Dow for assistance with mouse pathology sample preparation; and G. Blobel for comments on the manuscript. We thank the Don Monti Memorial Research Foundation and Laurie Strauss Leukemia Foundation for research support. J.Z. was supported by a research fellowship from the German Research Foundation (DFG) and by the Andrew Seligson Memorial Clinical Fellowship at CSHL; A. R. R. was supported by an NIH traineeship and the Barbara McClintock fellowship; J. E. B and J. Q. are supported by the Damon-Runyon Cancer Research Foundation and Smith Family Foundation. P. B. is supported by a Damon Runyon-Lilly Clinical Investigator Award and a Leukemia and Lymphoma Society (LLS) Translational Research Program Grant, and is an LLS Scholar in Clinical Research. S. W. L. is supported by a Specialized Center of Research (SCOR) grant from the Leukemia and Lymphoma Society of America, a Cancer Target Discovery and Development (CTD2) grant from the National Cancer Institute, and by the Howard Hughes Medical Institute; C. R. V., J. S. and E. W. are supported by the CSHL President's Council and the SASS Foundation for Medical Research.	BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Chen JJ, 2010, NAT REV CANCER, V10, P23, DOI 10.1038/nrc2765; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; French CA, 2003, CANCER RES, V63, P304; Gilliland D Gary, 2004, Hematology Am Soc Hematol Educ Program, P80; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Schmidt M, 2000, MOL CELL BIOL, V20, P1970, DOI 10.1128/MCB.20.6.1970-1981.2000; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor James, 2007, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s19; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wong P, 2010, CANCER RES, V70, P3833, DOI 10.1158/0008-5472.CAN-09-3268; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Wunderlich Mark, 2009, V538, P263, DOI 10.1007/978-1-59745-418-6_13; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; ZUBER J, GENES DEV IN PRESS, DOI DOI 10.1101/GAD.1726911; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	42	1370	1508	1	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					524	U124		10.1038/nature10334	http://dx.doi.org/10.1038/nature10334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21814200	Green Accepted			2022-12-28	WOS:000296194200045
J	O'Keefe, FR; Chiappe, LM				O'Keefe, F. R.; Chiappe, L. M.			Viviparity and K-Selected Life History in a Mesozoic Marine Plesiosaur (Reptilia, Sauropterygia)	SCIENCE			English	Article							EMBRYOS; BIRTH	Viviparity is known in several clades of Mesozoic aquatic reptiles, but evidence for it is lacking in the Plesiosauria. Here, we report a Late Cretaceous plesiosaur fossil consisting of a fetus preserved within an adult of the same taxon. We interpret this occurrence as a gravid female and unborn young and hence as definitive evidence for plesiosaur viviparity. Quantitative analysis indicates that plesiosaurs gave birth to large, probably single progeny. The combination of viviparity, large offspring size, and small brood number differs markedly from the pattern seen in other marine reptiles but does resemble the K-selected strategy of all extant marine mammals and a few extant lizards. Plesiosaurs may have shared other life history traits with these clades, such as sociality and maternal care.	[O'Keefe, F. R.] Marshall Univ, Dept Biol Sci, Huntington, WV 25755 USA; [Chiappe, L. M.] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA	Marshall University	O'Keefe, FR (corresponding author), Marshall Univ, Dept Biol Sci, Huntington, WV 25755 USA.	okeefef@marshall.edu		Chiappe, Luis/0000-0001-9661-0601	NSF [EPS-1003907]	NSF(National Science Foundation (NSF))	The fossil described here (LACM 129639) is reposited in the vertebrate paleontology collections of the Los Angeles County Museum and is currently on display in the public gallery. Metric data from the specimen is listed in tables S1 and S2. We thank Phil Fraley Productions for the skilled preparation and mounting of the fossil that made this study possible. B. Kear provided access to unpublished Leptocleidus data. Thanks to R. Cripps for the mount photograph in Fig. 1 and to D. Trankina for Fig. 1 line art. Many thanks to S. Abramowicz for the life reconstruction art, Fig. 3, and work on other figures. J. Long provided valuable feedback on an early version of this manuscript. This material is based on work supported by the NSF under award no. EPS-1003907.	Andrews R.M., 1982, Biology of Reptilia, V13, P273; Boness DJ, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P278; Bottcher R., 1990, STUTTGARTER BEITRA B, V164, P1; Brown D.S., 1981, Bulletin of the British Museum (Natural History) Geology, V35, P253; BULL CM, 1993, J HERPETOL, V27, P489, DOI 10.2307/1564848; Caldwell MW, 2001, P ROY SOC B-BIOL SCI, V268, P2397, DOI 10.1098/rspb.2001.1796; Chapple DG, 2003, HERPETOL MONOGR, V17, P145, DOI 10.1655/0733-1347(2003)017[0145:ELABIT]2.0.CO;2; Cheng YN, 2009, J VERTEBR PALEONTOL, V29, P401, DOI 10.1671/039.029.0230; Cheng YN, 2004, NATURE, V432, P383, DOI 10.1038/nature03050; Delfino M, 2010, SEMIN CELL DEV BIOL, V21, P432, DOI 10.1016/j.semcdb.2009.11.007; ESTES JA, 1979, J FISH RES BOARD CAN, V36, P1009, DOI 10.1139/f79-140; Everhart M. J., 2005, OCEANS KANSAS NATURA; Everhart Michael J., 2004, Mosasaur, V7, P41; Hill RV, 2005, SYST BIOL, V54, P530, DOI 10.1080/10635150590950326; Ji Q, 2010, NATURWISSENSCHAFTEN, V97, P423, DOI 10.1007/s00114-010-0654-2; Kear BP, 2007, J PALEONTOL, V81, P154, DOI 10.1666/0022-3360(2007)81[154:AJPPRS]2.0.CO;2; Lin K., 1998, FIELDIANA GEOLOGY, V39, P1, DOI 10.5962/bhl.title.5174; O'Keefe ER, 2004, J VERTEBR PALEONTOL, V24, P326; O'Keefe FR, 2009, J VERTEBR PALEONTOL, V29, P1306, DOI 10.1671/039.029.0403; O'Keefe FR, 1999, PALEOBIOLOGY, V25, P504, DOI 10.1017/S0094837300020352; Parker F., 1983, P435; Perrin W.F., 1984, Reports of the International Whaling Commission Special Issue, P97; Renesto S, 2003, J VERTEBR PALEONTOL, V23, P957, DOI 10.1671/1840-21; RIEPPEL O, 1994, J HERPETOL, V28, P145, DOI 10.2307/1564613; SANDER PM, 1988, SCIENCE, V239, P780, DOI 10.1126/science.3340859; Seeley H. G., 1896, ANN REP YORKSHIRE PH, V1895; Shine R., 1988, BIOL REPTILIA, V16, P275; Storrs Glenn W., 1999, University of Kansas Paleontological Contributions New Series, V10-11, P1; TAYLOR MA, 1986, NATURE, V319, P179, DOI 10.1038/319179a0; THULBORN RA, 1982, PALAEONTOLOGY, V25, P351	30	63	67	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					870	873		10.1126/science.1205689	http://dx.doi.org/10.1126/science.1205689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836013				2022-12-28	WOS:000293785400038
J	Kai, FM; Tyler, SC; Randerson, JT; Blake, DR				Kai, Fuu Ming; Tyler, Stanley C.; Randerson, James T.; Blake, Donald R.			Reduced methane growth rate explained by decreased Northern Hemisphere microbial sources	NATURE			English	Article							ATMOSPHERIC METHANE; WATER MANAGEMENT; RICE FIELDS; EMISSIONS; BUDGET; CHINA; MODEL; GAS	Atmospheric methane(CH4) increased through much of the twentieth century, but this trend gradually weakened until a stable state was temporarily reached around the turn of the millennium(1,2), after which levels increased once more(3). The reasons for the slowdown are incompletely understood, with past work identifying changes in fossil fuel, wetland and agricultural sources and hydroxyl (OH) sinks as important causal factors(1,4-8). Here we show that the late-twentieth century changes in the CH4 growth rates are best explained by reduced microbial sources in the Northern Hemisphere. Our results, based on synchronous time series of atmospheric CH4 mixing and C-13/C-12 ratios and a two-box atmospheric model, indicate that the evolution of the mixing ratio requires no significant change in Southern Hemisphere sources between 1984 and 2005. Observed changes in the interhemispheric difference of C-13 effectively exclude reduced fossil fuel emissions as the primary cause of the slowdown. The C-13 observations are consistent with long-term reductions in agricultural emissions or another microbial source within the Northern Hemisphere. Approximately half (51 +/- 18%) of the decrease in Northern Hemisphere CH4 emissions can be explained by reduced emissions from rice agriculture in Asia over the past three decades associated with increases in fertilizer application(9) and reductions in water use(10,11).	[Kai, Fuu Ming; Tyler, Stanley C.; Randerson, James T.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Blake, Donald R.] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Kai, FM (corresponding author), Singapore MIT Alliance Res & Technol, S16-05-08,3 Sci Dr 2, Singapore 117543, Singapore.	fmkai@smart.mit.edu	Randerson, James/Y-2550-2019; Kai, Fuu Ming/AAE-8903-2021; Kai, Fuu Ming/C-3890-2013	Randerson, James/0000-0001-6559-7387; Kai, Fuu Ming/0000-0002-4126-3515; Blake, Donald/0000-0002-8283-5014	NASA [NGT5-30409, NNX08AF64G]; NSF [ATM 9871077, ATM-0628637, AGS-1021776]; Div Atmospheric & Geospace Sciences [1021613] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the many researchers associated with the laboratories referred to as NOAA, NIWA, UW and UCI who took part in collecting and measuring many thousands of air samples over the years. We also thank P. Bousquet for detailed comments on earlier drafts that improved the manuscript. This work has been funded by NASA grants to S. C. T. (NGT5-30409) and J.T.R. (NNX08AF64G), NSF grants to S. C. T. (ATM 9871077) and J.T.R. (ATM-0628637 and AGS-1021776), and additional support from the W. M. Keck Foundation.	[Anonymous], 2008, WAT US STAT; Bloom AA, 2010, SCIENCE, V327, P322, DOI 10.1126/science.1175176; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; Dlugokencky EJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039780; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Dlugokencky EJ, 1998, NATURE, V393, P447, DOI 10.1038/30934; Etheridge DM, 1998, J GEOPHYS RES-ATMOS, V103, P15979, DOI 10.1029/98JD00923; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Fiore AM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026199; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Frolking S, 2004, GLOBAL CHANGE BIOL, V10, P1180, DOI 10.1111/j.1529-8817.2003.00798.x; Huang Y, 1998, GLOBAL CHANGE BIOL, V4, P247, DOI 10.1046/j.1365-2486.1998.00129.x; International Rice Research Institute, 2008, WORLD RIC STAT; Kai FM, 2010, J INTEGR ENVIRON SCI, V7, P49, DOI 10.1080/1943815X.2010.492227; Khalil MAK, 2000, ATMOSPHERIC METHANE, P98; Lassey KR, 2007, ATMOS CHEM PHYS, V7, P2119, DOI 10.5194/acp-7-2119-2007; Lassey KR, 2007, AGR FOREST METEOROL, V142, P120, DOI 10.1016/j.agrformet.2006.03.028; Li CS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015370; Lowe DC, 1997, GEOPHYS RES LETT, V24, P857, DOI 10.1029/97GL00830; Quay P, 1999, GLOBAL BIOGEOCHEM CY, V13, P445, DOI 10.1029/1998GB900006; Simpson IJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027330; Tans PP, 1997, GLOBAL BIOGEOCHEM CY, V11, P77, DOI 10.1029/96GB03940; Tyler SC, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007231; United States Environmental Protection Agency (EPA), 2006, GLOB ANTHR NONCO2 GR; van Aardenne JA, 2001, GLOBAL BIOGEOCHEM CY, V15, P909, DOI 10.1029/2000GB001265; van der Gon HD, 1999, GLOBAL BIOGEOCHEM CY, V13, P1053, DOI 10.1029/1999GB900048; Wassmann R, 2000, NUTR CYCL AGROECOSYS, V58, P23, DOI 10.1023/A:1009874014903; Worthy DEJ, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011239; Zhuang Q, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002239	30	122	123	5	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					194	197		10.1038/nature10259	http://dx.doi.org/10.1038/nature10259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21833086	Green Published			2022-12-28	WOS:000293731900033
J	Yaffe, K; Laffan, AM; Harrison, SL; Redline, S; Spira, AP; Ensrud, KE; Ancoli-Israel, S; Stone, KL				Yaffe, Kristine; Laffan, Alison M.; Harrison, Stephanie Litwack; Redline, Susan; Spira, Adam P.; Ensrud, Kristine E.; Ancoli-Israel, Sonia; Stone, Katie L.			Sleep-Disordered Breathing, Hypoxia, and Risk of Mild Cognitive Impairment and Dementia in Older Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINI-MENTAL-STATE; HEART HEALTH; CARDIOVASCULAR-DISEASE; INTERMITTENT HYPOXIA; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; NOCTURNAL HYPOXIA; ANIMAL-MODELS; APNEA; FRAGMENTATION	Context Sleep-disordered breathing (characterized by recurrent arousals from sleep and intermittent hypoxemia) is common among older adults. Cross-sectional studies have linked sleep-disordered breathing to poor cognition; however, it remains unclear whether sleep-disordered breathing precedes cognitive impairment in older adults. Objectives To determine the prospective relationship between sleep-disordered breathing and cognitive impairment and to investigate potential mechanisms of this association. Design, Setting, and Participants Prospective sleep and cognition study of 298 women without dementia (mean [SD] age: 82.3 [3.2] years) who had overnight polysomnography measured between January 2002 and April 2004 in a substudy of the Study of Osteoporotic Fractures. Sleep-disordered breathing was defined as an apnea-hypopnea index of 15 or more events per hour of sleep. Multivariate logistic regression was used to determine the independent association of sleep-disordered breathing with risk of mild cognitive impairment or dementia, adjusting for age, race, body mass index, education level, smoking status, presence of diabetes, presence of hypertension, medication use (antidepressants, benzodiazepines, or nonbenzodiazepine anxiolytics), and baseline cognitive scores. Measures of hypoxia, sleep fragmentation, and sleep duration were investigated as underlying mechanisms for this relationship. Main Outcome Measures Adjudicated cognitive status (normal, dementia, or mild cognitive impairment) based on data collected between November 2006 and September 2008. Results Compared with the 193 women without sleep-disordered breathing, the 105 women (35.2%) with sleep-disordered breathing were more likely to develop mild cognitive impairment or dementia (31.1% [n=60] vs 44.8% [n=47]; adjusted odds ratio [AOR], 1.85; 95% confidence interval [CI], 1.11-3.08). Elevated oxygen desaturation index (>= 15 events/hour) and high percentage of sleep time (>7%) in apnea or hypopnea (both measures of disordered breathing) were associated with risk of developing mild cognitive impairment or dementia (AOR, 1.71 [95% CI, 1.04-2.83] and AOR, 2.04 [95% CI, 1.10-3.78], respectively). Measures of sleep fragmentation (arousal index and wake after sleep onset) or sleep duration (total sleep time) were not associated with risk of cognitive impairment. Conclusion Among older women, those with sleep-disordered breathing compared with those without sleep-disordered breathing had an increased risk of developing cognitive impairment. JAMA. 2011;306(6):613-619 www.jama.com	[Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94121 USA; [Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA; [Laffan, Alison M.; Harrison, Stephanie Litwack; Stone, Katie L.] Calif Pacific Med Ctr, San Francisco Coordinating Ctr, San Francisco, CA USA; [Redline, Susan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Sleep Med, Boston, MA 02115 USA; [Redline, Susan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02115 USA; [Spira, Adam P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Ensrud, Kristine E.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Univ Minnesota, Dept Epidemiol, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Univ Minnesota, Dept Community Hlth, Minneapolis, MN 55455 USA; [Ensrud, Kristine E.] Vet Affairs Med Ctr, Minneapolis, MN USA; [Ancoli-Israel, Sonia] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; California Pacific Medical Center; California Pacific Medical Center Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of California System; University of California San Diego	Yaffe, K (corresponding author), Univ Calif San Francisco, Dept Psychiat, Box 181,4150 Clement St, San Francisco, CA 94121 USA.	kristine.yaffe@ucsf.edu		Spira, Adam/0000-0003-1507-0995; Ensrud, Kristine/0000-0002-9069-3036	National Institutes of Health; Alzheimer Association; Department of Defense; American Health Assistance Foundation; Beeson Scientific; Japan Geriatrics Society; Wake Forest University; State of California Department of Human Services; National Institute on Aging [AG05407, AR35582, AG05394, AR35584, AR35583, R01 AG005407, R01 AG027576-22, 2 R01 AG005394-22A1, 2 R01 AG027574-22A1, AG026720, K24AG031155, AG08415]; NIA [1K01AG033195]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035583, R01AR035582, R01AR035584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008415, R01AG027576, R01AG005394, K01AG033195, R01AG026720, R01AG027574, K24AG031155, R01AG005407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Department of Defense(United States Department of Defense); American Health Assistance Foundation; Beeson Scientific; Japan Geriatrics Society; Wake Forest University; State of California Department of Human Services; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Yaffe reported that she is a consultant for Novartis Inc; serves on data and safety monitoring boards for Pfizer, Medivation, and the National Institute of Mental Health; is a board member for Beeson Scientific Advisory; has grants pending with the National Institutes of Health, the Alzheimer Association, the Department of Defense, and the American Health Assistance Foundation; and has received funding for expenses unrelated to the activites listed from the Alzheimer Association, the National Institutes of Health, Beeson Scientific, Japan Geriatrics Society, Wake Forest University, and the State of California Department of Human Services. Dr Laffan reported that she received salary support and was reimbursed for travel to professional society meetings from the National Institutes of Health. Dr Redline reported that her institution received a California Pacific Medical Center subcontract via a National Institutes of Health grant; she is a board member for the American Academy of Sleep Medicine; her institution has received an endowment for a professorship in sleep medicine from Dr Peter Farrell, CEO of RosMed Inc; and has multiple grants pending with the National Institutes of Health on sleep apnea. Dr Spira reported that he has received honoraria as a clinical editor for the International Journal of Sleep and Wakefulness-Primary Care, which receives pharmaceutical industry support. Dr Ancoli-Israel reported that she is a consultant for Johnson & Johnson, Merck, Purdue Pharma LP, sanofi-aventis, and Pfizer and has grants pending with the National Institutes of Health. No other disclosures were reported.; The Study of Osteoporotic Fractures is supported by funding from the National Institutes of Health. The National Institute on Aging provided support for this study under grants AG05407, AR35582, AG05394, AR35584, AR35583, R01 AG005407, R01 AG027576-22, 2 R01 AG005394-22A1, and 2 R01 AG027574-22A1, AG05407, AR35582, AG05394, AR35584, AR35583, AG026720. In addition, this study was supported by National Institute on Aging grant AG026720. Dr Yaffe is supported in part by National Institute on Aging grant K24AG031155. Dr Spira is supported by a Mentored Research Scientist Development Award (NIA 1K01AG033195). Dr Ancoli-Israel is supported by National Institute on Aging grant AG08415.	Aloia MS, 2004, J INT NEUROPSYCH SOC, V10, P772, DOI 10.1017/S1355617704105134; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ancoli-Israel S, 2008, J AM GERIATR SOC, V56, P2076, DOI 10.1111/j.1532-5415.2008.01934.x; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; ANCOLIISRAEL S, 1991, J AM GERIATR SOC, V39, P258, DOI 10.1111/j.1532-5415.1991.tb01647.x; Born J, 2011, PSYCHOL RES; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Cooke JR, 2009, J CLIN SLEEP MED, V5, P305; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Dealberto MJ, 1996, J AM GERIATR SOC, V44, P1287, DOI 10.1111/j.1532-5415.1996.tb01397.x; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Dematteis M, 2009, ILAR J, V50, P262, DOI 10.1093/ilar.50.3.262; Drager LF, 2010, BEST PRACT RES CL EN, V24, P843, DOI 10.1016/j.beem.2010.08.011; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Foley DJ, 2003, SLEEP, V26, P596, DOI 10.1093/sleep/26.5.596; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghegan MD, 2006, LARYNGOSCOPE, V116, P859, DOI 10.1097/01.mlg.0000214866.32050.2e; Iber C, 2004, SLEEP, V27, P536, DOI 10.1093/sleep/27.3.536; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Kingshott RN, 2000, J SLEEP RES, V9, P353, DOI 10.1046/j.1365-2869.2000.00223.x; McDowell I, 1997, J CLIN EPIDEMIOL, V50, P377, DOI 10.1016/S0895-4356(97)00060-7; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Quan SF, 2002, SLEEP, V25, P843; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Reitan RM, 1985, HALSTEAD REITAN NEUR; Row BW, 2007, ADV EXP MED BIOL, V618, P51; Sforza E, 2010, SLEEP, V33, P515, DOI 10.1093/sleep/33.4.515; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Spira AP, 2008, J AM GERIATR SOC, V56, P45, DOI 10.1111/j.1532-5415.2007.01506.x; Spreen O., 1991, PROFILE TEST RESULTS; Stepanski EJ, 2002, SLEEP, V25, P268, DOI 10.1093/sleep/25.3.268; SULLIVAN CE, 1981, LANCET, V1, P862; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Thomas RJ, 2007, SLEEP, V30, P1195, DOI 10.1093/sleep/30.9.1195; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; Wechsler D, 1988, WECHSLER ADULT INTEL; Weiss MD, 2009, SLEEP MED, V10, P739, DOI 10.1016/j.sleep.2008.07.013; Yaffe K, 2011, ARCH NEUROL-CHICAGO, V68, P631, DOI 10.1001/archneurol.2011.82; Young T, 2000, SLEEP, V23, pS122	43	669	692	3	84	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2011	306	6					613	619		10.1001/jama.2011.1115	http://dx.doi.org/10.1001/jama.2011.1115			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804XD	21828324	Green Accepted			2022-12-28	WOS:000293687300022
J	Zhang, MZ; Zhang, RP; He, MG; Liang, WL; Li, XF; She, LB; Yang, YL; MacKenzie, G; Silver, JD; Ellwein, L; Moore, B; Congdon, N				Zhang, Mingzhi; Zhang, Riping; He, Mingguang; Liang, Wanling; Li, Xiaofeng; She, Lingbing; Yang, Yunli; MacKenzie, Graeme; Silver, Joshua D.; Ellwein, Leon; Moore, Bruce; Congdon, Nathan			Self correction of refractive error among young people in rural China: results of cross sectional investigation	BRITISH MEDICAL JOURNAL			English	Article							LOW-RESOURCE COUNTRIES; VISUAL IMPAIRMENT; SCHOOL-CHILDREN; SECONDARY SCHOOLCHILDREN; SOUTHERN CHINA; X-PRES; POPULATION; TEACHERS; DISTRICT; STUDENTS	Objective To compare outcomes between adjustable spectacles and conventional methods for refraction in young people. Design Cross sectional study. Setting Rural southern China. Participants 648 young people aged 12-18 (mean 14.9 (SD 0.98)), with uncorrected visual acuity <= 6/12 in either eye. Interventions All participants underwent self refraction without cycloplegia (paralysis of near focusing ability with topical eye drops), automated refraction without cycloplegia, and subjective refraction by an ophthalmologist with cycloplegia. Main outcome measures Uncorrected and corrected vision, improvement of vision (lines on a chart), and refractive error. Results Among the participants, 59% (384) were girls, 44% (288) wore spectacles, and 61% (393/648) had 2.00 dioptres or more of myopia in the right eye. All completed self refraction. The proportion with visual acuity >= 6/7.5 in the better eye was 5.2% (95% confidence interval 3.6% to 6.9%) for uncorrected vision, 30.2% (25.7% to 34.8%) for currently worn spectacles, 96.9% (95.5% to 98.3%) for self refraction, 98.4% (97.4% to 99.5%) for automated refraction, and 99.1% (98.3% to 99.9%) for subjective refraction (P=0.033 for self refraction v automated refraction, P=0.001 for self refraction v subjective refraction). Improvements over uncorrected vision in the better eye with self refraction and subjective refraction were within one line on the eye chart in 98% of participants. In logistic regression models, failure to achieve maximum recorded visual acuity of 6/7.5 in right eyes with self refraction was associated with greater absolute value of myopia/hyperopia (P<0.001), greater astigmatism (P=0.001), and not having previously worn spectacles (P=0.002), but not age or sex. Significant inaccuracies in power (>= 1.00 dioptre) were less common in right eyes with self refraction than with automated refraction (5% v 11%, P<0.001). Conclusions Though visual acuity was slightly worse with self refraction than automated or subjective refraction, acuity was excellent in nearly all these young people with inadequately corrected refractive error at baseline. Inaccurate power was less common with self refraction than automated refraction. Self refraction could decrease the requirement for scarce trained personnel, expensive devices, and cycloplegia in children's vision programmes in rural China.	[He, Mingguang; Congdon, Nathan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab, Ophthalmol Grp, Guangzhou 510060, Guangdong, Peoples R China; [He, Mingguang; Congdon, Nathan] Sun Yat Sen Univ, Div Prevent Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Zhang, Mingzhi] Joint Shantou Int Eye Ctr, Refract Serv, Shantou, Peoples R China; [MacKenzie, Graeme] Adlens, Oxford OX2 8AH, England; [MacKenzie, Graeme] John Radcliffe Hosp, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England; [Silver, Joshua D.] Univ Oxford St Catherines Coll, Ctr Vis Dev World, Oxford OX1 3UJ, England; [Ellwein, Leon] NEI, Bethesda, MD 20892 USA; [Moore, Bruce] New England Coll Optometry, Boston, MA USA	Sun Yat Sen University; Sun Yat Sen University; University of Oxford; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Congdon, N (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab, Ophthalmol Grp, 54 Xianlie S Rd, Guangzhou 510060, Guangdong, Peoples R China.	ncongdon1@gmail.com	He, Mingguang/AAY-5239-2020	He, Mingguang/0000-0002-6912-2810	Imperial College of Science, Technology and Medicine under the World Bank	Imperial College of Science, Technology and Medicine under the World Bank	This study was funded by grant to the Nuffield Laboratory of Ophthalmology (University of Oxford) from the Partnership for Child Development, (Imperial College of Science, Technology and Medicine) under the World Bank's FY2009 Development Grant Facility (DGF) Window 1. The adjustable spectacles used in this study were provided free of charge by Adaptive Eyecare. The study sponsor played no role in study design and the collection, analysis, and interpretation of data and the writing of the article and the decision to submit it for publication.	*AM AC OPHTH, 2011, PREF PRACT PATT AMBL; BERGER IB, 1993, OPTOMETRY VISION SCI, V70, P332, DOI 10.1097/00006324-199304000-00013; Bourne RRA, 2004, INVEST OPHTH VIS SCI, V45, P410, DOI 10.1167/iovs.03-0129; Congdon N, 2008, ARCH OPHTHALMOL-CHIC, V126, P1717, DOI 10.1001/archopht.126.12.1717; Congdon N, 2008, INVEST OPHTH VIS SCI, V49, P2888, DOI 10.1167/iovs.07-1160; Dandona R, 2002, INVEST OPHTH VIS SCI, V43, P615; Donovan L, 2008, BRIT J OPHTHALMOL, V92, P294, DOI 10.1136/bjo.2007.121699; Douali MG, 2004, OPHTHAL PHYSL OPT, V24, P234, DOI 10.1111/j.1475-1313.2004.00198.x; Esteso P, 2007, INVEST OPHTH VIS SCI, V48, P4949, DOI 10.1167/iovs.07-0052; Fotedar R, 2007, AM J OPHTHALMOL, V144, P307, DOI 10.1016/j.ajo.2007.03.041; Gilbert C, 2007, EYE, V21, P1338, DOI 10.1038/sj.eye.6702841; Goh PP, 2005, OPHTHALMOLOGY, V112, P678, DOI 10.1016/j.ophtha.2004.10.048; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; He MG, 2011, OPHTHALMOLOGY, V118, P1162, DOI 10.1016/j.ophtha.2010.10.003; Holguin AMC, 2006, INVEST OPHTH VIS SCI, V47, P925, DOI 10.1167/iovs.05-0895; Leone JF, 2010, ARCH OPHTHALMOL-CHIC, V128, P894, DOI 10.1001/archophthalmol.2010.134; Li LP, 2010, ARCH OPHTHALMOL-CHIC, V128, P759, DOI 10.1001/archophthalmol.2010.73; Maul E, 2000, AM J OPHTHALMOL, V129, P445, DOI 10.1016/S0002-9394(99)00454-7; Murthy GVS, 2002, INVEST OPHTH VIS SCI, V43, P623; Naidoo KS, 2003, INVEST OPHTH VIS SCI, V44, P3764, DOI 10.1167/iovs.03-0283; Odedra N, 2008, OPHTHAL EPIDEMIOL, V15, P410, DOI 10.1080/09286580802399094; Pokharel GP, 2000, AM J OPHTHALMOL, V129, P436, DOI 10.1016/S0002-9394(99)00453-5; Ramke J, 2008, CLIN EXP OPHTHALMOL, V36, P339, DOI 10.1111/j.1442-9071.2008.01768.x; RENGSTORFF RH, 1982, AM J OPTOM PHYS OPT, V59, P162; Sharma A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1434, DOI 10.1001/archopht.126.10.1434; Smith K, 2010, OPTOMETRY VISION SCI, V87, pE176, DOI 10.1097/OPX.0b013e3181cf86d6; *UN ED SCI CULT OR, ED ALL PROGR; World Health Organization, 2011, GLOB SCH HLTH IN; World Health Organization, 2000, EL AV VIS DIS DUE RE; Zeng YF, 2009, OPHTHALMOLOGY, V116, P1839, DOI 10.1016/j.ophtha.2009.04.004; Zhang MZ, 2009, INVEST OPHTH VIS SCI, V50, P2011, DOI 10.1167/iovs.08-2849; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	33	19	22	0	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2011	343								d4767	10.1136/bmj.d4767	http://dx.doi.org/10.1136/bmj.d4767			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808CX	21828207	hybrid, Green Published			2022-12-28	WOS:000293954000001
J	Sorger, VJ; Zhang, X				Sorger, Volker J.; Zhang, Xiang			Spotlight on Plasmon Lasers	SCIENCE			English	Editorial Material									[Sorger, Volker J.; Zhang, Xiang] Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA	National Science Foundation (NSF); University of California System; University of California Berkeley	Sorger, VJ (corresponding author), Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr, 3112 Etcheverry Hall, Berkeley, CA 94720 USA.	xiang@berkeley.edu	Zhang, Xiang/F-6905-2011	Zhang, Xiang/0000-0002-3272-894X	Div Of Civil, Mechanical, & Manufact Inn [0751621] Funding Source: National Science Foundation	Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Bergman DJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.027402; BJORK G, 1991, IEEE J QUANTUM ELECT, V27, P2386, DOI 10.1109/3.100877; Genov DA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245312; Hill MT, 2007, NAT PHOTONICS, V1, P589, DOI 10.1038/nphoton.2007.171; Hill MT, 2009, OPT EXPRESS, V17, P11107, DOI 10.1364/OE.17.011107; Ma RM, 2011, NAT MATER, V10, P110, DOI 10.1038/nmat2919; Nezhad MP, 2010, NAT PHOTONICS, V4, P395, DOI 10.1038/NPHOTON.2010.88; Noginov MA, 2009, NATURE, V460, P1110, DOI 10.1038/nature08318; Oulton RF, 2008, NAT PHOTONICS, V2, P496, DOI 10.1038/nphoton.2008.131; Oulton RF, 2009, NATURE, V461, P629, DOI 10.1038/nature08364; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; PURCELL EM, 1946, PHYS REV, V69, P681; Sorger VJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1315; Stockman MI, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/2/024004; Yu K, 2010, OPT EXPRESS, V18, P8790, DOI 10.1364/OE.18.008790	15	84	84	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					709	710		10.1126/science.1204862	http://dx.doi.org/10.1126/science.1204862			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817040				2022-12-28	WOS:000293512100029
J	Sheehan, SR; Montgomery, AA; Carey, M; McAuliffe, FM; Eogan, M; Gleeson, R; Geary, M; Murphy, DJ				Sheehan, Sharon R.; Montgomery, Alan A.; Carey, Michael; McAuliffe, Fionnuala M.; Eogan, Maeve; Gleeson, Ronan; Geary, Michael; Murphy, Deirdre J.		ECSSIT Study Grp	Oxytocin bolus versus oxytocin bolus and infusion for control of blood loss at elective caesarean section: double blind, placebo controlled, randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTPARTUM HEMORRHAGE; INTRAVENOUS OXYTOCIN; ACTIVE MANAGEMENT; UTERINE ATONY; DELIVERY; MISOPROSTOL; PREVENTION; CARBETOCIN; RISK	Objectives To determine the effects of adding an oxytocin infusion to bolus oxytocin on blood loss at elective caesarean section. Design Double blind, placebo controlled, randomised trial, conducted from February 2008 to June 2010. Setting Five maternity hospitals in the Republic of Ireland. Participants 2069 women booked for elective caesarean section at term with a singleton pregnancy. We excluded women with placenta praevia, thrombocytopenia, coagulopathies, previous major obstetric haemorrhage (>1000 mL), or known fibroids; women receiving anticoagulant treatment; those who did not understand English; and those who were younger than 18 years. Intervention Intervention group: intravenous slow 5 IU oxytocin bolus over 1 minute and additional 40 IU oxytocin infusion in 500 mL of 0.9% saline solution over 4 hours (bolus and infusion). Placebo group: 5 IU oxytocin bolus over 1 minute and 500 mL of 0.9% saline solution over 4 hours (placebo infusion) (bolus only). Main outcomes Major obstetric haemorrhage (blood loss >1000 mL) and need for an additional uterotonic agent. Results We found no difference in the occurrence of major obstetric haemorrhage between the groups (bolus and infusion 15.7% (158/1007) v bolus only 16.0% (159/994), adjusted odds ratio 0.98, 95% confidence intervals 0.77 to 1.25, P=0.86). The need for an additional uterotonic agent in the bolus and infusion group was lower than that in the bolus only group (12.2% (126/1033) v 18.4% (189/1025), 0.61, 0.48 to 0.78, P<0.001). Women were less likely to have a major obstetric haemorrhage in the bolus and infusion group than in the bolus only group if the obstetrician was junior rather than senior (0.57, 0.35 to 0.92, P=0.02). Conclusion The addition of an oxytocin infusion after caesarean delivery reduces the need for additional uterotonic agents but does not affect the overall occurrence of major obstetric haemorrhage.	[Sheehan, Sharon R.; Murphy, Deirdre J.] Coombe Women & Infants Univ Hosp, Trinity Coll Dublin, Acad Dept Obstet & Gynaecol, Dublin 8, Ireland; [Montgomery, Alan A.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [McAuliffe, Fionnuala M.] Natl Matern Hosp, Univ Coll Dublin, Dept Obstet & Gynaecol, Dublin 2, Ireland; [Eogan, Maeve; Gleeson, Ronan; Geary, Michael] Rotunda Hosp, Dublin, Ireland	Trinity College Dublin; University of Bristol; National Maternity Hospital, Dublin; University College Dublin	Sheehan, SR (corresponding author), Coombe Women & Infants Univ Hosp, Trinity Coll Dublin, Acad Dept Obstet & Gynaecol, Dublin 8, Ireland.	sharonrsheehan@gmail.com		Murphy, Deirdre/0000-0001-6074-6718; Montgomery, Alan/0000-0003-0450-1606	Health Research Board of Ireland [RP/2007/171]; Coombe Women; Infants University Hospital, Dublin; MRC [G0800800] Funding Source: UKRI; Medical Research Council [G0800800] Funding Source: researchfish	Health Research Board of Ireland; Coombe Women; Infants University Hospital, Dublin; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The trial was funded by the Health Research Board of Ireland (RP/2007/171), with additional financial support from the Coombe Women and Infants University Hospital, Dublin. None of the funding sources had a role in the trial design, writing of the report, or the decision to submit the paper for publication.	Acharya G, 2001, ACTA OBSTET GYN SCAN, V80, P245, DOI 10.1034/j.1600-0412.2001.080003245.x; ACOG, 2006, OBSTET GYNECOL, V108, P1039; Attilakos G, 2010, BJOG-INT J OBSTET GY, V117, P929, DOI 10.1111/j.1471-0528.2010.02585.x; Begley CM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007412.pub2; Bose P, 2006, BJOG-INT J OBSTET GY, V113, P919, DOI 10.1111/j.1471-0528.2006.01018.x; Boucher M, 1998, J Perinatol, V18, P202; Cai WW, 1998, AM J PUBLIC HEALTH, V88, P777, DOI 10.2105/AJPH.88.5.777; Carvalho JCA, 2004, OBSTET GYNECOL, V104, P1005, DOI 10.1097/01.AOG.0000142709.04450.bd; CHOU MM, 1994, AM J OBSTET GYNECOL, V171, P1356, DOI 10.1016/0002-9378(94)90160-0; COMBS CA, 1991, OBSTET GYNECOL, V77, P77; COTTER A, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001808, DOI 10.1002/14651858.CD001808]; Dansereau J, 1999, AM J OBSTET GYNECOL, V180, P670, DOI 10.1016/S0002-9378(99)70271-1; Eftekhari N, 2009, J OBSTET GYNAECOL, V29, P633, DOI 10.1080/01443610903061744; Elbourn DR., 2001, COCHRANE DB SYST REV, V4; GILSTRAP LC, 1987, OBSTET GYNECOL, V69, P328; Gungorduk K, 2010, AUST NZ J OBSTET GYN, V50, P36, DOI 10.1111/j.1479-828X.2009.01106.x; Hamilton BE, 2010, NATL VITAL STAT REP, V58, P24; King KJ, 2010, ANESTH ANALG, V111, P1460, DOI 10.1213/ANE.0b013e3181f8930a; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Kolas T, 2010, ACTA OBSTET GYN SCAN, V89, P658, DOI 10.3109/00016341003605727; Leduc D, 2009, J OBSTET GYNAECOL CA, V31, P980, DOI 10.1016/S1701-2163(16)34329-8; Lewis G., 2007, 7 CONFIDENTIAL ENQUI; Lokugamage AU, 2001, AUST NZ J OBSTET GYN, V41, P411, DOI 10.1111/j.1479-828X.2001.tb01319.x; Magann EF, 2005, SOUTH MED J, V98, P681, DOI 10.1097/01.SMJ.0000163309.53317.B8; Mockler JC, 2010, AUST NZ J OBSTET GYN, V50, P30, DOI 10.1111/j.1479-828X.2009.01108.x; Munn MB, 2001, OBSTET GYNECOL, V98, P386, DOI 10.1016/S0029-7844(01)01479-X; Murphy DJ, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-36; Murphy DJ, 2009, EUR J OBSTET GYN R B, V142, P30, DOI 10.1016/j.ejogrb.2008.09.004; National Collaborating Centre for Women's and Children's Health, 2004, CAES SECT CLIN GUID; Sheehan SR, 2010, EUR J OBSTET GYN R B, V148, P121, DOI 10.1016/j.ejogrb.2009.10.004; Shook PR, 2003, ANESTHESIOLOGY, V98, P1; Thomas J, 2001, NATL SENTINEL CAESAR; Wedisinghe L, 2008, EUR J OBSTET GYN R B, V137, P27, DOI 10.1016/j.ejogrb.2007.04.007	33	49	52	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 1	2011	343								d4661	10.1136/bmj.d4661	http://dx.doi.org/10.1136/bmj.d4661			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NK	21807773	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000293734400002
J	Hannedouche, S; Zhang, J; Yi, TS; Shen, WJ; Nguyen, D; Pereira, JP; Guerini, D; Baumgarten, BU; Roggo, S; Wen, B; Knochenmuss, R; Noel, S; Gessier, F; Kelly, LM; Vanek, M; Laurent, S; Preuss, I; Miault, C; Christen, I; Karuna, R; Li, W; Koo, DI; Suply, T; Schmedt, C; Peters, EC; Falchetto, R; Katopodis, A; Spanka, C; Roy, MO; Detheux, M; Chen, YA; Schultz, PG; Cho, CY; Seuwen, K; Cyster, JG; Sailer, AW				Hannedouche, Sebastien; Zhang, Juan; Yi, Tangsheng; Shen, Weijun; Nguyen, Deborah; Pereira, Joao P.; Guerini, Danilo; Baumgarten, Birgit U.; Roggo, Silvio; Wen, Ben; Knochenmuss, Richard; Noel, Sophie; Gessier, Francois; Kelly, Lisa M.; Vanek, Mirka; Laurent, Stephane; Preuss, Inga; Miault, Charlotte; Christen, Isabelle; Karuna, Ratna; Li, Wei; Koo, Dong-In; Suply, Thomas; Schmedt, Christian; Peters, Eric C.; Falchetto, Rocco; Katopodis, Andreas; Spanka, Carsten; Roy, Marie-Odile; Detheux, Michel; Chen, Yu Alice; Schultz, Peter G.; Cho, Charles Y.; Seuwen, Klaus; Cyster, Jason G.; Sailer, Andreas W.			Oxysterols direct immune cell migration via EBI2	NATURE			English	Article							DENDRITIC CELLS; CHOLESTEROL; EXPRESSION; MACROPHAGES; ENZYMES	Epstein-Barr virus-induced gene 2 (EBI2, also known as GPR183) is a G-protein-coupled receptor that is required for humoral immune responses; polymorphisms in the receptor have been associated with inflammatory autoimmune diseases(1-3). The natural ligand for EBI2 has been unknown. Here we describe the identification of 7 alpha,25-dihydroxycholesterol (also called 7 alpha,25-OHC or 5-cholesten-3 beta,7 alpha,25-triol) as a potent and selective agonist of EBI2. Functional activation of human EBI2 by 7 alpha,25-OHC and closely related oxysterols was verified by monitoring second messenger readouts and saturable, high-affinity radioligand binding. Furthermore, we find that 7 alpha,25-OHC and closely related oxysterols act as chemoattractants for immune cells expressing EBI2 by directing cell migration in vitro and in vivo. A critical enzyme required for the generation of 7 alpha,25-OHC is cholesterol 25-hydroxylase (CH25H)(4). Similar to EBI2 receptor knockout mice, mice deficient in CH25H fail to position activated B cells within the spleen to the outer follicle and mount a reduced plasma cell response after an immune challenge. This demonstrates that CH25H generates EBI2 biological activity in vivo and indicates that the EBI2-oxysterol signalling pathway has an important role in the adaptive immune response.	[Zhang, Juan; Guerini, Danilo; Baumgarten, Birgit U.; Roggo, Silvio; Knochenmuss, Richard; Gessier, Francois; Vanek, Mirka; Laurent, Stephane; Preuss, Inga; Miault, Charlotte; Christen, Isabelle; Karuna, Ratna; Suply, Thomas; Falchetto, Rocco; Katopodis, Andreas; Spanka, Carsten; Seuwen, Klaus; Sailer, Andreas W.] Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Hannedouche, Sebastien; Noel, Sophie; Roy, Marie-Odile; Detheux, Michel] Euroscreen SA, B-6041 Gosselies, Belgium; [Yi, Tangsheng; Pereira, Joao P.; Kelly, Lisa M.; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Yi, Tangsheng; Pereira, Joao P.; Kelly, Lisa M.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Shen, Weijun; Nguyen, Deborah; Wen, Ben; Li, Wei; Schmedt, Christian; Peters, Eric C.; Chen, Yu Alice; Schultz, Peter G.; Cho, Charles Y.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Shen, Weijun; Koo, Dong-In] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Novartis; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Novartis; Scripps Research Institute	Sailer, AW (corresponding author), Novartis Inst BioMed Res, CH-4056 Basel, Switzerland.	andreas.sailer@novartis.com	Karuna, Ratna/F-3653-2011; kelly, Lisa/GWU-9804-2022; yi, tangsheng/E-5014-2011; Peters, Eric/W-2739-2019; Sailer, Andreas/M-9913-2016	Shen, Weijun/0000-0001-8388-729X; Sailer, Andreas/0000-0002-9015-7946; Karuna, Ratna/0000-0003-0508-2490; Pereira, Joao/0000-0002-5694-4938; Nguyen, Deborah/0000-0002-1694-0617; Hannedouche, Sebastien/0000-0001-5909-242X	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI040098] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040098] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200; Dulos J, 2005, ARTHRITIS RHEUM-US, V52, P770, DOI 10.1002/art.20950; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; GAUWERKY CE, 1988, ONCOGENE, V2, P431; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Honda A, 2011, J LIPID RES, V52, P1509, DOI 10.1194/jlr.M014084; Lathe R, 2002, STEROIDS, V67, P967, DOI 10.1016/S0039-128X(02)00044-2; Li DS, 2000, STEROIDS, V65, P529, DOI 10.1016/S0039-128X(00)00131-8; Li XB, 2007, J LIPID RES, V48, P2587, DOI 10.1194/jlr.M700301-JLR200; LIU C, 2011, NATURE, DOI DOI 10.1038/10226; LUND E, 1993, BIOCHIM BIOPHYS ACTA, V1166, P177, DOI 10.1016/0005-2760(93)90094-P; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; REED JC, 1993, LEUKEMIA LYMPHOMA, V10, P157, DOI 10.3109/10428199309145877; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Wang JH, 2006, BIOCHEM BIOPH RES CO, V345, P720, DOI 10.1016/j.bbrc.2006.04.156	21	306	316	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					524	527		10.1038/nature10280	http://dx.doi.org/10.1038/nature10280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796212	Green Accepted			2022-12-28	WOS:000293167900046
J	Lypka, M; Hammoudeh, J				Lypka, Michael; Hammoudeh, Jeffrey			Tongue Mucocele	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lypka, Michael] Univ Texas Med Sch Houston, Houston, TX 77030 USA; [Hammoudeh, Jeffrey] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	University of Texas System; University of Texas Health Science Center Houston; Children's Hospital Los Angeles	Lypka, M (corresponding author), Univ Texas Med Sch Houston, Houston, TX 77030 USA.	michael.a.lypka@uth.tmc.edu							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					E9	E9		10.1056/NEJMicm1013092	http://dx.doi.org/10.1056/NEJMicm1013092			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21793741				2022-12-28	WOS:000293172200015
J	Shi, BY; Chen, LP				Shi, Bing-Yi; Chen, Li-Ping			Regulation of Organ Transplantation in China Difficult Exploration and Slow Advance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Shi, Bing-Yi] Chinese Peoples Liberat Army, Ctr Data, Organ Transplant Ctr, Chinese Sci Registry Kidney Transplantat,Hosp 309, Beijing, Peoples R China		Shi, BY (corresponding author), Chinese Peoples Liberat Army, Ctr Data, Organ Transplant Ctr, Chinese Sci Registry Kidney Transplantat,Hosp 309, 17 Heishanhu Rd, Beijing, Peoples R China.	paradiselily@163.com						Abbud M, 2008, LANCET, V372, P5, DOI 10.1016/S0140-6736(08)60967-8; Chinese Ministry of Health, 2008, REG HUM ORG TRANSPL; Chinese Ministry of Health, NO DIST RESTR WAS SE; Danovitch GM, 2011, AM J TRANSPLANT, V11, P426, DOI 10.1111/j.1600-6143.2010.03417.x; Huang JF, 2008, LANCET, V372, P1937, DOI 10.1016/S0140-6736(08)61359-8; Liu YF, 2010, CHIN J ORGAN TRANSPL, V31, P436	6	14	15	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					434	435		10.1001/jama.2011.1067	http://dx.doi.org/10.1001/jama.2011.1067			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797KL	21791694				2022-12-28	WOS:000293125800032
J	Sterne, JAC; Sutton, AJ; Ioannidis, JPA; Terrin, N; Jones, DR; Lau, J; Carpenter, J; Rucker, G; Harbord, RM; Schmid, CH; Tetzlaff, J; Deeks, JJ; Peters, J; Macaskill, P; Schwarzer, G; Duval, S; Altman, DG; Moher, D; Higgins, JPT				Sterne, Jonathan A. C.; Sutton, Alex J.; Ioannidis, John P. A.; Terrin, Norma; Jones, David R.; Lau, Joseph; Carpenter, James; Ruecker, Gerta; Harbord, Roger M.; Schmid, Christopher H.; Tetzlaff, Jennifer; Deeks, Jonathan J.; Peters, Jaime; Macaskill, Petra; Schwarzer, Guido; Duval, Sue; Altman, Douglas G.; Moher, David; Higgins, Julian P. T.			Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Funnel plots, and tests for funnel plot asymmetry, have been widely used to examine bias in the results of meta-analyses. Funnel plot asymmetry should not be equated with publication bias, because it has a number of other possible causes. This article describes how to interpret funnel plot asymmetry, recommends appropriate tests, and explains the implications for choice of meta-analysis model.	[Sterne, Jonathan A. C.; Harbord, Roger M.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Sutton, Alex J.; Jones, David R.] Univ Leicester, Dept Hlth Sc, Leicester LE1 7RH, Leics, England; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Terrin, Norma; Lau, Joseph; Schmid, Christopher H.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Carpenter, James] London Sch Hyg & Trop Med, Med Stat Unit, London, England; [Ruecker, Gerta; Schwarzer, Guido] Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, Freiburg, Germany; [Tetzlaff, Jennifer; Moher, David] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Deeks, Jonathan J.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Peters, Jaime] Univ Exeter, Peninsula Med Sch, Exeter EX4 4QJ, Devon, England; [Macaskill, Petra] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Duval, Sue] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN 55455 USA; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Higgins, Julian P. T.] MRC Biostat Unit, Cambridge, England	University of Bristol; University of Leicester; Stanford University; Tufts Medical Center; University of London; London School of Hygiene & Tropical Medicine; University of Freiburg; University of Ottawa; Ottawa Hospital Research Institute; University of Birmingham; University of Exeter; University of Sydney; University of Minnesota System; University of Minnesota Twin Cities; University of Oxford; MRC Biostatistics Unit	Sterne, JAC (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England.	jonathan.sterne@bristol.ac.uk	Rücker, Gerta/B-2965-2009; Ioannidis, John P. A./G-9836-2011; Moher, David/I-3408-2019; Schwarzer, Guido/A-8168-2009; Sterne, Jonathan/Z-3106-2019; Harbord, Roger M/A-8699-2008; Duval, Susan/AAI-1874-2020; Schmid, Christopher H./J-2398-2014; Higgins, Julian PT/H-4008-2011; Deeks, Jon/AAV-5745-2020	Rücker, Gerta/0000-0002-2192-2560; Moher, David/0000-0003-2434-4206; Schwarzer, Guido/0000-0001-6214-9087; Sterne, Jonathan/0000-0001-8496-6053; Harbord, Roger M/0000-0002-2257-8271; Schmid, Christopher H./0000-0002-0855-5313; Higgins, Julian PT/0000-0002-8323-2514; Deeks, Jon/0000-0002-8850-1971; Sutton, Alexander/0000-0002-8934-9940; Macaskill, Petra/0000-0001-5879-6193; Carpenter, James/0000-0003-3890-6206; Duval, Sue/0000-0003-1025-8665	Cochrane Collaboration Bias Methods Group; Canadian Institutes of Health Research (CIHR); Canadian Agency for Drugs and Technologies in Health (CADTH); MRC [U.1052.00.011]; Cancer Research UK; Deutsche Forschungsgemeinschaft [534 Schw 821/2-2]; MRC [G0800800, MC_U105285807, G0800808] Funding Source: UKRI; Medical Research Council [G0800808, G0800800, UD99999927, MC_U105285807] Funding Source: researchfish	Cochrane Collaboration Bias Methods Group; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Agency for Drugs and Technologies in Health (CADTH); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded in part by the Cochrane Collaboration Bias Methods Group, which receives infrastructure funding as part of a commitment by the Canadian Institutes of Health Research (CIHR) and the Canadian Agency for Drugs and Technologies in Health (CADTH) to fund Canadian based Cochrane entities. This supports dissemination activities, web hosting, travel, training, workshops and a full time coordinator position. JPTH was funded by MRC Grant U.1052.00.011. DGA is supported by Cancer Research UK. GR was supported by a grant from Deutsche Forschungsgemeinschaft (FOR 534 Schw 821/2-2).	[Anonymous], 2008, COCHRANE HDB SYSTEMA; Antman E, 2002, LANCET, V360, P1189, DOI 10.1016/S0140-6736(02)11278-5; BEGG CB, 1988, J ROY STAT SOC A STA, V151, P419, DOI 10.2307/2982993; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Egger M, 1998, BRIT MED J, V316, P140; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2003, Health Technol Assess, V7, P1; EGGER M, 1995, BMJ-BRIT MED J, V310, P752, DOI 10.1136/bmj.310.6982.752; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Hopewell S, 2009, COCHRANE DATABASE SY, V1; Hopewell S.McDonald, 2007, COCHRANE DATABASE SY, V2; Ioannidis JPA, 2008, J EVAL CLIN PRACT, V14, P951, DOI 10.1111/j.1365-2753.2008.00986.x; Ioannidis John P A, 2008, Philos Ethics Humanit Med, V3, P14, DOI 10.1186/1747-5341-3-14; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; * ISIS 4, 1995, LANCET, V345, P669; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Peters JL, 2010, J R STAT SOC A STAT, V173, P575, DOI 10.1111/j.1467-985X.2009.00629.x; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Poole C, 1999, AM J EPIDEMIOL, V150, P469, DOI 10.1093/oxfordjournals.aje.a010035; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rucker G, 2008, STAT MED, V27, P746, DOI 10.1002/sim.2971; Rucker G, 2011, BIOSTATISTICS, V12, P122, DOI 10.1093/biostatistics/kxq046; Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2; SMITH GD, 1994, BMJ-BRIT MED J, V308, P72, DOI 10.1136/bmj.308.6921.72; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; TEO KK, 1991, BMJ-BRIT MED J, V303, P1499, DOI 10.1136/bmj.303.6816.1499; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	41	3411	3433	8	59	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2011	343								d4002	10.1136/bmj.d4002	http://dx.doi.org/10.1136/bmj.d4002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797ZK	21784880	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000293169000008
J	Qian, L; Winfree, E; Bruck, J				Qian, Lulu; Winfree, Erik; Bruck, Jehoshua			Neural network computation with DNA strand displacement cascades	NATURE			English	Article							ASSOCIATIVE MEMORY; CHEMICAL-KINETICS; CIRCUITS; LOGIC; DEPTH	The impressive capabilities of the mammalian brain-ranging from perception, pattern recognition and memory formation to decision making and motor activity control-have inspired their re-creation in a wide range of artificial intelligence systems for applications such as face recognition, anomaly detection, medical diagnosis and robotic vehicle control(1). Yet before neuron-based brains evolved, complex biomolecular circuits provided individual cells with the 'intelligent' behaviour required for survival(2). However, the study of how molecules can 'think' has not produced an equal variety of computational models and applications of artificial chemical systems. Although biomolecular systems have been hypothesized to carry out neural-network-like computations in vivo(3,2,4) and the synthesis of artificial chemical analogues has been proposed theoretically(5-9), experimental work(10-13) has so far fallen short of fully implementing even a single neuron. Here, building on the richness of DNA computing(14) and strand displacement circuitry(15), we show how molecular systems can exhibit autonomous brain-like behaviours. Using a simple DNA gate architecture(16) that allows experimental scale-up of multilayer digital circuits(17), we systematically transform arbitrary linear threshold circuits(18) (an artificial neural network model) into DNA strand displacement cascades that function as small neural networks. Our approach even allows us to implement a Hopfield associative memory(19) with four fully connected artificial neurons that, after training in silico, remembers four single-stranded DNA patterns and recalls the most similar one when presented with an incomplete pattern. Our results suggest that DNA strand displacement cascades could be used to endow autonomous chemical systems with the capability of recognizing patterns of molecular events, making decisions and responding to the environment.	[Qian, Lulu; Winfree, Erik; Bruck, Jehoshua] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Winfree, E (corresponding author), CALTECH, Pasadena, CA 91125 USA.	winfree@caltech.edu	Winfree, Erik/L-4002-2013	Winfree, Erik/0000-0002-5899-7523; Bruck, Jehoshua/0000-0001-8474-0812	NSF [0728703, 0832824]; HFSP award [RGY0074/2006-C]	NSF(National Science Foundation (NSF)); HFSP award	We thank P. Rothemund, P. Yin, D. Woods, D. Soloveichik and N. Dabby for comments on the manuscript. We also thank R. Murray for the use of experimental facilities. This work was supported by the NSF (grant nos 0728703 and 0832824 (The Molecular Programming Project)) and by HFSP award no. RGY0074/2006-C.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; AMARI S, 1989, NEURAL NETWORKS, V2, P451, DOI 10.1016/0893-6080(89)90043-9; BAUM EB, 1995, SCIENCE, V268, P583, DOI 10.1126/science.7725109; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Fernando CT, 2009, J R SOC INTERFACE, V6, P463, DOI 10.1098/rsif.2008.0344; HAJNAL A, 1993, J COMPUT SYST SCI, V46, P129, DOI 10.1016/0022-0000(93)90001-D; HJELMFELT A, 1991, P NATL ACAD SCI USA, V88, P10983, DOI 10.1073/pnas.88.24.10983; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kautz W, 1961, IRE T ELECT COMPUTER, VEC-10, P371; Kim J., 2005, ADV NEURAL INFORM PR, V17, P681; Kim J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.119; LAPLANTE JP, 1995, J PHYS CHEM-US, V99, P10063, DOI 10.1021/j100025a001; Lederman H, 2006, BIOCHEMISTRY-US, V45, P1194, DOI 10.1021/bi051871u; Lim HW, 2010, BIOSYSTEMS, V100, P1, DOI 10.1016/j.biosystems.2009.12.001; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Mills A. P.  Jr, 2001, Soft Computing, V5, P10, DOI 10.1007/s005000000061; Mills AP, 1999, BIOSYSTEMS, V52, P175, DOI 10.1016/S0303-2647(99)00044-1; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; Muller D. E., 1963, SWITCHING THEORY SPA, P289; MUROGA S, 1971, THRESHOLD LOGIC ITS, V18; Pei RJ, 2010, NAT NANOTECHNOL, V5, P773, DOI [10.1038/nnano.2010.194, 10.1038/NNANO.2010.194]; Qian L, 2011, J R SOC INTERFACE, V8, P1281, DOI 10.1098/rsif.2010.0729; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rojas R., 1996, NEURAL NETWORKS SYST, DOI [10.1007/978-3-642-61068-4{\_}7, DOI 10.1007/978-3-642-61068-4]; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Simmel FC, 2007, NANOMEDICINE-UK, V2, P817, DOI 10.2217/17435889.2.6.817; Soloveichik D, 2010, P NATL ACAD SCI USA, V107, P5393, DOI 10.1073/pnas.0909380107; WEGENER I, 1991, THEOR COMPUT SCI, V85, P155, DOI 10.1016/0304-3975(91)90052-4; Zhang DY, 2011, LECT NOTES COMPUT SC, V6518, P176, DOI 10.1007/978-3-642-18305-8_16; Zhang DY, 2011, NAT CHEM, V3, P103, DOI 10.1038/NCHEM.957	31	639	674	18	605	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					368	372		10.1038/nature10262	http://dx.doi.org/10.1038/nature10262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21776082				2022-12-28	WOS:000292911200040
J	Abdi, Z				Abdi, Zeinab			Profile Mohammed Keshtgar-a pioneering surgical oncologist	LANCET			English	Biographical-Item																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2011	378	9789					393	393		10.1016/S0140-6736(11)61199-9	http://dx.doi.org/10.1016/S0140-6736(11)61199-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XM	21803195				2022-12-28	WOS:000293615900016
J	Wen, CP; Wai, JPM; Tsai, MK; Yang, YC; Cheng, TYD; Lee, MC; Chan, HT; Tsao, CK; Tsai, SP; Wu, XF				Wen, Chi Pang; Wai, Jackson Pui Man; Tsai, Min Kuang; Yang, Yi Chen; Cheng, Ting Yuan David; Lee, Meng-Chih; Chan, Hui Ting; Tsao, Chwen Keng; Tsai, Shan Pou; Wu, Xifeng			Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study	LANCET			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; DOSE-RESPONSE; RISK; EXERCISE; WALKING; ADULTS; HEALTH; WOMEN; PREVALENCE	Background The health benefits of leisure-time physical activity are well known, but whether less exercise than the recommended 150 min a week can have life expectancy benefits is unclear. We assessed the health benefits of a range of volumes of physical activity in a Taiwanese population. Methods In this prospective cohort study, 416 175 individuals (199 265 men and 216 910 women) participated in a standard medical screening programme in Taiwan between 1996 and 2008, with an average follow-up of 8.05 years (SD 4.21). On the basis of the amount of weekly exercise indicated in a self-administered questionnaire, participants were placed into one of five categories of exercise volumes: inactive, or low, medium, high, or very high activity. We calculated hazard ratios (HR) for mortality risks for every group compared with the inactive group, and calculated life expectancy for every group. Findings Compared with individuals in the inactive group, those in the low-volume activity group, who exercised for an average of 92 min per week (95% CI 71-112) or 15 min a day (SD 1.8), had a 14% reduced risk of all-cause mortality (0.86, 0.81-0.91), and had a 3 year longer life expectancy. Every additional 15 min of daily exercise beyond the minimum amount of 15 min a day further reduced all-cause mortality by 4% (95% CI 2.5-7.0) and all-cancer mortality by 1% (0.3-4.5). These benefits were applicable to all age groups and both sexes, and to those with cardiovascular disease risks. Individuals who were inactive had a 17% (HR 1.17, 95% CI 1.10-1.24) increased risk of mortality compared with individuals in the low-volume group. Interpretation 15 min a day or 90 min a week of moderate-intensity exercise might be of benefit, even for individuals at risk of cardiovascular disease.	[Wen, Chi Pang; Tsai, Min Kuang; Yang, Yi Chen; Chan, Hui Ting] Natl Hlth Res Inst, Inst Populat Sci, 35 Keyan Rd, Zhunan 350, Miaoli County, Taiwan; [Wen, Chi Pang; Tsai, Min Kuang; Yang, Yi Chen] China Med Univ Hosp, Taichung, Taiwan; [Wai, Jackson Pui Man] Natl Taiwan Sport Univ, Inst Sport Sci, Lab Exercise Physiol Res, Tao Yuan, Taiwan; [Cheng, Ting Yuan David] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Lee, Meng-Chih] Chung Shan Med Univ & Hosp, Inst Med, Taichung, Taiwan; [Lee, Meng-Chih] Chung Shan Med Univ & Hosp, Dept Family & Community Med, Taichung, Taiwan; [Tsao, Chwen Keng] MJ Hlth Management Inst, Taipei, Taiwan; [Tsai, Shan Pou] Univ Texas Sch Publ Hlth, Houston, TX USA; [Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Washington; University of Washington Seattle; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; UTMD Anderson Cancer Center	Wen, CP (corresponding author), Natl Hlth Res Inst, Inst Populat Sci, 35 Keyan Rd, Zhunan 350, Miaoli County, Taiwan.	cwengood@nhri.org.tw	Weaver, Marissa/C-4027-2012; Yang, yichen/AAB-5601-2022; Hug, Balthasar L./G-1568-2010		Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH 100-TD-B-111-004]; National Health Research Institutes	Taiwan Department of Health Clinical Trial and Research Center of Excellence; National Health Research Institutes(National Health Research Institutes, Japan)	Taiwan Department of Health Clinical Trial and Research Center of Excellence and National Health Research Institutes.r We thank MJ Health Management Institution for making their large dataset available to us. We thank Nelson Wen for his help in revising the English in this manuscript. This study was supported by Taiwan Department of Health Clinical Trial and Research Centre of Excellence (DOH 100-TD-B-111-004) and the institutional support from National Health Research Institutes.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; American College of Sports Medicine, 2000, ACSMS GUID EX TEST P; American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Bijnen FCH, 1998, ARCH INTERN MED, V158, P1499, DOI 10.1001/archinte.158.14.1499; Boecker H, 2008, CEREB CORTEX, V18, P2523, DOI 10.1093/cercor/bhn013; Carlson SA, 2009, J PHYS ACT HEALTH, V6, pS18, DOI 10.1123/jpah.6.s1.s18; Carlsson S, 2006, SCAND J PUBLIC HEALT, V34, P480, DOI 10.1080/14034940600551293; Cerin E., 2009, MENTAL HLTH PHYS ACT, V2, P55, DOI [10.1016/j.mhpa.2009.09.004, DOI 10.1016/J.MHPA.2009.09.004]; Chiang CL, 1984, LIFE TABLE ITS APPL; Department of Health Executive Yuan Taiwan, NAT DEATH FIL NAT CA; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foundation for Promotion of Cancer Research (FPCR), 2008, CANC STAT JAP 2010; Friedenreich CM, 2002, J NUTR, V132, p3456S, DOI 10.1093/jn/132.11.3456S; Global Advocacy for Physical Activity, TOR CHART PHYS ACT G; Gregg EW, 2003, ARCH INTERN MED, V163, P1440, DOI 10.1001/archinte.163.12.1440; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Kruger J., 2005, Morbidity and Mortality Weekly Report, V54, P991; Ku PW, 2006, PREV MED, V43, P454, DOI 10.1016/j.ypmed.2006.04.011; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; Lee I-M, 2009, EPIDEMIOLOGIC METHOD; Lee IM, 2004, AM J EPIDEMIOL, V160, P636, DOI 10.1093/aje/kwh274; Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; National Health Research Institutes, 2005, NAT HLTH INT SURV NH; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rockhill B, 2001, AM J PUBLIC HEALTH, V91, P578, DOI 10.2105/AJPH.91.4.578; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Schnohr P, 2007, EUR J CARDIOV PREV R, V14, P72, DOI 10.1097/HJR.0b013e3280144470; Schooling CM, 2006, ARCH INTERN MED, V166, P1498, DOI 10.1001/archinte.166.14.1498; Tanasescu M, 2003, CIRCULATION, V107, P2435, DOI 10.1161/01.CIR.0000066906.11109.1F; Thune I, 2001, MED SCI SPORT EXER, V33, pS530, DOI 10.1097/00005768-200106001-00025; Tsai SP, 2010, TAIWAN J PUBLIC HLTH, V29, P261; Wai JPM, 2008, ASIA PAC J CLIN NUTR, V17, P297; Warburton DER, 2006, CAN MED ASSOC J, V174, P961, DOI 10.1503/cmaj.1040750; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; Wen CP, 2005, TOB CONTROL, V14, pI76, DOI 10.1136/tc.2004.007955; Wisloff U, 2006, EUR J CARDIOV PREV R, V13, P798, DOI 10.1097/01.hjr.0000216548.84560.ac; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; World Health Organization, GLOB REC PHYS ACT HL; Ziegelmann JP, 2006, J GERONTOL B-PSYCHOL, V61, pP195, DOI 10.1093/geronb/61.4.P195	47	1111	1135	9	227	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2011	378	9798					1244	1253		10.1016/S0140-6736(11)60749-6	http://dx.doi.org/10.1016/S0140-6736(11)60749-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IO	21846575				2022-12-28	WOS:000295723600026
J	Joron, M; Frezal, L; Jones, RT; Chamberlain, NL; Lee, SF; Haag, CR; Whibley, A; Becuwe, M; Baxter, SW; Ferguson, L; Wilkinson, PA; Salazar, C; Davidson, C; Clark, R; Quail, MA; Beasley, H; Glithero, R; Lloyd, C; Sims, S; Jones, MC; Rogers, J; Jiggins, CD; Ffrench-Constant, RH				Joron, Mathieu; Frezal, Lise; Jones, Robert T.; Chamberlain, Nicola L.; Lee, Siu F.; Haag, Christoph R.; Whibley, Annabel; Becuwe, Michel; Baxter, Simon W.; Ferguson, Laura; Wilkinson, Paul A.; Salazar, Camilo; Davidson, Claire; Clark, Richard; Quail, Michael A.; Beasley, Helen; Glithero, Rebecca; Lloyd, Christine; Sims, Sarah; Jones, Matthew C.; Rogers, Jane; Jiggins, Chris D.; Ffrench-Constant, Richard H.			Chromosomal rearrangements maintain a polymorphic supergene controlling butterfly mimicry	NATURE			English	Article							GENE FLOW; PAPILIO-DARDANUS; EVOLUTION; SEQUENCE; INVERSIONS; LINKAGE; VISTA	Supergenes are tight clusters of loci that facilitate the co-segregation of adaptive variation, providing integrated control of complex adaptive phenotypes(1). Polymorphic supergenes, in which specific combinations of traits are maintained within a single population, were first described for 'pin' and 'thrum' floral types in Primula(1) and Fagopyrum(2), but classic examples are also found in insect mimicry(3-5) and snail morphology(6). Understanding the evolutionary mechanisms that generate these co-adapted gene sets, as well as the mode of limiting the production of unfit recombinant forms, remains a substantial challenge(7-10). Here we show that individual wing-pattern morphs in the polymorphic mimetic butterfly Heliconius numata are associated with different genomic rearrangements at the supergene locus P. These rearrangements tighten the genetic linkage between at least two colour-pattern loci that are known to recombine in closely related species(9-11), with complete suppression of recombination being observed in experimental crosses across a 400-kilobase interval containing at least 18 genes. In natural populations, notable patterns of linkage disequilibrium (LD) are observed across the entire P region. The resulting divergent haplotype clades and inversion breakpoints are found in complete association with wing-pattern morphs. Our results indicate that allelic combinations at known wing-patterning loci have become locked together in a polymorphic rearrangement at the P locus, forming a supergene that acts as a simple switch between complex adaptive phenotypes found in sympatry. These findings highlight how genomic rearrangements can have a central role in the coexistence of adaptive phenotypes involving several genes acting in concert, by locally limiting recombination and gene flow.	[Joron, Mathieu; Frezal, Lise; Whibley, Annabel] CNRS, Museum Natl Hist Nat, UMR 7205, F-75005 Paris, France; [Joron, Mathieu; Becuwe, Michel] Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; [Joron, Mathieu] Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands; [Jones, Robert T.; Chamberlain, Nicola L.; Wilkinson, Paul A.; Ffrench-Constant, Richard H.] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Penryn TR10 9EZ, Cornwall, England; [Lee, Siu F.] Univ Melbourne, Inst Bio21, Dept Genet, Parkville, Vic 3010, Australia; [Haag, Christoph R.] Univ Fribourg, Dept Ecol & Evolut Biol, CH-1700 Fribourg, Switzerland; [Baxter, Simon W.; Ferguson, Laura; Jiggins, Chris D.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Salazar, Camilo] NAOS Isl, Smithsonian Trop Res Inst, Panama City, Panama; [Davidson, Claire; Clark, Richard; Quail, Michael A.; Beasley, Helen; Glithero, Rebecca; Lloyd, Christine; Sims, Sarah; Jones, Matthew C.; Rogers, Jane] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Edinburgh; Leiden University; Leiden University - Excl LUMC; University of Exeter; University of Melbourne; University of Fribourg; University of Cambridge; Smithsonian Institution; Smithsonian Tropical Research Institute; Wellcome Trust Sanger Institute	Joron, M (corresponding author), CNRS, Museum Natl Hist Nat, UMR 7205, CP50,45 Rue Buffon, F-75005 Paris, France.	joron@mnhn.fr	Whibley, Annabel/P-2509-2017; Haag, Christoph/B-6488-2009; C, Salazar/A-1647-2010; GenePool, The/D-8812-2012; Jiggins, Chris D/B-9960-2008; Jiggins, Chris/T-4296-2019; Joron, Mathieu/C-9178-2009; Whibley, Annabel/G-2836-2011; Quail, michael/ABE-6131-2020; Frezal, Lise Helene/AAC-1783-2020; Lee, Siu Fai/L-4690-2018	Whibley, Annabel/0000-0003-1878-7705; Haag, Christoph/0000-0002-8817-1431; C, Salazar/0000-0001-9217-6588; Jiggins, Chris D/0000-0002-7809-062X; Jiggins, Chris/0000-0002-7809-062X; Joron, Mathieu/0000-0003-1043-4147; Frezal, Lise Helene/0000-0002-6518-0423; Jones, Robert/0000-0001-6421-0881; Baxter, Simon/0000-0001-5773-6578; Lee, Siu Fai/0000-0001-6234-4819; ffrench-Constant, Richard/0000-0001-5385-9888; Davidson, Claire/0000-0002-4910-8202	CNRS; EMBO [ALTF-431-2004]; Royal Society [516002.K5917/ROG]; European Research Council; BBSRC [BBE0118451]; Leverhulme Trust [F/00144AY)]; Leverhulme Research Leadership grant; Biotechnology and Biological Sciences Research Council [BB/E006191/1, BB/E008836/1, BB/H014268/1] Funding Source: researchfish; Medical Research Council [G0900740] Funding Source: researchfish; Natural Environment Research Council [NBAF010003, NE/D000114/2] Funding Source: researchfish; BBSRC [BB/E006191/1, BB/E008836/1, BB/H014268/1] Funding Source: UKRI; MRC [G0900740] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI	CNRS(Centre National de la Recherche Scientifique (CNRS)); EMBO(European Molecular Biology Organization (EMBO)); Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); Leverhulme Research Leadership grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank M. Blaxter and D. Charlesworth for advice throughout the study; The GenePool and S. Humphray for DNA sequencing; S. Kumar and A. Papanicolaou for bioinformatics support; M. Beltran, A. Bulski, M. Veuille and the Botanique-Entomologie-Mycologie molecular facility (BoEM) for laboratory support; S. Johnston for genome-size estimates in H. numata; D. Obbard for providing R scripts; M. Abanto, S. Gallusser, C. Ramirez, L. de Silva, J. Barbut, B. Gilles and G. Lamas for help with butterfly rearing, fieldwork and collecting permits; and the Peruvian National Institute of Natural Resources (INRENA) for granting collecting and export permits (076-2007-INRENA-IFFS-DCB). Fieldwork in French Guiana was supported by a CNRS 'Nouragues Research Grant'. This work was supported by an EMBO long-term fellowship (ALTF-431-2004), EMBO-matching funds from NWO (Netherlands), a Royal Society University Research Fellowship (516002.K5917/ROG), a CNRS grant (ATIP Biodiversite 2008, France) and a European Research Council Starting Grant (ERC-Stg 'MimEvol') to M. J., a BBSRC grant (BBE0118451) to C. D. J. and R.H.ff.-C., a Leverhulme Trust grant (F/00144AY) to R.H.ff.-C., and a Royal Society University Research Fellowship and a Leverhulme Research Leadership grant to C. D. J.	Alvarez G, 1997, GENETICS, V146, P717; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000794; BROWN K S JR, 1974, Biotropica, V6, P205, DOI 10.2307/2989666; BROWN K S JR, 1976, Transactions of the American Entomological Society (Philadelphia), V102, P373; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Chamberlain NL, 2009, SCIENCE, V326, P847, DOI 10.1126/science.1179141; CHARLESWORTH D, 1975, J THEOR BIOL, V55, P305, DOI 10.1016/S0022-5193(75)80082-8; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Clark R, 2008, P R SOC B, V275, P1181, DOI 10.1098/rspb.2007.1762; CLARKE CA, 1968, PHILOS T ROY SOC B, V254, P37, DOI 10.1098/rstb.1968.0013; Counterman BA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000796; DOBZHANSKY T, 1947, GENETICS, V32, P142; Ferguson L, 2010, MOL ECOL, V19, P240, DOI 10.1111/j.1365-294X.2009.04475.x; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Garber RJ, 1927, J AGRIC RES, V34, P0181; Hatadani LM, 2004, HEREDITY, V93, P525, DOI 10.1038/sj.hdy.6800544; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; HUDSON RR, 1992, GENETICS, V132, P583; Jones RT, 2012, P ROY SOC B-BIOL SCI, V279, P316, DOI 10.1098/rspb.2011.0882; Joron M, 1999, EVOL ECOL, V13, P721, DOI 10.1023/A:1010875213123; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Manfield IW, 2005, J EXP BOT, V56, P1177, DOI 10.1093/jxb/eri110; MATHER K, 1950, EVOLUTION, V4, P340, DOI 10.2307/2405601; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Merrill R. M., 2010, P R SOC B, V278, P511; MURRAY J, 1973, GENETICS, V74, pS188; Nijhout HF, 2003, EVOL DEV, V5, P579, DOI 10.1046/j.1525-142X.2003.03063.x; Papa R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-345; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Pringle EG, 2007, GENETICS, V177, P417, DOI 10.1534/genetics.107.073122; Saenko SV, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-111; Salazar C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-132; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Turner J. R. G., 1984, BIOL BUTTERFLIES, V11, P141; van't Hof AE, 2011, SCIENCE, V332, P958, DOI 10.1126/science.1203043; Zaykin DV, 2008, GENETICS, V180, P533, DOI 10.1534/genetics.108.089409	42	354	358	6	243	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2011	477	7363					203	U102		10.1038/nature10341	http://dx.doi.org/10.1038/nature10341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21841803	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000294603900034
J	Petersen, JM; Zielinski, FU; Pape, T; Seifert, R; Moraru, C; Amann, R; Hourdez, S; Girguis, PR; Wankel, SD; Barbe, V; Pelletier, E; Fink, D; Borowski, C; Bach, W; Dubilier, N				Petersen, Jillian M.; Zielinski, Frank U.; Pape, Thomas; Seifert, Richard; Moraru, Cristina; Amann, Rudolf; Hourdez, Stephane; Girguis, Peter R.; Wankel, Scott D.; Barbe, Valerie; Pelletier, Eric; Fink, Dennis; Borowski, Christian; Bach, Wolfgang; Dubilier, Nicole			Hydrogen is an energy source for hydrothermal vent symbioses	NATURE			English	Article							MID-ATLANTIC RIDGE; MEMBRANE-BOUND HYDROGENASE; RIFTIA-PACHYPTILA JONES; MOLECULAR-HYDROGEN; DUAL SYMBIOSIS; TUBE WORM; H-2; FLUIDS; 15-DEGREES-N; COMMUNITIES	The discovery of deep-sea hydrothermal vents in 1977 revolutionized our understanding of the energy sources that fuel primary productivity on Earth. Hydrothermal vent ecosystems are dominated by animals that live in symbiosis with chemosynthetic bacteria. So far, only two energy sources have been shown to power chemosynthetic symbioses: reduced sulphur compounds and methane. Using metagenome sequencing, single-gene fluorescence in situ hybridization, immunohistochemistry, shipboard incubations and in situ mass spectrometry, we show here that the symbionts of the hydrothermal vent mussel Bathymodiolus from the Mid-Atlantic Ridge use hydrogen to power primary production. In addition, we show that the symbionts of Bathymodiolus mussels from Pacific vents have hupL, the key gene for hydrogen oxidation. Furthermore, the symbionts of other vent animals such as the tubeworm Riftia pachyptila and the shrimp Rimicaris exoculata also have hupL. We propose that the ability to use hydrogen as an energy source is widespread in hydrothermal vent symbioses, particularly at sites where hydrogen is abundant.	[Petersen, Jillian M.; Zielinski, Frank U.; Moraru, Cristina; Amann, Rudolf; Fink, Dennis; Borowski, Christian; Dubilier, Nicole] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Zielinski, Frank U.] UFZ Helmholtz Ctr Environm Res, D-04318 Leipzig, Germany; [Pape, Thomas] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28334 Bremen, Germany; [Pape, Thomas; Bach, Wolfgang] Univ Bremen, Dept Geosci, D-28334 Bremen, Germany; [Seifert, Richard] Univ Hamburg, Inst Biogeochem & Marine Chem, D-20146 Hamburg, Germany; [Hourdez, Stephane] CNRS UPMC UMR 7144, Biol Stn, Equipe Genet Adaptat Milieux Extremes, F-29682 Roscoff, France; [Girguis, Peter R.; Wankel, Scott D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Barbe, Valerie; Pelletier, Eric] Commissariat Energie Atom Genoscope, F-91000 Evry, France; [Barbe, Valerie; Pelletier, Eric] CNRS, UMR8030, F-91000 Evry, France; [Barbe, Valerie; Pelletier, Eric] Univ Evry Val dEssone, F-91000 Evry, France	Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bremen; University of Bremen; University of Hamburg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Harvard University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Dubilier, N (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	ndubilie@mpi-bremen.de	Pape, Thomas/A-8138-2018; Amann, Rudolf I/C-6534-2014; Bach, Wolfgang/D-3713-2017; Dubilier, Nicole/I-8203-2018; Petersen, Jillian/K-6066-2015	Pape, Thomas/0000-0002-6872-2144; Amann, Rudolf I/0000-0002-0846-7372; Bach, Wolfgang/0000-0002-3099-7142; Dubilier, Nicole/0000-0002-9394-825X; Petersen, Jillian/0000-0002-9852-3445; Girguis, Peter/0000-0002-3599-8160; Pelletier, Eric/0000-0003-4228-1712	German Science Foundation (DFG) [1144, 60]; DFG Cluster of Excellence "The Ocean in the Earth System" at MARUM (Center for Marine Environmental Sciences); Max Planck Society	German Science Foundation (DFG)(German Research Foundation (DFG)); DFG Cluster of Excellence "The Ocean in the Earth System" at MARUM (Center for Marine Environmental Sciences); Max Planck Society(Max Planck Society)	We thank the chief scientists, and the captains and crews of the research vessels and remotely operated vehicles involved in sampling and analyses at sea. Thank you to D. Garbe-Schonberg, K. van der Heijden and J. Stecher for on-board sampling and analysis, and S. Duperron, M.-A. Cambon-Bonavita and M. Zbinden for providing samples. We acknowledge B. Friedrich and O. Lenz for the antiserum against the C. necator uptake hydrogenase, J. Milucka for help with western blots and T. Holler for culturing C. necator. S. Wetzel provided technical assistance. This work was supported by the German Science Foundation (DFG) Priority Program 1144 "From Mantle to Ocean: Energy-, Material- and Life Cycles at Spreading Axes" (publication number 60), the DFG Cluster of Excellence "The Ocean in the Earth System" at MARUM (Center for Marine Environmental Sciences), and the Max Planck Society.	Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1016/S0168-6445(00)00062-0; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bernhard M, 1996, J BACTERIOL, V178, P4522, DOI 10.1128/jb.178.15.4522-4529.1996; BOWIEN B, 1981, ANNU REV MICROBIOL, V35, P405, DOI 10.1146/annurev.mi.35.100181.002201; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; CAVANAUGH CM, 1987, NATURE, V325, P346, DOI 10.1038/325346a0; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; Constant P, 2009, SCI TOTAL ENVIRON, V407, P1809, DOI 10.1016/j.scitotenv.2008.10.064; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Csaki R, 2001, FEMS MICROBIOL LETT, V205, P203, DOI 10.1016/S0378-1097(01)00469-4; DiSpirito A. A., 2004, RESP ARCHAEA BACTERI, V2, P149; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Duperron S, 2006, ENVIRON MICROBIOL, V8, P1441, DOI 10.1111/j.1462-2920.2006.01038.x; FELBECK H, 1981, SCIENCE, V213, P336, DOI 10.1126/science.213.4505.336; Fisher CR, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.75; FRIEDRICH B, 1993, ANNU REV MICROBIOL, V47, P351, DOI 10.1146/annurev.mi.47.100193.002031; Garrity, 2005, BERGEYS MANUAL SYSTE, P119, DOI [10.1007/0-387-28021-9_15, DOI 10.1007/0-387-28021-9_15]; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P383, DOI 10.1017/S0025315499002088; Haase KM, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001509; Haase KM, 2009, MAR GEOL, V266, P52, DOI 10.1016/j.margeo.2009.07.012; Hugler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016018; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; LEPENNEC M, 1984, OCEANOL ACTA, V7, P517; LILLEY MD, 1982, NATURE, V300, P48, DOI 10.1038/300048a0; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MEYER O, 1978, ARCH MICROBIOL, V118, P35, DOI 10.1007/BF00406071; Moraru C, 2011, ENV MICROBIOL REP, V3, P69, DOI 10.1111/j.1758-2229.2010.00189.x; Moraru C, 2010, ENVIRON MICROBIOL, V12, P3057, DOI 10.1111/j.1462-2920.2010.02281.x; NELSON DC, 1995, MAR BIOL, V121, P487, DOI 10.1007/BF00349457; Ohmura N, 2002, J BACTERIOL, V184, P2081, DOI 10.1128/JB.184.8.2081-2087.2002; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; Perner M, 2007, FEMS MICROBIOL ECOL, V61, P97, DOI 10.1111/j.1574-6941.2007.00325.x; Perner M, 2010, FEMS MICROBIOL ECOL, V74, P55, DOI 10.1111/j.1574-6941.2010.00940.x; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; Petersen JM, 2009, ENV MICROBIOL REP, V1, P319, DOI 10.1111/j.1758-2229.2009.00081.x; Punshon S, 2007, MAR CHEM, V105, P129, DOI 10.1016/j.marchem.2007.01.009; Schmidt K, 2007, CHEM GEOL, V242, P1, DOI 10.1016/j.chemgeo.2007.01.023; Schwartz E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P496, DOI 10.1007/0-387-30742-7_17; Takail K, 2006, GEOPHYS MONOGR SER, V166, P185; Tivey MK, 2007, OCEANOGRAPHY, V20, P50, DOI 10.5670/oceanog.2007.80; Tromp TK, 2003, SCIENCE, V300, P1740, DOI 10.1126/science.1085169; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Wankel SD, 2011, NAT GEOSCI, V4, P461, DOI [10.1038/ngeo1183, 10.1038/NGEO1183]; Welhan JA, 1983, HYDROTHERMAL PROCESS, P391, DOI [DOI 10.1007/978-1-4899-0402-7_17, 10.1007/978-1-4899-0402-7_17]; Wendeberg A, 2012, ISME J, V6, P104, DOI 10.1038/ismej.2011.81; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996; Zielinski FU, 2009, ENVIRON MICROBIOL, V11, P1150, DOI 10.1111/j.1462-2920.2008.01847.x	48	170	177	13	278	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					176	180		10.1038/nature10325	http://dx.doi.org/10.1038/nature10325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21833083				2022-12-28	WOS:000293731900029
J	Devaney, SA; Palomaki, GE; Scott, JA; Bianchi, DW				Devaney, Stephanie A.; Palomaki, Glenn E.; Scott, Joan A.; Bianchi, Diana W.			Noninvasive Fetal Sex Determination Using Cell-Free Fetal DNA A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; CHROMOSOME-SPECIFIC DNA; MATERNAL PLASMA; GENDER DETERMINATION; PRENATAL-DIAGNOSIS; PREGNANT-WOMEN; QUANTITATIVE-ANALYSIS; SERUM; BLOOD	Context Noninvasive prenatal determination of fetal sex using cell-free fetal DNA provides an alternative to invasive techniques for some heritable disorders. In some countries this testing has transitioned to clinical care, despite the absence of a formal assessment of performance. Objective To document overall test performance of noninvasive fetal sex determination using cell-free fetal DNA and to identify variables that affect performance. Data Sources Systematic review and meta-analysis with search of PubMed (January 1, 1997-April 17, 2011) to identify English-language human studies reporting primary data. References from review articles were also searched. Study Selection and Data Extraction Abstracts were read independently to identify studies reporting primary data suitable for analysis. Covariates included publication year, sample type, DNA amplification methodology, Y chromosome sequence, and gestational age. Data were independently extracted by 2 reviewers. Results From 57 selected studies, 80 data sets (representing 3524 male-bearing pregnancies and 3017 female-bearing pregnancies) were analyzed. Overall performance of the test to detect Y chromosome sequences had the following characteristics: sensitivity, 95.4% (95% confidence interval [CI], 94.7%-96.1%) and specificity, 98.6% (95% CI, 98.1%-99.0%); diagnostic odds ratio (OR), 885; positive predictive value, 98.8%; negative predictive value, 94.8%; area under curve (AUC), 0.993 (95% CI, 0.989-0.995), with significant interstudy heterogeneity. DNA methodology and gestational age had the largest effects on test performance. Methodology test characteristics were AUC, 0.988 (95% CI, 0.979-0.993) for polymerase chain reaction (PCR) and AUC, 0.996 (95% CI, 0.993-0.998) for real-time quantitative PCR (RTQ-PCR) (P=.02). Gestational age test characteristics were AUC, 0.989 (95% CI, 0.965-0.998) (<7 weeks); AUC, 0.994 (95% CI, 0.987-0.997) (7-12 weeks); AUC, 0.992 (95% CI, 0.983-0.996) (13-20 weeks); and AUC, 0.998 (95% CI, 0.990-0.999) (>20 weeks) (P=.02 for comparison of diagnostic ORs across age ranges). RTQ-PCR (sensitivity, 96.0%; specificity, 99.0%) outperformed conventional PCR (sensitivity, 94.0%; specificity, 97.3%). Testing after 20 weeks (sensitivity, 99.0%; specificity, 99.6%) outperformed testing prior to 7 weeks (sensitivity, 74.5%; specificity, 99.1%), testing at 7 through 12 weeks (sensitivity, 94.8%; specificity, 98.9%), and 13 through 20 weeks (sensitivity, 95.5%; specificity, 99.1%). Conclusions Despite interstudy variability, performance was high using maternal blood. Sensitivity and specificity for detection of Y chromosome sequences was greatest using RTQ-PCR after 20 weeks' gestation. Tests using urine and tests performed before 7 weeks' gestation were unreliable. JAMA. 2011;306(6):627-636 www.jama.com	[Devaney, Stephanie A.] NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Devaney, Stephanie A.; Scott, Joan A.] Johns Hopkins Univ, Genet & Publ Policy Ctr, Washington, DC USA; [Palomaki, Glenn E.] Brown Univ, Women & Infants Hosp, Alpert Med Sch, Providence, RI USA; [Scott, Joan A.] Natl Coalit Hlth Profess Educ Genet, Lutherville Timonium, MD USA; [Bianchi, Diana W.] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA USA; [Bianchi, Diana W.] Floating Hosp Children, Div Genet, Boston, MA USA	National Institutes of Health (NIH) - USA; Johns Hopkins University; Brown University; Women & Infants Hospital Rhode Island; Tufts Medical Center; Floating Hospital For Children	Devaney, SA (corresponding author), NIH, Dept Hlth & Human Serv, 1 Ctr Dr,Room 103, Bethesda, MD 20892 USA.	stephanie.devaney@nih.gov			National Human Genome Research Institute [1R21HG004865-02]; Sequenom Inc; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042053] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004865] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Sequenom Inc; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by the National Human Genome Research Institute (1R21HG004865-02).; All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Palomaki reported having a sponsored research agreement with Sequenom Inc to study circulating cell-free fetal DNA. Dr Bianchi reported serving as a member of the scientific and clinical advisory boards of Verinata Health Inc, an early-stage biotechnology company; she receives honoraria and holds stock options in this company. No other authors reported disclosures.	Agresti A, 2007, INTRO CATEGORICAL DA, V2nd; Akolekar R, 2010, PRENATAL DIAG, V30, P918, DOI 10.1002/pd.2582; Al-Yatama MK, 2007, MED PRIN PRACT, V16, P327, DOI 10.1159/000104803; Al-Yatama MK, 2001, PRENATAL DIAG, V21, P399, DOI 10.1002/pd.69; Bauer M, 2006, PRENATAL DIAG, V26, P831, DOI 10.1002/pd.1513; Bianchi DW, 2006, OBSTET GYNECOL, V107, P216, DOI 10.1097/01.AOG.0000199427.83503.d0; Bischoff Farideh Z, 2003, Reprod Biomed Online, V6, P349; Boon EMJ, 2007, PRENATAL DIAG, V27, P932, DOI 10.1002/pd.1804; Bustamante-Aragones A, 2008, HAEMOPHILIA, V14, P593, DOI 10.1111/j.1365-2516.2008.01670.x; Chelli D, 2009, PRENATAL DIAG, V29, P1145, DOI 10.1002/pd.2374; Chen H, 2001, J Tongji Med Univ, V21, P329; Chi C, 2006, BJOG-INT J OBSTET GY, V113, P239, DOI 10.1111/j.1471-0528.2006.00813.x; Costa JM, 2001, PRENATAL DIAG, V21, P1070, DOI 10.1002/pd.219; Cremonesi L, 2004, ANN NY ACAD SCI, V1022, P105, DOI 10.1196/annals.1318.017; Davalieva K, 2006, J MATERN-FETAL NEO M, V19, P337, DOI 10.1080/14767050600593320; Eddleman KA, 2006, OBSTET GYNECOL, V108, P1067, DOI 10.1097/01.AOG.0000240135.13594.07; Egger M, 2003, Health Technol Assess, V7, P1; Falcinelli C, 1999, AM J OBSTET GYNECOL, V181, P675, DOI 10.1016/S0002-9378(99)70512-0; Galbiati S, 2005, HUM GENET, V117, P243, DOI 10.1007/s00439-005-1330-z; Ge QY, 2006, CLIN CHIM ACTA, V369, P82, DOI 10.1016/j.cca.2006.01.015; Gonzalez-Gonzalez C, 2005, J HISTOCHEM CYTOCHEM, V53, P307, DOI 10.1369/jhc.4A6400.2005; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill M, 2011, CLIN GENET, V80, P68, DOI 10.1111/j.1399-0004.2010.01533.x; Ho S S Y, 2004, Ann Acad Med Singap, V33, pS61; Honda H, 2002, HUM GENET, V110, P75, DOI 10.1007/s00439-001-0649-3; Honda H, 2001, CLIN CHEM, V47, P41; Horinek A, 2008, FETAL DIAGN THER, V24, P15, DOI 10.1159/000132400; Hung TH, 2010, REPROD SCI, V17, P401, DOI 10.1177/1933719109359704; Hwa HL, 2004, J FORMOS MED ASSOC, V103, P364; Hyett JA, 2005, PRENATAL DIAG, V25, P1111, DOI 10.1002/pd.1284; Illanes S, 2007, EARLY HUM DEV, V83, P563, DOI 10.1016/j.earlhumdev.2006.11.001; Illanes S, 2006, PRENATAL DIAG, V26, P1216, DOI 10.1002/pd.1591; Javitt GH, 2006, FERTIL STERIL, V86, P13, DOI 10.1016/j.fertnstert.2006.03.016; Johnson KL, 2004, CLIN CHEM, V50, P516, DOI 10.1373/clinchem.2003.024380; Jorgez CJ, 2006, GENET MED, V8, P615, DOI 10.1097/01.gim.0000241904.32039.6f; Koide K, 2005, PRENATAL DIAG, V25, P604, DOI 10.1002/pd.1213; Lagona F, 1998, HUM GENET, V102, P687, DOI 10.1007/s004390050762; Lapaire O, 2007, OBSTET GYNECOL, V110, P1358, DOI 10.1097/01.AOG.0000295654.55971.9f; Li Y, 2006, CLIN CHEM, V52, P2311, DOI 10.1373/clinchem.2006.076257; Liu FM, 2007, ACTA OBSTET GYN SCAN, V86, P535, DOI 10.1080/00016340601159124; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Majer S, 2007, PRENATAL DIAG, V27, P1219, DOI 10.1002/pd.1875; Martinhago CD, 2006, PRENATAL DIAG, V26, P1219, DOI 10.1002/pd.1592; Mazza V, 2002, PRENATAL DIAG, V22, P919, DOI 10.1002/pd.434; Miura K, 2011, J HUM GENET, V56, P296, DOI 10.1038/jhg.2011.7; Mortarino M, 2011, HAEMOPHILIA, V17, P952, DOI 10.1111/j.1365-2516.2011.02537.x; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Odeh M, 2009, OBSTET GYNECOL SURV, V64, P50, DOI 10.1097/OGX.0b013e318193299b; Pan PD, 2005, HUM REPROD, V20, P3152, DOI 10.1093/humrep/dei165; Picchiassi E, 2008, PRENATAL DIAG, V28, P525, DOI 10.1002/pd.2018; Rijnders RJP, 2004, OBSTET GYNECOL, V103, P157, DOI 10.1097/01.AOG.0000103996.44503.F1; Rijnders RJP, 2003, PRENATAL DIAG, V23, P1042, DOI 10.1002/pd.750; Rijnders RJP, 2001, OBSTET GYNECOL, V98, P374, DOI 10.1016/S0029-7844(01)01480-6; Rosman AS, 2007, ADV MED SCI, V52, P76; Sampson M, 2003, J CLIN EPIDEMIOL, V56, P943, DOI 10.1016/S0895-4356(03)00110-0; Samura O, 2003, CLIN CHEM, V49, P1193, DOI 10.1373/49.7.1193; Santacroce R, 2006, HAEMOPHILIA, V12, P417, DOI 10.1111/j.1365-2516.2006.01298.x; Scheffer PG, 2010, OBSTET GYNECOL, V115, P117, DOI 10.1097/AOG.0b013e3181c3c938; Sekizawa A, 2001, CLIN CHEM, V47, P1856; Shekhtman EM, 2009, CLIN CHEM, V55, P723, DOI 10.1373/clinchem.2008.113050; Sikora A, 2010, CLIN CHEM, V56, P136, DOI 10.1373/clinchem.2009.132951; Smid M, 1999, CLIN CHEM, V45, P1570; Stanghellini I, 2006, MOL HUM REPROD, V12, P587, DOI 10.1093/molehr/gal052; Tabor A, 2009, ULTRASOUND OBST GYN, V34, P19, DOI 10.1002/uog.6377; Teutsch SM, 2009, GENET MED, V11, P3, DOI 10.1097/GIM.0b013e318184137c; Treff NR, 2011, MOL HUM REPROD, V17, P434, DOI 10.1093/molehr/gar016; Tungwiwat W, 2003, CLIN CHIM ACTA, V334, P173, DOI 10.1016/S0009-8981(03)00224-9; Urato AC, 2008, PRENATAL DIAG, V28, P186, DOI 10.1002/pd.1950; Vainer OB, 2008, ANN NY ACAD SCI, V1137, P157, DOI 10.1196/annals.1448.041; Vora NL, 2010, OBSTET GYNECOL, V116, P673, DOI 10.1097/AOG.0b013e3181ea2dd1; Vora NL, 2010, PRENATAL DIAG, V30, P325, DOI 10.1002/pd.2456; Wagner J, 2008, PRENATAL DIAG, V28, P412, DOI 10.1002/pd.1986; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Wataganara T, 2005, CLIN CHEM, V51, P217; Wataganara T, 2005, AM J OBSTET GYNECOL, V193, P496, DOI 10.1016/j.ajog.2004.12.015; Wataganara T, 2004, FERTIL STERIL, V81, P638, DOI 10.1016/j.fertnstert.2003.07.028; Wataganara T, 2003, HUM GENET, V112, P204, DOI 10.1007/s00439-002-0853-9; Wei CW, 2001, CLIN CHEM, V47, P336; Ying L, 2003, J SOC GYNECOL INVEST, V10, P503, DOI 10.1016/S1071-5576(03)00155-2; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhao XX, 2004, GYNECOL OBSTET INVES, V58, P57, DOI 10.1159/000078577; Hristoskova Sashka, 2006, Archives of Gynecology and Obstetrics, V274, P25, DOI 10.1007/s00404-005-0109-8; Zhong XY, 2006, PRENATAL DIAG, V26, P850, DOI 10.1002/pd.1521; Zhong XY, 2000, OBSTET GYNECOL, V96, P991, DOI 10.1016/S0029-7844(00)01065-6; Zhong XY, 2001, SWISS MED WKLY, V131, P70; Zhu B, 2005, PRENATAL DIAG, V25, P577, DOI 10.1002/pd.1192; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235; Zolotukhina TV, 2005, J HISTOCHEM CYTOCHEM, V53, P297, DOI 10.1369/jhc.4B6398.2005	91	170	203	1	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2011	306	6					627	636		10.1001/jama.2011.1114	http://dx.doi.org/10.1001/jama.2011.1114			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804XD	21828326	Green Accepted			2022-12-28	WOS:000293687300024
J	Wolff, C; Haug, GH; Timmermann, A; Damste, JSS; Brauer, A; Sigman, DM; Cane, MA; Verschuren, D				Wolff, Christian; Haug, Gerald H.; Timmermann, Axel; Damste, Jaap S. Sinninghe; Brauer, Achim; Sigman, Daniel M.; Cane, Mark A.; Verschuren, Dirk			Reduced Interannual Rainfall Variability in East Africa During the Last Ice Age	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; INDIAN-OCEAN; GLACIAL MAXIMUM; SOUTHERN AFRICA; EQUATORIAL; ANOMALIES; SEDIMENTS; HOLOCENE; TERRESTRIAL; OSCILLATION	Interannual rainfall variations in equatorial East Africa are tightly linked to the El Nino Southern Oscillation (ENSO), with more rain and flooding during El Nino and droughts in La Nina years, both having severe impacts on human habitation and food security. Here we report evidence from an annually laminated lake sediment record from southeastern Kenya for interannual to centennial-scale changes in ENSO-related rainfall variability during the last three millennia and for reductions in both the mean rate and the variability of rainfall in East Africa during the Last Glacial period. Climate model simulations support forward extrapolation from these lake sediment data that future warming will intensify the interannual variability of East Africa's rainfall.	[Wolff, Christian; Haug, Gerald H.] Univ Potsdam, DFG Leibniz Ctr Earth Surface Proc & Climate Stud, D-14476 Potsdam, Germany; [Wolff, Christian; Brauer, Achim] GFZ German Res Ctr Geosci, Helmholtz Ctr Potsdam GeoForschungsZentrum, Sect Climate Dynam & Landscape Evolut 5 2, D-14473 Potsdam, Germany; [Wolff, Christian] Univ Potsdam, Inst Geosci, Deutsche Forsch Gemeinschaft DFG Grad Sch 1364, D-14476 Potsdam, Germany; [Haug, Gerald H.] ETH, ETH Swiss Fed Inst Technol, Dept Earth Sci, Inst Geol, CH-8092 Zurich, Switzerland; [Timmermann, Axel] Univ Hawaii, Int Pacific Res Ctr, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Damste, Jaap S. Sinninghe] Univ Utrecht, Fac Geosci, NL-3508 TA Utrecht, Netherlands; [Damste, Jaap S. Sinninghe] NIOZ Royal Netherlands Inst Sea Res, Nederlands Inst Zeeonderzoek, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Netherlands; [Sigman, Daniel M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Cane, Mark A.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Verschuren, Dirk] Univ Ghent, Dept Biol, Limnol Unit, B-9000 Ghent, Belgium	University of Potsdam; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Potsdam; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Hawaii System; Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Princeton University; Columbia University; Ghent University	Haug, GH (corresponding author), Univ Potsdam, DFG Leibniz Ctr Earth Surface Proc & Climate Stud, D-14476 Potsdam, Germany.	gerald.haug@erdw.ethz.ch	Timmermann, Axel/F-4977-2011; Damste, Jaap S Sinninghe/F-6128-2011; Cane, Mark/I-8086-2012; Sigman, Daniel M/A-2649-2008; Timmermann, Axel/Y-2799-2019	Timmermann, Axel/0000-0003-0657-2969; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Sigman, Daniel M/0000-0002-7923-1973; Timmermann, Axel/0000-0003-0657-2969; Cane, Mark/0000-0001-5408-2388; Brauer, Achim/0000-0002-6655-9451	European Science Foundation; DFG; Leibniz Center for Earth Surface Process and Climate Studies; NSF [AGS-1010869]; Japan Agency for Marine-Earth Science and Technology (JAMSTEC); Div Atmospheric & Geospace Sciences [0804107] Funding Source: National Science Foundation	European Science Foundation(European Science Foundation (ESF)European Commission); DFG(German Research Foundation (DFG)); Leibniz Center for Earth Surface Process and Climate Studies; NSF(National Science Foundation (NSF)); Japan Agency for Marine-Earth Science and Technology (JAMSTEC); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work received funding from the European Science Foundation EUROCORES program EuroCLIMATE [Framework Programme 28: Lake Challa: a Long Archive of Climate in Equatorial Africa (CHALLACEA)] and through the Graduate School GRK 1364 Shaping Earth's Surface in a Variable Environment funded by the DFG. C.W. is grateful for grant from Leibniz Center for Earth Surface Process and Climate Studies. A. T. received support from NSF grant AGS-1010869 and the Japan Agency for Marine-Earth Science and Technology (JAMSTEC). Fieldwork was conducted with research permission of the Kenyan Ministry of Education and Science to D.V. (MOEST 13/001/11C). We gratefully acknowledge C. M. Oluseno, I. Kristen, U. Frank, and A. Hoechner for comments and assistance and the CHALLACEA team for stimulating discussions. This is IPRC publication no. 805.	Black E, 2003, MON WEATHER REV, V131, P74, DOI 10.1175/1520-0493(2003)131<0074:AOSOTR>2.0.CO;2; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Gasse F, 2008, QUATERNARY SCI REV, V27, P2316, DOI 10.1016/j.quascirev.2008.08.027; Goddard L, 1999, J GEOPHYS RES-ATMOS, V104, P19099, DOI 10.1029/1999JD900326; Hastenrath S, 2004, Q J ROY METEOR SOC, V130, P503, DOI 10.1256/qj.03.79; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Hopmans EC, 2004, EARTH PLANET SC LETT, V224, P107, DOI 10.1016/j.epsl.2004.05.012; Justino F, 2008, J CLIMATE, V21, P459, DOI 10.1175/2007JCLI1703.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Kiladis GN, 1989, J CLIMATE, V2, P1069, DOI 10.1175/1520-0442(1989)002<1069:GCAAWE>2.0.CO;2; Latif M, 1999, J CLIMATE, V12, P3497, DOI 10.1175/1520-0442(1999)012<3497:TROIOS>2.0.CO;2; Mcgee D, 2010, QUATERNARY SCI REV, V29, P2340, DOI 10.1016/j.quascirev.2010.06.009; Moernaut J, 2010, EARTH PLANET SC LETT, V290, P214, DOI 10.1016/j.epsl.2009.12.023; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Nicholson S.E., 1996, LIMNOLOGY CLIMATOLOG, V1st ed., P25, DOI [DOI 10.1201/9780203748978-2, 10.1201/9780203748978-2]; Nicholson SE, 2000, GLOBAL PLANET CHANGE, V26, P137, DOI 10.1016/S0921-8181(00)00040-0; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Parry M. L., 2007, CLIMATE CHANGE 2007; PILSKALN CH, 1991, LIMNOL OCEANOGR, V36, P544, DOI 10.4319/lo.1991.36.3.0544; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; Sonzogni C, 1998, QUATERNARY SCI REV, V17, P1185, DOI 10.1016/S0277-3791(97)00099-1; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Verschuren D, 2009, NATURE, V462, P637, DOI 10.1038/nature08520; Yeager SG, 2006, J CLIMATE, V19, P2545, DOI 10.1175/JCLI3744.1	29	121	121	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					743	747		10.1126/science.1203724	http://dx.doi.org/10.1126/science.1203724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817050				2022-12-28	WOS:000293512100039
J	Volpp, KG; Asch, DA; Galvin, R; Loewenstein, G				Volpp, Kevin G.; Asch, David A.; Galvin, Robert; Loewenstein, George			Redesigning Employee Health Incentives - Lessons from Behavioral Economics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Volpp, Kevin G.; Asch, David A.] Univ Penn, Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.; Loewenstein, George] Univ Penn, Leonard Davis Inst Hlth Econ, Ctr Hlth Incent, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.; Loewenstein, George] Univ Penn, Penn CMU Roybal Ctr Behav Econ & Hlth, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Asch, David A.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA; [Galvin, Robert] Equity Healthcare, Black Stone Grp, New York, NY USA; [Galvin, Robert] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Loewenstein, George] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Carnegie Mellon University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Yale University; Carnegie Mellon University	Volpp, KG (corresponding author), Univ Penn, Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA 19104 USA.		Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474; Asch, David/0000-0002-7970-286X; Volpp, Kevin/0000-0003-1423-4599	NIA NIH HHS [P30 AG034546] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG034546] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Burd Steven A., 2009, WALL STREET J   0612, pA15; HAISLEY E, AM J HLTH P IN PRESS; HILZENRATH D, 2010, WASH POST       0117, pG1; Volpp KG, 2009, HEALTH AFFAIR, V28, P206, DOI 10.1377/hlthaff.28.1.206; Volpp KG, 2009, NEW ENGL J MED, V360, P699, DOI 10.1056/NEJMsa0806819	5	154	156	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					388	390		10.1056/NEJMp1105966	http://dx.doi.org/10.1056/NEJMp1105966			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801NW	21812669	Green Accepted			2022-12-28	WOS:000293447800002
J	Weber, BN; Chi, AWS; Chavez, A; Yashiro-Ohtani, Y; Yang, Q; Shestova, O; Bhandoola, A				Weber, Brittany Nicole; Chi, Anthony Wei-Shine; Chavez, Alejandro; Yashiro-Ohtani, Yumi; Yang, Qi; Shestova, Olga; Bhandoola, Avinash			A critical role for TCF-1 in T-lineage specification and differentiation	NATURE			English	Article							BETA-CATENIN; TRANSCRIPTION FACTOR; NOTCH1; CELLS; HEMATOPOIESIS; INACTIVATION; CHECKPOINT; EXPRESSION; RECEPTOR; FATE	The vertebrate thymus provides an inductive environment for T-cell development. Within the mouse thymus, Notch signals are indispensable for imposing the T-cell fate on multipotential haematopoietic progenitors, but the downstream effectors that impart T-lineage specification and commitment are not well understood. Here we show that a transcription factor, T-cell factor 1 (TCF-1; also known as transcription factor 7, T-cell specific, TCF7), is a critical regulator in T-cell specification. TCF-1 is highly expressed in the earliest thymic progenitors, and its expression is upregulated by Notch signals. Most importantly, when TCF-1 is forcibly expressed in bone marrow (BM) progenitors, it drives the development of T-lineage cells in the absence of T-inductive Notch1 signals. Further characterization of these TCF-1-induced cells revealed expression of many T-lineage genes, including T-cell-specific transcription factors Gata3 and Bcl11b, and components of the T-cell receptor. Our data suggest a model where Notch signals induce TCF-1, and TCF-1 in turn imprints the T-cell fate by upregulating expression of T-cell essential genes.	[Weber, Brittany Nicole; Chi, Anthony Wei-Shine; Chavez, Alejandro; Yashiro-Ohtani, Yumi; Yang, Qi; Shestova, Olga; Bhandoola, Avinash] Univ Penn, Dept Pathol & Lab Med, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Bhandoola, A (corresponding author), Univ Penn, Dept Pathol & Lab Med, Sch Med, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu			NIH [AI059621]; Leukemia and Lymphoma Society;  [T32AI055428];  [T32CA09140]; NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059621, R56AI059621, T32AI055428] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Clevers for permission to use TCF-1<SUP>-/-</SUP> mice and W. Pear, S. Reiner, C. Bassing, R. Sen and W. Bailis for critical comments. This work was supported by NIH grant AI059621 and a Scholar Award from the Leukemia and Lymphoma Society (A. B.), and institutional training grants T32AI055428 (B.N.W.) and T32CA09140 (A.W.-S.C.).	Brault V, 2001, DEVELOPMENT, V128, P1253; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Goux D, 2005, BLOOD, V106, P1726, DOI 10.1182/blood-2005-01-0337; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Huang JX, 2005, J IMMUNOL, V175, P4858, DOI 10.4049/jimmunol.175.8.4858; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu ZY, 2011, J CLIN INVEST, V121, P800, DOI 10.1172/JCI43114; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rothenberg EV, 2010, IMMUNOL REV, V238, P150, DOI 10.1111/j.1600-065X.2010.00964.x; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schilham MW, 1998, J IMMUNOL, V161, P3984; Schmitt TM, 2006, IMMUNOL REV, V209, P95, DOI 10.1111/j.0105-2896.2006.00353.x; Schwarz BA, 2007, J IMMUNOL, V178, P2008, DOI 10.4049/jimmunol.178.4.2008; SPANGRUDE GJ, 1990, J IMMUNOL, V145, P3661; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Tago K, 2000, GENE DEV, V14, P1741; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wendorff AA, 2010, IMMUNITY, V33, P671, DOI 10.1016/j.immuni.2010.11.014; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762	35	271	275	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					63	+		10.1038/nature10279	http://dx.doi.org/10.1038/nature10279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21814277	Green Accepted			2022-12-28	WOS:000293447300029
J	Zurovac, D; Sudoi, RK; Akhwale, WS; Ndiritu, M; Hamer, DH; Rowe, AK; Snow, RW				Zurovac, Dejan; Sudoi, Raymond K.; Akhwale, Willis S.; Ndiritu, Moses; Hamer, Davidson H.; Rowe, Alexander K.; Snow, Robert W.			The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial	LANCET			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ARTEMETHER-LUMEFANTRINE; CASE-MANAGEMENT; BEHAVIOR-CHANGE; PHARMACOKINETICS; PERFORMANCE; FACILITIES; QUALITY; PHARMACODYNAMICS; BENFLUMETOL	Background Health workers' malaria case-management practices often differ from national guidelines. We assessed whether text-message reminders sent to health workers' mobile phones could improve and maintain their adherence to treatment guidelines for outpatient paediatric malaria in Kenya. Methods From March 6, 2009, to May 31, 2010, we did a cluster-randomised controlled trial at 107 rural health facilities in 11 districts in coastal and western Kenya. With a computer-generated sequence, health facilities were randomly allocated to either the intervention group, in which all health workers received text messages on their personal mobile phones on malaria case-management for 6 months, or the control group, in which health workers did not receive any text messages. Health workers were not masked to the intervention, although patients were unaware of whether they were in an intervention or control facility. The primary outcome was correct management with artemether-lumefantrine, defined as a dichotomous composite indicator of treatment, dispensing, and counselling tasks concordant with Kenyan national guidelines. The primary analysis was by intention to treat. The trial is registered with Current Controlled Trials, ISRCTN72328636. Findings 119 health workers received the intervention. Case-management practices were assessed for 2269 children who needed treatment (1157 in the intervention group and 1112 in the control group). Intention-to-treat analysis showed that correct artemether-lumefantrine management improved by 23.7 percentage-points (95% CI 7.6-40.0; p=0.004) immediately after intervention and by 24.5 percentage-points (8.1-41.0; p=0.003) 6 months later. Interpretation In resource-limited settings, malaria control programmes should consider use of text messaging to improve health workers' case-management practices.	[Zurovac, Dejan] Kenya Med Res Inst Wellcome Trust, Malaria Publ Hlth & Epidemiol Grp, Res Programme, Nairobi, Kenya; [Zurovac, Dejan; Snow, Robert W.] Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England; [Zurovac, Dejan; Hamer, Davidson H.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Akhwale, Willis S.] Minist Publ Hlth & Sanitat, Dept Dis Prevent & Control, Nairobi, Kenya; [Hamer, Davidson H.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Rowe, Alexander K.] US Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA	Kenya Medical Research Institute; University of Oxford; Boston University; Boston University; Centers for Disease Control & Prevention - USA	Zurovac, D (corresponding author), Kenya Med Res Inst Wellcome Trust, Malaria Publ Hlth & Epidemiol Grp, Res Programme, POB 43640-00100, Nairobi, Kenya.	dzurovac@nairobi.kemri-wellcome.org	Hamer, Davidson Howes/J-2020-2019; Snow, Robert William/AFR-1436-2022	Hamer, Davidson Howes/0000-0002-4700-1495; Snow, Robert William/0000-0003-3725-6088	Wellcome Trust, UK [084253]; Wellcome Trust [079080]	Wellcome Trust, UK(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to all health workers, children, carers, and data collectors who participated in the study. We thank all members of the Kenyan Ministry of Public Health and Sanitation's Division of Malaria Control who participated in the intervention development and provided continued support. We also thank Mike English and Dayo Forster for comments on the paper. The trial was funded by the Wellcome Trust, UK through a project grant to RWS (grant number 084253), which also supported DZ. RWS is supported by the Wellcome Trust as Principal Research Fellow (grant number 079080). The paper is published with the permission of the Director of the Kenya Medical Research Institute.	Airtel, NEW TAR; [Anonymous], KEN MAL PROP ROUND 1; Barrington J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-298; Beer N, 2009, TROP MED INT HEALTH, V14, P1; Chi BH, 2010, LANCET, V376, P1807, DOI 10.1016/S0140-6736(10)62046-6; Cole-Lewis H, 2010, EPIDEMIOL REV, V32, P56, DOI 10.1093/epirev/mxq004; Communications Commission of Kenya, Q SECT STAT REP 3 QU; Communications Commission of Kenya, Q SECT STAT REP 1 QU; Eriksen J, 2007, TROP MED INT HEALTH, V12, P52, DOI 10.1111/j.1365-3156.2006.01753.x; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; Ezzet F, 1998, BRIT J CLIN PHARMACO, V46, P553, DOI 10.1046/j.1365-2125.1998.00830.x; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Fogg C, 2004, AM J TROP MED HYG, V71, P525, DOI 10.4269/ajtmh.2004.71.525; Green D, 2003, ESSENTIAL DRUGS MONI, V33, P8; International Telecommunications Union, WORLD 2010 ICT FACTS; Knebel E, 2000, QUALITY ASSURANCE PR; Krishna S, 2009, TELEMED J E-HEALTH, V15, P231, DOI 10.1089/tmj.2008.0099; Lester R, 2008, LANCET INFECT DIS, V8, P738, DOI 10.1016/S1473-3099(08)70265-2; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Ministry of Health, 2009, TRAIN GUID 2006 NAT; Ministry of Health, 2008, NAT GUID DIAGN TREAT; Ministry of Public Health and Sanitation Division of Malaria Control, 2010, NAT MAL POL; Nshakira N, 2002, TROP MED INT HEALTH, V7, P309, DOI 10.1046/j.1365-3156.2002.00858.x; Piola P, 2005, LANCET, V365, P1467, DOI 10.1016/S0140-6736(05)66416-1; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Roethlisberger F.J., 1939, MANAGEMENT WORKER AC; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2009, IMPROVING HLTH CARE; Rowe AK, 2010, 1 GLOB S HLTH SYST R; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Terry M, 2008, TELEMED J E-HEALTH, V14, P520, DOI 10.1089/tmj.2008.8495; Wasunna B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-261; White NJ, 1999, CLIN PHARMACOKINET, V37, P105, DOI 10.2165/00003088-199937020-00002; World Health Organization, INT STRAT IMPR US AN; Zurovac D, 2008, TROP MED INT HEALTH, V13, P99, DOI 10.1111/j.1365-3156.2007.01980.x; Zurovac D, 2006, ANN TROP MED PARASIT, V100, P283, DOI 10.1179/136485906X105633	37	236	237	1	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2011	378	9793					795	803		10.1016/S0140-6736(11)60783-6	http://dx.doi.org/10.1016/S0140-6736(11)60783-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816FY	21820166	Green Published, Green Submitted			2022-12-28	WOS:000294585300035
J	Thodey, K; Smolke, CD				Thodey, Kate; Smolke, Christina D.			Bringing It Together with RNA	SCIENCE			English	Editorial Material							PROTEIN ARRAYS; DNA; LIGANDS; DEVICES		[Thodey, Kate; Smolke, Christina D.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Thodey, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	csmolke@stanford.edu						Agapakis Christina M, 2010, J Biol Eng, V4, P3, DOI 10.1186/1754-1611-4-3; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Liu Y, 2005, ANGEW CHEM INT EDIT, V44, P4333, DOI 10.1002/anie.200501089; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; SRERE PA, 1974, ANNU REV MICROBIOL, V28, P61, DOI 10.1146/annurev.mi.28.100174.000425; STOLZ JF, 2007, BACTERIAL INTRACELLU; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913	14	4	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					412	413		10.1126/science.1209685	http://dx.doi.org/10.1126/science.1209685			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	795FR	21778388				2022-12-28	WOS:000292959600031
J	Paasche-Orlow, M				Paasche-Orlow, Michael			Caring for Patients With Limited Health Literacy A 76-Year-Old Man With Multiple Medical Problems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGED CARE ORGANIZATION; SELF-MANAGEMENT; HOSPITAL ADMISSION; CLINICAL-OUTCOMES; OVERLOOKED FACTOR; PROSTATE-CANCER; CHRONIC DISEASE; OLDER-ADULTS; COMMUNICATION; DISPARITIES	Health literacy is the degree to which individuals have the capacity to obtain, process, and understand health information, skills, and services needed to make informed health decisions and take informed actions. Narratives from Mr J, a 76-year-old man with multiple medical problems and limited health literacy, and his physician exhibit some of the difficulties experienced by patients with limited health literacy. Clinicians can help patients with limited health literacy by removing unneeded complexity in their treatment regimens and in the health care system and by using teach-back methods to assess and improve understanding. Rather than a selective screening approach for limited health literacy, a patient-based universal precaution approach for confirming patient comprehension of critical self-care activities helps ensure that all patients have their health literacy needs identified. JAMA. 2011;306(10):1122-1129 www.jama.com	Boston Univ, Med Ctr, Dept Med, Gen Internal Med Sect,Sch Med, Boston, MA 02118 USA	Boston University	Paasche-Orlow, M (corresponding author), Boston Univ, Med Ctr, Dept Med, Gen Internal Med Sect,Sch Med, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA.	mpo@bu.edu	Paasche-Orlow, Michael/ABF-7919-2020	Paasche-Orlow, Michael/0000-0002-9276-7190	Agency for Healthcare Research and Quality; National Institute on Aging,; National Heart, Lung, and Blood Institute, National Cancer Institute; National Institute on Minority Health and Health Disparities	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Aging,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Dr Paasche-Orlow has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. He reports receiving funding from multiple grants from the Agency for Healthcare Research and Quality, National Institute on Aging, National Heart, Lung, and Blood Institute, National Cancer Institute, and National Institute on Minority Health and Health Disparities to conduct research in the area of health literacy.	Agency for Healthcare Research and Quality, 2011, HLTH LIT INT OUTC UP; Agency for Healthcare Research and Quality, 2010, AHRQ PUBL; Apter AJ, 2009, PATIENT EDUC COUNS, V75, P386, DOI 10.1016/j.pec.2009.01.003; Apter AJ, 2008, J GEN INTERN MED, V23, P2117, DOI 10.1007/s11606-008-0803-x; Bailey CJ, 2011, INT J CLIN PRACT, V65, P314, DOI 10.1111/j.1742-1241.2010.02544.x; Baker DW, 2007, ARCH INTERN MED, V167, P1503, DOI 10.1001/archinte.167.14.1503; Baker DW, 1998, J GEN INTERN MED, V13, P791, DOI 10.1046/j.1525-1497.1998.00242.x; Baker DW, 1997, AM J PUBLIC HEALTH, V87, P1027, DOI 10.2105/AJPH.87.6.1027; Baker DW, 2002, AGING MENT HEALTH, V6, P22, DOI 10.1080/13607860120101121; Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; Bennett CL, 1998, J CLIN ONCOL, V16, P3101, DOI 10.1200/JCO.1998.16.9.3101; Bennett IM, 2009, ANN FAM MED, V7, P204, DOI 10.1370/afm.940; BERKMAN N, 2004, AHRQ PUBLICATION; Castro CM, 2007, AM J HEALTH BEHAV, V31, pS85; Cavanaugh K, 2008, ANN INTERN MED, V148, P737, DOI 10.7326/0003-4819-148-10-200805200-00006; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; Farrell TW, 2008, FAM MED, V40, P235; Ferguson B, 2011, J HEALTH COMMUN, V16, P124, DOI 10.1080/10810730.2010.535113; Funnell MM, 2010, FAM PRACT, V27, pI17, DOI 10.1093/fampra/cmp027; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; Hahn SR, 2010, OPHTHALMOLOGY, V117, P1339, DOI 10.1016/j.ophtha.2009.11.026; Harvey JN, 2009, DIABETIC MED, V26, P5, DOI 10.1111/j.1464-5491.2008.02628.x; Kalichman SC, 1999, J GEN INTERN MED, V14, P267, DOI 10.1046/j.1525-1497.1999.00334.x; Katz MG, 2007, J GEN INTERN MED, V22, P782, DOI 10.1007/s11606-007-0184-6; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kutner M, 2006, 2006483 NCES; Kutner M., 2007, NCES PUBLICATION; LEVINE J, 1987, PSYCHOSOM MED, V49, P109, DOI 10.1097/00006842-198703000-00001; Li BDL, 2000, ANN SURG, V231, P883, DOI 10.1097/00000658-200006000-00013; Makaryus AN, 2005, MAYO CLIN PROC, V80, P991, DOI 10.4065/80.8.991; Morris Nancy S, 2006, BMC Fam Pract, V7, P49, DOI 10.1186/1471-2296-7-49; National Center for Education Statistics, STAT COUNT EST LOW L; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Osborn CY, 2007, AM J PREV MED, V33, P374, DOI 10.1016/j.amepre.2007.07.022; Osborn CY, 2009, DIABETES CARE, V32, P1614, DOI 10.2337/dc09-0425; Paasche-Orlow MK, 2007, AM J HEALTH BEHAV, V31, pS19; Paasche-Orlow MK, 2006, J GEN INTERN MED, V21, P884, DOI 10.1111/j.1525-1497.2006.00544.x; Paasche-Orlow MK, 2006, J GEN INTERN MED, V21, P835, DOI 10.1111/j.1525-1497.2006.00527.x; Paasche-Orlow MK, 2010, J HEALTH COMMUN, V15, P34, DOI 10.1080/10810730.2010.499994; Paasche-Orlow MK, 2005, AM J RESP CRIT CARE, V172, P980, DOI 10.1164/rccm.200409-1291OC; Paasche-Orlow MK, 2005, MED CARE, V43, P558, DOI 10.1097/01.mlr.0000163646.90393.e4; Paasche-Orlow MK, 2005, J GEN INTERN MED, V20, P175, DOI 10.1111/j.1525-1497.2005.40245.x; Paosche-Orlow MK, 2008, J GEN INTERN MED, V23, P100, DOI 10.1007/s11606-007-0447-2; Peterson PN, 2011, JAMA-J AM MED ASSOC, V305, P1695, DOI 10.1001/jama.2011.512; Powers BJ, 2010, JAMA-J AM MED ASSOC, V304, P76, DOI 10.1001/jama.2010.896; Rosland AM, 2010, CHRONIC ILLN, V6, P7, DOI 10.1177/1742395309352254; Rothman RL, 2004, JAMA-J AM MED ASSOC, V292, P1711, DOI 10.1001/jama.292.14.1711; Russell LB, 2005, J FAM PRACTICE, V54, P52; Sarkar U, 2010, J GEN INTERN MED, V25, P962, DOI 10.1007/s11606-010-1389-7; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; Scott TL, 2002, MED CARE, V40, P395, DOI 10.1097/00005650-200205000-00005; Seligman HK, 2005, J GEN INTERN MED, V20, P1001, DOI 10.1111/j.1525-1497.2005.00189.x; Smith I, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003531.pub3; Sudore RL, 2006, J GEN INTERN MED, V21, P806, DOI 10.1111/j.1525-1497.2006.00539.x; Sudore RL, 2006, J GEN INTERN MED, V21, P867, DOI 10.1111/j.1525-1497.2006.00535.x; Tokuda Y, 2009, PATIENT EDUC COUNS, V75, P411, DOI 10.1016/j.pec.2009.03.031; Volandes AE, 2008, J PALLIAT MED, V11, P754, DOI 10.1089/jpm.2007.0224; Volandes AE, 2007, AM J BIOETHICS, V7, P5, DOI 10.1080/15265160701638520; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Wilson EAH, 2010, PATIENT EDUC COUNS, V80, P393, DOI 10.1016/j.pec.2010.07.011; Wolf MS, 2007, J HEALTH COMMUN, V12, P721, DOI 10.1080/10810730701672173; Wolf MS, 2006, UROLOGY, V68, P89, DOI 10.1016/j.urology.2006.01.064; Wolf MS, 2005, ARCH INTERN MED, V165, P1946, DOI 10.1001/archinte.165.17.1946; Woloshin S, 2011, ANN INTERN MED, V155, P87, DOI 10.7326/0003-4819-155-2-201107190-00004; STANDARDIZING MEDICA	66	36	38	1	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1122	1129		10.1001/jama.2011.1203	http://dx.doi.org/10.1001/jama.2011.1203			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819DS	21828309				2022-12-28	WOS:000294806200026
J	Halim, SA; Newby, LK				Halim, Sharif A.; Newby, L. Kristin			Review: Angiotensin-receptor blockers do not increase adverse cardiovascular outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Halim, Sharif A.; Newby, L. Kristin] Duke Univ, Med Ctr, Durham, NC 27705 USA	Duke University	Halim, SA (corresponding author), Duke Univ, Med Ctr, Durham, NC 27705 USA.			Bangalore, Sripal/0000-0001-9485-0652				Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Matchar DB, 2008, ANN INTERN MED, V148, P16, DOI 10.7326/0003-4819-148-1-200801010-00189	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4							JC2-2	10.7326/0003-4819-155-4-201108160-02002	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LM	21844535				2022-12-28	WOS:000208885100001
J	Wang, C; Cao, B; Liu, QQ; Zou, ZQ; Liang, ZA; Gu, L; Dong, JP; Liang, LR; Li, XW; Hu, K; He, XS; Sun, YH; An, Y; Yang, T; Cao, ZX; Guo, YM; Wen, XM; Wang, YG; Liu, YL; Jiang, LD				Wang, Chen; Cao, Bin; Liu, Qing-Quan; Zou, Zhi-Qiang; Liang, Zong-An; Gu, Li; Dong, Jian-Ping; Liang, Li-Rong; Li, Xing-Wang; Hu, Ke; He, Xue-Song; Sun, Yan-Hua; An, Yu; Yang, Ting; Cao, Zhi-Xin; Guo, Yan-Mei; Wen, Xian-Min; Wang, Yu-Guang; Liu, Ya-Ling; Jiang, Liang-Duo			Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan-Yinqiaosan in the Treatment of H1N1 Influenza	ANNALS OF INTERNAL MEDICINE			English	Article							NEURAMINIDASE INHIBITORS; DRUG-THERAPY; EPHEDRA; SAFETY; VIRUS; EFFICACY; A(H1N1); EVENTS	Background: Observational studies from Asia suggest that maxingshigan-yinqiaosan may be effective in the treatment of acute H1N1 influenza. Objective: To compare the efficacy and safety of oseltamivir and maxingshigan-yinqiaosan in treating uncomplicated H1N1 influenza. Design: Prospective, nonblinded, randomized, controlled trial. (ClinicalTrials.gov registration number: NCT00935194) Setting: Eleven hospitals from 4 provinces in China. Patients: 410 young adults aged 15 to 59 years with laboratory-confirmed H1N1 influenza. Intervention: Oseltamivir, 75 mg twice daily; maxingshigan-yinqiaosan decoction (composed of 12 Chinese herbal medicines, including honey-fried Herba Ephedrae), 200 mL 4 times daily; oseltamivir plus maxingshigan-yinqiaosan; or no intervention (control). Interventions and control were given for 5 days. Measurements: Primary outcome was time to fever resolution. Secondary outcomes included symptom scores and viral shedding determined by using real-time reverse transcriptase polymerase chain reaction. Results: Significant reductions in the estimated median time to fever resolution compared with the control group (26.0 hours [95% CI, 24.0 to 33.0 hours]) were seen with oseltamivir (34% [95% CI, 20% to 46%]; P < 0.001), maxingshigan-yinqiaosan (37% [CI, 23% to 49%]; P < 0.001), and oseltamivir plus maxingshigan-yinqiaosan (47% [CI, 35% to 56%]; P < 0.001). Time to fever resolution was reduced by 19% (CI, 0.3% to 34%; P = 0.05) with oseltamivir plus maxingshigan-yinqiaosan compared with oseltamivir. The interventions and control did not differ in terms of decrease in symptom scores (P = 0.38). Two patients who received maxingshigan-yinqiaosan reported nausea and vomiting. Limitations: Participants were young and had mild H1N1 influenza virus infection. Missing viral data precluded definitive conclusions about viral shedding. Conclusion: Oseltamivir and maxingshigan-yinqiaosan, alone and in combination, reduced time to fever resolution in patients with H1N1 influenza virus infection. These data suggest that maxingshigan-yinqiaosan may be used as an alternative treatment of H1N1 influenza virus infection.	[Cao, Bin] Capital Med Univ, Beijing Inst Resp Med, Beijing Chao Yang Hosp, Dept Infect Dis & Clin Microbiol, Gongti S Rd 8, Beijing 100020, Peoples R China; [Wang, Chen] Minist Hlth, Beijing Hosp, Beijing 100020, Peoples R China; Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing, Peoples R China; Chengdu Infect Dis Hosp, Chengdu, Sichuan, Peoples R China; Beijing Haidian Hosp, Beijing, Peoples R China; Capital Med Univ, Inst Infect Dis, Beijing Ditan Hosp, Beijing 100020, Peoples R China; Changxindian Hosp Fengtai Dist Beijing, Beijing, Peoples R China; Wuhan Univ, Renmin Hosp, Wuhan, Peoples R China; Second Hosp Chaoyang Dist Beijing, Beijing, Peoples R China; Second Hosp Beijing, Beijing, Peoples R China; Sichuan Univ, W China Hosp, W China Med Sch, Chengdu, Sichuan, Peoples R China	Capital Medical University; Beijing Hospital; Beijing University of Chinese Medicine; Capital Medical University; Wuhan University; Sichuan University	Cao, B (corresponding author), Capital Med Univ, Beijing Inst Resp Med, Beijing Chao Yang Hosp, Dept Infect Dis & Clin Microbiol, Gongti S Rd 8, Beijing 100020, Peoples R China.	cyh-birm@263.net; caobin1999@gmail.com			Beijing Science and Technology Project [Z08050700020801, Z09000700090903]; Beijing Nova Program [2007A037]	Beijing Science and Technology Project; Beijing Nova Program(Beijing Municipal Science & Technology Commission)	Grant Support: By the Beijing Science and Technology Project (grants Z08050700020801 and Z09000700090903) and the Beijing Nova Program (grant 2007A037).	Andraws R, 2005, PROG CARDIOVASC DIS, V47, P217, DOI 10.1016/j.pcad.2004.07.006; [Anonymous], 2007, HLTH CANADA REQUESTS; Baz M, 2009, NEW ENGL J MED, V361, P2296, DOI 10.1056/NEJMc0910060; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P431; Chan K, 2005, J ETHNOPHARMACOL, V96, P1, DOI 10.1016/j.jep.2004.09.019; Chen N, 2004, ACAD J GUANG DONG CO, P545; Cheng JT, 2000, J CLIN PHARMACOL, V40, P445, DOI 10.1177/00912700022009198; Chinese Pharmacopoeia Commission, 2005, PHARM PEOPL REP CHIN; Chow MS, 2008, FASEB J S, V22; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hallas J, 2008, AM J EPIDEMIOL, V168, P966, DOI 10.1093/aje/kwn191; Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502; Huang JM, 2003, J FUJIAN TRADITIONAL, V34, P38; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Lu F.G., 2007, PRACTICAL PREVENTIVE, V14, P1351; Lu GF, 2008, J TRADITIONAL CHINES, V28, P5; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Patel K, 2006, PHARM STAT, V5, P213, DOI 10.1002/pst.213; Poon PMK, 2006, AM J CHINESE MED, V34, P13, DOI 10.1142/S0192415X0600359X; Soni MG, 2004, TOXICOL LETT, V150, P97, DOI 10.1016/j.toxlet.2003.07.006; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; U.S. Food and Drug Administration, 2006, DIET SUPPL CONT EPH; Uyeki Tim, 2009, N Engl J Med, V361, pe110, DOI 10.1056/NEJMopv0910738; Wang J, 2007, CHINESE ARCH TRADITI, V25, P2200; WHO, 2009, WHO GUID PHARM MAN P; WHO (World Health Organization), 2010, PAND H1N1 2009 UPD 9; World Health Organization, 2009, CDC PROT REALT RTPCR; [杨金燕 YANG Jinyan], 2007, [华西药学杂志, West China Journal of Pharmaceutical Sciences], V22, P559; Zhao WN, 2007, PRACTICAL PREVENTIVE, V14, P178	35	177	246	10	90	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4					217	+		10.7326/0003-4819-155-4-201108160-00005	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807KN	21844547				2022-12-28	WOS:000293896400002
J	Kalwij, SA				Kalwij, Sebastian A.			CASE REPORT Opportunistic chlamydia screening in a general practice consultation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRACHOMATIS; INFECTION		Amersham Vale Practice, London SE14 6LD, England		Kalwij, SA (corresponding author), Amersham Vale Practice, London SE14 6LD, England.	sebastiankalwij@mac.com						Andrews WW, 2000, AM J OBSTET GYNECOL, V183, P662, DOI 10.1067/mob.2000.106556; Bias MM, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.022665; Centers for Disease Control and Prevention, CHLAM SCREEN 2 FACT; Clinical Effectiveness Group,, CHLAM TRACH UK TEST; Doshi JS, 2008, INT J STD AIDS, V19, P507, DOI 10.1258/ijsa.2008.008056; Health Protection Agency, 2008, SEX TRANSM INF YOUNG; Hogan AH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-616; Kalwij S, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1915; LaMontagne DS, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.022053; Land JA, 2010, HUM REPROD UPDATE, V16, P189, DOI 10.1093/humupd/dmp035; Mardh PA, 2004, CURR OPIN INFECT DIS, V17, P49, DOI 10.1097/00001432-200402000-00010; Mathew T, 2009, INT J STD AIDS, V20, P752, DOI 10.1258/ijsa.2009.009225; Skidmore S, 2006, SEX TRANSM INFECT, V82, P272, DOI 10.1136/sti.2005.019034; Tobin JM, 2004, INT J STD AIDS, V15, P737, DOI 10.1258/0956462042395096; Trelle S, 2007, BMJ-BRIT MED J, V334, P354, DOI 10.1136/bmj.39079.460741.7C; van Bergen JEAM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-42; van Dommelen L, 2010, SEX TRANSM INFECT, V86, P355, DOI 10.1136/sti.2010.042598; Wozniak J, 2008, STABILITY URINE SAMP	18	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2011	343								d5108	10.1136/bmj.d5108	http://dx.doi.org/10.1136/bmj.d5108			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811KK	21844158				2022-12-28	WOS:000294208300002
J	Holmes, MV; Newcombe, P; Hubacek, JA; Sofat, R; Ricketts, SL; Cooper, J; Breteler, MMB; Bautista, LE; Sharma, P; Whittaker, JC; Smeeth, L; Fowkes, FGR; Algra, A; Shmeleva, V; Szolnoki, Z; Roest, M; Linnebank, M; Zacho, J; Nalls, MA; Singleton, AB; Ferrucci, L; Hardy, J; Worrall, BB; Rich, SS; Matarin, M; Norman, PE; Flicker, L; Almeida, OP; van Bockxmeer, FM; Shimokata, H; Khaw, KT; Wareham, NJ; Bobak, M; Sterne, JAC; Smith, GD; Talmud, PJ; van Duijn, C; Humphries, SE; Price, JF; Ebrahim, S; Lawlor, DA; Hankey, GJ; Meschia, JF; Sandhu, MS; Hingorani, AD; Casas, JP				Holmes, Michael V.; Newcombe, Paul; Hubacek, Jaroslav A.; Sofat, Reecha; Ricketts, Sally L.; Cooper, Jackie; Breteler, Monique M. B.; Bautista, Leonelo E.; Sharma, Pankaj; Whittaker, John C.; Smeeth, Liam; Fowkes, F. Gerald R.; Algra, Ale; Shmeleva, Veronika; Szolnoki, Zoltan; Roest, Mark; Linnebank, Michael; Zacho, Jeppe; Nalls, Michael A.; Singleton, Andrew B.; Ferrucci, Luigi; Hardy, John; Worrall, Bradford B.; Rich, Stephen S.; Matarin, Mar; Norman, Paul E.; Flicker, Leon; Almeida, Osvaldo P.; van Bockxmeer, Frank M.; Shimokata, Hiroshi; Khaw, Kay-Tee; Wareham, Nicholas J.; Bobak, Martin; Sterne, Jonathan A. C.; Smith, George Davey; Talmud, Philippa J.; van Duijn, Cornelia; Humphries, Steve E.; Price, Jackie F.; Ebrahim, Shah; Lawlor, Debbie A.; Hankey, Graeme J.; Meschia, James F.; Sandhu, Manjinder S.; Hingorani, Aroon D.; Casas, Juan P.			Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials	LANCET			English	Article							CORONARY-HEART-DISEASE; FOLIC-ACID SUPPLEMENTATION; METHYLENETETRAHYDROFOLATE-REDUCTASE; CARDIOVASCULAR-DISEASE; B-VITAMINS; C677T POLYMORPHISM; LOWERING HOMOCYSTEINE; PLASMA HOMOCYSTEINE; VASCULAR-DISEASE; ISCHEMIC-STROKE	Background The MTHFR 677C -> T polymorphism has been associated with raised homocysteine concentration and increased risk of stroke. A previous overview showed that the effects were greatest in regions with low dietary folate consumption, but differentiation between the effect of folate and small-study bias was difficult. A meta-analysis of randomised trials of homocysteine-lowering interventions showed no reduction in coronary heart disease events or stroke, but the trials were generally set in populations with high folate consumption. We aimed to reduce the effect of small-study bias and investigate whether folate status modifies the association between MTHFR 677C -> T and stroke in a genetic analysis and meta-analysis of randomised controlled trials. Methods We established a collaboration of genetic studies consisting of 237 datasets including 59 995 individuals with data for homocysteine and 20 885 stroke events. We compared the genetic findings with a meta-analysis of 13 randomised trials of homocysteine-lowering treatments and stroke risk (45 549 individuals, 2314 stroke events, 269 transient ischaemic attacks). Findings The effect of the MTHFR 677C -> T variant on homocysteine concentration was larger in low folate regions (Asia; difference between individuals with TT versus CC genotype, 3.12 mu mol/L, 95% CI 2.23 to 4.01) than in areas with folate fortification (America, Australia, and New Zealand, high; 0.13 mu mol/L, -0.85 to 1.11). The odds ratio (OR) for stroke was also higher in Asia (1.68, 95% CI 1.44 to 1.97) than in America, Australia, and New Zealand, high (1.03, 0.84 to 1.25). Most randomised trials took place in regions with high or increasing population folate concentrations. The summary relative risk (RR) of stroke in trials of homocysteine-lowering interventions (0 94, 95% CI 085 to 1.04) was similar to that predicted for the same extent of homocysteine reduction in large genetic studies in populations with similar folate status (predicted RR 1.00, 95% CI 0.90 to 1.11). Although the predicted effect of homocysteine reduction from large genetic studies in low folate regions (Asia) was larger (RR 0.78, 95% CI 0.68 to 0.90), no trial has evaluated the effect of lowering of homocysteine on stroke risk exclusively in a low folate region. Interpretation In regions with increasing levels or established policies of population folate supplementation, evidence from genetic studies and randomised trials is concordant in suggesting an absence of benefit from lowering of homocysteine for prevention of stroke. Further large-scale genetic studies of the association between MTHFR 677C -> T and stroke in low folate settings are needed to distinguish effect modification by folate from small-study bias. If future randomised trials of homocysteine-lowering interventions for stroke prevention are undertaken, they should take place in regions with low folate consumption.	[Holmes, Michael V.; Bobak, Martin; Hingorani, Aroon D.; Casas, Juan P.] UCL, Res Dept Epidemiol & Publ Hlth, London, England; [Sofat, Reecha; Hingorani, Aroon D.] UCL, Dept Clin Pharmacol, London, England; [Cooper, Jackie; Talmud, Philippa J.; Humphries, Steve E.] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Genet, London, England; [Matarin, Mar] UCL, Dept Clin & Expt Epilepsy, London, England; [Hardy, John] UCL, Inst Neurol, London, England; [Newcombe, Paul; Whittaker, John C.; Smeeth, Liam; Ebrahim, Shah; Casas, Juan P.] London Sch Hyg & Trop Med, Fac Epidemiol & Publ Hlth, London WC1E 7HT, England; [Newcombe, Paul; Whittaker, John C.] GlaxoSmithKline, Genet, R&D, Stevenage, Herts, England; [Hubacek, Jaroslav A.] Inst Clin & Expt Med, Prague, Czech Republic; [Hubacek, Jaroslav A.] Cardiovasc Res Ctr, Prague, Czech Republic; [Ricketts, Sally L.] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge, England; [Khaw, Kay-Tee] Univ Cambridge, Sch Clin Med, Clin Gerontol Unit, Cambridge, England; [Wareham, Nicholas J.] Univ Cambridge, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Sandhu, Manjinder S.] Wellcome Trust Sanger Inst, Genet Epidemiol Grp, Cambridge, England; [Breteler, Monique M. B.; van Duijn, Cornelia] Univ Med Ctr, Dept Epidemiol, Erasmus MC, Rotterdam, Netherlands; [Breteler, Monique M. B.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Bautista, Leonelo E.] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI USA; [Sharma, Pankaj] Univ London Imperial Coll Sci Technol & Med, ICCRU, London, England; [Fowkes, F. Gerald R.; Price, Jackie F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Algra, Ale] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Shmeleva, Veronika] Russian Inst Haematol & Transfus, St Petersburg, Russia; [Szolnoki, Zoltan] Pandy Cty Hosp, Dept Neurol, Gyula, Hungary; [Algra, Ale] Univ Med Ctr Utrecht, Utrecht Stroke Ctr, Dept Neurol, Utrecht, Netherlands; [Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr, Utrecht, Netherlands; [Roest, Mark] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands; [Linnebank, Michael] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Zacho, Jeppe] Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Nalls, Michael A.; Singleton, Andrew B.] NIA, Neurogenet Lab, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Ferrucci, Luigi] NIA, Baltimore, MD 21224 USA; [Worrall, Bradford B.] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Norman, Paul E.] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia; [Flicker, Leon; Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA 6009, Australia; [van Bockxmeer, Frank M.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Flicker, Leon; Almeida, Osvaldo P.] WACHA, Western Australia Inst Med Res, Perth, WA, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia; [van Bockxmeer, Frank M.] Royal Perth Hosp, Cardiovasc Genet Lab, Div Lab Med, Perth, WA, Australia; [Shimokata, Hiroshi] Natl Ctr Geriatr & Gerontol, Obu City, Japan; [Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Sterne, Jonathan A. C.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Meschia, James F.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; Institute for Clinical & Experimental Medicine (IKEM); University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Wisconsin System; University of Wisconsin Madison; Imperial College London; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Russian Research Institute of Hematology & Transfusiology; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Zurich; University Zurich Hospital; University of Copenhagen; Herlev & Gentofte Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Virginia; University of Virginia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; National Center for Geriatrics & Gerontology; University of Bristol; University of Bristol; Mayo Clinic	Casas, JP (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.	juan.pablo-casas@lshtm.ac.uk	Flicker, Leon/AAE-1530-2022; Norman, Paul E/C-5485-2013; Meschia, James/GPP-1636-2022; Hankey, Graeme J/H-4968-2014; sharma, pankaj/HGE-4423-2022; Breteler, Monique M.B./J-5058-2014; Hubacek, Jaroslav Alois/AAN-6134-2021; Almeida, Osvaldo P./A-4925-2008; Matarin, Mar/F-1771-2016; Hardy, John/C-2451-2009; Singleton, Andrew B/C-3010-2009; Khaw, Kay-Tee/AAZ-3209-2021; Whittaker, John C/B-8609-2012; Sterne, Jonathan/Z-3106-2019; Papayan, Lydmila/X-1279-2019; Davey Smith, George/A-7407-2013; Smeeth, Liam/X-5862-2018	Flicker, Leon/0000-0002-3650-0475; Norman, Paul E/0000-0003-3406-0506; Meschia, James/0000-0002-4475-8142; Hankey, Graeme J/0000-0002-6044-7328; Breteler, Monique M.B./0000-0002-0626-9305; Hubacek, Jaroslav Alois/0000-0001-6537-1353; Almeida, Osvaldo P./0000-0002-8689-6199; Matarin, Mar/0000-0002-4717-5735; Hardy, John/0000-0002-3122-0423; Whittaker, John C/0000-0002-3529-2379; Sterne, Jonathan/0000-0001-8496-6053; Davey Smith, George/0000-0002-1407-8314; Talmud, Philippa/0000-0002-5560-1933; Bautista, Leonelo/0000-0002-9151-6920; Humphries, Stephen E/0000-0002-8221-6547; Rich, Stephen/0000-0003-3872-7793; Ricketts, Sally/0000-0002-5644-7958; Price, Jackie/0000-0003-3251-3970; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Sofat, Reecha/0000-0002-0242-6115; Hingorani, Aroon/0000-0001-8365-0081; Lawlor, Debbie A/0000-0002-6793-2262; s, hema/0000-0002-3440-9475; Smeeth, Liam/0000-0002-9168-6022; Van Duijn, Cornelia/0000-0002-2374-9204; Bobak, Martin/0000-0002-2633-6851	GlaxoSmithKline; AstraZeneca; Bayer; Boehringer Ingelheim; Merck Serono; Eisai; Johnson Johnson; NIH; Sanofi-Aventis; Sobering-Plough; Pfizer; Medical Research Council [G0802432, G0600580, 00023001]; British Heart Foundation [FS/07/011, FS05/125, RG/08/008]; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for Health Research and Development; Netherlands Organisation for Scientific Research; Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission; Municipality of Rotterdam; UK Department of Health; Wellcome Trust [082178]; Netherlands Heart Foundation [2001.06g]; Brain Foundation Netherlands [gF01.15]; Danish Medical Research Council; Danish Heart Foundation; Chief Physician Johan Boserup and Use Boserup's Fund; US National Institute of Neurological Disorders and Stroke [R01 NS39987, R01 NS42733]; National Institute on Aging, National Institutes of Health, Department of Health and Human Services [Z01 AG000015-50, Z01 AG000954-06, 2003-078]; National Center for Geriatrics and Gerontology, Japan [23-33]; National Health and Medical Research Council of Australia [279408, 379600, 403963, 513823]; Wellcome Trust; US National Institute of Aging; UK Medical Research Council [G0600705]; University of Bristol; British Heart Foundation Chair of Cardiovascular Genetics; Department of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042733, R01NS039987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000965, Z01AG000015, Z01AG000954] Funding Source: NIH RePORTER; MRC [G0600705, G0802432, G0600580] Funding Source: UKRI; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish; Medical Research Council [G0401527, G0600705, MC_U106179471, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Merck Serono(Merck & Company); Eisai(Eisai Co Ltd); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi-Aventis(Sanofi-Aventis); Sobering-Plough; Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; UK Department of Health; Wellcome Trust(Wellcome Trust); Netherlands Heart Foundation(Netherlands Heart Foundation); Brain Foundation Netherlands; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Heart Foundation; Chief Physician Johan Boserup and Use Boserup's Fund; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Geriatrics and Gerontology, Japan; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome Trust); US National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; British Heart Foundation Chair of Cardiovascular Genetics; Department of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	PN is a full-time employee of GlaxoSmithKline. PS has received honoraria for lecturing in industry-sponsored meetings and has received industry funding for attending national and international meetings. He has also received research grants from pharmaceutical companies and has been a paid consultant to the biotech industry and a member of industry advisory boards. JCW owns shares in GlaxoSmithlaine and is 90% employed at GlaxoSmithKline while retaining a 10% appointment at the London School of Hygiene and Tropical Medicine. LS has received consultancy fees from GlaxoSmithKline. FGRF has received funding from AstraZeneca for consultancy and grants from Bayer. AA received fees from Boehringer Ingelheim for consultancy, speaker fees, and participation in international advisory board meetings. He is a principal investigator of ESPIRIT, the European/Australian Stroke Prevention in Reversible Ischaemia Trial, a trial that was run independently of any pharmaceutical company, and in 2006, after completion and full analysis of ESPRIT, the study group accepted financial support from Boehringer Ingelheim for post-hoc exploratory analyses of the ESPRIT trial data. For this purpose a contract was signed in negotiated complete scientific freedom. ML has received money for board membership, consultancy, expert testimony, grants, and lectures from various pharmaceutical companies. JH has received consultancy fees from Merck Serono, Eisai, and Johnson & Johnson. BBW is co-principal investigator of the NIH funded GARNET, which funds genome-wide association studies of genetic samples from the Vitamin Intervention as Stroke Prevention randomised controlled trial. GH has received funds from Johnson & Johnson (executive committee for ROCKET-AF trial); Sanofi-Aventis (executive committee BOREALIS trial); Sobering-Plough (steering committee TRA 2P TIMI 50 trial); Pradaxa (dabigatran) advisory board, Australia; and payment for lectures at sponsored scientific symposia by Sanofi-Aventis and Pfizer.; We thank Robert Clarke, Sarah Parish, and Derrick A Bennett (Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, UK) for their insightful comments and advice; Barbara Voetsch, Yiingdong Zhang, Nina Salooja, Myeong-Kyu Kim, Hugh Markus, Ahamad Hassan, Koichi Miyaki, Jose Maria Grasa Ullrich, Belen Sanchez, Hui Rutai, Emel Gurkan, Nam Keun Kim, Tomohiro Katsuya, Ravindra Varma Alluri, Renu Saxena, Larry Baum, Kostantinos Kostulas, Fahri Ucar, Ali Sazci, Byung-Ok Choi, Yan Zhen Zheng, Christine Mannhalter, Bossella Marcucci, Alessandro Pezzini, John Eikelboom, Xin Fang, Use Lotte Husemoen, and Hiroki Narnba for providing relevant information about the genotype frequencies, homocysteine, and folic acid concentrations from their studies; and Dave Leon for his valuable comments on the report. Funding for this study was from: a Population Health Scientist Fellowship, Medical Research Council (G0802432; MVH); the Medical Research Council (G0600580; PN); Project 00023001 (IKEM; JAI-I); British Heart Foundation (Schillingford) clinical training fellowship (FS/07/011; RS); British Heart Foundation (SLR, FP); Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands Organization for Health Research and Development, The Netherlands Organisation for Scientific Research, the Research Institute for Diseases in the Elderly, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam (The Rotterdam Study; MMMB, CVD); UK Department of Health Senior Fellowship (PS); Senior Clinical Fellowship from the Wellcome Trust (082178, LS); British Heart Foundation (Edinburgh Artery Study, FGRF); the Netherlands Heart Foundation (2001.06g) and the Brain Foundation Netherlands (gF01.15; the RATIO Study; AA); the Danish Medical Research Council, the Danish Heart Foundation, and Chief Physician Johan Boserup and Use Boserup's Fund (JZ); the US National Institute of Neurological Disorders and Stroke, grant numbers R01 NS39987 and R01 NS42733 (ISGS and SWISS: MAN, ABS, LF, JH, BBW, SR, MM, J FM); Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services (LF; project numbers Z01 AG000015-50 and Z01 AG000954-06, human subjects protocol number 2003-078; portions of this study used the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health); Research Funding for Longevity Sciences (23-33) from the National Center for Geriatrics and Gerontology, Japan (HS); the National Health and Medical Research Council of Australia (the Health In Men Study, project grants 279408, 379600, 403963, and 513823; PEN, LF, OA, FvB, GH); Wellcome Trust and the US National Institute of Aging (the HAPIEE study; MB); the UK Medical Research Council (G0600705) and the University of Bristol (GDS and DAL); British Heart Foundation Chair of Cardiovascular Genetics (SD); British Heart Foundation Senior Fellowship (FS05/125; ADH); British Heart Foundation (RG/08/008; SEH, PJT, ADH); and the Department of Health Policy Research Programme and British Heart Foundation (the British Women's Heart and Health Study; SE). The views expressed in the publication are those of the authors and not necessarily those of any funding bodies.	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; [Anonymous], NCT00794885 CSPPT; Armitage JM, 2008, CIRCULATION, V118, P2310; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Brattstrom L, 2000, AM J CLIN NUTR, V72, P315; Casas JP, 2005, LANCET, V365, P224, DOI 10.1016/S0140-6736(05)70152-5; Chen ZM, 2005, INT J EPIDEMIOL, V34, P1243, DOI 10.1093/ije/dyi174; Chiuve SE, 2005, AM J CLIN NUTR, V82, P155, DOI 10.1093/ajcn/82.1.155; Clarke R, 2007, CLIN CHEM LAB MED, V45, P1575, DOI 10.1515/CCLM.2007.346; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Day N, 1999, BRIT J CANCER, V80, P95; de Bree A, 2003, AM J CLIN NUTR, V77, P687, DOI 10.1093/ajcn/77.3.687; Drenos F, 2009, HUM MOL GENET, V18, P2305, DOI 10.1093/hmg/ddp159; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eichholzer M, 2006, LANCET, V367, P1352, DOI 10.1016/S0140-6736(06)68582-6; Frederiksen J, 2004, BLOOD, V104, P3046, DOI 10.1182/blood-2004-03-0897; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; He K, 2004, STROKE, V35, P169, DOI 10.1161/01.STR.0000106762.55994.86; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hindorff LA, CATALOG PUBLISHED GE; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; House AA, 2010, JAMA-J AM MED ASSOC, V303, P1603, DOI 10.1001/jama.2010.490; Hustad S, 2007, AM J HUM GENET, V80, P846, DOI 10.1086/513520; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Jamison RL, 2007, JAMA-J AM MED ASSOC, V298, P1163, DOI 10.1001/jama.298.10.1163; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Kostulas K, 2008, ACTA NEUROL SCAND, V118, P146, DOI 10.1111/j.1600-0404.2008.00995.x; Lalouschek W, 2007, CLIN CHEM, V53, P600, DOI 10.1373/clinchem.2006.073494; Lawrence R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-367; Lewis SJ, 2005, BMJ-BRIT MED J, V331, P1053, DOI 10.1136/bmj.38611.658947.55; Li Cai-ming, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P264; Li ZH, 2003, STROKE, V34, P2085, DOI 10.1161/01.STR.0000086753.00555.0D; Liem A, 2005, HEART, V91, P1213, DOI 10.1136/hrt.2004.035030; Little J, HUGE REV HDB; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Meschia James F, 2003, BMC Neurol, V3, P4, DOI 10.1186/1471-2377-3-4; Meschia James F, 2002, BMC Med Genet, V3, P1, DOI 10.1186/1471-2350-3-1; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Pare G, 2009, CIRC-CARDIOVASC GENE, V2, P142, DOI 10.1161/CIRCGENETICS.108.829804; Righetti M, 2006, BLOOD PURIFICAT, V24, P379, DOI 10.1159/000093680; Sharp L, 2008, BRIT J NUTR, V99, P379, DOI 10.1017/S0007114507801073; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Somarajan BI, 2011, J NEUROL SCI, V304, P67, DOI 10.1016/j.jns.2011.02.010; Stern LL, 2000, CANCER EPIDEM BIOMAR, V9, P849; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Szolnoki Z, 2005, ACTA NEUROL SCAND, V111, P29, DOI 10.1111/j.1600-0404.2004.00345.x; Szolnoki Z, 2003, J NEUROL NEUROSUR PS, V74, P1615, DOI 10.1136/jnnp.74.12.1615; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Tsai MY, 2009, MOL GENET METAB, V98, P181, DOI 10.1016/j.ymgme.2009.05.012; Ueland PM, 2000, AM J CLIN NUTR, V72, P324; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Wrone EM, 2004, J AM SOC NEPHROL, V15, P420, DOI 10.1097/01.ASN.0000110181.64655.6C; Yamada Y, 2006, ARTERIOSCL THROM VAS, V26, P1920, DOI 10.1161/01.ATV.0000229694.97827.38; Zhu L, 2008, FOOD NUTR BULL, V29, pS196, DOI 10.1177/15648265080292S123; Zoungas S, 2006, J AM COLL CARDIOL, V47, P1108, DOI 10.1016/j.jacc.2005.10.064	62	234	258	1	64	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2011	378	9791					584	594		10.1016/S0140-6736(11)60872-6	http://dx.doi.org/10.1016/S0140-6736(11)60872-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812UX	21803414	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000294319500030
J	Shetty, P				Shetty, Priya			Nora Volkow-challenging the myths about drug addiction	LANCET			English	Biographical-Item																			0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 6	2011	378	9790					477	477		10.1016/S0140-6736(11)61239-7	http://dx.doi.org/10.1016/S0140-6736(11)61239-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809SO	21821175	Bronze			2022-12-28	WOS:000294077200014
J	Liu, ZY				Liu, Zhengyu			Glacial Cycles and Indian Monsoon-A Southern Push	SCIENCE			English	Editorial Material							SUMMER MONSOON		[Liu, Zhengyu] Univ Wisconsin Madison, Ctr Climat Res, Madison, WI 53706 USA; [Liu, Zhengyu] Univ Wisconsin Madison, Dept Atmospher Ocean & Space Sci, Madison, WI 53706 USA; [Liu, Zhengyu] Peking Univ, Lab Climate & Ocean Atmosphere Studies, Beijing 100871, Peoples R China	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Peking University	Liu, ZY (corresponding author), Univ Wisconsin Madison, Ctr Climat Res, Madison, WI 53706 USA.	zliu3@wisc.edu						An ZS, 2011, SCIENCE, V333, P719, DOI 10.1126/science.1203752; Boos WR, 2010, NATURE, V463, P218, DOI 10.1038/nature08707; IPCC, 2007, CLIMATE CHANGE 2007; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001071; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; RODWELL MJ, 1995, J ATMOS SCI, V52, P1341, DOI 10.1175/1520-0469(1995)052<1341:AMOTAS>2.0.CO;2; Tomas RA, 1997, Q J ROY METEOR SOC, V123, P1445, DOI 10.1002/qj.49712354202; Webster P.J., 2003, ENCY ATMOSPHERIC SCI, P1370, DOI DOI 10.1016/B0-12-227090-8/00236-0	9	9	9	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					706	708		10.1126/science.1210019	http://dx.doi.org/10.1126/science.1210019			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817038				2022-12-28	WOS:000293512100027
J	Angel, A; Song, J; Dean, C; Howard, M				Angel, Andrew; Song, Jie; Dean, Caroline; Howard, Martin			A Polycomb-based switch underlying quantitative epigenetic memory	NATURE			English	Article							ARABIDOPSIS-THALIANA; VERNALIZATION; CHROMATIN; PROTEIN; FLC; METHYLATION; INFORMATION; PROPAGATION; INHERITANCE; REPRESSOR	The conserved Polycomb repressive complex 2 (PRC2) generates trimethylation of histone 3 lysine 27 (H3K27me3)(1,2), a modification associated with stable epigenetic silencing(3,4). Much is known about PRC2-induced silencing but key questions remain concerning its nucleation and stability. Vernalization, the perception and memory of winter in plants, is a classic epigenetic process that, in Arabidopsis, involves PRC2-based silencing of the floral repressor FLC(5,6). The slow dynamics of vernalization, taking place over weeks in the cold, generate a level of stable silencing of FLC in the subsequent warm that depends quantitatively on the length of the prior cold. These features make vernalization an ideal experimental system to investigate both the maintenance of epigenetic states and the switching between them. Here, using mathematical modelling, chromatin immunoprecipitation and an FLC:GUS reporter assay, we show that the quantitative nature of vernalization is generated by H3K27me3-mediated FLC silencing in the warm in a subpopulation of cells whose number depends on the length of the prior cold. During the cold, H3K27me3 levels progressively increase at a tightly localized nucleation region within FLC. At the end of the cold, numerical simulations predict that such a nucleation region is capable of switching the bistable epigenetic state of an individual locus, with the probability of overall FLC coverage by silencing H3K27me3 marks depending on the length of cold exposure. Thus, the model predicts a bistable pattern of FLC gene expression in individual cells, a prediction we verify using the FLC: GUS reporter system. Our proposed switching mechanism, involving the local nucleation of an opposing histone modification, is likely to be widely relevant in epigenetic reprogramming.	[Song, Jie; Dean, Caroline] John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Angel, Andrew; Howard, Martin] John Innes Ctr, Dept Computat & Syst Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dean, C (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	caroline.dean@jic.ac.uk; martin.howard@jic.ac.uk	Howard, Martin/C-3629-2016	Howard, Martin/0000-0001-7670-0781; Dean, Caroline/0000-0002-6555-3525	European Research Council; Biotechnology and Biological Sciences Research Council; Royal Society; BBSRC [BBS/E/J/000CA369, BBS/E/J/000C0637] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C519670/1, BBS/E/J/000C0637, BBS/E/J/000CA369] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all members of the C. D. and M. H. groups for discussions. We also thank S. Costa for suggestions to improve the FLC:GUS imagery and V. Grieneisen, S. Maree, R. Morris, S. Swiezewski and P. Wigge for comments on the manuscript. This research was supported by an Advanced Investigator European Research Council grant and the Core Strategic Grant from the Biotechnology and Biological Sciences Research Council to the John Innes Centre. M. H. also acknowledges support from The Royal Society.	Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; BURN JE, 1993, P NATL ACAD SCI USA, V90, P287, DOI 10.1073/pnas.90.1.287; David-Rus D, 2009, J THEOR BIOL, V258, P112, DOI 10.1016/j.jtbi.2008.12.021; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Grandjean O, 2004, PLANT CELL, V16, P74, DOI 10.1105/tpc.017962; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Kelemen JZ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000332; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mukhopadhyaya S, 2010, BIOSYSTEMS, V102, P49, DOI 10.1016/j.biosystems.2010.07.012; PIERIK RLM, 1970, CELLULAR MOL ASPECTS, P409; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Salazar JD, 2008, ACTA HORTIC, V803, P187, DOI 10.17660/ActaHortic.2008.803.24; Sedighi M, 2007, PHYS BIOL, V4, P246, DOI 10.1088/1478-3975/4/4/002; Sheldon CC, 2008, P NATL ACAD SCI USA, V105, P2214, DOI 10.1073/pnas.0711453105; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129	30	299	299	3	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					105	+		10.1038/nature10241	http://dx.doi.org/10.1038/nature10241			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21785438				2022-12-28	WOS:000293447300039
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN Bariatric surgery and justice in an imperfect world	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						Beckett Samuel, 2010, WAITING GODOT; Dyer C, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4894; WAGNER A, PUBLIC PURSE STAYS C	3	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2011	343								d4944	10.1136/bmj.d4944	http://dx.doi.org/10.1136/bmj.d4944			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	805NM	21810883				2022-12-28	WOS:000293734600007
J	Balch, AL				Balch, Alan L.			H2O in a Desert of Carbon Atoms	SCIENCE			English	Editorial Material							WATER; ENCAPSULATION; CLUSTERS; C-60		Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis	Balch, AL (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	albalch@ucdavis.edu						CRAM DJ, 1991, ANGEW CHEM INT EDIT, V30, P1024, DOI 10.1002/anie.199110241; Garric J, 2007, CHEM-EUR J, V13, P8454, DOI 10.1002/chem.200700640; Hirsch A, 2010, NAT MATER, V9, P868, DOI 10.1038/nmat2885; Komatsu K, 2005, SCIENCE, V307, P238, DOI 10.1126/science.1106185; Kurotobi K, 2011, SCIENCE, V333, P613, DOI 10.1126/science.1206376; Lakshminarayanan PS, 2005, J AM CHEM SOC, V127, P13132, DOI 10.1021/ja054068w; Lu X, 2011, CHEM COMMUN, V47, P5942, DOI 10.1039/c1cc10123d; Ludwig R, 2001, ANGEW CHEM INT EDIT, V40, P1808, DOI 10.1002/1521-3773(20010518)40:10<1808::AID-ANIE1808>3.3.CO;2-T; Mal P, 2009, SCIENCE, V324, P1697, DOI 10.1126/science.1175313; Ramachandran CN, 2008, CHEM PHYS LETT, V461, P87, DOI 10.1016/j.cplett.2008.06.073; Ramachandran CN, 2005, CHEM PHYS LETT, V410, P348, DOI 10.1016/j.cplett.2005.04.113; Rodriguez-Fortea A, 2011, CHEM SOC REV, V40, P3551, DOI 10.1039/c0cs00225a; Saeed MA, 2010, CRYST GROWTH DES, V10, P1486, DOI 10.1021/cg100161a; Smith BW, 1998, NATURE, V396, P323, DOI 10.1038/24521; Solomon S., 2010, WATER EPIC STRUGGLE; Yagi K, 2009, INT J QUANTUM CHEM, V109, P2080, DOI 10.1002/qua.22066	16	16	16	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					531	532		10.1126/science.1209388	http://dx.doi.org/10.1126/science.1209388			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798920				2022-12-28	WOS:000293222400030
J	Bocquet-Appel, JP				Bocquet-Appel, Jean-Pierre			When the World's Population Took Off: The Springboard of the Neolithic Demographic Transition	SCIENCE			English	Editorial Material							ORIGIN	During the economic transition from foraging to farming, the signal of a major demographic shift can be observed in cemetery data of world archaeological sequences. This signal is characterized by an abrupt increase in the proportion of juvenile skeletons and is interpreted as the signature of a major demographic shift in human history, known as the Neolithic Demographic Transition (NDT). This expresses an increase in the input into the age pyramids of the corresponding living populations with an estimated increase in the total fertility rate of two births per woman. The unprecedented demographic masses that the NDT rapidly brought into play make this one of the fundamental structural processes of human history.										AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; Armelagos GJ, 2005, EVOL ANTHROPOL, V14, P109, DOI 10.1002/evan.20048; Bandy M. S., 2010, BECOMING VILLAGERS C, P1; Bellwood P, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P13, DOI 10.1007/978-1-4020-8539-0_2; Bellwood Peter, 2005, 1 FARMERS; BIRABEN JN, 1979, POPULATION, V34, P13, DOI 10.2307/1531855; Bocquet-Appel JP, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P35, DOI 10.1007/978-1-4020-8539-0_3; Bocquet-Appel JP, 2002, CURR ANTHROPOL, V43, P637, DOI 10.1086/342429; CHILDE VG, 1936, MAN MAKES HIMSELF; Drennan RD, 2006, P NATL ACAD SCI USA, V103, P3960, DOI 10.1073/pnas.0510862103; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Furuse Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-52; Guerrero E, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P57, DOI 10.1007/978-1-4020-8539-0_4; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Harris H. D., 2002, EXAMINING FARMING LA, P31; JOHANSSON SR, 1986, AM J PHYS ANTHROPOL, V71, P233, DOI 10.1002/ajpa.1330710211; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; da Silva MFM, 2011, J MED VIROL, V83, P357, DOI 10.1002/jmv.21968; Renfrew C., 2002, EXAMINING FARMING LA, P3; SATTENSPIEL L, 1983, AM ANTIQUITY, V48, P489, DOI 10.2307/280557; Valeggia C, 2004, J BIOSOC SCI, V36, P573, DOI 10.1017/S0021932003006382; Varien Mark D., 2010, BECOMING VILLAGERS C, P37; Vigne JD, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P179, DOI 10.1007/978-1-4020-8539-0_8; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94	25	223	224	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					560	561		10.1126/science.1208880	http://dx.doi.org/10.1126/science.1208880			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798934				2022-12-28	WOS:000293222400044
J	Colville, EJ; Carlson, AE; Beard, BL; Hatfield, RG; Stoner, JS; Reyes, AV; Ullman, DJ				Colville, Elizabeth J.; Carlson, Anders E.; Beard, Brian L.; Hatfield, Robert G.; Stoner, Joseph S.; Reyes, Alberto V.; Ullman, David J.			Sr-Nd-Pb Isotope Evidence for Ice-Sheet Presence on Southern Greenland During the Last Interglacial	SCIENCE			English	Article							SEA-LEVEL RISE; GLACIAL MAXIMUM; CLIMATE; CYCLES; CONSTRAINTS; INSOLATION; SEDIMENTS; HOLOCENE; HISTORY; RETREAT	To ascertain the response of the southern Greenland Ice Sheet (GIS) to a boreal summer climate warmer than at present, we explored whether southern Greenland was deglaciated during the Last Interglacial (LIG), using the Sr-Nd-Pb isotope ratios of silt-sized sediment discharged from southern Greenland. Our isotope data indicate that no single southern Greenland geologic terrane was completely deglaciated during the LIG, similar to the Holocene. Differences in sediment sources during the LIG relative to the early Holocene denote, however, greater southern GIS retreat during the LIG. These results allow the evaluation of a suite of GIS models and are consistent with a GIS contribution of 1.6 to 2.2 meters to the >= 4-meter LIG sea-level highstand, requiring a significant sea-level contribution from the Antarctic Ice Sheet.	[Colville, Elizabeth J.; Carlson, Anders E.; Beard, Brian L.; Reyes, Alberto V.; Ullman, David J.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA; [Hatfield, Robert G.; Stoner, Joseph S.] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA	University of Wisconsin System; University of Wisconsin Madison; Oregon State University	Carlson, AE (corresponding author), Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA.	acarlson@geology.wisc.edu	Hatfield, Robert/G-6854-2019	Hatfield, Robert/0000-0002-6372-0027; Reyes, Alberto/0000-0002-7838-4214	Geological Society of America; American Association of Petroleum Geologists; University of Wisconsin-Madison; Arctic Natural Sciences Division of NSF [0902571, 0902751]	Geological Society of America; American Association of Petroleum Geologists; University of Wisconsin-Madison; Arctic Natural Sciences Division of NSF	J. Briner and the Greenland Institute of Natural Resources kindly provided several stream and iceberg silt samples. E. Obbink, K. Winsor, B. Welke, S. Strano, and A. Leaf provided assistance in the field and laboratory. D. Kelly and C. Hillaire-Marcel supplied comments on this research and manuscript. A. de Vernal provided her pollen records. This research was supported by the Geological Society of America and American Association of Petroleum Geologists (E. J. C.), University of Wisconsin-Madison startup funds (A. E. C.), and the Arctic Natural Sciences Division of NSF, Arctic Natural Sciences grants 0902571 (A.E.C. and B.L.B.) and 0902751 (J.S.S.).	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Carlson AE, 2008, GEOLOGY, V36, P991, DOI 10.1130/G25080A.1; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Cuffey KM, 2000, NATURE, V404, P591, DOI 10.1038/35007053; Dawes PR, 2009, GEOL SURV DEN GREENL, P57; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; Evans HF, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001720; Fagel N, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000993; Hallet B, 1996, GLOBAL PLANET CHANGE, V12, P213, DOI 10.1016/0921-8181(95)00021-6; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Innocent C, 1997, EARTH PLANET SC LETT, V146, P607, DOI 10.1016/S0012-821X(96)00251-8; Koerner RM, 2002, ANN GLACIOL-SER, V35, P19, DOI 10.3189/172756402781817338; Kopp RE, 2009, NATURE, V462, P863, DOI 10.1038/nature08686; Lhomme N, 2005, QUATERNARY SCI REV, V24, P173, DOI 10.1016/j.quascirev.2004.08.020; Meehl G. A., 2007, PHYS BASIS CLIMATE C; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Rohling EJ, 2009, NAT GEOSCI, V2, P500, DOI 10.1038/ngeo557; Schurgers G, 2006, CLIM PAST, V2, P205, DOI 10.5194/cp-2-205-2006; STONER JS, 1995, GEOLOGY, V23, P241, DOI 10.1130/0091-7613(1995)023<0241:MPODSS>2.3.CO;2; Suwa M, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006032; Tarasov L, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001731; Thomas AL, 2009, SCIENCE, V324, P1186, DOI 10.1126/science.1168754; Thompson WG, 2005, SCIENCE, V308, P401, DOI 10.1126/science.1104035; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Yin QZ, 2010, NAT GEOSCI, V3, P243, DOI 10.1038/NGEO771	29	96	97	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					620	623		10.1126/science.1204673	http://dx.doi.org/10.1126/science.1204673			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798947				2022-12-28	WOS:000293222400059
J	Glaeser, E				Glaeser, Edward			Cities, Productivity, and Quality of Life	SCIENCE			English	Editorial Material							AGGLOMERATION; WEALTH	Technological changes and improved electronic communications seem, paradoxically, to be making cities more, rather than less, important. There is a strong correlation between urbanization and economic development across countries, and within-country evidence suggests that productivity rises in dense agglomerations. But urban economic advantages are often offset by the perennial urban curses of crime, congestion and contagious disease. The past history of the developed world suggests that these problems require more capable governments that use a combination of economic and engineering solutions. Though the scope of urban challenges can make remaining rural seem attractive, agrarian poverty has typically also been quite costly.	[Glaeser, Edward] Harvard Univ, Dept Econ, Sch Arts & Sci, Cambridge, MA 02138 USA; [Glaeser, Edward] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 01238 USA	Harvard University; Harvard University	Glaeser, E (corresponding author), Harvard Univ, Dept Econ, Sch Arts & Sci, Cambridge, MA 02138 USA.	eglaeser@harvard.edu						ARIAS E, 2010, NAT VIT STAT REP, V58; Bloom DE, 2008, SCIENCE, V319, P772, DOI 10.1126/science.1153057; Combes P.-P., 2010, AGGLOMERATION EC, P15; Cutler D., 2006, CORRUPTION REFORM LE, P153; Duranton Gilles, 2009, 15376 NAT BUR EC RES; Ellison G, 2010, AM ECON REV, V100, P1195, DOI 10.1257/aer.100.3.1195; Glaeser Edward, 2011, TRIUMPH CITY; Glaeser EL, 2010, J URBAN ECON, V67, P404, DOI 10.1016/j.jue.2009.11.006; Glaeser EL, 2009, J ECON LIT, V47, P983, DOI 10.1257/jel.47.4.983; Glaeser EL, 2001, J LABOR ECON, V19, P316, DOI 10.1086/319563; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; *NY CIT DEP HLTH M, 2008, SUMM VIT STAT 2008; *NY CIT DEP HLTH M, 1961, SUMM VIT STAT 1961; Rosenthal SS, 2003, REV ECON STAT, V85, P377, DOI 10.1162/003465303765299882; United Nations Population Fund, 2007, STAT WORLDS POP 2007; United Nations Statistics Division, 2008, DEM YB 2008; United Nations Statistics Division, NAT ACC MAIN AGGR DA; Xu JQ, 2010, NATL VITAL STAT REPO, V58; Zheng S., 2009, 15621 NAT BUR EC RES	19	120	128	6	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					592	594		10.1126/science.1209264	http://dx.doi.org/10.1126/science.1209264			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	798PI	21798941				2022-12-28	WOS:000293222400051
J	Lee, R				Lee, Ronald			The Outlook for Population Growth	SCIENCE			English	Review							UNITED-STATES; FERTILITY; DECLINE; FORECASTS	Projections of population size, growth rates, and age distribution, although extending to distant horizons, shape policies today for the economy, environment, and government programs such as public pensions and health care. The projections can lead to costly policy adjustments, which in turn can cause political and economic turmoil. The United Nations projects global population to grow from about 7 billion today to 9.3 billion in 2050 and 10.1 billion in 2100, while the Old Age Dependency Ratio doubles by 2050 and triples by 2100. How are such population projections made, and how certain can we be about the trends they foresee?	Univ Calif Berkeley, Dept Demog, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Lee, R (corresponding author), Univ Calif Berkeley, Dept Demog, 2232 Piedmont Ave, Berkeley, CA 94720 USA.	rlee@demog.berkeley.edu			National Institute on Aging [R37 AG025247, P30 AG01283]; NATIONAL INSTITUTE ON AGING [P30AG012839, R37AG025247] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research funding was provided by grants R37 AG025247 and P30 AG01283 from the National Institute on Aging. G. Donehower and C. Boe provided expert assistance with the figures and stochastic simulations.	Alho JM, 2008, UNCERTAIN DEMOGRAPHICS AND FISCAL SUSTAINABILITY, P1, DOI 10.1017/CBO9780511493393; [Anonymous], 1983, REGIONAL MODEL LIFE; BECKER GS, 1990, J POLIT ECON, V98, pS12, DOI 10.1086/261723; Bhat P.N. Mari, 1989, INDIAS HIST DEMOGRAP, P73; Bongaarts J, 1998, POPUL DEV REV, V24, P271, DOI 10.2307/2807974; Bongaarts J., 2000, 6 BILLION PROJECTING, V1st ed.; Bongaarts J, 2008, POPUL DEV REV, V34, P199, DOI 10.1111/j.1728-4457.2008.00217.x; Boserup Ester, 1981, POPULATION TECHNOLOG; Cohen J. E., 1995, MANY PEOPLE CAN EART; Cohen JE, 2008, P NATL ACAD SCI USA, V105, P15269, DOI 10.1073/pnas.0808185105; Crimmins EM, 2010, INT DIFFERENCES MORT; Girosi F., 2008, DEMOGRAPHIC FORECAST; Goldstein JR, 2009, POPUL DEV REV, V35, P663, DOI 10.1111/j.1728-4457.2009.00304.x; Lee R, 1998, AM ECON REV, V88, P237; Lee R, 2003, J ECON PERSPECT, V17, P167, DOI 10.1257/089533003772034943; LEE RD, 1994, J AM STAT ASSOC, V89, P1175, DOI 10.2307/2290980; Lee RD, 1998, POPUL DEV REV, V24, P156, DOI 10.2307/2808055; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Lee R, 2010, DEMOGRAPHY, V47, pS151; Li N, 2005, DEMOGRAPHY, V42, P575, DOI 10.1353/dem.2005.0021; Livi Bacci M., 2000, POPULATION EUROPE; Lutz W., 2004, END WORLD POPULATION; Malthus T., 1970, ESSAY PRINCIPLE POPU; Malthus TR, 1798, ESSAY PRINCIPLE POPU, V1; Mitchell B.R., 1975, EUROPEAN HIST STAT 1; Myrskyla M, 2009, NATURE, V460, P741, DOI 10.1038/nature08230; Nations United, 2011, WORLD POP PROSP 2010, V1; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Raftery Adrian E., 2009, WHITE PAPER PROBABIL; Sanderson WC, 2010, SCIENCE, V329, P1287, DOI 10.1126/science.1193647; STOTO MA, 1983, J AM STAT ASSOC, V78, P13, DOI 10.2307/2287094; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; UNAIDS, 2010, GLOB REP UNAIDS REP; United Nations Population Division, 1999, WORLD 6 BILL; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Wee CC, 2011, ANN INTERN MED, V154, P645, DOI 10.7326/0003-4819-154-10-201105170-00003	37	180	183	3	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					569	573		10.1126/science.1208859	http://dx.doi.org/10.1126/science.1208859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	798PI	21798936	Green Accepted			2022-12-28	WOS:000293222400046
J	Devakumar, D; Mandeville, K				Devakumar, Delan; Mandeville, Kate			Should UK membership exams be held overseas? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mandeville, Kate] London Sch Hyg & Trop Med, London, England; [Devakumar, Delan] UCL, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Mandeville, K (corresponding author), London Sch Hyg & Trop Med, London, England.	kate.mandeville@lshtm.ac.uk		Mandeville, Kate/0000-0002-5525-1574				[Anonymous], 2021, WHO GLOB COD PRACT I; [Anonymous], EX CTR OUTS UK 1; Crisp N, GLOBAL HLTH PARTNERS; Department of Health, FRAM NHS INV INT DEV; Lee ACK, 2011, J PUBLIC HEALTH-UK, V33, P310, DOI 10.1093/pubmed/fdr018; Mirza DM, 2010, EDUC PRIM CARE, V21, P132, DOI 10.1080/14739879.2010.11493895; NHS Employers, 2010, WORK TRAIN NAT HLTH; Royal College of General Practitioners, WHAT IS MRCGP INT; Royal College of Physicians, RCP S AS; Waterston T, 2009, LANCET, V373, P878, DOI 10.1016/S0140-6736(09)60104-5	10	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUL 28	2011	343								d4560	10.1136/bmj.d4560	http://dx.doi.org/10.1136/bmj.d4560			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801LT	21798971	Green Submitted			2022-12-28	WOS:000293441100004
J	Mishra, AC; Mehta, M; Mourya, DT; Gandhi, S				Mishra, Akhilesh C.; Mehta, Minesh; Mourya, Devendra T.; Gandhi, Sudhir			Crimean-Congo haemorrhagic fever in India	LANCET			English	Editorial Material									[Mishra, Akhilesh C.; Mourya, Devendra T.] Natl Inst Virol, Pune 411001, Maharashtra, India; [Mehta, Minesh] Shalby Hosp, Ahmadabad, Gujarat, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Mishra, AC (corresponding author), Natl Inst Virol, 20-A Dr Ambedkar Rd, Pune 411001, Maharashtra, India.	acm1750@gmail.com	Mehta, Minesh P./AAB-8915-2019	Mehta, Minesh P./0000-0002-4812-5713				Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.307; SHANMUGAM J, 1976, INDIAN J MED RES, V64, P1403	4	51	54	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 23	2011	378	9788					372	372		10.1016/S0140-6736(11)60680-6	http://dx.doi.org/10.1016/S0140-6736(11)60680-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21784269				2022-12-28	WOS:000293615800036
J	Bute, J; Waller, D				Bute, Jennifer; Waller, Derek			A PATIENT'S JOURNEY Dementia with cardiac problems	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Waller, Derek] Southampton Gen Hosp, Southampton SO16 6YD, Hants, England	University of Southampton	Bute, J (corresponding author), 47 Hapil Close, Sandford BS25 AA, Winscombe, England.	jennifer@kreativity.org							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 22	2011	343								d4278	10.1136/bmj.d4278	http://dx.doi.org/10.1136/bmj.d4278			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797ZK	21784881	Green Submitted, Bronze			2022-12-28	WOS:000293169000001
J	Challoner, DR; Vodra, WW				Challoner, David R.; Vodra, William W.			Medical Devices and Health - Creating a New Regulatory Framework for Moderate-Risk Devices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Challoner, David R.] Univ Florida, Gainesville, FL 32610 USA; [Vodra, William W.] Arnold & Porter LLP, Washington, DC USA	State University System of Florida; University of Florida	Challoner, DR (corresponding author), Univ Florida, Gainesville, FL 32610 USA.							Institute of Medicine, 2011, MED DEV PUBL HLTH FD; *OFF TECHN ASS, 1984, FED POL MED DEV, P128	2	54	55	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					977	979		10.1056/NEJMp1109150	http://dx.doi.org/10.1056/NEJMp1109150			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819UR	21830961				2022-12-28	WOS:000294857300003
J	Isbell, F; Calcagno, V; Hector, A; Connolly, J; Harpole, WS; Reich, PB; Scherer-Lorenzen, M; Schmid, B; Tilman, D; van Ruijven, J; Weigelt, A; Wilsey, BJ; Zavaleta, ES; Loreau, M				Isbell, Forest; Calcagno, Vincent; Hector, Andy; Connolly, John; Harpole, W. Stanley; Reich, Peter B.; Scherer-Lorenzen, Michael; Schmid, Bernhard; Tilman, David; van Ruijven, Jasper; Weigelt, Alexandra; Wilsey, Brian J.; Zavaleta, Erika S.; Loreau, Michel			High plant diversity is needed to maintain ecosystem services	NATURE			English	Article							GRASSLAND EXPERIMENT; BIOMASS PRODUCTION; CURRENT KNOWLEDGE; ELEVATED CO2; BIODIVERSITY; PRODUCTIVITY; COMMUNITIES; ECOLOGY; INSURANCE; STABILITY	Biodiversity is rapidly declining worldwide(1), and there is consensus that this can decrease ecosystem functioning and services(2-7). It remains unclear, though, whether few(8) or many(9) of the species in an ecosystem are needed to sustain the provisioning of ecosystem services. It has been hypothesized that most species would promote ecosystem services if many times, places, functions and environmental changes were considered(9); however, no previous study has considered all of these factors together. Here we show that 84% of the 147 grassland plant species studied in 17 biodiversity experiments promoted ecosystem functioning at least once. Different species promoted ecosystem functioning during different years, at different places, for different functions and under different environmental change scenarios. Furthermore, the species needed to provide one function during multiple years were not the same as those needed to provide multiple functions within one year. Our results indicate that even more species will be needed to maintain ecosystem functioning and services than previously suggested by studies that have either (1) considered only the number of species needed to promote one function under one set of environmental conditions, or (2) separately considered the importance of biodiversity for providing ecosystem functioning across multiple years(10-14), places(15,16), functions(14,17,18) or environmental change scenarios(12,19-22). Therefore, although species may appear functionally redundant when one function is considered under one set of environmental conditions(7), many species are needed to maintain multiple functions at multiple times and places in a changing world.	[Isbell, Forest; Calcagno, Vincent; Loreau, Michel] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Hector, Andy; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Connolly, John] Univ Coll Dublin, UCD Sch Math Sci, Dublin 4, Ireland; [Harpole, W. Stanley; Wilsey, Brian J.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Western Sydney, Hawkesbury Inst Environm, Richmond, NSW 2753, Australia; [Scherer-Lorenzen, Michael] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Tilman, David] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [van Ruijven, Jasper] Wageningen Univ, NL-6700 AA Wageningen, Netherlands; [Weigelt, Alexandra] Univ Leipzig, Inst Biol 1, D-04103 Leipzig, Germany; [Zavaleta, Erika S.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	McGill University; University of Zurich; University College Dublin; Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University; University of Freiburg; University of Minnesota System; University of Minnesota Twin Cities; Wageningen University & Research; Leipzig University; University of California System; University of California Santa Cruz	Isbell, F (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	forest.isbell@gmail.com	calcagno, vincent/B-1456-2015; van Ruijven, Jasper/D-9848-2011; Hector, Andrew/H-4199-2011; Harpole, William S/C-2814-2013; Schmid, Bernhard/C-8625-2009; Isbell, Forest/C-6915-2012; Tilman, David/ABD-5309-2021; Scherer-Lorenzen, Michael/AGB-4140-2022; van Ruijven, Jasper/ABE-7791-2020	calcagno, vincent/0000-0002-5781-967X; Hector, Andrew/0000-0002-1309-7716; Harpole, William S/0000-0002-3404-9174; Schmid, Bernhard/0000-0002-8430-3214; Isbell, Forest/0000-0001-9689-769X; Scherer-Lorenzen, Michael/0000-0001-9566-590X; van Ruijven, Jasper/0000-0003-0003-2363; Reich, Peter/0000-0003-4424-662X; Wilsey, Brian J./0000-0002-0628-5006	Swiss SystemsX.ch initiative [IPP-2008/23]; European Commission [ENV-CT95-0008]; Swiss Federal Office for Education and Science [EU-1311]; Deutsche Forschungsgemeinschaft (DFG) [FOR 456]; Friedrich Schiller University of Jena; Max Planck Society; University of Zurich; Swiss National Science Foundation [3100AO-107531]; ETH Zurich; Dutch Organisation for Scientific Research (NWO); EU Commission [852]; Science Foundation Ireland [09/RFP/EOB2546]; US Department of Energy [DOE/DE-FG02-96ER62291]; US National Science Foundation [0322057, LTER DEB 9411972, DEB 0080382, DEB 0620652, LTREB DEB 0716587, DEB 0639417]; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair program	Swiss SystemsX.ch initiative; European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss Federal Office for Education and Science; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich Schiller University of Jena; Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); Dutch Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EU Commission(European CommissionEuropean Commission Joint Research Centre); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); US Department of Energy(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair program(Canada Research Chairs)	We thank J. Byrnes, L. Gamfeldt and M. Emmerson for comments on an earlier version of this manuscript. We thank the Swiss SystemsX.ch initiative (IPP-2008/23) for supporting this project. The BIODEPTH project was funded by the European Commission within the Framework IV Environment and Climate Programme (ENV-CT95-0008) and by the Swiss Federal Office for Education and Science (Project EU-1311). The Jena Experiment was funded by the Deutsche Forschungsgemeinschaft (DFG, FOR 456), Friedrich Schiller University of Jena, Max Planck Society, University of Zurich, Swiss National Science Foundation (3100AO-107531) and ETH Zurich. The Wageningen experiment was funded by the Dutch Organisation for Scientific Research (NWO) within the framework of the Biodiversity Programme. Work on the Agrodiversity experiment was funded by the EU Commission through COST Action 852 and Science Foundation Ireland (09/RFP/EOB2546). The BioCON experiment was funded by the US Department of Energy (DOE/DE-FG02-96ER62291) and the US National Science Foundation (Biocomplexity 0322057, LTER DEB 9411972, DEB 0080382, DEB 0620652 and LTREB DEB 0716587). The MEND Irrigation, BioGEN and Rarity-Extinction experiments were funded by the US National Science Foundation (DEB 0639417). The Cedar Creek Biodiversity experiment was funded by the US National Science Foundation. M. L. was supported by The Natural Sciences and Engineering Research Council of Canada (Discovery Grant) and the Canada Research Chair program.	[Anonymous], 2005, EC HUM WELL BEING SY; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calcagno V, 2010, J STAT SOFTW, V34, P1; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Craine JM, 2003, ECOL LETT, V6, P623, DOI 10.1046/j.1461-0248.2003.00467.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; EHRLICH P, 1982, EXTINCTION CAUSES CO; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Griffin JN, 2009, OIKOS, V118, P1335, DOI 10.1111/j.1600-0706.2009.17572.x; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Isbell FI, 2008, OIKOS, V117, P996, DOI 10.1111/j.0030-1299.2008.16692.x; Isbell FI, 2011, OECOLOGIA, V165, P771, DOI 10.1007/s00442-010-1877-9; Kirwan L, 2007, J ECOL, V95, P530, DOI 10.1111/j.1365-2745.2007.01225.x; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Manly BFJ, 1997, RANDOMIZATION BOOTST; MCNAUGHTON SJ, 1977, AM NAT, V111, P515, DOI 10.1086/283181; Nyfeler D, 2009, J APPL ECOL, V46, P683, DOI 10.1111/j.1365-2664.2009.01653.x; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Ridder B, 2008, BIODIVERS CONSERV, V17, P781, DOI 10.1007/s10531-008-9316-5; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van Ruijven J, 2009, OIKOS, V118, P101, DOI 10.1111/j.1600-0706.2008.17119.x; Weigelt A, 2009, BIOGEOSCIENCES, V6, P1695, DOI 10.5194/bg-6-1695-2009; Wilsey BJ, 2009, ECOL LETT, V12, P432, DOI 10.1111/j.1461-0248.2009.01298.x; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	34	913	972	44	1461	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					199	U96		10.1038/nature10282	http://dx.doi.org/10.1038/nature10282			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21832994	Green Published, Green Accepted			2022-12-28	WOS:000294603900033
J	Dellomonaco, C; Clomburg, JM; Miller, EN; Gonzalez, R				Dellomonaco, Clementina; Clomburg, James M.; Miller, Elliot N.; Gonzalez, Ramon			Engineered reversal of the beta-oxidation cycle for the synthesis of fuels and chemicals	NATURE			English	Article							ESCHERICHIA-COLI; FATTY-ACIDS; CLOSTRIDIUM-ACETOBUTYLICUM; MOLECULAR CHARACTERIZATION; GLYCOLYTIC FLUX; METABOLISM; ENZYME; GENES; THIOLASE; GROWTH	Advanced (long-chain) fuels and chemicals are generated from short-chain metabolic intermediates through pathways that require carbon-chain elongation. The condensation reactions mediating this carbon-carbon bond formation can be catalysed by enzymes from the thiolase superfamily, including beta-ketoacyl-acyl-carrier protein (ACP) synthases, polyketide synthases, 3-hydroxy-3-methylglutaryl-CoA synthases, and biosynthetic thiolases(1). Pathways involving these enzymes have been exploited for fuel and chemical production, with fatty-acid biosynthesis (beta-ketoacyl-ACP synthases) attracting the most attention in recent years(2-4). Degradative thiolases, which are part of the thiolase superfamily and naturally function in the beta-oxidation of fatty acids(5,6), can also operate in the synthetic direction and thus enable carbon-chain elongation. Here we demonstrate that a functional reversal of the beta-oxidation cycle can be used as a metabolic platform for the synthesis of alcohols and carboxylic acids with various chain lengths and functionalities. This pathway operates with coenzyme A (CoA) thioester intermediates and directly uses acetylCoA for acyl-chain elongation (rather than first requiring ATP-dependent activation to malonyl-CoA), characteristics that enable product synthesis at maximum carbon and energy efficiency. The reversal of the beta-oxidation cycle was engineered in Escherichia coli and used in combination with endogenous dehydrogenases and thioesterases to synthesize n-alcohols, fatty acids and 3-hydroxy-, 3-keto- and trans-Delta(2)-carboxylic acids. The superior nature of the engineered pathway was demonstrated by producing higher-chain linear n-alcohols (C >= 4) and extracellular long-chain fatty acids (C > 10) at higher efficiency than previously reported(2,4,7-9). The ubiquitous nature of beta-oxidation, aldehyde/alcohol dehydrogenase and thioesterase enzymes has the potential to enable the efficient synthesis of these products in other industrial organisms.	[Dellomonaco, Clementina; Clomburg, James M.; Miller, Elliot N.; Gonzalez, Ramon] Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA; [Gonzalez, Ramon] Rice Univ, Dept Bioengn, Houston, TX 77005 USA	Rice University; Rice University	Gonzalez, R (corresponding author), Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA.	Ramon.Gonzalez@rice.edu	Gonzalez, Ramon/B-1961-2010					Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bond-Watts BB, 2011, NAT CHEM BIOL, V7, P222, DOI 10.1038/NCHEMBIO.537; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Cho BK, 2006, MICROBIOL-SGM, V152, P2207, DOI 10.1099/mic.0.28912-0; CHO HS, 1993, J BIOL CHEM, V268, P9238; Cirino PC, 2006, BIOTECHNOL BIOENG, V95, P1167, DOI 10.1002/bit.21082; Clark D. P., 2005, ESCHERICHIA COLI SAL, P343; Dellomonaco C, 2010, APPL ENVIRON MICROB, V76, P5067, DOI 10.1128/AEM.00046-10; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Dharmadi Y, 2005, J CHROMATOGR A, V1070, P89, DOI 10.1016/j.chroma.2005.02.075; DURRE P, 1987, APPL MICROBIOL BIOT, V26, P268; EICHLER K, 1994, MOL MICROBIOL, V13, P775, DOI 10.1111/j.1365-2958.1994.tb00470.x; EICHLER K, 1995, J BASIC MICROB, V35, P217, DOI 10.1002/jobm.3620350404; Eppler T, 1999, MOL MICROBIOL, V33, P1221, DOI 10.1046/j.1365-2958.1999.01570.x; FEIGENBAUM J, 1975, J BACTERIOL, V122, P407, DOI 10.1128/JB.122.2.407-411.1975; Feng Y, 2009, J BACTERIOL, V191, P6320, DOI 10.1128/JB.00835-09; Gonzalez R, 2002, BIOTECHNOL PROGR, V18, P6, DOI 10.1021/bp010121i; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; Handke P, 2011, METAB ENG, V13, P28, DOI 10.1016/j.ymben.2010.10.007; HARTMANIS MGN, 1984, APPL ENVIRON MICROB, V47, P1277, DOI 10.1128/AEM.47.6.1277-1283.1984; Jarboe LR, 2011, APPL MICROBIOL BIOT, V89, P249, DOI 10.1007/s00253-010-2912-9; JENKINS LS, 1987, J BACTERIOL, V169, P42, DOI 10.1128/jb.169.1.42-52.1987; Lalman JA, 2004, J AM OIL CHEM SOC, V81, P105, DOI 10.1007/s11746-004-0866-y; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nie L, 2008, BIOCHEMISTRY-US, V47, P9618, DOI 10.1021/bi801074e; OSMAN YA, 1987, J BACTERIOL, V169, P3726, DOI 10.1128/jb.169.8.3726-3736.1987; Papagianni M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-16; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Sambrook J., 2001, MOL CLONING LAB MANU; Shen CR, 2008, METAB ENG, V10, P312, DOI 10.1016/j.ymben.2008.08.001; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Walt A, 2002, J BACTERIOL, V184, P4044, DOI 10.1128/JB.184.14.4044-4047.2002; WIESENBORN DP, 1988, APPL ENVIRON MICROB, V54, P2717, DOI 10.1128/AEM.54.11.2717-2722.1988; YANG SY, 1990, J BIOL CHEM, V265, P10424; Yazdani SS, 2008, METAB ENG, V10, P340, DOI 10.1016/j.ymben.2008.08.005; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106; Zhuang ZH, 2008, BIOCHEMISTRY-US, V47, P2789, DOI 10.1021/bi702334h	40	413	474	6	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					355	U131		10.1038/nature10333	http://dx.doi.org/10.1038/nature10333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21832992				2022-12-28	WOS:000294206500043
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for Bladder Cancer: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							FLEXIBLE CYSTOSCOPY	Description: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for bladder cancer. Methods: The USPSTF performed a targeted literature search for new evidence on the benefits and harms of screening, the accuracy of primary care-feasible screening tests, and the benefits and harms of treatment. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults (I statement).	[Moyer, Virginia A.] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.				USPSTF; U.S. Congress mandates that the Agency for Healthcare Research and Quality	USPSTF; U.S. Congress mandates that the Agency for Healthcare Research and Quality	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	Aaronson DS, 2009, BJU INT, V104, P506, DOI 10.1111/j.1464-410X.2009.08417.x; American Academy of Family Physicians, 2011, REC CLIN PREV SERV B; American Cancer Society, 2010, BLADD CANC; Burke DM, 2002, BJU INT, V89, P347, DOI 10.1046/j.1464-4096.2001.01899.x; Chou R, 2010, EVIDENCE SYNTHESIS; Chou R, 2010, ANN INTERN MED, V153, P461, DOI 10.7326/0003-4819-153-7-201010050-00009; Collado A, 2000, J UROLOGY, V164, P1529, DOI 10.1016/S0022-5347(05)67021-8; Stav K, 2004, ISR MED ASSOC J, V6, P474; Stenzl A, 2009, EUR UROL, V55, P815, DOI 10.1016/j.eururo.2009.01.002; Turan H, 2006, INT J UROL, V13, P25, DOI 10.1111/j.1442-2042.2006.01219.x; *US PREV SERV TASK, 2004, SCREEN BLADD CANC BR	11	49	52	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4					246	+		10.7326/0003-4819-155-4-201108160-00008	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807KN	21844550				2022-12-28	WOS:000293896400005
J	Guillem, K; Bloem, B; Poorthuis, RB; Loos, M; Smit, AB; Maskos, U; Spijker, S; Mansvelder, HD				Guillem, Karine; Bloem, Bernard; Poorthuis, Rogier B.; Loos, Maarten; Smit, August B.; Maskos, Uwe; Spijker, Sabine; Mansvelder, Huibert D.			Nicotinic Acetylcholine Receptor beta 2 Subunits in the Medial Prefrontal Cortex Control Attention	SCIENCE			English	Article							REACTION-TIME-TASK; BASAL FOREBRAIN; INDUCED LESIONS; PERFORMANCE; RELEASE; RATS; ANTAGONIST; COGNITION; NEURONS; SYSTEMS	More than one-third of all people are estimated to experience mild to severe cognitive impairment as they age. Acetylcholine (ACh) levels in the brain diminish with aging, and nicotinic ACh receptor (nAChR) stimulation is known to enhance cognitive performance. The prefrontal cortex (PFC) is involved in a range of cognitive functions and is thought to mediate attentional focus. We found that mice carrying nAChR beta 2-subunit deletions have impaired attention performance. Efficient lentiviral vector-mediated reexpression of functional beta 2-subunit-containing nAChRs in PFC neurons of the prelimbic area (PrL) completely restored the attentional deficit but did not affect impulsive and motivational behavior. Our findings show that beta 2-subunit expression in the PrL PFC is sufficient for endogenous nAChR-mediated cholinergic regulation of attentional performance.	[Guillem, Karine; Bloem, Bernard; Poorthuis, Rogier B.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, CNCR, NL-1081 HV Amsterdam, Netherlands; [Loos, Maarten; Smit, August B.; Spijker, Sabine] Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, CNCR, NL-1081 HV Amsterdam, Netherlands; [Maskos, Uwe] Inst Pasteur, Dept Neurosci, Unite Neurobiol Integrat Syst Cholinerg, F-75724 Paris 15, France; [Maskos, Uwe] CNRS, URA2182, F-75724 Paris 15, France	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Mansvelder, HD (corresponding author), Vrije Univ Amsterdam, Dept Integrat Neurophysiol, CNCR, Neurosci Campus Amsterdam, NL-1081 HV Amsterdam, Netherlands.	huibert.mansvelder@cncr.vu.nl	Guillem, Karine/D-8705-2014; Loos, Maarten/A-2768-2012; Spijker, Sabine/F-2300-2011; Smit, August B/E-8410-2011; Mansvelder, Huibert/N-6138-2018	Guillem, Karine/0000-0002-9623-3698; Loos, Maarten/0000-0003-1629-2928; Mansvelder, Huibert/0000-0003-1365-5340; Spijker, Sabine/0000-0002-6814-2019	EU [HEALTH-F2-2007-202088]; Netherlands Organization for Scientific Research [917.76.360, 912.06.148]; Neurobasic PharmaPhenomics; VU University board	EU(European Commission); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Neurobasic PharmaPhenomics; VU University board	We thank J. Staal and H. Lodder. U. M. and A. B. S. received funding from the EU Seventh Framework Programme "Neurocypres" (HEALTH-F2-2007-202088); H. D. M., from the Netherlands Organization for Scientific Research (917.76.360 and 912.06.148), Neurobasic PharmaPhenomics, and the VU University board.	Avale ME, 2011, FASEB J, V25, P2145, DOI 10.1096/fj.10-178558; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dalley JW, 2004, CEREB CORTEX, V14, P922, DOI 10.1093/cercor/bhh052; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; Hahn B, 2003, NEUROPHARMACOLOGY, V44, P1054, DOI 10.1016/S0028-3908(03)00099-6; Howe WM, 2010, NEUROPSYCHOPHARMACOL, V35, P1391, DOI 10.1038/npp.2010.9; Kassam SM, 2008, J NEUROSCI, V28, P8756, DOI 10.1523/JNEUROSCI.2645-08.2008; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; Maruki K, 2003, NEUROSCI LETT, V351, P95, DOI 10.1016/j.neulet.2003.07.012; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MUIR JL, 1995, PSYCHOPHARMACOLOGY, V118, P82; Muir JL, 1996, BEHAV BRAIN RES, V82, P31, DOI 10.1016/S0166-4328(97)81106-0; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Parikh V, 2010, J NEUROSCI, V30, P3518, DOI 10.1523/JNEUROSCI.5712-09.2010; Poorthuis RB, 2009, BIOCHEM PHARMACOL, V78, P668, DOI 10.1016/j.bcp.2009.04.031; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Sarter M, 2009, NAT REV NEUROSCI, V10, P383, DOI 10.1038/nrn2635; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; STOLERMAN P, 1995, MED RES REV, V15, P47; Woolf NJ, 2011, BEHAV BRAIN RES, V221, P488, DOI 10.1016/j.bbr.2009.12.046	27	136	140	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					888	891		10.1126/science.1207079	http://dx.doi.org/10.1126/science.1207079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836018				2022-12-28	WOS:000293785400044
J	Mayorov, AS; Elias, DC; Mucha-Kruczynski, M; Gorbachev, RV; Tudorovskiy, T; Zhukov, A; Morozov, SV; Katsnelson, MI; Fal'ko, VI; Geim, AK; Novoselov, KS				Mayorov, A. S.; Elias, D. C.; Mucha-Kruczynski, M.; Gorbachev, R. V.; Tudorovskiy, T.; Zhukov, A.; Morozov, S. V.; Katsnelson, M. I.; Fal'ko, V. I.; Geim, A. K.; Novoselov, K. S.			Interaction-Driven Spectrum Reconstruction in Bilayer Graphene	SCIENCE			English	Article							BROKEN-SYMMETRY STATES; HIGH LANDAU-LEVELS; SUSPENDED GRAPHENE; TRANSPORT; PHASE; FIELD; METAL	The nematic phase transition in electronic liquids, driven by Coulomb interactions, represents a new class of strongly correlated electronic ground states. We studied suspended samples of bilayer graphene, annealed so that it achieves very high quasiparticle mobilities (greater than 10(6) square centimers per volt-second). Bilayer graphene is a truly two-dimensional material with complex chiral electronic spectra, and the high quality of our samples allowed us to observe strong spectrum reconstructions and electron topological transitions that can be attributed to a nematic phase transition and a decrease in rotational symmetry. These results are especially surprising because no interaction effects have been observed so far in bilayer graphene in the absence of an applied magnetic field.	[Mayorov, A. S.; Elias, D. C.; Novoselov, K. S.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Mucha-Kruczynski, M.; Fal'ko, V. I.] Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England; [Gorbachev, R. V.; Zhukov, A.; Geim, A. K.] Univ Manchester, Manchester Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England; [Tudorovskiy, T.; Katsnelson, M. I.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [Morozov, S. V.] Russian Acad Sci, Inst Microelect Technol, Chernogolovka 142432, Russia	University of Manchester; Lancaster University; University of Manchester; Radboud University Nijmegen; Russian Academy of Sciences	Novoselov, KS (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.	kostya@manchester.ac.uk	Novoselov, Kostya S/G-9581-2014; Cunha Elias, Daniel/A-7494-2013; Gorbachev, Roman/I-2512-2013; Katsnelson, Mikhail I./D-4359-2012; Morozov, Sergey V/H-3171-2014; Zhukov, Alexander A/E-1331-2014; Mayorov, Alexander/P-4737-2015; Mucha-Kruczynski, Marcin/K-4063-2015; Geim, Andre K/J-7888-2012	Novoselov, Kostya S/0000-0003-4972-5371; Cunha Elias, Daniel/0000-0002-0878-1409; Gorbachev, Roman/0000-0003-3604-5617; Morozov, Sergey V/0000-0003-3075-7787; Mayorov, Alexander/0000-0003-4558-3425; Mucha-Kruczynski, Marcin/0000-0002-6597-3888; Geim, Andre K/0000-0003-2861-8331; Fal'ko, Vladimir/0000-0003-0828-0310; hai yan, he/0000-0003-0366-6185	European Research Council; European Commision; Engineering and Physical Research Council (UK); Royal Society; U.S. Office of Naval Research; U.S. Air Force Office of Scientific Research; Korber Foundation; Engineering and Physical Sciences Research Council [EP/G035954/1, EP/I500510/1] Funding Source: researchfish; EPSRC [EP/I500510/1, EP/G035954/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); European Commision; Engineering and Physical Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); U.S. Office of Naval Research(Office of Naval Research); U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Korber Foundation; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by the European Research Council, European Commision FP7, Engineering and Physical Research Council (UK), the Royal Society, U.S. Office of Naval Research, U.S. Air Force Office of Scientific Research, and the Korber Foundation.	Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; Castro EV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.186803; Castro EV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.216802; Castro EV, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266601; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Cserti J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.066802; Du RR, 1999, SOLID STATE COMMUN, V109, P389, DOI 10.1016/S0038-1098(98)00578-X; Du X, 2008, NAT NANOTECHNOL, V3, P491, DOI 10.1038/nnano.2008.199; Fradkin E, 2007, SCIENCE, V315, P196, DOI 10.1126/science.1137172; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Katsnelson MI, 2006, EUR PHYS J B, V51, P157, DOI [10.1140/epjb/e2006-00203-1, 10.1140/epjb/e200S-00203-1]; Lemonik Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.201408; LIFSHITZ IM, 1960, SOV PHYS JETP-USSR, V11, P1130; Lilly MP, 1999, PHYS REV LETT, V82, P394, DOI 10.1103/PhysRevLett.82.394; Lilly MP, 1999, PHYS REV LETT, V83, P824, DOI 10.1103/PhysRevLett.83.824; McCann E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.086805; Mucha-Kruczynski M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.041404; Nandkishore R, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115124; Nandkishore R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156803; Novoselov KS, 2006, NAT PHYS, V2, P177, DOI 10.1038/nphys245; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Oganesyan V, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195109; Ponomarenko LA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.206603; Snyman I, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045322; Vafek O, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041401; Zhang F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041402	33	218	219	2	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					860	863		10.1126/science.1208683	http://dx.doi.org/10.1126/science.1208683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836011	Green Submitted			2022-12-28	WOS:000293785400035
J	Podolsky, SH; Greene, JA				Podolsky, Scott H.; Greene, Jeremy A.			HISTORY OF MEDICINE Combination Drugs - Hype, Harm, and Hope	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Podolsky, Scott H.] Brigham & Womens Hosp, Ctr Hist Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Podolsky, SH (corresponding author), Brigham & Womens Hosp, Ctr Hist Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.							Avorn J, 2005, NEW ENGL J MED, V352, P2573, DOI 10.1056/NEJMp058075; FINLAND M, 1974, NEW ENGL J MED, V291, P624, DOI 10.1056/NEJM197409192911209; Podolsky SH, 2010, J HIST MED ALL SCI, V65, P327, DOI 10.1093/jhmas/jrq003; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Woodcock J, 2011, NEW ENGL J MED, V364, P985, DOI 10.1056/NEJMp1101548	5	40	43	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					488	491		10.1056/NEJMp1106161	http://dx.doi.org/10.1056/NEJMp1106161			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805MW	21830965				2022-12-28	WOS:000293732100004
J	Hou, FJ; Sun, LJ; Zheng, H; Skaug, B; Jiang, QX; Chen, ZJJ				Hou, Fajian; Sun, Lijun; Zheng, Hui; Skaug, Brian; Jiang, Qiu-Xing; Chen, Zhijian J.			MAVS Forms Functional Prion-like Aggregates to Activate and Propagate Antiviral Innate Immune Response	CELL			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; RIG-I; ADAPTER PROTEIN; APLYSIA CPEB; RECOGNITION; VIRUS; PHOSPHORYLATION; INFLAMMATION; INHERITANCE	In response to viral infection, RIG-I-like RNA helicases bind to viral RNA and activate the mitochondrial protein MAVS, which in turn activates the transcription factors IRF3 and NF-kappa B to induce type I interferons. We have previously shown that RIG-I binds to unanchored lysine-63 (K63) polyubiquitin chains and that this binding is important for MAVS activation; however, the mechanism underlying MAVS activation is not understood. Here, we show that viral infection induces the formation of very large MAVS aggregates, which potently activate IRF3 in the cytosol. We find that a fraction of recombinant MAVS protein forms fibrils that are capable of activating IRF3. Remarkably, the MAVS fibrils behave like prions and effectively convert endogenous MAVS into functional aggregates. We also show that, in the presence of K63 ubiquitin chains, RIG-I catalyzes the conversion of MAVS on the mitochondrial membrane to prion-like aggregates. These results suggest that a prion-like conformational switch of MAVS activates and propagates the antiviral signaling cascade.	[Hou, Fajian; Sun, Lijun; Skaug, Brian; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Zheng, Hui; Jiang, Qiu-Xing] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Skaug, Brian/AAD-6152-2022; Jiang, Qiu-Xing/ABF-1143-2021; Sun, Lijun/ABD-4470-2021; Chen, Zhijian/C-6039-2012; zheng, Hui/I-3573-2013; Jiang, Qiu-Xing/AAI-8579-2020	Skaug, Brian/0000-0002-6689-4655; Chen, Zhijian/0000-0002-8475-8251; zheng, Hui/0000-0002-2504-9092; 	NIH [RO1-GM63692, R01-GM88745, GM007062]; Welch Foundation [I-1389, I-1684]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062, R01GM088745, R01GM063692, R01GM093271] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Xiaomo Jiang for the MDA5 plasmids. This work was supported by grants from NIH (RO1-GM63692) and the Welch Foundation (I-1389). H.Z. was supported by a Welch Foundation grant (I-1684) and partially by a EUREKA grant from NIH (R01-GM88745 to Q.-X.J.). B. S is supported by an NIH predoctoral training grant (GM007062). Z.J.C. is an Investigator of Howard Hughes Medical Institute.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; McWhirter SM, 2005, CELL, V122, P645, DOI 10.1016/j.cell.2005.08.026; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Stanker LH, 2010, J IMMUNOL, V185, P729, DOI 10.4049/jimmunol.0902930; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2002, J INTERF CYTOK RES, V22, P73, DOI 10.1089/107999002753452674; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037	35	814	837	5	136	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 5	2011	146	3					448	461		10.1016/j.cell.2011.06.041	http://dx.doi.org/10.1016/j.cell.2011.06.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21782231	Green Accepted, Bronze			2022-12-28	WOS:000293570500018
J	Scheinberg, P; Nunez, O; Weinstein, B; Scheinberg, P; Biancotto, A; Wu, CO; Young, NS				Scheinberg, Phillip; Nunez, Olga; Weinstein, Barbara; Scheinberg, Priscila; Biancotto, Angelique; Wu, Colin O.; Young, Neal S.			Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONY-STIMULATING FACTOR; ANTI-THYMOCYTE GLOBULIN; ANTILYMPHOCYTE GLOBULIN; IMMUNOSUPPRESSIVE THERAPY; T-CELLS; CYCLOSPORINE; ATG; THYMOGLOBULIN; ENGRAFTMENT; INDUCTION	BACKGROUND In severe acquired aplastic anemia, hematopoietic failure is the result of immune-mediated destruction of bone marrow stem and progenitor cells. Immunosuppressive therapy with antithymocyte globulin (ATG) plus cyclosporine is an effective alternative to stem-cell transplantation and improves blood counts and survival. Although horse ATG is the standard therapy, rabbit ATG is more potent in depleting peripheral-blood lymphocytes and is preferred in other clinical circumstances. METHODS From December 2005 through July 2010, we performed a randomized trial comparing these two ATG formulations in conventional regimens. Patients were treated at a single facility. The primary outcome was hematologic response at 6 months, as determined by blood counts. The study was designed to enroll 60 patients each for the rabbit-ATG and horse-ATG groups and was powered to detect a difference of 25 percentage points in the response rate. RESULTS A large, unexpected difference was observed in the rate of hematologic response at 6 months in favor of horse ATG (68%; 95% confidence interval [CI], 56 to 80) as compared with rabbit ATG (37%; 95% CI, 24 to 49; P < 0.001). Overall survival at 3 years also differed, with a survival rate of 96% (95% CI, 90 to 100) in the horse-ATG group as compared with 76% (95% CI, 61 to 95) in the rabbit-ATG group (P =0.04) when data were censored at the time of stem-cell transplantation, and 94% (95% CI, 88 to 100) as compared with 70% (95% CI, 56 to 86; P=0.008) in the respective groups when stem-cell-transplantation events were not censored. CONCLUSIONS In a randomized study, rabbit ATG was inferior to horse ATG as a first treatment for severe aplastic anemia, as indicated by hematologic response and survival.	[Scheinberg, Phillip; Nunez, Olga; Weinstein, Barbara; Scheinberg, Priscila; Young, Neal S.] NHLBI, Hematol Branch, Bethesda, MD 20892 USA; [Wu, Colin O.] NHLBI, Off Biostat Res, Bethesda, MD 20892 USA; [Biancotto, Angelique; Young, Neal S.] NIH, Trans NIH Ctr Human Immunol Auto Immunol & Inflam, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA	Scheinberg, P (corresponding author), 10 Ctr Dr,Bldg 10 CRC,Rm 3E-5140,MSC 1202, Bethesda, MD 20892 USA.	scheinbp@mail.nih.gov	Scheinberg, Phillip/H-5251-2012; biancotto, angelique/C-4632-2011	Scheinberg, Phillip/0000-0002-9047-4538; biancotto, angelique/0000-0003-2271-009X	National Institutes of Health [NCT00260689]; National Heart, Lung, and Blood Institute, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the Intramural Research Program of the National Institutes of Health; ClinicalTrials.gov number, NCT00260689.; Supported by the Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health.	Atta EH, 2010, ANN HEMATOL, V89, P851, DOI 10.1007/s00277-010-0944-y; Ayuk F, 2009, ANTICANCER RES, V29, P1355; Bacigalupo A, 2000, BLOOD, V95, P1931, DOI 10.1182/blood.V95.6.1931; Banham AH, 2006, TRENDS IMMUNOL, V27, P541, DOI 10.1016/j.it.2006.10.002; BARBANO GC, 1988, BLOOD, V72, P956; Brennan DC, 1999, TRANSPLANTATION, V67, P1011, DOI 10.1097/00007890-199904150-00013; Di Bona E, 1999, BRIT J HAEMATOL, V107, P330, DOI 10.1046/j.1365-2141.1999.01693.x; Feng XM, 2008, BLOOD, V111, P3675, DOI 10.1182/blood-2008-01-130146; FRICKHOFEN N, 1991, NEW ENGL J MED, V324, P1297, DOI 10.1056/NEJM199105093241901; Fuhrer M, 1998, KLIN PADIATR, V210, P173, DOI 10.1055/s-2008-1043875; Gaber AO, 1998, TRANSPLANTATION, V66, P29, DOI 10.1097/00007890-199807150-00005; Garg R, 2009, LEUKEMIA, V23, P1297, DOI 10.1038/leu.2009.28; Hanash AM, 2005, BLOOD, V105, P1828, DOI 10.1182/blood-2004-08-3213; KAWANO Y, 1990, BLUT, V60, P297, DOI 10.1007/BF01736232; Kojima S, 2000, BLOOD, V96, P2049; LaCorcia G, 2009, TRANSPLANTATION, V87, P966, DOI 10.1097/TP.0b013e31819c84b8; Locasciulli A, 2007, HAEMATOL-HEMATOL J, V92, P11, DOI 10.3324/haematol.10075; Lopez M, 2006, J AM SOC NEPHROL, V17, P2844, DOI 10.1681/ASN.2006050422; MATHE G, 1970, BMJ-BRIT MED J, V2, P131, DOI 10.1136/bmj.2.5702.131; Naparstek E, 1999, EXP HEMATOL, V27, P1210, DOI 10.1016/S0301-472X(99)00052-1; Passweg JR, 2009, HAEMATOL-HEMATOL J, V94, P310, DOI 10.3324/haematol.2008.002329; RAEFSKY EL, 1986, BLOOD, V68, P712; Rosenfeld S, 2003, JAMA-J AM MED ASSOC, V289, P1130, DOI 10.1001/jama.289.9.1130; ROSENFELD SJ, 1995, BLOOD, V85, P3058, DOI 10.1182/blood.V85.11.3058.bloodjournal85113058; Scheinberg P, 2006, BRIT J HAEMATOL, V133, P622, DOI 10.1111/j.1365-2141.2006.06098.x; Scheinberg P, 2006, BRIT J HAEMATOL, V133, P606, DOI 10.1111/j.1365-2141.2006.06085.x; Scheinberg P, 2010, BLOOD, V116, P1167; Scheinberg P, 2007, BLOOD, V109, P3219, DOI 10.1182/blood-2006-09-045625; Scheinberg P, 2009, HAEMATOL-HEMATOL J, V94, P348, DOI 10.3324/haematol.13829; SPECK B, 1981, BRIT MED J, V282, P860, DOI 10.1136/bmj.282.6267.860; Vallejo C, 2009, BLOOD, V114, P1237; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777	32	314	344	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					430	438		10.1056/NEJMoa1103975	http://dx.doi.org/10.1056/NEJMoa1103975			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801NW	21812672	Green Accepted			2022-12-28	WOS:000293447800007
J	Frey, JJ				Frey, John J., III			You Have No Idea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Frey, JJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.	john.frey@fammed.wisc.edu						Camus A, 1972, PLAGUE, P211	1	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2011	306	5					469	470		10.1001/jama.2011.1053	http://dx.doi.org/10.1001/jama.2011.1053			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800SH	21813420				2022-12-28	WOS:000293386500001
J	Rolfe, A; Sheikh, A				Rolfe, Alexandra; Sheikh, Aziz			10-MINUTE CONSULTATION Measles, mumps, and rubella vaccination in a child with suspected egg allergy	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland.	Aziz.Sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				[Anonymous], 2011, NICE CLIN GUID 116 F; Clark AT, 2010, CLIN EXP ALLERGY, V40, P1116, DOI 10.1111/j.1365-2222.2010.03557.x; Kelso JM, 2009, ANN ALLERG ASTHMA IM, V103, P1; Lack G, 2008, NEW ENGL J MED, V359, P1252, DOI 10.1056/NEJMcp0800871	4	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2011	343								d4536	10.1136/bmj.d4536	http://dx.doi.org/10.1136/bmj.d4536			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NN	21816740	Green Submitted			2022-12-28	WOS:000293734700004
J	Moonen, B; Cohen, JM				Moonen, Bruno; Cohen, Justin M.			Text messaging to improve adherence to malaria guidelines	LANCET			English	Editorial Material							HEALTH-WORKERS; ILLNESS		[Moonen, Bruno; Cohen, Justin M.] Clinton Hlth Access Initiat, Nairobi, Kenya		Moonen, B (corresponding author), Clinton Hlth Access Initiat, Nairobi, Kenya.	bmoonen@clintonhealthaccess.org		Cohen, Justin/0000-0003-4481-6784				*ACTWATCH GROUP, 2009, AV VOL PRIC US ANT 7; Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; Johansson EW, 2010, MALARIA FUNDING RESO; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2009, AM J PUBLIC HEALTH, V99, P837, DOI 10.2105/AJPH.2008.134411; Wasunna B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-29; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, GUID TREATM MAL, V2nd; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6	12	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2011	378	9793					750	752		10.1016/S0140-6736(11)61089-1	http://dx.doi.org/10.1016/S0140-6736(11)61089-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21820168				2022-12-28	WOS:000294585300009
J	Garner, S; Littlejohns, P				Garner, Sarah; Littlejohns, Peter			Disinvestment from low value clinical interventions: NICEly done?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarah.garner@nice.org.uk						BANTA HD, 1990, JAMA-J AM MED ASSOC, V264, P235, DOI 10.1001/jama.264.2.235; BURKE K, 2002, BRIT MED J, V324, P191; Chambers JB, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3531; Dobrossy L., 2005, NEPEGESZSEGUGYI ONKO; Elshaug Adam G, 2007, Aust New Zealand Health Policy, V4, P23, DOI 10.1186/1743-8462-4-23; Elshaug AG, 2009, MED J AUSTRALIA, V190, P269, DOI 10.5694/j.1326-5377.2009.tb02394.x; Giacomini MK, 1999, J HEALTH POLIT POLIC, V24, P715; *HLTH SEL COMM, 2002, 2 HLTH SEL COMM; National Institute for Health and Clinical Excellence (NICE), 2008, PRESCR ANT SELF LIM; NICE, COST SAV; NICE, 2006, DEP HLTH SEL CRIT RE; *NICE, KENN STUD; *NICE, PROP OPT PRACT REV T; *NICE, SHAP NICES AG RES CO; NICE, 2006, DIS PROJ PLAN; *NICE, 2000, OPT PRACT REV REC RE; NICE National Institute for Health and Clinical Excellence, 2008, SURG MAN CHILDR OT M; Pearson Steven, 2007, J Health Serv Res Policy, V12, P160	18	103	103	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2011	343								d4519	10.1136/bmj.d4519	http://dx.doi.org/10.1136/bmj.d4519			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LS	21795239	Green Submitted			2022-12-28	WOS:000293441000001
J	McWilliams, JM; Zaslavsky, AM; Huskamp, HA				McWilliams, J. Michael; Zaslavsky, Alan M.; Huskamp, Haiden A.			Implementation of Medicare Part D and Nondrug Medical Spending for Elderly Adults With Limited Prior Drug Coverage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; OLDER-ADULTS; COST; BENEFICIARIES; ADHERENCE; BENEFITS; IMPACT; GAP; INFARCTION; INSURANCE	Context Implementation of Medicare Part D was followed by increased use of prescription medications, reduced out-of-pocket costs, and improved medication adherence. Its effects on nondrug medical spending remain unclear. Objective To assess differential changes in nondrug medical spending following the implementation of Part D for traditional Medicare beneficiaries with limited prior drug coverage. Design, Setting, and Participants Nationally representative longitudinal survey data and linked Medicare claims from 2004-2007 were used to compare nondrug medical spending before and after the implementation of Part D by self-reported generosity of prescription drug coverage before 2006. Participants included 6001 elderly Medicare beneficiaries from the Health and Retirement Study, including 2538 with generous and 3463 with limited drug coverage before 2006. Comparisons were adjusted for sociodemographic and health characteristics and checked for residual confounding by conducting similar comparisons for a control cohort from 2002-2005. Main Outcome Measure Nondrug medical spending assessed from claims, in total and by type of service (inpatient and skilled nursing facility vs physician services). Results Total nondrug medical spending was differentially reduced after January 1, 2006, for beneficiaries with limited prior drug coverage (-$306/quarter [95% confidence interval {CI}, -$586 to -$51]; P=.02), relative to beneficiaries with generous prior drug coverage. This differential reduction was explained mostly by differential changes in spending on inpatient and skilled nursing facility care (-$204/quarter [95% CI, -$447 to $2]; P=.05). Differential reductions in spending on physician services (-$67/quarter [95% CI, -$134 to -$5]; P=.03) were not associated with differential changes in outpatient visits (-0.06 visits/quarter [95% CI, -0.21 to 0.08]; P=.37), suggesting reduced spending on inpatient physician services for beneficiaries with limited prior drug coverage. In contrast, nondrug medical spending in the control cohort did not differentially change after January 1, 2004, for beneficiaries with limited prior drug coverage in 2002 ($14/quarter [95% CI, -$338 to $324]; P=.93), relative to beneficiaries with generous prior coverage. Conclusion Implementation of Part D was associated with significant differential reductions in nondrug medical spending for Medicare beneficiaries with limited prior drug coverage. JAMA. 2011; 306(4): 402-409	[McWilliams, J. Michael; Zaslavsky, Alan M.; Huskamp, Haiden A.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [McWilliams, J. Michael] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	McWilliams, JM (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mcwilliams@hcp.med.harvard.edu			Doris Duke Charitable Foundation [2010053]; William F. Milton Fund; Robert Wood Johnson Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); William F. Milton Fund; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	This study was supported by grants from the Doris Duke Charitable Foundation (Clinical Scientist Development Award 2010053, Dr McWilliams), the William F. Milton Fund (Dr McWilliams), and a Robert Wood Johnson Foundation Investigator Award in Health Policy Research (Dr Huskamp).	Afendulis CC, 2011, HEALTH SERV RES, V46, P1022, DOI 10.1111/j.1475-6773.2011.01244.x; [Anonymous], 2011 EC REPORT PRESI; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Chandra A, 2010, AM ECON REV, V100, P193, DOI 10.1257/aer.100.1.193; Chernew ME, 2007, HEALTH AFFAIR, V26, pW195, DOI 10.1377/hlthaff.26.2.w195; Choudhry NK, 2008, CIRCULATION, V117, P1261, DOI 10.1161/CIRCULATIONAHA.107.735605; Choudhry NK, 2007, HEALTH AFFAIR, V26, P186, DOI 10.1377/hlthaff.26.1.186; Donohue JM, 2010, AM HEART J, V160, P159, DOI 10.1016/j.ahj.2010.04.023; Duggan M, 2010, AM ECON REV, V100, P590, DOI 10.1257/aer.100.1.590; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Fortess EE, 2001, J AM GERIATR SOC, V49, P793, DOI 10.1046/j.1532-5415.2001.49158.x; Fung V, 2010, HEALTH SERV RES, V45, P355, DOI 10.1111/j.1475-6773.2009.01071.x; Gu QA, 2010, AM J MANAG CARE, V16, P911; Hales John W, 2010, Manag Care, V19, P36; Health and Retirement Study, 2008, SAMPL SIZ RESP RAT 2; Health and Retirement Study (HRS), HRS 1992 2008 PUBL U; Heeringa S.G., 1995, TECHNICAL DESCRIPTIO; Heisler M, 2004, MED CARE, V42, P626, DOI 10.1097/01.mlr.0000129352.36733.cc; Hsu J, 2008, JAMA-J AM MED ASSOC, V299, P1929, DOI 10.1001/jama.299.16.1929; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Huskamp HA, 2009, PSYCHIAT SERV, V60, P1168, DOI 10.1176/ps.2009.60.9.1169; Ingber M, 2010, MEDICARE PART D PROG; Ketcham JD, 2008, AM J MANAG CARE, V14, pSP14; Lichtenberg FR, 2007, HEALTH AFFAIR, V26, P1735, DOI 10.1377/hlthaff.26.6.1735; Madden JM, 2009, JAMA-J AM MED ASSOC, V302, P1755, DOI 10.1001/jama.2009.1516; Raebel MA, 2008, MED CARE, V46, P1116, DOI 10.1097/MLR.0b013e318185cddd; Ray KK, 2005, J AM COLL CARDIOL, V46, P1405, DOI 10.1016/j.jacc.2005.03.077; Safran DG, 2010, J GEN INTERN MED, V25, P10, DOI 10.1007/s11606-009-1134-2; Schneeweiss S, 2009, HEALTH AFFAIR, V28, pW305, DOI 10.1377/hlthaff.28.2.w305; Shrank WH, 2011, NEW ENGL J MED, V364, P598, DOI 10.1056/NEJMp1011625; Stuart BC, 2009, DIABETES CARE, V32, P647, DOI 10.2337/dc08-1311; Stuart BC, 2009, HEALTH SERV RES, V44, P128, DOI 10.1111/j.1475-6773.2008.00897.x; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Yin W, 2008, ANN INTERN MED, V148, P169, DOI 10.7326/0003-4819-148-3-200802050-00200; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zhang YT, 2011, HEALTH SERV RES, V46, P185, DOI 10.1111/j.1475-6773.2010.01183.x; Zhang YT, 2010, ARCH INTERN MED, V170, P1308, DOI 10.1001/archinternmed.2010.235; Zhang YT, 2010, MED CARE, V48, P409, DOI 10.1097/MLR.0b013e3181d68978; Zhang Y, 2009, NEW ENGL J MED, V361, P52, DOI 10.1056/NEJMsa0807998; Zhang Y, 2009, HEALTH AFFAIR, V28, pW317, DOI 10.1377/hlthaff.28.2.w317	41	53	53	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					402	409		10.1001/jama.2011.1026	http://dx.doi.org/10.1001/jama.2011.1026			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797KL	21791689	Bronze			2022-12-28	WOS:000293125800026
J	Coolen, MJL				Coolen, Marco J. L.			7000 Years of Emiliania huxleyi Viruses in the Black Sea	SCIENCE			English	Article							GENOME SEQUENCE; SULFUR BACTERIA; SEDIMENTS; INFECTION; BLOOM	A 7000-year record of Coccolithovirus and its host, the calcifying haptophyte Emiliania huxleyi, was reconstructed on the basis of genetic signatures preserved in sediments underlying the Black Sea. The data show that the same virus and host populations can persist for centuries. Major changes in virus and host populations occurred during early sapropel deposition, similar to 5600 years ago, and throughout the formation of the coccolith-bearing sediments of Unit I during the past 2500 years, when the Black Sea experienced dramatic changes in hydrologic and nutrient regimes. Unit I saw a reoccurrence of the same host genotype thousands of years later in the presence of a different subset of viruses. Historical plankton virus populations can thus be included in paleoecological and paleoenvironmental studies.	Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Coolen, MJL (corresponding author), Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA.	mcoolen@whoi.edu	Coolen, Marco J. L./B-8263-2015	Coolen, Marco J. L./0000-0002-0417-920X	NSF [OCE 0602423, OCE 0825020]; Andrew W. Mellon Foundation	NSF(National Science Foundation (NSF)); Andrew W. Mellon Foundation	I thank C. Wuchter for suggestions for improving the manuscript, P. Dimitrov and D. Dimitrov for their expertise in Black Sea sedimentology, and T.-H. Yang and J. van de Giessen for analytical support. This research was supported by NSF grants OCE 0602423 and OCE 0825020 and a grant from the Andrew W. Mellon Foundation Endowed Fund for Innovative Research. PCR-obtained sequences encoding the coccolithoviral MCP and PGM genes have been deposited in GenBank as "environmental sequences" and are listed under accession numbers GU563596 to GU563628, GU584106 and GU584107, and HQ412623 to HQ412638.	Bird DF, 2001, MAR GEOL, V174, P227, DOI 10.1016/S0025-3227(00)00152-3; Coolen MJL, 2007, ENVIRON MICROBIOL, V9, P238, DOI 10.1111/j.1462-2920.2006.01134.x; Coolen MJL, 2009, EARTH PLANET SC LETT, V284, P610, DOI 10.1016/j.epsl.2009.05.029; Coolen MJL, 1998, APPL ENVIRON MICROB, V64, P4513; Coolen MJL, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001188; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; HAY BJ, 1991, DEEP-SEA RES, V38, pS1211; Huang YS, 2002, GEOLOGY, V30, P1103, DOI 10.1130/0091-7613(2002)030<1103:HIROPA>2.0.CO;2; Lawrence JE, 2002, LIMNOL OCEANOGR, V47, P545, DOI 10.4319/lo.2002.47.2.0545; Marret F, 2009, QUATERN INT, V197, P72, DOI 10.1016/j.quaint.2007.01.010; Martinez JM, 2007, APPL ENVIRON MICROB, V73, P554, DOI 10.1128/AEM.00864-06; Pope WH, 2007, J MOL BIOL, V368, P966, DOI 10.1016/j.jmb.2007.02.046; SCHAFER H, 2001, DENATURING GRADIENT, P425; Schroeder DC, 2003, APPL ENVIRON MICROB, V69, P2484, DOI 10.1128/AEM.69.5.2484-2490.2003; Suttle C.A., 2000, ECOLOGY CYANOBACTERI, P563, DOI DOI 10.1007/0-306-46855-7_20; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; van der Meer MTJ, 2008, EARTH PLANET SC LETT, V267, P426, DOI 10.1016/j.epsl.2007.12.001; Vardi A, 2009, SCIENCE, V326, P861, DOI 10.1126/science.1177322; VOLKMAN JK, 1980, PHYTOCHEMISTRY, V19, P2619, DOI 10.1016/S0031-9422(00)83930-8; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Winter C, 2004, APPL ENVIRON MICROB, V70, P804, DOI 10.1128/AEM.70.2.804-813.2004; Xu L, 2001, ORG GEOCHEM, V32, P633, DOI 10.1016/S0146-6380(01)00019-5	22	61	67	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					451	452		10.1126/science.1200072	http://dx.doi.org/10.1126/science.1200072			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778399				2022-12-28	WOS:000292959600045
J	Levey, AS; Coresh, J				Levey, Andrew S.; Coresh, Josef			Chronic kidney disease	LANCET			English	Article							GLOMERULAR-FILTRATION-RATE; CLINICAL-PRACTICE GUIDELINES; BLOOD-PRESSURE CONTROL; SERUM CYSTATIN-C; QUALITY-OF-LIFE; POSITION STATEMENT; CARDIOVASCULAR EVENTS; COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA; MEDICAL PROGRESS	Chronic kidney disease is a general term for heterogeneous disorders affecting kidney structure and function. The 2002 guidelines for definition and classification of this disease represented an important shift towards its recognition as a worldwide public health problem that should be managed in its early stages by general internists. Disease and management are classified according to stages of disease severity, which are assessed from glomerular filtration rate (GFR) and albuminuria, and clinical diagnosis (cause and pathology). Chronic kidney disease can be detected with routine laboratory tests, and some treatments can prevent development and slow disease progression, reduce complications of decreased GFR and risk of cardiovascular disease, and improve survival and quality of life. In this Seminar we discuss disease burden, recommendations for assessment and management, and future challenges. We emphasise clinical practice guidelines, clinical trials, and areas of uncertainty.	[Levey, Andrew S.] Tufts Med Ctr, William B Schwartz Div Nephrol, Boston, MA 02111 USA; [Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Tufts Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Levey, AS (corresponding author), Tufts Med Ctr, William B Schwartz Div Nephrol, 800 Washington St, Boston, MA 02111 USA.	alevey@tuftsmedicalcenter.org	Wilson, Matthew H/K-3193-2013		NKF; Amgen	NKF; Amgen(Amgen)	ASL has received payment for editorial board membership from the National Kidney Foundation (NKF), and grant support from NKF and Amgen. JC declares that he has no conflicts of interest.	Abboud H, 2010, NEW ENGL J MED, V362, P56, DOI 10.1056/NEJMcp0906797; APPEL GB, 1985, NEW ENGL J MED, V312, P1544, DOI 10.1056/NEJM198506133122404; Arici M, 2009, AM J KIDNEY DIS, V53, P332, DOI 10.1053/j.ajkd.2008.11.021; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Babitt JL, 2010, AM J KIDNEY DIS, V55, P726, DOI 10.1053/j.ajkd.2009.12.030; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Benigni A, 2010, LANCET, V375, P1310, DOI 10.1016/S0140-6736(10)60237-1; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Boulware LE, 2003, JAMA-J AM MED ASSOC, V290, P3101, DOI 10.1001/jama.290.23.3101; Chang TI, 2010, AM J KIDNEY DIS, V56, P1029, DOI 10.1053/j.ajkd.2010.08.007; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Jong PE, 2006, J AM SOC NEPHROL, V17, P2120, DOI 10.1681/ASN.2006010097; de Zeeuw D, 2004, KIDNEY INT, V66, pS2, DOI 10.1111/j.1523-1755.2004.09201.x; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Eckardt KU, 2009, NAT REV NEPHROL, V5, P650, DOI 10.1038/nrneph.2009.153; Eckardt KU, 2009, AM J KIDNEY DIS, V53, P915, DOI 10.1053/j.ajkd.2009.04.001; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Eknoyan G, 2001, AM J KIDNEY DIS, V37, P179, DOI 10.1016/S0272-6386(01)80074-3; Eknoyan G, 2009, KIDNEY INT, V75, P1015, DOI 10.1038/ki.2009.53; El Nahas M, 2010, KIDNEY INT, V78, P14, DOI 10.1038/ki.2010.123; Elsayed EF, 2007, ARCH INTERN MED, V167, P1130, DOI 10.1001/archinte.167.11.1130; European Agency for the Evaluation of Medicinal Products, 2002, COMM PROPR MED PROD; Feldt-Rasmussen B, 2007, J AM SOC NEPHROL, V18, P2161, DOI 10.1681/ASN.2006111207; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Field MJ, 1990, CLIN PRACTICE GUIDEL; Fink JC, 2009, AM J KIDNEY DIS, V53, P681, DOI 10.1053/j.ajkd.2008.12.016; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Galanter WL, 2010, AM J KIDNEY DIS, V56, P809, DOI 10.1053/j.ajkd.2010.09.006; Gandra SR, 2010, AM J KIDNEY DIS, V55, P519, DOI 10.1053/j.ajkd.2009.09.019; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gutierrez OM, 2010, CLIN J AM SOC NEPHRO, V5, P1710, DOI 10.2215/CJN.02640310; Hailpern SM, 2007, J AM SOC NEPHROL, V18, P2205, DOI 10.1681/ASN.2006101165; Hakim RM, 2009, AM J KIDNEY DIS, V54, P201, DOI 10.1053/j.ajkd.2009.04.018; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P1151, DOI 10.1001/jama.2010.303; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hoerger TJ, 2010, AM J KIDNEY DIS, V55, P463, DOI 10.1053/j.ajkd.2009.11.017; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Housman AE, 2010, INCIDENCE PREVALENCE, V2; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hug BL, 2009, KIDNEY INT, V76, P1192, DOI 10.1038/ki.2009.353; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jain AK, 2009, KIDNEY INT, V76, P318, DOI 10.1038/ki.2009.158; James MT, 2010, LANCET, V376, P2096, DOI 10.1016/S0140-6736(10)61271-8; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; James MT, 2009, AM J KIDNEY DIS, V54, P24, DOI 10.1053/j.ajkd.2009.04.005; Johansen KL, 2006, J AM SOC NEPHROL, V17, P2307, DOI 10.1681/ASN.2006010034; Johansen KL, 2010, AM J KIDNEY DIS, V55, P535, DOI 10.1053/j.ajkd.2009.12.018; Johnson ES, 2008, AM J KIDNEY DIS, V52, P653, DOI 10.1053/j.ajkd.2008.04.026; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1251, DOI 10.1053/ajkd.2001.29222; Kasiske BL, 2011, AM J KIDNEY DIS, V57, P466, DOI 10.1053/j.ajkd.2010.10.054; Kepler J, 2010, INT COMP US RENAL DA, V2; Kidney disease: Improving Global Outcomes (KDIGO), 2008, NEPHR GUID DAT; Knoll GA, 2009, AM J KIDNEY DIS, V54, P1131, DOI 10.1053/j.ajkd.2009.06.031; Kottgen A, 2010, AM J KIDNEY DIS, V56, P743, DOI 10.1053/j.ajkd.2010.05.018; Kottgen A, 2007, J AM SOC NEPHROL, V18, P1307, DOI 10.1681/ASN.2006101159; LAMBERSHEERSPIN.HJ, 2009, LANCET, V373, P1009, DOI DOI 10.1016/S0140-6736(09)60212-9; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2010, KIDNEY INT, V78, P19, DOI 10.1038/ki.2010.115; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Levey AS, 2009, AM J KIDNEY DIS, V54, P205, DOI 10.1053/j.ajkd.2009.04.029; Levey AS, 2009, AM J KIDNEY DIS, V53, P522, DOI 10.1053/j.ajkd.2008.11.019; Levey AS, 2009, AM J KIDNEY DIS, V53, pS4, DOI 10.1053/j.ajkd.2008.07.048; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2006, ANN INTERN MED, V144, P213, DOI 10.7326/0003-4819-144-3-200602070-00011; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1998, AM J KIDNEY DIS, V32, P853, DOI 10.1016/S0272-6386(98)70145-3; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levin A, 2008, AM J KIDNEY DIS, V52, P661, DOI 10.1053/j.ajkd.2008.06.023; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Manns B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5869; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Miller WG, 2009, CLIN CHEM LAB MED, V47, P1017, DOI 10.1515/CCLM.2009.264; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Montgomery RA, 2005, JAMA-J AM MED ASSOC, V294, P1655, DOI 10.1001/jama.294.13.1655; Nass R, 2008, ANN INTERN MED, V149, P601, DOI 10.7326/0003-4819-149-9-200811040-00003; O'Hare AM, 2009, ANN INTERN MED, V150, P717, DOI 10.7326/0003-4819-150-10-200905190-00010; Orth SR, 1998, NEW ENGL J MED, V338, P1202, DOI 10.1056/NEJM199804233381707; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Parfrey PS, 2010, AM J KIDNEY DIS, V55, P423, DOI 10.1053/j.ajkd.2009.12.014; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Powe NR, 2003, KIDNEY INT, V64, P763, DOI 10.1046/j.1523-1755.2003.00138.x; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Rettig RA, 2008, CLIN J AM SOC NEPHRO, V3, P1902, DOI 10.2215/CJN.02330508; Rocco MV, 2006, ANN INTERN MED, V145, P512, DOI 10.7326/0003-4819-145-7-200610030-00009; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Ruggenenti P, 2008, J AM SOC NEPHROL, V19, P1213, DOI 10.1681/ASN.2007090970; Rule AD, 2009, AM J KIDNEY DIS, V53, P932, DOI 10.1053/j.ajkd.2009.02.011; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Shastri S, 2010, AM J KIDNEY DIS, V56, P434, DOI 10.1053/j.ajkd.2010.04.007; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Silva Fred G., 2005, International Urology and Nephrology, V37, P419, DOI 10.1007/s11255-004-0874-5; Silva Fred G., 2005, International Urology and Nephrology, V37, P185, DOI 10.1007/s11255-004-0873-6; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Solomon SD, 2006, CIRCULATION, V114, P26, DOI 10.1161/CIRCULATIONAHA.105.592733; Solomon SD, 2010, NEW ENGL J MED, V363, P1146, DOI 10.1056/NEJMoa1005109; Steinberg EP, 2000, AM J KIDNEY DIS, V36, P1; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Stevens LA, 2009, AM J KIDNEY DIS, V54, P33, DOI 10.1053/j.ajkd.2009.03.008; Stevens LA, 2009, AM J KIDNEY DIS, V53, pS17, DOI 10.1053/j.ajkd.2008.07.047; Stevens LA, 2009, KIDNEY INT, V75, P652, DOI 10.1038/ki.2008.638; Stevens PE, 2009, SEMIN NEPHROL, V29, P475, DOI 10.1016/j.semnephrol.2009.06.004; Stoycheff N, 2009, AM J KIDNEY DIS, V54, P840, DOI 10.1053/j.ajkd.2009.04.016; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P411, DOI 10.1097/01.ASN.0000100125.21491.46; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tonelli M, 2003, ANN INTERN MED, V138, P98, DOI 10.7326/0003-4819-138-2-200301210-00010; Tonelli M, 2007, ANNU REV MED, V58, P123, DOI 10.1146/annurev.med.58.071105.111123; U.S. Food and Drug Administration, 1998, GUID IND PHARM PAT I; Uhlig K, 2006, KIDNEY INT, V70, P2058, DOI 10.1038/sj.ki.5001875; US Department of Health and Human Services . Food and Drug Administration, 2009, GUID IND PAT REP OUT; US Renal Data System, 2010, 2010 ANN DAT REP ATL; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vassalotti JA, 2007, AM J KIDNEY DIS, V50, P169, DOI 10.1053/j.ajkd.2007.06.013; Vassalotti JA, 2009, AM J KIDNEY DIS, V53, pS107, DOI 10.1053/j.ajkd.2008.07.049; Vo AA, 2008, NEW ENGL J MED, V359, P242, DOI 10.1056/NEJMoa0707894; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Weinstein JR, 2010, ADV CHRONIC KIDNEY D, V17, P302, DOI 10.1053/j.ackd.2010.05.002; Wilhelm-Leen ER, 2009, AM J MED, V122, P664, DOI 10.1016/j.amjmed.2009.01.026; Winearls CG, 2009, KIDNEY INT, V75, P1009, DOI 10.1038/ki.2009.49; WOOLF SH, 1990, ARCH INTERN MED, V150, P1811, DOI 10.1001/archinte.150.9.1811; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	142	1141	1176	17	179	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2012	379	9811					165	180		10.1016/S0140-6736(11)60178-5	http://dx.doi.org/10.1016/S0140-6736(11)60178-5			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879GM	21840587				2022-12-28	WOS:000299317700039
J	Nakamura, A; Takeda, S				Nakamura, Akinori; Takeda, Shin'ichi			Exon-skipping therapy for Duchenne muscular dystrophy	LANCET			English	Editorial Material									Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo, Japan; [Nakamura, Akinori] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 3908621, Japan	National Center for Neurology & Psychiatry - Japan; Shinshu University	Nakamura, A (corresponding author), Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Nagano 3908621, Japan.	anakamu@shinshu-u.ac.jp						AOKI Y, 2010, MOL THER, V5; Arechavala-Gomeza V, 2007, HUM GENE THER, V18, P798, DOI 10.1089/hum.2006.061; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Fletcher S, 2006, J GENE MED, V8, P207, DOI 10.1002/jgm.838; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; JEARAWIRIYAPAIS.N, 2008, MOL THER, V16, P207; Nakamura A, 2009, NEUROPATHOLOGY, V29, P494, DOI 10.1111/j.1440-1789.2009.01028.x; Nakamura A, 2008, J CLIN NEUROSCI, V15, P757, DOI 10.1016/j.jocn.2006.12.012; Yokota T, 2007, EXPERT OPIN BIOL TH, V7, P831, DOI 10.1517/14712598.7.6.831; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627	11	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 13	2011	378	9791					546	547		10.1016/S0140-6736(11)61028-3	http://dx.doi.org/10.1016/S0140-6736(11)61028-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812UX	21784507				2022-12-28	WOS:000294319500006
J	Solomon, S; Daniel, JS; Neely, RR; Vernier, JP; Dutton, EG; Thomason, LW				Solomon, S.; Daniel, J. S.; Neely, R. R., III; Vernier, J. -P.; Dutton, E. G.; Thomason, L. W.			The Persistently Variable "Background" Stratospheric Aerosol Layer and Global Climate Change	SCIENCE			English	Article								Recent measurements demonstrate that the "background" stratospheric aerosol layer is persistently variable rather than constant, even in the absence of major volcanic eruptions. Several independent data sets show that stratospheric aerosols have increased in abundance since 2000. Near-global satellite aerosol data imply a negative radiative forcing due to stratospheric aerosol changes over this period of about -0.1 watt per square meter, reducing the recent global warming that would otherwise have occurred. Observations from earlier periods are limited but suggest an additional negative radiative forcing of about -0.1 watt per square meter from 1960 to 1990. Climate model projections neglecting these changes would continue to overestimate the radiative forcing and global warming in coming decades if these aerosols remain present at current values or increase.	[Solomon, S.; Daniel, J. S.; Neely, R. R., III] NOAA, Chem Sci Div, Earth Syst Res Lab, Boulder, CO 80305 USA; [Solomon, S.; Neely, R. R., III] Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80305 USA; [Vernier, J. -P.; Thomason, L. W.] NASA, Langley Res Ctr, Hampton, VA 23665 USA; [Vernier, J. -P.] Univ Paris 06, Univ Versailles St Quentin, Lab Atmospheres, CNRS,Inst Natl Sci Univers, F-75252 Paris 05, France; [Neely, R. R., III; Dutton, E. G.] NOAA, Global Monitoring Div, Earth Syst Res Lab, Boulder, CO 80305 USA; [Neely, R. R., III] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Langley Research Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder	Solomon, S (corresponding author), NOAA, Chem Sci Div, Earth Syst Res Lab, Boulder, CO 80305 USA.	susan.solomon@colorado.edu	Daniel, John S/D-9324-2011; Neely, Ryan/F-8702-2010	Neely, Ryan/0000-0003-4560-4812; Thomason, Larry/0000-0002-1902-0840	Centre National de la Recherche Scientifique at LATMOS/Universite de Versailles St Quentin; NOAA	Centre National de la Recherche Scientifique at LATMOS/Universite de Versailles St Quentin; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	The satellite aerosol observations were analyzed by J.P.V. during his fellowship through the NASA Postdoctoral Program at Langley Research Center, administrated by Oak Ridge Associated Universities. It is also a part of his Ph.D. thesis financed by the Centre National de la Recherche Scientifique at LATMOS/Universite de Versailles St Quentin. The CALIPSO data were made available at the ICARE data center (www-icare.univ-lille1.fr/). The authors also acknowledge help from A. Hauchecorne, J. P. Pommereau, J. Pelon, and A. Garnier in the analysis of the GOMOS and CALIPSO data sets; J. Barnes for Mauna Loa lidar data; and C. Wehrli for Precision Filter Radiometer data. Funding has also been provided by the Atmospheric Composition and Climate Program of NOAA's Climate Program. Helpful discussions with J. Gregory and D. M. Murphy are gratefully acknowledged.	Ammann CM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016388; BROCK CA, 1995, SCIENCE, V270, P1650, DOI 10.1126/science.270.5242.1650; CHIN M, 1995, J GEOPHYS RES-ATMOS, V100, P8993, DOI 10.1029/95JD00275; CRUTZEN PJ, 1976, GEOPHYS RES LETT, V3, P73, DOI 10.1029/GL003i002p00073; Deshler T, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006089; Dutton EG, 2001, J CLIMATE, V14, P3255, DOI 10.1175/1520-0442(2001)014<3255:SIACBC>2.0.CO;2; ELLIS HT, 1971, SCIENCE, V172, P845, DOI 10.1126/science.172.3985.845; Gregory JM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045507; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; HANSEN J, 1992, GEOPHYS RES LETT, V19, P215, DOI 10.1029/91GL02788; Haywood JM, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014447; Hofmann D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039008; HOFMANN DJ, 1990, SCIENCE, V248, P996, DOI 10.1126/science.248.4958.996; HOFMANN DJ, 1980, SCIENCE, V208, P1368, DOI 10.1126/science.208.4450.1368; JUNGE CE, 1961, J METEOROL, V18, P81, DOI 10.1175/1520-0469(1961)018<0081:SA>2.0.CO;2; Kravitz B, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014448; Myhre G, 2004, TELLUS B, V56, P294, DOI 10.1111/j.1600-0889.2004.00106.x; NEWHALL CG, 1982, J GEOPHYS RES-OCEANS, V87, P1231, DOI 10.1029/JC087iC02p01231; Plattner GK, 2008, J CLIMATE, V21, P2721, DOI 10.1175/2007JCLI1905.1; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; SATO M, 1993, J GEOPHYS RES-ATMOS, V98, P22987, DOI 10.1029/93JD02553; Solomon S., 2007, PHYS SCI BASIS WORKI; Thomason LW, 2008, ATMOS CHEM PHYS, V8, P983, DOI 10.5194/acp-8-983-2008; Vanhellemont F, 2010, ATMOS CHEM PHYS, V10, P7997, DOI 10.5194/acp-10-7997-2010; Vernier JP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047563; Vernier JP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046614; Vernier JP, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011946; Wehrli C., 2005, WMO GAW EXP WORKSH G, P36	28	373	393	2	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					866	870		10.1126/science.1206027	http://dx.doi.org/10.1126/science.1206027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21778361				2022-12-28	WOS:000293785400037
J	Birdi, K; Weir-McCall, J; Grace, R; Howlett, DC				Birdi, K.; Weir-McCall, J.; Grace, R.; Howlett, D. C.			PICTURE QUIZ Increasing confusion in a man after a fall-just a head injury?	BRITISH MEDICAL JOURNAL			English	Editorial Material							MULTIPLE-MYELOMA; CRITERIA		[Birdi, K.; Weir-McCall, J.; Grace, R.; Howlett, D. C.] Eastbourne Dist Gen Hosp, Eastbourne BN21 2UD, England		Birdi, K (corresponding author), Eastbourne Dist Gen Hosp, Kings Dr, Eastbourne BN21 2UD, England.	kbirdi@doctors.org.uk						Dahnert W, 2007, RADIOLOGY REV MANUAL; DSA S, 2008, MIMS ONCOL PALLIAT C, V2, P24; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; 2003, BR J HAEMATOL, V121, P749	6	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2011	343								d4806	10.1136/bmj.d4806	http://dx.doi.org/10.1136/bmj.d4806			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808DP	21835869	Green Submitted			2022-12-28	WOS:000293956900002
J	Greenhalgh, T				Greenhalgh, Trisha			OUTSIDE THE BOX Getting out more	BRITISH MEDICAL JOURNAL			English	Editorial Material									Barts & London Queen Marys Sch Med & Dent, London, England	University of London; Queen Mary University London	Greenhalgh, T (corresponding author), Barts & London Queen Marys Sch Med & Dent, London, England.	p.greenhalgh@qmul.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 10	2011	343								d5014	10.1136/bmj.d5014	http://dx.doi.org/10.1136/bmj.d5014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808DL	21831940				2022-12-28	WOS:000293956300008
J	Yuan, J; Cheng, KCC; Johnson, RL; Huang, RL; Pattaradilokrat, S; Liu, AN; Guha, R; Fidock, DA; Inglese, J; Wellems, TE; Austin, CP; Su, XZ				Yuan, Jing; Cheng, Ken Chih-Chien; Johnson, Ronald L.; Huang, Ruili; Pattaradilokrat, Sittiporn; Liu, Anna; Guha, Rajarshi; Fidock, David A.; Inglese, James; Wellems, Thomas E.; Austin, Christopher P.; Su, Xin-zhuan			Chemical Genomic Profiling for Antimalarial Therapies, Response Signatures, and Molecular Targets	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; IN-VITRO ACTIVITY; DRUG-RESISTANCE; CHLOROQUINE RESISTANCE; DIGESTIVE VACUOLE; ARTEMISININ; GENE; SUSCEPTIBILITY; AMODIAQUINE; DIVERSITY	Malaria remains a devastating disease largely because of widespread drug resistance. New drugs and a better understanding of the mechanisms of drug action and resistance are essential for fulfilling the promise of eradicating malaria. Using high-throughput chemical screening and genome-wide association analysis, we identified 32 highly active compounds and genetic loci associated with differential chemical phenotypes (DCPs), defined as greater than or equal to fivefold differences in half-maximum inhibitor concentration (IC50) between parasite lines. Chromosomal loci associated with 49 DCPs were confirmed by linkage analysis and tests of genetically modified parasites, including three genes that were linked to 96% of the DCPs. Drugs whose responses mapped to wild-type or mutant pfcrt alleles were tested in combination in vitro and in vivo, which yielded promising new leads for antimalarial treatments.	[Cheng, Ken Chih-Chien; Johnson, Ronald L.; Huang, Ruili; Guha, Rajarshi; Inglese, James; Austin, Christopher P.] NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20895 USA; [Yuan, Jing; Pattaradilokrat, Sittiporn; Liu, Anna; Wellems, Thomas E.; Su, Xin-zhuan] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; Columbia University	Austin, CP (corresponding author), NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20895 USA.	austinc@mail.nih.gov; xsu@niaid.nih.gov		Yuan, Jing/0000-0002-8907-9143; Su, Xinzhuan/0000-0003-3246-3248; Pattaradilokrat, Sittiporn/0000-0002-1516-1961; Fidock, David/0000-0001-6753-8938	Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute; NIH; Burroughs Wellcome Fund [R01 AI50234]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050234, R01AI050234, ZIAAI000483] Funding Source: NIH RePORTER	Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research at the National Institute of Allergy and Infectious Diseases (NIAID), the National Human Genome Research Institute, and the Director's Challenge Award Program, all at NIH. Funding for the studies from D.A.F. was provided by R01 AI50234 and the Burroughs Wellcome Fund.	BASCO LK, 1993, AM J TROP MED HYG, V49, P301, DOI 10.4269/ajtmh.1993.49.301; Billups SJ, 1998, ANN PHARMACOTHER, V32, P659, DOI 10.1345/aph.17323; Bonnet M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-192; Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; Burgess SJ, 2010, J MED CHEM, V53, P6477, DOI 10.1021/jm1006484; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Ferdig MT, 2004, MOL MICROBIOL, V52, P985, DOI 10.1111/j.1365-2958.2004.04035.x; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; GERSHON P, 1986, T ROY SOC TROP MED H, V80, P753, DOI 10.1016/0035-9203(86)90376-7; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hayton K, 2008, CURR GENET, V54, P223, DOI 10.1007/s00294-008-0214-x; Huang R, 2008, CHEM RES TOXICOL, V21, P659, DOI 10.1021/tx700365e; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Kazzim OJ, 2006, ANN TROP MED PARASIT, V100, P579, DOI 10.1179/136485906X118477; KYLE DE, 1993, AM J TROP MED HYG, V48, P126, DOI 10.4269/ajtmh.1993.48.126; Lell B, 2002, ANTIMICROB AGENTS CH, V46, P2315, DOI 10.1128/AAC.46.8.2315-2320.2002; Mu JB, 2010, NAT GENET, V42, P268, DOI 10.1038/ng.528; Mungthin M, 2010, AM J TROP MED HYG, V83, P1005, DOI 10.4269/ajtmh.2010.10-0339; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Patel JJ, 2010, MOL MICROBIOL, V78, P770, DOI 10.1111/j.1365-2958.2010.07366.x; Randic M, 1997, J CHEM INF COMP SCI, V37, P672, DOI 10.1021/ci960174t; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; Seed J, 2005, CRIT REV TOXICOL, V35, P663, DOI 10.1080/10408440591007133; Singh N, 2000, ACTA TROP, V77, P185, DOI 10.1016/S0001-706X(00)00133-9; Sowunmi A, 2003, ANN TROP MED PARASIT, V97, P103, DOI 10.1179/000349803235001516; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; Wellems TE, 2004, NAT MED, V10, P1169, DOI 10.1038/nm1104-1169; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 1996, PARASITOL TODAY, V12, P399, DOI 10.1016/0169-4758(96)10055-7; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Yuan J, 2009, NAT CHEM BIOL, V5, P765, DOI 10.1038/nchembio.215	39	109	114	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					724	729		10.1126/science.1205216	http://dx.doi.org/10.1126/science.1205216			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817045	Green Accepted			2022-12-28	WOS:000293512100034
J	Annas, GJ				Annas, George J.			Assisted Reproduction - Canada's Supreme Court and the "Global Baby"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 2008, FAM LAW QUART, V42, P511; Annas GJ, 2002, AM J LAW MED, V28, P151; ATWOOD M, 1986, HANDMAIDS TALE, P176; Audi T., 2010, WALL STREET J, pD1; *CAN COMM GROUP, 1993, PROC CAR FIN REP ROY; CARNEY S, 2011, RED MARKET TRAIL WOR, P135; CHAYUTWORAKAN S, 2011, BANGKOK POST    0531; Coeytaux F, 2011, CONTRACEPTION, V83, P1, DOI 10.1016/j.contraception.2010.08.016; FUKUYAMA F, 2007, BIOETHICS PROPOSAL M; *HUM FERT EMBR AUT, 2011, HOUS LORDS P FEBR 1; Joint Council of Europe/United Nations Study, 2009, TRAFF ORG TISS CELLS; New York State Task Force on Life and the Law, 1998, ASS REPR TECHN AN RE; ROBERTSON JR, 2011, REPROD RIGHTS REPROD; Somerville M, 2007, J FAM STUD, V13, P179, DOI 10.5172/jfs.327.13.2.179; THE PRESIDENT'S COUNCIL ON BIOETHICS, 2004, REPR RESP REG NEW BI; Todres J., 2011, LEGAL STUDIES RES PA, V89, P447	16	7	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					459	463		10.1056/NEJMhle1101361	http://dx.doi.org/10.1056/NEJMhle1101361			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801NW	21812677				2022-12-28	WOS:000293447800013
J	Xu, RN				Xu, Rena			BECOMING A PHYSICIAN A Differentiation Diagnosis - Specialization and the Medical Student	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Xu, RN (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Elnicki DM, 1999, J GEN INTERN MED, V14, P341, DOI 10.1046/j.1525-1497.1999.00352.x; Kogan JR, 2010, J GEN INTERN MED, V25, P403, DOI 10.1007/s11606-010-1263-7; Navarro AM, 2011, ACAD MED, V86, P72, DOI 10.1097/ACM.0b013e3181ff7dfc; Pugno PA, 2010, FAM MED, V42, P552; Zink BJ, 2007, TEACH LEARN MED, V19, P55, DOI 10.1207/s15328015tlm1901_10	5	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					391	393		10.1056/NEJMp1105004	http://dx.doi.org/10.1056/NEJMp1105004			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801NW	21812670				2022-12-28	WOS:000293447800003
J	Wang, YZ; Robinson, GH				Wang, Yuzhong; Robinson, Gregory H.			Building a Lewis Base with Boron	SCIENCE			English	Editorial Material							BORYLENE		[Wang, Yuzhong; Robinson, Gregory H.] Univ Georgia, Dept Chem, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Wang, YZ (corresponding author), Univ Georgia, Dept Chem, Athens, GA 30602 USA.	wyzhong@chem.uga.edu; robinson@chem.uga.edu	Wang, Yuzhong/G-8842-2012	Wang, Yuzhong/0000-0003-3557-5085				Abraham MY, 2011, J AM CHEM SOC, V133, P8874, DOI 10.1021/ja203208t; Al-Rafia SMI, 2011, J AM CHEM SOC, V133, P777, DOI 10.1021/ja1106223; Bettinger HF, 2006, J AM CHEM SOC, V128, P2534, DOI 10.1021/ja0548642; Bissinger P, 2011, ANGEW CHEM INT EDIT, V50, P4704, DOI 10.1002/anie.201007543; Braunschweig H, 2010, CHEM REV, V110, P3924, DOI 10.1021/cr900333n; Fischer RC, 2010, CHEM REV, V110, P3877, DOI 10.1021/cr100133q; Kinjo R, 2011, SCIENCE, V333, P610, DOI 10.1126/science.1207573; Martin D, 2011, CHEM SCI, V2, P389, DOI 10.1039/c0sc00388c; Melaimi M, 2010, ANGEW CHEM INT EDIT, V49, P8810, DOI 10.1002/anie.201000165; POPLE JA, 1986, CHEM PHYS LETT, V129, P279, DOI 10.1016/0009-2614(86)80211-1; Segawa Y, 2006, SCIENCE, V314, P113, DOI 10.1126/science.1131914; Vidovic D, 2009, CHEM COMMUN, P1157, DOI 10.1039/b816042b; Wang Y, 2007, J AM CHEM SOC, V129, P12412, DOI 10.1021/ja075932i; Wang YZ, 2011, INORG CHEM, V50, P12326, DOI 10.1021/ic200675u; Wang YZ, 2010, ORGANOMETALLICS, V29, P4778, DOI 10.1021/om100335j	15	17	17	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					530	531		10.1126/science.1209588	http://dx.doi.org/10.1126/science.1209588			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798919				2022-12-28	WOS:000293222400029
J	Liu, YZ; Hu, CH; Comotti, A; Ward, MD				Liu, Yuzhou; Hu, Chunhua; Comotti, Angiolina; Ward, Michael D.			Supramolecular Archimedean Cages Assembled with 72 Hydrogen Bonds	SCIENCE			English	Article							CRYSTAL-STRUCTURES; FRAMEWORKS; MOLECULES; POLYHEDRA; NETWORKS; CAVITIES; HGI2; PBI2	Self-assembly of multiple components into well-defined and predictable structures remains one of the foremost challenges in chemistry. Here, we report on the rational design of a supramolecular cage assembled from 20 ions of three distinct species through 72 hydrogen bonds. The cage is constructed from two kinds of hexagonal molecular tiles, a tris(guanidinium) nitrate cluster and a hexa(4-sulfonatophenyl)benzene, joined at their edges through complementary and metrically matched N-H center dot center dot center dot O-S hydrogen bonds to form a truncated octahedron, one of the Archimedean polyhedra. The truncated octahedron, with an interior volume of 2200 cubic angstroms, serves as the composite building unit of a body-centered cubic zeolite-like framework, which exhibits an ability to encapsulate a wide range of differently charged species, including organic molecules, transition metal complexes, and "ship-in-a-bottle" nanoclusters not observed otherwise.	[Liu, Yuzhou; Hu, Chunhua; Ward, Michael D.] NYU, Dept Chem, New York, NY 10003 USA; [Liu, Yuzhou; Hu, Chunhua; Ward, Michael D.] NYU, Inst Mol Design, New York, NY 10003 USA; [Comotti, Angiolina] Univ Milano Bicocca, Dept Mat Sci, I-20125 Milan, Italy	New York University; New York University; University of Milano-Bicocca	Ward, MD (corresponding author), NYU, Dept Chem, 100 Washington Sq E, New York, NY 10003 USA.	mdw3@nyu.edu	Liu, Yuzhou/C-1130-2008	Liu, Yuzhou/0000-0002-1109-7704	National Science Foundation [DMR-0906576, CRIF/CHE-0840277]; Materials Research Science and Engineering Center [DMR-0820341]; Cariplo Foundation; ESRF (Grenoble); New York University; National Science Foundation/Department of Energy [NSF/CHE-0822838]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	National Science Foundation(National Science Foundation (NSF)); Materials Research Science and Engineering Center(National Science Foundation (NSF)); Cariplo Foundation(Fondazione Cariplo); ESRF (Grenoble); New York University; National Science Foundation/Department of Energy(National Science Foundation (NSF)United States Department of Energy (DOE)); U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the National Science Foundation, primarily by DMR-0906576 and partially by CRIF/CHE-0840277 and the Materials Research Science and Engineering Center Program under award DMR-0820341. A. C. acknowledges support from the Cariplo Foundation and ESRF (Grenoble). Y.L. is grateful for financial support provided by New York University through a Doctoral Dissertation Fellowship. The authors also acknowledge Y.-S. Chen at Chemistry and Materials Science Sector of the Center for Advanced Radiation Sources (ChemMatCARS) at the Advanced Photon Source (APS), Sector 15, which is principally supported by the National Science Foundation/Department of Energy (NSF/CHE-0822838). Use of the APS was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. The authors also acknowledge P. Song for technical assistance, A. Soegiarto for helpful discussions, and S. Torquato and Y. Jiao for renderings of the Archimedean polyhedra for the supporting online material. Crystal structure data for compounds 1 to 15 can be accessed at the Cambridge Crystallographic Data Centre (CCDC) (www.ccdc.cam.ac.uk) and have been allocated the accession numbers CCDC 823027 to 823041. M. D. W. supervised the project. M. D. W. and Y. L. designed the experiments. Y. L. performed the experiments and collected and analyzed the data. Y. L. and C. H. performed the crystallographic work. A. C. evaluated the thermal stability of compound 1. M. D. W. and Y. L. wrote the manuscript, with input from C.H. and A.C.	Agger JR, 1998, J PHYS CHEM B, V102, P3345, DOI 10.1021/jp972994u; Ajami D, 2009, NAT CHEM, V1, P87, DOI [10.1038/nchem.111, 10.1038/NCHEM.111]; FELSCHE J, 1986, ZEOLITES, V6, P367, DOI 10.1016/0144-2449(86)90064-3; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Heo NH, 2004, J PHYS CHEM B, V108, P3168, DOI 10.1021/jp031137p; Holman KT, 2001, J AM CHEM SOC, V123, P4421, DOI 10.1021/ja0030257; Horner MJ, 2007, J AM CHEM SOC, V129, P14640, DOI 10.1021/ja0741574; KATRUSIAK A, 1994, ACTA CRYSTALLOGR C, V50, P1161, DOI 10.1107/S0108270193012272; Kim HS, 2006, J AM CHEM SOC, V128, P15070, DOI 10.1021/ja0661966; Kim HS, 2011, J AM CHEM SOC, V133, P1642, DOI 10.1021/ja109126w; Kuehl CJ, 2002, P NATL ACAD SCI USA, V99, P4932, DOI 10.1073/pnas.012540799; Liu TF, 2010, ANGEW CHEM INT EDIT, V49, P4121, DOI 10.1002/anie.201000416; MacGillivray LR, 1997, NATURE, V389, P469, DOI 10.1038/38985; Mal P, 2009, SCIENCE, V324, P1697, DOI 10.1126/science.1175313; Mastalerz M, 2010, ANGEW CHEM INT EDIT, V49, P5042, DOI 10.1002/anie.201000443; MICIC OI, 1987, J PHYS CHEM-US, V91, P6221, DOI 10.1021/j100308a031; Ni Z, 2005, J AM CHEM SOC, V127, P12752, DOI 10.1021/ja052055c; Perry JJ, 2007, J AM CHEM SOC, V129, P10076, DOI 10.1021/ja0734952; Pluth MD, 2007, SCIENCE, V316, P85, DOI 10.1126/science.1138748; Prins LJ, 1999, NATURE, V398, P498, DOI 10.1038/19053; RUSSELL VA, 1994, CHEM MATER, V6, P1206, DOI 10.1021/cm00044a019; Shimizu GKH, 2009, CHEM SOC REV, V38, P1430, DOI 10.1039/b802423p; Soegiarto AC, 2010, J AM CHEM SOC, V132, P14603, DOI 10.1021/ja106106d; STUCKY GD, 1990, SCIENCE, V247, P669, DOI 10.1126/science.247.4943.669; Sun QF, 2010, SCIENCE, V328, P1144, DOI 10.1126/science.1188605; TANG ZK, 1992, J PHYS SOC JPN, V61, P2943, DOI 10.1143/JPSJ.61.2943; Thaimattam R, 1998, NEW J CHEM, V22, P143, DOI 10.1039/a707637a; Wang XY, 2007, INORG CHEM, V46, P4626, DOI 10.1021/ic070324p; Wu LM, 2009, COORDIN CHEM REV, V253, P2787, DOI 10.1016/j.ccr.2009.08.003; Yoshizawa M, 2009, ANGEW CHEM INT EDIT, V48, P3418, DOI 10.1002/anie.200805340	30	225	225	6	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					436	440		10.1126/science.1204369	http://dx.doi.org/10.1126/science.1204369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778396				2022-12-28	WOS:000292959600040
J	Wu, XL; Zhou, TQ; Zhu, J; Zhang, BS; Georgiev, I; Wang, C; Chen, XJ; Longo, NS; Louder, M; McKee, K; O'Dell, S; Perfetto, S; Schmidt, SD; Shi, W; Wu, L; Yang, YP; Yang, ZY; Yang, ZJ; Zhang, ZH; Bonsignori, M; Crump, JA; Kapiga, SH; Sam, NE; Haynes, BF; Simek, M; Burton, DR; Koff, WC; Doria-Rose, NA; Connors, M; Mullikin, JC; Nabel, GJ; Roederer, M; Shapiro, L; Kwong, PD; Mascola, JR				Wu, Xueling; Zhou, Tongqing; Zhu, Jiang; Zhang, Baoshan; Georgiev, Ivelin; Wang, Charlene; Chen, Xuejun; Longo, Nancy S.; Louder, Mark; McKee, Krisha; O'Dell, Sijy; Perfetto, Stephen; Schmidt, Stephen D.; Shi, Wei; Wu, Lan; Yang, Yongping; Yang, Zhi-Yong; Yang, Zhongjia; Zhang, Zhenhai; Bonsignori, Mattia; Crump, John A.; Kapiga, Saidi H.; Sam, Noel E.; Haynes, Barton F.; Simek, Melissa; Burton, Dennis R.; Koff, Wayne C.; Doria-Rose, Nicole A.; Connors, Mark; Mullikin, James C.; Nabel, Gary J.; Roederer, Mario; Shapiro, Lawrence; Kwong, Peter D.; Mascola, John R.		NISC Comparative Sequencing Progra	Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; BROAD; SELECTION; BREADTH; EPITOPE; GLYCOPROTEIN; DIVERSITY; DESIGN; DOMAIN; GP120	Antibody VRC01 is a human immunoglobulin that neutralizes about 90% of HIV-1 isolates. To understand how such broadly neutralizing antibodies develop, we used x-ray crystallography and 454 pyrosequencing to characterize additional VRC01-like antibodies from HIV-1-infected individuals. Crystal structures revealed a convergent mode of binding for diverse antibodies to the same CD4-binding-site epitope. A functional genomics analysis of expressed heavy and light chains revealed common pathways of antibody-heavy chain maturation, confined to the IGHV1-2*02 lineage, involving dozens of somatic changes, and capable of pairing with different light chains. Broadly neutralizing HIV-1 immunity associated with VRC01-like antibodies thus involves the evolution of antibodies to a highly affinity-matured state required to recognize an invariant viral structure, with lineages defined from thousands of sequences providing a genetic roadmap of their development.	[Wu, Xueling; Zhou, Tongqing; Zhu, Jiang; Zhang, Baoshan; Georgiev, Ivelin; Wang, Charlene; Chen, Xuejun; Longo, Nancy S.; Louder, Mark; McKee, Krisha; O'Dell, Sijy; Perfetto, Stephen; Schmidt, Stephen D.; Shi, Wei; Wu, Lan; Yang, Yongping; Yang, Zhi-Yong; Yang, Zhongjia; Zhang, Zhenhai; Nabel, Gary J.; Roederer, Mario; Shapiro, Lawrence; Kwong, Peter D.; Mascola, John R.] NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Zhang, Zhenhai; Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Bonsignori, Mattia; Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Crump, John A.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Crump, John A.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Dept Med, Durham, NC 27710 USA; [Crump, John A.; Sam, Noel E.] Tumaini Univ, Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Crump, John A.; Sam, Noel E.] Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Kapiga, Saidi H.; Sam, Noel E.] Kilimanjaro Reprod Hlth Programme, Moshi, Tanzania; [Simek, Melissa; Koff, Wayne C.] Int AIDS Vaccine Initiat IAVI, New York, NY 10038 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Massachusetts Gen Hosp, Massachusetts Inst Technol & Harvard, Ragon Inst, Cambridge, MA 02129 USA; [Doria-Rose, Nicole A.; Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Mullikin, James C.; NISC Comparative Sequencing Progra] NHGRI, NIH Intramural Sequencing Ctr NISC, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; Columbia University; Duke University; Duke University; Duke University; Kilimanjaro Christian Medical Centre; International AIDS Vaccine Initiative; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Kwong, PD (corresponding author), NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA.	pdkwong@nih.gov; jmascola@nih.gov	Crump, John A./AAZ-6412-2020; Schmidt, Stephen/AAC-6967-2019; Bonsignori, Mattia/AAE-7678-2019; Roederer, Mario/G-1887-2011; Mascola, John/AAI-7193-2021; Zhang, Zhenhai/GRX-5887-2022; Crump, John A./AAZ-6289-2020; Zhou, Tongqing/A-6880-2010; Schmidt, Stephen/B-5398-2012; Shapiro, Lawrence/AAE-7172-2019	Crump, John A./0000-0002-4529-102X; Bonsignori, Mattia/0000-0003-2973-2101; Zhang, Zhenhai/0000-0002-4310-0525; Crump, John A./0000-0002-4529-102X; Zhou, Tongqing/0000-0002-3935-4637; Kapiga, Saidi/0000-0003-1753-4060	Vaccine Research Center, National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute, NIH; International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; NIH [AI 5U19 AI 067854-06]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196, ZIAHG200330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005095, ZIAAI005022, U19AI067854, R01AI033292] Funding Source: NIH RePORTER	Vaccine Research Center, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	X.W., T.Z., J.Z., G.J.N., M. R., L. S., P. D. K., and J.R.M. designed research; B.Z., C. W., X. C., M. L., K. M., S.O.D., S. P., S. D. S., W. S., L. W., Y.Y., Z.Y.Y., Z.Y., NISC, and J.M. performed experiments; X. W. isolated and characterized VRC01-like antibodies by RSC3 probe, devised and prepared samples for 454 pyrosequencing, and assisted with functional characterization; T.Z. determined and analyzed structures of VRC-PG04 and VRC03 with gp120 and assisted with functional characterization; J.Z. devised and carried out computational bioinformatics on the antibodyome; M. B., J.A.C, S. H. K, N.E.S., and B. F. H. contributed donor 0219 materials; M. S., D. R. B., and W. C. K contributed Protocol G materials, including donor 74; N.D.R. and M. C. contributed donor 45 materials; X. W., T.Z., J.Z, I. G., N.S.L., Z.Z., L. S., P. D. K., and J. R. M. analyzed the data; and L. S., G.J.N., P. D. K., and J. R. M. wrote the paper, on which all authors commented. We thank J. Almeida and D. Douek for protocols of PBMC cDNA preparation and for helpful discussions; J. Stuckey for assistance with figures; T. Wrin for sequence information on the donor 74 virus; J. Binley, D. Montefiori, L. Morris, and G. Tomaras for donor 0219 serum characterization; and all of the IAVI Protocol G team members and the Protocol G clinical investigators, specifically, G. Miiro, A. Pozniak, D. McPhee, O. Manigart, E. Karita, A. Inwoley, W. Jaoko, J. DeHovitz, L.-G. Bekker, P. Pitisuttithum, R. Paris, J. Serwanga, and S. Allen. We also thank H. Sato, I. Wilson, and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions or comments on the manuscript. Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, and the National Human Genome Research Institute, NIH; by grants from the International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; and by the Center for HIV AIDS Vaccine Immunology grant AI 5U19 AI 067854-06 from NIH. Use of sector 22 (Southeast Region Collaborative Access Team) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. Structure factors and coordinates for antibodies VRC03 and VRC-PG04 in complex with HIV-1 gp120 have been deposited with the Protein Data Bank under accession codes 3SE8 and 3SE9, respectively. We have also deposited deep sequencing data for donors 45 and 74 (Appendices 1 to 4) used in this study to National Center for Biotechnology Information Short Reads Archives (SRA) under accession no. SRP006992. Information deposited with GenBank includes the heavy-and light-chain variable region sequences of probe-identified antibodies VRC-PG04 and VRC-PG04b (accession nos. JN159464 to JN159467), VRC-CH30, VRC-CH31, and VRC-CH32 (JN159434 to JN159439), and VRC-CH33 and VRC-CH34 (JN159470 to 159473), as well as the sequences of genomically identified neutralizers: 24 heavy chains from donor 74, 2008 (JN159440 to JN159463), two heavy chains from donor 45, 2008 (JN159474 and JN159475), two light chains from donor 45, 2001 (JN159468 and JN159469), and 1561 unique sequences associated with neutralizing CDR H3 distributions with at least one low divergent member shown in Fig. 6B and fig. S16 (JN157873 to JN159433).	Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Breden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016857; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Edry E, 2004, J IMMUNOL, V173, P4265, DOI 10.4049/jimmunol.173.7.4265; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Huber M, 2010, J VIROL, V84, P10700, DOI 10.1128/JVI.01111-10; Kabat EA, 1991, SEQUENCES PROTEINS I; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Lerner RA, 2011, MOL BIOSYST, V7, P1004, DOI 10.1039/c0mb00310g; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	37	652	713	2	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1593	1602		10.1126/science.1207532	http://dx.doi.org/10.1126/science.1207532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21835983	Green Accepted			2022-12-28	WOS:000294900900034
J	He, YF; Li, BZ; Li, Z; Liu, P; Wang, Y; Tang, QY; Ding, JP; Jia, YY; Chen, ZC; Li, L; Sun, Y; Li, XX; Dai, Q; Song, CX; Zhang, KL; He, C; Xu, GL				He, Yu-Fei; Li, Bin-Zhong; Li, Zheng; Liu, Peng; Wang, Yang; Tang, Qingyu; Ding, Jianping; Jia, Yingying; Chen, Zhangcheng; Li, Lin; Sun, Yan; Li, Xiuxue; Dai, Qing; Song, Chun-Xiao; Zhang, Kangling; He, Chuan; Xu, Guo-Liang			Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; GLYCOSYLASE ACTIVITY; GENE-EXPRESSION; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; METHYLATION; REPAIR; DEAMINATION	The prevalent DNA modification in higher organisms is the methylation of cytosine to 5-methylcytosine (5mC), which is partially converted to 5-hydroxymethylcytosine (5hmC) by the Tet (ten eleven translocation) family of dioxygenases. Despite their importance in epigenetic regulation, it is unclear how these cytosine modifications are reversed. Here, we demonstrate that 5mC and 5hmC in DNA are oxidized to 5-carboxylcytosine (5caC) by Tet dioxygenases in vitro and in cultured cells. 5caC is specifically recognized and excised by thymine-DNA glycosylase (TDG). Depletion of TDG in mouse embyronic stem cells leads to accumulation of 5caC to a readily detectable level. These data suggest that oxidation of 5mC by Tet proteins followed by TDG-mediated base excision of 5caC constitutes a pathway for active DNA demethylation.	[He, Yu-Fei; Li, Bin-Zhong; Li, Zheng; Liu, Peng; Wang, Yang; Xu, Guo-Liang] Chinese Acad Sci, Grp DNA Metab, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Sun, Yan; Li, Xiuxue] Chinese Acad Sci, Inst Mat Med, Shanghai 201203, Peoples R China; [Dai, Qing; Song, Chun-Xiao; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Dai, Qing; Song, Chun-Xiao; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Zhang, Kangling] Loma Linda Univ, Sch Med, Dept Biochem, Loma Linda, CA 92350 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Chicago; University of Chicago; Loma Linda University	Xu, GL (corresponding author), Chinese Acad Sci, Grp DNA Metab, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	glxu@sibs.ac.cn	Li, Binzhong/I-2307-2013; Dai, Qing/ABD-8444-2021; li, zheng/AAI-1750-2020; Tang, Qingyu/W-4530-2018	li, zheng/0000-0002-4987-0205; Tang, Qingyu/0000-0002-5554-6540; Song, Chun-Xiao/0000-0002-7781-6521; Liu, Peng/0000-0002-6469-6460; ding, jian ping/0000-0001-7029-7346; He, Yu-Fei/0000-0002-0648-6430	Ministry of Science and Technology China [2007CB947503, 2009CB941101, 2010CB912100]; National Science Foundation of China [30730059, 30930052, 30821065]; Chinese Academy of Sciences [XDA01010301]; NIH [GM071440, 1S10RR027643-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440] Funding Source: NIH RePORTER	Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Walsh for critical reading of the manuscript, G. Shi and S. Klimasauskas for discussions, J. Ju for providing Tet cDNA clones, T. Carell for 2'-deoxy-5-carboxylcytidine and Z. Hua for the TDG antibody. This study was supported by grants from the Ministry of Science and Technology China (2007CB947503 and 2009CB941101 to G.-L. X., 2010CB912100 to L. L.), National Science Foundation of China (30730059 to G.-L. X., 30930052 and 30821065 to L. L.), and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01010301 to G.-L. X.) and by the NIH (GM071440 to C. H.) and (1S10RR027643-01 to K.Z.).	Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dahl C, 2011, CLIN CHIM ACTA, V412, P831, DOI 10.1016/j.cca.2011.02.013; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Krokan HE, 1997, BIOCHEM J, V325, P1; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597	26	1881	1992	5	365	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1303	1307		10.1126/science.1210944	http://dx.doi.org/10.1126/science.1210944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21817016	Green Accepted			2022-12-28	WOS:000294406400058
J	Glantz, LH; Annas, GJ				Glantz, Leonard H.; Annas, George J.			Impossible? Outlawing State Safety Laws for Generic Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREEMPTION; FDA		[Glantz, Leonard H.; Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Glantz, LH (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831; Glantz, Leonard/0000-0003-4591-2305				Annas GJ, 2009, NEW ENGL J MED, V361, P1206, DOI 10.1056/NEJMhle0902889; Glantz LH, 2008, NEW ENGL J MED, V358, P1883, DOI 10.1056/NEJMp0802108; *US DRUG SAF SYST, 2007, FUT DRUG SAF PROM PR	3	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					681	683		10.1056/NEJMp1107832	http://dx.doi.org/10.1056/NEJMp1107832			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	811JM	21830958				2022-12-28	WOS:000294205300001
J	Morin, RD; Mendez-Lago, M; Mungall, AJ; Goya, R; Mungall, KL; Corbett, RD; Johnson, NA; Severson, TM; Chiu, R; Field, M; Jackman, S; Krzywinski, M; Scott, DW; Trinh, DL; Tamura-Wells, J; Li, S; Firme, MR; Rogic, S; Griffith, M; Chan, S; Yakovenko, O; Meyer, IM; Zhao, EY; Smailus, D; Moksa, M; Chittaranjan, S; Rimsza, L; Brooks-Wilson, A; Spinelli, JJ; Ben-Neriah, S; Meissner, B; Woolcock, B; Boyle, M; McDonald, H; Tam, A; Zhao, YJ; Delaney, A; Zeng, T; Tse, K; Butterfield, Y; Birol, I; Holt, R; Schein, J; Horsman, DE; Moore, R; Jones, SJM; Connors, JM; Hirst, M; Gascoyne, RD; Marra, MA				Morin, Ryan D.; Mendez-Lago, Maria; Mungall, Andrew J.; Goya, Rodrigo; Mungall, Karen L.; Corbett, Richard D.; Johnson, Nathalie A.; Severson, Tesa M.; Chiu, Readman; Field, Matthew; Jackman, Shaun; Krzywinski, Martin; Scott, David W.; Trinh, Diane L.; Tamura-Wells, Jessica; Li, Sa; Firme, Marlo R.; Rogic, Sanja; Griffith, Malachi; Chan, Susanna; Yakovenko, Oleksandr; Meyer, Irmtraud M.; Zhao, Eric Y.; Smailus, Duane; Moksa, Michelle; Chittaranjan, Suganthi; Rimsza, Lisa; Brooks-Wilson, Angela; Spinelli, John J.; Ben-Neriah, Susana; Meissner, Barbara; Woolcock, Bruce; Boyle, Merrill; McDonald, Helen; Tam, Angela; Zhao, Yongjun; Delaney, Allen; Zeng, Thomas; Tse, Kane; Butterfield, Yaron; Birol, Inanc; Holt, Rob; Schein, Jacqueline; Horsman, Douglas E.; Moore, Richard; Jones, Steven J. M.; Connors, Joseph M.; Hirst, Martin; Gascoyne, Randy D.; Marra, Marco A.			Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma	NATURE			English	Article							B-CELL LYMPHOMA; NF-KAPPA-B; FOLLICULAR LYMPHOMA; SOMATIC MUTATIONS; RNA-SEQ; INACTIVATION; CANCER; EXPRESSION; SUBTYPES; PHOSPHORYLATION	Follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are the two most common non-Hodgkin lymphomas (NHLs). Here we sequenced tumour and matched normal DNA from 13 DLBCL cases and one FL case to identify genes with mutations in B-cell NHL. We analysed RNA-seq data from these and another 113 NHLs to identify genes with candidate mutations, and then re-sequenced tumour and matched normal DNA from these cases to confirm 109 genes with multiple somatic mutations. Genes with roles in histone modification were frequent targets of somatic mutation. For example, 32% of DLBCL and 89% of FL cases had somatic mutations in MLL2, which encodes a histone methyltransferase, and 11.4% and 13.4% of DLBCL and FL cases, respectively, had mutations in MEF2B, a calcium-regulated gene that cooperates with CREBBP and EP300 in acetylating histones. Our analysis suggests a previously unappreciated disruption of chromatin biology in lymphomagenesis.	[Morin, Ryan D.; Mendez-Lago, Maria; Mungall, Andrew J.; Goya, Rodrigo; Mungall, Karen L.; Corbett, Richard D.; Severson, Tesa M.; Chiu, Readman; Field, Matthew; Jackman, Shaun; Krzywinski, Martin; Trinh, Diane L.; Tamura-Wells, Jessica; Li, Sa; Firme, Marlo R.; Griffith, Malachi; Chan, Susanna; Yakovenko, Oleksandr; Zhao, Eric Y.; Smailus, Duane; Moksa, Michelle; Chittaranjan, Suganthi; Brooks-Wilson, Angela; McDonald, Helen; Tam, Angela; Zhao, Yongjun; Delaney, Allen; Zeng, Thomas; Tse, Kane; Butterfield, Yaron; Birol, Inanc; Holt, Rob; Schein, Jacqueline; Moore, Richard; Jones, Steven J. M.; Hirst, Martin; Marra, Marco A.] BC Canc Agcy Vancouver, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Johnson, Nathalie A.; Scott, David W.; Rogic, Sanja; Ben-Neriah, Susana; Meissner, Barbara; Woolcock, Bruce; Boyle, Merrill; Horsman, Douglas E.; Connors, Joseph M.; Gascoyne, Randy D.] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC V5Z 1L3, Canada; [Meyer, Irmtraud M.] Centre High Throughput Biol, Dept Comp Sci, Vancouver, BC V6T 1Z4, Canada; [Rimsza, Lisa] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Connors, Joseph M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada; [Gascoyne, Randy D.] Univ British Columbia, Dept Pathol, Vancouver, BC V6T 2B5, Canada; [Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; University of Arizona; Simon Fraser University; University of British Columbia; University of British Columbia; University of British Columbia	Marra, MA (corresponding author), BC Canc Agcy Vancouver, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada.	mmarra@bcgsc.ca	Connors, Joseph/AAF-5284-2019; Hirst, Martin/B-7684-2016; Birol, Inanc/G-5440-2011; Brooks-Wilson, Angela/E-9399-2012; Jones, Steven J/C-3621-2009; Holt, Robert A/C-3303-2009; Morin, Ryan/AAE-7824-2019; Marra, Marco A/B-5987-2008; Spinelli, John J./B-6210-2013; Mungall, Andrew J./U-7067-2018; Griffith, Malachi/P-1285-2014; Schein, Jacquie E/G-3674-2015; Gascoyne, Randy D/A-6009-2013; Jackman, Shaun/G-9622-2013	Connors, Joseph/0000-0002-1361-7531; Birol, Inanc/0000-0003-0950-7839; Brooks-Wilson, Angela/0000-0003-1009-6408; Jones, Steven J/0000-0003-3394-2208; Holt, Robert A/0000-0002-7259-1247; Morin, Ryan/0000-0003-2932-7800; Marra, Marco A/0000-0001-7146-7175; Spinelli, John J./0000-0002-9119-3287; Mungall, Andrew J./0000-0002-0905-2742; Griffith, Malachi/0000-0002-6388-446X; Gascoyne, Randy D/0000-0002-2610-5690; Jackman, Shaun/0000-0002-9275-5966; Rogic, Sanja/0000-0002-9988-3661; Stutheit-Zhao, Eric/0000-0003-1277-6335; Field, Matthew/0000-0003-0788-6513	National Cancer Institute Office of Cancer Genomics [HHSN261200800001E]; Terry Fox Foundation [019001, NCIC 019005]; Genome Canada/Genome British Columbia; NIH [P50CA130805-01, 1U01CA114778]; Michael Smith Foundation for Health Research [ST-PDF-01793]; MSFHR; Spanish Ministry of Education; Terry Fox Foundation at Canadian Institutes of Health Research [TGT-53912]; Canadian Cancer Society; Canadian Institutes of Health Research; UBC Four Year Fellowship; Canadian Foundation for Innovation; NATIONAL CANCER INSTITUTE [P50CA130805, U01CA114778, U24CA143866] Funding Source: NIH RePORTER	National Cancer Institute Office of Cancer Genomics; Terry Fox Foundation; Genome Canada/Genome British Columbia(Genome Canada); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); MSFHR(Michael Smith Foundation for Health Research); Spanish Ministry of Education(Spanish Government); Terry Fox Foundation at Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UBC Four Year Fellowship; Canadian Foundation for Innovation(Canada Foundation for Innovation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by funding from the National Cancer Institute Office of Cancer Genomics (Contract No. HHSN261200800001E), the Terry Fox Foundation (grant 019001, Biology of Cancer: Insights from Genomic Analyses of Lymphoid Neoplasms) and Genome Canada/Genome British Columbia Grant Competition III (Project Title: High Resolution Analysis of Follicular Lymphoma Genomes) to J.M.C., R. D. G. and M. A. M. We acknowledge support from NIH grants P50CA130805-01 "SPORE in Lymphoma, Tissue Resource Core (PI Fisher)" and 1U01CA114778 "Molecular Signatures to Improve Diagnosis and Outcome in Lymphoma (PIChan)". A.J.M. is a Career Development Program Fellow of the Leukemia and Lymphoma Society. N.A.J. was a research fellow of the Terry Fox Foundation(award NCIC 019005) and the Michael Smith Foundation for Health Research (ST-PDF-01793). M. A. M. is a Terry Fox Young Investigator and a Michael Smith Senior Research Scholar. R. D. M. is a Vanier Scholar (CIHR) and holds a MSFHR senior graduate studentship. M.M.-L. acknowledges support from a Postdoctoral Fellowship from the Spanish Ministry of Education, under the "Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I-D+i 2008-2011". D. W. S. was supported by the Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at Canadian Institutes of Health Research (Grant No. TGT-53912). J.J.S. acknowledges funding from The Canadian Cancer Society and the Canadian Institutes of Health Research. R. G. is supported by a UBC Four Year Fellowship. I. M. M. acknowledges the Canadian Foundation for Innovation for a Leaders Opportunity Fund. The laboratory work for this study was undertaken at the Genome Sciences Centre, British Columbia Cancer Research Centre and the Centre for Translational and Applied Genomics, a program of the Provincial Health Services Authority Laboratories. The authors would like to thank C. Greenman for supplying his software and also acknowledge D. Gerhard and S. Aparicio for discussions and guidance. Special thanks to C. Suragh, R. Roscoe, A. Troussard and A. Drobnies for expert project management assistance, and to the Library Construction, Sequencing and Bioinformatics teams at the Genome Sciences Centre. The content of this publication does not necessarily reflect the views of policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.	Anderson JR, 1998, ANN ONCOL, V9, P717, DOI 10.1023/A:1008265532487; Bhattacharyya R, 2000, J BIOL CHEM, V275, P14992, DOI 10.1074/jbc.M000415200; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Canaani E, 2004, BRIT J CANCER, V90, P756, DOI 10.1038/sj.bjc.6601639; Cheung KJJ, 2010, CANCER RES, V70, P9166, DOI 10.1158/0008-5472.CAN-10-2460; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Du MQ, 2000, BLOOD, V95, P3885; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Han AD, 2005, J MOL BIOL, V345, P91, DOI 10.1016/j.jmb.2004.10.033; HE J, 2011, NUCL ACIDS RES; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Iqbal J, 2004, AM J PATHOL, V165, P159, DOI 10.1016/S0002-9440(10)63284-1; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kreutz B, 2007, CELL SIGNAL, V19, P1681, DOI 10.1016/j.cellsig.2007.03.004; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manganello JM, 2003, J BIOL CHEM, V278, P124, DOI 10.1074/jbc.M209219200; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mo JS, 2011, J CELL SCI, V124, P100, DOI 10.1242/jcs.073924; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; PASINI D, 2010, NUCL ACIDS RES; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Saito M, 2009, P NATL ACAD SCI USA, V106, P11294, DOI 10.1073/pnas.0903854106; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Tai DJC, 2009, J BIOL CHEM, V284, P4073, DOI 10.1074/jbc.M805055200; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Young KH, 2008, BLOOD, V112, P3088, DOI 10.1182/blood-2008-01-129783; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	50	1127	1170	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					298	303		10.1038/nature10351	http://dx.doi.org/10.1038/nature10351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21796119	Green Accepted, hybrid			2022-12-28	WOS:000294206500031
J	Deedwania, P				Deedwania, Prakash			Review: Rosiglitazone increases risk for cardiovascular outcomes and mortality compared with pioglitazone in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif San Francisco, Sch Med, Fresno, CA 93701 USA	University of California System; University of California San Francisco; University of California San Francisco at Fresno	Deedwania, P (corresponding author), Univ Calif San Francisco, Sch Med, Fresno, CA 93701 USA.							Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; Montori VM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1354; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4							JC2-12	10.7326/0003-4819-155-4-201108160-02012	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LM	21844545				2022-12-28	WOS:000208885100011
J	Denman, M				Denman, Michael			Review: Evidence for the effectiveness of acupuncture for pain is mixed	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Imperial Coll Sch Med, Northwick Pk Hosp, Harrow, Middx, England	Imperial College London	Denman, M (corresponding author), Imperial Coll Sch Med, Northwick Pk Hosp, Harrow, Middx, England.							Ernst E, 2011, RHEUMATOLOGY, V50, P1007, DOI 10.1093/rheumatology/keq265	1	1	1	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4							JC2-6	10.7326/0003-4819-155-4-201108160-02006	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LM	21844539				2022-12-28	WOS:000208885100005
J	Helm, ML; Stewart, MP; Bullock, RM; DuBois, MR; DuBois, DL				Helm, Monte L.; Stewart, Michael P.; Bullock, R. Morris; DuBois, M. Rakowski; DuBois, Daniel L.			A Synthetic Nickel Electrocatalyst with a Turnover Frequency Above 100,000 s(-1) for H-2 Production	SCIENCE			English	Article							IRON-ONLY HYDROGENASE; MOLECULAR ELECTROCATALYSTS; LOW OVERPOTENTIALS; FUNCTIONAL MODELS; PROTON RELAYS; ACTIVE-SITE; COMPLEXES; EVOLUTION; REDUCTION; OXIDATION	Reduction of acids to molecular hydrogen as a means of storing energy is catalyzed by platinum, but its low abundance and high cost are problematic. Precisely controlled delivery of protons is critical in hydrogenase enzymes in nature that catalyze hydrogen (H-2) production using earth-abundant metals (iron and nickel). Here, we report that a synthetic nickel complex, [Ni((P2NPh)-N-Ph)(2)](BF4)(2), ((P2NPh)-N-Ph = 1,3,6-triphenyl-1-aza-3,6-diphosphacycloheptane), catalyzes the production of H2 using protonated dimethylformamide as the proton source, with turnover frequencies of 33,000 per second (s(-1)) in dry acetonitrile and 106,000 s(-1) in the presence of 1.2 M of water, at a potential of -1.13 volt (versus the ferrocenium/ferrocene couple). The mechanistic implications of these remarkably fast catalysts point to a key role of pendant amines that function as proton relays.	[Helm, Monte L.; Stewart, Michael P.; Bullock, R. Morris; DuBois, M. Rakowski; DuBois, Daniel L.] Pacific NW Natl Lab, Ctr Mol Electrocatalysis, Chem & Mat Sci Div, Richland, WA 99352 USA; [Helm, Monte L.] Ft Lewis Coll, Dept Chem, Durango, CO 81301 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Bullock, RM (corresponding author), Pacific NW Natl Lab, Ctr Mol Electrocatalysis, Chem & Mat Sci Div, POB 999,K2-57, Richland, WA 99352 USA.	morris.bullock@pnnl.gov; daniel.dubois@pnnl.gov	Bullock, R. Morris/L-6802-2016	Bullock, R. Morris/0000-0001-6306-4851	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences; U.S. Department of Energy	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported as part of the Center for Molecular Electrocatalysis, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences. Pacific Northwest National Laboratory is operated by Battelle for the U.S. Department of Energy. Structural parameters for 4 are available free of charge from the Cambridge Crystallographic Data Centre under CCDC 828010. We thank J. A. S. Roberts for help with the simulations of the cyclic voltammograms.	Appel AM, 2011, ACS CATAL, V1, P777, DOI 10.1021/cs2000939; Appel AM, 2005, J AM CHEM SOC, V127, P12717, DOI 10.1021/ja054034o; Artero V, 2005, COORDIN CHEM REV, V249, P1518, DOI 10.1016/j.ccr.2005.01.014; Bard A. J., 2001, ELECTROCHEMICAL METH; Barton BE, 2008, J AM CHEM SOC, V130, P16834, DOI 10.1021/ja8057666; Berning DE, 2001, ORGANOMETALLICS, V20, P1832, DOI 10.1021/om0100582; Cracknell JA, 2008, CHEM REV, V108, P2439, DOI 10.1021/cr0680639; Curtis CJ, 2003, INORG CHEM, V42, P216, DOI 10.1021/ic020610v; Dempsey JL, 2009, ACCOUNTS CHEM RES, V42, P1995, DOI 10.1021/ar900253e; DuBois DL, 2011, EUR J INORG CHEM, P1017, DOI 10.1002/ejic.201001081; Dubois MR, 2009, ACCOUNTS CHEM RES, V42, P1974, DOI 10.1021/ar900110c; Dupuis M, 2011, J PHYS CHEM A, V115, P4861, DOI 10.1021/jp111479z; Felton GAN, 2006, INORG CHEM, V45, P9181, DOI 10.1021/ic060984e; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Frey M, 2002, CHEMBIOCHEM, V3, P153, DOI 10.1002/1439-7633(20020301)3:2/3<153::AID-CBIC153>3.0.CO;2-B; Gloaguen F, 2009, CHEM SOC REV, V38, P100, DOI 10.1039/b801796b; Hu XL, 2007, J AM CHEM SOC, V129, P8988, DOI 10.1021/ja067876b; Izutsu K., 1990, ACID BASE DISSOCIATI; Jacques PA, 2009, P NATL ACAD SCI USA, V106, P20627, DOI 10.1073/pnas.0907775106; Karunadasa HI, 2010, NATURE, V464, P1329, DOI 10.1038/nature08969; Kaur-Ghumaan S, 2010, ANGEW CHEM INT EDIT, V49, P8033, DOI 10.1002/anie.201002719; Kilgore UJ, 2011, J AM CHEM SOC, V133, P5861, DOI 10.1021/ja109755f; Le Goff A, 2009, SCIENCE, V326, P1384, DOI 10.1126/science.1179773; Liu TB, 2007, J AM CHEM SOC, V129, P7008, DOI 10.1021/ja071851a; Tard C, 2005, NATURE, V433, P610, DOI 10.1038/nature03298; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Wilson AD, 2007, P NATL ACAD SCI USA, V104, P6951, DOI 10.1073/pnas.0608928104; Wilson AD, 2006, J AM CHEM SOC, V128, P358, DOI 10.1021/ja056442y	29	892	895	5	598	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					863	866		10.1126/science.1205864	http://dx.doi.org/10.1126/science.1205864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836012	Green Published			2022-12-28	WOS:000293785400036
J	Timoney, N; Baumgart, I; Johanning, M; Varon, AF; Plenio, MB; Retzker, A; Wunderlich, C				Timoney, N.; Baumgart, I.; Johanning, M.; Varon, A. F.; Plenio, M. B.; Retzker, A.; Wunderlich, Ch.			Quantum gates and memory using microwave-dressed states	NATURE			English	Article							DECOHERENCE; SIMULATION	Trapped atomic ions have been used successfully to demonstrate(1) basic elements of universal quantum information processing. Nevertheless, scaling up such methods to achieve large-scale, universal quantum information processing (or more specialized quantum simulations(2-5)) remains challenging. The use of easily controllable and stable microwave sources, rather than complex laser systems(6,7), could remove obstacles to scalability. However, the microwave approach has drawbacks: it involves the use of magnetic-field sensitive states, which shorten coherence times considerably, and requires large, stable magnetic field gradients. Here we show how to overcome both problems by using stationary atomic quantum states as qubits that are induced by microwave fields (that is, by dressing magnetic-field-sensitive states with microwave fields). This permits fast quantum logic, even in the presence of a small (effective) Lamb-Dicke parameter (and, therefore, moderate magnetic field gradients). We experimentally demonstrate the basic building blocks of this scheme, showing that the dressed states are long lived and that coherence times are increased by more than two orders of magnitude relative to those of bare magnetic-field-sensitive states. This improves the prospects of microwave-driven ion trap quantum information processing, and offers a route to extending coherence times in all systems that suffer from magnetic noise, such as neutral atoms, nitrogen-vacancy centres, quantum dots or circuit quantum electrodynamic systems.	[Timoney, N.; Baumgart, I.; Johanning, M.; Varon, A. F.; Wunderlich, Ch.] Univ Siegen, Dept Phys, Fac Sci & Technol, D-57068 Siegen, Germany; [Plenio, M. B.; Retzker, A.] Univ Ulm, Inst Theoret Phys, D-89069 Ulm, Germany	Universitat Siegen; Ulm University	Wunderlich, C (corresponding author), Univ Siegen, Dept Phys, Fac Sci & Technol, D-57068 Siegen, Germany.	alex.retzker@uni-ulm.de; wunderlich@physik.uni-siegen.de	Plenio, Martin B/Y-8282-2019; Plenio, Martin B/I-7895-2013	Plenio, Martin B/0000-0003-4238-8843	Bundesministerium fur Bildung und Forschung [FK 01BQ1012, P3352014]; Deutsche Forschungsgemeinschaft; European Commission under the STREP PICC; German-Israeli Foundation; secunet AG; Alexander von Humboldt Foundation	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission under the STREP PICC; German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); secunet AG; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Technical help with the microwave set-up by T. F. Gloger is acknowledged. We acknowledge support by the Bundesministerium fur Bildung und Forschung (FK 01BQ1012 and P3352014), the Deutsche Forschungsgemeinschaft, the European Commission under the STREP PICC, the German-Israeli Foundation, secunet AG and the Alexander von Humboldt Foundation.	Biercuk MJ, 2009, NATURE, V458, P996, DOI 10.1038/nature07951; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Bluhm H, 2011, NAT PHYS, V7, P109, DOI 10.1038/NPHYS1856; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Friedenauer A, 2008, NAT PHYS, V4, P757, DOI 10.1038/nphys1032; Gerritsma R, 2010, NATURE, V463, P68, DOI 10.1038/nature08688; Haffner H, 2005, APPL PHYS B-LASERS O, V81, P151, DOI 10.1007/s00340-005-1917-z; Hannemann T, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.050303; Johanning M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.073004; Johanning M, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/15/154009; Kielpinski D, 2001, SCIENCE, V291, P1013, DOI 10.1126/science.1057357; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; Mc Hugh D, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.012315; Milburn GJ, 2000, FORTSCHR PHYS, V48, P801, DOI 10.1002/1521-3978(200009)48:9/11<801::AID-PROP801>3.0.CO;2-1; Mintert F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.257904; Ozeri R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.042329; Plenio MB, 1997, P ROY SOC A-MATH PHY, V453, P2017, DOI 10.1098/rspa.1997.0109; Rabl P, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.041302; Simon C, 2010, EUR PHYS J D, V58, P1, DOI 10.1140/epjd/e2010-00103-y; Sorensen J., 2006, NEW J PHYS, V8, p[261, 1]; Specht HP, 2011, NATURE, V473, P190, DOI 10.1038/nature09997; Viola L, 1998, PHYS REV A, V58, P2733, DOI 10.1103/PhysRevA.58.2733; Vitanov NV, 2001, ADV ATOM MOL OPT PHY, V46, P55, DOI 10.1016/S1049-250X(01)80063-X; Wang SX, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3095520; Wunderlich C, 2002, LASER PHYSICS AT THE LIMITS, P261; Wunderlich C, 2003, ADV ATOM MOL OPT PHY, V49, P293	30	175	175	0	60	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					185	U83		10.1038/nature10319	http://dx.doi.org/10.1038/nature10319			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21833085	Green Submitted			2022-12-28	WOS:000293731900031
J	Yang, JJ; Plenge, RM				Yang, Jun J.; Plenge, Robert M.			Genomic Technology Applied to Pharmacological Traits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ASSOCIATION		[Yang, Jun J.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Plenge, Robert M.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Plenge, Robert M.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Yang, JJ (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 262 Danny Thomas Pl,MS313, Memphis, TN 38105 USA.	jun.yang@stjude.org; rplenge@partners.org	Yang, Jun/B-6976-2008; Yang, Jun J./ABG-5646-2020	Yang, Jun/0000-0002-0770-9659; Yang, Jun J./0000-0002-0770-9659	NCI NIH HHS [R21 CA158568, R21 CA158568-02, R21-CA158568, RC4 CA156449, RC4 CA156449-01, RC4-CA156449] Funding Source: Medline; NIAMS NIH HHS [R01-AR059648, R01 AR059648-02, R01 AR056768, R01-AR056768, R01 AR057108-02, R01 AR056768-04, R01 AR059648, R01-AR057108, R01 AR057108] Funding Source: Medline; NIGMS NIH HHS [U01 GM092691, U01-GM092691, U01-GM92666, U01 GM092666-03, U01 GM092691-03, U01 GM092666] Funding Source: Medline; NATIONAL CANCER INSTITUTE [RC4CA156449, R21CA158568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059648, R01AR056768, R01AR057108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691, U01GM092666] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Wilke RA, 2011, CLIN PHARMACOL THER, V89, P379, DOI 10.1038/clpt.2010.260; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735	10	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2011	306	6					652	653		10.1001/jama.2011.1125	http://dx.doi.org/10.1001/jama.2011.1125			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804XD	21828330	Green Accepted			2022-12-28	WOS:000293687300030
J	Burt, RK; Shah, SJ; Dill, K; Grant, T; Gheorghiade, M; Schroeder, J; Craig, R; Hirano, I; Marshall, K; Ruderman, E; Jovanovic, B; Milanetti, F; Jain, S; Boyce, K; Morgan, A; Carr, J; Barr, W				Burt, Richard K.; Shah, Sanjiv J.; Dill, Karin; Grant, Thomas; Gheorghiade, Mihai; Schroeder, James; Craig, Robert; Hirano, Ikuo; Marshall, Karin; Ruderman, Eric; Jovanovic, Borko; Milanetti, Francesca; Jain, Sandeep; Boyce, Kristin; Morgan, Amy; Carr, James; Barr, Walter			Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial	LANCET			English	Article							TERM-FOLLOW-UP; LUNG-DISEASE; MARROW TRANSPLANTATION; MULTICENTER; BLOOD; MORTALITY; PLACEBO	Background Non-randomised studies of haemopoietic stem-cell transplantation (HSCT) in systemic sclerosis have shown improvements in lung function and skin flexibility but high treatment-related mortality. We aimed to assess safety and efficacy of autologous non-myeloablative HSCT in a phase 2 trial compared with the standard of care, cyclophosphamide. Methods In our open-label, randomised, controlled phase 2 trial, we consecutively enrolled patients at Northwestern Memorial Hospital (Chicago, IL, USA) who were aged younger than 60 years with diffuse systemic sclerosis, modified Rodnan skin scores (mRSS) of more than 14, and internal organ involvement or restricted skin involvement (mRSS <14) but coexistent pulmonary involvement. We randomly allocated patients 1:1 by use of a computer-generated sequence with a mixed block design (blocks often and four) to receive HSCT, 200 mg/kg intravenous cyclophosphamide, and 6.5 mg/kg intravenous rabbit antithymocyte globulin or to receive 1.0 g/m(2) intravenous cyclophosphamide once per month for 6 months. The primary outcome for all enrolled patients was improvement at 12 months' follow-up, defined as a decrease in mRSS (>25% for those with initial mRSS >14) or an increase in forced vital capacity by more than 10%. Patients in the control group with disease progression (>25% increase in mRSS or decrease of >10% in forced vital capacity) despite treatment with cyclophosphamide could switch to HSCT 12 months after enrolment. This study is registered with ClinicalTrials.gov, number NCT00278525. Findings Between Jan 18, 2006, and Nov 10, 2009 we enrolled 19 patients. All ten patients randomly allocated to receive HSCT improved at or before 12 months' follow-up, compared with none of nine allocated to cyclophosphamide (odds ratio 110, 95% CI 14.04-infinity; p=0.00001). Eight of nine controls had disease progression (without interval improvement) compared with no patients treated by HSCT (p=0.0001), and seven patients switched to HSCT. Compared with baseline, data for 11 patients with follow-up to 2 years after HSCT suggested that improvements in mRSS (p<0.0001) and forced vital capacity (p<0.03) persisted. Interpretation Non-myeloablative autologous HSCT improves skin and pulmonary function in patients with systemic sclerosis for up to 2 years and is preferable to the current standard of care, but longer follow-up is needed.	[Burt, Richard K.] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Immunotherapy, Chicago, IL 60611 USA; [Shah, Sanjiv J.] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA; [Dill, Karin; Grant, Thomas; Marshall, Karin; Carr, James] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Schroeder, James; Ruderman, Eric; Barr, Walter] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Craig, Robert; Hirano, Ikuo] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gastroenterol, Chicago, IL 60611 USA; [Jovanovic, Borko] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Milanetti, Francesca] Univ Roma La Sapienza, St Andrea Hosp, Div Clin Immunol & Rheumatol, Rome, Italy	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Burt, RK (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Div Immunotherapy, Chicago, IL 60611 USA.	rburt@northwestern.edu	Shah, Sanjiv J./AFQ-9480-2022	Burt, Richard K/0000-0002-0922-4145				Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; Annas GJ, 1992, NAZI DOCTORS NUREMBE, P339; Broad K, 2010, MED SCI MONITOR, V16, pRA187; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Burt RK, 2010, SCIENCE, V328, P825, DOI 10.1126/science.328.5980.825-e; BUSH CA, 1977, CIRCULATION, V56, P924, DOI 10.1161/01.CIR.56.6.924; CLEMENTS PJ, 1993, J RHEUMATOL, V20, P1892; Englert H, 2008, INTERN MED J, V38, P692, DOI 10.1111/j.1445-5994.2007.01593.x; Farge D, 2004, ANN RHEUM DIS, V63, P974, DOI 10.1136/ard.2003.011205; Farge D, 2002, BRIT J HAEMATOL, V119, P726, DOI 10.1046/j.1365-2141.2002.03895.x; Farge D, 2010, HAEMATOL-HEMATOL J, V95, P284, DOI 10.3324/haematol.2009.013458; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Hoyles RK, 2006, ARTHRITIS RHEUM-US, V54, P3962, DOI 10.1002/art.22204; Ioannidis JPA, 2005, AM J MED, V118, P2, DOI 10.1016/j.amjmed.2004.04.031; Launay D, 2009, J RHEUMATOL, V36, P1460, DOI 10.3899/jrheum.081212; Loberiza FR, 2005, BLOOD, V105, P2979, DOI 10.1182/blood-2004-10-3863; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Marmont AM, 2008, J AUTOIMMUN, V30, P145, DOI 10.1016/j.jaut.2007.12.009; Milanetti F, 2011, CURR STEM CELL RES T, V6, P16, DOI 10.2174/157488811794480663; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nannini C, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2534; Nash RA, 2007, BLOOD, V110, P1388, DOI 10.1182/blood-2007-02-072389; Oda S, 2010, AM J ROENTGENOL, V194, P398, DOI 10.2214/AJR.09.2583; Oyama Y, 2007, BONE MARROW TRANSPL, V40, P549, DOI 10.1038/sj.bmt.1705782; POCOCK SJ, 1992, BMJ-BRIT MED J, V305, P235, DOI 10.1136/bmj.305.6847.235; Saccardi R, 2004, Bone Marrow Transplant, V34, P877, DOI 10.1038/sj.bmt.1704656; Shah SJ, 2012, SCLERODERMA: FROM PATHOGENESIS TO COMPREHENSIVE MANAGEMENT, P373, DOI 10.1007/978-1-4419-5774-0_30; STEEN VD, 1994, ARTHRITIS RHEUM, V37, P1283, DOI 10.1002/art.1780370903; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Tashkin DP, 2007, AM J RESP CRIT CARE, V176, P1026, DOI 10.1164/rccm.200702-326OC; Tsukamoto H, 2006, ANN RHEUM DIS, V65, P508, DOI 10.1136/ard.2005.037879; Uchiyama Y, 2003, MED PHYS, V30, P2440, DOI 10.1118/1.1597431; van Laar JM, 2005, ANN RHEUM DIS, V64, P1515, DOI 10.1136/ard.2005.043240; Vonk MC, 2008, ANN RHEUM DIS, V67, P98, DOI 10.1136/ard.2007.071464; Wing M, 2008, J IMMUNOTOXICOL, V5, P11, DOI 10.1080/15476910801897433	35	342	359	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2011	378	9790					498	506		10.1016/S0140-6736(11)60982-3	http://dx.doi.org/10.1016/S0140-6736(11)60982-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809SO	21777972				2022-12-28	WOS:000294077200029
J	Bauer, T; Bouman, HJ; van Werkum, JW; Ford, NF; ten Berg, JM; Taubert, D				Bauer, Tim; Bouman, Heleen J.; van Werkum, Jochem W.; Ford, Neville F.; ten Berg, Jurrien M.; Taubert, Dirk			Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OF-FUNCTION POLYMORPHISM; PERCUTANEOUS CORONARY INTERVENTION; PROTON-PUMP INHIBITORS; PLATELET REACTIVITY; STENT THROMBOSIS; GENETIC ASSOCIATION; CYP2C19-ASTERISK-17 ALLELE; CARDIOVASCULAR RISK; COMPOSITE OUTCOMES; MAJOR DETERMINANT	Objective To evaluate the accumulated information from genetic association studies investigating the impact of variants of the cytochrome P450 (CYP) 2C19 genotype on the clinical efficacy of clopidogrel. Design Systematic review and meta-analysis with a structured search algorithm and prespecified eligibility criteria for retrieval of relevant studies; dominant genetic model assumptions and quantitative methods for calculating summary effect estimates from study level odds ratios; systematic assessment of bias within and between studies; and grading of the cumulative evidence by consensus criteria. Data sources Medline, Embase, the Cochrane Library, online databases, contents pages and bibliographies of general medical, cardiovascular, pharmacological, and genetic journals. Eligibility criteria for selecting studies Original full length reports assessing the cumulative incidence of major adverse cardiovascular events or stent thrombosis over a follow-up period of at least a month in association with carrier status for the loss of function or gain of function CYP2C19 allele in adult patients with coronary artery disease and a clinical presentation of acute coronary syndrome or stable angina pectoris who were taking clopidogrel. Results 15 studies met the inclusion criteria. The random effects summary odds ratio for stent thrombosis in carriers of at least one CYP2C19 loss of function allele versus non-carriers combining nine studies was 1.77 (95% confidence interval 1.31 to 2.40; P<0.001). This nominally significant odds ratio was subject to considerable bias across the studies (small study effect bias and replication diversity). The adjustment for these quality modifiers tended to abolish the association. The corresponding random effects summary odds ratio of major adverse cardiovascular events for 12 studies combined was 1.11 (0.89 to 1.39; P=0.36). The random effects summary odds ratio of stent thrombosis in carriers versus non-carriers of at least one CYP2C19*17 gain of function allele for three studies combined was 0.99 (0.60 to 1.62; P=0.96), and the corresponding odds ratio of major adverse cardiovascular events in five studies was 0.93 (0.75 to 1.14; P=0.48). The overall quality of epidemiological evidence was graded as low, which excludes reliable clinical assessments. Conclusions Accumulated information from genetic association studies does not indicate a substantial or consistent influence of CYP2C19 gene polymorphisms on the clinical efficacy of clopidogrel. The current evidence does not support the use of individualised antiplatelet regimens guided by CYP2C19 genotype.	[Bauer, Tim; Taubert, Dirk] Univ Hosp Cologne, Dept Pharmacol, D-50931 Cologne, Germany; [Bouman, Heleen J.; van Werkum, Jochem W.] Univ Maastricht, Dept Biochem, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Bouman, Heleen J.; van Werkum, Jochem W.; ten Berg, Jurrien M.] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands; [Ford, Neville F.] UMDNJ Robert Wood Johnson Med Sch, New Brunswick, NJ USA; [Ford, Neville F.] Woodfield Clin Consulting LLC, Green Valley, AZ USA	University of Cologne; Maastricht University; St. Antonius Hospital Utrecht; Rutgers State University New Brunswick; Rutgers State University Medical Center	Taubert, D (corresponding author), Univ Hosp Cologne, Dept Pharmacol, D-50931 Cologne, Germany.	dirk.taubert@medizin.uni-koeln.de						Akey JM, 2001, AM J HUM GENET, V68, P1447, DOI 10.1086/320607; Anderson JL, 2009, J AM COLL CARDIOL, V53, pA27; [Anonymous], 2010, FDA DRUG SAF COMM RE; Attia J, 2009, JAMA-J AM MED ASSOC, V301, P191, DOI 10.1001/jama.2008.946; Barbui C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000322; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Brackbill ML, 2009, HEART VESSELS, V24, P73, DOI 10.1007/s00380-008-1085-2; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Charisma Genomics Substudy, 2009, EV CYP2C19 POL PROSP; Charlot M, 2010, ANN INTERN MED, V153, P378, DOI 10.7326/0003-4819-153-6-201009210-00005; Clarke TA, 2003, DRUG METAB DISPOS, V31, P53, DOI 10.1124/dmd.31.1.53; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Cordoba G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3920; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Damani SB, 2010, J AM COLL CARDIOL, V56, P109, DOI 10.1016/j.jacc.2010.03.029; Debnath B, 2010, DRUG NEWS PERSPECT, V23, P670, DOI 10.1358/dnp.2010.23.10.1506088; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; FLEISS JL, 1979, PSYCHOL BULL, V86, P974, DOI 10.1037/0033-2909.86.5.974; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Frere C, 2009, J THROMB HAEMOST, V7, P1409, DOI 10.1111/j.1538-7836.2009.03500.x; Giusti B, 2009, AM J CARDIOL, V103, P806, DOI 10.1016/j.amjcard.2008.11.048; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Harmsze AM, 2010, EUR HEART J, V31, P3046, DOI 10.1093/eurheartj/ehq321; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Hulot JS, 2010, J AM COLL CARDIOL, V56, P134, DOI 10.1016/j.jacc.2009.12.071; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jin B, 2011, MOL BIOL REP, V38, P1697, DOI 10.1007/s11033-010-0282-0; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Lau WC, 2004, CIRCULATION, V109, P166, DOI 10.1161/01.CIR.0000112378.09325.F9; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Malek LA, 2008, CIRC J, V72, P1165, DOI 10.1253/circj.72.1165; Malek LA, 2010, CARDIOLOGY, V117, P81, DOI 10.1159/000320093; Man M, 2010, J CLIN PHARMACOL, V50, P929, DOI 10.1177/0091270009355161; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mega JL, 2008, J AM COLL CARDIOL  S, V51, P178, DOI DOI 10.1016/J.JACC.2008.02.007; Montalescot G, 2009, EUR HEART J, V30, P2685, DOI 10.1093/eurheartj/ehp436; Mueller PS, 2007, ANN INTERN MED, V146, P878, DOI 10.7326/0003-4819-146-12-200706190-00009; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Poole C, 1999, AM J EPIDEMIOL, V150, P469, DOI 10.1093/oxfordjournals.aje.a010035; Rudberg I, 2008, CLIN PHARMACOL THER, V83, P322, DOI 10.1038/sj.clpt.6100291; Sawada T, 2011, CIRC J, V75, P99, DOI 10.1253/circj.CJ-10-0525; Schenk PW, 2010, PHARMACOGENOMICS J, V10, P219, DOI 10.1038/tpj.2009.50; Scholz I, 2009, BRIT J CLIN PHARMACO, V68, P906, DOI 10.1111/j.1365-2125.2009.03534.x; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2010, J THROMB HAEMOST, V8, P1685, DOI 10.1111/j.1538-7836.2010.03921.x; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Sim SC, 2006, CLIN PHARMACOL THER, V79, P103, DOI 10.1016/j.clpt.2005.10.002; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Snoep JD, 2007, AM HEART J, V154, P221, DOI 10.1016/j.ahj.2007.04.014; Sofi F, 2011, PHARMACOGENOMICS J, V11, P199, DOI 10.1038/tpj.2010.21; Sofi F, 2010, THROMB HAEMOSTASIS, V103, P841, DOI 10.1160/TH09-06-0418; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Tiroch KA, 2010, AM HEART J, V160, P506, DOI 10.1016/j.ahj.2010.06.039; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Worrall A, 2009, EUR HEART J, V30, P327; Yasui-Furukori N, 2004, BRIT J CLIN PHARMACO, V57, P487, DOI 10.1111/j.1365-2125.2003.02047.x; Yoo HD, 2010, BRIT J CLIN PHARMACO, V69, P27, DOI 10.1111/j.1365-2125.2009.03558.x; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011	83	191	205	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2011	343								d4588	10.1136/bmj.d4588	http://dx.doi.org/10.1136/bmj.d4588			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NO	21816733	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000293734800002
J	Cerling, TE; Wynn, JG; Andanje, SA; Bird, MI; Korir, DK; Levin, NE; Mace, W; Macharia, AN; Quade, J; Remien, CH				Cerling, Thure E.; Wynn, Jonathan G.; Andanje, Samuel A.; Bird, Michael I.; Korir, David Kimutai; Levin, Naomi E.; Mace, William; Macharia, Anthony N.; Quade, Jay; Remien, Christopher H.			Woody cover and hominin environments in the past 6 million years	NATURE			English	Article							HUMAN-EVOLUTION; ARDIPITHECUS-RAMIDUS; CLIMATE-CHANGE; STABLE CARBON; ISOTOPIC COMPOSITION; TURKANA BASIN; EAST-AFRICA; C-4 PLANTS; VEGETATION; DELTA-C-13	The role of African savannahs in the evolution of early hominins has been debated for nearly a century. Resolution of this issue has been hindered by difficulty in quantifying the fraction of woody cover in the fossil record. Here we show that the fraction of woody cover in tropical ecosystems can be quantified using stable carbon isotopes in soils. Furthermore, we use fossil soils from hominin sites in the Awash and Omo-Turkana basins in eastern Africa to reconstruct the fraction of woody cover since the Late Miocene epoch (about 7 million years ago). C-13/C-12 ratio data from 1,300 palaeosols at or adjacent to hominin sites dating to at least 6 million years ago show that woody cover was predominantly less than similar to 40% at most sites. These data point to the prevalence of open environments at the majority of hominin fossil sites in eastern Africa over the past 6 million years.	[Cerling, Thure E.; Mace, William; Macharia, Anthony N.; Remien, Christopher H.] Univ Utah, Salt Lake City, UT 84112 USA; [Wynn, Jonathan G.] Univ S Florida, Tampa, FL 33620 USA; [Andanje, Samuel A.; Korir, David Kimutai] Kenya Wildlife Serv, Nairobi, Kenya; [Bird, Michael I.] James Cook Univ, Cairns, Qld 4870, Australia; [Levin, Naomi E.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Quade, Jay] Univ Arizona, Tucson, AZ 85721 USA	Utah System of Higher Education; University of Utah; State University System of Florida; University of South Florida; James Cook University; Johns Hopkins University; University of Arizona	Cerling, TE (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	thure.cerling@utah.edu	Bird, Michael/G-5364-2010; Wynn, Jonathan/C-1646-2010; Levin, Naomi E/B-4124-2010	Bird, Michael/0000-0003-1801-8703; Levin, Naomi E/0000-0001-5703-3717; Cerling, Thure/0000-0002-3590-294X	LSB Leakey Foundation; NSF [BCS 0621542, EAR-0617010, EAR-0937819, BCS-0321893]	LSB Leakey Foundation; NSF(National Science Foundation (NSF))	We thank the governments of Kenya and Ethiopia for permission to conduct this research, and F. H. Brown for discussions. The authors thank Kenya Wildlife Service and members of the Dikika and Gona Research Projects for support in the field, and Z. Bedaso for aid with analyses. This research was supported by funding from the LSB Leakey Foundation and NSF grants BCS 0621542, EAR-0617010, EAR-0937819 and BCS-0321893.	Aronson JL, 2008, J HUM EVOL, V55, P532, DOI 10.1016/j.jhevol.2008.04.004; Behrensmeyer AK, 2006, SCIENCE, V311, P476, DOI 10.1126/science.1116051; Bird MI, 2004, GLOBAL CHANGE BIOL, V10, P342, DOI 10.1046/j.1365-2486.2003.00695.x; Bird MI, 1996, NATURE, V381, P143, DOI 10.1038/381143a0; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; Cerling TE, 2010, SCIENCE, V328, DOI 10.1126/science.1185274; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; deMenocal PB, 2011, SCIENCE, V331, P540, DOI 10.1126/science.1190683; Feakins SJ, 2005, GEOLOGY, V33, P977, DOI 10.1130/G21814.1; Feibel C.S., 1991, P321; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Gibbons A, 2009, SCIENCE, V326, P36, DOI 10.1126/science.326_36; Good SP, 2011, P NATL ACAD SCI USA, V108, P4902, DOI 10.1073/pnas.1013100108; Keeling R.F., 2010, TRENDS COMPENDIUM DA; Klein R. G., 1999, HUMAN CAREER HUMAN B; Levin NE, 2011, PALAEOGEOGR PALAEOCL, V307, P75, DOI 10.1016/j.palaeo.2011.04.026; Levin NE, 2004, EARTH PLANET SC LETT, V219, P93, DOI 10.1016/S0012-821X(03)00707-6; Lloyd J, 2008, TREE PHYSIOL, V28, P451, DOI 10.1093/treephys/28.3.451; Lovejoy C.O., 1978, EARLY HOMINIDAFRIC, P433; Ometto JPHB, 2006, BIOGEOCHEMISTRY, V79, P251, DOI 10.1007/s10533-006-9008-8; Passey BH, 2010, P NATL ACAD SCI USA, V107, P11245, DOI 10.1073/pnas.1001824107; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; Pickering TR, 2007, J HUM EVOL, V53, P434, DOI 10.1016/j.jhevol.2007.01.012; Plummer TW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007199; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Quade J., 2008, GEOLOGICAL SOC AM SP, V446; Quinn RL, 2007, J HUM EVOL, V53, P560, DOI 10.1016/j.jhevol.2007.01.013; Ratnam J, 2011, GLOBAL ECOL BIOGEOGR, V20, P653, DOI 10.1111/j.1466-8238.2010.00634.x; Richmond BG, 2001, YEARB PHYS ANTHROPOL, V44, P70, DOI 10.1002/ajpa.10019; ROGERS MJ, 1994, J HUM EVOL, V27, P139, DOI 10.1006/jhev.1994.1039; Salzmann U, 2008, GLOBAL ECOL BIOGEOGR, V17, P432, DOI 10.1111/j.1466-8238.2008.00381.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sept J, 1998, AM J PRIMATOL, V46, P85, DOI 10.1002/(SICI)1098-2345(1998)46:1<85::AID-AJP7>3.3.CO;2-1; Sikes NE, 2007, J HUM EVOL, V53, P574, DOI 10.1016/j.jhevol.2006.12.008; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; Vrba Elizabeth S., 1995, PALEOCLIMATE EVOLUTI; WHEELER PE, 1994, J HUM EVOL, V26, P339, DOI 10.1006/jhev.1994.1021; White F., 1983, VEGETATION AFRICA, V20; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; WoldeGabriel G, 2009, SCIENCE, V326, DOI 10.1126/science.1175817; Wood B, 2008, J ANAT, V212, P354, DOI 10.1111/j.1469-7580.2008.00871.x; Wood B, 2011, NATURE, V470, P347, DOI 10.1038/nature09709; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Wynn JG, 2000, J HUM EVOL, V39, P411, DOI 10.1006/jhev.2000.0431; Wynn JG, 2008, TELLUS B, V60, P604, DOI 10.1111/j.1600-0889.2008.00361.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	50	324	328	4	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					51	56		10.1038/nature10306	http://dx.doi.org/10.1038/nature10306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	801NR	21814275				2022-12-28	WOS:000293447300027
J	Jutzi, M; Asphaug, E				Jutzi, M.; Asphaug, E.			Forming the lunar farside highlands by accretion of a companion moon	NATURE			English	Article							ORIGIN; IMPACT; SIMULATIONS; ASYMMETRY; EVOLUTION; MANTLE	The most striking geological feature of the Moon is the terrain and elevation dichotomy(1) between the hemispheres: the nearside is low and flat, dominated by volcanic maria, whereas the farside is mountainous and deeply cratered. Associated with this geological dichotomy is a compositional and thermal variation(2,3), with the nearside Procellarum KREEP (potassium/rare-earth element/phosphorus) Terrane and environs interpreted as having thin, compositionally evolved crust in comparison with the massive feldspathic highlands. The lunar dichotomy may have been caused by internal effects (for example spatial variations in tidal heating(4), asymmetric convective processes(5) or asymmetric crystallization of the magma ocean(6)) or external effects (such as the event that formed the South Pole/Aitken basin(1) or asymmetric cratering(7)). Here we consider its origin as a late carapace added by the accretion of a companion moon. Companion moons are a common outcome of simulations(8) of Moon formation from a protolunar disk resulting from a giant impact, and although most coplanar configurations are unstable(9), a similar to 1,200-km-diameter moon located at one of the Trojan points could be dynamically stable for tens of millions of years after the giant impact(10). Most of the Moon's magma ocean would solidify on this timescale(11,12), whereas the companion moon would evolve more quickly into a crust and a solid mantle derived from similar disk material, and would presumably have little or no core. Its likely fate would be to collide with the Moon at similar to 2-3 km s(-1), well below the speed of sound in silicates. According to our simulations, a large moon/Moon size ratio (similar to 0.3) and a subsonic impact velocity lead to an accretionary pile rather than a crater, contributing a hemispheric layer of extent and thickness consistent with the dimensions of the farside highlands(1,13) and in agreement with the degree-two crustal thickness profile(4). The collision furthermore displaces the KREEP-rich layer to the opposite hemisphere, explaining the observed concentration(2,3).	[Jutzi, M.; Asphaug, E.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95060 USA; [Jutzi, M.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	University of California System; University of California Santa Cruz; University of Bern	Jutzi, M (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, 1156 Highst, Santa Cruz, CA 95060 USA.	martin.jutzi@space.unibe.ch	Asphaug, Erik/AAC-9455-2020	Jutzi, Martin/0000-0002-1800-2974	NASA; NSF-MRI	NASA(National Aeronautics & Space Administration (NASA)); NSF-MRI(National Science Foundation (NSF)NSF - Office of the Director (OD))	Our work is sponsored by NASA's Planetary Geology and Geophysics programme 'Small Bodies and Planetary Collisions'. All simulations were run at the University of California, Santa Cruz, on the NSF-MRI-sponsored 'pleiades' cluster. We are grateful to M. Cuk, B. Gladman and R. Canup for guidance.	BENZ W, 1986, ICARUS, V66, P515, DOI 10.1016/0019-1035(86)90088-6; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 1999, ASTRON J, V117, P603, DOI 10.1086/300667; Cuk M, 2009, ICARUS, V199, P237, DOI 10.1016/j.icarus.2008.10.022; Elkins-Tanton LT, 2011, EARTH PLANET SC LETT, V304, P326, DOI 10.1016/j.epsl.2011.02.004; Garrick-Bethell I, 2010, SCIENCE, V330, P949, DOI 10.1126/science.1193424; HOUSEN KR, 1983, J GEOPHYS RES, V88, P2485, DOI 10.1029/JB088iB03p02485; Ida S, 1997, NATURE, V389, P353, DOI 10.1038/38669; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Jop P, 2006, NATURE, V441, P727, DOI 10.1038/nature04801; Jutzi M, 2008, ICARUS, V198, P242, DOI 10.1016/j.icarus.2008.06.013; Jutzi M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045517; Lawrence DJ, 1998, SCIENCE, V281, P1484, DOI 10.1126/science.281.5382.1484; Loper D.E., 2002, J GEOPHYS RES-PLANET, V107, P131; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; Meyer J, 2010, ICARUS, V208, P1, DOI 10.1016/j.icarus.2010.01.029; Parmentier EM, 2002, EARTH PLANET SC LETT, V201, P473, DOI 10.1016/S0012-821X(02)00726-4; WARREN PH, 1985, ANNU REV EARTH PL SC, V13, P201, DOI 10.1146/annurev.ea.13.050185.001221; WASSON JT, 1980, ICARUS, V44, P752, DOI 10.1016/0019-1035(80)90142-6; Wieczorek MA, 2006, REV MINERAL GEOCHEM, V60, P221, DOI 10.2138/rmg.2006.60.3; Wood J. A., 1973, Moon, V8, P73, DOI 10.1007/BF00562751; ZUBER MT, 1994, SCIENCE, V266, P1839, DOI 10.1126/science.266.5192.1839; Zuber MT, 2008, P 39 LUN PLAN SCI C	24	50	50	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					69	72		10.1038/nature10289	http://dx.doi.org/10.1038/nature10289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21814278				2022-12-28	WOS:000293447300030
J	Dyer, C				Dyer, Clare			CHILD PROTECTION Great Ormond Street and Baby P: was there a cover up?	BRITISH MEDICAL JOURNAL			English	Editorial Material							OFFLINE		BMJ, London, England		Dyer, C (corresponding author), BMJ, London, England.	ClareDyer@aol.com						[Anonymous], 2011, LANCET, V378, P123; Goldin J, 2011, LANCET, V378, P318, DOI 10.1016/S0140-6736(11)61105-7; Haringey Local Safeguarding Children Board, 2010, SER CAS REV CHILD A; Horton R, 2011, LANCET, V377, P2068, DOI 10.1016/S0140-6736(11)60898-2; Sibert J, 2008, REV CHILD PROTECTION; Widdowson D, 2009, REPORT INVESTIGATION	6	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2011	343								d4691	10.1136/bmj.d4691	http://dx.doi.org/10.1136/bmj.d4691			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	805NM	21810873				2022-12-28	WOS:000293734600005
J	Ewer, AK; Middleton, LJ; Furmston, AT; Bhoyar, A; Daniels, JP; Thangaratinam, S; Deeks, JJ; Khan, KS				Ewer, Andrew K.; Middleton, Lee J.; Furmston, Alexandra T.; Bhoyar, Abhay; Daniels, Jane P.; Thangaratinam, Shakila; Deeks, Jonathan J.; Khan, Khalid S.		PulseOx Study Grp	Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study	LANCET			English	Article							FETAL DIAGNOSIS; DISEASE; PREVALENCE; SURVIVAL; IMPACT	Background Screening for congenital heart defects relies on antenatal ultrasonography and postnatal clinical examination; however, life-threatening defects often are not detected. We prospectively assessed the accuracy of pulse oximetry as a screening test for congenital heart defects. Methods In six maternity units in the UK, asymptomatic newborn babies (gestation >34 weeks) were screened with pulse oximetry before discharge. Infants who did not achieve predetermined oxygen saturation thresholds underwent echocardiography. All other infants were followed up to 12 months of age by use of regional and national registries and clinical follow-up. The main outcome was the sensitivity and specificity of pulse oximetry for detection of critical congenital heart defects (causing death or requiring invasive intervention before 28 days) or major congenital heart disease (causing death or requiring invasive intervention within 12 months of age). Findings 20055 newborn babies were screened and 53 had major congenital heart disease (24 critical), a prevalence of 2.6 per 1000 livebirths. Analyses were done on all babies for whom a pulse oximetry reading was obtained. Sensitivity of pulse oximetry was 75.00% (95%. CI 53.29-90.23) for critical cases and 49.06% (35.06-63.16) for all major congenital heart defects. In 35 cases, congenital heart defects were already suspected after antenatal ultrasonography, and exclusion of these reduced the sensitivity to 58.33% (27.67-84.83) for critical cases and 28.57% (14.64-46.30) for all cases of major congenital heart defects. False-positive results were noted for 169 (0.8%) babies (specificity 99.16%, 99.02-99.28), of which six cases were significant, but not major, congenital heart defects, and 40 were other illnesses that required urgent medical intervention. Interpretation Pulse oximetry is a safe, feasible test that adds value to existing screening. It identifies cases of critical congenital heart defects that go undetected with antenatal ultrasonography. The early detection of other diseases is an additional advantage.	[Ewer, Andrew K.] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Ewer, Andrew K.] Birmingham Womens Healthcare NHS Fdn Trust, Birmingham, W Midlands, England; [Middleton, Lee J.] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham, W Midlands, England; [Daniels, Jane P.] Birmingham Childrens Hosp NHS Fdn Trust, Birmingham, W Midlands, England; [Bhoyar, Abhay] Queen Mary Univ London, Birmingham, W Midlands, England; [Bhoyar, Abhay] Barts & London Queen Marys Sch Med & Dent, London, England; [Thangaratinam, Shakila; Deeks, Jonathan J.; Khan, Khalid S.] Univ Birmingham, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Birmingham	Ewer, AK (corresponding author), Birmingham Womens Hosp, Neonatal Unit, Birmingham B15 2TG, W Midlands, England.	a.k.ewer@bham.ac.uk	Deeks, Jon/AAV-5745-2020; Khan, Khalid S/AAT-8824-2020; Ewer, Andrew K/B-1050-2013; Thangaratinam, Shakila/AAP-3724-2021	Deeks, Jon/0000-0002-8850-1971; Khan, Khalid S/0000-0001-5084-7312; Thangaratinam, Shakila/0000-0002-4254-460X; Ewer, Andrew/0000-0002-3825-4781; Middleton, Lee/0000-0003-4621-1922	National Institute for Health Research; National Institute for Health Research (NIHR) [06/06/03]; Medical Research Council [G0800808] Funding Source: researchfish; MRC [G0800808] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme (project number 06/06/03) and will be published this year in full in Health Technology Assessment. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, National Health Service, or Department of Health. We thank the members of the joint steering and data monitoring committee for their assistance throughout the project-Gerben ter Riet (chair, Academisch Medisch Centrum, Universiteit van Amsterdam), Suzie Hutchinson (Little Hearts Matter), Carole Cummins (University of Birmingham), Sam Richmond (Sunderland Royal Hospital), and Stavros Petrou (University of Oxford). The PulseOx study was coordinated by Birmingham Clinical Trials Unit at the University of Birmingham and we acknowledge the work of all the staff involved in the study, especially Leanne Fulcher, who was the data manager, and Edward Tyler who designed and developed the study database. We thank John Wright and Tarak Desai (Birmingham Children's Hospital) for their advice with the assessments of echocardiograms and grading echocardiographic findings; all the echocardiographers who helped with the additional echocardiography required by the study, particularly Vishna Rasiah, David Roden, Mrinalini Rajimwale, and Askar Kukkadi; David Cunningham who searched the Central Cardiac Audit Database; and all the midwives and midwifery assistants who worked so hard with recruitment and screening and use women who consented to take part in the study.	ABUHARB M, 1994, ARCH DIS CHILD-FETAL, V71, pF179, DOI 10.1136/fn.71.3.F179; [Anonymous], 2003, HLTH STAT Q, V18, P57; Arlettaz R, 2006, EUR J PEDIATR, V165, P94, DOI 10.1007/s00431-005-0006-y; Bakr AF, 2005, PEDIATR CARDIOL, V26, P832, DOI 10.1007/s00246-005-0981-9; Botto LD, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e32; Brown JW, 2001, ANN THORAC SURG, V71, P1978, DOI 10.1016/S0003-4975(01)02529-2; Brown KL, 2006, HEART, V92, P1298, DOI 10.1136/hrt.2005.078097; Bull C, 1999, LANCET, V354, P1242, DOI 10.1016/S0140-6736(99)01167-8; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; de Wahl Granelli Anne, 2005, Acta Paediatr, V94, P1590, DOI 10.1080/08035250510039900; de-Wahl GA, 2009, BMJ-BRIT MED J, V338, pa3037, DOI DOI 10.1136/BMJ.A3037; Franklin O, 2002, HEART, V87, P67, DOI 10.1136/heart.87.1.67; Garne E, 2001, ULTRASOUND OBST GYN, V17, P386, DOI 10.1046/j.1469-0705.2001.00385.x; Hoke TR, 2002, PEDIATR CARDIOL, V23, P403, DOI 10.1007/s00246-002-1482-8; Koppel RI, 2003, PEDIATRICS, V111, P451, DOI 10.1542/peds.111.3.451; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mahle WT, 2009, CIRCULATION, V120, P447, DOI 10.1161/CIRCULATIONAHA.109.192576; Meberg A, 2008, J PEDIATR-US, V152, P761, DOI 10.1016/j.jpeds.2007.12.043; Reich JD, 2003, J PEDIATR-US, V142, P268, DOI 10.1067/mpd.2003.87; Richmond S, 2002, ARCH DIS CHILD-FETAL, V87, pF83, DOI 10.1136/fn.87.2.F83; Riede FT, 2010, EUR J PEDIATR, V169, P975, DOI 10.1007/s00431-010-1160-4; Rosati E, 2005, J PERINAT MED, V33, P455, DOI 10.1515/JPM.2005.080; Sendelbach DM, 2008, PEDIATRICS, V122, pE815, DOI 10.1542/peds.2008-0781; Tegnander E, 2006, ULTRASOUND OBST GYN, V27, P252, DOI 10.1002/uog.2710; Thangaratinam S, 2007, ARCH DIS CHILD-FETAL, V92, pF176, DOI 10.1136/adc.2006.107656; Tworetzky W, 2001, CIRCULATION, V103, P1269, DOI 10.1161/01.cir.103.9.1269; Wren C, 2008, ARCH DIS CHILD-FETAL, V93, pF33, DOI 10.1136/adc.2007.119032; Wren C, 1999, ARCH DIS CHILD-FETAL, V80, pF49, DOI 10.1136/fn.80.1.F49	28	192	207	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2011	378	9793					785	794		10.1016/S0140-6736(11)60753-8	http://dx.doi.org/10.1016/S0140-6736(11)60753-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816FY	21820732				2022-12-28	WOS:000294585300034
J	Braun, P; Carvunis, AR; Charloteaux, B; Dreze, M; Ecker, JR; Hill, DE; Roth, FP; Vidal, M; Galli, M; Balumuri, P; Bautista, V; Chesnut, JD; Kim, RC; de los Reyes, C; Gilles, P; Kim, CJ; Matrubutham, U; Mirchandani, J; Olivares, E; Patnaik, S; Quan, R; Ramaswamy, G; Shinn, P; Swamilingiah, GM; Wu, S; Ecker, JR; Dreze, M; Byrdsong, D; Dricot, A; Duarte, M; Gebreab, F; Gutierrez, BJ; MacWilliams, A; Monachello, D; Mukhtar, MS; Poulin, MM; Reichert, P; Romero, V; Tam, S; Waaijers, S; Weiner, EM; Vidal, M; Hill, DE; Braun, P; Galli, M; Carvunis, AR; Cusick, ME; Dreze, M; Romero, V; Roth, FP; Tasan, M; Yazaki, J; Braun, P; Ecker, JR; Carvunis, AR; Ahn, YY; Barabasi, AL; Charloteaux, B; Chen, HM; Cusick, ME; Dangl, JL; Dreze, M; Ecker, JR; Fan, CY; Gai, LT; Galli, M; Ghoshal, G; Hao, T; Hill, DE; Lurin, C; Milenkovic, T; Moore, J; Mukhtar, MS; Pevzner, SJ; Przulj, N; Rabello, S; Rietman, EA; Rolland, T; Roth, FP; Santhanam, B; Schmitz, RJ; Spooner, W; Stein, J; Tasan, M; Vandenhaute, J; Ware, D; Braun, P; Vidal, M; Braun, P; Carvunis, AR; Charloteaux, B; Dreze, M; Galli, M; Vidal, M				Braun, Pascal; Carvunis, Anne-Ruxandra; Charloteaux, Benoit; Dreze, Matija; Ecker, Joseph R.; Hill, David E.; Roth, Frederick P.; Vidal, Marc; Galli, Mary; Balumuri, Padmavathi; Bautista, Vanessa; Chesnut, Jonathan D.; Kim, Rosa Cheuk; de los Reyes, Chris; Gilles, Patrick, II; Kim, Christopher J.; Matrubutham, Uday; Mirchandani, Jyotika; Olivares, Eric; Patnaik, Suswapna; Quan, Rosa; Ramaswamy, Gopalakrishna; Shinn, Paul; Swamilingiah, Geetha M.; Wu, Stacy; Ecker, Joseph R.; Dreze, Matija; Byrdsong, Danielle; Dricot, Amelie; Duarte, Melissa; Gebreab, Fana; Gutierrez, Bryan J.; MacWilliams, Andrew; Monachello, Dario; Mukhtar, M. Shahid; Poulin, Matthew M.; Reichert, Patrick; Romero, Viviana; Tam, Stanley; Waaijers, Selma; Weiner, Evan M.; Vidal, Marc; Hill, David E.; Braun, Pascal; Galli, Mary; Carvunis, Anne-Ruxandra; Cusick, Michael E.; Dreze, Matija; Romero, Viviana; Roth, Frederick P.; Tasan, Murat; Yazaki, Junshi; Braun, Pascal; Ecker, Joseph R.; Carvunis, Anne-Ruxandra; Ahn, Yong-Yeol; Barabasi, Albert-Laszlo; Charloteaux, Benoit; Chen, Huaming; Cusick, Michael E.; Dangl, Jeffery L.; Dreze, Matija; Ecker, Joseph R.; Fan, Changyu; Gai, Lantian; Galli, Mary; Ghoshal, Gourab; Hao, Tong; Hill, David E.; Lurin, Claire; Milenkovic, Tijana; Moore, Jonathan; Mukhtar, M. Shahid; Pevzner, Samuel J.; Przulj, Natasa; Rabello, Sabrina; Rietman, Edward A.; Rolland, Thomas; Roth, Frederick P.; Santhanam, Balaji; Schmitz, Robert J.; Spooner, William; Stein, Joshua; Tasan, Murat; Vandenhaute, Jean; Ware, Doreen; Braun, Pascal; Vidal, Marc; Braun, Pascal; Carvunis, Anne-Ruxandra; Charloteaux, Benoit; Dreze, Matija; Galli, Mary; Vidal, Marc		Arabidopsis Interactome Mapping Co	Evidence for Network Evolution in an Arabidopsis Interactome Map	SCIENCE			English	Article							PROTEIN-INTERACTION NETWORKS; DUPLICATED GENES; GENOME; DIVERGENCE; EXPRESSION; PLASTICITY; BINDING; EVOLVES; PLANTS; FATE	Plants have unique features that evolved in response to their environments and ecosystems. A full account of the complex cellular networks that underlie plant-specific functions is still missing. We describe a proteome-wide binary protein-protein interaction map for the interactome network of the plant Arabidopsis thaliana containing about 6200 highly reliable interactions between about 2700 proteins. A global organization of plant biological processes emerges from community analyses of the resulting network, together with large numbers of novel hypothetical functional links between proteins and pathways. We observe a dynamic rewiring of interactions following gene duplication events, providing evidence for a model of evolution acting upon interactome networks. This and future plant interactome maps should facilitate systems approaches to better understand plant biology and improve crops.	[Carvunis, Anne-Ruxandra; Charloteaux, Benoit; Dricot, Amelie; Gutierrez, Bryan J.; MacWilliams, Andrew; Carvunis, Anne-Ruxandra; Barabasi, Albert-Laszlo; Fan, Changyu; Santhanam, Balaji] Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA; [Carvunis, Anne-Ruxandra; Dricot, Amelie; MacWilliams, Andrew; Carvunis, Anne-Ruxandra; Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Carvunis, Anne-Ruxandra; Dricot, Amelie; MacWilliams, Andrew; Carvunis, Anne-Ruxandra] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Carvunis, Anne-Ruxandra] CNRS, Computat & Math Biol Grp, UMR5525, F-38706 La Tronche, France; [Carvunis, Anne-Ruxandra] Univ Grenoble, Fac Med, F-38706 La Tronche, France; [Charloteaux, Benoit] Univ Liege, GIGA R, Unit Anim Genom, B-4000 Liege, Wallonia Brusse, Belgium; [Charloteaux, Benoit] Univ Liege, Fac Vet Med, B-4000 Liege, Wallonia Brusse, Belgium; [Dreze, Matija; Vandenhaute, Jean] Fac Univ Notre Dame Paix, Unite Rech Biol Mol, B-5000 Namur, Wallonia Brusse, Belgium; [Ecker, Joseph R.; de los Reyes, Chris; Kim, Christopher J.; Chen, Huaming] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Balumuri, Padmavathi; Chesnut, Jonathan D.; Gilles, Patrick, II; Matrubutham, Uday; Mirchandani, Jyotika; Olivares, Eric; Patnaik, Suswapna; Ramaswamy, Gopalakrishna; Swamilingiah, Geetha M.] Harvard Univ, Sch Med, Dept Biol Chem, Boston, MA 02115 USA; [Balumuri, Padmavathi; Chesnut, Jonathan D.; Gilles, Patrick, II; Matrubutham, Uday; Mirchandani, Jyotika; Olivares, Eric; Patnaik, Suswapna; Ramaswamy, Gopalakrishna; Swamilingiah, Geetha M.] Harvard Univ, Sch Med, Dept Mol Pharmacol, Boston, MA 02115 USA; [Ahn, Yong-Yeol; Barabasi, Albert-Laszlo; Ghoshal, Gourab; Rabello, Sabrina] Northeastern Univ, Dept Phys, Ctr Complex Network Res CCNR, Boston, MA 02115 USA; [Mukhtar, M. Shahid; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Monachello, Dario; Lurin, Claire] Univ Evry Val Essonne, Unite Rech Genom Vegetale, Inst Natl Rech Agron, Unite Mixtes Rech,ERL Ctr Natl Rech Sci, F-91057 Evry, France; [Milenkovic, Tijana] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA; [Moore, Jonathan] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Pevzner, Samuel J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Pevzner, Samuel J.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Przulj, Natasa] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London SW7 2AZ, England; [Spooner, William; Stein, Joshua; Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Spooner, William] Eagle Genom Ltd, Cambridge CB4 1JD, England; [Ware, Doreen] Cornell Univ, USDA, ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Liege; University of Liege; University of Namur; Salk Institute; Salk Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Northeastern University; University of North Carolina; University of North Carolina Chapel Hill; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Notre Dame; University of Warwick; Boston University; Boston University; Imperial College London; Cold Spring Harbor Laboratory; Cornell University; United States Department of Agriculture (USDA)	Vidal, M (corresponding author), Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA.	ecker@salk.edu; david_hill@dfci.harvard.edu; marc_vidal@dfci.harvard.edu; pascal_braun@dfci.harvard.edu	Roth, Frederick P/H-6308-2011; Moore, Jonathan D/D-1796-2013; Ecker, Joseph R/B-9144-2008; Przulj, Natasa/AAO-2850-2020; Barabasi, Albert-Laszlo/S-6474-2017; Dreze, Matija/AAZ-3293-2020; Hill, David E/B-6617-2011; Schmitz, Robert/AAY-7659-2020; Braun, Pascal/B-9669-2013; Ahn, Yong-Yeol/C-6334-2011; Yazaki, Junshi/B-1557-2012; /AAD-1735-2020; Vidal, Marc/Y-2466-2019	Moore, Jonathan D/0000-0002-5486-0407; Ecker, Joseph R/0000-0001-5799-5895; Schmitz, Robert/0000-0001-7538-6663; Braun, Pascal/0000-0003-2012-6746; Ahn, Yong-Yeol/0000-0002-4352-4301; /0000-0003-3516-4438; Vidal, Marc/0000-0003-3391-5410; /0000-0001-7002-8488; Rolland, Thomas/0000-0001-6468-8391; Mukhtar, Shahid/0000-0002-1104-6931; Przulj, Natasa/0000-0002-1290-853X; Barabasi, Albert/0000-0002-4028-3522; Carvunis, Anne-Ruxandra/0000-0002-6474-6413	NSF [0703905, 0520253, 0313578, 0703908]; National Human Genome Research Institute [R01HG001715]; Canada Excellence Research Chairs Program; Canadian Institute for Advanced Research Fellowship; James S. McDonnell Foundation [220020084]; Sixth Framework Programme [LSHG-CT-2006-037704]; National Institute of General Medical Sciences [R01GM066025]; U.S. Department of Agriculture, Agricultural Research Service [1907-21000-030]; NIH [F32HG004098, F32HG004830]; Biotechnology and Biological Sciences Research Council [F005806]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715, F32HG004098, F32HG004830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066025] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Canada Excellence Research Chairs Program(Canada Research Chairs); Canadian Institute for Advanced Research Fellowship(Canadian Institute for Advanced Research (CIFAR)); James S. McDonnell Foundation; Sixth Framework Programme(European Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Benfey, H. Yu, M. Nordborg, P. Ronald, M Snyder, and R. Wing as well as members of the Dana-Farber Cancer Institute Center for Cancer Systems Biology, for helpful discussions. This work was supported by the following grants: NSF 0703905 to M. V., J.R.E., and D. E. H.; National Human Genome Research Institute R01HG001715 to M. V., D. E. H., and F. P. R.; NSF 0520253 and NSF 0313578 to J.R.E.; Canada Excellence Research Chairs Program and Canadian Institute for Advanced Research Fellowship to F. P. R.; James S. McDonnell Foundation 220020084 to A.-L. B; Sixth Framework Programme LSHG-CT-2006-037704 (AGRON-OMICS) to C. L.; National Institute of General Medical Sciences R01GM066025 to J.L.D.; U.S. Department of Agriculture, Agricultural Research Service 1907-21000-030 to D. W.; NIH National Research Service Award fellowships F32HG004098 to M. T. and F32HG004830 to R.J.S.; Biotechnology and Biological Sciences Research Council grant F005806 to Jim Beynon in support of J.M.; and NSF 0703908 to D. W. in support of J.S. and W. S. M. V. is a Chercheur Qualifie Honoraire from the Fonds de la Recherche Scientifique (FRS-FNRS, Wallonia- Brussels Federation, Belgium). Data reported here are available at the Web site http://interactome.dfci.harvard.edu/A_thaliana	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Amoutzias GD, 2010, P NATL ACAD SCI USA, V107, P2967, DOI 10.1073/pnas.0911603107; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Casneuf T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r13; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Dreze M, 2009, NAT METHODS, V6, P843, DOI [10.1038/NMETH.1394, 10.1038/nmeth.1394]; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Ganko EW, 2007, MOL BIOL EVOL, V24, P2298, DOI 10.1093/molbev/msm158; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Hanada K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000781; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704; Kieffer M, 2006, PLANT CELL, V18, P560, DOI 10.1105/tpc.105.039107; Krogan NT, 2009, CURR OPIN PLANT BIOL, V12, P628, DOI 10.1016/j.pbi.2009.07.011; Levy ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.260pe11; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maslov S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-9; Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045; Mazzucotelli E, 2006, CURR GENOMICS, V7, P509, DOI 10.2174/138920206779315728; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Seo PJ, 2008, TRENDS PLANT SCI, V13, P550, DOI 10.1016/j.tplants.2008.06.008; Shou C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001050; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Wen R, 2008, PLANT CELL, V20, P213, DOI 10.1105/tpc.107.051862; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	42	653	1041	11	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					601	607		10.1126/science.1203877	http://dx.doi.org/10.1126/science.1203877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798944	Green Accepted			2022-12-28	WOS:000293222400054
J	Ranasinghe, AM; Strong, D; Boland, B; Bonser, RS				Ranasinghe, Aaron M.; Strong, Daniel; Boland, Barry; Bonser, Robert S.			EASILY MISSED? Acute aortic dissection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERNATIONAL REGISTRY; D-DIMER; DIAGNOSIS; OUTCOMES; IRAD		[Ranasinghe, Aaron M.; Bonser, Robert S.] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Dept Cardiac Surg, Birmingham B15 2TH, W Midlands, England; [Ranasinghe, Aaron M.; Bonser, Robert S.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Strong, Daniel] Royal Wolverhampton Hosp NHS Trust, New Cross Hosp, Wolverhampton WV10 0QP, W Midlands, England; [Boland, Barry] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Emergency Dept, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham; New Cross Hospital; University of Birmingham	Bonser, RS (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Dept Cardiac Surg, Birmingham B15 2TH, W Midlands, England.	robert.bonser@uhb.nhs.uk						Bossone E, 2002, AM J CARDIOL, V89, P851, DOI 10.1016/S0002-9149(02)02198-7; Collins JS, 2004, CIRCULATION, V110, pII237, DOI 10.1161/01.CIR.0000138219.67028.2a; Estrera AL, 2006, J THORAC CARDIOV SUR, V132, P1404, DOI 10.1016/j.jtcvs.2006.07.026; Fattori R, 2008, JACC-CARDIOVASC INTE, V1, P395, DOI 10.1016/j.jcin.2008.04.009; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Meszaros I, 2000, CHEST, V117, P1271, DOI 10.1378/chest.117.5.1271; National Institute for Health and Clinical Excellence, 2010, CHEST PAIN REC ONS A; Nienaber CA, 2003, CIRCULATION, V108, P628, DOI 10.1161/01.CIR.0000087009.16755.E4; Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400; Raghupathy A, 2008, AM J CARDIOL, V102, P1562, DOI 10.1016/j.amjcard.2008.07.049; Sabik JF, 2000, J THORAC CARDIOV SUR, V119, P946, DOI 10.1016/S0022-5223(00)70090-0; Sodeck G, 2007, EUR HEART J, V28, P3067, DOI 10.1093/eurheartj/ehm484; Suzuki T, 2009, CIRCULATION, V119, P2702, DOI 10.1161/CIRCULATIONAHA.108.833004; von Kodolitsch Y, 2000, ARCH INTERN MED, V160, P2977, DOI 10.1001/archinte.160.19.2977	14	8	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2011	343								d4487	10.1136/bmj.d4487	http://dx.doi.org/10.1136/bmj.d4487			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LU	21803810				2022-12-28	WOS:000293441200001
J	Williams, G				Williams, Gareth			Museum Dr Jenner's House: the birthplace of vaccination	LANCET			English	Editorial Material												Gareth.Williams@bristol.ac.uk							0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 23	2011	378	9788					307	308		10.1016/S0140-6736(11)61154-9	http://dx.doi.org/10.1016/S0140-6736(11)61154-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XL	21789788				2022-12-28	WOS:000293615800011
J	Andelman, S				Andelman, Sandy			Conservation science outside the comfort zone	NATURE			English	Editorial Material									Conservat Int, Trop Ecol Assessment & Monitoring Network, Arlington, VA 22202 USA	Conservation International	Andelman, S (corresponding author), Conservat Int, Trop Ecol Assessment & Monitoring Network, Arlington, VA 22202 USA.	s.andelman@conservation.org							0	9	9	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					290	291		10.1038/475290a	http://dx.doi.org/10.1038/475290a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	794PA	21776060	Bronze			2022-12-28	WOS:000292911200015
J	Li, GW; Xie, XS				Li, Gene-Wei; Xie, X. Sunney			Central dogma at the single-molecule level in living cells	NATURE			English	Review							REPRESSOR-OPERATOR INTERACTION; DIFFUSION-DRIVEN MECHANISMS; STOCHASTIC GENE-EXPRESSION; ESCHERICHIA-COLI; RNA-POLYMERASE; REAL-TIME; MESSENGER-RNA; PROTEIN TRANSLOCATION; FLUORESCENT MOLECULES; REGULATORY NETWORKS	Gene expression originates from individual DNA molecules within living cells. Like many single-molecule processes, gene expression and regulation are stochastic, that is, sporadic in time. This leads to heterogeneity in the messenger-RNA and protein copy numbers in a population of cells with identical genomes. With advanced single-cell fluorescence microscopy, it is now possible to quantify transcriptomes and proteomes with single-molecule sensitivity. Dynamic processes such as transcription-factor binding, transcription and translation can be monitored in real time, providing quantitative descriptions of the central dogma of molecular biology and the demonstration that a stochastic single-molecule event can determine the phenotype of a cell.	[Li, Gene-Wei; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Li, Gene-Wei/E-7657-2010	Li, Gene-Wei/0000-0001-7036-8511	National Institutes of Health; Bill & Melinda Gates Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Cai, J. Xiao, J. Yu, N. Friedman, J. Elf, P. Choi, H. Chen and Y. Taniguchi for their key contributions to the work described, and W. Greenleaf, P. Sims and H. Ge for their helpful comments on this review. This work is supported by the National Institutes of Health Director's Pioneer Award and the Bill & Melinda Gates Foundation.	Andersson H, 1998, J MICROSC-OXFORD, V191, P1; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bonnet I, 2008, NUCLEIC ACIDS RES, V36, P4118, DOI 10.1093/nar/gkn376; BOUCHE JP, 1982, J MOL BIOL, V154, P1, DOI 10.1016/0022-2836(82)90413-2; BREMER H, 1986, J THEOR BIOL, V118, P351, DOI 10.1016/S0022-5193(86)80066-2; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Delbruck M., 1940, J CHEM PHYS, V8, P120, DOI [10.1063/1.1750549, DOI 10.1063/1.1750549]; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Fuchs E, 2002, OPT EXPRESS, V10, P145, DOI 10.1364/OE.10.000145; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gowers DM, 2003, EMBO J, V22, P1410, DOI 10.1093/emboj/cdg125; Graneli A, 2006, P NATL ACAD SCI USA, V103, P1221, DOI 10.1073/pnas.0508366103; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Harada Y, 1999, BIOPHYS J, V76, P709, DOI 10.1016/S0006-3495(99)77237-1; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HIRSCHFELD T, 1976, APPL OPTICS, V15, P2965, DOI 10.1364/AO.15.002965; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Johansson HE, 1998, P NATL ACAD SCI USA, V95, P9244, DOI 10.1073/pnas.95.16.9244; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kim JH, 2007, NUCLEIC ACIDS RES, V35, P3848, DOI 10.1093/nar/gkm332; Le TT, 2005, P NATL ACAD SCI USA, V102, P9160, DOI 10.1073/pnas.0503311102; Li GW, 2009, NAT PHYS, V5, P294, DOI 10.1038/NPHYS1222; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; PTASHNE M, 2004, GENETIC SWITCH; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; RICHTER PH, 1974, BIOPHYS CHEM, V2, P255, DOI 10.1016/0301-4622(74)80050-5; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; RIGNEY DR, 1979, J THEOR BIOL, V76, P453, DOI 10.1016/0022-5193(79)90013-4; Ritter JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011639; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sanchez EJ, 1997, J PHYS CHEM A, V101, P7019, DOI 10.1021/jp971915b; SCHMIDT T, 1995, J PHYS CHEM-US, V99, P17662, DOI 10.1021/j100049a030; SCHURR JM, 1979, BIOPHYS CHEM, V9, P413, DOI 10.1016/0301-4622(75)80057-3; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; SHERA EB, 1990, CHEM PHYS LETT, V174, P553, DOI 10.1016/0009-2614(90)85485-U; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tafvizi A, 2008, BIOPHYS J, V95, pL1, DOI 10.1529/biophysj.108.134122; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tyagi S, 2009, NAT METHODS, V6, P331, DOI [10.1038/NMETH.1321, 10.1038/nmeth.1321]; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Wilson T., 1990, CONFOCAL MICROSCOPY; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; Xie XS, 2008, ANNU REV BIOPHYS, V37, P417, DOI 10.1146/annurev.biophys.37.092607.174640; Xie XS, 2006, SCIENCE, V312, P228, DOI 10.1126/science.1127566; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	93	294	304	3	339	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					308	315		10.1038/nature10315	http://dx.doi.org/10.1038/nature10315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21776076	Green Accepted, Green Submitted			2022-12-28	WOS:000292911200031
J	Reckamp, KL				Reckamp, Karen L.			Combination chemotherapy for older adults with advanced non-small-cell lung cancer	LANCET			English	Editorial Material							ELDERLY-PATIENTS; IMPACT		City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA	City of Hope	Reckamp, KL (corresponding author), City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA.	kreckamp@coh.org		Reckamp, Karen/0000-0002-9213-0325				Abe T, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7509; Davidoff AJ, 2010, J CLIN ONCOL, V28, P2191, DOI 10.1200/JCO.2009.25.4052; Frasci G, 2000, J CLIN ONCOL, V18, P2529, DOI 10.1200/JCO.2000.18.13.2529; Gridelli C, 2003, JNCI-J NATL CANCER I, V95, P362, DOI 10.1093/jnci/95.5.362; Howlander N, 2011, SEER CANC STAT REV 1; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Maione P, 2005, J CLIN ONCOL, V23, P6865, DOI 10.1200/JCO.2005.02.527; Quoix E, 2011, LANCET, V378, P1079, DOI 10.1016/S0140-6736(11)60780-0; Sawhney R, 2005, CANCER J, V11, P449, DOI 10.1097/00130404-200511000-00004; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2011	378	9796					1055	1057		10.1016/S0140-6736(11)61259-2	http://dx.doi.org/10.1016/S0140-6736(11)61259-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829BE	21831419				2022-12-28	WOS:000295548900006
J	Santoro, AE; Buchwald, C; McIlvin, MR; Casciotti, KL				Santoro, Alyson E.; Buchwald, Carolyn; McIlvin, Matthew R.; Casciotti, Karen L.			Isotopic Signature of N2O Produced by Marine Ammonia-Oxidizing Archaea	SCIENCE			English	Article							NITROUS-OXIDE; NITRIFYING ARCHAEA; OXIDATION; NITRIFICATION; NITROSOMONAS; CONSTRAINTS; BACTERIA; BUDGET; NO2	The ocean is an important global source of nitrous oxide (N2O), a greenhouse gas that contributes to stratospheric ozone destruction. Bacterial nitrification and denitrification are thought to be the primary sources of marine N2O, but the isotopic signatures of N2O produced by these processes are not consistent with the marine contribution to the global N2O budget. Based on enrichment cultures, we report that archaeal ammonia oxidation also produces N2O. Natural-abundance stable isotope measurements indicate that the produced N2O had bulk delta N-15 and delta O-18 values higher than observed for ammonia-oxidizing bacteria but similar to the delta N-15 and delta O-18 values attributed to the oceanic N2O source to the atmosphere. Our results suggest that ammonia-oxidizing archaea may be largely responsible for the oceanic N2O source.	[Santoro, Alyson E.; McIlvin, Matthew R.; Casciotti, Karen L.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Buchwald, Carolyn] Massachusetts Inst Technol Woods Hole Oceanog Ins, Joint Program Chem Oceanog, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; Massachusetts Institute of Technology (MIT)	Santoro, AE (corresponding author), Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD 21613 USA.	asantoro@umces.edu; kcasciotti@stanford.edu	McIlvin, Matthew/ABB-4762-2020; Santoro, Alyson E/E-5686-2013	Santoro, Alyson E/0000-0003-2503-8219; Casciotti, Karen/0000-0002-5286-7795	Woods Hole Oceanographic Institution Ocean Life Institute; Woods Hole Oceanographic Institution; U.S. National Science Foundation [OCE-0526277, OCE-0961098]	Woods Hole Oceanographic Institution Ocean Life Institute; Woods Hole Oceanographic Institution; U.S. National Science Foundation(National Science Foundation (NSF))	We thank C. Wuchter, S. Sievert, and M. Johnson for assistance in the laboratory. We also thank C. Frame, L. Codispoti, and three anonymous reviewers for helpful discussions and feedback. Funding for this work was provided by the Woods Hole Oceanographic Institution Ocean Life Institute, a Woods Hole Oceanographic Institution Postdoctoral Scholar Fellowship to A. E. S., and U.S. National Science Foundation grants OCE-0526277 and OCE-0961098 to K. L. C. The 16S ribosomal RNA gene and amoA gene sequences for CN25 and CN75 have been deposited in GenBank under the accession nos. HQ338108, JF521547, and JF521548. The CN25 and CN75 strains are available by request from A.E.S.	ANDERSSON KK, 1983, FEBS LETT, V164, P236, DOI 10.1016/0014-5793(83)80292-0; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Casciotti KL, 2010, LIMNOL OCEANOGR, V55, P753, DOI 10.4319/lo.2009.55.2.0753; Casciotti KL, 2002, ANAL CHEM, V74, P4905, DOI 10.1021/ac020113w; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; Dore JE, 1998, NATURE, V396, P63, DOI 10.1038/23921; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; DUA RD, 1979, FEBS LETT, V106, P401, DOI 10.1016/0014-5793(79)80541-4; ELKINS JW, 1978, NATURE, V275, P602, DOI 10.1038/275602a0; Frame CH, 2010, BIOGEOSCIENCES, V7, P2695, DOI 10.5194/bg-7-2695-2010; GOREAU TJ, 1980, APPL ENVIRON MICROB, V40, P526, DOI 10.1128/AEM.40.3.526-532.1980; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; KIM KR, 1993, SCIENCE, V262, P1855, DOI 10.1126/science.262.5141.1855; KIM KR, 1990, NATURE, V347, P58, DOI 10.1038/347058a0; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Naqvi SWA, 1998, NATURE, V394, P462, DOI 10.1038/28828; Nevison CD, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002110; Ostrom N.E., 2000, CHEM GLOB CHANGE SCI, V2, P281, DOI [DOI 10.1016/S1465-9972(00)00031-3, 10.1016/S1465-9972(00)00031-3]; Popp BN, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001806; Rahn T, 2000, GLOBAL BIOGEOCHEM CY, V14, P537, DOI 10.1029/1999GB900070; Santoro AE, 2011, ISME J, V5, P1796, DOI 10.1038/ismej.2011.58; Santoro AE, 2010, ENVIRON MICROBIOL, V12, P1989, DOI 10.1111/j.1462-2920.2010.02205.x; Solomon S., 2007, PHYS SCI BASIS WORKI; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Yoshida N, 2000, NATURE, V405, P330, DOI 10.1038/35012558; YOSHIDA N, 1988, NATURE, V335, P528, DOI 10.1038/335528a0	27	302	329	8	387	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1282	1285		10.1126/science.1208239	http://dx.doi.org/10.1126/science.1208239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21798895				2022-12-28	WOS:000294406400052
J	Smith, ADM; Brown, CJ; Bulman, CM; Fulton, EA; Johnson, P; Kaplan, IC; Lozano-Montes, H; Mackinson, S; Marzloff, M; Shannon, LJ; Shin, YJ; Tam, J				Smith, Anthony D. M.; Brown, Christopher J.; Bulman, Catherine M.; Fulton, Elizabeth A.; Johnson, Penny; Kaplan, Isaac C.; Lozano-Montes, Hector; Mackinson, Steven; Marzloff, Martin; Shannon, Lynne J.; Shin, Yunne-Jai; Tam, Jorge			Impacts of Fishing Low-Trophic Level Species on Marine Ecosystems	SCIENCE			English	Article							FORAGE FISH; FOOD WEBS; FISHERIES; VARIABILITY; CONSEQUENCES; MANAGEMENT; ABUNDANCE; PATTERNS; ECOSIM; MODEL	Low-trophic level species account for more than 30% of global fisheries production and contribute substantially to global food security. We used a range of ecosystem models to explore the effects of fishing low-trophic level species on marine ecosystems, including marine mammals and seabirds, and on other commercially important species. In five well-studied ecosystems, we found that fishing these species at conventional maximum sustainable yield (MSY) levels can have large impacts on other parts of the ecosystem, particularly when they constitute a high proportion of the biomass in the ecosystem or are highly connected in the food web. Halving exploitation rates would result in much lower impacts on marine ecosystems while still achieving 80% of MSY.	[Smith, Anthony D. M.; Bulman, Catherine M.; Fulton, Elizabeth A.; Johnson, Penny; Marzloff, Martin] Commonwealth Sci & Ind Res Org, Hobart, Tas 7001, Australia; [Brown, Christopher J.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Brown, Christopher J.] Commonwealth Sci & Ind Res Org, Brisbane, Qld 4163, Australia; [Kaplan, Isaac C.] NOAA, NW Fisheries Sci Ctr, Natori, Miyagi 98112, Japan; [Lozano-Montes, Hector] Commonwealth Sci & Ind Res Org, Floreat, WA 6014, Australia; [Mackinson, Steven] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England; [Marzloff, Martin] Univ Tasmania, Inst Marine & Antarct Studies, Sandy Bay, Tas 7005, Australia; [Shannon, Lynne J.; Shin, Yunne-Jai] Univ Cape Town, Marine Res MA RE Inst, ZA-7701 Rondebosch, South Africa; [Shannon, Lynne J.; Shin, Yunne-Jai] Univ Cape Town, Dept Zool, ZA-7701 Rondebosch, South Africa; [Shin, Yunne-Jai] Inst Rech Dev, UMR EME 212, F-34203 Sete, France; [Tam, Jorge] Inst Mar Peru, Callao, Peru	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre for Environment Fisheries & Aquaculture Science; University of Tasmania; University of Cape Town; University of Cape Town; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Instituto del Mar del Peru	Smith, ADM (corresponding author), Commonwealth Sci & Ind Res Org, Hobart, Tas 7001, Australia.	tony.d.smith@csiro.edu	Marzloff, Martin/AAY-3833-2020; Brown, Christopher J/G-4287-2011; Lozano-Montes, Hector M/E-5034-2014; Smith, Tony D/A-4017-2012; Marzloff, Martin/J-7186-2014; Fulton, Beth/A-2871-2008; Shannon, Lynne J/A-1612-2015; Bulman, Catherine M/A-9795-2012; Shin, Yunne-Jai/A-7575-2012; Fulton, Beth/AAJ-1398-2021	Marzloff, Martin/0000-0002-8152-4273; Brown, Christopher J/0000-0002-7271-4091; Marzloff, Martin/0000-0002-8152-4273; Fulton, Beth/0000-0002-5904-7917; Shannon, Lynne J/0000-0001-7842-0636; Bulman, Catherine M/0000-0002-8997-4615; Shin, Yunne-Jai/0000-0002-7259-9265; Fulton, Beth/0000-0002-5904-7917; Mackinson, Steven/0000-0002-0262-1180; Tam, Jorge/0000-0001-8224-4313	Marine Stewardship Council (MSC); Commonwealth Scientific and Industrial Research Organization (Australia); National Oceanographic and Atmospheric Administration (USA); Institut de Recherche pour le Developpement (France); Instituto del Mar del Peru (Peru); Gordon and Betty Moore Foundation; David and Lucile Packard Foundation; European Union (EU) [244966]; Department of Environment Food and Rural Affairs [M1202]; South African Research Chair Initiative; South African Department of Science and Technology; EU [212085]	Marine Stewardship Council (MSC); Commonwealth Scientific and Industrial Research Organization (Australia); National Oceanographic and Atmospheric Administration (USA)(National Oceanic Atmospheric Admin (NOAA) - USA); Institut de Recherche pour le Developpement (France); Instituto del Mar del Peru (Peru); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); European Union (EU)(CGIAREuropean Commission); Department of Environment Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); South African Research Chair Initiative; South African Department of Science and Technology; EU(European Commission)	This work was partly funded by the Marine Stewardship Council (MSC) to investigate "Developing best practice management for low trophic level fisheries: evaluation of harvest strategies." The authors also acknowledge funding from the Commonwealth Scientific and Industrial Research Organization (Australia), National Oceanographic and Atmospheric Administration (USA), Institut de Recherche pour le Developpement (France), and Instituto del Mar del Peru (Peru). I.C.K. (not funded by MSC) and E.A.F. acknowledge support from the Gordon and Betty Moore Foundation and the David and Lucile Packard Foundation. S.M. acknowledges support from European Union (EU) FP7 grant FACTS (Forage Fish Interactions), grant agreement 244966, and Department of Environment Food and Rural Affairs contract M1202. L.S. acknowledges the support of the South African Research Chair Initiative, funded through the South African Department of Science and Technology and administered by the South African National Research Foundation (NRF). Y.J.S. acknowledges support from EU FP7 project MEECE (Marine Ecosystem Evolution in a Changing Environment), grant agreement 212085. J. Field kindly provided the EcoSim model for the northern California current and advised on its use. C. de Moor provided information on management targets for sardines and anchovy in the Southern Benguela.	Ainley DG, 2009, FISH FISH, V10, P13, DOI 10.1111/j.1467-2979.2008.00293.x; Alder J, 2008, ANNU REV ENV RESOUR, V33, P153, DOI 10.1146/annurev.environ.33.020807.143204; Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Constable AJ, 2000, ICES J MAR SCI, V57, P778, DOI 10.1006/jmsc.2000.0725; Crawford RJM, 2007, ICES J MAR SCI, V64, P570, DOI 10.1093/icesjms/fsm009; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Frederiksen M, 2005, MAR ECOL PROG SER, V300, P201, DOI 10.3354/meps300201; Freon P, 2008, PROG OCEANOGR, V79, P401, DOI 10.1016/j.pocean.2008.10.011; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Fulton EA, 2004, ECOL MODEL, V173, P371, DOI 10.1016/j.ecolmodel.2003.09.024; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Greenstreet SPR, 2006, ICES J MAR SCI, V63, P1530, DOI 10.1016/j.icesjms.2006.05.009; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Jahncke J, 2004, FISH OCEANOGR, V13, P208, DOI 10.1111/j.1365-2419.2004.00283.x; Llope M, 2011, GLOBAL CHANGE BIOL, V17, P1251, DOI 10.1111/j.1365-2486.2010.02331.x; Lo N.C., 2009, ASSESSMENT PACIFIC S; MAY RM, 1979, SCIENCE, V205, P267, DOI 10.1126/science.205.4403.267; Merino G, 2010, J MARINE SYST, V81, P196, DOI 10.1016/j.jmarsys.2009.12.010; Montoya JM, 2009, ECOLOGY, V90, P2426, DOI 10.1890/08-0657.1; Santora JA, 2009, FISH OCEANOGR, V18, P20, DOI 10.1111/j.1365-2419.2008.00490.x; Shannon LJ, 2000, ICES J MAR SCI, V57, P720, DOI 10.1006/jmsc.2000.0716; Shin YJ, 2004, CAN J FISH AQUAT SCI, V61, P414, DOI 10.1139/F03-154; Tacon AGJ, 2009, AMBIO, V38, P294; Travers M, 2009, ECOL MODEL, V220, P3089, DOI 10.1016/j.ecolmodel.2009.08.016; Tyrrell MC, 2011, FISH RES, V108, P1, DOI 10.1016/j.fishres.2010.12.025; Walters C, 2000, ECOSYSTEMS, V3, P70, DOI 10.1007/s100210000011; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	32	413	423	8	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1147	1150		10.1126/science.1209395	http://dx.doi.org/10.1126/science.1209395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21778363				2022-12-28	WOS:000294244300049
J	Seitan, VC; Hao, BT; Tachibana-Konwalski, K; Lavagnolli, T; Mira-Bontenbal, H; Brown, KE; Teng, G; Carroll, T; Terry, A; Horan, K; Marks, H; Adams, DJ; Schatz, DG; Aragon, L; Fisher, AG; Krangel, MS; Nasmyth, K; Merkenschlager, M				Seitan, Vlad C.; Hao, Bingtao; Tachibana-Konwalski, Kikue; Lavagnolli, Thais; Mira-Bontenbal, Hegias; Brown, Karen E.; Teng, Grace; Carroll, Tom; Terry, Anna; Horan, Katie; Marks, Hendrik; Adams, David J.; Schatz, David G.; Aragon, Luis; Fisher, Amanda G.; Krangel, Michael S.; Nasmyth, Kim; Merkenschlager, Matthias			A role for cohesin in T-cell-receptor rearrangement and thymocyte differentiation	NATURE			English	Article							ANTIGEN-RECEPTOR; CHROMATIN ARCHITECTURE; V(D)J RECOMBINATION; POSITIVE SELECTION; TRANSGENIC MICE; DAD1 GENES; TCR-ALPHA; ACCESSIBILITY; REGION; LOCUS	Cohesin enables post-replicative DNA repair and chromosome segregation by holding sister chromatids together from the time of DNA replication in S phase until mitosis(1). There is growing evidence that cohesin also forms long-range chromosomal cis-interactions(2-4) and may regulate gene expression(2-10) in association with CTCF8,9, mediator(4) or tissue-specific transcription factors(10). Human cohesinopathies such as Cornelia de Lange syndrome are thought to result from impaired non-canonical cohesin functions(7), but a clear distinction between the cell-division-related and cell-division-independent functions of cohesion-as exemplified in Drosophila(11-13)-has not been demonstrated in vertebrate systems. To address this, here we deleted the cohesin locus Rad21 in mouse thymocytes at a time in development when these cells stop cycling and rearrange their T-cell receptor (TCR) a locus (Tcra). Rad21-deficient thymocytes had a normal lifespan and retained the ability to differentiate, albeit with reduced efficiency. Loss of Rad21 led to defective chromatin architecture at the Tcra locus, where cohesion-binding sites flank the TEA promoter and the Ea enhancer, and demarcate Tcra from interspersed Tcrd elements and neighbouring housekeeping genes. Cohesin was required for long-range promoter-enhancer interactions, Tcra transcription, H3K4me3 histone modifications that recruit the recombination machinery(14,15) and Tcra rearrangement. Provision of pre-rearranged TCR transgenes largely rescued thymocyte differentiation, demonstrating that among thousands of potential target genes across the genome(4,8-10), defective Tcra rearrangement was limiting for the differentiation of cohesin-deficient thymocytes. These findings firmly establish a cell-division-independent role for cohesin in Tcra locus rearrangement and provide a comprehensive account of the mechanisms by which cohesin enables cellular differentiation in a well-characterized mammalian system.	[Seitan, Vlad C.; Lavagnolli, Thais; Mira-Bontenbal, Hegias; Brown, Karen E.; Terry, Anna; Fisher, Amanda G.; Merkenschlager, Matthias] Univ London Imperial Coll Sci Technol & Med, MRC, Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England; [Seitan, Vlad C.; Aragon, Luis] Univ London Imperial Coll Sci Technol & Med, MRC, Clin Sci Ctr, Cell Cycle Grp, London W12 0NN, England; [Seitan, Vlad C.; Lavagnolli, Thais; Mira-Bontenbal, Hegias; Brown, Karen E.; Carroll, Tom; Terry, Anna; Aragon, Luis; Fisher, Amanda G.; Merkenschlager, Matthias] Univ London Imperial Coll Sci Technol & Med, MRC, Clin Sci Ctr, Epigenet Sect, London W12 0NN, England; [Hao, Bingtao; Krangel, Michael S.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Tachibana-Konwalski, Kikue; Nasmyth, Kim] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Teng, Grace; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Horan, Katie] Univ London Imperial Coll Sci Technol & Med, Cent Biol Serv, London W12 0NN, England; [Marks, Hendrik] Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6500 HB Nijmegen, Netherlands; [Adams, David J.] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Schatz, David G.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Imperial College London; Imperial College London; Imperial College London; Duke University; University of Oxford; Yale University; Imperial College London; Radboud University Nijmegen; Wellcome Trust Sanger Institute; Howard Hughes Medical Institute; Yale University	Krangel, MS (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Clin Sci Ctr, Lymphocyte Dev Grp, Du Cane Rd, London W12 0NN, England.	krang001@mc.duke.edu; kim.nasmyth@bioch.ox.ac.uk; matthias.merkenschlager@csc.mrc.ac.uk	Marks, Hendrik/E-2801-2012; hao, Bingtao/G-6648-2011; Schatz, David/A-6748-2013	Marks, Hendrik/0000-0002-4198-3731; hao, Bingtao/0000-0003-1997-9338; Schatz, David/0000-0002-5669-1176; Seitan, Vlad/0000-0002-4546-340X; Nasmyth, Kim/0000-0001-7030-4403; Terry, Anna/0000-0002-1946-8223; Merkenschlager, Matthias/0000-0003-2889-3288; Adams, David/0000-0001-9490-0306	Medical Research Council, UK; European Union; Boehringer Ingelheim Fonds; Wellcome Trust; National Institutes of Health; Medical Research Council [MC_U120027516, MC_U120081295] Funding Source: researchfish; MRC [MC_U120027516, MC_U120081295] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041052] Funding Source: NIH RePORTER	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Hadjur, D. Tough, L. Williams, Z. Webster, J. Godwin and H.-Y. Shih for help and advice, L. Game and M. Jones for high-throughput sequencing, A. Giess for sequence alignment, and J. Elliott and P. Hexley for cell sorting. Supported by the Medical Research Council, UK (V.S., T.L., H.M.-B., K.E.B., T.C., A.T., L.A., A.G.F., K.N., M.M.), the European Union FP6 integrated project HEROIC (H.M.), EU and the Marie Curie Research Training Network Chromatin Plasticity (H.M.-B.), the Boehringer Ingelheim Fonds (T.L.), the Wellcome Trust (D.J.A., K.N.) and the National Institutes of Health (B.H., M.S.K., G.T., D.G.S.). D.G.S. is an investigator of the Howard Hughes Medical Institute.	Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Abarrategui I, 2009, ADV EXP MED BIOL, V650, P93; BREKELMANS P, 1994, CELL IMMUNOL, V159, P331, DOI 10.1006/cimm.1994.1319; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Desiderio S, 1996, CURR TOP MICROBIOL, V217, P45; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Jackson A, 2005, NAT IMMUNOL, V6, P189, DOI 10.1038/ni1157; Jhunjhunwala S, 2009, CELL, V138, P435, DOI 10.1016/j.cell.2009.07.016; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Krangel MS, 2009, CURR OPIN IMMUNOL, V21, P133, DOI 10.1016/j.coi.2009.03.009; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee YN, 2009, P NATL ACAD SCI USA, V106, P17487, DOI 10.1073/pnas.0909723106; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Magdinier F, 2004, J BIOL CHEM, V279, P25381, DOI 10.1074/jbc.M403121200; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pauli A, 2010, CURR BIOL, V20, P1787, DOI 10.1016/j.cub.2010.09.006; Rollins RA, 1999, GENETICS, V152, P577; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; Strachan T, 2005, CURR OPIN GENET DEV, V15, P258, DOI 10.1016/j.gde.2005.04.005; Toyoda Y, 2006, MOL BIOL CELL, V17, P2287, DOI 10.1091/mbc.E05-11-1089; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zhong XP, 1999, J IMMUNOL, V163, P295	39	179	183	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					467	U126		10.1038/nature10312	http://dx.doi.org/10.1038/nature10312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21832993	Green Accepted, Green Submitted			2022-12-28	WOS:000294209400040
J	Kuhlenkoetter, S; Wintermeyer, W; Rodnina, MV				Kuhlenkoetter, Stephan; Wintermeyer, Wolfgang; Rodnina, Marina V.			Different substrate-dependent transition states in the active site of the ribosome	NATURE			English	Article							PEPTIDE-BOND FORMATION; TRANSLATION TERMINATION; TRANSFERASE REACTION; RELEASE FACTORS; TRANSFER-RNA; 70S RIBOSOME; GGQ MOTIF; RF2; CATALYSIS; INSIGHTS	The active site of the ribosome, the peptidyl transferase centre, catalyses two reactions, namely, peptide bond formation between peptidyl-tRNA and aminoacyl-tRNA as well as the release-factor-dependent hydrolysis of peptidyl-tRNA. Unlike peptide bond formation, peptide release is strongly impaired by mutations of nucleotides within the active site, in particular by base exchanges at position A2602 (refs 1, 2). The 2'-OH group of A76 of the peptidyl-tRNA substrate seems to have a key role in peptide release(3). According to computational analysis(4), the 2'-OH may take part in a concerted 'proton shuttle' by which the leaving group is protonated, in analogy to similar current models of peptide bond formation(4-6). Here we report kinetic solvent isotope effects and proton inventories (reaction rates measured in buffers with increasing content of deuterated water, D(2)O) of the two reactions catalysed by the active site of the Escherichia coli ribosome. The transition state of the release factor 2 (RF2)-dependent hydrolysis reaction is characterized by the rate-limiting formation of a single strong hydrogen bond. This finding argues against a concerted proton shuttle in the transition state of the hydrolysis reaction. In comparison, the proton inventory for peptide bond formation indicates the rate-limiting formation of three hydrogen bonds with about equal contributions, consistent with a concerted eight-membered proton shuttle in the transition state(5). Thus, the ribosome supports different rate-limiting transition states for the two reactions that take place in the peptidyl transferase centre.	[Kuhlenkoetter, Stephan; Wintermeyer, Wolfgang; Rodnina, Marina V.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Am Fassberg 11, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Rodnina, Marina V./AAD-4667-2019	Rodnina, Marina V./0000-0003-0105-3879; Wintermeyer, Wolfgang/0000-0001-5119-8481	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank H.-H. Limbach for discussions and advice. This work was supported by the Deutsche Forschungsgemeinschaft (M.V.R. and W.W.).	Amort M, 2007, NUCLEIC ACIDS RES, V35, P5130, DOI 10.1093/nar/gkm539; Beringer M, 2005, J BIOL CHEM, V280, P36065, DOI 10.1074/jbc.M507961200; Beringer M, 2003, RNA, V9, P919, DOI 10.1261/rna.5600503; Bieling P, 2006, NAT STRUCT MOL BIOL, V13, P423, DOI 10.1038/nsmb1091; Brunelle JL, 2008, RNA, V14, P1526, DOI 10.1261/rna.1057908; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Huang KS, 2008, BIOCHEMISTRY-US, V47, P8822, DOI 10.1021/bi800299u; Jin H, 2010, P NATL ACAD SCI USA, V107, P8593, DOI 10.1073/pnas.1003995107; Katunin VI, 2002, MOL CELL, V10, P339, DOI 10.1016/S1097-2765(02)00566-X; Kingery DA, 2008, CHEM BIOL, V15, P493, DOI 10.1016/j.chembiol.2008.04.005; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Polacek N, 2003, MOL CELL, V11, P103, DOI 10.1016/S1097-2765(02)00825-0; Quinn D.M., 2006, ISOTOPE EFFECTS CHEM, P995; Rangelov MA, 2006, J AM CHEM SOC, V128, P4964, DOI 10.1021/ja060648x; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; SCHOWEN KBJ, 1972, TRANSITION STATES BI, P225; Seila AC, 2005, BIOCHEMISTRY-US, V44, P4018, DOI 10.1021/bi047742f; Shaw JJ, 2007, MOL CELL, V28, P458, DOI 10.1016/j.molcel.2007.09.007; Sievers A, 2004, P NATL ACAD SCI USA, V101, P7897, DOI 10.1073/pnas.0402488101; Trobro S, 2006, BIOCHEMISTRY-US, V45, P7049, DOI 10.1021/bi0605383; Trobro S, 2009, BIOCHEMISTRY-US, V48, P11296, DOI 10.1021/bi9017297; Wallin G, 2010, P NATL ACAD SCI USA, V107, P1888, DOI 10.1073/pnas.0914192107; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8	29	62	62	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					351	U124		10.1038/nature10247	http://dx.doi.org/10.1038/nature10247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21804565	Green Published			2022-12-28	WOS:000294206500042
J	Rimm, EB; Stampfer, MJ				Rimm, Eric B.; Stampfer, Meir J.			Folate and cardiovascular disease: one size does not fit all	LANCET			English	Editorial Material							LOWERING HOMOCYSTEINE; STROKE PREVENTION; MALE SMOKERS; RISK; VITAMIN-B-6; INFARCTION; CANCER		[Rimm, Eric B.] Harvard Univ, Channing Lab, Dept Med, Brigham & Womens Hosp,Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Rimm, EB (corresponding author), Harvard Univ, Channing Lab, Dept Med, Brigham & Womens Hosp,Sch Med, Boston, MA 02115 USA.	eric.rimm@channing.harvard.edu						Chiuve SE, 2005, AM J CLIN NUTR, V82, P155, DOI 10.1093/ajcn/82.1.155; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Fallon UB, 2003, STROKE, V34, P1359, DOI 10.1161/01.STR.0000074035.64365.2D; Forman JP, 2005, JAMA-J AM MED ASSOC, V293, P320, DOI 10.1001/jama.293.3.320; He K, 2004, STROKE, V35, P169, DOI 10.1161/01.STR.0000106762.55994.86; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Koushik A, 2006, CANCER EPIDEM BIOMAR, V15, P2408, DOI 10.1158/1055-9965.EPI-06-0624; Larsson SC, 2008, AM J EPIDEMIOL, V167, P954, DOI 10.1093/aje/kwm395; Lee M, 2010, STROKE, V41, P1205, DOI 10.1161/STROKEAHA.109.573410; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X	11	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 13	2011	378	9791					544	546		10.1016/S0140-6736(11)61057-X	http://dx.doi.org/10.1016/S0140-6736(11)61057-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812UX	21803413				2022-12-28	WOS:000294319500005
J	Altman, DG; Bland, JM				Altman, Douglas G.; Bland, J. Martin			Brackets (parentheses) in formulas	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Stat Med, Oxford OX2 6UD, England; [Bland, J. Martin] Univ York, Dept Hlth Sci, Hlth Stat, York YO10 5DD, N Yorkshire, England	University of Oxford; University of York - UK	Altman, DG (corresponding author), Univ Oxford, Ctr Stat Med, Stat Med, Oxford OX2 6UD, England.	doug.altman@csm.ox.ac.uk						Bland JM, 1996, BRIT MED J, V313, P744; Bland JM, 2009, PHYS THER SPORT, V10, P39, DOI 10.1016/j.ptsp.2008.10.002; Collinson P, 1998, HEART, V80, P215, DOI 10.1136/hrt.80.3.215; Eechaute C, 2008, PHYS THER SPORT, V9, P57, DOI 10.1016/j.ptsp.2008.02.001; Leyland M, 2004, EYE, V18, P357, DOI 10.1038/sj.eye.6700659	5	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2011	343								d570	10.1136/bmj.d570	http://dx.doi.org/10.1136/bmj.d570			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KT	21835875	Green Submitted, Bronze			2022-12-28	WOS:000209545800001
J	Miron, IM; Garello, K; Gaudin, G; Zermatten, PJ; Costache, MV; Auffret, S; Bandiera, S; Rodmacq, B; Schuhl, A; Gambardella, P				Mihai Miron, Ioan; Garello, Kevin; Gaudin, Gilles; Zermatten, Pierre-Jean; Costache, Marius V.; Auffret, Stephane; Bandiera, Sebastien; Rodmacq, Bernard; Schuhl, Alain; Gambardella, Pietro			Perpendicular switching of a single ferromagnetic layer induced by in-plane current injection	NATURE			English	Article							MAGNETIC-FIELDS; SPIN; MANIPULATION; RASHBA	Modern computing technology is based on writing, storing and retrieving information encoded as magnetic bits. Although the giant magnetoresistance effect has improved the electrical read out of memory elements, magnetic writing remains the object of major research efforts(1). Despite several reports of methods to reverse the polarity of nanosized magnets by means of local electric fields(2,3) and currents(4-6), the simple reversal of a high-coercivity, single-layer ferromagnet remains a challenge. Materials with large coercivity and perpendicular magnetic anisotropy represent the mainstay of data storage media, owing to their ability to retain a stable magnetization state over long periods of time and their amenability to miniaturization(7). However, the same anisotropy properties that make a material attractive for storage also make it hard to write to(8). Here we demonstrate switching of a perpendicularly magnetized cobalt dot driven by in-plane current injection at room temperature. Our device is composed of a thin cobalt layer with strong perpendicular anisotropy and Rashba interaction induced by asymmetric platinum and AlO(x) interface layers(9,10). The effective switching field is orthogonal to the direction of the magnetization and to the Rashba field. The symmetry of the switching field is consistent with the spin accumulation induced by the Rashba interaction and the spin-dependent mobility observed in non-magnetic semiconductors(11,12), as well as with the torque induced by the spin Hall effect in the platinum layer(13,14). Our measurements indicate that the switching efficiency increases with the magnetic anisotropy of the cobalt layer and the oxidation of the aluminium layer, which is uppermost, suggesting that the Rashba interaction has a key role in the reversal mechanism. To prove the potential of in-plane current switching for spintronic applications, we construct a reprogrammable magnetic switch that can be integrated into non-volatile memory and logic architectures. This device is simple, scalable and compatible with present-day magnetic recording technology.	[Mihai Miron, Ioan; Garello, Kevin; Costache, Marius V.; Gambardella, Pietro] Catalan Inst Nanotechnol ICN CIN2, E-08193 Barcelona, Spain; [Gaudin, Gilles; Zermatten, Pierre-Jean; Auffret, Stephane; Bandiera, Sebastien; Rodmacq, Bernard; Schuhl, Alain] INAC, CEA CNRS UJF GINP, UMR 8191, SPINTEC, F-38054 Grenoble, France; [Gambardella, Pietro] ICREA, E-08010 Barcelona, Spain; [Gambardella, Pietro] Univ Autonoma Barcelona, Dept Fis, E-08193 Barcelona, Spain	Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); CEA; ICREA; Autonomous University of Barcelona	Miron, IM (corresponding author), Catalan Inst Nanotechnol ICN CIN2, E-08193 Barcelona, Spain.	mihai.miron.icn@uab.es; pietro.gambardella.icn@uab.es	Garello, Kevin/AAA-8539-2020; Costache, Marius Vasile/AAQ-3947-2021; Gambardella, Pietro/B-1880-2009	Garello, Kevin/0000-0003-0236-322X; Costache, Marius Vasile/0000-0001-7432-6175; Gambardella, Pietro/0000-0003-0031-9217	European Research Council [StG 203239 NOMAD]; Ministerio de Ciencia y Innovacion [ERA-Net EUI2008-03884, MAT2010-15659]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2009 SGR 695]; ICREA Funding Source: Custom	European Research Council(European Research Council (ERC)European Commission); Ministerio de Ciencia y Innovacion(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ICREA(ICREA)	We thank S. O. Valenzuela and S. F. Alvarado for reading the manuscript and for discussions. This work was supported by the European Research Council (StG 203239 NOMAD), the Ministerio de Ciencia y Innovacion (ERA-Net EUI2008-03884, MAT2010-15659) and the Agencia de Gestio d'Ajuts Universitaris i de Recerca (2009 SGR 695). Samples were patterned at the NANOFAB facility of the Institut Neel (CNRS).	Ando K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.036601; Awschalom David, 2009, Physics, V2, DOI 10.1103/Physics.2.50; Batra S, 2004, IEEE T MAGN, V40, P319, DOI 10.1109/TMAG.2003.821163; CAMPBELL A, 1982, FERROMAGNETIC MAT, V3, P747; Chappert C, 2007, NAT MATER, V6, P813, DOI 10.1038/nmat2024; Chernyshov A, 2009, NAT PHYS, V5, P656, DOI 10.1038/NPHYS1362; Chiba D, 2008, NATURE, V455, P515, DOI 10.1038/nature07318; Dieny B, 2010, INT J NANOTECHNOL, V7, P591, DOI 10.1504/IJNT.2010.031735; Engel HA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.036602; Gambardella P, 2003, SCIENCE, V300, P1130, DOI 10.1126/science.1082857; Ganichev SD, 2006, J MAGN MAGN MATER, V300, P127, DOI 10.1016/j.jmmm.2005.10.048; Garate I, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.134403; Kato Y, 2004, NATURE, V427, P50, DOI 10.1038/nature02202; Kato YK, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.176601; Krupin O, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.201403; Liu LQ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.036601; Manchon A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.212405; Meier L, 2007, NAT PHYS, V3, P650, DOI 10.1038/nphys675; Miron IM, 2010, NAT MATER, V9, P230, DOI [10.1038/nmat2613, 10.1038/NMAT2613]; MOSER KA, 2002, J PHYS D, V35, pR157; Myers EB, 1999, SCIENCE, V285, P867, DOI 10.1126/science.285.5429.867; Ney A, 2003, NATURE, V425, P485, DOI 10.1038/nature02014; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Pi UH, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3502596; Ralph DC, 2008, J MAGN MAGN MATER, V320, P1190, DOI 10.1016/j.jmmm.2007.12.019; Rodmacq B, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.024423; Silov AY, 2004, APPL PHYS LETT, V85, P5929, DOI 10.1063/1.1833565; Stern NP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.126603; Tudosa I, 2004, NATURE, V428, P831, DOI 10.1038/nature02438	30	1802	1890	63	857	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					189	U88		10.1038/nature10309	http://dx.doi.org/10.1038/nature10309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21804568	Green Published			2022-12-28	WOS:000293731900032
J	Morgan, JA; LeCain, DR; Pendall, E; Blumenthal, DM; Kimball, BA; Carrillo, Y; Williams, DG; Heisler-White, J; Dijkstra, FA; West, M				Morgan, Jack A.; LeCain, Daniel R.; Pendall, Elise; Blumenthal, Dana M.; Kimball, Bruce A.; Carrillo, Yolima; Williams, David G.; Heisler-White, Jana; Dijkstra, Feike A.; West, Mark			C-4 grasses prosper as carbon dioxide eliminates desiccation in warmed semi-arid grassland	NATURE			English	Article							ATMOSPHERIC CO2; WATER RELATIONS; ELEVATED CO2; CLIMATE; NORTH; RESPONSES; ECOSYSTEM; DROUGHT; IMPACT; FUTURE	Global warming is predicted to induce desiccation in many world regions through increases in evaporative demand(1-3). Rising CO2 may counter that trend by improving plant water-use efficiency(4,5). However, it is not clear how important this CO2-enhanced water use efficiency might be in offsetting warming-induced desiccation because higher CO2 also leads to higher plant biomass, and therefore greater transpirational surface(2,6,7). Furthermore, although warming is predicted to favour warm-season, C-4 grasses, rising CO2 should favour C-3, or cool-season plants(8). Here we show in a semi-arid grassland that elevated CO2 can completely reverse the desiccating effects of moderate warming. Although enrichment of air to 600 p. p. m. v. CO2 increased soil water content (SWC), 1.5/3.0 degrees C day/night warming resulted in desiccation, such that combined CO2 enrichment and warming had no effect on SWC relative to control plots. As predicted, elevated CO2 favoured C-3 grasses and enhanced stand productivity, whereas warming favoured C-4 grasses. Combined warming and CO2 enrichment stimulated above-ground growth of C-4 grasses in 2 of 3 years when soil moisture most limited plant productivity. The results indicate that in a warmer, CO2-enriched world, both SWC and productivity in semi-arid grasslands may be higher than previously expected.	[Morgan, Jack A.; LeCain, Daniel R.; Blumenthal, Dana M.; Dijkstra, Feike A.; West, Mark] USDA ARS, Rangeland Resources Res Unit, Ft Collins, CO 80526 USA; [Morgan, Jack A.; LeCain, Daniel R.; Blumenthal, Dana M.; Dijkstra, Feike A.; West, Mark] USDA ARS, No Plains Area, Ft Collins, CO 80526 USA; [Pendall, Elise; Carrillo, Yolima; Williams, David G.; Heisler-White, Jana] Univ Wyoming, Dept Bot, Laramie, WY 82071 USA; [Pendall, Elise; Carrillo, Yolima; Williams, David G.; Heisler-White, Jana] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Kimball, Bruce A.] ARS, US Arid Land Agr Res Ctr, USDA, Maricopa, AZ 85238 USA; [Dijkstra, Feike A.] Univ Sydney, Fac Agr Food & Nat Resources, Sydney, NSW 2006, Australia	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Wyoming; University of Wyoming; United States Department of Agriculture (USDA); University of Sydney	Morgan, JA (corresponding author), USDA ARS, Rangeland Resources Res Unit, Ft Collins, CO 80526 USA.	jack.morgan@ars.usda.gov	Dijkstra, Feike A/H-2182-2012; Blumenthal, Dana M/J-3106-2012; Williams, David G/A-6407-2014; Pendall, Elise/AAF-5667-2020	Dijkstra, Feike A/0000-0002-6191-6018; Williams, David G/0000-0003-3627-5260; Pendall, Elise/0000-0002-1651-8969	US Department of Agriculture; US Department of Agriculture-Cooperative State Research, Education, and Extension Service [2008-35107-18655]; US Department of Energy's Office of Science (Biological and Environmental Research) through the Western Regional Center of the National Institute for Climatic Change Research at Northern Arizona University; National Science Foundation [1021559]; Direct For Biological Sciences [1027319, 0823405, 1021559] Funding Source: National Science Foundation	US Department of Agriculture(United States Department of Agriculture (USDA)); US Department of Agriculture-Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); US Department of Energy's Office of Science (Biological and Environmental Research) through the Western Regional Center of the National Institute for Climatic Change Research at Northern Arizona University(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank D. Smith for installation and operation of the PHACE experiment, E. Hardy for assistance in installation, A. Eden and C. Brooks for data collection and analysis, F. Miglietta for advice and help on installation of the FACE system, and R. Seager, A. Leakey, B. Cook and G. Wang for comments on the manuscript. The work was supported by the US Department of Agriculture-Agricultural Research Service Climate Change, Soils & Emissions Program, the US Department of Agriculture-Cooperative State Research, Education, and Extension Service Soil Processes Program (grant no. 2008-35107-18655), the US Department of Energy's Office of Science (Biological and Environmental Research) through the Western Regional Center of the National Institute for Climatic Change Research at Northern Arizona University, and the National Science Foundation (DEB no. 1021559). Mention of commercial products is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the USDA.	Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Derner JD, 2007, RANGELAND ECOL MANAG, V60, P270, DOI 10.2111/1551-5028(2007)60[270:GMTPSC]2.0.CO;2; Dijkstra FA, 2010, NEW PHYTOL, V187, P426, DOI 10.1111/j.1469-8137.2010.03293.x; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Epstein HE, 2002, J BIOGEOGR, V29, P875, DOI 10.1046/j.1365-2699.2002.00701.x; Frelich LE, 2010, FRONT ECOL ENVIRON, V8, P371, DOI 10.1890/080191; Hovenden MJ, 2008, NEW PHYTOL, V180, P143, DOI 10.1111/j.1469-8137.2008.02563.x; Kimball B. A., 2007, AGRONOMY MONOGRAPH, P627; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Lecain DR, 2003, ANN BOT-LONDON, V92, P41, DOI 10.1093/aob/mcg109; Luo YQ, 2009, GCB BIOENERGY, V1, P62, DOI 10.1111/j.1757-1707.2008.01005.x; MCNAUGHTON KG, 1991, AGR FOREST METEOROL, V54, P279, DOI 10.1016/0168-1923(91)90010-N; Miglietta F, 2001, NEW PHYTOL, V150, P465, DOI 10.1046/j.1469-8137.2001.00115.x; Milchunas DG, 2005, GLOBAL CHANGE BIOL, V11, P1837, DOI 10.1111/j.1365-2486.2005.001009.x; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Morgan JA, 2007, P NATL ACAD SCI USA, V104, P14724, DOI 10.1073/pnas.0703427104; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Piao SL, 2007, P NATL ACAD SCI USA, V104, P15242, DOI 10.1073/pnas.0707213104; Polley HW, 1997, J RANGE MANAGE, V50, P562, DOI 10.2307/4003450; Seager R, 2010, P NATL ACAD SCI USA, V107, P21277, DOI 10.1073/pnas.0910856107; Semmartin M, 2004, OIKOS, V107, P148, DOI 10.1111/j.0030-1299.2004.13153.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Suttie J. M., 2006, P1; Tieszen LL, 1997, ECOL APPL, V7, P59, DOI 10.2307/2269407; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Wang GL, 2005, CLIM DYNAM, V25, P739, DOI 10.1007/s00382-005-0057-9; Woodhouse CA, 2010, P NATL ACAD SCI USA, V107, P21283, DOI 10.1073/pnas.0911197107	28	356	375	10	346	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					202	U101		10.1038/nature10274	http://dx.doi.org/10.1038/nature10274			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21814202				2022-12-28	WOS:000293731900035
J	Cammack, N				Cammack, Nick			Exploiting Malaria Drug Resistance to Our Advantage	SCIENCE			English	Editorial Material							PLASMODIUM-FALCIPARUM		GlaxoSmithKline Inc, Madrid 28760, Spain	GlaxoSmithKline	Cammack, N (corresponding author), GlaxoSmithKline Inc, Madrid 28760, Spain.	c.cammack@gsk.com						Cortez KJ, 2011, VIRUSES-BASEL, V3, P347, DOI 10.3390/v3040347; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hayton K, 2008, CURR GENET, V54, P223, DOI 10.1007/s00294-008-0214-x; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; WHO, 2010, GUID TREATM MAL, V2nd; Yuan J, 2011, SCIENCE, V333, P724, DOI 10.1126/science.1205216	9	8	8	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					705	706		10.1126/science.1210875	http://dx.doi.org/10.1126/science.1210875			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817037				2022-12-28	WOS:000293512100026
J	Mosqueda, L; Dong, XQ				Mosqueda, Laura; Dong, XinQi			Elder Abuse and Self-neglect "I Don't Care Anything About Going to the Doctor, to Be Honest ...."	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADULT PROTECTIVE SERVICES; OLDER-ADULTS; COGNITIVE FUNCTION; UNITED-STATES; RISK; MISTREATMENT; PREVALENCE; IMPAIRMENT; VALIDATION; DEPRESSION	Elder mistreatment encompasses a range of behaviors including emotional, financial, physical, and sexual abuse, neglect by other individuals, and self-neglect. This article discusses the range of elder mistreatment in community-living older adults, associated factors, and consequences. Although self-neglect is not considered a type of abuse in many research definitions, it is the most commonly reported form of elder mistreatment and is associated with increased morbidity and mortality. The case on which this article is based describes a 70-year-old woman who neglects herself and dies despite multiple contacts with the medical community. Despite significant gaps in research, enough is known to guide clinical practice. This article presents the practical approaches a health care professional can take when a reasonable suspicion of elder mistreatment arises. Public health and interdisciplinary team approaches are needed to manage what is becoming an increasing problem as the number of older adults around the world increases.	[Mosqueda, Laura] Univ Calif Irvine, Dept Family Med, Sch Med, Orange, CA 92868 USA; [Dong, XinQi] Rush Univ, Rush Inst Healthy Aging, Med Ctr, Chicago, IL 60612 USA	University of California System; University of California Irvine; Rush University	Mosqueda, L (corresponding author), Univ Calif Irvine, Dept Family Med, Sch Med, 101 City Dr S,Bldg 200,Ste 512,Rt 81, Orange, CA 92868 USA.	mosqueda@uci.edu			Archstone Foundation; National Institute on Aging [R21 AG028060, R01 AG11101]; American Recovery and Reinvestment Act [RC4 AG039085]; Paul B. Beeson Award in Aging [K23 AG030944]; Starr Foundation; John A. Hartford Foundation; Atlantic Philanthropies; SCAN Foundation; NATIONAL INSTITUTE ON AGING [R21AG028060, RC4AG039085, R01AG011101, K23AG030944] Funding Source: NIH RePORTER	Archstone Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Recovery and Reinvestment Act; Paul B. Beeson Award in Aging; Starr Foundation; John A. Hartford Foundation; Atlantic Philanthropies; SCAN Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Mosqueda reports receipt of support from the Archstone Foundation and National Institute on Aging grant R21 AG028060. Dr Dong reports receipt of support from National Institute on Aging grant R01 AG11101, American Recovery and Reinvestment Act (RC4 AG039085), Paul B. Beeson Award in Aging (K23 AG030944), The Starr Foundation, John A. Hartford Foundation, and The Atlantic Philanthropies. The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Abrams RC, 2002, AM J PSYCHIAT, V159, P1724, DOI 10.1176/appi.ajp.159.10.1724; Acierno R, 2010, AM J PUBLIC HEALTH, V100, P292, DOI 10.2105/AJPH.2009.163089; American Bar Association Commission on Law and Aging, MAND REP COMP CHARTS; Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Begle AM, 2011, J INTERPERS VIOLENCE, V26, P2321, DOI 10.1177/0886260510383037; Bitondo C, 2007, AM J PUBLIC HEALTH, V97, P1671, DOI 10.2105/AJPH.2006.097113; Blakely BE, 2001, J ELDER ABUSE NEGL, V13, P1, DOI 10.1300/J084v13n03_01; Bonnie R. J., 2003, ELDER MISTREATMENT A; Burnett J, 2009, ARCH PHYS MED REHAB, V90, P1948, DOI 10.1016/j.apmr.2009.05.021; Choi NG, 2009, J GERONTOL SOC WORK, V52, P171, DOI 10.1080/01634370802609239; Comijs HC, 1999, J GERONTOL B-PSYCHOL, V54, pP240, DOI 10.1093/geronb/54B.4.P240; Cooper C, 2010, J AFFECT DISORDERS, V121, P136, DOI 10.1016/j.jad.2009.05.001; Cooper C, 2008, INT J GERIATR PSYCH, V23, P283, DOI 10.1002/gps.1875; Dong X, AM J EMERG MED; Dong XQ, 2010, GERONTOLOGY, V56, P325, DOI 10.1159/000243164; Dong XQ, 2007, J ELDER ABUSE NEGL, V19, P79, DOI 10.1300/J084v19n03_05; Dong XQ, 2005, J ELDER ABUSE NEGL, V17, P19, DOI 10.1300/J084v17n03_02; Dong X, 2007, J AM GERIATR SOC, V55, P1831, DOI 10.1111/j.1532-5415.2007.01429.x; Dong XQ, 2011, AM J GERIAT PSYCHIAT, V19, P743, DOI 10.1097/JGP.0b013e3182006a53; Dong XQ, 2011, J GERONTOL A-BIOL, V66, P695, DOI 10.1093/gerona/glr053; Dong XQ, 2010, J AM GERIATR SOC, V58, P2292, DOI 10.1111/j.1532-5415.2010.03156.x; Dong XQ, 2010, PUBLIC HEALTH REP, V125, P743; Dong XQ, 2010, INT J GERIATR PSYCH, V25, P798, DOI 10.1002/gps.2420; Dong XQ, 2010, GERONTOLOGIST, V50, P316, DOI 10.1093/geront/gnp164; Dong XQ, 2010, AGING MENT HEALTH, V14, P74, DOI 10.1080/13607860903421037; Dong XQ, 2010, ARCH GERONTOL GERIAT, V50, P202, DOI 10.1016/j.archger.2009.03.011; Dong XQ, 2008, J ELDER ABUSE NEGL, V20, P25, DOI 10.1300/J084v20n01_02; Dong XQ, 2009, J AGING HEALTH, V21, P596, DOI 10.1177/0898264309333323; Dong XQ, 2009, JAMA-J AM MED ASSOC, V302, P517, DOI 10.1001/jama.2009.1109; Dong XQ, GERONTOLOGY; Dyer C. B., 2003, ELDER MISTREATMENT A; Dyer CB, 2005, J GERONTOL A-BIOL, V60, P1000, DOI 10.1093/gerona/60.8.1000; Dyer CB, 2000, J AM GERIATR SOC, V48, P205, DOI 10.1111/j.1532-5415.2000.tb03913.x; Fisher JW, 2003, POSTGRAD MED, V113, P21, DOI 10.3810/pgm.2003.04.1403; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fulmer T, 2005, GERONTOLOGIST, V45, P525, DOI 10.1093/geront/45.4.525; Hildreth Carolyn J, 2011, JAMA, V306, P568, DOI 10.1001/jama.306.5.568; Kennedy RD, 2005, FAM MED, V37, P481; Lachs MS, 1998, JAMA-J AM MED ASSOC, V280, P428, DOI 10.1001/jama.280.5.428; Lachs MS, 2002, GERONTOLOGIST, V42, P734, DOI 10.1093/geront/42.6.734; LACHS MS, 1995, NEW ENGL J MED, V332, P437, DOI 10.1056/NEJM199502163320706; Lachs MS, 1996, ARCH INTERN MED, V156, P449, DOI 10.1001/archinte.156.4.449; Laumann EO, 2008, J GERONTOL B-PSYCHOL, V63, pS248, DOI 10.1093/geronb/63.4.S248; Mosqueda L, 2004, GERONTOLOGIST, V44, P703, DOI 10.1093/geront/44.5.703; Mosqueda L, 2010, J ELDER ABUSE NEGL, V22, P219, DOI 10.1080/08946566.2010.489884; Mouton CP, 2010, ANN FAM MED, V8, P206, DOI 10.1370/afm.1095; Naik AD, 2008, GERONTOLOGIST, V48, P388, DOI 10.1093/geront/48.3.388; National Center on Elder Abuse, MAJ TYP ELD AB; Navarro AE, 2010, GERONTOLOGIST, V50, P702, DOI 10.1093/geront/gnq018; Otto JM, 2000, GENERATIONS, V24, P33; Podnieks E, 2010, J ELDER ABUSE NEGL, V22, P131, DOI 10.1080/08946560903436403; Rinker AG, 2009, ARCH GERONTOL GERIAT, V48, P110, DOI 10.1016/j.archger.2007.11.002; Rodriguez MA, 2006, ANN FAM MED, V4, P403, DOI 10.1370/afm.575; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Schillerstrom JE, 2009, AM J GERIAT PSYCHIAT, V17, P907, DOI 10.1097/JGP.0b013e3181b4bf64; Sessums LL, 2011, JAMA-J AM MED ASSOC, V306, P420, DOI 10.1001/jama.2011.1023; Smith SM, 2006, J NUTR, V136, P2534, DOI 10.1093/jn/136.10.2534; Spensley C, 2008, J ELDER ABUSE NEGL, V20, P43, DOI 10.1300/J084v20n01_03; Teaster PB, 2000, RESPONSE ABUSE VULNE; THOMSON LK, 1992, KOHLMAN EVALUATION L; Widera E, 2011, JAMA-J AM MED ASSOC, V305, P698, DOI 10.1001/jama.2011.164; Wiglesworth A, 2006, GERONTOLOGIST, V46, P277, DOI 10.1093/geront/46.2.277; Wiglesworth A, 2010, J AM GERIATR SOC, V58, P493, DOI 10.1111/j.1532-5415.2010.02737.x; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zou Y, 1998, Int Psychogeriatr, V10, P303, DOI 10.1017/S1041610298005390	65	58	59	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2011	306	5					532	540		10.1001/jama.2011.1085	http://dx.doi.org/10.1001/jama.2011.1085			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	800SH	21813431				2022-12-28	WOS:000293386500020
J	Ruhl, M; Bonis, NR; Reichart, GJ; Damste, JSS; Kurschner, WM				Ruhl, Micha; Bonis, Nina R.; Reichart, Gert-Jan; Damste, Jaap S. Sinninghe; Kurschner, Wolfram M.			Atmospheric Carbon Injection Linked to End-Triassic Mass Extinction	SCIENCE			English	Article							CYCLE; OCEAN; ACIDIFICATION; BIODIVERSITY; TERRESTRIAL; CONSTRAINTS; ANGIOSPERMS; CONIFERS; RELEASE; METHANE	The end-Triassic mass extinction (similar to 201.4 million years ago), marked by terrestrial ecosystem turnover and up to similar to 50% loss in marine biodiversity, has been attributed to intensified volcanic activity during the break-up of Pangaea. Here, we present compound-specific carbon-isotope data of long-chain n-alkanes derived from waxes of land plants, showing a similar to 8.5 per mil negative excursion, coincident with the extinction interval. These data indicate strong carbon-13 depletion of the end-Triassic atmosphere, within only 10,000 to 20,000 years. The magnitude and rate of this carbon-cycle disruption can be explained by the injection of at least similar to 12 x 10(3) gigatons of isotopically depleted carbon as methane into the atmosphere. Concurrent vegetation changes reflect strong warming and an enhanced hydrological cycle. Hence, end-Triassic events are robustly linked to methane-derived massive carbon release and associated climate change.	[Ruhl, Micha; Bonis, Nina R.; Kurschner, Wolfram M.] Univ Utrecht, Fac Sci, Inst Environm Biol, NL-3584 CD Utrecht, Netherlands; [Ruhl, Micha] Univ Copenhagen, Nat Hist Museum Denmark, NordCEE, DK-1350 Copenhagen K, Denmark; [Bonis, Nina R.] Shell Global Solut Int BV, NL-2288 GS Rijswijk, Netherlands; [Reichart, Gert-Jan; Damste, Jaap S. Sinninghe] Univ Utrecht, Fac Geosci, Dept Earth Sci, NL-3508 TA Utrecht, Netherlands; [Damste, Jaap S. Sinninghe] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Netherlands; [Kurschner, Wolfram M.] Univ Oslo, Dept Geosci, N-0316 Oslo, Norway	Utrecht University; University of Copenhagen; Royal Dutch Shell; Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Oslo	Ruhl, M (corresponding author), Univ Utrecht, Fac Sci, Inst Environm Biol, Budapestlaan 4, NL-3584 CD Utrecht, Netherlands.	micharuhl@gmail.com	Opazo, Luis-Felipe/G-9586-2011; Reichart, Gert-Jan/N-6308-2018; Damste, Jaap S Sinninghe/F-6128-2011; Kürschner, Wolfram Michael/AAC-7769-2020; Kürschner, Wolfram Michael/B-4724-2009	Reichart, Gert-Jan/0000-0002-7256-2243; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Kürschner, Wolfram Michael/0000-0001-6883-6486; Kürschner, Wolfram Michael/0000-0001-6883-6486; Ruhl, Micha/0000-0001-8170-0399	Utrecht University	Utrecht University	We thank G. Nobbe for lab assistance with stable-isotope measurements, and H. Visscher and A. Sluijs for suggestions and comments during the initial drafting of the manuscript. We also thank H. Svensen and three anonymous reviewers for suggestions and comments during the review of this paper. W. M. K., M. R., and N.R.B. acknowledge funding from the Utrecht University High Potential program. This contribution is publication 20110601 of the Netherlands Research School of Sedimentary Geology.	Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Beerling DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001637; Bonis NR, 2010, PALAEOGEOGR PALAEOCL, V290, P151, DOI 10.1016/j.palaeo.2009.06.016; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Deenen MHL, 2010, EARTH PLANET SC LETT, V291, P113, DOI 10.1016/j.epsl.2010.01.003; Dickens GR, 2003, EARTH PLANET SC LETT, V213, P169, DOI 10.1016/S0012-821X(03)00325-X; Hautmann M, 2008, NEUES JAHRB GEOL P-A, V249, P119, DOI 10.1127/0077-7749/2008/0249-0119; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Kemp DB, 2005, NATURE, V437, P396, DOI 10.1038/nature04037; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McElwain JC, 2009, SCIENCE, V324, P1554, DOI 10.1126/science.1171706; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; Pancost RD, 2004, MAR CHEM, V92, P239, DOI 10.1016/j.marchem.2004.06.029; Pedentchouk N, 2008, ORG GEOCHEM, V39, P1066, DOI 10.1016/j.orggeochem.2008.02.005; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Ruhl M, 2011, GEOLOGY, V39, P431, DOI 10.1130/G31680.1; Ruhl M, 2010, EARTH PLANET SC LETT, V295, P262, DOI 10.1016/j.epsl.2010.04.008; Ruhl M, 2010, EARTH PLANET SC LETT, V292, P17, DOI 10.1016/j.epsl.2009.12.046; Ruhl M, 2009, EARTH PLANET SC LETT, V281, P169, DOI 10.1016/j.epsl.2009.02.020; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schaller MF, 2011, SCIENCE, V331, P1404, DOI 10.1126/science.1199011; Schoene B, 2010, GEOLOGY, V38, P387, DOI 10.1130/G30683.1; Schouten S, 2007, EARTH PLANET SC LETT, V258, P581, DOI 10.1016/j.epsl.2007.04.024; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; Svensen H, 2004, NATURE, V429, P542, DOI 10.1038/nature02566; Svensen H, 2007, EARTH PLANET SC LETT, V256, P554, DOI 10.1016/j.epsl.2007.02.013; Svensen H, 2009, EARTH PLANET SC LETT, V277, P490, DOI 10.1016/j.epsl.2008.11.015; van de Schootbrugge B, 2009, NAT GEOSCI, V2, P589, DOI 10.1038/NGEO577; Von Hillebrandt A. V, 2007, INT SUBCOMMISSION JU, V34, P2; Ward PD, 2001, SCIENCE, V292, P1148, DOI 10.1126/science.1058574; Whiteside JH, 2010, P NATL ACAD SCI USA, V107, P6721, DOI 10.1073/pnas.1001706107; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004	33	149	152	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					430	434		10.1126/science.1204255	http://dx.doi.org/10.1126/science.1204255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778394				2022-12-28	WOS:000292959600038
J	Wu, CC; Li, TK; Farh, L; Lin, LY; Lin, TS; Yu, YJ; Yen, TJ; Chiang, CW; Chan, NL				Wu, Chyuan-Chuan; Li, Tsai-Kun; Farh, Lynn; Lin, Li-Ying; Lin, Te-Sheng; Yu, Yu-Jen; Yen, Tien-Jui; Chiang, Chia-Wang; Chan, Nei-Li			Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide	SCIENCE			English	Article							DNA TOPOISOMERASE; CRYSTAL-STRUCTURE; CLEAVAGE; BETA; RESISTANCE; COMPLEX; TARGET; CANCER; IA; SUBSTITUENTS	Type II topoisomerases (TOP2s) resolve the topological problems of DNA by transiently cleaving both strands of a DNA duplex to form a cleavage complex through which another DNA segment can be transported. Several widely prescribed anticancer drugs increase the population of TOP2 cleavage complex, which leads to TOP2-mediated chromosome DNA breakage and death of cancer cells. We present the crystal structure of a large fragment of human TOP2 beta complexed to DNA and to the anticancer drug etoposide to reveal structural details of drug-induced stabilization of a cleavage complex. The interplay between the protein, the DNA, and the drug explains the structure-activity relations of etoposide derivatives and the molecular basis of drug-resistant mutations. The analysis of protein-drug interactions provides information applicable for developing an isoform-specific TOP2-targeting strategy.	[Wu, Chyuan-Chuan; Lin, Li-Ying; Lin, Te-Sheng; Yu, Yu-Jen; Yen, Tien-Jui; Chiang, Chia-Wang; Chan, Nei-Li] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 100, Taiwan; [Li, Tsai-Kun] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 100, Taiwan; [Li, Tsai-Kun] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 100, Taiwan; [Li, Tsai-Kun] Natl Taiwan Univ, Ctr Biotechnol, Taipei 106, Taiwan; [Farh, Lynn] Natl Pingtung Univ Educ, Dept Biol Chem, Pingtung 900, Taiwan; [Lin, Li-Ying; Lin, Te-Sheng; Chiang, Chia-Wang; Chan, Nei-Li] Natl Chung Hsing Univ, Coll Life Sci, Inst Biochem, Taichung 402, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Pingtung University; National Chung Hsing University	Chan, NL (corresponding author), Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 100, Taiwan.	nlchan@ntu.edu.tw	Yen, Tien-Jui/AGF-8092-2022; Wu, Chyuan-Chuan/S-3997-2017	Wu, Chyuan-Chuan/0000-0002-7389-8777; CHAN, NEI-LI/0000-0003-0139-6513; LI, TSAI-KUN/0000-0003-0393-2340	National Science Council [99-2113-M-002-008-MY3, 99-2320-B-002-058-MY3, 100-2325-B-002-019]; National Taiwan University College of Medicine [99R311001]; National Health Research Institute [EX100-9939NI]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University College of Medicine(National Taiwan University); National Health Research Institute(National Health Research Institutes - Taiwan)	Atomic coordinates and structure factors have been deposited in the Protein DataBank (PDB) under accession code 3QX3. This work was supported by the National Science Council (99-2113-M-002-008-MY3 to N.C.; 99-2320-B-002-058-MY3 and 100-2325-B-002-019 to T. L.), National Taiwan University College of Medicine (99R311001 to N.C. and T. L.), and National Health Research Institute (EX100-9939NI to T. L.). We thank T.-S. Hsieh for stimulating discussion, and critical reading and editing of the manuscript. Portions of this research were carried out at beamline BL13B1 of the National Synchrotron Radiation Research Center (Taiwan) and beamline SP12B2 of the SPring-8 (Japan). We thank the Protein Crystallography teams at both facilities for assistance during data collection. The National Taiwan University has applied for a patent concerning use of the hTOP2 beta<SUP>core</SUP>-DNA structure in drug development.	AUSTIN CA, 1995, J BIOL CHEM, V270, P15739, DOI 10.1074/jbc.270.26.15739; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; BECK WT, 1993, ADV ENZYME REGUL, V33, P113; Bender RP, 2008, BIOCHEMISTRY-US, V47, P4501, DOI 10.1021/bi702019z; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Bromberg KD, 2003, J BIOL CHEM, V278, P7406, DOI 10.1074/jbc.M212056200; Byl JAW, 2001, BIOCHEMISTRY-US, V40, P712, DOI 10.1021/bi0021838; Capranico G, 1998, BBA-GENE STRUCT EXPR, V1400, P185, DOI 10.1016/S0167-4781(98)00135-3; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Collins TRL, 2009, NUCLEIC ACIDS RES, V37, P712, DOI 10.1093/nar/gkn1059; DARPA P, 1990, CANCER RES, V50, P6919; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Dingemans AMC, 1998, BBA-GENE STRUCT EXPR, V1400, P275, DOI 10.1016/S0167-4781(98)00141-9; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gentry AC, 2011, BIOCHEMISTRY-US, V50, P3240, DOI 10.1021/bi200094z; Gilroy KL, 2006, NUCLEIC ACIDS RES, V34, P1597, DOI 10.1093/nar/gkl057; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Jarvinen TAH, 2003, CYTOPATHOLOGY, V14, P309, DOI 10.1046/j.0956-5507.2003.00105.x; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Laponogov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011338; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; Lee KH, 1999, J BIOMED SCI, V6, P236, DOI 10.1007/BF02253565; Leontiou C, 2006, MOL PHARMACOL, V69, P130, DOI 10.1124/mol.105.015933; Leontiou C, 2007, MOL PHARMACOL, V71, P1006, DOI 10.1124/mol.106.032953; Liu QY, 1999, P NATL ACAD SCI USA, V96, P881, DOI 10.1073/pnas.96.3.881; LONG BH, 1994, CANCER CHEMOTH PHARM, V34, pS26, DOI 10.1007/BF00684860; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009; Meresse P, 2004, CURR MED CHEM, V11, P2443, DOI 10.2174/0929867043364531; Neto BAD, 2009, MOLECULES, V14, P1725, DOI 10.3390/molecules14051725; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; ROSS W, 1984, CANCER RES, V44, P5857; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; SPITZNER JR, 1988, NUCLEIC ACIDS RES, V16, P5533, DOI 10.1093/nar/16.12.5533; Strumberg D, 1999, J BIOL CHEM, V274, P28246, DOI 10.1074/jbc.274.40.28246; VASSETZKY YS, 1995, BIOESSAYS, V17, P767, DOI 10.1002/bies.950170906; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang JC, 2009, UNTANGLING DOUBLE HE; Wilstermann AM, 2007, BIOCHEMISTRY-US, V46, P8217, DOI 10.1021/bi700272u; Wohlkonig A, 2010, NAT STRUCT MOL BIOL, V17, P1152, DOI 10.1038/nsmb.1892; Zhang ZT, 2011, P NATL ACAD SCI USA, V108, P6939, DOI 10.1073/pnas.1100300108; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	49	350	354	4	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					459	462		10.1126/science.1204117	http://dx.doi.org/10.1126/science.1204117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778401				2022-12-28	WOS:000292959600048
J	Hartl, FU; Bracher, A; Hayer-Hartl, M				Hartl, F. Ulrich; Bracher, Andreas; Hayer-Hartl, Manajit			Molecular chaperones in protein folding and proteostasis	NATURE			English	Review							IN-VIVO; CRYSTAL-STRUCTURE; QUALITY-CONTROL; TRIGGER FACTOR; CAENORHABDITIS-ELEGANS; EXPANSION PROTEINS; CELLULAR FUNCTIONS; ESCHERICHIA-COLI; NMR-SPECTROSCOPY; HSP70 CHAPERONE	Most proteins must fold into defined three-dimensional structures to gain functional activity. But in the cellular environment, newly synthesized proteins are at great risk of aberrant folding and aggregation, potentially forming toxic species. To avoid these dangers, cells invest in a complex network of molecular chaperones, which use ingenious mechanisms to prevent aggregation and promote efficient folding. Because protein molecules are highly dynamic, constant chaperone surveillance is required to ensure protein homeostasis (proteostasis). Recent advances suggest that an age-related decline in proteostasis capacity allows the manifestation of various protein-aggregation diseases, including Alzheimer's disease and Parkinson's disease. Interventions in these and numerous other pathological states may spring from a detailed understanding of the pathways underlying proteome maintenance.	[Hartl, F. Ulrich; Bracher, Andreas; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Hayer-Hartl, Manajit/V-8078-2017; Hartl, F. Ulrich/Y-8206-2019	Hayer-Hartl, Manajit/0000-0001-8213-6742; 				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; Chakraborty K, 2010, CELL, V142, P112, DOI 10.1016/j.cell.2010.05.027; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Douglas NR, 2011, CELL, V144, P240, DOI 10.1016/j.cell.2010.12.017; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Eichmann C, 2010, P NATL ACAD SCI USA, V107, P9111, DOI 10.1073/pnas.0914300107; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Elcock AH, 2006, PLOS COMPUT BIOL, V2, P824, DOI 10.1371/journal.pcbi.0020098; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Frydman J, 1999, NAT STRUCT BIOL, V6, P697, DOI 10.1038/10754; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Herbst R, 1997, J BIOL CHEM, V272, P7099, DOI 10.1074/jbc.272.11.7099; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kern A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008568; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; O'Brien EP, 2010, J AM CHEM SOC, V132, P16928, DOI 10.1021/ja106530y; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Raineri E, 2010, BIOINFORMATICS, V26, P1685, DOI 10.1093/bioinformatics/btq287; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Tartaglia GG, 2010, J MOL BIOL, V400, P579, DOI 10.1016/j.jmb.2010.03.066; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005036	100	2103	2165	27	933	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					324	332		10.1038/nature10317	http://dx.doi.org/10.1038/nature10317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21776078				2022-12-28	WOS:000292911200033
J	Wellings, K; Datta, J; Wilkinson, P; Petticrew, M				Wellings, Kaye; Datta, Jessica; Wilkinson, Paul; Petticrew, Mark			The 2012 Olympics: assessing the public health effect	LANCET			English	Editorial Material							EVENTS; WILL		[Wellings, Kaye; Datta, Jessica; Wilkinson, Paul; Petticrew, Mark] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Fac Publ Hlth & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Wellings, K (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Fac Publ Hlth & Policy, Keppel St, London WC1E 7HT, England.	kaye.wellings@lshtm.ac.uk	Petticrew, Mark/AAY-6274-2021; Weatherburn, Peter/AAC-2701-2019	Wilkinson, Paul/0000-0001-7456-259X	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Department for Culture Media and Sport, LOND 2012 OL PAR GAM; Girginov V., 2008, International Journal of the History of Sport, V25, P2091, DOI 10.1080/09523360802439015; Hamlyn PJ, 2005, BRIT J SPORT MED, V39, P882, DOI 10.1136/bjsm.2005.021006; Kavetsos G, 2010, J ECON PSYCHOL, V31, P158, DOI 10.1016/j.joep.2009.11.005; Kruk J, 2007, ASIAN PAC J CANCER P, V8, P325; Lensky Helen, 2002, BEST OLYMPICS EVER S; London 2012, RESP QUEST CIT APPL; McCartney G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2369; Olympic Delivery Authority, 2006, WESTM BRIEF COUNTD L; Rao M, 2007, LANCET, V370, P1111, DOI 10.1016/S0140-6736(07)61260-4; Tsouros A. D., 2007, Mass gatherings and public health: the experience of the Athens 2004 Olympic Games, P253; Veal AJ, 2009, 6 U TECHN SCH LEIS S; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; Watts J, 2005, LANCET, V366, P1761, DOI 10.1016/S0140-6736(05)67711-2; Weed M., 2009, SYSTEMATIC REV EVIDE; Weed M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2202	16	13	13	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2011	378	9797					1193	1195		10.1016/S0140-6736(11)60550-3	http://dx.doi.org/10.1016/S0140-6736(11)60550-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829RH	21798591				2022-12-28	WOS:000295601500027
J	Agrawal, N; Frederick, MJ; Pickering, CR; Bettegowda, C; Chang, K; Li, RJ; Fakhry, C; Xie, TX; Zhang, JX; Wang, J; Zhang, NX; El-Naggar, AK; Jasser, SA; Weinstein, JN; Trevino, L; Drummond, JA; Muzny, DM; Wu, YQ; Wood, LD; Hruban, RH; Westra, WH; Koch, WM; Califano, JA; Gibbs, RA; Sidransky, D; Vogelstein, B; Velculescu, VE; Papadopoulos, N; Wheeler, DA; Kinzler, KW; Myers, JN				Agrawal, Nishant; Frederick, Mitchell J.; Pickering, Curtis R.; Bettegowda, Chetan; Chang, Kyle; Li, Ryan J.; Fakhry, Carole; Xie, Tong-Xin; Zhang, Jiexin; Wang, Jing; Zhang, Nianxiang; El-Naggar, Adel K.; Jasser, Samar A.; Weinstein, John N.; Trevino, Lisa; Drummond, Jennifer A.; Muzny, Donna M.; Wu, Yuanqing; Wood, Laura D.; Hruban, Ralph H.; Westra, William H.; Koch, Wayne M.; Califano, Joseph A.; Gibbs, Richard A.; Sidransky, David; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Wheeler, David A.; Kinzler, Kenneth W.; Myers, Jeffrey N.			Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1	SCIENCE			English	Article							HUMAN-PAPILLOMAVIRUS; TUMOR-SUPPRESSOR; PATHWAY; GENE; P53	Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. To explore the genetic origins of this cancer, we used whole-exome sequencing and gene copy number analyses to study 32 primary tumors. Tumors from patients with a history of tobacco use had more mutations than did tumors from patients who did not use tobacco, and tumors that were negative for human papillomavirus (HPV) had more mutations than did HPV-positive tumors. Six of the genes that were mutated in multiple tumors were assessed in up to 88 additional HNSCCs. In addition to previously described mutations in TP53, CDKN2A, PIK3CA, and HRAS, we identified mutations in FBXW7 and NOTCH1. Nearly 40% of the 28 mutations identified in NOTCH1 were predicted to truncate the gene product, suggesting that NOTCH1 may function as a tumor suppressor gene rather than an oncogene in this tumor type.	[Agrawal, Nishant; Li, Ryan J.; Fakhry, Carole; Koch, Wayne M.; Califano, Joseph A.; Sidransky, David] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; [Agrawal, Nishant; Bettegowda, Chetan; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21231 USA; [Agrawal, Nishant; Bettegowda, Chetan; Vogelstein, Bert; Velculescu, Victor E.; Papadopoulos, Nickolas; Kinzler, Kenneth W.] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Frederick, Mitchell J.; Pickering, Curtis R.; Xie, Tong-Xin; Jasser, Samar A.; Myers, Jeffrey N.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Bettegowda, Chetan] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21287 USA; [Chang, Kyle; Trevino, Lisa; Drummond, Jennifer A.; Muzny, Donna M.; Wu, Yuanqing; Gibbs, Richard A.; Wheeler, David A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Zhang, Jiexin; Wang, Jing; Zhang, Nianxiang; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [El-Naggar, Adel K.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wood, Laura D.; Hruban, Ralph H.; Westra, William H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Califano, Joseph A.; Gibbs, Richard A.] Greater Baltimore Med Ctr, Milton J Dance Head & Neck Ctr, Baltimore, MD 21204 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Greater Baltimore Medical Center; Baylor College of Medicine	Agrawal, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 600 N Wolfe St, Baltimore, MD 21287 USA.	nagrawal@jhmi.edu; velculescu@jhmi.edu; kinzlke@jhmi.edu; jmyers@mdanderson.org	Drummond, Jennifer/AAG-1654-2020; Wheeler, David A/M-9740-2018; Papadopoulos, Nickolas/K-7272-2012; Velculescu, Victor/ABF-4846-2020; Wood, Laura/ABF-1531-2020	Drummond, Jennifer/0000-0002-2612-5958; Wheeler, David A/0000-0002-9056-6299; Velculescu, Victor/0000-0003-1195-438X; Chang, Kyle/0000-0001-5295-9676; Weinstein, John/0000-0001-9401-6908; Pickering, Curtis/0000-0002-7942-728X	National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research [RC2DE020957, RC2DE020958]; NIH [CA121113, CA43460, CA57345, CN43302, P50DE019032, 5P50CA09700708]; Cancer Prevention Research Institute of Texas [RP100233]; Cancer Center [CA16672]; AACR; Virginia and D. K. Ludwig Fund for Cancer Research; NIH/National Cancer Institute National Research Service [T32 CA009574]; GSK Translational Research Fellowship; NATIONAL CANCER INSTITUTE [R01CA057345, T32CA009574, P50CA097007, R37CA043460, P30CA016672, R37CA057345, R01CA043460, R01CA121113] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012588, P50DE019032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020958, RC2DE020957] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; Cancer Center; AACR; Virginia and D. K. Ludwig Fund for Cancer Research; NIH/National Cancer Institute National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GSK Translational Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank our patients for their courage and generosity. We thank N. Silliman, J. Ptak, M. Whalen, L. Dobbyn, J. Schaeffer, X. Li, O. Folawiyo, and Z. Khan for expert technical assistance. This work was supported by the National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research grants RC2DE020957, and RC2DE020958; NIH grants CA121113, CA43460, CA57345, and CN43302; NIH Specialized Program of Research Excellence grants P50DE019032 and 5P50CA09700708; Cancer Prevention Research Institute of Texas grant RP100233; Cancer Center Support grant CA16672; AACR Stand Up To Cancer-Dream Team Translational Cancer Research grant; and the Virginia and D. K. Ludwig Fund for Cancer Research. Under agreements between the Johns Hopkins University, Genzyme, Exact Sciences, Inostics, Qiagen, Invitrogen, and Personal Genome Diagnostics, N.P., B.V., K.W.K., and V.E.V are entitled to a share of the royalties received by the university on sales of products related to genes and technologies described in this manuscript. N.P., B.V., K.W.K., and V.E.V are co-founders of Inostics and Personal Genome Diagnostics, are members of their Scientific Advisory Boards, and own Inostics and Personal Genome Diagnostics stock, which is subject to certain restrictions under Johns Hopkins University policy. J.C. is the Director of Research of the Milton J. Dance Head and Neck Endowment. The terms of these arrangements are managed by the Johns Hopkins University in accordance with its conflict-of-interest policies. C.B. is a recipient of T32 CA009574 NIH/National Cancer Institute National Research Service Award. C.R.P. is a TRIUMPH Fellow and supported by the GSK Translational Research Fellowship. This paper is based on a web database application provided by Research Information Technology Systems (RITS) www.rits.onc.jhmi.edu/.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Aster JC, 1997, J BIOL CHEM, V272, P11336; Baldus CD, 2009, HAEMATOL-HEMATOL J, V94, P1383, DOI 10.3324/haematol.2008.005272; Balz V, 2003, CANCER RES, V63, P1188; BERENSON JR, 1989, ONCOGENE, V4, P1111; BRENNAN JA, 1995, NEW ENGL J MED, V332, P712, DOI 10.1056/NEJM199503163321104; Cohen LY, 2005, CELL DEATH DIFFER, V12, P243, DOI 10.1038/sj.cdd.4401568; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hafkamp HC, 2003, INT J CANCER, V107, P394, DOI 10.1002/ijc.11389; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Klussmann JP, 2009, CLIN CANCER RES, V15, P1779, DOI 10.1158/1078-0432.CCR-08-1463; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106	22	1250	1270	2	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2011	333	6046					1154	1157		10.1126/science.1206923	http://dx.doi.org/10.1126/science.1206923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21798897	Green Accepted			2022-12-28	WOS:000294244300051
J	Penkman, KEH; Preece, RC; Bridgland, DR; Keen, DH; Meijer, T; Parfitt, SA; White, TS; Collins, MJ				Penkman, Kirsty E. H.; Preece, Richard C.; Bridgland, David R.; Keen, David H.; Meijer, Tom; Parfitt, Simon A.; White, Tom S.; Collins, Matthew J.			A chronological framework for the British Quaternary based on Bithynia opercula	NATURE			English	Article							PLEISTOCENE; MIDDLE; GEOCHRONOLOGY; OCCUPATION; FRACTION; BRITAIN; SYSTEMS; EUROPE; RECORD	Marine and ice-core records show that the Earth has experienced a succession of glacials and interglacials during the Quaternary (last similar to 2.6 million years), although it is often difficult to correlate fragmentary terrestrial records with specific cycles. Aminostratigraphy is a method potentially able to link terrestrial sequences to the marine isotope stages (MIS) of the deep-sea record(1,2). We have used new methods of extraction and analysis of amino acids, preserved within the calcitic opercula of the freshwater gastropod Bithynia, to provide the most comprehensive data set for the British Pleistocene based on a single dating technique. A total of 470 opercula from 74 sites spanning the entire Quaternary are ranked in order of relative age based on the extent of protein degradation, using aspartic acid/asparagine (Asx), glutamic acid/glutamine (Glx), serine (Ser), alanine (Ala) and valine (Val). This new aminostratigraphy is consistent with the stratigraphical relationships of stratotypes, sites with independent geochronology, biostratigraphy and terrace stratigraphy(3-6). The method corroborates the existence of four interglacial stages between the Anglian (MIS 12) and the Holocene in the terrestrial succession. It establishes human occupation of Britain in most interglacial stages after MIS 15, but supports the notion of human absence during the Last Interglacial (MIS 5e)(7). Suspicions that the treeless 'optimum of the Upton Warren interstadial' at Isleworth pre-dates MIS 3 are confirmed. This new aminostratigraphy provides a robust framework against which climatic, biostratigraphical and archaeological models can be tested.	[Penkman, Kirsty E. H.; Collins, Matthew J.] Univ York, BioArCh, Dept Archaeol, York YO10 5DD, N Yorkshire, England; [Penkman, Kirsty E. H.; Collins, Matthew J.] Univ York, Dept Chem, BioArCh, York YO10 5DD, N Yorkshire, England; [Preece, Richard C.; White, Tom S.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Bridgland, David R.] Univ Durham, Dept Geog, Durham DH1 3LE, England; [Keen, David H.] Univ Birmingham, Inst Archaeol & Antiqu, Birmingham B15 2TT, W Midlands, England; [Meijer, Tom] Netherlands Ctr Biodivers, Cainozo Mollusca, NL-2300 RA Leiden, Netherlands; [Parfitt, Simon A.] UCL, Inst Archaeol, London WC1H 0PY, England; [Parfitt, Simon A.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	University of York - UK; University of York - UK; University of Cambridge; Durham University; University of Birmingham; Naturalis Biodiversity Center; University of London; University College London; Natural History Museum London	Penkman, KEH (corresponding author), Univ York, BioArCh, Dept Archaeol, York YO10 5DD, N Yorkshire, England.	kirsty.penkman@york.ac.uk	Collins, Matthew James/O-1095-2019; Collins, Matthew J/A-7534-2008; White, Tom/A-2474-2013; Penkman, Kirsty E/D-1952-2012	Collins, Matthew James/0000-0003-4226-5501; Collins, Matthew J/0000-0003-4226-5501; Penkman, Kirsty E/0000-0002-6226-9799; White, Tom/0000-0001-9056-7286	English Heritage, NERC; Wellcome Trust [GR076905MA]; Leverhulme Trust; Engineering and Physical Sciences Research Council [EP/I001514/1] Funding Source: researchfish; EPSRC [EP/I001514/1] Funding Source: UKRI	English Heritage, NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank D. Maddy, P. Allen, N. Ashton, D. Bain, M. Bates, S. Boreham, D. Bowen, R. Briant, C. Buckingham, J. Clayden, G. R. Coope, A. Cruickshanks, P. Dark, B. Demarchi, M. Greenwood, D. Kaufman, T. van Kolfschoten, H. Langford, S. Lewis, R. Markham, D. Mayhew, H. Roe, J. Rose, D. Schreve, R. Scott, K. Scott, C. Stringer, R. Waghorne, M. Warren and F. Wenban-Smith for providing some of the material analysed and general discussion. C. Helmsley and J. Todd released material from the Natural History Museum, London, for destructive analysis. R. Allen provided technical support. G. Peeters gave permission to reproduce images of Bithynia. The analyses were funded by English Heritage, NERC and the Wellcome Trust (grant GR076905MA). This is a contribution to the Ancient Human Occupation of Britain (AHOB) project funded by the Leverhulme Trust.	Ashton N, 2002, ANTIQUITY, V76, P388, DOI 10.1017/S0003598X00090505; Boreham S, 2010, P GEOLOGIST ASSOC, V121, P393, DOI 10.1016/j.pgeola.2010.02.003; Bowen D.Q., 1999, REVISED CORRELATION; BOWEN DQ, 1989, NATURE, V340, P49, DOI 10.1038/340049a0; Bridgland D, 2004, J QUATERNARY SCI, V19, P203, DOI 10.1002/jqs.819; Bridgland D.R., 1994, GEOLOGICAL CONSERVAT; Bridgland DR, 2006, P GEOLOGIST ASSOC, V117, P281, DOI 10.1016/S0016-7878(06)80036-2; Bridgland DR, 2006, J QUATERNARY SCI, V21, P437, DOI 10.1002/jqs.1042; Bridgland DR, 2010, J QUATERNARY SCI, V25, P433, DOI 10.1002/jqs.1383; Bridgland DR, 2000, QUATERNARY SCI REV, V19, P1293, DOI 10.1016/S0277-3791(99)00095-5; COOPE GR, 1975, J ANIM ECOL, V44, P365, DOI 10.2307/3603; Gibbard P., 1994, PLEISTOCENE HIST LOW; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Kaufman DS, 1998, QUATERNARY SCI REV, V17, P987, DOI 10.1016/S0277-3791(97)00086-3; Keen DH, 2001, QUATERNARY SCI REV, V20, P1657, DOI 10.1016/S0277-3791(01)00030-0; Lewis S. G., 2010, ANCIENT HUMAN OCCUPA, P125; Maddy D, 1998, J QUATERNARY SCI, V13, P205, DOI 10.1002/(SICI)1099-1417(199805/06)13:3<205::AID-JQS357>3.0.CO;2-N; MADDY D, 1991, J GEOL SOC LONDON, V148, P473, DOI 10.1144/gsjgs.148.3.0473; Meijer T, 2000, GEOL MIJNBOUW-N J G, V79, P241; MILLER GH, 1979, NATURE, V281, P539, DOI 10.1038/281539a0; Penkman KEH, 2007, QUATERNARY SCI REV, V26, P2958, DOI 10.1016/j.quascirev.2007.06.034; Penkman KEH, 2008, QUAT GEOCHRONOL, V3, P2, DOI 10.1016/j.quageo.2007.07.001; Penkman KEH, 2010, QUATERN INT, V228, P25, DOI 10.1016/j.quaint.2010.06.020; Preece RC, 2005, P GEOLOGIST ASSOC, V116, P363, DOI 10.1016/S0016-7878(05)80053-7; Preece RC, 2009, J QUATERNARY SCI, V24, P557, DOI 10.1002/jqs.1245; Schreve DC, 2001, QUATERNARY SCI REV, V20, P1693, DOI 10.1016/S0277-3791(01)00033-6; Sykes GA, 1995, ORG GEOCHEM, V23, P1059, DOI 10.1016/0146-6380(95)00086-0; von Koenigswald W., 1996, EARLY MIDDLE PLEISTO, P211; White M, 2003, CURR ANTHROPOL, V44, P598, DOI 10.1086/377653; White T., 2007, FOREST GENETICS	30	103	105	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					446	449		10.1038/nature10305	http://dx.doi.org/10.1038/nature10305			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21804567	Green Accepted, Green Submitted			2022-12-28	WOS:000294209400035
J	Shannon, MT				Shannon, Mary T.			Parallel Universe	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Narrat Connect Consulting, Dialogue & Discourse Med Setting, Portland, OR USA		Shannon, MT (corresponding author), Narrat Connect Consulting, Dialogue & Discourse Med Setting, Portland, OR USA.	marytshannon@comcast.net							0	0	0	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					686	687		10.1001/jama.2011.1128	http://dx.doi.org/10.1001/jama.2011.1128			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807LP	21846844				2022-12-28	WOS:000293900000001
J	Amon, JJ				Amon, Joseph J.			Hepatitis in drug users: time for attention, time for action	LANCET			English	Editorial Material									Human Rights Watch, Hlth & Human Rights Div, New York, NY 10118 USA		Amon, JJ (corresponding author), Human Rights Watch, Hlth & Human Rights Div, New York, NY 10118 USA.	amonj@hrw.org		Amon, Joseph/0000-0002-2455-6703				[Anonymous], WORLD DRUG REP 2011; Beyrer C, 2010, LANCET, V376, P208, DOI 10.1016/S0140-6736(10)61005-7; ELLIOT R, TREATMENT TORTURE AP; Global Commission on Drug Policy, WAR DRUGS REP GLOB C; Jurgens R, 2010, LANCET, V376, P475, DOI 10.1016/S0140-6736(10)60830-6; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Pisani E, 2010, LANCET, V376, P226, DOI 10.1016/S0140-6736(10)61132-4; *UN EC SOC COUNC, 5 UN EC SOC COUNC; United Nations, 2011, POL DECL HIV AIDS IN; WHO, 2011, WORLD CANC DAY; *WHO, 2011, WORLD AIDS DAY; World Health Organization, 2004, GLOB BURD DIS 2004 U; *WORLD STROK CAMP, 2011, WORLD STROK DAY	13	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 13	2011	378	9791					543	544		10.1016/S0140-6736(11)61132-X	http://dx.doi.org/10.1016/S0140-6736(11)61132-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812UX	21802133				2022-12-28	WOS:000294319500004
J	Gadagkar, R				Gadagkar, Raghavendra			Altruistic Wasps?	SCIENCE			English	Editorial Material							INCLUSIVE FITNESS THEORY; EUSOCIALITY; EVOLUTION		Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Gadagkar, R (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	ragh@ces.iisc.ernet.in	Gadagkar, Raghavendra/E-3944-2012	Gadagkar, Raghavendra/0000-0002-0328-9378				Abbot P, 2011, NATURE, V471, pE1, DOI [10.1038/nature09831, 10.1038/nature09835]; Boomsma JJ, 2011, NATURE, V471, pE4, DOI 10.1038/nature09832; Ferriere R, 2011, NATURE, V471, pE6, DOI 10.1038/nature09834; Gadagkar R, 2010, CURR SCI INDIA, V99, P1036; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Herre EA, 2011, NATURE, V471, pE8, DOI 10.1038/nature09835; Leadbeater E, 2011, SCIENCE, V333, P874, DOI 10.1126/science.1205140; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Queller DC, 2000, NATURE, V405, P784, DOI 10.1038/35015552; SHERMAN PW, 1977, SCIENCE, V197, P1246, DOI 10.1126/science.197.4310.1246; Strassmann JE, 2011, NATURE, V471, pE5, DOI 10.1038/nature09833	11	9	10	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					833	834		10.1126/science.1210420	http://dx.doi.org/10.1126/science.1210420			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836006				2022-12-28	WOS:000293785400028
J	McEwen, AS; Ojha, L; Dundas, CM; Mattson, SS; Byrne, S; Wray, JJ; Cull, SC; Murchie, SL; Thomas, N; Gulick, VC				McEwen, Alfred S.; Ojha, Lujendra; Dundas, Colin M.; Mattson, Sarah S.; Byrne, Shane; Wray, James J.; Cull, Selby C.; Murchie, Scott L.; Thomas, Nicolas; Gulick, Virginia C.			Seasonal Flows on Warm Martian Slopes	SCIENCE			English	Article							MARS; STABILITY; EVAPORATION; STREAKS; BRINES; WET	Water probably flowed across ancient Mars, but whether it ever exists as a liquid on the surface today remains debatable. Recurring slope lineae (RSL) are narrow (0.5 to 5 meters), relatively dark markings on steep (25 degrees to 40 degrees) slopes; repeat images from the Mars Reconnaissance Orbiter High Resolution Imaging Science Experiment show them to appear and incrementally grow during warm seasons and fade in cold seasons. They extend downslope from bedrock outcrops, often associated with small channels, and hundreds of them form in some rare locations. RSL appear and lengthen in the late southern spring and summer from 48 degrees S to 32 degrees S latitudes favoring equator-facing slopes, which are times and places with peak surface temperatures from similar to 250 to 300 kelvin. Liquid brines near the surface might explain this activity, but the exact mechanism and source of water are not understood.	[McEwen, Alfred S.; Ojha, Lujendra; Mattson, Sarah S.; Byrne, Shane] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Dundas, Colin M.] US Geol Survey, Flagstaff, AZ 86001 USA; [Wray, James J.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Cull, Selby C.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Murchie, Scott L.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Thomas, Nicolas] Univ Bern, Inst Phys, Bern, Switzerland; [Gulick, Virginia C.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Gulick, Virginia C.] SETI Inst, Moffett Field, CA 94035 USA	University of Arizona; United States Department of the Interior; United States Geological Survey; Cornell University; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Bern; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	McEwen, AS (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	mcewen@lpl.arizona.edu	Byrne, Shane/B-8104-2012; Wray, James J/B-8457-2008; Ojha, Lujendra/B-2805-2013; Murchie, Scott L/E-8030-2015; Thomas, Nicolas/G-4693-2015	Wray, James J/0000-0001-5559-2179; Murchie, Scott L/0000-0002-1616-8751; Thomas, Nicolas/0000-0002-0146-0071; Dundas, Colin/0000-0003-2343-7224	NASA	NASA(National Aeronautics & Space Administration (NASA))	This research was supported by NASA's MRO project; we thank them along with the reviewers. All original data reported in this paper are tabulated in the SOM and archived by NASA's Planetary Data System.	Altheide T, 2009, EARTH PLANET SC LETT, V282, P69, DOI 10.1016/j.epsl.2009.03.002; Baratoux D, 2006, ICARUS, V183, P30, DOI 10.1016/j.icarus.2006.01.023; BRASS GW, 1980, ICARUS, V42, P20, DOI 10.1016/0019-1035(80)90237-7; Christensen PR, 2004, SPACE SCI REV, V110, P85, DOI 10.1023/B:SPAC.0000021008.16305.94; CLARK BC, 1978, ICARUS, V34, P645, DOI 10.1016/0019-1035(78)90052-0; Cull SC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045269; Diniega S, 2010, GEOLOGY, V38, P1047, DOI 10.1130/G31287.1; Dundas CM, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041351; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Goldspiel JM, 2011, ICARUS, V211, P238, DOI 10.1016/j.icarus.2010.10.008; Hansen CJ, 2011, SCIENCE, V331, P575, DOI 10.1126/science.1197636; Hecht MH, 2009, SCIENCE, V325, P64, DOI 10.1126/science.1172466; Kereszturi A, 2010, ICARUS, V207, P149, DOI 10.1016/j.icarus.2009.10.012; King C. M., 2010, LUNAR PLANET SCI, V41, P1542; Kossacki KJ, 2010, ICARUS, V210, P83, DOI 10.1016/j.icarus.2010.06.029; Kreslavsky MA, 2009, ICARUS, V201, P517, DOI 10.1016/j.icarus.2009.01.026; Malin MC, 2006, SCIENCE, V314, P1573, DOI 10.1126/science.1135156; McEwen AS, 2010, ICARUS, V205, P2, DOI 10.1016/j.icarus.2009.04.023; Mellon MT, 2004, ICARUS, V169, P324, DOI 10.1016/j.icarus.2003.10.022; Mohlmann D, 2011, ICARUS, V212, P123, DOI 10.1016/j.icarus.2010.11.025; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; Osterloo MM, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003613; Renno NO, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003362; Sears DWG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023443; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Stoker CR, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003421; Ulrich R, 2010, ASTROBIOLOGY, V10, P643, DOI 10.1089/ast.2010.0472; Wray JJ, 2009, GEOLOGY, V37, P1043, DOI 10.1130/G30331A.1; Zhang H, 2006, APPL OPTICS, V45, P8753, DOI 10.1364/AO.45.008753; Zorzano MP, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040315	31	325	330	2	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					740	743		10.1126/science.1204816	http://dx.doi.org/10.1126/science.1204816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817049				2022-12-28	WOS:000293512100038
J	Park, KT; Wu, W; Battaile, KP; Lovell, S; Holyoak, T; Lutkenhaus, J				Park, Kyung-Tae; Wu, Wei; Battaile, Kevin P.; Lovell, Scott; Holyoak, Todd; Lutkenhaus, Joe			The Min Oscillator Uses MinD-Dependent Conformational Changes in MinE to Spatially Regulate Cytokinesis	CELL			English	Article							TOPOLOGICAL SPECIFICITY FACTOR; DIVISION SITE SELECTION; TO-POLE OSCILLATION; ESCHERICHIA-COLI; CELL-DIVISION; PROPER PLACEMENT; MEMBRANE INTERACTION; PATTERN-FORMATION; INHIBITOR MINC; DATA QUALITY	In E. coli, MinD recruits MinE to the membrane, leading to a coupled oscillation required for spatial regulation of the cytokinetic Z ring. How these proteins interact, however, is not clear because the MinD-binding regions of MinE are sequestered within a six-stranded beta sheet and masked by N-terminal helices. minE mutations that restore interaction between some MinD and MinE mutants were isolated. These mutations alter the MinE structure leading to release of the MinD-binding regions and the N-terminal helices that bind the membrane. Crystallization of MinD-MinE complexes revealed a four-stranded beta sheet MinE dimer with the released beta strands (MinD-binding regions) converted to alpha helices bound to MinD dimers. These results identify the MinD-dependent conformational changes in MinE that convert it from a latent to an active form and lead to a model of how MinE persists at the MinD-membrane surface.	[Park, Kyung-Tae; Wu, Wei; Lutkenhaus, Joe] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA; [Holyoak, Todd] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Battaile, Kevin P.] APS Argonne Natl Lab, Hauptman Woodward Med Res Inst, IMCA CAT, Sect 17, Argonne, IL 60439 USA; [Lovell, Scott] Univ Kansas, Struct Biol Ctr, Lawrence, KS 66047 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Hauptman Woodward Medical Research Institute; United States Department of Energy (DOE); Argonne National Laboratory; University of Kansas	Lutkenhaus, J (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA.	jlutkenh@kumc.edu		Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health [GM29764]; Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NIH, National Center for Research Resources [P20 RR-17708]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029764, R01GM029764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM29764 from the National Institutes of Health to J.L. We thank members of the lab for discussion and Alex Dajkovic for reading of the manuscript. Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Use of the KU COBRE Protein Structure Laboratory was supported by NIH Grant Number P20 RR-17708 from the National Center for Research Resources.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Arjunan Satya Nanda Vel, 2010, Syst Synth Biol, V4, P35, DOI 10.1007/s11693-009-9047-2; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Ghasriani H, 2010, P NATL ACAD SCI USA, V107, P18416, DOI 10.1073/pnas.1007141107; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 2003, J BACTERIOL, V185, P196, DOI 10.1128/JB.185.1.196-203.2003; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Ivanov V, 2010, P NATL ACAD SCI USA, V107, P8071, DOI 10.1073/pnas.0911036107; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kang GB, 2010, MOL MICROBIOL, V76, P1222, DOI 10.1111/j.1365-2958.2010.07160.x; King GF, 2000, NAT STRUCT BIOL, V7, P1013, DOI 10.1038/80917; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Ma LY, 2004, MOL MICROBIOL, V54, P99, DOI 10.1111/j.1365-2958.2004.04265.x; Ma LY, 2003, J BACTERIOL, V185, P4948, DOI 10.1128/JB.185.16.4948-4955.2003; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; PICHOFF S, 1995, MOL MICROBIOL, V18, P321, DOI 10.1111/j.1365-2958.1995.mmi_18020321.x; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Zhang Y, 1998, MOL MICROBIOL, V30, P265, DOI 10.1046/j.1365-2958.1998.01059.x; ZHAO CR, 1995, P NATL ACAD SCI USA, V92, P4313, DOI 10.1073/pnas.92.10.4313; Zhou HJ, 2005, J BACTERIOL, V187, P2846, DOI 10.1128/JB.187.8.2846-2857.2005	39	108	110	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					396	407		10.1016/j.cell.2011.06.042	http://dx.doi.org/10.1016/j.cell.2011.06.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816275	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000293570500014
J	Murphy, KM				Murphy, Kenneth M.			Comment on "Activation of beta-Catenin in Dendritic Cells Regulates Immunity Versus Tolerance in the Intestine"	SCIENCE			English	Editorial Material								Manicassamy et al. (Reports, 13 August 2010, p. 849) deleted beta-catenin in intestinal immune cells using a CD11c-driven Cre recombinase, which decreased anti-inflammatory mediators and increased inflammatory bowel disease. However, the deletion of beta-catenin in macrophages remains a caveat to their interpretation that Wnt signaling programs dendritic cells into a tolerogenic state. Development of strains expressing Cre in a more finely lineage-restricted pattern may help resolve this issue.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	kmurphy@wustl.edu			NIAID NIH HHS [U54 AI057157, R01 AI056499, U19 AI057266] Funding Source: Medline; NIDDK NIH HHS [R01 DK057665, R37 DK057665] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, R01AI056499, U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665, R01DK057665] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Domont J, 2010, BRIT J CANCER, V102, P1032, DOI 10.1038/sj.bjc.6605557; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x	6	12	12	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041								10.1126/science.1198277	http://dx.doi.org/10.1126/science.1198277			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	795FR	21778384				2022-12-28	WOS:000292959600024
J	Curfman, GD; Redberg, RF				Curfman, Gregory D.; Redberg, Rita F.			Medical Devices - Balancing Regulation and Innovation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*BRIT HIP SOC BRIT, 2011, UPD GUID LARG DIAM M; Centers for Disease Control and Prevention, 2009, NAT HOSP DISCH SURV; Challoner DR, 2011, NEW ENGL J MED, V365, P977, DOI 10.1056/NEJMp1109150; Institute of Medicine, 2011, MED DEV PUBL HLTH FD	4	94	98	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2011	365	11					975	977		10.1056/NEJMp1109094	http://dx.doi.org/10.1056/NEJMp1109094			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	819UR	21830959				2022-12-28	WOS:000294857300002
J	Mukherjee, S; Liu, XY; Arasaki, K; McDonough, J; Galan, JE; Roy, CR				Mukherjee, Shaeri; Liu, Xiaoyun; Arasaki, Kohei; McDonough, Justin; Galan, Jorge E.; Roy, Craig R.			Modulation of Rab GTPase function by a protein phosphocholine transferase	NATURE			English	Article							LEGIONELLA-PNEUMOPHILA; IDENTIFICATION; AMPYLATION; DOMAIN; DRRA; DISPLACEMENT	The intracellular pathogen Legionella pneumophila modulates the activity of host GTPases to direct the transport and assembly of the membrane-bound compartment in which it resides(1-6). In vitro studies have indicated that the Legionella protein DrrA post-translationally modifies the GTPase Rab1 by a process called AMPylation(7). Here we used mass spectrometry to investigate post-translational modifications to Rab1 that occur during infection of host cells by Legionella. Consistent with in vitro studies, DrrA-mediated AMPylation of a conserved tyrosine residue in the switch II region of Rab1 was detected during infection. In addition, a modification to an adjacent serine residue in Rab1 was discovered, which was independent of DrrA. The Legionella effector protein AnkX was required for this modification. Biochemical studies determined that AnkX directly mediates the covalent attachment of a phosphocholine moiety to Rab1. This phosphocholine transferase activity used CDP-choline as a substrate and required a conserved histidine residue located in the FIC domain of the AnkX protein. During infection, AnkX modified both Rab1 and Rab35, which explains how this protein modulates membrane transport through both the endocytic and exocytic pathways of the host cell. Thus, phosphocholination of Rab GTPases represents a mechanism by which bacterial FIC-domain-containing proteins can alter host-cell functions.	[Mukherjee, Shaeri; Liu, Xiaoyun; Arasaki, Kohei; McDonough, Justin; Galan, Jorge E.; Roy, Craig R.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Roy, CR (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	craig.roy@yale.edu		Roy, Craig/0000-0003-4490-440X	Anna Fuller Fellowship; National Institutes of Health (NIH) [F32 AI082927, R01-AI064559, R01-AI048770]; Northeast Biodefense Center [U54-AI057158-Lipkin]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI048770, R01AI064559, F32AI082927, R01AI041699] Funding Source: NIH RePORTER	Anna Fuller Fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Gulcicek and K. Stone at the Yale Keck Proteomic Facility for advice and providing the high-resolution MS/MS analysis, K. Reinish and X. Wu for providing purified connecdenn, L. Lucast and P. De Camilli for assistance with lipid analysis, X. Pan for assistance in constructing AnkX plasmids, A. Hubber for technical assistance and H. Newton for editorial assistance. This work was supported by an Anna Fuller Fellowship (S.M.), National Institutes of Health (NIH) Grants F32 AI082927 (J.M.), and NIH grants R01-AI064559, R01-AI048770 and Northeast Biodefense Center Grant U54-AI057158-Lipkin (C.R.R.).	Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Arasaki K, 2010, TRAFFIC, V11, P587, DOI 10.1111/j.1600-0854.2010.01050.x; BERGER KH, 1994, MOL MICROBIOL, V14, P809, DOI 10.1111/j.1365-2958.1994.tb01317.x; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; Grabitzki J, 2008, MOL BIOCHEM PARASIT, V161, P101, DOI 10.1016/j.molbiopara.2008.06.014; GROSS ML, 1994, J AM SOC MASS SPECTR, V5, P57, DOI 10.1016/1044-0305(94)85036-4; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Lovell TM, 2007, J MOL ENDOCRINOL, V39, P189, DOI 10.1677/JME-07-0007; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Suh HY, 2010, EMBO J, V29, P496, DOI 10.1038/emboj.2009.347; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yarbrough ML, 2009, NAT CHEM BIOL, V5, P378, DOI 10.1038/nchembio0609-378; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	27	219	233	3	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2011	477	7362					103	U122		10.1038/nature10335	http://dx.doi.org/10.1038/nature10335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21822290	Green Accepted, Green Submitted			2022-12-28	WOS:000294404300040
J	Hernandez, AF				Hernandez, Adrian F.			Review: Cardiac resynchronization reduces mortality and hospitalizations in patients with either more or less symptomatic HF	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Duke Univ, Durham, NC 27708 USA	Duke University	Hernandez, AF (corresponding author), Duke Univ, Durham, NC 27708 USA.		Ezekowitz, Justin A/C-4579-2013; Hernandez, Adrian F/A-7818-2016	Ezekowitz, Justin A/0000-0002-2724-4086; Hernandez, Adrian F/0000-0003-3387-9616				Al-Khatib SM, 2011, JAMA-J AM MED ASSOC, V305, P43, DOI 10.1001/jama.2010.1915; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Piccini JP, 2008, CIRCULATION, V118, P926, DOI 10.1161/CIRCULATIONAHA.108.773838	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4							JC2-7	10.7326/0003-4819-155-4-201108160-02007	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LM	21844540				2022-12-28	WOS:000208885100006
J	Vidan, MT; Sanchez, E; Gracia, Y; Maranon, E; Vaquero, J; Serra, JA				Vidan, Maria T.; Sanchez, Elisabet; Gracia, Yassira; Maranon, Eugenio; Vaquero, Javier; Serra, Jose A.			Causes and Effects of Surgical Delay in Patients With Hip Fracture A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PROXIMAL FEMORAL FRACTURES; TIME-TO-SURGERY; ELDERLY-PATIENTS; OPERATIVE DELAY; OLDER PATIENTS; MORTALITY; MORBIDITY; OUTCOMES; IMPACT; FEMUR	Background: The clinical effect of surgical delay in older patients with hip fracture is controversial. Discrepancies among study findings may be due to confounding that is caused by the reason for the delay or a differential effect on patient risk subgroups. Objective: To assess the effect of surgical delay on hospital outcomes according to the cause of delay. Design: Prospective cohort study. Setting: A hip fracture unit in a university hospital in Spain. Patients: 2250 consecutive elderly patients with hip fracture. Measurements: Time to surgery, reasons for surgical delay, adjusted in-hospital death, and risk for complications. Results: Median time to surgery was 72 hours. Lack of operating room availability (60.7%) and acute medical problems (33.1%) were the main reasons for delays longer than 48 hours. Overall, rates of hospital death and complications were 4.35% and 45.9%, respectively, but were 13.7% and 74.2% in clinically unstable patients. Longer delays were associated with higher mortality rates and rates of medical complications. After adjustment for age, dementia, chronic comorbid conditions, and functionality, this association did not persist for delays of 120 hours or less but did persist for delays longer than 120 hours (P = 0.002 for overall time effect on death and 0.002 for complications). The risks were attenuated after adjustment for the presence of acute medical conditions as the cause of the delay (P = 0.06 for time effect on mortality and 0.31 on medical complications). Risk for urinary tract infection remained elevated (odds ratio, 1.54 [95% CI, 0.99 to 2.44]). No interaction between delay and age, dementia, or functional status was found. Limitation: This was a single-center study without postdischarge follow-up. Conclusion: The reported association between late surgery and higher morbidity and mortality in patients with hip fracture is mostly explained by medical reasons for surgical delay, although some association between very delayed surgery and worse outcomes persists.	[Vidan, Maria T.] Hosp Gen Univ Gregorio Maranon, Dept Geriatr Med, Dr Esquerdo 46, Madrid 28007, Spain	General University Gregorio Maranon Hospital	Vidan, MT (corresponding author), Hosp Gen Univ Gregorio Maranon, Dept Geriatr Med, Dr Esquerdo 46, Madrid 28007, Spain.	mvidan.hgugm@salud.madrid.org		Serra Rexach, Jose A./0000-0003-1698-0624	Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III, Ministry of Science and Innovation, Spain [INT 09/078]	Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III, Ministry of Science and Innovation, Spain	Dr. Vidan was partially supported by a Program for research intensification grant of the Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III, Ministry of Science and Innovation, Spain (INT 09/078).	[Anonymous], 2010, SCOTTISH HIP FRACTUR; Bottle A, 2006, BMJ-BRIT MED J, V332, P947, DOI 10.1136/bmj.38790.468519.55; Elliott J, 2003, J CLIN EPIDEMIOL, V56, P788, DOI 10.1016/S0895-4356(03)00129-X; Fleisher Lee A, 2009, Cleve Clin J Med, V76 Suppl 4, pS9, DOI 10.3949/ccjm.76.s4.02; Franzo A, 2006, BRIT MED J, V332, P1093, DOI 10.1136/bmj.332.7549.1093-a; Friedman SM, 2009, ARCH INTERN MED, V169, P1712, DOI 10.1001/archinternmed.2009.321; Gdalevich M, 2004, ARCH ORTHOP TRAUM SU, V124, P334, DOI 10.1007/s00402-004-0662-9; Grimes JP, 2002, AM J MED, V112, P702, DOI 10.1016/S0002-9343(02)01119-1; Hamlet W P, 1997, Am J Orthop (Belle Mead NJ), V26, P621; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Khan SK, 2009, INJURY, V40, P692, DOI 10.1016/j.injury.2009.01.010; Lyons AR, 1997, AM J MED, V103, P51; Majumdar SR, 2006, MED CARE, V44, P552, DOI 10.1097/01.mlr.0000215812.13720.2e; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; New Zealand Guidelines Group, 2003, AC MAN IMM REH HIP F, pa; Novack V, 2007, INT J QUAL HEALTH C, V19, P170, DOI 10.1093/intqhc/mzm003; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; Orosz GM, 2002, J AM GERIATR SOC, V50, P1336, DOI 10.1046/j.1532-5415.2002.50353.x; PARKER MJ, 1992, J BONE JOINT SURG BR, V74, P203, DOI 10.1302/0301-620X.74B2.1544952; PEREZ JV, 1995, INJURY, V26, P237, DOI 10.1016/0020-1383(95)90008-L; Rae HC, 2007, ANZ J SURG, V77, P889, DOI 10.1111/j.1445-2197.2007.04267.x; ROGERS FB, 1995, J TRAUMA, V39, P261, DOI 10.1097/00005373-199508000-00012; Scottish Intercollegiate Guidelines Network, 2009, MAN HIP FRACT OLD PA; Siegmeth AW, 2005, J BONE JOINT SURG BR, V87B, P1123, DOI 10.1302/0301-620X.87B8; Simunovic N, 2010, CAN MED ASSOC J, V182, P1609, DOI 10.1503/cmaj.092220; Smektala R, 2000, ZBL CHIR, V125, P744, DOI 10.1055/s-2000-10657; Smektala R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-171; Soderqvist A, 2009, GERONTOLOGY, V55, P496, DOI 10.1159/000230587; Vidan M, 2005, J AM GERIATR SOC, V53, P1476, DOI 10.1111/j.1532-5415.2005.53466.x; Weller I, 2005, J BONE JOINT SURG BR, V87B, P361, DOI 10.1302/0301-620X.87B3.15300; Zuckerman JD, 1996, NEW ENGL J MED, V334, P1519, DOI 10.1056/NEJM199606063342307; ZUCKERMAN JD, 1995, J BONE JOINT SURG AM, V77, P1551, DOI 10.2106/00004623-199510000-00010	34	132	141	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4					226	+		10.7326/0003-4819-155-4-201108160-00006	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	807KN	21844548				2022-12-28	WOS:000293896400003
J	Preiswerk, B; Allemann, IB; Maggiorini, M; Muller, V				Preiswerk, Benjamin; Allemann, Inja B.; Maggiorini, Marco; Mueller, Veronique			From a pimple to a crater	LANCET			English	Editorial Material							PYODERMA-GANGRENOSUM		[Preiswerk, Benjamin; Maggiorini, Marco; Mueller, Veronique] Univ Zurich Hosp, Med Intens Care Unit, CH-8091 Zurich, Switzerland; [Allemann, Inja B.] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Preiswerk, B (corresponding author), Univ Spital, Zurich Klin Infekt Krankheiten & Spitalhyg, Ramistr 100, CH-8091 Zurich, Switzerland.	benjamin.preiswerk@usz.ch		Maggiorini, Marco/0000-0001-8180-2117				Brooklyn T, 2006, BRIT MED J, V333, P181, DOI 10.1136/bmj.333.7560.181; Crowson AN, 2003, J CUTAN PATHOL, V30, P97; MAVERAKIS E, 2011, CLIN REV ALLERGY IMM; Weenig RH, 2002, NEW ENGL J MED, V347, P1412, DOI 10.1056/NEJMoa013383; Wong Chin-Ho, 2005, Curr Opin Infect Dis, V18, P101, DOI 10.1097/01.qco.0000160896.74492.ea	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 13	2011	378	9791					636	636		10.1016/S0140-6736(11)60826-X	http://dx.doi.org/10.1016/S0140-6736(11)60826-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812UX	21840461				2022-12-28	WOS:000294319500036
J	Ma, ZQ				Ma, Zhenqiang			An Electronic Second Skin	SCIENCE			English	Editorial Material							THIN-FILM TRANSISTORS; ARTIFICIAL SKIN; MATRIX		Univ Wisconsin, Dept Elect & Comp Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Ma, ZQ (corresponding author), Univ Wisconsin, Dept Elect & Comp Engn, 1415 Johnson Dr, Madison, WI 53706 USA.	mazq@engr.wisc.edu						Fan ZY, 2008, NANO LETT, V8, P20, DOI 10.1021/nl071626r; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/NMAT2834, 10.1038/nmat2834]; Menard E, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866637; Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101; Sun L, 2010, SMALL, V6, P2553, DOI 10.1002/smll.201000522; Takei K, 2010, NAT MATER, V9, P821, DOI [10.1038/nmat2835, 10.1038/NMAT2835]	7	62	67	4	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					830	831		10.1126/science.1209094	http://dx.doi.org/10.1126/science.1209094			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836004				2022-12-28	WOS:000293785400026
J	Berkowitz, SA; Miller, ED				Berkowitz, Scott A.; Miller, Edward D.			The Individual Mandate and Patient-Centered Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Berkowitz, Scott A.] Johns Hopkins Univ, Sch Med, Billings Adm, Dept Med, Baltimore, MD 21287 USA	Johns Hopkins University	Berkowitz, SA (corresponding author), Johns Hopkins Univ, Sch Med, Billings Adm, Dept Med, 600 N Wolfe St,Room 327A, Baltimore, MD 21287 USA.	sberkow3@jhmi.edu						Atlas SJ, 2009, ANN INTERN MED, V150, P325, DOI 10.7326/0003-4819-150-5-200903030-00008; Chandra A, 2011, NEW ENGL J MED, V364, P293, DOI 10.1056/NEJMp1013067; Congressional Budget Office, EFF EL IND MAND OBT; Department of Health and Human Services, ASPE RES BRIEF VAL H; Families USA, HIDD HLTH TAX AM PAY; Galvin DM, 2007, J PUBLIC HEALTH POL, V28, P102, DOI 10.1057/palgrave.jphp.3200105; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012; Oberlander J, 2011, NEW ENGL J MED, V364, P1085, DOI 10.1056/NEJMp1101240; RAND Compare, AN IND MAND; The Commonwealth Fund, INS COV REC PREV CAR	10	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2011	306	6					648	649		10.1001/jama.2011.1137	http://dx.doi.org/10.1001/jama.2011.1137			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804XD	21828328				2022-12-28	WOS:000293687300028
J	Hawkes, N				Hawkes, Nigel			WORLD HEALTH ORGANIZATION "Irrelevant" WHO outpaced by younger rivals	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Bloom BR, 2011, NATURE, V473, P143, DOI 10.1038/473143a; Chow J., 2010, IS WHO BECOMING IRRE; Institute for Health Metrics and Evaluation, 2010, FIN GLOB HLTH 2010	3	14	14	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2011	343								d5012	10.1136/bmj.d5012	http://dx.doi.org/10.1136/bmj.d5012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808CX	21828204				2022-12-28	WOS:000293954000005
J	Marx, CJ				Marx, Christopher J.			Regulatory Revolution: Evolving the "Anti-LacI" Repressor	CELL			English	Editorial Material							BENEFICIAL MUTATIONS; ADAPTATION; EVOLUTION; EPISTASIS	Much of adaptation is based upon changes in gene expression, but the emergence of new regulatory logic has not been observed directly. Now, Poelwijk et al. report evolving the lac repressor (LacI) to reverse its regulatory logic, resulting in an "anti-LacI" that represses transcription when bound to its "inducer."	[Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Marx, Christopher J.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	cmarx@oeb.harvard.edu			NIGMS NIH HHS [R01 GM078209-01A1, R01 GM078209] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078209] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Mallarino R, 2011, P NATL ACAD SCI USA, V108, P4057, DOI 10.1073/pnas.1011480108; Poelwijk FJ, 2011, CELL, V146, P462, DOI 10.1016/j.cell.2011.06.035; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539	10	3	3	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 5	2011	146	3					350	352		10.1016/j.cell.2011.07.015	http://dx.doi.org/10.1016/j.cell.2011.07.015			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816271	Bronze, Green Accepted			2022-12-28	WOS:000293570500009
J	von Kleist, L; Stahlschmidt, W; Bulut, H; Gromova, K; Puchkov, D; Robertson, MJ; MacGregor, KA; Tomlin, N; Pechstein, A; Chau, N; Chircop, M; Sakoff, J; von Kries, JP; Saenger, W; Krausslich, HG; Shupliakov, O; Robinson, PJ; McCluskey, A; Haucke, V				von Kleist, Lisa; Stahlschmidt, Wiebke; Bulut, Haydar; Gromova, Kira; Puchkov, Dmytro; Robertson, Mark J.; MacGregor, Kylie A.; Tomlin, Nikolay; Pechstein, Arndt; Ngoc Chau; Chircop, Megan; Sakoff, Jennette; von Kries, Jens Peter; Saenger, Wolfram; Kraeusslich, Hans-Georg; Shupliakov, Oleg; Robinson, Phillip J.; McCluskey, Adam; Haucke, Volker			Role of the Clathrin Terminal Domain in Regulating Coated Pit Dynamics Revealed by Small Molecule Inhibition	CELL			English	Article							MEDIATED ENDOCYTOSIS; PROTEINS; CELLS; ENTRY; ENDOSOMES; BIOLOGY; ACTIN; SITES	Clathrin-mediated endocytosis (CME) regulates many cell physiological processes such as the internalization of growth factors and receptors, entry of pathogens, and synaptic transmission. Within the endocytic network, clathrin functions as a central organizing platform for coated pit assembly and dissociation via its terminal domain (TD). We report the design and synthesis of two compounds named pitstops that selectively block endocytic ligand association with the clathrin TD as confirmed by X-ray crystallography. Pitstop-induced inhibition of clathrin TD function acutely interferes with receptor-mediated endocytosis, entry of HIV, and synaptic vesicle recycling. Endocytosis inhibition is caused by a dramatic increase in the lifetimes of clathrin coat components, including FCHo, clathrin, and dynamin, suggesting that the clathrin TD regulates coated pit dynamics. Pitstops provide new tools to address clathrin function in cell physiology with potential applications as inhibitors of virus and pathogen entry and as modulators of cell signaling.	[von Kleist, Lisa; Stahlschmidt, Wiebke; Bulut, Haydar; Gromova, Kira; Puchkov, Dmytro; Pechstein, Arndt; Saenger, Wolfram; Haucke, Volker] Free Univ Berlin, Inst Chem & Biochem & Neurocure Cluster Excellenc, D-14195 Berlin, Germany; [Robertson, Mark J.; MacGregor, Kylie A.; McCluskey, Adam] Univ Newcastle, Ctr Chem Biol, Callaghan, NSW 2308, Australia; [Tomlin, Nikolay; Pechstein, Arndt; Shupliakov, Oleg] Karolinska Inst, DBRM, Dept Neurosci, S-17117 Stockholm, Sweden; [Ngoc Chau; Chircop, Megan; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Sydney, NSW 2145, Australia; [Sakoff, Jennette] Calvary Mater Newcastle Hosp, Dept Med Oncol, Waratah, NSW 2298, Australia; [von Kries, Jens Peter; Haucke, Volker] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Kraeusslich, Hans-Georg] Heidelberg Univ, Dept Infect Dis, D-69120 Heidelberg, Germany	Free University of Berlin; University of Newcastle; Karolinska Institutet; Children's Medical Research Institute - Australia; University of Sydney; Calvary Mater Newcastle Hospital; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Ruprecht Karls University Heidelberg	Haucke, V (corresponding author), Free Univ Berlin, Inst Chem & Biochem & Neurocure Cluster Excellenc, D-14195 Berlin, Germany.	volker.haucke@fu-berlin.de	Shupliakov, Oleg/R-9148-2016; Robinson, Phillip J/G-4008-2011; Robertson, Mark/E-9173-2014; McCluskey, Adam/F-1894-2011; Tomilin, Nikolay V/B-4676-2014; Sakoff, Jennette/AAU-6469-2021	Shupliakov, Oleg/0000-0001-5352-6848; Robinson, Phillip J/0000-0002-7878-0313; Robertson, Mark/0000-0002-2140-2717; McCluskey, Adam/0000-0001-7125-863X; Tomilin, Nikolay V/0000-0002-5581-3848; Sakoff, Jennette/0000-0002-7009-5792; Haucke, Volker/0000-0003-3119-6993; Puchkov, Dmytro/0000-0001-8341-4847; von Kleist, Lisa/0000-0001-9938-6510	Deutsche Forschungsgemeinschaft [FOR 806-HA2686/3-1, FOR 806-HA2686/3-2, SFB765/B4, Exc-257]; European Science Foundation [Euromembrane-HA2686/6-1]; Swedish Research Council [13473, 20587]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Science Foundation(European Science Foundation (ESF)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank Drs. Gilbert Di Paolo, Ludger Johannes, and Oliver Daumke for critical comments and Drs. Harvey Mc Mahon, Ludger Johannes, Pietro De Camilli, Tom Sudhof, and Sven Carlsson for reagents. Cytotoxicity assays were conducted with help from Aimee Novelle, Swetha Perera, and Dr. Jayne Gilbert. This work was supported by grants from the Deutsche Forschungsgemeinschaft (FOR 806-HA2686/3-1,3-2; SFB765/B4 to V. H.; Exc-257), the European Science Foundation (Euromembrane-HA2686/6-1), and the Swedish Research Council (grants 13473 and 20587 to O.S.).	Bhattacharyya S, 2010, VIROLOGY, V401, P18, DOI 10.1016/j.virol.2010.02.015; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Heerssen H, 2008, CURR BIOL, V18, P401, DOI 10.1016/j.cub.2008.02.055; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103; Hirst J, 2009, TRAFFIC, V10, P1696, DOI 10.1111/j.1600-0854.2009.00983.x; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Joshi S, 2010, MOL CANCER THER, V9, P1995, DOI 10.1158/1535-7163.MCT-10-0161; Knuehl C, 2006, TRAFFIC, V7, P1688, DOI 10.1111/j.1600-0854.2006.00499.x; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mettlen M, 2009, MOL BIOL CELL, V20, P3251, DOI 10.1091/mbc.E09-03-0256; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Pechstein A, 2010, P NATL ACAD SCI USA, V107, P4206, DOI 10.1073/pnas.0911073107; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001	33	361	369	3	77	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					471	484		10.1016/j.cell.2011.06.025	http://dx.doi.org/10.1016/j.cell.2011.06.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816279	Bronze			2022-12-28	WOS:000293570500020
J	Ye, JQ; Maniatis, T				Ye, Junqiang; Maniatis, Tom			A Prion-like Trigger of Antiviral Signaling	CELL			English	Editorial Material							LONG-TERM FACILITATION; NF-KAPPA-B; ACTIVATION; PROTEIN; APLYSIA; CPEB; IRF3	The MAVS protein plays a critical role in the assembly of an antiviral signaling complex on mitochondrial membranes. Hou et al. (2011) now report that virus infection induces a conformational change in MAVS, leading to the prion-like formation of functional self-aggregates that provide a sensitive trigger for antiviral signaling.	[Ye, Junqiang; Maniatis, Tom] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Maniatis, Tom] Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Harvard University; Columbia University	Maniatis, T (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	tm2472@mail.cumc.columbia.edu		Ye, Junqiang/0000-0002-4529-0713	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020642] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI020642, R01 AI020642-27] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Fiumara F, 2010, CELL, V143, P1121, DOI 10.1016/j.cell.2010.11.042; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037	10	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 5	2011	146	3					348	350		10.1016/j.cell.2011.07.018	http://dx.doi.org/10.1016/j.cell.2011.07.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816270	Bronze, Green Accepted			2022-12-28	WOS:000293570500008
J	Muir, G; Thacker, J				Muir, Graeme; Thacker, Justin			Should UK membership exams be held overseas? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							GLOBAL CODE; LIGHT		[Muir, Graeme; Thacker, Justin] Royal Coll Paediat & Child Hlth, London, England		Muir, G (corresponding author), Royal Coll Paediat & Child Hlth, London, England.	Graeme.Muir@rcpch.ac.uk						Crisp N., 2007, GLOBAL HLTH PARTNERS; Ferrinho P, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-9; George Jyothis T, 2007, Hum Resour Health, V5, P6, DOI 10.1186/1478-4491-5-6; Koplan JP, 2009, LANCET, V373, P1993, DOI 10.1016/S0140-6736(09)60332-9; Mandeville K, 2010, LANCET, V376, P594, DOI 10.1016/S0140-6736(10)61298-6; Newell SJ, 2010, LANCET, V376, P1541, DOI 10.1016/S0140-6736(10)61930-7; NHS and Department of Health, FRAM NHS INV INT DEV; Oman KM, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-9; PARIS DECLARATION AI	9	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2011	343								d4566	10.1136/bmj.d4566	http://dx.doi.org/10.1136/bmj.d4566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801LT	21798972				2022-12-28	WOS:000293441100005
J	Nath, D; Shadan, S				Nath, Deepa; Shadan, Sadaf			DYNAMICS OF THE CELL	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					307	307		10.1038/475307a	http://dx.doi.org/10.1038/475307a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21776075	Bronze			2022-12-28	WOS:000292911200030
J	He, FJ; MacGregor, GA				He, Feng J.; MacGregor, Graham A.			Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials	LANCET			English	Editorial Material							DIETARY SALT; DISEASE; PREVENTION		[He, Feng J.; MacGregor, Graham A.] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London EC1M 6BQ, England	University of London; Queen Mary University London	MacGregor, GA (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London EC1M 6BQ, England.	g.macgregor@qmul.ac.uk	He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744; He, Feng/0000-0003-2807-4119				[Anonymous], 2011, DAILY EXPRESS   0706; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Food Standards Agency, 2008, DIET SOD LEV SURV; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; LAW MR, 1991, BMJ-BRIT MED J, V302, P811, DOI 10.1136/bmj.302.6780.811; National Institute for Health and Clinical Excellence, 2010, GUID PREV CARD DIS P; Paterna S, 2008, CLIN SCI, V114, P221, DOI 10.1042/CS20070193; Strazzullo Pasquale, 2009, BMJ, V339, pb4567, DOI 10.1136/bmj.b4567; Taylor RS, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003331.pub4; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115	12	258	272	2	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					380	382		10.1016/S0140-6736(11)61174-4	http://dx.doi.org/10.1016/S0140-6736(11)61174-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21803192				2022-12-28	WOS:000293615900007
J	Aeschlimann, M; Brixner, T; Fischer, A; Kramer, C; Melchior, P; Pfeiffer, W; Schneider, C; Struber, C; Tuchscherer, P; Voronine, DV				Aeschlimann, Martin; Brixner, Tobias; Fischer, Alexander; Kramer, Christian; Melchior, Pascal; Pfeiffer, Walter; Schneider, Christian; Strueber, Christian; Tuchscherer, Philip; Voronine, Dmitri V.			Coherent Two-Dimensional Nanoscopy	SCIENCE			English	Article							2-PHOTON PHOTOEMISSION; SPECTROSCOPY; NANOSTRUCTURES; LIMIT	We introduce a spectroscopic method that determines nonlinear quantum mechanical response functions beyond the optical diffraction limit and allows direct imaging of nanoscale coherence. In established coherent two-dimensional (2D) spectroscopy, four-wave-mixing responses are measured using three ingoing waves and one outgoing wave; thus, the method is diffraction-limited in spatial resolution. In coherent 2D nanoscopy, we use four ingoing waves and detect the final state via photoemission electron microscopy, which has 50-nanometer spatial resolution. We recorded local nanospectra from a corrugated silver surface and observed subwavelength 2D line shape variations. Plasmonic phase coherence of localized excitations persisted for about 100 femtoseconds and exhibited coherent beats. The observations are best explained by a model in which coupled oscillators lead to Fano-like resonances in the hybridized dark-and bright-mode response.	[Brixner, Tobias; Kramer, Christian; Tuchscherer, Philip] Univ Wurzburg, Inst Phys & Theoret Chem, D-97074 Wurzburg, Germany; [Aeschlimann, Martin; Fischer, Alexander; Melchior, Pascal; Schneider, Christian] Tech Univ Kaiserslautern, Fachbereich Phys, D-67663 Kaiserslautern, Germany; [Aeschlimann, Martin; Fischer, Alexander; Melchior, Pascal; Schneider, Christian] Tech Univ Kaiserslautern, Res Ctr OPTIMAS, D-67663 Kaiserslautern, Germany; [Brixner, Tobias] Rontgen Res Ctr Complex Mat Syst, D-97074 Wurzburg, Germany; [Pfeiffer, Walter; Strueber, Christian; Voronine, Dmitri V.] Univ Bielefeld, Fak Phys, D-33615 Bielefeld, Germany	University of Wurzburg; University of Kaiserslautern; University of Kaiserslautern; University of Bielefeld	Brixner, T (corresponding author), Univ Wurzburg, Inst Phys & Theoret Chem, D-97074 Wurzburg, Germany.	brixner@phys-chemie.uni-wuerzburg.de	Brixner, Tobias/S-1451-2016; Aeschlimann, Martin/D-7141-2011; Pfeiffer, Walter/A-6378-2012	Brixner, Tobias/0000-0002-6529-704X; Aeschlimann, Martin/0000-0003-3413-5029; 	Deutsche Forschungsgemeinschaft [SPP 1391]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	All authors of this work are listed in alphabetical order. Supported by the Deutsche Forschungsgemeinschaft Priority Program "Ultrafast Nano-Optics" (SPP 1391). We thank B. Hecht for providing a nanostructured gold sample used for determining spatial resolution (14).	AESCHLIMANN M, 1995, J CHEM PHYS, V102, P8606, DOI 10.1063/1.468962; [Anonymous], 1999, PRINCIPLES NONLINEAR; Brixner T, 2001, OPT LETT, V26, P557, DOI 10.1364/OL.26.000557; Cho MH, 2008, CHEM REV, V108, P1331, DOI 10.1021/cr078377b; Guenther T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.057401; Hanke T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.257404; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Jonas DM, 2003, ANNU REV PHYS CHEM, V54, P425, DOI 10.1146/annurev.physchem.54.011002.103907; Kasprzak J, 2011, NAT PHOTONICS, V5, P57, DOI 10.1038/NPHOTON.2010.284; Liu N, 2009, NAT MATER, V8, P758, DOI [10.1038/NMAT2495, 10.1038/nmat2495]; Luk'yanchuk B, 2010, NAT MATER, V9, P707, DOI [10.1038/NMAT2810, 10.1038/nmat2810]; Mukamel S, 2000, ANNU REV PHYS CHEM, V51, P691, DOI 10.1146/annurev.physchem.51.1.691; Murray WA, 2007, ADV MATER, V19, P3771, DOI 10.1002/adma.200700678; Nilius N, 2000, PHYS REV LETT, V84, P3994, DOI 10.1103/PhysRevLett.84.3994; Novotny L., 2012, PRINCIPLES NANOOPTIC; Prodan E, 2003, SCIENCE, V302, P419, DOI 10.1126/science.1089171; Raether H., 1988, SURFACE PLASMONS SMO, P4; Rahav S, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.063810; Ropers C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.113901; Schmidt O, 2002, APPL PHYS B-LASERS O, V74, P223, DOI 10.1007/s003400200803; Shim SH, 2007, P NATL ACAD SCI USA, V104, P14197, DOI 10.1073/pnas.0700804104; Tekavec PF, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2800560; Tian PF, 2003, SCIENCE, V300, P1553, DOI 10.1126/science.1083433; Timm C, 2004, J PHYS-CONDENS MAT, V16, P661, DOI 10.1088/0953-8984/16/4/015; Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614; Word RC, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3457921; Zhang S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047401	29	174	175	2	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2011	333	6050					1723	1726		10.1126/science.1209206	http://dx.doi.org/10.1126/science.1209206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21835982				2022-12-28	WOS:000295121500035
J	Murtagh, L; Miller, M				Murtagh, Lindsey; Miller, Matthew			Censorship of the Patient-Physician Relationship A New Florida Law	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Murtagh, Lindsey; Miller, Matthew] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Miller, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mmiller@hsph.harvard.edu	miller, matthew/GQH-4858-2022; miller, matthew/H-4624-2011	miller, matthew/0000-0002-3267-6510				Albright TL, 2003, J AM BOARD FAM PRACT, V16, P40, DOI 10.3122/jabfm.16.1.40; Grossman DC, 2005, JAMA-J AM MED ASSOC, V293, P707, DOI 10.1001/jama.293.6.707; HEMENWAY D, AM J LIFESTYLE MED, DOI DOI 10.1177/1559827610396294; Vernick JS, 2006, PEDIATRICS, V118, P2168, DOI 10.1542/peds.2006-1120	4	11	11	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1131	1132		10.1001/jama.2011.1235	http://dx.doi.org/10.1001/jama.2011.1235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819DS	21835978				2022-12-28	WOS:000294806200028
J	Alexander, JH; Lopes, RD; James, S; Kilaru, R; He, YH; Mohan, P; Bhatt, DL; Goodman, S; Verheugt, FW; Flather, M; Huber, K; Liaw, D; Husted, SE; Lopez-Sendon, J; De Caterina, R; Jansky, P; Darius, H; Vinereanu, D; Cornel, JH; Cools, F; Atar, D; Leiva-Pons, JL; Keltai, M; Ogawa, H; Pais, P; Parkhomenko, A; Ruzyllo, W; Diaz, R; White, H; Ruda, M; Geraldes, M; Lawrence, J; Harrington, RA; Wallentin, L				Alexander, John H.; Lopes, Renato D.; James, Stefan; Kilaru, Rakhi; He, Yaohua; Mohan, Puneet; Bhatt, Deepak L.; Goodman, Shaun; Verheugt, Freek W.; Flather, Marcus; Huber, Kurt; Liaw, Danny; Husted, Steen E.; Lopez-Sendon, Jose; De Caterina, Raffaele; Jansky, Petr; Darius, Harald; Vinereanu, Dragos; Cornel, Jan H.; Cools, Frank; Atar, Dan; Luis Leiva-Pons, Jose; Keltai, Matyas; Ogawa, Hisao; Pais, Prem; Parkhomenko, Alexander; Ruzyllo, Witold; Diaz, Rafael; White, Harvey; Ruda, Mikhail; Geraldes, Margarida; Lawrence, Jack; Harrington, Robert A.; Wallentin, Lars		APPRAISE-2 Investigators	Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR XA INHIBITOR; HIGH-RISK PATIENTS; MYOCARDIAL-INFARCTION; DOUBLE-BLIND; ASPIRIN; CLOPIDOGREL; WARFARIN; THROMBOPROPHYLAXIS; ENOXAPARIN; INTERVENTION	Background Apixaban, an oral, direct factor Xa inhibitor, may reduce the risk of recurrent ischemic events when added to antiplatelet therapy after an acute coronary syndrome. Methods We conducted a randomized, double-blind, placebo-controlled clinical trial comparing apixaban, at a dose of 5 mg twice daily, with placebo, in addition to standard antiplatelet therapy, in patients with a recent acute coronary syndrome and at least two additional risk factors for recurrent ischemic events. Results The trial was terminated prematurely after recruitment of 7392 patients because of an increase in major bleeding events with apixaban in the absence of a counterbalancing reduction in recurrent ischemic events. With a median follow-up of 241 days, the primary outcome of cardiovascular death, myocardial infarction, or ischemic stroke occurred in 279 of the 3705 patients (7.5%) assigned to apixaban (13.2 events per 100 patient-years) and in 293 of the 3687 patients (7.9%) assigned to placebo (14.0 events per 100 patient-years) (hazard ratio with apixaban, 0.95; 95% confidence interval [CI], 0.80 to 1.11; P = 0.51). The primary safety outcome of major bleeding according to the Thrombolysis in Myocardial Infarction (TIMI) definition occurred in 46 of the 3673 patients (1.3%) who received at least one dose of apixaban (2.4 events per 100 patient-years) and in 18 of the 3642 patients (0.5%) who received at least one dose of placebo (0.9 events per 100 patient-years) (hazard ratio with apixaban, 2.59; 95% CI, 1.50 to 4.46; P = 0.001). A greater number of intracranial and fatal bleeding events occurred with apixaban than with placebo. Conclusions The addition of apixaban, at a dose of 5 mg twice daily, to antiplatelet therapy in high-risk patients after an acute coronary syndrome increased the number of major bleeding events without a significant reduction in recurrent ischemic events. (Funded by BristolMyers Squibb and Pfizer; APPRAISE-2 ClinicalTrials. gov number, NCT00831441.)	[Alexander, John H.; Lopes, Renato D.; Kilaru, Rakhi; Harrington, Robert A.] Duke Univ, Duke Clin Res Inst, Med Ctr, Durham, NC 27715 USA; [James, Stefan; Wallentin, Lars] Uppsala Clin Res Ctr, Uppsala, Sweden; [He, Yaohua; Mohan, Puneet; Liaw, Danny; Geraldes, Margarida; Lawrence, Jack] Bristol Myers Squibb Co, Princeton, NJ USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Bhatt, Deepak L.] Vet Affairs Boston Healthcare Syst, Boston, MA USA; [Goodman, Shaun] Canadian Heart Res Ctr, Toronto, ON, Canada; [Verheugt, Freek W.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Flather, Marcus] Royal Brompton Hosp, Clin Trials & Evaluat Unit, London, England; [Huber, Kurt] Wilhelminenspital Stadt Wien, Vienna, Austria; [Husted, Steen E.] Aarhus Univ Hosp, Dept Cardiol & Med A, Aarhus Amtssygehus, DK-8000 Aarhus, Denmark; [Lopez-Sendon, Jose] Hosp Univ La Paz, Madrid, Spain; [De Caterina, Raffaele] Univ G DAnnunzio, Inst Cardiol, Chieti, Italy; [De Caterina, Raffaele] Univ G DAnnunzio, Univ Cardiol Div, Chieti, Italy; [Jansky, Petr] Motol Univ Hosp, Prague, Czech Republic; [Darius, Harald] Neukoelln Med Ctr, Berlin, Germany; [Vinereanu, Dragos] Univ Hosp Bucharest, Bucharest, Romania; [Cornel, Jan H.] Med Ctr Alkmaar, Alkmaar, Netherlands; [Cools, Frank] Acad Ziekenhuis Klina, Brasschaat, Belgium; [Atar, Dan] Oslo Univ Hosp, Oslo, Norway; [Luis Leiva-Pons, Jose] Hosp Cent Dr Ignacio Morones Prieto, San Luis Potosi, Mexico; [Keltai, Matyas] Hungarian Inst Cardiol, Budapest, Hungary; [Ogawa, Hisao] Kumamoto Univ, Kumamoto, Japan; [Pais, Prem] St Johns Med Coll, Bangalore, Karnataka, India; [Parkhomenko, Alexander] Inst Cardiol, Kiev, Ukraine; [Ruzyllo, Witold] Inst Cardiol, Warsaw, Poland; [Diaz, Rafael] ECLA Estudios Cardiol Latinoamer, Rosario, Santa Fe, Argentina; [White, Harvey] Auckland City Hosp, Green Lane Cardiovasc Res Unit, Auckland, New Zealand; [Ruda, Mikhail] Cardiol Res Ctr, Moscow, Russia; [Flather, Marcus] Harefield NHS Fdn Trust, London, England	Duke University; Uppsala University; Bristol-Myers Squibb; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Canadian Heart Research Centre; University of Toronto; Onze Lieve Vrouwe Gasthuis Hospital; Royal Brompton Hospital; Wilhelminenspital; Aarhus University; Hospital Universitario La Paz; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Motol University Hospital; Medical Center Of Alkmaar; University of Oslo; Hospital Central Dr. Ignacio Morones Prieto; Kumamoto University; St. John's National Academy of Health Sciences; St. John's Medical College; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; Institute of Cardiology - Poland; Auckland City Hospital; National Medical Research Center of Cardiology; Royal Brompton & Harefield NHS Foundation Trust	Alexander, JH (corresponding author), Duke Univ, Duke Clin Res Inst, Med Ctr, DUMC Box 3850, Durham, NC 27715 USA.	john.h.alexander@duke.edu	Leonardi, Sergio/K-4334-2018; Zadionchenko, Vladimir/A-7445-2016; De Caterina, Raffaele/K-3857-2016; Verheugt, F.W.A./H-8105-2014; Leonardi, Sergio/AAK-1490-2020; Reshetko, Olga/I-7011-2013; Alexander, John/GVS-7271-2022; Svistov, Aleksandr S/G-8291-2018; Drapkina, Oksana/AAE-5376-2021; Maggioni, Aldo Pietro/AAL-5334-2020; Urina-Triana, Miguel A/H-2605-2016; cornel, jan hein/Y-7065-2019; Avanzas, Pablo/B-6811-2008; Hug, Balthasar L./G-1568-2010; James, Stefan K/J-4554-2014; Colquhoun, David M/F-9078-2013	Leonardi, Sergio/0000-0002-4800-6132; Zadionchenko, Vladimir/0000-0003-2377-5266; De Caterina, Raffaele/0000-0003-1637-574X; Leonardi, Sergio/0000-0002-4800-6132; Reshetko, Olga/0000-0003-3107-7636; Svistov, Aleksandr S/0000-0003-0246-5680; Drapkina, Oksana/0000-0002-4453-8430; Maggioni, Aldo Pietro/0000-0003-2764-6779; Urina-Triana, Miguel A/0000-0001-6003-4622; cornel, jan hein/0000-0002-1006-2112; Avanzas, Pablo/0000-0002-4958-6108; Rha, Seung-Woon/0000-0001-9456-9852; Brilakis, Emmanouil/0000-0001-9416-9701; Alexander, John/0000-0002-1444-2462	Bristol-Myers Squibb; Pfizer	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer)	Supported by Bristol-Myers Squibb and Pfizer.	Alexander JH, 2009, CIRCULATION, V119, P2877, DOI 10.1161/CIRCULATIONAHA.108.832139; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Andreotti F, 2006, EUR HEART J, V27, P519, DOI 10.1093/eurheartj/ehi485; Antithrombotic Trialists' Collaboration, 2002, BMJ-BRIT MED J, V324, P141, DOI DOI 10.1136/BMJ.324.7330.141; Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Fox KAA, 2010, EUR HEART J, V31, P2755, DOI 10.1093/eurheartj/ehq326; Gibson CM, 2011, AM HEART J, V161, p815e6; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Karjalainen PP, 2007, EUR HEART J, V28, P726, DOI 10.1093/eurheartj/ehl488; Lassen MR, 2007, J THROMB HAEMOST, V5, P2368, DOI 10.1111/j.1538-7836.2007.02764.x; Lassen MR, 2009, NEW ENGL J MED, V361, P1814; Lassen MR, 2010, NEW ENGL J MED, V363, P2487, DOI 10.1056/NEJMoa1006885; Lassen MR, 2010, LANCET, V375, P807, DOI 10.1016/S0140-6736(09)62125-5; Lassen MR, 2009, NEW ENGL J MED, V361, P594, DOI 10.1056/NEJMoa0810773; Lewis BS, 2005, AM HEART J, V150, P1177, DOI 10.1016/j.ahj.2005.01.044; Mega JL, 2009, LANCET, V374, P29, DOI 10.1016/S0140-6736(09)60738-8; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Oldgren J, 2011, EUR HEART J     0507; Rothberg MB, 2005, ANN INTERN MED, V143, P241, DOI 10.7326/0003-4819-143-4-200508160-00005; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; van Es RF, 2002, LANCET, V360, P109, DOI 10.1016/S0140-6736(02)09409-6; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wong PC, 2008, J THROMB HAEMOST, V6, P820, DOI 10.1111/j.1538-7836.2008.02939.x; Yusuf S, 2001, NEW ENGL J MED, V345, P494; 2001, N ENGL J MED, V345, P1506; 2001, N ENGL J MED, V345, P1716	40	762	796	0	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					699	708		10.1056/NEJMoa1105819	http://dx.doi.org/10.1056/NEJMoa1105819			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811JM	21780946	Green Accepted, Green Published			2022-12-28	WOS:000294205300005
J	Rohde, H; Qin, JJ; Cui, YJ; Li, DF; Loman, NJ; Hentschke, M; Chen, WT; Pu, F; Peng, YQ; Li, JH; Xi, F; Li, SH; Li, Y; Zhang, ZX; Yang, XW; Zhao, MR; Wang, P; Guan, YL; Cen, Z; Zhao, XN; Christner, M; Kobbe, R; Loos, S; Oh, J; Yang, L; Danchin, A; Gao, GF; Song, YJ; Li, YR; Yang, HM; Wang, J; Xu, JG; Pallen, MJ; Wang, J; Aepfelbacher, M; Yang, RF				Rohde, Holger; Qin, Junjie; Cui, Yujun; Li, Dongfang; Loman, Nicholas J.; Hentschke, Moritz; Chen, Wentong; Pu, Fei; Peng, Yangqing; Li, Junhua; Xi, Feng; Li, Shenghui; Li, Yin; Zhang, Zhaoxi; Yang, Xianwei; Zhao, Meiru; Wang, Peng; Guan, Yuanlin; Cen, Zhong; Zhao, Xiangna; Christner, Martin; Kobbe, Robin; Loos, Sebastian; Oh, Jun; Yang, Liang; Danchin, Antoine; Gao, George F.; Song, Yajun; Li, Yingrui; Yang, Huanming; Wang, Jian; Xu, Jianguo; Pallen, Mark J.; Wang, Jun; Aepfelbacher, Martin; Yang, Ruifu		E coli O104 H4 Genome Anal Crowd-Sourcing	Open-Source Genomic Analysis of Shiga-Toxin-Producing E. coli O104:H4	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI	An outbreak caused by Shiga-toxin-producing Escherichia coli O104:H4 occurred in Germany in May and June of 2011, with more than 3000 persons infected. Here, we report a cluster of cases associated with a single family and describe an open-source genomic analysis of an isolate from one member of the family. This analysis involved the use of rapid, bench-top DNA sequencing technology, open-source data release, and prompt crowd-sourced analyses. In less than a week, these studies revealed that the outbreak strain belonged to an enteroaggregative E. coli lineage that had acquired genes for Shiga toxin 2 and for antibiotic resistance.	[Rohde, Holger; Hentschke, Moritz; Christner, Martin; Yang, Liang; Aepfelbacher, Martin] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Kobbe, Robin; Loos, Sebastian; Oh, Jun] Univ Med Ctr Hamburg Eppendorf, Dept Pediat, Hamburg, Germany; [Qin, Junjie; Cui, Yujun; Li, Dongfang; Chen, Wentong; Pu, Fei; Peng, Yangqing; Li, Junhua; Xi, Feng; Li, Shenghui; Li, Yin; Zhang, Zhaoxi; Yang, Xianwei; Zhao, Meiru; Wang, Peng; Guan, Yuanlin; Cen, Zhong; Li, Yingrui; Yang, Huanming; Wang, Jian; Wang, Jun; Yang, Ruifu] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Li, Yingrui] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Cui, Yujun; Zhao, Xiangna; Song, Yajun; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Gao, George F.; Xu, Jianguo] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Gao, George F.; Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Danchin, Antoine] AMAbiotics, Evry, France; [Loman, Nicholas J.; Pallen, Mark J.] Univ Birmingham, Ctr Syst Biol, Birmingham B15 2TT, W Midlands, England	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Beijing Genomics Institute (BGI); South China University of Technology; Beijing Institute of Microbiology & Epidemiology; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Birmingham	Pallen, MJ (corresponding author), Univ Birmingham, Ctr Syst Biol, Birmingham B15 2TT, W Midlands, England.	yangruifu@genomics.org.cn; m.pallen@bham.ac.uk; yangruifu@genomics.org.cn	Danchin, Antoine/F-3745-2018; Li, Yingrui/K-1064-2015; Yang, Ruifu/A-2273-2011; Song, Yajun/F-3714-2011; Song, Yajun/GQQ-0476-2022; Gao, George Fu/ABD-5229-2021; Loman, Nicholas/Z-1573-2019; Li, Junhua/AAG-3919-2019; Holt, Kathryn E/A-8108-2012; Wang, Jun/A-7261-2013; Yang, Liang/C-8487-2011; Cui, Yujun/E-7015-2012; Oh, Jun/K-4039-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Danchin, Antoine/0000-0002-6350-5001; Yang, Ruifu/0000-0003-3219-7269; Song, Yajun/0000-0002-6628-2747; Song, Yajun/0000-0002-6628-2747; Li, Junhua/0000-0001-6784-1873; Holt, Kathryn E/0000-0003-3949-2471; Yang, Liang/0000-0002-2362-0128; Yang, Xianwei/0000-0003-4388-9674; Wang, Jun/0000-0002-8540-8931; guan, yuanlin/0000-0002-4839-0146; Li, Dongfang/0000-0002-6587-2892; Loos, Sebastian/0000-0002-8620-042X; Loman, Nicholas/0000-0002-9843-8988; Wang, Jun/0000-0002-2113-5874; Pallen, Mark/0000-0003-1807-3657	State Key Development Program for Basic Research of China [2009CB522600]; National Key Program for Infectious Diseases of China [2008ZX10004-009]; Shenzhen Biological Industry Development Special Foundation [JC201005250088A]; Shenzhen City [ZD200806180054A]; European Union [FP7-KBBE-2007-3-2-08-222886]; Alexander von Humboldt Foundation; Medical Faculty of the University Medical Center Hamburg-Eppendorf; British Biotechnology and Biological Sciences Research Council [BB/E011179/1]; BBSRC [BB/E011179/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E011179/1] Funding Source: researchfish	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Key Program for Infectious Diseases of China; Shenzhen Biological Industry Development Special Foundation(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Shenzhen City; European Union(European Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Medical Faculty of the University Medical Center Hamburg-Eppendorf; British Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by grants from the State Key Development Program for Basic Research of China (2009CB522600), the National Key Program for Infectious Diseases of China (2008ZX10004-009), Shenzhen Biological Industry Development Special Foundation-Basic Research Key Projects (JC201005250088A), Key Laboratory Project Supported by Shenzhen City (ZD200806180054A), the European Union Microme Program (FP7-KBBE-2007-3-2-08-222886), the Alexander von Humboldt Foundation (to Dr. L. Yang), the Medical Faculty of the University Medical Center Hamburg-Eppendorf, and the British Biotechnology and Biological Sciences Research Council (BB/E011179/1).	Bae WK, 2006, YONSEI MED J, V47, P437, DOI 10.3349/ymj.2006.47.3.437; Bielaszewska M, 2011, LANCET INFECT D 0622; Chattaway MA, 2011, J INFECT DEV COUNTR, V5, P425, DOI 10.3855/jidc.2166; Cordesmeyer S., 2011, EURO SURVEILL, V16; Creuzburg K, 2011, ENVIRON MICROBIOL, V13, P439, DOI 10.1111/j.1462-2920.2010.02349.x; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; *GITHUB, 2011, E COL O104 H4 GEN AN; Hobman JL, 2007, MOL MICROBIOL, V64, P881, DOI 10.1111/j.1365-2958.2007.05710.x; Itoh Y, 1997, J CLIN MICROBIOL, V35, P2546, DOI 10.1128/JCM.35.10.2546-2550.1997; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kuijper E. J., 2011, EURO SURVEILL, V16, P19897; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Mossoro C, 2002, J CLIN MICROBIOL, V40, P3086, DOI 10.1128/JCM.40.8.3086-3088.2002; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Robert Koch Institute, 2011, INF UPD EHEC HUS OUT; Scheutz F, 2011, EURO SURVEILL, V16; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; *U COLL CORK, 2011, ESCH COL MLST DAT; Weintraub A, 2007, J MED MICROBIOL, V56, P4, DOI 10.1099/jmm.0.46930-0	21	313	343	2	104	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					718	724		10.1056/NEJMoa1107643	http://dx.doi.org/10.1056/NEJMoa1107643			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811JM	21793736	Green Published			2022-12-28	WOS:000294205300007
J	Boyce, N				Boyce, Niall			Profile Alys Cole-King: a pioneer of suicide mitigation in the UK	LANCET			English	Biographical-Item												niall.boyce@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 13	2011	378	9791					561	561		10.1016/S0140-6736(11)61279-8	http://dx.doi.org/10.1016/S0140-6736(11)61279-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812UX	21840448				2022-12-28	WOS:000294319500013
J	Cappuccio, FP; Capewell, S; Lincoln, P; McPherson, K				Cappuccio, Francesco P.; Capewell, Simon; Lincoln, Paul; McPherson, Klim			Policy options to reduce population salt intake	BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIALS; SODIUM-CHLORIDE; PUBLIC-HEALTH; METAANALYSIS; FOOD		[Cappuccio, Francesco P.] Univ Warwick, Warwick Med Sch, WHO Collaborating Ctr Nutr, WHO Collaborating Ctr, Coventry CV2 2DX, W Midlands, England; [Capewell, Simon] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Lincoln, Paul] Natl Heart Forum, London, England; [McPherson, Klim] Univ Oxford, Oxford, England	University of Warwick; World Health Organization; University of Liverpool; University of Oxford	Cappuccio, FP (corresponding author), Univ Warwick, Warwick Med Sch, WHO Collaborating Ctr Nutr, WHO Collaborating Ctr, Coventry CV2 2DX, W Midlands, England.	f.p.cappuccio@warwick.ac.uk	Cappuccio, Francesco Paolo/ABF-1094-2020	Cappuccio, Francesco Paolo/0000-0002-7842-5493				Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; BLAIS CA, 1986, AM J CLIN NUTR, V44, P232, DOI 10.1093/ajcn/44.2.232; Cappuccio FP, 2007, BMJ-BRIT MED J, V334, P859, DOI 10.1136/bmj.39175.364954.BE; FORTE JG, 1989, J HUM HYPERTENS, V3, P179; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Malik VS, 2006, AM J CLIN NUTR, V84, P274; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS POP LE; Sasaki N., 1979, PROPHYLACTIC APPROAC, P467; Sharma LL, 2010, AM J PUBLIC HEALTH, V100, P240, DOI 10.2105/AJPH.2009.160960; Strazzullo P, 2011, J HYPERTENS, V29, P829, DOI 10.1097/HJH.0b013e3283459568; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Takahashi Y, 2006, J HYPERTENS, V24, P451, DOI 10.1097/01.hjh.0000209980.36359.16; TEOW BH, 1985, CLIN EXP HYPERTENS A, V7, P1681, DOI 10.3109/10641968509073618; Turnbull F, 2003, LANCET, V362, P1527; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83	19	86	90	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 11	2011	343								d4995	10.1136/bmj.d4995	http://dx.doi.org/10.1136/bmj.d4995			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808DP	21835876	Green Submitted			2022-12-28	WOS:000293956900003
J	St Noble, V; Davagnanam, I; Farmer, S				St Noble, V.; Davagnanam, I.; Farmer, S.			PICTURE QUIZ Intractable headache after lumbar puncture	BRITISH MEDICAL JOURNAL			English	Editorial Material							SPONTANEOUS INTRACRANIAL HYPOTENSION; HYPOVOLEMIA; FEATURES; LEAKS		[Davagnanam, I.] Natl Hosp Neurol & Neurosurg, Lysholm Dept Neuroradiol, London WC1N 3BG, England; [St Noble, V.] Chelsea & Westminster Hosp, Dept Radiol, London, England; [Farmer, S.] Natl Hosp Neurol & Neurosurg, Dept Neurol, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Imperial College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Davagnanam, I (corresponding author), Natl Hosp Neurol & Neurosurg, Lysholm Dept Neuroradiol, Queen Sq, London WC1N 3BG, England.	indran_davagnanam@yahoo.co.uk	Farmer, Simon F/D-1969-2012	Farmer, Simon F/0000-0001-5193-8195				Ahmed SV, 2006, POSTGRAD MED J, V82, P713, DOI 10.1136/pgmj.2006.044792; Chiapparini L, 2004, NEUROL SCI, V25, pS138, DOI 10.1007/s10072-004-0273-9; Chung SJ, 2006, NEUROLOGY, V67, P1088, DOI 10.1212/01.wnl.0000237338.44702.61; Chung SJ, 2000, NEUROLOGY, V55, P1321, DOI 10.1212/WNL.55.9.1321; Mokri B, 2000, NEUROLOGY, V55, P573, DOI 10.1212/WNL.55.4.573; Raymond JR, 1998, W J MED, V148, P551; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Spelle L, 2001, NEURORADIOLOGY, V43, P622, DOI 10.1007/s002340000529; Sudlow C, 2010, COCHRANE DB SYST REV, V1; Turnbull DK, 2003, BRIT J ANAESTH, V91, P718, DOI 10.1093/bja/aeg231; Wang YF, 2009, NEUROLOGY, V73, P1892, DOI 10.1212/WNL.0b013e3181c3fd99	11	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 8	2011	343								d4529	10.1136/bmj.d4529	http://dx.doi.org/10.1136/bmj.d4529			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808CQ	21824906				2022-12-28	WOS:000293953000001
J	Funder, S; Goosse, H; Jepsen, H; Kaas, E; Kjaer, KH; Korsgaard, NJ; Larsen, NK; Linderson, H; Lysa, A; Moller, P; Olsen, J; Willerslev, E				Funder, Svend; Goosse, Hugues; Jepsen, Hans; Kaas, Eigil; Kjaer, Kurt H.; Korsgaard, Niels J.; Larsen, Nicolaj K.; Linderson, Hans; Lysa, Astrid; Moller, Per; Olsen, Jesper; Willerslev, Eske			A 10,000-Year Record of Arctic Ocean Sea-Ice Variability-View from the Beach	SCIENCE			English	Article							HOLOCENE CLIMATE; NORTH-ATLANTIC; GREENLAND; DRIFTWOOD; HISTORY; SHELF; DEPOSITION; SVALBARD; MODEL; AGE	We present a sea-ice record from northern Greenland covering the past 10,000 years. Multiyear sea ice reached a minimum between similar to 8500 and 6000 years ago, when the limit of year-round sea ice at the coast of Greenland was located similar to 1000 kilometers to the north of its present position. The subsequent increase in multiyear sea ice culminated during the past 2500 years and is linked to an increase in ice export from the western Arctic and higher variability of ice-drift routes. When the ice was at its minimum in northern Greenland, it greatly increased at Ellesmere Island to the west. The lack of uniformity in past sea-ice changes, which is probably related to large-scale atmospheric anomalies such as the Arctic Oscillation, is not well reproduced in models. This needs to be further explored, as it is likely to have an impact on predictions of future sea-ice distribution.	[Funder, Svend; Jepsen, Hans; Kjaer, Kurt H.; Korsgaard, Niels J.; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark; [Goosse, Hugues] Catholic Univ Louvain, Earth & Life Inst, Ctr Rech Terre & Climat Georges Lemaitre, B-1348 Louvain, Belgium; [Kaas, Eigil] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Larsen, Nicolaj K.] Univ Aarhus, Inst Geol, DK-8000 Aarhus C, Denmark; [Linderson, Hans; Moller, Per] Lund Univ, GeoBiosphere Sci Ctr, SE-22362 Lund, Sweden; [Lysa, Astrid] Geol Survey Norway, N-7491 Trondheim, Norway; [Olsen, Jesper] Queens Univ, Sch Geog Archaeol & Palaeoecol, Belfast BT7 1NN, Antrim, North Ireland	University of Copenhagen; Universite Catholique Louvain; University of Copenhagen; Niels Bohr Institute; Aarhus University; Lund University; Geological Survey of Norway; Queens University Belfast	Funder, S (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.	svf@snm.ku.dk	Korsgaard, Niels Jákup/D-8256-2013; Möller, Per/AAJ-7963-2020; Kaas, Eigil/M-2590-2014; Olsen, Jesper/F-1656-2013; Willerslev, Eske/AAA-5686-2019; Willerslev, Eske/A-9619-2011; Larsen, Nicolaj K./A-3509-2012; Kjaer, Kurt/A-4199-2013	Korsgaard, Niels Jákup/0000-0002-8700-7023; Möller, Per/0000-0001-5365-2668; Kaas, Eigil/0000-0001-6970-2404; Olsen, Jesper/0000-0002-4445-5520; Willerslev, Eske/0000-0002-7081-6748; Larsen, Nicolaj K./0000-0002-0117-1106; Kjaer, Kurt/0000-0002-8871-5179	Danish Research Council (FNU); Commission for Scientific Research in Greenland (KVUG) with Danish Polar Centre; Swedish Research Council (VR); Norwegian Research Council; Geological Survey of Norway; Research Associate with the Fonds National de la Recherche Scientifique (F.R.S.-FNRS-Belgium)	Danish Research Council (FNU)(Danish Natural Science Research CouncilDet Frie Forskningsrad (DFF)); Commission for Scientific Research in Greenland (KVUG) with Danish Polar Centre; Swedish Research Council (VR)(Swedish Research Council); Norwegian Research Council(Research Council of NorwayEuropean Commission); Geological Survey of Norway; Research Associate with the Fonds National de la Recherche Scientifique (F.R.S.-FNRS-Belgium)(Fonds de la Recherche Scientifique - FNRS)	The field work was funded mainly by the Danish Research Council (FNU) and the Commission for Scientific Research in Greenland (KVUG) with grants to S.F. and K.K. Logistic planning and support came from the Danish Polar Centre. P.M. and N.K.L. thank the Swedish Research Council (VR) for financial support and the Swedish Polar Research Secretariat for logistic support. A.L. thanks the Norwegian Research Council (SciencePub) and the Geological Survey of Norway for support. H.G. is a Research Associate with the Fonds National de la Recherche Scientifique (F.R.S.-FNRS-Belgium). N. Fischer of the Max Planck Institute for Meteorology provided sea-level pressure maps (see supporting online material).	Andersen C, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2002PA000873; Andrews JT, 2009, HOLOCENE, V19, P71, DOI 10.1177/0959683608098953; *ARCT MON ASS PROG, 2009, AMAP 2009 UPD SEL CL; CARTER RWG, 2002, COASTAL ENV; *DAN MET I, GREENL IC CHART 1999; Darby DA, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000961; Dyke AS, 1997, ARCTIC, V50, P1; EGGERTSSON O, 1994, ARCTIC, V47, P128; England JH, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034470; Fischer N, 2010, CLIM PAST, V6, P155, DOI 10.5194/cp-6-155-2010; Goosse H, 2007, CLIM PAST, V3, P683, DOI 10.5194/cp-3-683-2007; HAGGBLOM A, 1982, GEOGR ANN A, V64, P81, DOI 10.2307/520496; Jennings AE, 2002, HOLOCENE, V12, P49, DOI 10.1191/0959683602hl519rp; Kaufman DS, 2009, SCIENCE, V325, P1236, DOI 10.1126/science.1173983; Kaufman DS, 2004, QUATERNARY SCI REV, V23, P2059, DOI 10.1016/j.quascirev.2004.06.001; Larsen NK, 2010, QUATERNARY SCI REV, V29, P3399, DOI 10.1016/j.quascirev.2010.07.027; Overland JE, 2010, TELLUS A, V62, P1, DOI 10.1111/j.1600-0870.2009.00421.x; Pavlov V, 2004, J MARINE SYST, V48, P133, DOI 10.1016/j.jmarsys.2003.11.024; Polyak L, 2010, QUATERNARY SCI REV, V29, P1757, DOI 10.1016/j.quascirev.2010.02.010; Ramsey CB, 2008, QUATERNARY SCI REV, V27, P42, DOI 10.1016/j.quascirev.2007.01.019; Reeh N, 2004, SEDIMENT GEOL, V165, P333, DOI 10.1016/j.sedgeo.2003.11.023; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Rigor IG, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019492; Rigor IG, 2002, J CLIMATE, V15, P2648, DOI 10.1175/1520-0442(2002)015<2648:ROSITT>2.0.CO;2; Serreze MC, 2007, SCIENCE, V315, P1533, DOI 10.1126/science.1139426; Slubowska-Wodengen M, 2007, QUATERNARY SCI REV, V26, P463, DOI 10.1016/j.quascirev.2006.09.009; Wadhams P., 2000, ICE OCEAN, DOI [10.1201/9781482283082, DOI 10.1201/9781482283082]	27	132	133	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					747	750		10.1126/science.1202760	http://dx.doi.org/10.1126/science.1202760			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817051				2022-12-28	WOS:000293512100040
J	Pritt, BS; Sloan, LM; Johnson, DKH; Munderloh, UG; Paskewitz, SM; McElroy, KM; McFadden, JD; Binnicker, MJ; Neitzel, DF; Liu, GP; Nicholson, WL; Nelson, CM; Franson, JJ; Martin, SA; Cunningham, SA; Steward, CR; Bogumill, K; Bjorgaard, ME; Davis, JP; McQuiston, JH; Warshauer, DM; Wilhelm, MP; Patel, R; Trivedi, VA; Eremeeva, ME				Pritt, Bobbi S.; Sloan, Lynne M.; Johnson, Diep K. Hoang; Munderloh, Ulrike G.; Paskewitz, Susan M.; McElroy, Kristina M.; McFadden, Jevon D.; Binnicker, Matthew J.; Neitzel, David F.; Liu, Gongping; Nicholson, William L.; Nelson, Curtis M.; Franson, Joni J.; Martin, Scott A.; Cunningham, Scott A.; Steward, Christopher R.; Bogumill, Kay; Bjorgaard, Mary E.; Davis, Jeffrey P.; McQuiston, Jennifer H.; Warshauer, David M.; Wilhelm, Mark P.; Patel, Robin; Trivedi, Vipul A.; Eremeeva, Marina E.			Emergence of a New Pathogenic Ehrlichia Species, Wisconsin and Minnesota, 2009	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANAPLASMA-PHAGOCYTOPHILUM; AGENT; TICKS; IDENTIFICATION; CHAFFEENSIS; EPIDEMIOLOGY; HUMANS; MURIS; ASSAY	BACKGROUND Ehrlichiosis is a clinically important, emerging zoonosis. Only Ehrlichia chaffeensis and E. ewingii have been thought to cause ehrlichiosis in humans in the United States. Patients with suspected ehrlichiosis routinely undergo testing to ensure proper diagnosis and to ascertain the cause. Methods We used molecular methods, culturing, and serologic testing to diagnose and ascertain the cause of cases of ehrlichiosis. RESULTS On testing, four cases of ehrlichiosis in Minnesota or Wisconsin were found not to be from E. chaffeensis or E. ewingii and instead to be caused by a newly discovered ehrlichia species. All patients had fever, malaise, headache, and lymphopenia; three had thrombocytopenia; and two had elevated liver-enzyme levels. All recovered after receiving doxycycline treatment. At least 17 of 697 Ixodes scapularis ticks collected in Minnesota or Wisconsin were positive for the same ehrlichia species on polymerase-chain-reaction testing. Genetic analyses revealed that this new ehrlichia species is closely related to E. muris. CONCLUSIONS We report a new ehrlichia species in Minnesota and Wisconsin and provide supportive clinical, epidemiologic, culture, DNA-sequence, and vector data. Physicians need to be aware of this newly discovered close relative of E. muris to ensure appropriate testing, treatment, and regional surveillance.	[Pritt, Bobbi S.] Mayo Clin, Div Clin Microbiol, Rochester, MN 55905 USA; [Munderloh, Ulrike G.; Nelson, Curtis M.] Univ Minnesota, St Paul, MN 55108 USA; [Neitzel, David F.; Liu, Gongping] Minnesota Dept Hlth, St Paul, MN USA; [Johnson, Diep K. Hoang; McFadden, Jevon D.; Steward, Christopher R.; Davis, Jeffrey P.] Wisconsin Div Publ Hlth, Madison, WI USA; [Paskewitz, Susan M.] Univ Wisconsin, Madison, WI 53706 USA; [Franson, Joni J.; Martin, Scott A.; Trivedi, Vipul A.] Mayo Clin Hlth Syst, Eau Claire, WI USA; [Bogumill, Kay] Eau Claire City Cty Hlth Dept, Eau Claire, WI USA; [Bjorgaard, Mary E.] Dept Hlth & Human Serv, Siren, WI USA; [Warshauer, David M.] Univ Wisconsin, Wisconsin State Lab Hyg, Madison, WI 53706 USA; [McFadden, Jevon D.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Nicholson, William L.; McQuiston, Jennifer H.; Eremeeva, Marina E.] Ctr Dis Control & Prevent, Rickettsial Zoonoses Branch, Atlanta, GA USA	Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Minnesota Department of Health (MHD); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Pritt, BS (corresponding author), Mayo Clin, Div Clin Microbiol, Hilton 470-B,200 1st St, Rochester, MN 55905 USA.	pritt.bobbi@mayo.edu	Cunningham, Scott A/ABC-6171-2020	Pritt, Bobbi/0000-0003-0261-1326; Cunningham, Scott/0000-0002-7589-1712	National Institutes of Health [R01 AI042792]; Centers for Disease Control and Prevention;  [5U50C1000483-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health and the Centers for Disease Control and Prevention.; Supported in part by a grant from the National Institutes of Health (R01 AI042792, to Dr. Munderloh) and a cooperative agreement with the CDC (5U50C1000483-03, to Mr. Neitzel).	Alekseev AN, 2001, J CLIN MICROBIOL, V39, P2237, DOI 10.1128/JCM.39.6.2237-2242.2001; ANDERSON BE, 1991, J CLIN MICROBIOL, V29, P2838, DOI 10.1128/JCM.29.12.2838-2842.1991; Bell CA, 2005, DIAGN MICR INFEC DIS, V53, P301, DOI 10.1016/j.diagmicrobio.2005.06.019; Buller RS, 1999, NEW ENGL J MED, V341, P148, DOI 10.1056/NEJM199907153410303; Cao WC, 2000, J CLIN MICROBIOL, V38, P2778, DOI 10.1128/JCM.38.7.2778-2780.2000; CHEN SM, 1994, J CLIN MICROBIOL, V32, P589, DOI 10.1128/JCM.32.3.589-595.1994; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Demma LJ, 2005, AM J TROP MED HYG, V73, P400, DOI 10.4269/ajtmh.2005.73.400; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Eremeeva ME, 2007, VECTOR-BORNE ZOONOT, V7, P426, DOI 10.1089/vbz.2007.0112; Eremeeva ME, 2007, NEW ENGL J MED, V356, P2381, DOI 10.1056/NEJMoa065987; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Kawahara M, 1999, J CLIN MICROBIOL, V37, P1123, DOI 10.1128/JCM.37.4.1123-1129.1999; Munderloh UG, 2009, ANN NY ACAD SCI, V1166, P112, DOI 10.1111/j.1749-6632.2009.04520.x; Nefedova V. V., 2008, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P47; Nelson CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-364; Nicholson WL, 1997, J CLIN MICROBIOL, V35, P1510, DOI 10.1128/JCM.35.6.1510-1516.1997; Olano JP, 2003, CLIN DIAGN LAB IMMUN, V10, P891, DOI 10.1128/CDLI.10.5.891-896.2003; Perez M, 1996, J CLIN MICROBIOL, V34, P2133, DOI 10.1128/JCM.34.9.2133-2139.1996; Rar VA, 2005, EMERG INFECT DIS, V11, P1708, DOI 10.3201/eid1111.041195; Spitalska E, 2008, ACTA VIROL, V52, P175; Takano A, 2009, MICROBIOL IMMUNOL, V53, P101, DOI 10.1111/j.1348-0421.2008.00093.x; Tamamoto C, 2007, VET PARASITOL, V150, P370, DOI 10.1016/j.vetpar.2007.09.017; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Telford Iii Sam R, 2011, Open Microbiol J, V5, P18, DOI 10.2174/1874285801105010018	25	151	157	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					422	429		10.1056/NEJMoa1010493	http://dx.doi.org/10.1056/NEJMoa1010493			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801NW	21812671	Green Accepted			2022-12-28	WOS:000293447800006
J	Ray, RS; Corcoran, AE; Brust, RD; Kim, JC; Richerson, GB; Nattie, E; Dymecki, SM				Ray, Russell S.; Corcoran, Andrea E.; Brust, Rachael D.; Kim, Jun Chul; Richerson, George B.; Nattie, Eugene; Dymecki, Susan M.			Impaired Respiratory and Body Temperature Control Upon Acute Serotonergic Neuron Inhibition	SCIENCE			English	Article							MEDULLARY RAPHE NEURONS; INFANT-DEATH-SYNDROME; BRAIN-STEM; RETROTRAPEZOID NUCLEUS; K+ CHANNELS; CO2; CHEMORECEPTION; RAT; CHEMOSENSITIVITY; VENTILATION	Physiological homeostasis is essential for organism survival. Highly responsive neuronal networks are involved, but their constituent neurons are just beginning to be resolved. To query brain serotonergic neurons in homeostasis, we used a neuronal silencing tool, mouse RC::FPDi (based on the synthetic G protein-coupled receptor Di), designed for cell type-specific, ligand-inducible, and reversible suppression of action potential firing. In mice harboring Di-expressing serotonergic neurons, administration of the ligand clozapine-N-oxide (CNO) by systemic injection attenuated the chemoreflex that normally increases respiration in response to tissue carbon dioxide (CO2) elevation and acidosis. At the cellular level, CNO suppressed firing rate increases evoked by CO2 acidosis. Body thermoregulation at room temperature was also disrupted after CNO triggering of Di; core temperatures plummeted, then recovered. This work establishes that serotonergic neurons regulate life-sustaining respiratory and thermoregulatory networks, and demonstrates a noninvasive tool for mapping neuron function.	[Corcoran, Andrea E.; Nattie, Eugene] Dartmouth Med Sch, Dept Physiol & Neurobiol, Lebanon, NH 03756 USA; [Kim, Jun Chul] Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; [Richerson, George B.] Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA; [Ray, Russell S.; Brust, Rachael D.; Dymecki, Susan M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Dartmouth College; University of Toronto; University of Iowa; Harvard University; Harvard Medical School	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	dymecki@genetics.med.harvard.edu		Brust, Rachael/0000-0001-5375-6731; Richerson, George/0000-0001-5696-1554	NIH [F32HD063257-01A1, 5R21DA023643-02, 5R21MH083613-02, 5P01HD036379-13, 5R01HL028066-30, 5R01HD052772]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD063257, P01HD036379] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052772] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS073276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023643] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by NIH grants F32HD063257-01A1 (R. R.), 5R21DA023643-02 (R. B., S. D.), 5R21MH083613-02 (R. R., J.C.K., S. D.), 5P01HD036379-13 (R. R., A. C., R. B., J.C.K., E.N., G. R., S. D.), 5R01HL028066-30 (A. C., E.N.), and 5R01HD052772 (G. R.). Clozapine-N-oxide used in some preliminary experiments was provided through the NIH Rapid Access to Intervention Development Program. We thank B. Roth for providing the Di-encoding cDNA; B. Roth, W. Regehr, C. Hull, B. Sabatini, and members of the Dymecki lab for helpful discussions; and Y. Wu and J. J. Mai for technical assistance. The authors declare no conflicts of interest.	Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Bonnavion P, 2010, J COMP NEUROL, V518, P2744, DOI 10.1002/cne.22331; Cano G, 2003, J COMP NEUROL, V460, P303, DOI 10.1002/cne.10643; Corcoran AE, 2009, RESP PHYSIOL NEUROBI, V168, P49, DOI 10.1016/j.resp.2009.04.014; Depuy SD, 2011, J NEUROSCI, V31, P1981, DOI 10.1523/JNEUROSCI.4639-10.2011; Dias MB, 2008, J APPL PHYSIOL, V105, P83, DOI 10.1152/japplphysiol.00120.2008; Dubreuil V, 2009, J NEUROSCI, V29, P14836, DOI 10.1523/JNEUROSCI.2623-09.2009; Duncan JR, 2010, JAMA-J AM MED ASSOC, V303, P430, DOI 10.1001/jama.2010.45; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; ELAM M, 1981, BRAIN RES, V222, P373, DOI 10.1016/0006-8993(81)91040-4; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Gobbi G, 2007, EUR NEUROPSYCHOPHARM, V17, P328, DOI 10.1016/j.euroneuro.2006.07.004; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Haldine JS, 1905, J PHYSIOL-LONDON, V32, P225; HAYASHI F, 1991, RESP PHYSIOL, V84, P61, DOI 10.1016/0034-5687(91)90019-F; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Hodges MR, 2010, J APPL PHYSIOL, V108, P1425, DOI 10.1152/japplphysiol.01270.2009; INNIS RB, 1987, EUR J PHARMACOL, V143, P195, DOI 10.1016/0014-2999(87)90533-4; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Kety S S, 2001, Biogr Mem Natl Acad Sci, V79, P66; Kim JC, 2009, NEURON, V63, P305, DOI 10.1016/j.neuron.2009.07.010; Kinney HC, 2009, ANNU REV PATHOL-MECH, V4, P517, DOI 10.1146/annurev.pathol.4.110807.092322; LEUSEN IR, 1954, AM J PHYSIOL, V176, P39, DOI 10.1152/ajplegacy.1953.176.1.39; Li A, 2008, ADV EXP MED BIOL, V605, P371; Marina N, 2010, J NEUROSCI, V30, P12466, DOI 10.1523/JNEUROSCI.3141-10.2010; Mark MD, 2000, EUR J BIOCHEM, V267, P5830, DOI 10.1046/j.1432-1327.2000.01670.x; MITCHELL RA, 1963, J APPL PHYSIOL, V18, P523, DOI 10.1152/jappl.1963.18.3.523; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nattie E, 2011, J APPL PHYSIOL, V110, P1, DOI 10.1152/japplphysiol.01061.2010; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; PENINGTON NJ, 1993, J PHYSIOL-LONDON, V469, P387, DOI 10.1113/jphysiol.1993.sp019819; Pineyro G, 1999, PHARMACOL REV, V51, P533; RICHERSON GB, 1995, J NEUROPHYSIOL, V73, P933, DOI 10.1152/jn.1995.73.3.933; Smith CA, 2006, J APPL PHYSIOL, V100, P13, DOI 10.1152/japplphysiol.00926.2005; St-John WM, 2000, RESP PHYSIOL, V123, P201, DOI 10.1016/S0034-5687(00)00177-8; STERNBACH H, 1991, AM J PSYCHIAT, V148, P705; Wang W, 1999, NEUROSCIENCE, V90, P1001, DOI 10.1016/S0306-4522(98)00505-3; Wang WG, 1998, J PHYSIOL-LONDON, V511, P433, DOI 10.1111/j.1469-7793.1998.433bh.x; Washburn CP, 2002, J NEUROSCI, V22, P1256, DOI 10.1523/JNEUROSCI.22-04-01256.2002; Wenker IC, 2010, J NEUROPHYSIOL, V104, P3042, DOI 10.1152/jn.00544.2010; Williams RH, 2007, P NATL ACAD SCI USA, V104, P10685, DOI 10.1073/pnas.0702676104	43	234	235	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					637	642		10.1126/science.1205295	http://dx.doi.org/10.1126/science.1205295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798952	Green Accepted			2022-12-28	WOS:000293222400064
J	Lauher, JW				Lauher, Joseph W.			A Versatile Molecular Trap Built from Hydrogen-Bonded Tiles	SCIENCE			English	Editorial Material							CAGES		SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Lauher, JW (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.	joseph.lauher@stonybrook.edu						Inokuma Y, 2011, NAT CHEM, V3, P349, DOI [10.1038/NCHEM.1031, 10.1038/nchem.1031]; Kuberski B, 2009, CHEM COMMUN, P1959, DOI 10.1039/b820990a; Liu YZ, 2011, SCIENCE, V333, P436, DOI 10.1126/science.1204369; MacGillivray LR, 1999, ANGEW CHEM INT EDIT, V38, P1019, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1018::AID-ANIE1018>3.0.CO;2-G; Seidel SR, 2002, ACCOUNTS CHEM RES, V35, P972, DOI 10.1021/ar010142d; Tozawa T, 2009, NAT MATER, V8, P973, DOI [10.1038/nmat2545, 10.1038/NMAT2545]; Vernizzi G, 2011, P NATL ACAD SCI USA, V108, P4292, DOI 10.1073/pnas.1012872108; Zhao D, 2011, ACCOUNTS CHEM RES, V44, P123, DOI 10.1021/ar100112y	8	4	4	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					415	416		10.1126/science.1209090	http://dx.doi.org/10.1126/science.1209090			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	795FR	21778390				2022-12-28	WOS:000292959600033
J	Michel-Kerjan, E; Kunreuther, H				Michel-Kerjan, Erwann; Kunreuther, Howard			Redesigning Flood Insurance	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; ENVIRONMENT; PROGRAM		[Michel-Kerjan, Erwann; Kunreuther, Howard] Univ Penn, Wharton Sch, Ctr Risk Management & Decis Proc, Operat & Informat Management Dept, Philadelphia, PA 19104 USA	University of Pennsylvania	Michel-Kerjan, E (corresponding author), Univ Penn, Wharton Sch, Ctr Risk Management & Decis Proc, Operat & Informat Management Dept, Philadelphia, PA 19104 USA.	erwannmk@wharton.upenn.edu						[Anonymous], 2010, PAK FLOODS 2010 PREL; Burby R. J., 2001, Environmental Hazards, V3, P111; Congressional Budget Office (CBO), 2007, VAL PROPR NAT FLOOD; Cummins D., 2010, MEASURING MANAGING F, P61; Cummins JD, 2009, CATASTROPHE RISK FINANCING IN DEVELOPING COUNTRIES: PRINCIPLES FOR PUBLIC INTERVENTION, P1, DOI 10.1596/978-0-8213-7736-9; Dixon L., 2006, NATL FLOOD INSURANCE, DOI [10.7249/TR300, DOI 10.7249/TR300]; General Accountability Office (GAO), 2011, GAO11670T; Gron A., 1999, FINANCING CATASTROPH; Guy Carpenter and Co, 2010, CHIN FLOODS REP; King DA, 2004, SCIENCE, V303, P176, DOI 10.1126/science.1094329; King R., 2010, 75700 C RES SERV; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kriesel W, 2004, J RISK INSUR, V71, P405, DOI 10.1111/j.0022-4367.2004.00096.x; Kunreuther H., 1978, DISASTER INSURANCE P; Kunreuther H., BEHAV FDN P IN PRESS; Kunreuther HC, 2009, AT WAR WITH THE WEATHER: MANAGING LARGE-SCALE RISKS IN A NEW ERA OF CATASTROPHES, P1; Michel-Kerjan E, 2012, RISK ANAL, V32, P644, DOI 10.1111/j.1539-6924.2011.01671.x; Michel-Kerjan EO, 2010, J ECON PERSPECT, V24, P165, DOI 10.1257/jep.24.4.165; Michel-Kerjan EO, 2010, J RISK INSUR, V77, P369, DOI 10.1111/j.1539-6975.2009.01349.x; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Pinter N, 2005, SCIENCE, V308, P207, DOI 10.1126/science.1108411; Sunstein CR, 2002, YALE LAW J, V112, P61, DOI 10.2307/1562234; Thieken AH, 2006, RISK ANAL, V26, P383, DOI 10.1111/j.1539-6924.2006.00741.x; Wetmore F., 2006, EVALUATION NATL FLOO; *WHIT HOUS, 2007, EC REP PRES	25	134	136	5	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					408	409		10.1126/science.1202616	http://dx.doi.org/10.1126/science.1202616			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	795FR	21778385				2022-12-28	WOS:000292959600028
J	Peng, CH				Peng, Changhui			Focus on quality, not just quantity	NATURE			English	Editorial Material									[Peng, Changhui] NW A&F Univ, Coll Forestry, Yangling, Peoples R China; [Peng, Changhui] Univ Quebec, Inst Environm Sci, Montreal, PQ H3C 3P8, Canada	Northwest A&F University - China; University of Quebec; University of Quebec Montreal	Peng, CH (corresponding author), NW A&F Univ, Coll Forestry, Yangling, Peoples R China.	peng.changhui@uqam.ca	Peng, Changhui/G-8248-2012						0	10	10	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					267	267		10.1038/475267a	http://dx.doi.org/10.1038/475267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	794PA	21776039	Bronze			2022-12-28	WOS:000292911200004
J	Wang, M; Gamo, NJ; Yang, Y; Jin, LE; Wang, XJ; Laubach, M; Mazer, JA; Lee, D; Arnsten, AFT				Wang, Min; Gamo, Nao J.; Yang, Yang; Jin, Lu E.; Wang, Xiao-Jing; Laubach, Mark; Mazer, James A.; Lee, Daeyeol; Arnsten, Amy F. T.			Neuronal basis of age-related working memory decline	NATURE			English	Article							MONKEY PREFRONTAL-CORTEX; COGNITIVE DECLINE; RHESUS-MONKEY; EXECUTIVE FUNCTION; IMPAIRMENT; DYSFUNCTION; NETWORK; MACAQUE	Many of the cognitive deficits of normal ageing (forgetfulness, distractibility, inflexibility and impaired executive functions) involve prefrontal cortex (PFC) dysfunction(1-4). The PFC guides behaviour and thought using working memory(5), which are essential functions in the information age. Many PFC neurons hold information in working memory through excitatory networks that can maintain persistent neuronal firing in the absence of external stimulation(6). This fragile process is highly dependent on the neurochemical environment(7). For example, elevated cyclic-AMP signalling reduces persistent firing by opening HCN and KCNQ potassium channels(8,9). It is not known if molecular changes associated with normal ageing alter the physiological properties of PFC neurons during working memory, as there have been no in vivo recordings, to our knowledge, from PFC neurons of aged monkeys. Here we characterize the first recordings of this kind, revealing a marked loss of PFC persistent firing with advancing age that can be rescued by restoring an optimal neurochemical environment. Recordings showed an age-related decline in the firing rate of DELAY neurons, whereas the firing of CUE neurons remained unchanged with age. The memory-related firing of aged DELAY neurons was partially restored to more youthful levels by inhibiting cAMP signalling, or by blocking HCN or KCNQ channels. These findings reveal the cellular basis of age-related cognitive decline in dorsolateral PFC, and demonstrate that physiological integrity can be rescued by addressing the molecular needs of PFC circuits.	[Wang, Min; Gamo, Nao J.; Yang, Yang; Jin, Lu E.; Wang, Xiao-Jing; Laubach, Mark; Mazer, James A.; Lee, Daeyeol; Arnsten, Amy F. T.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Laubach, Mark] John B Pierce Lab, New Haven, CT 06510 USA	Yale University; Yale University; The John B Pierce Laboratory, Inc	Arnsten, AFT (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	amy.arnsten@yale.edu	Lee, Daeyeol/A-6794-2008; Wang, Xiao-Jing/D-2722-2009	Lee, Daeyeol/0000-0003-3474-019X; Yang, Yang/0000-0001-6612-8865; Laubach, Mark/0000-0002-2403-4497	PHS, National Institute on Aging [PO1AG030004]; NATIONAL INSTITUTE ON AGING [P01AG030004] Funding Source: NIH RePORTER	PHS, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)United States Public Health Service); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by PHS grant PO1AG030004 from the National Institute on Aging. The authors would like to thank J. Thomas, L. Ciavarella, S. Johnson, B. Brunson and M. Horn for their assistance in making this work possible.	Alexander GE, 2008, J NEUROSCI, V28, P2710, DOI 10.1523/JNEUROSCI.1852-07.2008; Arnsten AFT, 2010, TRENDS COGN SCI, V14, P365, DOI 10.1016/j.tics.2010.05.003; Bowles RP, 2003, PSYCHOL AGING, V18, P608, DOI 10.1037/0882-7974.18.3.608; Bucur B, 2010, EXP AGING RES, V36, P153, DOI 10.1080/03610731003613482; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P197, DOI 10.1162/089892900561832; Cappell KA, 2010, CORTEX, V46, P462, DOI 10.1016/j.cortex.2009.11.009; DAVIS HP, 1990, BEHAV NEUROSCI, V104, P288, DOI 10.1037/0735-7044.104.2.288; Downs JL, 2007, NEUROBIOL AGING, V28, P1286, DOI 10.1016/j.neurobiolaging.2006.05.025; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Herndon JG, 1997, BEHAV BRAIN RES, V87, P25, DOI 10.1016/S0166-4328(96)02256-5; Luebke JI, 2007, NEUROSCIENCE, V150, P556, DOI 10.1016/j.neuroscience.2007.09.042; Luebke J, 2010, BRAIN RES REV, V62, P212, DOI 10.1016/j.brainresrev.2009.12.002; Moore TL, 2006, NEUROBIOL AGING, V27, P1484, DOI 10.1016/j.neurobiolaging.2005.08.004; Moore TL, 2005, BEHAV BRAIN RES, V160, P208, DOI 10.1016/j.bbr.2004.12.003; Peters A, 1996, J NEUROPATH EXP NEUR, V55, P861, DOI 10.1097/00005072-199608000-00001; Prakash RS, 2009, BRAIN COGNITION, V71, P328, DOI 10.1016/j.bandc.2009.07.005; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; RAPP PR, 1989, J NEUROSCI, V9, P3568; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Royall DR, 2005, J INT NEUROPSYCH SOC, V11, P899, DOI 10.1017/S135561770505109X; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Schoenbaum G, 2006, J NEUROPHYSIOL, V95, P1509, DOI 10.1152/jn.01052.2005; Sisodia S S, 1995, Neuroimaging Clin N Am, V5, P59; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272	30	269	282	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					210	U110		10.1038/nature10243	http://dx.doi.org/10.1038/nature10243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21796118	Green Accepted			2022-12-28	WOS:000293731900037
J	Green, IX; Tang, WJ; Neurock, M; Yates, JT				Green, Isabel Xiaoye; Tang, Wenjie; Neurock, Matthew; Yates, John T., Jr.			Spectroscopic Observation of Dual Catalytic Sites During Oxidation of CO on a Au/TiO2 Catalyst	SCIENCE			English	Article							SUPPORTED AU NANOPARTICLES; GOLD NANOPARTICLES; CARBON-MONOXIDE; ADSORPTION; TEMPERATURE; TIO2; FTIR; TIO2(110); CLUSTERS; OXYGEN	The prevailing view of CO oxidation on gold-titanium oxide (Au/TiO2) catalysts is that the reaction occurs on metal sites at the Au/TiO2 interface. We observed dual catalytic sites at the perimeter of 3-nanometer Au particles supported on TiO2 during CO oxidation. Infrared-kinetic measurements indicate that O-O bond scission is activated by the formation of a CO-O-2 complex at dual Ti-Au sites at the Au/TiO2 interface. Density functional theory calculations, which provide the activation barriers for the formation and bond scission of the CO-O-2 complex, confirm this model as well as the measured apparent activation energy of 0.16 electron volt. The observation of sequential delivery and reaction of CO first from TiO2 sites and then from Au sites indicates that catalytic activity occurs at the perimeter of Au nanoparticles.	[Green, Isabel Xiaoye; Neurock, Matthew; Yates, John T., Jr.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Tang, Wenjie; Neurock, Matthew; Yates, John T., Jr.] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA	University of Virginia; University of Virginia	Yates, JT (corresponding author), Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA.	johnt@virginia.edu	Green, Isabel/D-6004-2012	Green, Isabel/0000-0001-6125-6454	U.S. Department of Energy-Office of Basic Energy Sciences [DE-FG02-09ER16080]; NSF; Texas Advanced Computing Center for Teragrid resources	U.S. Department of Energy-Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Texas Advanced Computing Center for Teragrid resources	We acknowledge the support of this work by the U.S. Department of Energy-Office of Basic Energy Sciences, grant number DE-FG02-09ER16080 as well as the NSF and the Texas Advanced Computing Center for Teragrid resources. All data are archived at University of Virginia.	Boccuzzi F, 2000, J PHYS CHEM B, V104, P5414, DOI 10.1021/jp000749w; Boccuzzi F, 2001, J CATAL, V202, P256, DOI 10.1006/jcat.2001.3290; Bollinger MA, 1996, APPL CATAL B-ENVIRON, V8, P417, DOI 10.1016/0926-3373(96)90129-0; Boronat M, 2009, J PHYS CHEM C, V113, P16772, DOI 10.1021/jp905157r; CERRATO G, 1993, APPL SURF SCI, V70-1, P200, DOI 10.1016/0169-4332(93)90427-D; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; Date M, 2004, ANGEW CHEM INT EDIT, V43, P2129, DOI 10.1002/anie.200453796; Derrouiche S, 2004, J AM CHEM SOC, V126, P13010, DOI 10.1021/ja0470719; Diemant T, 2007, J CATAL, V252, P171, DOI 10.1016/j.jcat.2007.09.024; DUMAS P, 1986, SURF SCI, V171, P579, DOI 10.1016/0039-6028(86)91061-7; Green IX, 2010, J PHYS CHEM C, V114, P16649, DOI 10.1021/jp1061489; HARUTA M, 1993, J CATAL, V144, P175, DOI 10.1006/jcat.1993.1322; HARUTA M, 1987, CHEM LETT, P405, DOI 10.1246/cl.1987.405; Janssens TVW, 2007, TOP CATAL, V44, P15, DOI 10.1007/s11244-007-0335-3; Kotobuki M, 2009, J CATAL, V264, P67, DOI 10.1016/j.jcat.2009.03.013; Laursen S, 2009, PHYS CHEM CHEM PHYS, V11, P11006, DOI 10.1039/b912641d; Lee JS, 2011, J PHYS CHEM C, V115, P4163, DOI 10.1021/jp1112697; LINSEBIGLER A, 1995, J CHEM PHYS, V103, P9438, DOI 10.1063/1.470005; Liu ZP, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.266102; Long CG, 2008, J AM CHEM SOC, V130, P10103, DOI 10.1021/ja801279a; Lopez N, 2004, J CATAL, V223, P232, DOI 10.1016/j.jcat.2004.01.001; Meier DC, 2004, J AM CHEM SOC, V126, P1892, DOI 10.1021/ja030359y; Meyer R, 2004, GOLD BULL, V37, P72, DOI 10.1007/BF03215519; Molina LM, 2004, J CHEM PHYS, V120, P7673, DOI 10.1063/1.1687337; Remediakis IN, 2005, ANGEW CHEM INT EDIT, V44, P1824, DOI 10.1002/anie.200461699; Rodriguez JA, 2007, SCIENCE, V318, P1757, DOI 10.1126/science.1150038; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; Wang JG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.136107; Wang Z, 2010, J PHYS CHEM C, V114, P18222, DOI 10.1021/jp1059165	29	802	815	23	1213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					736	739		10.1126/science.1207272	http://dx.doi.org/10.1126/science.1207272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817048				2022-12-28	WOS:000293512100037
J	Uchihashi, T; Iino, R; Ando, T; Noji, H				Uchihashi, Takayuki; Iino, Ryota; Ando, Toshio; Noji, Hiroyuki			High-Speed Atomic Force Microscopy Reveals Rotary Catalysis of Rotorless F-1-ATPase	SCIENCE			English	Article							ATP SYNTHESIS; ROTATION; F1-ATPASE; SUBUNIT; PS3	F-1 is an adenosine triphosphate (ATP)-driven motor in which three torque-generating beta subunits in the alpha(3)beta(3) stator ring sequentially undergo conformational changes upon ATP hydrolysis to rotate the central shaft gamma unidirectionally. Although extensive experimental and theoretical work has been done, the structural basis of cooperative torque generation to realize the unidirectional rotation remains elusive. We used high-speed atomic force microscopy to show that the rotorless F-1 still "rotates"; in the isolated alpha(3)beta(3) stator ring, the three beta subunits cyclically propagate conformational states in the counterclockwise direction, similar to the rotary shaft rotation in F-1. The structural basis of unidirectionality is programmed in the stator ring. These findings have implications for cooperative interplay between subunits in other hexameric ATPases.	[Uchihashi, Takayuki; Ando, Toshio] Kanazawa Univ, Dept Phys, Kanazawa, Ishikawa 9201192, Japan; [Uchihashi, Takayuki; Ando, Toshio] Kanazawa Univ, BioAFM Frontier Res Ctr, Coll Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Uchihashi, Takayuki; Iino, Ryota; Ando, Toshio; Noji, Hiroyuki] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan; [Iino, Ryota; Noji, Hiroyuki] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Iino, Ryota; Noji, Hiroyuki] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Kanazawa University; Kanazawa University; Japan Science & Technology Agency (JST); Osaka University; University of Tokyo	Ando, T (corresponding author), Kanazawa Univ, Dept Phys, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	tando@staff.kanazawa-u.ac.jp; hnoji@appchem.t.u-tokyo.ac.jp	Uchihashi, Takayuki/D-5209-2011; Iino, Ryota/B-7746-2011; ANDO, Toshio/E-7054-2015	Uchihashi, Takayuki/0000-0002-0263-5312; Iino, Ryota/0000-0003-0110-5704; ANDO, Toshio/0000-0001-8819-154X	Ministry of Education, Culture, Sports, Science and Technology [18074005, 18201025, 21770168, 21681017, 2102301, 21107517, 22247025, 20221006]; Knowledge Cluster Initiative; Japan Science and Technology Agency for Core Research for Evolutional Science and Technology; Grants-in-Aid for Scientific Research [21681017] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Knowledge Cluster Initiative(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency for Core Research for Evolutional Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Tanigawara, H. Yamashita, R. Hasegawa, and D. Okuno for technical help and members of the Noji and Ando laboratories for valuable comments. This work was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology project ID nos. 18074005, 18201025, 21770168, 21681017, 2102301, 21107517, 22247025, and 20221006); the Knowledge Cluster Initiative; and the Japan Science and Technology Agency for Core Research for Evolutional Science and Technology.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; ALOISE P, 1991, J BIOL CHEM, V266, P10368; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Furuike S, 2008, SCIENCE, V319, P955, DOI 10.1126/science.1151343; Garcia JJ, 1998, J BIOL CHEM, V273, P15940, DOI 10.1074/jbc.273.26.15940; GRESSER MJ, 1982, J BIOL CHEM, V257, P2030; Iko Y, 2009, FEBS LETT, V583, P3187, DOI 10.1016/j.febslet.2009.08.042; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kaibara C, 1996, J BIOL CHEM, V271, P2433, DOI 10.1074/jbc.271.5.2433; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Nakamoto RK, 1999, ANNU REV BIOPH BIOM, V28, P205, DOI 10.1146/annurev.biophys.28.1.205; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/NNANO.2010.7, 10.1038/nnano.2010.7]; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; YOSHIDA M, 1990, J BIOL CHEM, V265, P2483	25	305	312	3	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					755	758		10.1126/science.1205510	http://dx.doi.org/10.1126/science.1205510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817054	Green Submitted			2022-12-28	WOS:000293512100043
J	Nair, U; Jotwani, A; Geng, JF; Gammoh, N; Richerson, D; Yen, WL; Griffith, J; Nag, S; Wang, K; Moss, T; Baba, M; Mcnew, JA; Jiang, XJ; Reggiori, F; Melia, TJ; Klionsky, DJ				Nair, Usha; Jotwani, Anjali; Geng, Jiefei; Gammoh, Noor; Richerson, Diana; Yen, Wei-Lien; Griffith, Janice; Nag, Shanta; Wang, Ke; Moss, Tyler; Baba, Misuzu; Mcnew, James A.; Jiang, Xuejun; Reggiori, Fulvio; Melia, Thomas J.; Klionsky, Daniel J.			SNARE Proteins Are Required for Macroautophagy	CELL			English	Article							PRE-AUTOPHAGOSOMAL STRUCTURE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; VESICLE FORMATION; SEC PROTEINS; YEAST; FUSION; TRANSPORT; COMPLEX	Macroautophagy mediates the degradation of long-lived proteins and organelles via the de novo formation of double-membrane autophagosomes that sequester cytoplasm and deliver it to the vacuole/lysosome; however, relatively little is known about autophagosome biogenesis. Atg8, a phosphatidylethanolamine-conjugated protein, was previously proposed to function in autophagosome membrane expansion, based on the observation that it mediates liposome tethering and hemifusion in vitro. We show here that with physiological concentrations of phosphatidylethanolamine, Atg8 does not act as a fusogen. Rather, we provide evidence for the involvement of exocytic Q/t-SNAREs in autophagosome formation, acting in the recruitment of key autophagy components to the site of autophagosome formation, and in regulating the organization of Atg9 into tubulovesicular clusters. Additionally, we found that the endosomal Q/t-SNARE Tlg2 and the R/v-SNAREs Sec22 and Ykt6 interact with Sso1-Sec9, and are required for normal Atg9 transport. Thus, multiple SNARE-mediated fusion events are likely to be involved in autophagosome biogenesis.	[Griffith, Janice; Reggiori, Fulvio] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Griffith, Janice; Reggiori, Fulvio] Univ Med Ctr Utrecht, Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; [Nair, Usha; Geng, Jiefei; Yen, Wei-Lien; Wang, Ke; Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Jotwani, Anjali; Nag, Shanta] Yale Coll, New Haven, CT 06520 USA; [Gammoh, Noor; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY USA; [Richerson, Diana; Melia, Thomas J.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Moss, Tyler; Mcnew, James A.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Baba, Misuzu] Kogakuin Univ, Collaborat Open Res Ctr, Tokyo 1920015, Japan	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Michigan System; University of Michigan; Yale University; Memorial Sloan Kettering Cancer Center; Yale University; Rice University; Kogakuin University	Reggiori, F (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands.	f.reggiori@umcutrecht.nl; thomas.melia@yale.edu; klionsky@umich.edu	Reggiori, Fulvio/U-8327-2019; Geng, Jiefei/G-1536-2013; McNew, James/AAV-4911-2020; McNew, James/ABD-8081-2020	Reggiori, Fulvio/0000-0003-2652-2686; McNew, James/0000-0001-8459-3664; Moss, Tyler/0000-0001-7140-9987	National Institutes of Health [GM53396, NS063973, CA113890, GM071832]; Netherlands Organization for Health Research and Development [ZonMW-VIDI-917.76.329]; Netherlands Organization for Scientific Research [700.59.003]; NATIONAL CANCER INSTITUTE [R01CA113890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071832, R01GM053396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Hans Ronne (Uppsala University) for providing strain H603, Charlie Boone and Zhijian Li for providing the sec mutants, Phil Hieter for providing the ykt6 mutant, Zhifen Yang for the pCUP1-PA-SEC22 and pCUP1-PA-YKT6 constructs, Midori Umekawa for pMU1 (pATG8 under the control of its endogenous promoter, with the hygromycin resistance marker) and Clinton Bartholomew (University of Michigan) and Ai Yamamoto (Columbia University) for helpful discussions. This work was supported by National Institutes of Health grants GM53396 (to D.J.K.), NS063973 (to T.J.M.), CA113890 (to X.J.; also supported by the Geoffrey Beene Cancer Research Fund) and GM071832 (to J.A.M.), as well as the Netherlands Organization for Health Research and Development (ZonMW-VIDI-917.76.329) and the Netherlands Organization for Scientific Research (Chemical Sciences, ECHO grant 700.59.003 to F.R.).	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Abeliovich H, 1999, EMBO J, V18, P6005, DOI 10.1093/emboj/18.21.6005; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Brugger B, 2000, EMBO J, V19, P1272, DOI 10.1093/emboj/19.6.1272; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Fukasawa M, 2004, P NATL ACAD SCI USA, V101, P4815, DOI 10.1073/pnas.0401183101; Geng JF, 2010, MOL BIOL CELL, V21, P2257, DOI 10.1091/mbc.E09-11-0969; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; Isahara K, 1999, NEUROSCIENCE, V91, P233, DOI 10.1016/S0306-4522(98)00566-1; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Jantti J, 2002, J CELL SCI, V115, P409; Liu YT, 2004, J BIOL CHEM, V279, P27225, DOI 10.1074/jbc.M312122200; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Paumet F, 2001, J CELL BIOL, V155, P961, DOI 10.1083/jcb.200104092; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; Scott BL, 2004, J CELL BIOL, V167, P75, DOI 10.1083/jcb.200405018; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yen WL, 2010, J CELL BIOL, V188, P101, DOI 10.1083/jcb.200904075	36	324	333	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 22	2011	146	2					290	302		10.1016/j.cell.2011.06.022	http://dx.doi.org/10.1016/j.cell.2011.06.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784249	Green Accepted, Bronze			2022-12-28	WOS:000293013000011
J	Sanchez, T; Welch, D; Nicastro, D; Dogic, Z				Sanchez, Timothy; Welch, David; Nicastro, Daniela; Dogic, Zvonimir			Cilia-Like Beating of Active Microtubule Bundles	SCIENCE			English	Article							SEA-URCHIN SPERM; SELF-ORGANIZATION; MOTORS; FILAMENTS; MOLECULE; FLAGELLA; COMPLEX; DRIVEN; FLOW	The mechanism that drives the regular beating of individual cilia and flagella, as well as dense ciliary fields, remains unclear. We describe a minimal model system, composed of microtubules and molecular motors, which self-assemble into active bundles exhibiting beating patterns reminiscent of those found in eukaryotic cilia and flagella. These observations suggest that hundreds of molecular motors, acting within an elastic microtubule bundle, spontaneously synchronize their activity to generate large-scale oscillations. Furthermore, we also demonstrate that densely packed, actively bending bundles spontaneously synchronize their beating patterns to produce collective behavior similar to metachronal waves observed in ciliary fields. The simple in vitro system described here could provide insights into beating of isolated eukaryotic cilia and flagella, as well as their synchronization in dense ciliary fields.	[Sanchez, Timothy; Dogic, Zvonimir] Brandeis Univ, Dept Phys, Waltham, MA 02454 USA; [Welch, David] Brandeis Univ, Grad Program Biophys & Struct Biol, Waltham, MA 02454 USA; [Nicastro, Daniela] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University; Brandeis University	Dogic, Z (corresponding author), Brandeis Univ, Dept Phys, 415 South St, Waltham, MA 02454 USA.	zdogic@brandeis.edu	Sanchez, Tim/H-6339-2013	Nicastro, Daniela/0000-0002-0122-7173	W. M. Keck Foundation; National Science Foundation [DMR-MRSEC-0820492]; National Institutes of Health [5K25GM85613, 5R01GM083122]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083122, K25GM085613, T32GM007596] Funding Source: NIH RePORTER	W. M. Keck Foundation(W.M. Keck Foundation); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge useful discussions with S. Fraden and M. Hagan. We are grateful to J. Chung and J. Gelles for their help in purification of microtubules and kinesin and also acknowledge D. Chen and E. Peck for images of beating Chlamydomonas reinhardtii. We are thankful to the IWF for their permission to use images of Opalina ranarum (Fig. 3C). This work was supported by funding from the W. M. Keck Foundation, National Science Foundation (DMR-MRSEC-0820492), and National Institutes of Health (5K25GM85613 to Z.D. and 5R01GM083122 to D.N.).	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Brangwynne CP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118104; Bray D., 2000, CELL MOVEMENTS MOL M; Brokaw CJ, 2009, CELL MOTIL CYTOSKEL, V66, P425, DOI 10.1002/cm.20313; Camalet S, 1999, PHYS REV LETT, V82, P1590, DOI 10.1103/PhysRevLett.82.1590; Claessens MMAE, 2006, NAT MATER, V5, P748, DOI 10.1038/nmat1718; Dreyfus R, 2005, NATURE, V437, P862, DOI 10.1038/nature04090; Dymek EE, 2007, J CELL BIOL, V179, P515, DOI 10.1083/jcb.200703107; GIBBONS BH, 1972, J CELL BIOL, V54, P75, DOI 10.1083/jcb.54.1.75; Gittes F, 1996, BIOPHYS J, V70, P418, DOI 10.1016/S0006-3495(96)79585-1; Guerin T, 2010, CURR OPIN CELL BIOL, V22, P14, DOI 10.1016/j.ceb.2009.12.012; Gueron S, 1999, P NATL ACAD SCI USA, V96, P12240, DOI 10.1073/pnas.96.22.12240; Guirao B, 2007, BIOPHYS J, V92, P1900, DOI 10.1529/biophysj.106.084897; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Horstmann E., 1964, IWF MOVIE C792 1959; Julicher F, 1997, PHYS REV LETT, V78, P4510, DOI 10.1103/PhysRevLett.78.4510; Lau AWC, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48006; Minoura I, 1999, CELL STRUCT FUNCT, V24, P27, DOI 10.1247/csf.24.27; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Needleman DJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.198104; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Placais PY, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.158102; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; SATIR P, 1968, J CELL BIOL, V39, P77, DOI 10.1083/jcb.39.1.77; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vilfan M, 2010, P NATL ACAD SCI USA, V107, P1844, DOI 10.1073/pnas.0906819106	32	169	171	1	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					456	459		10.1126/science.1203963	http://dx.doi.org/10.1126/science.1203963			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778400	Green Accepted			2022-12-28	WOS:000292959600047
J	Weinberg, DE; Nakanishi, K; Patel, DJ; Bartel, DP				Weinberg, David E.; Nakanishi, Kotaro; Patel, Dinshaw J.; Bartel, David P.			The Inside-Out Mechanism of Dicers from Budding Yeasts	CELL			English	Article							DOUBLE-STRANDED-RNA; COLI RIBONUCLEASE-III; STRUCTURAL BASIS; NUCLEASE DOMAIN; IN-VITRO; CLEAVAGE; RECOGNITION; DROSOPHILA; INSIGHTS; DSRNA	The Dicer ribonuclease III (RNase III) enzymes process long double-stranded RNA (dsRNA) into small interfering RNAs (siRNAs) that direct RNA interference. Here, we describe the structure and activity of a catalytically active fragment of Kluyveromyces polysporus Dcr1, which represents the noncanonical Dicers found in budding yeasts. The crystal structure revealed a homodimer resembling that of bacterial RNase III but extended by a unique N-terminal domain, and it identified additional catalytic residues conserved throughout eukaryotic RNase III enzymes. Biochemical analyses showed that Dcr1 dimers bind cooperatively along the dsRNA substrate such that the distance between consecutive active sites determines the length of the siRNA products. Thus, unlike canonical Dicers, which successively remove siRNA duplexes from the dsRNA termini, budding-yeast Dicers initiate processing in the interior and work outward. The distinct mechanism of budding-yeast Dicers establishes a paradigm for natural molecular rulers and imparts substrate preferences with ramifications for biological function.	[Nakanishi, Kotaro; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Weinberg, David E.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Weinberg, David E.; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Weinberg, David E.; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA	Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org; dbartel@wi.mit.edu		Nakanishi, Kotaro/0000-0002-9857-6010	National Institutes of Health [GM061835, AI121493]; National Science Foundation; Human Frontier Science Program Long-term Fellowship; Japan Society for the Promotion of Science for Research Abroad; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061835, R37GM061835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program Long-term Fellowship(Human Frontier Science Program); Japan Society for the Promotion of Science for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. A. Drinnenberg, G. Fink, R. Fukunaga, C. Jan, R. Sauer, and D. Shechner for helpful discussions, D. Koppstein for performing mammalian gene knockdown experiments, the Whitehead Genome Technology Core for high-throughput sequencing, P. Zamore for providing DmDcr-2 enzyme, F. Roth for providing pAG416Gal-Dicer plasmid, Q. Yin in the H. Wu laboratory for assistance with light scattering experiments, the X29 beamline at Brookhaven National Laboratory, and the NE-CAT beamline at the Advanced Photon Source, Argonne National Laboratory. This work was supported by National Institutes of Health grants GM061835 (D.P.B.) and AI121493 (D.J.P.), a National Science Foundation graduate research fellowship (D.E.W.), a Human Frontier Science Program Long-term Fellowship (K.N.), and a fellowship from the Japan Society for the Promotion of Science for Research Abroad (K.N.). D.P.B. is an Investigator of the Howard Hughes Medical Institute.	Akey DL, 2005, PROTEIN SCI, V14, P2744, DOI 10.1110/ps.051665905; Blaszczyk J, 2004, STRUCTURE, V12, P457, DOI 10.1016/j.str.2004.02.004; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Cenik ES, 2011, MOL CELL, V42, P172, DOI 10.1016/j.molcel.2011.03.002; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Du Z, 2008, P NATL ACAD SCI USA, V105, P2391, DOI 10.1073/pnas.0711506105; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gan JH, 2006, CELL, V124, P355, DOI 10.1016/j.cell.2005.11.034; Gan J, 2008, MOL MICROBIOL, V67, P143, DOI 10.1111/j.1365-2958.2007.06032.x; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOPWOOD D, 1975, HISTOCHEM J, V7, P267, DOI 10.1007/BF01003595; Lamontagne B, 2000, MOL CELL BIOL, V20, P1104, DOI 10.1128/MCB.20.4.1104-1115.2000; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leulliot N, 2004, EMBO J, V23, P2468, DOI 10.1038/sj.emboj.7600260; MacRae IJ, 2007, NAT STRUCT MOL BIOL, V14, P934, DOI 10.1038/nsmb1293; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Meng WZ, 2008, BIOCHEM J, V410, P39, DOI 10.1042/BJ20071047; Nussbaum AK, 1998, P NATL ACAD SCI USA, V95, P12504, DOI 10.1073/pnas.95.21.12504; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Sun WM, 2004, BIOCHEMISTRY-US, V43, P13054, DOI 10.1021/bi049258i; Sun WM, 2001, BIOCHEMISTRY-US, V40, P5102, DOI 10.1021/bi010022d; Takeshita D, 2007, J MOL BIOL, V374, P106, DOI 10.1016/j.jmb.2007.08.069; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; VAUCHERET H, 2005, SCI STKE, pPE43, DOI DOI 10.1126/STKE.3002005PE42; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005; WENZEL T, 1994, FEBS LETT, V349, P205, DOI 10.1016/0014-5793(94)00665-2; Wu HH, 2004, P NATL ACAD SCI USA, V101, P8307, DOI 10.1073/pnas.0402627101; Xiao JP, 2009, RNA, V15, P984, DOI 10.1261/rna.1196509; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	39	50	52	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 22	2011	146	2					262	276		10.1016/j.cell.2011.06.021	http://dx.doi.org/10.1016/j.cell.2011.06.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784247	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000293013000009
J	Laurance, J				Laurance, Jeremy			On Reflection A bug's life	LANCET			English	Editorial Material												j.laurance@independent.co.uk							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2011	378	9789					392	392		10.1016/S0140-6736(11)61198-7	http://dx.doi.org/10.1016/S0140-6736(11)61198-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XM	21803193				2022-12-28	WOS:000293615900015
J	Tanji-Suzuki, H; Chen, WL; Landig, R; Simon, J; Vuletic, V				Tanji-Suzuki, Haruka; Chen, Wenlan; Landig, Renate; Simon, Jonathan; Vuletic, Vladan			Vacuum-Induced Transparency	SCIENCE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; OPTICAL CAVITY; PHASE-SHIFTS; ATOMIC GAS; QUANTUM; INTERFERENCE	Photons are excellent information carriers but normally pass through each other without consequence. Engineered interactions between photons would enable applications as varied as quantum information processing and simulation of condensed matter systems. Using an ensemble of cold atoms strongly coupled to an optical cavity, we found that the transmission of light through a medium may be controlled with few photons and even by the electromagnetic vacuum field. The vacuum induces a group delay of 25 nanoseconds on the input optical pulse, corresponding to a light velocity of 1600 meters per second, and a transparency of 40% that increases to 80% when the cavity is filled with 10 photons. This strongly nonlinear effect provides prospects for advanced quantum devices such as photon number-state filters.	[Tanji-Suzuki, Haruka; Simon, Jonathan] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Tanji-Suzuki, Haruka; Chen, Wenlan; Landig, Renate; Vuletic, Vladan] MIT, Dept Phys, MIT Harvard Ctr Ultracold Atoms, Cambridge, MA 02139 USA; [Tanji-Suzuki, Haruka; Chen, Wenlan; Landig, Renate; Vuletic, Vladan] MIT, Elect Res Lab, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Tanji-Suzuki, H (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	haruka.tanji@post.harvard.edu	Vuletic, Vladan/M-8736-2019; Tanji-Suzuki, Haruka/AAC-7555-2019	Simon, Jonathan/0000-0001-7854-4647; Chen, Wenlan/0000-0003-1521-5365	NSF [PHY-0855052, PHY-0551153]; Defense Advanced Research Projects Agency through the Army Research Office	NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency through the Army Research Office	Supported by NSF grant PHY-0855052, the NSF-funded Center for Ultracold Atoms (grant PHY-0551153), and the Defense Advanced Research Projects Agency (QuASAR program) through the Army Research Office.	Bajcsy M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.203902; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; BOLLER KJ, 1991, PHYS REV LETT, V66, P2593, DOI 10.1103/PhysRevLett.66.2593; Brennecke F, 2007, NATURE, V450, P268, DOI 10.1038/nature06120; Chang DE, 2008, NAT PHYS, V4, P884, DOI 10.1038/nphys1074; Colombe Y, 2007, NATURE, V450, P272, DOI 10.1038/nature06331; FIELD JE, 1993, PHYS REV A, V47, P5064, DOI 10.1103/PhysRevA.47.5064; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Fushman I, 2008, SCIENCE, V320, P769, DOI 10.1126/science.1154643; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Gupta S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.213601; HARRIS SE, 1989, PHYS REV LETT, V62, P1033, DOI 10.1103/PhysRevLett.62.1033; Harris SE, 1998, PHYS REV LETT, V81, P3611, DOI 10.1103/PhysRevLett.81.3611; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; Kampschulte T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.153603; Kash MM, 1999, PHYS REV LETT, V82, P5229, DOI 10.1103/PhysRevLett.82.5229; Mucke M, 2010, NATURE, V465, P755, DOI 10.1038/nature09093; Munstermann P, 1999, PHYS REV LETT, V82, P3791, DOI 10.1103/PhysRevLett.82.3791; Nikoghosyan G, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.013601; Nussmann S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.173602; PELLIZZARI T, 1995, PHYS REV LETT, V75, P3788, DOI 10.1103/PhysRevLett.75.3788; Rauschenbeutel A, 1999, PHYS REV LETT, V83, P5166, DOI 10.1103/PhysRevLett.83.5166; Rice PR, 1996, OPT COMMUN, V126, P230, DOI 10.1016/0030-4018(96)00102-2; Schuster DI, 2007, NATURE, V445, P515, DOI 10.1038/nature05461; TANJISUZUKI H, 2011, ARXIVQUANTPH11043594; THOMPSON RJ, 1992, PHYS REV LETT, V68, P1132, DOI 10.1103/PhysRevLett.68.1132; TURCHETTE QA, 1995, PHYS REV LETT, V75, P4710, DOI 10.1103/PhysRevLett.75.4710; Vuletic V, 1998, PHYS REV LETT, V81, P5768, DOI 10.1103/PhysRevLett.81.5768	29	105	106	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1266	1269		10.1126/science.1208066	http://dx.doi.org/10.1126/science.1208066			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21817017	Green Submitted			2022-12-28	WOS:000294406400047
J	Sedzinski, J; Biro, M; Oswald, A; Tinevez, JY; Salbreux, G; Paluch, E				Sedzinski, Jakub; Biro, Mate; Oswald, Annelie; Tinevez, Jean-Yves; Salbreux, Guillaume; Paluch, Ewa			Polar actomyosin contractility destabilizes the position of the cytokinetic furrow	NATURE			English	Article							CLEAVAGE FURROW; CELL-SHAPE; MYOSIN-II; DYNAMICS; ANILLIN; ACTIN; RECRUITMENT; SIGNALS; TENSION; MITOSIS	Cytokinesis, the physical separation of daughter cells at the end of mitosis, requires precise regulation of the mechanical properties of the cell periphery(1,2). Although studies of cytokinetic mechanics mostly focus on the equatorial constriction ring(3), a contractile actomyosin cortex is also present at the poles of dividing cells(2,4). Whether polar forces influence cytokinetic cell shape and furrow positioning remains an open question. Here we demonstrate that the polar cortex makes cytokinesis inherently unstable. We show that limited asymmetric polar contractions occur during cytokinesis, and that perturbing the polar cortex leads to cell shape oscillations, resulting in furrow displacement and aneuploidy. A theoretical model based on a competition between cortex turnover and contraction dynamics accurately accounts for the oscillations. We further propose that membrane blebs, which commonly form at the poles of dividing cells(5) and whose role in cytokinesis has long been enigmatic, stabilize cell shape by acting as valves releasing cortical contractility. Our findings reveal an inherent instability in the shape of the dividing cell and unveil a novel, spindle-independent mechanism ensuring the stability of cleavage furrow positioning.	[Sedzinski, Jakub; Biro, Mate; Oswald, Annelie; Tinevez, Jean-Yves; Paluch, Ewa] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Sedzinski, Jakub; Biro, Mate; Tinevez, Jean-Yves; Paluch, Ewa] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Salbreux, Guillaume] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Max Planck Society; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Max Planck Society	Paluch, E (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	paluch@mpi-cbg.de	Tinevez, Jean-Yves/E-8398-2012; Biro, Maté/H-6292-2014; Tinevez, Jean-Yves/L-7581-2015; Tinevez, Jean-Yves/O-4551-2019	Tinevez, Jean-Yves/0000-0002-0998-4718; Biro, Maté/0000-0001-5852-3726; Tinevez, Jean-Yves/0000-0002-0998-4718; Tinevez, Jean-Yves/0000-0002-0998-4718; Paluch, Ewa/0000-0003-4691-2323; Sedzinski, Jakub/0000-0002-1788-0329; Salbreux, Guillaume/0000-0001-7041-1292	Polish Ministry of Science and Higher Education; Max Planck Society	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Max Planck Society(Max Planck Society)	We thank J. S. Bois, A. G. Clark, S. W. Grill, C. P. Heisenberg, J. Howard, A. A. Hyman, J. F. Joanny, D. K. Lubensky, A. Oates, M. Piel, I. M. Tolic-Norrelykke, W. Zachariae and M. Zerial for discussions and comments on the manuscript, and J. Roensch and the Max Planck Institute of Molecular Cell Biology and Genetics Light Microscopy Facility for technical assistance. This work was supported by the Polish Ministry of Science and Higher Education and by the Max Planck Society.	Blanchard GB, 2010, DEVELOPMENT, V137, P2743, DOI 10.1242/dev.045872; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; Burgess DR, 2005, TRENDS CELL BIOL, V15, P156, DOI 10.1016/j.tcb.2005.01.006; Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Dean SO, 2005, P NATL ACAD SCI USA, V102, P13473, DOI 10.1073/pnas.0506810102; Effler JC, 2007, CELL CYCLE, V6, P30, DOI 10.4161/cc.6.1.3674; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Hickson GRX, 2008, J CELL BIOL, V180, P285, DOI 10.1083/jcb.200709005; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; O'Connell CB, 2001, CURR BIOL, V11, P702, DOI 10.1016/S0960-9822(01)00181-6; Ou GS, 2010, SCIENCE, V330, P677, DOI 10.1126/science.1196112; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; PLATEAU JAF, 1873, STAT EXPT THEORIQUE, V2, pCH7; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0; Rankin KE, 2010, J CELL BIOL, V190, P35, DOI 10.1083/jcb.201004017; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Smith TC, 2010, CYTOSKELETON, V67, P346, DOI 10.1002/cm.20449; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Wang YL, 2005, TRENDS CELL BIOL, V15, P581, DOI 10.1016/j.tcb.2005.09.006; Werner M, 2008, BIOCHEM SOC T, V36, P371, DOI 10.1042/BST0360371; Werner M, 2007, CURR BIOL, V17, P1286, DOI 10.1016/j.cub.2007.06.070; YONEDA M, 1972, J EXP BIOL, V57, P575; Zhang WD, 2005, P NATL ACAD SCI USA, V102, P7186, DOI 10.1073/pnas.0502545102	33	238	240	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 25	2011	476	7361					462	U119		10.1038/nature10286	http://dx.doi.org/10.1038/nature10286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21822289				2022-12-28	WOS:000294209400039
J	Haymart, MR; Banerjee, M; Stewart, AK; Koenig, RJ; Birkmeyer, JD; Griggs, JJ				Haymart, Megan R.; Banerjee, Mousumi; Stewart, Andrew K.; Koenig, Ronald J.; Birkmeyer, John D.; Griggs, Jennifer J.			Use of Radioactive Iodine for Thyroid Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							2ND PRIMARY MALIGNANCIES; REMNANT ABLATION; PROGNOSTIC-FACTORS; PAPILLARY MICROCARCINOMA; INCREASING INCIDENCE; RADIOIODINE THERAPY; UNITED-STATES; CARCINOMA; I-131; SURVIVAL	Context Substantial uncertainty persists about the indications for radioactive iodine for thyroid cancer. Use of radioactive iodine over time and the correlates of its use remain unknown. Objective To determine practice patterns, the degree to which hospitals vary in their use of radioactive iodine, and factors that contribute to this variation. Design, Setting, and Patients Time trend analysis of radioactive iodine use in a cohort of 189 219 patients with well-differentiated thyroid cancer treated at 981 hospitals associated with the US National Cancer Database between 1990 and 2008. We used multilevel analysis to assess the correlates of patient and hospital characteristics on radioactive iodine use in the cohort treated from 2004 to 2008. Main Outcome Measure Use of radioactive iodine after total thyroidectomy. Results Between 1990 and 2008, across all tumor sizes, there was a significant increase in the proportion of patients with well-differentiated thyroid cancer receiving radioactive iodine (1373/3397 [40.4%] vs 11 539/20 620 [56.0%]; P<.001). Multivariable analysis of patients treated from 2004 to 2008 found that there was a statistical difference in radioactive iodine use between American Joint Committee on Cancer stages I and IV (odds ratio [OR], 0.34; 95% confidence interval [CI], 0.31-0.37) but not between stages II/III and IV (for stage II vs stage IV, OR, 0.97; 95% CI, 0.88-1.07 and for stage III vs stage IV, OR, 1.06; 95% CI, 0.95-1.17). In addition to patient and tumor characteristics, hospital volume was associated with radioactive iodine use. Wide variation in radioactive iodine use existed, and only 21.1% of this variation was accounted for by patient and tumor characteristics. Hospital type and case volume accounted for 17.1% of the variation. After adjusting for available patient, tumor, and hospital characteristics, 29.1% of the variance was attributable to unexplained hospital characteristics. Conclusion Among patients treated for well-differentiated thyroid cancer at hospitals in the National Cancer Database, there was an increase in the proportion receiving radioactive iodine between 1990 and 2008; much of the variation in use was associated with hospital characteristics.	[Haymart, Megan R.; Koenig, Ronald J.] Univ Michigan, Dept Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Haymart, Megan R.; Griggs, Jennifer J.] Univ Michigan, Dept Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Banerjee, Mousumi] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Birkmeyer, John D.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Griggs, Jennifer J.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Stewart, Andrew K.] Amer Coll Surg Commiss Canc, Chicago, IL USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Haymart, MR (corresponding author), Univ Michigan Hlth Syst, Dept Med, Div Metab Endocrinol & Diabet, 300 N Ingalls Bldg,NI 3A17, Ann Arbor, MI 48109 USA.	meganhay@umich.edu		Haymart, Megan/0000-0002-1083-1575	National Institutes of Health [1K07CA154595-01]; NATIONAL CANCER INSTITUTE [K07CA154595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Haymart is funded by grant 1K07CA154595-01 from the National Institutes of Health.	[Anonymous], 2003, MULTILEVEL METHODS P; Birkmeyer JD, 1998, SURGERY, V124, P917, DOI 10.1067/msy.1998.90268; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Bonnet S, 2009, J CLIN ENDOCR METAB, V94, P1162, DOI 10.1210/jc.2008-1931; Brierley J, 2005, CLIN ENDOCRINOL, V63, P418, DOI 10.1111/j.1365-2265.2005.02358.x; Brown AP, 2008, J CLIN ENDOCR METAB, V93, P504, DOI 10.1210/jc.2007-1154; Burns JA, 2004, OPHTHAL PLAST RECONS, V20, P126, DOI 10.1097/01.IOP.0000117340.41849.81; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Chow SM, 2006, ENDOCR-RELAT CANCER, V13, P1159, DOI 10.1677/erc.1.01320; Chow SM, 2006, LARYNGOSCOPE, V116, P2060, DOI 10.1097/01.mlg.0000240287.57704.01; Cobin R H, 2001, Endocr Pract, V7, P202; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Gilliland FD, 1997, CANCER-AM CANCER SOC, V79, P564, DOI 10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO;2-0; Greenberg CC, 2011, ARCH SURG-CHICAGO, V146, P1128, DOI 10.1001/archsurg.2011.141; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Griggs JJ, 2009, MED CARE, V47, P749, DOI 10.1097/MLR.0b013e31819748b3; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Hay ID, 2008, J NUCL MED, V49, P1395, DOI 10.2967/jnumed.108.052654; Hay ID, 2006, J SURG ONCOL, V94, P692, DOI 10.1002/jso.20696; Hay Ian D, 2002, Trans Am Clin Climatol Assoc, V113, P241; Hay ID, 2010, WORLD J SURG, V34, P1291, DOI 10.1007/s00268-010-0469-5; Hay ID, 2002, WORLD J SURG, V26, P879, DOI 10.1007/s00268-002-6612-1; Hughes DT, 2011, THYROID, V21, P231, DOI 10.1089/thy.2010.0137; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Hyer S, 2002, CLIN ENDOCRINOL, V56, P755, DOI 10.1046/j.1365-2265.2002.t01-1-01545.x; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Ito Y, 2010, WORLD J SURG, V34, P1285, DOI 10.1007/s00268-009-0356-0; Iyer NG, 2011, CANCER-AM CANCER SOC, V117, P4439, DOI 10.1002/cncr.26070; Jonklaas J, 2006, THYROID, V16, P1229, DOI 10.1089/thy.2006.16.1229; Jonklaas J, 2010, THYROID, V20, P1423, DOI 10.1089/thy.2010.0308; Jung TS, 2007, ENDOCR J, V54, P265, DOI 10.1507/endocrj.K06-166; Kloos RT, 2009, THYROID, V19, P925, DOI 10.1089/thy.2009.0236; Lin HW, 2009, LARYNGOSCOPE, V119, P1983, DOI 10.1002/lary.20617; Luster M, 2008, EUR J NUCL MED MOL I, V35, P1941, DOI 10.1007/s00259-008-0883-1; Malpani BL, 1996, INT J RADIAT ONCOL, V35, P535, DOI 10.1016/0360-3016(95)02138-8; MARTINEZTELLO FJ, 1993, CANCER-AM CANCER SOC, V71, P4022, DOI 10.1002/1097-0142(19930615)71:12<4022::AID-CNCR2820711236>3.0.CO;2-O; Mazzaferri EL, 2009, ONCOLOGY-NY, V23, P579; Molinaro E, 2009, THYROID, V19, P1035, DOI 10.1089/thy.2008.0430; Morgenstern KE, 2005, OPHTHAL PLAST RECONS, V21, P337, DOI 10.1097/01.iop.0000179369.75569.a8; National Cancer Institute, SURV EP END RES; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; Pace-Asciak PZ, 2007, ARCH OTOLARYNGOL, V133, P870, DOI 10.1001/archotol.133.9.870; Percy C, 2000, INT CLASSIFICATION D; Phillips JK, 2006, FACILITY ONCOLOGY DA; Podnos YD, 2007, J SURG ONCOL, V96, P3, DOI 10.1002/jso.20656; Raval MV, 2009, J SURG ONCOL, V99, P488, DOI 10.1002/jso.21173; RAYMOND JP, 1989, J CLIN ENDOCR METAB, V69, P186, DOI 10.1210/jcem-69-1-186; Rosario PW, 2008, J NUCL MED, V49, P1776, DOI 10.2967/jnumed.108.050591; Roti E, 2008, EUR J ENDOCRINOL, V159, P659, DOI 10.1530/EJE-07-0896; Rubino C, 2003, BRIT J CANCER, V89, P1638, DOI 10.1038/sj.bjc.6601319; Sandeep TC, 2006, J CLIN ENDOCR METAB, V91, P1819, DOI 10.1210/jc.2005-2009; Sawka AM, 2004, J CLIN ENDOCR METAB, V89, P3668, DOI 10.1210/jc.2003-031167; Sawka AM, 2009, THYROID, V19, P451, DOI 10.1089/thy.2008.0392; Sawka AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004191; Sherman Steven I, 2007, J Natl Compr Canc Netw, V5, P568; Sherman Steven I, 2005, J Natl Compr Canc Netw, V3, P404; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Sisson JC, 2011, THYROID, V21, P335, DOI 10.1089/thy.2010.0403; SISSON JC, 1983, J NUCL MED, V24, P743; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Snijders T, 1999, MULTILEVEL ANAL; Solans R, 2001, J NUCL MED, V42, P738; Tuttle RM, 2010, J NATL COMPR CANC NE, V8, P1228, DOI 10.6004/jnccn.2010.0093; VANNOSTRAND D, 1986, J NUCL MED, V27, P1519; VARMA VM, 1970, J AMER MED ASSOC, V214, P1437, DOI 10.1001/jama.214.8.1437; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Wennberg JE, 1999, NEW ENGL J MED, V340, P52, DOI 10.1056/NEJM199901073400111; WENNBERG JE, 1982, SOC SCI MED, V16, P811, DOI 10.1016/0277-9536(82)90234-9	73	144	151	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					721	728		10.1001/jama.2011.1139	http://dx.doi.org/10.1001/jama.2011.1139			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807LP	21846853	Green Accepted			2022-12-28	WOS:000293900000021
J	Warlow, C				Warlow, Charles			Ombudsman's ninth report	LANCET			English	Editorial Material									Univ Edinburgh, Dept Clin Neurosci, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Warlow, C (corresponding author), Univ Edinburgh, Dept Clin Neurosci, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland.	ombudsman@lancet.com						Horton R, 2004, LANCET, V363, P747, DOI 10.1016/S0140-6736(04)15714-0	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 13	2011	378	9791					548	549		10.1016/S0140-6736(11)60995-1	http://dx.doi.org/10.1016/S0140-6736(11)60995-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812UX	21840446				2022-12-28	WOS:000294319500007
J	Elimelech, M; Phillip, WA				Elimelech, Menachem; Phillip, William A.			The Future of Seawater Desalination: Energy, Technology, and the Environment	SCIENCE			English	Review							REVERSE-OSMOSIS MEMBRANE; CARBON NANOTUBE MEMBRANES; WATER DESALINATION; THERMODYNAMIC RESTRICTION; RO; PURIFICATION; POLYAMIDE; PROTEIN; DESIGN; DERIVATIVES	In recent years, numerous large-scale seawater desalination plants have been built in water-stressed countries to augment available water resources, and construction of new desalination plants is expected to increase in the near future. Despite major advancements in desalination technologies, seawater desalination is still more energy intensive compared to conventional technologies for the treatment of fresh water. There are also concerns about the potential environmental impacts of large-scale seawater desalination plants. Here, we review the possible reductions in energy demand by state-of-the-art seawater desalination technologies, the potential role of advanced materials and innovative technologies in improving performance, and the sustainability of desalination as a technological solution to global water shortages.	[Elimelech, Menachem; Phillip, William A.] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA	Yale University	Elimelech, M (corresponding author), Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.	menachem.elimelech@yale.edu	Phillip, William A/B-4580-2011; Elimelech, Menachem/E-7137-2012	Elimelech, Menachem/0000-0003-4186-1563	WaterCAMPWS, a Science and Technology Center of Advanced Materials for the Purification of Water with Systems under NSF [CTS-0120978]	WaterCAMPWS, a Science and Technology Center of Advanced Materials for the Purification of Water with Systems under NSF	We acknowledge the support of WaterCAMPWS, a Science and Technology Center of Advanced Materials for the Purification of Water with Systems under NSF grant CTS-0120978. We also thank L. Hoover and A. Martinez for help with the manuscript, and E. L. Cussler, T. Pankratz, and M. Wilf for helpful discussions.	Busch M, 2004, DESALINATION, V165, P299, DOI 10.1016/j.desal.2004.06.035; Callow JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1251; Cath TY, 2010, J MEMBRANE SCI, V362, P417, DOI 10.1016/j.memsci.2010.06.056; Committee on Advancing Desalination Technology of the National Research Council (U.S.), 2008, DES NAT PERSP; Cooley H, 2006, DESALINATION GRAIN S; Coronell O, 2008, ENVIRON SCI TECHNOL, V42, P5260, DOI 10.1021/es8002712; Corry B, 2008, J PHYS CHEM B, V112, P1427, DOI 10.1021/jp709845u; Dreizin Y, 2008, DESALINATION, V220, P132, DOI 10.1016/j.desal.2007.01.028; Efraty A., 2010, Patent No. [US7695614B2, 7695614]; Elimelech M, 1997, J MEMBRANE SCI, V127, P101, DOI 10.1016/S0376-7388(96)00351-1; Falk K, 2010, NANO LETT, V10, P4067, DOI 10.1021/nl1021046; Fritzmann C, 2007, DESALINATION, V216, P1, DOI 10.1016/j.desal.2006.12.009; Geise GM, 2011, J MEMBRANE SCI, V369, P130, DOI 10.1016/j.memsci.2010.11.054; Gilron J, 2007, IND ENG CHEM RES, V46, P2324, DOI 10.1021/ie060999k; GLATER J, 1994, DESALINATION, V95, P325, DOI 10.1016/0011-9164(94)00068-9; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407; Johnson J, 2010, DESALIN WATER TREAT, V15, P236, DOI 10.5004/dwt.2010.1756; Kang S, 2007, J MEMBRANE SCI, V296, P42, DOI 10.1016/j.memsci.2007.03.012; Kim SJ, 2010, NAT NANOTECHNOL, V5, P297, DOI [10.1038/NNANO.2010.34, 10.1038/nnano.2010.34]; Koros WJ, 2004, AICHE J, V50, P2326, DOI 10.1002/aic.10330; Kumar M, 2007, P NATL ACAD SCI USA, V104, P20719, DOI 10.1073/pnas.0708762104; LARSON RE, 1981, DESALINATION, V38, P473, DOI 10.1016/S0011-9164(00)86092-0; Lattemann S, 2008, DESALINATION, V220, P1, DOI 10.1016/j.desal.2007.03.009; Lee KP, 2011, J MEMBRANE SCI, V370, P1, DOI 10.1016/j.memsci.2010.12.036; Loeb S. S. S., 1963, ADV CHEM SER, V38, P117, DOI [10.1021/ba-1963-0038, DOI 10.1021/ADVANCES]; MacHarg J., 2008, DESALINATION WATER R, V18, P30; Majumder M, 2005, NATURE, V438, P930, DOI 10.1038/438930b; McCutcheon JR, 2005, DESALINATION, V174, P1, DOI 10.1016/j.desal.2004.11.002; McGinnis RL, 2007, DESALINATION, V207, P370, DOI 10.1016/j.desal.2006.08.012; Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m; Pacheco FA, 2010, J MEMBRANE SCI, V358, P51, DOI 10.1016/j.memsci.2010.04.032; Park HB, 2008, ANGEW CHEM INT EDIT, V47, P6019, DOI 10.1002/anie.200800454; Paul DR, 2004, J MEMBRANE SCI, V241, P371, DOI 10.1016/j.memsci.2004.05.026; Raluy G, 2006, ENERGY, V31, P2361, DOI 10.1016/j.energy.2006.02.005; Schiermeier Q, 2008, NATURE, V452, P260, DOI 10.1038/452260a; Semiat R, 2008, ENVIRON SCI TECHNOL, V42, P8193, DOI 10.1021/es801330u; Service RF, 2006, SCIENCE, V313, P1088, DOI 10.1126/science.313.5790.1088; Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599; Siegers C, 2004, CHEM-EUR J, V10, P2831, DOI 10.1002/chem.200306073; Song LF, 2003, DESALINATION, V155, P213, DOI 10.1016/S0011-9164(03)00300-X; Spiegler KS, 2001, DESALINATION, V134, P109, DOI 10.1016/S0011-9164(01)00121-7; STOUGHTON RW, 1965, J CHEM ENG DATA, V10, P254, DOI 10.1021/je60026a016; Stover RL, 2007, DESALINATION, V203, P168, DOI 10.1016/j.desal.2006.03.528; Tal A, 2006, SCIENCE, V313, P1081, DOI 10.1126/science.1126011; Tang CYY, 2009, DESALINATION, V242, P168, DOI 10.1016/j.desal.2008.04.004; von Medeazza GLM, 2005, DESALINATION, V185, P57, DOI 10.1016/j.desal.2005.03.071; Wilf M, 1997, DESALINATION, V113, P157, DOI 10.1016/S0011-9164(97)00124-0; Zhou MJ, 2007, J AM CHEM SOC, V129, P9574, DOI 10.1021/ja073067w; Zhu AZ, 2009, IND ENG CHEM RES, V48, P6010, DOI 10.1021/ie800735q	50	3931	4040	271	4453	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					712	717		10.1126/science.1200488	http://dx.doi.org/10.1126/science.1200488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817042				2022-12-28	WOS:000293512100031
J	Cohen, D				Cohen, David			PROFILE Edzard Ernst: the prince and me	BRITISH MEDICAL JOURNAL			English	Biographical-Item												mail@davidcohen.net							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2011	343								d4937	10.1136/bmj.d4937	http://dx.doi.org/10.1136/bmj.d4937			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NN	21816747				2022-12-28	WOS:000293734700010
J	Kesavelu, D; Dalzell, M; Eaton, V				Kesavelu, Dhanasekhar; Dalzell, Mark; Eaton, Vicki			CASE REPORT Abdominal distension in a 4 year old	BRITISH MEDICAL JOURNAL			English	Editorial Material							CELIAC-DISEASE; DIAGNOSIS; SENSITIVITY; CHILDREN		[Kesavelu, Dhanasekhar; Dalzell, Mark] Alder Hey Childrens Hosp, Liverpool L12 2AP, Merseyside, England; [Eaton, Vicki] Mersey Deanery, Liverpool L3 4BL, Merseyside, England	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital	Kesavelu, D (corresponding author), Alder Hey Childrens Hosp, Liverpool L12 2AP, Merseyside, England.	dkesavelu@doctors.org.uk	KESAVELU, DHANASEKHAR/AAV-8310-2020	KESAVELU, DHANASEKHAR/0000-0003-4051-3102				Cataldo F, 1997, J PEDIATR-US, V131, P306, DOI 10.1016/S0022-3476(97)70172-0; Hill ID, 2005, GASTROENTEROLOGY, V128, pS25, DOI 10.1053/j.gastro.2005.02.012; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Hopper AD, 2007, BMJ-BRIT MED J, V334, P729, DOI 10.1136/bmj.39133.668681.BE; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; *NAT I HLTH CLIN E, 2009, CG86 NAT I HLTH CLIN; Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition, 1990, ARCH DIS CHILD, V65, P909; Tumer L, 2001, PEDIATR INT, V43, P71, DOI 10.1046/j.1442-200x.2001.01327.x	8	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2011	343								d3614	10.1136/bmj.d3614	http://dx.doi.org/10.1136/bmj.d3614			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	805NN	21816738				2022-12-28	WOS:000293734700001
J	Rees, S; Silove, D; Chey, T; Ivancic, L; Steel, Z; Creamer, M; Teesson, M; Bryant, R; McFarlane, AC; Mills, KL; Slade, T; Carragher, N; O'Donnell, M; Forbes, D				Rees, Susan; Silove, Derrick; Chey, Tien; Ivancic, Lorraine; Steel, Zachary; Creamer, Mark; Teesson, Maree; Bryant, Richard; McFarlane, Alexander C.; Mills, Katherine L.; Slade, Tim; Carragher, Natacha; O'Donnell, Meaghan; Forbes, David			Lifetime Prevalence of Gender-Based Violence in Women and the Relationship With Mental Disorders and Psychosocial Function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTIMATE PARTNER VIOLENCE; NATIONALLY REPRESENTATIVE SAMPLE; DOMESTIC VIOLENCE; HEALTH; ORGANIZATION; VERSION	Context Intimate partner physical violence, rape, sexual assault, and stalking are pervasive and co-occurring forms of gender-based violence (GBV). An association between these forms of abuse and lifetime mental disorder and psychosocial disability among women needs to be examined. Objectives To assess the association of GBV and mental disorder, its severity and comorbidity, and psychosocial functioning among women. Design, Setting, and Participants A cross-sectional study based on the Australian National Mental Health and Well-being Survey in 2007, of 4451 women (65% response rate) aged 16 to 85 years. Main Outcome Measures The Composite International Diagnostic Interview version 3.0 of the World Health Organization's World Mental Health Survey Initiative was used to assess lifetime prevalence of any mental disorder, anxiety, mood disorder, substance use disorder, and posttraumatic stress disorder (PTSD). Also included were indices of lifetime trauma exposure, including GBV, sociodemographic characteristics, economic status, family history of mental disorder, social supports, general mental and physical functioning, quality of life, and overall disability. Results A total of 1218 women (27.4%) reported experiencing at least 1 type of GBV. For women exposed to 3 or 4 types of GBV (n=139), the rates of mental disorders were 77.3% (odds ratio [OR], 10.06; 95% confidence interval [CI], 5.85-17.30) for anxiety disorders, 52.5% (OR, 3.59; 95% CI, 2.31-5.60) for mood disorder, 47.1% (OR, 5.61; 95% CI, 3.46-9.10) for substance use disorder, 56.2% (OR, 15.90; 95% CI, 8.32-30.20) for PTSD, 89.4% (OR, 11.00; 95% CI, 5.46-22.17) for any mental disorder, and 34.7% (OR, 14.80; 95% CI, 6.89-31.60) for suicide attempts. Gender-based violence was associated with more severe current mental disorder (OR, 4.60; 95% CI, 2.93-7.22), higher rates of 3 or more lifetime disorders (OR, 7.79; 95% CI, 6.10-9.95), physical disability (OR, 4.00; 95% CI, 1.82-8.82), mental disability (OR, 7.14; 95% CI, 2.87-17.75), impaired quality of life (OR, 2.96; 95% CI, 1.60-5.47), an increase in disability days (OR, 3.14; 95% CI, 2.43-4.05), and overall disability (OR, 2.73; 95% CI, 1.99-3.75). Conclusion Among a nationally representative sample of Australian women, GBV was significantly associated with mental health disorder, dysfunction, and disability.	[Rees, Susan; Silove, Derrick; Ivancic, Lorraine; Steel, Zachary] Univ New S Wales, Sch Psychiat, Sydney, NSW 2170, Australia; [Bryant, Richard] Univ New S Wales, Sch Psychol, Sydney, NSW 2170, Australia; [Rees, Susan; Silove, Derrick; Chey, Tien; Ivancic, Lorraine; Steel, Zachary] Sydney SW Area Hlth Network, Ctr Populat Mental Hlth Res, Sydney, NSW, Australia; [Creamer, Mark; O'Donnell, Meaghan; Forbes, David] Univ Melbourne, Dept Psychiat, Australian Ctr Posttraumat Mental Hlth, Melbourne, Vic, Australia; [Teesson, Maree; Mills, Katherine L.; Slade, Tim; Carragher, Natacha] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2170, Australia; [McFarlane, Alexander C.] Univ Adelaide, Ctr Mil & Vet Hlth, Adelaide, SA, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Melbourne; University of New South Wales Sydney; University of Adelaide	Rees, S (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW 2170, Australia.	s.j.rees@unsw.edu.au	Bryant, Richard/AAA-6479-2019; Teesson, Maree/AFM-2972-2022; Slade, Tim/O-2031-2019	Bryant, Richard/0000-0002-9607-819X; Steel, Zachary/0000-0002-5048-2920; Teesson, Maree Rose/0000-0002-6744-463X; Forbes, David/0000-0001-9145-1605; O'Donnell, Meaghan/0000-0003-4349-0022	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grant funding from the National Health and Medical Research Council of Australia.	Afifi TO, 2009, J INTERPERS VIOLENCE, V24, P1398, DOI 10.1177/0886260508322192; [Anonymous], WHODAS 2 DIS ASS SCH; Australian Bureau of Statistics, 2004, DIS AG CAR; Australian Bureau of Statistics, 2006, INF PAP INTR SOC IND; Basile KC, 2004, J TRAUMA STRESS, V17, P413, DOI 10.1023/B:JOTS.0000048954.50232.d8; Berntsen D, 2003, APPL COGNITIVE PSYCH, V17, P675, DOI 10.1002/acp.894; Brown PJ, 2003, TRAUMA AND SUBSTANCE ABUSE: CAUSES, CONSEQUENCES, AND TREATMENT OF COMORBID DISORDERS, P171, DOI 10.1037/10460-009; Carragher N, 2010, J ANXIETY DISORD, V24, P520, DOI 10.1016/j.janxdis.2010.03.009; Center for Health and Gender Equity, 1999, MENT HLTH BEH OUTC S; Coker AL, 2000, AM J PUBLIC HEALTH, V90, P553, DOI 10.2105/AJPH.90.4.553; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; Ellsberg M, 2002, LANCET, V359, P1599, DOI 10.1016/S0140-6736(02)08521-5; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Hawthorne G, 2001, 12 CTR HLTH PROGR EV, P69; Headspace, 2020, HEADSP NAT YOUTH MEN; Hegarty K, 2000, MED J AUSTRALIA, V173, P363, DOI 10.5694/j.1326-5377.2000.tb125688.x; HYMAN A, 1995, JAMA-J AM MED ASSOC, V273, P1781, DOI 10.1001/jama.273.22.1781; Jordan CE, 2010, ANNU REV CLIN PSYCHO, V6, P607, DOI 10.1146/annurev-clinpsy-090209-151437; Kershaw C, 2001 BRIT CRIME SURV; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; MacMillan HL, 2006, JAMA-J AM MED ASSOC, V296, P530, DOI 10.1001/jama.296.5.530; Ramsay J, 2002, BRIT MED J, V325, P314, DOI 10.1136/bmj.325.7359.314; Rees, 2004, AUSTR J HUMAN RIGHTS, V10, P97, DOI [10.1080/1323238x.2004.11910772, DOI 10.1080/1323238X.2004.11910772, https://doi.org/10.1080/1323238X.2004.11910772]; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Slade T, 2009, AUST NZ J PSYCHIAT, V43, P594, DOI 10.1080/00048670902970882; Spitzberg B.H., 2002, TRAUMA VIOLENCE ABUS, V3, P261, DOI [DOI 10.1177/1524838002237330, 10.1177/1524838002237330]; Testa M, 2007, J CONSULT CLIN PSYCH, V75, P52, DOI 10.1037/0022-006X.75.1.52; Tjaden P, 2000, EXTENT NATURE CONSEQ; US Department of Justice, 2004, VIOL WOM ID RISK FAC; Wathen CN, 2003, JAMA-J AM MED ASSOC, V289, P589, DOI 10.1001/jama.289.5.589; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1	34	262	265	2	72	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2011	306	5					513	521		10.1001/jama.2011.1098	http://dx.doi.org/10.1001/jama.2011.1098			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	800SH	21813429	Bronze			2022-12-28	WOS:000293386500018
J	Kuo, YF; Goodwin, JS				Kuo, Yong-Fang; Goodwin, James S.			Association of Hospitalist Care With Medical Utilization After Discharge: Evidence of Cost Shift From a Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							PATIENT SAFETY; OUTPATIENT; SERVICE; CONTINUITY; PHYSICIANS; INPATIENT; OUTCOMES; COMMUNICATION; TRANSITIONS; RISK	Background: Hospitalist care has grown rapidly, in part because it is associated with decreased length of stay and hospital costs. No national studies examining the effect of hospitalist care on hospital costs or on medical utilization and costs after discharge have been done. Objective: To assess the relationship of hospitalist care with hospital length of stay, hospital charges, and medical utilization and Medicare costs after discharge. Design: Population-based national cohort study. Setting: Hospital care of Medicare patients. Patients: A 5% national sample of enrollees in Medicare parts A and B with a primary care physician who were cared for by their primary care physician or a hospitalist during medical hospitalizations from 2001 to 2006. Measurements: Length of stay, hospital charges, discharge location and physician visits, emergency department visits, rehospitalization, and Medicare spending within 30 days after discharge. Results: In propensity score analysis, hospital length of stay was 0.64 day less among patients receiving hospitalist care. Hospital charges were $282 lower, whereas Medicare costs in the 30 days after discharge were $332 higher (P < 0.001 for both). Patients cared for by hospitalists were less likely to be discharged to home (odds ratio, 0.82 [95% CI, 0.78 to 0.86]) and were more likely to have emergency department visits (odds ratio, 1.18 [CI, 1.12 to 1.24]) and readmissions (odds ratio, 1.08 [CI, 1.02 to 1.14]) after discharge. They also had fewer visits with their primary care physician and more nursing facility visits after discharge. Limitation: Observational studies are subject to selection bias. Conclusion: Decreased length of stay and hospital costs associated with hospitalist care are offset by higher medical utilization and costs after discharge.	[Kuo, Yong-Fang] Univ Texas Med Branch, Dept Internal Med, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Kuo, YF (corresponding author), Univ Texas Med Branch, Dept Internal Med, Sealy Ctr Aging, 301 Univ Blvd, Galveston, TX 77555 USA.	yokuo@utmb.edu			National Institute on Aging [1R01-AG033134, P30AG024832]; National Cancer Institute [K05-CA134923]; NATIONAL CANCER INSTITUTE [K05CA134923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033134, P30AG024832] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Institute on Aging (grants 1R01-AG033134 and P30AG024832) and the National Cancer Institute (grant K05-CA134923).	Anderson GF, 1999, ARCH FAM MED, V8, P149, DOI 10.1001/archfami.8.2.149; Centers for Medicare & Medicaid Services, 100 MEDPAR INP HOSP; Coleman EA, 2004, HEALTH SERV RES, V39, P1449, DOI 10.1111/j.1475-6773.2004.00298.x; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Donini-Lenhoff F, 2005, GUIDEBOOK GME PROGRA, P59; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Forster AJ, 2005, J GEN INTERN MED, V20, P317, DOI 10.1111/j.1525-1497.2005.30390.x; Frakt AB, 2005, HEALTH CARE FINANC R, V26, P21; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Go JT, 2010, J HOSP MED, V5, P133, DOI 10.1002/jhm.612; Griswold ME, 2010, ANN INTERN MED, V152, P393, DOI 10.7326/0003-4819-152-6-201003160-00010; Hinami K, 2009, J HOSP MED, V4, P535, DOI 10.1002/jhm.523; Howrey B, MED CARE IN PRESS; Kearns PJ, 2001, ARCH INTERN MED, V161, P235, DOI 10.1001/archinte.161.2.235; Koroukian SM, 2008, MED CARE, V46, P1184, DOI 10.1097/MLR.0b013e31817925d2; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kuo YF, 2010, J AM GERIATR SOC, V58, P1649, DOI 10.1111/j.1532-5415.2010.03007.x; Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Lindenauer PK, 2007, NEW ENGL J MED, V357, P2589, DOI 10.1056/NEJMsa067735; McWilliams JM, 2009, ANN INTERN MED, V151, P757, DOI 10.7326/0003-4819-151-11-200912010-00149; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Mullahy J, 1998, J HEALTH ECON, V17, P247, DOI 10.1016/S0167-6296(98)00030-7; Palmer HC, 2001, AM J MED, V111, P627, DOI 10.1016/S0002-9343(01)00976-7; Pham HH, 2008, HEALTH AFFAIR, V27, P1315, DOI 10.1377/hlthaff.27.5.1315; Rabe-Hesketh S.S.A., 2005, MULTILEVEL LONGITUDI; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Shah BR, 2007, HEALTH SERV RES, V42, P1783, DOI 10.1111/j.1475-6773.2006.00681.x; Sharma G, 2010, ARCH INTERN MED, V170, P1664, DOI 10.1001/archinternmed.2010.345; Sharma G, 2009, JAMA-J AM MED ASSOC, V301, P1671, DOI 10.1001/jama.2009.517; Sharma G, 2009, ARCH INTERN MED, V169, P81, DOI 10.1001/archinternmed.2008.514; Wachter RM, 1998, JAMA-J AM MED ASSOC, V279, P1560, DOI 10.1001/jama.279.19.1560; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103	35	81	82	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2011	155	3					152	+		10.7326/0003-4819-155-3-201108020-00005	http://dx.doi.org/10.7326/0003-4819-155-3-201108020-00005			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	800DJ	21810708	Green Accepted			2022-12-28	WOS:000293339600003
J	Mahle, W; Koppel, R				Mahle, William; Koppel, Robert			Screening with pulse oximetry for congenital heart disease	LANCET			English	Editorial Material									[Mahle, William] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Mahle, William] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Koppel, Robert] Cohen Childrens Med Ctr, New York, NY USA	Children's Healthcare of Atlanta (CHOA); Emory University; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York	Mahle, W (corresponding author), Childrens Healthcare Atlanta, Atlanta, GA 30322 USA.	mahlew@kidsheart.com						Bakr AF, 2005, PEDIATR CARDIOL, V26, P832, DOI 10.1007/s00246-005-0981-9; Chang RKR, 2008, ARCH PEDIAT ADOL MED, V162, P969, DOI 10.1001/archpedi.162.10.969; *DEP HLTH HUM RES, 2005, NEWB SCREEN UN SCREE; Ewer AK, 2011, LANCET, V378, P785, DOI 10.1016/S0140-6736(11)60753-8; Granelli AD, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3037; GROSSE SD, 2008, 30 ANN M SOC MED DEC, pE26; Koppel RI, 2003, PEDIATRICS, V111, P451, DOI 10.1542/peds.111.3.451; Riede FT, 2010, EUR J PEDIATR, V169, P975, DOI 10.1007/s00431-010-1160-4; Varness TS, 2005, J PEDIATR-US, V147, P493, DOI 10.1016/j.jpeds.2005.04.035; Wilson JMG, 1968, PRINCIPLES PRACTICE	10	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2011	378	9793					749	750		10.1016/S0140-6736(11)61032-5	http://dx.doi.org/10.1016/S0140-6736(11)61032-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21820731				2022-12-28	WOS:000294585300008
J	Peng, XZ				Peng, Xizhe			China's Demographic History and Future Challenges	SCIENCE			English	Review							FERTILITY; POLICY	On 28 April 2011, China's state statistics bureau released its first report on the country's 2010 population census. The report states that the total population of mainland China reached 1.3397 billion in 2010, with an annual average population growth rate of 0.57% during the previous 10 years. The share of the total population aged 0 to 14 declined from 22.9% in 2000 to 16.6% in 2010, whereas the proportion aged 65 and above grew from 7.0% to 8.9% during the same period. This indicates that China's population is aging rapidly. The report also shows that China is urbanizing, with nearly half of the population-665.57 million people, or 49.7%-living in urban areas, an increase of 13 percentage points over the 2000 figure. Moreover, about 260 million Chinese people are living away from where they are formally registered, and the overwhelming majority of them (about 220 million) are rural migrants living and working in urban areas but without formal urban household registration status. China is at a demographic turning point: It is changing from an agricultural society into an urban one, from a young society to an old one, and from a society attached to the land to one that is very much on the move.	Fudan Univ, Sch Social Dev & Publ Policy, Shanghai 200433, Peoples R China	Fudan University	Peng, XZ (corresponding author), Fudan Univ, Sch Social Dev & Publ Policy, Shanghai 200433, Peoples R China.	xzpeng@fudan.edu.cn			Fudan University [07FCZD033]	Fudan University	I thank T. Dyson, Z. Zhai, Y. Cheng, Z. Hu, and Z. Su for their valuable comments, encouragement, and efficient assistance in writing this article. I am indebted to various colleagues and students who provided and compiled review materials. I am very grateful for the insight, comments, and suggestions of two referees. This review is partially supported by Fudan University 985 Fund (serial no. 07FCZD033).	[Anonymous], 2011, CHINA DAILY     0609; Banister J., 1992, POPULATION MODERN CH, P163; Bloom DE, 2009, ASIAN ECON POLICY R, V4, P45, DOI 10.1111/j.1748-3131.2009.01106.x; Cai F., 2008, LEWIS TURNING POINT; Cai Y, 2010, POPUL DEV REV, V36, P419, DOI 10.1111/j.1728-4457.2010.00341.x; Chen X., 2011, INT J COMP SOCIOL, V48, P167; Dalton M., 2007, POP ASS AM ANN M NEW; Dyson T, 2010, POPULATION DEV DEMOG; Feng W, 2011, POPUL DEV REV, V37, P173, DOI 10.1111/j.1728-4457.2011.00383.x; Feng W, 2010, CURR HIST, V109, P244; Feng X., 2000, SOC SCI CHINA; Gao P., 2011, COMP STUDIES, V53, P24; Ge QS, 2011, PRESENT CARBON EMISS; Gu BC, 2007, POPUL DEV REV, V33, P129, DOI 10.1111/j.1728-4457.2007.00161.x; Hu A., 2011, EC INFORM DAILY 0627; Huang YP, 2010, CHINA ECON J, V3, P191, DOI 10.1080/17538963.2010.511920; Hussain A., 2009, DEVISSUES, V11, P9; Jiang Z., 2007, REPORT CHINAS NATL S; Li, 2007, IMBALANCED SEX RATIO; Mao Y., 2007, THERE IS NO FOOD CRI; Ministry of Education, STAT COMM NAT ED DEV; [Ministry of Human Resources & Social Security PRC], 2011, PRC CHIN HUM RES SOC; Morgan SP, 2009, POPUL DEV REV, V35, P605, DOI 10.1111/j.1728-4457.2009.00298.x; [Nation Bureau of Statistics PRC], 2011, PRC CHIN MAIN DEM IN; Peng X., 2011, SOC SCI CHINA, V189, P121; PENG XZ, 1987, POPUL DEV REV, V13, P639, DOI 10.2307/1973026; Qiao H. H., 2007, BRICS, P4558; Shen JF, 2007, HABITAT INT, V31, P303, DOI 10.1016/j.habitatint.2007.04.001; SMIL V, 1999, CHINA QUART, V158, P414, DOI DOI 10.1017/S030574100000583X; United Nations Population Division, 2011, WORLD POP PROSP 2010; Wei S., 2009, 15093 NBER; Woetzel J, 2008, PREPARING CHINAS URB; Yang J. F., 2005, CHINA J EPIDEMIOL, V26, P934; Yu Y., 1997, P 23 IUSSP GEN POP C, P25; Zeng Y, 2007, POPUL DEV REV, V33, P215, DOI 10.1111/j.1728-4457.2007.00168.x; Zhai Z., 2010, CHINAS DEMOGRAPHIC T; Zhang L, 2008, HABITAT INT, V32, P452, DOI 10.1016/j.habitatint.2008.01.001; Zhao Z., 2007, TRANSITION CHALLENGE, P160; Zheng X., 2003, POPUL SCI CHINA, V4, P23; Zhu L., 2010, CHIN J POPUL SCI, V140, P2; Zhu Q., 2011, POPULATION CONSUMPTI	41	303	319	15	325	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					581	587		10.1126/science.1209396	http://dx.doi.org/10.1126/science.1209396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	798PI	21798939				2022-12-28	WOS:000293222400049
J	Bobrow, M				Bobrow, Martin			Regulate research at the animal-human interface	NATURE			English	Editorial Material									[Bobrow, Martin] Univ Cambridge, Cambridge CB2 1TN, England	University of Cambridge	Bobrow, M (corresponding author), Univ Cambridge, Cambridge CB2 1TN, England.	Laura.Boothman@acmedsci.ac.uk						Academy of Medical Sciences, 2011, AN CONT HUM MAT, V4; Greely HT, 2007, AM J BIOETHICS, V7, P27, DOI 10.1080/15265160701290371; *IPSOS MORI, 2010, EXPL BOUND REP PUBL; Zeng FY, 2006, P NATL ACAD SCI USA, V103, P7801, DOI 10.1073/pnas.0602646103	4	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					448	448		10.1038/475448a	http://dx.doi.org/10.1038/475448a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	797ZA	21796184				2022-12-28	WOS:000293167900015
J	Bermejo, R; Capra, T; Jossen, R; Colosio, A; Frattini, C; Carotenuto, W; Cocito, A; Doksani, Y; Klein, H; Gomez-Gonzalez, B; Aguilera, A; Katou, Y; Shirahige, K; Foiani, M				Bermejo, Rodrigo; Capra, Thelma; Jossen, Rachel; Colosio, Arianna; Frattini, Camilla; Carotenuto, Walter; Cocito, Andrea; Doksani, Ylli; Klein, Hannah; Gomez-Gonzalez, Belen; Aguilera, Andres; Katou, Yuki; Shirahige, Katsuhiko; Foiani, Marco			The Replication Checkpoint Protects Fork Stability by Releasing Transcribed Genes from Nuclear Pores	CELL			English	Article							HEAD-ON COLLISION; DNA-DAMAGE; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; GENOME STABILITY; ORIGINS; RECOMBINATION; PROGRESSION; LOCALIZATION; ORGANIZATION	Transcription hinders replication fork progression and stability, and the Mec1/ATR checkpoint protects fork integrity. Examining checkpoint-dependent mechanisms controlling fork stability, we find that fork reversal and dormant origin firing due to checkpoint defects are rescued in checkpoint mutants lacking THO, TREX-2, or inner-basket nucleoporins. Gene gating tethers transcribed genes to the nuclear periphery and is counteracted by checkpoint kinases through phosphorylation of nucleoporins such as Mlp1. Checkpoint mutants fail to detach transcribed genes from nuclear pores, thus generating topological impediments for incoming forks. Releasing this topological complexity by introducing a doublestrand break between a fork and a transcribed unit prevents fork collapse. Mlp1 mutants mimicking constitutive checkpoint-dependent phosphorylation also alleviate checkpoint defects. We propose that the checkpoint assists fork progression and stability at transcribed genes by phosphorylating key nucleoporins and counteracting gene gating, thus neutralizing the topological tension generated at nuclear pore gated genes.	[Bermejo, Rodrigo; Capra, Thelma; Jossen, Rachel; Colosio, Arianna; Frattini, Camilla; Carotenuto, Walter; Cocito, Andrea; Doksani, Ylli; Foiani, Marco] Fdn Ist FIRC Oncol Mol IFOM, I-20139 Milan, Italy; [Doksani, Ylli] Rockefeller Univ, New York, NY 10065 USA; [Klein, Hannah] NYU, Sch Med, New York, NY 10016 USA; [Gomez-Gonzalez, Belen; Aguilera, Andres] Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville 41004, Spain; [Katou, Yuki] Tokyo Inst Technol, Yokohama, Kanagawa 2268503, Japan; [Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Bunkyo Ku, Tokyo 1088639, Japan; [Foiani, Marco] Univ Milan, DSBB, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO); Rockefeller University; New York University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Tokyo Institute of Technology; University of Tokyo; University of Milan	Bermejo, R (corresponding author), Fdn Ist FIRC Oncol Mol IFOM, IFOM IEO Campus,Via Adamello 16, I-20139 Milan, Italy.	rodrigo.bermejo@ifom-ieo-campus.it; marco.foiani@ifom-ieo-campus.it	Bermejo, Rodrigo/AAG-7830-2019; Capra, Thelma/AAN-4064-2020; Bermejo, Rodrigo/K-6613-2014; Aguilera, Andres/L-1825-2014; Bermejo, Rodrigo/S-2445-2019; Gonzalez, Belen Gomez/B-2365-2014; Foiani, Marco/M-8234-2014	Bermejo, Rodrigo/0000-0002-2692-7045; Aguilera, Andres/0000-0003-4782-1714; Gonzalez, Belen Gomez/0000-0003-1655-8407; Doksani, Ylli/0000-0002-2392-5722; Shirahige, Katsuhiko/0000-0002-7862-1144; Klein, Hannah/0000-0003-4228-8535; Foiani, Marco/0000-0003-4795-834X	FIRC; AIRC; AICR; Telethon-Italy; E.U.; Italian Ministry of Health; Spanish Ministry of Science and Innovation [BFU2006-05260, CSD2007-0015]; NIH [GM053738]; UICC Yamagiwa-Yoshida Memorial International Cancer Study; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053738] Funding Source: NIH RePORTER	FIRC(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); AICR; Telethon-Italy(Fondazione Telethon); E.U.(European Commission); Italian Ministry of Health(Ministry of Health, Italy); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UICC Yamagiwa-Yoshida Memorial International Cancer Study; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Markus Smolka, Nancy Kleckner, Ed Hurt, Massimo Lopes, Giordano Liberi, Dana Branzei, and all members of our laboratories for discussions and Robert Crouch, Francesca Storici, Arta Ajazi, Giulia Bastianello, Dario Parazzoli, Amanda Oldani, and Maria Garcia-Rubio for reagents, advice, and technical support. M.F. was supported by grants from FIRC, AIRC, AICR, Telethon-Italy, E.U. GENICA-project, and Italian Ministry of Health. A.A. was supported by the Spanish Ministry of Science and Innovation (grants BFU2006-05260 and Consolider Ingenio 2010 CSD2007-0015); H.K. by NIH grant GM053738; and R.B. by a UICC Yamagiwa-Yoshida Memorial International Cancer Study. T.C. and A.C. were supported by FIRC fellowships.	Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; AGUILERA A, 1990, MOL CELL BIOL, V10, P1439, DOI 10.1128/MCB.10.4.1439; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Bermejo R, 2008, GENE DEV, V22, P2297, DOI 10.1101/gad.1719308; Bermejo R, 2009, CELL, V138, P870, DOI 10.1016/j.cell.2009.06.022; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Chavez S, 1997, GENE DEV, V11, P3459, DOI 10.1101/gad.11.24.3459; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Conti E, 2009, CURR OPIN STRUC BIOL, V19, P62, DOI 10.1016/j.sbi.2009.01.003; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Doksani Y, 2009, CELL, V137, P247, DOI 10.1016/j.cell.2009.02.016; Drubin DA, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-19; EliasArnanz M, 1997, EMBO J, V16, P5775, DOI 10.1093/emboj/16.18.5775; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Fay DS, 1997, CURR GENET, V31, P97, DOI 10.1007/s002940050181; Feng WY, 2006, NAT CELL BIOL, V8, P148, DOI 10.1038/ncb1358; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gomez-Gonzalez B, 2009, MOL CELL BIOL, V29, P5203, DOI 10.1128/MCB.00402-09; Gonzalez-Aguilera C, 2008, MOL BIOL CELL, V19, P4310, DOI 10.1091/mbc.E08-04-0355; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jani DY, 2009, MOL CELL, V33, P727, DOI 10.1016/j.molcel.2009.01.033; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kohler A, 2010, MOL CELL, V38, P6, DOI 10.1016/j.molcel.2010.01.040; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee SE, 2000, COLD SPRING HARB SYM, V65, P303, DOI 10.1101/sqb.2000.65.303; Lee YD, 2006, GENE DEV, V20, P334, DOI 10.1101/gad.1380506; Light WH, 2010, MOL CELL, V40, P112, DOI 10.1016/j.molcel.2010.09.007; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; Lucca C, 2004, ONCOGENE, V23, P1206, DOI 10.1038/sj.onc.1207199; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; Nguyen VC, 2010, NAT STRUCT MOL BIOL, V17, P976, DOI 10.1038/nsmb.1857; Olavarrieta L, 2002, J MOL BIOL, V322, P1, DOI 10.1016/S0022-2836(02)00740-4; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Pomerantz RT, 2010, SCIENCE, V327, P590, DOI 10.1126/science.1179595; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rougemaille M, 2008, CELL, V135, P308, DOI 10.1016/j.cell.2008.08.005; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Schvartzman JB, 2004, EMBO REP, V5, P256, DOI 10.1038/sj.embor.7400101; Segurado M, 2008, GENE DEV, V22, P1816, DOI 10.1101/gad.477208; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WANG JC, 1990, CELL, V62, P403, DOI 10.1016/0092-8674(90)90002-V; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299; ZHENG P, 1993, MOL CELL BIOL, V13, P5829, DOI 10.1128/MCB.13.9.5829; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	85	166	169	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 22	2011	146	2					233	246		10.1016/j.cell.2011.06.033	http://dx.doi.org/10.1016/j.cell.2011.06.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784245	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000293013000007
J	Star, B; Nederbragt, AJ; Jentoft, S; Grimholt, U; Malmstrom, M; Gregers, TF; Rounge, TB; Paulsen, J; Solbakken, MH; Sharma, A; Wetten, OF; Lanzen, A; Winer, R; Knight, J; Vogel, JH; Aken, B; Andersen, O; Lagesen, K; Tooming-Klunderud, A; Edvardsen, RB; Tina, KG; Espelund, M; Nepal, C; Previti, C; Karlsen, BO; Moum, T; Skage, M; Berg, PR; Gjoen, T; Kuhl, H; Thorsen, J; Malde, K; Reinhardt, R; Du, L; Johansen, SD; Searle, S; Lien, S; Nilsen, F; Jonassen, I; Omholt, SW; Stenseth, NC; Jakobsen, KS				Star, Bastiaan; Nederbragt, Alexander J.; Jentoft, Sissel; Grimholt, Unni; Malmstrom, Martin; Gregers, Tone F.; Rounge, Trine B.; Paulsen, Jonas; Solbakken, Monica H.; Sharma, Animesh; Wetten, Ola F.; Lanzen, Anders; Winer, Roger; Knight, James; Vogel, Jan-Hinnerk; Aken, Bronwen; Andersen, Oivind; Lagesen, Karin; Tooming-Klunderud, Ave; Edvardsen, Rolf B.; Tina, Kirubakaran G.; Espelund, Mari; Nepal, Chirag; Previti, Christopher; Karlsen, Bard Ove; Moum, Truls; Skage, Morten; Berg, Paul R.; Gjoen, Tor; Kuhl, Heiner; Thorsen, Jim; Malde, Ketil; Reinhardt, Richard; Du, Lei; Johansen, Steinar D.; Searle, Steve; Lien, Sigbjorn; Nilsen, Frank; Jonassen, Inge; Omholt, Stig W.; Stenseth, Nils Chr.; Jakobsen, Kjetill S.			The genome sequence of Atlantic cod reveals a unique immune system	NATURE			English	Article							MHC CLASS-I; OXYGEN-BINDING PROPERTIES; GADUS-MORHUA L.; GENES; POLYMORPHISM; TEMPERATURE; NEUTROPHILS; EXPRESSION; SELECTION; GENOTYPES	Atlantic cod (Gadus morhua) is a large, cold-adapted teleost that sustains long-standing commercial fisheries and incipient aquaculture(1,2). Here we present the genome sequence of Atlantic cod, showing evidence for complex thermal adaptations in its haemoglobin gene cluster and an unusual immune architecture compared to other sequenced vertebrates. The genome assembly was obtained exclusively by 454 sequencing of shotgun and paired-end libraries, and automated annotation identified 22,154 genes. The major histocompatibility complex (MHC) II is a conserved feature of the adaptive immune system of jawed vertebrates(3,4), but we show that Atlantic cod has lost the genes for MHC II, CD4 and invariant chain (Ii) that are essential for the function of this pathway. Nevertheless, Atlantic cod is not exceptionally susceptible to disease under natural conditions(5). We find a highly expanded number of MHC I genes and a unique composition of its Toll-like receptor (TLR) families. This indicates how the Atlantic cod immune system has evolved compensatory mechanisms in both adaptive and innate immunity in the absence of MHC II. These observations affect fundamental assumptions about the evolution of the adaptive immune system and its components in vertebrates.	[Star, Bastiaan; Nederbragt, Alexander J.; Jentoft, Sissel; Grimholt, Unni; Malmstrom, Martin; Rounge, Trine B.; Paulsen, Jonas; Solbakken, Monica H.; Lagesen, Karin; Tooming-Klunderud, Ave; Tina, Kirubakaran G.; Espelund, Mari; Skage, Morten; Berg, Paul R.; Omholt, Stig W.; Stenseth, Nils Chr.; Jakobsen, Kjetill S.] Univ Oslo, Dept Biol, CEES, N-0316 Oslo, Norway; [Gregers, Tone F.] Univ Oslo, Dept Mol Biosci, Ctr Immune Regulat, N-0316 Oslo, Norway; [Paulsen, Jonas] Oslo Univ Hosp, Inst Med Informat, Bioinformat Core Facil, N-0310 Oslo, Norway; [Sharma, Animesh; Nepal, Chirag; Jonassen, Inge] Univ Bergen, Dept Informat, N-5020 Bergen, Norway; [Wetten, Ola F.] Hedmark Univ Coll, Dept Nat Sci & Technol, N-2306 Bedriftsenteret, Hamar, Norway; [Wetten, Ola F.] Univ Life Sci, Dept Anim & Aquacultural Sci, N-1432 As, Norway; [Lanzen, Anders] Univ Bergen, Ctr Geobiol, Dept Biol, N-5020 Bergen, Norway; [Lanzen, Anders; Nepal, Chirag; Previti, Christopher; Jonassen, Inge] Uni Res AS, Uni Comp, Computat Biol Unit, N-5020 Bergen, Norway; [Winer, Roger; Knight, James; Du, Lei] 454 Life Sci, Branford, CT 06405 USA; [Vogel, Jan-Hinnerk; Aken, Bronwen; Searle, Steve] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Andersen, Oivind] Nofima Marine, N-1430 As, Norway; [Edvardsen, Rolf B.; Malde, Ketil] Inst Marine Res, N-5817 Bergen, Norway; [Tina, Kirubakaran G.; Lien, Sigbjorn; Omholt, Stig W.] Norwegian Univ Life Sci, Ctr Integrat Genet, CIGENE, Dept Anim & Aquacultural Sci, N-1432 As, Norway; [Karlsen, Bard Ove; Moum, Truls; Johansen, Steinar D.] Univ Nordland, Fac Biosci & Aquaculture, N-8049 Bodo, Norway; [Gjoen, Tor] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, N-0316 Oslo, Norway; [Kuhl, Heiner; Reinhardt, Richard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Thorsen, Jim] Sch Vet Sci, Inst Basic Sci & Aquat Med, N-0033 Oslo, Norway; [Johansen, Steinar D.] Univ Tromso, Fac Hlth Sci, Dept Med Biol, N-9037 Tromso, Norway	University of Oslo; University of Oslo; University of Oslo; University of Bergen; Inland Norway University of Applied Sciences; Norwegian University of Life Sciences; University of Bergen; University of Bergen; Wellcome Trust Sanger Institute; Nofima; Institute of Marine Research - Norway; Norwegian University of Life Sciences; Nord University; University of Oslo; Max Planck Society; UiT The Arctic University of Tromso	Jakobsen, KS (corresponding author), Univ Oslo, Dept Biol, CEES, POB 1066, N-0316 Oslo, Norway.	k.s.jakobsen@bio.uio.no	Stenseth, Nils Chr./G-5212-2016; M, Ketil/AAH-5604-2020; Berg, Paul Ragnar/Q-1584-2019; Kuhl, Heiner/L-2737-2019; Berg, Paul/A-3648-2011; Vogel, Jan-Hinnerk/C-4582-2013; Lanzén, Anders/AAG-5048-2019; wenji, huang/F-4860-2015; Gjoen, Tor/F-2740-2013; Nepal, Chirag/K-5866-2019; Jonassen, Inge/AAC-7035-2020; Lanzén, Anders/F-3818-2016	Stenseth, Nils Chr./0000-0002-1591-5399; Berg, Paul Ragnar/0000-0002-4974-8509; Berg, Paul/0000-0002-4974-8509; Lanzén, Anders/0000-0002-7138-6364; Gjoen, Tor/0000-0003-4040-5793; Lanzén, Anders/0000-0002-7138-6364; Nepal, Chirag/0000-0001-8402-3805; Rounge, Trine/0000-0003-2677-2722; Nederbragt, Lex/0000-0001-5539-0999; Jentoft, Sissel/0000-0001-8707-531X; Star, Bastiaan/0000-0003-0235-9810; Grimholt, Unni/0000-0002-0202-8061; Jonassen, Inge/0000-0003-4110-0748; Aken, Bronwen/0000-0002-3032-4095; Edvardsen, Rolf/0000-0001-8430-8042; Hongro Solbakken, Monica/0000-0002-9677-403X; Lagesen, Karin/0000-0003-1329-9032; Moum, Truls/0000-0002-0651-6863; Reinhardt, Richard/0000-0001-9376-2132	Research Council of Norway	Research Council of Norway(Research Council of Norway)	This work was supported by a grant from the Research Council of Norway (FUGE program) to K.S.J. The authors wish to thank the following people and organizations: the 454 Life Science Sequencing Center (Branford, USA); the 454 and Illumina nodes of the Norwegian Sequencing Centre (University of Oslo); M. Egholm (formerly 454 Life Science); the Norwegian Metacenter for Computational Science (Notur) and the Norwegian Storage Infrastructure (Norstore); the Research Computing Services group, especially B.-H. Mevik, at the Center for Information Technology (University of Oslo); B. Walenz (Celera); the Canadian Cod Genomics and Broodstock Development Consortium; P. Olsvik, K. Lie and E. Holen at the Norwegian National Institute of Nutrition and Seafood Research (NIFES); J. Gaup and H. Bakke (CEES, University of Oslo); M. Kent (CIGENE, Norwegian University of Life Sciences); S. Bowman (Genome Atlantic); the FUGE bioinformatics platforms group, especially S. Grindhaug; I. Sandlie and O. B. Landsverk (Centre for Immune Regulation, University of Oslo); and Roche Norway.	Amigorena S, 2010, CURR OPIN IMMUNOL, V22, P109, DOI 10.1016/j.coi.2010.01.022; Andersen O, 2009, P ROY SOC B-BIOL SCI, V276, P833, DOI 10.1098/rspb.2008.1529; Borza T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-51; Brix O, 2004, COMP BIOCHEM PHYS A, V138, P241, DOI 10.1016/j.cbpb.2004.04.004; Dijkstra JM, 2007, IMMUNOGENETICS, V59, P305, DOI 10.1007/s00251-007-0198-6; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Gamperl AK, 2009, PHYSIOL BIOCHEM ZOOL, V82, P483, DOI 10.1086/603636; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Johansen SD, 2009, NEW BIOTECHNOL, V25, P263, DOI 10.1016/j.nbt.2009.03.014; Jozsef L, 2006, J IMMUNOL, V176, P1195, DOI 10.4049/jimmunol.176.2.1195; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Kurlansky M., 1998, COD BIOGRAPHY FISH C; Landsverk OJB, 2009, SCAND J IMMUNOL, V70, P184, DOI 10.1111/j.1365-3083.2009.02301.x; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Magnadottir B, 2009, COMP BIOCHEM PHYS B, V154, P309, DOI 10.1016/j.cbpb.2009.07.005; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Miller KM, 2002, IMMUNOGENETICS, V53, P941, DOI 10.1007/s00251-001-0398-4; Overland HS, 2010, FISH SHELLFISH IMMUN, V28, P193, DOI 10.1016/j.fsi.2009.10.021; Persson AC, 1999, IMMUNOGENETICS, V50, P49, DOI 10.1007/s002510050685; Petersen MF, 2003, J EXP BIOL, V206, P359, DOI 10.1242/jeb.00111; Pilstrom L, 2005, FISHERIES SCI, V71, P961, DOI 10.1111/j.1444-2906.2005.01052.x; Rebl A, 2010, VET IMMUNOL IMMUNOP, V134, P139, DOI 10.1016/j.vetimm.2009.09.021; Ronneseth A, 2007, FISH SHELLFISH IMMUN, V23, P493, DOI 10.1016/j.fsi.2006.08.017; SICK K, 1961, NATURE, V192, P894, DOI 10.1038/192894a0; Solem ST, 2006, DEV COMP IMMUNOL, V30, P57, DOI 10.1016/j.dci.2005.06.007; Stenseth NC, 2009, NATURE, V457, P803, DOI 10.1038/457803a; Tournefier A, 1998, IMMUNOL REV, V166, P259, DOI 10.1111/j.1600-065X.1998.tb01268.x; Weber RE, 2004, RESP PHYSIOL NEUROBI, V144, P141, DOI 10.1016/j.resp.2004.04.018; Wetten OF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-315	30	530	558	3	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					207	210		10.1038/nature10342	http://dx.doi.org/10.1038/nature10342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21832995	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000294603900035
J	Moynihan, R				Moynihan, Ray			DISEASE MARKERS Surrogates under scrutiny: fallible correlations, fatal consequences	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVENTION; ARTICLES		Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					[Anonymous], 1989, NEW ENGL J MED, V321, P406; [Anonymous], 2010, THERAPEUTICS LETT, V77; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bossuyt PMM, 2011, JAMA-J AM MED ASSOC, V305, P2229, DOI 10.1001/jama.2011.729; Deckers JW, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1048; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Greene Jeremy A., 2007, PRESCRIBING NUMBERS; Heath I, 2007, BRIT MED J, V335, P1075, DOI 10.1136/bmj.39377.387373.AD; Inst Med, 2010, EVALUATION OF BIOMARKERS AND SURROGATE ENDPOINTS IN CHRONIC DISEASE, P1; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Jarvinen TLN, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2175; Montori V, 2007, BMJ-BRIT MED J, V334, P882, DOI 10.1136/bmj.39169.447488.94; Moore TJ, 1995, DEADLY MED; Moynihan R, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2548; NIH Consensus Development Conference Management of Hepatitis B, 2008, NIH CONS DEV C MAN H; Press release, 2011, NIH NEWS        0526; Preventing Alzheimer's disease and cognitive declin, 2010, PREVENTING ALZHEIMER; Rose J, 2003, QUAL MANAG HEALTH CA, V17, P27; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shaughnessy AF, 2003, BRIT MED J, V327, P266, DOI 10.1136/bmj.327.7409.266; Starfield B, 2008, J EPIDEMIOL COMMUN H, V62, P580, DOI 10.1136/jech.2007.071027; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9	24	24	24	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2011	343								d5160	10.1136/bmj.d5160	http://dx.doi.org/10.1136/bmj.d5160			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811KK	21844159	Green Submitted			2022-12-28	WOS:000294208300003
J	Yach, D				Yach, Derek			PERSONAL PAPER Nutritional change is not a simple answer to non-communicable diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									PepsiCo, Purchase, NY USA	PepsiCo	Yach, D (corresponding author), PepsiCo, 700 Anderson Hill Rd, Purchase, NY USA.	derek.yach@pepsico.com						Acharya T, 2010, ROLE FOOD IND STRENG; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; Alexander E, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-26; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Block B, GLOBAL PALM OIL DEMA; Geller M., 2011, REUTERS; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; Institute of Medicine, 2010, PROM CARD HLTH DEV W; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Nestle M, 2011, DECONSTRUCTING USDAS; Nishtar S, 2007, LANCET, V370, P1887, DOI 10.1016/S0140-6736(07)61791-7; PepsiCo, 2010 ANN REP PEPSICO; Produce for Better Health Foundation, 2010 GAP AN FED FRUI; Speirs C, 2011, SALT REDUCTION PREMI; The Government Office for Science, 2011, FOR FUT FOOD FARM FI; von Schirnding Y, 2002, REV SAUDE PUBL, V36, P379, DOI 10.1590/S0034-89102002000400001; WHO, 2003, DIET NUTR PREVENTION, V916; WHO, 2011, TARG MON PROGR RED B; World Health Organization, 2004, GLOB STRAT DIET PHYS	20	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2011	343								d5097	10.1136/bmj.d5097	http://dx.doi.org/10.1136/bmj.d5097			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808DP	21835872				2022-12-28	WOS:000293956900005
J	Chapman, S				Chapman, Simon			TOBACCO CONTROL Tar wars over smoking cessation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NICOTINE REPLACEMENT THERAPY; CONTROL POLICIES; UNITED-STATES; IMPACT; SMOKERS; TRIALS		Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sydney, NSW 2006, Australia.	simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009					American Cancer Society, 1986, CANC FACTS FIG 2010; Bauld L, 2011, NICOTINE TOB RES, V13, P135, DOI 10.1093/ntr/ntq222; Blouin C, 2010, J PUBLIC HEALTH POL, V31, P244, DOI 10.1057/jphp.2010.4; Chapman S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000216; Chapman S, 2009, LANCET, V373, P701, DOI 10.1016/S0140-6736(09)60416-5; Etter JF, 2007, ADDICTION, V102, P815, DOI 10.1111/j.1360-0443.2007.01822.x; FIORE MC, 1990, JAMA-J AM MED ASSOC, V263, P2760, DOI 10.1001/jama.263.20.2760; Giovino GA, 2009, CIGARETTE SMOKING PR; Heydari G, 2011, STATUS SMOKING CESSA; Hyland A, 2006, TOB CONTROL, V15, P83, DOI 10.1136/tc.2005.013516; Le Strat Y, 2011, TOB CONTROL     0106; Lee CW, 2007, AM J PUBLIC HEALTH, V97, P1503, DOI 10.2105/AJPH.2005.083527; Levy DT, 2008, TOB CONTROL, V17, P53, DOI 10.1136/tc.2007.022319; Mooney M, 2004, ADDICT BEHAV, V29, P673, DOI 10.1016/j.addbeh.2004.02.010; Morris Philip, 1985, PERSPECTIVE PM INT S; National Cancer Institute, 2000, POP BAS SMOK CESS P; Peto R, 1997, P 10 WORLD C TOB HLT; Raw M, 2009, ADDICTION, V104, P279, DOI 10.1111/j.1360-0443.2008.02443.x; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Shiffman S, 2008, AM J PREV MED, V34, P102, DOI 10.1016/j.amepre.2007.09.033; Thun MJ, 2006, TOB CONTROL, V15, P345, DOI 10.1136/tc.2006.017749; Tzelepis F, 2009, AM J PREV MED, V37, P324, DOI 10.1016/j.amepre.2009.05.022; Wakefield MA, 2008, AM J PUBLIC HEALTH, V98, P1443, DOI 10.2105/AJPH.2007.128991; Walsh RA, 2008, DRUG ALCOHOL REV, V27, P529, DOI 10.1080/09595230802245527; Walsh RA, 2011, ADDICTION, V106, P451, DOI 10.1111/j.1360-0443.2010.03282.x; WARNER KE, 1977, AM J PUBLIC HEALTH, V67, P645, DOI 10.2105/AJPH.67.7.645; Warner KE, 2003, NICOTINE TOB RES, V5, P37, DOI 10.1080/1462220021000060428; West R, 2010, ADDICTION, V105, P1867, DOI 10.1111/j.1360-0443.2010.03111.x; White VM, 2011, ADDICTION, V106, P1493, DOI 10.1111/j.1360-0443.2011.03429.x; Wilson A, 2005, TOB CONTROL, V14, P242, DOI 10.1136/tc.2004.010090; World Bank, 2010, GROSS NAT INC PER CA; Zwar NA, 2002, MED J AUSTRALIA, V177, P277, DOI 10.5694/j.1326-5377.2002.tb04772.x	32	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 8	2011	343								d5008	10.1136/bmj.d5008	http://dx.doi.org/10.1136/bmj.d5008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	808CQ	21824908				2022-12-28	WOS:000293953000004
J	Bhopal, R; Macfarlane, GJ; Smith, WC; West, R				Bhopal, Raj; Macfarlane, Gary J.; Smith, William Cairns; West, Robert		Management Executive Comm XIX Worl	What is the future of epidemiology?	LANCET			English	Editorial Material									[Smith, William Cairns] Univ Aberdeen, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland; [Bhopal, Raj] Univ Edinburgh, Edinburgh Ethn & Hlth Res Grp, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Macfarlane, Gary J.] Univ Aberdeen, Epidemiol Grp, Inst Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland; [West, Robert] Cardiff Univ, Wales Heart Res Inst, Cardiff, S Glam, Wales	University of Aberdeen; University of Edinburgh; University of Aberdeen; Cardiff University	Smith, WC (corresponding author), Univ Aberdeen, Dept Publ Hlth, Aberdeen AB25 2ZD, Scotland.	w.c.s.smith@abdn.ac.uk	Macfarlane, Gary J/I-9521-2014	Macfarlane, Gary J/0000-0003-2322-3314				[Anonymous], 2010, 1 WHO; *INT EP ASS, 2011, INT EP ASS 19 WORLD; *WHO COLL CTR U PI, SUP EP INT GLOB HLTH	3	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 6	2011	378	9790					464	465		10.1016/S0140-6736(11)61147-1	http://dx.doi.org/10.1016/S0140-6736(11)61147-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	809SO	21821173				2022-12-28	WOS:000294077200007
J	Goldstein, DB				Goldstein, David B.			Growth of genome screening needs debate	NATURE			English	Editorial Material							RARE		Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA	Duke University	Goldstein, DB (corresponding author), Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC 27708 USA.	d.goldstein@duke.edu	Goldstein, David/AAY-8125-2020					Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Fan HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010439; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006; Potter S., 2010, DESIGNER GENES NEW E; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Zhu QQ, 2011, AM J HUM GENET, V88, P458, DOI 10.1016/j.ajhg.2011.03.008	10	9	9	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					27	28		10.1038/476027a	http://dx.doi.org/10.1038/476027a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	801NR	21814258				2022-12-28	WOS:000293447300013
J	Kozlowski, S; Woodcock, J; Midthun, K; Sherman, RB				Kozlowski, Steven; Woodcock, Janet; Midthun, Karen; Sherman, Rachel Behrman			Developing the Nation's Biosimilars Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kozlowski, Steven; Woodcock, Janet; Sherman, Rachel Behrman] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Midthun, Karen] Ctr Biol Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Kozlowski, S (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							European Medicenes Agency, 2005, GUID SIM BIOL MED PR; European Medicines Agency, 2010, GUID SIM BI IN PRESS; Fed. Trade CoMM'n, 2009, EMERGING HLTH CARE I; Woodcock J, 2007, NAT REV DRUG DISCOV, V6, P437, DOI 10.1038/nrd2307	4	144	148	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					385	388		10.1056/NEJMp1107285	http://dx.doi.org/10.1056/NEJMp1107285			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801NW	21812668				2022-12-28	WOS:000293447800001
J	Savin, T; Kurpios, NA; Shyer, AE; Florescu, P; Liang, HY; Mahadevan, L; Tabin, CJ				Savin, Thierry; Kurpios, Natasza A.; Shyer, Amy E.; Florescu, Patricia; Liang, Haiyi; Mahadevan, L.; Tabin, Clifford J.			On the growth and form of the gut	NATURE			English	Article								The developing vertebrate gut tube forms a reproducible looped pattern as it grows into the body cavity. Here we use developmental experiments to eliminate alternative models and show that gut looping morphogenesis is driven by the homogeneous and isotropic forces that arise from the relative growth between the gut tube and the anchoring dorsal mesenteric sheet, tissues that grow at different rates. A simple physical mimic, using a differentially strained composite of a pliable rubber tube and a soft latex sheet is consistent with this mechanism and produces similar patterns. We devise a mathematical theory and a computational model for the number, size and shape of intestinal loops based solely on the measurable geometry, elasticity and relative growth of the tissues. The predictions of our theory are quantitatively consistent with observations of intestinal loops at different stages of development in the chick embryo. Our model also accounts for the qualitative and quantitative variation in the distinct gut looping patterns seen in a variety of species including quail, finch and mouse, illuminating how the simple macroscopic mechanics of differential growth drives the morphology of the developing gut.	[Savin, Thierry; Florescu, Patricia; Liang, Haiyi; Mahadevan, L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Kurpios, Natasza A.; Shyer, Amy E.; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Mahadevan, L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Mahadevan, L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard University	Mahadevan, L (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	lm@seas.harvard.edu	Liang, Haiyi/B-2969-2008; liang, haiyi/Q-3422-2019	Liang, Haiyi/0000-0001-7458-8036; liang, haiyi/0000-0001-7458-8036; Savin, Thierry/0000-0002-3956-7077	Harvard NSF MRSEC; MacArthur Foundation; NIH [RO1 HD047360]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD047360] Funding Source: NIH RePORTER	Harvard NSF MRSEC; MacArthur Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank R. Prum for pointing out to us the literature on avian intestines, and the Harvard NSF MRSEC, the MacArthur Foundation (L.M.) and NIH RO1 HD047360 (C.J.T.) for support.	Beddard F.E., 1898, STRUCTURE CLASSIFICA; BELOUSSOV LV, 1994, INT REV CYTOL, V150, P1; Davis NM, 2008, DEV CELL, V15, P134, DOI 10.1016/j.devcel.2008.05.001; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Fung Y C, 2004, BIOMECHANICS MECH PR, P242; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hamburger H, 1951, J MORPHOL, V88, P49; Hecksher-Sorensen J, 2004, DEVELOPMENT, V131, P4665, DOI 10.1242/dev.01364; His W., 1880, ANATOMIE MENSCHLICHE; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kleinman R. E., 2008, WALKERS PEDIAT GASTR, P207; Kurpios NA, 2008, P NATL ACAD SCI USA, V105, P8499, DOI 10.1073/pnas.0803578105; Liang HY, 2009, P NATL ACAD SCI USA, V106, P22049, DOI 10.1073/pnas.0911954106; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Mitchell C. P., 1896, P ZOOL SOC LOND, V64, P136; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Schoenwolf G., 2008, LARSENS HUMAN EMBRYO; Taber LA, 2001, ANNU REV BIOMED ENG, V3, P1, DOI 10.1146/annurev.bioeng.3.1.1; Thompson D.W, 1917, GROWTH FORM	20	315	322	7	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					57	+		10.1038/nature10277	http://dx.doi.org/10.1038/nature10277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21814276	Green Accepted			2022-12-28	WOS:000293447300028
J	Jain, S				Jain, Shaili			Treating Posttraumatic Stress Disorder via the Internet Does Therapeutic Alliance Matter?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIAL; DISTRESS		[Jain, Shaili] Natl Ctr Posttraumat Stress Disorder, Menlo Pk, CA 94205 USA; [Jain, Shaili] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Jain, Shaili] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Jain, S (corresponding author), Natl Ctr Posttraumat Stress Disorder, 795 Willow Rd, Menlo Pk, CA 94205 USA.	shaili.jain@va.gov						Benight CC, 2008, J TRAUMA STRESS, V21, P513, DOI 10.1002/jts.20371; Hirai M, 2005, J TRAUMA STRESS, V18, P631, DOI 10.1002/jts.20071; Klein B, 2010, J ANXIETY DISORD, V24, P635, DOI 10.1016/j.janxdis.2010.04.005; Klein Britt, 2009, Cognitive Behaviour Therapy, V38, P121, DOI 10.1080/16506070902803483; Knaevelsrud C, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e31; Knaevelsrud C, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-13; Lange A, 2003, J CONSULT CLIN PSYCH, V71, P901, DOI 10.1037/0022-006X.71.5.901; Litz BT, 2007, AM J PSYCHIAT, V164, P1676, DOI 10.1176/appi.ajp.2007.06122057; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132	10	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2011	306	5					543	544		10.1001/jama.2011.1097	http://dx.doi.org/10.1001/jama.2011.1097			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	800SH	21813433				2022-12-28	WOS:000293386500022
J	Qaseem, A; Wilt, TJ; Weinberger, SE; Hanania, NA; Criner, G; van der Molen, T; Marciniuk, DD; Denberg, T; Schunemann, H; Wedzicha, W; MacDonald, R; Shekelle, P				Qaseem, Amir; Wilt, Timothy J.; Weinberger, Steven E.; Hanania, Nicola A.; Criner, Gerard; van der Molen, Thys; Marciniuk, Darcy D.; Denberg, Tom; Schuenemann, Holger; Wedzicha, Wisia; MacDonald, Roderick; Shekelle, Paul		Amer Coll Phys; Amer Coll Chest Phys; Amer Thoracic Soc; European Resp Soc	Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; INHALED ANTICHOLINERGIC BRONCHODILATOR; SMOKING-CESSATION ADVICE; OXYGEN-THERAPY; SALMETEROL/FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE; MEDICAL HISTORY; HEALTH OUTCOMES; BETA-AGONISTS; LUNG-FUNCTION	Description: This guideline is an official statement of the American College of Physicians (ACP), American College of Chest Physicians (ACCP), American Thoracic Society (ATS), and European Respiratory Society (ERS). It represents an update of the 2007 ACP clinical practice guideline on diagnosis and management of stable chronic obstructive pulmonary disease (COPD) and is intended for clinicians who manage patients with COPD. This guideline addresses the value of history and physical examination for predicting airflow obstruction; the value of spirometry for screening or diagnosis of COPD; and COPD management strategies, specifically evaluation of various inhaled therapies (anticholinergics, long-acting beta-agonists, and corticosteroids), pulmonary rehabilitation programs, and supplemental oxygen therapy. Methods: This guideline is based on a targeted literature update from March 2007 to December 2009 to evaluate the evidence and update the 2007 ACP clinical practice guideline on diagnosis and management of stable COPD. Recommendation 1: ACP, ACCP, ATS, and ERS recommend that spirometry should be obtained to diagnose airflow obstruction in patients with respiratory symptoms (Grade: strong recommendation, moderate-quality evidence). Spirometry should not be used to screen for airflow obstruction in individuals without respiratory symptoms (Grade: strong recommendation, moderate-quality evidence). Recommendation 2: For stable COPD patients with respiratory symptoms and FEV1 between 60% and 80% predicted, ACP, ACCP, ATS, and ERS suggest that treatment with inhaled bronchodilators may be used (Grade: weak recommendation, low-quality evidence). Recommendation 3: For stable COPD patients with respiratory symptoms and FEV1 <60% predicted, ACP, ACCP, ATS, and ERS recommend treatment with inhaled bronchodilators (Grade: strong recommendation, moderate-quality evidence). Recommendation 4: ACP, ACCP, ATS, and ERS recommend that clinicians prescribe monotherapy using either long-acting inhaled anticholinergics or long-acting inhaled beta-agonists for symptomatic patients with COPD and FEV1 <60% predicted. (Grade: strong recommendation, moderate-quality evidence). Clinicians should base the choice of specific monotherapy on patient preference, cost, and adverse effect profile. Recommendation 5: ACP, ACCP, ATS, and ERS suggest that clinicians may administer combination inhaled therapies (long-acting inhaled anticholinergics, long-acting inhaled beta-agonists, or inhaled corticosteroids) for symptomatic patients with stable COPD and FEV1 < 60% predicted (Grade: weak recommendation, moderate-quality evidence). Recommendation 6: ACP, ACCP, ATS, and ERS recommend that clinicians should prescribe pulmonary rehabilitation for symptomatic patients with an FEV1 <50% predicted (Grade: strong recommendation, moderate-quality evidence). Clinicians may consider pulmonary rehabilitation for symptomatic or exercise-limited patients with an FEV1 >50% predicted. (Grade: weak recommendation, moderate-quality evidence). Recommendation 7: ACP, ACCP, ATS, and ERS recommend that clinicians should prescribe continuous oxygen therapy in patients with COPD who have severe resting hypoxemia (PaO2 <= 55 mm Hg or SpO(2) <= 88%) (Grade: strong recommendation, moderate-quality evidence).			Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	Hanania, Nicola A/C-5875-2016	Hanania, Nicola A/0000-0003-3087-9530; Schunemann, Holger/0000-0003-3211-8479	ACP	ACP	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Aaron SD, 2007, ANN INTERN MED, V146, P545, DOI 10.7326/0003-4819-146-8-200704170-00152; Agency for Healthcare Research and Quality, 2005, 290020009 AG HEALTHC; Altose MD, 2000, NEW ENGL J MED, V343, P1902; American Thoracic Society/European Respiratory Society Task Force, 2004, STAND DIAGN MAN PAT; [Anonymous], 1980, Ann Intern Med, V93, P391; [Anonymous], 2009, MORB MORT 2009 CHART; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; BADGETT RG, 1993, AM J MED, V94, P188, DOI 10.1016/0002-9343(93)90182-O; Barr RG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002876.pub2; Bohadana A B, 1982, Indian J Chest Dis Allied Sci, V24, P133; Brusasco V, 2003, THORAX, V58, P399, DOI 10.1136/thorax.58.5.399; Buffels J, 2006, RESP MED, V100, P2012, DOI 10.1016/j.rmed.2006.02.014; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley P, 2006, EUR RESP SOC ANN M M; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Chaouat A, 1999, EUR RESPIR J, V14, P1002, DOI 10.1183/09031936.99.14510029; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Drummond MB, 2008, JAMA-J AM MED ASSOC, V300, P2407, DOI 10.1001/jama.2008.717; Dusser D, 2006, EUR RESPIR J, V27, P547, DOI 10.1183/09031936.06.00062705; Eaton T, 2002, EUR RESPIR J, V20, P306, DOI 10.1183/09031936.02.00301002; FLENLEY DC, 1981, LANCET, V1, P681; Geddes EL, 2008, RESP MED, V102, P1715, DOI 10.1016/j.rmed.2008.07.005; Gorecka D, 1997, THORAX, V52, P674, DOI 10.1136/thx.52.8.674; HEPPER NG, 1969, ARCH ENVIRON HEALTH, V19, P806, DOI 10.1080/00039896.1969.10666934; HOLLEMAN DR, 1993, J GEN INTERN MED, V8, P63, DOI 10.1007/BF02599985; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Jenkins CR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-59; Krahn Murray, 2003, Can Respir J, V10, P320; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Maltais F, 2008, ANN INTERN MED, V149, P869, DOI 10.7326/0003-4819-149-12-200812160-00006; MANNINO DM, 1993, ARCH INTERN MED, V153, P1892, DOI 10.1001/archinte.153.16.1892; MCDONALD CF, 1995, AM J RESP CRIT CARE, V152, P1616, DOI 10.1164/ajrccm.152.5.7582304; Melbye H, 1998, SCAND J PRIM HEALTH, V16, P160; Michele TM, 2010, NEW ENGL J MED, V363, P1097, DOI 10.1056/NEJMp1008502; Minino AM, 2010, NATL VITAL STAT REP, V59, P7; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; National Heart Lung and Blood Institute, 2003, 035229 NAT HEART LUN; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; PARDEE NE, 1980, CHEST, V77, P354, DOI 10.1378/chest.77.3.354; Parkes G, 2008, BMJ-BRIT MED J, V336, P598, DOI 10.1136/bmj.39503.582396.25; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Puhan M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005305.pub2; Qaseem A, 2007, ANN INTERN MED, V147, P633, DOI 10.7326/0003-4819-147-9-200711060-00008; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Salpeter SR, 2006, J GEN INTERN MED, V21, P1011, DOI 10.1111/j.1525-1497.2006.00507.x; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Shaker SB, 2009, COPD, V6, P104, DOI 10.1080/15412550902772593; Simel DL, 2008, RATIONAL CLIN EXAMIN; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Stratelis G, 2006, SCAND J PRIM HEALTH, V24, P133, DOI 10.1080/02813430600819751; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Troosters T, 2000, AM J MED, V109, P207, DOI 10.1016/S0002-9343(00)00472-1; van Wetering CR, 2010, THORAX, V65, P7, DOI 10.1136/thx.2009.118620; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702; Vogelmeier C, 2011, NEW ENGL J MED, V364, P1093, DOI 10.1056/NEJMoa1008378; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Welsh EJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007891.pub2; Wilt TJ, 2007, ANN INTERN MED, V147, P639, DOI 10.7326/0003-4819-147-9-200711060-00009	62	722	763	0	71	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2011	155	3					179	+		10.7326/0003-4819-155-3-201108020-00008	http://dx.doi.org/10.7326/0003-4819-155-3-201108020-00008			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800DJ	21810710				2022-12-28	WOS:000293339600006
J	Roff, SR				Roff, Sue Rabbitt			PERSONAL VIEW We should consider paying kidney donors	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Dundee, Dundee DD2 1LR, Scotland	University of Dundee	Roff, SR (corresponding author), Univ Dundee, Dundee DD2 1LR, Scotland.	s.l.roff@dundee.ac.uk							0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 2	2011	343								d4867	10.1136/bmj.d4867	http://dx.doi.org/10.1136/bmj.d4867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	805NM	21810888				2022-12-28	WOS:000293734600006
J	Davies, C; Godwin, J; Gray, R; Clarke, M; Darby, S; McGale, P; Wang, YC; Peto, R; Pan, HC; Cutter, D; Taylor, C; Ingle, J				Davies, C.; Godwin, J.; Gray, R.; Clarke, M.; Darby, S.; McGale, P.; Wang, Y. C.; Peto, R.; Pan, H. C.; Cutter, D.; Taylor, C.; Ingle, J.		EBCTCG	Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials	LANCET			English	Article							ESTROGEN-RECEPTOR; PREMENOPAUSAL WOMEN; PROGESTERONE-RECEPTOR; HIGH-RISK; THERAPY; CHEMOTHERAPY; POSTMENOPAUSAL; IMMUNOHISTOCHEMISTRY; DOXORUBICIN; PREVENTION	Background As trials of 5 years of tamoxifen in early breast cancer mature, the relevance of hormone receptor measurements (and other patient characteristics) to long-term outcome can be assessed increasingly reliably. We report updated meta-analyses of the trials of 5 years of adjuvant tamoxifen. Methods We undertook a collaborative meta-analysis of individual patient data from 20 trials (n=21457) in early breast cancer of about 5 years of tamoxifen versus no adjuvant tamoxifen, with about 80% compliance. Recurrence and death rate ratios (RRs) were from log-rank analyses by allocated treatment. Findings In oestrogen receptor (ER)-positive disease (n=10 645), allocation to about 5 years of tamoxifen substantially reduced recurrence rates throughout the first 10 years (RR 0.53 [SE 0.03] during years 0-4 and RR 0.68 [0.06] during years 5-9 [both 2p<0.00001]; but RR 0.97 [0.10] during years 10-14, suggesting no further gain or loss after year 10). Even in marginally ER-positive disease (10-19 fmol/mg cytosol protein) the recurrence reduction was substantial (RR 0.67 [0.08]). In ER-positive disease, the RR was approximately independent of progesterone receptor status (or level), age, nodal status, or use of chemotherapy. Breast cancer mortality was reduced by about a third throughout the first 15 years (RR 0.71 [0.05] during years 0-4, 0.66 [0.05] during years 5-9, and 0.68 [0.08] during years 10-14; p<0.0001 for extra mortality reduction during each separate time period). Overall non-breast-cancer mortality was little affected, despite small absolute increases in thromboembolic and uterine cancer mortality (both only in women older than 55 years), so all-cause mortality was substantially reduced. In ER-negative disease, tamoxifen had little or no effect on breast cancer recurrence or mortality. Interpretation 5 years of adjuvant tamoxifen safely reduces 15-year risks of breast cancer recurrence and death. ER status was the only recorded factor importantly predictive of the proportional reductions. Hence, the absolute risk reductions produced by tamoxifen depend on the absolute breast cancer risks (after any chemotherapy) without tamoxifen.	[Godwin, J.; Gray, R.; Clarke, M.; Darby, S.; McGale, P.; Pan, H. C.; Cutter, D.; Taylor, C.] Royal Marsden Hosp, Breakthrough Breast Canc Ctr, Inst Canc Res, London SW3 6JJ, England; [Davies, C.] Clin Trial Serv Unit, Oxford, England; [Ingle, J.] Mayo Clin, Rochester, MN USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oxford; Mayo Clinic			Gkiokas, Georgios/AAE-6312-2020; Rutgers, Emiel J T/C-5934-2015; Greil, Richard F/C-7673-2017; Cutter, David/AAU-6599-2021; Di Mauro, Maria Gaetana/AAB-1869-2021; Gnant, Michael/AAN-7054-2020; De Laurentiis, Michelino/AAC-6321-2022; MUSTACCHI, GIORGIO/AAE-7643-2020; Boccardo, Francesco Mario/AAF-2654-2019; Del Mastro, Lucia/J-6163-2016	Greil, Richard F/0000-0002-4462-3694; Cutter, David/0000-0001-7307-7488; Di Mauro, Maria Gaetana/0000-0002-2200-9060; Gnant, Michael/0000-0003-1002-2118; De Laurentiis, Michelino/0000-0001-9009-1572; Swain, Sandra/0000-0002-1320-3830; GIANNI, LUCA/0000-0002-2372-9625; Bowden, Sarah/0000-0001-7506-1340; RUBAGOTTI, Alessandra/0000-0002-4009-8829; de Vries, Elisabeth/0000-0002-8949-7425; Ellis, Ian/0000-0001-5292-8474; Bliss, Judith/0000-0001-7957-7424; DE PLACIDO, Sabino/0000-0001-5077-6286; /0000-0003-4167-8910; Cardoso, Fatima/0000-0002-6692-2249; Sparano, Joseph/0000-0002-9031-2010; Ewertz, Marianne/0000-0002-5965-969X; Bergh, Jonas/0000-0001-5526-1847; SEGUI PALMER, MIQUEL ANGEL/0000-0002-5103-6746; Di Leo, Angelo/0000-0002-3665-9056; MUSTACCHI, GIORGIO/0000-0002-5721-7855; Fyles, Anthony/0000-0002-3633-2483; Fredriksson, Irma/0000-0001-7811-9317; Boccardo, Francesco Mario/0000-0002-5392-4077; Kilburn, Lucy/0000-0002-1987-7545; Adolfsson, Jan/0000-0003-2992-1869; Tinterri, Corrado/0000-0002-7272-3924; Valagussa, Pinuccia/0000-0003-3590-7916; Warnberg, Fredrik/0000-0002-0130-7296; Markopoulos, Christos/0000-0002-5072-6390; Wang, Xiang/0000-0002-1522-9532; Valentini, Miriam/0000-0002-1421-6975; Lang, Alois Hermann/0000-0002-8773-735X; Paltuev, Ruslan/0000-0002-0871-9453; Howell, Anthony/0000-0002-6233-719X; Coombes, Raoul Charles/0000-0002-4811-1100; Delmestri, Antonella/0000-0003-0388-3403; Del Mastro, Lucia/0000-0002-9546-5841; Hans, Trampisch/0000-0001-9136-1079; Davies, Kelvin/0000-0001-7790-3003; Blomqvist, Carl/0000-0003-3041-1938; van Tinteren, Harm/0000-0002-4626-8702; Anderson, Stewart/0000-0001-8948-0650	Cancer Research UK; British Heart Foundation; Medical Research Council; MRC [MC_U137686850] Funding Source: UKRI; Cancer Research UK [10588] Funding Source: researchfish; Medical Research Council [MC_U137686850] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Cancer Research UK, British Heart Foundation, and Medical Research Council.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ayme Y, 1987, 4 EORTC BREAST CANC; Badve SS, 2008, J CLIN ONCOL, V26, P2473, DOI 10.1200/JCO.2007.13.6424; Blamey RW, 2008, EJC SUPPL, V6, P55; Bliss JM, 2002, P AN M AM SOC CLIN, V21, pA2017; BOCCARDO F, 1990, J CLIN ONCOL, V8, P1310, DOI 10.1200/JCO.1990.8.8.1310; Bramwell VHC, 2010, ANN ONCOL, V21, P283, DOI 10.1093/annonc/mdp326; Colleoni M, 2006, J CLIN ONCOL, V24, P1332, DOI 10.1200/JCO.2005.03.0783; Davidson NE, 2005, J CLIN ONCOL, V23, P5973, DOI 10.1200/JCO.2005.05.551; DELOZIER T, 1986, BREAST CANCER RES TR, V7, P105, DOI 10.1007/BF01806795; Delozier T, 1993, 4 INT C ANT CHEM 199, P53; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Early Breast Cancer Trialists' Collaborative Group, 1990, TREATM EARL BREAST C; Ferlay J, 2010, IARC CANCERBASE, V10; Fisher B, 2001, J CLIN ONCOL, V19, P931, DOI 10.1200/JCO.2001.19.4.931; Fisher B, 2001, JNCI-J NATL CANCER I, V93, P684, DOI 10.1093/jnci/93.9.684; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 2002, J CLIN ONCOL, V20, P4141, DOI 10.1200/JCO.2002.11.101; Fisher B, 1996, JNCI-J NATL CANCER I, V88, P1529, DOI 10.1093/jnci/88.21.1529; Fisher ER, 2005, CANCER-AM CANCER SOC, V103, P164, DOI 10.1002/cncr.20761; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hutchins LF, 2005, J CLIN ONCOL, V23, P8313, DOI 10.1200/JCO.2005.08.071; Kaufmann M, 2005, J CLIN ONCOL, V23, P7842, DOI 10.1200/JCO.2005.01.3433; Khoshnoud MR, 2011, BREAST CANCER RES TR, V126, P421, DOI 10.1007/s10549-010-1202-7; MARTIN PM, 1991, B CANCER, V78, P709; McCowan C, 2008, BRIT J CANCER, V99, P1763, DOI 10.1038/sj.bjc.6604758; Molino A, 1997, BREAST CANCER RES TR, V45, P241, DOI 10.1023/A:1005769925670; Morales L, 2007, EUR J CANCER, V43, P331, DOI 10.1016/j.ejca.2006.10.009; Namer M, 2006, ANN ONCOL, V17, P65, DOI 10.1093/annonc/mdj022; Owusu C, 2008, J CLIN ONCOL, V26, P549, DOI 10.1200/JCO.2006.10.1022; Paradiso A., 2003, Breast, V12, pS40, DOI 10.1016/S0960-9776(03)80129-7; Paradiso A, 2003, BREAST, V12, p[S40, P90]; Peto R, 2011, BRIT J CANCER, V104, P1057, DOI 10.1038/bjc.2011.79; Rutqvist LE, 2007, ACTA ONCOL, V46, P133, DOI 10.1080/02841860601034834; STEWART HJ, 1987, LANCET, V2, P171; Stewart HJ, 2001, JNCI-J NATL CANCER I, V93, P456, DOI 10.1093/jnci/93.6.456; Surveillance Epidemiology and End Results Program, 2010, 1973 2007 SEER DAT; von Minckwitz G, 2001, J CLIN ONCOL, V19, P3506, DOI 10.1200/JCO.2001.19.15.3506	40	1938	1966	5	141	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2011	378	9793					771	784		10.1016/S0140-6736(11)60993-8	http://dx.doi.org/10.1016/S0140-6736(11)60993-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816FY	21802721	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000294585300033
J	Bloom, DE				Bloom, David E.			7 Billion and Counting	SCIENCE			English	Review							POPULATION; TRANSITION; MORTALITY; DEMOGRAPHY	The world is currently in the midst of the greatest demographic upheaval in human history. Dramatic reductions in mortality, followed (but with a lag) by equally marked reductions in fertility, resulted in a doubling of world population between 1960 and 2000. A further increase of 2 to 4.5 billion is projected for the current half-century, with the increase concentrated in the world's least developed countries. Despite alarmist predictions, historical increases in population have not been economically catastrophic. Moreover, changes in population age structure have opened the door to increased prosperity. Demographic changes have had and will continue to have profound repercussions for human well-being and progress, with some possibilities for mediating those repercussions through policy intervention.	Harvard Univ, Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Bloom, DE (corresponding author), Harvard Univ, Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	dbloom@hsph.harvard.edu			National Institute on Aging [P30AG024409]; NATIONAL INSTITUTE ON AGING [P30AG024409] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	I am indebted to L. Rosenberg for superb assistance and comments; H. Zlotnik and P. Gerland for facilitating access to UN Population Division data and other helpful comments and guidance; M. Castro for comments; N. Bennett, D. Canning, J. Finlay, G. Fink, R. Greenhill, and J. Lamstein for helpful discussions; and two anonymous referees for thoughtful insights and suggestions. Support for this work was provided by the Program on the Global Demography of Aging at Harvard University, funded by award no. P30AG024409 from the National Institute on Aging.	Alkema L, 2011, DEMOGRAPHY, V48, P815, DOI 10.1007/s13524-011-0040-5; [Anonymous], 2000, STATE FAILURE TASK F; [Anonymous], 1994, DETERMINANTS REPROD; Bacci Massimo, 2006, CONCISE HIST WORLD P; Bloom DE, 2008, POPUL DEV REV, V34, P17; Bloom DE, 2010, OXFORD REV ECON POL, V26, P583, DOI 10.1093/oxrep/grq038; Bocquet-Appel JP, 2011, SCIENCE, V333, P560, DOI 10.1126/science.1208880; Bongaarts J, 2011, SCIENCE, V333, P574, DOI 10.1126/science.1207558; Boserup Ester, 1981, POPULATION TECHNOLOG; Brainerd E, 1998, WORLD DEV, V26, P2013, DOI 10.1016/S0305-750X(98)00096-5; Chesnais J-C., 1992, DEMOGRAPHIC TRANSITI; Coale A.J., 1958, POPULATION GROWTH EC; Cohen JE, 2005, SCI AM, V293, P48, DOI 10.1038/scientificamerican0905-48; Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97; Dyson Tim, 2010, POPULATION DEV; Ehrlich PR, 1968, POPULATION BOMB; Eskes T, 2007, EUR J OBSTET GYN R B, V133, P126, DOI 10.1016/j.ejogrb.2007.01.006; Fogel R., 2004, ESCAPE HUNGER PREMAT, DOI [10.1017/CBO9780511817649, DOI 10.1017/CBO9780511817649]; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Galor O, 2011, UNIFIED GROWTH THEORY, P1; GERTLER PJ, 1994, DEMOGRAPHY, V31, P33, DOI 10.2307/2061907; Glaeser E, 2011, SCIENCE, V333, P592, DOI 10.1126/science.1209264; Guilmoto CZ, 2009, POPUL DEV REV, V35, P519, DOI 10.1111/j.1728-4457.2009.00295.x; Guttmacher Inst, 2010, FACTS INV FAM PLANN; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; James KS, 2011, SCIENCE, V333, P576, DOI 10.1126/science.1207969; Kohler H.-P., 2006, BABY BUST WHO WILL W, P48; KUZNETS S, 1967, P AM PHILOS SOC, V111, P170; Lee R, 2003, J ECON PERSPECT, V17, P167, DOI 10.1257/089533003772034943; Lee R, 2011, SCIENCE, V333, P569, DOI 10.1126/science.1208859; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Lutz W, 2011, SCIENCE, V333, P587, DOI 10.1126/science.1206964; Mason A., 2001, POPULATION CHANGE EC; McKeown Thomas, 1976, MODERN RISE POPULATI; Miller G, 2010, ECON J, V120, P709, DOI 10.1111/j.1468-0297.2009.02306.x; Notestein F., 1945, FOOD WORLD, P36; Nyonator FK, 2005, HEALTH POLICY PLANN, V20, P25, DOI 10.1093/heapol/czi003; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Olshansky SJ, 2001, SCIENCE, V291, P1491, DOI 10.1126/science.291.5508.1491; Peng XZ, 2011, SCIENCE, V333, P581, DOI 10.1126/science.1209396; PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509; PRITCHETT LH, 1994, POPUL DEV REV, V20, P1, DOI 10.2307/2137629; Sachs Jeffrey D., 2008, COMMON WEALTH EC CRO; Sen A., 1990, NY REV BOOKS, V37; Shkolnikov VM, 1998, WORLD DEV, V26, P1995, DOI 10.1016/S0305-750X(98)00102-8; Simon J. L, 1981, ULTIMATE RESOURCE; Stuckler D, 2009, LANCET, V373, P399, DOI 10.1016/S0140-6736(09)60005-2; Thompson WS, 1929, AM J SOCIOL, V34, P959, DOI 10.1086/214874; UN Population Division, 2011, WORLD CONTR US 2011; UNAIDS, 2010, GLOB REP UNAIDS REP; United Nations Conference on Trade and Development, 2010, LEAST DEV COUNTR REP; United Nations Interagency Group for Child Mortality Estimations, 2010, LEV TRENDS CHILD MOR; United Nations Population Division, 2009, TRENDS INT MIGR STOC; United Nations Population Division, 2010, WORLD URB PROSP 2010; United Nations Population Division, 2011, WORLD POP PROSP 2010; Van de Walle E., 1974, FEMALE POPULATION FR; WHO, 2010, GLOB STAT REP NONC D; World Bank, 2010, MIGR REM; World Bank, 2009, WORLD DEV REP; World Bank, 2010, WORLD DEV IND 2010; World Health Organization, 2008, 2008 2013 ACT PLAN G	61	183	193	2	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					562	569		10.1126/science.1209290	http://dx.doi.org/10.1126/science.1209290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	798PI	21798935				2022-12-28	WOS:000293222400045
J	Mellars, P; French, JC				Mellars, Paul; French, Jennifer C.			Tenfold Population Increase in Western Europe at the Neandertal-to-Modern Human Transition	SCIENCE			English	Article							MODERN HUMAN COLONIZATION; EXTINCTION; AURIGNACIAN; CONTEXT; FRANCE	European Neandertals were replaced by modern human populations from Africa similar to 40,000 years ago. Archaeological evidence from the best-documented region of Europe shows that during this replacement human populations increased by one order of magnitude, suggesting that numerical supremacy alone may have been a critical factor in facilitating this replacement.	[Mellars, Paul; French, Jennifer C.] Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England	University of Cambridge	Mellars, P (corresponding author), Univ Cambridge, Dept Archaeol, Cambridge CB2 3DZ, England.	pam59@cam.ac.uk		French, Jennifer Clair/0000-0001-5947-6669	British Academy; Arts and Humanities Research Council; St. John's College, Cambridge	British Academy; Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); St. John's College, Cambridge	We thank S. Bohndiek, K. Boyle, L. Bourguinon, J.-P. Chadelle, L. Chiotti, P.-Y. Demars, H. Dibble, T. Higham, S. Kuhn, S. McPherron, P. Nigst, S. Shennan, R. White, and E. Zubrow for useful discussions and provision of data; D. Kemp for preparing the illustrations; and the British Academy, the Arts and Humanities Research Council, and St. John's College, Cambridge, for research funding.	Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bailey Shara E., 2005, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V17, P115; Banks WE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003972; Bar-Yosef O, 2010, J HUM EVOL, V59, P586, DOI 10.1016/j.jhevol.2010.06.009; BARYOSEF O, 2006, DEFINITION AURIGNACI; Bocquet-Appel JP, 2000, ANTIQUITY, V74, P544, DOI 10.1017/S0003598X00059901; Bocquet-Appel JP, 2000, J ARCHAEOL SCI, V27, P551, DOI 10.1006/jasc.1999.0471; BORDES F, 1968, OLD STONE AGE; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; Conard N.J., 2006, NEANDERTHALS MODERN; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; d'Errico F, 2003, QUATERNARY SCI REV, V22, P769, DOI 10.1016/S0277-3791(03)00009-X; Davis W, 2003, MACDONALD I MONOGRAP; de Sonneville-Bordes D, 1960, PALEOLITHIQUE SUPERI; Demars, 1996, PREHISTOIRE EUROPEEN, V8, P3; Demars PY, 2008, ANTHROPOLOGIE, V112, P157, DOI 10.1016/j.anthro.2008.02.001; Fabre V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005151; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Gamble Clive., 1986, PALAEOLITHIC SETTLEM; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; HARROLD FB, 1989, HUMAN REVOLUTION, P677; Hawks J, 2008, RECENT ADVANCES IN PALAEODEMOGRAPHY, P9, DOI 10.1007/978-1-4020-6424-1_1; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Hockett B, 2005, QUATERN INT, V137, P21, DOI 10.1016/j.quaint.2004.11.017; Klein R., 2009, HUMAN CAREER; Marean C.W., 2005, TOOLS SYMBOLS EARLY, P333; Mellars P, 2005, EVOL ANTHROPOL, V14, P12, DOI 10.1002/evan.20037; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; MELLARS P, 1989, CURR ANTHROPOL, V30, P349, DOI 10.1086/203755; Mellars P, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P493; Mellars P.A., 1991, CAMB ARCHAEOL J, V1, P269; MELLARS PA, 1987, CURR ANTHROPOL, V28, P128, DOI 10.1086/203504; Mellars PA, 1985, PREHISTORIC HUNTER G, P271; Mellars P, 2006, EVOL ANTHROPOL, V15, P167, DOI 10.1002/evan.20103; Mellars Paul A., 1996, NEANDERTHAL LEGACY A; Nigst PR, 2006, NEANDERTHALS MODERN, P269; O'Connell J. F., 2006, NEANDERTHALS MODERN, P43; Pelegrin J., 2009, NEANDERTALIENS BIOL, P283; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; Soressi M, 2007, J HUM EVOL, V52, P455, DOI 10.1016/j.jhevol.2006.11.006; Soressi M., 2002, THESIS U BORDEAUX; Svoboda J.A., 2006, NEANDERTALS MODERN H, P233; VALLADAS H, 1986, NATURE, V322, P452, DOI 10.1038/322452a0; Vandermeersch B., 2009, NEANDERTALIENS BIOL, P109; ZUBROW E, 1989, HUMAN REVOLUTION, P212	47	122	126	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					623	627		10.1126/science.1206930	http://dx.doi.org/10.1126/science.1206930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	798PI	21798948				2022-12-28	WOS:000293222400060
J	McIntosh, SW; De Pontieu, B; Carlsson, M; Hansteen, V; Boerner, P; Goossens, M				McIntosh, Scott W.; De Pontieu, Bart; Carlsson, Mats; Hansteen, Viggo; Boerner, Paul; Goossens, Marcel			Alfvenic waves with sufficient energy to power the quiet solar corona and fast solar wind	NATURE			English	Article							MAGNETOHYDRODYNAMIC TURBULENCE; DRIVEN; ACCELERATION; CHROMOSPHERE; MODEL; HOLES; TEMPERATURES	Energy is required to heat the outer solar atmosphere to millions of degrees (refs 1, 2) and to accelerate the solar wind to hundreds of kilometres per second (refs 2-6). Alfven waves (travelling oscillations of ions and magnetic field) have been invoked as a possible mechanism to transport magneto-convective energy upwards along the Sun's magnetic field lines into the corona. Previous observations(7) of Alfvenic waves in the corona revealed amplitudes far too small (0.5 km s(-1)) to supply the energy flux (100-200 W m(-2)) required to drive the fast solar wind(8) or balance the radiative losses of the quiet corona(9). Here we report observations of the transition region (between the chromosphere and the corona) and of the corona that reveal how Alfvenic motions permeate the dynamic and finely structured outer solar atmosphere. The ubiquitous outward-propagating Alfvenic motions observed have amplitudes of the order of 20 km s(-1) and periods of the order of 100-500 s throughout the quiescent atmosphere (compatible with recent investigations(7,10)), and are energetic enough to accelerate the fast solar wind and heat the quiet corona.	[McIntosh, Scott W.] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; [De Pontieu, Bart; Hansteen, Viggo; Boerner, Paul] Lockheed Martin Solar & Astrophys Lab, Palo Alto, CA 94304 USA; [Carlsson, Mats; Hansteen, Viggo] Univ Oslo, Inst Theoret Astrophys, N-0315 Oslo, Norway; [Goossens, Marcel] Katholieke Univ Leuven, Dept Math, Ctr Plasma Astrophys, B-3001 Heverlee, Belgium	National Center Atmospheric Research (NCAR) - USA; Lockheed Martin; University of Oslo; KU Leuven	McIntosh, SW (corresponding author), Natl Ctr Atmospher Res, High Altitude Observ, POB 3000, Boulder, CO 80307 USA.	mscott@ucar.edu		Goossens, Maarcel/0000-0002-7830-7147	NSF	NSF(National Science Foundation (NSF))	SDO is the first mission of NASA's Living With a Star Program. NCAR is sponsored by the NSF.	Axford WI, 1999, SPACE SCI REV, V87, P25, DOI 10.1023/A:1005197529250; Beckers J. M., 1968, SOL PHYS, V3, P367, DOI DOI 10.1007/BF00171614; BELCHER JW, 1975, ASTROPHYS J, V200, P369, DOI 10.1086/153798; Chandran BDG, 2010, ASTROPHYS J, V720, P548, DOI 10.1088/0004-637X/720/1/548; Cranmer SR, 2007, ASTROPHYS J SUPPL S, V171, P520, DOI 10.1086/518001; Cranmer SR, 2010, ASTROPHYS J, V720, P824, DOI 10.1088/0004-637X/720/1/824; De Pontieu B, 2007, SCIENCE, V318, P1574, DOI 10.1126/science.1151747; De Pontieu B, 2011, SCIENCE, V331, P55, DOI 10.1126/science.1197738; De Pontieu B, 2007, PUBL ASTRON SOC JPN, V59, pS655, DOI 10.1093/pasj/59.sp3.S655; De Pontieu B, 2009, ASTROPHYS J LETT, V701, pL1, DOI 10.1088/0004-637X/701/1/L1; HANSTEEN VH, 1995, J GEOPHYS RES-SPACE, V100, P21577, DOI 10.1029/95JA02300; HOLLWEG JV, 1973, ASTROPHYS J, V181, P547, DOI 10.1086/152072; Lemen J. R., SOL PHYS UNPUB; Matthaeus WH, 1999, ASTROPHYS J, V523, pL93, DOI 10.1086/312259; McIntosh SW, 2007, ASTROPHYS J, V654, P650, DOI 10.1086/509071; McIntosh SW, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/7; Patsourakos S, 2006, ASTROPHYS J, V647, P1452, DOI 10.1086/505517; Suzuki TK, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011502; Tomczyk S, 2007, SCIENCE, V317, P1192, DOI 10.1126/science.1143304; Tomczyk S, 2009, ASTROPHYS J, V697, P1384, DOI 10.1088/0004-637X/697/2/1384; Tsuneta S, 2008, SOL PHYS, V249, P167, DOI 10.1007/s11207-008-9174-z; Verdini A, 2010, ASTROPHYS J LETT, V708, pL116, DOI 10.1088/2041-8205/708/2/L116; WITHBROE GL, 1977, ANNU REV ASTRON ASTR, V15, P363, DOI 10.1146/annurev.aa.15.090177.002051	23	410	420	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					477	480		10.1038/nature10235	http://dx.doi.org/10.1038/nature10235			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796206				2022-12-28	WOS:000293167900035
J	Shiwani, MH				Shiwani, Muhammad Hanif			PERSONAL VIEW Surgical meshes containing animal products should be labelled	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shiwani, Muhammad Hanif] Barnsley Gen Hosp, Barnsley, England; [Shiwani, Muhammad Hanif] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Shiwani, MH (corresponding author), Barnsley Gen Hosp, Barnsley, England.	mhshiwani@gmail.com							0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 27	2011	343								d4625	10.1136/bmj.d4625	http://dx.doi.org/10.1136/bmj.d4625			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LS	21795240				2022-12-28	WOS:000293441000002
J	Shirey, SB; Richardson, SH				Shirey, Steven B.; Richardson, Stephen H.			Start of the Wilson Cycle at 3 Ga Shown by Diamonds from Subcontinental Mantle	SCIENCE			English	Article							BILLION YEARS AGO; RE-OS ISOTOPES; LITHOSPHERIC MANTLE; KAAPVAAL CRATON; PILBARA CRATON; SUBDUCTION; CRUST; DELAMINATION; CONSTRAINTS; INCLUSIONS	Mineral inclusions encapsulated in diamonds are the oldest, deepest, and most pristine samples of Earth's mantle. They provide age and chemical information over a period of 3.5 billion years-a span that includes continental crustal growth, atmospheric evolution, and the initiation of plate tectonics. We compiled isotopic and bulk chemical data of silicate and sulfide inclusions and found that a compositional change occurred 3.0 billion years ago (Ga). Before 3.2 Ga, only diamonds with peridotitic compositions formed, whereas after 3.0 Ga, eclogitic diamonds became prevalent. We suggest that this resulted from the capture of eclogite and diamond-forming fluids in subcontinental mantle via subduction and continental collision, marking the onset of the Wilson cycle of plate tectonics.	[Shirey, Steven B.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Richardson, Stephen H.] Univ Cape Town, Dept Geol Sci, ZA-7701 Rondebosch, South Africa	Carnegie Institution for Science; University of Cape Town	Shirey, SB (corresponding author), Carnegie Inst Washington, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	shirey@dtm.ciw.edu; steve.richardson@uct.ac.za			NASA [NNA09DA81A]; NSF [EAR-1049992]; National Research Foundation (South Africa) [IFR73219]	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); National Research Foundation (South Africa)(National Research Foundation - South Africa)	We thank S. Aulbach, D. Bowen, G. Duke, D. Foustoukos, E. Gaillou, J. Harris, W. Nelson, D. Pearson, S. Solomon, M. Van Kranendonk, and two anonymous reviewers for helpful discussions. Supported by NASA Astrobiology grant NNA09DA81A (S. B. S.), NSF grant EAR-1049992 (S. B. S.), and National Research Foundation (South Africa) grant IFR73219 (S.H.R.)	Aulbach S, 2011, CONTRIB MINERAL PETR, V161, P947, DOI 10.1007/s00410-010-0573-4; Aulbach S, 2009, LITHOS, V112, P747, DOI 10.1016/j.lithos.2009.03.048; Bedard JH, 2006, GEOCHIM COSMOCHIM AC, V70, P1188, DOI 10.1016/j.gca.2005.11.008; Bleeker W, 2003, LITHOS, V71, P99, DOI 10.1016/j.lithos.2003.07.003; Bowring SA, 1999, CONTRIB MINERAL PETR, V134, P3, DOI 10.1007/s004100050465; BURKE K, 1976, TECTONOPHYSICS, V33, P287, DOI 10.1016/0040-1951(76)90149-9; Burke K, 2011, ANNU REV EARTH PL SC, V39, P1, DOI 10.1146/annurev-earth-040809-152521; Burov E, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041535; Chen CW, 2009, SCIENCE, V326, P1089, DOI 10.1126/science.1178477; Creighton S, 2010, CONTRIB MINERAL PETR, V159, P645, DOI 10.1007/s00410-009-0446-x; Furnes H, 2007, SCIENCE, V315, P1704, DOI 10.1126/science.1139170; Gurney JJ, 2010, ECON GEOL, V105, P689, DOI 10.2113/gsecongeo.105.3.689; Harvey J, 2006, EARTH PLANET SC LETT, V244, P606, DOI 10.1016/j.epsl.2006.02.031; Helmstaedt HH, 2010, CAN MINERAL, V48, P1385, DOI 10.3749/canmin.48.5.1385; Hoffman P.F., 1980, GEOLOGICAL ASS CANAD, V20, P523; Kamber BS, 2002, CONTRIB MINERAL PETR, V144, P38, DOI 10.1007/s00410-002-0374-5; Lloyd F.E., 1975, PHYS CHEM EARTH, V9, P389, DOI DOI 10.1016/0079-1946(75)90030-0; Menzies M., 1986, MANTLE METASOMATISM; MORGAN JW, 1986, J GEOPHYS RES-SOLID, V91, P2375, DOI 10.1029/JB091iB12p12375; Moser DE, 2001, SCIENCE, V291, P465, DOI 10.1126/science.291.5503.465; Nutman AP, 2006, ELEMENTS, V2, P223, DOI 10.2113/gselements.2.4.223; O'Neil J, 2011, J PETROL, V52, P985, DOI 10.1093/petrology/egr014; PEARSON DG, 1999, APPL RADIOGENIC ISOT, V12, P143; Richardson SH, 2001, EARTH PLANET SC LETT, V191, P257, DOI 10.1016/S0012-821X(01)00419-8; RICHARDSON SH, 1984, NATURE, V310, P198, DOI 10.1038/310198a0; Schmitz MD, 2004, EARTH PLANET SC LETT, V222, P363, DOI 10.1016/j.epsl.2004.03.036; Shirey SB, 2001, GEOPHYS RES LETT, V28, P2509, DOI 10.1029/2000GL012589; Stachel T, 2005, ELEMENTS, V1, P73, DOI 10.2113/gselements.1.2.73; Ueda K, 2008, PHYS EARTH PLANET IN, V171, P296, DOI 10.1016/j.pepi.2008.06.032; Van Kranendonk MJ, 2007, TERRA NOVA, V19, P1, DOI 10.1111/j.1365-3121.2006.00723.x; Van Kranendonk MJ, 2010, PRECAMBRIAN RES, V177, P145, DOI 10.1016/j.precamres.2009.11.007; Westerlund KJ, 2006, CONTRIB MINERAL PETR, V152, P275, DOI 10.1007/s00410-006-0101-8; WILSON JT, 1968, P AM PHILOS SOC, V112, P309; Zegers TE, 2001, GEOLOGY, V29, P1083, DOI 10.1130/0091-7613(2001)029<1083:MACFBC>2.0.CO;2	34	367	380	4	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					434	436		10.1126/science.1206275	http://dx.doi.org/10.1126/science.1206275			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778395				2022-12-28	WOS:000292959600039
J	Corren, J; Lemanske, RF; Hanania, NA; Korenblat, PE; Parsey, MV; Arron, JR; Harris, JM; Scheerens, H; Wu, LC; Su, Z; Mosesova, S; Eisner, MD; Bohen, SP; Matthews, JG				Corren, Jonathan; Lemanske, Robert F., Jr.; Hanania, Nicola A.; Korenblat, Phillip E.; Parsey, Merdad V.; Arron, Joseph R.; Harris, Jeffrey M.; Scheerens, Heleen; Wu, Lawren C.; Su, Zheng; Mosesova, Sofia; Eisner, Mark D.; Bohen, Sean P.; Matthews, John G.			Lebrikizumab Treatment in Adults with Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLUSTER-ANALYSIS; PHENOTYPES; IL-13; QUESTIONNAIRE; INFLAMMATION; VALIDATION; PERIOSTIN; INSIGHTS; DISEASES; CELLS	Background Many patients with asthma have uncontrolled disease despite treatment with inhaled glucocorticoids. One potential cause of the variability in response to treatment is heterogeneity in the role of interleukin-13 expression in the clinical asthma phenotype. We hypothesized that anti-interleukin-13 therapy would benefit patients with asthma who had a pretreatment profile consistent with interleukin-13 activity. Methods We conducted a randomized, double-blind, placebo-controlled study of lebrikizumab, a monoclonal antibody to interleukin-13, in 219 adults who had asthma that was inadequately controlled despite inhaled glucocorticoid therapy. The primary efficacy outcome was the relative change in prebronchodilator forced expiratory volume in 1 second (FEV(1)) from baseline to week 12. Among the secondary outcomes was the rate of asthma exacerbations through 24 weeks. Patient subgroups were prespecified according to baseline type 2 helper T-cell (Th2) status (assessed on the basis of total IgE level and blood eosinophil count) and serum periostin level. Results At baseline, patients had a mean FEV(1) that was 65% of the predicted value and were taking a mean dose of inhaled glucocorticoids of 580 mu g per day; 80% were also taking a long-acting beta-agonist. At week 12, the mean increase in FEV(1) was 5.5 percentage points higher in the lebrikizumab group than in the placebo group (P=0.02). Among patients in the high-periostin subgroup, the increase from baseline FEV(1) was 8.2 percentage points higher in the lebrikizumab group than in the placebo group (P=0.03). Among patients in the low-periostin subgroup, the increase from baseline FEV(1) was 1.6 percentage points higher in the lebrikizumab group than in the placebo group (P=0.61). Musculoskeletal side effects were more common with lebrikizumab than with placebo (13.2% vs. 5.4%, P=0.045). Conclusions Lebrikizumab treatment was associated with improved lung function. Patients with high pretreatment levels of serum periostin had greater improvement in lung function with lebrikizumab than did patients with low periostin levels. (Funded by Genentech; ClinicalTrials.gov number, NCT00930163.)	[Matthews, John G.] Genentech Inc, Prod Dev Immunol, San Francisco, CA 94080 USA; [Corren, Jonathan] Allergy Med Clin, Los Angeles, CA USA; [Parsey, Merdad V.] 3 V Biosci, Menlo Pk, CA USA; [Lemanske, Robert F., Jr.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Hanania, Nicola A.] Baylor Coll Med, Houston, TX 77030 USA; [Korenblat, Phillip E.] Clin Res Ctr, St Louis, MO USA	Roche Holding; Genentech; University of Wisconsin System; University of Wisconsin Madison; Baylor College of Medicine	Matthews, JG (corresponding author), Genentech Inc, Prod Dev Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	matthews.john@gene.com	Hanania, Nicola A/C-5875-2016	Hanania, Nicola A/0000-0003-3087-9530; Arron, Joseph/0000-0001-7677-9979	Genentech [NCT00930163]; Merck; Allergy Medical Clinic; Boehringer Ingelheim; Actelion; Novartis; Sepracor; SA Boney; GlaxoSmithKline; American Institute of Research; Pharmaxis; Pfizer; AstraZeneca; Hollister-Stier Laboratories; MediciNova; Amgen; Amphastar; Apotex; Astellas; Biota; Centocor; Forest; Cephalon; MAP Pharmaceuticals; MedImmune; Sanofi Pasteur; Sanofi-Aventis; Schering-Plough (currently Merck); Sunovion (formerly Sepracor); Amplyx	Genentech(Roche HoldingGenentech); Merck(Merck & Company); Allergy Medical Clinic; Boehringer Ingelheim(Boehringer Ingelheim); Actelion; Novartis(Novartis); Sepracor; SA Boney; GlaxoSmithKline(GlaxoSmithKline); American Institute of Research; Pharmaxis; Pfizer(Pfizer); AstraZeneca(AstraZeneca); Hollister-Stier Laboratories(Randox Laboratories); MediciNova; Amgen(Amgen); Amphastar; Apotex; Astellas(Astellas Pharmaceuticals); Biota; Centocor; Forest; Cephalon; MAP Pharmaceuticals; MedImmune(AstraZenecaMedimmune); Sanofi Pasteur; Sanofi-Aventis(Sanofi-Aventis); Schering-Plough (currently Merck)(Merck & CompanySchering Plough Corporation); Sunovion (formerly Sepracor); Amplyx	Funded by Genentech; ClinicalTrials.gov number, NCT00930163.; Supported by Genentech, a member of the Roche Group. Dr. Corren reports receiving lecture fees from Genentech and Merck and grant support from Allergy Medical Clinic, Genentech, Boehringer Ingelheim, Actelion, Novartis, and Merck; Dr. Lemanske, receiving travel support from Genentech, consulting fees from Genentech, Merck, Sepracor, SA Boney, GlaxoSmithKline, and the American Institute of Research, and grant support from Pharmaxis, and his institution receiving fees from Genentech as a site for clinical research trials; Dr. Hanania, receiving fees for board membership from Genentech, Novartis, Pfizer, and GlaxoSmithKline, lecture fees from GlaxoSmithKline, AstraZeneca, Merck, and Genentech, and grant support from Pfizer, Novartis, and GlaxoSmithKline; Dr. Korenblat, receiving travel support from Genentech, consulting fees from Hollister-Stier Laboratories and MediciNova, lecture fees from Novartis and Genentech, stock or stock options from Alcon, Biotech Holdings, Johnson & Johnson, and King Pharmaceuticals, being a director and owner of the Clinical Research Center, and receiving grant support from Actelion, Amgen, Amphastar, Apotex, Astellas, Biota, Boehringer Ingelheim, Centocor, Forest, Cephalon, Genentech, GlaxoSmithKline, MAP Pharmaceuticals, MedImmune, Merck, Novartis, Pfizer, Sanofi Pasteur, Sanofi-Aventis, Schering-Plough (currently Merck), and Sunovion (formerly Sepracor), and his spouse's receiving stock from Dendreon and GlaxoSmithKline; Dr. Parsey, being a former employee of Genentech and receiving travel support, consulting fees, and stock or stock options while employed by Genentech; Dr. Arron, being an employee of Genentech and receiving consulting fees from Amplyx, holding stock or stock options from The Roche Group, and being named as an inventor on four provisional patent applications related to asthma diagnosis and treatment with Genentech; Dr. Harris, being an employee of Genentech/Roche and receiving stock or stock options from Roche; Dr. Scheerens, being an employee of Genentech/Roche and receiving stock or stock options from Genentech/Roche; Dr. Wu, being an employee of Genentech and receiving stock or stock options from Roche; Dr. Su, being an employee of Genentech and receiving stock or stock options from Genentech; Dr. Mosesova, being an employee of Roche and receiving stock or stock options from Roche; Dr. Eisner, being an employee of Genentech and receiving stock or stock options from Genentech/Roche; Dr. Bohen, being an employee of Genentech and receiving stock or stock options from Roche; and Dr. Matthews, being an employee of Genentech, receiving travel support and stock or stock options from Genentech, and being named as an inventor on a patent application regarding asthma diagnosis and treatment with Genentech. Dr. Matthews also reports that Roche/Genentech is developing a periostin assay as a potential companion diagnostic for lebrikizumab. No other potential conflict of interest relevant to this article was reported.	Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Bel EH, 2004, CURR OPIN PULM MED, V10, P44, DOI 10.1097/00063198-200401000-00008; Bradding P, 2010, CURR OPIN ALLERGY CL, V10, P54, DOI 10.1097/ACI.0b013e32833489a9; Chibana K, 2008, CLIN EXP ALLERGY, V38, P936, DOI 10.1111/j.1365-2222.2008.02969.x; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; Gibson PG, 2009, CLIN RESPIR J, V3, P198, DOI 10.1111/j.1752-699X.2009.00162.x; Hakonarson H, 2005, P NATL ACAD SCI USA, V102, P14789, DOI 10.1073/pnas.0409904102; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kraft M, 2001, AM J RESP CRIT CARE, V163, P1219, DOI 10.1164/ajrccm.163.5.2002058; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Saha SK, 2008, J ALLERGY CLIN IMMUN, V121, P685, DOI 10.1016/j.jaci.2008.01.005; SCHEERENS H, 2011, ANN M AM AC ALL ASTH; Siddiqui Salman, 2007, Allergy Asthma Clin Immunol, V3, P60, DOI 10.1186/1710-1492-3-2-60; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Spahn JD, 1996, J IMMUNOL, V157, P2654; St Ledger K, 2009, J IMMUNOL METHODS, V350, P161, DOI 10.1016/j.jim.2009.08.012; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Taylor DR, 2008, POSTGRAD MED J, V84, P628, DOI 10.1136/pgmj.2008.069864; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P796; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC	29	1172	1248	1	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1088	1098		10.1056/NEJMoa1106469	http://dx.doi.org/10.1056/NEJMoa1106469			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822WR	21812663				2022-12-28	WOS:000295081600008
J	Lindhurst, MJ; Sapp, JC; Teer, JK; Johnston, JJ; Finn, EM; Peters, K; Turner, J; Cannons, JL; Bick, D; Blakemore, L; Blumhorst, C; Brockmann, K; Calder, P; Cherman, N; Deardorff, MA; Everman, DB; Golas, G; Greenstein, RM; Kato, BM; Keppler-Noreuil, KM; Kuznetsov, SA; Miyamoto, RT; Newman, K; Ng, D; O'Brien, K; Rothenberg, S; Schwartzentruber, DJ; Singhal, V; Tirabosco, R; Upton, J; Wientroub, S; Zackai, EH; Hoag, K; Whitewood-Neal, T; Robey, PG; Schwartzberg, PL; Darling, TN; Tosi, LL; Mullikin, JC; Biesecker, LG				Lindhurst, Marjorie J.; Sapp, Julie C.; Teer, Jamie K.; Johnston, Jennifer J.; Finn, Erin M.; Peters, Kathryn; Turner, Joyce; Cannons, Jennifer L.; Bick, David; Blakemore, Laurel; Blumhorst, Catherine; Brockmann, Knut; Calder, Peter; Cherman, Natasha; Deardorff, Matthew A.; Everman, David B.; Golas, Gretchen; Greenstein, Robert M.; Kato, B. Maya; Keppler-Noreuil, Kim M.; Kuznetsov, Sergei A.; Miyamoto, Richard T.; Newman, Kurt; Ng, David; O'Brien, Kevin; Rothenberg, Steven; Schwartzentruber, Douglas J.; Singhal, Virender; Tirabosco, Roberto; Upton, Joseph; Wientroub, Shlomo; Zackai, Elaine H.; Hoag, Kimberly; Whitewood-Neal, Tracey; Robey, Pamela G.; Schwartzberg, Pamela L.; Darling, Thomas N.; Tosi, Laura L.; Mullikin, James C.; Biesecker, Leslie G.			A Mosaic Activating Mutation in AKT1 Associated with the Proteus Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR-SUPPRESSOR PTEN; GERMLINE MUTATION; GENE; CELLS; CHALLENGES; DEFECTS; GROWTH	BACKGROUND The Proteus syndrome is characterized by the overgrowth of skin, connective tissue, brain, and other tissues. It has been hypothesized that the syndrome is caused by somatic mosaicism for a mutation that is lethal in the nonmosaic state. METHODS We performed exome sequencing of DNA from biopsy samples obtained from patients with the Proteus syndrome and compared the resultant DNA sequences with those of unaffected tissues obtained from the same patients. We confirmed and extended an observed association, using a custom restriction-enzyme assay to analyze the DNA in 158 samples from 29 patients with the Proteus syndrome. We then assayed activation of the AKT protein in affected tissues, using phosphorylation-specific antibodies on Western blots. RESULTS Of 29 patients with the Proteus syndrome, 26 had a somatic activating mutation (c.49G -> A, p.Glu17Lys) in the oncogene AKT1, encoding the AKT1 kinase, an enzyme known to mediate processes such as cell proliferation and apoptosis. Tissues and cell lines from patients with the Proteus syndrome harbored admixtures of mutant alleles that ranged from 1% to approximately 50%. Mutant cell lines showed greater AKT phosphorylation than did control cell lines. A pair of single-cell clones that were established from the same starting culture and differed with respect to their mutation status had different levels of AKT phosphorylation. CONCLUSIONS The Proteus syndrome is caused by a somatic activating mutation in AKT1, proving the hypothesis of somatic mosaicism and implicating activation of the PI3K-AKT pathway in the characteristic clinical findings of overgrowth and tumor susceptibility in this disorder. (Funded by the Intramural Research Program of the National Human Genome Research Institute.)	[Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Cherman, Natasha; Kuznetsov, Sergei A.; Robey, Pamela G.] Natl Inst Dent & Craniofacial Res, Bethesda, MD USA; [Schwartzentruber, Douglas J.] NCI, Bethesda, MD 20892 USA; [Darling, Thomas N.] Uniformed Serv Univ Hlth Sci, Dept Dermatol, Bethesda, MD 20814 USA; [Mullikin, James C.; Biesecker, Leslie G.] Natl Inst Hlth Intramural Sequencing Ctr, Rockville, MD USA; [Bick, David] Med Coll Wisconsin, Dept Pediat, Div Genet, Milwaukee, WI 53226 USA; [Blakemore, Laurel; Tosi, Laura L.] Childrens Natl Med Ctr, Div Orthopaed & Sports Med, Washington, DC 20010 USA; [Newman, Kurt] Childrens Natl Med Ctr, Dept Surg, Washington, DC 20010 USA; [Brockmann, Knut] Univ Gottingen, Dept Pediat & Pediat Neurol, Gottingen, Germany; [Calder, Peter; Tirabosco, Roberto] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England; [Deardorff, Matthew A.; Zackai, Elaine H.] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Everman, David B.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Greenstein, Robert M.] Univ Connecticut, Dept Genet & Dev Biol, Hartford, CT USA; [Kato, B. Maya] Ear Inst, Palm Desert, CA USA; [Keppler-Noreuil, Kim M.] Univ Iowa, Dept Pediat, Div Genet, Iowa City, IA 52242 USA; [Miyamoto, Richard T.] Indiana Univ Purdue Univ, Dept Otolaryngol, Indianapolis, IN 46202 USA; [Rothenberg, Steven] Rocky Mt Hosp Children, Dept Pediat Surg, Denver, CO USA; [Singhal, Virender] Childrens Mercy Hosp & Clin, Dept Pediat Plast & Craniofacial Surg, Kansas City, MO USA; [Upton, Joseph] Childrens Hosp, Div Plast Surg, Boston, MA 02115 USA; [Wientroub, Shlomo] Tel Aviv Univ, Tel Aviv Med Ctr, Dana Childrens Hosp, Dept Pediat Orthopaed, IL-69978 Tel Aviv, Israel; [Hoag, Kimberly] Proteus Syndrome Fdn, Colorado Springs, CO USA; [Whitewood-Neal, Tracey] Proteus Syndrome Fdn UK, Bexhill On Sea, England	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; Medical College of Wisconsin; Children's National Health System; Children's National Health System; University of Gottingen; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Greenwood Genetic Center; University of Connecticut; University of Iowa; Indiana University System; Indiana University-Purdue University Indianapolis; Children's Mercy Hospital; Harvard University; Boston Children's Hospital; Tel Aviv University; Sackler Faculty of Medicine	Biesecker, LG (corresponding author), NHGRI, Genet Dis Res Branch, NIH, Bldg 49,Rm 4A56, Bethesda, MD 20892 USA.	leslieb@helix.nih.gov	Robey, Pamela Gehron/H-1429-2011; Lindhurst, Marjorie/AHD-3412-2022	Robey, Pamela Gehron/0000-0002-5316-5576; Sapp, Julie/0000-0002-4003-258X; Darling, Thomas/0000-0002-5161-1974	National Human Genome Research Institute; Proteus Syndrome Foundation in the United States; Proteus Syndrome Foundation in the United Kingdom; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIBHG000196, ZIAHG200328, ZIAHG000123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Proteus Syndrome Foundation in the United States; Proteus Syndrome Foundation in the United Kingdom; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by the Intramural Research Program of the National Human Genome Research Institute. The Proteus Syndrome Foundations in the United States and the United Kingdom contributed financial support for the sequencing.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barker K, 2001, J MED GENET, V38, P480, DOI 10.1136/jmg.38.7.480; Biesecker L. G., 2005, MANAGEMENT GENETIC S, P449; Biesecker L, 2006, EUR J HUM GENET, V14, P1151, DOI 10.1038/sj.ejhg.5201638; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Biesecker LG, 2001, LANCET, V358, P2079, DOI 10.1016/S0140-6736(01)07109-4; Biesecker LG, 2001, JAMA-J AM MED ASSOC, V285, P2240, DOI 10.1001/jama.285.17.2240; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; Brockmann K, 2008, AM J MED GENET A, V146A, P2122, DOI 10.1002/ajmg.a.32417; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Caux F, 2007, EUR J HUM GENET, V15, P767, DOI 10.1038/sj.ejhg.5201823; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fukai A, 2010, ARTHRITIS RHEUM-US, V62, P826, DOI 10.1002/art.27296; Happle R, 2007, BRIT J DERMATOL, V156, P1089, DOI 10.1111/j.1365-2133.2007.07818.x; HAPPLE R, 1986, HUM GENET, V72, P280, DOI 10.1007/BF00291899; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; HAPPLE R, 1986, CLIN GENET, V29, P321; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Segrelles C, 2008, MOL BIOL CELL, V19, P137, DOI 10.1091/mbc.E07-08-0764; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Slavotinek AM, 2000, CLIN GENET, V58, P386, DOI 10.1034/j.1399-0004.2000.580509.x; Smith JM, 2002, J MED GENET, V39, P937, DOI 10.1136/jmg.39.12.937; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Thiffault I, 2004, AM J MED GENET A, V130A, P123, DOI 10.1002/ajmg.a.30335; Vandoorne K, 2010, MAGN RESON MED, V64, P54, DOI 10.1002/mrm.22395; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; WEINSTEIN LS, 1992, NEW ENGL J MED, V326, P1648; Xue W, 2011, NATURE, V473, P544, DOI 10.1038/nature09909; Zhou F, 2010, AM J PATHOL, V177, P2124, DOI 10.2353/ajpath.2010.091301; Zhou XP, 2000, HUM MOL GENET, V9, P765, DOI 10.1093/hmg/9.5.765; Zhou XP, 2001, LANCET, V358, P210, DOI 10.1016/S0140-6736(01)05412-5	35	556	575	1	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2011	365	7					611	619		10.1056/NEJMoa1104017	http://dx.doi.org/10.1056/NEJMoa1104017			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808ER	21793738	Green Accepted			2022-12-28	WOS:000293960500008
J	Nelson, PK; Mathers, BM; Cowie, B; Hagan, H; Des Jarlais, D; Horyniak, D; Degenhardt, L				Nelson, Paul K.; Mathers, Bradley M.; Cowie, Benjamin; Hagan, Holly; Des Jarlais, Don; Horyniak, Danielle; Degenhardt, Louisa			Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews	LANCET			English	Article							VIRUS-INFECTIONS; VIRAL-HEPATITIS; USERS; HIV; SEROPREVALENCE; TRANSMISSION; PREVENTION; DISEASE	Background Injecting drug use is an important risk factor for transmission of viral hepatitis, but detailed, transparent estimates of the scale of the issue do not exist. We estimated national, regional, and global prevalence and population size for hepatitis C virus (HCV) and hepatitis B virus (HBV) in injecting drug users (ID Us). Methods We systematically searched for data for HBV and HCV in IDUs in peer-reviewed databases (Medline, Embase, and PsycINFO), grey literature, conference abstracts, and online resources, and made a widely distributed call for additional data. From 4386 peer-reviewed and 1019 grey literature sources, we reviewed 1125 sources in full. We extracted studies into a customised database and graded them according to their methods. We included serological reports of HCV antibodies (anti-HCV), HBV antibodies (anti-HBc), or HBV surface antigen (HBsAg) in studies of IDUs with more than 40 participants (<100% HIV-positive) and sampling frames that did not exclude participants on the basis of age or sex. With endorsed decision rules, we calculated prevalence estimates with anti-HCV and anti-HBc as proxies for exposure and HBsAg as proxy for current infection. We combined these estimates with IDU population sizes to calculate the number of IDUs with positive HBV or HCV statuses. Findings We located eligible reports with data for prevalence of anti-HCV in IDUs for 77 countries; midpoint prevalence estimates suggested 60-80% of IDUs had anti-HCV in 25 countries and more than 80% of IDUs did so in 12 countries. About 10.0 million (range 6.0-15.2) IDUs worldwide might be anti-HCV positive. China (1.6 million), USA (1.5 million), and Russia (1.3 million) had the largest such populations. We identified eligible HBsAg reports for 59 countries, with midpoint prevalence estimates of 5-10% in 21 countries and more than 10% in ten countries. Worldwide, we estimate 6.4 million IDUs are anti-HBc positive (2.3-9.7 million), and 1.2 million (0.3-2.7 million) are HBsAg positive. Interpretation More IDUs have anti-HCV than HIV infection, and viral hepatitis poses a key challenge to public health. Variation in the coverage and quality of existing research creates uncertainty around estimates. Improved and more complete data and reporting are needed to estimate the scale of the issue, which will inform efforts to prevent and treat HCV and HBV in IDUs.	[Horyniak, Danielle; Degenhardt, Louisa] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic 3004, Australia; [Degenhardt, Louisa] Univ Melbourne, Sch Populat Hlth, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia; [Nelson, Paul K.; Mathers, Bradley M.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Cowie, Benjamin] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Hagan, Holly] NYU, Coll Nursing, New York, NY USA; [Des Jarlais, Don] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA	Burnet Institute; University of Melbourne; University of New South Wales Sydney; Victorian Infectious Diseases Reference Laboratory; New York University; Harvard University; Beth Israel Deaconess Medical Center	Degenhardt, L (corresponding author), Burnet Inst, Ctr Populat Hlth, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	louisa@burnet.edu.au	Mathers, Bradley M/J-6118-2012; Cowie, Benjamin/HFZ-9941-2022; Degenhardt, Louisa J/D-4515-2012	Mathers, Bradley M/0000-0003-2827-0697; Cowie, Benjamin/0000-0002-7087-5895; Degenhardt, Louisa J/0000-0002-8513-2218	HIV/AIDS (UNAIDS); United Nations Office on Drugs and Crime (UNODC); WHO; Reckitt Benckiser in Australia [2006-08]; WHO's HIV department and the Australian National Drug and Alcohol Research Centre; Australian Department of Health and Ageing; US National Institute on Drug Abuse [R01 DA018609]; US National Institutes of Health [DA003574]; Australian National Health and Medical Research Council; Australian Postgraduate Awards; WHO, Geneva, Switzerland; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018609, R01DA003574] Funding Source: NIH RePORTER	HIV/AIDS (UNAIDS); United Nations Office on Drugs and Crime (UNODC); WHO(World Health Organization); Reckitt Benckiser in Australia; WHO's HIV department and the Australian National Drug and Alcohol Research Centre; Australian Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Awards(Australian Government); WHO, Geneva, Switzerland(World Health Organization); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	LD and BMM have received grant money and have acted as independent consultants to WHO, the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Office on Drugs and Crime (UNODC). DO) has been funded by and consulted for WHO. LD received an untied educational grant (2006-08) from Reckitt Benckiser in Australia to do a postmarketing surveillance study of buprenorphine-naloxone for the treatment of heroin dependence in Australia.; This report received funding support from WHO's HIV department and the Australian National Drug and Alcohol Research Centre, which receives funding from the Australian Department of Health and Ageing. The HCV Synthesis Project was funded by US National Institute on Drug Abuse Grant R01 DA018609. DDJ is supported by US National Institutes of Health grant DA003574. LD is supported by an Australian National Health and Medical Research Council Senior Research Fellowship. PKN and DH are supported by Australian Postgraduate Awards. This study was completed as part of the work of the 2010 Global Burden of Disease (GBD) Illicit Drugs expert group. The work of the Reference Group to the UN on HIV and Injecting Drug Use in 2007 was undertaken by the Secretariat, based at the National Drug and Alcohol Research Centre (NDARC) at the University of New South Wales (UNSW; Sydney, Australia). We thank the GBD team from the NDARC (Bianca Calabria, Chiara Bucello, and Anna Roberts, who contributed to earlier phases of the work and Mary Kumvaj and Eva Congreve who assisted with the compilation of the literature); Paul McElwee (Burnet Institute, Melbourne, VIC, Australia) for assistance with data extraction; Benjamin Phillips (NDARC) for his work on the systematic review of HIV and injecting drug use and his assistance with generation of maps; the many local and international experts who assisted with compilation of data, provided further data, commented on estimates, or provided support during the data collection process; the European Monitoring Centre on Drugs and Drug Addiction (EMCDDA) for the data published online, submitted by their network of Focal Points across the EU; Maria Elena Medina-Mora (National Institute on Psychiatry Ramon de la Fuente Muniz, Mexico) for sourcing and translation efforts; Khayriyyah Mohd Hanafiah (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA); Steven Wiersma (WHO, Geneva, Switzerland) for advice on hepatitis epidemiology and early results from the GBD hepatitis expert group; and Annette Verster (WHO, Geneva, Switzerland) for financial support of part of this review. Contributors of data and advice on this review are listed fully at http://www.gbd.unsw.edu.au/gbdweb.nsf/page/Contribution%20of%20Data.	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Ali H, 314 NDARC; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Amin J, 2006, LANCET, V368, P938, DOI 10.1016/S0140-6736(06)69374-4; Cowie B, 2011, AUST NZ J PUBL HEAL, V35, P12, DOI 10.1111/j.1753-6405.2010.00634.x; Degenhardt L, LANCET IN PRESS; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V117, P85, DOI 10.1016/j.drugalcdep.2010.11.032; Donoghoe MC, 1998, SOC AS AIDS, P42; Dore GJ, 2002, J GASTROEN HEPATOL, V17, P423, DOI 10.1046/j.1440-1746.2002.02730.x; Gibson A, ADDICTION IN PRESS; Hagan H, 2008, AM J EPIDEMIOL, V168, P1099, DOI 10.1093/aje/kwn237; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Hunt DR, 2009, AM J GASTROENTEROL, V104, P1024, DOI 10.1038/ajg.2008.143; International Harm Reduction Association, POOR ACC HCV TREATM; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Kenny DT, YOUNG OFFENDERS COMM; Kimber J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3172; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; LEVINE OS, 1994, EPIDEMIOL REV, V16, P418, DOI 10.1093/oxfordjournals.epirev.a036161; Limberg W., 2004, HEPATITIS C INJECTIN, P21; Martin NK, 2011, J THEOR BIOL, V274, P58, DOI 10.1016/j.jtbi.2010.12.041; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Matthews G.DoreGJ, COINFECTION HIV VIRA; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Palmateer N, 2010, ADDICTION, V105, P844, DOI 10.1111/j.1360-0443.2009.02888.x; Papatheodoridis GV, 2010, J HEPATOL, V53, P348, DOI 10.1016/j.jhep.2010.02.035; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Stern R, 2008, BMC MED RES METHODOL, V18, P341; Swan T, HEPATITIS C TREATMEN; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; UN Population Division, 2009, WORLD POP PROSP 2008; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Walsh N, 2010, GLOBAL STATE HARM RE, P71	36	929	957	0	92	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2011	378	9791					571	583		10.1016/S0140-6736(11)61097-0	http://dx.doi.org/10.1016/S0140-6736(11)61097-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	812UX	21802134	Green Accepted			2022-12-28	WOS:000294319500029
J	Kim, DH; Lu, NS; Ma, R; Kim, YS; Kim, RH; Wang, SD; Wu, J; Won, SM; Tao, H; Islam, A; Yu, KJ; Kim, TI; Chowdhury, R; Ying, M; Xu, LZ; Li, M; Chung, HJ; Keum, H; McCormick, M; Liu, P; Zhang, YW; Omenetto, FG; Huang, YG; Coleman, T; Rogers, JA				Kim, Dae-Hyeong; Lu, Nanshu; Ma, Rui; Kim, Yun-Soung; Kim, Rak-Hwan; Wang, Shuodao; Wu, Jian; Won, Sang Min; Tao, Hu; Islam, Ahmad; Yu, Ki Jun; Kim, Tae-il; Chowdhury, Raeed; Ying, Ming; Xu, Lizhi; Li, Ming; Chung, Hyun-Joong; Keum, Hohyun; McCormick, Martin; Liu, Ping; Zhang, Yong-Wei; Omenetto, Fiorenzo G.; Huang, Yonggang; Coleman, Todd; Rogers, John A.			Epidermal Electronics	SCIENCE			English	Article							MECHANICAL-PROPERTIES; INTEGRATED-CIRCUITS; SKIN; INTERCONNECTS; INDENTATION	We report classes of electronic systems that achieve thicknesses, effective elastic moduli, bending stiffnesses, and areal mass densities matched to the epidermis. Unlike traditional wafer-based technologies, laminating such devices onto the skin leads to conformal contact and adequate adhesion based on van der Waals interactions alone, in a manner that is mechanically invisible to the user. We describe systems incorporating electrophysiological, temperature, and strain sensors, as well as transistors, light-emitting diodes, photodetectors, radio frequency inductors, capacitors, oscillators, and rectifying diodes. Solar cells and wireless coils provide options for power supply. We used this type of technology to measure electrical activity produced by the heart, brain, and skeletal muscles and show that the resulting data contain sufficient information for an unusual type of computer game controller.	[Kim, Dae-Hyeong; Lu, Nanshu; Kim, Yun-Soung; Kim, Rak-Hwan; Won, Sang Min; Islam, Ahmad; Yu, Ki Jun; Kim, Tae-il; Ying, Ming; Xu, Lizhi; Chung, Hyun-Joong; Keum, Hohyun; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Kim, Dae-Hyeong; Lu, Nanshu; Kim, Yun-Soung; Kim, Rak-Hwan; Won, Sang Min; Islam, Ahmad; Yu, Ki Jun; Kim, Tae-il; Ying, Ming; Xu, Lizhi; Chung, Hyun-Joong; Keum, Hohyun; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Ma, Rui; Chowdhury, Raeed; McCormick, Martin; Coleman, Todd] Univ Illinois, Dept Elect & Comp Engn, Coordinated Sci Lab, Urbana, IL 61801 USA; [Wang, Shuodao; Wu, Jian; Li, Ming; Huang, Yonggang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Wang, Shuodao; Wu, Jian; Li, Ming; Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL 60208 USA; [Tao, Hu; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Liu, Ping; Zhang, Yong-Wei] Inst High Performance Comp, Singapore 138632, Singapore; [Li, Ming] Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University; Tufts University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Dalian University of Technology	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	jrogers@uiuc.edu	Lu, Nanshu/B-1611-2008; Chowdhury, Raeed Hasan/J-4443-2019; Xu, Lizhi/D-8143-2016; Wu, Jian/I-3466-2012; Kim, Tae-il/C-4769-2015; Chung, Hyun-Joong/H-6208-2011; Huang, Yonggang/B-6998-2009; huang, yonggang/O-6236-2019; Islam, Ahmad Ehteshamul/A-6569-2008; Wang, Shuodao/H-6014-2011; li, ming/F-6060-2010; Zhang, Yong-Wei/D-5191-2012; Chung, Hyun-Joong/D-5383-2013; Rogers, John/L-2798-2016; Kim, Rak-Hwan/A-6155-2012; Tao, Hu/C-1528-2013	Lu, Nanshu/0000-0002-3595-3851; Chowdhury, Raeed Hasan/0000-0002-5934-919X; Xu, Lizhi/0000-0001-6888-0524; Wu, Jian/0000-0003-2295-6815; Kim, Tae-il/0000-0002-6667-5356; Islam, Ahmad Ehteshamul/0000-0002-4233-1233; Wang, Shuodao/0000-0002-0481-7902; Zhang, Yong-Wei/0000-0001-7255-1678; Chung, Hyun-Joong/0000-0003-0569-6951; Coleman, Todd/0000-0002-2144-2495; Kim, Dae-Hyeong/0000-0002-4722-1893	National Security Science and Engineering Faculty; Air Force Research Laboratory; National Science Foundation (NSF) [CMMI 07-49028, ECCS-0824129, OISE-1043143]; U.S. Department of Energy, Division of Materials Sciences [DE-FG02-07ER46471, DE-FG02-07ER46453]; Beckman Institute postdoctoral fellowship	National Security Science and Engineering Faculty; Air Force Research Laboratory; National Science Foundation (NSF)(National Science Foundation (NSF)); U.S. Department of Energy, Division of Materials Sciences(United States Department of Energy (DOE)); Beckman Institute postdoctoral fellowship	This material is based on work supported by a National Security Science and Engineering Faculty Fellowship and a grant from the Air Force Research Laboratory. The manufacturing techniques were developed with support from the National Science Foundation (NSF) under grant CMMI 07-49028 and used facilities at the Materials Research Laboratory and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign, supported by the U.S. Department of Energy, Division of Materials Sciences under awards DE-FG02-07ER46471 and DE-FG02-07ER46453. N.L. acknowledges support from a Beckman Institute postdoctoral fellowship. Y.H. acknowledges NSF grants ECCS-0824129 and OISE-1043143. We thank K. Shenoy and R. Nuzzo for useful discussions. One or more provisional patents are being filed on this work. J.A.R. is a co-founder and equity holder in the company MC10, which pursues the commercialization of biointegrated devices.	ARUMUGAM V, 1994, J BIOSCIENCE, V19, P307, DOI 10.1007/BF02716820; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Cheung KC, 2007, BIOSENS BIOELECTRON, V22, P1783, DOI 10.1016/j.bios.2006.08.035; FOX EJ, 1976, PAIN, V2, P141, DOI 10.1016/0304-3959(76)90109-3; Geerligs M, 2011, J BIOMECH, V44, P1176, DOI 10.1016/j.jbiomech.2011.01.015; GERDLE B, 1999, MODERN TECHNIQUES NE, P705; Gonzalez M, 2008, MICROELECTRON RELIAB, V48, P825, DOI 10.1016/j.microrel.2008.03.025; Griss P, 2002, IEEE T BIO-MED ENG, V49, P597, DOI 10.1109/TBME.2002.1001974; HARDYCK CD, 1966, SCIENCE, V154, P1467, DOI 10.1126/science.154.3755.1467; Hu LB, 2010, NANO LETT, V10, P708, DOI 10.1021/nl903949m; Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031; Ives JR, 2007, CLIN NEUROPHYSIOL, V118, P1633, DOI 10.1016/j.clinph.2007.03.013; Kaneko A, 2005, J HAND THER, V18; Kaneko Atsushi, 2005, J Hand Ther, V18, P421, DOI 10.1197/j.jht.2005.09.010; Keplinger C, 2010, P NATL ACAD SCI USA, V107, P4505, DOI 10.1073/pnas.0913461107; Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367; Kim DH, 2008, P NATL ACAD SCI USA, V105, P18675, DOI 10.1073/pnas.0807476105; Kim RH, 2010, NAT MATER, V9, P929, DOI [10.1038/NMAT2879, 10.1038/nmat2879]; Kubo M, 2010, ADV MATER, V22, P2749, DOI 10.1002/adma.200904201; Kuwazuru O, 2008, MED ENG PHYS, V30, P516, DOI 10.1016/j.medengphy.2007.06.001; Lacour SP, 2005, P IEEE, V93, P1459, DOI 10.1109/JPROC.2005.851502; Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/NMAT2834, 10.1038/nmat2834]; Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011; Searle A, 2000, PHYSIOL MEAS, V21, P271, DOI 10.1088/0967-3334/21/2/307; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Sornmo L., 2005, PEM FUEL CELLS, DOI DOI 10.1016/B978-0-12-078142-3.X5000-9; Spreen O, 2006, COMPENDIUM NEUROPSYC; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Takei K, 2010, NAT MATER, V9, P821, DOI [10.1038/nmat2835, 10.1038/NMAT2835]; Tchvialeva  L., 2010, SKIN ROUGHNESS ASSES; Webster J G, 2009, MED INSTRUM, P189; Wilhelm K. P., 1997, BIOENGINEERING SKIN; Yu LM, 2009, SENSOR ACTUAT A-PHYS, V151, P17, DOI 10.1016/j.sna.2009.01.020	33	3207	3341	134	2246	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					838	843		10.1126/science.1206157	http://dx.doi.org/10.1126/science.1206157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836009	Green Submitted			2022-12-28	WOS:000293785400031
J	Mounce, RCP; Wills, MA				Mounce, Ross C. P.; Wills, Matthew A.			Phylogenetic position of Diania challenged	NATURE			English	Letter									[Mounce, Ross C. P.; Wills, Matthew A.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Mounce, RCP (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	rcpm20@bath.ac.uk	Mounce, Ross/A-2538-2010; Wills, Matthew Albion/AAE-1790-2019	Mounce, Ross/0000-0002-3520-2046; Wills, Matthew/0000-0002-7344-7749				GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Liu JN, 2011, NATURE, V470, P526, DOI 10.1038/nature09704; Swofford D.L., 2002, PAUP PHYLOGENETIC AN	3	12	12	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					E1	E1		10.1038/nature10266	http://dx.doi.org/10.1038/nature10266			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21833044	Green Accepted, Green Submitted			2022-12-28	WOS:000293731900001
J	Turner, MS				Turner, Michael S.			The dark clouds over US astronomy	NATURE			English	Editorial Material									Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA	University of Chicago	Turner, MS (corresponding author), Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA.	mturner@uchicago.edu							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					127	127		10.1038/476127a	http://dx.doi.org/10.1038/476127a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	805MU	21833049	Bronze			2022-12-28	WOS:000293731900006
J	Mazzoleni, LE; Francesconi, CF; Sander, GB				Mazzoleni, Luiz Edmundo; Francesconi, Carlos Fernando; Sander, Guilherme Becker			Mass eradication of Helicobacter pylori: feasible and advisable?	LANCET			English	Editorial Material							GASTRIC-CANCER; INFECTION; OUTCOMES; TRIAL; RISK		[Mazzoleni, Luiz Edmundo; Francesconi, Carlos Fernando] Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil; [Mazzoleni, Luiz Edmundo; Francesconi, Carlos Fernando; Sander, Guilherme Becker] Hosp Clin Porto Alegre, Dept Gastroenterol, BR-90035903 Porto Alegre, RS, Brazil; [Mazzoleni, Luiz Edmundo; Francesconi, Carlos Fernando] Univ Fed Rio Grande do Sul, Post Grad Program Gastroenterol & Hepatol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Mazzoleni, LE (corresponding author), Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil.	lemazzoleni@yahoo.com.br	Mazzoleni, Luiz/AAA-7128-2019; Francesconi, Carlos/U-6040-2019; de Magalhães Francesconi, Carlos Fernando/V-3123-2019					Davit BM, 2009, ANN PHARMACOTHER, V43, P1583, DOI 10.1345/aph.1M141; Del Giudice G, 2009, EXPERT REV VACCINES, V8, P1037, DOI 10.1586/ERV.09.62; Everhart JE, 2000, GASTROENTEROL CLIN N, V29, P559, DOI 10.1016/S0889-8553(05)70130-8; Fuccio L, 2009, ANN INTERN MED, V151, P121, DOI 10.7326/0003-4819-151-2-200907210-00009; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Greenberg ER, 2011, LANCET, V378, P507, DOI 10.1016/S0140-6736(11)60825-8; International Agency for Research on Cancer WHO, 1994, SCHIST LIV FLUK HEL, P177; Mazzoleni LE, 2006, DIGEST DIS SCI, V51, P89, DOI 10.1007/s10620-006-3090-6; Mazzoleni LE, 2010, GASTROENTEROLOGY, V138, pS719; Nightingale CH, 2005, CLIN DRUG INVEST, V25, P135, DOI 10.2165/00044011-200525020-00006; Niv Y, 2008, WORLD J GASTROENTERO, V14, P1477, DOI 10.3748/wjg.14.1477; Parsonnet J, 2004, JAMA-J AM MED ASSOC, V291, P244, DOI 10.1001/jama.291.2.244; Winkel P, 2011, CARDIOLOGY, V118, P63, DOI 10.1159/000324533; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Zuluaga AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010744	15	6	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 6	2011	378	9790					462	464		10.1016/S0140-6736(11)61099-4	http://dx.doi.org/10.1016/S0140-6736(11)61099-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	809SO	21777975				2022-12-28	WOS:000294077200006
J	Naya, Y; Suzuki, WA				Naya, Yuji; Suzuki, Wendy A.			Integrating What and When Across the Primate Medial Temporal Lobe	SCIENCE			English	Article							INFEROTEMPORAL CORTEX; EPISODIC MEMORY; HIPPOCAMPUS; REPRESENTATION; CONTEXT; MONKEY; ORDER; OBJECTS; EVENTS	Episodic memory or memory for the detailed events in our lives is critically dependent on structures of the medial temporal lobe (MTL). A fundamental component of episodic memory is memory for the temporal order of items within an episode. To understand the contribution of individual MTL structures to temporal-order memory, we recorded single-unit activity and local field potential from three MTL areas (hippocampus and entorhinal and perirhinal cortex) and visual area TE as monkeys performed a temporal-order memory task. Hippocampus provided incremental timing signals from one item presentation to the next, whereas perirhinal cortex signaled the conjunction of items and their relative temporal order. Thus, perirhinal cortex appeared to integrate timing information from hippocampus with item information from visual sensory area TE.	[Naya, Yuji; Suzuki, Wendy A.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Naya, Y (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	yujin@cns.nyu.edu			NIH [RO1 MH086563, RO1 MH058847]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086563, R01MH058847] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The present study was funded by NIH grants RO1 MH086563 to W.A.S. and Y.N. and RO1 MH058847 to W.A.S. We thank E. Wang, A. Shang, and N. Nystrom for expert animal care and E. Hargreaves, M. Yanike, and M. Shapiro for helpful comments. The authors declare no competing financial interests. Y.N. and W.A.S. designed the experiments and wrote the manuscript. Y.N. performed the experiment and analyzed the data.	Barak O, 2010, J NEUROSCI, V30, P9424, DOI 10.1523/JNEUROSCI.1875-10.2010; Downes JJ, 2002, NEUROPSYCHOLOGIA, V40, P853, DOI 10.1016/S0028-3932(01)00172-5; Eichenbaum H, 2003, CURR DIR PSYCHOL SCI, V12, P53, DOI 10.1111/1467-8721.01225; Gill PR, 2011, HIPPOCAMPUS, V21, P1240, DOI 10.1002/hipo.20832; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Howard MW, 2002, J MATH PSYCHOL, V46, P269, DOI 10.1006/jmps.2001.1388; Jenkins LJ, 2010, J NEUROSCI, V30, P15558, DOI 10.1523/JNEUROSCI.1337-10.2010; Lehky SR, 2005, VISION RES, V45, P57, DOI 10.1016/j.visres.2004.07.021; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Naya Y, 2003, J NEUROSCI, V23, P2861; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Ninokura Y, 2003, J NEUROPHYSIOL, V89, P2868, DOI 10.1152/jn.00647.2002; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Paz R, 2010, P NATL ACAD SCI USA, V107, P6046, DOI 10.1073/pnas.0910834107; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tubridy S, 2011, CEREB CORTEX, V21, P272, DOI 10.1093/cercor/bhq092; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Warden MR, 2007, CEREB CORTEX, V17, pI41, DOI 10.1093/cercor/bhm070; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324	22	155	157	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					773	776		10.1126/science.1206773	http://dx.doi.org/10.1126/science.1206773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817056				2022-12-28	WOS:000293512100048
J	Alter, G; Heckerman, D; Schneidewind, A; Fadda, L; Kadie, CM; Carlson, JM; Oniangue-Ndza, C; Martin, M; Li, B; Khakoo, SI; Carrington, M; Allen, TM; Altfeld, M				Alter, Galit; Heckerman, David; Schneidewind, Arne; Fadda, Lena; Kadie, Carl M.; Carlson, Jonathan M.; Oniangue-Ndza, Cesar; Martin, Maureen; Li, Bin; Khakoo, Salim I.; Carrington, Mary; Allen, Todd M.; Altfeld, Marcus			HIV-1 adaptation to NK-cell-mediated immune pressure	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NATURAL-KILLER-CELLS; MHC CLASS-I; HLA-B; INHIBITORY RECEPTOR; VIRAL PEPTIDES; BINDING-SITE; RECOGNITION; KIR3DL1; RESPONSES	Natural killer (NK) cells have an important role in the control of viral infections, recognizing virally infected cells through a variety of activating and inhibitory receptors(1-3). Epidemiological and functional studies have recently suggested that NK cells can also contribute to the control of HIV-1 infection through recognition of virally infected cells by both activating and inhibitory killer immunoglobulin-like receptors (KIRs)(4-7). However, it remains unknown whether NK cells can directly mediate antiviral immune pressure in vivo in humans. Here we describe KIR-associated amino-acid polymorphisms in the HIV-1 sequence of chronically infected individuals, on a population level. We show that these KIR-associated HIV-1 sequence polymorphisms can enhance the binding of inhibitory KIRs to HIV-1-infected CD4(+) T cells, and reduce the antiviral activity of KIR-positive NK cells. These data demonstrate that KIR-positive NK cells can place immunological pressure on HIV-1, and that the virus can evade such NK-cell-mediated immune pressure by selecting for sequence polymorphisms, as was previously described for virus-specific T cells and neutralizing antibodies(8). NK cells might therefore have a previously underappreciated role in contributing to viral evolution.	[Alter, Galit; Schneidewind, Arne; Fadda, Lena; Oniangue-Ndza, Cesar; Li, Bin; Carrington, Mary; Allen, Todd M.; Altfeld, Marcus] Harvard Univ, Ragon Inst MGH MIT & Harvard, Massachusetts Gen Hosp, Sch Med, Boston, MA 02129 USA; [Heckerman, David; Kadie, Carl M.; Carlson, Jonathan M.] Microsoft Res, Redmond, WA 98053 USA; [Martin, Maureen; Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA; [Khakoo, Salim I.] Univ London Imperial Coll Sci Technol & Med, Div Med, London W2 1PG, England	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Microsoft; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Imperial College London	Altfeld, M (corresponding author), Harvard Univ, Ragon Inst MGH MIT & Harvard, Massachusetts Gen Hosp, Sch Med, Boston, MA 02129 USA.	maltfeld@partners.org	Allen, Todd/F-5473-2011; Altfeld, Marcus/AAE-7306-2019	Allen, Todd/0000-0002-6609-1318; Altfeld, Marcus/0000-0001-5972-2997; Li, Bin/0000-0003-2248-4002; Khakoo, Salim/0000-0002-4057-9091	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [R01 AI067031, PO1 AI074415]; Doris Duke Charitable Foundation; National Cancer Institute (NIH) [HHSN261200800001E]; NIH, National Cancer Institute, Center for Cancer Research; Wellcome Trust; Microsoft Research; Bill & Melinda Gates Foundation; Mark and Lisa Schwartz Foundation; Phillip T. and Susan M. Ragon Foundation; NATIONAL CANCER INSTITUTE [ZIABC010791] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome Trust); Microsoft Research(Microsoft); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Mark and Lisa Schwartz Foundation; Phillip T. and Susan M. Ragon Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases grants R01 AI067031 (M. A.) and PO1 AI074415 (M. A. and T. M. A.), and by the Doris Duke Charitable Foundation (M. A.). This project was funded in whole or in part with federal funds from the National Cancer Institute (NIH) under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. S. I. K. is a recipient of a Wellcome Trust Senior Clinical Fellowship and M. A. is a Distinguished Clinical Scientist of the Doris Duke Charitable Foundation. We thank Microsoft Research, the Bill & Melinda Gates Foundation, the Mark and Lisa Schwartz Foundation and the Phillip T. and Susan M. Ragon Foundation for their support.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Altfeld M, 2007, NAT GENET, V39, P708, DOI 10.1038/ng0607-708; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Fadda L, 2011, J VIROL, V85, P5970, DOI 10.1128/JVI.00412-11; Fadda L, 2010, P NATL ACAD SCI USA, V107, P10160, DOI 10.1073/pnas.0913745107; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Le Gall S, 2007, J CLIN INVEST, V117, P3563, DOI 10.1172/JCI32047; MALNATI MS, 1995, SCIENCE, V267, P1016, DOI 10.1126/science.7863326; Mandelboim O, 1997, P NATL ACAD SCI USA, V94, P4604, DOI 10.1073/pnas.94.9.4604; Mandelboim O, 1997, IMMUNITY, V6, P341, DOI 10.1016/S1074-7613(00)80336-2; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Peruzzi M, 1996, J IMMUNOL, V157, P3350; Rajagopalan S, 1997, J EXP MED, V185, P1523, DOI 10.1084/jem.185.8.1523; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Stewart CA, 2005, P NATL ACAD SCI USA, V102, P13224, DOI 10.1073/pnas.0503594102; Stewart-Jones GBE, 2005, EUR J IMMUNOL, V35, P341, DOI 10.1002/eji.200425724; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; Ward J, 2007, BLOOD, V110, P1207, DOI 10.1182/blood-2006-06-028175; Ward J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000613; Yokoyama WM, 2005, ADV EXP MED BIOL, V560, P57	29	256	262	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					96	+		10.1038/nature10237	http://dx.doi.org/10.1038/nature10237			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21814282	Green Accepted, Green Published			2022-12-28	WOS:000293447300037
J	Wintemute, GJ; Claire, B; McHenry, V; Wright, MA				Wintemute, Garen J.; Claire, Barbara; McHenry, Vanessa; Wright, Mona A.			Stray Bullet Shootings in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							VIOLENCE		[Wintemute, Garen J.; Claire, Barbara; McHenry, Vanessa; Wright, Mona A.] Univ Calif Davis, Violence Prevent Res Program, Sacramento, CA 95817 USA	University of California System; University of California Davis	Wintemute, GJ (corresponding author), Univ Calif Davis, Violence Prevent Res Program, Sacramento, CA 95817 USA.	gjwintemute@ucdavis.edu						Centers for Disease Control and Prevention, WISQARS WEB BAS INJ; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1174; Horowitz K, 2005, AM J ORTHOPSYCHIAT, V75, P356, DOI 10.1037/0002-9432.75.3.356; Howard DE, 2003, AM J HEALTH BEHAV, V27, P483, DOI 10.5993/AJHB.27.5.1; Sorenson SB, 1998, AM J PUBLIC HEALTH, V88, P1510, DOI 10.2105/AJPH.88.10.1510; Wolfer T A, 2000, Violence Vict, V15, P283	6	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2011	306	5					491	492		10.1001/jama.2011.1066	http://dx.doi.org/10.1001/jama.2011.1066			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800SH	21813426	Bronze			2022-12-28	WOS:000293386500015
J	Coupland, C; Dhiman, P; Morriss, R; Arthur, A; Barton, G; Hippisley-Cox, J				Coupland, Carol; Dhiman, Paula; Morriss, Richard; Arthur, Antony; Barton, Garry; Hippisley-Cox, Julia			Antidepressant use and risk of adverse outcomes in older people: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN-REUPTAKE INHIBITORS; ISCHEMIC-HEART-DISEASE; MYOCARDIAL-INFARCTION; DRUG-USE; DEPRESSION; HYPONATREMIA; ASSOCIATION; MORTALITY; HEALTH; FALLS	Objectives To investigate the association between antidepressant treatment and risk of several potential adverse outcomes in older people with depression and to examine risks by class of antidepressant, duration of use, and dose. Design Cohort study of people aged 65 and over diagnosed as having depression. Setting 570 general practices in the United Kingdom supplying data to the QResearch primary care database. Participants 60 746 patients diagnosed as having a new episode of depression between the ages of 65 and 100 years from 1 January 1996 to 31 December 2007 and followed up until 31 December 2008. Main outcome measures Hazard ratios associated with antidepressant use for all cause mortality, attempted suicide/self harm, myocardial infarction, stroke/transient ischaemic attack, falls, fractures, upper gastrointestinal bleeding, epilepsy/seizures, road traffic accidents, adverse drug reactions, and hyponatraemia, adjusted for a range of potential confounding variables. Hazard ratios were calculated for antidepressant class (tricyclic and related antidepressants, selective serotonin reuptake inhibitors, other antidepressants), dose, and duration of use and for commonly prescribed individual drugs. Results 54 038 (89.0%) patients received at least one prescription for an antidepressant during follow-up. A total of 1 398 359 antidepressant prescriptions were issued: 764 659 (54.7%) for selective serotonin reuptake inhibitors, 442 192 (31.6%) for tricyclic antidepressants, 2203 (0.2%) for monoamine oxidase inhibitors, and 189 305 (13.5%) for the group of other antidepressants. The associations with the adverse outcomes differed significantly between the antidepressant classes for seven outcomes. Selective serotonin reuptake inhibitors were associated with the highest adjusted hazard ratios for falls (1.66, 95% confidence interval 1.58 to 1.73) and hyponatraemia (1.52, 1.33 to 1.75) compared with when antidepressants were not being used. The group of other antidepressants was associated with the highest adjusted hazard ratios for all cause mortality (1.66, 1.56 to 1.77), attempted suicide/self harm (5.16, 3.90 to 6.83), stroke/transient ischaemic attack (1.37, 1.22 to 1.55), fracture (1.64, 1.46 to 1.84), and epilepsy/seizures (2.24, 1.60 to 3.15), compared with when antidepressants were not being used. Tricyclic antidepressants did not have the highest hazard ratio for any of the outcomes. Significantly different associations also existed between the individual drugs for the same seven outcomes; trazodone (tricyclic antidepressant), mirtazapine, and venlafaxine (both in the group of other antidepressants) were associated with the highest rates for some of these outcomes. Absolute risks over 1 year for all cause mortality were 7.04% for patients while not taking antidepressants, 8.12% for those taking tricyclic antidepressants, 10.61% for selective serotonin reuptake inhibitors, and 11.43% for other antidepressants. Conclusions Selective serotonin reuptake inhibitors and drugs in the group of other antidepressants were associated with an increased risk of several adverse outcomes compared with tricyclic antidepressants. Among individual drugs, trazodone, mirtazapine, and venlafaxine were associated with the highest risks for some outcomes. As this is an observational study, it is susceptible to confounding by indication, channelling bias, and residual confounding, so differences in characteristics between patients prescribed different antidepressant drugs that could account for some of the associations between the drugs and the adverse outcomes may remain. Further research is needed to confirm these findings, but the risks and benefits of different antidepressants should be carefully evaluated when these drugs are prescribed to older people.	[Coupland, Carol; Dhiman, Paula; Hippisley-Cox, Julia] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Morriss, Richard] Univ Nottingham, Div Psychiat, Nottingham NG7 2RD, England; [Arthur, Antony] Univ Nottingham, Div Nursing, Nottingham NG7 2RD, England; [Barton, Garry] Univ E Anglia, Sch Med Hlth Policy & Practice, HEG, Norwich NR4 7TJ, Norfolk, England	University of Nottingham; University of Nottingham; University of Nottingham; University of East Anglia	Coupland, C (corresponding author), Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England.	carol.coupland@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Arthur, Antony/0000-0001-8617-5714; Coupland, Carol/0000-0002-2327-3306; Morriss, Richard/0000-0003-2910-4121	NIHR [06/42/01]; National Institute for Health Research [06/42/01] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the NIHR Health Technology Assessment Programme (project number 06/42/01). The views and opinions expressed are those of the authors and do not necessarily reflect those of the Department of Health.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Arfken CL, 2001, INT PSYCHOGERIATR, V13, P85, DOI 10.1017/S1041610201007487; Barbui C, 2009, CAN MED ASSOC J, V180, P291, DOI 10.1503/cmaj.081514; Beekman ATF, 1999, BRIT J PSYCHIAT, V174, P307, DOI 10.1192/bjp.174.4.307; Bingefors K, 1996, BRIT J PSYCHIAT, V169, P647, DOI 10.1192/bjp.169.5.647; Blanchette CM, 2008, ANN EPIDEMIOL, V18, P316, DOI 10.1016/j.annepidem.2007.11.004; [British Medical Association Royal Pharmaceutical Society of Great Britain], 2007, BRIT NAT FORM; Cadieux RJ, 1999, POSTGRAD MED, V106, P231, DOI 10.3810/pgm.1999.11.780; Cassano P, 2002, J PSYCHOSOM RES, V53, P849, DOI 10.1016/S0022-3999(02)00304-5; Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0; Coupland C, 2011, HLTH TECHNO IN PRESS; Darowski A, 2009, DRUG AGING, V26, P381, DOI 10.2165/00002512-200926050-00002; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; de Abajo FJ, 2006, BASIC CLIN PHARMACOL, V98, P304, DOI 10.1111/j.1742-7843.2006.pto_303.x; de Abajo FJ, 2008, ARCH GEN PSYCHIAT, V65, P795, DOI 10.1001/archpsyc.65.7.795; Diem SJ, 2007, J AM GERIATR SOC, V55, P824, DOI 10.1111/j.1532-5415.2007.01194.x; FURUKAWA T, 2003, COCHRANE DB SYST REV, V3; Giron MST, 2005, INT J GERIATR PSYCH, V20, P201, DOI 10.1002/gps.1273; Haney EM, 2007, ARCH INTERN MED, V167, P1246, DOI 10.1001/archinte.167.12.1246; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2001, BRIT MED J, V323, P666, DOI 10.1136/bmj.323.7314.666; Hippisley-Cox J, 1998, BMJ-BRIT MED J, V316, P1714, DOI 10.1136/bmj.316.7146.1714; Hippisley- Cox J., 2005, COMP KEY PRACTICE CH; Hubbard R, 2003, AM J EPIDEMIOL, V158, P77, DOI 10.1093/aje/kwg114; Jacob S, 2006, ANN PHARMACOTHER, V40, P1618, DOI 10.1345/aph.1G293; Kallin K, 2004, AGING CLIN EXP RES, V16, P270; Kerse N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002423; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kirby D, 2001, INT J GERIATR PSYCH, V16, P484, DOI 10.1002/gps.367; Kirby D, 2002, INT J GERIATR PSYCH, V17, P231, DOI 10.1002/gps.591; LEVEILLE SG, 1994, EPIDEMIOLOGY, V5, P591, DOI 10.1097/00001648-199411000-00006; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Mcdougall FA, 2007, AGE AGEING, V36, P562, DOI 10.1093/ageing/afm111; Monster TBM, 2004, AM J MED, V117, P732, DOI 10.1016/j.amjmed.2004.06.027; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; Movig KLL, 2002, BRIT J CLIN PHARMACO, V53, P363, DOI 10.1046/j.1365-2125.2002.01550.x; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Opatrny L, 2008, BRIT J CLIN PHARMACO, V66, P76, DOI 10.1111/j.1365-2125.2008.03154.x; Parikh C, 2000, BRIT J CLIN PHARMACO, V49, P539, DOI 10.1046/j.1365-2125.2000.00201.x; Pollock BG, 1999, J CLIN PSYCHIAT, V60, P4; RAY WA, 1992, AM J EPIDEMIOL, V136, P873, DOI 10.1093/aje/136.7.873; Reid S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1468; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; ROSENSTEIN DL, 1993, J CLIN PSYCHIAT, V54, P289; Ryan J, 2008, BRIT J PSYCHIAT, V192, P12, DOI 10.1192/bjp.bp.107.039164; Sauer WH, 2003, CIRCULATION, V108, P32, DOI 10.1161/01.CIR.0000079172.43229.CD; Schlienger Raymond G, 2003, Am J Cardiovasc Drugs, V3, P149, DOI 10.2165/00129784-200303030-00001; Schlienger RG, 2004, DRUG SAFETY, V27, P1157, DOI 10.2165/00002018-200427140-00006; Skop BP, 1996, PSYCHOSOMATICS, V37, P12, DOI 10.1016/S0033-3182(96)71592-X; Smoller JW, 2009, ARCH INTERN MED, V169, P2128, DOI 10.1001/archinternmed.2009.436; Spigset O, 1997, PHARMACOTHERAPY, V17, P348; Stone M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2880; Tata LJ, 2005, HEART, V91, P465, DOI 10.1136/hrt.2004.037457; The NHS Information Centre Prescribing Support Unit, 2010, PRESCR COST AN ENGL; The NHS Information Centre Prescribing Support Unit, 2010, PRESCR DISP COMM STA; The NHS Information Centre Prescribing Support Unit, 2005, PRESCR COST AN ENGL; Tiihonen J, 2006, ARCH GEN PSYCHIAT, V63, P1358, DOI 10.1001/archpsyc.63.12.1358; Townsend PP., 1988, HLTH DEPRIVATION INE; Trifiro G, 2010, J CLIN PSYCHOPHARM, V30, P252, DOI 10.1097/JCP.0b013e3181dca10a; van Walraven C, 2001, BMJ-BRIT MED J, V323, P655, DOI 10.1136/bmj.323.7314.655; Vassilev ZP, 2009, AM J HEALTH-SYST PH, V66, P481, DOI 10.2146/ajhp080267; Vestergaard P, 2008, CALCIFIED TISSUE INT, V82, P92, DOI 10.1007/s00223-007-9099-9; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Ziere G, 2008, J CLIN PSYCHOPHARM, V28, P411, DOI 10.1097/JCP.0b013e31817e0ecb	65	481	489	8	87	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2011	343								d4551	10.1136/bmj.d4551	http://dx.doi.org/10.1136/bmj.d4551			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	805NM	21810886	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000293734600003
J	Simon, R; Holderied, MW; Koch, CU; von Helversen, O				Simon, Ralph; Holderied, Marc W.; Koch, Corinna U.; von Helversen, Otto			Floral Acoustics: Conspicuous Echoes of a Dish-Shaped Leaf Attract Bat Pollinators	SCIENCE			English	Article							OBJECT RECOGNITION; ECHOLOCATION; SIZE; FLOWERS	The visual splendor of many diurnal flowers serves to attract visually guided pollinators such as bees and birds, but it remains to be seen whether bat-pollinated flowers have evolved analogous echo-acoustic signals to lure their echolocating pollinators. Here, we demonstrate how an unusual dish-shaped leaf displayed above the inflorescences of the vine Marcgravia evenia attracts bat pollinators. Specifically, this leaf's echoes fulfilled requirements for an effective beacon, that is, they were strong, multidirectional, and had a recognizable invariant echo signature. In behavioral experiments, presence of the leaves halved foraging time for flower-visiting bats.	[Simon, Ralph] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Holderied, Marc W.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Koch, Corinna U.; von Helversen, Otto] Univ Erlangen Nurnberg, Inst Zool 2, D-91058 Erlangen, Germany	Ulm University; University of Bristol; University of Erlangen Nuremberg	Simon, R (corresponding author), Univ Ulm, Inst Expt Ecol, Albert Einstein Allee 11, D-89069 Ulm, Germany.	ralph.simon@uni-ulm.de	Holderied, Marc/M-9382-2013	Holderied, Marc/0000-0002-1573-7908; Simon, Ralph/0000-0002-6083-0394	Deutsche Forschungsgemeinschaft [HE 1180/15, HE 1180/13, HO 3914/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to S. Dressler and M. Tschapka for information on pollination biology of Marcgravia and S. Dressler and J. Gutierrez for providing localities of M. evenia in Cuba. We thank E. K. V. Kalko, G. Jones, M. Knornschild, D. Kelm, H. Baldwin, N. Muchhala, and two anonymous reviewers for helpful comments on this manuscript. This work was supported by Deutsche Forschungsgemeinschaft (HE 1180/15, HE 1180/13, and HO 3914/1-1).	Armbruster WS, 2005, ECOLOGY, V86, P3323, DOI 10.1890/04-1873; Dressler S, 2000, WILLDENOWIA, V30, P369; Fleming TH, 2009, ANN BOT-LONDON, V104, P1017, DOI 10.1093/aob/mcp197; Forrest J, 2009, NATURWISSENSCHAFTEN, V96, P921, DOI 10.1007/s00114-009-0549-2; Herrera J, 1997, ECOLOGY, V78, P494, DOI 10.1890/0012-9658(1997)078[0494:TROCAB]2.0.CO;2; Heywood VH, 1993, FLOWERING PLANTS WOR; Holderied MW, 2006, J EXP BIOL, V209, P3457, DOI 10.1242/jeb.02386; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; Kalko EKV, 1998, FUNCT ECOL, V12, P364, DOI 10.1046/j.1365-2435.1998.00198.x; Muller R, 2000, J ACOUST SOC AM, V108, P836, DOI 10.1121/1.429617; Simon R, 2006, J EXP BIOL, V209, P3599, DOI 10.1242/jeb.02398; Smith WK, 1997, BIOSCIENCE, V47, P785, DOI 10.2307/1313100; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; TERASHIMA I, 1995, PLANT CELL ENVIRON, V18, P1111, DOI 10.1111/j.1365-3040.1995.tb00623.x; Tschapka M, 2006, FLORA, V201, P383, DOI 10.1016/j.flora.2005.07.014; von Helversen D, 2004, J COMP PHYSIOL A, V190, P515, DOI 10.1007/s00359-004-0492-9; Von Helversen D, 2003, J EXP BIOL, V206, P1025, DOI 10.1242/jeb.00203; von Helversen D, 2003, J COMP PHYSIOL A, V189, P327, DOI 10.1007/s00359-003-0405-3; von Helversen D, 1999, NATURE, V398, P759, DOI 10.1038/19648; von Helversen O, 2003, BAT ECOLOGY, P346; von Helversen O., 1993, ANIMAL PLANT INTERAC, P41; Weberling F., 1992, MORPHOLOGY FLOWERS I; Winter Y, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P148, DOI 10.1017/CBO9780511542268.009; Yovel Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000429	24	66	68	4	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					631	633		10.1126/science.1204210	http://dx.doi.org/10.1126/science.1204210			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798950				2022-12-28	WOS:000293222400062
J	Hong, MY; Chi, CH				Hong, Ming-Yuan; Chi, Chih-Hsien			Small-Intestinal Volvulus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hong, Ming-Yuan; Chi, Chih-Hsien] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital	Hong, MY (corresponding author), Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan.	chich@mail.ncku.edu.tw		Hong, Ming-Yuan/0000-0003-0320-1484					0	2	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					358	358		10.1056/NEJMicm0806895	http://dx.doi.org/10.1056/NEJMicm0806895			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21793747				2022-12-28	WOS:000293172200014
J	Hori, M; Soter, A; Barna, D; Dax, A; Hayano, R; Friedreich, S; Juhasz, B; Pask, T; Widmann, E; Horvath, D; Venturelli, L; Zurlo, N				Hori, Masaki; Soter, Anna; Barna, Daniel; Dax, Andreas; Hayano, Ryugo; Friedreich, Susanne; Juhasz, Bertalan; Pask, Thomas; Widmann, Eberhard; Horvath, Dezso; Venturelli, Luca; Zurlo, Nicola			Two-photon laser spectroscopy of antiprotonic helium and the antiproton-to-electron mass ratio	NATURE			English	Article							CPT	Physical laws are believed to be invariant under the combined transformations of charge, parity and time reversal (CPT symmetry(1)). This implies that an antimatter particle has exactly the same mass and absolute value of charge as its particle counterpart. Metastable antiprotonic helium ((p) over bar He+) is a three-body atom(2) consisting of a normal helium nucleus, an electron in its ground state and an antiproton ((p) over bar) occupying a Rydberg state with high principal and angular momentum quantum numbers, respectively n and l, such that n approximate to l + 1 approximate to 38. These atoms are amenable to precision laser spectroscopy, the results of which can in principle be used to determine the antiproton-to-electron mass ratio and to constrain the equality between the antiproton and proton charges and masses. Here we report two-photon spectroscopy of antiprotonic helium, in which (p) over bar He-3(+) and (p) over bar He-4(+) isotopes are irradiated by two-counter-propagating laser beams. This excites nonlinear, two-photon transitions of the antiproton of the type (n, l) -> (n - 2, l - 2) at deep-ultraviolet wavelengths (lambda = 139.8, 193.0 and 197.0 nm), which partly cancel the Doppler broadening of the laser resonance caused by the thermal motion of the atoms. The resulting narrow spectral lines allowed us to measure three transition frequencies with fractional precisions of 2.3-5 parts in 10(9). By comparing the results with three-body quantum electrodynamics calculations, we derived an antiproton-to-electron mass ratio of 1,836.1526736(23), where the parenthetical error represents one standard deviation. This agrees with the proton-to-electron value known to a similar precision.	[Hori, Masaki; Soter, Anna] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Hori, Masaki; Barna, Daniel; Dax, Andreas; Hayano, Ryugo] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Barna, Daniel; Horvath, Dezso] KFKI Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; [Friedreich, Susanne; Juhasz, Bertalan; Pask, Thomas; Widmann, Eberhard] Stefan Meyer Inst Subatomare Phys, A-1090 Vienna, Austria; [Horvath, Dezso] Inst Nucl Res, H-4001 Debrecen, Hungary; [Venturelli, Luca; Zurlo, Nicola] Univ Brescia, Dipartimento Chim & Fis Ingn & Mat, I-25133 Brescia, Italy; [Venturelli, Luca; Zurlo, Nicola] Grp Col Brescia, Ist Nazl Fis Nucl, I-25133 Brescia, Italy	Max Planck Society; University of Tokyo; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Nuclear Research; University of Brescia; Istituto Nazionale di Fisica Nucleare (INFN)	Hori, M (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	masaki.hori@mpq.mpg.de	Hayano, Ryugo/F-7889-2012; Soter, Anna/B-6794-2014; Hori, Masaki/AAV-3409-2021; Widmann, Eberhard/GLU-6068-2022; Widmann, Eberhard/G-2545-2011; Hori, Masaki/D-8231-2011	Hayano, Ryugo/0000-0002-1214-7806; Soter, Anna/0000-0002-3751-9944; Hori, Masaki/0000-0002-4999-3141; Widmann, Eberhard/0000-0003-0486-6023; Widmann, Eberhard/0000-0003-0486-6023; Hori, Masaki/0000-0002-4999-3141	European Science Foundation (EURYI); Monbukagakusho [20002003]; Deutsche Forschungsgemeinschaft; Hungarian Research Foundation [K72172]; Austrian Federal Ministry of Science and Research	European Science Foundation (EURYI)(European Science Foundation (ESF)); Monbukagakusho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hungarian Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Austrian Federal Ministry of Science and Research	This work was supported by the European Science Foundation (EURYI), Monbukagakusho (grant no. 20002003), the Munich Advanced Photonics cluster of the Deutsche Forschungsgemeinschaft, the Hungarian Research Foundation (K72172) and the Austrian Federal Ministry of Science and Research. We thank the CERN Antiproton Decelerator and Proton Synchrotron operational staff, the CERN cryogenics laboratory, J. Alnis, D. Bakalov, J. Eades, R. Holzwarth, V. I. Korobov, M. Mitani, W. Pirkl and T. Udem.	Andresen GB, 2010, NATURE, V468, P673, DOI 10.1038/nature09610; Bakalov D, 2000, PHYS REV LETT, V84, P2350, DOI 10.1103/PhysRevLett.84.2350; Bakule P, 2000, APPL PHYS B-LASERS O, V71, P11, DOI 10.1007/PL00021153; Beier T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.011603; BJORKHOLM JE, 1974, PHYS REV LETT, V33, P128, DOI 10.1103/PhysRevLett.33.128; Bluhm R, 1999, PHYS REV LETT, V82, P2254, DOI 10.1103/PhysRevLett.82.2254; Eikema KSE, 1997, PHYS REV A, V55, P1866, DOI 10.1103/PhysRevA.55.1866; FARNHAM DL, 1995, PHYS REV LETT, V75, P3598, DOI 10.1103/PhysRevLett.75.3598; Fendel P, 2007, OPT LETT, V32, P701, DOI 10.1364/OL.32.000701; Gabrielse G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.113001; Gabrielse G, 1999, PHYS REV LETT, V82, P3198, DOI 10.1103/PhysRevLett.82.3198; Hayano RS, 2007, REP PROG PHYS, V70, P1995, DOI 10.1088/0034-4885/70/12/R01; Hori M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.243401; Hori M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.123401; Hori M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.093401; Hori M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.062508; Hori M, 2009, OPT LETT, V34, P1273, DOI 10.1364/OL.34.001273; HUGHES RJ, 1992, PHYS REV LETT, V69, P578, DOI 10.1103/PhysRevLett.69.578; Koelemeij JCJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.173002; Korobov VI, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.022509; Korobov VI, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.042506; Meyer V, 2000, PHYS REV LETT, V84, P1136, DOI 10.1103/PhysRevLett.84.1136; Mohr PJ, 2005, REV MOD PHYS, V77, P1, DOI 10.1103/RevModPhys.77.1; Nakamura K, 2010, J PHYS G NUCL PARTIC, V37, P1, DOI 10.1088/0954-3899/37/7A/075021; Parthey CG, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.233001; Pohl R, 2010, NATURE, V466, P213, DOI 10.1038/nature09250; Thompson JK, 2004, NATURE, V430, P58, DOI 10.1038/nature02682; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a; VANDICK RS, 1986, B AM PHYS SOC, V31, P244; Verdu J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.093002	30	127	127	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					484	488		10.1038/nature10260	http://dx.doi.org/10.1038/nature10260			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796208	Green Submitted			2022-12-28	WOS:000293167900037
J	Orloff, M; Peterson, C; He, X; Ganapathi, S; Heald, B; Yang, YR; Bebek, G; Romigh, T; Song, JH; Wu, WJ; David, S; Cheng, YL; Meltzer, SJ; Eng, C				Orloff, Mohammed; Peterson, Charissa; He, Xin; Ganapathi, Shireen; Heald, Brandie; Yang, Yi-ran; Bebek, Gurkan; Romigh, Todd; Song, Jee Hoon; Wu, Wenjing; David, Stefan; Cheng, Yulan; Meltzer, Stephen J.; Eng, Charis			Germline Mutations in MSR1, ASCC1, and CTHRC1 in Patients With Barrett Esophagus and Esophageal Adenocarcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOBAL SEARCH DESIGNS; SCAVENGER RECEPTOR-1 GENE; PROSTATE-CANCER; LINKAGE ANALYSIS; EXPRESSION ANALYSIS; SEQUENCE VARIANTS; MOUSE MODEL; CELL-CYCLE; ASSOCIATION; POPULATION	Context Barrett esophagus (BE) occurs in 1% to 10% of the general population and is believed to be the precursor of esophageal adenocarcinoma (EAC). The incidence of EAC has increased 350% in the last 3 decades without clear etiology. Finding predisposition genes may improve premorbid risk assessment, genetic counseling, and management. Genome-wide multiplatform approaches may lead to the identification of genes important in BE/EAC development. Objective To identify risk alleles or mutated genes associated with BE/EAC. Design, Setting, and Patients Model-free linkage analyses of 21 concordant-affected sibling pairs with BE/EAC and 11 discordant sibling pairs (2005-2006). Significant germline genomic regions in independent prospectively accrued series of 176 white patients with BE/EAC and 200 ancestry-matched controls (2007-2010) were validated and fine mapped. Integrating data from these significant genomic regions with somatic gene expression data from 19 BE/EAC tissues yielded 12 "priority" candidate genes for mutation analysis (2010). Genes that showed mutations in cases but not in controls were further screened in an independent prospectively accrued validation series of 58 cases (2010). Main Outcome Measures Identification of germline mutations in genes associated with BE/EAC cases. Functional interrogation of the most commonly mutated gene. Results Three major genes, MSR1, ASCC1, and CTHRC1 were associated with BE/EAC (all P<.001). In addition, 13 patients (11.2%) with BE/EAC carried germline mutations in MSR1, ASCC1, or CTHRC1. MSR1 was the most frequently mutated, with 8 of 116 (proportion, 0.069; 95% confidence interval [CI], 0.030-0.130; P<.001) cases with c.877C>T (p.R293X). An independent validation series confirmed germline MSR1 mutations in 2 of 58 cases (proportion, 0.035; 95% CI, 0.004-0.120; P=.09). MSR1 mutation resulted in CCND1 up-regulation in peripheral-protein lysate. Immunohistochemistry of BE tissues in MSR1-mutation carriers showed increased nuclear expression of CCND1. Conclusion MSR1 was significantly associated with the presence of BE/EAC in derivation and validation samples, although it was only present in a small percentage of the cases. JAMA. 2011; 306(4): 410-419	[Orloff, Mohammed; Peterson, Charissa; He, Xin; Ganapathi, Shireen; Heald, Brandie; Yang, Yi-ran; Bebek, Gurkan; Romigh, Todd; Eng, Charis] Cleveland Clin, Genom Med Inst, Cleveland, OH 44195 USA; [Orloff, Mohammed; Heald, Brandie; Eng, Charis] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44195 USA; [Eng, Charis] Cleveland Clin, Stanley Shalom Zielony Inst Nursing Excellence, Cleveland, OH 44195 USA; [Bebek, Gurkan] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH USA; [Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Bebek, Gurkan; Eng, Charis] Case Western Reserve Univ, Sch Med, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Song, Jee Hoon; Wu, Wenjing; David, Stefan; Cheng, Yulan; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Song, Jee Hoon; Wu, Wenjing; David, Stefan; Cheng, Yulan; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Eng, C (corresponding author), Cleveland Clin, Genom Med Inst, 9500 Euclid Ave,Mailstop NE-50, Cleveland, OH 44195 USA.	engc@ccf.org	he, xin/C-3122-2011	Heald, Brandie/0000-0003-4227-3675; Eng, Charis/0000-0002-3693-5145	National Institutes of Health (NIH); National Cancer Institute (NCI); National Institute of Diabetes and Digestive and Kidney Diseases; Hong Kong University; Rudy Endowment; NCI/NIH [CA30722, DK087454, CA146799, CA133012]; Johns Hopkins University School of Medicine; Doris Duke Distinguished Clinical Scientist Award; M. Kirby Foundation; NATIONAL CANCER INSTITUTE [R01CA146799, R01CA133012, R21CA030722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087454] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hong Kong University(University of Hong Kong); Rudy Endowment; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Johns Hopkins University School of Medicine(Johns Hopkins University); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); M. Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bebek reported receiving grant funding from the National Institutes of Health (NIH). Dr Meltzer reported receiving grants from the National Cancer Institute (NCI) and the National Institute of Diabetes and Digestive and Kidney Diseases; and travel, accommodations, and meeting expenses from Hong Kong University. Dr Eng reported receiving grants from the NCI and Rudy Endowment. All other authors reported no financial disclosures.; This work was funded in part by the M. Frank and Margaret Domiter Rudy Endowment of the Cleveland Clinic Taussig Cancer Institute and grants CA30722, DK087454, CA146799, and CA133012 from the NCI/NIH (S.J.M. and C. E.). Dr Meltzer is the Harry & Betty Myerberg/Thomas R. Hendrix Professor of Gastroenterology and was funded in part by the Esophageal Cancer Research Fund at the Johns Hopkins University School of Medicine. Dr Eng was a recipient of the Doris Duke Distinguished Clinical Scientist Award, is an American Cancer Society Clinical Research Professor generously funded in part by the F. M. Kirby Foundation, holds the Sondra J. & Stephen R. Hardis Chair in Cancer Genomic Medicine at the Cleveland Clinic, and is an honorary fellow of the Cancer Research UK Human Cancer Genetics Research Group, University of Cambridge, Cambridge, England.	[Anonymous], 2003, SAGE STAT AN GEN EP; Arber N, 1996, CANCER EPIDEM BIOMAR, V5, P457; Cameron AJ, 1997, GASTROENTEROL CLIN N, V26, P487, DOI 10.1016/S0889-8553(05)70308-3; Chak A, 2006, CANCER EPIDEM BIOMAR, V15, P1668, DOI 10.1158/1055-9965.EPI-06-0293; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Drovdlic CM, 2003, J MED GENET, V40, P651, DOI 10.1136/jmg.40.9.651; Durmus T, 2006, GENE EXPR PATTERNS, V6, P935, DOI 10.1016/j.modgep.2006.03.008; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elston RC, 1996, GENET EPIDEMIOL, V13, P535, DOI 10.1002/(SICI)1098-2272(1996)13:6<535::AID-GEPI2>3.3.CO;2-R; EMI M, 1993, J BIOL CHEM, V268, P2120; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Fitzgerald RC, 2005, CLIN GASTROENTEROL H, V3, P529, DOI 10.1016/S1542-3565(05)00248-X; Goddard KAB, 2001, AM J HUM GENET, V68, P1197, DOI 10.1086/320103; Groopman JD, 2005, TOXICOL APPL PHARM, V206, P131, DOI 10.1016/j.taap.2004.09.020; Guo XQ, 2000, GENET EPIDEMIOL, V18, P97, DOI 10.1002/(SICI)1098-2272(200002)18:2<97::AID-GEPI1>3.0.CO;2-J; Guo XQ, 2000, GENET EPIDEMIOL, V18, P111, DOI 10.1002/(SICI)1098-2272(200002)18:2<111::AID-GEPI2>3.0.CO;2-M; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Jung DJ, 2002, MOL CELL BIOL, V22, P5203, DOI 10.1128/MCB.22.14.5203-5211.2002; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee YS, 2002, BIOL REPROD, V67, P1580, DOI 10.1095/biolreprod.102.006155; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Maier C, 2006, HUM MUTAT, V27, P98, DOI 10.1002/humu.20271; Maier C, 2005, EUR J HUM GENET, V13, P352, DOI 10.1038/sj.ejhg.5201333; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Mueller A, 1997, CANCER RES, V57, P5542; Murray L, 2003, BRIT MED J, V327, P534, DOI 10.1136/bmj.327.7414.534; Nakou M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013351; Opitz OG, 2002, J CLIN INVEST, V110, P761, DOI 10.1172/JCI200215324; Osterheld MC, 2002, AM J CLIN PATHOL, V117, P451; Pakakasama S, 2002, PEDIATR CLIN N AM, V49, P1393, DOI 10.1016/S0031-3955(02)00095-0; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; REID BJ, 1993, GASTROENTEROLOGY, V105, P119, DOI 10.1016/0016-5085(93)90017-7; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; SPECHLER SJ, 1986, NEW ENGL J MED, V315, P362, DOI 10.1056/NEJM198608073150605; Stairs DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003534; Sugar Linda M, 2006, Can J Urol, V13 Suppl 1, P46; van Dekken H, 2006, CANCER GENET CYTOGEN, V166, P157, DOI 10.1016/j.cancergencyto.2005.11.002; von Holzen U, 2010, TRANSL ONCOL, V3, P33, DOI 10.1593/tlo.09187; Wang L, 2003, NAT GENET, V35, P128, DOI 10.1038/ng1239; Winters C, 1987, GASTROENTEROLOGY, V92, P118, DOI 10.1016/0016-5085(87)90847-X; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Xu JF, 2003, AM J HUM GENET, V72, P208, DOI 10.1086/345802; Xu JY, 2006, PROSTATE, V66, P1082, DOI 10.1002/pros.20430; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Ziegler A, 2001, GENET EPIDEMIOL, V20, P397, DOI 10.1002/gepi.9	53	74	81	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					410	419		10.1001/jama.2011.1029	http://dx.doi.org/10.1001/jama.2011.1029			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797KL	21791690	Green Accepted, Bronze			2022-12-28	WOS:000293125800027
J	Carson, C; Kelly, Y; Kurinczuk, JJ; Sacker, A; Redshaw, M; Quigley, MA				Carson, C.; Kelly, Y.; Kurinczuk, J. J.; Sacker, A.; Redshaw, M.; Quigley, M. A.			Effect of pregnancy planning and fertility treatment on cognitive outcomes in children at ages 3 and 5: longitudinal cohort study	BRITISH MEDICAL JOURNAL			English	Article							INTRACYTOPLASMIC SPERM INJECTION; IN-VITRO FERTILIZATION; UNINTENDED PREGNANCIES; INFERTILITY TREATMENT; CONTRACEPTION; CONCEPTION; WOMEN; RISK; BORN; CARE	Objective To investigate how pregnancy planning, time to conception, and infertility treatment influence cognitive development at ages 3 and 5. Design Prospective population based cohort study. Setting Millennium Cohort Study in the United Kingdom. Participants 18 818 children recruited at 9 months and followed up at 3 and 5 years. 11 790 singletons with available data on pregnancy, cognitive outcomes, and confounders were included in analyses at age 3 and 12 136 at age 5. Exposure measures Mothers reported whether the pregnancy was planned, and their feelings when first pregnant; those in whom the pregnancy was planned provided time to conception, and details of any assisted reproductive technologies. The population was divided into "unplanned" (unplanned and unhappy), "mistimed" (unplanned but happy), "planned" (planned, time to conception <12 months), "subfertile" (planned, time to conception >= 12 months), "induced ovulation" (received clomiphene citrate), and "assisted reproduction" (in vitro fertilisation or intracytoplasmic sperm injection). The "planned" group was the comparison group in all analyses. Outcome measures Three components of the British Ability Scales (BAS II). Naming vocabulary assessed verbal ability at age 3; this test was repeated at age 5 with the picture similarities and pattern construction subscales, which measure non-verbal and spatial abilities. Results In unadjusted analyses, the scores on all scales in children from unplanned pregnancies were significantly lower than in those from planned pregnancies-for example, the difference in mean verbal ability score at age 3 was -4.8 (95% confidence interval -6.0 to -3.7; P<0.05), equivalent to an average delay of four months. After adjustment for sociodemographic factors these differences were attenuated: -0.3 (-1.3 to 0.7), equivalent to no delay. Children born after assisted reproduction age 3 and 3.5 (0.2 to 6.8) at age 5), which suggests that on average these children are three to four months ahead; this difference did not completely disappear with adjustment for confounders. Children born after infertility treatment had lower mean scores in non-verbal tests (-1.2 (-4.1 to 1.6) after assisted reproduction and -1.5 (-3.5 to 0.4) after induced ovulation) and in spatial ability tests (-2.7 (-6.9 to 1.6) after assisted reproduction), though the differences were not significant. Conclusions Pregnancy planning, subfertility, or assisted reproduction do not adversely affect children's cognitive development at age 3 or 5. The differences observed in the unadjusted analyses are almost entirely explained by marked inequalities in socioeconomic circumstances between the groups.	[Carson, C.; Kurinczuk, J. J.; Redshaw, M.; Quigley, M. A.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; [Kelly, Y.] Univ Essex, Inst Social & Econ Res, Colchester CO4 3SQ, Essex, England; [Kelly, Y.; Sacker, A.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of Oxford; University of Essex; University of London; University College London	Carson, C (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	claire.carson@npeu.ox.ac.uk	Carson, Claire/F-1662-2011	Kelly, Yvonne/0000-0002-2936-3994; Quigley, Maria/0000-0002-8058-6181; Sacker, Amanda/0000-0001-8796-5398	Medical Research Council; ESRC [ES/H00811X/1, ES/G002452/1] Funding Source: UKRI; MRC [G0701009] Funding Source: UKRI; Economic and Social Research Council [ES/G002452/1, ES/H00811X/1] Funding Source: researchfish; Medical Research Council [G0701009] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a grant from the Medical Research Council.	Agarwal P, 2005, BJOG-INT J OBSTET GY, V112, P1376, DOI 10.1111/j.1471-0528.2005.00663.x; Bachrach CA, 1999, FAM PLANN PERSPECT, V31, P251, DOI 10.2307/2991577; Barrett G, 2002, SOC SCI MED, V55, P545, DOI 10.1016/S0277-9536(01)00187-3; Baydar N, 1995, FAM PLANN PERSPECT, V27, P228, DOI 10.2307/2136174; Bowen JR, 1998, LANCET, V351, P1529, DOI 10.1016/S0140-6736(98)10168-X; Condon J.T., 1998, J REPROD INFANT PSYC, V16, P57, DOI [10.1080/02646839808404558, DOI 10.1080/02646839808404558]; D'Angelo DV, 2004, PERSPECT SEX REPRO H, V36, P192, DOI 10.1111/j.1931-2393.2004.tb00022.x; Earle Sarah, 2004, Hum Fertil (Camb), V7, P39, DOI 10.1080/1464727042000198078; Elliott C. D., 1997, TECHNICAL MANUAL BRI; Ermisch J, 2008, NATL INST ECON REV, V205, P62, DOI 10.1177/0027950108096589; Farrow A, 2002, HUM REPROD, V17, P2754, DOI 10.1093/humrep/17.10.2754; FLEISSIG A, 1991, BRIT MED J, V302, P147, DOI 10.1136/bmj.302.6769.147; Gibson FL, 1998, HUM REPROD, V13, P1727, DOI 10.1093/humrep/13.6.1727; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Hansen K., 2008, MILLENNIUM COHORT ST; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; Hellerstedt WL, 1998, AM J PUBLIC HEALTH, V88, P663, DOI 10.2105/AJPH.88.4.663; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Hill Vivian, 2005, Child Adolesc Ment Health, V10, P87, DOI 10.1111/j.1475-3588.2004.00123.x; JAYAWEERA H, 2005, CHILDREN 21 CENTURY, P109; Jones E, 2010, CHILDREN OF THE 21ST CENTURY: THE FIRST FIVE YEARS, P53; Joyce T, 2002, DEMOGRAPHY, V39, P199, DOI 10.2307/3088371; Joyce TJ, 2000, DEMOGRAPHY, V37, P83, DOI 10.2307/2648098; Kelly Y, 2009, INT J EPIDEMIOL, V38, P129, DOI 10.1093/ije/dyn230; Ketende S, 2008, MILLENNIUM COHORT ST; Kiernan KE, 2008, BRIT J SOCIOL, V59, P783, DOI 10.1111/j.1468-4446.2008.00219.x; Knoester M, 2008, FERTIL STERIL, V90, P289, DOI 10.1016/j.fertnstert.2007.06.090; Kost K, 1998, FAM PLANN PERSPECT, V30, P223, DOI 10.2307/2991608; Lakha F, 2006, LANCET, V368, P1782, DOI 10.1016/S0140-6736(06)69737-7; Ludwig AK, 2006, EUR J OBSTET GYN R B, V127, P3, DOI 10.1016/j.ejogrb.2006.02.009; Lugo-Gil J, 2008, CHILD DEV, V79, P1065, DOI 10.1111/j.1467-8624.2008.01176.x; Middelburg KJ, 2008, HUM REPROD UPDATE, V14, P219, DOI 10.1093/humupd/dmn005; Oakley L, 2008, HUM REPROD, V23, P447, DOI 10.1093/humrep/dem369; *OFF NAT STAT, 2004, INF PER MORT 2004 HL; PIANTA RC, 1995, CHILD PARENT R UNPUB; Plewis I., 2007, INT J SOC RES METHOD, V10, P325, DOI [DOI 10.1080/13645570701676955, 10.1080/13645570701676955]; Plewis I., 2007, MILLENNIUM COHORT ST; Ponjaert-Kristoffersen I, 2005, PEDIATRICS, V115, pE283, DOI 10.1542/peds.2004-1445; Rosenberg KD, 2003, PEDIATRICS, V111, P1142; Rutter M., 1970, ED HLTH BEHAV; StataCorp, 2007, STAT STAT SOFTW REL; Wang PS, 2007, JAMA-J AM MED ASSOC, V298, P1401, DOI 10.1001/jama.298.12.1401; Zhu JL, 2009, PAEDIATR PERINAT EP, V23, P98, DOI 10.1111/j.1365-3016.2008.00989.x	43	46	47	1	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2011	343								d4473	10.1136/bmj.d4473	http://dx.doi.org/10.1136/bmj.d4473			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801LP	21791498	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000293440700008
J	Caplan, A				Caplan, Arthur			The art of medicine Time to mandate influenza vaccination in health-care workers	LANCET			English	Editorial Material									Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Caplan, A (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.	caplan@mail.med.upenn.edu						Caplan A., 2011, HEALTH AFFAIR, V30, P1205, DOI [https://doi.org/10.1377/hlthaff.2011.0472, DOI 10.1377/HLTHAFF.2011.0472]; Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; deSante JE, 2010, VACCINE, V28, P2517, DOI 10.1016/j.vaccine.2010.01.042; Feemster KA, 2011, VACCINE, V29, P1762, DOI 10.1016/j.vaccine.2010.12.115; Field RI, 2008, KENNEDY INST ETHIC J, V18, P111; Lantos JD, 2010, CURR PROB PEDIATR AD, V40, P38, DOI 10.1016/j.cppeds.2010.01.003; Poland GA, 2010, VACCINE, V28, P5757, DOI 10.1016/j.vaccine.2010.07.057; Talbot TR, 2010, INFECT CONT HOSP EP, V31, P987, DOI 10.1086/656558	8	35	35	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 23	2011	378	9788					310	311		10.1016/S0140-6736(11)61156-2	http://dx.doi.org/10.1016/S0140-6736(11)61156-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XL	21789789				2022-12-28	WOS:000293615800013
J	Holmes, D				Holmes, David			Profile Richard Moxon: a virtuoso of vaccinology	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 23	2011	378	9788					309	309		10.1016/S0140-6736(11)61155-0	http://dx.doi.org/10.1016/S0140-6736(11)61155-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21784255				2022-12-28	WOS:000293615800012
J	Kubatko, LS; Pearl, DK				Kubatko, Laura S.; Pearl, Dennis K.			Seeing the Trees in Your Terrace	SCIENCE			English	Editorial Material									[Kubatko, Laura S.; Pearl, Dennis K.] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Kubatko, Laura S.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kubatko, LS (corresponding author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.	lkubatko@stat.osu.edu	Pearl, Dennis/AAO-5314-2020	Pearl, Dennis/0000-0003-1981-1826				Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Sanderson MJ, 2011, SCIENCE, V333, P448, DOI 10.1126/science.1206357	4	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					411	412		10.1126/science.1209690	http://dx.doi.org/10.1126/science.1209690			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	795FR	21778387				2022-12-28	WOS:000292959600030
J	Balarajan, Y; Ramakrishnan, U; Ozaltin, E; Shankar, AH; Subramanian, SV				Balarajan, Yarlini; Ramakrishnan, Usha; Oezaltin, Emre; Shankar, Anuraj H.; Subramanian, S. V.			Anaemia in low-income and middle-income countries	LANCET			English	Review							IRON-DEFICIENCY ANEMIA; ROUTINE PROPHYLACTIC SUPPLEMENTATION; TRANSMITTED HELMINTH INFECTIONS; FOLIC-ACID; HEMOGLOBIN CONCENTRATION; FOLATE-DEFICIENCY; HIGH PREVALENCE; WHEAT-FLOUR; HEALTH; WOMEN	Anaemia affects a quarter of the global population, including 293 million (47%) children younger than 5 years and 468 million (30%) non-pregnant women. In addition to anaemia's adverse health consequences, the economic effect of anaemia on human capital results in the loss of billions of dollars annually. In this paper, we review the epidemiology, clinical assessment, pathophysiology, and consequences of anaemia in low-income and middle-income countries. Our analysis shows that anaemia is disproportionately concentrated in low socioeconomic groups, and that maternal anaemia is strongly associated with child anaemia. Anaemia has multifactorial causes involving complex interaction between nutrition, infectious diseases, and other factors, and this complexity presents a challenge to effectively address the population determinants of anaemia. Reduction of knowledge gaps in research and policy and improvement of the implementation of effective population-level strategies will help to alleviate the anaemia burden in low-resource settings.	[Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Balarajan, Yarlini; Oezaltin, Emre] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Shankar, Anuraj H.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ramakrishnan, Usha] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Emory University; Rollins School Public Health	Subramanian, SV (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	svsubram@hsph.harvard.edu	Ramakrishnan, Usha/L-8921-2016; Shankar, Anuraj/U-3764-2018	Shankar, Anuraj/0000-0001-7268-6708				Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Adetifa I, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006736.pub2; Albonico M, 1998, INT J EPIDEMIOL, V27, P530, DOI 10.1093/ije/27.3.530; Alderman H, 2009, FOOD NUTR BULL, V30, P265, DOI 10.1177/156482650903000308; Allen L, 2008, Med Trop (Mars), V68, P182; Allen LH, 2004, NUTR REV, V62, pS29, DOI 10.1111/j.1753-4887.2004.tb00069.x; Allen LH, 2002, J NUTR, V132, p813S, DOI 10.1093/jn/132.4.813S; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; ANDERSON RM, 1985, ADV PARASIT, V24, P1, DOI 10.1016/S0065-308X(08)60561-8; [Anonymous], DEM HLTH SURV; [Anonymous], 2008, WORLDW PREV AN 1993; Antony AC, 2003, AM J CLIN NUTR, V78, P3, DOI 10.1093/ajcn/78.1.3; Antony AC, 2001, AM J CLIN NUTR, V74, P157; Baltussen R, 2004, J NUTR, V134, P2678, DOI 10.1093/jn/134.10.2678; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bondevik GT, 2001, EUR J CLIN NUTR, V55, P856, DOI 10.1038/sj.ejcn.1601236; Bothwell TH, 2000, AM J CLIN NUTR, V72, p257S, DOI 10.1093/ajcn/72.1.257S; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Brooker S, 2009, INT J PARASITOL, V39, P591, DOI 10.1016/j.ijpara.2008.10.014; Calis JCJ, 2008, AIDS, V22, P1099, DOI 10.1097/QAD.0b013e3282fa759f; Chalco Juan P, 2005, BMC Pediatr, V5, P46, DOI 10.1186/1471-2431-5-46; Chaparro CM, 2008, J NUTR, V138, P2529, DOI 10.1093/jn/138.12.2529; Colomer J, 1990, Paediatr Perinat Epidemiol, V4, P196, DOI 10.1111/j.1365-3016.1990.tb00638.x; Consensus Consensus Center, 2008, COP CONS 2008 RES; DALLMAN PR, 1978, AM J CLIN NUTR, V31, P377, DOI 10.1093/ajcn/31.3.377; de Pee S, 2002, J NUTR, V132, P2215, DOI 10.1093/jn/132.8.2215; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Duggan CMD, 2008, NUTR PEDIAT BASIC SC; Ezzati M., 2004, GLOBAL REGIONAL BURD; Fiedler JL, 2008, INT J HEALTH PLAN M, V23, P373, DOI 10.1002/hpm.928; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fishman SM, 2000, PUBLIC HEALTH NUTR, V3, P125, DOI 10.1017/S1368980000000173; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; Ghosh S, 2009, J BIOSOC SCI, V41, P763, DOI 10.1017/S0021932009990149; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; GUILLEBAUD J, 1976, LANCET, V1, P387; Gulani A, 2007, BMJ-BRIT MED J, V334, P1095, DOI 10.1136/bmj.39150.510475.AE; Gwatkin DR, 2000, SOCIOECONOMIC DIFF E; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Himes JH, 1997, AM J CLIN NUTR, V65, P831, DOI 10.1093/ajcn/65.3.831; Horton S, 2007, FOOD POLICY, V32, P141, DOI 10.1016/j.foodpol.2006.08.002; Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2; Horton S, 2008, CHALLENGE PAPER HUNG; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Hurrell RF, 1999, BRIT J NUTR, V81, P289, DOI 10.1017/S0007114599000537; Hurrell R, 2010, FOOD NUTR BULL, V31, pS7, DOI 10.1177/15648265100311S102; JOHNSONSPEAR MA, 1994, AM J CLIN NUTR, V60, P117, DOI 10.1093/ajcn/60.1.117; Kalaivani K, 2009, INDIAN J MED RES, V130, P627; Khusun H, 1999, J NUTR, V129, P1669, DOI 10.1093/jn/129.9.1669; Klemm RDW, 2010, FOOD NUTR BULL, V31, pS47, DOI 10.1177/15648265100311S105; Lengeler C, 2004, COCHRANE DB SYST REV, V2; Lozoff B, 2003, PEDIATRICS, V112, P846; Lutter CK, 2008, J NUTR, V138, P2523, DOI 10.3945/jn.108.095406; Mason John, 2005, Food and Nutrition Bulletin, V26, P59; McCann JC, 2007, AM J CLIN NUTR, V85, P931, DOI 10.1093/ajcn/85.4.931; McDonald C., 2010, SCALING NUTR WHAT WI; McGarvey ST, 1996, AM J TROP MED HYG, V54, P498, DOI 10.4269/ajtmh.1996.54.498; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mei ZG, 2005, J NUTR, V135, P1974, DOI 10.1093/jn/135.8.1974; Meinzen-Derr JK, 2006, J NUTR, V136, P452, DOI 10.1093/jn/136.2.452; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Meremikwu M, 2008, COCHRANE DB SYST REV, V2; Metz J, 2008, FOOD NUTR BULL, V29, pS74, DOI 10.1177/15648265080292S111; Micronutrient Initiative, 2009, INV FUT UN CALL ACT; Milman N, 2008, ANN HEMATOL, V87, P949, DOI 10.1007/s00277-008-0518-4; Milman N, 2006, ANN HEMATOL, V85, P559, DOI 10.1007/s00277-006-0108-2; Misra A, 2002, EUR J NUTR, V41, P68, DOI 10.1007/s003940200010; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Modood-ul-Mannan, 1995, J Pak Med Assoc, V45, P187; Muhsen K, 2008, HELICOBACTER, V13, P323, DOI 10.1111/j.1523-5378.2008.00617.x; Ngnie-Teta I, 2009, PUBLIC HEALTH NUTR, V12, P1462, DOI 10.1017/S1368980008004400; Ojukwu J, 2009, COCHRANE DB SYST REV, V4; Pena-Rosas JP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub3; Prentice AM, 2008, J NUTR, V138, P2537, DOI 10.3945/jn.108.098806; Qu XH, 2010, WORLD J GASTROENTERO, V16, P886, DOI 10.3748/wjg.v16.i7.886; Ramakrishnan U, 2001, NUTR ANEMIAS; Rasmussen KM, 2001, J NUTR, V131, p590S, DOI 10.1093/jn/131.2.590S; Rutstein SO, 2003, GUIDE DHS STAT; Rutstein SO, 2004, 6 ORC MACR; Sari M, 2001, B WORLD HEALTH ORGAN, V79, P506; SAVAGE D, 1994, BRIT J HAEMATOL, V86, P844, DOI 10.1111/j.1365-2141.1994.tb04840.x; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Semba RD, 2008, NUTR HEALTH SER, P1, DOI 10.1007/978-1-59745-464-3; Semba RD, 2010, AM J CLIN NUTR, V92, P170, DOI 10.3945/ajcn.2010.29254; Shamah-Levy T, 2003, SALUD PUBLICA MEXICO, V45, pS499; Shankar A, 2008, LANCET, V371, P1223, DOI 10.1016/S0140-6736(08)60536-X; Sharman A, 2000, ANEMIA TESTING POPUL; Smith JL, 2010, TROP MED INT HEALTH, V15, P776, DOI 10.1111/j.1365-3156.2010.02542.x; Stabler SP, 2004, ANNU REV NUTR, V24, P299, DOI 10.1146/annurev.nutr.24.012003.132440; Stoltzfus RJ, 1997, LANCET, V349, P1764, DOI 10.1016/S0140-6736(96)12355-2; Stoltzfus RJ, 1999, J NUTR, V129, P1675, DOI 10.1093/jn/129.9.1675; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Tielsch JM, 2006, LANCET, V367, P144, DOI 10.1016/S0140-6736(06)67963-4; Tolentino K, 2007, AM J TROP MED HYG, V77, P44, DOI 10.4269/ajtmh.2007.77.44; United Nations. Subcommittee on Nutrition International Food Policy Research Institute, 1992, 2 UN NUTR INT FOOD P; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Volberding Paul A, 2004, Clin Infect Dis, V38, P1454, DOI 10.1086/383031; Warrell D, 2003, OXFORD TXB MED; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Weatherall DJ, 2008, CURR MOL MED, V8, P592, DOI 10.2174/156652408786241375; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704; WHO, 2005, HDB IMCI INT MAN CHI; WHO Centers for Disease Control and Prevention, 2004, ASS IR STAT POP REP; WHO UNICEF, 2010, COUNTD 2015 DEC REP; World Health Organization. Department of Reproductive Health and Research, 2006, PREGN CHILDB POSTP N; Xiong X, 2000, AM J PERINAT, V17, P137, DOI 10.1055/s-2000-9508; Yip R, 2002, J NUTR, V132, p827S, DOI 10.1093/jn/132.4.827S; Zhang QY, 2009, ANN EPIDEMIOL, V19, P793, DOI 10.1016/j.annepidem.2009.06.002; Zimmermann MB, 2008, BRIT J NUTR, V99, pS2, DOI 10.1017/S000711450800679X; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	119	564	585	3	78	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2011	378	9809					2123	2135		10.1016/S0140-6736(10)62304-5	http://dx.doi.org/10.1016/S0140-6736(10)62304-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865EL	21813172				2022-12-28	WOS:000298293600034
J	Steliga, MA; Dresler, CM				Steliga, Matthew A.; Dresler, Carolyn M.			Smoking cessation: crucial to target women as well as men	LANCET			English	Editorial Material							NICOTINE		[Dresler, Carolyn M.] Arkansas Dept Hlth, Tobacco Prevent & Cessat Program, Little Rock, AR 72205 USA; [Steliga, Matthew A.] Univ Arkansas Med Sci, Div Cardiothorac Surg, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Dresler, CM (corresponding author), Arkansas Dept Hlth, Tobacco Prevent & Cessat Program, Little Rock, AR 72205 USA.	carolyn_dresler@ksg03.harvard.edu		Steliga, Matthew/0000-0002-4319-5798				*ACT SMOK HLTH, 2011, ASH FACTSH; Benowitz NL, 2008, CLIN PHARMACOL THER, V83, P531, DOI 10.1038/clpt.2008.3; Benowitz NL, 2006, CLIN PHARMACOL THER, V79, P480, DOI 10.1016/j.clpt.2006.01.008; *CAMP TOB FREE KID, TOB IND TARG WOM GIR; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; *IARC, 2007, IARC HDB CANC PREV, V11, P241; MARCUS M, P MORRIS PROFITS HEA; Piper ME, 2010, NICOTINE TOB RES, V12, P647, DOI 10.1093/ntr/ntq067; WHO, PROJ MORT BURD DIS 2; World Health Organization (WHO), 10 LEAD CAUS DEATH 2	10	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 8	2011	378	9799					1278	1279		10.1016/S0140-6736(11)61035-0	http://dx.doi.org/10.1016/S0140-6736(11)61035-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IU	21839504				2022-12-28	WOS:000295724300005
J	Vitale, J; Carbone, F				Vitale, Jose; Carbone, Francesca			Haemorrhagic herpes zoster	LANCET			English	Editorial Material									[Vitale, Jose; Carbone, Francesca] Osped Circolo, Dept Internal Med, I-21037 Lavena Ponte Tresa, Varese, Italy	Ospedale Circolo & Fondazione Macchi	Vitale, J (corresponding author), Osped Circolo, Dept Internal Med, I-21037 Lavena Ponte Tresa, Varese, Italy.	myownjo@gmail.com	Vitale, Josè/AAH-5984-2019						0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 8	2011	378	9799					1324	1324		10.1016/S0140-6736(11)60238-9	http://dx.doi.org/10.1016/S0140-6736(11)60238-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IU	21840045				2022-12-28	WOS:000295724300027
J	Nigam, A; Juneau, M				Nigam, Anil; Juneau, Martin			Survival benefit associated with low-level physical activity	LANCET			English	Editorial Material							EXERCISE		[Nigam, Anil] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; Univ Montreal, Montreal, PQ H1T 1C8, Canada	Universite de Montreal; Universite de Montreal	Nigam, A (corresponding author), Montreal Heart Inst, 5000 Belanger St, Montreal, PQ H1T 1C8, Canada.	anil.nigam@icm-mhi.org						Bauman A, 2005, REV BEST PRACT INT P; Grandes G, 2009, ARCH INTERN MED, V169, P694, DOI 10.1001/archinternmed.2009.23; HASKELL WL, 1994, MED SCI SPORT EXER, V26, P649, DOI 10.1249/00005768-199406000-00001; Inoue S, 2000, ASIA PACIFIC PERSPEC; Jolliffe JA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800, DOI 10.1093/eurheartj/ehm316, DOI 10.1002/14651858.CD001800]; Juneau M, 2010, ACUTE CORONARY SYNDR; Newton RU, 2008, CURR TREAT OPTION ON, V9, P135, DOI 10.1007/s11864-008-0065-1; Pan SY, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-21; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; United States Department of Health and Human Services, 2008 PHYS ACT GUID A; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; World Health Organization, GLOB REC PHYS ACT HL	14	9	9	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 1	2011	378	9798					1202	1203		10.1016/S0140-6736(11)61029-5	http://dx.doi.org/10.1016/S0140-6736(11)61029-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IO	21846576				2022-12-28	WOS:000295723600006
J	Gebhardt, T; Whitney, PG; Zaid, A; Mackay, LK; Brooks, AG; Heath, WR; Carbone, FR; Mueller, SN				Gebhardt, Thomas; Whitney, Paul G.; Zaid, Ali; Mackay, Laura K.; Brooks, Andrew G.; Heath, William R.; Carbone, Francis R.; Mueller, Scott N.			Different patterns of peripheral migration by memory CD4(+) and CD8(+) T cells	NATURE			English	Article							HERPES-SIMPLEX-VIRUS; DENDRITIC CELLS; NONLYMPHOID TISSUE; INFECTION; SKIN; EFFECTOR; ACTIVATION; ADHESION; LYMPHOCYTES; INTEGRIN	Infections localized to peripheral tissues such as the skin result in the priming of T-cell responses that act to control pathogens. Activated T cells undergo migrational imprinting within the draining lymph nodes(1), resulting in memory T cells that provide local and systemic protection(2). Combinations of migrating and resident memory T cells have been implicated in long-term peripheral immunity, especially at the surfaces that form pathogen entry points into the body(3). However, T-cell immunity consists of separate CD4(+) helper T cells and CD8(+) killer T cells, with distinct effector and memory programming requirements(4). Whether these subsets also differ in their ability to form a migrating pool involved in peripheral immunosurveillance or a separate resident population responsible for local infection control has not been explored. Here, using mice, we show key differences in the migration and tissue localization of memory CD4(+) and CD8(+) T cells following infection of the skin by herpes simplex virus. On resolution of infection, the skin contained two distinct virus-specific memory subsets; a slow-moving population of sequestered CD8(+) T cells that were resident in the epidermis and confined largely to the original site of infection, and a dynamic population of CD4(+) T cells that trafficked rapidly through the dermis as part of a wider recirculation pattern. Unique homing-molecule expression by recirculating CD4(+) T effector-memory cells mirrored their preferential skin-migratory capacity. Overall, these results identify a complexity in memory T-cell migration, illuminating previously unappreciated differences between the CD4(+) and CD8(+) subsets.	[Gebhardt, Thomas; Whitney, Paul G.; Zaid, Ali; Mackay, Laura K.; Brooks, Andrew G.; Heath, William R.; Carbone, Francis R.; Mueller, Scott N.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia	University of Melbourne	Gebhardt, T (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.	gebhardt@unimelb.edu.au; smue@unimelb.edu.au	Mueller, Scott N/B-1918-2012; Mackay, Laura K/HGC-6580-2022; Carbone, Francis/ABF-2141-2020	Mueller, Scott N/0000-0002-3838-3989; Mackay, Laura K/0000-0002-8496-6632; Whitney, Paul/0000-0003-3836-7601; Heath, William/0000-0001-9670-259X; Gebhardt, Thomas/0000-0002-3768-9468; Brooks, Andrew/0000-0002-4085-9683; Zaid, Ali/0000-0002-2528-2783	Australian NHMRC; ARC	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council)	We thank members of the Carbone and Heath laboratories for discussions. This work was supported by the Australian NHMRC and ARC.	Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; MILLER CJ, 1992, LAB INVEST, V67, P628; Mueller SN, 2010, CURR OPIN IMMUNOL, V22, P293, DOI 10.1016/j.coi.2009.12.009; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schon MP, 1999, J IMMUNOL, V162, P6641; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Stock AT, 2011, IMMUNOL CELL BIOL, V89, P143, DOI 10.1038/icb.2010.66; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wakim LM, 2008, IMMUNOL CELL BIOL, V86, P666, DOI 10.1038/icb.2008.47; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Yawalkar N, 2000, EUR J IMMUNOL, V30, P491, DOI 10.1002/1521-4141(200002)30:2<491::AID-IMMU491>3.3.CO;2-8; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	25	371	378	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 8	2011	477	7363					216	U119		10.1038/nature10339	http://dx.doi.org/10.1038/nature10339			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	816MC	21841802				2022-12-28	WOS:000294603900037
J	Ito, S; Shen, L; Dai, Q; Wu, SC; Collins, LB; Swenberg, JA; He, C; Zhang, Y				Ito, Shinsuke; Shen, Li; Dai, Qing; Wu, Susan C.; Collins, Leonard B.; Swenberg, James A.; He, Chuan; Zhang, Yi			Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine	SCIENCE			English	Article							ACTIVE DNA DEMETHYLATION; 5-HYDROXYMETHYLCYTOSINE	5-methylcytosine (5mC) in DNA plays an important role in gene expression, genomic imprinting, and suppression of transposable elements. 5mC can be converted to 5-hydroxymethylcytosine (5hmC) by the Tet (ten eleven translocation) proteins. Here, we show that, in addition to 5hmC, the Tet proteins can generate 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) from 5mC in an enzymatic activity-dependent manner. Furthermore, we reveal the presence of 5fC and 5caC in genomic DNA of mouse embryonic stem cells and mouse organs. The genomic content of 5hmC, 5fC, and 5caC can be increased or reduced through overexpression or depletion of Tet proteins. Thus, we identify two previously unknown cytosine derivatives in genomic DNA as the products of Tet proteins. Our study raises the possibility that DNA demethylation may occur through Tet-catalyzed oxidation followed by decarboxylation.	[Ito, Shinsuke; Shen, Li; Wu, Susan C.; Zhang, Yi] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Ito, Shinsuke; Shen, Li; Wu, Susan C.; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Ito, Shinsuke; Shen, Li; Wu, Susan C.; Swenberg, James A.; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Dai, Qing; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Dai, Qing; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Collins, Leonard B.; Swenberg, James A.] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Chicago; University of Chicago; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Dai, Qing/ABD-8444-2021	Zhang, Yi/0000-0002-2789-0811; Collins, Leonard/0000-0002-7734-9708	NIH [GM68804, GM071440, P42ES5948, P30ES10126]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, P42ES005948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440, R01GM068804] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q. Zhang for suggestion of the NaBH<INF>4</INF> experiment and C. X. Song for help in oligo purification. This work was supported by NIH grants GM68804 (Y.Z.), GM071440 (C. H.), and P42ES5948 and P30ES10126 (J.A.S.). S. I. is a research fellow of the Japan Society for the Promotion of Science. Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Boysen G, 2010, J CHROMATOGR B, V878, P375, DOI 10.1016/j.jchromb.2009.12.004; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dai Q, 2011, ORG LETT, V13, P3446, DOI 10.1021/ol201189n; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; HUANG LH, 1982, NUCLEIC ACIDS RES, V10, P1579, DOI 10.1093/nar/10.5.1579; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kukushkin VY, 1999, COORDIN CHEM REV, V181, P147, DOI 10.1016/S0010-8545(98)00215-X; Neidigh JW, 2009, CHEM RES TOXICOL, V22, P885, DOI 10.1021/tx8004482; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Smiley JA, 2005, BBA-GEN SUBJECTS, V1723, P256, DOI 10.1016/j.bbagen.2005.02.001; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; WILLIAMS A, 1981, ANAL BIOCHEM, V114, P173, DOI 10.1016/0003-2697(81)90470-X; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	17	2316	2437	5	432	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2011	333	6047					1300	1303		10.1126/science.1210597	http://dx.doi.org/10.1126/science.1210597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21778364	Green Accepted, Green Submitted			2022-12-28	WOS:000294406400057
J	Martin, LT; Parker, RM				Martin, Laurie T.; Parker, Ruth M.			Insurance Expansion and Health Literacy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAID; REFORM		[Martin, Laurie T.] RAND Corp, Arlington, VA 22202 USA; [Parker, Ruth M.] Emory Univ, Atlanta, GA 30322 USA	RAND Corporation; Emory University	Martin, LT (corresponding author), RAND Corp, 1200 S Hayes St, Arlington, VA 22202 USA.	lamartin@rand.org	MARTIN, LAURIE/GRY-5272-2022; Parker, Ruth M/S-4583-2017	Parker, Ruth M/0000-0001-9685-6396				[Anonymous], 2011, LEAD HLTH IND HLTH P; Dorn S., 2011, IMPLEMENTING NATL HL; *HARV SCH PUBL HLT, HLTH LIT STUD RES FI; *I MED, 2004, HLTH LIT PRESCR END; Institute of Medicine, 2011, HLTH LIT IMPL HLTH C; Kutner M, 2007, LITERACY EVERYDAY LI; Rudd R., 2007, REV ADULT LEARNING L, V7, P174; Sommers BD, 2011, HEALTH AFFAIR, V30, P228, DOI 10.1377/hlthaff.2010.1000; Sommers BD, 2010, NEW ENGL J MED, V363, P2085, DOI 10.1056/NEJMp1010866	9	34	34	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 24	2011	306	8					874	875		10.1001/jama.2011.1212	http://dx.doi.org/10.1001/jama.2011.1212			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	810VY	21828311				2022-12-28	WOS:000294157300026
J	Martinez-Garcia, A; Rosell-Mele, A; Jaccard, SL; Geibert, W; Sigman, DM; Haug, GH				Martinez-Garcia, Alfredo; Rosell-Mele, Antoni; Jaccard, Samuel L.; Geibert, Walter; Sigman, Daniel M.; Haug, Gerald H.			Southern Ocean dust-climate coupling over the past four million years	NATURE			English	Article							ATMOSPHERIC CO2; EQUATORIAL PACIFIC; POLAR OCEAN; IRON; STRATIFICATION; PRODUCTIVITY; CIRCULATION	Dust has the potential to modify global climate by influencing the radiative balance of the atmosphere and by supplying iron and other essential limiting micronutrients to the ocean(1,2). Indeed, dust supply to the Southern Ocean increases during ice ages, and 'iron fertilization' of the subantarctic zone may have contributed up to 40 parts per million by volume (p. p. m. v.) of the decrease (80-100 p. p. m. v.) in atmospheric carbon dioxide observed during late Pleistocene glacial cycles(3-7). So far, however, the magnitude of Southern Ocean dust deposition in earlier times and its role in the development and evolution of Pleistocene glacial cycles have remained unclear. Here we report a high-resolution record of dust and iron supply to the Southern Ocean over the past four million years, derived from the analysis of marine sediments from ODP Site 1090, located in the Atlantic sector of the subantarctic zone. The close correspondence of our dust and iron deposition records with Antarctic ice core reconstructions of dust flux covering the past 800,000 years (refs 8, 9) indicates that both of these archives record large-scale deposition changes that should apply to most of the Southern Ocean, validating previous interpretations of the ice core data. The extension of the record beyond the interval covered by the Antarctic ice cores reveals that, in contrast to the relatively gradual intensification of glacial cycles over the past three million years, Southern Ocean dust and iron flux rose sharply at the Mid-Pleistocene climatic transition around 1.25 million years ago. This finding complements previous observations over late Pleistocene glacial cycles(5,8,9), providing new evidence of a tight connection between high dust input to the Southern Ocean and the emergence of the deep glaciations that characterize the past one million years of Earth history.	[Martinez-Garcia, Alfredo; Jaccard, Samuel L.; Haug, Gerald H.] ETH, Inst Geol, CH-8092 Zurich, Switzerland; [Martinez-Garcia, Alfredo; Haug, Gerald H.] Univ Potsdam, Inst Geosci, DFG Leibniz Ctr Surface Proc & Climate Studies, D-14476 Potsdam, Germany; [Martinez-Garcia, Alfredo; Rosell-Mele, Antoni] Univ Autonoma Barcelona, ICTA, Bellaterra 08193, Catalonia, Spain; [Rosell-Mele, Antoni] ICREA, Barcelona 08010, Catalonia, Spain; [Rosell-Mele, Antoni] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Geibert, Walter] Univ Edinburgh, Sch GeoSci, Edinburgh EH9 3JW, Midlothian, Scotland; [Geibert, Walter] Scottish Assoc Marine Sci SAMS, Scottish Marine Lab, Oban PA37 1QA, Argyll, Scotland; [Sigman, Daniel M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Potsdam; Autonomous University of Barcelona; ICREA; Oregon State University; University of Edinburgh; Princeton University	Martinez-Garcia, A (corresponding author), ETH, Inst Geol, CH-8092 Zurich, Switzerland.	alfredo.martinez-garcia@erdw.ethz.ch	Rosell-Melé, Antoni/B-3433-2013; Geibert, Walter/C-3722-2011; Sigman, Daniel M/A-2649-2008; Geibert, Walter/ABA-9785-2020; Jaccard, Samuel/G-3447-2014; Martínez-García, Alfredo/A-6244-2010	Rosell-Melé, Antoni/0000-0002-5513-2647; Sigman, Daniel M/0000-0002-7923-1973; Geibert, Walter/0000-0001-8646-2334; Jaccard, Samuel/0000-0002-5793-0896; Martínez-García, Alfredo/0000-0002-7206-5079	Spanish Ministry of Science and Innovation (MICINN); European Commission; Deutsche Forschungsgemeinschaft (DFG); NERC [dml010007] Funding Source: UKRI; Natural Environment Research Council [dml010007] Funding Source: researchfish; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ICREA(ICREA)	We thank S. Stefer for performing the XRF scanner measurements at the University of Bremen; and I. Voge for assistance in the ICP-SFMS analysis at the Alfred Wegener Institute for Polar and Marine Research. We thank the Integrated Ocean Drilling Program for providing the samples used in this study. This research used data acquired at the XRF Core Scanner Laboratory at the MARUM - Center for Marine Environmental Sciences, University of Bremen. Support for this work was provided by the Spanish Ministry of Science and Innovation (MICINN), the European Commission, and the Deutsche Forschungsgemeinschaft (DFG).	Blurn P., 1997, 26 ODP; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; Brovkin V, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001380; Cassar N, 2007, SCIENCE, V317, P1067, DOI 10.1126/science.1144602; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Cortese G, 2008, MAR GEOL, V252, P100, DOI 10.1016/j.margeo.2008.03.015; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Gersonde R., 1999, P ODP INIT REP, V177; Hain MP, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003790; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Jouzel J, 2010, QUATERNARY SCI REV, V29, P3683, DOI 10.1016/j.quascirev.2010.10.002; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; Kohler P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002345; Kornilova O, 2003, ORG GEOCHEM, V34, P1517, DOI 10.1016/S0146-6380(03)00155-4; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; Lambert F, 2008, NATURE, V452, P616, DOI 10.1038/nature06763; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001071; Lunt DJ, 2008, NATURE, V454, P1102, DOI 10.1038/nature07223; MARTIN JH, 1990, NATURE, V345, P156, DOI 10.1038/345156a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; Matsumoto K, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001442; McClymont EL, 2007, ORG GEOCHEM, V38, P1002, DOI 10.1016/j.orggeochem.2007.01.006; Ridgwell AJ, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000563; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Sigman DM, 2004, NATURE, V428, P59, DOI 10.1038/nature02357; SIMONEIT BRT, 1977, NATURE, V267, P682, DOI 10.1038/267682a0; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; Venz KA, 2002, PALAEOGEOGR PALAEOCL, V182, P197, DOI 10.1016/S0031-0182(01)00496-5; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Winckler G, 2008, SCIENCE, V320, P93, DOI 10.1126/science.1150595; Wolff EW, 2006, NATURE, V440, P491, DOI 10.1038/nature04614; Zielinski U, 2002, MAR MICROPALEONTOL, V45, P225, DOI 10.1016/S0377-8398(02)00031-2	36	235	246	3	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					312	U141		10.1038/nature10310	http://dx.doi.org/10.1038/nature10310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21814203				2022-12-28	WOS:000294206500033
J	Taoka, K; Ohki, I; Tsuji, H; Furuita, K; Hayashi, K; Yanase, T; Yamaguchi, M; Nakashima, C; Purwestri, YA; Tamaki, S; Ogaki, Y; Shimada, C; Nakagawa, A; Kojima, C; Shimamoto, K				Taoka, Ken-ichiro; Ohki, Izuru; Tsuji, Hiroyuki; Furuita, Kyoko; Hayashi, Kokoro; Yanase, Tomoko; Yamaguchi, Midori; Nakashima, Chika; Purwestri, Yekti Asih; Tamaki, Shojiro; Ogaki, Yuka; Shimada, Chihiro; Nakagawa, Atsushi; Kojima, Chojiro; Shimamoto, Ko			14-3-3 proteins act as intracellular receptors for rice Hd3a florigen	NATURE			English	Article							STRUCTURAL BASIS; SIGNALS; SYSTEM; GROWTH; FT; CRYSTALLOGRAPHY; AGROBACTERIUM; REGULATOR; REVEALS; VECTORS	'Florigen' was proposed 75 years ago(1) to be synthesized in the leaf and transported to the shoot apex, where it induces flowering. Only recently have genetic and biochemical studies established that florigen is encoded by FLOWERING LOCUS T (FT), a gene that is universally conserved in higher plants(2-4). Nonetheless, the exact function of florigen during floral induction remains poorly understood and receptors for florigen have not been identified. Here we show that the rice FT homologue Hd3a(5) interacts with 14-3-3 proteins in the apical cells of shoots, yielding a complex that translocates to the nucleus and binds to the Oryza sativa (Os)FD1 transcription factor, a rice homologue of Arabidopsis thaliana FD. The resultant ternary 'florigen activation complex' (FAC) induces transcription of OsMADS15, a homologue of A. thaliana APETALA1 (AP1), which leads to flowering. We have determined the 2.4 angstrom crystal structure of rice FAC, which provides a mechanistic basis for florigen function in flowering. Our results indicate that 14-3-3 proteins act as intracellular receptors for florigen in shoot apical cells, and offer new approaches to manipulate flowering in various crops and trees.	[Ohki, Izuru; Furuita, Kyoko; Hayashi, Kokoro; Kojima, Chojiro] Nara Inst Sci & Technol, Lab Biophys, Grad Sch Biol Sci, Nara 6300192, Japan; [Taoka, Ken-ichiro; Tsuji, Hiroyuki; Yanase, Tomoko; Yamaguchi, Midori; Nakashima, Chika; Purwestri, Yekti Asih; Tamaki, Shojiro; Ogaki, Yuka; Shimada, Chihiro; Shimamoto, Ko] Nara Inst Sci & Technol, Lab Plant Mol Genet, Grad Sch Biol Sci, Nara 6300192, Japan; [Nakagawa, Atsushi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Nara Institute of Science & Technology; Nara Institute of Science & Technology; Osaka University	Kojima, C (corresponding author), Nara Inst Sci & Technol, Lab Biophys, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	kojima@protein.osaka-u.ac.jp; simamoto@bs.naist.jp	Kojima, Chojiro/AFV-4592-2022; Nakagawa, Atsushi/M-5731-2019; Ohki, Izuru/O-4816-2019; Ohki, Izuru/C-7883-2013; Purwestri, Yekti Asih/AAK-2777-2021; Ding, Cheng-Qiang/B-6287-2011; Nakagawa, Atsushi/D-4329-2009	Nakagawa, Atsushi/0000-0002-1700-7861; Ohki, Izuru/0000-0002-0667-5936; Purwestri, Yekti Asih/0000-0002-7032-9253; Nakagawa, Atsushi/0000-0002-1700-7861; Kojima, Chojiro/0000-0003-2723-8249; Furuita, Kyoko/0000-0002-9272-0026; Tsuji, Hiroyuki/0000-0002-6444-559X	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Global COE Program at NAIST; Bio-oriented Research Advancement Institution (BRAIN)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program at NAIST; Bio-oriented Research Advancement Institution (BRAIN)	We thank Y. Takahashi for the anti-14-3-3 antibody and S. Takayama for the BiFC vectors. We are grateful to I. Smith for critical reading of the manuscript. We also thank N. Inada for FRET measurement; Y. Nishio, Y. Ohno, E. Kawano and M. Kanda for technical assistance; Y. Tamaki, Y. Konomi and J. Naritomi for rice transformation; M. Yoneyama, H. Kinoshita and A. Yasuba for sample preparation; J. Tsukamoto for mass spectroscopy analysis; H. Fukada for ITC measurement; K. Takeshita and Y. Hara for crystallization; and members of the Laboratory of Plant Molecular Genetics and the Laboratory of Biophysics at Nara Institute of Science and Technology (NAIST) for discussions. We thank beamline staff of BL41XU and BL44XU at SPring-8 and Photon Factory for data collection. We also thank Academia Sinica and National Synchrotron Radiation Research Center (Taiwan) for use of the MX225-HE detector at BL44XU. This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) through the Target Proteins Research Program, by the Global COE Program at NAIST, by Grants-in-Aid for Scientific Research to I.O., C. K. and K. S., by Grants-in-Aid for Scientific Research on Priority Areas to K. S. and by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry from Bio-oriented Research Advancement Institution (BRAIN) to H.T.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; [Anonymous], 2008, ROWLAND NMR TOOLKIT; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cailachjan MC, 1936, CR ACAD SCI URSS, V12, P443; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delano D.W., 2002, PYMOL MOL GRAPHICS S; Goddard D. T., 2004, SPARKY 3; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Kaufmann K, 2010, SCIENCE, V328, P85, DOI 10.1126/science.1185244; Kawano Y, 2010, CELL HOST MICROBE, V7, P362, DOI 10.1016/j.chom.2010.04.010; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Kwaaitaal M, 2010, PLANT PHYSIOL, V152, P1135, DOI 10.1104/pp.109.151142; Kyozuka J, 1991, PLANT TISSUE CULT, V1, P1; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Okano Y, 2008, PLANT J, V53, P65, DOI 10.1111/j.1365-313X.2007.03313.x; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pnueli L, 2001, PLANT CELL, V13, P2687, DOI 10.1105/tpc.13.12.2687; Purwestri YA, 2009, PLANT CELL PHYSIOL, V50, P429, DOI 10.1093/pcp/pcp012; Rovnyak D, 2004, J MAGN RESON, V170, P15, DOI 10.1016/j.jmr.2004.05.016; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Shyu YJ, 2008, P NATL ACAD SCI USA, V105, P151, DOI 10.1073/pnas.0705181105; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009	46	424	471	10	237	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					332	U97		10.1038/nature10272	http://dx.doi.org/10.1038/nature10272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21804566				2022-12-28	WOS:000294206500038
J	Lim, LS				Lim, Lionel S.			Review: High-calorie supplements increase weight in persons with dementia and feeding problems; no evidence exists for other outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Griffin Hosp, Derby, CT 06418 USA		Lim, LS (corresponding author), Griffin Hosp, Derby, CT 06418 USA.			Lim, Lionel/0000-0002-0730-8767				Avenell A, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001880.pub5, 10.1002/14651858.CD001880.pub6]; Langer G, 2014, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD003216; Milne Anne C, 2009, Cochrane Database Syst Rev, pCD003288, DOI 10.1002/14651858.CD003288.pub3	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4							JC2-5	10.7326/0003-4819-155-4-201108160-02005	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LM	21844538				2022-12-28	WOS:000208885100004
J	Morris, A				Morris, Andrew			Active surveillance and use of barrier precautions did not reduce colonization and infection with MRSA and VRE in adult ICUs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Morris, Andrew] Univ Hlth Network, Mt Sinai Hosp, Toronto, ON, Canada; [Morris, Andrew] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto; University of Toronto	Morris, A (corresponding author), Univ Hlth Network, Mt Sinai Hosp, Toronto, ON, Canada.							Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601	1	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4							JC2-13	10.7326/0003-4819-155-4-201108160-02013	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LM	21844546				2022-12-28	WOS:000208885100012
J	Crump, JA; Gove, S; Parry, CM				Crump, John A.; Gove, Sandy; Parry, Christopher M.			Management of adolescents and adults with febrile illness in resource limited areas	BRITISH MEDICAL JOURNAL			English	Review							BLOOD-STREAM INFECTIONS; RAPID DIAGNOSTIC-TESTS; NORTHEASTERN THAILAND; HEALTH-CARE; TANZANIA; MALARIA; TUBERCULOSIS; RESISTANCE; COUNTRIES; AFRICA		[Crump, John A.] Duke Univ, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA; [Crump, John A.] Duke Univ, Dept Pathol, Durham, NC 27710 USA; [Crump, John A.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA; [Crump, John A.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Crump, John A.] Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Gove, Sandy] WHO, CH-1211 Geneva, Switzerland; [Parry, Christopher M.] Mahidol Oxford Trop Med Res Unit, Wellcome Trust Major Overseas Programme, Bangkok, Thailand; [Parry, Christopher M.] Angkor Hosp Children, Siem Reap, Cambodia	Duke University; Duke University; Duke University; Kilimanjaro Christian Medical Centre; World Health Organization; Mahidol Oxford Tropical Medicine Research Unit (MORU)	Crump, JA (corresponding author), Duke Univ, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA.	john.crump@duke.edu	Crump, John A./AAZ-6289-2020; Crump, John A./AAZ-6412-2020	Crump, John A./0000-0002-4529-102X; Crump, John A./0000-0002-4529-102X	United States National Institutes of Health (NIH) [U01 AI062563, D43 PA-03-018, U01 AI069484, P30 AI 64518, U01 AI067854]; Wellcome Trust; Li Ka Shing Foundation; FOGARTY INTERNATIONAL CENTER [D43TW006732, R01TW009237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, U01AI062563, U01AI067854, U01AI069484, U19AI067854] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Li Ka Shing Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JAC received support from United States National Institutes of Health (NIH) funded programs International Studies on AIDS Associated Co-infections (U01 AI062563); AIDS International Training and Research Program (D43 PA-03-018); the Duke Clinical Trials Unit and Clinical Research Sites (U01 AI069484); the Duke Center for AIDS Research (P30 AI 64518); and the Center for HIV/AIDS Vaccine Immunology (U01 AI067854). CMP received support from the Wellcome Trust and the Li Ka Shing Foundation.	[Anonymous], 2007, MANUAL ESTIMATING NA; Archibald LK, 2001, EMERG INFECT DIS, V7, P302, DOI 10.3201/eid0702.010232; Archibald LK, 1998, CLIN INFECT DIS, V26, P290, DOI 10.1086/516297; Biggs HM, 2011, AM J TROP MED HYG, V85, P275, DOI 10.4269/ajtmh.2011.11-0176; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Chheng K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006630; Chierakul W, 2004, T ROY SOC TROP MED H, V98, P678, DOI 10.1016/j.trstmh.2004.01.011; Crump JA, 2011, CLIN INFECT DIS, V52, P341, DOI 10.1093/cid/ciq103; Grant AD, 1997, AIDS, V11, P1357, DOI 10.1097/00002030-199711000-00010; Louie JK, 2004, INT J STD AIDS, V15, P758, DOI 10.1258/0956462042395159; Mundy CJF, 2003, T ROY SOC TROP MED H, V97, P403, DOI 10.1016/S0035-9203(03)90070-8; Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670; Olliaro PL, 1995, B WORLD HEALTH ORGAN, V73, P735; Olsen SJ, 2004, J CLIN MICROBIOL, V42, P1885, DOI 10.1128/JCM.42.5.1885-1889.2004; PETIT PLC, 1995, J TROP MED HYG, V98, P217; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Phetsouvanh R, 2006, AM J TROP MED HYG, V75, P978; Prabhu M, 2011, CLIN INFECT DIS, V53, pe8, DOI 10.1093/cid/cir411; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Sanders EJ, 2011, AIDS, V25, P1219, DOI 10.1097/QAD.0b013e3283474ed5; Smith MD, 2003, J CLIN MICROBIOL, V41, P2810, DOI 10.1128/JCM.41.7.2810-2813.2003; *WHO, 2011, IMAI DISTR IN PRESS; WHO, 2010, GUID TREATM MAL, V2nd; *WHO, 2008, CONS TECHN OP REC CL, P20; World Health Organization, 2009, IMAI AC CAR GUID 1 L; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	30	47	47	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 8	2011	343								d4847	10.1136/bmj.d4847	http://dx.doi.org/10.1136/bmj.d4847			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	808CQ	21824901	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000293953000002
J	Cheng, LY; Bailey, AP; Leevers, SJ; Ragan, TJ; Driscoll, PC; Gould, AP				Cheng, Louise Y.; Bailey, Andrew P.; Leevers, Sally J.; Ragan, Timothy J.; Driscoll, Paul C.; Gould, Alex P.			Anaplastic Lymphoma Kinase Spares Organ Growth during Nutrient Restriction in Drosophila	CELL			English	Article							RECEPTOR TYROSINE KINASE; ASYMMETRIC CELL-DIVISION; INSULIN-LIKE PEPTIDES; PHOSPHOINOSITIDE 3-KINASE; ACTIVATING MUTATIONS; SIGNALING PATHWAY; BRAIN-DEVELOPMENT; ALK KINASE; FAT-CELLS; LIFE-SPAN	Developing animals survive periods of starvation by protecting the growth of critical organs at the expense of other tissues. Here, we use Drosophila to explore the as yet unknown mechanisms regulating this privileged tissue growth. As in mammals, we observe in Drosophila that the CNS is more highly spared than other tissues during nutrient restriction (NR). We demonstrate that anaplastic lymphoma kinase (Alk) efficiently protects neural progenitor (neuroblast) growth against reductions in amino acids and insulin-like peptides during NR via two mechanisms. First, Alk suppresses the growth requirement for amino acid sensing via Slimfast/Rheb/TOR complex 1. And second, Alk, rather than insulin-like receptor, primarily activates PI3-kinase. Alk maintains PI3-kinase signaling during NR as its ligand, Jelly belly (Jeb), is constitutively expressed from a glial cell niche surrounding neuroblasts. Together, these findings identify a brain-sparing mechanism that shares some regulatory features with the starvation-resistant growth programs of mammalian tumors.	[Cheng, Louise Y.; Bailey, Andrew P.; Gould, Alex P.] Natl Inst Med Res, MRC, Div Dev Neurobiol, London NW7 1AA, England; [Ragan, Timothy J.; Driscoll, Paul C.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Leevers, Sally J.] Canc Res UK London Res Inst, London WC2A 3PX, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; Cancer Research UK	Gould, AP (corresponding author), Natl Inst Med Res, MRC, Div Dev Neurobiol, Mill Hill, London NW7 1AA, England.	agould@nimr.mrc.ac.uk	Gould, Alex/M-5353-2019; Cheng, Louise/B-5112-2012; Ragan, Timothy/F-9251-2012; Gould, Alex/A-7479-2010	Gould, Alex/0000-0002-6875-6985; Gould, Alex/0000-0002-6875-6985; Driscoll, Paul/0000-0002-4124-6950; Cheng, Louise/0000-0001-9712-4082; Bailey, Andrew/0000-0003-2143-1689; Ragan, Timothy/0000-0002-6233-3375	Medical Research Council [U117584237]; Cancer Research UK; MRC [MC_U117533887, MC_U117584237] Funding Source: UKRI; Medical Research Council [MC_U117584237, MC_U117574559, MC_U117533887] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Steve Cohen, Bruce Edgar, Ernst Hafen, Jean-Luc Imler, Pierre Leopold, Fumio Matsuzaki, Tom Neufeld, James Nowick, Ruth Palmer, Linda Partridge, Iris Salecker, Hugo Stocker, Gary Struhl, Nic Tapon, and Tian Xu and also to the Bloomington, Kyoto Drosophila Genetic Resource, and Vienna Drosophila RNAi Centers for fly stocks, antibodies, and chemicals. We also acknowledge Tom Frenkiel and the Biomedical NMR Centre, and Steve Morris, Ruth Palmer, Iris Salecker, Patricia Serpente, Rita Sousa-Nunes, Caroline Vincent, and Joe Weiss for advice and critical reading of the manuscript. L.Y.C., A.B., T.J.R., P.C.D., and A.P.G. are supported by the Medical Research Council (U117584237), and S.J.L. is supported by Cancer Research UK.	Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; BAKKER K., 1959, Entomologia Experimentalis et Applicata, V2, P171, DOI 10.1007/BF00302537; Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Beadle GW, 1938, BIOL BULL-US, V75, P447, DOI 10.2307/1537573; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bowden ET, 2002, J BIOL CHEM, V277, P35862, DOI 10.1074/jbc.M203963200; Britton JS, 1998, DEVELOPMENT, V125, P2149; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Calikoglu AS, 2001, PEDIATR RES, V49, P197, DOI 10.1203/00006450-200102000-00011; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Delanoue R, 2010, DEV CELL, V18, P1012, DOI 10.1016/j.devcel.2010.05.007; DOBBING J, 1971, BIOL NEONATE, V19, P363, DOI 10.1159/000240430; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Grewal SS, 2009, INT J BIOCHEM CELL B, V41, P1006, DOI 10.1016/j.biocel.2008.10.010; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; GRUENWALD P, 1963, BIOL NEONATORUM, V5, P215; Gu TL, 2004, BLOOD, V103, P4622, DOI 10.1182/blood-2003-03-0820; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hentges K, 1999, DEVELOPMENT, V126, P1601; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kaneko K, 2010, CELL METAB, V12, P619, DOI 10.1016/j.cmet.2010.11.005; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; Lee G, 2007, BIOCHEM BIOPH RES CO, V357, P1154, DOI 10.1016/j.bbrc.2007.04.086; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Liu W, 2009, J NEUROSCI RES, V87, P2821, DOI 10.1002/jnr.22129; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Powers C, 2002, J BIOL CHEM, V277, P14153, DOI 10.1074/jbc.M112354200; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Randhawa R, 2005, MOL GENET METAB, V86, P84, DOI 10.1016/j.ymgme.2005.07.028; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; Shi P, 2009, BLOOD, V114, P360, DOI 10.1182/blood-2007-11-125658; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Slupianek A, 2001, CANCER RES, V61, P2194; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Weiss JB, 2001, CELL, V107, P387, DOI 10.1016/S0092-8674(01)00540-2; Wu MYW, 2007, EMBO J, V26, P371, DOI 10.1038/sj.emboj.7601487; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	85	155	158	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					435	447		10.1016/j.cell.2011.06.040	http://dx.doi.org/10.1016/j.cell.2011.06.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816278	Bronze			2022-12-28	WOS:000293570500017
J	Nightingale, SL				Nightingale, Stuart L.			Scientific Publication and Global Security	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MOUSEPOX					Stuart.nightingale@comcast.net						Atlas Ronald, 2003, Science, V299, P1149; Jackson RJ, 2001, J VIROL, V75, P1205, DOI 10.1128/JVI.75.3.1205-1210.2001; National Research Council, 2004, BIOT RES AG TERR, DOI [10.17226/10827, DOI 10.17226/10827]; National Science Advisory Board for Biosecurity, SUST PROGR LIF SCI; National Science Advisory Board for Biosecurity, PROP FRAM OV DUAL US; Resnik DB, 2011, BIOSECUR BIOTERROR, V9, P49, DOI 10.1089/bsp.2010.0067; Selgelid MJ, 2010, EMBO REP, V11, P18, DOI 10.1038/embor.2009.270; Suk JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001253; The World Association of Medical Editors, GEOP INTR ED DEC; World Health Organization,, 2010, RESP LIF SCI RES GLO	10	3	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2011	306	5					545	546		10.1001/jama.2011.1083	http://dx.doi.org/10.1001/jama.2011.1083			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800SH	21813434				2022-12-28	WOS:000293386500023
J	Su, JR; Beltrami, JF; Zaidi, AA; Weinstock, HS				Su, John R.; Beltrami, John F.; Zaidi, Akbar A.; Weinstock, Hillard S.			Primary and Secondary Syphilis Among Black and Hispanic Men Who Have Sex With Men: Case Report Data From 27 States	ANNALS OF INTERNAL MEDICINE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; HIV PREVENTION INTERVENTION; REPRODUCTIVE HEALTH; SOCIAL DETERMINANTS; UNITED-STATES; EPIDEMIOLOGY; ORIENTATION; NETWORKS; CONTEXT; RATES	Background: Until 2005, national-level data on the sex of sex partners that describe how primary and secondary syphilis affects men who have sex with men (MSM) of different races or ethnicities were not reported. Objective: To present data from 27 states comparing trends in primary and secondary syphilis among MSM of different races or ethnicities. Design: Review of case report data and regression analysis. Setting: Federal database of case reports in the National Electronic Telecommunications System for Surveillance. Participants: Men reported to be MSM. Measurements: Cases of primary and secondary syphilis per 100 000 males of matching race or ethnicity ("rates"), determined by using population data from the National Center for Health Statistics as the denominator to compare age and racial and ethnic differences. Results: For each year during 2005 to 2008, 27 states from all U. S. census regions reported data on the sex of sex partners for 70% or more of male cases of primary and secondary syphilis. Regression analysis revealed significantly different trends in rates of primary and secondary syphilis: Absolute increases in rates among black MSM and Hispanic MSM were, respectively, 8.0 times and 2.4 times the absolute increase in rate among white MSM. By region, rates among MSM increased 30% in the Midwest, 48% in the South, 73% in the Northeast, and 77% in the West. By age group, the largest absolute increase in rates occurred among MSM aged 20 to 29 years. Limitation: Results from 27 states may not be generalizable to the United States as a whole. Conclusion: Rates of primary and secondary syphilis disproportionately increased among black and Hispanic MSM (compared with white MSM) and among young MSM. Care providers should offer counseling about safer sexual practices and screening for syphilis and other sexually transmitted infections when caring for MSM.	[Su, John R.] Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Su, JR (corresponding author), Ctr Dis Control & Prevent, Div STD Prevent, 1600 Clifton Rd,MS-E02, Atlanta, GA 30333 USA.	ezu2@cdc.gov			Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Centers for Disease Control and Prevention.	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Anderson John E, 2006, Adv Data, P1; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P269; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P77; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P681; [Anonymous], 2010, 2009 NATL SCH CLIMAT; Blas E, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P1; Bowen AM, 2007, HEALTH EDUC RES, V22, P120, DOI 10.1093/her/cyl057; Brindis CD, 2005, J ADOLESCENT HEALTH, V37, P155, DOI 10.1016/j.jadohealth.2004.09.015; Brookmeyer KA, 2009, J PRIM PREV, V30, P677, DOI 10.1007/s10935-009-0196-6; Brooks RA, 2005, AIDS PATIENT CARE ST, V19, P737, DOI 10.1089/apc.2005.19.737; Carpenter KM, 2010, AIDS BEHAV, V14, P549, DOI 10.1007/s10461-009-9578-2; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P773; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P853; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P117; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P817; Centers for Disease Control and Prevention (CDCP), 2010, SEX TRANSM DIS SURV; D'Souza G, 2003, SEX TRANSM DIS, V30, P872, DOI 10.1097/01.OLQ.0000091144.72555.13; Dean HD, 2010, PUBLIC HEALTH REP, V125, P1, DOI 10.1177/00333549101250S401; Diaz E. M., 2009, SHARED DIFFERENCES E; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Garofalo R, 1998, PEDIATRICS, V101, P895, DOI 10.1542/peds.101.5.895; Gavin Lorrie, 2009, Morbidity and Mortality Weekly Report, V58, P1; Grossman AH, 1998, J HOMOSEXUAL, V35, P25, DOI 10.1300/J082v35n02_02; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Heffelfinger JD, 2007, AM J PUBLIC HEALTH, V97, P1076, DOI 10.2105/AJPH.2005.070417; Hogben M, 2008, SEX TRANSM DIS, V35, pS13, DOI 10.1097/OLQ.0b013e31818d3cad; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; Jones KT, 2008, AM J PUBLIC HEALTH, V98, P1043, DOI 10.2105/AJPH.2007.120337; Kimbrough LW, 2009, AM J PUBLIC HEALTH, V99, P1093, DOI 10.2105/AJPH.2008.139329; Lieb S, 2009, J URBAN HEALTH, V86, P887, DOI 10.1007/s11524-009-9401-4; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Mosher William D, 2005, Adv Data, P1; Nakashima AK, 1996, SEX TRANSM DIS, V23, P16, DOI 10.1097/00007435-199601000-00006; O'Leary A, 2007, AIDS BEHAV, V11, P706, DOI 10.1007/s10461-006-9205-4; Peterman TA, 2005, SEX TRANSM DIS, V32, P144, DOI 10.1097/01.olq.0000156552.91788.25; Peterman TA, 2005, SEX TRANSM DIS, V32, pS4, DOI 10.1097/01.olq.0000180455.79024.e9; Rhodes SD, 2004, AIDS EDUC PREV, V16, P315, DOI 10.1521/aeap.16.4.315.40399; Rivers Ian, 2004, Crisis, V25, P169; *SAS I, 2009, SAS ONLINEDOC 9 2; Sifakis F, 2010, AIDS BEHAV, V14, P904, DOI 10.1007/s10461-007-9317-5; Silenzio VMB, 2007, AM J PUBLIC HEALTH, V97, P2017, DOI 10.2105/AJPH.2006.095943; St Lawrence JS, 2002, AM J PUBLIC HEALTH, V92, P1784, DOI 10.2105/AJPH.92.11.1784; Valentine JA, 2008, SEX TRANSM DIS, V35, pS23, DOI 10.1097/OLQ.0b013e31818d3cc7; Valleroy LA, 2000, JAMA-J AM MED ASSOC, V284, P198, DOI 10.1001/jama.284.2.198; Warner L, 2008, PLOS MED, V5, P919, DOI 10.1371/journal.pmed.0050135; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	48	50	53	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2011	155	3					145	+		10.7326/0003-4819-155-3-201108020-00004	http://dx.doi.org/10.7326/0003-4819-155-3-201108020-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	800DJ	21810707				2022-12-28	WOS:000293339600002
J	Korb, MA; Thakkar, U				Korb, Michele A.; Thakkar, Umesh			Facilitating Scientific Investigations and Training Data Scientists	SCIENCE			English	Editorial Material									[Korb, Michele A.] Calif State Univ Hayward, Dept Teacher Educ, Coll Educ & Allied Studies, Hayward, CA 94542 USA; [Thakkar, Umesh] Univ Illinois, Coordinated Sci Lab, Urbana, IL 61801 USA; [Thakkar, Umesh] Vet Hlth Adm, Off Publ Hlth, US Dept Vet Affairs, Washington, DC 20420 USA	California State University System; California State University East Bay; University of Illinois System; University of Illinois Urbana-Champaign; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Korb, MA (corresponding author), Calif State Univ Hayward, Dept Teacher Educ, Coll Educ & Allied Studies, Hayward, CA 94542 USA.	michele.korb@csueastbay.edu; uthakkar@illinois.edu						Alberts B, 2008, SCIENCE, V319, P1589, DOI 10.1126/science.1157518; HADLEY K, 2007, SCI CHILD, V45, P29; *NSF CYB COUNC, 2007, CYB VIS 21 CENT DISC; NSF Task Force on Cyberlearning, 2008, FOST LEARN NETW WORL; President's Council of Advisors on Science and Technology, 2010, PREP INSP K 12 ED SC; ROBINSON S, 2011, MICROSC TODAY, V19, P46; THAKKAR U, 2000, AM ED RES ASS ANN M; Wieman CE, 2008, SCIENCE, V322, P682, DOI 10.1126/science.1161948	8	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					534	535		10.1126/science.1196981	http://dx.doi.org/10.1126/science.1196981			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798922				2022-12-28	WOS:000293222400032
J	Sepkowitz, KA				Sepkowitz, Kent A.			One Hundred Years of Salvarsan	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Sepkowitz, KA (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.							FRENCH HC, 1911, LANCET, V178, P326; Jones HW, 1911, BOSTON MED SURG J, V164, P381, DOI 10.1056/NEJM191103161641103; Riethmiller S, 2005, CHEMOTHERAPY, V51, P234, DOI 10.1159/000087453; Schwartz RS, 2004, NEW ENGL J MED, V350, P1079, DOI 10.1056/NEJMp048021; 1911, BOSTON MED SURG J, V164, P591	5	12	13	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					291	293		10.1056/NEJMp1105345	http://dx.doi.org/10.1056/NEJMp1105345			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21793743				2022-12-28	WOS:000293172200004
J	Mesaros, A; Fujita, K; Eisaki, H; Uchida, S; Davis, JC; Sachdev, S; Zaanen, J; Lawler, MJ; Kim, EA				Mesaros, A.; Fujita, K.; Eisaki, H.; Uchida, S.; Davis, J. C.; Sachdev, S.; Zaanen, J.; Lawler, M. J.; Kim, Eun-Ah			Topological Defects Coupling Smectic Modulations to Intra-Unit-Cell Nematicity in Cuprates	SCIENCE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; COPPER-OXIDE SUPERCONDUCTORS; T-C SUPERCONDUCTOR; MOTT INSULATOR; SYMMETRY; STRIPES; PHASE; ORDER; BI2SR2CACU2O8+DELTA; BREAKING	We study the coexisting smectic modulations and intra-unit-cell nematicity in the pseudogap states of underdoped Bi2Sr2CaCu2O8+delta. By visualizing their spatial components separately, we identified 2 pi topological defects throughout the phase-fluctuating smectic states. Imaging the locations of large numbers of these topological defects simultaneously with the fluctuations in the intra-unit-cell nematicity revealed strong empirical evidence for a coupling between them. From these observations, we propose a Ginzburg-Landau functional describing this coupling and demonstrate how it can explain the coexistence of the smectic and intra-unit-cell broken symmetries and also correctly predict their interplay at the atomic scale. This theoretical perspective can lead to unraveling the complexities of the phase diagram of cuprate high-critical-temperature superconductors.	[Mesaros, A.; Fujita, K.; Davis, J. C.; Lawler, M. J.; Kim, Eun-Ah] Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Mesaros, A.; Zaanen, J.] Leiden Univ, Inst Lorentz Theoret Phys, NL-2300 Leiden, Netherlands; [Fujita, K.; Davis, J. C.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; [Fujita, K.; Uchida, S.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Eisaki, H.] Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Davis, J. C.] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Sachdev, S.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Lawler, M. J.] SUNY Binghamton, Dept Phys Appl Phys & Astron, Binghamton, NY 13902 USA	Cornell University; Leiden University; Leiden University - Excl LUMC; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of St Andrews; Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Kim, EA (corresponding author), Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	eun-ah.kim@cornell.edu	Sachdev, Subir/Y-3037-2019; Sachdev, Subir/A-8781-2013; Mesaros, Andrej/L-6463-2013; Lawler, Michael/K-6770-2012; Kim, Eun-Ah/K-6711-2012; Eisaki, Hiroshi/F-6317-2018	Sachdev, Subir/0000-0002-2432-7070; Sachdev, Subir/0000-0002-2432-7070; Mesaros, Andrej/0000-0002-5971-832X; Lawler, Michael/0000-0002-2319-2274; Kim, Eun-Ah/0000-0002-9554-4443; Eisaki, Hiroshi/0000-0002-8299-6416	NSF [DMR-0520404, DMR-0955822]; Center for Emergent Superconductivity at Brookhaven National Laboratory; U.S. Department of Energy [DE-2009-BNL-PM015]; Ministry of Science and Education (Japan); Global Centers of Excellence Program for Japan Society for the Promotion of Science; Nederlandse Organisatie voor Wetenschappelijk Onderzoek;  [DMR-0757145]; Division Of Materials Research [0955822] Funding Source: National Science Foundation; Engineering and Physical Sciences Research Council [EP/I031014/1] Funding Source: researchfish; EPSRC [EP/I031014/1] Funding Source: UKRI	NSF(National Science Foundation (NSF)); Center for Emergent Superconductivity at Brookhaven National Laboratory; U.S. Department of Energy(United States Department of Energy (DOE)); Ministry of Science and Education (Japan); Global Centers of Excellence Program for Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); ; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank E. Fradkin, S. Kivelson, M. Norman, J. P. Sethna, and J. Tranquada for helpful discussions and communications. Theoretical studies at Cornell were supported by NSF grant DMR-0520404 to the Cornell Center for Materials Research and by NSF grant DMR-0955822. Experimental studies are supported by the Center for Emergent Superconductivity, an Energy Frontier Research Center headquartered at Brookhaven National Laboratory and funded by the U.S. Department of Energy under DE-2009-BNL-PM015, as well as by a Grant-in-Aid for Scientific Research from the Ministry of Science and Education (Japan) and the Global Centers of Excellence Program for Japan Society for the Promotion of Science. The work at Harvard University was supported by DMR-0757145. The work at Leiden University was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek through a Spinoza Award. A. M. is grateful for the hospitality of E.-A.K.	Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; [Anonymous], 2007, PRINCIPLES CONDENSED; [Anonymous], 1990, SUPERFLUIDITY SUPERC; Choi T, 2010, NAT MATER, V9, P253, DOI [10.1038/NMAT2632, 10.1038/nmat2632]; Cvetkovic V, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.045701; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; DEGENNES PG, 1972, SOLID STATE COMMUN, V10, P753, DOI 10.1016/0038-1098(72)90186-X; Del Maestro A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.024520; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; Gruner G., 1994, DENSITY WAVES SOLIDS; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Howald C, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.014533; Kaminski A, 2002, NATURE, V416, P610, DOI 10.1038/416610a; Kim EA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.184514; Kim YJ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.064520; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Lee J, 2009, SCIENCE, V325, P1099, DOI 10.1126/science.1176369; Li Y, 2008, NATURE, V455, P372, DOI 10.1038/nature07251; McElroy K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197005; MCMILLAN WL, 1975, PHYS REV B, V12, P1187, DOI 10.1103/PhysRevB.12.1187; MERMIN ND, 1979, REV MOD PHYS, V51, P591, DOI 10.1103/RevModPhys.51.591; Robertson JA, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.134507; Sun XF, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.107001; TONER J, 1981, PHYS REV B, V23, P316, DOI 10.1103/PhysRevB.23.316; Tranquada JM, 2004, NATURE, V429, P534, DOI 10.1038/nature02574; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Vojta M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.097001; Vojta M, 2009, ADV PHYS, V58, P699, DOI 10.1080/00018730903122242; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391	36	125	128	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					426	430		10.1126/science.1201082	http://dx.doi.org/10.1126/science.1201082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778393	Green Submitted			2022-12-28	WOS:000292959600037
J	Gong, R; Ding, C; Hu, J; Lu, Y; Liu, F; Mann, E; Xu, FQ; Cohen, MB; Luo, MM				Gong, Rong; Ding, Cheng; Hu, Ji; Lu, Yao; Liu, Fei; Mann, Elizabeth; Xu, Fuqiang; Cohen, Mitchell B.; Luo, Minmin			Role for the Membrane Receptor Guanylyl Cyclase-C in Attention Deficiency and Hyperactive Behavior	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; MICE LACKING; DOPAMINE; AMPHETAMINE; UROGUANYLIN; RESISTANT; PATHWAY	Midbrain dopamine neurons regulate many important behavioral processes, and their dysfunctions are associated with several human neuropsychiatric disorders such as attention deficit hyperactivity disorder (ADHD) and schizophrenia. Here, we report that these neurons in mice selectively express guanylyl cyclase-C (GC-C), a membrane receptor previously thought to be expressed mainly in the intestine. GC-C activation potentiates the excitatory responses mediated by glutamate and acetylcholine receptors via the activity of guanosine 3',5'-monophosphate-dependent protein kinase (PKG). Mice in which GC-C has been knocked out exhibit hyperactivity and attention deficits. Moreover, their behavioral phenotypes are reversed by ADHD therapeutics and a PKG activator. These results indicate important behavioral and physiological functions for the GC-C/PKG signaling pathway within the brain and suggest new therapeutic targets for neuropsychiatric disorders related to the malfunctions of midbrain dopamine neurons.	[Gong, Rong; Ding, Cheng; Hu, Ji; Lu, Yao; Luo, Minmin] NIBS, Beijing 102206, Peoples R China; [Gong, Rong] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Gong, Rong] Peking Union Med Coll, Beijing 100730, Peoples R China; [Ding, Cheng] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Liu, Fei; Xu, Fuqiang] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan 430071, Peoples R China; [Mann, Elizabeth; Cohen, Mitchell B.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Luo, Minmin] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Normal University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Cincinnati Children's Hospital Medical Center; Tsinghua University	Luo, MM (corresponding author), NIBS, Beijing 102206, Peoples R China.	luominmin@nibs.ac.cn	xu, fuqiang/AAI-1571-2019; Ding, Cheng/N-6735-2016; Gong, Rong/A-6358-2017; Hu, Ji/H-2293-2011	Gong, Rong/0000-0002-9775-118X; Luo, Minmin/0000-0003-3535-6624; Cohen, Mitchell/0000-0002-4412-350X; xu, fu qiang/0000-0002-4382-9797	China Ministry of Science and Technology	China Ministry of Science and Technology(Ministry of Science and Technology, China)	We thank K. Kobayashi (Fukushima Medical University, Japan) for TH-GFP transgenic mice, X. Lei (NIBS) for behavioral reagents, and J. Zhang (Chinese Academy of Medical Sciences) for high-pressure liquid chromatography/electrochemical detection service. We also thank D. Perkel and Y. Rao for comments on the manuscript. M. L. is supported by China Ministry of Science and Technology 973 Grants. In situ hybridization and immunostaining was performed by R. G. and J. H.; slice recording was performed by R. G. and J. H.; behavioral assays were performed by C. D., Y. L., and J. H.; in vivo microdialysis was performed by C. D., F. L., and F. X.; in vivo drug delivery was performed by C. D.; GC-C KO generation was performed by E. M. and M. B. C.; and experimental design and manuscript writing were performed by M. L. The authors declare no conflicts of interest. Cincinnati Children's Hospital requires a materials transfer agreement for use of the GC-C KO mice.	Bengtson CP, 2004, J PHYSIOL-LONDON, V555, P323, DOI 10.1113/jphysiol.2003.060061; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Emilien G, 1999, PHARMACOL THERAPEUT, V84, P133, DOI 10.1016/S0163-7258(99)00029-7; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; HAMRA FK, 1993, P NATL ACAD SCI USA, V90, P10464, DOI 10.1073/pnas.90.22.10464; Hess EJ, 1996, J NEUROSCI, V16, P3104, DOI 10.1523/jneurosci.16-09-03104.1996; Kinoshita H, 1997, KIDNEY INT, V52, P1028, DOI 10.1038/ki.1997.424; KRAUSE WJ, 1994, J ANAT, V184, P407; Kwan HY, 2004, P NATL ACAD SCI USA, V101, P2625, DOI 10.1073/pnas.0304471101; LACEY MG, 1990, J PHARMACOL EXP THER, V253, P395; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lucas KA, 2000, PHARMACOL REV, V52, P375; Mann EA, 1997, BIOCHEM BIOPH RES CO, V239, P463, DOI 10.1006/bbrc.1997.7487; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Reaume Christopher J., 2009, V191, P423, DOI 10.1007/978-3-540-68964-5_18; Sagvolden T, 2005, BIOL PSYCHIAT, V57, P1239, DOI 10.1016/j.biopsych.2005.02.002; Scheving LA, 1999, AM J PHYSIOL-CELL PH, V277, pC1177, DOI 10.1152/ajpcell.1999.277.6.C1177; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; Schulz S, 1997, J CLIN INVEST, V100, P1590, DOI 10.1172/JCI119683; Spencer T, 2001, ARCH GEN PSYCHIAT, V58, P775, DOI 10.1001/archpsyc.58.8.775; TIPPER SP, 1989, J EXP CHILD PSYCHOL, V48, P353, DOI 10.1016/0022-0965(89)90047-7; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	31	82	85	5	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1642	1646		10.1126/science.1207675	http://dx.doi.org/10.1126/science.1207675			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21835979				2022-12-28	WOS:000294900900047
J	Harris, DN				Harris, Douglas N.			Value-Added Measures and the Future of Educational Accountability	SCIENCE			English	Editorial Material									[Harris, Douglas N.] Univ Wisconsin, Dept Educ Policy Studies, Madison, WI 53706 USA; [Harris, Douglas N.] Univ Wisconsin, La Follette Sch Publ Affairs, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Harris, DN (corresponding author), Univ Wisconsin, Dept Educ Policy Studies, Madison, WI 53706 USA.	dnharris3@wisc.edu						Adams S.J, 2009, TEACHERS PERFORMANCE; BALLOU D, 1997, TEACHER PAY TEACHER, P129; CAMPBELL DT, 1976, 8 DARM COLL PUBL AFF, P54214; Fryer RG, 2004, REV ECON STAT, V86, P447, DOI 10.1162/003465304323031049; Fryer RG., 2011, 16850 NAT BUR EC RES; Glazerman S., 2010, EVALUATING TEACHERS; GORDON R, 2006, 1 BROOK I HAM PROJ, P54214; GUARINO CM, 2011, ANN M ASS ED FIN POL, P54214; Hanushek E., 2010, 16606 NAT BUR EC RES; Harris D., 2011, VALUE ADDED MEASURES; HARRIS DN, 2011, ANN M ASS ED FIN POL, P54214; Harris DN, 2011, J PUBLIC ECON, V95, P798, DOI 10.1016/j.jpubeco.2010.11.009; Harris DN, 2009, J POLICY ANAL MANAG, V28, P693, DOI 10.1002/pam.20464; Hill HC, 2009, J POLICY ANAL MANAG, V28, P700, DOI 10.1002/pam.20463; Jacob BA, 2008, J LABOR ECON, V26, P101, DOI 10.1086/522974; Kane T.J., 2008, 14607 NAT BUR EC RES; KENNEDY MM, 2010, HDB TEACHER ASSESSME, P225; Lee VE., 2002, INEQUALITY STARTING; McCaffrey DF, 2009, EDUC FINANC POLICY, V4, P572, DOI 10.1162/edfp.2009.4.4.572; Papay JP, 2011, AM EDUC RES J, V48, P163, DOI 10.3102/0002831210362589; Rothstein J, 2009, EDUC FINANC POLICY, V4, P537, DOI 10.1162/edfp.2009.4.4.537; Sass T., 2009, 30 CALDER URB I; Springer M.G., 2010, TEACHER PAY PERFORMA; WEISS M, 2008, ANN M SOC RES ED EFF, P54214	24	14	14	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					826	827		10.1126/science.1193793	http://dx.doi.org/10.1126/science.1193793			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	806DJ	21836001				2022-12-28	WOS:000293785400023
J	Leadbeater, E; Carruthers, JM; Green, JP; Rosser, NS; Field, J				Leadbeater, Ellouise; Carruthers, Jonathan M.; Green, Jonathan P.; Rosser, Neil S.; Field, Jeremy			Nest Inheritance Is the Missing Source of Direct Fitness in a Primitively Eusocial Insect	SCIENCE			English	Article							POLISTES-DOMINULUS; FUTURE FITNESS; KIN SELECTION; MODELS FAIL; SKEW	Animals that cooperate with nonrelatives represent a challenge to inclusive fitness theory, unless cooperative behavior is shown to provide direct fitness benefits. Inheritance of breeding resources could provide such benefits, but this route to cooperation has been little investigated in the social insects. We show that nest inheritance can explain the presence of unrelated helpers in a classic social insect model, the primitively eusocial wasp Polistes dominulus. We found that subordinate helpers produced more direct offspring than lone breeders, some while still subordinate but most after inheriting the dominant position. Thus, while indirect fitness obtained through helping relatives has been the dominant paradigm for understanding eusociality in insects, direct fitness is vital to explain cooperation in P. dominulus.	[Leadbeater, Ellouise; Carruthers, Jonathan M.; Green, Jonathan P.; Field, Jeremy] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Carruthers, Jonathan M.] Univ Sheffield, NERC, Biomol Anal Facil, Sheffield S10 2TN, S Yorkshire, England; [Rosser, Neil S.] UCL, Dept Genet Evolut & Environm, London NW1 2HE, England	University of Sussex; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Sheffield; University of London; University College London	Leadbeater, E (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW4 4RY, England.	ellouise.leadbeater@ioz.ac.uk		Rosser, Neil/0000-0001-7796-2548	NERC [NE/E017894/1]; Natural Environment Research Council [NBAF010001] Funding Source: researchfish; NERC [NBAF010001] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are grateful to J. M. Mancera Romero for facilities in Spain and to P. Nonacs and N. Raihani for comments on an earlier version of the manuscript. Primer design and genotyping was carried out at the NERC Biomolecular Analysis Facility, Sheffield, for which we thank T. Burke, D. Dawson, and A. Krupa. Funded by NERC grant NE/E017894/1 (J.F.). Data have been deposited in the Dryad Digital Repository, 10.5061/dryad.85g00.	[Anonymous], 1991, SOCIAL BIOL WASPS; Boomsma JJ, 2007, CURR BIOL, V17, pR673, DOI 10.1016/j.cub.2007.06.033; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Cant MA, 2006, P ROY SOC B-BIOL SCI, V273, P2977, DOI 10.1098/rspb.2006.3669; Cant MA, 2001, P ROY SOC B-BIOL SCI, V268, P1959, DOI 10.1098/rspb.2001.1754; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Field J, 2006, NATURE, V441, P214, DOI 10.1038/nature04560; Field J., 2009, REPROD SKEW VERTEBRA; Karsai I, 1996, BEHAV ECOL SOCIOBIOL, V39, P97, DOI 10.1007/s002650050271; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P571, DOI 10.1098/rspb.1999.0674; Leadbeater E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011997; Liebert AE, 2006, ANIM BEHAV, V71, P913, DOI 10.1016/j.anbehav.2005.09.005; Liebert AE, 2005, BEHAV ECOL SOCIOBIOL, V57, P445, DOI 10.1007/s00265-004-0875-5; Nonacs P, 2006, AM NAT, V167, P467, DOI 10.1086/501168; PETERS JM, 1995, P ROY SOC B-BIOL SCI, V260, P7, DOI 10.1098/rspb.1995.0052; Queller DC, 2000, NATURE, V405, P784, DOI 10.1038/35015552; Ragsdale JE, 1999, EVOL ECOL RES, V1, P859; Reeve Hudson K., 1993, P45; Shreeves G, 2003, P ROY SOC B-BIOL SCI, V270, P1617, DOI 10.1098/rspb.2003.2409; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Zanette LRS, 2008, MOL ECOL, V17, P2590, DOI 10.1111/j.1365-294X.2008.03785.x	21	127	128	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					874	876		10.1126/science.1205140	http://dx.doi.org/10.1126/science.1205140			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836014				2022-12-28	WOS:000293785400039
J	Ginsparg, P				Ginsparg, Paul			ArXiv at 20	NATURE			English	Editorial Material							READERSHIP; CITATION		Cornell Univ, Dept Phys, Ithaca, NY 14853 USA	Cornell University	Ginsparg, P (corresponding author), Cornell Univ, Dept Phys, Ithaca, NY 14853 USA.	ginsparg@cornell.edu			Direct For Computer & Info Scie & Enginr [0926550] Funding Source: National Science Foundation	Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))		Haque AU, 2010, J AM SOC INF SCI TEC, V61, P2381, DOI 10.1002/asi.21428; Haque AU, 2009, J AM SOC INF SCI TEC, V60, P2203, DOI 10.1002/asi.21166; MERMIN ND, 1991, PHYS TODAY, V44, P9, DOI 10.1063/1.2810102	3	61	63	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					145	147		10.1038/476145a	http://dx.doi.org/10.1038/476145a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	805MU	21833066				2022-12-28	WOS:000293731900013
J	Yamasaki, T; Terai, S; Sakaida, I				Yamasaki, Takahiro; Terai, Shuji; Sakaida, Isao			Deferoxamine for Advanced Hepatocellular Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							IRON CHELATOR		[Yamasaki, Takahiro; Terai, Shuji; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 755, Japan	Yamaguchi University	Yamasaki, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 755, Japan.	t.yama@yamaguchi-u.ac.jp			Grants-in-Aid for Scientific Research [23590978] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		DONFRANCESCO A, 1990, CANCER RES, V50, P4929; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Sakaida I, 1999, DIGEST DIS SCI, V44, P560, DOI 10.1023/A:1026661508553; SAKAIDA I, 1995, SCAND J GASTROENTERO, V30, P61, DOI 10.3109/00365529509093237; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603	5	101	106	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					576	578		10.1056/NEJMc1105726	http://dx.doi.org/10.1056/NEJMc1105726			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805MW	21830988				2022-12-28	WOS:000293732100030
J	Akre, KL; Farris, HE; Lea, AM; Page, RA; Ryan, MJ				Akre, Karin L.; Farris, Hamilton E.; Lea, Amanda M.; Page, Rachel A.; Ryan, Michael J.			Signal Perception in Frogs and Bats and the Evolution of Mating Signals	SCIENCE			English	Article							TUNGARA FROGS; SEXUAL SELECTION; MATE CHOICE; FEMALE PREFERENCES; CALL DURATION; ADVERTISEMENT; PSYCHOPHYSICS; COMPLEXITY; CUES	Psychophysics measures the relationship between a stimulus's physical magnitude and its perceived magnitude. Because decisions are based on perception of stimuli, this relationship is critical to understanding decision-making. We tested whether psychophysical laws explain how female tungara frogs (Physalaemus pustulosus) and frog-eating bats (Trachops cirrhosus) compare male frog calls, and how this imposes selection on call evolution. Although both frogs and bats prefer more elaborate calls, they are less selective as call elaboration increases, because preference is based on stimulus ratios. Thus, as call elaboration increases, both relative attractiveness and relative predation risk decrease because of how receivers perceive and compare stimuli. Our data show that female cognition can limit the evolution of sexual signal elaboration.	[Akre, Karin L.; Lea, Amanda M.; Ryan, Michael J.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Farris, Hamilton E.] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; [Farris, Hamilton E.] Louisiana State Univ, Hlth Sci Ctr, Kresge Hearing Labs, New Orleans, LA 70112 USA; [Page, Rachel A.; Ryan, Michael J.] Smithsonian Trop Res Inst, Balboa, Panama	University of Texas System; University of Texas Austin; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Smithsonian Institution; Smithsonian Tropical Research Institute	Akre, KL (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	kakre@mail.utexas.edu	Page, Rachel A/GQQ-2818-2022; Page, Rachel/AAE-4816-2021	Page, Rachel A/0000-0001-7072-0669; 	NSF [IBN0078150]; NIH [P20RR016816]; STRI, NSF [0608131]; American Association of University Women; P.E.O. Scholar award; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016816] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STRI, NSF(Smithsonian InstitutionSmithsonian Tropical Research InstituteNational Science Foundation (NSF)); American Association of University Women; P.E.O. Scholar award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank J. Saunders, S. Ozeroff, A. Shah, K. Miller, K. Loukes, S. Troxell, S. Griffin, M. Moscoso, V. Fugere, and W. Wohlwend for help conducting experiments. A. Mason and WABC 2011 participants gave helpful suggestions. STRI provided excellent logistical support. Supported by an NSF graduate research fellowship (K.L.A.), NIH grant P20RR016816 (H.E.F.), NSF grant IBN0078150 (M.J.R.), STRI, NSF grant 0608131, the American Association of University Women, and a P.E.O. Scholar award (R.A.P.).	Akre KL, 2010, ETHOLOGY, V116, P1138, DOI 10.1111/j.1439-0310.2010.01825.x; Andersson Malte, 1994; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; Bee MA, 2008, ANIM BEHAV, V76, P845, DOI 10.1016/j.anbehav.2008.01.029; Bernal XE, 2007, AM NAT, V169, P409, DOI 10.1086/510729; Bernal XE, 2009, BEHAV ECOL SOCIOBIOL, V63, P1269, DOI 10.1007/s00265-009-0795-5; Bonachea LA, 2011, ETHOLOGY, V117, P56, DOI 10.1111/j.1439-0310.2010.01843.x; COHEN JA, 1984, Z TIERPSYCHOL, V64, P1; Endler JA, 2005, EVOLUTION, V59, P1795, DOI 10.1111/j.0014-3820.2005.tb01827.x; Fechner G.T., 1912, CLASSICAL PSYCHOLOGI, P562; Gerhardt HC, 2000, BEHAV ECOL, V11, P663, DOI 10.1093/beheco/11.6.663; GREEN DM, 1989, J ACOUST SOC AM, V86, P629, DOI 10.1121/1.398759; Holland B, 1998, EVOLUTION, V52, P1, DOI 10.1111/j.1558-5646.1998.tb05132.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Page RA, 2005, P ROY SOC B-BIOL SCI, V272, P841, DOI 10.1098/rspb.2004.2998; Page RA, 2008, ANIM BEHAV, V76, P761, DOI 10.1016/j.anbehav.2008.05.006; Popper A. N., 1995, SPRINGER HDB AUDITOR; PRICE DK, 1994, AM NAT, V144, P908, DOI 10.1086/285718; Prum RO, 2010, EVOLUTION, V64, P3085, DOI 10.1111/j.1558-5646.2010.01054.x; Pryke SR, 2008, BEHAV ECOL, V19, P1116, DOI 10.1093/beheco/arn100; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Ryan M.J., 1990, Oxford Surveys in Evolutionary Biology, V7, P157; Ryan M. J., 1985, TUNGARA FROG STUDY S; Ryan MJ, 2010, CURR ZOOL, V56, P343, DOI 10.1093/czoolo/56.3.343; RYAN MJ, 1982, AM NAT, V119, P136, DOI 10.1086/283899; Shettleworth S. J., 2009, COGNITION EVOLUTION; Stevens S. S., 2017, PSYCHOPHYSICS INTRO; Wyttenbach RA, 2004, MICROSC RES TECHNIQ, V63, P375, DOI 10.1002/jemt.20054	29	104	106	2	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					751	752		10.1126/science.1205623	http://dx.doi.org/10.1126/science.1205623			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817052				2022-12-28	WOS:000293512100041
J	Alvania, R				Alvania, Rebecca			Slick Science: Will New BP Funds Keep Gulf Genomics Afloat?	CELL			English	Editorial Material									Trends Cell Biol, Cambridge, MA USA		Alvania, R (corresponding author), Trends Cell Biol, Cambridge, MA USA.	ralvania@cell.com		Alvania, Rebecca/0000-0002-3846-0702					0	0	0	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 5	2011	146	3					343	345		10.1016/j.cell.2011.07.017	http://dx.doi.org/10.1016/j.cell.2011.07.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816268	Bronze			2022-12-28	WOS:000293570500006
J	Franzoni, C; Scellato, G; Stephan, P				Franzoni, Chiara; Scellato, Giuseppe; Stephan, Paula			Changing Incentives to Publish	SCIENCE			English	Article									[Stephan, Paula] Georgia State Univ, Andrew Young Sch Policy Studies, Atlanta, GA 30302 USA; [Franzoni, Chiara] Politecn Milan, Dept Ind Engn & Management, I-20133 Milan, Italy; [Scellato, Giuseppe] Politecn Torino, Dept Prod Syst & Business Econ, I-10129 Turin, Italy; [Scellato, Giuseppe] Coll Carlo Alberto, Bur Res Innovat Complex & Knowledge, I-10024 Moncalieri, Italy; [Stephan, Paula] Univ Turin, Dept Econ Cognetti de Martiis, I-10124 Turin, Italy; [Stephan, Paula] Natl Bur Econ Res, Cambridge, MA 02138 USA	University System of Georgia; Georgia State University; Polytechnic University of Milan; Polytechnic University of Turin; Collegio Carlo Alberto; University of Turin; National Bureau of Economic Research	Stephan, P (corresponding author), Georgia State Univ, Andrew Young Sch Policy Studies, Atlanta, GA 30302 USA.	pstephan@gsu.edu	Franzoni, Chiara/AAH-3119-2019	Franzoni, Chiara/0000-0002-6092-0074; Scellato, Giuseppe/0000-0003-0927-9346				Ding YM, 2001, SCIENCE, V291, P1477; Fuyuno I, 2006, NATURE, V441, P792, DOI 10.1038/441792b; Hicks D. M., 2007, SCI U, P223; Kean S., 2006, CHRON HIGH ED, V52, pA23; Mervis J, 2007, SCIENCE, V317, P582, DOI 10.1126/science.317.5838.582; National Science Foundation (NSF), 2007, NSF07320; NSF, 2010, SCI ENG IND; RAE2008, RAE2008; Research Directorate-General European Commission (EC), 2007, REM RES PUBL PRIV SE; Stephan PE, 2001, INT J TECHNOL MANAGE, V22, P676, DOI 10.1504/IJTM.2001.002985	10	136	140	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					702	703		10.1126/science.1197286	http://dx.doi.org/10.1126/science.1197286			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	802LH	21817035				2022-12-28	WOS:000293512100024
J	de Groot, JAH; Bossuyt, PMM; Reitsma, JB; Rutjes, AWS; Dendukuri, N; Janssen, KJM; Moons, KGM				de Groot, Joris A. H.; Bossuyt, Patrick M. M.; Reitsma, Johannes B.; Rutjes, Anne W. S.; Dendukuri, Nandini; Janssen, Kristel J. M.; Moons, Karel G. M.			Verification problems in diagnostic accuracy studies: consequences and solutions	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIPLE IMPUTATION; BIAS; DISEASE		[de Groot, Joris A. H.; Janssen, Kristel J. M.] UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Moons, Karel G. M.] UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Clin Epidemiol, NL-3508 GA Utrecht, Netherlands; [Bossuyt, Patrick M. M.; Reitsma, Johannes B.] Acad Med Ctr Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Clin Epidemiol, NL-1100 DE Amsterdam, Netherlands; [Rutjes, Anne W. S.] Univ Bern, Inst Social & Prevent Med, Div Clin Epidemiol & Biostat, CH-3012 Bern, Switzerland; [Dendukuri, Nandini] Royal Victoria Hosp, Clin Epidemiol & Biostat, Montreal, PQ H3A 1A1, Canada	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Bern; McGill University; Royal Victoria Hospital	de Groot, JAH (corresponding author), UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, POB 85500, NL-3508 GA Utrecht, Netherlands.	j.degroot-17@umcutrecht.nl	Bossuyt, Patrick M./B-4557-2016; Rutjes, Anne/L-8750-2017; Bossuyt, Patrick M/AAR-1183-2021	Bossuyt, Patrick M./0000-0003-4427-0128; Rutjes, Anne/0000-0001-9782-779X; Bossuyt, Patrick M/0000-0003-4427-0128; de Groot, Joris/0000-0002-4846-5697; Reitsma, Johannes/0000-0003-4026-4345	Netherlands Organization for Scientific Research [9120.8004, 918.10.615]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We acknowledge the support of the Netherlands Organization for Scientific Research (projects 9120.8004 and 918.10.615).	[Anonymous], EVIDENCE BASE CLIN D; Appelboam A, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2428; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; Bleeker SE, 2001, ACTA PAEDIATR, V90, P1226, DOI 10.1080/080352501317130236; Buller HR, 2009, ANN INTERN MED, V150, P229, DOI 10.7326/0003-4819-150-4-200902170-00003; de Groot JAH, 2008, STAT MED, V27, P5880, DOI 10.1002/sim.3410; de Groot JAH, 2011, EPIDEMIOLOGY, V22, P234, DOI 10.1097/EDE.0b013e318207fc5c; de Groot JAH, 2011, ANN EPIDEMIOL, V21, P139, DOI 10.1016/j.annepidem.2010.10.004; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; DRUM DE, 1972, J NUCL MED, V13, P908; Elhendy A, 1998, DIABETES CARE, V21, P1797, DOI 10.2337/diacare.21.11.1797; Harel O, 2006, STAT MED, V25, P3769, DOI 10.1002/sim.2494; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Kline JA, 2001, JAMA-J AM MED ASSOC, V285, P761, DOI 10.1001/jama.285.6.761; Kosinski AS, 2003, STAT MED, V22, P2711, DOI 10.1002/sim.1517; Kosinski AS, 2003, BIOMETRICS, V59, P163, DOI 10.1111/1541-0420.00019; Lee J, 2001, CHEST, V120, P1791, DOI 10.1378/chest.120.6.1791; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Little R. J. A., 1987, STAT ANAL MISSING DA; Mackinnon A, 2010, J INTERN MED, V268, P586, DOI 10.1111/j.1365-2796.2010.02274.x; Oostenbrink R, 2003, J CLIN EPIDEMIOL, V56, P501, DOI 10.1016/S0895-4356(03)00080-5; PODE D, 1995, ISRAEL J MED SCI, V31, P125; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Rutjes A W S, 2007, Health Technol Assess, V11, pix; Rutjes AW, 2005, PARTIAL DIFFERENTIAL, P31; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010	29	51	51	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 2	2011	343								d4770	10.1136/bmj.d4770	http://dx.doi.org/10.1136/bmj.d4770			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KM	21810869	Green Submitted, Green Published			2022-12-28	WOS:000209545100001
J	Reuben, DB; Cassel, CK				Reuben, David B.; Cassel, Christine K.			Physician Stewardship of Health Care in an Era of Finite Resources	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Reuben, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, Los Angeles, CA 90095 USA; [Cassel, Christine K.] Amer Board Internal Med, Philadelphia, PA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; American Board of Internal Medicine	Reuben, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, 0945 LeConte Ave,Ste 2339, Los Angeles, CA 90095 USA.	dreuben@mednet.ucla.edu						American College of Physicians, 2011, CAN OUR NAT CONS DIS; Centers for Medicare and Medicaid Services, NAT HLTH EXP DAT FAC; Centers for Medicare & Medicaid Services, 2011, 2011 ANN REP BOARDS; DiPrete B, 2007, BRIEF HIST HLTH SERV; Gawande A, 2010, NEW YORKER      0802; Gawande A., 2009, NEW YORKER; Rawls J., 1971, THEORY JUSTICE; Reuben DB, 2010, JAMA-J AM MED ASSOC, V304, P467, DOI 10.1001/jama.2010.1048; Swensen SJ, 2011, BMJ QUAL SAF, V20, P534, DOI 10.1136/bmjqs.2010.049213; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96	10	24	24	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					430	431		10.1001/jama.2011.999	http://dx.doi.org/10.1001/jama.2011.999			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797KL	21791692				2022-12-28	WOS:000293125800030
J	Sessums, LL; Zembrzuska, H; Jackson, JL				Sessums, Laura L.; Zembrzuska, Hanna; Jackson, Jeffrey L.			Does This Patient Have Medical Decision-Making Capacity?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MACARTHUR TREATMENT COMPETENCE; PHYSICIANS LEGAL STANDARD; MENTALLY-ILL PATIENTS; ALZHEIMERS-DISEASE; INFORMED-CONSENT; COGNITIVE PREDICTORS; PERSONAL JUDGMENTS; OLDER PERSONS; HOSPITALIZATION; ABILITY	Context Evaluation of the capacity of a patient to make medical decisions should occur in the context of specific medical decisions when incapacity is considered. Objective To determine the prevalence of incapacity and assessment accuracy in adult medicine patients without severe mental illnesses. Data Sources MEDLINE and EMBASE (from their inception through April 2011) and bibliographies of retrieved articles. Study Selection We included high-quality prospective studies (n=43) of instruments that evaluated medical decision-making capacity for treatment decisions. Data Extraction Two authors independently appraised study quality, extracted relevant data, and resolved disagreements by consensus. Data Synthesis Incapacity was uncommon in healthy elderly control participants (2.8%; 95% confidence interval [CI], 1.7%-3.9%) compared with medicine inpatients (26%; 95% CI, 18%-35%). Clinicians accurately diagnosed incapacity (positive likelihood ratio [LR+] of 7.9; 95% CI, 2.7-13), although they recognized it in only 42% (95% CI, 30%-53%) of affected patients. Although not designed to assess incapacity, Mini-Mental State Examination (MMSE) scores less than 20 increased the likelihood of incapacity (LR, 6.3; 95% CI, 3.7-11), scores of 20 to 24 had no effect (LR, 0.87; 95% CI, 0.53-1.2), and scores greater than 24 significantly lowered the likelihood of incapacity (LR, 0.14; 95% CI, 0.06-0.34). Of 9 instruments compared with a gold standard, only 3 are easily performed and have useful test characteristics: the Aid to Capacity Evaluation (ACE) (LR+, 8.5; 95% CI, 3.9-19; negative LR [LR-], 0.21; 95% CI, 0.11-0.41), the Hopkins Competency Assessment Test (LR+, 54; 95% CI, 3.5-846; LR-, 0; 95% CI, 0.0-0.52), and the Understanding Treatment Disclosure (LR+, 6.0; 95% CI, 2.1-17; LR-, 0.16; 95% CI, 0.06-0.41). The ACE was validated in the largest study; it is freely available online and includes a training module. Conclusions Incapacity is common and often not recognized. The MMSE is useful only at extreme scores. The ACE is the best available instrument to assist physicians in making assessments of medical decision-making capacity. JAMA. 2011; 306(4): 420-427	[Sessums, Laura L.; Zembrzuska, Hanna] Walter Reed Army Med Ctr, Gen Internal Med Sect, Washington, DC 20307 USA; [Jackson, Jeffrey L.] Zablocki VA Med Ctr, Div Gen Internal Med, Milwaukee, WI USA; [Jackson, Jeffrey L.] Med Coll Wisconsin, Milwaukee, WI 53226 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Medical College of Wisconsin	Sessums, LL (corresponding author), Walter Reed Army Med Ctr, Gen Internal Med Sect, 6900 Georgia Ave NW, Washington, DC 20307 USA.	laura.sessums@us.army.mil	Jackson, Jeffrey/AAA-3519-2019	Jackson, Jeffrey/0000-0002-9820-5834; Zembrzuska, Hanna/0000-0002-8066-7379				Abram MB, 1982, MAKING HLTH CARE DEC; APPELBAUM PS, 1995, LAW HUMAN BEHAV, V19, P105, DOI 10.1007/BF01499321; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Arscott K, 1999, PSYCHOL MED, V29, P1367, DOI 10.1017/S0033291799008715; Baird AD, 2009, EXP AGING RES, V35, P297, DOI 10.1080/03610730902922085; Barton CD, 1996, PSYCHIATR SERV, V47, P956; Bassett SS, 1999, J GERIATR PSYCH NEUR, V12, P200, DOI 10.1177/089198879901200406; Betancourt J R, 2000, Bioethics Forum, V16, P27; Billick SB, 1997, J AM ACAD PSYCHIATRY, V25, P191; Billick SB, 2009, J FORENSIC SCI, V54, P943, DOI 10.1111/j.1556-4029.2009.01047.x; Community tools: Aid to Capacity Evaluation (ACE), COMM TOOLS AID CAP E; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Dunn LB, 2006, AM J PSYCHIAT, V163, P1323, DOI 10.1176/appi.ajp.163.8.1323; Dymek MP, 2001, NEUROLOGY, V56, P17, DOI 10.1212/WNL.56.1.17; Dymek MP, 1999, J FORENSIC NEUROPSYC, V1, P27, DOI DOI 10.1300/J151V01N01_; Earnst KS, 2000, J AM GERIATR SOC, V48, P919, DOI 10.1111/j.1532-5415.2000.tb06888.x; Etchells E, 1999, J GEN INTERN MED, V14, P27, DOI 10.1046/j.1525-1497.1999.00277.x; Etchells E, 1997, PSYCHOSOMATICS, V38, P239, DOI 10.1016/S0033-3182(97)71460-9; Fassassi S, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-15; Fazel S, 1999, BRIT MED J, V318, P493, DOI 10.1136/bmj.318.7182.493; FITTEN LJ, 1990, J AM GERIATR SOC, V38, P1097, DOI 10.1111/j.1532-5415.1990.tb01372.x; FITTEN LJ, 1990, ARCH INTERN MED, V150, P1717, DOI 10.1001/archinte.150.8.1717; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Griffith HR, 2005, NEUROLOGY, V65, P483, DOI 10.1212/01.wnl.0000171346.02965.80; Grisso T, 1997, PSYCHIATR SERV, V48, P1415; GRISSO T, 1995, LAW HUMAN BEHAV, V19, P149, DOI 10.1007/BF01499323; GRISSO T, 1991, LAW HUMAN BEHAV, V15, P377, DOI 10.1007/BF02074077; GRISSO T, 1995, AM J PSYCHIAT, V152, P1033; GRISSO T, 1995, LAW HUMAN BEHAV, V19, P127, DOI 10.1007/BF01499322; Grisso T, 1998, ASSESSING COMPETENCE; Grisso T, 1992, MANUAL UNDERSTANDING; Gurrera RJ, 2007, AM J GERIAT PSYCHIAT, V15, P168, DOI 10.1097/JGP.0b013e31802e705c; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Holzer JC, 1997, J AM ACAD PSYCHIATRY, V25, P531; JANOFSKY JS, 1992, HOSP COMMUNITY PSYCH, V43, P132; JOURDAN JB, 1991, PSYCHOSOMATICS, V32, P413, DOI 10.1016/S0033-3182(91)72043-4; Karlawish JHT, 2005, NEUROLOGY, V64, P1514, DOI 10.1212/01.WNL.0000160000.01742.9D; Kim SY, 2006, PSYCHOSOMATICS, V47, P325, DOI 10.1176/appi.psy.47.4.325; Kitamura F, 1998, INT J LAW PSYCHIAT, V21, P223, DOI 10.1016/S0160-2527(98)00016-8; Kitamura T, 1993, STRUCTURED INTERVIEW; Lai JM, 2008, AM J GERIAT PSYCHIAT, V16, P693, DOI 10.1097/JGP.0b013e31816c7b54; Marson DC, 2000, J AM GERIATR SOC, V48, P911, DOI 10.1111/j.1532-5415.2000.tb06887.x; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P955, DOI 10.1001/archneur.1995.00540340035011; Marson DC, 1996, NEUROLOGY, V46, P666, DOI 10.1212/WNL.46.3.666; Marson DC, 1997, J AM GERIATR SOC, V45, P453, DOI 10.1111/j.1532-5415.1997.tb05170.x; Martin RC, 2008, MOVEMENT DISORD, V23, P1867, DOI 10.1002/mds.22170; Molloy DW, 1996, J AM GERIATR SOC, V44, P660, DOI 10.1111/j.1532-5415.1996.tb01828.x; MORRIS CD, 1993, AM J MENT RETARD, V98, P263; Moye J, 2004, GERONTOLOGIST, V44, P166, DOI 10.1093/geront/44.2.166; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Palmer BW, 2005, ARCH GEN PSYCHIAT, V62, P726, DOI 10.1001/archpsyc.62.7.726; PRUCHNO RA, 1995, GERONTOLOGIST, V35, P622, DOI 10.1093/geront/35.5.622; Raymont V, 2004, LANCET, V364, P1421, DOI 10.1016/S0140-6736(04)17224-3; Royall DR, 1997, EXP AGING RES, V23, P301, DOI 10.1080/03610739708254033; RUTMAN D, 1992, CAN J PSYCHIAT, V37, P634, DOI 10.1177/070674379203700907; Schmand B, 1999, ALZ DIS ASSOC DIS, V13, P80, DOI 10.1097/00002093-199904000-00004; Sturman ED, 2005, CLIN PSYCHOL REV, V25, P954, DOI 10.1016/j.cpr.2005.04.010; Tan J, 2003, INT J LAW PSYCHIAT, V26, P697, DOI 10.1016/j.ijlp.2003.09.010; Tomoda A, 1997, J CLIN PSYCHOL, V53, P443, DOI 10.1002/(SICI)1097-4679(199708)53:5<443::AID-JCLP4>3.0.CO;2-O; Triebel KL, 2009, NEUROLOGY, V73, P2086, DOI 10.1212/WNL.0b013e3181c67bce; TYMCHUK AJ, 1988, GERONTOLOGIST, V28, P59, DOI 10.1093/geront/28.Suppl.59; Vellinga A, 2005, AGING MENT HEALTH, V9, P40, DOI 10.1080/13607860512331334059; Vellinga A, 2004, INT J GERIATR PSYCH, V19, P645, DOI 10.1002/gps.1139; Vollmann J, 2003, PSYCHOL MED, V33, P1463, DOI 10.1017/S0033291703008389; Wang P, 1987, CCT MANUAL; Welie J V, 2001, Med Health Care Philos, V4, P127, DOI 10.1023/A:1011441816143; Wong JG, 2000, PSYCHOL MED, V30, P295, DOI 10.1017/S0033291700001768; Wong JG, 1999, PSYCHOL MED, V29, P437, DOI 10.1017/S0033291798008113	71	177	180	1	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					420	427		10.1001/jama.2011.1023	http://dx.doi.org/10.1001/jama.2011.1023			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	797KL	21791691				2022-12-28	WOS:000293125800028
J	Sehgal, A; Mignot, E				Sehgal, Amita; Mignot, Emmanuel			Genetics of Sleep and Sleep Disorders	CELL			English	Review							RESTLESS-LEGS-SYNDROME; GENOME-WIDE ASSOCIATION; KAPPA-B RELISH; CIRCADIAN CLOCK; REGULATES SLEEP; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; LOCOMOTOR-ACTIVITY; MUSHROOM BODIES; NARCOLEPSY-CATAPLEXY	Sleep remains one of the least understood phenomena in biology-even its role in synaptic plasticity remains debatable. Since sleep was recognized to be regulated genetically, intense research has launched on two fronts: the development of model organisms for deciphering the molecular mechanisms of sleep and attempts to identify genetic underpinnings of human sleep disorders. In this Review, we describe how unbiased, high-throughput screens in model organisms are uncovering sleep regulatory mechanisms and how pathways, such as the circadian clock network and specific neurotransmitter signals, have conserved effects on sleep from Drosophila to humans. At the same time, genome-wide association studies (GWAS) have uncovered similar to 14 loci increasing susceptibility to sleep disorders, such as narcolepsy and restless leg syndrome. To conclude, we discuss how these different strategies will be critical to unambiguously defining the function of sleep.	[Sehgal, Amita] Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Philadelphia, PA 19104 USA; [Mignot, Emmanuel] Stanford Univ, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA	Howard Hughes Medical Institute; University of Pennsylvania; Stanford University	Sehgal, A (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu			Sehgal laboratory [P01 AG017628]; Mignot laboratory [NS23724]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023724, P01NS023724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017628] Funding Source: NIH RePORTER	Sehgal laboratory; Mignot laboratory; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank laboratory members for helpful discussions, Juliette Faraco for assistance in writing this Review, and Julie Williams for comments on the role of immune genes. Our work on sleep is supported by P01 AG017628 (Sehgal laboratory) and NS23724 (Mignot laboratory).	Adamantidis A, 2008, TRENDS ENDOCRIN MET, V19, P362, DOI 10.1016/j.tem.2008.08.007; Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Allada R, 2008, CURR BIOL, V18, pR670, DOI 10.1016/j.cub.2008.06.033; Ambrosius U, 2008, BIOL PSYCHIAT, V64, P344, DOI 10.1016/j.biopsych.2008.03.002; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Andretic R, 2008, P NATL ACAD SCI USA, V105, P20392, DOI 10.1073/pnas.0806776105; Andretic R, 2008, ANNU REV GENET, V42, P361, DOI 10.1146/annurev.genet.42.110807.091541; Arnulf I, 2008, ANN NEUROL, V63, P482, DOI 10.1002/ana.21333; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Bjorness TE, 2009, CURR NEUROPHARMACOL, V7, P238, DOI 10.2174/157015909789152182; Bjorness TE, 2009, J NEUROSCI, V29, P1267, DOI 10.1523/JNEUROSCI.2942-08.2009; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Chabas D, 2003, ANNU REV GENOM HUM G, V4, P459, DOI 10.1146/annurev.genom.4.070802.110432; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chen ZT, 1999, AM J PHYSIOL-REG I, V276, pR1812, DOI 10.1152/ajpregu.1999.276.6.R1812; Cheng LP, 2005, NAT NEUROSCI, V8, P1510, DOI 10.1038/nn1569; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Cirelli C, 2009, NAT REV NEUROSCI, V10, P549, DOI 10.1038/nrn2683; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Crocker A, 2010, GENE DEV, V24, P1220, DOI 10.1101/gad.1913110; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dauvilliers Y, 2010, SLEEP, V33, P1428, DOI 10.1093/sleep/33.11.1428; De Gennaro L, 2008, ANN NEUROL, V64, P455, DOI 10.1002/ana.21434; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Douglas CL, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-42; DRENNAN MD, 1991, J AFFECT DISORDERS, V23, P93, DOI 10.1016/0165-0327(91)90096-B; Faraco JH, 2006, J BIOL CHEM, V281, P29753, DOI 10.1074/jbc.M605811200; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Frank MG, 2006, REV NEUROSCIENCE, V17, P375; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Goel N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005874; Gottlieb DJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S9; Gottlieb DJ, 2004, NEUROLOGY, V63, P664, DOI 10.1212/01.WNL.0000134671.99649.32; Graves LA, 2003, J NEUROPHYSIOL, V90, P1152, DOI 10.1152/jn.00882.2002; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2003, J BIOL RHYTHM, V18, P12, DOI 10.1177/0748730402239673; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Hong SC, 2007, HUM IMMUNOL, V68, P59, DOI 10.1016/j.humimm.2006.10.006; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Hublin C, 2001, PSYCHIAT GENET, V11, P65, DOI 10.1097/00041444-200106000-00002; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Isaac RE, 2010, P ROY SOC B-BIOL SCI, V277, P65, DOI 10.1098/rspb.2009.1236; Ishimoto H, 2010, GENETICS, V185, P269, DOI 10.1534/genetics.110.114587; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Josephs KA, 2004, J CLIN NEUROPHYSIOL, V21, P440, DOI 10.1097/00004691-200411000-00008; Kalinchuk AV, 2010, J NEUROSCI, V30, P13254, DOI 10.1523/JNEUROSCI.0014-10.2010; Keene AC, 2010, CURR BIOL, V20, P1209, DOI 10.1016/j.cub.2010.05.029; Kerkhof GA, 2010, PROG BRAIN RES, V185, P1, DOI 10.1016/B978-0-444-53702-7.00001-4; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kuo TH, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-17; Langmesser S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004238; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lim ASP, 2010, SLEEP, V33, P857, DOI 10.1093/sleep/33.7.857; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Longstreth WT, 2009, SLEEP, V32, P1548, DOI 10.1093/sleep/32.12.1548; Maret S, 2005, SCIENCE, V310, P111, DOI 10.1126/science.1117623; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Marrus SB, 1996, EMBO J, V15, P6877, DOI 10.1002/j.1460-2075.1996.tb01080.x; Massicotte-Marquez J, 2008, NEUROLOGY, V70, P1250, DOI 10.1212/01.wnl.0000286943.79593.a6; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Mignot E, 1997, AM J HUM GENET, V60, P1289, DOI 10.1086/515487; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Mignot E, 2008, PLOS BIOL, V6, P661, DOI 10.1371/journal.pbio.0060106; Mignot E, 2007, CELL, V128, P22, DOI 10.1016/j.cell.2006.12.024; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Miyagawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005394; Muller-Preuss P, 2002, NEUROREPORT, V13, P487; Naidoo N, 2005, J NEUROCHEM, V92, P1150, DOI 10.1111/j.1471-4159.2004.02952.x; Naidoo N, 2007, SLEEP, V30, P557, DOI 10.1093/sleep/30.5.557; Naylor E, 2000, J NEUROSCI, V20, P8138; Nelson SE, 2004, NEUROSCI LETT, V367, P105, DOI 10.1016/j.neulet.2004.05.089; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Overeem S, 2008, SLEEP MED REV, V12, P95, DOI 10.1016/j.smrv.2007.07.010; Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Salas RE, 2010, CURR OPIN NEUROL, V23, P401, DOI 10.1097/WCO.0b013e32833bcdd8; Scharf MT, 2008, PROG NEUROBIOL, V86, P264, DOI 10.1016/j.pneurobio.2008.08.003; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Shimizu H, 2008, MOL CELL BIOL, V28, P6278, DOI 10.1128/MCB.02242-07; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Thimgan MS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000466; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Trenkwalder C, 2009, J NEUROL, V256, P539, DOI 10.1007/s00415-009-0134-9; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; van Swinderen B, 2004, CURR BIOL, V14, P81, DOI 10.1016/j.cub.2003.12.057; Vecsey CG, 2009, NATURE, V461, P1122, DOI 10.1038/nature08488; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; White DP, 2005, AM J RESP CRIT CARE, V172, P1363, DOI 10.1164/rccm.200412-1631SO; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0; Williams JA, 2007, SLEEP, V30, P389, DOI 10.1093/sleep/30.4.389; Winkelmann J, 2008, MOVEMENT DISORD, V23, P350, DOI 10.1002/mds.21647; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Winkelmann J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002171; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Wu MN, 2010, NAT NEUROSCI, V13, P69, DOI 10.1038/nn.2454; Wu MN, 2009, J NEUROSCI, V29, P11029, DOI 10.1523/JNEUROSCI.1653-09.2009; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658; Zimmerman JE, 2006, PHYSIOL GENOMICS, V27, P337, DOI 10.1152/physiolgenomics.00030.2006	128	236	243	4	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 22	2011	146	2					194	207		10.1016/j.cell.2011.07.004	http://dx.doi.org/10.1016/j.cell.2011.07.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784243	Green Accepted, Bronze			2022-12-28	WOS:000293013000004
J	Tonkin, ML; Roques, M; Lamarque, MH; Pugniere, M; Douguet, D; Crawford, J; Lebrun, M; Boulanger, MJ				Tonkin, Michelle L.; Roques, Magali; Lamarque, Mauld H.; Pugniere, Martine; Douguet, Dominique; Crawford, Joanna; Lebrun, Maryse; Boulanger, Martin J.			Host Cell Invasion by Apicomplexan Parasites: Insights from the Co-Structure of AMA1 with a RON2 Peptide	SCIENCE			English	Article							APICAL MEMBRANE ANTIGEN-1; TOXOPLASMA-GONDII; MOVING JUNCTION; INHIBITORY ANTIBODY; COMPLEX; ERYTHROCYTE	Apicomplexan parasites such as Toxoplasma gondii and Plasmodium species actively invade host cells through a moving junction (MJ) complex assembled at the parasite-host cell interface. MJ assembly is initiated by injection of parasite rhoptry neck proteins (RONs) into the host cell, where RON2 spans the membrane and functions as a receptor for apical membrane antigen 1 (AMA1) on the parasite. We have determined the structure of TgAMA1 complexed with a RON2 peptide at 1.95 angstrom resolution. A stepwise assembly mechanism results in an extensive buried surface area, enabling the MJ complex to resist the mechanical forces encountered during host cell invasion. Besides providing insights into host cell invasion by apicomplexan parasites, the structure offers a basis for designing therapeutics targeting these global pathogens.	[Roques, Magali; Lamarque, Mauld H.; Lebrun, Maryse] Univ Montpellier 2, CNRS, UMR 5235, F-34095 Montpellier, France; [Tonkin, Michelle L.; Crawford, Joanna; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Pugniere, Martine] INSERM, U896, Inst Rech Cancerol Montpellier, F-34298 Montpellier, France; [Douguet, Dominique] Univ Nice Sophia Antipolis, CNRS, UMR6097, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Victoria; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Lebrun, M (corresponding author), Univ Montpellier 2, CNRS, UMR 5235, F-34095 Montpellier, France.	mylebrun@univ-montp2.fr; mboulang@uvic.ca	douguet, dominique/D-5644-2017; Crawford, Joanna/F-9135-2013; PUGNIERE, Martine/AAD-4315-2020; Lebrun, Maryse/I-7728-2016; Pugniere, Martine/T-1355-2017	Crawford, Joanna/0000-0003-0786-6889; PUGNIERE, Martine/0000-0002-2049-2909; Pugniere, Martine/0000-0002-2049-2909; Lebrun, Maryse/0000-0002-0962-0156	Canadian Institutes of Health Research (CIHR) [MOP82915]; Julie Payette Natural Sciences and Engineering Research Council;  [ANR-MIE-2009]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Julie Payette Natural Sciences and Engineering Research Council; 	This work was supported by Canadian Institutes of Health Research (CIHR) grant MOP82915 to M.J.B. and ANR-MIE-2009 grant to M. L. M.J.B. is a CIHR New Investigator and a Michael Smith Foundation for Health Research scholar. M. L. T. is supported by a Julie Payette Natural Sciences and Engineering Research Council Research Scholarship. M. H. L. is supported by ANR-MIE-2009. We are grateful to G. Labesse and R. Cerdan for helpful discussions and to J.-F. Dubremetz and M. Murphy for critical reading of the manuscript. Structure factors and coordinates have been deposited in the Protein Data Bank (PDB) under accession nos.: 2y8t, r2y8tsf (TgAMA1-TgRON2sp), 2y8r, r2y8rsf (TgAMA1 Y230A) and 2y8s, r2y8ssf (TgAMA1 Y230A-TgRON2sp). The CNRS and the University of Victoria Innovation and Development Corporation have filed a European Patent Application (application number EP 11305540.4) on the identification of a region of RON2 involved in AMA1 binding and its potential targeting by vaccines and drugs.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Crawford J, 2010, J BIOL CHEM, V285, P15644, DOI 10.1074/jbc.M109.092619; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Mordue DG, 1999, J EXP MED, V190, P1783, DOI 10.1084/jem.190.12.1783; MORISAKI JH, 1995, J CELL SCI, V108, P2457; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282	26	143	155	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					463	467		10.1126/science.1204988	http://dx.doi.org/10.1126/science.1204988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778402				2022-12-28	WOS:000292959600049
J	Clay, J				Clay, Jason			Freeze the footprint of food	NATURE			English	Editorial Material									WWF, Market Transformat, Washington, DC 20037 USA	World Wildlife Fund	Clay, J (corresponding author), WWF, Market Transformat, Washington, DC 20037 USA.	jason.clay@wwfus.org							0	53	53	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2011	475	7356					287	289		10.1038/475287a	http://dx.doi.org/10.1038/475287a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	794PA	21776059	hybrid			2022-12-28	WOS:000292911200014
J	Rothberg, JM; Hinz, W; Rearick, TM; Schultz, J; Mileski, W; Davey, M; Leamon, JH; Johnson, K; Milgrew, MJ; Edwards, M; Hoon, J; Simons, JF; Marran, D; Myers, JW; Davidson, JF; Branting, A; Nobile, JR; Puc, BP; Light, D; Clark, TA; Huber, M; Branciforte, JT; Stoner, IB; Cawley, SE; Lyons, M; Fu, YT; Homer, N; Sedova, M; Miao, X; Reed, B; Sabina, J; Feierstein, E; Schorn, M; Alanjary, M; Dimalanta, E; Dressman, D; Kasinskas, R; Sokolsky, T; Fidanza, JA; Namsaraev, E; McKernan, KJ; Williams, A; Roth, GT; Bustillo, J				Rothberg, Jonathan M.; Hinz, Wolfgang; Rearick, Todd M.; Schultz, Jonathan; Mileski, William; Davey, Mel; Leamon, John H.; Johnson, Kim; Milgrew, Mark J.; Edwards, Matthew; Hoon, Jeremy; Simons, Jan F.; Marran, David; Myers, Jason W.; Davidson, John F.; Branting, Annika; Nobile, John R.; Puc, Bernard P.; Light, David; Clark, Travis A.; Huber, Martin; Branciforte, Jeffrey T.; Stoner, Isaac B.; Cawley, Simon E.; Lyons, Michael; Fu, Yutao; Homer, Nils; Sedova, Marina; Miao, Xin; Reed, Brian; Sabina, Jeffrey; Feierstein, Erika; Schorn, Michelle; Alanjary, Mohammad; Dimalanta, Eileen; Dressman, Devin; Kasinskas, Rachel; Sokolsky, Tanya; Fidanza, Jacqueline A.; Namsaraev, Eugeni; McKernan, Kevin J.; Williams, Alan; Roth, G. Thomas; Bustillo, James			An integrated semiconductor device enabling non-optical genome sequencing	NATURE			English	Article							SENSOR ARRAY CHIP; CMOS TECHNOLOGY; DNA; CHARGE; TRANSISTOR; SEA	The seminal importance of DNA sequencing to the life sciences, biotechnology and medicine has driven the search for more scalable and lower-cost solutions. Here we describe a DNA sequencing technology in which scalable, low-cost semiconductor manufacturing techniques are used to make an integrated circuit able to directly perform non-optical DNA sequencing of genomes. Sequence data are obtained by directly sensing the ions produced by template-directed DNA polymerase synthesis using all-natural nucleotides on this massively parallel semiconductor-sensing device or ion chip. The ion chip contains ion-sensitive, field-effect transistor-based sensors in perfect register with 1.2 million wells, which provide confinement and allow parallel, simultaneous detection of independent sequencing reactions. Use of the most widely used technology for constructing integrated circuits, the complementary metal-oxide semiconductor (CMOS) process, allows for low-cost, large-scale production and scaling of the device to higher densities and larger array sizes. We show the performance of the system by sequencing three bacterial genomes, its robustness and scalability by producing ion chips with up to 10 times as many sensors and sequencing a human genome.	[Rothberg, Jonathan M.; Hinz, Wolfgang; Rearick, Todd M.; Schultz, Jonathan; Mileski, William; Davey, Mel; Leamon, John H.; Johnson, Kim; Milgrew, Mark J.; Edwards, Matthew; Hoon, Jeremy; Simons, Jan F.; Marran, David; Myers, Jason W.; Davidson, John F.; Branting, Annika; Nobile, John R.; Puc, Bernard P.; Light, David; Clark, Travis A.; Huber, Martin; Branciforte, Jeffrey T.; Stoner, Isaac B.; Cawley, Simon E.; Lyons, Michael; Fu, Yutao; Homer, Nils; Sedova, Marina; Miao, Xin; Reed, Brian; Sabina, Jeffrey; Feierstein, Erika; Schorn, Michelle; Alanjary, Mohammad; Dimalanta, Eileen; Dressman, Devin; Kasinskas, Rachel; Sokolsky, Tanya; Fidanza, Jacqueline A.; Namsaraev, Eugeni; McKernan, Kevin J.; Williams, Alan; Roth, G. Thomas; Bustillo, James] Ion Torrent Life Technol, Guilford, CT 06437 USA	Thermo Fisher Scientific	Rothberg, JM (corresponding author), Ion Torrent Life Technol, Suite 100,246 Goose Lane, Guilford, CT 06437 USA.	Jonathan.Rothberg@Lifetech.com	Alanjary, Mohammad/D-3896-2016; schorn, michelle/AAD-6284-2020	Alanjary, Mohammad/0000-0001-8420-1325; McKernan, Kevin/0000-0002-3908-1122	National Human Genome Research Institute (NHGRI) [RFA-HG-08-008];  [R01 HG005094]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005094] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We want to thank G. Moore for his willingness to participate in this study. We thank G. Fergus, M. Jain, J. Kole, L. Stevens and the ION team for supporting our efforts, and H. Peckman, V. Tadigotla, D. Holloway and S. Mclaughlin for help on the variant analysis, and M. Ross of the Broad Institute for help on quality scores. This research was supported, in part, by a grant from the National Human Genome Research Institute (NHGRI), RFA-HG-08-008, Revolutionary Genome Sequencing Technologies-The $1000 Genome. Grant number: R01 HG005094.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Bausells J, 1999, SENSOR ACTUAT B-CHEM, V57, P56, DOI 10.1016/S0925-4005(99)00135-5; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bergveld P, 2003, SENSOR ACTUAT B-CHEM, V88, P1, DOI 10.1016/S0925-4005(02)00301-5; BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688; BRANDSTATTER AK, 2011, HUM MUTAT, V32, P25; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; DAVIES K, 2010, 1000 GENOME; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fritz J, 2002, P NATL ACAD SCI USA, V99, P14142, DOI 10.1073/pnas.232276699; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Hammond PA, 2004, MICROELECTRON ENG, V73-4, P893, DOI 10.1016/j.mee.2004.03.071; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hizawa T, 2006, SENSOR ACTUAT B-CHEM, V117, P509, DOI 10.1016/j.snb.2006.01.056; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mikolajick T, 1997, SENSOR ACTUAT B-CHEM, V44, P262, DOI 10.1016/S0925-4005(97)00166-4; Milgrew MJ, 2008, IEEE T ELECTRON DEV, V55, P1074, DOI 10.1109/TED.2008.916680; Milgrew MJ, 2005, SENSOR ACTUAT B-CHEM, V111, P347, DOI 10.1016/j.snb.2005.01.020; Milgrew MJ, 2004, SENSOR ACTUAT B-CHEM, V103, P37, DOI 10.1016/j.snb.2004.03.004; Moore GE, 1965, ELECTRONICS, V38, P114; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Pourmand N, 2006, P NATL ACAD SCI USA, V103, P6466, DOI 10.1073/pnas.0601184103; Purushothaman S, 2006, SENSOR ACTUAT B-CHEM, V114, P964, DOI 10.1016/j.snb.2005.06.069; SAKATA T, 2006, ANGEW CHEM, V118, P2283; SAKURAI T, 1992, ANAL CHEM, V64, P1996, DOI 10.1021/ac00041a040; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Themissen AJP, 2008, SOLID STATE ELECTRON, V52, P1401, DOI 10.1016/j.sse.2008.04.012; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wanlass F. M., 1967, US Pat., Patent No. [3,356,858, 3356858]; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yeow TCW, 1997, SENSOR ACTUAT B-CHEM, V44, P434, DOI 10.1016/S0925-4005(97)00207-4	46	1384	1633	15	472	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					348	352		10.1038/nature10242	http://dx.doi.org/10.1038/nature10242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21776081	hybrid			2022-12-28	WOS:000292911200036
J	Smith, BRK; Shaw, AG; Howlett, DC				Smith, Benjamin R. K.; Shaw, Aidan G.; Howlett, David C.			A case of head injury	BRITISH MEDICAL JOURNAL			English	Editorial Material							FRONTAL-SINUS FRACTURES; SKULL FRACTURES; MANAGEMENT; COMPLICATIONS		[Smith, Benjamin R. K.; Shaw, Aidan G.; Howlett, David C.] E Sussex Hosp Trust, Eastbourne Dist Gen Hosp, Eastbourne BN21 2UD, England		Smith, BRK (corresponding author), E Sussex Hosp Trust, Eastbourne Dist Gen Hosp, Eastbourne BN21 2UD, England.	brksmith@doctors.org.uk						Ali B, 2002, EMERG MED J, V19, P552, DOI 10.1136/emj.19.6.552; Bell RB, 2007, J ORAL MAXIL SURG, V65, P825, DOI 10.1016/j.joms.2006.05.058; ELJAMEL M S, 1990, British Journal of Neurosurgery, V4, P381, DOI 10.3109/02688699008992759; French J G, 1909, Proc R Soc Med, V2, P19; Gerbino G, 2000, J CRANIO MAXILL SURG, V28, P133, DOI 10.1054/jcms.2000.0134; Manolidis S, 2007, PLAST RECONSTR SURG, V120, p32S, DOI 10.1097/01.prs.0000260732.58496.1b; Mendelow A D, 1983, J R Coll Surg Edinb, V28, P80; MILLER JD, 1968, LANCET, V2, P991; Nahum A M, 1975, Clin Plast Surg, V2, P59; National Institute for Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I, V56; Price SJ, 2003, INJURY, V34, P834, DOI 10.1016/S0020-1383(03)00028-7; STANLEY RB, 1991, OTOLARYNG CLIN N AM, V24, P139; Stanwix MG, 2010, J ORAL MAXIL SURG, V68, P2714, DOI 10.1016/j.joms.2010.05.019	13	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2011	343								d4155	10.1136/bmj.d4155	http://dx.doi.org/10.1136/bmj.d4155			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797ZJ	21778200				2022-12-28	WOS:000293168900001
J	Greiner, AN; Hellings, PW; Rotiroti, G; Scadding, GK				Greiner, Alexander N.; Hellings, Peter W.; Rotiroti, Guiseppina; Scadding, Glenis K.			Allergic rhinitis	LANCET			English	Article							STROMAL LYMPHOPOIETIN EXPRESSION; LEUKOTRIENE RECEPTOR ANTAGONISTS; REGULATORY T-CELLS; SUBLINGUAL IMMUNOTHERAPY; INTRANASAL CORTICOSTEROIDS; BRONCHIAL HYPERREACTIVITY; EPITHELIAL-CELLS; POSITION PAPER; SEVERE ASTHMA; HAY-FEVER	Allergic rhinitis is a very common disorder that affects people of all ages, peaking in the teenage years. It is frequently ignored, underdiagnosed, misdiagnosed, and mistreated, which not only is detrimental to health but also has societal costs. Although allergic rhinitis is not a serious illness, it is clinically relevant because it underlies many complications, is a major risk factor for poor asthma control, and affects quality of life and productivity at work or school. Management of allergic rhinitis is best when directed by guidelines. A diagnostic trial of a pharmacotherapeutic agent could be started in people with clinically identified allergic rhinitis; however, to confirm the diagnosis, specific IgE reactivity needs to be recorded. Documented IgE reactivity has the added benefit of guiding implementation of environmental controls, which could substantially ameliorate symptoms of allergic rhinitis and might prevent development of asthma, especially in an occupational setting. Many classes of drug are available, effective, and safe. In meta-analyses, intranasal corticosteroids are superior to other treatments, have a good safety profile, and treat all symptoms of allergic rhinitis effectively. First-generation antihistamines are associated with sedation, psychomotor retardation, and reduced academic performance. Only immunotherapy with individually targeted allergens has the potential to alter the natural history of allergic rhinitis. Patients' education is a vital component of treatment. Even with the best pharmacotherapy, one in five affected individuals remains highly symptomatic, and further research is needed in this area.	[Rotiroti, Guiseppina; Scadding, Glenis K.] Royal Natl Throat Nose & Ear Hosp, London WC1X 8DA, England; [Greiner, Alexander N.] Ctr Asthma & Allergy, San Diego, CA USA; [Hellings, Peter W.] Univ Hosp Leuven, Dept Otorhinolaryngol, Louvain, Belgium	University College London Hospitals NHS Foundation Trust; University of London; University College London; KU Leuven; University Hospital Leuven	Scadding, GK (corresponding author), Royal Natl Throat Nose & Ear Hosp, Grays Inn Rd, London WC1X 8DA, England.	g.scadding@ucl.ac.uk	Hellings, Peter/I-4068-2018	Hellings, Peter/0000-0001-6898-688X	GlaxoSmithKline; ALK; UCB; Schering Plough; Alcon; Alexa; Allux; Amgen; Antigen Labs; Apotex; Astellas; AstraZeneca; Boehringer Ingelheim; Clay-Park Labs; Critical Therapeutics; Genentech; Hoffmann-LaRoche; MAP; MEDA; Medicinova; MedPointe; Merck; Novartis; Nycomed (Altana); Pharmaxis; Rigel; Sanofi-Aventis; Schering-Plough; Teva; Wyeth; MSD; Fund for Scientific Research (FWO) Flanders; Institute for Science and Technology (IWETE) Flanders	GlaxoSmithKline(GlaxoSmithKline); ALK; UCB(UCB Pharma SA); Schering Plough(Merck & CompanySchering Plough Corporation); Alcon(Novartis); Alexa; Allux; Amgen(Amgen); Antigen Labs; Apotex; Astellas(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Clay-Park Labs; Critical Therapeutics; Genentech(Roche HoldingGenentech); Hoffmann-LaRoche(Hoffmann-La Roche); MAP; MEDA; Medicinova; MedPointe; Merck(Merck & Company); Novartis(Novartis); Nycomed (Altana); Pharmaxis; Rigel; Sanofi-Aventis(Sanofi-Aventis); Schering-Plough(Merck & CompanySchering Plough Corporation); Teva(Teva Pharmaceutical Industries); Wyeth(Wyeth); MSD; Fund for Scientific Research (FWO) Flanders(FWO); Institute for Science and Technology (IWETE) Flanders	GKS is a consultant or advisory board member for ALK, Abello, Britannia Pharmaceuticals, CMP Therapeutics, Groupo Uriach, GlaxoSmithKline, Merck, Sanofi-Aventis, Schering Plough, and UCB; received a grant from GlaxoSmithKline for a clinical trial; has received research funds from ALK, GlaxoSmithKline, UCB, and Schering Plough; has been a speaker for ALK, GlaxoSmithKline, Merck, Schering Plough, Uriach, and UCB; has co-written articles for Schering Plough and GlaxoSmithKline; receives royalties for the books Fast Facts in Rhinitis, Investigative Rhinology, and Paediatric ENT; received payment for development of a GlaxoSmithKline educational presentations video and a Schering Plough teaching slide set; and is a member of the ARIA and EPOS working groups. ANG has received grants from Alcon, Alexa, Allux, Amgen, Antigen Labs, Apotex, Astellas, AstraZeneca, Boehringer Ingelheim, Clay-Park Labs, Critical Therapeutics, Genentech, GlaxoSmithKline, Hoffmann-LaRoche, MAP, MEDA, Medicinova, MedPointe, Merck, Novartis, Nycomed (Altana), Pharmaxis, Rigel, Sanofi-Aventis, Schering-Plough, Teva, UCB, and Wyeth; and has been a speaker for MEDA, Sanofi-Aventis, and UCB. GR has had expenses reimbursed by ALK-Abello, Allergen Therapeutics, and UCB; and has received a fee for a lecture by Schering Plough. PWH has received grants from GlaxoSmithKline, MSD, and Schering Plough; and support from the Fund for Scientific Research (FWO) Flanders, and the Institute for Science and Technology (IWETE) Flanders.	Adams RJ, 2002, J ALLERGY CLIN IMMUN, V109, P636, DOI 10.1067/mai.2002.123237; [Anonymous], 2007, J PEDIAT-BRAZIL, V83, P555, DOI [10.1590/S0021-75572007000800013, 10.2223/JPED.1727]; Arrighi H. M., 1996, Journal of Allergy and Clinical Immunology, V97, P430, DOI 10.1016/S0091-6749(96)81208-5; Baroody FM, 2008, ANN ALLERG ASTHMA IM, V100, P194, DOI 10.1016/S1081-1206(10)60442-5; Bendtsen P, 2008, CLIN EXP ALLERGY, V38, P1179, DOI 10.1111/j.1365-2222.2008.02945.x; Bjorksten B, 2008, PEDIAT ALLERG IMM-UK, V19, P110, DOI 10.1111/j.1399-3038.2007.00601.x; Bostock J, 1828, Med Chir Trans, V14, P437; BOULET LP, 1989, ANN ALLERGY, V63, P114; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2006, ALLERGY, V61, P1086, DOI 10.1111/j.1398-9995.2006.01144.x; Bousquet J, 2006, J ALLERGY CLIN IMMUN, V117, P158, DOI 10.1016/j.jaci.2005.09.047; Bousquet J, 2003, ALLERGY, V58, P733, DOI 10.1034/j.1398-9995.2003.00076.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Bousquet J, 2009, J ALLERGY CLIN IMMUN, V124, P428, DOI 10.1016/j.jaci.2009.06.027; Bousquet J, 2009, INT ARCH ALLERGY IMM, V150, P75, DOI 10.1159/000210383; Bousquet PJ, 2007, ALLERGY, V62, P301, DOI 10.1111/j.1398-9995.2006.01293.x; Braunstahl GJ, 2000, AM J RESP CRIT CARE, V161, P2051, DOI 10.1164/ajrccm.161.6.9906121; Braunstahl GJ, 2001, J ALLERGY CLIN IMMUN, V107, P469, DOI 10.1067/mai.2001.113046; Bresciani M, 2001, J ALLERGY CLIN IMMUN, V107, P73, DOI 10.1067/mai.2001.111593; Calderon MA, 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001936.PUB2; Calderon MA, 2008, DRUG TODAY, V44, P31; Callebaut I, 2010, ALLERGY, V65, P1173, DOI 10.1111/j.1398-9995.2010.02360.x; Canonica GW, 2007, ALLERGY, V62, P17, DOI 10.1111/j.1398-9995.2007.01549.x; Canonica GW, 2009, ALLERGY, V64, P1, DOI 10.1111/j.1398-9995.2009.02309.x; Church MK, 2010, ALLERGY, V65, P459, DOI 10.1111/j.1398-9995.2009.02325.x; Ciprandi G, 1995, J ALLERGY CLIN IMMUN, V96, P971, DOI 10.1016/S0091-6749(95)70235-0; Cirillo I, 2007, ALLERGY, V62, P1087, DOI 10.1111/j.1398-9995.2007.01401.x; Corren J, 2004, J ALLERGY CLIN IMMUN, V113, P415, DOI 10.1016/j.jaci.2003.11.034; Crystal-Peters J, 2002, J ALLERGY CLIN IMMUN, V109, P57, DOI 10.1067/mai.2002.120554; Durham SR, 1998, CLIN EXP ALLERGY, V28, P20; Durham SR, 2010, J ALLERGY CLIN IMMUN, V125, P131, DOI 10.1016/j.jaci.2009.10.035; Eggleston PA, 2001, ANN ALLERG ASTHMA IM, V87, P44, DOI 10.1016/S1081-1206(10)62340-X; FLEMING DM, 1987, BRIT MED J, V294, P279, DOI 10.1136/bmj.294.6567.279; Fokkens W, 2007, RHINOLOGY, P1; Garavello W, 2010, INT ARCH ALLERGY IMM, V151, P137, DOI 10.1159/000236003; Hamilton RG, 2004, J ALLERGY CLIN IMMUN, V114, P213, DOI 10.1016/j.jaci.2004.06.046; Harvey R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006394; Hellgren J, 2010, ALLERGY, V65, P776, DOI 10.1111/j.1398-9995.2009.02269.x; Hellings PW, 2006, ALLERGY, V61, P656, DOI 10.1111/j.1398-9995.2006.01109.x; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; James LK, 2008, CLIN EXP ALLERGY, V38, P1074, DOI 10.1111/j.1365-2222.2008.02976.x; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Keil T, 2010, PEDIAT ALLERG IMM-UK, V21, P962, DOI 10.1111/j.1399-3038.2010.01046.x; Kocevar VS, 2005, ALLERGY, V60, P338, DOI 10.1111/j.1398-9995.2005.00712.x; Krouse JH, 2009, OTOLARYNG HEAD NECK, V140, P622, DOI 10.1016/j.otohns.2009.01.024; Kundig TM, 2010, HUM VACCINES, V6, P673, DOI 10.4161/hv.6.8.12007; Kuo CH, 2009, PEDIATR NEONATOL, V50, P44, DOI 10.1016/S1875-9572(09)60031-0; Larenas-Linnemann D, 2009, CURR OPIN ALLERGY CL, V9, P168, DOI 10.1097/ACI.0b013e328329a2a9; Lasisi AO, 2008, J NATL MED ASSOC, V100, P903, DOI 10.1016/S0027-9684(15)31403-6; Leynaert B, 2000, AM J RESP CRIT CARE, V162, P1391; Leynaert N, 2004, J ALLERGY CLIN IMMUN, V113, P86, DOI 10.1016/j.jaci.2003.10.010; Li HB, 2009, ORL-J OTO-RHIN-LARYN, V71, P50, DOI 10.1159/000178165; LOWHAGEN O, 1985, J ALLERGY CLIN IMMUN, V75, P460, DOI 10.1016/S0091-6749(85)80018-X; Magnan A, 2008, ALLERGY, V63, P292, DOI 10.1111/j.1398-9995.2007.01584.x; Maurer M, 2007, ALLERGY, V62, P1057, DOI 10.1111/j.1398-9995.2007.01367.x; Meltzer EO, 2001, J ALLERGY CLIN IMMUN, V108, pS45, DOI 10.1067/mai.2001.115566; Miyata M, 2008, EUR J IMMUNOL, V38, P1487, DOI 10.1002/eji.200737809; Moscato G, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-16; Moscato G, 2009, CURR OPIN ALLERGY CL, V9, P110, DOI 10.1097/ACI.0b013e328328cfe7; Murray Clare S, 2004, Proc Am Thorac Soc, V1, P99, DOI 10.1513/pats.2306027; Naclerio RM, 2008, ALLERGY ASTHMA PROC, V29, P24, DOI 10.2500/aap2008.29.3075; Nakamura Y, 2008, J ALLERGY CLIN IMMUN, V122, P1208, DOI 10.1016/j.jaci.2008.09.022; Nasser SMS, 2001, BRIT MED J, V322, P1589, DOI 10.1136/bmj.322.7302.1589; Nguyen LHP, 2004, J ALLERGY CLIN IMMUN, V114, P1110, DOI 10.1016/j.jaci.2004.07.061; Nouri-Aria Kayhan T., 2008, Inflammation & Allergy Drug Targets, V7, P237, DOI 10.2174/187152808786848405; O'Meara TJ, 2005, ALLERGY, V60, P529, DOI 10.1111/j.1398-9995.2005.00741.x; Ponte EV, 2008, ALLERGY, V63, P564, DOI 10.1111/j.1398-9995.2007.01624.x; Portnoy JM, 2004, CURR ALLERGY ASTHM R, V4, P439, DOI 10.1007/s11882-004-0009-1; Powe DG, 2010, J ALLERGY CLIN IMMUN, V125, P139, DOI 10.1016/j.jaci.2009.07.025; Powe DG, 2003, CLIN EXP ALLERGY, V33, P1374, DOI 10.1046/j.1365-2222.2003.01737.x; Raap U, 2010, CURR OPIN ALLERGY CL, V10, P8, DOI 10.1097/ACI.0b013e328334f5de; Scadding GK, 2008, CLIN EXP ALLERGY, V38, P19, DOI 10.1111/j.1365-2222.2007.02888.x; Scadding GW, 2010, CLIN EXP ALLERGY, V40, P598, DOI 10.1111/j.1365-2222.2010.03462.x; Scadding G, 2010, EXPERT REV PHARM OUT, V10, P87, DOI 10.1586/ERP.09.69; Scadding GK, 2001, CURR OPIN ALLERGY CL, V1, P15, DOI 10.1097/00130832-200102000-00004; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4; Smurthwaite Lyn, 2002, Curr Allergy Asthma Rep, V2, P231, DOI 10.1007/s11882-002-0024-z; Srouji IA, 2007, J LARYNGOL OTOL, V121, P653, DOI 10.1017/S0022215106005032; Srouji I, 2008, AM J RHINOL, V22, P406, DOI 10.2500/ajr.2008.22.3204; Stelmach R, 2005, CHEST, V128, P3140, DOI 10.1378/chest.128.5.3140; ten Brinke A, 2002, J ALLERGY CLIN IMMUN, V109, P621, DOI 10.1067/mai.2002.122458; Tewfik Ted L, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P187, DOI 10.1097/01.moo.0000193190.24849.f0; Tilles SA, 1997, CLIN REV ALLERG IMMU, V15, P169, DOI 10.1007/BF02826585; Van Cauwenberge P, 2007, RHINOLOGY, V45, P112; van den Oord R, 2009, BRIT MED J, V339, P86; von Mutius E, 2010, CLIN EXP IMMUNOL, V160, P130, DOI 10.1111/j.1365-2249.2010.04138.x; Von Mutius E, 2003, MIDDLETONS ALLERGY P, P1169; Walker S, 2007, J ALLERGY CLIN IMMUN, V120, P381, DOI 10.1016/j.jaci.2007.03.034; Webber CM, 2010, ANN ALLERG ASTHMA IM, V104, P101, DOI 10.1016/j.anai.2009.11.007; Weiner JM, 1998, BMJ-BRIT MED J, V317, P1624, DOI 10.1136/bmj.317.7173.1624; Wilson AM, 2004, AM J MED, V116, P338, DOI 10.1016/j.amjmed.2003.10.030; Wilson AM, 2001, CLIN EXP ALLERGY, V31, P61, DOI 10.1046/j.1365-2222.2001.00964.x; Yanez A, 2002, ANN ALLERG ASTHMA IM, V89, P479, DOI 10.1016/S1081-1206(10)62085-6; Zeitlin JF, 2000, AM J RHINOL, V14, P157, DOI 10.2500/105065800782102753; Zhu DD, 2009, CHINESE MED J-PEKING, V122, P2303, DOI 10.3760/cma.j.issn.0366-6999.2009.19.021	95	492	532	5	143	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2011	378	9809					2112	2122		10.1016/S0140-6736(11)60130-X	http://dx.doi.org/10.1016/S0140-6736(11)60130-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865EL	21783242				2022-12-28	WOS:000298293600033
J	Sethuraman, G; Chouhan, K; Kaushal, S; Sharma, VK				Sethuraman, Gomathy; Chouhan, Kavish; Kaushal, Seema; Sharma, Vinod K.			Fabry's disease	LANCET			English	Editorial Material									[Sethuraman, Gomathy; Chouhan, Kavish; Sharma, Vinod K.] All India Inst Med Sci, Dept Dermatol, New Delhi 110029, India; [Kaushal, Seema] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Sethuraman, G (corresponding author), All India Inst Med Sci, Dept Dermatol, New Delhi 110029, India.	kgsethu@yahoo.com	Gomathy, Sethuraman/AAR-7307-2021						0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 1	2011	378	9798					1254	1254		10.1016/S0140-6736(11)60473-X	http://dx.doi.org/10.1016/S0140-6736(11)60473-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IO	21802720				2022-12-28	WOS:000295723600027
J	Paolicelli, RC; Bolasco, G; Pagani, F; Maggi, L; Scianni, M; Panzanelli, P; Giustetto, M; Ferreira, TA; Guiducci, E; Dumas, L; Ragozzino, D; Gross, CT				Paolicelli, Rosa C.; Bolasco, Giulia; Pagani, Francesca; Maggi, Laura; Scianni, Maria; Panzanelli, Patrizia; Giustetto, Maurizio; Ferreira, Tiago Alves; Guiducci, Eva; Dumas, Laura; Ragozzino, Davide; Gross, Cornelius T.			Synaptic Pruning by Microglia Is Necessary for Normal Brain Development	SCIENCE			English	Article							IN-VIVO; FRACTALKINE RECEPTOR; TARGETED DELETION; RAT HIPPOCAMPUS; CELLS; REVEALS; ELIMINATION; PARENCHYMA; DEATH; FATE	Microglia are highly motile phagocytic cells that infiltrate and take up residence in the developing brain, where they are thought to provide a surveillance and scavenging function. However, although microglia have been shown to engulf and clear damaged cellular debris after brain insult, it remains less clear what role microglia play in the uninjured brain. Here, we show that microglia actively engulf synaptic material and play a major role in synaptic pruning during postnatal development in mice. These findings link microglia surveillance to synaptic maturation and suggest that deficits in microglia function may contribute to synaptic abnormalities seen in some neurodevelopmental disorders.	[Paolicelli, Rosa C.; Bolasco, Giulia; Ferreira, Tiago Alves; Guiducci, Eva; Dumas, Laura; Gross, Cornelius T.] European Mol Biol Lab, Mouse Biol Unit, I-00015 Monterotondo, Italy; [Pagani, Francesca; Maggi, Laura; Scianni, Maria; Ragozzino, Davide] Univ Rome, Inst Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Pagani, Francesca; Maggi, Laura; Scianni, Maria; Ragozzino, Davide] Univ Rome, Dept Human Physiol & Pharmacol, Ctr Excellence BEMM, I-00185 Rome, Italy; [Panzanelli, Patrizia; Giustetto, Maurizio] Univ Turin, Dept Anat Pharmacol & Forens Med, I-10124 Turin, Italy; [Giustetto, Maurizio] Natl Inst Neurosci, I-10126 Turin, Italy	European Molecular Biology Laboratory (EMBL); Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; University of Turin	Gross, CT (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Via Ramarini 32, I-00015 Monterotondo, Italy.	gross@embl.it	maggi, laura/H-2535-2012; Panzanelli, Patrizia/AAE-7773-2022; giustetto, maurizio/D-6606-2011; ragozzino, davide/K-6521-2016; Ferreira, Tiago/AFM-8050-2022	maggi, laura/0000-0002-0566-0433; giustetto, maurizio/0000-0003-1323-4060; ragozzino, davide/0000-0002-3290-7665; Panzanelli, Patrizia/0000-0002-5127-2757; Paolicelli, Rosa Chiara/0000-0001-6851-0849; Ferreira, Tiago/0000-0001-6866-1540	EMBL; Foundation Cenci Bolognetti	EMBL; Foundation Cenci Bolognetti	We thank R. Mellwig, U. Haselmann, and C. Antony at the EMBL Electron Microscopy Core Facility; F. Zonfrillo for expert mouse husbandry; the EMBL Transgenic Facility for help in rederiving mouse lines; J. Griesbach and M. Al Banchaabouchi for help in videoscoring; W. Fouquet at Leica Microsystems, Mannheim, Germany, for access to the STED microscope and microscopy expertise; and A. Pinto, F. Peri, P. Heppenstall, and M. Jechlinger for critical discussions. This work was supported by funds from EMBL to C.T.G and R.C.P. and Foundation Cenci Bolognetti to F.P., L.M., M.S., and D.R. R.C.P. carried out and analyzed all fluorescent imaging experiments except a portion of the microglia morphological analyses that were carried out by T.A.F., L.D., and E.G. Electron microscopy was carried out and analyzed by G.B., P.P., and M.G. Electrophysiological experiments were designed, carried out, and analyzed by M.S., F.P., L.M., and D.R. C.T.G conceived the projects and wrote the manuscript with input from R.C.P. and D.R.	Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; Dalmau I, 1998, HIPPOCAMPUS, V8, P458, DOI 10.1002/(SICI)1098-1063(1998)8:5<458::AID-HIPO6>3.0.CO;2-N; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Imaizumi Tadaatsu, 2004, J Atheroscler Thromb, V11, P15; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Klioueva IA, 2001, PHYSIOL BEHAV, V72, P421, DOI 10.1016/S0031-9384(00)00425-X; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Monier A, 2006, J COMP NEUROL, V499, P565, DOI 10.1002/cne.21123; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ruitenberg MJ, 2008, J NEUROIMMUNOL, V205, P80, DOI 10.1016/j.jneuroim.2008.09.010; Schafer DP, 2010, BIOCHEM SOC T, V38, P476, DOI 10.1042/BST0380476; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008	29	2213	2259	12	301	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2011	333	6048					1456	1458		10.1126/science.1202529	http://dx.doi.org/10.1126/science.1202529			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817KU	21778362				2022-12-28	WOS:000294672200045
J	Burns, EM; Bottle, A; Aylin, P; Darzi, A; Nicholls, RJ; Faiz, O				Burns, Elaine M.; Bottle, Alex; Aylin, Paul; Darzi, Ara; Nicholls, R. John; Faiz, Omar			Variation in reoperation after colorectal surgery in England as an indicator of surgical performance: retrospective analysis of Hospital Episode Statistics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH-SERVICE TRUSTS; POSTOPERATIVE MORTALITY; ADMINISTRATIVE DATA; OPEN COLECTOMY; QUALITY INDICATOR; GREAT-BRITAIN; CANCER; OUTCOMES; MORBIDITY; DEPRIVATION	Objective To describe national reoperation rates after elective and emergency colorectal resection and to assess the feasibility of using reoperation as a quality indicator derived from routinely collected data in England. Design Retrospective observational study of Hospital Episode Statistics (HES) data. Setting HES dataset, an administrative dataset covering the entire English National Health Service. Participants All patients undergoing a primary colorectal resection in England between 2000 and 2008. Main outcome measures Reoperation after colorectal resection, defined as any reoperation for an intra-abdominal procedure or wound complication within 28 days of surgery on the index or subsequent admission to hospital. Results The national reoperation rate was 6.5% (15 986/246 469). A large degree of variation was identified among institutions and surgeons. Even among institutions and surgical teams with high caseloads, threefold and fivefold differences in reoperation rates were observed between the highest and lowest performing trusts and surgeons. Of the NHS trusts studied, 14.1% (22/156) had adjusted reoperation rates above the upper 99.8% control limit. Factors independently associated with higher risk of reoperation were diagnosis of inflammatory bowel disease (odds ratio 1.33 (95% CI 1.24 to 1.42), P<0.001), presence of multiple comorbidity (odds ratio 1.34 (1.29 to 1.39), P<0.001), social deprivation (1.14 (1.08 to 1.20) for most deprived, P<0.001), male sex (1.33 (1.29 to 1.38), P<0.001), rectal resection (1.63 (1.56 to 1.71), P<0.001), laparoscopic surgery (1.11 (1.03 to 1.20), P=0.006), and emergency admission (1.21 (1.17 to 1.26), P<0.001). Conclusions There is large variation in reoperation after colorectal surgery between hospitals and surgeons in England. If data accuracy can be assured, reoperation may allow performance to be checked against national standards from current routinely collected data, alongside other indicators such as mortality.	[Burns, Elaine M.; Darzi, Ara; Nicholls, R. John; Faiz, Omar] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Surg, London W2 1NY, England; [Bottle, Alex; Aylin, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, Dr Foster Unit, London EC1A 9LA, England	Imperial College London; Imperial College London	Faiz, O (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Surg, London W2 1NY, England.	o.faiz@imperial.ac.uk	Aylin, Paul/A-1073-2014; Burns, Elaine/V-5416-2019	Aylin, Paul/0000-0003-4589-1743; Bottle, Alex/0000-0001-9978-2011	National Institute of Health Research (NIHR)	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR))	The Dr Foster Unit at Imperial is largely funded by a research grant from Dr Foster Intelligence (an independent health service research organisation). The unit is affiliated with the Centre for Patient Safety and Service Quality at Imperial College Healthcare NHS Trust, which is funded by the National Institute of Health Research (NIHR). We are grateful for support from the NIHR Biomedical Research Centre funding scheme. This research is independent of any bodies funding the authors of this research.	Almoudaris A, 2010, COLORECTAL DIS; Alves A, 2005, ARCH SURG-CHICAGO, V140, P278, DOI 10.1001/archsurg.140.3.278; Alves A, 2005, ARCH SURG-CHICAGO, V140, P284; Aylin P, 2007, EUR J VASC ENDOVASC, V33, P461, DOI 10.1016/j.ejvs.2006.10.033; Aylin P, 2007, BRIT MED J, V335, P839, DOI 10.1136/bmj.39374.474965.BE; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Bentrem DJ, 2009, ARCH SURG-CHICAGO, V144, P1013, DOI 10.1001/archsurg.2009.114; Bilimoria KY, 2008, J GASTROINTEST SURG, V12, P2001, DOI 10.1007/s11605-008-0568-x; Billingsley KG, 2008, J AM COLL SURGEONS, V206, P1167, DOI 10.1016/j.jamcollsurg.2007.12.042; Birkmeyer JD, 2001, ARCH SURG-CHICAGO, V136, P405, DOI 10.1001/archsurg.136.4.405; Boccola MA, 2011, WORLD J SURG, V35, P186, DOI 10.1007/s00268-010-0831-7; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Delaney CP, 2008, ANN SURG, V247, P819, DOI 10.1097/SLA.0b013e31816d950e; Faiz O, 2011, COLORECTAL DIS, V13, P779, DOI 10.1111/j.1463-1318.2010.02290.x; Faiz O, 2009, DIS COLON RECTUM, V52, P1695, DOI 10.1007/DCR.0b013e3181b55254; Faiz O, 2010, DIS COLON RECTUM, V53, P393, DOI 10.1007/DCR.0b013e3181cc6fd2; Garout M, 2008, INT J COLORECTAL DIS, V23, P155, DOI 10.1007/s00384-007-0390-z; [HES ONS], 2002, LINK METH; Kemp JA, 2008, SURG INNOV, V15, P277, DOI 10.1177/1553350608327171; MCARDLE CS, 1991, BRIT MED J, V302, P1501, DOI 10.1136/bmj.302.6791.1501; Merkow RP, 2009, J AM COLL SURGEONS, V209, P557, DOI 10.1016/j.jamcollsurg.2009.07.003; Mirnezami A, 2011, ANN SURG, V253, P890, DOI 10.1097/SLA.0b013e3182128929; Morris AM, 2007, ANN SURG, V245, P73, DOI 10.1097/01.sla.0000231797.37743.9f; Morris E, 2008, GUT, V57, P1690, DOI 10.1136/gut.2007.137877; Morris EJA, 2011, GUT, V60, P806, DOI 10.1136/gut.2010.232181; Ouellette JR, 2004, J GASTROINTEST SURG, V8, P1061, DOI 10.1016/j.gassur.2004.09.045; Tilney H, 2009, DIS COLON RECTUM, V52, P1046, DOI 10.1007/DCR.0b013e3181a65f41; Wrigley H, 2003, J EPIDEMIOL COMMUN H, V57, P301, DOI 10.1136/jech.57.4.301	30	90	91	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2011	343								d4836	10.1136/bmj.d4836	http://dx.doi.org/10.1136/bmj.d4836			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811KU	21846714	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000294209500002
J	Corti, D; Voss, J; Gamblin, SJ; Codoni, G; Macagno, A; Jarrossay, D; Vachieri, SG; Pinna, D; Minola, A; Vanzetta, F; Silacci, C; Fernandez-Rodriguez, BM; Agatic, G; Bianchi, S; Giacchetto-Sasselli, I; Calder, L; Sallusto, F; Collins, P; Haire, LF; Temperton, N; Langedijk, JPM; Skehel, JJ; Lanzavecchia, A				Corti, Davide; Voss, Jarrod; Gamblin, Steven J.; Codoni, Giosiana; Macagno, Annalisa; Jarrossay, David; Vachieri, Sebastien G.; Pinna, Debora; Minola, Andrea; Vanzetta, Fabrizia; Silacci, Chiara; Fernandez-Rodriguez, Blanca M.; Agatic, Gloria; Bianchi, Siro; Giacchetto-Sasselli, Isabella; Calder, Lesley; Sallusto, Federica; Collins, Patrick; Haire, Lesley F.; Temperton, Nigel; Langedijk, Johannes P. M.; Skehel, John J.; Lanzavecchia, Antonio			A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins	SCIENCE			English	Article							MEMBRANE-FUSION; RECEPTOR-BINDING; MONOCLONAL-ANTIBODIES; VIRUS HEMAGGLUTININ; B-CELLS; COMPLEX; SEQUENCES; SUBTYPES; EPITOPE; SITE	The isolation of broadly neutralizing antibodies against influenza A viruses has been a long-sought goal for therapeutic approaches and vaccine design. Using a single-cell culture method for screening large numbers of human plasma cells, we isolated a neutralizing monoclonal antibody that recognized the hemagglutinin (HA) glycoprotein of all 16 subtypes and neutralized both group 1 and group 2 influenza A viruses. Passive transfer of this antibody conferred protection to mice and ferrets. Complexes with HAs from the group 1 H1 and the group 2 H3 subtypes analyzed by x-ray crystallography showed that the antibody bound to a conserved epitope in the F subdomain. This antibody may be used for passive protection and to inform vaccine design because of its broad specificity and neutralization potency.	[Voss, Jarrod; Gamblin, Steven J.; Vachieri, Sebastien G.; Calder, Lesley; Collins, Patrick; Haire, Lesley F.; Skehel, John J.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Corti, Davide; Vanzetta, Fabrizia; Agatic, Gloria; Bianchi, Siro] Humabs BioMed SA, CH-6500 Bellinzona, Switzerland; [Corti, Davide; Codoni, Giosiana; Macagno, Annalisa; Jarrossay, David; Pinna, Debora; Minola, Andrea; Silacci, Chiara; Fernandez-Rodriguez, Blanca M.; Giacchetto-Sasselli, Isabella; Sallusto, Federica; Lanzavecchia, Antonio] Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Temperton, Nigel] Univ Kent, Sch Pharm, Viral Pseudotype Unit, Chatham ME4 4TB, Kent, England; [Langedijk, Johannes P. M.] Pepscan Therapeut BV, NL-8243 RC Lelystad, Netherlands; [Lanzavecchia, Antonio] ETH, Inst Microbiol, CH-8032 Zurich, Switzerland	MRC National Institute for Medical Research; Universita della Svizzera Italiana; University of Kent; Pepscan Therapeutics B.V.; Swiss Federal Institutes of Technology Domain; ETH Zurich	Skehel, JJ (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	skeheljj@nimr.mrc.ac.uk; lanzavecchia@irb.unisi.ch	Temperton, Nigel James/M-1164-2019; Temperton, Nigel James/K-5158-2013	Temperton, Nigel James/0000-0002-7978-3815; Temperton, Nigel James/0000-0002-7978-3815; Bianchi, Siro/0000-0002-5100-8905; Zatta, Fabrizia/0000-0003-4945-8058	European Research Council [250348 IMMUNExplore]; Swiss National Science Foundation [31003A-126027]; Human Frontier Science Program [RGP9/2007]; U.K. Medical Research Council; Wellcome Trust; Helmut Horten Foundation; MRC [G0600369, MC_U117584222] Funding Source: UKRI; Medical Research Council [G0600369, MC_U117584222] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontier Science Program(Human Frontier Science Program); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Helmut Horten Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Research Council (grant 250348 IMMUNExplore), the Swiss National Science Foundation (31003A-126027), the Human Frontier Science Program (RGP9/2007), the U.K. Medical Research Council, and the Wellcome Trust. A. L. is supported by the Helmut Horten Foundation. We gratefully acknowledge Diamond for access to synchrotron time. We thank M. Nussenzweig and H. Wardemann for providing reagents for antibody cloning and expression, A. Ritchie at BioFocus for supervising the FI6-H1 structural work, K. Harrod at Lovelace Research Respiratory Institute for supervising the ferret study, E. Soethout at the National Institute for Public Health and the Environment (Netherlands) for providing the H3N2 HK-x31 virus, and W. J. Rutter and L. Varani for critical reading and comments. A. L. is the scientific founder and acting chief scientific officer of Humabs BioMed SA. A. L. and F. S. hold shares in Humabs BioMed SA. The Institute for Research in Biomedicine has two pending patent applications: PCT/IB/2009/007375 (Methods for producing antibodies from plasma cells, A. L. and D. J.) and PCT/US2009/051851 (Neutralizing anti-influenza virus antibodies and uses thereof, A. L.). J. P. M. L. has a patent application on the use of helical peptides for epitope mapping, EP 11160745.3 (Helical peptide libraries for lead identification and interaction site mapping). Antibody sequences for all described FI6 variants are available in fig. S1. Nucleotide sequences for the antibodies described have been deposited in GenBank (accession numbers JN234430, JN234431, JN234432, JN234433, JN234434, JN234435, JN234436, JN234437, JN234438, JN234439, JN234440, JN234441, JN234442, JN234443, JN234444, JN234445, JN234446, JN234447, JN234448). The FI6 and FI6v3 antibodies can be obtained for research purposes under a material transfer agreement.	Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; CUSACK S, 1985, J MOL BIOL, V186, P565, DOI 10.1016/0022-2836(85)90131-7; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Garten W, 1999, TRENDS MICROBIOL, V7, P99, DOI 10.1016/S0966-842X(99)01460-2; GODLEY L, 1992, CELL, V68, P635, DOI 10.1016/0092-8674(92)90140-8; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Langedijk JPM, 2011, ANAL BIOCHEM, V417, P149, DOI 10.1016/j.ab.2011.06.002; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Rossman JS, 2011, VIROLOGY, V411, P229, DOI 10.1016/j.virol.2010.12.003; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; WATOWICH SJ, 1994, STRUCTURE, V2, P719, DOI 10.1016/S0969-2126(00)00073-3; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350	33	871	982	2	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					850	856		10.1126/science.1205669	http://dx.doi.org/10.1126/science.1205669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21798894				2022-12-28	WOS:000293785400033
J	Trivedi, NS; Delbanco, T				Trivedi, Neha S.; Delbanco, Tom			Update: An 86-Year-Old Woman With Cardiac Cachexia Contemplating the End of Her Life Review of Hospice Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Trivedi, Neha/0000-0003-1006-1408				Kutner JS, 2010, JAMA-J AM MED ASSOC, V303, P349, DOI 10.1001/jama.2009.2015	1	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2011	306	6					645	645		10.1001/jama.2011.1134	http://dx.doi.org/10.1001/jama.2011.1134			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804XD	21828327				2022-12-28	WOS:000293687300026
J	Panizza, S; Mendoza, MA; Berlinger, M; Huang, LZ; Nicolas, A; Shirahige, K; Klein, F				Panizza, Silvia; Mendoza, Marco A.; Berlinger, Marc; Huang, Lingzhi; Nicolas, Alain; Shirahige, Katsuhiko; Klein, Franz			Spo11-Accessory Proteins Link Double-Strand Break Sites to the Chromosome Axis in Early Meiotic Recombination	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL INTERACTIONS; SYNAPTONEMAL COMPLEXES; CHIASMA FORMATION; DNA-REPLICATION; YEAST; INITIATION; MEIOSIS; SPO11	Meiotic recombination between homologous chromosomes initiates via programmed DNA double-strand breaks (DSBs), generated by complexes comprising Spo11 transesterase plus accessory proteins. DSBs arise concomitantly with the development of axial chromosome structures, where the coalescence of axis sites produces linear arrays of chromatin loops. Recombining DNA sequences map to loops, but are ultimately tethered to the underlying axis. How and when such tethering occurs is currently unclear. Using ChIPchip in yeast, we show that Spo11-accessory proteins Rec114, Mer2, and Mei4 stably interact with chromosome axis sequences, upon phosphorylation of Mer2 by S phase Cdk. This axis tethering requires meiotic axis components (Red1/Hop1) and is modulated in a domain-specific fashion by cohesin. Loss of Rec114, Mer2, and Mei4 binding correlates with loss of DSBs. Our results strongly suggest that hot-spot sequences become tethered to axis sites by the DSB machinery prior to DSB formation.	[Panizza, Silvia; Mendoza, Marco A.; Berlinger, Marc; Huang, Lingzhi; Klein, Franz] Univ Vienna, Dept Chromosome Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Nicolas, Alain] Univ Paris 06, CNRS, UMR3244, Inst Curie,Ctr Rech, F-75248 Paris 05, France; [Shirahige, Katsuhiko] Univ Tokyo, Inst Mol & Cellular Biosci, Res Ctr Epigenet Dis, Lab Genome Struct & Funct,Bunkyo Ku, Tokyo 1130032, Japan	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; University of Tokyo	Klein, F (corresponding author), Univ Vienna, Dept Chromosome Biol, Max F Perutz Labs, Dr Bohr Gasse 1, A-1030 Vienna, Austria.	franz.klein@univie.ac.at		Shirahige, Katsuhiko/0000-0002-7862-1144; Mendoza-Parra, Marco Antonio/0000-0002-1809-1727; Panizza, Silvia/0000-0002-2435-5485; Klein, Franz/0000-0001-7204-1432	Austrian Science Foundation [F34, P18847]; MEXT; JST	Austrian Science Foundation(Austrian Science Fund (FWF)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST))	We would like to thank Y. Katou and S. Mori-Uehara for initial help with ChIPchip, B. Huttel for advice, and M. and A. Matzke for sharing the Affymetrix facility. Thanks to I. Tamir and D. Chen for important advice with bioinformatics. We thank N. Uematsu for the Rec114-myc13 construct, N. Hollingsworth, S. Keeney, K. Nasmyth, and T. F. Wang for plasmids, strains, and antibodies, B. Byers for early foundational input and N. Kleckner for valuable, critical comments on the manuscript. We are grateful to B. Wohlrab and C. Zierhut for making Zip1 and Hop1 antibody and to M. Madalinsky for Rec114 peptide synthesis. We are indebted to G. Ammerer and the Verein zur Forderung der Genomforschung for generously supplying most of the microarrays used in this study. This work was funded by SFB grant F34 and P18847 of the Austrian Science Foundation to F. K. and by aGrant-in-Aid for Scientific Research (S) from the MEXT and Strategic International Cooperative Program from JST to K. S.	Anderson LK, 1997, P NATL ACAD SCI USA, V94, P6868, DOI 10.1073/pnas.94.13.6868; Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Bardhan A, 2010, MOL BIOL CELL, V21, P1799, DOI 10.1091/mbc.E09-05-0392; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; CARPENTER ATC, 1987, BIOESSAYS, V6, P232, DOI 10.1002/bies.950060510; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Dekker J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r116; Dirick L, 1998, SCIENCE, V281, P1854, DOI 10.1126/science.281.5384.1854; Fan QQ, 1997, GENETICS, V145, P661; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; GILLIES CB, 1979, GENETICS, V91, P1; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; Hunter N., 2007, HOMOLOGOUS RECOMBINA, P1; Jessop L, 2005, GENETICS, V169, P1353, DOI 10.1534/genetics.104.036509; Jones GH, 2006, CELL, V126, P246, DOI 10.1016/j.cell.2006.07.010; Joshi N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000557; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Katis VL, 2010, DEV CELL, V18, P397, DOI 10.1016/j.devcel.2010.01.014; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; Kee K, 2002, GENETICS, V160, P111; Kee K, 2004, EMBO J, V23, P1815, DOI 10.1038/sj.emboj.7600184; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Kumar R, 2010, GENE DEV, V24, P1266, DOI 10.1101/gad.571710; Li J, 2006, GENETICS, V173, P1969, DOI 10.1534/genetics.106.058768; Lichten Michael, 2008, V3, P165, DOI 10.1007/7050_2008_040; Lorenz A, 2006, CHROMOSOMA, V115, P330, DOI 10.1007/s00412-006-0053-9; Maleki S, 2007, CHROMOSOMA, V116, P471, DOI 10.1007/s00412-007-0111-y; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mendoza MA, 2009, METHODS MOL BIOL, V557, P267, DOI 10.1007/978-1-59745-527-5_17; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Mieczkowski PA, 2007, P NATL ACAD SCI USA, V104, P3955, DOI 10.1073/pnas.0700412104; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Penkner AM, 2005, CELL, V120, P789, DOI 10.1016/j.cell.2005.01.017; Prieler S, 2005, GENE DEV, V19, P255, DOI 10.1101/gad.321105; Robine N, 2007, MOL CELL BIOL, V27, P1868, DOI 10.1128/MCB.02063-06; Sasanuma H, 2007, NUCLEIC ACIDS RES, V35, P1119, DOI 10.1093/nar/gkl1162; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; STACK SM, 1986, AM J BOT, V73, P264, DOI 10.2307/2444181; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Wan LH, 2004, MOL BIOL CELL, V15, P11, DOI 10.1091/mbc.E03-07-0499; WU TC, 1995, GENETICS, V140, P55; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x; Yamashita K, 2004, P NATL ACAD SCI USA, V101, P11380, DOI 10.1073/pnas.0400078101; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	68	222	225	3	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 5	2011	146	3					372	383		10.1016/j.cell.2011.07.003	http://dx.doi.org/10.1016/j.cell.2011.07.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816273	Bronze			2022-12-28	WOS:000293570500012
J	Berardi, MJ; Shih, WM; Harrison, SC; Chou, JJ				Berardi, Marcelo J.; Shih, William M.; Harrison, Stephen C.; Chou, James J.			Mitochondrial uncoupling protein 2 structure determined by NMR molecular fragment searching	NATURE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; DIPOLAR COUPLINGS; INDUCED ALIGNMENT; ADP/ATP CARRIER; SECRETION; UCP2; ADP	Mitochondrial uncoupling protein 2 (UCP2) is an integral membrane protein in the mitochondrial anion carrier protein family, the members of which facilitate the transport of small molecules across the mitochondrial inner membrane(1,2). When the mitochondrial respiratory complex pumps protons from the mitochondrial matrix to the intermembrane space, it builds up an electrochemical potential(2). A fraction of this electrochemical potential is dissipated as heat, in a process involving leakage of protons back to the matrix(2). This leakage, or 'uncoupling' of the proton electrochemical potential, is mediated primarily by uncoupling proteins(2). However, the mechanism of UCP-mediated proton translocation across the lipid bilayer is unknown. Here we describe a solution-NMR method for structural characterization of UCP2. The method, which overcomes some of the challenges associated with membrane-protein structure determination(3), combines orientation restraints derived from NMR residual dipolar couplings (RDCs) and semiquantitative distance restraints from paramagnetic relaxation enhancement (PRE) measurements. The local and secondary structures of the protein were determined by piecing together molecular fragments from the Protein Data Bank that best fit experimental RDCs from samples weakly aligned in a DNA nanotube liquid crystal. The RDCs also determine the relative orientation of the secondary structural segments, and the PRE restraints provide their spatial arrangement in the tertiary fold. UCP2 closely resembles the bovine ADP/ATP carrier (the only carrier protein of known structure(4)), but the relative orientations of the helical segments are different, resulting in a wider opening on the matrix side of the inner membrane. Moreover, the nitroxide-labelled GDP binds inside the channel and seems to be closer to transmembrane helices 1-4. We believe that this biophysical approach can be applied to other membrane proteins and, in particular, to other mitochondrial carriers, not only for structure determination but also to characterize various conformational states of these proteins linked to substrate transport.	[Berardi, Marcelo J.; Harrison, Stephen C.; Chou, James J.] Harvard Univ, Jack & Eileen Connors Struct Biol Lab, Sch Med, Boston, MA 02115 USA; [Berardi, Marcelo J.; Shih, William M.; Harrison, Stephen C.; Chou, James J.] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Shih, William M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Shih, William M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02138 USA; [Harrison, Stephen C.] Harvard Univ, Howard Hughes Med Inst, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Chou, JJ (corresponding author), Harvard Univ, Jack & Eileen Connors Struct Biol Lab, Sch Med, Boston, MA 02115 USA.	chou@cmcd.hms.harvard.edu	Chou, James/AAD-6230-2022; Chou, James J/N-9840-2013	Chou, James/0000-0002-4442-0344; Chou, James J/0000-0002-4442-0344	NIH [1U54GM094608, 1DP2OD004641]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094608] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Oxenoid and R. Sounier for discussions, M. McClintock for help with DNA nanotube preparation, I. Stokes-Rees and P. Sliz for help with computations, and N. Voigt for help with figures. The work was supported by NIH grants 1U54GM094608 (to J.J.C.) and 1DP2OD004641 (to W. M. S.). S. C. H. is an Investigator at the Howard Hughes Medical Institute.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; AQUILA H, 1985, EMBO J, V4, P2369, DOI 10.1002/j.1460-2075.1985.tb03941.x; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Chou JJ, 2000, J BIOMOL NMR, V18, P101, DOI 10.1023/A:1008358318863; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; Dehez F, 2008, J AM CHEM SOC, V130, P12725, DOI 10.1021/ja8033087; Delaglio F, 2000, J AM CHEM SOC, V122, P2142, DOI 10.1021/ja993603n; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Gautier A, 2010, NAT STRUCT MOL BIOL, V17, P768, DOI 10.1038/nsmb.1807; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Jaroniec CP, 2004, J BIOMOL NMR, V30, P181, DOI 10.1023/B:JNMR.0000048946.71249.2f; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Kunji ERS, 2010, CURR OPIN STRUC BIOL, V20, P440, DOI 10.1016/j.sbi.2010.06.004; Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Salzmann M, 1999, J BIOMOL NMR, V15, P181, DOI 10.1023/A:1008358030477; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Tate CG, 2010, CURR OPIN STRUC BIOL, V20, P399, DOI 10.1016/j.sbi.2010.07.002; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Wang Y, 2008, P NATL ACAD SCI USA, V105, P9598, DOI 10.1073/pnas.0801786105; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	37	310	317	2	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					109	113		10.1038/nature10257	http://dx.doi.org/10.1038/nature10257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21785437	Green Accepted			2022-12-28	WOS:000293447300040
J	Mukhtar, MS; Carvunis, AR; Dreze, M; Epple, P; Steinbrenner, J; Moore, J; Tasan, M; Galli, M; Hao, T; Nishimura, MT; Pevzner, SJ; Donovan, SE; Ghamsari, L; Santhanam, B; Romero, V; Poulin, MM; Gebreab, F; Gutierrez, BJ; Tam, S; Monachello, D; Boxem, M; Harbort, CJ; McDonald, N; Gai, LT; Chen, HM; He, YJ; Vandenhaute, J; Roth, FP; Hill, DE; Ecker, JR; Vidal, M; Beynon, J; Braun, P; Dangl, JL				Mukhtar, M. Shahid; Carvunis, Anne-Ruxandra; Dreze, Matija; Epple, Petra; Steinbrenner, Jens; Moore, Jonathan; Tasan, Murat; Galli, Mary; Hao, Tong; Nishimura, Marc T.; Pevzner, Samuel J.; Donovan, Susan E.; Ghamsari, Lila; Santhanam, Balaji; Romero, Viviana; Poulin, Matthew M.; Gebreab, Fana; Gutierrez, Bryan J.; Tam, Stanley; Monachello, Dario; Boxem, Mike; Harbort, Christopher J.; McDonald, Nathan; Gai, Lantian; Chen, Huaming; He, Yijian; Vandenhaute, Jean; Roth, Frederick P.; Hill, David E.; Ecker, Joseph R.; Vidal, Marc; Beynon, Jim; Braun, Pascal; Dangl, Jeffery L.		European Union Effectoromics Conso	Independently Evolved Virulence Effectors Converge onto Hubs in a Plant Immune System Network	SCIENCE			English	Article							DISEASE RESISTANCE; ARMS-RACE; ARABIDOPSIS; VIRUS	Plants generate effective responses to infection by recognizing both conserved and variable pathogen-encoded molecules. Pathogens deploy virulence effector proteins into host cells, where they interact physically with host proteins to modulate defense. We generated an interaction network of plant-pathogen effectors from two pathogens spanning the eukaryote-eubacteria divergence, three classes of Arabidopsis immune system proteins, and similar to 8000 other Arabidopsis proteins. We noted convergence of effectors onto highly interconnected host proteins and indirect, rather than direct, connections between effectors and plant immune receptors. We demonstrated plant immune system functions for 15 of 17 tested host proteins that interact with effectors from both pathogens. Thus, pathogens from different kingdoms deploy independently evolved virulence proteins that interact with a limited set of highly connected cellular hubs to facilitate their diverse life-cycle strategies.	[Carvunis, Anne-Ruxandra; Dreze, Matija; Hao, Tong; Pevzner, Samuel J.; Ghamsari, Lila; Santhanam, Balaji; Romero, Viviana; Poulin, Matthew M.; Gebreab, Fana; Gutierrez, Bryan J.; Tam, Stanley; Monachello, Dario; Roth, Frederick P.; Hill, David E.; Vidal, Marc; Braun, Pascal] Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA; [Carvunis, Anne-Ruxandra; Dreze, Matija; Hao, Tong; Pevzner, Samuel J.; Ghamsari, Lila; Santhanam, Balaji; Romero, Viviana; Poulin, Matthew M.; Gebreab, Fana; Gutierrez, Bryan J.; Tam, Stanley; Monachello, Dario; Roth, Frederick P.; Hill, David E.; Vidal, Marc; Braun, Pascal] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Mukhtar, M. Shahid; Epple, Petra; Nishimura, Marc T.; Harbort, Christopher J.; McDonald, Nathan; He, Yijian; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Carvunis, Anne-Ruxandra; Dreze, Matija; Hao, Tong; Pevzner, Samuel J.; Ghamsari, Lila; Santhanam, Balaji; Romero, Viviana; Poulin, Matthew M.; Gebreab, Fana; Gutierrez, Bryan J.; Tam, Stanley; Hill, David E.; Vidal, Marc; Braun, Pascal] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Carvunis, Anne-Ruxandra] CNRS, Computat & Math Biol Grp, TIMC IMAG, UMR5525, F-38706 La Tronche, France; [Carvunis, Anne-Ruxandra] Univ Grenoble, Fac Med, F-38706 La Tronche, France; [Dreze, Matija; Vandenhaute, Jean] Fac Univ Notre Dame Paix, Unite Rech Biol Mol, B-5000 Namur, Wallonia Brusse, Belgium; [Steinbrenner, Jens; Donovan, Susan E.] Univ Warwick, Sch Life Sci, Wellesbourne CV35, Warwick, England; [Moore, Jonathan] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Tasan, Murat] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Galli, Mary; Gai, Lantian; Chen, Huaming; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Pevzner, Samuel J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; [Monachello, Dario] Univ Evry Val Essonne European Res Lab UEVE ERL, CNRS, Inst Natl Rech Agron INRA, Unite Mixte Rech Genom Vegetale URGV,UM, F-91057 Evry, France; [Boxem, Mike] Univ Utrecht, NL-3584 CH Utrecht, Netherlands; [Roth, Frederick P.] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Biol Lab, La Jolla, CA 92037 USA; [Dangl, Jeffery L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of Namur; University of Warwick; University of Warwick; Harvard University; Harvard Medical School; Salk Institute; Boston University; Boston University; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Utrecht University; Harvard University; Harvard Medical School; Salk Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Vidal, M (corresponding author), Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA.	marc_vidal@dfci.harvard.edu; jim.beynon@warwick.ac.uk; pascal_braun@dfci.harvard.edu; dangl@email.unc.edu	Braun, Pascal/B-9669-2013; Roth, Frederick P/H-6308-2011; Dreze, Matija/AAZ-3293-2020; Boxem, Mike/B-8857-2011; Ecker, Joseph R/B-9144-2008; Hill, David E/B-6617-2011; Van den Ackerveken, Guido/B-8568-2011; Cabral, Adriana/AAX-3284-2021; Harbort, Christopher/AAJ-7642-2020; Moore, Jonathan D/D-1796-2013	Braun, Pascal/0000-0003-2012-6746; Ecker, Joseph R/0000-0001-5799-5895; Van den Ackerveken, Guido/0000-0002-0183-8978; Moore, Jonathan D/0000-0002-5486-0407; /0000-0001-7002-8488; Yatusevich, Ruslan/0000-0001-5382-4079; Carvunis, Anne-Ruxandra/0000-0002-6474-6413; Steinbrenner, Jens/0000-0003-1008-2268; McDonald, Nathan/0000-0003-2716-3881; Nishimura, Marc Tad/0000-0003-4666-6900; Chen, Huaming/0000-0001-5289-7882; Roth, Frederick/0000-0002-6628-649X; Harbort, CJ/0000-0002-2564-8941; Mukhtar, Shahid/0000-0002-1104-6931	NIH [GM-066025, P50-HG004233]; NSF [2010 0929410, 0703905, 0520253, 0313578, 0726408]; U.S. Department of Energy (DOE) [FG02-95ER20187]; U.K. Biotechnology and Biological Sciences Research Council [E024815, F005806, G015066]; European Commission [LSHG-CT-2006-037704]; European Research Area in Plant Genomics; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066025] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E024815/1, BB/G015066/1] Funding Source: researchfish; BBSRC [BB/E024815/1, BB/G015066/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Area in Plant Genomics; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by NIH GM-066025, NSF 2010 0929410, and U.S. Department of Energy (DOE) FG02-95ER20187 to J.L.D.; U.K. Biotechnology and Biological Sciences Research Council E024815, F005806 and G015066 to J.B.; NSF 0703905 to M. V., J.R.E., D. E. H.; NIH P50-HG004233 to M. V.; and NSF 0520253, 0313578 and 0726408 to J.R.E. D. M. was supported by AGRONOMICS LSHG-CT-2006-037704 from Sixth Framework Programme of the European Commission to C. Lurin. We acknowledge that the NSF funded the Arabidopsis Biological Research Center and the Salk Institute Genomic Analysis Laboratory (SIGnAL) projects for seeds and clones, respectively. We thank L. Baxter (Warwick Systems Biology, UK) for Arabidopsis/Papaya ortholog identification; B. Charloteaux (Center of Cancer Systems Biology, Boston, USA) for assisting in some bioinformatics analyses; B. Kemmerling (University of Tuebingen, Germany) for several RLK clones not contained in SIGnAL; and C. Somerville and Y. Gu (University of California, Berkeley, USA), T. Mengiste (Purdue University, USA), and X.-W. Deng (Yale University, USA) for seeds. The EU Effectoromics Consortium was funded by the European Research Area in Plant Genomics and includes A. Cabral and G. van den Ackerveken (Utrecht University, The Netherlands); J. Bator, R. Yatusevich, S. Katou and J. Parker (Max Planck Institute for Plant Breeding Research, Cologne, Germany); G. Fabro and J. Jones (The Sainsbury Laboratory, Norwich, UK); and M. Coates and T. Payne (University of Warwick, Warwick, UK). M. V. is a Chercheur Qualifie Honoraire from the Fonds de la Recherche Scientifique (FRS-FNRS, Wallonia-Brussels Federation, Belgium). Binary interaction data are supplied in table S2 in SOM. Homozygous mutant seed stocks noted in Figure 4 are available from the Arabidopsis Biological Resource Center (ABRC). Author contributions are listed in the SOM.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Dyer MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012089; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lewis JD, 2009, SEMIN CELL DEV BIOL, V20, P1055, DOI 10.1016/j.semcdb.2009.06.003; Lozano-Duran R, 2011, PLANT CELL, V23, P1014, DOI 10.1105/tpc.110.080267; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Peng ZY, 2009, NUCLEIC ACIDS RES, V37, pD975, DOI 10.1093/nar/gkn873; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang PF, 2005, PLANT PHYSIOL, V138, P27, DOI 10.1104/pp.105.060376; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	33	577	593	4	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					596	601		10.1126/science.1203659	http://dx.doi.org/10.1126/science.1203659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798943	Green Accepted, Green Submitted			2022-12-28	WOS:000293222400053
J	Liu, CL; Yang, XV; Wu, JJ; Kuei, C; Mani, NS; Zhang, L; Yu, JX; Sutton, SW; Qin, N; Banie, H; Karlsson, L; Sun, SQ; Lovenberg, TW				Liu, Changlu; Yang, Xia V.; Wu, Jiejun; Kuei, Chester; Mani, Neelakandha S.; Zhang, Li; Yu, Jingxue; Sutton, Steven W.; Qin, Ning; Banie, Homayon; Karlsson, Lars; Sun, Siquan; Lovenberg, Timothy W.			Oxysterols direct B-cell migration through EBI2	NATURE			English	Article							CHOLESTEROL-METABOLISM; NUCLEAR RECEPTOR; IDENTIFICATION; ACTIVATION; CATALYZES; RESPONSES; MOUSE	EBI2 (also called GPR183) is an orphan G-protein-coupled receptor that is highly expressed in spleen and upregulated upon Epstein-Barr-virus infection(1). Recent studies indicated that this receptor controls follicular B-cell migration and T-cell-dependent antibody production(2-6). Oxysterols elicit profound effects on immune and inflammatory responses as well as on cholesterol metabolism(7-9). The biological effects of oxysterols have largely been credited to the activation of nuclear hormone receptors(10,11). Here we isolate oxysterols from porcine spleen extracts and show that they are endogenous ligands for EBI2. The most potent ligand and activator is 7 alpha,25-dihydroxycholesterol (OHC), with a dissociation constant of 450 pM for EBI2. In vitro, 7 alpha,25-OHC stimulated the migration of EBI2-expressing mouse B and T cells with half-maximum effective concentration values around 500 pM, but had no effect on EBI2-deficient cells. In vivo, EBI2-deficient B cells or normal B cells desensitized by 7 alpha,25-OHC pre-treatment showed reduced homing to follicular areas of the spleen. Blocking the synthesis of 7 alpha,25-OHC in vivo with clotrimazole, a CYP7B1 inhibitor, reduced the content of 7 alpha,25-OHC in the mouse spleen and promoted the migration of adoptively transferred pre-activated B cells to the T/B boundary (the boundary between the T-zone and B-zone in the spleen follicle), mimicking the phenotype of pre-activated B cells from EBI2-deficient mice. Our results show an unexpected causal link between EBI2, an orphan G-protein-coupled receptor controlling B-cell migration, and the known immunological effects of certain oxysterols, thus uncovering a previously unknown role for this class of molecules.	[Liu, Changlu; Yang, Xia V.; Wu, Jiejun; Kuei, Chester; Mani, Neelakandha S.; Zhang, Li; Yu, Jingxue; Sutton, Steven W.; Qin, Ning; Banie, Homayon; Karlsson, Lars; Sun, Siquan; Lovenberg, Timothy W.] Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA	Liu, CL (corresponding author), Johnson & Johnson Pharmaceut Res & Dev LLC, 3210 Merryfield Row, San Diego, CA 92121 USA.	cliu9@its.jnj.com	Yang, Xia V/F-6911-2011	Zhang, Li/0000-0001-6656-6064				Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; CALI JJ, 1991, J BIOL CHEM, V266, P7774; Chan TD, 2010, IMMUNOL REV, V237, P90, DOI 10.1111/j.1600-065X.2010.00942.x; Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; HANNEDOUCHE S, 2011, NATURE, DOI DOI 10.1038/10280; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kesteman N, 2008, J LEUKOCYTE BIOL, V83, P640, DOI 10.1189/jlb.0807578; Kumar BS, 2011, ANAL BIOCHEM, V408, P242, DOI 10.1016/j.ab.2010.09.031; Li DS, 2000, STEROIDS, V65, P529, DOI 10.1016/S0039-128X(00)00131-8; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Paila YD, 2010, SUBCELL BIOCHEM, V51, P439, DOI 10.1007/978-90-481-8622-8_16; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rose KA, 1997, P NATL ACAD SCI USA, V94, P4925, DOI 10.1073/pnas.94.10.4925; Russell DW, 2000, BBA-MOL CELL BIOL L, V1529, P126, DOI 10.1016/S1388-1981(00)00142-6; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; SMITH LL, 1987, CHEM PHYS LIPIDS, V44, P87, DOI 10.1016/0009-3084(87)90046-6; St'astna E, 2010, STEROIDS, V75, P721, DOI 10.1016/j.steroids.2010.04.010; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271	29	248	254	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					519	U121		10.1038/nature10226	http://dx.doi.org/10.1038/nature10226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796211				2022-12-28	WOS:000293167900045
J	Merchant, RM; Elmer, S; Lurie, N				Merchant, Raina M.; Elmer, Stacy; Lurie, Nicole			Integrating Social Media into Emergency-Preparedness Efforts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Merchant, Raina M.] Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA; [Merchant, Raina M.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Merchant, Raina M.; Elmer, Stacy; Lurie, Nicole] US Dept HHS, Off Assistant Secretary Preparedness & Response, Washington, DC 20201 USA	University of Pennsylvania; University of Pennsylvania	Merchant, RM (corresponding author), Univ Penn, Dept Emergency Med, Philadelphia, PA 19104 USA.							*ED RES, SOC HAB FREQ SOC NET; *GOOGL, GOOGL CRIS RESP CHRI; Palen L, 2009, SOC SCI COMPUT REV, V27, P467, DOI 10.1177/0894439309332302; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203	4	224	232	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					289	291		10.1056/NEJMp1103591	http://dx.doi.org/10.1056/NEJMp1103591			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798AJ	21793742	Bronze			2022-12-28	WOS:000293172200003
J	Hack, M; Schluchter, M; Andreias, L; Margevicius, S; Taylor, HG; Drotar, D; Cuttler, L				Hack, Maureen; Schluchter, Mark; Andreias, Laura; Margevicius, Seunghee; Taylor, H. Gerry; Drotar, Dennis; Cuttler, Leona			Change in Prevalence of Chronic Conditions Between Childhood and Adolescence Among Extremely Low-Birth-Weight Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE NEEDS; CHRONIC LUNG-DISEASE; BODY-MASS INDEX; IDENTIFYING CHILDREN; FOLLOW-UP; FUNCTIONAL LIMITATIONS; 12-YEAR-OLD CHILDREN; EXTREMELY PRETERM; YOUNG ADULTHOOD; PREMATURE BIRTH	Context Extremely low-birth-weight (ELBW) children have high rates of chronic conditions during childhood. Information on their trajectory of health during adolescence is needed for health care planning. Objective To examine changes in the rates of chronic conditions between the ages of 8 and 14 years among ELBW children compared with normal-birth-weight (NBW) controls. Design, Setting, and Participants Cohort study conducted from 2004 through 2009 of 181 ELBW children (weight < 1 kg) and 115 NBW controls of similar sociodemographic status born from 1992 through 1995 in Cleveland, Ohio. Main Outcome Measures Rates of chronic conditions overall (measured with the revised Questionnaire for Identifying Children With Chronic Conditions) and rates of asthma and obesity. Results The overall rates of chronic conditions did not change significantly between the ages of 8 and 14 years among ELBW children (75% at age 8 years vs 74% at age 14 years) or NBW controls (37% at age 8 years vs 47% at age 14 years). In generalized estimating equations logistic regression adjusting for sociodemographic status, sex, and race, ELBW children continued to have a higher rate of chronic conditions than NBW controls at age 14 years (74% vs 47%, respectively, adjusted odds ratio [AOR], 2.8 [95% confidence interval {CI}, 1.7 to 4.6]). Rates of asthma requiring medication did not change between the ages of 8 and 14 years among ELBW children (23% at both ages) but increased among NBW controls from 8% at age 8 years to 17% at age 14 years (P=.002). Differences in rates of asthma between ELBW and NBW children were no longer significant at the age of 14 years (23% vs 17%, respectively; AOR, 1.5 [95% CI, 0.8 to 2.8]). Mean z scores for body mass index increased in ELBW children from 0.06 at age 8 years to 0.38 at age 14 years (P<.001) and rates of obesity increased from 12% at age 8 years to 19% at age 14 years (P=.02). However, the scores and rates did not change among NBW controls such that at the age of 14 years the differences between ELBW and NBW children in mean z scores for body mass index (0.38 vs 0.56, respectively; adjusted mean difference -0.2 [95% CI, -0.5 to 0.1]) or rates of obesity (19% vs 20%, respectively; AOR, 1.1 [95% CI, 0.6 to 2.0]) were not significant. Conclusions Among ELBW children, rates of overall chronic conditions and asthma did not change between the ages of 8 and 14 years but the rate of obesity increased. Compared with NBW controls, the rates of chronic conditions were higher but there were no significant differences in the rates of asthma or obesity. JAMA. 2011;306(4): 394-401 www.jama.com	[Hack, Maureen; Andreias, Laura; Taylor, H. Gerry; Cuttler, Leona] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Schluchter, Mark; Margevicius, Seunghee] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Drotar, Dennis] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Case Western Reserve University; Case Western Reserve University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hack, M (corresponding author), Univ Hosp Cleveland, Case Med Ctr, Rainbow Babies & Childrens Hosp, 11100 Euclid Ave, Cleveland, OH 44106 USA.	mxh7@case.edu			National Institutes of Health [R01 HD 39756, M01 RR000, ULI RR024989]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039756] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by grants R01 HD 39756, M01 RR000, and ULI RR024989 from the National Institutes of Health. Part of the salaries of Drs Hack, Schluchter, Taylor, and Andreias and Ms Margivicius was funded by the National Institutes of Health grants.	Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Bethell CD, 2008, MATERN CHILD HLTH J, V12, P1, DOI 10.1007/s10995-007-0220-5; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bloom Barbara, 2009, Vital Health Stat 10, P1; Breslau N, 2004, PEDIATRICS, V114, P1035, DOI 10.1542/peds.2004-0069; Data Resource Center for Child and Adolescent Health supported by Cooperative Agreement from the U.S. Department of Health and Human Services HRaSA Maternal and Child Health Bureau, CHILD AD HLTH MEAS I; Doyle LW, 1999, PEDIATR PULM, V27, P185, DOI 10.1002/(SICI)1099-0496(199903)27:3<185::AID-PPUL6>3.0.CO;2-0; Doyle LW, 2003, PEDIATRICS, V112, P565, DOI 10.1542/peds.112.3.565; Doyle LW, 2001, ARCH DIS CHILD-FETAL, V85, pF159, DOI 10.1136/fn.85.3.F159; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Farooqi A, 2006, PEDIATRICS, V118, pE1466, DOI 10.1542/peds.2006-1070; Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC; FEUER EJ, 1989, BIOMETRICS, V45, P629, DOI 10.2307/2531505; Gaddlin PO, 2007, ACTA PAEDIATR, V96, P499, DOI 10.1111/j.1651-2227.2007.00183.x; Hack M, 2005, JAMA-J AM MED ASSOC, V294, P318, DOI 10.1001/jama.294.3.318; Hack M, 2003, PEDIATRICS, V112, pE30, DOI 10.1542/peds.112.1.e30; Halvorsen T, 2005, PEDIAT ALLERG IMM-UK, V16, P487, DOI 10.1111/j.1399-3038.2005.00314.x; Koumbourlis AC, 1996, PEDIATR PULM, V21, P28, DOI 10.1002/(SICI)1099-0496(199601)21:1<28::AID-PPUL5>3.0.CO;2-M; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Mai XM, 2003, PEDIATR ALLERGY IMMU, V14, P184, DOI 10.1034/j.1399-3038.2003.00045.x; McPherson M, 1998, PEDIATRICS, V102, P137, DOI 10.1542/peds.102.1.137; Newacheck PW, 2005, ARCH PEDIAT ADOL MED, V159, P10, DOI 10.1001/archpedi.159.1.10; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Perrin JM, 2007, JAMA-J AM MED ASSOC, V297, P2755, DOI 10.1001/jama.297.24.2755; Saigal S, 2001, PEDIATRICS, V108, P407, DOI 10.1542/peds.108.2.407; Saigal S, 2006, PEDIATR RES, V60, P751, DOI 10.1203/01.pdr.0000246201.93662.8e; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Stein REK, 1997, PEDIATRICS, V99, P513, DOI 10.1542/peds.99.4.513; Stein REK, 2000, ARCH PEDIAT ADOL MED, V154, P447, DOI 10.1001/archpedi.154.5.447; Stein REK, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.4.e61; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; Taylor HG, 2004, J INT NEUROPSYCH SOC, V10, P149, DOI 10.1017/S1355617704102038; Van Cleave J, 2010, JAMA-J AM MED ASSOC, V303, P623, DOI 10.1001/jama.2010.104; van der Lee JH, 2007, JAMA-J AM MED ASSOC, V297, P2741, DOI 10.1001/jama.297.24.2741; *WHO, 1999, INT CLASS FUNCT DIS; Wise PH, 2007, CRITICAL ANAL CARE C	40	41	47	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					394	401		10.1001/jama.2011.1025	http://dx.doi.org/10.1001/jama.2011.1025			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797KL	21791688	Green Accepted, Bronze			2022-12-28	WOS:000293125800025
J	Slagman, MCJ; Waanders, F; Hemmelder, MH; Woittiez, AJ; Janssen, WMT; Lambers Heerspink, HJ; Navis, G; Laverman, GD				Slagman, Maartje C. J.; Waanders, Femke; Hemmelder, Marc H.; Woittiez, Arend-Jan; Janssen, Wilbert M. T.; Lambers Heerspink, Hiddo J.; Navis, Gerjan; Laverman, Gozewijn D.		HONEST Grp	Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC KIDNEY-DISEASE; TERM ANTIHYPERTENSIVE TREATMENT; GLOMERULAR-FILTRATION-RATE; ANTIPROTEINURIC EFFICACY; ACE-INHIBITION; CARDIOVASCULAR RISK; ALDOSTERONE SYSTEM; RENAL HEMODYNAMICS; PROGRESSION; METAANALYSIS	Objective To compare the effects on proteinuria and blood pressure of addition of dietary sodium restriction or angiotensin receptor blockade at maximum dose, or their combination, in patients with non-diabetic nephropathy receiving background treatment with angiotensin converting enzyme (ACE) inhibition at maximum dose. Design Multicentre crossover randomised controlled trial. Setting Outpatient clinics in the Netherlands. Participants 52 patients with non-diabetic nephropathy. Interventions All patients were treated during four 6 week periods, in random order, with angiotensin receptor blockade (valsartan 320 mg/day) or placebo, each combined with, consecutively, a low sodium diet (target 50 mmol Na+/day) and a regular sodium diet (target 200 mmol Na+/day), with a background of ACE inhibition (lisinopril 40 mg/day) during the entire study. The drug interventions were double blind; the dietary interventions were open label. Main outcome measures The primary outcome measure was proteinuria; the secondary outcome measure was blood pressure. Results Mean urinary sodium excretion, a measure of dietary sodium intake, was 106 (SE 5) mmol Na+/day during a low sodium diet and 184 (6) mmol Na+/day during a regular sodium diet (P<0.001). Geometric mean residual proteinuria was 1.68 (95% confidence interval 1.31 to 2.14) g/day during ACE inhibition plus a regular sodium diet. Addition of angiotensin receptor blockade to ACE inhibition reduced proteinuria to 1.44 (1.07 to 1.93) g/day (P=0.003), addition of a low sodium diet reduced it to 0.85 (0.66 to 1.10) g/day (P<0.001), and addition of angiotensin receptor blockade plus a low sodium diet reduced it to 0.67 0.50 to 0.91) g/day (P<0.001). The reduction of proteinuria by the addition of a low sodium diet to ACE inhibition (51%, 95% confidence interval 43% to 58%) was significantly larger (P<0.001) than the reduction of proteinuria by the addition of angiotensin receptor blockade to ACE inhibition (21%, (8% to 32%) and was comparable (P=0.009, not significant after Bonferroni correction) to the reduction of proteinuria by the addition of both angiotensin receptor blockade and a low sodium diet to ACE inhibition (62%, 53% to 70%). Mean systolic blood pressure was 134 (3) mm Hg during ACE inhibition plus a regular sodium diet. Mean systolic blood pressure was not significantly altered by the addition of angiotensin receptor blockade (131 (3) mm Hg; P=0.12) but was reduced by the addition of a low sodium diet (123 (2) mm Hg; P<0.001) and angiotensin receptor blockade plus a low sodium diet (121 (3) mm Hg; P<0.001) to ACE inhibition. The reduction of systolic blood pressure by the addition of a low sodium diet (7% (SE 1%)) was significantly larger (P=0.003) than the reduction of systolic blood pressure by the addition of angiotensin receptor blockade (2% (1)) and was similar (P=0.14) to the reduction of systolic blood pressure by the addition of both angiotensin receptor blockade and low sodium diet (9% (1)), to ACE inhibition. Conclusions Dietary sodium restriction to a level recommended in guidelines was more effective than dual blockade for reduction of proteinuria and blood pressure in non-diabetic nephropathy. The findings support the combined endeavours of patients and health professionals to reduce sodium intake.	[Slagman, Maartje C. J.; Waanders, Femke; Navis, Gerjan; Laverman, Gozewijn D.] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands; [Hemmelder, Marc H.] Med Ctr Leeuwarden, Div Nephrol, Dept Internal Med, Leeuwarden, Netherlands; [Woittiez, Arend-Jan; Laverman, Gozewijn D.] ZGT Hosp Almelo, Div Nephrol, Dept Internal Med, Almelo, Netherlands; [Janssen, Wilbert M. T.] Martini Hosp Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands; [Lambers Heerspink, Hiddo J.] Univ Groningen, Univ Med Ctr Groningen, Dept Pharmacol, Groningen, Netherlands	University of Groningen; Medical Center Leeuwarden; Martini Hospital; University of Groningen; University of Groningen	Laverman, GD (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands.	g.d.laverman@umcg.nl	Hemmelder, Marc/AFQ-0383-2022; Heerspink, Hiddo J Lambers/K-3358-2014	Heerspink, Hiddo J Lambers/0000-0002-3126-3730	Novartis [CVAL489ANL08]	Novartis(Novartis)	The study was supported by an unrestricted grant from Novartis (CVAL489ANL08). The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	[Anonymous], 2009, Lancet, V374, P1226, DOI 10.1016/S0140-6736(09)61768-2; Apperloo AJ, 1997, KIDNEY INT, V51, P793, DOI 10.1038/ki.1997.111; Bakris GL, 2000, ARCH INTERN MED, V160, P685, DOI 10.1001/archinte.160.5.685; Basi S, 2006, AM J KIDNEY DIS, V47, P927, DOI 10.1053/j.ajkd.2006.02.182; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Buter H, 1998, NEPHROL DIAL TRANSPL, V13, P1682, DOI 10.1093/ndt/13.7.1682; Catapano F, 2008, AM J KIDNEY DIS, V52, P475, DOI 10.1053/j.ajkd.2008.03.008; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Correa JA, 2001, STAT MED, V20, P1185, DOI 10.1002/sim.776; De Nicola L, 2006, KIDNEY INT, V69, P538, DOI 10.1038/sj.ki.5000085; Einhorn LM, 2009, ARCH INTERN MED, V169, P1156, DOI 10.1001/archinternmed.2009.132; Ekinci EI, 2009, DIABETES CARE, V32, P1398, DOI 10.2337/dc08-2297; Esnault VLM, 2010, NEPHROL DIAL TRANSPL, V25, P2218, DOI 10.1093/ndt/gfp776; Esnault VLM, 2005, J AM SOC NEPHROL, V16, P474, DOI 10.1681/ASN.2004060505; HANSEN HP, 1995, KIDNEY INT, V47, P1726, DOI 10.1038/ki.1995.238; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; Heaney RP, 2006, J AM COLL NUTR, V25, p271S, DOI 10.1080/07315724.2006.10719577; HEEG JE, 1989, KIDNEY INT, V36, P272, DOI 10.1038/ki.1989.190; Houlihan CA, 2002, DIABETES CARE, V25, P663, DOI 10.2337/diacare.25.4.663; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Korgaonkar S, 2010, CLIN J AM SOC NEPHRO, V5, P762, DOI 10.2215/CJN.05850809; Krikken JA, 2007, KIDNEY INT, V71, P260, DOI 10.1038/sj.ki.5002011; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Laverman GD, 2004, J AM SOC NEPHROL, V15, pS64, DOI 10.1097/01.ASN.0000093368.27046.3C; Laverman GD, 2002, KIDNEY INT, V62, P1020, DOI 10.1046/j.1523-1755.2002.00536.x; Laverman GD, 2001, AM J KIDNEY DIS, V38, P1381, DOI 10.1053/ajkd.2001.29262; Levey AS, 1999, J AM SOC NEPHROL, V10, P2426; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; MARONI BJ, 1985, KIDNEY INT, V27, P58, DOI 10.1038/ki.1985.10; Masud T, 2002, KIDNEY INT, V62, P1750, DOI 10.1046/j.1523-1755.2002.00606.x; National Kidney Foundation, 2004, AM J KIDNEY DIS S, V43, pS1, DOI [DOI 10.1053/J.AJKD.2004.03.003, 10.1053/j.ajkd.2004.03.003]; NAVIS G, 1987, J CARDIOVASC PHARM, V9, P743, DOI 10.1097/00005344-198706000-00016; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pijls LTJ, 1999, NEPHROL DIAL TRANSPL, V14, P1445, DOI 10.1093/ndt/14.6.1445; Rossing K, 2005, KIDNEY INT, V68, P1190, DOI 10.1111/j.1523-1755.2005.00511.x; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 2001, LANCET, V357, P1601, DOI 10.1016/S0140-6736(00)04728-0; Ruggenenti P, 2008, J AM SOC NEPHROL, V19, P1213, DOI 10.1681/ASN.2007090970; Slagman MCJ, 2010, AM J KIDNEY DIS, V56, P601, DOI 10.1053/j.ajkd.2010.06.008; Slagman MCJ, 2010, CURR OPIN NEPHROL HY, V19, P140, DOI 10.1097/MNH.0b013e3283361887; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Suzuki T, 2009, CLIN NEPHROL, V72, P274; Thomas MC, 2008, DIABETES RES CLIN PR, V80, P83, DOI 10.1016/j.diabres.2007.10.024; Vallon V, 2005, CURR HYPERTENS REP, V7, P141, DOI 10.1007/s11906-005-0089-x; van Zuilen AD, 2008, J NEPHROL, V21, P261; Vogt L, 2008, J AM SOC NEPHROL, V19, P999, DOI 10.1681/ASN.2007060693; WEIR MR, 1995, HYPERTENSION, V25, P1339, DOI 10.1161/01.HYP.25.6.1339; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zhou JH, 2006, CLIN PHARMACOKINET, V45, P623, DOI 10.2165/00003088-200645060-00005	52	166	170	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2011	343								d4366	10.1136/bmj.d4366	http://dx.doi.org/10.1136/bmj.d4366			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LP	21791491	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000293440700004
J	Welz, PS; Wullaert, A; Vlantis, K; Kondylis, V; Fernandez-Majada, V; Ermolaeva, M; Kirsch, P; Sterner-Kock, A; van Loo, G; Pasparakis, M				Welz, Patrick-Simon; Wullaert, Andy; Vlantis, Katerina; Kondylis, Vangelis; Fernandez-Majada, Vanesa; Ermolaeva, Maria; Kirsch, Petra; Sterner-Kock, Anja; van Loo, Geert; Pasparakis, Manolis			FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation	NATURE			English	Article							NEMO/IKK-GAMMA; DEFICIENT MICE; TNF-ALPHA; B-CELL; DEATH; REGULATOR; APOPTOSIS; DELETION; IMMUNITY; RIP3	Intestinal immune homeostasis depends on a tightly regulated cross talk between commensal bacteria, mucosal immune cells and intestinal epithelial cells (IECs)(1-4). Epithelial barrier disruption is considered to be a potential cause of inflammatory bowel disease; however, the mechanisms regulating intestinal epithelial integrity are poorly understood(1,5). Here we show that mice with IEC-specific knockout of FADD (FADD(IEC-KO)), an adaptor protein required for death-receptor-induced apoptosis(6), spontaneously developed epithelial cell necrosis, loss of Paneth cells, enteritis and severe erosive colitis. Genetic deficiency in RIP3, a critical regulator of programmed necrosis(7-9), prevented the development of spontaneous pathology in both the small intestine and colon of FADD(IEC-KO) mice, demonstrating that intestinal inflammation is triggered by RIP3-dependent death of FADD-deficient IECs. Epithelial-specific inhibition of CYLD, a deubiquitinase that regulates cellular necrosis(10), prevented colitis development in FADD(IEC-KO) but not in NEMOIEC-KO mice(11), showing that different mechanisms mediated death of colonic epithelial cells in these two models. In FADD(IEC-KO) mice, TNF deficiency ameliorated colon inflammation, whereas MYD88 deficiency and also elimination of the microbiota prevented colon inflammation, indicating that bacteria-mediated Toll-like-receptor signalling drives colitis by inducing the expression of TNF and other cytokines. However, neither CYLD, TNF or MYD88 deficiency nor elimination of the microbiota could prevent Paneth cell loss and enteritis in FADD(IEC-KO) mice, showing that different mechanisms drive RIP3-dependent necrosis of FADD-deficient IECs in the small and large bowel. Therefore, by inhibiting RIP3-mediated IEC necrosis, FADD preserves epithelial barrier integrity and antibacterial defence, maintains homeostasis and prevents chronic intestinal inflammation. Collectively, these results show that mechanisms preventing RIP3-mediated epithelial cell death are critical for the maintenance of intestinal homeostasis and indicate that programmed necrosis of IECs might be implicated in the pathogenesis of inflammatory bowel disease, in which Paneth cell and barrier defects are thought to contribute to intestinal inflammation.	[Welz, Patrick-Simon; Wullaert, Andy; Vlantis, Katerina; Kondylis, Vangelis; Fernandez-Majada, Vanesa; Ermolaeva, Maria; Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50674 Cologne, Germany; [Kirsch, Petra] Univ Ulm, Tierforschungszentrum, D-89081 Ulm, Germany; [Sterner-Kock, Anja] Univ Cologne, Uniklin Koln, Ctr Med Expt, D-50931 Cologne, Germany; [van Loo, Geert] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [van Loo, Geert] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	University of Cologne; Ulm University; University of Cologne; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Pasparakis, M (corresponding author), Univ Cologne, Ctr Mol Med CMMC, Inst Genet, Zulpicher Str 47A, D-50674 Cologne, Germany.	Pasparakis@uni-koeln.de	van Loo, Geert/C-1505-2009; Welz, Patrick-Simon/F-3856-2016; Wullaert, Andy/R-1924-2019; , van Loo Geert/AAD-1220-2019; Wullaert, Andy/D-2975-2018; Pasparakis, Manolis/N-4350-2019; Kondylis, Vangelis/S-6276-2019; Pasparakis, Manolis/H-9292-2017; Fernandez Majada, Vanesa/K-8564-2017	Welz, Patrick-Simon/0000-0001-8370-625X; Wullaert, Andy/0000-0001-5012-654X; , van Loo Geert/0000-0002-8427-4775; Wullaert, Andy/0000-0001-5012-654X; Pasparakis, Manolis/0000-0002-9870-0966; Kondylis, Vangelis/0000-0002-6970-8731; Pasparakis, Manolis/0000-0002-9870-0966; Fernandez Majada, Vanesa/0000-0003-4287-5086	Deutsche Forschungsgemeinschaft [SFB670, SFB829]; European Commission (EC) [223151, 223404]; EMBO; 'Group-IDMRP' of Ghent University; International Graduate School in Genetics and Functional Genomics at the University of Cologne	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); EMBO(European Molecular Biology Organization (EMBO)); 'Group-IDMRP' of Ghent University; International Graduate School in Genetics and Functional Genomics at the University of Cologne	We thank C. Uthoff-Hachenberg, J. Pfeiffer, E. Mahlberg, D. Beier, J. Buchholz, B. Huelser, B. Wolff, E. Merkel and S. Schmidt for technical support. We also thank V. Dixit and K. Newton for providing Ripk3<SUP>-/-</SUP> mice and R. Massoumi for providing anti-CYLD antibody. This work was funded by grants from the Deutsche Forschungsgemeinschaft (SFB670, SFB829, CECAD) and European Commission FP7 program grants 'INFLA-CARE' and 'Masterswitch' (EC contract numbers 223151 and 223404 respectively) to M. P. V. F.-M. was supported by a long-term EMBO fellowship, G. v. L. was supported by 'Group-IDMRP' of Ghent University and P.-S.W. was supported by a fellowship from the International Graduate School in Genetics and Functional Genomics at the University of Cologne.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; DOURMASHKIN RR, 1983, HUM PATHOL, V14, P643, DOI 10.1016/S0046-8177(83)80207-X; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kollias G, 2005, SEMIN ARTHRITIS RHEU, V34, P3, DOI 10.1016/j.semarthrit.2005.01.002; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mc Guire C, 2010, J IMMUNOL, V185, P7646, DOI 10.4049/jimmunol.1000930; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Peyrin-Biroulet L, 2010, Minerva Gastroenterol Dietol, V56, P233; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	36	443	463	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					330	U102		10.1038/nature10273	http://dx.doi.org/10.1038/nature10273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21804564				2022-12-28	WOS:000294852400031
J	Sundy, JS; Baraf, HSB; Yood, RA; Edwards, NL; Gutierrez-Urena, SR; Treadwell, EL; Vazquez-Mellado, J; White, WB; Lipsky, PE; Horowitz, Z; Huang, W; Maroli, AN; Waltrip, RW; Hamburger, SA; Becker, MA				Sundy, John S.; Baraf, Herbert S. B.; Yood, Robert A.; Edwards, N. Lawrence; Gutierrez-Urena, Sergio R.; Treadwell, Edward L.; Vazquez-Mellado, Janitzia; White, William B.; Lipsky, Peter E.; Horowitz, Zeb; Huang, William; Maroli, Allan N.; Waltrip, Royce W., II; Hamburger, Steven A.; Becker, Michael A.			Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment Two Randomized Controlled Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; HEALTH-ASSESSMENT QUESTIONNAIRE; TREATMENT-FAILURE GOUT; URATE OXIDASE; HYPERURICEMIA; ALLOPURINOL; MANAGEMENT; ARTHRITIS; RECOMMENDATIONS; FEBUXOSTAT	Context Patients with chronic disabling gout refractory to conventional urate-lowering therapy need timely treatment to control disease manifestations related to tissue urate crystal deposition. Pegloticase, monomethoxypoly(ethylene glycol)-conjugated mammalian recombinant uricase, was developed to fulfill this need. Objective To assess the efficacy and tolerability of pegloticase in managing refractory chronic gout. Design, Setting, and Patients Two replicate, randomized, double-blind, placebo-controlled trials (C0405 and C0406) were conducted between June 2006 and October 2007 at 56 rheumatology practices in the United States, Canada, and Mexico in patients with severe gout, allopurinol intolerance or refractoriness, and serum uric acid concentration of 8.0 mg/dL or greater. A total of 225 patients participated: 109 in trial C0405 and 116 in trial C0406. Intervention Twelve biweekly intravenous infusions containing either pegloticase 8 mg at each infusion (biweekly treatment group), pegloticase alternating with placebo at successive infusions (monthly treatment group), or placebo (placebo group). Main Outcome Measure Primary end point was plasma uric acid levels of less than 6.0 mg/dL in months 3 and 6. Results In trial C0405 the primary end point was reached in 20 of 43 patients in the biweekly group (47%; 95% CI, 31%-62%), 8 of 41 patients in the monthly group (20%; 95% CI, 9%-35%), and in 0 patients treated with placebo (0/20; 95% CI, 0%-17%; P<.001 and <.04 for comparisons between biweekly and monthly groups vs placebo, respectively). Among patients treated with pegloticase in trial C0406, 16 of 42 in the biweekly group (38%; 95% CI, 24%-54%) and 21 of 43 in the monthly group (49%; 95% CI, 33%-65%) achieved the primary end point; no placebo-treated patients reached the primary end point (0/23; 95% CI, 0%-15%; P=.001 and <.001, respectively). When data in the 2 trials were pooled, the primary end point was achieved in 36 of 85 patients in the biweekly group (42%; 95% CI, 32%-54%), 29 of 84 patients in the monthly group (35%; 95% CI, 24%-46%), and 0 of 43 patients in the placebo group (0%; 95% CI, 0%-8%; P<.001 for each comparison). Seven deaths (4 in patients receiving pegloticase and 3 in the placebo group) occurred between randomization and closure of the study database (February 15, 2008). Conclusion Among patients with chronic gout, elevated serum uric acid level, and allopurinol intolerance or refractoriness, the use of pegloticase 8 mg either every 2 weeks or every 4 weeks for 6 months resulted in lower uric acid levels compared with placebo.	[Sundy, John S.] Duke Univ, Med Ctr, Duke Clin Res Unit, Durham, NC USA; [Baraf, Herbert S. B.] Ctr Rheumatol & Bone Res, Wheaton, MD USA; [Yood, Robert A.] Fallon Clin Inc, Worcester, MA USA; [Edwards, N. Lawrence] Univ Florida, Div Rheumatol, Gainesville, FL USA; [Gutierrez-Urena, Sergio R.] Hosp Civil Guadalajara, Guadalajara, Jalisco, Mexico; [Treadwell, Edward L.] E Carolina Univ, Div Rheumatol, Greenville, NC USA; [Vazquez-Mellado, Janitzia] Hosp Gen Mexico City, Mexico City, DF, Mexico; [White, William B.] Univ Connecticut, Sch Med, Calhoun Cardiol Ctr, Farmington, CT USA; [Horowitz, Zeb; Huang, William; Maroli, Allan N.; Waltrip, Royce W., II; Hamburger, Steven A.] Savient Pharmaceut, E Brunswick, NJ USA; [Becker, Michael A.] Univ Chicago, Rheumatol Sect, Chicago, IL 60637 USA	Duke University; State University System of Florida; University of Florida; University of North Carolina; East Carolina University; Hospital General de Mexico; University of Connecticut; University of Chicago	Becker, MA (corresponding author), 237 E Delaware Pl, Chicago, IL 60611 USA.	mbecker@medicine.bsd.uchicago.edu	Huang, WW/GXH-0977-2022; huang, wen/GXW-0661-2022		Savient Pharmaceuticals; Ardea Biosciences; Nuon Therapeutics; Regeneron; Novartis; Savient; URL/Mutual Pharmaceuticals; Takeda Pharmaceuticals; Takeda Pharmaceuticals North America; BioCryst Pharmaceuticals; Metabolex; UpToDate	Savient Pharmaceuticals; Ardea Biosciences; Nuon Therapeutics; Regeneron(Regeneron); Novartis(Novartis); Savient; URL/Mutual Pharmaceuticals; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Takeda Pharmaceuticals North America(Takeda Pharmaceutical Company Ltd); BioCryst Pharmaceuticals; Metabolex; UpToDate	Drs Horowitz, Huang, Maroli, and Waltrip were employees of Savient Pharmaceuticals at the time of conception and performance of the reported study. Dr Sundy reported receiving fees for consulting and grants from Savient Pharmaceuticals, Ardea Biosciences, Nuon Therapeutics, Regeneron, and Novartis and payment for lectures, including service on the speakers' bureau, for Takeda Pharmaceuticals North America. While Duke University, Dr Sundy's institution, may receive royalties as a result of the licensing agreement with Savient Pharmaceuticals, an institutional conflict-of-interest management plan is in place and Dr Sundy does not receive royalties or financial remuneration in relationship to this licensing agreement. Dr Baraf reported receiving consulting fees from Savient for participation in this study and/or preparation/attendance at the FDA Arthritis Advisory Committee meeting on pegloticase in June 2009; serving as a site principal investigator for the current trial, for which a grant was provided to his institution; receiving travel expense reimbursement from Savient; and receiving consulting fees and/or pending clinical trial grants from Ardea Biosciences, Nuon Therapeutics, Regeneron, Novartis, URL/Mutual Pharmaceuticals, and Takeda Pharmaceuticals. Dr Yood reported serving as a site principal investigator for the current trial, for which a grant was provided to his institution; receiving travel expense reimbursement from Savient; and serving as an investigator for a clinical trial sponsored by Takeda Pharmaceuticals North America, for which a grant was paid to his institution. Dr Edwards reported consulting income from Savient Pharmaceuticals, Takeda Pharmaceutical North America, Ardea Biosciences, Novartis, and Regeneron. Dr Treadwell reported serving as a site principal investigator for the current trial, for which a grant was provided to his institution; receiving travel expense reimbursement from Savient; and owning stock in Savient that was purchased through a commercial vendor. Dr White reported receiving consulting fees for chairing the CV Adjudication Committee and for participation in the FDA Arthritis Advisory Committee meeting on pegloticase. Dr Lipsky reported receiving consulting fees from Savient for participation in this study and/or preparation/attendance at the FDA Arthritis Advisory Committee meeting on pegloticase in June 2009. Dr Horowitz reported consulting for Ardea Biosciences in 2010 after leaving Savient Pharmaceuticals and holding stock and stock options in Savient at the time the study was performed and analyzed but having no financial interest in the company at the time of this submission. Dr Huang reported consulting for Ardea Biosciences in 2010 after leaving Savient Pharmaceuticals and currently holding stock and/or stock options in Savient. Dr Maroli reported holding stock and stock options in Savient at the time the study was performed and analyzed but having no financial interest in the company at the time of this submission. Dr Waltrip reported consulting for Ardea Biosciences in 2010 after leaving Savient Pharmaceuticals. Dr Hamburger is currently an employee of Savient Pharmaceuticals and reported currently holding stock and/or stock options in Savient.; Dr Becker reported receiving consulting fees from Savient for participation in this study and/or preparation/attendance at the FDA Arthritis Advisory Committee meeting on pegloticase in June 2009; serving as a site principal investigator for the current trial, for which a grant was provided to his institution; receiving travel expense reimburement from Savient; receiving fees from Takeda Pharmaceuticals, BioCryst Pharmaceuticals, Ardea Biosciences, Metabolex, URL/Mutual Pharmaceuticals, and Regeneron for consultation regarding research and development of gout-related products; and receiving fees from UpToDate, where he edits the section on crystal-induced arthritis. No other authors reported conflicts.	ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Alvarez-Hernandez E, 2008, ARTHRITIS RHEUM, V59, P665; Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; [Anonymous], PEGLOTICASE FULL PRE; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Becker MA, 2006, RHEUM DIS CLIN N AM, V32, P275, DOI 10.1016/j.rdc.2006.02.005; Becker MA, 2009, J RHEUMATOL, V36, P1041, DOI 10.3899/jrheum.071229; Bruce B, 2003, J RHEUMATOL, V30, P167; Choi H, 2006, RHEUM DIS CLIN N AM, V32, P255, DOI 10.1016/j.rdc.2006.03.002; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Crowther J. R, 1995, METHOD MOL BIOL, P35; DeSouza CM, 2009, J BIOPHARM STAT, V19, P1055, DOI 10.1080/10543400903242795; Edwards NL, 2008, ARTHRITIS RHEUM-US, V58, P2587, DOI 10.1002/art.23803; Hershfield MS, 2010, P NATL ACAD SCI USA, V107, P14351, DOI 10.1073/pnas.1001072107; Kosinski M, 2000, ARTHRITIS RHEUM-US, V43, P1478, DOI 10.1002/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lubeck DP, 2004, PHARMACOECONOMICS, V22, P27; Mire-Sluis AR, 2004, J IMMUNOL METHODS, V289, P1, DOI 10.1016/j.jim.2004.06.002; Perez-Ruiz F, 1998, ANN RHEUM DIS, V57, P545, DOI 10.1136/ard.57.9.545; Sampson HA, 2006, ANN EMERG MED, V47, P373, DOI 10.1016/j.annemergmed.2006.01.018; Sarawate CA, 2006, MAYO CLIN PROC, V81, P925, DOI 10.4065/81.7.925; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209; Sherman MR, 2008, ADV DRUG DELIVER REV, V60, P59, DOI 10.1016/j.addr.2007.06.011; Singh JA, 2008, ANN RHEUM DIS, V67, P1310, DOI 10.1136/ard.2007.081604; Singh JA, 2011, ANN RHEUM DIS, V70, P1277, DOI 10.1136/ard.2010.144022; Sundy JS, 2008, ARTHRITIS RHEUM, V58, P2882, DOI 10.1002/art.23810; Sundy JS, 2007, ARTHRITIS RHEUM-US, V56, P1021, DOI 10.1002/art.22403; Taylor WJ, 2008, CLIN EXP RHEUMATOL, V26, P620; Terkeltaub RA, 2003, NEW ENGL J MED, V349, P1647, DOI 10.1056/NEJMcp030733; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Ware JE, 2000, SCORE VERSION 2 SF 3, P27; WELLS GA, 1993, J RHEUMATOL, V20, P557; White WB, 2003, AM J CARDIOL, V92, P411, DOI 10.1016/S0002-9149(03)00659-3; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269	38	369	390	4	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					711	720		10.1001/jama.2011.116	http://dx.doi.org/10.1001/jama.2011.116			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807LP	21846852				2022-12-28	WOS:000293900000020
J	Meystre, P				Meystre, Pierre			Cool Vibrations	SCIENCE			English	Editorial Material							QUANTUM GROUND-STATE		[Meystre, Pierre] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA; [Meystre, Pierre] Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Meystre, P (corresponding author), Univ Arizona, Dept Phys, Tucson, AZ 85721 USA.	pierre@optics.arizona.edu						Braginsky V. B., 1992, QUANTUM MEASUREMENT; CAVES CM, 1980, REV MOD PHYS, V52, P341, DOI 10.1103/RevModPhys.52.341; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Medley P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.195301; MEYSTRE P, 1983, QUANTUM MEASUREMENT, P54214; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Teufel JD, 2011, NATURE, V475, P359, DOI 10.1038/nature10261	7	4	4	4	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					832	833		10.1126/science.1208322	http://dx.doi.org/10.1126/science.1208322			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836005				2022-12-28	WOS:000293785400027
J	Gandhi, TK; Zuccotti, G; Lee, TH				Gandhi, Tejal K.; Zuccotti, Gianna; Lee, Thomas H.			Incomplete Care - On the Trail of Flaws in the System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gandhi, Tejal K.] Partners HealthCare Syst, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Partners Healthcare System; Harvard University; Harvard Medical School	Gandhi, TK (corresponding author), Partners HealthCare Syst, Boston, MA USA.							[Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P1102; Pang J, 2010, J GEN INTERN MED, V25, P216; Shojania KG, 2010, CAN MED ASSOC J, V182, pE216, DOI 10.1503/cmaj.090578; Sumaraju V, 2001, INFECT DIS CLIN N AM, V15, P551, DOI 10.1016/S0891-5520(05)70159-8; Turchin A, 2010, P AMIA 2010 ANN S WA, P1282	5	18	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					486	488		10.1056/NEJMp1106313	http://dx.doi.org/10.1056/NEJMp1106313			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	805MW	21830964				2022-12-28	WOS:000293732100003
J	Rowe, C; Healy, SD				Rowe, Candy; Healy, Susan D.			Is Bigger Always Better?	SCIENCE			English	Editorial Material							FEMALE; CALLS		[Rowe, Candy] Newcastle Univ, Ctr Behav & Evolut, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Healy, Susan D.] Univ St Andrews, Sch Biol, St Andrews KY16 9JP, Fife, Scotland; [Healy, Susan D.] Univ St Andrews, Sch Psychol, St Andrews KY16 9JP, Fife, Scotland	Newcastle University - UK; University of St Andrews; University of St Andrews	Rowe, C (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	candy.rowe@ncl.ac.uk; sdh11@st-andrews.ac.uk	Rowe, Candy/B-7157-2008	Healy, Susan/0000-0002-8059-4480; Rowe, Candy/0000-0001-5379-843X				Akre KL, 2011, SCIENCE, V333, P751, DOI 10.1126/science.1205623; Andersson S., 1994, SEXUAL SELECTION; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; Bernal XE, 2007, AM NAT, V169, P409, DOI 10.1086/510729; Bernal XE, 2009, BEHAV ECOL SOCIOBIOL, V63, P1269, DOI 10.1007/s00265-009-0795-5; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Pryke SR, 2008, BEHAV ECOL, V19, P1116, DOI 10.1093/beheco/arn100; TREISMAN M, 1964, PSYCHOL REV, V71, P314, DOI 10.1037/h0042445; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	9	4	5	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					708	709		10.1126/science.1210723	http://dx.doi.org/10.1126/science.1210723			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817039				2022-12-28	WOS:000293512100028
J	Grover, C				Grover, Casey			"Thumb Sign" of Epiglottitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Grover, Casey] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Grover, Casey] Kaiser Permanente, Stanford, CA USA	Stanford University; Kaiser Permanente	Grover, C (corresponding author), Stanford Univ, Med Ctr, Stanford, CA 94305 USA.	cgrover@stanford.edu							0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					447	447		10.1056/NEJMicm1009990	http://dx.doi.org/10.1056/NEJMicm1009990			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801NW	21812674				2022-12-28	WOS:000293447800009
J	Ertl, V; Pfeiffer, A; Schauer, E; Elbert, T; Neuner, F				Ertl, Verena; Pfeiffer, Anett; Schauer, Elisabeth; Elbert, Thomas; Neuner, Frank			Community-Implemented Trauma Therapy for Former Child Soldiers in Northern Uganda A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NARRATIVE EXPOSURE THERAPY; MENTAL-HEALTH INTERVENTION; AFRICAN REFUGEE SETTLEMENT; SCHOOL-BASED INTERVENTION; ADMINISTERED PTSD SCALE; WAR; ADOLESCENTS; ISRAELI; TSUNAMI	Context The psychological rehabilitation of former child soldiers and their successful reintegration into postconflict society present challenges. Despite high rates of impairment, there have been no randomized controlled trials examining the feasibility and efficacy of mental health interventions for former child soldiers. Objective To assess the efficacy of a community-based intervention targeting symptoms of posttraumatic stress disorder (PTSD) in formerly abducted individuals. Design, Setting, and Participants Randomized controlled trial recruiting 85 former child soldiers with PTSD from a population-based survey of 1113 Northern Ugandans aged 12 to 25 years, conducted between November 2007 and October 2009 in camps for internally displaced persons. Participants were randomized to 1 of 3 groups: narrative exposure therapy (n=29), an academic catch-up program with elements of supportive counseling (n=28), or a waiting list (n=28). Symptoms of PTSD and trauma-related feelings of guilt were measured using the Clinician-Administered PTSD Scale. The respective sections of the Mini International Neuropsychiatric Interview were used to assess depression and suicide risk, and a locally adapted scale was used to measure perceived stigmatization. Symptoms of PTSD, depression, and related impairment were assessed before treatment and at 3 months, 6 months, and 12 months postintervention. Intervention Treatments were carried out in 8 sessions by trained local lay therapists, directly in the communities. Main Outcome Measures Change in PTSD severity, assessed over a 1-year period after treatment. Secondary outcome measures were depression symptoms, severity of suicidal ideation, feelings of guilt, and perceived stigmatization. Results PTSD symptom severity (range, 0-148) was significantly more improved in the narrative exposure therapy group than in the academic catch-up (mean change difference, -14.06 [95% confidence interval, -27.19 to -0.92]) and waiting-list (mean change difference, -13.04 [95% confidence interval, -26.79 to 0.72]) groups. Contrast analyses of the time x treatment interaction of the mixed-effects model on PTSD symptom change over time revealed a superiority of narrative exposure therapy compared with academic catch-up (F-1,F-234.1=5.21, P=.02) and wait-listing (F-1,F-228.3=5.28, P=.02). Narrative exposure therapy produced a larger within-treatment effect size (Cohen d=1.80) than academic catch-up (d=0.83) and wait-listing (d=0.81). Conclusion Among former Ugandan child soldiers, short-term trauma-focused treatment compared either with an academic catch-up program including supportive counseling or with wait-listing resulted in greater reduction of PTSD symptoms.	[Ertl, Verena; Neuner, Frank] Univ Bielefeld, Dept Psychol, D-33501 Bielefeld, Germany; [Pfeiffer, Anett; Elbert, Thomas] Univ Konstanz, Dept Psychol, Constance, Germany; [Ertl, Verena; Pfeiffer, Anett; Schauer, Elisabeth; Elbert, Thomas; Neuner, Frank] Vivo, Allensbach, Germany	University of Bielefeld; University of Konstanz	Ertl, V (corresponding author), Univ Bielefeld, Dept Psychol, POB 100131, D-33501 Bielefeld, Germany.	verena.ertl@uni-bielefeld.de	Elbert, Thomas/C-8556-2009	Elbert, Thomas/0000-0003-1332-4939; Neuner, Frank/0000-0001-5427-3432	nongovernmental organization vivo; DFG (Deutsche Forschungsgemeinschaft); Ein Herz fur Kinder foundation	nongovernmental organization vivo; DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Ein Herz fur Kinder foundation	This study was supported by the nongovernmental organization vivo and by funding from the DFG (Deutsche Forschungsgemeinschaft) and the Ein Herz fur Kinder foundation.	Al-Krenawi A, 2009, BRIT J PSYCHIAT, V195, P427, DOI 10.1192/bjp.bp.108.050393; Annan J., 2006, J CONFLICT RESOLUT; [Anonymous], 2009, REL REINT CHILD SOLD; [Anonymous], 2006, A61275 OFF SPEC REPR; [Anonymous], 2011, UPD IDPS MOV 73239 I; Bayer CP, 2007, JAMA-J AM MED ASSOC, V298, P555, DOI 10.1001/jama.298.5.555; Beers SR, 2002, AM J PSYCHIAT, V159, P483, DOI 10.1176/appi.ajp.159.3.483; Berger R, 2009, PSYCHOTHER PSYCHOSOM, V78, P364, DOI 10.1159/000235976; Berger R, 2007, J TRAUMA STRESS, V20, P541, DOI 10.1002/jts.20225; Betancourt TS, 2008, PSYCHOSOCIAL ADJUSTM; Bichescu Dana, 2005, Clin Pract Epidemiol Ment Health, V1, P17, DOI 10.1186/1745-0179-1-17; Bichescu D, 2007, BEHAV RES THER, V45, P2212, DOI 10.1016/j.brat.2006.12.006; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Catani C, 2010, CHILD DEV, V81, P1176, DOI 10.1111/j.1467-8624.2010.01461.x; Catani C, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-22; Elbert T, 2009, CHILD ABUSE NEGLECT, V33, P238, DOI 10.1016/j.chiabu.2008.02.008; Eytan A, 2007, J NERV MENT DIS, V195, P723, DOI 10.1097/NMD.0b013e318142c9f6; Faul F., G POWER COMPUTER PRO; Foa E.B., 1995, PDS POSTTRAUMATIC ST; Gelkopf M, 2009, J CHILD PSYCHOL PSYC, V50, P962, DOI 10.1111/j.1469-7610.2008.02021.x; Hamama-Raz Y, 2008, J TRAUMA STRESS, V21, P521, DOI 10.1002/jts.20376; Jordans MJD, 2010, J CHILD PSYCHOL PSYC, V51, P818, DOI 10.1111/j.1469-7610.2010.02209.x; Klasen F, 2010, CHILD DEV, V81, P1096, DOI 10.1111/j.1467-8624.2010.01456.x; Kohrt BA, 2008, JAMA-J AM MED ASSOC, V300, P691, DOI 10.1001/jama.300.6.691; Kubany ES, 2004, J CONSULT CLIN PSYCH, V72, P3, DOI 10.1037/0022-006X.72.1.3; Lawrence JW, 2006, PSYCHOL ASSESSMENT, V18, P106, DOI 10.1037/1040-3590.18.1.106; Layne CM, 2008, J AM ACAD CHILD PSY, V47, P1048, DOI 10.1097/CHI.0b013e31817eecae; Neuner F, 2004, J CONSULT CLIN PSYCH, V72, P579, DOI 10.1037/0022-006X.72.4.579; Neuner F, 2008, J CONSULT CLIN PSYCH, V76, P686, DOI 10.1037/0022-006X.76.4.686; Neuner F, 2008, CHILD ADOL PSYCH CL, V17, P641, DOI 10.1016/j.chc.2008.03.001; Neuner Frank, 2010, Cognitive Behaviour Therapy, V39, P81, DOI 10.1080/16506070903121042; Okello J, 2007, Afr J Psychiatry (Johannesbg), V10, P225; Onyut LP, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-7; Ovuga E, 2008, AFR HEALTH SCI, V8, P136; Pham PN, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-23; Robjant K, 2010, CLIN PSYCHOL REV, V30, P1030, DOI 10.1016/j.cpr.2010.07.004; Ruf M, 2010, J TRAUMA STRESS, V23, P437, DOI 10.1002/jts.20548; Schaal S, 2009, PSYCHOTHER PSYCHOSOM, V78, P298, DOI 10.1159/000229768; Schauer, 2004, INTERVENTION, V2, P18; Schauer M., 2005, NARRATIVE EXPOSURE T; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Siddiqui O, 2009, J BIOPHARM STAT, V19, P227, DOI 10.1080/10543400802609797; Stein BD, 2003, JAMA-J AM MED ASSOC, V290, P603, DOI 10.1001/jama.290.5.603; Teicher MH, 2002, PSYCHIAT CLIN N AM, V25, P397, DOI 10.1016/S0193-953X(01)00003-X; Thabet AA, 2005, EUR CHILD ADOLES PSY, V14, P262, DOI 10.1007/s00787-005-0466-7; Tol WA, 2008, JAMA-J AM MED ASSOC, V300, P655, DOI 10.1001/jama.300.6.655; Vinck P, 2007, JAMA-J AM MED ASSOC, V298, P543, DOI 10.1001/jama.298.5.543; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	48	175	175	5	76	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2011	306	5					503	512		10.1001/jama.2011.1060	http://dx.doi.org/10.1001/jama.2011.1060			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	800SH	21813428				2022-12-28	WOS:000293386500017
J	Husain, F; Anderson, M; Cardozo, BL; Becknell, K; Blanton, C; Araki, D; Vithana, EK				Husain, Farah; Anderson, Mark; Cardozo, Barbara Lopes; Becknell, Kristin; Blanton, Curtis; Araki, Diane; Vithana, Eeshara Kottegoda			Prevalence of War-Related Mental Health Conditions and Association With Displacement Status in Postwar Jaffna District, Sri Lanka	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REFUGEES; METAANALYSIS; INSTRUMENT; CONFLICT; TORTURE; TRAUMA	Context Nearly 2.7 million individuals worldwide are internally displaced (seeking refuge in secure areas of their own country) annually by armed conflict. Although the psychological impact of war has been well documented, less is known about the mental health symptoms of forced displacement among internally displaced persons. Objectives To estimate the prevalence of the most common war-related mental health conditions, symptoms of posttraumatic stress disorder (PTSD), anxiety, and depression, and to assess the association between displacement status and these conditions in postwar Jaffna District, Sri Lanka. Design, Setting, and Participants Between July and September 2009, a cross-sectional multistage cluster sample survey was conducted among 1517 Jaffna District households including 2 internally displaced persons camps. The response rate was 92% (1448 respondents, 1409 eligible respondents). Two percent of participants (n=80) were currently displaced, 29.5% (n=539) were recently resettled, and 68.5% (n=790) were long-term residents. Bivariable analyses followed by multivariable logistic regression models were performed to determine the association between displacement status and mental health. Main Outcome Measures Symptom criteria of PTSD, anxiety, and depression as measured by the Harvard Trauma Questionnaire and the Hopkins Symptom Checklist-25. Results The overall prevalences of symptoms of PTSD, anxiety, and depression were 7.0% (95% confidence interval [CI], 5.1%-9.7%), 32.6% (95% CI, 28.5%-36.9%), and 22.2% (95% CI, 18.2%-26.5%), respectively. Currently displaced participants were more likely to report symptoms of PTSD (odds ratio [OR], 2.71; 95% CI, 1.285.73), anxiety (OR, 2.91; 95% CI, 1.89-4.48), and depression (OR, 4.55; 95% CI, 2.47-8.39) compared with long-term residents. Recently resettled residents were more likely to report symptoms of PTSD (OR, 1.96; 95% CI, 1.11-3.47) compared with long-term residents. However, displacement was no longer associated with mental health symptoms after controlling for trauma exposure. Conclusion Among residents of Jaffna District in Sri Lanka, prevalence of symptoms of war-related mental health conditions was substantial and significantly associated with displacement status and underlying trauma exposure.	[Husain, Farah] Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Atlanta, GA 30341 USA; [Araki, Diane] United Nations Childrens Fund, Jaffna, Sri Lanka; [Vithana, Eeshara Kottegoda] Minist Healthcare & Nutr, Colombo, Sri Lanka	Centers for Disease Control & Prevention - USA	Husain, F (corresponding author), Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, 4770 Buford Hwy NE,MS F-60, Atlanta, GA 30341 USA.	fhusain@cdc.gov			CDC; UNICEF	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UNICEF	This study was supported by the CDC and UNICEF.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 2009, ABC NEWS        0520; [Anonymous], 2005, SPSS COMP PROGR VERS; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Cardozo BL, 2004, JAMA-J AM MED ASSOC, V292, P575, DOI 10.1001/jama.292.5.575; Centers for Disease Control and Prevention, EP INF COMP PROGR VE; De Vries J, 2001, PATIENT EDUC COUNS, V42, P15, DOI 10.1016/S0738-3991(99)00120-2; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Inter-Agency Standing Committee (IASC), 2007, IASC GUID MENT HLTH; Internal Displacement Monitoring Centre, 2009, GLOB STAT; Miller KE, 2010, SOC SCI MED, V70, P7, DOI 10.1016/j.socscimed.2009.09.029; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; Mooney E., 1998, OHCHR HUM PRINC WORK; Nagai M, 2007, HEALTH POLICY, V83, P84, DOI 10.1016/j.healthpol.2006.12.001; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Price S, 2000, SRI LANK ARM ROP; Sadavoy J, 2004, CAN J PSYCHIAT, V49, P192, DOI 10.1177/070674370404900307; Siva N, 2010, LANCET, V375, P880, DOI 10.1016/S0140-6736(10)60370-4; Snyder D, LEFT DISPLACED SRI L; Somasundaram Daya, 2007, Int J Ment Health Syst, V1, P5, DOI 10.1186/1752-4458-1-5; Sri Lanka Department of Census and Statistics, 2008, BAS POP INF JAFFN DI; Sri Lanka Mental Health Directorate, MENT HLTH POL SRI LA; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; TamilCanadian, 1995, EX TAM JAFFN DISPL C; United Nations High Commissioner for Refugees, UNHCR GLOB APP 2010; VIVO [Victims' Voice], 2003, EP SURV CHILDR MENT; Weaver M, 2009, SRI LANK DECL END WA; World Bank, 2007, SRI LANK POV ASS ENG	30	69	71	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2011	306	5					522	531		10.1001/jama.2011.1052	http://dx.doi.org/10.1001/jama.2011.1052			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	800SH	21813430	Bronze			2022-12-28	WOS:000293386500019
J	Autier, P; Boniol, M; Gavin, A; Vatten, LJ				Autier, Philippe; Boniol, Mathieu; Gavin, Anna; Vatten, Lars J.			Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; MAMMOGRAPHY; IMPLEMENTATION; SURVIVAL; RATES	Objective To compare trends in breast cancer mortality within three pairs of neighbouring European countries in relation to implementation of screening. Design Retrospective trend analysis. Setting Three country pairs (Northern Ireland (United Kingdom) v Republic of Ireland, the Netherlands v Belgium and Flanders (Belgian region south of the Netherlands), and Sweden v Norway). Data sources WHO mortality database on cause of death and data sources on mammography screening, cancer treatment, and risk factors for breast cancer mortality. Main outcome measures Changes in breast cancer mortality calculated from linear regressions of log transformed, age adjusted death rates. Joinpoint analysis was used to identify the year when trends in mortality for all ages began to change. Results From 1989 to 2006, deaths from breast cancer decreased by 29% in Northern Ireland and by 26% in the Republic of Ireland; by 25% in the Netherlands and by 20% in Belgium and 25% in Flanders; and by 16% in Sweden and by 24% in Norway. The time trend and year of downward inflexion were similar between Northern Ireland and the Republic of Ireland and between the Netherlands and Flanders. In Sweden, mortality rates have steadily decreased since 1972, with no downward inflexion until 2006. Countries of each pair had similar healthcare services and prevalence of risk factors for breast cancer mortality but differing implementation of mammography screening, with a gap of about 10-15 years. Conclusions The contrast between the time differences in implementation of mammography screening and the similarity in reductions in mortality between the country pairs suggest that screening did not play a direct part in the reductions in breast cancer mortality.	[Autier, Philippe; Boniol, Mathieu] Int Prevent Res Inst, F-69006 Lyon, France; [Gavin, Anna] No Ireland Canc Registry, Belfast, Antrim, North Ireland; [Vatten, Lars J.] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Autier, P (corresponding author), Int Prevent Res Inst, 95 Cours Lafayette, F-69006 Lyon, France.	philippe.autier@i-pri.org	Vatten, Lars/AFK-2073-2022; Vatten, Lars/AAF-9380-2022; Boniol, Mathieu/F-9623-2011; Autier, Philippe/A-4402-2014	Boniol, Mathieu/0000-0003-1052-5604; Autier, Philippe/0000-0003-1538-5321	Public Health Agency for Northern Ireland	Public Health Agency for Northern Ireland	The institutions in which the authors work had no influence on the conduct of the research or the writing of the paper. The work of the Northern Ireland Cancer Registry is funded by the Public Health Agency for Northern Ireland.	ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; ANDERSSON I, 1995, J NATL CANCER I, V87, P1263; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; [Anonymous], 2011, WHO STAT INF SYST; [Anonymous], 2011, JOINP REGR PROGR VER; Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018; Association of Public Health Observatories, 2009, INT COMP OB PREV; Autier P, 2011, ANN ONCOL; Autier P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3620; Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Barnett GC, 2008, J CLIN ONCOL, V26, P3310, DOI 10.1200/JCO.2006.10.3168; Bernardi D, 2008, ACTA ONCOL, V47, P187, DOI 10.1080/02841860701630234; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Boniol M, 2010, EUR J CANCER, V46, P2534, DOI 10.1016/j.ejca.2010.07.049; BreastCheck-The National Breast Screening Programme, 2009, PROGR REP 2008 09; Broeders MJM, 2001, INT J CANCER, V92, P303, DOI 10.1002/1097-0215(200102)9999:9999&lt;::AID-IJC1186&gt;3.0.CO;2-B; De Bock C, 2009, SUCCES CONTRASTES PR; Doll R, 1981, CAUSES CANC; Donnelly DW, 2009, CANC IRELAND 1994 20; Duffy SW, 2006, CANCER EPIDEM BIOMAR, V15, P45, DOI 10.1158/1055-9965.EPI-05-0349; Eaker S, 2006, PLOS MED, V3, P321, DOI 10.1371/journal.pmed.0030025; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; European Commission, 2011, EUR DAT; Fabri V, 2009, 6 AG INT; Fracheboud J, 2004, BRIT J CANCER, V91, P861, DOI 10.1038/sj.bjc.6602075; Goed Gevoel, 2011, GEZ PSYCH; Herman PM, 2011, AM J PUBLIC HEALTH, V101, P491, DOI 10.2105/AJPH.2009.179572; Hery C, 2008, ANN ONCOL, V19, P1187, DOI 10.1093/annonc/mdn025; Hofvind S, 2007, EUR J EPIDEMIOL, V22, P447, DOI 10.1007/s10654-007-9137-y; HSC Public Health Agency, 2011, NI CANC SCREEN PROGR; Institut National de Statistiques, 1982, REC POP LOG 1 MARS 8; International Agency for Research on Cancer, 2002, IARC WHO HDB CANC PR, V7; International Agency for Research on Cancer, 2005, IARC WHO HDB CANC PR, V10; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones AL, 2005, BRIT MED J, V330, P205, DOI 10.1136/bmj.330.7485.205; Jonsson B, 2007, ANN ONCOL, V18, P1, DOI 10.1093/annonc/mdm095; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Kee F, 1992, Eur J Cancer Prev, V1, P311, DOI 10.1097/00008469-199206000-00006; LAARA E, 1987, LANCET, V1, P1247; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Miettinen OS, 2002, LANCET, V359, P404, DOI 10.1016/S0140-6736(02)07592-X; National Evaluation Team for Breast Cancer Screening, 2007, NETB INT REP 2007 MA; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Olsson S, 2000, J MED SCREEN, V7, P14, DOI 10.1136/jms.7.1.14; Otten JDM, 2008, INT J CANCER, V123, P1929, DOI 10.1002/ijc.23736; Siebel Marisa F, 2005, Curr Oncol Rep, V7, P23, DOI 10.1007/s11912-005-0022-0; Statistics Press Notice, 2007, BIRTHS NO IR 2006; Van Bavel J, 2006, EVOLUTIE VRUCHTBAARH; Vandenbroucke A, 1993, Eur J Cancer Prev, V2, P269, DOI 10.1097/00008469-199305000-00014; Von Karsa L, 2008, 1 DIR GEN HLTH CONS; World Health Organization, 2010, MORT DAT	52	190	191	2	44	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2011	343								d4411	10.1136/bmj.d4411	http://dx.doi.org/10.1136/bmj.d4411			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LT	21798968	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000293441100003
J	Li, FY; Chaigne-Delalande, B; Kanellopoulou, C; Davis, JC; Matthews, HF; Douek, DC; Cohen, JI; Uzel, G; Su, HC; Lenardo, MJ				Li, Feng-Yen; Chaigne-Delalande, Benjamin; Kanellopoulou, Chrysi; Davis, Jeremiah C.; Matthews, Helen F.; Douek, Daniel C.; Cohen, Jeffrey I.; Uzel, Gulbu; Su, Helen C.; Lenardo, Michael J.			Second messenger role for Mg2+ revealed by human T-cell immunodeficiency	NATURE			English	Article							ACQUIRED-IMMUNODEFICIENCY; SIGNAL-TRANSDUCTION; HIV-INFECTION; MAGNESIUM; ACTIVATION; CALCIUM; LYMPHOCYTOPENIA; RECEPTOR; DEFICIENCY; IDENTIFICATION	The magnesium ion, Mg2+, is essential for all life as a cofactor for ATP, polyphosphates such as DNA and RNA, and metabolic enzymes, but whether it plays a part in intracellular signalling (as Ca2+ does) is unknown. Here we identify mutations in the magnesium transporter gene, MAGT1, in a novel X-linked human immunodeficiency characterized by CD4 lymphopenia, severe chronic viral infections, and defective T-lymphocyte activation. We demonstrate that a rapid transient Mg2+ influx is induced by antigen receptor stimulation in normal T cells and by growth factor stimulation in non-lymphoid cells. MAGT1 deficiency abrogates the Mg2+ influx, leading to impaired responses to antigen receptor engagement, including defective activation of phospholipase C gamma 1 and a markedly impaired Ca2+ influx in T cells but not B cells. These observations reveal a role for Mg2+ as an intracellular second messenger coupling cell-surface receptor activation to intracellular effectors and identify MAGT1 as a possible target for novel therapeutics.	[Li, Feng-Yen; Chaigne-Delalande, Benjamin; Kanellopoulou, Chrysi; Matthews, Helen F.; Lenardo, Michael J.] NIAID, Mol Dev Sect, Lymphocyte Mol Genet Unit, Immunol Lab,NIH, Bethesda, MD 20892 USA; [Li, Feng-Yen] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Davis, Jeremiah C.; Su, Helen C.] NIAID, Human Immunol Dis Unit, Host Def Lab, NIH, Bethesda, MD 20892 USA; [Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Cohen, Jeffrey I.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Uzel, Gulbu] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Li, FY (corresponding author), NIAID, Mol Dev Sect, Lymphocyte Mol Genet Unit, Immunol Lab,NIH, Bethesda, MD 20892 USA.	lenardo@nih.gov	Su, Helen C/H-9541-2015	Su, Helen C/0000-0002-5582-9110	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000769, ZIAAI000913, ZIAAI001059] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Zheng, A. Weiss, R. Germain, R. Siegel, F. Wolf and P. Schwartzberg for critically reading the manuscript; F. Wolf for advice on magnesium assessments; L. Zheng, C. Lowell and A. Weiss for advice on experiments and data; H. Jing for making HVS lines from patient cells; P. Chen for assistance with plasmid DNA preparation; N. Sandler for flow cytometry assistance; A. Snow and H. Jing for assistance with genomic DNA library preparation for Solexa sequencing; J. Almenara and Illumina staff for Solexa assistance; D. Killilea for assistance with MS-ICP data interpretation; and A. Irani for referring the patients. F.-Y.L. is in the Medical Scientist Training Program at the University of California-San Francisco and thanks K. Shannon and J. Toutolmin for support and encouragement. This work was supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health.	ABBOUD CN, 1985, J CELL PHYSIOL, V122, P64, DOI 10.1002/jcp.1041220111; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Cakmak I, 2008, PHYSIOL PLANTARUM, V133, P692, DOI 10.1111/j.1399-3054.2007.01042.x; Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P541; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Cossu F, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-76; Cowan JA, 2002, BIOMETALS, V15, P225, DOI 10.1023/A:1016022730880; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; FAUCI AS, 1993, NEW ENGL J MED, V328, P429, DOI 10.1056/NEJM199302113280610; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Filipovich AH, 2010, BLOOD, V116, P3398, DOI 10.1182/blood-2010-03-275909; FLYNN A, 1984, J NUTR, V114, P2034, DOI 10.1093/jn/114.11.2034; Freier S, 1998, ARCH DIS CHILD, V78, P371, DOI 10.1136/adc.78.4.371; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Goytain A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-48; GRUBBS RD, 1987, MAGNESIUM, V6, P113; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Junge S, 2007, EUR J IMMUNOL, V37, P3270, DOI 10.1002/eji.200636976; Killilea DW, 2008, P NATL ACAD SCI USA, V105, P5768, DOI 10.1073/pnas.0712401105; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Kohler S, 2009, BLOOD, V113, P769, DOI 10.1182/blood-2008-02-139154; LAURENCE J, 1992, LANCET, V340, P273, DOI 10.1016/0140-6736(92)92359-N; Lin SA, 2001, PEDIATR HEMAT ONCOL, V18, P153, DOI 10.1080/088800101300003008; LOBATO MN, 1995, PEDIATR INFECT DIS J, V14, P527, DOI 10.1097/00006454-199506000-00011; MODIANO JF, 1988, J CELL PHYSIOL, V135, P451, DOI 10.1002/jcp.1041350312; Murphy E, 2000, CIRC RES, V86, P245, DOI 10.1161/01.RES.86.3.245; Nel AE, 2002, J ALLERGY CLIN IMMUN, V109, P758, DOI 10.1067/mai.2002.124259; NG LL, 1991, CLIN SCI, V80, P539, DOI 10.1042/cs0800539; Notarangelo LD, 2010, J ALLERGY CLIN IMMUN, V125, pS182, DOI 10.1016/j.jaci.2009.07.053; Permyakov EA, 2009, J INORG BIOCHEM, V103, P77, DOI 10.1016/j.jinorgbio.2008.09.006; Peterson EJ, 1999, CLIN EXP RHEUMATOL, V17, P107; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; RIJKERS GT, 1993, BIOCHEM J, V289, P373, DOI 10.1042/bj2890373; Romani AMP, 2007, FRONT BIOSCI-LANDMRK, V12, P308, DOI 10.2741/2066; Sabbagh F, 2008, TRANSPL IMMUNOL, V20, P83, DOI 10.1016/j.trim.2008.07.005; SMITH DK, 1993, NEW ENGL J MED, V328, P373, DOI 10.1056/NEJM199302113280601; SUTHERLAND EW, 1972, SCIENCE, V177, P401, DOI 10.1126/science.177.4047.401; Takaya J, 2000, MAGNESIUM RES, V13, P139; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wengler GS, 1997, LIFE SCI, V61, P1405, DOI 10.1016/S0024-3205(97)00686-3; WHITNEY RB, 1972, J IMMUNOL, V108, P1179; Xie ZJ, 2010, BIOCHEM BIOPH RES CO, V399, P425, DOI 10.1016/j.bbrc.2010.07.098; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106	51	353	364	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					471	U63		10.1038/nature10246	http://dx.doi.org/10.1038/nature10246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796205	Green Accepted			2022-12-28	WOS:000293167900034
J	Bartels, T; Choi, JG; Selkoe, DJ				Bartels, Tim; Choi, Joanna G.; Selkoe, Dennis J.			alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation	NATURE			English	Article							PARKINSONS-DISEASE; BINDING; NEURODEGENERATION; MUTATIONS; COMPLEXES; PROTEINS	Parkinson's disease is the second most common neurodegenerative disorder(1,2). Growing evidence indicates a causative role of misfolded forms of the protein alpha-synuclein in the pathogenesis of Parkinson's disease(3,4). Intraneuronal aggregates of alpha-synuclein occur in Lewy bodies and Lewy neurites(5), the cytopathological hallmarks of Parkinson's disease and related disorders called synucleinopathies(4). alpha-Synuclein has long been defined as a 'natively unfolded' monomer of about 14 kDa (ref. 6) that is believed to acquire alpha-helical secondary structure only upon binding to lipid vesicles(7). This concept derives from the widespread use of recombinant bacterial expression protocols for in vitro studies, and of overexpression, sample heating and/or denaturing gels for cell culture and tissue studies. In contrast, we report that endogenous alpha-synuclein isolated and analysed under non-denaturing conditions from neuronal and non-neuronal cell lines, brain tissue and living human cells occurs in large part as a folded tetramer of about 58 kDa. Several methods, including analytical ultracentrifugation, scanning transmission electron microscopy and in vitro cell crosslinking confirmed the occurrence of the tetramer. Native, cell-derived alpha-synuclein showed alpha-helical structure without lipid addition and had much greater lipid-binding capacity than the recombinant alpha-synuclein studied heretofore. Whereas recombinantly expressed monomers readily aggregated intoamyloid-like fibrilsin vitro, native human tetramers underwent little or no amyloid-like aggregation. On the basis of these findings, we propose that destabilization of the helically folded tetramer precedes alpha-synuclein misfolding and aggregation in Parkinson's disease and other human synucleinopathies, and that small molecules that stabilize the physiological tetramer could reduce alpha-synuclein pathogenicity.	[Bartels, Tim; Choi, Joanna G.; Selkoe, Dennis J.] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Bartels, Tim; Choi, Joanna G.; Selkoe, Dennis J.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Selkoe, DJ (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu	Bartels, Tim/AAD-6128-2021	Bartels, Tim/0000-0002-4071-5612	NIH [NS051318, NS038375]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038375, R01NS051318] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Mass measurements were carried out at the Brookhaven National Laboratory STEM facility, a user facility supported by the US Department of Energy. We are grateful to D. Walker and J. Anderson (Elan Pharmaceuticals) for conducting mass spectrometry of our purified alpha-synuclein samples and for comments. We thank X. Simon and I. Perovic (Brandeis University) for their assistance with the AUC and phosphate analyses. Supported by NIH grants NS051318 and NS038375 (D.J.S.). We thank our colleagues at the Center for Neurologic Diseases for many discussions.	Beyer K, 2007, CELL BIOCHEM BIOPHYS, V47, P285, DOI 10.1007/s12013-007-0014-9; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DeTure M, 2000, BRAIN RES, V853, P5, DOI 10.1016/S0006-8993(99)02124-1; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; Klucken J, 2006, FASEB J, V20, P2050, DOI 10.1096/fj.05-5422com; Ko LW, 2008, J NEUROPATH EXP NEUR, V67, P1084, DOI 10.1097/NEN.0b013e31818c3618; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Quintas A, 1999, J BIOL CHEM, V274, P32943, DOI 10.1074/jbc.274.46.32943; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Smith DP, 2008, BIOCHEMISTRY-US, V47, P1425, DOI 10.1021/bi701522m; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tong JC, 2010, BRAIN, V133, P172, DOI 10.1093/brain/awp282; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Wall JS, 2008, METHOD ENZYMOL, V436, P487, DOI 10.1016/S0076-6879(08)36027-3; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081	24	855	867	2	294	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					107	U123		10.1038/nature10324	http://dx.doi.org/10.1038/nature10324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21841800	Green Accepted			2022-12-28	WOS:000294404300041
J	Vader, G; Blitzblau, HG; Tame, MA; Falk, JE; Curtin, L; Hochwagen, A				Vader, Gerben; Blitzblau, Hannah G.; Tame, Mihoko A.; Falk, Jill E.; Curtin, Lisa; Hochwagen, Andreas			Protection of repetitive DNA borders from self-induced meiotic instability	NATURE			English	Article							DOUBLE-STRAND-BREAK; SACCHAROMYCES-CEREVISIAE; RECOMBINATION INITIATION; HISTONE DEACETYLASE; BUDDING YEAST; PROTEIN; GENE; REPLICATION; METABOLISM; MECHANISMS	DNA double strand breaks (DSBs) in repetitive sequences are a potent source of genomic instability, owing to the possibility of non-allelic homologous recombination (NAHR). Repetitive sequences are especially at risk during meiosis, when numerous programmed DSBs are introduced into the genome to initiate meiotic recombination(1). In the repetitive ribosomal DNA (rDNA) array of the budding yeast Saccharomyces cerevisiae, meiotic DSB formation is prevented in part through Sir2-dependent heterochromatin formation(2,3). Here we show that the edges of the rDNA array are exceptionally susceptible to meiotic DSBs, revealing an inherent heterogeneity in the rDNA array. We find that this localized DSB susceptibility necessitates a border-specific protection system consisting of the meiotic ATPase Pch2 and the origin recognition complex subunit Orc1. Upon disruption of these factors, DSB formation and recombination increased specifically in the outermost rDNA repeats, leading to NAHR and rDNA instability. Notably, the Sir2-dependent heterochromatin of the rDNA itself was responsible for the induction of DSBs at the rDNA borders in pch2 Delta cells. Thus, although the activity of Sir2 globally prevents meiotic DSBs in the rDNA, it creates a highly permissive environment for DSB formation at the junctions between heterochromatin and euchromatin. Heterochromatinized repetitive DNA arrays are abundant in most eukaryotic genomes. Our data define the borders of such chromatin domains as distinct high-risk regions for meiotic NAHR, the protection of which may be a universal requirement to prevent meiotic genome rearrangements that are associated with genomic diseases and birth defects.	[Vader, Gerben; Blitzblau, Hannah G.; Tame, Mihoko A.; Falk, Jill E.; Curtin, Lisa; Hochwagen, Andreas] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Curtin, Lisa] Somerville High Sch, Somerville, MA 02143 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Hochwagen, A (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	andi@nyu.edu		Hochwagen, Andreas/0000-0002-6184-443X; Falk, Jill/0000-0003-2910-9803; Vader, Gerben/0000-0001-5729-0991	NIH [GM088248]; Netherlands Organisation for Scientific Research [NWO Rubicon-825.08.009, NWO VENI-016.111.004]; HHMI [52005879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088248] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. P. Bell, A. Shinohara, N. Hunter, N. Hollingsworth and F. Klein for sharing reagents and data. We thank I. Cheeseman, M. Gehring and V. Subramanian for discussions and critical reading of the manuscript. This work was supported by NIH grant GM088248 to A.H. and by fellowships from the Netherlands Organisation for Scientific Research (NWO Rubicon-825.08.009 and NWO VENI-016.111.004) to G.V.; L.C. was supported by an HHMI Institutional Undergraduate Education Grant to MIT (grant 52005879).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Blitzblau HG, 2011, METHODS MOL BIOL, V745, P47, DOI 10.1007/978-1-61779-129-1_4; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; CHERNOFF YO, 1994, EMBO J, V13, P906, DOI 10.1002/j.1460-2075.1994.tb06334.x; Coelho PSR, 2002, GENE DEV, V16, P2755, DOI 10.1101/gad.1035002; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gibson DG, 2006, GENES CELLS, V11, P557, DOI 10.1111/j.1365-2443.2006.00967.x; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hoang ML, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001228; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; James P, 1996, GENETICS, V144, P1425; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kobayashi T, 2006, GENES GENET SYST, V81, P155, DOI 10.1266/ggs.81.155; LOIDL J, 1991, CHROMOSOMA, V100, P221, DOI 10.1007/BF00344155; Mieczkowski PA, 2007, P NATL ACAD SCI USA, V104, P3955, DOI 10.1073/pnas.0700412104; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Peoples TL, 2002, GENE DEV, V16, P1682, DOI 10.1101/gad.983802; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Vader G, 2010, CURR BIOL, V20, pR879, DOI 10.1016/j.cub.2010.09.037; Wu HY, 2006, CURR BIOL, V16, P2473, DOI 10.1016/j.cub.2006.10.069	30	70	70	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 1	2011	477	7362					115	U141		10.1038/nature10331	http://dx.doi.org/10.1038/nature10331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813XT	21822291	Green Accepted			2022-12-28	WOS:000294404300043
J	Shinzato, C; Shoguchi, E; Kawashima, T; Hamada, M; Hisata, K; Tanaka, M; Fujie, M; Fujiwara, M; Koyanagi, R; Ikuta, T; Fujiyama, A; Miller, DJ; Satoh, N				Shinzato, Chuya; Shoguchi, Eiichi; Kawashima, Takeshi; Hamada, Mayuko; Hisata, Kanako; Tanaka, Makiko; Fujie, Manabu; Fujiwara, Mayuki; Koyanagi, Ryo; Ikuta, Tetsuro; Fujiyama, Asao; Miller, David J.; Satoh, Nori			Using the Acropora digitifera genome to understand coral responses to environmental change	NATURE			English	Article							IMMUNE GENE REPERTOIRE; CLIMATE-CHANGE; REVEALS; COMPLEXITY; BIOSYNTHESIS; ALIGNMENTS; MECHANISMS; EVOLUTION; SEQUENCE; DATABASE	Despite the enormous ecological and economic importance of coral reefs, the keystone organisms in their establishment, the scleractinian corals, increasingly face a range of anthropogenic challenges including ocean acidification and seawater temperature rise(1-4). To understand better the molecular mechanisms underlying coral biology, here we decoded the approximately 420-megabase genome of Acropora digitifera using next-generation sequencing technology. This genome contains approximately 23,700 gene models. Molecular phylogenetics indicate that the coral and the sea anemone Nematostella vectensis diverged approximately 500 million years ago, considerably earlier than the time over which modern corals are represented in the fossil record (similar to 240 million years ago)(5). Despite the long evolutionary history of the endosymbiosis, no evidence was found for horizontal transfer of genes from symbiont to host. However, unlike several other corals, Acropora seems to lack an enzyme essential for cysteine biosynthesis, implying dependency of this coral on its symbionts for this amino acid. Corals inhabit environments where they are frequently exposed to high levels of solar radiation, and analysis of the Acropora genome data indicates that the coral host can independently carry out de novo synthesis of mycosporine-like amino acids, which are potent ultraviolet-protective compounds. In addition, the coral innate immunity repertoire is notably more complex than that of the sea anemone, indicating that some of these genes may have roles in symbiosis or coloniality. A number of genes with putative roles in calcification were identified, and several of these are restricted to corals. The coral genome provides a platform for understanding the molecular basis of symbiosis and responses to environmental changes.	[Shinzato, Chuya; Shoguchi, Eiichi; Kawashima, Takeshi; Hamada, Mayuko; Hisata, Kanako; Tanaka, Makiko; Fujiwara, Mayuki; Koyanagi, Ryo; Ikuta, Tetsuro; Satoh, Nori] Okinawa Inst Sci & Technol Promot Corp, Marine Genom Unit, Okinawa 9040412, Japan; [Fujiyama, Asao] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Fujie, Manabu] Okinawa Inst Sci & Technol Promot Corp, DNA Sequencing Ctr Sect, Okinawa 9040412, Japan; [Miller, David J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Miller, David J.] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia	Okinawa Institute of Science & Technology Graduate University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Okinawa Institute of Science & Technology Graduate University; James Cook University; James Cook University	Satoh, N (corresponding author), Okinawa Inst Sci & Technol Promot Corp, Marine Genom Unit, Okinawa 9040412, Japan.	norisky@oist.jp	Kawashima, Takeshi/M-4510-2015; Satoh, Nori/C-4123-2009; Shinzato, Chuya/G-2958-2015	Satoh, Nori/0000-0002-4480-3572; Koyanagi, Ryo/0000-0002-9694-0288	IT Section of OIST; Human Genome Center, University of Tokyo; MEXT; JSPS, Japan; Grants-in-Aid for Scientific Research [20121002] Funding Source: KAKEN	IT Section of OIST; Human Genome Center, University of Tokyo; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge A. Iguchi, K. Sakai and all other staff members of the Sesoko Station, Tropical Biosphere Research Center, University of the Ryukyus for their help in collection and maintenance of the coral, M. Hidaka and V. Weis for suggestions, Y. Yokoyama, T. Usami and other staff members of our Unit for sequencing, and S. Brenner, R. Baughman and T. Ichikawa for their support. D. Rokhsar and J. Chapman are acknowledged for suggestions on sequence assembly and gene prediction. The super-computing was supported by the IT Section of OIST and the Human Genome Center, University of Tokyo. This work was supported in part by Grants-in-Aids from MEXT and JSPS, Japan.	Balskus EP, 2010, SCIENCE, V329, P1653, DOI 10.1126/science.1193637; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Davies D.C., 2007, FLOW CYTOMETRY PRINC; Dayarian A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-345; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fujiyama A, 2002, SCIENCE, V295, P131, DOI 10.1126/science.1065199; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hemmrich G, 2008, BIOESSAYS, V30, P1010, DOI 10.1002/bies.20813; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Huang SF, 2008, GENOME RES, V18, P1112, DOI 10.1101/gr.069674.107; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Miller DJ, 2005, TRENDS GENET, V21, P536, DOI 10.1016/j.tig.2005.08.002; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rastogi RP, 2010, J IND MICROBIOL BIOT, V37, P537, DOI 10.1007/s10295-010-0718-5; Sarashina Isao, 2006, Paleontological Research, V10, P311; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Shoguchi E, 2006, GENOME RES, V16, P297, DOI 10.1101/gr.4156606; Smit A, 1996, REPEATMASKER OPEN 30; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wilkinson C., 2004, STATUS CORAL REEFS W; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	44	563	577	20	361	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					320	U82		10.1038/nature10249	http://dx.doi.org/10.1038/nature10249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21785439	Green Accepted, hybrid			2022-12-28	WOS:000294206500035
J	Kaan, HYK; Hackney, DD; Kozielski, F				Kaan, Hung Yi Kristal; Hackney, David D.; Kozielski, Frank			The Structure of the Kinesin-1 Motor-Tail Complex Reveals the Mechanism of Autoinhibition	SCIENCE			English	Article							DIMERIC KINESIN; MOTILITY; PROTEIN; DOMAIN; HEAD; SITE	When not transporting cargo, kinesin-1 is autoinhibited by binding of a tail region to the motor domains, but the mechanism of inhibition is unclear. We report the crystal structure of a motor domain dimer in complex with its tail domain at 2.2 angstroms and compare it with a structure of the motor domain alone at 2.7 angstroms. These structures indicate that neither an induced conformational change nor steric blocking is the cause of inhibition. Instead, the tail cross-links the motor domains at a second position, in addition to the coiled coil. This "double lockdown," by cross-linking at two positions, prevents the movement of the motor domains that is needed to undock the neck linker and release adenosine diphosphate. This autoinhibition mechanism could extend to some other kinesins.	[Kaan, Hung Yi Kristal; Kozielski, Frank] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Hackney, David D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Beatson Institute; Carnegie Mellon University	Kozielski, F (corresponding author), Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	f.kozielski@beatson.gla.ac.uk			Agency for Science, Technology, and Research (A*STAR, Singapore); Cancer Research UK; NIH [NS058848]; NSF [MCB-0615549]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058848] Funding Source: NIH RePORTER	Agency for Science, Technology, and Research (A*STAR, Singapore)(Agency for Science Technology & Research (A*STAR)); Cancer Research UK(Cancer Research UK); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Flot of the European Synchrotron Radiation Facility and European Molecular Biology Laboratory-Grenoble, and M. Muller of Swiss Light Source for assistance and support in using beamlines ID23-2 and PXI, respectively. We also thank E. Dodson for valuable crystallography advice, O. Rath for data collection, V. Ulaganathan for useful discussion, Y. Yeo and M. Kim for assistance in cloning and preparation of mutant kinesin motor domains, and A. Snyder for assistance in preparation of the tail fusion peptide. H. Y. K. K. holds a National Science Scholarship, financed by Agency for Science, Technology, and Research (A*STAR, Singapore), and this publication contains part of her doctoral thesis. We thank Cancer Research UK, NIH (NS058848) and NSF (MCB-0615549) for financial support. Coordinates and structure factor files for the dimer and dimer-tail complex have been deposited in the Protein Data Bank under accession numbers 2Y5W and 2Y65, respectively. The authors declare no competing financial interests.	Cheng JQ, 1998, BIOCHEMISTRY-US, V37, P5288, DOI 10.1021/bi972742j; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Endow SA, 2010, J CELL SCI, V123, P3420, DOI 10.1242/jcs.064113; Hackney DD, 2009, BIOCHEMISTRY-US, V48, P3448, DOI 10.1021/bi8022575; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; Hahlen K, 2006, J BIOL CHEM, V281, P18868, DOI 10.1074/jbc.M508019200; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Kull FJ, 2002, J CELL SCI, V115, P15; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782	15	105	108	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					883	885		10.1126/science.1204824	http://dx.doi.org/10.1126/science.1204824			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836017	Green Accepted			2022-12-28	WOS:000293785400042
J	Aydin, M; Verhulst, KR; Saltzman, ES; Battle, MO; Montzka, SA; Blake, DR; Tang, Q; Prather, MJ				Aydin, Murat; Verhulst, Kristal R.; Saltzman, Eric S.; Battle, Mark O.; Montzka, Stephen A.; Blake, Donald R.; Tang, Qi; Prather, Michael J.			Recent decreases in fossil-fuel emissions of ethane and methane derived from firn air	NATURE			English	Article							VARIABILITY; BUDGET	Methane and ethane are the most abundant hydrocarbons in the atmosphere and they affect both atmospheric chemistry and climate. Both gases are emitted from fossil fuels and biomass burning, whereas methane (CH4) alone has large sources from wetlands, agriculture, landfills and waste water. Here we use measurements in firn (perennial snowpack) air from Greenland and Antarctica to reconstruct the atmospheric variability of ethane (C2H6) during the twentieth century. Ethane levels rose from early in the century until the 1980s, when the trend reversed, with a period of decline over the next 20 years. We find that this variability was primarily driven by changes in ethane emissions from fossil fuels; these emissions peaked in the 1960s and 1970s at 14-16 teragrams per year (1 Tg = 10(12) g) and dropped to 8-10 Tg yr(-1) by the turn of the century. The reduction in fossil-fuel sources is probably related to changes in light hydrocarbon emissions associated with petroleum production and use. The ethane-based fossil-fuel emission history is strikingly different from bottom-up estimates of methane emissions from fossil-fuel use(1,2), and implies that the fossil-fuel source of methane started to decline in the 1980s and probably caused the late twentieth century slow-down in the growth rate of atmospheric methane(3,4).	[Aydin, Murat; Verhulst, Kristal R.; Saltzman, Eric S.; Blake, Donald R.; Tang, Qi; Prather, Michael J.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Battle, Mark O.] Bowdoin Coll, Dept Phys & Astron, Brunswick, ME 04011 USA; [Montzka, Stephen A.] Natl Ocean & Atmospher Adm, Earth Syst Res Labs, Global Monitoring Div, Boulder, CO 80305 USA	University of California System; University of California Irvine; Bowdoin College; National Oceanic Atmospheric Admin (NOAA) - USA	Aydin, M (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	maydin@uci.edu	Tang, Qi/C-1032-2011; montzka, stephen/V-6162-2019	Tang, Qi/0000-0003-2959-0203; montzka, stephen/0000-0002-9396-0400; Blake, Donald/0000-0002-8283-5014	National Science Foundation [ANT-0739598, ANT-0440602, ANT-0440509, ARC-0520460]; NASA [NAG58935]	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	We thank T. Sowers, M. Drier and ICDS drillers for support during firn-air sampling and drilling in the field, and T. Sowers for discussions during preparation of the manuscript. We thank M. Bender and J. Severinghaus for <SUP>15</SUP>N measurements in firn air, S. Meinardi for ethane measurements in surface flasks, and P. Tans and P. Lang for firn-air CO<INF>2</INF> data. This work was supported by the National Science Foundation (grants ANT-0739598, ANT-0440602, ANT-0440509, ARC-0520460) and NASA (grant NAG58935).	Allan W, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007369; Andreae MO, 2001, GLOBAL BIOGEOCHEM CY, V15, P955, DOI 10.1029/2000GB001382; Aydin M, 2010, ATMOS CHEM PHYS, V10, P5135, DOI 10.5194/acp-10-5135-2010; Aydin M, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008027; Barns D. W., 1990, TR047 US DEP COMM NA; Battle M, 1996, NATURE, V383, P231, DOI 10.1038/383231a0; Boissard C, 1996, J ATMOS CHEM, V25, P115, DOI 10.1007/BF00053788; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Dlugokencky EJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039780; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Fain X, 2008, ATMOS CHEM PHYS, V8, P3441, DOI 10.5194/acp-8-3441-2008; Gilardoni A., 2008, WORLD MARKET NATURAL; Hsu J, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006045; Lawler MJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036666; Meure CM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026152; Montzka SA, 2011, SCIENCE, V331, P67, DOI 10.1126/science.1197640; Pozzer A, 2010, ATMOS CHEM PHYS, V10, P4403, DOI 10.5194/acp-10-4403-2010; Prather M., 2001, CLIMATE CHANGE 2001; Prather MJ, 2008, P NATL ACAD SCI USA, V105, P19617, DOI 10.1073/pnas.0806541106; Prinn RG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022228; REMER DS, 1978, ENG PROCESS ECON, V3, P267, DOI 10.1016/0377-841X(78)90007-4; Rigby M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036037; RUDOLPH J, 1995, J GEOPHYS RES-ATMOS, V100, P11369, DOI 10.1029/95JD00693; Schultz MG, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003031; Simpson IJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027330; Stern DI, 1996, CHEMOSPHERE, V33, P159, DOI 10.1016/0045-6535(96)00157-9; Tang Q, 2010, ATMOS CHEM PHYS, V10, P9681, DOI 10.5194/acp-10-9681-2010; Thornton JA, 2010, NATURE, V464, P271, DOI 10.1038/nature08905; van Aardenne JA, 2001, GLOBAL BIOGEOCHEM CY, V15, P909, DOI 10.1029/2000GB001265; Xiao YP, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009415	30	119	119	1	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2011	476	7359					198	201		10.1038/nature10352	http://dx.doi.org/10.1038/nature10352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21833087	Green Published			2022-12-28	WOS:000293731900034
J	Legg, DA; Ma, XY; Wolfe, JM; Ortega-Hernandez, J; Edgecombe, GD; Sutton, MD				Legg, David A.; Ma, Xiaoya; Wolfe, Joanna M.; Ortega-Hernandez, Javier; Edgecombe, Gregory D.; Sutton, Mark D.			Lobopodian phylogeny reanalysed	NATURE			English	Letter							BURGESS SHALE; APPENDAGES		[Legg, David A.; Sutton, Mark D.] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Legg, David A.; Ma, Xiaoya; Edgecombe, Gregory D.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Wolfe, Joanna M.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Ortega-Hernandez, Javier] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	Imperial College London; Natural History Museum London; Yale University; University of Cambridge	Legg, DA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England.	d.legg10@imperial.ac.uk	Wolfe, Joanna M/H-8272-2019	Wolfe, Joanna M/0000-0001-6708-8332; Edgecombe, Gregory/0000-0002-9591-8011				Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Liu JN, 2011, NATURE, V470, P526, DOI 10.1038/nature09704; Ma XY, 2009, ARTHROPOD STRUCT DEV, V38, P271, DOI 10.1016/j.asd.2009.03.001; Zhang XL, 2007, LETHAIA, V40, P161, DOI 10.1111/j.1502-3931.2007.00013.x	5	13	13	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					E2	E3		10.1038/nature10267	http://dx.doi.org/10.1038/nature10267			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21833046				2022-12-28	WOS:000293731900002
J	Kong, MF; Kela, R; Gregory, R				Kong, Marie-France; Kela, Ram; Gregory, Robert			CASE REPORT Weight loss and nausea in a patient taking digoxin	BRITISH MEDICAL JOURNAL			English	Editorial Material							GLUTAMIC-ACID DECARBOXYLASE; SEVERE DIABETIC-KETOACIDOSIS; HYPERGLYCEMIC CRISES; BICARBONATE THERAPY; ADULT PATIENTS; INSULIN; MANAGEMENT; AUTOANTIBODIES; MELLITUS; SERVICE		[Kong, Marie-France; Kela, Ram; Gregory, Robert] Univ Hosp Leicester NHS Trust, Dept Endocrinol & Diabet, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester	Kong, MF (corresponding author), Univ Hosp Leicester NHS Trust, Dept Endocrinol & Diabet, Leicester LE5 4PW, Leics, England.	marie-france.kong@uhl-tr.nhs.uk						ADROGUE HJ, 1982, NEW ENGL J MED, V307, P1603, DOI 10.1056/NEJM198212233072603; Alberti KGGM, 1973, LANCET, V5, P515; Cayir A., 2018, INTERNAL MED REV, V4, DOI [10.18103/imr.v4i12.776, DOI 10.18103/IMR.V4I12.776]; Davies M, 2001, DIABETIC MED, V18, P301, DOI 10.1046/j.1464-5491.2001.00470.x; Edge JA., 2009, BSPED RECOMMENDED DK; GOTTSATER A, 1995, DIABETES RES CLIN PR, V27, P133, DOI 10.1016/0168-8227(95)01026-A; HAMBLIN PS, 1989, MED J AUSTRALIA, V151, P439, DOI 10.5694/j.1326-5377.1989.tb101253.x; Joint British Diabetes Societies Inpatient Care Group, 2010, MAN DIAB KET AD; Kitabchi AE, 2008, DIABETES CARE, V31, P2081, DOI 10.2337/dc08-0509; Kitabchi AE, 2006, DIABETES CARE, V29, P2739, DOI 10.2337/dc06-9916; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; KITABCHI AE, 1976, ANN INTERN MED, V84, P633, DOI 10.7326/0003-4819-84-6-633; LIU P, 2004, J CHIN MED ASSOC, V76, P355; Lohmann T, 2001, DIABETOLOGIA, V44, P1005, DOI 10.1007/s001250100602; Ma OJ, 2003, ACAD EMERG MED, V10, P836, DOI 10.1197/aemj.10.8.836; MORRIS LR, 1986, ANN INTERN MED, V105, P836, DOI 10.7326/0003-4819-105-6-836; Pozzilli P, 2001, DIABETES CARE, V24, P1460, DOI 10.2337/diacare.24.8.1460; Sampson MJ, 2006, DIABETIC MED, V23, P1008, DOI 10.1111/j.1464-5491.2006.01928.x; SOLER NG, 1975, LANCET, V2, P1221; TUOMI T, 1993, DIABETES, V42, P359, DOI 10.2337/diabetes.42.2.359; Turner R, 1997, LANCET, V350, P1288, DOI 10.1016/S0140-6736(97)03062-6; Umpierrez GE, 2006, ANN INTERN MED, V144, P350, DOI 10.7326/0003-4819-144-5-200603070-00011; Viallon A, 1999, CRIT CARE MED, V27, P2690, DOI 10.1097/00003246-199912000-00014; Wiggam MI, 1997, DIABETES CARE, V20, P1347, DOI 10.2337/diacare.20.9.1347; WILSON HK, 1982, ARCH INTERN MED, V142, P517, DOI 10.1001/archinte.142.3.517; Wolfsdorf J, 2006, DIABETES CARE, V29, P1150, DOI 10.2337/dc06-9909	26	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 4	2011	343								d4617	10.1136/bmj.d4617	http://dx.doi.org/10.1136/bmj.d4617			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NO	21816736				2022-12-28	WOS:000293734800003
J	Staines, K; Sloan, P				Staines, Konrad; Sloan, Philip			Syphilitic Chancre of the Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Staines, Konrad; Sloan, Philip] Newcastle Dent Sch, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Staines, K (corresponding author), Newcastle Dent Sch, Newcastle Upon Tyne, Tyne & Wear, England.			, konrad/0000-0001-9108-2790					0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					E11	E11		10.1056/NEJMicm1011576	http://dx.doi.org/10.1056/NEJMicm1011576			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801NW	21812667				2022-12-28	WOS:000293447800010
J	Sharp, PA; Langer, R				Sharp, Phillip A.; Langer, Robert			Promoting Convergence in Biomedical Science	SCIENCE			English	Editorial Material									[Sharp, Phillip A.; Langer, Robert] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu						Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI 10.1038/NNANO.2010.246; Sharp P.A., 2011, 3 REVOLUTION CONVERG; 2011, MIT AAAS FORUM CONVE	3	80	82	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					527	527		10.1126/science.1205008	http://dx.doi.org/10.1126/science.1205008			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798916				2022-12-28	WOS:000293222400026
J	Wu, YH; Vendome, J; Shapiro, L; Ben-Shaul, A; Honig, B				Wu, Yinghao; Vendome, Jeremie; Shapiro, Lawrence; Ben-Shaul, Avinoam; Honig, Barry			Transforming binding affinities from three dimensions to two with application to cadherin clustering	NATURE			English	Article							CELL-ADHESION MOLECULES; SPECIFICITY; MACROMOLECULES; CD2	Membrane-bound receptors often form large assemblies resulting from binding to soluble ligands, cell-surface molecules on other cells and extracellular matrix proteins(1). For example, the association of membrane proteins with proteins on different cells (trans-interactions) can drive the oligomerization of proteins on the same cell(2) (cis-interactions). A central problem in understanding the molecular basis of such phenomena is that equilibrium constants are generally measured in three-dimensional solution and are thus difficult to relate to the two-dimensional environment of a membrane surface. Here we present a theoretical treatment that converts three-dimensional affinities to two dimensions, accounting directly for the structure and dynamics of the membrane-bound molecules. Using a multiscale simulation approach, we apply the theory to explain the formation of ordered, junction-like clusters by classical cadherin adhesion proteins. The approach features atomic-scale molecular dynamics simulations to determine interdomain flexibility, Monte Carlo simulations of multidomain motion and lattice simulations of junction formation(3). A finding of general relevance is that changes in interdomain motion on trans-binding have a crucial role in driving the lateral, cis-, clustering of adhesion receptors.	[Ben-Shaul, Avinoam] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Ben-Shaul, Avinoam] Hebrew Univ Jerusalem, Fritz Haber Res Ctr, IL-91904 Jerusalem, Israel; [Wu, Yinghao; Vendome, Jeremie; Shapiro, Lawrence; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Wu, Yinghao; Vendome, Jeremie; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Wu, Yinghao; Vendome, Jeremie; Honig, Barry] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Shapiro, Lawrence] Columbia Univ, Edward S Harkness Eye Inst, New York, NY 10032 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Ben-Shaul, A (corresponding author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.	abs@fh.huji.ac.il; bh6@columbia.edu	Shapiro, Lawrence/AAE-7172-2019; Califano, Andrea/F-7239-2012		National Science Foundation [MCB-0918535]; National Institutes of Health [R01 GM062270-07]; US-Israel Binational Science Foundation [2006-401]; Israel Science Foundation (ISF) [1448/10, 695/06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062270] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation (ISF)(Israel Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant MCB-0918535 (to B. H.) and National Institutes of Health grant R01 GM062270-07 (to L. S.). The financial support of the US-Israel Binational Science Foundation (grant no. 2006-401, to A.B.-S., B. H. and L. S.) and the Israel Science Foundation (ISF 1448/10 and 695/06) (to A.B.-S.) is acknowledged. We thank E. Sackmann for an email exchange concerning membrane fluctuations.	Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Aricescu AR, 2007, CURR OPIN CELL BIOL, V19, P543, DOI 10.1016/j.ceb.2007.09.010; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; BELL GI, 1984, BIOPHYS J, V45, P1051, DOI 10.1016/S0006-3495(84)84252-6; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Gov NS, 2005, BIOPHYS J, V88, P1859, DOI 10.1529/biophysj.104.045328; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; HILL TL, 1987, INTRO STAT THERMODYN, P147; Hong S, 2010, P NATL ACAD SCI USA, V107, P3528, DOI 10.1073/pnas.0911027107; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Katsamba P, 2009, P NATL ACAD SCI USA, V106, P11594, DOI 10.1073/pnas.0905349106; Li GH, 2002, BIOPHYS J, V83, P2457, DOI 10.1016/S0006-3495(02)75257-0; Milstein O, 2008, J BIOL CHEM, V283, P34414, DOI 10.1074/jbc.M804756200; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Tama F, 2000, PROTEINS, V41, P1; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wu YH, 2010, P NATL ACAD SCI USA, V107, P17592, DOI 10.1073/pnas.1011247107; ZILKER A, 1987, J PHYS-PARIS, V48, P2139, DOI 10.1051/jphys:0198700480120213900	23	165	169	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					510	U107		10.1038/nature10183	http://dx.doi.org/10.1038/nature10183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796210	Green Accepted			2022-12-28	WOS:000293167900043
J	Beatty, PH; Good, AG				Beatty, Perrin H.; Good, Allen G.			Future Prospects for Cereals That Fix Nitrogen	SCIENCE			English	Editorial Material							IRON-MOLYBDENUM COFACTOR; BACTERIA; PROTEINS; SULFUR; RICE		[Beatty, Perrin H.; Good, Allen G.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Alberta	Beatty, PH (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	allen.good@ualberta.ca	Beatty, Perrin H./H-6487-2019; Good, Allen G/A-2644-2014	Beatty, Perrin H./0000-0002-9240-447X; Good, Allen G/0000-0003-4256-355X				Burrill TJ, 1917, AGR EXP STATION B, V202, P113; Charpentier M, 2010, CURR OPIN PLANT BIOL, V13, P556, DOI 10.1016/j.pbi.2010.08.003; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Madsen LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1009; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; MERRICK M, 1984, TRENDS BIOTECHNOL, V2, P162, DOI 10.1016/0167-7799(84)90034-9; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Stoltzfus JR, 1997, PLANT SOIL, V194, P25, DOI 10.1023/A:1004298921641; Yanni YG, 2010, PLANT SOIL, V336, P129, DOI 10.1007/s11104-010-0454-7	14	125	132	7	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					416	417		10.1126/science.1209467	http://dx.doi.org/10.1126/science.1209467			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	795FR	21778391				2022-12-28	WOS:000292959600034
J	Russell, AB; Hood, RD; Bui, NK; LeRoux, M; Vollmer, W; Mougous, JD				Russell, Alistair B.; Hood, Rachel D.; Bui, Nhat Khai; LeRoux, Michele; Vollmer, Waldemar; Mougous, Joseph D.			Type VI secretion delivers bacteriolytic effectors to target cells	NATURE			English	Article							COMPLETE GENOME SEQUENCE; PSEUDOMONAS-AERUGINOSA; STRUCTURAL FEATURES; PROTEIN; SYSTEM; GENE; CATALOG; TOXIN	Peptidoglycan is the major structural constituent of the bacterial cell wall, forming a meshwork outside the cytoplasmic membrane that maintains cell shape and prevents lysis. In Gram-negative bacteria, peptidoglycan is located in the periplasm, where it is protected from exogenous lytic enzymes by the outer membrane. Here we show that the type VI secretion system of Pseudomonas aeruginosa breaches this barrier to deliver two effector proteins, Tse1 and Tse3, to the periplasm of recipient cells. In this compartment, the effectors hydrolyse peptidoglycan, thereby providing a fitness advantage for P. aeruginosa cells in competition with other bacteria. To protect itself from lysis by Tse1 and Tse3, P. aeruginosa uses specific periplasmically localized immunity proteins. The requirement for these immunity proteins depends on intercellular self-intoxication through an active type VI secretion system, indicating a mechanism for export whereby effectors do not access donor cell periplasm in transit.	[Russell, Alistair B.; Hood, Rachel D.; Mougous, Joseph D.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Bui, Nhat Khai; Vollmer, Waldemar] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [LeRoux, Michele] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Newcastle University - UK; University of Washington; University of Washington Seattle	Mougous, JD (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	mougous@u.washington.edu		LeRoux, Michele/0000-0003-2075-4208; Russell, Alistair/0000-0002-5342-2309	National Institutes of Health [RO1 AI080609]; European Commission; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Singh, E. Nester, H. Kulasekara, N. Salama, E. P. Greenberg, L. Ramakrishnan and members of the Mougous laboratory for discussions and critical reading of the manuscript, the Harwood laboratory for use of their microscope, and J. Gray of the Pinnacle Laboratory of Newcastle University for MS analysis. This work was supported by the National Institutes of Health (J. D. M.; RO1 AI080609) and the European Commission within the DIVINOCELL programme (W. V.). A. B. R was supported by a Graduate Research Fellowship from the National Science Foundation.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brook I, 1999, CRIT REV MICROBIOL, V25, P155, DOI 10.1080/10408419991299211; BROTZ H, 1995, ANTIMICROB AGENTS CH, V39, P714, DOI 10.1128/AAC.39.3.714; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; Cardona ST, 2005, PLASMID, V54, P219, DOI 10.1016/j.plasmid.2005.03.004; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Grundling A, 2006, J BACTERIOL, V188, P2463, DOI 10.1128/JB.188.7.2463-2472.2006; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; Imperi F, 2009, PROTEOMICS, V9, P1901, DOI 10.1002/pmic.200800618; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Kanamaru S, 2009, P NATL ACAD SCI USA, V106, P4067, DOI 10.1073/pnas.0901205106; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; LIU J, 1990, P NATL ACAD SCI USA, V87, P4028, DOI 10.1073/pnas.87.11.4028; MORTENSEN JE, 1995, INFECT CONT HOSP EP, V16, P30; Mougous JD, 2004, NAT STRUCT MOL BIOL, V11, P721, DOI 10.1038/nsmb802; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; Reid G, 2001, TRENDS MICROBIOL, V9, P424, DOI 10.1016/S0966-842X(01)02132-1; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Vollmer W, 1997, J BACTERIOL, V179, P1580, DOI 10.1128/jb.179.5.1580-1583.1997; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; WATT SR, 1994, FEMS MICROBIOL LETT, V124, P113, DOI 10.1111/j.1574-6968.1994.tb07270.x; WOOD PM, 1978, FEBS LETT, V92, P214, DOI 10.1016/0014-5793(78)80757-1	48	447	456	6	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					343	U92		10.1038/nature10244	http://dx.doi.org/10.1038/nature10244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21776080	Green Accepted			2022-12-28	WOS:000292911200035
J	Fazel, M; Reed, RV; Panter-Brick, C; Stein, A				Fazel, Mina; Reed, Ruth V.; Panter-Brick, Catherine; Stein, Alan			Mental health of displaced and refugee children resettled in high-income countries: risk and protective factors	LANCET			English	Review							POSTTRAUMATIC-STRESS-DISORDER; ADOLESCENT CAMBODIAN REFUGEES; 6-YEAR FOLLOW-UP; ORGANIZED VIOLENCE; BEHAVIORAL-PROBLEMS; TRAUMATIC STRESS; PSYCHOLOGICAL DISTRESS; CHILDHOOD ADVERSITIES; PRESCHOOL-CHILDREN; POLITICAL VIOLENCE	We undertook a systematic search and review of individual, family, community, and societal risk and protective factors for mental health in children and adolescents who are forcibly displaced to high-income countries. Exposure to violence has been shown to be a key risk factor, whereas stable settlement and social support in the host country have a positive effect on the child's psychological functioning. Further research is needed to identify the relevant processes, contexts, and interplay between the many predictor variables hitherto identified as affecting mental health vulnerability and resilience. Research designs are needed that enable longitudinal investigation of individual, community, and societal contexts, rather than designs restricted to investigation of the associations between adverse exposures and psychological symptoms. We emphasise the need to develop comprehensive policies to ensure a rapid resolution of asylum claims and the effective integration of internally displaced and refugee children.	[Fazel, Mina] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Reed, Ruth V.] Oxford Hlth NHS Fdn Trust, Oxford, England; [Panter-Brick, Catherine] Yale Univ, New Haven, CT USA	University of Oxford; Yale University	Fazel, M (corresponding author), Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England.	mina.fazel@psych.ox.ac.uk		Fazel, Mina/0000-0001-9342-2365; Stein, Alan/0000-0001-8207-2822	Department of Health [PDF-2010-03-10] Funding Source: Medline; National Institute for Health Research [PDF-2010-03-10] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Ager A, 2010, CHILD DEV, V81, P1271, DOI 10.1111/j.1467-8624.2010.01467.x; AJDUKOVIC M, 1993, CHILD ABUSE NEGLECT, V17, P843, DOI 10.1016/S0145-2134(08)80014-2; Almqvist K, 1999, J AM ACAD CHILD PSY, V38, P723, DOI 10.1097/00004583-199906000-00020; Almqvist K, 1997, CHILD ABUSE NEGLECT, V21, P351, DOI 10.1016/S0145-2134(96)00176-7; ALMQVIST K, 1995, AM J ORTHOPSYCHIAT, V65, P225, DOI 10.1037/h0079611; Angel B, 2001, AM J ORTHOPSYCHIAT, V71, P4, DOI 10.1037/0002-9432.71.1.4; Barber BK, 2009, ADOLESCENTS WAR YOUT; Bean T, 2007, J NERV MENT DIS, V195, P288, DOI 10.1097/01.nmd.0000243751.49499.93; Bean TM, 2007, SOC SCI MED, V64, P1204, DOI 10.1016/j.socscimed.2006.11.010; BERRY JW, 1987, INT MIGR REV, V21, P491, DOI 10.2307/2546607; Berthold S. M., 2000, J MULTICULTURAL SOCI, V8, P15, DOI [DOI 10.1300/J285V08N01_, DOI 10.1300/J285V08N01_02]; Berthold SM, 1999, J TRAUMA STRESS, V12, P455, DOI 10.1023/A:1024715003442; Betancourt TS, 2008, INTERVENTION, V6, P39, DOI 10.1097/WTF.0b013e3282f761ff; Betancourt TS, 2008, INT REV PSYCHIATR, V20, P317, DOI 10.1080/09540260802090363; Bodegard G, 2005, ACTA PAEDIATR, V94, P1706, DOI 10.1080/08035250510036778; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Catani C, 2010, CHILD DEV, V81, P1176, DOI 10.1111/j.1467-8624.2010.01461.x; COHN J, 1985, LANCET, V2, P437; Correa-Velez I, 2010, SOC SCI MED, V71, P1399, DOI 10.1016/j.socscimed.2010.07.018; CSDH, 2008, CLOS GAP GEN HLTH EQ; Daud A., 2008, CHILD ADOLESCENT PSY, V2, P1; Derluyn I, 2008, EUR CHILD ADOLES PSY, V17, P54, DOI 10.1007/s00787-007-0636-x; Derluyn I, 2007, ETHNIC HEALTH, V12, P141, DOI 10.1080/13557850601002296; Derluyn I, 2009, J ADOLESCENT HEALTH, V44, P291, DOI 10.1016/j.jadohealth.2008.07.016; Eggerman M, 2010, SOC SCI MED, V71, P71, DOI 10.1016/j.socscimed.2010.03.023; EKBLAD S, 1993, STRESS MEDICINE, V9, P159, DOI 10.1002/smi.2460090306; Ellis BH, 2008, J CONSULT CLIN PSYCH, V76, P184, DOI 10.1037/0022-006X.76.2.184; Ellis BH, 2010, AM J ORTHOPSYCHIAT, V80, P564, DOI 10.1111/j.1939-0025.2010.01061.x; Feijen L, 2008, REFUG SURV Q, V27, P63, DOI 10.1093/rsq/hdn049; Fox P G, 1999, Int J Psychiatr Nurs Res, V5, P589; Geltman PL, 2005, ARCH PEDIAT ADOL MED, V159, P585, DOI 10.1001/archpedi.159.6.585; Goldin S, 2001, Med Confl Surviv, V17, P25, DOI 10.1080/13623690108409553; Goodman JH, 2004, QUAL HEALTH RES, V14, P1177, DOI 10.1177/1049732304265923; Green H., 2005, J RES SPEC EDUC NEED; Grgic M, 2005, COLLEGIUM ANTROPOL, V29, P537; Grgic M, 2005, DRUS ISTRAZ, V14, P597; Heptinstall E, 2004, EUR CHILD ADOLES PSY, V13, P373, DOI 10.1007/s00787-004-0422-y; Hinton DE, 2009, SOC SCI MED, V69, P1387, DOI 10.1016/j.socscimed.2009.08.018; Hjern A, 1998, SCAND J SOC MED, V26, P18, DOI 10.1177/14034948980260010701; HJERN A, 1991, CHILD ABUSE NEGLECT, V15, P239, DOI 10.1016/0145-2134(91)90068-O; Hjern A, 2000, ACTA PAEDIATR, V89, P722, DOI 10.1080/080352500750044089; Hobfoll SE, 2001, APPL PSYCHOL-INT REV, V50, P337, DOI 10.1111/1464-0597.00062; Hodes M, 2008, J CHILD PSYCHOL PSYC, V49, P723, DOI 10.1111/j.1469-7610.2008.01912.x; HUBBARD J, 1995, J AM ACAD CHILD PSY, V34, P1167, DOI 10.1097/00004583-199509000-00014; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Kia-Keating Maryam, 2007, Clin Child Psychol Psychiatry, V12, P29, DOI 10.1177/1359104507071052; Kocijan-Hercigonja D, 1998, NORD J PSYCHIAT, V52, P45, DOI 10.1080/080394898422562; Kostelny K., 2006, WORLD TURNED UPSIDE, P19; Kovacev L, 2004, INT J BEHAV DEV, V28, P259, DOI 10.1080/01650250344000497; Kuwert P, 2009, INT PSYCHOGERIATR, V21, P748, DOI 10.1017/S1041610209009107; Leao TS, 2005, ETHNIC HEALTH, V10, P243, DOI 10.1080/13557850500096878; Liebkind K, 1996, J CROSS CULT PSYCHOL, V27, P161, DOI 10.1177/0022022196272002; Liebkind K., 1993, J REFUG STUD, V6, P25, DOI DOI 10.1093/JRS/6.1.25; Lorek A, 2009, CHILD ABUSE NEGLECT, V33, P573, DOI 10.1016/j.chiabu.2008.10.005; Luthar SS, 2006, DEV PSYCHOL, V3, P739, DOI DOI 10.1002/9780470939406.CH20; Mares S., 2002, AUSTRALAS PSYCHIATRY, V10, P91, DOI [DOI 10.1046/J.1440-1665.2002, DOI 10.1046/j.1440-1665.2002.00414.x]; Mghir R, 1999, INT J SOC PSYCHIATR, V45, P29, DOI 10.1177/002076409904500104; Miller KE, 2010, SOC SCI MED, V70, P7, DOI 10.1016/j.socscimed.2009.09.029; Montgomery E, 2008, SOC SCI MED, V67, P1596, DOI 10.1016/j.socscimed.2008.07.020; Montgomery E, 2006, INT J METH PSYCH RES, V15, P64, DOI 10.1002/mpr.186; Montgomery E, 2010, DEV PSYCHOPATHOL, V22, P477, DOI 10.1017/S0954579410000180; Mortimore P, 1979, 15000 HOURS SECONDAR; NGUYEN NA, 1989, J AM ACAD CHILD PSY, V28, P505, DOI 10.1097/00004583-198907000-00007; Nielsen SS, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-293; Panter-Brick C, 2011, J AM ACAD CHILD PSY, V50, P349, DOI 10.1016/j.jaac.2010.12.001; PHINNEY JS, 1990, PSYCHOL BULL, V108, P499, DOI 10.1037/0033-2909.108.3.499; PORTE Z, 1987, AM J ORTHOPSYCHIAT, V57, P536, DOI 10.1111/j.1939-0025.1987.tb03569.x; Powell S, 2003, J CLIN PSYCHOL, V59, P71, DOI 10.1002/jclp.10117; PSIH, SAR 2000 PSYCH CONS; Pynoos RS, 1999, BIOL PSYCHIAT, V46, P1542, DOI 10.1016/S0006-3223(99)00262-0; Reed RV, 2012, LANCET, V379, P250, DOI 10.1016/S0140-6736(11)60050-0; Reijneveld SA, 2005, J NERV MENT DIS, V193, P759, DOI 10.1097/01.nmd.0000185870.55678.82; RICK K, 1992, J CROSS CULT PSYCHOL, V23, P85, DOI 10.1177/0022022192231006; Rothe EM, 2002, PSYCHIAT SERV, V53, P970, DOI 10.1176/appi.ps.53.8.970; Rousseau C, 1997, SOC SCI MED, V44, P1115, DOI 10.1016/S0277-9536(96)00243-2; Rousseau C, 2003, CHILD ABUSE NEGLECT, V27, P1277, DOI 10.1016/j.chiabu.2003.07.001; Rousseau C, 1998, Psychoanal Rev, V85, P615; Rousseau C, 2000, CAN J PSYCHIAT, V45, P905, DOI 10.1177/070674370004501005; Rousseau C, 1999, CHILD ABUSE NEGLECT, V23, P1263, DOI 10.1016/S0145-2134(99)00100-3; Rousseau C., 1998, J REFUG STUD, V11, P20, DOI [DOI 10.1093/JRS/11.1.20, 10.1093/jrs/11.1.20]; Rousseau Cecile, 2004, Med Confl Surviv, V20, P151, DOI 10.1080/1362369042000234735; Ryan D, 2008, J REFUG STUD, V21, P1, DOI 10.1093/jrs/fem047; SACK WH, 1995, J NERV MENT DIS, V183, P177, DOI 10.1097/00005053-199503000-00009; SACK WH, 1994, J NERV MENT DIS, V182, P387, DOI 10.1097/00005053-199407000-00004; SACK WH, 1993, J AM ACAD CHILD PSY, V32, P431, DOI 10.1097/00004583-199303000-00027; Sack WH, 1999, J AM ACAD CHILD PSY, V38, P1173, DOI 10.1097/00004583-199909000-00023; Sack WH, 1998, CHILD ADOL PSYCH CL, V7, P153, DOI 10.1016/S1056-4993(18)30265-7; Sagi-Schwartz A, 2003, AM J PSYCHIAT, V160, P1086, DOI 10.1176/appi.ajp.160.6.1086; Silove D, 2000, JAMA-J AM MED ASSOC, V284, P604, DOI 10.1001/jama.284.5.604; Slodnjak Vera, 2002, Crisis, V23, P127; Sourander A, 1998, CHILD ABUSE NEGLECT, V22, P719, DOI 10.1016/S0145-2134(98)00053-2; Steel Z, 2004, AUST NZ J PUBL HEAL, V28, P527, DOI 10.1111/j.1467-842X.2004.tb00042.x; Stein A, 2008, RUTTERS CHILD ADOLES, P407, DOI DOI 10.1002/9781444300895.CH27; Sujoldzic A, 2006, COLLEGIUM ANTROPOL, V30, P703; Tol WA, 2008, JAMA-J AM MED ASSOC, V300, P655, DOI 10.1001/jama.300.6.655; Tousignant M, 1999, J AM ACAD CHILD PSY, V38, P1426, DOI 10.1097/00004583-199911000-00018; UNHCR, 2009, 2008 GLOB TRENDS REF; Williams N, 2010, J CHILD HEALTH CARE, V14, P35, DOI 10.1177/1367493509347116; ZIVCIC I, 1993, J AM ACAD CHILD PSY, V32, P709, DOI 10.1097/00004583-199307000-00002	99	712	718	3	215	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2012	379	9812					266	282		10.1016/S0140-6736(11)60051-2	http://dx.doi.org/10.1016/S0140-6736(11)60051-2			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879FW	21835459				2022-12-28	WOS:000299316100041
J	Reed, RV; Fazel, M; Jones, L; Panter-Brick, C; Stein, A				Reed, Ruth V.; Fazel, Mina; Jones, Lynne; Panter-Brick, Catherine; Stein, Alan			Mental health of displaced and refugee children resettled in low-income and middle-income countries: risk and protective factors	LANCET			English	Review							POSTTRAUMATIC-STRESS-DISORDER; POLITICAL VIOLENCE; PSYCHOSOCIAL INTERVENTION; WAR TRAUMA; PSYCHOLOGICAL DISTRESS; CHILDHOOD ADVERSITIES; DOMESTIC VIOLENCE; CENTRAL-AMERICAN; NORTHERN UGANDA; ADOLESCENTS	Children and adolescents who are forcibly displaced represent almost half the world's internally displaced and refugee populations. We undertook a two-part systematic search and review of the evidence-base for individual, family, community, and societal risk and protective factors for the mental health outcomes of children and adolescents. Here we review data for displacement to low-income and middle-income settings. We draw together the main findings from reports to identify important issues and establish recommendations for future work. We draw attention to exposure to violence as a well established risk factor for poor mental health. We note the paucity of research into predictor variables other than those in the individual domain and the neglect of other variables for the assessment of causal associations, including potential mediators and moderators identifiable in longitudinal work. We conclude with research and policy recommendations to guide the development and assessment of effective interventions.	[Fazel, Mina] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Reed, Ruth V.] Oxford Hlth NHS Fdn Trust, Oxford, England; [Jones, Lynne] Harvard Univ, Radcliff Inst Adv Study, Cambridge, MA 02138 USA; [Panter-Brick, Catherine] Yale Univ, New Haven, CT USA	University of Oxford; Harvard University; Yale University	Fazel, M (corresponding author), Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England.	mina.fazel@psych.ox.ac.uk	Breakwell, Lauren/ABD-2739-2020; bolzani, berliete/F-8406-2013	Stein, Alan/0000-0001-8207-2822; Fazel, Mina/0000-0001-9342-2365	Department of Health [PDF-2010-03-10] Funding Source: Medline; National Institute for Health Research [PDF-2010-03-10] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Ahmad A, 2000, EUR CHILD ADOLES PSY, V9, P235, DOI 10.1007/s007870070026; AJDUKOVIC M, 1993, CHILD ABUSE NEGLECT, V17, P843, DOI 10.1016/S0145-2134(08)80014-2; Al-Krenawi A, 2007, AM J ORTHOPSYCHIAT, V77, P427, DOI 10.1037/0002-9432.77.3.427; Allden K, 2009, PREHOSP DISASTER MED, V24, pE217, DOI 10.1017/S1049023X00021622; Allwood MA, 2002, J AM ACAD CHILD PSY, V41, P450, DOI 10.1097/00004583-200204000-00018; Attanayake Vindya, 2009, Med Confl Surviv, V25, P4, DOI 10.1080/13623690802568913; Barber BK, 2009, ADOLESCENTS WAR YOUT; Bayer CP, 2007, JAMA-J AM MED ASSOC, V298, P555, DOI 10.1001/jama.298.5.555; Bean T, 2007, J NERV MENT DIS, V195, P288, DOI 10.1097/01.nmd.0000243751.49499.93; Bean TM, 2007, SOC SCI MED, V64, P1204, DOI 10.1016/j.socscimed.2006.11.010; Betancourt TS, 2008, INTERVENTION, V6, P39, DOI 10.1097/WTF.0b013e3282f761ff; Bolton P, 2007, JAMA-J AM MED ASSOC, V298, P519, DOI 10.1001/jama.298.5.519; Boothby N., 1992, J REFUGEE STUD, V5, P106, DOI [10.1093/jrs/5.2.106, DOI 10.1093/JRS/5.2.106]; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Cairns E, 1996, CHILD DEV, V67, P129, DOI 10.2307/1131691; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Catani C, 2008, J MARITAL FAM THER, V34, P165, DOI 10.1111/j.1752-0606.2008.00062.x; Catani C, 2010, CHILD DEV, V81, P1176, DOI 10.1111/j.1467-8624.2010.01461.x; Clark CJ, 2010, LANCET, V375, P310, DOI 10.1016/S0140-6736(09)61827-4; CSDH, 2008, CLOS GAP GEN HLTH EQ; Dapo N., 2002, SARAJEVO 2000 THEPSY, P150; de Jong JP, 2000, ACTA PSYCHIAT SCAND, V102, P171, DOI 10.1034/j.1600-0447.2000.102003171.x; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; De Jong JTVM, 2002, TRANSCULT PSYCHIATRY, V39, P422, DOI DOI 10.1177/136346150203900402; Derluyn I, 2007, ETHNIC HEALTH, V12, P141, DOI 10.1080/13557850601002296; Dolma S, 2006, AM J PUBLIC HEALTH, V96, P2061, DOI 10.2105/AJPH.2005.067777; Dugan J, 2000, J HUMANITARIAN ASSIS; Dybdahl R, 2001, CHILD DEV, V72, P1214, DOI 10.1111/1467-8624.00343; Dyregrov K, 2000, J TRAUMA STRESS, V13, P413, DOI 10.1023/A:1007777006605; Eggerman M, 2010, SOC SCI MED, V71, P71, DOI 10.1016/j.socscimed.2010.03.023; EISENBRUCH M, 1988, INT MIGR REV, V22, P282, DOI 10.2307/2546651; EKBLAD S, 1993, STRESS MEDICINE, V9, P159, DOI 10.1002/smi.2460090306; Erol NE, 2005, EUR PSYCHIAT, V20, P152, DOI 10.1016/j.eurpsy.2004.09.033; Farwell N., 2003, INT J MENT HEALTH, V32, P20, DOI [10.1080/00207411.2003.11449596, DOI 10.1080/00207411.2003.11449596]; Fazel M, 2005, LANCET, V365, P1309, DOI 10.1016/S0140-6736(05)61027-6; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; Freud A., 1973, WRITINGS A FREUD, V3; Gagnon Anita J, 2004, Health Care Women Int, V25, P111, DOI 10.1080/07399330490267503; GARMEZY N, 1971, AM J ORTHOPSYCHIAT, V41, P101, DOI 10.1111/j.1939-0025.1971.tb01111.x; Giacaman R, 2007, PUBLIC HEALTH, V121, P563, DOI 10.1016/j.puhe.2006.10.021; Goldin S, 2003, NORD J PSYCHIAT, V57, P173, DOI 10.1080/08039480310001319; Goldstein RD, 1997, PEDIATRICS, V100, P873, DOI 10.1542/peds.100.5.873; Goodman R, 2005, SOC PSYCH PSYCH EPID, V40, P11, DOI 10.1007/s00127-005-0851-z; Green H., 2005, J RES SPEC EDUC NEED; Gupta L, 2008, BRIT J PSYCHIAT, V192, P212, DOI 10.1192/bjp.bp.107.038182; Harrell-Bond B, 2001, REFUGEE CHILDREN CAI; Hasanovic M, 2005, CROAT MED J, V46, P105; Hodes M, 2008, J CHILD PSYCHOL PSYC, V49, P723, DOI 10.1111/j.1469-7610.2008.01912.x; Hollifield M, 2002, JAMA-J AM MED ASSOC, V288, P611, DOI 10.1001/jama.288.5.611; Inter-Agency Standing Committee (IASC), 2007, AM PSYCHOL ASS, DOI [DOI 10.1037/E518422011-002, 10.1037/e518422011-002]; Izutsu T, 2005, Asia Pac J Public Health, V17, P93, DOI 10.1177/101053950501700206; Jones L, 2002, SOC SCI MED, V55, P1351, DOI 10.1016/S0277-9536(01)00275-1; Jones L., 2005, CLIN CHILD PSYCHOL P, V10, P157, DOI [10.1177/1359104505051209, DOI 10.1177/1359104505051209]; Jones L, 2005, THEN THEY STARTED SH; Jones L, 2009, LANCET, V374, P654, DOI 10.1016/S0140-6736(09)61253-8; Jordans MJD, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-15; Kalipeni E, 1998, SOC SCI MED, V46, P1637, DOI 10.1016/S0277-9536(97)10129-0; Karacic S, 2000, SARAJEVO 2000 PSYCHO, P192; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Khamis V, 2000, CHILD ABUSE NEGLECT, V24, P1047, DOI 10.1016/S0145-2134(00)00157-5; Khamis V, 2005, CHILD ABUSE NEGLECT, V29, P81, DOI 10.1016/j.chiabu.2004.06.013; Kohli R., 2003, CHILD FAM SOC WORK, V8, P201, DOI DOI 10.1046/J; Kostelny K., 2008, DJP, V3, P13; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; Locke CJ, 1996, ARCH PEDIAT ADOL MED, V150, P822, DOI 10.1001/archpedi.1996.02170330048008; Loughry M, 2001, CHILD ABUSE NEGLECT, V25, P249, DOI 10.1016/S0145-2134(00)00240-4; Maegusuku-Hewett T., 2007, CHILDREN SOC, V21, P309, DOI [10.1111/j.1099-0860.2007.00102.xMagyar-Haas,Veronika(2017).AusgesetzterKu┬rper,verletzbarerLeib.ZurRegulierbarkeitvonEmotionen.ZeitschriftfuarSoziologiederErziehungundSozialisation,37(1),39-54, DOI 10.1111/J.1099-0860.2007.00102.X]; Marshall GN, 2005, JAMA-J AM MED ASSOC, V294, P571, DOI 10.1001/jama.294.5.571; Masten A, 2006, BLACKWELL HDB EARLY; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; McCallin M., 1988, REPORT PILOT STUDY A; McDermott B, 2004, J PSYCHIAT, V11, P269; Mels C, 2010, J CHILD PSYCHOL PSYC, V51, P1096, DOI 10.1111/j.1469-7610.2010.02241.x; Miller KE, 1996, CHILD DEV, V67, P89, DOI 10.1111/j.1467-8624.1996.tb01721.x; Miller KE, 2010, SOC SCI MED, V70, P7, DOI 10.1016/j.socscimed.2009.09.029; Mills Edward, 2008, Med Confl Surviv, V24, P5, DOI 10.1080/13623690701775171; Mollica RF, 1997, J AM ACAD CHILD PSY, V36, P1098, DOI 10.1097/00004583-199708000-00017; Mollica RF, 2004, LANCET, V364, P2058, DOI 10.1016/S0140-6736(04)17519-3; Montgomery E, 1998, SCAND J SOC MED, P1; Montgomery E, 2006, INT J METH PSYCH RES, V15, P64, DOI 10.1002/mpr.186; Morgos D, 2007, OMEGA-J DEATH DYING, V56, P229, DOI 10.2190/OM.56.3.b; Moss WJ, 2006, B WORLD HEALTH ORGAN, V84, P58, DOI 10.2471/BLT.04.019570; Muchini B., 1993, Journal of Social Development in Africa, V8, P49; Osmanovic A, 2000, SARAJEVO 2000 PSYCHO, P188; Paardekooper B, 1999, J CHILD PSYCHOL PSYC, V40, P529, DOI 10.1017/S002196309900390X; Panter-Brick C, 2011, J AM ACAD CHILD PSY, V50, P349, DOI 10.1016/j.jaac.2010.12.001; Panter-Brick C, 2009, LANCET, V374, P807, DOI 10.1016/S0140-6736(09)61080-1; Pedersen D, 2002, SOC SCI MED, V55, P175, DOI 10.1016/S0277-9536(01)00261-1; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Qouta S, 2003, EUR CHILD ADOLES PSY, V12, P265, DOI 10.1007/s00787-003-0328-0; Rahman A, 2003, ACTA PSYCHIAT SCAND, V108, P392, DOI 10.1034/j.1600-0447.2003.00220.x; Rodin D, 2009, INT J EPIDEMIOL, V38, P1045, DOI 10.1093/ije/dyp203; Rose BM, 2004, J DEV BEHAV PEDIATR, V25, P58, DOI 10.1097/00004703-200402000-00013; Rousseau C, 1998, Psychoanal Rev, V85, P615; Rousseau C, 2000, CAN J PSYCHIAT, V45, P905, DOI 10.1177/070674370004501005; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Rutter ML, 1999, BRIT J PSYCHIAT, V174, P480, DOI 10.1192/bjp.174.6.480; Seedat Soraya, 2004, Curr Psychiatry Rep, V6, P262, DOI 10.1007/s11920-004-0075-z; Servan-Schreiber D, 1998, J AM ACAD CHILD PSY, V37, P874, DOI 10.1097/00004583-199808000-00018; Sharan P, 2007, RES CAPACITY MENTAL; SHISANA O, 1985, SOC SCI MED, V21, P1251, DOI 10.1016/0277-9536(85)90274-6; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Stein A, 2008, RUTTERS CHILD ADOLES, P407, DOI DOI 10.1002/9781444300895.CH27; Sujoldzic A, 2006, COLLEGIUM ANTROPOL, V30, P703; Thabet AAM, 2004, J CHILD PSYCHOL PSYC, V45, P533, DOI 10.1111/j.1469-7610.2004.00243.x; Thabet AAM, 1998, ARCH DIS CHILD, V78, P439, DOI 10.1136/adc.78.5.439; Thomas S, 2003, BRIT MED J, V327, P1400, DOI 10.1136/bmj.327.7428.1400; Tol WA, 2008, JAMA-J AM MED ASSOC, V300, P655, DOI 10.1001/jama.300.6.655; Tol WA, 2010, J CONSULT CLIN PSYCH, V78, P818, DOI 10.1037/a0021348; Tousignant M, 1999, J AM ACAD CHILD PSY, V38, P1426, DOI 10.1097/00004583-199911000-00018; UNDP, 2009, OV BARR HUM MOB DEV; UNHCR, 2010, GLOB REP 2009 GLOB REP 2009; UNHCR, 2003, SEX GEND BAS VIOL RE; UNHCR, 2005, GLOB REP 2004; UNHCR, 2009, 2008 GLOB TRENDS REF; UNHCR, 2010, UNHCR DEPL FORC RET; UNHRC, 2007, REP HIGH LEV MISS SI; US Committee for Refugees and Immigrants, 2008, WORLD REF SURV 2007; Van Ommeren M, 2001, PSYCHOL MED, V31, P1259, DOI 10.1017/S0033291701004470; Wadsworth ME, 2005, J CONSULT CLIN PSYCH, V73, P1146, DOI 10.1037/0022-006X.73.6.1146; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; Weiss MG, 2003, J NERV MENT DIS, V191, P611, DOI 10.1097/01.nmd.0000087188.96516.a3; WILLIAMS HA, 1990, HUM ORGAN, V49, P100, DOI 10.17730/humo.49.2.r2614223v222l7x5; Williams N, 2010, J CHILD HEALTH CARE, V14, P35, DOI 10.1177/1367493509347116; World Bank, 2009, WORLD DEV IND DAT; Yurtbay T, 2003, COMMUNITY MENT HLT J, V39, P203, DOI 10.1023/A:1023386122344	126	274	274	1	77	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2012	379	9812					250	265		10.1016/S0140-6736(11)60050-0	http://dx.doi.org/10.1016/S0140-6736(11)60050-0			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879FW	21835460				2022-12-28	WOS:000299316100040
J	Mello, MM; Messing, NA				Mello, Michelle M.; Messing, Noah A.			Restrictions on the Use of Prescribing Data for Drug Promotion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIANS; 1ST-AMENDMENT		[Mello, Michelle M.] Harvard Univ, Sch Med, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Messing, Noah A.] Yale Univ, Sch Law, New Haven, CT 06520 USA	Harvard University; Harvard Medical School; Yale University	Mello, MM (corresponding author), Harvard Univ, Sch Med, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mmello@hsph.harvard.edu		Mello, Michelle/0000-0003-2877-4270				*AM MED ASS, AMA PROGR HELPS PROT; Campo Katia, 2005, Health Mark Q, V22, P73; Caudill TS, 1996, ARCH FAM MED, V5, P201, DOI 10.1001/archfami.5.4.201; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Curfman GD, 2011, NEW ENGL J MED, V364, P2053, DOI 10.1056/NEJMe1104460; Grande D, 2007, ANN INTERN MED, V146, P751, DOI 10.7326/0003-4819-146-10-200705150-00010; Grande D, 2009, NEW ENGL J MED, V360, P747, DOI 10.1056/NEJMp0810410; Greene JA, 2007, ANN INTERN MED, V146, P742, DOI 10.7326/0003-4819-146-10-200705150-00008; Kesselheim AS, 2008, NEW ENGL J MED, V358, P1727, DOI 10.1056/NEJMsb0708920; Orentlicher D, 2010, J LAW MED ETHICS, V38, P74, DOI 10.1111/j.1748-720X.2010.00468.x; PEAY MY, 1988, SOC SCI MED, V26, P1183, DOI 10.1016/0277-9536(88)90149-9; Post R, 2009, NEW ENGL J MED, V360, P745, DOI 10.1056/NEJMp0810339; Steinbrook R, 2006, NEW ENGL J MED, V354, P2745, DOI 10.1056/NEJMp068125; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; 2004, INT M AMA HOUS DEL D, P140	15	16	17	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1248	1254		10.1056/NEJMhle1107678	http://dx.doi.org/10.1056/NEJMhle1107678			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825YO	21812664				2022-12-28	WOS:000295318400016
J	Nowack, KC; Shafiei, M; Laforest, M; Prawiroatmodjo, GEDK; Schreiber, LR; Reichl, C; Wegscheider, W; Vandersypen, LMK				Nowack, K. C.; Shafiei, M.; Laforest, M.; Prawiroatmodjo, G. E. D. K.; Schreiber, L. R.; Reichl, C.; Wegscheider, W.; Vandersypen, L. M. K.			Single-Shot Correlations and Two-Qubit Gate of Solid-State Spins	SCIENCE			English	Article							QUANTUM-DOT; ELECTRON-SPIN; COHERENT MANIPULATION; SPECTROSCOPY; COMPUTATION; READOUT	Measurement of coupled quantum systems plays a central role in quantum information processing. We have realized independent single-shot read-out of two electron spins in a double quantum dot. The read-out method is all-electrical, cross-talk between the two measurements is negligible, and read-out fidelities are similar to 86% on average. This allows us to directly probe the anticorrelations between two spins prepared in a singlet state and to demonstrate the operation of the two-qubit exchange gate on a complete set of basis states. The results provide a possible route to the realization and efficient characterization of multiqubit quantum circuits based on single quantum dot spins.	[Nowack, K. C.; Shafiei, M.; Laforest, M.; Prawiroatmodjo, G. E. D. K.; Schreiber, L. R.; Vandersypen, L. M. K.] Delft Univ Technol, Kavli Inst Nanosci, NL-2600 GA Delft, Netherlands; [Reichl, C.; Wegscheider, W.] ETH, Solid State Phys Lab, CH-8093 Zurich, Switzerland	Delft University of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich	Nowack, KC (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, POB 5046, NL-2600 GA Delft, Netherlands.	k.c.nowack@tudelft.nl; l.m.k.vandersypen@tudelft.nl		Schreiber, Lars/0000-0003-0904-9612	Army Research Office; Dutch Foundation for Fundamental Research on Matter; European Research Council (ERC); European Commission (SOLID); Swiss National Science Foundation; Le Fonds Quebecois de la Recherche sur la Nature et les Technologies	Army Research Office; Dutch Foundation for Fundamental Research on Matter(FOM (The Netherlands)); European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission (SOLID)(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Le Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT)	We thank P. Barthelemy, F. Braakman, L. DiCarlo, S. Frolov, R. Hanson, E. Laird, J. Mooij, and P. Scarlino for useful discussions; R. Schouten for electronics support; P. de Groot and R. Heeres for help with the measurement software; and A. van der Enden, J. Haanstra, and R. Roeleveld for general technical support. We acknowledge funding from the Intelligence Advanced Research Projects Activity through the Army Research Office, the Dutch Foundation for Fundamental Research on Matter, the European Research Council (ERC starting grant), and the European Commission (SOLID). C. R. and W. W. acknowledge financial support by the Swiss National Science Foundation. M. L. acknowledges support from Le Fonds Quebecois de la Recherche sur la Nature et les Technologies.	Amasha S, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.041306; Atature M, 2007, NAT PHYS, V3, P101, DOI 10.1038/nphys521; Barthel C, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161308; Barthel C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.160503; Berezovsky J, 2006, SCIENCE, V314, P1916, DOI 10.1126/science.1133862; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Engel HA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.106804; Foletti S, 2009, NAT PHYS, V5, P903, DOI 10.1038/NPHYS1424; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hanson R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196802; Hanson R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.196802; Hanson R, 2008, NATURE, V453, P1043, DOI 10.1038/nature07129; Heinrich AJ, 2004, SCIENCE, V306, P466, DOI 10.1126/science.1101077; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Khaetskii AV, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.125316; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Meier F, 2008, SCIENCE, V320, P82, DOI 10.1126/science.1154415; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Oosterkamp TH, 1998, NATURE, V395, P873, DOI 10.1038/27617; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Potok RM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.016802; Reilly DJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2794995; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Sellier H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.206805; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700; Simmons CB, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.156804; Taubert D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.176805; Taylor JM, 2005, NAT PHYS, V1, P177, DOI 10.1038/nphys174; Vamivakas AN, 2010, NATURE, V467, P297, DOI 10.1038/nature09359	31	160	162	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 2	2011	333	6047					1269	1272		10.1126/science.1209524	http://dx.doi.org/10.1126/science.1209524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	813YM	21817015				2022-12-28	WOS:000294406400048
J	Porter, DL; Levine, BL; Kalos, M; Bagg, A; June, CH				Porter, David L.; Levine, Bruce L.; Kalos, Michael; Bagg, Adam; June, Carl H.			Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; ADVERSE EVENT; PHASE-I; SURVIVAL; CANCER; TRANSPLANTATION; SPECIFICITY; EXPRESSION; RITUXIMAB	We designed a lentiviral vector expressing a chimeric antigen receptor with specificity for the B-cell antigen CD19, coupled with CD137 (a costimulatory receptor in T cells [4-1BB]) and CD3-zeta (a signal-transduction component of the T-cell antigen receptor) signaling domains. A low dose (approximately 1.5x10(5) cells per kilogram of body weight) of autologous chimeric antigen receptor-modified T cells reinfused into a patient with refractory chronic lymphocytic leukemia (CLL) expanded to a level that was more than 1000 times as high as the initial engraftment level in vivo, with delayed development of the tumor lysis syndrome and with complete remission. Apart from the tumor lysis syndrome, the only other grade 3/4 toxic effect related to chimeric antigen receptor T cells was lymphopenia. Engineered cells persisted at high levels for 6 months in the blood and bone marrow and continued to express the chimeric antigen receptor. A specific immune response was detected in the bone marrow, accompanied by loss of normal B cells and leukemia cells that express CD19. Remission was ongoing 10 months after treatment. Hypogammaglobulinemia was an expected chronic toxic effect.	[Porter, David L.; Levine, Bruce L.; Kalos, Michael; Bagg, Adam; June, Carl H.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Porter, David L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Levine, Bruce L.; Kalos, Michael; Bagg, Adam; June, Carl H.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Levine, Bruce L.; Kalos, Michael; June, Carl H.] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Porter, David L.] Univ Penn, Med Ctr, Div Hematol & Oncol, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Porter, DL (corresponding author), Univ Penn, Med Ctr, Div Hematol & Oncol, Dept Med, 3400 Civ Ctr Blvd,PCAM 2 W Pavil, Philadelphia, PA 19104 USA.	david.porter@uphs.upenn.edu	Bagg, Adam/R-8450-2019; Levine, Bruce L/D-1688-2009	June, Carl/0000-0003-0241-3557	National Institutes of Health [K24 CA11787901, 1PN2-EY016586, R01CA120409]; Alliance for Cancer Gene Therapy; Leukemia and Lymphoma Society [7000-02]; NATIONAL CANCER INSTITUTE [R01CA120409, K24CA117879] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Cancer Gene Therapy; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by grants from the National Institutes of Health (K24 CA11787901, 1PN2-EY016586, and R01CA120409), the Alliance for Cancer Gene Therapy, and the Leukemia and Lymphoma Society (7000-02).	Baeksgaard L, 2003, CANCER CHEMOTH PHARM, V51, P187, DOI 10.1007/s00280-002-0556-x; Brentjens R, 2010, MOL THER, V18, P666, DOI 10.1038/mt.2010.31; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; DOHNER H, 1995, BLOOD, V85, P1580, DOI 10.1182/blood.V85.6.1580.bloodjournal8561580; Gribben JG, 2011, BIOL BLOOD MARROW TR, V17, pS63, DOI 10.1016/j.bbmt.2010.10.011; GROSS G, 1989, P NATL ACAD SCI USA, V86, P10024, DOI 10.1073/pnas.86.24.10024; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Jena B, 2010, BLOOD, V116, P1035, DOI 10.1182/blood-2010-01-043737; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; June CH, 2009, NAT REV IMMUNOL, V9, P704, DOI 10.1038/nri2635; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Klebanoff CA, 2005, TRENDS IMMUNOL, V26, P298, DOI 10.1016/j.it.2004.04.006; Klebanoff CA, 2005, TRENDS IMMUNOL, V26, P111, DOI 10.1016/j.it.2004.12.003; Kohn DB, 2011, MOL THER, V19, P432, DOI 10.1038/mt.2011.1; Lamanna N, 2006, J CLIN ONCOL, V24, P1575, DOI 10.1200/JCO.2005.04.3836; Milone MC, 2009, MOL THER, V17, P1453, DOI 10.1038/mt.2009.83; Molina A, 2008, ANNU REV MED, V59, P237, DOI 10.1146/annurev.med.59.060906.220345; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Porter DL, 2006, BLOOD, V107, P1325, DOI 10.1182/blood-2005-08-3373; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Ramakrishnan R, 2010, J CLIN INVEST, V120, P1111, DOI 10.1172/JCI40269; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; Sorror ML, 2008, BLOOD, V111, P446, DOI 10.1182/blood-2007-07-098483; Till BG, 2008, BLOOD, V112, P2261, DOI 10.1182/blood-2007-12-128843; UCKUN FM, 1988, BLOOD, V71, P13; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	27	2453	2832	93	816	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 25	2011	365	8					725	733		10.1056/NEJMoa1103849	http://dx.doi.org/10.1056/NEJMoa1103849			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811JM	21830940	Green Accepted			2022-12-28	WOS:000294205300008
J	Sobolev, AV; Hofmann, AW; Jochum, KP; Kuzmin, DV; Stoll, B				Sobolev, Alexander V.; Hofmann, Albrecht W.; Jochum, Klaus Peter; Kuzmin, Dmitry V.; Stoll, Brigitte			A young source for the Hawaiian plume	NATURE			English	Article							MELT INCLUSIONS; OCEANIC-CRUST; MANTLE; PB; EVOLUTION; BASALTS; HETEROGENEITY; SR-87/SR-86; ENRICHMENT; OLIVINE	Recycling of oceanic crust through subduction, mantle upwelling, and remelting in mantle plumes is a widely accepted mechanism to explain ocean island volcanism(1). The timescale of this recycling is important to our understanding of mantle circulation rates. Correlations of uranogenic lead isotopes in lavas from ocean islands such as Hawaii or Iceland, when interpreted as model isochrons, have yielded source differentiation ages between 1 and 2.5 billion years (Gyr)(2-5). However, if such correlations are produced by mixing of unrelated mantle components(6) they will have no direct age significance. Re-Os decay model ages take into account the mixing of sources with different histories(7,8), but they depend on the assumed initial Re/Os ratio of the subducted crust, which is poorly constrained because of the high mobility of rhenium during subduction(9). Here we report the first data on Sr-87/Sr-86 ratios for 138 melt inclusions in olivine phenocrysts from lavas of Mauna Loa shield volcano, Hawaii, indicating enormous mantle source heterogeneity. We show that highly radiogenic strontium in severely rubidium-depleted melt inclusions matches the isotopic composition of 200-650-Myr-old sea water. We infer that such sea water must have contaminated the Mauna Loa source rock, before subduction, imparting a unique 'time stamp' on this source. Small amounts of seawater-derived strontium in plume sources may be common but can be identified clearly only in ultra-depleted melts originating from generally highly (incompatible-element) depleted source components. The presence of 200-650-Myr-old oceanic crust in the source of Hawaiian lavas implies a timescale of general mantle circulation with an average rate of about 2 (+/- 1) cm yr(-1), much faster than previously thought. [GRAPHICS] .	[Sobolev, Alexander V.] Univ Grenoble 1, ISTerre, F-38041 Grenoble, France; [Sobolev, Alexander V.] CNRS, F-38041 Grenoble, France; [Sobolev, Alexander V.; Hofmann, Albrecht W.; Jochum, Klaus Peter; Kuzmin, Dmitry V.; Stoll, Brigitte] Max Planck Inst Chem, D-55020 Mainz, Germany; [Sobolev, Alexander V.] Russian Acad Sci, VI Vernadskii Inst Geochem & Analyt Chem, Moscow 119991, Russia; [Hofmann, Albrecht W.] Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Kuzmin, Dmitry V.] Russian Acad Sci, Siberian Branch, VS Sobolev Inst Geol & Mineral, Novosibirsk 630090, Russia	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); Max Planck Society; Russian Academy of Sciences; Vernadsky Institute of Geochemistry & Analytical Chemistry; Columbia University; Russian Academy of Sciences; Sobolev Institute of Geology & Mineralogy of the Russian Academy of Sciences	Sobolev, AV (corresponding author), Univ Grenoble 1, ISTerre, BP 53, F-38041 Grenoble, France.	alexander.sobolev@ujf-grenoble.fr	Kuzmin, Dmitry/A-3809-2014; Sobolev, Alexander/AAQ-6001-2021; Sobolev, Alexander/E-6367-2010; Sobolev, Alexander/AAB-4269-2021	Sobolev, Alexander/0000-0002-1997-2032; 	Agence Nationale de la Recherche, France, Chair of Excellence [ANR-09-CEXC-003-01]; Russian Foundation for Basic Research [09-05-01193a]; Russian President grant for leading Russian scientific schools [HIII-3919.2010.5]; Earth Sciences Department of Russian Academy	Agence Nationale de la Recherche, France, Chair of Excellence(French National Research Agency (ANR)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian President grant for leading Russian scientific schools; Earth Sciences Department of Russian Academy	We thank A. T. Anderson for providing the Puu-Wahi sample, N. Groschopf for help in managing the electron probe microanalyser, A. Yasevich and O. Kuzmina for sample preparation, and G. Worner, N. Arndt and F. Holtz for discussions. This study was funded by an Agence Nationale de la Recherche, France, Chair of Excellence grant (ANR-09-CEXC-003-01) to A.V.S.. Partial support by a Gauss Professorship in Gottingen University, Germany, the Russian Foundation for Basic Research (09-05-01193a), a Russian President grant for leading Russian scientific schools (HIII-3919.2010.5), and Earth Sciences Department of Russian Academy grants to A.V.S. are also acknowledged. This is Lamont Doherty Earth Observatory contribution 7479.	Abouchami W, 2000, CHEM GEOL, V169, P187, DOI 10.1016/S0009-2541(00)00328-4; Bach W, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000419; Benoit M, 1999, NATURE, V402, P514, DOI 10.1038/990073; Brandon AD, 2007, GEOCHIM COSMOCHIM AC, V71, P4570, DOI 10.1016/j.gca.2007.07.015; CHASE CG, 1981, EARTH PLANET SC LETT, V52, P277, DOI 10.1016/0012-821X(81)90182-5; Coggon RM, 2010, SCIENCE, V327, P1114, DOI 10.1126/science.1182252; Farnetani CG, 2009, EARTH PLANET SC LETT, V282, P314, DOI 10.1016/j.epsl.2009.03.035; Halverson GP, 2007, PALAEOGEOGR PALAEOCL, V256, P103, DOI 10.1016/j.palaeo.2007.02.028; Hofmann A.W., 2003, TREAT GEOCHEM, V2, P61, DOI DOI 10.1016/B0-08-043751-6/02123-X; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; Jackson MG, 2006, EARTH PLANET SC LETT, V245, P260, DOI 10.1016/j.epsl.2006.02.040; Jarosewich E., 1980, GEOSTANDARD NEWSLETT, V4, P43, DOI [10.1111/j.1751-908X.1980.tb00273.x, DOI 10.1111/J.1751-908X.1980.TB00273.X]; Jochum KP, 2009, J ANAL ATOM SPECTROM, V24, P1237, DOI 10.1039/b905045k; Jochum KP, 2006, J ANAL ATOM SPECTROM, V21, P666, DOI 10.1039/b603890e; Jochum KP, 2000, GEOSTANDARD NEWSLETT, V24, P87, DOI 10.1111/j.1751-908X.2000.tb00590.x; Marschall HR, 2007, CHEM GEOL, V239, P323, DOI 10.1016/j.chemgeo.2006.08.008; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; McKenzie D, 2004, GEOCHIM COSMOCHIM AC, V68, P2699, DOI 10.1016/j.gca.2003.10.029; Muinos SB, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001766; Niu YL, 2004, J PETROL, V45, P2423, DOI 10.1093/petrology/egh068; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; ROSS K, 1993, NATURE, V365, P826, DOI 10.1038/365826a0; Saal AE, 1998, SCIENCE, V282, P1481, DOI 10.1126/science.282.5393.1481; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Shields G, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000266; Sobolev AV, 2008, SCIENCE, V321, P536, DOI 10.1126/science.1158452; Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; Sobolev AV, 2005, NATURE, V434, P590, DOI 10.1038/nature03411; Sobolev AV, 2000, NATURE, V404, P986, DOI 10.1038/35010098; SOBOLEV AV, 1993, NATURE, V363, P151, DOI 10.1038/363151a0; Sobolev AV, 1996, PETROLOGY+, V4, P209; STAUDIGEL H, 1981, EARTH PLANET SC LETT, V52, P311, DOI 10.1016/0012-821X(81)90186-2; Staudigel H., 1996, SUBDUCTION TOP BOTTO, V96, P19; SUN SS, 1975, CONTRIB MINERAL PETR, V52, P77, DOI 10.1007/BF00395006; Sun WD, 2004, EARTH PLANET SC LETT, V222, P101, DOI 10.1016/j.epsl.2004.02.011; TATSUMOTO M, 1978, EARTH PLANET SC LETT, V38, P63, DOI 10.1016/0012-821X(78)90126-7; Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9	38	71	75	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					434	437		10.1038/nature10321	http://dx.doi.org/10.1038/nature10321			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21832996				2022-12-28	WOS:000294209400032
J	Selosse, MA; Rousset, F				Selosse, Marc-Andre; Rousset, Francois			The Plant-Fungal Marketplace	SCIENCE			English	Editorial Material							MYCORRHIZAL; LAND		[Selosse, Marc-Andre] CNRS, CEFE, Montpellier, France; [Rousset, Francois] Univ Montpellier 2, Inst Sci Evolut ISEM, Montpellier, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Selosse, MA (corresponding author), CNRS, CEFE, Montpellier, France.	marc-andre.selosse@cefe.cnrs.fr	Rousset, Francois/C-7360-2008; Rousset, Francois/GRJ-3980-2022	Rousset, Francois/0000-0003-4670-0371; Rousset, Francois/0000-0003-4670-0371				Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bshary R, 2004, ADV STUD BEHAV, V34, P59, DOI 10.1016/S0065-3454(04)34002-7; Courty PE, 2011, PLANT PHYSIOL, V156, P952, DOI 10.1104/pp.111.177618; Johnstone RA, 2008, J EVOLUTION BIOL, V21, P879, DOI 10.1111/j.1420-9101.2008.01505.x; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Nehls U, 2010, PLANT BIOLOGY, V12, P292, DOI 10.1111/j.1438-8677.2009.00312.x; NEWSHAM KK, 1995, TRENDS ECOL EVOL, V10, P407, DOI 10.1016/S0169-5347(00)89157-0; Peterson R. L., 2004, Mycorrhizas: anatomy and cell biology; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Selosse MA, 1998, TRENDS ECOL EVOL, V13, P15, DOI 10.1016/S0169-5347(97)01230-5; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd; Wang B, 2010, NEW PHYTOL, V186, P514, DOI 10.1111/j.1469-8137.2009.03137.x	15	57	67	3	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					828	829		10.1126/science.1210722	http://dx.doi.org/10.1126/science.1210722			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836002				2022-12-28	WOS:000293785400024
J	Van Doren, M				Van Doren, Mark			Determining Sexual Identity	SCIENCE			English	Editorial Material							DROSOPHILA-MELANOGASTER; GERM-CELLS; SOMA; LETHAL; LINE		Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Van Doren, M (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	vandoren@jhu.edu						BACHILLER D, 1986, DEV BIOL, V118, P379, DOI 10.1016/0012-1606(86)90007-2; Bergere M, 2002, HUM REPROD, V17, P32, DOI 10.1093/humrep/17.1.32; Camara N, 2008, CURR TOP DEV BIOL, V83, P65, DOI 10.1016/S0070-2153(08)00403-1; CLINE TW, 1979, DEV BIOL, V72, P266, DOI 10.1016/0012-1606(79)90117-9; GRANADINO B, 1993, DEVELOPMENT, V118, P813; Hager JH, 1997, DEVELOPMENT, V124, P5033; Hashiyama K, 2011, SCIENCE, V333, P885, DOI 10.1126/science.1208146; MARSH JL, 1978, NATURE, V272, P249, DOI 10.1038/272249a0; Murray SM, 2010, CURR OPIN CELL BIOL, V22, P722, DOI 10.1016/j.ceb.2010.09.006; Reynaud K, 2004, FERTIL STERIL, V81, P1112, DOI 10.1016/j.fertnstert.2003.12.011; Sciurano RB, 2009, HUM REPROD, V24, P2353, DOI 10.1093/humrep/dep180; STEINMANNZWICKY M, 1993, DEVELOPMENT, V117, P763; Van Doren M, 1998, CURR BIOL, V8, P243; Wawersik M, 2005, NATURE, V436, P563, DOI 10.1038/nature03849; Wikstrom AM, 2008, HORM RES, V69, P317, DOI 10.1159/000117387	15	5	5	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2011	333	6044					829	830		10.1126/science.1210282	http://dx.doi.org/10.1126/science.1210282			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836003				2022-12-28	WOS:000293785400025
J	Sawcer, S; Hellenthal, G; Pirinen, M; Spencer, CCA; Patsopoulos, NA; Moutsianas, L; Dilthey, A; Su, Z; Freeman, C; Hunt, SE; Edkins, S; Gray, E; Booth, DR; Potter, SC; Goris, A; Band, G; Oturai, AB; Strange, A; Saarela, J; Bellenguez, C; Fontaine, B; Gillman, M; Hemmer, B; Gwilliam, R; Zipp, F; Jayakumar, A; Martin, R; Leslie, S; Hawkins, S; Giannoulatou, E; D'alfonso, S; Blackburn, H; Boneschi, FM; Liddle, J; Harbo, HF; Perez, ML; Spurkland, A; Waller, MJ; Mycko, MP; Ricketts, M; Comabella, M; Hammond, N; Kockum, I; McCann, OT; Ban, M; Whittaker, P; Kemppinen, A; Weston, P; Hawkins, C; Widaa, S; Zajicek, J; Dronov, S; Robertson, N; Bumpstead, SJ; Barcellos, LF; Ravindrarajah, R; Abraham, R; Alfredsson, L; Ardlie, K; Aubin, C; Baker, A; Baker, K; Baranzini, SE; Bergamaschi, L; Bergamaschi, R; Bernstein, A; Berthele, A; Boggild, M; Bradfield, JP; Brassat, D; Broadley, SA; Buck, D; Butzkueven, H; Capra, R; Carroll, WM; Cavalla, P; Celius, EG; Cepok, S; Chiavacci, R; Clerget-Darpoux, F; Clysters, K; Comi, G; Cossburn, M; Cournu-Rebeix, I; Cox, MB; Cozen, W; Cree, BAC; Cross, AH; Cusi, D; Daly, MJ; Davis, E; de Bakker, PIW; Debouverie, M; D'hooghe, MB; Dixon, K; Dobosi, R; Dubois, B; Ellinghaus, D; Elovaara, I; Esposito, F; Fontenille, C; Foote, S; Franke, A; Galimberti, D; Ghezzi, A; Glessner, J; Gomez, R; Gout, O; Graham, C; Grant, SFA; Guerini, FR; Hakonarson, H; Hall, P; Hamsten, A; Hartung, HP; Heard, RN; Heath, S; Hobart, J; Hoshi, M; Infante-Duarte, C; Ingram, G; Ingram, W; Islam, T; Jagodic, M; Kabesch, M; Kermode, AG; Kilpatrick, TJ; Kim, C; Klopp, N; Koivisto, K; Larsson, M; Lathrop, M; Lechner-Scott, JS; Leone, MA; Leppa, V; Liljedahl, U; Bomfim, IL; Lincoln, RR; Link, J; Liu, JJ; Lorentzen, AR; Lupoli, S; Macciardi, F; Mack, T; Marriott, M; Martinelli, V; Mason, D; McCauley, JL; Mentch, F; Mero, IL; Mihalova, T; Montalban, X; Mottershead, J; Myhr, KM; Naldi, P; Ollier, W; Page, A; Palotie, A; Pelletier, J; Piccio, L; Pickersgill, T; Piehl, F; Pobywajlo, S; Quach, HL; Ramsay, PP; Reunanen, M; Reynolds, R; Rioux, J; Rodegher, M; Roesner, S; Rubio, JP; Ruckert, IM; Salvetti, M; Salvi, E; Santaniello, A; Schaefer, CA; Schreiber, S; Schulze, C; Scott, RJ; Sellebjerg, F; Selmaj, KW; Sexton, D; Shen, L; Simms-Acuna, B; Skidmore, S; Sleiman, PMA; Smestad, C; Sorensen, PS; Sondergaard, HB; Stankovich, J; Strange, RC; Sulonen, AM; Sundqvist, E; Syvanen, AC; Taddeo, F; Taylor, B; Blackwell, JM; Tienari, P; Bramon, E; Tourbah, A; Brown, MA; Tronczynska, E; Casas, JP; Tubridy, N; Corvin, A; Vickery, J; Jankowski, J; Villoslada, P; Markus, HS; Wang, K; Mathew, CG; Wason, J; Palmer, CNA; Wichmann, HE; Plomin, R; Willoughby, E; Rautanen, A; Winkelmann, J; Wittig, M; Trembath, RC; Yaouanq, J; Viswanathan, AC; Zhang, HT; Wood, NW; Zuvich, R; Deloukas, P; Langford, C; Duncanson, A; Oksenberg, JR; Pericak-Vance, MA; Haines, JL; Olsson, T; Hillert, J; Ivinson, AJ; De Jager, PL; Peltonen, L; Stewart, GJ; Hafler, DA; Hauser, SL; McVean, G; Donnelly, P; Compston, A				Sawcer, Stephen; Hellenthal, Garrett; Pirinen, Matti; Spencer, Chris C. A.; Patsopoulos, Nikolaos A.; Moutsianas, Loukas; Dilthey, Alexander; Su, Zhan; Freeman, Colin; Hunt, Sarah E.; Edkins, Sarah; Gray, Emma; Booth, David R.; Potter, Simon C.; Goris, An; Band, Gavin; Oturai, Annette Bang; Strange, Amy; Saarela, Janna; Bellenguez, Celine; Fontaine, Bertrand; Gillman, Matthew; Hemmer, Bernhard; Gwilliam, Rhian; Zipp, Frauke; Jayakumar, Alagurevathi; Martin, Roland; Leslie, Stephen; Hawkins, Stanley; Giannoulatou, Eleni; D'alfonso, Sandra; Blackburn, Hannah; Boneschi, Filippo Martinelli; Liddle, Jennifer; Harbo, Hanne F.; Perez, Marc L.; Spurkland, Anne; Waller, Matthew J.; Mycko, Marcin P.; Ricketts, Michelle; Comabella, Manuel; Hammond, Naomi; Kockum, Ingrid; McCann, Owen T.; Ban, Maria; Whittaker, Pamela; Kemppinen, Anu; Weston, Paul; Hawkins, Clive; Widaa, Sara; Zajicek, John; Dronov, Serge; Robertson, Neil; Bumpstead, Suzannah J.; Barcellos, Lisa F.; Ravindrarajah, Rathi; Abraham, Roby; Alfredsson, Lars; Ardlie, Kristin; Aubin, Cristin; Baker, Amie; Baker, Katharine; Baranzini, Sergio E.; Bergamaschi, Laura; Bergamaschi, Roberto; Bernstein, Allan; Berthele, Achim; Boggild, Mike; Bradfield, Jonathan P.; Brassat, David; Broadley, Simon A.; Buck, Dorothea; Butzkueven, Helmut; Capra, Ruggero; Carroll, William M.; Cavalla, Paola; Celius, Elisabeth G.; Cepok, Sabine; Chiavacci, Rosetta; Clerget-Darpoux, Francoise; Clysters, Katleen; Comi, Giancarlo; Cossburn, Mark; Cournu-Rebeix, Isabelle; Cox, Mathew B.; Cozen, Wendy; Cree, Bruce A. C.; Cross, Anne H.; Cusi, Daniele; Daly, Mark J.; Davis, Emma; de Bakker, Paul I. W.; Debouverie, Marc; D'hooghe, Marie Beatrice; Dixon, Katherine; Dobosi, Rita; Dubois, Benedicte; Ellinghaus, David; Elovaara, Irina; Esposito, Federica; Fontenille, Claire; Foote, Simon; Franke, Andre; Galimberti, Daniela; Ghezzi, Angelo; Glessner, Joseph; Gomez, Refujia; Gout, Olivier; Graham, Colin; Grant, Struan F. A.; Guerini, Franca Rosa; Hakonarson, Hakon; Hall, Per; Hamsten, Anders; Hartung, Hans-Peter; Heard, Rob N.; Heath, Simon; Hobart, Jeremy; Hoshi, Muna; Infante-Duarte, Carmen; Ingram, Gillian; Ingram, Wendy; Islam, Talat; Jagodic, Maja; Kabesch, Michael; Kermode, Allan G.; Kilpatrick, Trevor J.; Kim, Cecilia; Klopp, Norman; Koivisto, Keijo; Larsson, Malin; Lathrop, Mark; Lechner-Scott, Jeannette S.; Leone, Maurizio A.; Leppa, Virpi; Liljedahl, Ulrika; Bomfim, Izaura Lima; Lincoln, Robin R.; Link, Jenny; Liu, Jianjun; Lorentzen, Aslaug R.; Lupoli, Sara; Macciardi, Fabio; Mack, Thomas; Marriott, Mark; Martinelli, Vittorio; Mason, Deborah; McCauley, Jacob L.; Mentch, Frank; Mero, Inger-Lise; Mihalova, Tania; Montalban, Xavier; Mottershead, John; Myhr, Kjell-Morten; Naldi, Paola; Ollier, William; Page, Alison; Palotie, Aarno; Pelletier, Jean; Piccio, Laura; Pickersgill, Trevor; Piehl, Fredrik; Pobywajlo, Susan; Quach, Hong L.; Ramsay, Patricia P.; Reunanen, Mauri; Reynolds, Richard; Rioux, Johnd.; Rodegher, Mariaemma; Roesner, Sabine; Rubio, Justin P.; Rueckert, Ina-Maria; Salvetti, Marco; Salvi, Erika; Santaniello, Adam; Schaefer, Catherine A.; Schreiber, Stefan; Schulze, Christian; Scott, Rodney J.; Sellebjerg, Finn; Selmaj, Krzysztof W.; Sexton, David; Shen, Ling; Simms-Acuna, Brigid; Skidmore, Sheila; Sleiman, Patrick M. A.; Smestad, Cathrine; Sorensen, Per Soelberg; Sondergaard, Helle Bach; Stankovich, Jim; Strange, Richard C.; Sulonen, Anna-Maija; Sundqvist, Emilie; Syvaenen, Ann-Christine; Taddeo, Francesca; Taylor, Bruce; Blackwell, Jenefer M.; Tienari, Pentti; Bramon, Elvira; Tourbah, Ayman; Brown, Matthew A.; Tronczynska, Ewa; Casas, Juan P.; Tubridy, Niall; Corvin, Aiden; Vickery, Jane; Jankowski, Janusz; Villoslada, Pablo; Markus, Hugh S.; Wang, Kai; Mathew, Christopher G.; Wason, James; Palmer, Colin N. A.; Wichmann, H-Erich; Plomin, Robert; Willoughby, Ernest; Rautanen, Anna; Winkelmann, Juliane; Wittig, Michael; Trembath, Richard C.; Yaouanq, Jacqueline; Viswanathan, Ananth C.; Zhang, Haitao; Wood, Nicholas W.; Zuvich, Rebecca; Deloukas, Panos; Langford, Cordelia; Duncanson, Audrey; Oksenberg, Jorge R.; Pericak-Vance, Margaret A.; Haines, Jonathan L.; Olsson, Tomas; Hillert, Jan; Ivinson, Adrian J.; De Jager, Philip L.; Peltonen, Leena; Stewart, Graeme J.; Hafler, David A.; Hauser, Stephen L.; McVean, Gil; Donnelly, Peter; Compston, Alastair		Int Multiple Sclerosis Genetics Co; Wellcome Trust Case Control Consor	Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis	NATURE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; HETEROGENEITY; HAPLOTYPES; VARIANTS; ALLELES	Multiple sclerosis is a common disease of the central nervous system in which the interplay between inflammatory and neurodegenerative processes typically results in intermittent neurological disturbance followed by progressive accumulation of disability(1). Epidemiological studies have shown that genetic factors are primarily responsible for the substantially increased frequency of the disease seen in the relatives of affected individuals(2,3), and systematic attempts to identify linkage in multiplex families have confirmed that variation within the major histocompatibility complex (MHC) exerts the greatest individual effect on risk(4). Modestly powered genome-wide association studies (GWAS)(5-10) have enabled more than 20 additional risk loci to be identified and have shown that multiple variants exerting modest individual effects have a key role in disease susceptibility(11). Most of the genetic architecture underlying susceptibility to the disease remains to be defined and is anticipated to require the analysis of sample sizes that are beyond the numbers currently available to individual research groups. In a collaborative GWAS involving 9,772 cases of European descent collected by 23 research groups working in 15 different countries, we have replicated almost all of the previously suggested associations and identified at least a further 29 novel susceptibility loci. Within the MHC we have refined the identity of the HLA-DRB1 risk alleles and confirmed that variation in the HLA-A gene underlies the independent protective effect attributable to the class I region. Immunologically relevant genes are significantly overrepresented among those mapping close to the identified loci and particularly implicate T-helper-cell differentiation in the pathogenesis of multiple sclerosis.	[Sawcer, Stephen; Ban, Maria; Kemppinen, Anu; Baker, Amie; Skidmore, Sheila; Compston, Alastair] Univ Cambridge, Dept Clin Neurosci, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Hellenthal, Garrett; Pirinen, Matti; Spencer, Chris C. A.; Su, Zhan; Freeman, Colin; Band, Gavin; Strange, Amy; Bellenguez, Celine; Giannoulatou, Eleni; Rautanen, Anna; McVean, Gil; Donnelly, Peter] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Patsopoulos, Nikolaos A.; de Bakker, Paul I. W.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet,Dept Med, Boston, MA 02115 USA; [Patsopoulos, Nikolaos A.; Ardlie, Kristin; Aubin, Cristin; Daly, Mark J.; de Bakker, Paul I. W.; De Jager, Philip L.; Hafler, David A.] Broad Inst Harvard Univ & Massachusetts Inst Tech, Cambridge, MA 02142 USA; [Patsopoulos, Nikolaos A.; Pobywajlo, Susan; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; [Moutsianas, Loukas; Dilthey, Alexander; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Hunt, Sarah E.; Edkins, Sarah; Gray, Emma; Potter, Simon C.; Gillman, Matthew; Gwilliam, Rhian; Jayakumar, Alagurevathi; Blackburn, Hannah; Liddle, Jennifer; Perez, Marc L.; Waller, Matthew J.; Ricketts, Michelle; Hammond, Naomi; McCann, Owen T.; Whittaker, Pamela; Weston, Paul; Widaa, Sara; Dronov, Serge; Bumpstead, Suzannah J.; Ravindrarajah, Rathi; Palotie, Aarno; Deloukas, Panos; Langford, Cordelia] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Booth, David R.; Heard, Rob N.; Stewart, Graeme J.] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2145, Australia; [Goris, An; Clysters, Katleen; Dobosi, Rita; Dubois, Benedicte] Katholieke Univ Leuven, Sect Expt Neurol, Lab Neuroimmunol, B-3000 Louvain, Belgium; [Oturai, Annette Bang; Sellebjerg, Finn; Sorensen, Per Soelberg; Sondergaard, Helle Bach] Rigshosp, Copenhagen Univ Hosp, Dept Neurol, Danish Multiple Sclerosis Ctr, DK-2100 Copenhagen, Denmark; [Saarela, Janna; Leppa, Virpi; Palotie, Aarno; Sulonen, Anna-Maija] Univ Helsinki, Inst Mol Med Finland FIMM, FIN-00290 Helsinki, Finland; [Fontaine, Bertrand; Cournu-Rebeix, Isabelle; Fontenille, Claire] UPMC, AP HP, INSERM UMR S CRICM 975, Dept Neurol Pitie Salpetriere, F-75013 Paris, France; [Hemmer, Bernhard; Berthele, Achim; Buck, Dorothea; Cepok, Sabine; Hoshi, Muna; Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-81675 Munich, Germany; [Zipp, Frauke] Johannes Gutenberg Univ Mainz, Univ Med Mainz, Dept Neurol, D-55131 Mainz, Germany; [Zipp, Frauke; Martin, Roland] Max Delbrueck Ctr Mol Med, D-13092 Berlin, Germany; [Roesner, Sabine] Ctr Mol Neurobiol, Inst Neuroimmunol & Clin MS Res Inims, D-20251 Hamburg, Germany; [Leslie, Stephen] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England; [Hawkins, Stanley] Queens Univ Belfast, Belfast BT7 1NN, Antrim, North Ireland; [D'alfonso, Sandra; Bergamaschi, Laura] Univ Piemonte Orientale, Dept Med Sci, I-28100 Novara, Italy; [D'alfonso, Sandra; Bergamaschi, Laura] Univ Piemonte Orientale, IRCAD, I-28100 Novara, Italy; [Boneschi, Filippo Martinelli; Comi, Giancarlo; Esposito, Federica; Martinelli, Vittorio; Rodegher, Mariaemma] Ist Sci San Raffaele, Dept Neurol, Inst Expt Neurol INSPE, Div Neurosci, I-20132 Milan, Italy; [Harbo, Hanne F.; Celius, Elisabeth G.; Mero, Inger-Lise; Smestad, Cathrine] Oslo Univ Hosp, Dept Neurol, N-0407 Oslo, Norway; [Harbo, Hanne F.; Lorentzen, Aslaug R.] Univ Oslo, Dept Neurol, N-0318 Oslo, Norway; [Spurkland, Anne] Univ Oslo, Inst Basal Med Sci, N-0317 Oslo, Norway; [Mycko, Marcin P.; Selmaj, Krzysztof W.; Tronczynska, Ewa] Med Univ Lodz, Lab Neuroimmunol, Dept Neurol, PL-90153 Lodz, Poland; [Comabella, Manuel; Montalban, Xavier] Vall dHebron Univ Hosp, Multiple Sclerosis Ctr Catalonia CEM Cat, Clin Neuroinmunol Unit, Barcelona 08035, Spain; [Kockum, Ingrid; Jagodic, Maja; Bomfim, Izaura Lima; Link, Jenny; Piehl, Fredrik; Sundqvist, Emilie; Olsson, Tomas; Hillert, Jan] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med CMM, Dept Clin Neurosci, SE-17176 Stockholm, Sweden; [Hawkins, Clive; Abraham, Roby; Mihalova, Tania; Strange, Richard C.] Keele Univ, Sch Med, Stoke On Trent ST4 7NY, Staffs, England; [Zajicek, John; Hobart, Jeremy; Ingram, Wendy; Vickery, Jane] Univ Exeter, Peninsula Coll Med & Dent, Plymouth PL6 8BX, Devon, England; [Zajicek, John; Hobart, Jeremy; Ingram, Wendy; Vickery, Jane] Univ Plymouth, Clin Neurol Res Grp, Plymouth PL6 8BX, Devon, England; [Robertson, Neil; Baker, Katharine; Cossburn, Mark; Ingram, Gillian; Pickersgill, Trevor] Univ Wales Hosp, Dept Neurol, Cardiff CF14 4XW, S Glam, Wales; [Barcellos, Lisa F.; Quach, Hong L.; Ramsay, Patricia P.] Univ Calif Berkeley, Genet Epidemiol & Genom Lab, Div Epidemiol, Sch Publ Hlth, Berkeley, CA 94720 USA; [Barcellos, Lisa F.; Bernstein, Allan; Schaefer, Catherine A.; Shen, Ling; Simms-Acuna, Brigid] Kaiser Permanente No Calif Div Res, Oakland, CA 94612 USA; [Alfredsson, Lars] Karolinska Inst, Inst Expt Med, S-17177 Stockholm, Sweden; [Baranzini, Sergio E.; Cree, Bruce A. C.; Gomez, Refujia; Lincoln, Robin R.; Santaniello, Adam; Oksenberg, Jorge R.; Hauser, Stephen L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Bergamaschi, Roberto] IRCCS, Neurol Inst C Mondino, I-27100 Pavia, Italy; [Boggild, Mike] Walton Ctr Neurol & Neurosurg, Liverpool L7 9LJ, Merseyside, England; [Bradfield, Jonathan P.; Chiavacci, Rosetta; Glessner, Joseph; Grant, Struan F. A.; Hakonarson, Hakon; Kim, Cecilia; Mentch, Frank; Sleiman, Patrick M. A.; Wang, Kai; Zhang, Haitao] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Brassat, David] INSERM, U1043, F-31059 Toulouse, France; [Brassat, David] Hop Purpan, F-31059 Toulouse, France; [Broadley, Simon A.] Griffith Univ, Sch Med, Gold Coast, Qld 4222, Australia; [Butzkueven, Helmut; Kilpatrick, Trevor J.; Marriott, Mark; Rubio, Justin P.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic 3010, Australia; [Butzkueven, Helmut; Kilpatrick, Trevor J.; Marriott, Mark; Tubridy, Niall] Royal Melbourne Hosp, Parkville, Vic 3050, Australia; [Butzkueven, Helmut] Monash Univ, Box Hill Hosp, Clayton, Vic 3800, Australia; [Butzkueven, Helmut] Univ Melbourne, Dept Med, RMH Cluster, Melbourne, Vic 3010, Australia; [Capra, Ruggero] Osped Civili Brescia, Dept Neurol, Multiple Sclerosis Ctr, I-25018 Brescia, Italy; [Carroll, William M.; Kermode, Allan G.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; [Cavalla, Paola] Univ Turin, AOU San Giovanni Battista, Dept Neurosci, I-10126 Turin, Italy; [Clerget-Darpoux, Francoise] Univ Paris 11, INSERM, U669, F-94800 Villejuif, France; [Cox, Mathew B.; Lechner-Scott, Jeannette S.; Scott, Rodney J.] Univ Newcastle, Callaghan, NSW 2308, Australia; [Cozen, Wendy; Islam, Talat; Mack, Thomas] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Cross, Anne H.; Piccio, Laura] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Cusi, Daniele; Lupoli, Sara; Macciardi, Fabio; Salvi, Erika] Univ Milan, Filarete Fdn, AO San Paolo, Dept Med Surg & Dent, I-20139 Milan, Italy; [Daly, Mark J.; Ivinson, Adrian J.; De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Davis, Emma; Dixon, Katherine; Ollier, William] Univ Manchester, UK DNA Banking Network, Ctr Integrated Genom Med Res, Manchester M13 9PT, Lancs, England; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Div Biomed Genet, Dept Med Genet, NL-3508 GA Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Debouverie, Marc] Hop Cent, Serv Neurol, F-54035 Nancy, France; [D'hooghe, Marie Beatrice] Natl Multiple Sclerosis Ctr, B-1820 Melsbroek, Belgium; [Ellinghaus, David; Franke, Andre; Schreiber, Stefan; Wittig, Michael] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Elovaara, Irina] Tampere Univ Hosp, Dept Neurol, FIN-33014 Tampere, Finland; [Elovaara, Irina] Univ Tampere, Sch Med, Tampere 33014, Finland; [Foote, Simon; Stankovich, Jim; Taylor, Bruce] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Galimberti, Daniela] Univ Milan, Fdn Ca Granda, Ctr Dino Ferrari, Dept Neurol Sci,Osped Maggiore Policlin, I-20122 Milan, Italy; [Ghezzi, Angelo] Osped Gallarate, Ctr Studi Sclerosi Multipla, I-21013 Gallarate, VA, Italy; [Gout, Olivier] Fdn Ophtalmol Adolphe de Rothschild, Serv Neurol, F-75019 Paris, France; [Graham, Colin] Belfast Hlth & Social Care Trust, City Hosp, Belfast BT9 7AB, Antrim, North Ireland; [Grant, Struan F. A.; Hakonarson, Hakon; Sleiman, Patrick M. A.; Wang, Kai; Zhang, Haitao] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Guerini, Franca Rosa] Don C Gnocchi Fdn IRCCS, Lab Mol Med & Biotechnol, I-20148 Milan, Italy; [Hall, Per] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Hamsten, Anders; Larsson, Malin] Karolinska Inst, Karolinska Univ, Dept Med Solna, Atherosclerosis Res Unit, S-17176 Stockholm, Sweden; [Hartung, Hans-Peter] Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; [Heath, Simon; Lathrop, Mark] Commissariat Energie Atom, Inst Genom, Ctr Natl Genotypage, F-91057 Evry, France; [Infante-Duarte, Carmen] Univ Med Berlin, Charite, Expt & Clin Res Ctr, D-13125 Berlin, Germany; [Infante-Duarte, Carmen] Max Delbrueck Ctr Mol Med, D-13125 Berlin, Germany; [Kabesch, Michael] Hannover Med Sch, Dept Paediat Pneumol Allergy & Neonatol, D-30625 Hannover, Germany; [Kilpatrick, Trevor J.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Klopp, Norman; Rueckert, Ina-Maria; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Munich, Germany; [Koivisto, Keijo] Seinajoki Cent Hosp, Seinajoki 60220, Finland; [Lechner-Scott, Jeannette S.] John Hunter Hosp, Hunter Med Res Inst, New Lambton, NSW 2305, Australia; [Leone, Maurizio A.; Naldi, Paola] Maggiore della Carita Hosp, SCDU Neurol, I-28100 Novara, Italy; [Leppa, Virpi; Sulonen, Anna-Maija] Natl Inst Hlth & Welf, Unit Publ Hlth Genom, Helsinki 00290, Finland; [Liljedahl, Ulrika; Syvaenen, Ann-Christine] Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Univ Hosp,Res Dept 2, S-75185 Uppsala, Sweden; [Liu, Jianjun] Genome Inst Singapore, Singapore 138672, Singapore; [Lorentzen, Aslaug R.; Mero, Inger-Lise] Oslo Univ Hosp, Inst Immunol, N-0027 Oslo, Norway; [Lupoli, Sara] Ist Sci San Raffaele, Inst Expt Neurol INSPE, I-20132 Milan, Italy; [Macciardi, Fabio] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92617 USA; [Mason, Deborah] Univ Otago, Christchurch Sch Med, Christchurch 8041, New Zealand; [McCauley, Jacob L.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [McCauley, Jacob L.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL 33136 USA; [Mottershead, John] Hope Hosp, Greater Manchester Ctr Clin Neurosci, Salford M6 8HD, Lancs, England; [Mottershead, John] Dunedin Publ Hosp, Dept Neurol, Otago 9016, New Zealand; [Myhr, Kjell-Morten] Haukeland Hosp, Dept Neurol, Norwegian Multiple Sclerosis Competence Ctr, N-5021 Bergen, Norway; [Myhr, Kjell-Morten] Univ Bergen, Dept Clin Med, N-5021 Bergen, Norway; [Page, Alison] Derriford Hosp, Dept Neurol, Plymouth Hosp NHS Trust, Plymouth PL6 8DH, Devon, England; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki 00014, Finland; [Palotie, Aarno] Univ Cent Hosp, Helsinki 00014, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard, Program Med & Populat Genet & Genet Anal Platform, Cambridge, MA 02142 USA; [Pelletier, Jean] Hop La Timone, Serv Neurol, Pole Neurosci Clin, F-13005 Marseille, France; [Reunanen, Mauri] Oulu Univ Hosp, Dept Neurol, Oulu 90029, Finland; [Reynolds, Richard] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Wolfson Neurosci Labs, UK MS Tissue Bank, London W12 0NN, England; [Rioux, Johnd.] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Rioux, Johnd.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Salvetti, Marco] Univ Roma La Sapienza, Ctr Expt Neurol Therapy CENTERS, I-00189 Rome, Italy; [Salvi, Erika; Taddeo, Francesca] KOS Genet Srl, I-20123 Milan, Italy; [Schreiber, Stefan] Univ Kiel, Univ Hosp, Dept Gen Internal Med, D-24105 Kiel, Germany; [Schulze, Christian] Ctr Mol Neurobiol, D-20251 Hamburg, Germany; [Sexton, David; Zuvich, Rebecca; Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA; [Blackwell, Jenefer M.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Subiaco, WA 6008, Australia; [Blackwell, Jenefer M.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Tienari, Pentti] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland; [Blackwell, Jenefer M.; Tienari, Pentti] Univ Helsinki, Biomedicum, Mol Neurol Programme, FIN-00290 Helsinki, Finland; [Bramon, Elvira] Kings Coll London, Inst Psychiat, Biomed Res Ctr Mental Hlth, Div Psychol Med & Psychiat, London SE5 8AF, England; [Bramon, Elvira] S London & Maudsley NHS Fdn Trust, London SE5 8AF, England; [Tourbah, Ayman] Univ Reims, Serv Neurol, F-51100 Reims, France; [Tourbah, Ayman] Univ Reims, Fac Med Reims, F-51100 Reims, France; [Brown, Matthew A.] Univ Queensland, Brisbane, Qld 4102, Australia; [Brown, Matthew A.] Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Casas, Juan P.] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Tubridy, Niall] St Vincents Univ Hosp, Dublin 4, Ireland; [Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin 2, Eire, Ireland; [Jankowski, Janusz] Barts & London Queen Marys Sch Med & Dent, Ctr Gastroenterol, London E1 2AT, England; [Villoslada, Pablo] Hosp Clin Barcelona, Inst Biomed Res August Pi Sunyer IDIBAPS, Dept Neurosci, Barcelona 08036, Spain; [Markus, Hugh S.] St Georges Univ London, London SW17 0RE, England; [Mathew, Christopher G.; Trembath, Richard C.] Kings Coll London, Guys Hosp, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; [Wason, James] Med Res Council Biostat Unit, Cambridge CB2 0SR, England; [Palmer, Colin N. A.] Univ Dundee, Inst Biomed Res, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Wichmann, H-Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Plomin, Robert] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London SE5 8AF, England; [Willoughby, Ernest] Auckland City Hosp, Dept Neurol, Auckland 1010, New Zealand; [Winkelmann, Juliane] Tech Univ Munich, Inst Humangenet, D-81675 Munich, Germany; [Winkelmann, Juliane] Helmholtz Zentrum Munchen, Inst Humangenet, D-85764 Munich, Germany; [Wittig, Michael] Univ Kiel, Popgen Biobank, D-24105 Kiel, Germany; [Yaouanq, Jacqueline] CHU Pontchaillou, F-35033 Rennes, France; [Viswanathan, Ananth C.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London EC1V 2PD, England; [Viswanathan, Ananth C.] UCL Inst Ophthalmol, London EC1V 2PD, England; [Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Duncanson, Audrey] Wellcome Trust Res Labs, London NW1 2BE, England; [Ivinson, Adrian J.] Harvard Univ, Sch Med, Harvard NeuroDiscovery Ctr, Boston, MA 02115 USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Neurol & Immunol, New Haven, CT 06520 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; University of Oxford; Wellcome Trust Sanger Institute; University of Sydney; Westmead Institute for Medical Research; KU Leuven; Rigshospitalet; University of Copenhagen; University of Helsinki; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Technical University of Munich; Johannes Gutenberg University of Mainz; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Oxford; Queens University Belfast; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Oslo; University of Oslo; University of Oslo; Medical University Lodz; Hospital Universitari Vall d'Hebron; Karolinska Institutet; Karolinska University Hospital; Keele University; University of Exeter; University of Plymouth; University of Plymouth; Cardiff University; University of California System; University of California Berkeley; Kaiser Permanente; Karolinska Institutet; University of California System; University of California San Francisco; IRCCS Fondazione Casimiro Mondino; University of Pavia; Walton Centre; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Griffith University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; Box Hill Hospital; Monash University; University of Melbourne; Hospital Spedali Civili Brescia; University of Western Australia; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Newcastle; University of Southern California; Washington University (WUSTL); University of Milan; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Manchester; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; CHU de Nancy; University of Kiel; Tampere University; Tampere University Hospital; Tampere University; University of Tasmania; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Belfast City Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; IRCCS Fondazione Don Carlo Gnocchi Onlus; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Heinrich Heine University Dusseldorf; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Hannover Medical School; University of Melbourne; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Seinajoki Central Hospital; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; Finland National Institute for Health & Welfare; Uppsala University; Uppsala University Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Oslo; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of California System; University of California Irvine; University of Otago; University of Miami; University of Miami; University of Bergen; Haukeland University Hospital; University of Bergen; Derriford Hospital; University of Plymouth; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Oulu; Imperial College London; Universite de Montreal; Universite de Montreal; Sapienza University Rome; University of Kiel; Schleswig Holstein University Hospital; Vanderbilt University; Telethon Kids Institute; University of Western Australia; University of Cambridge; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of London; King's College London; South London & Maudsley NHS Trust; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; University of Queensland; University of Queensland; University of London; London School of Hygiene & Tropical Medicine; University College Dublin; Saint Vincent's University Hospital; Trinity College Dublin; University of London; Queen Mary University London; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; St Georges University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; MRC Biostatistics Unit; University of Dundee; University of Munich; University of Munich; University of London; King's College London; Auckland City Hospital; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; CHU Rennes; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; Harvard University; Harvard Medical School; Yale University	Compston, A (corresponding author), Univ Cambridge, Dept Clin Neurosci, Addenbrookes Hosp, BOX 165,Hills Rd, Cambridge CB2 0QQ, England.	donnelly@well.ox.ac.uk; alastair.compston@medschl.cam.ac.uk	de Bakker, Paul IW/B-8730-2009; Goris, An/F-2943-2010; Villoslada, Pablo/AAF-9547-2019; Bramon, Elvira/A-9463-2011; D'Alfonso, Sandra/K-7295-2014; Bramon, Elvira/HHC-3809-2022; Daly, Mark J/B-2453-2017; D'hooghe, Marie BGJ/G-3423-2013; Foote, Simon J/F-2802-2013; Esposito, Federica/K-6537-2016; Zipp, Frauke/C-9968-2015; , Talat/AAV-6834-2020; Link, Jenny/J-1629-2012; Celius, Elisabeth Gulowsen/S-1387-2019; Spurkland, Anne/L-3369-2019; Deloukas, Panos/B-2922-2013; Galimberti, Daniela/N-7209-2019; Alfredsson, Lars/AAC-9007-2019; Schulze, Christian/AGJ-7744-2022; Bellenguez, Céline/X-4004-2019; Blackwell, Jenefer M/H-3015-2015; Salvi, Erika/C-1033-2015; Liu, Jianjun/AAK-4989-2020; Tienari, Pentti J/A-4893-2012; Haines, Jonathan/C-3374-2012; Rioux, John D/A-9599-2015; Mathew, Christopher G/G-3434-2015; Leone, Maurizio A./J-4130-2016; Myhr, Kjell-Morten/H-1528-2018; Montalban, Xavier/J-5938-2016; Brassat, David/L-2173-2014; Villoslada, Pablo/O-1757-2019; Cree, Bruce C/AAV-6109-2020; Belllenguez, Céline/Y-3183-2018; Heath, Simon C/J-4138-2012; Jankowski, Janusz/H-2706-2012; Kabesch, Michael/GZM-1583-2022; Mycko, Marcin Przemyslaw/S-9386-2016; Macciardi, Fabio/N-3768-2014; Baranzini, Sergio/A-9422-2013; Ellinghaus, David/G-4467-2012; Bergamaschi, Laura/ABE-1175-2020; Hemmer, Bernhard/GPX-8451-2022; Wichmann, Heinz Erich/AAA-5695-2022; Kockum, Ingrid/O-8781-2018; Piccio, Laura/AAE-1706-2020; Piehl, Fredrik/E-3451-2013; Brown, Matthew A/E-5749-2010; Boneschi, Filippo Martinelli/H-8592-2012; Wood, Nicholas W/C-2505-2009; Salvetti, Marco/K-3836-2016; Guerini, Franca R./G-8055-2012; Saarela, Janna S/E-5369-2014; Martinelli, Vittorio/AAN-7240-2020; Plomin, Robert/B-8911-2008; Kermode, Allan/G-3568-2019; Kabesch, Michael/AAB-5701-2020; Hauser, Stephen L/J-2978-2016; Palmer, Colin NA/C-7053-2008; Ellinghaus, David/ABC-3610-2020; Scott, Rodney J/B-2827-2013; ghezzi, angelo/AAJ-9606-2020; Salvi, Erika/AAA-1415-2019; Lima Bomfim, Izaura/J-3462-2012; Goris, An/L-5852-2019; Hemmer, Bernhard/AAT-8388-2021; Franke, Andre/B-2151-2010; Dubois, Benedicte/A-4338-2019; Clerget-Darpoux, Francoise/I-4825-2017	de Bakker, Paul IW/0000-0001-7735-7858; Goris, An/0000-0002-1276-6682; D'Alfonso, Sandra/0000-0002-3983-9925; Bramon, Elvira/0000-0003-1369-5983; Daly, Mark J/0000-0002-0949-8752; Esposito, Federica/0000-0003-2550-0805; Zipp, Frauke/0000-0002-1231-1928; , Talat/0000-0002-2837-865X; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Spurkland, Anne/0000-0003-4421-0766; Deloukas, Panos/0000-0001-9251-070X; Galimberti, Daniela/0000-0002-9284-5953; Alfredsson, Lars/0000-0003-1688-6697; Schulze, Christian/0000-0001-9442-7141; Bellenguez, Céline/0000-0002-1240-7874; Salvi, Erika/0000-0002-2724-2291; Liu, Jianjun/0000-0002-3255-3019; Haines, Jonathan/0000-0002-4351-4728; Rioux, John D/0000-0001-7560-8326; Mathew, Christopher G/0000-0003-4178-1838; Leone, Maurizio A./0000-0002-6339-5738; Myhr, Kjell-Morten/0000-0002-0980-510X; Montalban, Xavier/0000-0002-0098-9918; Villoslada, Pablo/0000-0002-8735-6119; Cree, Bruce C/0000-0001-7689-2533; Belllenguez, Céline/0000-0002-1240-7874; Heath, Simon C/0000-0002-9550-0897; Jankowski, Janusz/0000-0003-2130-9181; Macciardi, Fabio/0000-0003-0537-4266; Baranzini, Sergio/0000-0003-0067-194X; Hemmer, Bernhard/0000-0001-5985-6784; Kockum, Ingrid/0000-0002-0867-4726; Piccio, Laura/0000-0002-8760-109X; Brown, Matthew A/0000-0003-0538-8211; Wood, Nicholas W/0000-0002-9500-3348; Guerini, Franca R./0000-0001-9461-5927; Kermode, Allan/0000-0002-4476-4016; Palmer, Colin NA/0000-0002-6415-6560; Ellinghaus, David/0000-0002-4332-6110; Scott, Rodney J/0000-0001-7724-3404; Salvi, Erika/0000-0002-2724-2291; Goris, An/0000-0002-1276-6682; Franke, Andre/0000-0003-1530-5811; Walters, James/0000-0002-6980-4053; Corvin, Aiden/0000-0001-6717-4089; Gomez, Refujia/0000-0003-0730-8019; Wason, James/0000-0002-4691-126X; Infante Duarte, Carmen/0000-0003-3005-351X; Pirinen, Matti/0000-0002-1664-1350; Glessner, Joseph/0000-0001-5131-2811; Hunt, Sarah/0000-0002-8350-1235; Kilpatrick, Trevor/0000-0003-3999-085X; Dubois, Benedicte/0000-0003-0604-8702; Lima Bomfim, Izaura/0000-0003-0890-3872; McVean, Gil/0000-0002-5012-4162; Band, Gavin/0000-0002-1710-9024; Link, Jenny/0000-0002-6134-9404; Saarela, Janna/0000-0002-0853-6219; Patsopoulos, Nikolaos/0000-0003-3757-8941; Sellebjerg, Finn/0000-0002-1333-9623; Foote, Simon/0000-0002-9142-2107; Potter, Simon/0000-0003-4208-4102; Cavalla, Paola/0000-0003-4589-4864; Sorensen, Per Soelberg/0000-0002-2818-3780; martinelli boneschi, filippo/0000-0002-9955-1368; Stankovich, Jim/0000-0001-9344-7749; Palotie, Aarno/0000-0002-2527-5874; Giannoulatou, Eleni/0000-0002-7084-6736; Mycko, Marcin/0000-0002-2226-1784; Butzkueven, Helmut/0000-0003-3940-8727; Grant, Struan/0000-0003-2025-5302; Sulonen, Anna-Maija/0000-0002-5518-1975; Martin, Roland/0000-0002-0982-1329; Winkelmann, Juliane/0000-0003-2667-9691; Gillman, Matthew S./0000-0002-2340-6930; Schulze, Christian/0000-0002-1442-1987; Plomin, Robert/0000-0002-0756-3629; Comabella Lopez, Manuel/0000-0002-2373-6657; Lechner-Scott, Jeannette/0000-0002-3850-447X; Selmaj, Krzysztof/0000-0003-1213-7218; D'hooghe, Marie/0000-0002-0917-4176; Rapa, Anna/0000-0002-5523-5224; Olsson, Tomas/0000-0002-2938-1877; Clerget-Darpoux, Francoise/0000-0003-4816-6619; Murray, Dianna/0000-0003-3481-825X; RUBIO, JUSTIN/0000-0003-3750-917X; Trembath, Richard/0000-0003-0550-3400; Cross, Anne/0000-0003-0829-7569; Leppa, Virpi/0000-0003-2942-2656; Sondergaard, Helle Bach/0000-0001-9435-0658	Wellcome Trust [085475/B/08/Z, 085475/Z/08/Z, 075491/Z/04/Z, 068545/Z/02]; National Institutes of Health [AI076544, NS032830, NS049477, NS19142, NS049510, NS26799, NS43559, NS067305, CA104021, RR020092, RR024992, K23N/S048869]; US National Multiple Sclerosis Society [RG 4201-A-1]; Nancy Davis Foundation; Cambridge NIHR Biomedical Research Centre; UK Medical Research Council [G0700061, G0000934]; Multiple Sclerosis Society of Great Britain and Northern Ireland [898/08]; Wolfson Royal Society; Peter Doherty fellowship; Lagrange Fellowship; Harry Weaver Neuroscience Scholarships; Australian National Health and Medical Research Council (NHMRC); Australian Research Council; JHH Charitable Trust; Multiple Sclerosis Research Australia; Health Research Council New Zealand; National MS Society of New Zealand; Wetenschappelijk Onderzoek Multiple Sclerose; Bayer Chair on Fundamental Genetic Research; Biogen Idec Chair Translational Research in Multiple Sclerosis; FWO-Vlaanderen; Belgian Neurological Society; Danish Multiple Sclerosis Society; Neuropromise EU [LSHM-CT-2005-018637]; Center of Excellence for Disease Genetics of the Academy of Finland; Sigrid Juselius Foundation; Helsinki University Central Hospital Research Foundation; Bundesministerium fur Bildung und Technologie (KKNMS consortium Control MS); Deutsche Forschungsgemeinschaft; Institut National de la Sante et de la Recherche Medicale (INSERM); Association pour la Recherche sur la Sclerose En Plaques (ARSEP); Association Francaise contre les Myopathies (AFM); Italian Foundation for Multiple Sclerosis [2002/R/40, 2005/R/10, 2008/R/11, 2008/R/15]; Italian Ministry of Health [Giovani Ricercatori 2007-D.lgs 502/92]; Regione Piemonte [2003, 2004, 2008, 2009]; CRT Foundation; Turin; Moorfields/UCL Institute of Ophthalmology NIHR Biomedical Research Centre; Norwegian MS Register and Biobank; Research Council of Norway; South-Eastern and Western Norway regional Health Authories; Ulleval University Hospital Scientific Advisory Council; Haukeland University Hospital; Amici Centro Sclerosi Multipla del San Raffaele (ACESM); Association of British Neurologists; Spanish Ministry of Health [FISPI060117]; Bibbi and Niels Jensens Foundation; Montel Williams foundation; Hjarnfonden and Swedish medical research council [8691]; Stockholm County Council [562183]; Swedish Council for Working life and Social Research; Gemeinnutzige Hertie Stiftung; Northern California Kaiser Permanente members and Polpharma Foundation; Washington University Institute of Clinical and Translational Sciences-Brain, Behavioral and Performance Unit; German Ministry of Education and Research; Helmholtz Zentrum Munchen-National Research Center; German National Genome Research Network (NGFN); LMUinnovativ; Knut and Alice Wallenberg Foundation; Children's Hospital of Philadelphia; Agency for Science & Technology and Research of Singapore; Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA104021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992, C06RR020092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019142, R01NS049510, R01NS049477, R01NS067305, R01NS032830, R01NS026799, R01NS043559] Funding Source: NIH RePORTER; MRC [MC_EX_G0800860, G0901461, G19/2, G0100594, G0901310, G0700061] Funding Source: UKRI; Medical Research Council [G0100594, G9817803B, G0700061, MC_EX_G0800860, G0801418B, G0400017, G0901461, G19/2, G0901310] Funding Source: researchfish; National Institute for Health Research [PDA/02/06/016, NF-SI-0507-10379] Funding Source: researchfish; Parkinson&quot;s UK [J-0804] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Multiple Sclerosis Society(National Multiple Sclerosis Society); Nancy Davis Foundation; Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Multiple Sclerosis Society of Great Britain and Northern Ireland; Wolfson Royal Society(Royal Society of London); Peter Doherty fellowship; Lagrange Fellowship; Harry Weaver Neuroscience Scholarships; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); JHH Charitable Trust; Multiple Sclerosis Research Australia; Health Research Council New Zealand(Health Research Council of New Zealand); National MS Society of New Zealand; Wetenschappelijk Onderzoek Multiple Sclerose; Bayer Chair on Fundamental Genetic Research; Biogen Idec Chair Translational Research in Multiple Sclerosis; FWO-Vlaanderen(FWO); Belgian Neurological Society; Danish Multiple Sclerosis Society; Neuropromise EU; Center of Excellence for Disease Genetics of the Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Central Hospital Research Foundation; Bundesministerium fur Bildung und Technologie (KKNMS consortium Control MS)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche sur la Sclerose En Plaques (ARSEP); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Italian Foundation for Multiple Sclerosis; Italian Ministry of Health(Ministry of Health, Italy); Regione Piemonte(Regione Piemonte); CRT Foundation; Turin; Moorfields/UCL Institute of Ophthalmology NIHR Biomedical Research Centre; Norwegian MS Register and Biobank; Research Council of Norway(Research Council of Norway); South-Eastern and Western Norway regional Health Authories; Ulleval University Hospital Scientific Advisory Council; Haukeland University Hospital; Amici Centro Sclerosi Multipla del San Raffaele (ACESM); Association of British Neurologists; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Bibbi and Niels Jensens Foundation; Montel Williams foundation; Hjarnfonden and Swedish medical research council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stockholm County Council(Stockholm County Council); Swedish Council for Working life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Gemeinnutzige Hertie Stiftung; Northern California Kaiser Permanente members and Polpharma Foundation; Washington University Institute of Clinical and Translational Sciences-Brain, Behavioral and Performance Unit; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Zentrum Munchen-National Research Center; German National Genome Research Network (NGFN); LMUinnovativ; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Children's Hospital of Philadelphia; Agency for Science & Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	The principal funding for this study was provided by the Wellcome Trust (085475/B/08/Z, 085475/Z/08/Z, 075491/Z/04/Z and 068545/Z/02). The work was also supported by National Institutes of Health (AI076544, NS032830, NS049477, NS19142, NS049510, NS26799, NS43559, NS067305, CA104021, RR020092, RR024992 and K23N/S048869), US National Multiple Sclerosis Society (RG 4201-A-1), Nancy Davis Foundation, Cambridge NIHR Biomedical Research Centre, UK Medical Research Council (G0700061, G0000934), Multiple Sclerosis Society of Great Britain and Northern Ireland (898/08), Wolfson Royal Society Merit Award, Peter Doherty fellowship, Lagrange Fellowship, Harry Weaver Neuroscience Scholarships, Australian National Health and Medical Research Council (NHMRC), Australian Research Council Linkage Program Grant, JHH Charitable Trust Fund, Multiple Sclerosis Research Australia, Health Research Council New Zealand, National MS Society of New Zealand, Wetenschappelijk Onderzoek Multiple Sclerose, Bayer Chair on Fundamental Genetic Research regarding the Neuroimmunological Aspects of Multiple Sclerosis, Biogen Idec Chair Translational Research in Multiple Sclerosis, FWO-Vlaanderen, Belgian Neurological Society, Danish Multiple Sclerosis Society, Neuropromise EU grant (LSHM-CT-2005-018637), Center of Excellence for Disease Genetics of the Academy of Finland, Sigrid Juselius Foundation, Helsinki University Central Hospital Research Foundation, Bundesministerium fur Bildung und Technologie (KKNMS consortium Control MS), Deutsche Forschungsgemeinschaft, Institut National de la Sante et de la Recherche Medicale (INSERM), Association pour la Recherche sur la Sclerose En Plaques (ARSEP), Association Francaise contre les Myopathies (AFM), Italian Foundation for Multiple Sclerosis (FISM grants 2002/R/40, 2005/R/10, 2008/R/11 and 2008/R/15), Italian Ministry of Health (grant Giovani Ricercatori 2007-D.lgs 502/92), Regione Piemonte (grants 2003, 2004, 2008, 2009), CRT Foundation, Turin, Moorfields/UCL Institute of Ophthalmology NIHR Biomedical Research Centre, Norwegian MS Register and Biobank, Research Council of Norway, South-Eastern and Western Norway regional Health Authories, Ulleval University Hospital Scientific Advisory Council, Haukeland University Hospital, Amici Centro Sclerosi Multipla del San Raffaele (ACESM), Association of British Neurologists, Spanish Ministry of Health (FISPI060117), Bibbi and Niels Jensens Foundation, Montel Williams foundation, Hjarnfonden and Swedish medical research council (8691), Stockholm County Council (562183), Swedish Council for Working life and Social Research, Gemeinnutzige Hertie Stiftung, Northern California Kaiser Permanente members and Polpharma Foundation, and Washington University Institute of Clinical and Translational Sciences-Brain, Behavioral and Performance Unit. We acknowledge use of data from the British 1958 Birth Cohort, the UK National Blood Service, the popgen biobank, the KORA and MONICA Augsburg studies, the Accelerated Cure Project, the Brigham & Women's Hospital PhenoGenetic Project, the Swedish CAD project, the Norwegian Bone Marrow Donor Registry, the Children's Hospital of Philadelphia (CHOP), the Swedish Breast Cancer study, BRC-REFGENSEP (Pitie-Salpetriere Centre d'Investigation Clinique (CIC) and Genethon) and HYPERGENES (HEALTH-F4-2007-201550).; Projects received support from the German Ministry of Education and Research, the Helmholtz Zentrum Munchen-National Research Center, the German National Genome Research Network (NGFN), the LMUinnovativ, the Knut and Alice Wallenberg Foundation, the Cener for Applied Genomics from the Children's Hospital of Philadelphia Development Award, the Agency for Science & Technology and Research of Singapore, and the Susan G. Komen Breast Cancer Foundation. We thank S. Bertrand, J. Bryant, S. L. Clark, L. Collimedaglia, G. Coniglio, J. S. Conquer, B. Colombo, T. Dibling, G. Eckstein, J. C. Eldred, G. Fischer, S. Gamble, P. Gregersen, R. Guerrero, C. Hind, P. Lichtner, L. Moiola, H. Mousavi, R. Naismith, R. J. Parks, R. Pearson, V. Pilato, M. Radaelli, E. Scarpini, C. R. Stribling, T. Strom, S. Taylor, D. Vukcevic and A. Wilk for their help and support. Detailed acknowledgements are available in Supplementary Information. This manuscript is dedicated to the memory of L. Peltonen, a member of both the IMSGC and the WTCCC2, in recognition of her contributions to, and her leadership in, human genetics.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Bielekova B, 2009, ARCH NEUROL-CHICAGO, V66, P483, DOI 10.1001/archneurol.2009.50; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Bush WS, 2010, AM J HUM GENET, V86, P621, DOI 10.1016/j.ajhg.2010.02.027; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dyment DA, 2006, J NEUROL NEUROSUR PS, V77, P258, DOI 10.1136/jnnp.2005.063008; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Field J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013454; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hemminki K, 2009, NEUROGENETICS, V10, P5, DOI 10.1007/s10048-008-0156-y; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pierrot-Deseilligny C, 2010, BRAIN, V133, P1869, DOI 10.1093/brain/awq147; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sawcer S, 2005, AM J HUM GENET, V77, P454; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Su Z, 2009, STAT SCI, V24, P430, DOI 10.1214/09-STS311	26	1911	1945	10	460	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2011	476	7359					214	219		10.1038/nature10251	http://dx.doi.org/10.1038/nature10251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	805MU	21833088	Green Submitted, Green Accepted			2022-12-28	WOS:000293731900038
J	Salmena, L; Poliseno, L; Tay, Y; Kats, L; Pandolfi, PP				Salmena, Leonardo; Poliseno, Laura; Tay, Yvonne; Kats, Lev; Pandolfi, Pier Paolo			A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?	CELL			English	Article							NONCODING RNAS; UNTRANSLATED REGION; MICRORNA SPONGES; DOWN-REGULATION; MESSENGER-RNAS; GENE; EXPRESSION; GENOME; PSEUDOGENES; REVEALS	Here, we present a unifying hypothesis about how messenger RNAs, transcribed pseudogenes, and long noncoding RNAs "talk" to each other using microRNA response elements (MREs) as letters of a new language. We propose that this "competing endogenous RNA" (ceRNA) activity forms a large-scale regulatory network across the transcriptome, greatly expanding the functional genetic information in the human genome and playing important roles in pathological conditions, such as cancer.	[Salmena, Leonardo; Poliseno, Laura; Tay, Yvonne; Kats, Lev; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA; [Salmena, Leonardo; Poliseno, Laura; Tay, Yvonne; Kats, Lev; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Pathol, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Kats, Lev/AAW-3252-2021; Poliseno, Laura/B-5711-2012	Kats, Lev/0000-0001-8742-8138; Poliseno, Laura/0000-0001-6557-955X; Pandolfi, Pier Paolo/0000-0002-5352-5295; Salmena, Leonardo/0000-0003-4023-658X	Canadian Institutes of Health Research; Human Frontier Science Program; Istituto Toscano Tumori; American Italian Cancer Foundation; Leukemia & Lymphoma Society; NHMRC; NIH [R01 CA-82328-09]; NATIONAL CANCER INSTITUTE [R01CA082328] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program(Human Frontier Science Program); Istituto Toscano Tumori; American Italian Cancer Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all Pandolfi lab members for critical discussions. L. S. was supported by fellowships from the Canadian Institutes of Health Research and the Human Frontier Science Program. L. P. was supported by fellowships from the Istituto Toscano Tumori and the American Italian Cancer Foundation. Y.T. is supported by a Special Fellow Award from The Leukemia & Lymphoma Society. L. K. is supported by a NHMRC Overseas Biomedical Postdoctoral Fellowship. This work was supported by NIH grant R01 CA-82328-09 awarded to P. P. P.	Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Balasubramanian S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r2; Baltimore D, 2001, NATURE, V409, P814, DOI 10.1038/35057267; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Costa FF, 2008, GENE, V410, P9, DOI 10.1016/j.gene.2007.12.008; D'Errico Ilenia, 2004, Briefings in Functional Genomics & Proteomics, V3, P157, DOI 10.1093/bfgp/3.2.157; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013599; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Pink RC, 2011, RNA, V17, P792, DOI 10.1261/rna.2658311; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; RASTINEJAD F, 1993, CELL, V75, P1107, DOI 10.1016/0092-8674(93)90320-P; Scaglioni PP, 2007, CURR TOP MICROBIOL, V313, P85; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285	50	4580	4826	32	377	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					353	358		10.1016/j.cell.2011.07.014	http://dx.doi.org/10.1016/j.cell.2011.07.014			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21802130	Green Accepted, Bronze			2022-12-28	WOS:000293570500010
J	McCartney, M				McCartney, Margaret			FROM THE FRONTLINE We shouldn't fear social media	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2011	343								d4864	10.1136/bmj.d4864	http://dx.doi.org/10.1136/bmj.d4864			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	805NN	21816745				2022-12-28	WOS:000293734700007
J	Silva, R; Price, M				Silva, Romesh; Price, Megan			Trade-offs in Using Indirect Sampling to Measure Conflict Violence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY		[Silva, Romesh; Price, Megan] Benetech, Human Rights Data Anal Grp, Palo Alto, CA 94306 USA		Silva, R (corresponding author), Benetech, Human Rights Data Anal Grp, 480 Calif Ave Ste 201, Palo Alto, CA 94306 USA.	romesh.s@benetech.org						Brown V, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-9; Checchi F, 2009, NEW METHOD ESTIMATE; Checchi F, 2008, PLOS MED, V5, P1025, DOI 10.1371/journal.pmed.0050146; Lavallee P., 2007, SPRINGER SERIES STAT; Roberts B, 2010, INT J EPIDEMIOL, V39, P1584, DOI 10.1093/ije/dyq188; Roberts L., 2005, 52 HUM PRACT NETW; Silva R, 2011, POP ASS AM ANN M SIL; Silva Romesh, 2010, JOINT STAT M, P552; Stark L, 2010, J EPIDEMIOL COMMUN H, V64, P1056, DOI 10.1136/jech.2009.093799; YIP PSF, 1995, AM J EPIDEMIOL, V142, P1047	10	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2011	306	5					547	548		10.1001/jama.2011.1032	http://dx.doi.org/10.1001/jama.2011.1032			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800SH	21813435				2022-12-28	WOS:000293386500024
J	van den Boezem, PB; Klem, TMAL; d'Armandville, EL; Wittens, CHA				van den Boezem, P. B.; Klem, T. M. A. L.; d'Armandville, E. Le Cocq; Wittens, C. H. A.			The management of superficial venous incompetence	BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CLINICAL-TRIAL; ENDOVENOUS LASER-ABLATION; SAPHENOUS VARICOSE-VEINS; QUALITY-OF-LIFE; RADIOFREQUENCY ABLATION; FOAM SCLEROTHERAPY; GENERAL-POPULATION; FOLLOW-UP; SURGERY; REFLUX		[van den Boezem, P. B.] Gelderse Vallei Hosp, Dept Surg, Ede, Netherlands; [Klem, T. M. A. L.] St Franciscus Gasthuis, Dept Surg, Rotterdam, Netherlands; [d'Armandville, E. Le Cocq] Surg Venous Res Fdn, Rotterdam, Netherlands; [Wittens, C. H. A.] Maastricht Univ Ctr, Maastricht, Netherlands; [Wittens, C. H. A.] Univ Hosp RWTH Aachen, Dept Vasc Surg, Nordrhein Westfalen, Germany	Gelderse Vallei Hospital; Franciscus Gasthuis; Maastricht University; Maastricht University Medical Centre (MUMC)	van den Boezem, PB (corresponding author), Gelderse Vallei Hosp, Dept Surg, Ede, Netherlands.	boezem@hotmail.com	van den Boezem, Peter/E-1539-2019					Almeida JI, 2006, ANN VASC SURG, V20, P547, DOI 10.1007/s10016-006-9098-8; Almeida JI, 2009, J VASC INTERV RADIOL, V20, P752, DOI 10.1016/j.jvir.2009.03.008; Beale RJ, 2005, EUR J VASC ENDOVASC, V30, P83, DOI 10.1016/j.ejvs.2005.02.023; Blomgren L, 2011, BRIT J SURG, V98, P1112, DOI 10.1002/bjs.7579; Bountouroglou DG, 2006, EUR J VASC ENDOVASC, V31, P93, DOI 10.1016/j.ejvs.2005.08.024; Bradbury AW, 2010, J VASC SURG, V52, P939, DOI 10.1016/j.jvs.2010.04.077; Carradice D, 2011, BRIT J SURG, V98, P1089, DOI 10.1002/bjs.7500; Christenson JT, 2010, J VASC SURG, V52, P1234, DOI 10.1016/j.jvs.2010.06.104; CORDER A P, 1991, Journal of the Royal College of Surgeons of Edinburgh, V36, P100; Darvall KAL, 2009, EUR J VASC ENDOVASC, V38, P642, DOI 10.1016/j.ejvs.2009.07.014; Darwood RJ, 2008, BRIT J SURG, V95, P294, DOI 10.1002/bjs.6101; Dwerryhouse S, 1999, J VASC SURG, V29, P589, DOI 10.1016/S0741-5214(99)70302-2; Eklof B, 2004, J VASC SURG, V40, P1248, DOI 10.1016/j.jvs.2004.09.027; ElKaffas KH, 2011, ANGIOLOGY, V62, P49, DOI 10.1177/0003319710380680; Evans CJ, 1999, J EPIDEMIOL COMMUN H, V53, P149, DOI 10.1136/jech.53.3.149; Fischer R, 2001, J VASC SURG, V34, P236, DOI 10.1067/mva.2001.115802; Goodwin H, 2000, BRIT J SURG, V87, P977, DOI 10.1046/j.1365-2168.2000.01562.x; Klem TMAL, 2009, EUR J VASC ENDOVASC, V37, P470, DOI 10.1016/j.ejvs.2008.11.036; Klem TMAL, 2009, J VASC SURG, V49, P403, DOI 10.1016/j.jvs.2008.09.016; LABROPOULOS N, 1994, J VASC SURG, V20, P953, DOI 10.1016/0741-5214(94)90233-X; Lim CS, 2009, BRIT J SURG, V96, P1231, DOI 10.1002/bjs.6798; Maurins U, 2008, J VASC SURG, V48, P680, DOI 10.1016/j.jvs.2008.04.029; Mercer KG, 1998, BRIT J SURG, V85, P1495; Pronk P, 2010, EUR J VASC ENDOVASC, V40, P649, DOI 10.1016/j.ejvs.2010.08.007; Puggioni A, 2009, J VASC SURG, V49, P1248, DOI 10.1016/j.jvs.2008.12.016; Rasmussen LH, 2011, BRIT J SURG, V98, P1079, DOI 10.1002/bjs.7555; Rasmussen LH, 2010, EUR J VASC ENDOVASC, V39, P630, DOI 10.1016/j.ejvs.2009.11.040; Shepherd AC, 2010, BRIT J SURG, V97, P810, DOI 10.1002/bjs.7091; Subramonia S, 2005, J VASC SURG, V42, P510, DOI 10.1016/j.jvs.2005.05.021; Subramonia S, 2010, BRIT J SURG, V97, P328, DOI 10.1002/bjs.6867; TELLINGS SS, 2011, PHLEBOLOGY; Theivacumar NS, 2007, BRIT J SURG, V94, P722, DOI 10.1002/bjs.5804; van den Bos RR, 2009, DERMATOL SURG, V35, P1206, DOI 10.1111/j.1524-4725.2009.01215.x; van Rij AM, 2004, BRIT J SURG, V91, P1582, DOI 10.1002/bjs.4701; Wright D, 2006, PHLEBOLOGY, V21, P180, DOI 10.1258/026835506779115807	35	9	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2011	343								d4489	10.1136/bmj.d4489	http://dx.doi.org/10.1136/bmj.d4489			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NN	21816743	Green Submitted			2022-12-28	WOS:000293734700003
J	Weiler, R; Ingram, M; Wolman, R				Weiler, Richard; Ingram, Michael; Wolman, Roger			10-MINUTE CONSULTATION Osgood-Schlatter disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Weiler, Richard] Homerton Univ Hosp NHS Fdn Trust, London E9 6SR, England; [Ingram, Michael] Red House Grp, Radlett, Herts, England; [Wolman, Roger] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Weiler, R (corresponding author), Homerton Univ Hosp NHS Fdn Trust, London E9 6SR, England.	rweiler@doctors.org.uk						Australian Acute Musculoskeletal Pain Guidelines Group, 2004, EV BAS MAN AC MUSC P; de Lucena GL, 2011, AM J SPORT MED, V39, P415, DOI 10.1177/0363546510383835; Gholve PA, 2007, CURR OPIN PEDIATR, V19, P44, DOI 10.1097/MOP.0b013e328013dbea; KUJALA UM, 1985, AM J SPORT MED, V13, P236, DOI 10.1177/036354658501300404; Pihlajamaki HK, 2010, J BONE JOINT SURG AM, V92A, P258, DOI 10.2106/JBJS.J.00450	5	8	9	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 1	2011	343								d4534	10.1136/bmj.d4534	http://dx.doi.org/10.1136/bmj.d4534			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NK	21807772				2022-12-28	WOS:000293734400001
J	Kinjo, R; Donnadieu, B; Celik, MA; Frenking, G; Bertrand, G				Kinjo, Rei; Donnadieu, Bruno; Celik, Mehmet Ali; Frenking, Gernot; Bertrand, Guy			Synthesis and Characterization of a Neutral Tricoordinate Organoboron Isoelectronic with Amines	SCIENCE			English	Article							STRUCTURAL-CHARACTERIZATION; BORYL; CARBENES; BORON; REACTIVITY; 1ST	Amines and boranes are the archetypical Lewis bases and acids, respectively. The former can readily undergo one-electron oxidation to give radical cations, whereas the latter are easily reduced to afford radical anions. Here, we report the synthesis of a neutral tricoordinate boron derivative, which acts as a Lewis base and undergoes one-electron oxidation into the corresponding radical cation. These compounds can be regarded as the parent borylene (H-B:) and borinylium (H-B+center dot), respectively, stabilized by two cyclic (alkyl)(amino)carbenes. Ab initio calculations show that the highest occupied molecular orbital of the borane as well as the singly occupied molecular orbital of the radical cation are essentially a pair and a single electron, respectively, in the p(pi) orbital of boron.	[Kinjo, Rei; Donnadieu, Bruno; Bertrand, Guy] Univ Calif Riverside, Dept Chem, UCR CNRS Joint Res Chem Lab UMI 2957, Riverside, CA 92521 USA; [Celik, Mehmet Ali; Frenking, Gernot] Philipps Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany	University of California System; University of California Riverside; Philipps University Marburg	Bertrand, G (corresponding author), Univ Calif Riverside, Dept Chem, UCR CNRS Joint Res Chem Lab UMI 2957, Riverside, CA 92521 USA.	guy.bertrand@ucr.edu	Kinjo, Rei/AAA-7212-2020; Kinjo, Rei/E-4504-2014	Kinjo, Rei/0000-0002-4425-3937; Kinjo, Rei/0000-0002-4425-3937	NSF [CHE-0924410]; U.S. Department of Energy [DE-FG02-09ER16069]; DFG; Japan Society for the Promotion of Science	NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); DFG(German Research Foundation (DFG)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to the NSF (CHE-0924410), U.S. Department of Energy (DE-FG02-09ER16069), and DFG for financial support of this work and to the Japan Society for the Promotion of Science for a postdoctoral fellowship (R. K.). We thank E. Stoyanov for helpful advice in infrared spectroscopy. Metrical data for the solid state structures of 3, [3<SUP>+center dot</SUP>] GaCl<INF>4</INF><SUP>-</SUP>, and [3H<SUP>+</SUP>]TfO<SUP>-</SUP> are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-822246, CCDC-822247, and CCDC-822248, respectively. The authors and UC Riverside have filed a patent.	Back O, 2010, NAT CHEM, V2, P369, DOI [10.1038/NCHEM.617, 10.1038/nchem.617]; Bettinger HF, 2006, J AM CHEM SOC, V128, P2534, DOI 10.1021/ja0548642; Bissinger P, 2011, ANGEW CHEM INT EDIT, V50, P4704, DOI 10.1002/anie.201007543; Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; Braunschweig H, 1998, ANGEW CHEM INT EDIT, V37, P3179, DOI 10.1002/(SICI)1521-3773(19981204)37:22<3179::AID-ANIE3179>3.0.CO;2-Z; Braunschweig H, 2007, ANGEW CHEM INT EDIT, V46, P1946, DOI 10.1002/anie.200605053; Braunschweig H, 2010, CHEM REV, V110, P3924, DOI 10.1021/cr900333n; Braunschweig H, 2010, ANGEW CHEM INT EDIT, V49, P2041, DOI 10.1002/anie.200906884; Cheung MS, 2011, ORGANOMETALLICS, V30, P3018, DOI 10.1021/om200115y; Dinda R, 2007, ANGEW CHEM INT EDIT, V46, P9110, DOI 10.1002/anie.200703616; Fischer RC, 2010, CHEM REV, V110, P3877, DOI 10.1021/cr100133q; Frey GD, 2007, SCIENCE, V316, P439, DOI 10.1126/science.1141474; Grimes RN, 2004, J CHEM EDUC, V81, P658; Hahn FE, 2008, ANGEW CHEM INT EDIT, V47, P3122, DOI 10.1002/anie.200703883; HASSANZADEH P, 1993, J PHYS CHEM-US, V97, P4910, DOI 10.1021/j100121a008; Lavallo V, 2005, ANGEW CHEM INT EDIT, V44, P5705, DOI 10.1002/anie.200501841; Lavallo V, 2006, ANGEW CHEM INT EDIT, V45, P3488, DOI 10.1002/anie.200600987; Marder TB, 2006, SCIENCE, V314, P69, DOI 10.1126/science.1133326; Martin D, 2011, CHEM SCI, V2, P389, DOI 10.1039/c0sc00388c; Matsumoto T, 2009, ORGANOMETALLICS, V28, P4252, DOI 10.1021/om900476g; Melaimi M, 2010, ANGEW CHEM INT EDIT, V49, P8810, DOI 10.1002/anie.201000165; Monot J, 2010, ANGEW CHEM INT EDIT, V49, P9166, DOI 10.1002/anie.201004215; Nozaki K, 2010, NATURE, V464, P1136, DOI 10.1038/4641136a; OLMSTEAD MM, 1986, J AM CHEM SOC, V108, P4235, DOI 10.1021/ja00274a071; OLMSTEAD MM, 1987, J AM CHEM SOC, V109, P2541, DOI 10.1021/ja00242a064; Piers WE, 2005, ANGEW CHEM INT EDIT, V44, P5016, DOI 10.1002/anie.200500402; Segawa Y, 2006, SCIENCE, V314, P113, DOI 10.1126/science.1131914; Sigl M, 1997, CHEM BER-RECL, V130, P1411, DOI 10.1002/cber.19971301009; Tonner R, 2008, CHEMPHYSCHEM, V9, P1474, DOI 10.1002/cphc.200800208; Vidovic D, 2011, CHEM SCI, V2, P601, DOI 10.1039/c0sc00508h; Walton JC, 2010, J AM CHEM SOC, V132, P2350, DOI 10.1021/ja909502q; Wang YZ, 2008, J AM CHEM SOC, V130, P3298, DOI 10.1021/ja800257j; Wang Y, 2007, J AM CHEM SOC, V129, P12412, DOI 10.1021/ja075932i; Wang YZ, 2009, CHEM COMMUN, P5201, DOI 10.1039/b908048a; Yamashita M, 2010, J SYN ORG CHEM JPN, V68, P359, DOI 10.5059/yukigoseikyokaishi.68.359	35	395	395	4	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					610	613		10.1126/science.1207573	http://dx.doi.org/10.1126/science.1207573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798945				2022-12-28	WOS:000293222400056
J	Barton, P; Andronis, L; Briggs, A; McPherson, K; Capewell, S				Barton, Pelham; Andronis, Lazaros; Briggs, Andrew; McPherson, Klim; Capewell, Simon			Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; HEALTH; MORTALITY; CHOLESTEROL; REDUCTION; PROFILE; DECLINE; WALES; SALT	Objective To estimate the potential cost effectiveness of a population-wide risk factor reduction programme aimed at preventing cardiovascular disease. Design Economic modelling analysis. Setting England and Wales. Population Entire population. Model Spreadsheet model to quantify the reduction in cardiovascular disease over a decade, assuming the benefits apply consistently for men and women across age and risk groups. Main outcome measures Cardiovascular events avoided, quality adjusted life years gained, and savings in healthcare costs for a given effectiveness; estimates of how much it would be worth spending to achieve a specific outcome. Results A programme across the entire population of England and Wales (about 50 million people) that reduced cardiovascular events by just 1% would result in savings to the health service worth at least 30m pound ((sic)34m; $48m) a year compared with no additional intervention. Reducing mean cholesterol concentrations or blood pressure levels in the population by 5% (as already achieved by similar interventions in some other countries) would result in annual savings worth at least 80m pound to 100m pound. Legislation or other measures to reduce dietary salt intake by 3 g/day (current mean intake approximately 8.5 g/day) would prevent approximately 30 000 cardiovascular events, with savings worth at least 40m pound a year. Legislation to reduce intake of industrial trans fatty acid by approximately 0.5% of total energy content might gain around 570 000 life years and generate NHS savings worth at least 230m pound a year. Conclusions Any intervention that achieved even a modest population-wide reduction in any major cardiovascular risk factor would produce a net cost saving to the NHS, as well as improving health. Given the conservative assumptions used in this model, the true benefits would probably be greater.	[Barton, Pelham; Andronis, Lazaros] Univ Birmingham, Hlth Econ Unit, Birmingham B15 2TT, W Midlands, England; [Briggs, Andrew] Univ Glasgow, Glasgow, Lanark, Scotland; [Capewell, Simon] Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Birmingham; University of Glasgow; University of Liverpool	Barton, P (corresponding author), Univ Birmingham, Hlth Econ Unit, Publ Hlth Bldg, Birmingham B15 2TT, W Midlands, England.	p.m.barton@bham.ac.uk	Briggs, Andrew/ABA-9009-2020	Briggs, Andrew/0000-0002-0777-1997	NICE; West Midlands Health Technology Assessment Collaboration (WMHTAC); Peninsula Technology Appraisal Group (PenTAG); MRC [G0900847] Funding Source: UKRI; Medical Research Council [G0900847] Funding Source: researchfish	NICE; West Midlands Health Technology Assessment Collaboration (WMHTAC); Peninsula Technology Appraisal Group (PenTAG); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PB and LA were funded by NICE. KMcP, AB, and SC were all members of the NICE Programme Development Group on cardiovascular disease prevention in populations. However, the conclusions do not necessarily reflect official NICE views. West Midlands Health Technology Assessment Collaboration (WMHTAC) and Peninsula Technology Appraisal Group (PenTAG) were funded to provide support to the NICE Centre for Public Health Excellence (CPHE).	Abelson P., 2001, RETURNS INVESTMENT P; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; [Anonymous], PREV HLTH AM INV DIS; Aspelund T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013957; Barton P, 2009, PREVENTION CARDIOVAS; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; British Heart Foundation, 2011, HEART STAT; Capewell S, 2008, MODELLING UK BURDEN; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Capewell S, 2010, B WORLD HEALTH ORGAN, V88, P120, DOI 10.2471/BLT.08.057885; Catford J, 2009, HEALTH PROMOT INT, V24, P1, DOI 10.1093/heapro/dap003; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Curtis L., 2010, UNIT COSTS HLTH SOCI; Daviglus ML, 1998, NEW ENGL J MED, V339, P1122, DOI 10.1056/NEJM199810153391606; Department of Health, 2008, PUTT PREV 1 VASC CHE; Food Standards Agency, 2007, LOW INC DIET NUTR SU; Food Standards Agency, 2008, DIET SOD LEV SURV; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; Institute of Medicine, 2010, PROM CARD HLTH DEV W; KRISTIANSEN IS, 1991, BRIT MED J, V302, P1119, DOI 10.1136/bmj.302.6785.1119; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Luengo-Fernandez R, 2006, HEART, V92, P1384, DOI 10.1136/hrt.2005.072173; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS5, DOI 10.1038/sj.ejcn.1602973; Mozaffarian D, 2010, BRIT MED J, V340, pc1826; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS POP LE; Office for National Statistics, 2010, POP EST UK ENGL WAL; Smith-Spangler CM, 2010, ANN INTERN MED, V4819, P152; Stender S, 2006, ATHEROSCLEROSIS SUPP, V7, P47, DOI 10.1016/j.atherosclerosissup.2006.04.011; Strategy Unit, 2008, FOOD MATT STRAT 21 C; Tudor-Smith C, 1998, BRIT MED J, V316, P818, DOI 10.1136/bmj.316.7134.818; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Veerman L., 2010, ASSESSING COST EFFEC; Wanless D., 2004, SECURING GOOD HLTH W; Ward S, 2011, STATINS PREVENTION C; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	40	133	135	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2011	343								d4044	10.1136/bmj.d4044	http://dx.doi.org/10.1136/bmj.d4044			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LT	21798967	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000293441100002
J	Montgomery, RA; Lonze, BE; King, KE; Kraus, ES; Kucirka, LM; Locke, JE; Warren, DS; Simpkins, CE; Dagher, NN; Singer, AL; Zachary, AA; Segev, DL				Montgomery, Robert A.; Lonze, Bonnie E.; King, Karen E.; Kraus, Edward S.; Kucirka, Lauren M.; Locke, Jayme E.; Warren, Daniel S.; Simpkins, Christopher E.; Dagher, Nabil N.; Singer, Andrew L.; Zachary, Andrea A.; Segev, Dorry L.			Desensitization in HLA-Incompatible Kidney Recipients and Survival	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-TRANSPLANT RECIPIENTS; INTRAVENOUS IMMUNE GLOBULIN; DONOR-SPECIFIC ANTIBODY; CROSS-MATCH; PAIRED DONATION; REJECTION; PLASMAPHERESIS; ALLOANTIBODY; MORTALITY; DIALYSIS	BACKGROUND More than 20,000 candidates for kidney transplantation in the United States are sensitized to HLA and may have a prolonged wait for a transplant, with a reduced transplantation rate and an increased rate of death. One solution is to perform live-donor renal transplantation after the depletion of donor-specific anti-HLA antibodies. Whether such antibody depletion results in a survival benefit as compared with waiting for an HLA-compatible kidney is unknown. METHODS We used a protocol that included plasmapheresis and the administration of low-dose intravenous immune globulin to desensitize 211 HLA-sensitized patients who subsequently underwent renal transplantation (treatment group). We compared rates of death between the group undergoing desensitization treatment and two carefully matched control groups of patients on a waiting list for kidney transplantation who continued to undergo dialysis (dialysis-only group) or who underwent either dialysis or HLA-compatible transplantation (dialysis-or-transplantation group). RESULTS In the treatment group, Kaplan-Meier estimates of patient survival were 90.6% at 1 year, 85.7% at 3 years, 80.6% at 5 years, and 80.6% at 8 years, as compared with rates of 91.1%, 67.2%, 51.5%, and 30.5%, respectively, for patients in the dialysis-only group and rates of 93.1%, 77.0%, 65.6%, and 49.1%, respectively, for patients in the dialysis-or-transplantation group (P<0.001 for both comparisons). CONCLUSIONS Live-donor transplantation after desensitization provided a significant survival benefit for patients with HLA sensitization, as compared with waiting for a compatible organ. By 8 years, this survival advantage more than doubled. These data provide evidence that desensitization protocols may help overcome incompatibility barriers in live-donor renal transplantation. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the Charles T. Bauer Foundation.)	[Montgomery, Robert A.; Lonze, Bonnie E.; Kucirka, Lauren M.; Locke, Jayme E.; Warren, Daniel S.; Simpkins, Christopher E.; Dagher, Nabil N.; Singer, Andrew L.; Segev, Dorry L.] Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21205 USA; [King, Karen E.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Kraus, Edward S.; Zachary, Andrea A.] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Kucirka, Lauren M.; Segev, Dorry L.] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Montgomery, RA (corresponding author), 720 Rutland Ave,Ross Res 765, Baltimore, MD 21205 USA.	rmonty@jhmi.edu		Lonze, Bonnie/0000-0002-0973-1657; Dagher, Nabil/0000-0002-8973-6588; Locke, Jayme/0000-0002-0220-8716	National Institute of Diabetes and Digestive and Kidney Diseases [RC1 DK086731]; Charles T. Bauer Foundation; Alexion; Genzyme; Viropharma; Astellas; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086731] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Charles T. Bauer Foundation; Alexion; Genzyme(Sanofi-AventisGenzyme Corporation); Viropharma; Astellas(Astellas Pharmaceuticals); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a grant (RC1 DK086731) from the National Institute of Diabetes and Digestive and Kidney Diseases and by a grant from the Charles T. Bauer Foundation (to Drs. Montgomery, Warren, and Segev).; Dr. Montgomery reports that his institution, John Hopkins University, has received grant support from Alexion, Genzyme, and Viropharma related to HLA-incompatible transplantation and that he has received lecture fees from educational grants to sponsoring academic institutions from Astellas and Genzyme; Dr. Zachary, receiving lecture fees from Genzyme and having an equity interest in Luminex; and Dr. Segev, receiving consulting and lecture fees from Genzyme. No other potential conflict of interest relevant to this article was reported.	Gentry SE, 2005, AM J TRANSPLANT, V5, P1914, DOI 10.1111/j.1600-6143.2005.00964.x; Gloor JM, 2010, AM J TRANSPLANT, V10, P582, DOI 10.1111/j.1600-6143.2009.02985.x; Glotz D, 2002, AM J TRANSPLANT, V2, P758, DOI 10.1034/j.1600-6143.2002.20809.x; Haririan A, 2009, AM J TRANSPLANT, V9, P536, DOI 10.1111/j.1600-6143.2008.02524.x; Higgins RM, 1996, LANCET, V348, P1208, DOI 10.1016/S0140-6736(96)03452-6; Higgins R, 2007, TRANSPLANTATION, V84, P876, DOI 10.1097/01.tp.0000284729.39137.6e; Issa N, 2008, TRANSPLANTATION, V86, P681, DOI 10.1097/TP.0b013e3181837626; Lee AJ, 2005, CURR MED RES OPIN, V21, P1777, DOI 10.1185/030079905X65277; Lee PC, 2002, TRANSPLANTATION, V74, P1192, DOI 10.1097/00007890-200210270-00025; Montgomery RA, 2010, AM J TRANSPLANT, V10, P449, DOI 10.1111/j.1600-6143.2009.03001.x; Montgomery RA, 2005, JAMA-J AM MED ASSOC, V294, P1655, DOI 10.1001/jama.294.13.1655; Montgomery RA, 2004, PEDIATR TRANSPLANT, V8, P535, DOI 10.1111/j.1399-3046.2004.00214.x; Montgomery RA, 2000, TRANSPLANTATION, V70, P887, DOI 10.1097/00007890-200009270-00006; Montgomery RA, 2006, LANCET, V368, P419, DOI 10.1016/S0140-6736(06)69115-0; Montgomery RA, 2009, TRANSPLANTATION, V87, P1246, DOI 10.1097/TP.0b013e31819f2024; Organ Procurement and Transplant Network, SCI REG TRANSPL REC; PATEL R, 1969, NEW ENGL J MED, V280, P735, DOI 10.1056/NEJM196904032801401; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Segev DL, 2005, AM J TRANSPLANT, V5, P2570, DOI 10.1111/j.1600-6143.2005.01031.x; Segev DL, 2005, JAMA-J AM MED ASSOC, V293, P1883, DOI 10.1001/jama.293.15.1883; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; STARZL TE, 1964, SURGERY, V55, P195; Stegall MD, 2006, AM J TRANSPLANT, V6, P346, DOI 10.1111/j.1600-6143.2005.01178.x; TYAN DB, 1994, TRANSPLANTATION, V57, P553; Vo AA, 2008, NEW ENGL J MED, V359, P242, DOI 10.1056/NEJMoa0707894; West-Thielke P, 2008, AM J TRANSPLANT, V8, P348, DOI 10.1111/j.1600-6143.2007.02085.x; WILLIAMS GM, 1969, ANN SURG, V170, P603, DOI 10.1097/00000658-196910000-00012; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Zachary AA, 2003, TRANSPLANTATION, V76, P1519, DOI 10.1097/01.TP.0000090868.88895.E0	29	482	500	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					318	326		10.1056/NEJMoa1012376	http://dx.doi.org/10.1056/NEJMoa1012376			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21793744				2022-12-28	WOS:000293172200010
J	Tugwell, P; Singh, JA; Wells, GA				Tugwell, Peter; Singh, Jasvinder A.; Wells, George A.			THERAPEUTICS Biologicals for rheumatoid arthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MODIFYING ANTIRHEUMATIC DRUGS; EULAR RECOMMENDATIONS; DISEASE; SAFETY; MANAGEMENT; INFLIXIMAB; AGENTS	This is one of a series of occasional articles on therapeutics for common or serious conditions, covering new drugs and old drugs with important new indications or concerns. The series advisers are Robin Ferner, honorary professor of clinical pharmacology, University of Birmingham and Birmingham City Hospital, and Philip Routledge, professor of clinical pharmacology, Cardiff University. To suggest a topic for this series, please email us at practice@bmj.com.	[Tugwell, Peter] Univ Ottawa, Dept Med, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada; [Tugwell, Peter] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1N 6N5, Canada; [Singh, Jasvinder A.] Birmingham VA Med Ctr, Dept Med, Birmingham, AL 35294 USA; [Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL 35294 USA; [Wells, George A.] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Wells, George A.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Ottawa; University of Ottawa; University of Ottawa Heart Institute	Tugwell, P (corresponding author), Univ Ottawa, Dept Med, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada.	tugwell.bb@uottawa.ca	Singh, Jasvinder/R-6172-2019; Tugwell, Peter/AFD-8076-2022	Singh, Jasvinder/0000-0003-3485-0006; Tugwell, Peter/0000-0001-5062-0556	Canadian Institutes of Health Research (CIHR); Takeda; Savient; Wyeth; Amgen; URL Pharma; Novartis; Bristol-Myers Squibb	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Takeda(Takeda Pharmaceutical Company Ltd); Savient; Wyeth(Wyeth); Amgen(Amgen); URL Pharma; Novartis(Novartis); Bristol-Myers Squibb(Bristol-Myers Squibb)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work. PT received honorariums for quality of life consultancy with Bristol-Myers Squibb; chairs data safety monitoring boards for Chelsea Therapeutics and UCB, mandated for the Food and Drug Administration; is a member of the executive of OMERACT, an organisation that develops outcome measures in rheumatology and receives "arms length" funding from 36 companies; co-chaired an industry board of six companies (Abbott, Bristol-Myers Squibb, Merck, Roche, Schering Plough, UCB) for a biologicals registry of the Ontario Rheumatology Association, the Ontario Biologics Research Initiative (an arms-length registry that independently collects information, supported by a grant from the Canadian Institutes of Health Research (CIHR) matched by funding from these drug companies); and receives an honorarium from the CIHR grant. JAS has received speaker honorariums from Abbott, research and travel grants from Takeda, Savient, Wyeth, and Amgen, and consultant fees from URL Pharma, Takeda, Savient, and Novartis; he is a member of the executive of OMERACT. GAW received honorariums for consultancy with Novartis, Bristol-Myers Squibb, and Abbott; a grant from Bristol-Myers Squibb; and speaker honorariums from Abbott; he is a member of the executive of OMERACT and of the Scientific Committee for the Ontario Biologics Research Initiative.	Bucher C, 2005, GUT, V54, P732; Clinicaltrials.gov, RHEUM ARTHR COMP ACT; Delabaye I, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3058; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Gaujoux-Viala C, 2010, ANN RHEUM DIS, V69, P1004, DOI 10.1136/ard.2009.127225; Gea-Banacloche JC, 2010, SEMIN HEMATOL, V47, P187, DOI 10.1053/j.seminhematol.2010.01.002; Graudal N, 2010, ARTHRITIS RHEUM-US, V62, P2852, DOI 10.1002/art.27592; Katchamart W, 2010, COCHRANE DB SYST REV, V4; Kievit W, 2011, RHEUMATOLOGY, V50, P196, DOI 10.1093/rheumatology/keq325; Maxwell L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007277.pub2; Mertens M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005121.pub3; National Institute for Health and Clinical Excellence, 2010, RHEUM ARTHR; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Schoels M, 2010, ANN RHEUM DIS, V69, P995, DOI 10.1136/ard.2009.126714; Simon LS, 2009, J RHEUMATOL, V36, P2110, DOI 10.3899/jrheum.090590; Singh JA, 2010, COCHRANE DB SYST REV, V10; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P1058, DOI 10.1136/ard.2009.114652; Solomon DH, 2006, ARTHRITIS RHEUM-US, V54, P3790, DOI 10.1002/art.22255; van der Velde G, 2011, ARTHRIT CARE RES, V63, P65, DOI 10.1002/acr.20338; Vandenbroucke JP, 2004, BRIT MED J, V329, P2, DOI 10.1136/bmj.329.7456.2	23	14	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2011	343								d4027	10.1136/bmj.d4027	http://dx.doi.org/10.1136/bmj.d4027			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LT	21798970				2022-12-28	WOS:000293441100001
J	Watts, G				Watts, Geoff			REGENERATIVE MEDICINE Will medicine ever be able to halt the process of ageing?	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						*A4M, WHAT IS ANT MED; *AM AC ANT MED, GLOB ANT PROD MARK R; de Grey A., 2007, ENDING AGEING REJUVE; Hayflick L, 2004, J GERONTOL A-BIOL, V59, P573, DOI 10.1093/gerona/59.6.B573; *SENS FDN, RES THEM	5	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 25	2011	343								d4119	10.1136/bmj.d4119	http://dx.doi.org/10.1136/bmj.d4119			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	801LM	21788257				2022-12-28	WOS:000293440400001
J	Amlacher, S; Sarges, P; Flemming, D; van Noort, V; Kunze, R; Devos, DP; Arumugam, M; Bork, P; Hurt, E				Amlacher, Stefan; Sarges, Phillip; Flemming, Dirk; van Noort, Vera; Kunze, Ruth; Devos, Damien P.; Arumugam, Manimozhiyan; Bork, Peer; Hurt, Ed			Insight into Structure and Assembly of the Nuclear Pore Complex by Utilizing the Genome of a Eukaryotic Thermophile	CELL			English	Article							OPEN READING FRAMES; MOLECULAR ARCHITECTURE; ELECTRON-MICROSCOPY; BASE COMPOSITION; NEW-GENERATION; YEAST; NUCLEOPORINS; MEMBRANE; EXPORT; TEMPERATURE	Despite decades of research, the structure and assembly of the nuclear pore complex (NPC), which is composed of similar to 30 nucleoporins (Nups), remain elusive. Here, we report the genome of the thermophilic fungus Chaetomium thermophilum (ct) and identify the complete repertoire of Nups therein. The thermophilic proteins show improved properties for structural and biochemical studies compared to their mesophilic counterparts, and purified ctNups enabled the reconstitution of the inner pore ring module that spans the width of the NPC from the anchoring membrane to the central transport channel. This module is composed of two large Nups, Nup192 and Nup170, which are flexibly bridged by short linear motifs made up of linker Nups, Nic96 and Nup53. This assembly illustrates how Nup interactions can generate structural plasticity within the NPC scaffold. Our findings therefore demonstrate the utility of the genome of a thermophilic eukaryote for studying complex molecular machines.	[van Noort, Vera; Devos, Damien P.; Arumugam, Manimozhiyan; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Amlacher, Stefan; Sarges, Phillip; Flemming, Dirk; Kunze, Ruth; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bork@embl.de; ed.hurt@bzh.uni-heidelberg.de	Flemming, Dirk/AAP-3274-2021; Ed Hurt, Dr./AAE-8874-2019; van Noort, Vera/E-1053-2011; van Noort, Vera/GWZ-9038-2022; Bork, Peer/F-1813-2013; devos, damien/ABH-5348-2020; Arumugam, Manimozhiyan/E-1211-2011; Arumugam, Manimozhiyan/AAJ-2394-2020	Ed Hurt, Dr./0000-0002-4535-8255; van Noort, Vera/0000-0002-8436-6602; Bork, Peer/0000-0002-2627-833X; Arumugam, Manimozhiyan/0000-0002-0886-9101; Arumugam, Manimozhiyan/0000-0002-0886-9101; Devos, Damien/0000-0002-9453-4753	Deutsche Forschungsgemeinschaft [SFB 638/B2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Eurofins MWG Operon, in particular Dr. Georg Gradl, for a very competent cooperation in the DNA sequencing project. We thank Christian von Mering for help using the eggNOG pipeline and Sheila Lutz for initial help in setting up blast searches using the C. thermophilum genomic sequence. We thank Andrea Hellwig (Prof. Hilmar Bading, Department of Neurobiology, University of Heidelberg) for performing thin-section electron microscopy. E.H. is recipient of grants from the Deutsche Forschungsgemeinschaft (SFB 638/B2).	Al-Samarrai TH, 2000, LETT APPL MICROBIOL, V30, P53, DOI 10.1046/j.1472-765x.2000.00664.x; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Belgareh N, 1998, MOL BIOL CELL, V9, P3475, DOI 10.1091/mbc.9.12.3475; Boussau B, 2008, NATURE, V456, P942, DOI 10.1038/nature07393; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Brohawn SG, 2009, NAT STRUCT MOL BIOL, V16, P1173, DOI 10.1038/nsmb.1713; Cook AG, 2009, NATURE, V461, P60, DOI 10.1038/nature08394; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Dong XH, 2009, NAT STRUCT MOL BIOL, V16, P558, DOI 10.1038/nsmb.1586; Doye V, 1997, CURR OPIN CELL BIOL, V9, P401, DOI 10.1016/S0955-0674(97)80014-2; Fahrenkrog B, 2000, MOL BIOL CELL, V11, P3885, DOI 10.1091/mbc.11.11.3885; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Flemming D, 2010, NAT STRUCT MOL BIOL, V17, P775, DOI 10.1038/nsmb.1811; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; Hakulinen N, 2003, EUR J BIOCHEM, V270, P1399, DOI 10.1046/j.1432-1033.2003.03496.x; Handa N, 2006, J MOL BIOL, V363, P114, DOI 10.1016/j.jmb.2006.07.089; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Hickey DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-117; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Hurwitz ME, 1998, P NATL ACAD SCI USA, V95, P11241, DOI 10.1073/pnas.95.19.11241; James P, 1996, GENETICS, V144, P1425; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kosova B, 1999, J BIOL CHEM, V274, P22646, DOI 10.1074/jbc.274.32.22646; Lambros RJ, 2003, EXTREMOPHILES, V7, P443, DOI 10.1007/s00792-003-0353-4; LATOUCHE CJ, 1948, NATURE, V161, P320; Leksa NC, 2009, STRUCTURE, V17, P1082, DOI 10.1016/j.str.2009.06.003; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lin FH, 2007, EXTREMOPHILES, V11, P9, DOI 10.1007/s00792-006-0005-6; Lu DV, 2009, BIOINFORMATICS, V25, P1587, DOI 10.1093/bioinformatics/btp273; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lutzmann M, 2005, J BIOL CHEM, V280, P18442, DOI 10.1074/jbc.M412787200; Makio T, 2009, J CELL BIOL, V185, P459, DOI 10.1083/jcb.200810029; Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Miller BR, 2000, MOL BIOL CELL, V11, P3381, DOI 10.1091/mbc.11.10.3381; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Nagy V, 2009, P NATL ACAD SCI USA, V106, P17693, DOI 10.1073/pnas.0909373106; Nehrbass U, 1996, J CELL BIOL, V133, P1153, DOI 10.1083/jcb.133.6.1153; Onischenko E, 2009, J CELL BIOL, V185, P475, DOI 10.1083/jcb.200810030; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roca MG, 2010, EUKARYOT CELL, V9, P1171, DOI 10.1128/EC.00329-09; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; RUTHERFORD K, 2000, ARTEMIS SEQUENCE VIS, V16, P944; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Tcheperegine SE, 1999, J BIOL CHEM, V274, P5252, DOI 10.1074/jbc.274.8.5252; Theerthagiri G, 2010, J CELL BIOL, V189, P1129, DOI 10.1083/jcb.200912045; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005	71	194	269	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 22	2011	146	2					277	289		10.1016/j.cell.2011.06.039	http://dx.doi.org/10.1016/j.cell.2011.06.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784248	Bronze			2022-12-28	WOS:000293013000010
J	Darnell, JC; Van Driesche, SJ; Zhang, CL; Hung, KYS; Mele, A; Fraser, CE; Stone, EF; Chen, C; Fak, JJ; Chi, SW; Licatalosi, DD; Richter, JD; Darnell, RB				Darnell, Jennifer C.; Van Driesche, Sarah J.; Zhang, Chaolin; Hung, Ka Ying Sharon; Mele, Aldo; Fraser, Claire E.; Stone, Elizabeth F.; Chen, Cynthia; Fak, John J.; Chi, Sung Wook; Licatalosi, Donny D.; Richter, Joel D.; Darnell, Robert B.			FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism	CELL			English	Article							X MENTAL-RETARDATION; LOCAL PROTEIN-SYNTHESIS; DEPENDENT TRANSLATION; INHIBITS TRANSLATION; KNOCKOUT MICE; MOUSE MODEL; PLASTICITY; POLYRIBOSOMES; MEMORY; INITIATION	FMRP loss of function causes Fragile X syndrome (FXS) and autistic features. FMRP is a polyribosome-associated neuronal RNA-binding protein, suggesting that it plays a key role in regulating neuronal translation, but there has been little consensus regarding either its RNA targets or mechanism of action. Here, we use high-throughput sequencing of RNAs isolated by crosslinking immunoprecipitation (HITS-CLIP) to identify FMRP interactions with mouse brain polyribosomal mRNAs. FMRP interacts with the coding region of transcripts encoding pre- and postsynaptic proteins and transcripts implicated in autism spectrum disorders (ASD). We developed a brain polyribosome-programmed translation system, revealing that FMRP reversibly stalls ribosomes specifically on its target mRNAs. Our results suggest that loss of a translational brake on the synthesis of a subset of synaptic proteins contributes to FXS. In addition, they provide insight into the molecular basis of the cognitive and allied defects in FXS and ASD and suggest multiple targets for clinical intervention.	[Darnell, Jennifer C.; Van Driesche, Sarah J.; Zhang, Chaolin; Hung, Ka Ying Sharon; Mele, Aldo; Fraser, Claire E.; Stone, Elizabeth F.; Chen, Cynthia; Fak, John J.; Chi, Sung Wook; Licatalosi, Donny D.; Darnell, Robert B.] Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10065 USA; [Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Richter, Joel D.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; University of Massachusetts System; University of Massachusetts Worcester	Darnell, JC (corresponding author), Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10065 USA.	darneje@rockefeller.edu; darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008; Hung, Ka Ying Sharon/AAI-1685-2021	Darnell, Robert B/0000-0002-5134-8088; Hung, Ka Ying Sharon/0000-0002-4084-6030; Stone, Elizabeth/0000-0002-4148-7957	NIH [HD40647, AG30323, GM46779, HD37267, GM95713, NS34389, NS40955]; NSF [MSTP-GM07749]; Rockefeller University Hospital CTSA [UL1 RR024143]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040647] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD037267, R01HD037267] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046779, K99GM095713, R00GM095713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040955, R01NS034389, R56NS034389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030323] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Rockefeller University Hospital CTSA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Pelletier for providing hippuristanol, E. Khandjian for anti-FXR1P antibody, N. Heintz for the transgenic mice expressing tagged ribosomal protein EGFP-rpL10a, and the members of the Darnell laboratory for advice and suggestions throughout the course of this work. We are grateful to E. Sphicas and K. Uryu for help with electron microscopy, and Xuning Wang and Scott Dewell for help with bioinformatics and high-throughput sequencing. This work was supported by the NIH (HD40647 to J.C.D., AG30323, GM46779, and HD37267 to J.D.R., GM95713 to C.Z., and NS34389 and NS40955 to R.B.D.), an NSF grant to S.J.V., MSTP-GM07749 to C.E.F., and the Rockefeller University Hospital CTSA Grant UL1 RR024143. R.B.D. is an Investigator of the Howard Hughes Medical Institute.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Abul-Husn NS, 2009, PROTEOMICS, V9, P3303, DOI 10.1002/pmic.200800767; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Beaulieu MA, 2000, BIOCHEM BIOPH RES CO, V275, P608, DOI 10.1006/bbrc.2000.3313; Braat AK, 2004, DEV CELL, V7, P125, DOI 10.1016/j.devcel.2004.06.009; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Christie SB, 2009, J NEUROSCI, V29, P1514, DOI 10.1523/JNEUROSCI.3937-08.2009; Clark IE, 2000, CURR BIOL, V10, P1311, DOI 10.1016/S0960-9822(00)00754-5; Conrad B, 2007, ANNU REV GENOM HUM G, V8, P17, DOI 10.1146/annurev.genom.8.021307.110233; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Croning MDR, 2009, NUCLEIC ACIDS RES, V37, pD846, DOI 10.1093/nar/gkn700; Darnell JC, 2005, GENES BRAIN BEHAV, V4, P341, DOI 10.1111/j.1601-183X.2005.00144.x; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2009, HUM MOL GENET, V18, P3164, DOI 10.1093/hmg/ddp255; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gatto CL, 2009, MOL NEUROBIOL, V39, P107, DOI 10.1007/s12035-009-8057-0; Hagerman R.J., 2002, FRAGILE X SYNDROME D; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hernandez RN, 2009, AM J MED GENET A, V149A, P1125, DOI 10.1002/ajmg.a.32848; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Khandjian EW, 1996, NAT GENET, V12, P91, DOI 10.1038/ng0196-91; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Pilpel Y, 2009, J PHYSIOL-LONDON, V587, P787, DOI 10.1113/jphysiol.2008.160929; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Price TJ, 2007, J NEUROSCI, V27, P13958, DOI 10.1523/JNEUROSCI.4383-07.2007; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Symons FJ, 2003, AM J MED GENET A, V118A, P115, DOI 10.1002/ajmg.a.10078; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zang JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000758; Zukin RS, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.014.2009	72	1333	1359	0	140	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 22	2011	146	2					247	261		10.1016/j.cell.2011.06.013	http://dx.doi.org/10.1016/j.cell.2011.06.013			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784246	Bronze, Green Accepted			2022-12-28	WOS:000293013000008
J	Hechinger, RF; Lafferty, KD; Dobson, AP; Brown, JH; Kuris, AM				Hechinger, Ryan F.; Lafferty, Kevin D.; Dobson, Andy P.; Brown, James H.; Kuris, Armand M.			A Common Scaling Rule for Abundance, Energetics, and Production of Parasitic and Free-Living Species	SCIENCE			English	Article							POPULATION ENERGY-USE; BODY-SIZE; FOOD WEBS; EQUIVALENCE RULE; METABOLIC-RATE; DENSITY; MASS; ECOLOGY; TEMPERATURE; COMMUNITIES	The metabolic theory of ecology uses the scaling of metabolism with body size and temperature to explain the causes and consequences of species abundance. However, the theory and its empirical tests have never simultaneously examined parasites alongside free-living species. This is unfortunate because parasites represent at least half of species diversity. We show that metabolic scaling theory could not account for the abundance of parasitic or free-living species in three estuarine food webs until accounting for trophic dynamics. Analyses then revealed that the abundance of all species uniformly scaled with body mass to the -3/4 power. This result indicates "production equivalence," where biomass production within trophic levels is invariant of body size across all species and functional groups: invertebrate or vertebrate, ectothermic or endothermic, and free-living or parasitic.	[Hechinger, Ryan F.; Lafferty, Kevin D.] Univ Calif Santa Barbara, Inst Marine Sci, US Geol Survey, Western Ecol Res Ctr, Santa Barbara, CA 93106 USA; [Hechinger, Ryan F.; Lafferty, Kevin D.; Kuris, Armand M.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Dobson, Andy P.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Dobson, Andy P.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Brown, James H.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Princeton University; The Santa Fe Institute; University of New Mexico	Hechinger, RF (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, US Geol Survey, Western Ecol Res Ctr, Santa Barbara, CA 93106 USA.	hechinger@lifesci.ucsb.edu	Lafferty, Kevin D./B-3888-2009	Hechinger, Ryan/0000-0002-6633-253X	NSF/NIH [DEB-0224565]; CA Sea Grant [R/OPCENV-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018754] Funding Source: NIH RePORTER	NSF/NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CA Sea Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank S. Sokolow, J. McLaughlin, J. Childress, and J. Damuth for discussion or comments on the manuscript. Supported by NSF/NIH EID grant DEB-0224565 and by CA Sea Grant R/OPCENV-01. The analyses in this manuscript used data published in Hechinger et al. (25), available at Ecological Archives (accession no. E092-066).	Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Arneberg P, 1998, AM NAT, V151, P497, DOI 10.1086/286136; BAIRD D, 1991, PHILOS T R SOC B, V333, P15, DOI 10.1098/rstb.1991.0058; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown JH, 2003, P NATL ACAD SCI USA, V100, P1467, DOI 10.1073/pnas.0630310100; CALOW P, 1983, PARASITOLOGY, V86, P197, DOI 10.1017/S0031182000050897; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; Cyr H, 1997, OIKOS, V79, P333, DOI 10.2307/3546017; Cyr H, 2000, SFI S SCI C, P267; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; de Meeus T, 2002, TRENDS PARASITOL, V18, P247, DOI 10.1016/S1471-4922(02)02269-9; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hechinger R. F., 2011, Ecology, V92, P791, DOI 10.1890/10-1383.1; HEMMINGSEN AXEL M., 1960, REPTS STENO HOSP COPENHAGEN, V9, P7; Jennings S, 2003, ECOL LETT, V6, P971, DOI 10.1046/j.1461-0248.2003.00529.x; KLEIBER MAX, 1932, HILGARDIA, V6, P315; KOZLOVSKY DG, 1968, ECOLOGY, V49, P48, DOI 10.2307/1933560; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; McGill BJ, 2008, AM NAT, V172, P88, DOI 10.1086/588044; Meehan TD, 2006, ECOLOGY, V87, P1650, DOI 10.1890/0012-9658(2006)87[1650:EUAAAI]2.0.CO;2; Morand S, 2002, EVOL ECOL RES, V4, P951; NEE S, 1991, NATURE, V351, P312, DOI 10.1038/351312a0; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Price P. W., 1980, EVOLUTIONARY BIOL PA; Reuman DC, 2008, ECOL LETT, V11, P1216, DOI 10.1111/j.1461-0248.2008.01236.x; Reuman DC, 2009, ADV ECOL RES, V41, P1, DOI 10.1016/S0065-2504(09)00401-2; ROBINSON WR, 1983, CAN J ZOOL, V61, P281, DOI 10.1139/z83-037	31	84	86	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					445	448		10.1126/science.1204337	http://dx.doi.org/10.1126/science.1204337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21778398	Green Accepted			2022-12-28	WOS:000292959600043
J	Grunwald, D; Singer, RH; Rout, M				Gruenwald, David; Singer, Robert H.; Rout, Michael			Nuclear export dynamics of RNA-protein complexes	NATURE			English	Review							MESSENGER-RNA; PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; BINDING-SITE; TRANSLOCATION; MRNP; NUCLEOPORINS; DBP5; PERMEABILITY; ENVELOPE	The central dogma of molecular biology - DNA makes RNA makes proteins - is a flow of information that in eukaryotes encounters a physical barrier: the nuclear envelope, which encapsulates, organizes and protects the genome. Nuclearpore complexes, embedded in the nuclear envelope, regulate the passage of molecules to and from the nucleus, including the poorly understood process of the export of RNAs from the nucleus. Recent imaging approaches focusing on single molecules have provided unexpected insight into this crucial step in the information flow. This review addresses the latest studies of RNA export and presents some models for how this complex process may work.	[Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Gruenwald, David] Delft Univ Technol, Kavli Inst NanoSci, Fac Sci Appl, Dept Bionanosci, NL-2628 CJ Delft, Netherlands; [Rout, Michael] Rockefeller Univ, New York, NY 10065 USA	Yeshiva University; Albert Einstein College of Medicine; Delft University of Technology; Rockefeller University	Singer, RH (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA.	robert.singer@einstein.yu.edu		Grunwald, David/0000-0001-9067-804X; Rout, Michael/0000-0003-2010-706X	Kavli Foundation; National Institutes of Health [GM86217, GM84364, GM062427, RR022220, GM071329]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084364, R01GM062427, R01GM086217, R01GM071329, R01GM057071] Funding Source: NIH RePORTER	Kavli Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to those colleagues whose work, through space considerations, could not be discussed or cited in this review. This work has been supported by funds from the Kavli Foundation to D. G., National Institutes of Health grants GM86217 and GM84364 to R. H. S., and GM062427, RR022220 and GM071329 to M. R. We thank A. Joseph for critically reading the manuscript.	AKEY CW, 1990, BIOPHYS J, V58, P341, DOI 10.1016/S0006-3495(90)82381-X; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; Alvisi G, 2008, BBA-PROTEINS PROTEOM, V1784, P213, DOI 10.1016/j.bbapap.2007.08.021; Bolger Timothy A, 2008, Cell, V134, P624, DOI 10.1016/j.cell.2008.06.027; Braun IC, 2002, MOL CELL BIOL, V22, P5405, DOI 10.1128/MCB.22.15.5405-5418.2002; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Cole CN, 2006, CURR OPIN CELL BIOL, V18, P299, DOI 10.1016/j.ceb.2006.04.006; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173; DARGEMONT C, 1992, J CELL BIOL, V118, P1, DOI 10.1083/jcb.118.1.1; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dimitrov DI, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2211615; DWORETZKY SI, 1988, J CELL BIOL, V106, P575, DOI 10.1083/jcb.106.3.575; Eisele NB, 2010, EMBO REP, V11, P366, DOI 10.1038/embor.2010.34; Ellis RJ, 2006, NATURE, V442, P360, DOI 10.1038/442360a; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; FELDHERR CM, 1984, J CELL BIOL, V99, P2216, DOI 10.1083/jcb.99.6.2216; Fiserova J, 2010, J CELL SCI, V123, P2773, DOI 10.1242/jcs.070730; Forler D, 2004, MOL CELL BIOL, V24, P1155, DOI 10.1128/MCB.24.3.1155-1167.2004; FRANKE WW, 1970, J ULTRA MOL STRUCT R, V30, P288, DOI 10.1016/S0022-5320(70)80064-8; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grunwald D, 2010, NATURE, V467, P604, DOI 10.1038/nature09438; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Huve J, 2008, BIOPHYS J, V95, P877, DOI 10.1529/biophysj.107.127449; Hurt JA, 2008, DIS MODEL MECH, V1, P103, DOI 10.1242/dmm.000745; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Iborra FJ, 2000, J CELL SCI, V113, P291; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600; Kahms M, 2009, TRAFFIC, V10, P1228, DOI 10.1111/j.1600-0854.2009.00947.x; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Kiseleva E, 2004, J STRUCT BIOL, V145, P272, DOI 10.1016/j.jsb.2003.11.010; Kiseleva E, 1998, J CELL SCI, V111, P223; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kopito RB, 2007, P NATL ACAD SCI USA, V104, P12743, DOI 10.1073/pnas.0702690104; Kopito RB, 2009, HFSP J, V3, P130, DOI 10.2976/1.3080807; Kota KP, 2008, J CELL SCI, V121, P1526, DOI 10.1242/jcs.021055; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Lee CP, 2010, REV MED VIROL, V20, P214, DOI 10.1002/rmv.643; Li Y, 2006, NATURE, V443, P234, DOI 10.1038/nature05107; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Linder P, 2008, CURR BIOL, V18, pR297, DOI 10.1016/j.cub.2008.02.027; Lo KY, 2009, MOL BIOL CELL, V20, P1545, DOI 10.1091/mbc.E08-10-1000; Lowe AR, 2010, NATURE, V467, P600, DOI 10.1038/nature09285; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Ma J, 2010, P NATL ACAD SCI USA, V107, P7305, DOI 10.1073/pnas.0908269107; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Marenduzzo D, 2006, J CELL BIOL, V175, P681, DOI 10.1083/jcb.200609066; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Montpetit B, 2011, NATURE, V472, P238, DOI 10.1038/nature09862; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; Noble KN, 2011, GENE DEV, V25, P1065, DOI 10.1101/gad.2040611; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Peters R, 2005, TRAFFIC, V6, P199, DOI 10.1111/j.1600-0854.2005.00269.x; Powrie EA, 2011, RNA, V17, P134, DOI 10.1261/rna.1210411; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; RICHARDSON WD, 1988, CELL, V52, P655, DOI 10.1016/0092-8674(88)90403-5; RIS H, 1993, J STRUCT BIOL, V111, P148, DOI 10.1006/jsbi.1993.1045; Rodriguez-Navarro S, 2011, CURR OPIN CELL BIOL, V23, P302, DOI 10.1016/j.ceb.2010.12.002; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Shitashige M, 2008, GASTROENTEROLOGY, V134, P1961, DOI 10.1053/j.gastro.2008.03.010; Siebrasse JP, 2008, P NATL ACAD SCI USA, V105, P20291, DOI 10.1073/pnas.0810692105; Siebrasse Jan Peter, 2008, V464, P343; Soop T, 2005, MOL BIOL CELL, V16, P5610, DOI 10.1091/mbc.E05-08-0715; Stewart M, 2007, MOL CELL, V25, P327, DOI 10.1016/j.molcel.2007.01.016; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Stutz F, 2003, TRENDS CELL BIOL, V13, P319, DOI 10.1016/S0962-8924(03)00106-5; Sun C, 2008, P NATL ACAD SCI USA, V105, P8613, DOI 10.1073/pnas.0710867105; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053; Zhao J, 2002, EMBO J, V21, P1177, DOI 10.1093/emboj/21.5.1177; Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125; Zilman A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000804	100	135	137	3	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					333	341		10.1038/nature10318	http://dx.doi.org/10.1038/nature10318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21776079	Green Accepted			2022-12-28	WOS:000292911200034
J	Efremov, RG; Sazanov, LA				Efremov, Rouslan G.; Sazanov, Leonid A.			Structure of the membrane domain of respiratory complex I	NATURE			English	Article							NADH-QUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI NDH-1; UBIQUINONE OXIDOREDUCTASE; PROTON TRANSLOCATION; CRYSTAL-STRUCTURE; SUBUNIT; MODEL; RESIDUES; SENSITIVITY; ANTIPORTER	Complex I is the first and largest enzyme of the respiratory chain, coupling electron transfer between NADH and ubiquinone to the translocation of four protons across the membrane. It has a central role in cellular energy production and has been implicated in many human neurodegenerative diseases. The L-shaped enzyme consists of hydrophilic and membrane domains. Previously, we determined the structure of the hydrophilic domain. Here we report the crystal structure of the Esherichia coli complex I membrane domain at 3.0 angstrom resolution. It includes six subunits, NuoL, NuoM, NuoN, NuoA, NuoJ and NuoK, with 55 transmembrane helices. The fold of the homologous antiporter-like subunits L, M and N is novel, with two inverted structural repeats of five transmembrane helices arranged, unusually, face-to-back. Each repeat includes a discontinuous transmembrane helix and forms half of a channel across the membrane. A network of conserved polar residues connects the two half-channels, completing the proton translocation pathway. Unexpectedly, lysines rather than carboxylate residues act as the main elements of the proton pump in these subunits. The fourth probable proton-translocation channel is at the interface of subunits N, K, J and A. The structure indicates that proton translocation in complex I, uniquely, involves coordinated conformational changes in six symmetrical structural elements.	[Efremov, Rouslan G.; Sazanov, Leonid A.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Sazanov, LA (corresponding author), MRC, Mitochondrial Biol Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	sazanov@mrc-mbu.cam.ac.uk	Sazanov, Leonid A/ABF-2125-2021; Efremov, Rouslan/P-9085-2015	Sazanov, Leonid A/0000-0002-0977-7989; Efremov, Rouslan/0000-0001-7516-8658	Medical Research Council; Medical Research Council [MC_U105674180] Funding Source: researchfish; MRC [MC_U105674180] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council. We thank the ESRF and the SLS for provision of synchrotron radiation facilities. Weare grateful to the staff of beamlines ID29 (ESRF) and X06SA (SLS) for assistance.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cooley RB, 2010, J MOL BIOL, V404, P232, DOI 10.1016/j.jmb.2010.09.034; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; KRISHNAMOORTHY G, 1988, J BIOL CHEM, V263, P17566; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017420; Morino M, 2010, J BIOL CHEM, V285, P30942, DOI 10.1074/jbc.M110.118661; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1891, DOI 10.1016/j.bbabio.2010.06.010; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 2010, FEBS LETT, V584, P4131, DOI 10.1016/j.febslet.2010.08.039; Patsi J, 2008, BIOCHEM J, V409, P129, DOI 10.1042/BJ20070866; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2003, J BIOL CHEM, V278, P19483, DOI 10.1074/jbc.M208959200; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Steimle S, 2011, BIOCHEMISTRY-US, V50, P3386, DOI 10.1021/bi200264q; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Treberg JR, 2011, J BIOL CHEM, V286, P17579, DOI 10.1074/jbc.M111.227751; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vik SB, 2011, FEBS LETT, V585, P1180, DOI 10.1016/j.febslet.2011.03.029; Vinothkumar KR, 2010, Q REV BIOPHYS, V43, P65, DOI 10.1017/S0033583510000041; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yip CY, 2011, J BIOL CHEM, V286, P5023, DOI 10.1074/jbc.M110.194993	60	282	284	5	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2011	476	7361					414	U62		10.1038/nature10330	http://dx.doi.org/10.1038/nature10330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811KT	21822288				2022-12-28	WOS:000294209400028
J	Ward, JW; Averhoff, FM; Koh, HK				Ward, John W.; Averhoff, Francisco M.; Koh, Howard K.			World Hepatitis Day: a new era for hepatitis control	LANCET			English	Editorial Material									[Ward, John W.; Averhoff, Francisco M.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA; [Ward, John W.; Averhoff, Francisco M.; Koh, Howard K.] US Dept Hlth & Human Serv, Off Secretary, Washington, DC 20201 USA	Centers for Disease Control & Prevention - USA	Ward, JW (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA.	jward@cdc.gov						Blumberg BS, 2002, HEPATITIS B HUNT KIL; *CDCP, 2011, 2009 AD VACC COV NHI; Dumolard L., 2008, Morbidity and Mortality Weekly Report, V57, P1249; *GAVI ALL, 2011, HEP B VACC; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; Hu DJ., 2010, ATLAS SEXUALLY TRANS, P203; Jensen DM, 2011, NEW ENGL J MED, V364, P1272, DOI 10.1056/NEJMe1100829; OraSure Technologies Inc., 2011, ORAQUICK HCV RAP ANT; US Department of Health Human Services, 2011, COMB SIL EP VIR HEP; WHO, 2010, VIR HEP REP SECR; World Health Organization (WHO), 2011, IMM SURV ASS MON; Zhu FC, 2010, LANCET, V376, P895, DOI 10.1016/S0140-6736(10)61030-6; 2006, C RECORD MAKING SAFE	13	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 13	2011	378	9791					552	553		10.1016/S0140-6736(11)60839-8	http://dx.doi.org/10.1016/S0140-6736(11)60839-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812UX	21802132				2022-12-28	WOS:000294319500009
J	Sternberg, A; Gal-Yam, A; Simon, JD; Leonard, DC; Quimby, RM; Phillips, MM; Morrell, N; Thompson, IB; Ivans, I; Marshall, JL; Filippenko, AV; Marcy, GW; Bloom, JS; Patat, F; Foley, RJ; Yong, D; Penprase, BE; Beeler, DJ; Prieto, CA; Stringfellow, GS				Sternberg, A.; Gal-Yam, A.; Simon, J. D.; Leonard, D. C.; Quimby, R. M.; Phillips, M. M.; Morrell, N.; Thompson, I. B.; Ivans, I.; Marshall, J. L.; Filippenko, A. V.; Marcy, G. W.; Bloom, J. S.; Patat, F.; Foley, R. J.; Yong, D.; Penprase, B. E.; Beeler, D. J.; Allende Prieto, C.; Stringfellow, G. S.			Circumstellar Material in Type Ia Supernovae via Sodium Absorption Features	SCIENCE			English	Article							HIGH-RESOLUTION OBSERVATIONS; INTERSTELLAR-MEDIUM; D-LINES; PROGENITORS; GAS; CONSTRAINTS; BINARIES; OUTFLOWS; DISTANCE; NAI	Type Ia supernovae are key tools for measuring distances on a cosmic scale. They are generally thought to be the thermonuclear explosion of an accreting white dwarf in a close binary system. The nature of the mass donor is still uncertain. In the single-degenerate model it is a main-sequence star or an evolved star, whereas in the double-degenerate model it is another white dwarf. We show that the velocity structure of absorbing material along the line of sight to 35 type Ia supernovae tends to be blueshifted. These structures are likely signatures of gas outflows from the supernova progenitor systems. Thus, many type Ia supernovae in nearby spiral galaxies may originate in single-degenerate systems.	[Sternberg, A.; Gal-Yam, A.] Weizmann Inst Sci, Fac Phys, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel; [Simon, J. D.; Thompson, I. B.] Observ Carnegie Inst Washington, Pasadena, CA 91101 USA; [Leonard, D. C.] San Diego State Univ, Dept Astron, San Diego, CA 92182 USA; [Quimby, R. M.] CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA; [Phillips, M. M.; Morrell, N.] Las Campanas Observ, Carnegie Observ, La Serena, Chile; [Ivans, I.] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [Marshall, J. L.] Texas A&M Univ, Dept Phys, College Stn, TX 77843 USA; [Filippenko, A. V.; Marcy, G. W.; Bloom, J. S.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Patat, F.] ESO, D-85748 Garching, Germany; [Foley, R. J.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Yong, D.] Australian Natl Univ, Res Sch Astron & Astrophys, Mt Stromlo Observ, Weston, ACT 2611, Australia; [Penprase, B. E.; Beeler, D. J.] Pomona Coll, Dept Phys & Astron, Claremont, CA 91711 USA; [Allende Prieto, C.] Inst Astrofis Canarias, Tenerife 38205, Spain; [Allende Prieto, C.] Univ La Laguna, Dept Astrofis, E-38206 Tenerife, Spain; [Stringfellow, G. S.] Univ Colorado, Ctr Astrophys & Space Astron, Boulder, CO 80309 USA	Weizmann Institute of Science; Carnegie Institution for Science; California State University System; San Diego State University; California Institute of Technology; Carnegie Institution for Science; Utah System of Higher Education; University of Utah; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Berkeley; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Australian National University; Claremont Colleges; Pomona College; Instituto de Astrofisica de Canarias; Universidad de la Laguna; University of Colorado System; University of Colorado Boulder	Sternberg, A (corresponding author), Weizmann Inst Sci, Fac Phys, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel.	assaf.sternberg@weizmann.ac.il; avishay.gal-yam@weizmann.ac.il	Marcy, Geoff/AAC-6050-2019; Simon, Joshua D/AAX-7117-2021; PRIETO, CARLOS ALLENDE/AAE-3759-2019	Patat, Ferdinando/0000-0002-0537-3573; Phillips, Mark/0000-0003-2734-0796; Yong, David/0000-0002-6502-1406; Foley, Ryan/0000-0002-2445-5275; Gal-Yam, Avishay/0000-0002-3653-5598; Bloom, Joshua/0000-0002-7777-216X	W. M. Keck Foundation; French-Israeli Astrophysics Network; Israeli Science Foundation; European Union; Weizmann-UK program; Peter Gruber Award; Patricia Gruber Award; NSF [AST-0908886]; TABASGO Foundation; Clay Fellowship	W. M. Keck Foundation(W.M. Keck Foundation); French-Israeli Astrophysics Network; Israeli Science Foundation(Israel Science Foundation); European Union(European Commission); Weizmann-UK program; Peter Gruber Award; Patricia Gruber Award; NSF(National Science Foundation (NSF)); TABASGO Foundation; Clay Fellowship	We thank the anonymous reviewers for their comments. Some of the data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA; the observatory was made possible by the generous financial support of the W. M. Keck Foundation. We thank the staffs of the various observatories at which we obtained data, as well as J. G. Cohen, G. D. Becker, A. L. Kraus, W. L. W. Sargent, E. Norris, G. J. Herczeg, G. Preston, and I. Toro-Martinez for their data contributions. We thank T. Barlow for work on developing the MAKEE reduction pipeline, and J. X. Prochaska and B. Weiner for advice. A. G. acknowledges support by The French-Israeli Astrophysics Network program, The Israeli Science Foundation, a European Union FP7 Marie Curie IRG Fellowship, The Weizmann-UK program, and a research grant from the Peter and Patricia Gruber Awards. A.V.F.'s group at the University of California Berkeley has been supported by NSF grant AST-0908886 and the TABASGO Foundation. R. J. F. is supported by a Clay Fellowship. G. S. S. thanks S. Hawley for allocating Director's Discretionary Time at Apache Point Observatory (APO), and the APO observing staff. The data described in the paper are presented in the Supporting Online Material.	BALDWIN JA, 1985, MON NOT R ASTRON SOC, V216, pP41, DOI 10.1093/mnras/216.1.41P; BENBEKHTI N, 2008, ASTRON ASTROPHYS, V487, P583; Blondin S, 2009, ASTROPHYS J, V693, P207, DOI 10.1088/0004-637X/693/1/207; BRANCH D, 1995, PUBL ASTRON SOC PAC, V107, P1019, DOI 10.1086/133657; BREGMAN JN, 1980, ASTROPHYS J, V237, P280, DOI 10.1086/157867; Chugai NN, 2008, ASTRON LETT+, V34, P389, DOI 10.1134/S1063773708060030; DODORICO S, 1985, ASTROPHYS J, V299, P852, DOI 10.1086/163752; DODORICO S, 1989, ASTRON ASTROPHYS, V215, P21; Fassia A, 2000, MON NOT R ASTRON SOC, V318, P1093, DOI 10.1046/j.1365-8711.2000.03797.x; Fraternali F, 2004, ASTRON ASTROPHYS, V424, P485, DOI 10.1051/0004-6361:20040529; Hachisu I, 1999, ASTROPHYS J, V522, P487, DOI 10.1086/307608; Hachisu I, 2008, ASTROPHYS J, V679, P1390, DOI 10.1086/586700; Hachisu I, 2008, ASTROPHYS J LETT, V683, pL127, DOI 10.1086/591646; HO LC, 1995, ASTROPHYS J, V444, P165, DOI 10.1086/175591; IBEN I, 1984, ASTROPHYS J SUPPL S, V54, P335, DOI 10.1086/190932; James PA, 2006, ASTRON ASTROPHYS, V453, P57, DOI 10.1051/0004-6361:20054509; Kelson DD, 2003, PUBL ASTRON SOC PAC, V115, P688, DOI 10.1086/375502; Krug HB, 2010, ASTROPHYS J, V708, P1145, DOI 10.1088/0004-637X/708/2/1145; Leonard DC, 2002, PUBL ASTRON SOC PAC, V114, P35, DOI 10.1086/324785; Mannucci F, 2005, ASTRON ASTROPHYS, V433, P807, DOI 10.1051/0004-6361:20041411; Patat F, 2007, ASTRON ASTROPHYS, V474, P931, DOI 10.1051/0004-6361:20078393; Patat F, 2007, SCIENCE, V317, P924, DOI 10.1126/science.1143005; Patat F, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913959; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; SHAPIRO PR, 1976, ASTROPHYS J, V205, P762, DOI 10.1086/154332; Simon JD, 2007, ASTROPHYS J LETT, V671, pL25, DOI 10.1086/524707; Simon JD, 2009, ASTROPHYS J, V702, P1157, DOI 10.1088/0004-637X/702/2/1157; Soderberg AM, 2008, NATURE, V453, P469, DOI 10.1038/nature06997; Sollerman J, 2005, ASTRON ASTROPHYS, V429, P559, DOI 10.1051/0004-6361:20041465; Steidel C. C., 1990, ASTRON J, V99, P5; Stritzinger M, 2010, ASTRON J, V140, P2036, DOI 10.1088/0004-6256/140/6/2036; Takada-Hidai M, 2002, PUBL ASTRON SOC JPN, V54, P899, DOI 10.1093/pasj/54.6.899; VIDALMADJAR A, 1987, ASTRON ASTROPHYS, V177, pL17; WHELAN J, 1973, ASTROPHYS J, V186, P1007, DOI 10.1086/152565	38	198	200	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					856	859		10.1126/science.1203836	http://dx.doi.org/10.1126/science.1203836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836010	Green Submitted			2022-12-28	WOS:000293785400034
J	Brook, RH				Brook, Robert H.			The Role of Physicians in Controlling Medical Care Costs and Reducing Waste	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brook, Robert H.] RAND Corp, Santa Monica, CA 90401 USA; [Brook, Robert H.] David Geffen Univ Calif Los Angeles, Sch Med, Santa Monica, CA USA	RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Brook, RH (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	brook@rand.org						AARON HJ, 1984, PAINFUL PRESCRIPTION; [Anonymous], NY TIMES; Cutler DM, 2004, YOUR MONEY YOUR LIFE; Ryan Paul, ISS HLTH CAR	4	38	38	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2011	306	6					650	651		10.1001/jama.2011.1136	http://dx.doi.org/10.1001/jama.2011.1136			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804XD	21828329				2022-12-28	WOS:000293687300029
J	Backman, L; Nyberg, L; Soveri, A; Johansson, J; Andersson, M; Dahlin, E; Neely, AS; Virta, J; Laine, M; Rinne, JO				Backman, Lars; Nyberg, Lars; Soveri, Anna; Johansson, Jarkko; Andersson, Micael; Dahlin, Erika; Neely, Anna S.; Virta, Jere; Laine, Matti; Rinne, Juha O.			Effects of Working-Memory Training on Striatal Dopamine Release	SCIENCE			English	Article									[Backman, Lars] Karolinska Inst, Aging Res Ctr, S-17177 Stockholm, Sweden; [Nyberg, Lars; Andersson, Micael; Dahlin, Erika] Umea Ctr Funct Brain Imaging UFBI, Dept Integrat Med Biol, S-90187 Umea, Sweden; [Nyberg, Lars; Andersson, Micael; Dahlin, Erika] Umea Ctr Funct Brain Imaging UFBI, Dept Radiat Sci, S-90187 Umea, Sweden; [Soveri, Anna; Laine, Matti] Abo Akad Univ, Dept Psychol & Logoped, FI-20500 Turku, Finland; [Johansson, Jarkko; Virta, Jere; Rinne, Juha O.] Univ Turku, Turku PET Ctr, FI-20500 Turku, Finland; [Neely, Anna S.] Umea Univ, Dept Psychol, S-90187 Umea, Sweden	Karolinska Institutet; Abo Akademi University; University of Turku; Umea University	Backman, L (corresponding author), Karolinska Inst, Aging Res Ctr, S-17177 Stockholm, Sweden.	lars.backman.1@ki.se	Johansson, Jarkko/M-1443-2019; Nyberg, Lars/C-2514-2009; Stigsdotter Neely, Anna/H-4140-2012; Nyberg, Lars/M-5986-2019	Johansson, Jarkko/0000-0002-4501-4735; Nyberg, Lars/0000-0002-3367-1746; Nyberg, Lars/0000-0002-3367-1746; Soveri, Anna/0000-0002-1443-6097; Virta, Jere/0000-0001-8586-653X	Swedish Research Council; Alexander von Humboldt Research Award; af Jochnik Foundation; Nordic-Center-of-Excellence, Umea University; Wallenberg Scholar Award; Academy of Finland; Finnish National Doctoral Program of Psychology	Swedish Research Council(Swedish Research CouncilEuropean Commission); Alexander von Humboldt Research Award(Alexander von Humboldt Foundation); af Jochnik Foundation; Nordic-Center-of-Excellence, Umea University; Wallenberg Scholar Award; Academy of Finland(Academy of Finland); Finnish National Doctoral Program of Psychology	Supported by grants from the Swedish Research Council, an Alexander von Humboldt Research Award, a donation from the af Jochnik Foundation (L.B.); Nordic-Center-of-Excellence, Umea University's Strategic Neuroscience Program, Wallenberg Scholar Award (L.N.); Academy of Finland (M.L., J.O.R.); and Finnish National Doctoral Program of Psychology (A.S.). We are grateful to A. Lundquist for valuable comments.	Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Alpert NM, 2003, NEUROIMAGE, V19, P1049, DOI 10.1016/S1053-8119(03)00186-1; Cohen J, 2002, CURR OPIN NEUROBIOL, V12, P223, DOI 10.1016/S0959-4388(02)00314-8; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008	8	152	158	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					718	718		10.1126/science.1204978	http://dx.doi.org/10.1126/science.1204978			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817043				2022-12-28	WOS:000293512100032
J	Hu, YL; Lee, CC; Ribbe, MW				Hu, Yilin; Lee, Chi Chung; Ribbe, Markus W.			Extending the Carbon Chain: Hydrocarbon Formation Catalyzed by Vanadium/Molybdenum Nitrogenases	SCIENCE			English	Article							FISCHER-TROPSCH SYNTHESIS; AZOTOBACTER-VINELANDII; VANADIUM NITROGENASE; D2O; MECHANISM; PROTEIN	In a small-scale reaction, vanadium-dependent nitrogenase has previously been shown to catalyze reductive catenation of carbon monoxide (CO) to ethylene, ethane, propylene, and propane. Here, we report the identification of additional hydrocarbon products [alpha-butylene, n-butane, and methane (CH4)] in a scaled-up reaction featuring 20 milligrams of vanadium-iron protein, the catalytic component of vanadium nitrogenase. Additionally, we show that the more common molybdenum-dependent nitrogenase can generate the same hydrocarbons from CO, although CH4 was not detected. The identification of CO as a substrate for both molybdenum-and vanadium-nitrogenases strengthens the hypothesis that CO reduction is an evolutionary relic of the function of the nitrogenase family. Moreover, the comparison between the CO-reducing capacities of the two nitrogenases suggests that the identity of heterometal at the active cofactor site affects the efficiency and product distribution of this reaction.	[Hu, Yilin; Lee, Chi Chung; Ribbe, Markus W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hu, YL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	yilinh@uci.edu; mribbe@uci.edu			Herman Frasch Foundation [617-HF07]; NIH [GM 67626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626] Funding Source: NIH RePORTER	Herman Frasch Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. C. Rees and N. Dalleska of the California Institute of Technology (Pasadena, CA) for help with the GC-MS analysis. This work was supported by Herman Frasch Foundation grant 617-HF07 (M.W.R.) and NIH grant GM 67626 (M.W.R.).	Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; BURGESS BK, 1980, BIOCHIM BIOPHYS ACTA, V614, P196, DOI 10.1016/0005-2744(80)90180-1; CARNAHAN EM, 1993, ACCOUNTS CHEM RES, V26, P90, DOI 10.1021/ar00027a003; CASSMAN M, 1974, ARCH BIOCHEM BIOPHYS, V165, P60, DOI 10.1016/0003-9861(74)90141-6; Churchill DG, 2003, J AM CHEM SOC, V125, P1403, DOI 10.1021/ja027670k; Hales B J, 1990, Adv Inorg Biochem, V8, P165; KARSTEN WE, 1995, J AM CHEM SOC, V117, P5914, DOI 10.1021/ja00127a002; Khodadadi AA, 1996, CAN J CHEM ENG, V74, P695, DOI 10.1002/cjce.5450740520; Kurtz KA, 1997, J AM CHEM SOC, V119, P1155, DOI 10.1021/ja962783n; Lee CC, 2011, ANGEW CHEM INT EDIT, V50, P5545, DOI 10.1002/anie.201100869; Lee CC, 2010, SCIENCE, V329, P642, DOI 10.1126/science.1191455; Lee CC, 2009, P NATL ACAD SCI USA, V106, P9209, DOI 10.1073/pnas.0904408106; MORGAN TV, 1990, BIOCHEMISTRY-US, V29, P3077, DOI 10.1021/bi00464a026; ROFERDEPOORTER CK, 1981, CHEM REV, V81, P447, DOI 10.1021/cr00045a002; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Sheu SY, 2008, J PHYS CHEM A, V112, P797, DOI 10.1021/jp0771668; Yang ZY, 2011, J BIOL CHEM, V286, P19417, DOI 10.1074/jbc.M111.229344	17	167	167	4	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					753	755		10.1126/science.1206883	http://dx.doi.org/10.1126/science.1206883			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817053	Green Accepted			2022-12-28	WOS:000293512100042
J	Poelwijk, FJ; de Vos, MGJ; Tans, SJ				Poelwijk, Frank J.; de Vos, Marjon G. J.; Tans, Sander J.			Tradeoffs and Optimality in the Evolution of Gene Regulation	CELL			English	Article							LAC REPRESSOR; PHENOTYPIC PLASTICITY; ESCHERICHIA-COLI; EXPRESSION	Cellular regulation is believed to evolve in response to environmental variability. However, this has been difficult to test directly. Here, we show that a gene regulation system evolves to the optimal regulatory response when challenged with variable environments. We engineered a genetic module subject to regulation by the lac repressor (LacI) in E. coli, whose expression is beneficial in one environmental condition and detrimental in another. Measured tradeoffs in fitness between environments predict the competition between regulatory phenotypes. We show that regulatory evolution in adverse environments is delayed at specific boundaries in the phenotype space of the regulatory LacI protein. Once this constraint is relieved by mutation, adaptation proceeds toward the optimum, yielding LacI with an altered allosteric mechanism that enables an opposite response to its regulatory ligand IPTG. Our results indicate that regulatory evolution can be understood in terms of tradeoff optimization theory.	[Poelwijk, Frank J.; de Vos, Marjon G. J.; Tans, Sander J.] AMOLF Inst, NL-1098 XG Amsterdam, Netherlands	AMOLF	Tans, SJ (corresponding author), AMOLF Inst, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	tans@amolf.nl	Tans, Sander/AAS-2901-2020	Poelwijk, Frank/0000-0002-5696-4357; de Vos, Marjon GJ/0000-0003-0601-908X	Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO)	Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank Kathleen S. Matthews for kindly providing the BLIM cells and pTara plasmid for our expression of the lac repressors. We thank Kim Renders and Roland Dries for technical assistance and Bertus Beaumont, Tom Shimizu, Ron Milo, and members of the Tans and ten Wolde groups for critical reading of the manuscript. We thank Walraj Gosal and other members of the Ranganathan lab for help with lac repressor purification. This work is part of the research program of the Stichting voor Fundamenteel Onderzoek der Materie (FOM), which is financially supported by the Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO).	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHAMNESS GC, 1970, J MOL BIOL, V53, P561, DOI 10.1016/0022-2836(70)90084-7; CHOI KY, 1992, J BACTERIOL, V174, P6207, DOI 10.1128/JB.174.19.6207-6214.1992; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper TF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040035; Flynn TC, 2003, PROTEIN SCI, V12, P2523, DOI 10.1110/ps.03188303; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; LEVINS RICHARD, 1968; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MADAN BM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI DOI 10.1093/NAR/GKG210; MILLER JH, 1979, J MOL BIOL, V131, P223, DOI 10.1016/0022-2836(79)90074-3; Miller SP, 2006, SCIENCE, V314, P458, DOI 10.1126/science.1133479; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; PFAHL M, 1976, J MOL BIOL, V106, P857, DOI 10.1016/0022-2836(76)90269-2; Pigliucci M., 2001, SYN ECO EVO; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; ROFF DA, 2001, LIFE HIST EVOLUTION; Sawaragi Y., 1985, THEORY MULTIOBJECTIV; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Scheiner SM, 2002, J EVOLUTION BIOL, V15, P889, DOI 10.1046/j.1420-9101.2002.00468.x; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Suiter AM, 2003, P NATL ACAD SCI USA, V100, P12782, DOI 10.1073/pnas.2134994100; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; vanTienderen PH, 1997, EVOLUTION, V51, P1372, DOI [10.1111/j.1558-5646.1997.tb01460.x, 10.2307/2411189]; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Wycuff DR, 2000, ANAL BIOCHEM, V277, P67, DOI 10.1006/abio.1999.4385; Zhan HL, 2010, BIOCHEMISTRY-US, V49, P8636, DOI 10.1021/bi101106x	41	83	85	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					462	470		10.1016/j.cell.2011.06.035	http://dx.doi.org/10.1016/j.cell.2011.06.035			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21802129	Bronze, Green Submitted			2022-12-28	WOS:000293570500019
J	Etzioni, O				Etzioni, Oren			Search needs a shake-up	NATURE			English	Editorial Material									Univ Washington, Turing Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Etzioni, O (corresponding author), Univ Washington, Turing Ctr, Seattle, WA 98195 USA.	etzioni@cs.washington.edu							0	33	36	4	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2011	476	7358					25	26		10.1038/476025a	http://dx.doi.org/10.1038/476025a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	801NR	21814257				2022-12-28	WOS:000293447300012
J	Liu, X; Bushnell, DA; Silva, DA; Huang, XH; Kornberg, RD				Liu, Xin; Bushnell, David A.; Silva, Daniel-Adriano; Huang, Xuhui; Kornberg, Roger D.			Initiation Complex Structure and Promoter Proofreading	SCIENCE			English	Article							RNA-POLYMERASE-II; START SITE UTILIZATION; TRANSCRIPTION INITIATION; ABORTIVE INITIATION; ELONGATION COMPLEX; IN-VITRO; MECHANISM; STEPS; TFIIB; PREINITIATION	The initiation of transcription by RNA polymerase II is a multistage process. X-ray crystal structures of transcription complexes containing short RNAs reveal three structural states: one with 2- and 3-nucleotide RNAs, in which only the 3'-end of the RNA is detectable; a second state with 4- and 5-nucleotide RNAs, with an RNA-DNA hybrid in a grossly distorted conformation; and a third state with RNAs of 6 nucleotides and longer, essentially the same as a stable elongating complex. The transition from the first to the second state correlates with a markedly reduced frequency of abortive initiation. The transition from the second to the third state correlates with partial "bubble collapse" and promoter escape. Polymerase structure is permissive for abortive initiation, thereby setting a lower limit on polymerase-promoter complex lifetime and allowing the dissociation of nonspecific complexes. Abortive initiation may be viewed as promoter proofreading, and the structural transitions as checkpoints for promoter control.	[Liu, Xin; Bushnell, David A.; Kornberg, Roger D.] Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA; [Silva, Daniel-Adriano; Huang, Xuhui] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China	Stanford University; Hong Kong University of Science & Technology	Kornberg, RD (corresponding author), Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA.	kornberg@stanford.edu	Huang, Xuhui/ABE-3207-2021	Huang, Xuhui/0000-0002-7119-9358; Silva Manzano, Daniel/0000-0002-3195-9009	NIH [GM049985, AI21144]; Jane Coffin Childs Memorial Fund; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; National Institute of General Medical Sciences; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049985, R01GM036659] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants GM049985 and AI21144 (R. D. K.) and by a Jane Coffin Childs Memorial Fund fellowship (X. L.). Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. Computing resources were provided by Dawning TC5000 supercomputing cluster, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences. Coordinates and structure factors have been deposited at the Protein Data Bank under accession codes 3RZO, 3RZD, 3S14, 3S15, 3S16, 3S17, 3S1M, 3S1N, 3S2H, 3S2D, 3S1Q, and 3S1R (see table S2).	Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; CAI H, 1987, J BIOL CHEM, V262, P298; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Domecq C, 2010, PROTEIN EXPRES PURIF, V69, P83, DOI 10.1016/j.pep.2009.06.016; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Keene RG, 1999, J BIOL CHEM, V274, P11526, DOI 10.1074/jbc.274.17.11526; Kennedy WP, 2007, J MOL BIOL, V370, P256, DOI 10.1016/j.jmb.2007.03.041; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kugel JF, 2002, MOL CELL BIOL, V22, P762, DOI 10.1128/MCB.22.3.762-773.2002; Kugel JF, 2000, J BIOL CHEM, V275, P40483, DOI 10.1074/jbc.M006401200; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; LUSE DS, 1987, J BIOL CHEM, V262, P289; Majovski RC, 2005, J BIOL CHEM, V280, P34917, DOI 10.1074/jbc.M502932200; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pal M, 2002, MOL CELL BIOL, V22, P30, DOI 10.1128/MCB.22.1.30-40.2002; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Yan M, 1997, EMBO J, V16, P7457, DOI 10.1093/emboj/16.24.7457; Yan M, 1999, J BIOL CHEM, V274, P34819, DOI 10.1074/jbc.274.49.34819	24	46	47	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					633	637		10.1126/science.1206629	http://dx.doi.org/10.1126/science.1206629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798951	Green Accepted			2022-12-28	WOS:000293222400063
J	Kravitz, LC				Kravitz, Larry C.			Throwback	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Austin Reg Clin Quarry Lake, Dept Family Med, Austin, TX USA		Kravitz, LC (corresponding author), Austin Reg Clin Quarry Lake, Dept Family Med, Austin, TX USA.	lkravitz@austin.rr.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2011	306	4					355	356		10.1001/jama.2011.1031	http://dx.doi.org/10.1001/jama.2011.1031			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797KL	21791677				2022-12-28	WOS:000293125800001
J	Casetta, I; Fainardi, E; Granieri, E				Casetta, Ilaria; Fainardi, Enrico; Granieri, Enrico			An acutely confused young woman	LANCET			English	Editorial Material							REVERSIBLE ENCEPHALOPATHY SYNDROME		[Casetta, Ilaria; Granieri, Enrico] Univ Ferrara, Neurol Clin, Dept Med & Surg Sci Commun & Behav, I-44100 Ferrara, Italy; [Fainardi, Enrico] Azienda Osped Univ, Dept Neurosci & Rehabil, Neuroradiol Unit, Ferrara, Italy	University of Ferrara; University of Ferrara; Arcispedale Sant'Anna	Casetta, I (corresponding author), Univ Ferrara, Neurol Clin, Dept Med & Surg Sci Commun & Behav, Corso Giovecca 203, I-44100 Ferrara, Italy.	cti@unife.it	Casetta, Ilaria/K-5289-2016	Casetta, Ilaria/0000-0003-4099-8875; Granieri, Enrico/0000-0003-4038-3192				Bartynski WS, 2008, AM J NEURORADIOL, V29, P1043, DOI 10.3174/ajnr.A0929; Finsterer J, 2003, NEUROLOGY, V61, P715, DOI 10.1212/01.WNL.0000080369.87484.06; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Ricaurte GA, 2005, LANCET, V365, P2137, DOI 10.1016/S0140-6736(05)66737-2	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2011	378	9789					456	456		10.1016/S0140-6736(11)60700-9	http://dx.doi.org/10.1016/S0140-6736(11)60700-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XM	21803207				2022-12-28	WOS:000293615900037
J	Housri, N; Coombs, M; Orandi, BJ; Pawlik, TM; Koniaris, LG				Housri, Nadine; Coombs, Mary; Orandi, Babak J.; Pawlik, Timothy M.; Koniaris, Leonidas G.			Ethics and the Law: Is There Common Ground on Informed Consent for Disparities in Hospital Outcomes?	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-VOLUME CENTERS; CANCER-SURGERY; OPERATIVE MORTALITY; LATE SURVIVAL; COLON-CANCER; RESECTION; CARE; PERFORMANCE; PHYSICIANS; CYSTECTOMY	The association between procedure volume at institutions and outcomes of cancer surgeries has been widely published in the medical literature; discussed in the lay press; and, during the past 15 years, incorporated into quality improvement endeavors. In certain cases, institutional volume has become a proxy for quality. Despite the vast amount of retrospective data on this topic, physicians generally have been unsure how to approach the information and interpret it for their patients. Even more challenging to some physicians has been deciding whether the data oblige them to either direct patients with cancer to high-volume centers for care or discuss the data with these patients as part of informed consent. An additional challenge is that physicians must understand laws related to these issues and that these laws are unclear. This article reviews the ethical arguments for including disparities in hospital outcomes as part of informed consent and examines whether legal precedent can shed light on this debate.	Thomas Jefferson Univ, Coll Med, Philadelphia, PA 19107 USA; UMDNJ Robert Wood Johnson Med Sch, New Brunswick, NJ USA; Univ Miami, Sch Law, Miami, FL USA; Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA	Jefferson University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Miami; Johns Hopkins University; Johns Hopkins Medicine	Koniaris, LG (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, 1015 Walnut St,620 Curtis Bldg, Philadelphia, PA 19107 USA.	Leonidas.Koniaris@jefferson.edu	Orandi, Babak/I-6760-2019; Pawlik, Timothy/AAO-9335-2020		State of Florida; Ethics Program at the University of Miami	State of Florida; Ethics Program at the University of Miami	By the James and Esther King Tobacco Research Award from the State of Florida and Arsht Research Grant from the Ethics Program at the University of Miami.	Agency for Healthcare Research and Quality, 2011, INP QUAL IND OV; Annas GJ, 2004, RIGHTS PATIENTS AUTH; Beauchamp TL, 2001, PRINCIPLES BIOMEDICA, P90; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Birkmeyer J D, 1999, Eff Clin Pract, V2, P277; Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1016/S0039-6060(99)70152-2; Birkmeyer JD, 2002, HEALTH AFFAIR, V21, P234, DOI 10.1377/hlthaff.21.5.234; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Birkmeyer JD, 2007, ANN SURG, V245, P777, DOI 10.1097/01.sla.0000252402.33814.dd; Birkmeyer JD, 2006, CANCER-AM CANCER SOC, V106, P2476, DOI 10.1002/cncr.21888; BOBINSKI MA, 1994, U PITT LAW REV, V55, P291; Bouknight III HH, 2003, WASH LEE L REV, V60, P1515; BROOK RH, 1994, ANN INTERN MED, V120, P84, DOI 10.7326/0003-4819-120-1-199401010-00015; California HealthCare Foundation, 2008, JUST LOOK CONS US IN; CAPRON AM, 1974, U PENN LAW REV, V123, P340, DOI 10.2307/3311492; Cedars-Sinai, 2011, QUAL MEAS COL SURG; Chapman CB, 1984, PHYS LAW ETHICS; Christian CK, 2005, WORLD J SURG, V29, P1241, DOI 10.1007/s00268-005-7993-8; Clarke S, 2004, J MED PHILOS, V29, P11, DOI 10.1076/jmep.29.1.11.30415; Dolgin JL, 2010, CAMB Q HEALTHC ETHIC, V19, P97, DOI 10.1017/S0963180109990284; Finlayson EVA, 2003, J AM COLL SURGEONS, V196, P410, DOI 10.1016/S1072-7515(02)01753-2; Finlayson EVA, 2003, ARCH SURG-CHICAGO, V138, P721, DOI 10.1001/archsurg.138.7.721; Fong Y, 2005, ANN SURG, V242, P540, DOI 10.1097/01.sla.0000184190.20289.4b; Furrow BR, 1996, CAMB Q HEALTHC ETHIC, V5, P204, DOI 10.1017/S0963180100006940; Furrow BR, 2009, DREXEL L REV, V1, P439; Grady D, 2007, NY TIMES        0729, pA18; Gupta S, 2003, TIME            1208; Gutierrez JC, 2007, ANN SURG, V245, P952, DOI 10.1097/01.sla.0000250438.04393.a8; Hatch C, 2005, US NEWS WORLD R 0718; Heinemann RA, 1997, WISC LAW REV, P1079; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Hollenbeck BK, 2007, UROLOGY, V69, P871, DOI 10.1016/j.urology.2007.01.040; Hollenbeck BK, 2007, J UROLOGY, V177, P2095, DOI 10.1016/j.juro.2007.01.153; Housri N, 2008, PLOS MED, V5, P1413, DOI 10.1371/journal.pmed.0050214; Iheukwumere Emmanuel O, 2002, J Contemp Health Law Policy, V18, P373; Johns Hopkins Hospital, 2010, IMP EXP SURG; Kolata G, 2006, NY TIMES        0702; Patrick R, 2010, SEMIN ONCOL, V37, P47, DOI 10.1053/j.seminoncol.2009.12.008; Pawlik Timothy M, 2007, Virtual Mentor, V9, P44, DOI 10.1001/virtualmentor.2007.9.1.pfor2-0701; Perry P, 2002, SATURDAY EVENIN 0501, P2399; Robert Wood Johnson University Hospital, 2011, ES QUAL MEAS; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; Rosoff AJ, 1981, INFORMED CONSENT GUI; Rutten LJF, 2005, PATIENT EDUC COUNS, V57, P250, DOI 10.1016/j.pec.2004.06.006; Schneider EC, 1998, JAMA-J AM MED ASSOC, V279, P1638, DOI 10.1001/jama.279.20.1638; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Schrag D, 2006, JNCI-J NATL CANCER I, V98, P163, DOI 10.1093/jnci/djj018; Schrag D, 2003, J SURG ONCOL, V83, P68, DOI 10.1002/jso.10244; Schrag D, 2002, ANN SURG, V236, P583, DOI 10.1097/00000658-200211000-00008; Sharrott D, 1992, BROOK L REV, V58, P85; King JS, 2006, AM J LAW MED, V32, P429, DOI 10.1177/009885880603200401; Szabo L, 2005, USA TODAY       0725; The Leapfrog Group, 2009, FACTSH EV BAS HOSP R; Twerski AD, 1992, BROOK L REV, V58, P5; Vevaina J, 1989, LEGAL ASPECTS MED; Villarosa L, 2002, NY TIMES        0411	56	2	2	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4					260	+		10.7326/0003-4819-155-4-201108160-00010	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	807KN	21844552	Green Published			2022-12-28	WOS:000293896400007
J	Mant, J; Al-Mohammad, A; Swain, S; Laramee, P				Mant, Jonathan; Al-Mohammad, Abdallah; Swain, Sharon; Laramee, Philippe		Guideline Dev Grp	Management of Chronic Heart Failure in Adults: Synopsis of the National Institute for Health and Clinical Excellence Guideline	ANNALS OF INTERNAL MEDICINE			English	Article							VENTRICULAR SYSTOLIC FUNCTION; CONVERTING-ENZYME INHIBITORS; MORTALITY; THERAPY; CANDESARTAN; CARVEDILOL; METOPROLOL; MORBIDITY; DIAGNOSIS; SURVIVAL	Description: The National Institute for Health and Clinical Excellence released its first clinical guideline on heart failure in 2003. This synopsis describes the update of that guideline, which was released in August 2010 and discusses the diagnosis, treatment, and monitoring of heart failure. Methods: Guideline developers considered clinical evidence, health economic analyses, clinical expert opinion, and patient views. Systematic literature searches were performed, and an original decision model assessed the cost-effectiveness of serial measurement of serum natriuretic peptide to monitor patients with chronic heart failure. Recommendations: First, this guideline update describes the role of serum natriuretic peptide measurement, echocardiography, and specialist assessment in the diagnosis of heart failure. Second, it presents a pathway for pharmacologic treatment, rehabilitation, and pacing therapy (including implantable cardioverter-defibrillator and cardiac resynchronization therapy) for patients with heart failure and left ventricular systolic dysfunction and patients with heart failure and preserved ejection fraction. Finally, it explains the recommendation to monitor patients with heart failure by using serial measurement of serum natriuretic peptide.	[Mant, Jonathan] Univ Cambridge, Gen Practice & Primary Care Res Unit, Cambridge CB2 0SR, England; Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; Royal Coll Physicians, London NW1 4LE, England	University of Cambridge; University of Sheffield; Royal College of Physicians	Mant, J (corresponding author), Univ Cambridge, Gen Practice & Primary Care Res Unit, Cambridge CB2 0SR, England.	jm677@medschl.cam.ac.uk	Al-Mohammad, Abdallah/I-5663-2019; Dawda, Paresh/I-6947-2015	Al-Mohammad, Abdallah/0000-0001-6517-8692; Dawda, Paresh/0000-0003-2727-8320; Mant, Jonathan/0000-0002-9531-0268	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Clinical Guideline Centre was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Goldstein S, 1999, CLIN CARDIOL, V22, pV30; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Hill J, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00007; Houghton A R, 2000, Am Heart J, V140, pe25; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Krum H, 2004, EUR J HEART FAIL, V6, P937, DOI 10.1016/j.ejheart.2004.09.005; Lechat P, 1999, LANCET, V353, P9; Mant J, 2009, HEALTH TECHNOL ASSES, V13, pIX, DOI 10.3310/hta13320; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; National Clinical Guideline Centre, 2010, FULL VERS NICE CLIN, V108; National Clinical Guideline Centre, 2010, CHRON HEART FAIL NAT; National Institute for Health and Clinical Excellence, 2010, NICE CLIN GUID, V108; National Institute for Health and Clinical Excellence, 2007, TECHN APPR GUID NIH, V120; National Institute for Health and Clinical Excellence, 2009, GUID MAN JAN 2009; National Institute for Health and Clinical Excellence, 2008, NICE CLIN GUID, V73; National Institute for Health and Clinical Excellence, 2003, CLIN GUID ROYAL COLL, V5; National Institute for Health and Clinical Excellence, 2006, TECHN APPR GUID NIH, V95; Neal B, 2000, LANCET, V356, P1955; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Shibata MC, 2001, EUR J HEART FAIL, V3, P351, DOI 10.1016/S1388-9842(01)00144-1; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Willenheimer R, 2005, CIRCULATION, V112, P2426, DOI 10.1161/CIRCULATIONAHA.105.582320; Wonderling D, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00008; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	34	51	55	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4					252	+		10.7326/0003-4819-155-4-201108160-00009	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	807KN	21844551				2022-12-28	WOS:000293896400006
J	Lembo, AJ; Schneier, HA; Shiff, SJ; Kurtz, CB; MacDougall, JE; Jia, XWD; Shao, JZ; Lavins, BJ; Currie, MG; Fitch, DA; Jeglinski, BI; Eng, P; Fox, SM; Johnston, JM				Lembo, Anthony J.; Schneier, Harvey A.; Shiff, Steven J.; Kurtz, Caroline B.; MacDougall, James E.; Jia, Xinwei D.; Shao, James Z.; Lavins, Bernard J.; Currie, Mark G.; Fitch, Donald A.; Jeglinski, Brenda I.; Eng, Paul; Fox, Susan M.; Johnston, Jeffrey M.			Two Randomized Trials of Linaclotide for Chronic Constipation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; NORTH-AMERICA; TRANSIT; CGMP	Background Linaclotide is a minimally absorbed peptide agonist of the guanylate cyclase C receptor. In two trials, we aimed to determine the efficacy and safety of linaclotide in patients with chronic constipation. Methods We conducted two randomized, 12-week, multicenter, double-blind, parallel-group, placebo-controlled, dual-dose trials (Trials 303 and 01) involving 1276 patients with chronic constipation. Patients received either placebo or linaclotide, 145 mu g or 290 mu g, once daily for 12 weeks. The primary efficacy end point was three or more complete spontaneous bowel movements (CSBMs) per week and an increase of one or more CSBMs from baseline during at least 9 of the 12 weeks. Adverse events were also monitored. Results For Trials 303 and 01, respectively, the primary end point was reached by 21.2% and 16.0% of the patients who received 145 mu g of linaclotide and by 19.4% and 21.3% of the patients who received 290 mu g of linaclotide, as compared with 3.3% and 6.0% of those who received placebo (P<0.01 for all comparisons of linaclotide with placebo). Improvements in all secondary end points were significantly greater in both linaclotide groups than in the placebo groups. The incidence of adverse events was similar among all study groups, with the exception of diarrhea, which led to discontinuation of treatment in 4.2% of patients in both linaclotide groups. Conclusions In these two 12-week trials, linaclotide significantly reduced bowel and abdominal symptoms in patients with chronic constipation. Additional studies are needed to evaluate the potential long-term risks and benefits of linaclotide in chronic constipation.	[Kurtz, Caroline B.; MacDougall, James E.; Shao, James Z.; Lavins, Bernard J.; Currie, Mark G.; Fitch, Donald A.; Jeglinski, Brenda I.; Johnston, Jeffrey M.] Ironwood Pharmaceut Inc, Cambridge, MA 02142 USA; [Lembo, Anthony J.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gastroenterol, Boston, MA 02215 USA; [Lembo, Anthony J.] Harvard Univ, Sch Med, Dept Med, Div Gastroenterol, Boston, MA USA; [Schneier, Harvey A.; Shiff, Steven J.; Jia, Xinwei D.; Eng, Paul; Fox, Susan M.] Forest Res Inst, Jersey City, NJ USA	Ironwood Pharmaceuticals, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Johnston, JM (corresponding author), Ironwood Pharmaceut Inc, 301 Binney St, Cambridge, MA 02142 USA.				Ironwood Pharmaceuticals and Forest Research Institute	Ironwood Pharmaceuticals and Forest Research Institute	Supported by Ironwood Pharmaceuticals and Forest Research Institute.	Andresen V, 2007, GASTROENTEROLOGY, V133, P761, DOI 10.1053/j.gastro.2007.06.067; Brandt LJ, 2005, AM J GASTROENTEROL, V100, pS5, DOI 10.1111/j.1572-0241.2005.50613_2.x; Bryant AP, 2010, LIFE SCI, V86, P760, DOI 10.1016/j.lfs.2010.03.015; Eutamene H, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01385.x; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.037, 10.1053/j.gastro.2009.12.035]; FIELD M, 1978, P NATL ACAD SCI USA, V75, P2800, DOI 10.1073/pnas.75.6.2800; Higgins PDR, 2004, AM J GASTROENTEROL, V99, P750, DOI 10.1111/j.1572-0241.2004.04114.x; Johanson JF, 2007, ALIMENT PHARM THER, V25, P599, DOI 10.1111/j.1365-2036.2006.03238.x; Lembo A, 2003, NEW ENGL J MED, V349, P1360, DOI 10.1056/NEJMra020995; Lembo A, 2010, GASTROENTEROLOGY, V138, pS53, DOI 10.1053/j.gastro.2009.12.050; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Marquis P, 2005, SCAND J GASTROENTERO, V40, P540, DOI 10.1080/00365520510012208; Martin Bradley C, 2006, Manag Care Interface, V19, P43; Pare P, 2001, AM J GASTROENTEROL, V96, P3130, DOI 10.1111/j.1572-0241.2001.05259.x; Seidler U, 1997, J PHYSIOL-LONDON, V505, P411, DOI 10.1111/j.1469-7793.1997.411bb.x; Talley NJ, 2008, NEUROGASTROENT MOTIL, V20, P121, DOI 10.1111/j.1365-2982.2008.01097.x; TIEN XY, 1994, J BIOL CHEM, V269, P51; Wald A, 2007, ALIMENT PHARM THER, V26, P227, DOI 10.1111/j.1365-2036.2007.03376.x	18	227	247	3	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					527	536		10.1056/NEJMoa1010863	http://dx.doi.org/10.1056/NEJMoa1010863			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805MW	21830967				2022-12-28	WOS:000293732100008
J	An, ZS; Clemens, SC; Shen, J; Qiang, XK; Jin, ZD; Sun, YB; Prell, WL; Luo, JJ; Wang, SM; Xu, H; Cai, YJ; Zhou, WJ; Liu, XD; Liu, WG; Shi, ZG; Yan, LB; Xiao, XY; Chang, H; Wu, F; Ai, L; Lu, FY				An Zhisheng; Clemens, Steven C.; Shen, Ji; Qiang, Xiaoke; Jin, Zhangdong; Sun, Youbin; Prell, Warren L.; Luo, Jingjia; Wang, Sumin; Xu, Hai; Cai, Yanjun; Zhou, Weijian; Liu, Xiaodong; Liu, Weiguo; Shi, Zhengguo; Yan, Libin; Xiao, Xiayun; Chang, Hong; Wu, Feng; Ai, Li; Lu, Fengyan			Glacial-Interglacial Indian Summer Monsoon Dynamics	SCIENCE			English	Article							CLIMATE SIMULATION; VARIABILITY; HOLOCENE; HISTORY; RECORD; EVOLUTION; MAXIMUM; CORE	The modern Indian summer monsoon (ISM) is characterized by exceptionally strong interhemispheric transport, indicating the importance of both Northern and Southern Hemisphere processes driving monsoon variability. Here, we present a high-resolution continental record from southwestern China that demonstrates the importance of interhemispheric forcing in driving ISM variability at the glacial-interglacial time scale as well. Interglacial ISM maxima are dominated by an enhanced Indian low associated with global ice volume minima. In contrast, the glacial ISM reaches a minimum, and actually begins to increase, before global ice volume reaches a maximum. We attribute this early strengthening to an increased cross-equatorial pressure gradient derived from Southern Hemisphere high-latitude cooling. This mechanism explains much of the nonorbital scale variance in the Pleistocene ISM record.	[An Zhisheng; Qiang, Xiaoke; Jin, Zhangdong; Sun, Youbin; Xu, Hai; Cai, Yanjun; Zhou, Weijian; Liu, Xiaodong; Liu, Weiguo; Shi, Zhengguo; Yan, Libin; Chang, Hong; Wu, Feng; Ai, Li; Lu, Fengyan] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710075, Peoples R China; [An Zhisheng; Zhou, Weijian] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Peoples R China; [Clemens, Steven C.; Prell, Warren L.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Shen, Ji; Wang, Sumin; Xiao, Xiayun] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing 210008, Peoples R China; [Luo, Jingjia] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Kanagawa 2360001, Japan	Chinese Academy of Sciences; Institute of Earth Environment, CAS; Xi'an Jiaotong University; Brown University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	An, ZS (corresponding author), Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710075, Peoples R China.	anzs@loess.llqg.ac.cn	Zhou, Weijian/I-8953-2014; Yan, Libin/C-5644-2011; Liu, Xiaodong/E-9512-2011; Luo, Jing-Jia/B-2481-2008; AN, Zhisheng/F-8834-2012; Xiao, Xiayun/G-1396-2012; Zhou, Weijian/D-3393-2015; Shi, Zhengguo/F-3106-2011; Luo, Jing-Jia/T-9612-2019; 徐海, Hai Xu/D-9895-2012; Zhou, Weijian/T-1412-2019; Cai, Yanjun/A-9462-2010; Sun, Youbin/K-8357-2012; Liu, Weiguo/J-1824-2014; Jin, Zhangdong/I-8642-2014	Liu, Xiaodong/0000-0003-0355-5610; Luo, Jing-Jia/0000-0003-2181-0638; Luo, Jing-Jia/0000-0003-2181-0638; 徐海, Hai Xu/0000-0002-5356-8156; Zhou, Weijian/0000-0001-9641-5734; Cai, Yanjun/0000-0001-7063-5050; Sun, Youbin/0000-0002-6696-6620; shi, zheng guo/0000-0002-6656-5675; an, zhi sheng/0000-0002-9538-9826	National Natural Science Foundation of China; Ministry of Science and Technology of China; Chinese Academy of Sciences; U.S. NSF	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); U.S. NSF(National Science Foundation (NSF))	We thank Y. Chen, J. Kutzbach, P. Molnar, G. Wu, L. Edward, S. Colman, and Y. Wang for discussion and valuable suggestions. We also thank two anonymous referees for their valuable suggestions. This work was funded by the National Natural Science Foundation of China, the Ministry of Science and Technology of China, the Chinese Academy of Sciences, and U.S. NSF.	An Z S., 1990, LOESS QUATERNARY G 2, P1; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; An ZS, 2000, QUATERNARY SCI REV, V19, P171, DOI 10.1016/S0277-3791(99)00060-8; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Cai YJ, 2006, GEOLOGY, V34, P621, DOI 10.1130/G22567.1; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Channell JET, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000491; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; Clemens SC, 1996, SCIENCE, V274, P943, DOI 10.1126/science.274.5289.943; Clemens SC, 1998, PALEOCEANOGRAPHY, V13, P471, DOI 10.1029/98PA02131; Clemens SC, 2003, MAR GEOL, V201, P35, DOI 10.1016/S0025-3227(03)00207-X; Clemens SC, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001638; Draxler R.R., 1997, DESCRIPTION HYSPLIT, P197; Farjon A, 1990, PINACEAE DRAWINGS DE, P149; Fleitmann D, 2007, QUATERNARY SCI REV, V26, P170, DOI 10.1016/j.quascirev.2006.04.012; Guillou H, 2004, EARTH PLANET SC LETT, V227, P331, DOI 10.1016/j.epsl.2004.09.018; Gupta AK, 2003, NATURE, V421, P354, DOI 10.1038/nature01340; Hodell DA, 1999, QUATERNARY RES, V52, P369, DOI 10.1006/qres.1999.2072; HOLTON JR, 1992, INTRO DYNAMIC METEOR, P310; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; Jansen E, 2000, PALEOCEANOGRAPHY, V15, P709, DOI 10.1029/1999PA000435; Jia C., 1989, SCI GEOGR SIN, V9, P274; Jin ZD, 2006, EARTH SURF PROC LAND, V31, P285, DOI 10.1002/esp.1243; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kiefer T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027097; Kim SJ, 2008, CLIM DYNAM, V31, P1, DOI 10.1007/s00382-007-0332-z; Kong Z., 1992, CLIMATES ENV HOLOCEN, P48; Kutzbach JE, 2008, CLIM DYNAM, V30, P567, DOI 10.1007/s00382-007-0308-z; Kutzbach J. E., 1993, P24; Lange CB, 1999, MAR GEOL, V161, P93, DOI 10.1016/S0025-3227(99)00081-X; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Liu XQ, 2009, EARTH PLANET SC LETT, V280, P276, DOI 10.1016/j.epsl.2009.01.041; Liu Z, 2003, J CLIMATE, V16, P2472, DOI 10.1175/1520-0442(2003)016<2472:CCSOTE>2.0.CO;2; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Mashiotta TA, 1999, EARTH PLANET SC LETT, V170, P417, DOI 10.1016/S0012-821X(99)00116-8; Meyers PA, 1999, J PALEOLIMNOL, V21, P345, DOI 10.1023/A:1008073732192; NESBITT HW, 1982, NATURE, V299, P715, DOI 10.1038/299715a0; Overpeck J, 1996, CLIM DYNAM, V12, P213, DOI 10.1007/BF00211619; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Prell W, 1997, TECTONIC UPLIFT CLIM, P171, DOI DOI 10.1007/978-1-4615-5935-18; PRELL WL, 1992, NATURE, V360, P647, DOI 10.1038/360647a0; Rohling EJ, 2009, QUATERNARY SCI REV, V28, P3291, DOI 10.1016/j.quascirev.2009.09.007; Tomas RA, 1997, Q J ROY METEOR SOC, V123, P1445, DOI 10.1002/qj.49712354202; VERNEKAR AD, 1995, J CLIMATE, V8, P248, DOI 10.1175/1520-0442(1995)008<0248:TEOESC>2.0.CO;2; Webster P.J., 2003, ENCY ATMOSPHERIC SCI, P1370, DOI DOI 10.1016/B0-12-227090-8/00236-0; Webster PJ, 1987, MONSOONS, P3; Xiao XY, 2007, SCI CHINA SER D, V50, P1189, DOI 10.1007/s11430-007-0058-0; Xue F, 2004, J METEOROL SOC JPN, V82, P1173, DOI 10.2151/jmsj.2004.1173; Yang Qing-Song, 2009, Acta Botanica Yunnanica, V31, P389, DOI 10.3724/SP.J.1143.2009.09178	52	308	364	19	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					719	723		10.1126/science.1203752	http://dx.doi.org/10.1126/science.1203752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817044				2022-12-28	WOS:000293512100033
J	Peterson, TR; Sengupta, SS; Harris, TE; Carmack, AE; Kang, SA; Balderas, E; Guertin, DA; Madden, KL; Carpenter, AE; Finck, BN; Sabatini, DM				Peterson, Timothy R.; Sengupta, Shomit S.; Harris, Thurl E.; Carmack, Anne E.; Kang, Seong A.; Balderas, Eric; Guertin, David A.; Madden, Katherine L.; Carpenter, Anne E.; Finck, Brian N.; Sabatini, David M.			mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway	CELL			English	Article							MG2+-DEPENDENT PHOSPHATIDATE PHOSPHATASE; P70 S6 KINASE; MAMMALIAN TARGET; CELL-GROWTH; LAMIN-A; MULTISITE PHOSPHORYLATION; ADIPOCYTE DIFFERENTIATION; PARTIAL LIPODYSTROPHY; BINDING PARTNER; FATTY-ACID	The nutrient-and growth factor-responsive kinase mTOR complex 1 (mTORC1) regulates many processes that control growth, including protein synthesis, autophagy, and lipogenesis. Through unknown mechanisms, mTORC1 promotes the function of SREBP, a master regulator of lipo- and sterolgenic gene transcription. Here, we demonstrate that mTORC1 regulates SREBP by controlling the nuclear entry of lipin 1, a phosphatidic acid phosphatase. Dephosphorylated, nuclear, catalytically active lipin 1 promotes nuclear remodeling and mediates the effects of mTORC1 on SREBP target gene, SREBP promoter activity, and nuclear SREBP protein abundance. Inhibition of mTORC1 in the liver significantly impairs SREBP function and makes mice resistant, in a lipin 1-dependent fashion, to the hepatic steatosis and hypercholesterolemia induced by a high-fat and -cholesterol diet. These findings establish lipin 1 as a key component of the mTORC1-SREBP pathway.	[Sabatini, David M.] MIT, Dept Biol, Koch Ctr Integrat Canc Res, Whitehead Inst Biomed Res,Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Harris, Thurl E.; Carmack, Anne E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Guertin, David A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Madden, Katherine L.; Carpenter, Anne E.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Finck, Brian N.] Washington Univ, Sch Med, Div Geriatr & Nutr Sci, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Virginia; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL)	Sabatini, DM (corresponding author), MIT, Dept Biol, Koch Ctr Integrat Canc Res, Whitehead Inst Biomed Res,Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Nichols, Anne E.C./J-3150-2019; Carpenter, Anne/C-4982-2008	Nichols, Anne E.C./0000-0001-8754-7735; Carpenter, Anne/0000-0003-1555-8261; Finck, Brian/0000-0001-5411-3674; /0000-0002-1446-7256	National Institutes of Health [R01 AI47389, R01 CA103866]; Keck Foundation; LAM Foundation; American Diabetes Association; Jane Coffin Childs Memorial Fund;  [NIH R01 GM089652-01];  [RO1 DK078187]; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); LAM Foundation; American Diabetes Association(American Diabetes Association); Jane Coffin Childs Memorial Fund; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following for technical assistance: We thank members of the Sabatini lab (in particular, Mathieu Laplante and Peggy Hsu), Ayce Yesilatay, and Monty Krieger for helpful discussions. D. M. S. is an investigator of the Howard Hughes Medical Institute. This work was additionally supported by grants from the National Institutes of Health (R01 AI47389 and R01 CA103866) to D. M. S.; awards from the Keck Foundation and LAM Foundation to D. M. S.; an NIH R01 GM089652-01 to A. E. C.; fellowships from the American Diabetes Association, Ludwig Cancer Fund, and Jane Coffin Childs Memorial Fund to T. R. P; and an RO1 DK078187 to B.N.F.	Abraham RT, 2008, EXPERT OPIN THER TAR, V12, P209, DOI [10.1517/14728222.12.2.209, 10.1517/14728222.12.2.209 ]; Blum CB, 2002, AM J TRANSPLANT, V2, P551, DOI 10.1034/j.1600-6143.2002.20610.x; Boguslavsky RL, 2006, HUM MOL GENET, V15, P653, DOI 10.1093/hmg/ddi480; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Capanni C, 2005, HUM MOL GENET, V14, P1489, DOI 10.1093/hmg/ddi158; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Caron M, 2003, AIDS, V17, P2437, DOI 10.1097/00002030-200311210-00005; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jiang XY, 2008, AM J PATHOL, V172, P1748, DOI 10.2353/ajpath.2008.070958; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lempiainen H, 2009, MOL CELL, V33, P704, DOI 10.1016/j.molcel.2009.01.034; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; MOULE SK, 1995, BIOCHEM J, V311, P595, DOI 10.1042/bj3110595; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rehnmark S, 1998, J LIPID RES, V39, P2209; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Sharpe LJ, 2008, BIOCHEM BIOPH RES CO, V373, P670, DOI 10.1016/j.bbrc.2008.06.108; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; SINGH K, 1979, J ANTIBIOT, V32, P630, DOI 10.7164/antibiotics.32.630; Tange Y, 2002, J CELL SCI, V115, P4375, DOI 10.1242/jcs.00135; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	61	775	815	4	114	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					408	420		10.1016/j.cell.2011.06.034	http://dx.doi.org/10.1016/j.cell.2011.06.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816276	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000293570500015
J	Qiang, L; Fujita, R; Yamashita, T; Angulo, S; Rhinn, H; Rhee, D; Doege, C; Chau, L; Aubry, L; Vanti, WB; Moreno, H; Abeliovich, A				Qiang, Liang; Fujita, Ryousuke; Yamashita, Toru; Angulo, Sergio; Rhinn, Herve; Rhee, David; Doege, Claudia; Chau, Lily; Aubry, Laetitia; Vanti, William B.; Moreno, Herman; Abeliovich, Asa			Directed Conversion of Alzheimer's Disease Patient Skin Fibroblasts into Functional Neurons	CELL			English	Article							AMYLOID PRECURSOR PROTEIN; LYSOSOMAL SYSTEM; STEM-CELLS; TRAFFICKING; PRESENILINS; EXPRESSION; HYPOTHESIS; MUTATIONS	Directed conversion of mature human cells, as from fibroblasts to neurons, is of potential clinical utility for neurological disease modeling as well as cell therapeutics. Here, we describe the efficient generation of human-induced neuronal (hiN) cells from adult skin fibroblasts of unaffected individuals and Alzheimer's patients, using virally transduced transcription regulators and extrinsic support factors. hiN cells from unaffected individuals display morphological, electrophysiological, and gene expression profiles that typify glutamatergic forebrain neurons and are competent to integrate functionally into the rodent CNS. hiN cells from familial Alzheimer disease (FAD) patients with presenilin-1 or -2 mutations exhibit altered processing and localization of amyloid precursor protein (APP) and increased production of Ab, relative to the source patient fibroblasts or hiN cells from unaffected individuals. Together, our findings demonstrate directed conversion of human fibroblasts to a neuronal phenotype and reveal cell type-selective pathology in hiN cells derived from FAD patients.	[Qiang, Liang; Fujita, Ryousuke; Yamashita, Toru; Rhinn, Herve; Rhee, David; Doege, Claudia; Chau, Lily; Aubry, Laetitia; Vanti, William B.; Abeliovich, Asa] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Qiang, Liang; Fujita, Ryousuke; Yamashita, Toru; Rhinn, Herve; Rhee, David; Doege, Claudia; Chau, Lily; Aubry, Laetitia; Vanti, William B.; Abeliovich, Asa] Columbia Univ, Dept Cell Biol, New York, NY 10032 USA; [Qiang, Liang; Fujita, Ryousuke; Yamashita, Toru; Rhinn, Herve; Rhee, David; Doege, Claudia; Chau, Lily; Aubry, Laetitia; Vanti, William B.; Abeliovich, Asa] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Qiang, Liang; Fujita, Ryousuke; Yamashita, Toru; Rhinn, Herve; Rhee, David; Doege, Claudia; Chau, Lily; Aubry, Laetitia; Vanti, William B.; Abeliovich, Asa] Columbia Univ, Taub Inst, New York, NY 10032 USA; [Angulo, Sergio; Moreno, Herman] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Neurol, Brooklyn, NY 11203 USA; [Angulo, Sergio; Moreno, Herman] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA	Columbia University; Columbia University; Columbia University; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Abeliovich, A (corresponding author), Columbia Univ, Dept Pathol, Black Bldg 1208,650 W 168th St, New York, NY 10032 USA.	aa900@columbia.edu		Aubry, Laetitia/0000-0001-8152-6036; Yamashita, Toru/0000-0003-3634-5679	Helmsley Foundation; New York State Stem Cell Science NYSTEM [C024402, C024403]; NIH [AG027476]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG027476] Funding Source: NIH RePORTER	Helmsley Foundation; New York State Stem Cell Science NYSTEM; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to David Holtzman and John Cirrito for generously providing reagents for ELISA and Laura Baur for assistance with plasmid construction. We thank Arnon Rosenthal, Scott Small, and Oliver Hobert for reviewing the manuscript. Peter Koppensteiner, Laura Baur, and Ottavio Arancio helped in early stages of the project. We thank Mikako Sakurai for technical advice on in utero transplantation and the New York Stem Cell Foundation for FACS facility services. This work was funded, in part, by the Helmsley Foundation, New York State Stem Cell Science NYSTEM grants C024402 and C024403, and an anonymous foundation grant to A. A., as well as NIH grant AG027476 to H. M..	Abeliovich A, 2009, NEURON, V61, P337, DOI 10.1016/j.neuron.2009.01.024; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Brustle O, 1997, P NATL ACAD SCI USA, V94, P14809, DOI 10.1073/pnas.94.26.14809; Cataldo AM, 1997, J NEUROSCI, V17, P6142; Cataldo AM, 1996, J NEUROSCI, V16, P186; Cirrito JR, 2003, J NEUROSCI, V23, P8844; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Forti L, 2000, J PHYSIOL-LONDON, V527, P33, DOI 10.1111/j.1469-7793.2000.00033.x; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; LLANO I, 1980, P NATL ACAD SCI-BIOL, V77, P7484, DOI 10.1073/pnas.77.12.7484; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang BL, 2009, CELL ADHES MIGR, V3, P118, DOI 10.4161/cam.3.1.7254; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	30	188	200	1	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3					359	371		10.1016/j.cell.2011.07.007	http://dx.doi.org/10.1016/j.cell.2011.07.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816272	Bronze, Green Accepted			2022-12-28	WOS:000293570500011
J	Teleman, AA				Teleman, Aurelio A.			Privileged Signaling for Brain Growth	CELL			English	Editorial Material							ORGAN SIZE; DROSOPHILA	When developing animals encounter nutrient restriction, most tissues stop growing. Some vital tissues, however, such as the brain, continue to grow. Now, Cheng et al. (2011) identify Alk as the kinase that allows the Drosophila brain to continue growing during nutrient restriction by bypassing the requirements for insulin receptor and TOR activation.	German Canc Res Ctr, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Teleman, AA (corresponding author), German Canc Res Ctr, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	a.teleman@dkfz-heidelberg.de	Teleman, Aurelio/V-8470-2019; Teleman, Aurelio A/E-6864-2013	Teleman, Aurelio/0000-0002-4237-9368; Teleman, Aurelio A/0000-0002-4237-9368				Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; GRUENWALD P, 1963, BIOL NEONATORUM, V5, P215; Koh I, 2005, NEUROREPORT, V16, P2029, DOI 10.1097/00001756-200512190-00012; Mirth CK, 2009, DEVELOPMENT, V136, P2345, DOI 10.1242/dev.032672; Ogawa S, 2011, CANCER SCI, V102, P302, DOI 10.1111/j.1349-7006.2010.01825.x; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Roza SJ, 2008, AM J EPIDEMIOL, V168, P1145, DOI 10.1093/aje/kwn233; Shingleton AW, 2010, ORGANOGENESIS, V6, P76, DOI 10.4161/org.6.2.10375; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009	11	2	2	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 5	2011	146	3					346	347		10.1016/j.cell.2011.07.010	http://dx.doi.org/10.1016/j.cell.2011.07.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816269	Bronze			2022-12-28	WOS:000293570500007
J	Donagh, C; Bruzzi, J; MacNeill, B; DaCosta, M; Berman, JS; O'Regan, AW				Donagh, Carol; Bruzzi, John; MacNeill, Briain; DaCosta, Mark; Berman, Jeffrey S.; O'Regan, Anthony W.			Looking at the Whole Picture	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PATENT FORAMEN OVALE; PARADOXICAL EMBOLISM; PULMONARY; TREPOPNEA; SHUNT	A 50-year-old woman presented with rapidly progressive shortness of breath. Five months earlier, she had received a diagnosis of invasive breast carcinoma, at a tumor-node-metastasis (TNM) clinical stage of T2N1M0, and had undergone mastectomy. She received four cycles of cyclophosphamide and doxorubicin, followed by one cycle of paclitaxel with prednisolone. Her fifth cycle of chemotherapy was completed 10 days before presentation. She reported no cough, fever, or chest pain.	[Donagh, Carol; O'Regan, Anthony W.] Galway Univ Hosp, Dept Resp Med, Galway, Ireland; [Bruzzi, John] Galway Univ Hosp, Dept Radiol, Galway, Ireland; [MacNeill, Briain] Galway Univ Hosp, Dept Cardiol, Galway, Ireland; [DaCosta, Mark] Galway Univ Hosp, Dept Cardiothorac Surg, Galway, Ireland; [Berman, Jeffrey S.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Boston University	O'Regan, AW (corresponding author), Galway Univ Hosp, Dept Resp Med, Galway, Ireland.	anthony.oregan@hse.ie	Da Costa, Mark/AAI-7436-2020	Berman, Jeffrey/0000-0001-8523-4778	AstraZeneca; Allen and Hanbury's; Pfizer	AstraZeneca(AstraZeneca); Allen and Hanbury's; Pfizer(Pfizer)	Dr. O'Regan reports receiving grant support and travel or meeting expenses from AstraZeneca, Allen and Hanbury's, and Pfizer. Dr. MacNeil reports serving as a paid consultant on advisory boards with Boston Scientific and Medtronic. No other potential conflict of interest relevant to this article was reported.	Alfaifi S, 1998, CHEST, V113, P1726, DOI 10.1378/chest.113.6.1726; AlKhouzaie T, 1997, CHEST, V112, P1681, DOI 10.1378/chest.112.6.1681; Batsis JA, 2005, NEUROCRIT CARE, V2, P185, DOI 10.1385/NCC:2:2:185; FOURNIER P, 1992, ARCH MAL COEUR VAISS, V85, P877; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; Konstantinov IE, 2008, TEX HEART I J, V35, P475; Murayama H, 2001, Ann Thorac Cardiovasc Surg, V7, P166; Rose PS, 2002, CHEST, V121, P806, DOI 10.1378/chest.121.3.806; SANCHEZ JDA, 2007, SUPPORT CANC THER, V4, P145; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; VICOL C, 1995, ANN THORAC SURG, V60, P1111, DOI 10.1016/0003-4975(95)00473-X; WOOD FC, 1959, ARCH INTERN MED, V104, P966, DOI 10.1001/archinte.1959.00270120122016; Yared K, 2009, CIRC-CARDIOVASC IMAG, V2, P141, DOI 10.1161/CIRCIMAGING.108.832436	13	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					448	453		10.1056/NEJMcps1003398	http://dx.doi.org/10.1056/NEJMcps1003398			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801NW	21812675				2022-12-28	WOS:000293447800011
J	Montzka, SA; Dlugokencky, EJ; Butler, JH				Montzka, S. A.; Dlugokencky, E. J.; Butler, J. H.			Non-CO2 greenhouse gases and climate change	NATURE			English	Review							NITROUS-OXIDE; METHANE EMISSIONS; CARBON-DIOXIDE; ATMOSPHERIC METHANE; HYDROXYL RADICALS; N2O; WATER; SOIL; CYCLE; CH4	Earth's climate is warming as a result of anthropogenic emissions of greenhouse gases, particularly carbon dioxide (CO2) from fossil fuel combustion. Anthropogenic emissions of non-CO2 greenhouse gases, such as methane, nitrous oxide and ozone-depleting substances (largely from sources other than fossil fuels), also contribute significantly to warming. Some non-CO2 greenhouse gases have much shorter lifetimes than CO2, so reducing their emissions offers an additional opportunity to lessen future climate change. Although it is clear that sustainably reducing the warming influence of greenhouse gases will be possible only with substantial cuts in emissions of CO2, reducing non-CO2 greenhouse gas emissions would be a relatively quick way of contributing to this goal.	[Montzka, S. A.; Dlugokencky, E. J.; Butler, J. H.] Natl Ocean & Atmospher Adm, Boulder, CO 80305 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Montzka, SA (corresponding author), Natl Ocean & Atmospher Adm, Boulder, CO 80305 USA.	stephen.a.montzka@noaa.gov	Dlugokencky, Edward/AAN-8746-2020; montzka, stephen/V-6162-2019	Dlugokencky, Edward/0000-0003-0612-6985; montzka, stephen/0000-0002-9396-0400	NOAA's Climate Program Office	NOAA's Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA)	We acknowledge discussions with P. Tans and J. Daniel, updates to data published in ref. 33 from J. Elkins, G. Dutton and T. Conway, and technical assistance from C. Siso and B. Miller. This work was supported in part by the Atmospheric Composition and Climate Program and the Carbon Cycle Program of NOAA's Climate Program Office.	Archer D, 2008, CLIMATIC CHANGE, V90, P283, DOI 10.1007/s10584-008-9413-1; Arneth A, 2010, NAT GEOSCI, V3, P525, DOI [10.1038/NGEO905, 10.1038/ngeo905]; Bergamaschi P, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007268; Bergamaschi P, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014180; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Bouwman AF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI [10.1029/2001GB001811, 10.1029/2001GB001812]; Brook E, 2008, ABRUPT CLIMATE CHANG; Butchart N, 2001, NATURE, V410, P799, DOI 10.1038/35071047; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Daniel J. S., 2011, SCI ASSESSMENT OZONE; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dlugokencky EJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039780; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; European Commission Joint Research Centre, 2010, EDGARV4 1 EM DAT GLO; Fiore AM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015601; Fluckiger J, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002122; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Goldberg SD, 2010, GLOBAL CHANGE BIOL, V16, P220, DOI 10.1111/j.1365-2486.2009.02015.x; Goldberg SD, 2009, GLOBAL CHANGE BIOL, V15, P850, DOI 10.1111/j.1365-2486.2008.01752.x; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gschrey B., 2009, UBAFB001318 FED ENV; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; Hirsch AI, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002443; Hofmann DJ, 2006, TELLUS B, V58, P614, DOI 10.1111/j.1600-0889.2006.00201.x; Hsu J., 2010, GEOPHYS RES LETT, V37, P256; Huang J, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009381; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Janssens IA, 2009, NAT GEOSCI, V2, P318, DOI 10.1038/ngeo505; Keller M, 2005, EARTH INTERACT, V9; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; Kort EA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034031; Lelieveld J, 2004, ATMOS CHEM PHYS, V4, P2337, DOI 10.5194/acp-4-2337-2004; Levin I, 2010, ATMOS CHEM PHYS, V10, P2655, DOI 10.5194/acp-10-2655-2010; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Lucas PL, 2007, ENVIRON SCI POLICY, V10, P85, DOI 10.1016/j.envsci.2006.10.007; Martin ME, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032349; McCarthy HR, 2010, NEW PHYTOL, V185, P514, DOI 10.1111/j.1469-8137.2009.03078.x; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; McKinley DC, 2009, GLOBAL CHANGE BIOL, V15, P2035, DOI 10.1111/j.1365-2486.2008.01836.x; Melillo JM, 2009, SCIENCE, V326, P1397, DOI 10.1126/science.1180251; Miller BR, 2010, ATMOS CHEM PHYS, V10, P7875, DOI 10.5194/acp-10-7875-2010; Montzka S, 2011, SCI ASSESSMENT OZONE, P11; Montzka SA, 2011, SCIENCE, V331, P67, DOI 10.1126/science.1197640; Montzka SA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041195; Montzka S. A., 2008, TRENDS EMISSIONS OZO; Montzka SA, 1999, NATURE, V398, P690, DOI 10.1038/19499; Muhle J, 2010, ATMOS CHEM PHYS, V10, P5145, DOI 10.5194/acp-10-5145-2010; Nevison CD, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002755; Nisbet RER, 2009, P ROY SOC B-BIOL SCI, V276, P1347, DOI 10.1098/rspb.2008.1731; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Parrish DD, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000720; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Petrenko VV, 2009, SCIENCE, V324, P506, DOI 10.1126/science.1168909; Prather MJ, 1998, SCIENCE, V279, P1339, DOI 10.1126/science.279.5355.1339; Prinn RG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022228; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Rigby M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036037; Rutting T, 2010, GLOBAL CHANGE BIOL, V16, P2530, DOI 10.1111/j.1365-2486.2009.02089.x; Schilt A, 2010, QUATERNARY SCI REV, V29, P182, DOI 10.1016/j.quascirev.2009.03.011; Schimel D., 1996, CLIMATE CHANGE 1995; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Seitzinger S.P., 2000, CHEMOSPHERE GLOBAL C, V2, P267, DOI [DOI 10.1016/S1465-9972(00)00015-5, 10.1016/S1465-9972(00)00015-5]; Seitzinger SP, 1998, GLOBAL BIOGEOCHEM CY, V12, P93, DOI 10.1029/97GB03657; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; Shindell DT, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021009; Shindell DT, 2001, GEOPHYS RES LETT, V28, P1551, DOI 10.1029/1999GL011197; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Skiba U., 2000, CHEMOSPHERE GLOBAL C, V2, P379, DOI DOI 10.1016/S1465-9972(00)00016-7; Smeets EMW, 2009, GLOBAL CHANGE BIOL, V15, P1, DOI 10.1111/j.1365-2486.2008.01704.x; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Solomon S., 2010, CLIMATE STABILIZATIO; Solomon S, 2010, P NATL ACAD SCI USA, V107, P18354, DOI 10.1073/pnas.1006282107; Spahni R, 2005, SCIENCE, V310, P1317, DOI 10.1126/science.1120132; Spivakovsky CM, 2000, J GEOPHYS RES-ATMOS, V105, P8931, DOI 10.1029/1999JD901006; Stohl A, 2010, ATMOS CHEM PHYS, V10, P3545, DOI 10.5194/acp-10-3545-2010; Sturges WT, 2000, SCIENCE, V289, P611, DOI 10.1126/science.289.5479.611; Suntharalingam P, 2000, GLOBAL BIOGEOCHEM CY, V14, P429, DOI 10.1029/1999GB900032; Syakila A., 2011, GREENH GAS MEAS MANA, V4, P17, DOI DOI 10.3763/GHGMM.2010.0007; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Thomas RQ, 2010, NAT GEOSCI, V3, P13, DOI 10.1038/NGEO721; Thornton PE, 2009, BIOGEOSCIENCES, V6, P2099, DOI 10.5194/bg-6-2099-2009; Towie N., 2007, NATURE          1206, DOI [10.1038/news.2007.361, DOI 10.1038/NEWS.2007.361]; Townsend AR, 2010, SCI AM, V302, P64, DOI 10.1038/scientificamerican0210-64; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Unger N, 2010, P NATL ACAD SCI USA, V107, P3382, DOI 10.1073/pnas.0906548107; van Groenigen K. J., NATURE IN PRESS; van Vuuren DP, 2006, ENERG J, P201; van Vuuren DP, 2006, ENERG ECON, V28, P102, DOI 10.1016/j.eneco.2005.10.003; Velders GJM, 2007, P NATL ACAD SCI USA, V104, P4814, DOI 10.1073/pnas.0610328104; Velders GJM, 2009, P NATL ACAD SCI USA, V106, P10949, DOI 10.1073/pnas.0902817106; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Walter BP, 2001, J GEOPHYS RES-ATMOS, V106, P34189, DOI 10.1029/2001JD900165; Wunch D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039825; Zaehle S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041345	96	627	670	69	1036	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 4	2011	476	7358					43	50		10.1038/nature10322	http://dx.doi.org/10.1038/nature10322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	801NR	21814274				2022-12-28	WOS:000293447300026
J	Patel, RV; Lebwohl, M				Patel, Rita V.; Lebwohl, Mark			Psoriasis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK-FACTORS; NATIONAL PSORIASIS; PSYCHOLOGICAL DISTRESS; PREGNANCY OUTCOMES; MEDICAL BOARD; FOUNDATION; GUIDELINES; MANAGEMENT; ARTHRITIS; EMPHASIS											Bandoli G, 2010, BRIT J DERMATOL, V163, P334, DOI 10.1111/j.1365-2133.2010.09899.x; BOLOGNIA JL, 2001, HARRISONS PRINCIPLES, P315; Eichenfield LF, 2007, PEDIATR DERMATOL, V24, P289, DOI 10.1111/j.1525-1470.2007.00405.x; Elder JT, 2010, J INVEST DERMATOL, V130, P1213, DOI 10.1038/jid.2009.319; Feldman SR, 2010, J DRUGS DERMATOL, V9, P908; Fortune DG, 2003, ARCH DERMATOL, V139, P752, DOI 10.1001/archderm.139.6.752; Gelfand JM, 2009, J INVEST DERMATOL, V129, P2411, DOI 10.1038/jid.2009.112; Gelmetti Carlo, 2009, Am J Clin Dermatol, V10 Suppl 1, P7, DOI 10.2165/0128071-200910001-00002; Gottlieb A, 2008, J AM ACAD DERMATOL, V58, P851, DOI 10.1016/j.jaad.2008.02.040; Henseler T, 1997, J AM ACAD DERMATOL, V37, pS1, DOI 10.1016/S0190-9622(97)80394-5; Herron MD, 2005, ARCH DERMATOL, V141, P1527, DOI 10.1001/archderm.141.12.1527; Icen M, 2009, J AM ACAD DERMATOL, V60, P394, DOI 10.1016/j.jaad.2008.10.062; Kalb RE, 2009, J AM ACAD DERMATOL, V60, P824, DOI 10.1016/j.jaad.2008.11.906; KATZ HI, 1987, J AM ACAD DERMATOL, V16, P804; Kaye JA, 2008, BRIT J DERMATOL, V159, P895, DOI 10.1111/j.1365-2133.2008.08707.x; Kirby B, 2008, BRIT J DERMATOL, V158, P138, DOI 10.1111/j.1365-2133.2007.08299.x; Kurd SK, 2010, ARCH DERMATOL, V146, P891, DOI 10.1001/archdermatol.2010.186; Lebwohl M, 1998, J AM ACAD DERMATOL, V39, P464, DOI 10.1016/S0190-9622(98)70325-1; Lebwohl M, 2008, J AM ACAD DERMATOL, V58, P94, DOI 10.1016/j.jaad.2007.08.030; Lowe NJ, 1996, J AM ACAD DERMATOL, V35, P710, DOI 10.1016/S0190-9622(96)90726-4; MENTER A, 2011, J AM ACAD DERMATOL; Menter A, 2008, J AM ACAD DERMATOL, V58, P826, DOI 10.1016/j.jaad.2008.02.039; Menter A, 2010, J AM ACAD DERMATOL, V62, P114, DOI 10.1016/j.jaad.2009.08.026; Menter A, 2009, J AM ACAD DERMATOL, V61, P451, DOI 10.1016/j.jaad.2009.03.027; Menter A, 2009, J AM ACAD DERMATOL, V60, P643, DOI 10.1016/j.jaad.2008.12.032; Morelli V, 2010, PRIMARY CARE, V37, P285, DOI 10.1016/j.pop.2010.02.005; Naldi L, 2001, J AM ACAD DERMATOL, V44, P433, DOI 10.1067/mjd.2001.110876; Naldi L, 2007, CLIN DERMATOL, V25, P510, DOI 10.1016/j.clindermatol.2007.08.003; Neimann A.L., 2006, EXPERT REV DERMATOL, V1, P63; Prey S, 2010, J EUR ACAD DERMATOL, V24, P23, DOI 10.1111/j.1468-3083.2009.03564.x; PULG L, 2010, DERMATOLOGY, V220, P71; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Rosenbach M, 2010, J AM ACAD DERMATOL, V62, P655, DOI 10.1016/j.jaad.2009.05.048; Rosmarin DM, 2010, J AM ACAD DERMATOL, V62, P838, DOI 10.1016/j.jaad.2009.05.017; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Van Voorhees AS, 2009, PSORIASIS PSORIATIC; Yang YW, 2011, J AM ACAD DERMATOL, V64, P71, DOI 10.1016/j.jaad.2010.02.005	37	6	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2011	155	3							ITC2	10.7326/0003-4819-155-3-201108020-01002	http://dx.doi.org/10.7326/0003-4819-155-3-201108020-01002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800DJ	21810705				2022-12-28	WOS:000293339600026
J	James, KS				James, K. S.			India's Demographic Change: Opportunities and Challenges	SCIENCE			English	Review							SELECTIVE ABORTIONS; FERTILITY DECLINE; ANDHRA-PRADESH; TRANSITION; EDUCATION	This paper discusses emerging demographic patterns and its opportunities and challenges for India. It investigates the specificities in the demographic transition in terms of various demographic parameters and the lack of homogeneity in the transition across states in the country. It presents some opportunities that can arise from having demographic changes, particularly the demographic dividend and interstate migration to overcome labor shortage in some parts. At the same time, there are serious challenges in the form of enhancing human capital development, addressing the issue of skewed sex ratio, and the possible rise in social and political unrest and conflict.	Inst Social & Econ Change, Populat Res Ctr, Bangalore 560072, Karnataka, India		James, KS (corresponding author), Inst Social & Econ Change, Populat Res Ctr, Bangalore 560072, Karnataka, India.	james@isec.ac.in	James, KS/AAZ-5363-2020	JAMES, KS/0000-0002-5364-5326				Aiyar S., 2011, 1138 IMF; [Anonymous], 45 DESA UN; Arnold F, 2002, POPUL DEV REV, V28, P759, DOI 10.1111/j.1728-4457.2002.00759.x; BHAT PNM, 1990, ECON POLIT WEEKLY, V25, P1957; Bhat PNM, 2002, WORLD DEV, V30, P1791, DOI 10.1016/S0305-750X(02)00065-7; Bloom D. E., 2011, RESHAPING TOMORROW I; Bloom DE, 2011, CURR HIST, V110, P143; Chandrasekhar C. P., 2006, ECON POLIT WEEKLY, P5055; Coale A.J., 1958, POPULATION GROWTH EC; Davis K., 1951, POPULATION INDIA PAK; Desai Sonalde, 2010, Econ Polit Wkly, V45, P12; Dev S. M., 2002, EC POLIT WKLY, V37, P4447; Dyson T., 1994, EC POLIT WKLY, V24, P3235; Dyson Tim, 2004, 21 CENTURY INDIA POP; Forsberg E., 2011, ANN M POP ASS AM PAA; Guilmoto CZ, 2001, POPUL DEV REV, V27, P713, DOI 10.1111/j.1728-4457.2001.00713.x; International Institute for Population Sciences & Macro International, 2007, NAT FAM HLTH SURV NF, V1; James K.S., 2008, ECON POLIT WEEKLY, V43, P63; James KS, 1999, ECON POLIT WEEKLY, V34, P491; Jha P, 2011, LANCET, V377, P1921, DOI 10.1016/S0140-6736(11)60649-1; John TJ, 2011, LANCET, V377, P252, DOI 10.1016/S0140-6736(10)61265-2; Krishnan T. N., 1976, Economic and Political Weekly, V11, P1203; Kumar U., INDIAS DEMOGRAPHIC T; Lutz W, 2004, INT STAT REV, V72, P81; McMillan A., 2001, ECON POLIT WEEKLY, V36, P1171; Office of the Registrar General of India, 2009, SAMPL REG SYST REP 2; Office of the Registrar General of India, 2011, SAMPL REG SYST B; Office of the Registrar General of India, 2011, PREOV POP TOT; Office of the Registrar General of India, 2006, POP PROJ IND STAT 20; Padmadas SS, 2004, INT FAM PLAN PERSPEC, V30, P12, DOI 10.1363/3001204; Population Foundation of India and Population Reference Bureau, 2007, FUT POP IND LONG RAN; Pratham, ANN SURVEY ED REPORT; Srinivasan K., 1991, International Family Planning Perspectives, V17, P14, DOI 10.2307/2133214; Srinivasan K., 1995, REGULATING REPROD IN; United Nations, 2011, WORLD POP PROSP 2010; United Nations, 2009, WORLD POP PROSP 2008; Visaria Leela, 2004, 21 CENTURY INDIA POP; VISARIA P, 1994, ECON POLIT WEEKLY, V29, P3281; Visaria P, 1998, DO POPULATION POLICIES MATTER?, P53; Zachariah K.C., 2004, 363 CTR DEV STUD	40	67	68	5	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					576	580		10.1126/science.1207969	http://dx.doi.org/10.1126/science.1207969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	798PI	21798938				2022-12-28	WOS:000293222400048
J	Perrachione, TK; Del Tufo, SN; Gabrieli, JDE				Perrachione, Tyler K.; Del Tufo, Stephanie N.; Gabrieli, John D. E.			Human Voice Recognition Depends on Language Ability	SCIENCE			English	Article									[Perrachione, Tyler K.; Del Tufo, Stephanie N.; Gabrieli, John D. E.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Gabrieli, John D. E.] McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Gabrieli, John D. E.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Perrachione, TK (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	tkp@mit.edu; gabrieli@mit.edu	Gabrieli, John/AAJ-2869-2020	Del Tufo, Stephanie/0000-0002-2463-1785	Ellison Medical Foundation; NIH [UL1RR025758]; NSF; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank J. A. Christodoulou, E. S. Norton, B. Levy, C. Cardenas-Iniguez, J. Lymberis, P. Saxler, P. C. M. Wong, C. I. Moore, and S. Shattuck-Hufnagel. This work was supported by the Ellison Medical Foundation and NIH grant UL1RR025758. T. K. P. is supported by an NSF Graduate Research Fellowship.	Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; BRADLEY L, 1983, NATURE, V301, P419, DOI 10.1038/301419a0; Gabrieli JDE, 2009, SCIENCE, V325, P280, DOI 10.1126/science.1171999; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Perrachione TK, 2007, NEUROPSYCHOLOGIA, V45, P1899, DOI 10.1016/j.neuropsychologia.2006.11.015	5	122	124	34	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					595	595		10.1126/science.1207327	http://dx.doi.org/10.1126/science.1207327			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798942	Green Accepted, Green Submitted			2022-12-28	WOS:000293222400052
J	Xu, X; You, HL; Du, K; Han, FL				Xu, Xing; You, Hailu; Du, Kai; Han, Fenglu			An Archaeopteryx-like theropod from China and the origin of Avialae	NATURE			English	Article							EARLY EVOLUTION; BIRDS; DINOSAURS; SPECIMEN	Archaeopteryx is widely accepted as being the most basal bird, and accordingly it is regarded as central to understanding avialan origins; however, recent discoveries of derived maniraptorans have weakened the avialan status of Archaeopteryx. Here we report a new Archaeopteryx-like theropod from China. This find further demonstrates that many features formerly regarded as being diagnostic of Avialae, including long and robust forelimbs, actually characterize the more inclusive group Paraves (composed of the avialans and the deinonychosaurs). Notably, adding the new taxon into a comprehensive phylogenetic analysis shifts Archaeopteryx to the Deinonychosauria. Despite only tentative statistical support, this result challenges the centrality of Archaeopteryx in the transition to birds. If this new phylogenetic hypothesis can be confirmed by further investigation, current assumptions regarding the avialan ancestral condition will need to be re-evaluated.	[Xu, Xing] Linyi Univ, Coll Life Sci, Linyi 276005, Shandong, Peoples R China; [Xu, Xing; Han, Fenglu] Chinese Acad Sci, Key Lab Evolutionary Systemat Vertebrates, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [You, Hailu] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Du, Kai] Capital Normal Univ, Dept Biol, Beijing 100037, Peoples R China	Linyi University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Geological Sciences; Capital Normal University	Xu, X (corresponding author), Linyi Univ, Coll Life Sci, Shuangling Rd, Linyi 276005, Shandong, Peoples R China.	xingxu@vip.sina.com		You, Hai-Lu/0000-0003-2203-6461	National Natural Science Foundation of China; Chinese Academy of Sciences; Special Funds for Major State Basic Research Projects of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Special Funds for Major State Basic Research Projects of China	The authors thank X. Zheng for permission to study the holotype specimen of Xiaotingia zhengi and for discussions; P. Chen, L. Hou and Z. Zhou for coordinating the project; C. Sullivan for editing and commenting on the manuscript; R. Li for illustrations; T. Yu for preparing the specimen; X. Ding for editing the illustrations; D. Pol for help in using the TNT software package; P. Barrett, O. Rauhut, M. Kolbl-Ebert and M. Roper for facilitating access to the Archaeopteryx specimens under their care; and G. Mayr for discussions. This work was supported by grants from the National Natural Science Foundation of China, Chinese Academy of Sciences, and Special Funds for Major State Basic Research Projects of China.	Chiappe Luis M., 1999, Bulletin of the American Museum of Natural History, V242, P1; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Frobisch J, 2009, P ROY SOC B-BIOL SCI, V276, P3611, DOI 10.1098/rspb.2009.0911; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Holtz Jr T. R., 2000, GAIA, V15, P5; Holtz TR, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P99; Hu DY, 2010, ACTA GEOL SIN-ENGL, V84, P472, DOI 10.1111/j.1755-6724.2010.00188.x; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Maryanska T, 2002, ACTA PALAEONTOL POL, V47, P97; Mayr G, 2005, SCIENCE, V310, P1483, DOI 10.1126/science.1120331; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Norell MA, 2004, DINOSAURIA, 2ND EDITION, P196; Novas FE, 2004, LIFE O PAST, P150; Novas FE, 1997, NATURE, V387, P390, DOI 10.1038/387390a0; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; Paul G., 1988, PREDATORY DINOSAURS; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Tamura K, 2011, SCIENCE, V331, P753, DOI 10.1126/science.1198229; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Wellnhofer P, 2008, ARCHAEOPTERYX URVOGE; Witmer Lawrence M., 2002, P3; Xu K., 2003, JURASSIC SYSTEM N CH, VVII; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X., 2002, THESIS CHINESE ACAD; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Xu X, 2010, CHINESE SCI BULL, V55, P3971, DOI 10.1007/s11434-010-4150-z; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zheng X. T., 2009, ORIGIN BIRDS; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P455, DOI 10.1007/s00114-004-0570-4	44	174	197	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2011	475	7357					465	470		10.1038/nature10288	http://dx.doi.org/10.1038/nature10288			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797ZA	21796204				2022-12-28	WOS:000293167900033
J	Boussageon, R; Bejan-Angoulvant, T; Saadatian-Elahi, M; Lafont, S; Bergeonneau, C; Kassai, B; Erpeldinger, S; Wright, JM; Gueyffier, F; Cornu, C				Boussageon, Remy; Bejan-Angoulvant, Theodora; Saadatian-Elahi, Mitra; Lafont, Sandrine; Bergeonneau, Claire; Kassai, Behrouz; Erpeldinger, Sylvie; Wright, James M.; Gueyffier, Francois; Cornu, Catherine			Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLYCEMIC CONTROL; COMPLICATIONS; OUTCOMES; ROSIGLITAZONE; ASSOCIATION; METFORMIN; MELLITUS; DISEASE; RISK; HYPERGLYCEMIA	Objective To determine all cause mortality and deaths from cardiovascular events related to intensive glucose lowering treatment in people with type 2 diabetes. Design Meta-analysis of randomised controlled trials. Data sources Medline, Embase, and the Cochrane database of systematic reviews. Study selection Randomised controlled trials that assessed the effect of intensive glucose lowering treatment on cardiovascular events and microvascular complications in adults (>= 18 years) with type 2 diabetes. Data extraction Primary end points were all cause mortality and death from cardiovascular causes. Secondary end points were severe hypoglycaemia and macrovascular and microvascular events. Synthesis of results Results are reported as risk ratios with 99% confidence intervals. Statistical heterogeneity between trials was assessed with. chi(2), tau(2), and I-2 statistics. A fixed effect model was used to assess the effect on the outcomes of intensive glucose lowering versus standard treatment. The quality of clinical trials was assessed by the Jadad score. Results 13 studies were included. Of 34 533 patients, 18 315 received intensive glucose lowering treatment and 16 218 standard treatment. Intensive treatment did not significantly affect all cause mortality (risk ratio 1.04, 99% confidence interval 0.91 to 1.19) or cardiovascular death (1.11, 0.86 to 1.43). Intensive therapy was, however, associated with reductions in the risk of non-fatal myocardial infarction (0.85, 0.74 to 0.96, P<0.001), and microalbuminuria (0.90, 0.85 to 0.96, P<0.001) but a more than twofold increase in the risk of severe hypoglycaemia (2.33, 21.62 to 3.36, P<0.001). Over a treatment period of five years, 117 to 150 patients would need to be treated to avoid one myocardial infarction and 32 to 142 patients to avoid one episode of microalbuminuria, whereas one severe episode of hypoglycaemia would occur for every 15 to 52 patients. In analysis restricted to high quality studies (Jadad score >3), intensive treatment was not associated with any significant risk of reductions but resulted in a 47% increase in risk of congestive heart failure (P<0.001). Conclusions The overall results of this meta-analysis show limited benefits of intensive glucose lowering treatment on all cause mortality and deaths from cardiovascular causes. We cannot exclude a 9% reduction or a 19% increase in all cause mortality and a 14% reduction or a 43% increase in cardiovascular death. The benefit: risk ratio of intensive glucose lowering treatment in the prevention of macrovascular and microvascular events remains uncertain. The harm associated with severe hypoglycaemia might counterbalance the potential benefit of intensive glucose lowering treatment. More double blind randomised controlled trials are needed to establish the best therapeutic approach in people with type 2 diabetes.	[Kassai, Behrouz; Gueyffier, Francois; Cornu, Catherine] Hop Louis Pradel, Ctr Invest Clin, F-69500 Bron, France; [Boussageon, Remy; Lafont, Sandrine; Bergeonneau, Claire; Erpeldinger, Sylvie] Univ Lyon 1, Dept Gen Med, F-69365 Lyon, France; [Bejan-Angoulvant, Theodora; Saadatian-Elahi, Mitra; Kassai, Behrouz; Gueyffier, Francois; Cornu, Catherine] Hosp Civils Lyon, Dept Clin Pharmacol, Lyon, France; [Bejan-Angoulvant, Theodora; Bergeonneau, Claire; Kassai, Behrouz; Gueyffier, Francois; Cornu, Catherine] CNRS, UMR 5558, Villeurbanne, France; [Wright, James M.] Univ British Columbia, Dept Anaesthesiol, Vancouver, BC V5Z 1M9, Canada; [Wright, James M.] Univ British Columbia, Dept Pharm & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Wright, James M.] Univ British Columbia, Dept Med, Vancouver, BC, Canada	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; University of British Columbia; University of British Columbia; University of British Columbia	Cornu, C (corresponding author), Hop Louis Pradel, Ctr Invest Clin, 48 Ave Doyen Lepine, F-69500 Bron, France.	catherine.cornu@chu-lyon.fr	Cornu, Catherine/AAV-9003-2020; Hug, Balthasar L./G-1568-2010; Boussageon, Rémy RB/O-3782-2015; Gueyffier, François/B-8545-2008	Gueyffier, François/0000-0002-9921-0977; Kassai, Behrouz/0000-0002-1712-120X; Bejan-Angoulvant, Theodora/0000-0002-0018-9996				Abraira C, 1997, ARCH INTERN MED, V157, P181, DOI 10.1001/archinte.157.2.181; [Anonymous], 1982, Diabetes, V31 Suppl 5, P1; Azad N, 1999, J DIABETES COMPLICAT, V13, P307, DOI 10.1016/S1056-8727(99)00062-8; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Dargie HJ, 2007, J AM COLL CARDIOL, V49, P1696, DOI 10.1016/j.jacc.2006.10.077; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Eurich DT, 2007, BMJ-BRIT MED J, V335, P497, DOI 10.1136/bmj.39314.620174.80; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gamble JM, 2010, DIABETES OBES METAB, V12, P47, DOI 10.1111/j.1463-1326.2009.01125.x; Gandhi GY, 2008, JAMA-J AM MED ASSOC, V299, P2543, DOI 10.1001/jama.299.21.2543; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 1999, DIABETES CARE, V22, P960, DOI 10.2337/diacare.22.6.960; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Kooy A, 2009, ARCH INTERN MED, V169, P616, DOI 10.1001/archinternmed.2009.20; Malmberg K, 1996, EUR HEART J, V17, P1337; McCormack J, 2000, BMJ-BRIT MED J, V320, P1720, DOI 10.1136/bmj.320.7251.1720; MILLER M, 1976, DIABETES, V25, P1129; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; RICHTER B, 2006, COCHRANE DB SYST REV, V4; Roussel R, 2010, ARCH INTERN MED, V170, P1892, DOI 10.1001/archinternmed.2010.409; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shaughnessy AF, 2003, BRIT MED J, V327, P266, DOI 10.1136/bmj.327.7409.266; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; The University Group Diabetes Program, 1975, DIABETES, V24, P65; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; TZOULAKI I, 2009, BMJ-BRIT MED J, V339, pb4731, DOI DOI 10.1136/BMJ.B4731; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zoungas S, N ENGL J MED, V363, P1410	45	386	393	1	35	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 26	2011	343								d4169	10.1136/bmj.d4169	http://dx.doi.org/10.1136/bmj.d4169			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LP	21791495	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000293440700002
J	Lukas, J; Bartek, J				Lukas, Jiri; Bartek, Jiri			Tethered Genes Get Checked during Replication	CELL			English	Editorial Material							DNA-DAMAGE; CANCER; LINKS	Although events associated with replication stress have long formed the cornerstone of checkpoint activation, questions remain about how cells maintain the integrity of replicating genomes. Now, Bermejo et al. (2011) identify a mechanism directly linking checkpoint function to the relief of topological tension at nuclear pore tethered genes.	[Lukas, Jiri; Bartek, Jiri] Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Bartek, Jiri] Palacky Univ, Inst Mol & Translat Med, Olomouc 77900, Czech Republic	Danish Cancer Society; Palacky University Olomouc	Lukas, J (corresponding author), Danish Canc Soc, Ctr Genotox Stress Res, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	jil@cancer.dk; jb@cancer.dk	Bartek, Jiri/G-5870-2014	Lukas, Jiri/0000-0001-9087-506X				Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Khadaroo B, 2009, NAT CELL BIOL, V11, P980, DOI 10.1038/ncb1910; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Kohler A, 2010, MOL CELL, V38, P6, DOI 10.1016/j.molcel.2010.01.040; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021	10	4	4	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 22	2011	146	2					189	191		10.1016/j.cell.2011.06.046	http://dx.doi.org/10.1016/j.cell.2011.06.046			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784241	Bronze			2022-12-28	WOS:000293013000002
J	Van Kranendonk, MJ				Van Kranendonk, Martin J.			Onset of Plate Tectonics	SCIENCE			English	Editorial Material							WILSON CYCLE; SUBDUCTION; CRUST; GA; GROWTH; CRATON; MANTLE		[Van Kranendonk, Martin J.] Geol Survey Western Australia, Perth, WA 6004, Australia; [Van Kranendonk, Martin J.] Univ Western Australia, Sch Earth & Environm, Crawley, WA 6009, Australia	Geological Survey of Western Australia; University of Western Australia	Van Kranendonk, MJ (corresponding author), Geol Survey Western Australia, Perth, WA 6004, Australia.	martin.vankranendonk@dmp.wa.gov.au	Van Kranendonk, Martin J/J-8755-2012	Van Kranendonk, Martin J/0000-0002-0611-2703				Belousova EA, 2010, LITHOS, V119, P457, DOI 10.1016/j.lithos.2010.07.024; Cawood P. A., 2006, GSA TODAY, V16, P4, DOI [10.1130/GSAT01607.1, DOI 10.1130/GSAT01607.1]; Hoffmann JE, 2011, GEOCHIM COSMOCHIM AC, V75, P4157, DOI 10.1016/j.gca.2011.04.027; Kisters AFM, 2010, PRECAMBRIAN RES, V178, P15, DOI 10.1016/j.precamres.2010.01.002; Moyen JF, 2006, NATURE, V442, P559, DOI [10.1038/nature04972, 10.1038/natureO4972]; Nutman AP, 2002, TECTONICS, V21, DOI 10.1029/2000TC001203; Schmitz MD, 2004, EARTH PLANET SC LETT, V222, P363, DOI 10.1016/j.epsl.2004.03.036; Scholl DW, 2007, GEOL SOC AM MEM, V200, P9, DOI 10.1130/2007.1200(02); Shirey SB, 2011, SCIENCE, V333, P434, DOI 10.1126/science.1206275; Smithies RH, 2005, EARTH PLANET SC LETT, V231, P221, DOI 10.1016/j.epsl.2004.12.026; Stern RJ, 2005, GEOLOGY, V33, P557, DOI 10.1130/G21365.1; Van Kranendonk MJ, 2011, J AFR EARTH SCI, V60, P346, DOI 10.1016/j.jafrearsci.2011.03.012; Van Kranendonk MJ, 2010, AM J SCI, V310, P1187, DOI 10.2475/10.2010.01; Van Kranendonk MJ, 2010, PRECAMBRIAN RES, V177, P145, DOI 10.1016/j.precamres.2009.11.007	14	63	63	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					413	414		10.1126/science.1208766	http://dx.doi.org/10.1126/science.1208766			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	795FR	21778389				2022-12-28	WOS:000292959600032
J	Zhou, RB; Kozlov, AG; Roy, R; Zhang, JC; Korolev, S; Lohman, TM; Ha, T				Zhou, Ruobo; Kozlov, Alexander G.; Roy, Rahul; Zhang, Jichuan; Korolev, Sergey; Lohman, Timothy M.; Ha, Taekjip			SSB Functions as a Sliding Platform that Migrates on DNA via Reptation	CELL			English	Article							SINGLE-STRANDED-DNA; COLI RECO PROTEIN; ESCHERICHIA-COLI; BINDING-PROTEIN; GENETIC-RECOMBINATION; POLYMER-CHAIN; COMPLEXES; MULTIPLE; DYNAMICS; KINETICS	SSB proteins bind to and control the accessibility of single-stranded DNA (ssDNA), likely facilitated by their ability to diffuse on ssDNA. Using a hybrid single-molecule method combining fluorescence and force, we probed how proteins with large binding site sizes can migrate rapidly on DNA and how protein-protein interactions and tension may modulate the motion. Weobserved force-induced progressive unraveling of ssDNA from the SSB surface between 1 and 6 pN, followed by SSB dissociation at similar to 10 pN, and obtained experimental evidence of a reptation mechanism for protein movement along DNA wherein a protein slides via DNA bulge formation and propagation. SSB diffusion persists even when bound with RecO and at forces under which the fully wrapped state is perturbed, suggesting that even in crowded cellular conditions SSB can act as a sliding platform to recruit and carry its interacting proteins for use in DNA replication, recombination and repair.	[Kozlov, Alexander G.; Lohman, Timothy M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Zhou, Ruobo; Roy, Rahul; Zhang, Jichuan; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Zhou, Ruobo; Roy, Rahul; Zhang, Jichuan; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Zhang, Jichuan] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Korolev, Sergey] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	Washington University (WUSTL); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Saint Louis University; Howard Hughes Medical Institute	Lohman, TM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	lohman@biochem.wustl.edu; tjha@illinois.edu	Korolev, Sergey/ABA-7517-2020; Roy, Rahul/D-5329-2009; Ha, Taekjip/B-9506-2009; Roy, Rahul/Y-5878-2019	Roy, Rahul/0000-0003-3329-8803; Ha, Taekjip/0000-0003-2195-6258; Roy, Rahul/0000-0003-3329-8803; Zhou, Ruobo/0000-0001-8628-0282; Korolev, Sergey/0000-0001-9313-7126	National Institutes of Health [GM030498, GM073837, RR025341, GM065367]; National Science Foundation [0822613, 0646550]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030498, R01GM073837, R01GM065367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all the members of Ha laboratory for experimental help and discussion. These studies were supported by grants from the National Institutes of Health (GM030498 to T.M.L., GM073837 to S.K., and RR025341 and GM065367 to T.H.) and the National Science Foundation (0822613 and 0646550 to T.H.). T.H. is an employee of the Howard Hughes Medical Institute.	BEARD P, 1978, CELL, V15, P955, DOI 10.1016/0092-8674(78)90279-9; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; Dudko OK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.108101; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Gorman J, 2008, NAT STRUCT MOL BIOL, V15, P768, DOI 10.1038/nsmb.1441; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kim HD, 2002, P NATL ACAD SCI USA, V99, P4284, DOI 10.1073/pnas.032077799; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P6032, DOI 10.1021/bi020122z; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; Kulic IM, 2003, BIOPHYS J, V84, P3197, DOI 10.1016/S0006-3495(03)70044-7; Kulic IM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148103; Kumaran S, 2006, BIOCHEMISTRY-US, V45, P11958, DOI 10.1021/bi060994r; Kuznetsov SV, 2006, J MOL BIOL, V359, P55, DOI 10.1016/j.jmb.2006.02.070; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; LOHMAN TM, 1984, BIOCHEMISTRY-US, V23, P4656, DOI 10.1021/bi00315a022; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; LUISIDELUCA C, 1994, J MOL BIOL, V236, P124, DOI 10.1006/jmbi.1994.1123; Makharashvili N, 2004, STRUCTURE, V12, P1881, DOI 10.1016/j.str.2004.08.006; Makharashvili N, 2009, J BIOL CHEM, V284, P1425, DOI 10.1074/jbc.M806378200; Manfredi C, 2008, J BIOL CHEM, V283, P24837, DOI 10.1074/jbc.M802002200; Mihardja S, 2006, P NATL ACAD SCI USA, V103, P15871, DOI 10.1073/pnas.0607526103; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; PERKINS TT, 1994, SCIENCE, V264, P819, DOI 10.1126/science.8171335; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Ranjith P, 2007, P NATL ACAD SCI USA, V104, P13649, DOI 10.1073/pnas.0701459104; Richard DJ, 2009, CRIT REV BIOCHEM MOL, V44, P98, DOI 10.1080/10409230902849180; ROMER R, 1984, BIOCHEMISTRY-US, V23, P6132; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Ryzhikov M., 2011, NUCL ACIDS IN PRESS; Sakai A, 2009, J BIOL CHEM, V284, P3264, DOI 10.1074/jbc.M807220200; Schiessel H, 2001, PHYS REV LETT, V86, P4414, DOI 10.1103/PhysRevLett.86.4414; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Sukhishvili SA, 2000, NATURE, V406, P146, DOI 10.1038/35018166; UMEZU K, 1994, J BIOL CHEM, V269, P30005	51	132	135	1	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 22	2011	146	2					222	232		10.1016/j.cell.2011.06.036	http://dx.doi.org/10.1016/j.cell.2011.06.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784244	Green Accepted, Bronze			2022-12-28	WOS:000293013000006
J	Huxley, RR; Woodward, M				Huxley, Rachel R.; Woodward, Mark			Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies	LANCET			English	Review							CAUSE-SPECIFIC MORTALITY; ASIA-PACIFIC REGION; FOLLOW-UP; CARDIOVASCULAR-DISEASE; LUNG-CANCER; MYOCARDIAL-INFARCTION; BRITISH DOCTORS; BLOOD-PRESSURE; POPULATION; HEALTH	Background Prevalence of smoking is increasing in women in some populations and is a risk factor for coronary heart disease. Whether smoking confers the same excess risk of coronary heart disease for women as it does for men is unknown. Therefore, we aimed to estimate the effect of smoking on coronary heart disease in women compared with men after accounting for sex differences in other major risk factors. Methods We undertook a systematic review and meta-analysis of prospective cohort studies published between Jan 1, 1966, and Dec 31, 2010, from four online databases. We selected cohort studies that were stratified by sex with measures of relative risk (RR), and associated variability, for coronary heart disease and current smoking compared with not smoking. We pooled data with a random effects model with inverse variance weighting, and estimated RR ratios (RRRs) between men and women. Findings We reviewed 8005 abstracts and included 26 articles with data for 3 912 809 individuals and 67 075 coronary heart disease events from 86 prospective trials. In 75 cohorts (2.4 million participants) that adjusted for cardiovascular risk factors other than coronary heart disease, the pooled adjusted female-to-male RRR of smoking compared with not smoking for coronary heart disease was 1.25 (95% CI 1.12-1.39, p<0.0001). This outcome was unchanged after adjustment for potential publication bias and there was no evidence of important between-study heterogeneity (p=0.21). The RRR increased by 2% for every additional year of study follow-up (p=0.03). In pooled data from 53 studies, there was no evidence of a sex difference in the RR between participants who had previously smoked compared with those who never had (RRR 0.96, 95% CI 0.86-1.08, p=0.53). Interpretation Whether mechanisms underlying the sex difference in risk of coronary heart disease are biological or related to differences in smoking behaviour between men and women is unclear. Tobacco-control programmes should consider women, particularly in those countries where smoking among young women is increasing in prevalence.	[Huxley, Rachel R.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; [Huxley, Rachel R.; Woodward, Mark] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Woodward, Mark] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA	University of Minnesota System; University of Minnesota Twin Cities; George Institute for Global Health; University of Sydney; Johns Hopkins University	Huxley, RR (corresponding author), Univ Minnesota, Div Epidemiol & Community Hlth, 1300 S 2nd St,Suite 300, Minneapolis, MN 55454 USA.	rachux@gmail.com	Woodward, Mark/D-8492-2015; Woodward, Mark/L-6817-2017; Huxley, Rachel R/J-4638-2013; Huxley, Rachel R/C-7032-2013	Huxley, Rachel R/0000-0002-2705-6616; Huxley, Rachel R/0000-0002-2705-6616; Woodward, Mark/0000-0001-9800-5296				Bain C, 2004, JNCI-J NATL CANCER I, V96, P826, DOI 10.1093/jnci/djh143; Boreham R, 2001, USE TOBACCO PRODUCTS, V1; Carnethon MR, 2006, ARCH INTERN MED, V166, P1196, DOI 10.1001/archinte.166.11.1196; Centers for Disease Control and Prevention, 2006, JAMA-J AM MED ASSOC, V295, P749; Collins VR, 1996, INT J EPIDEMIOL, V25, P59, DOI 10.1093/ije/25.1.59; DeRoo LA, 2010, PREV MED, V51, P497, DOI 10.1016/j.ypmed.2010.09.013; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; DOLL R, 1980, BRIT MED J, V280, P967, DOI 10.1136/bmj.280.6219.967; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; Ferrie JE, 2009, HEART, V95, P1250, DOI 10.1136/hrt.2008.164251; FLODERUS B, 1988, INT J EPIDEMIOL, V17, P332, DOI 10.1093/ije/17.2.332; FRASER GE, 1992, CIRCULATION, V86, P406, DOI 10.1161/01.CIR.86.2.406; Freedman ND, 2008, LANCET ONCOL, V9, P649, DOI 10.1016/S1470-2045(08)70154-2; Gilmore A, 2004, AM J PUBLIC HEALTH, V94, P2177, DOI 10.2105/AJPH.94.12.2177; Goldbourt U, 2004, PREV MED, V38, P834, DOI 10.1016/j.ypmed.2003.12.022; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Honjo K, 2010, TOB CONTROL, V19, P50, DOI 10.1136/tc.2009.029751; Houterman S, 2003, EPIDEMIOLOGY, V14, P24, DOI 10.1097/00001648-200301000-00010; Hozawa A, 2007, HYPERTENS RES, V30, P1169, DOI 10.1291/hypres.30.1169; Huxley R, 2007, AM J EPIDEMIOL, V165, P1280, DOI 10.1093/aje/kwm002; Jensen MK, 2008, CIRCULATION, V117, P3062, DOI 10.1161/CIRCULATIONAHA.107.759951; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Juutilainen A, 2004, DIABETES CARE, V27, P2898, DOI 10.2337/diacare.27.12.2898; Kenfield SA, 2010, TOB CONTROL, V19, P248, DOI 10.1136/tc.2009.032839; LACROIX AZ, 1991, NEW ENGL J MED, V324, P1619, DOI 10.1056/NEJM199106063242303; Lam TH, 2007, J AM GERIATR SOC, V55, P2090, DOI 10.1111/j.1532-5415.2007.01441.x; Lee ET, 2006, CIRCULATION, V113, P2897, DOI 10.1161/CIRCULATIONAHA.105.593178; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Marin A, 2006, BMC PUBLIC HEALTH, V6, P1, DOI 10.1186/1471-2458-6-38; Martiniuk ALC, 2006, TOB CONTROL, V15, P181, DOI 10.1136/tc.2005.013284; McClave AK, 2010, WOMEN HEALTH ISS, V20, P380, DOI 10.1016/j.whi.2010.06.006; National Cancer Institute, SMOK TOB CONTR MON; Nilsson PM, 2006, J INTERN MED, V260, P134, DOI 10.1111/j.1365-2796.2006.01671.x; Njolstad I, 1996, CIRCULATION, V93, P450; Onat A, 2007, ATHEROSCLEROSIS, V193, P380, DOI 10.1016/j.atherosclerosis.2006.07.002; PAGANINIHILL A, 1994, AM J PUBLIC HEALTH, V84, P992, DOI 10.2105/AJPH.84.6.992; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Qvist J, 1996, SCAND J SOC MED, V24, P67, DOI 10.1177/140349489602400111; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; Shankar A, 2008, EUR J CANCER, V44, P100, DOI 10.1016/j.ejca.2007.10.015; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; THUN MJ, 1995, AM J PUBLIC HEALTH, V85, P1223, DOI 10.2105/AJPH.85.9.1223; Wen CP, 2004, PREV MED, V39, P528, DOI 10.1016/j.ypmed.2004.02.010; Woodward M, 2005, INT J EPIDEMIOL, V34, P1036, DOI 10.1093/ije/dyi104; WOODWARD M, 1991, J CLIN EPIDEMIOL, V44, P1405, DOI 10.1016/0895-4356(91)90101-E; Woodward M., 2013, EPIDEMIOLOGY STUDY D; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; World Health Organization, 1997, TOB HLTH GLOB STAT R; World Health Organization, 2019, WHO REP GLOB TOB EP; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183; [No title captured]	54	505	522	1	94	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 8	2011	378	9799					1297	1305		10.1016/S0140-6736(11)60781-2	http://dx.doi.org/10.1016/S0140-6736(11)60781-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IU	21839503				2022-12-28	WOS:000295724300024
J	Emanuel, EJ; Menikoff, J				Emanuel, Ezekiel J.; Menikoff, Jerry			Reforming the Regulations Governing Research with Human Subjects	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STANDARDS		[Emanuel, Ezekiel J.] NIH, Dept Bioeth, Bethesda, MD 20892 USA; [Menikoff, Jerry] Dept Hlth & Human Serv, Off Human Res Protect, Rockville, MD USA	National Institutes of Health (NIH) - USA	Emanuel, EJ (corresponding author), NIH, Dept Bioeth, Bldg 10, Bethesda, MD 20892 USA.							Albala Ilene, 2010, IRB, V32, P7; [Anonymous], [No title captured]; [Anonymous], 2011, FED REGISTER, V76, P3821; Department of Health and Human Services, 2011, FED REG, V76, P44512; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Dziak K, 2005, HEALTH SERV RES, V40, P279, DOI 10.1111/j.1475-6773.2005.00353.x; Emanuel EJ, 2004, ANN INTERN MED, V141, P282, DOI 10.7326/0003-4819-141-4-200408170-00008; Federman D.D., 2003, RESPONSIBLE RES; Kim S, 2009, NATURE, V457, P534, DOI 10.1038/457534a; MENIKOFF JERRY, 2006, WHAT DOCTOR DIDNT SA, P113; National Bioethics Advisory Commission, 2001, ETH POL ISS RES INV; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; Shah S, 2004, JAMA-J AM MED ASSOC, V291, P476, DOI 10.1001/jama.291.4.476; Silverman H, 2001, CRIT CARE MED, V29, P235, DOI 10.1097/00003246-200102000-00002	14	86	87	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1145	1150		10.1056/NEJMsb1106942	http://dx.doi.org/10.1056/NEJMsb1106942			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822WR	21787202				2022-12-28	WOS:000295081600016
J	Crandall, CJ; Cauley, JA				Crandall, Carolyn J.; Cauley, Jane A.			Calcium plus vitamin D was associated with increased cardiovascular risk in women not taking personal calcium supplements	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Crandall, Carolyn J.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Cauley, Jane A.] Univ Pittsburgh, Pittsburgh, PA USA	University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Crandall, CJ (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.			Cauley, Jane A/0000-0003-0752-4408				Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; IOM, 2011, DIETARY REFERENCE IN; Manson JE, 2010, MENOPAUSE, V17, P683, DOI 10.1097/gme.0b013e3181d683b5; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010	4	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4							JC2-3	10.7326/0003-4819-155-4-201108160-02003	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LM	21844536				2022-12-28	WOS:000208885100002
J	Imray, C; Booth, A; Wright, A; Bradwell, A				Imray, Chris; Booth, Adam; Wright, Alex; Bradwell, Arthur			Acute altitude illnesses	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACUTE MOUNTAIN-SICKNESS; RAPID ASCENT; PREVENTION; DEXAMETHASONE; OXYGEN; ACETAZOLAMIDE; PERFORMANCE; PREDICTION; EXPOSURES; SYMPTOMS		[Imray, Chris] Univ Hosp Coventry & Warwickshire NHS Trust, Warwick Med Sch, Coventry CV2 2DX, W Midlands, England; [Booth, Adam] Jiggins Lane Med Ctr, Birmingham, W Midlands, England; [Bradwell, Arthur] Univ Birmingham, Sch Med, Immunodiagost Res Lab, Birmingham B15 2TT, W Midlands, England	University of Warwick; University of Birmingham	Imray, C (corresponding author), Univ Hosp Coventry & Warwickshire NHS Trust, Warwick Med Sch, Coventry CV2 2DX, W Midlands, England.	Christopher.imray@uhcw.nhs.uk		Bradwell, Arthur/0000-0002-1562-1606				[Anonymous], 2008, HIGH ALT MED BIOL, V9, P1, DOI 10.1089/ham.2008.9101; Beidleman BA, 2004, CLIN SCI, V106, P321, DOI 10.1042/CS20030161; Beidleman BA, 2009, HIGH ALT MED BIOL, V10, P253, DOI 10.1089/ham.2009.1004; Bernhard WN, 1998, AVIAT SPACE ENVIR MD, V69, P883; Burtscher M, 2008, SLEEP BREATH, V12, P103, DOI 10.1007/s11325-007-0131-0; Dumont L, 2000, BRIT MED J, V321, P267, DOI 10.1136/bmj.321.7256.267; FORSTER PJG, 1985, AVIAT SPACE ENVIR MD, V56, P758; Fulco CS, 2009, AVIAT SPACE ENVIR MD, V80, P955, DOI 10.3357/ASEM.2540.2009; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Imray C, 2010, PROG CARDIOVASC DIS, V52, P467, DOI 10.1016/j.pcad.2010.02.003; JOHNSON TS, 1984, NEW ENGL J MED, V310, P683, DOI 10.1056/NEJM198403153101103; Karinen HM, 2010, HIGH ALT MED BIOL, V11, P325, DOI 10.1089/ham.2009.1060; KELLER HR, 1995, BMJ-BRIT MED J, V310, P1232, DOI 10.1136/bmj.310.6989.1232; Leadbetter G, 2009, WILD ENVIRON MED, V20, P66, DOI 10.1580/08-WEME-BR-247.1; MacInnis MJ, 2011, J OCCUP ENVIRON MED, V53, P159, DOI 10.1097/JOM.0b013e318206b112; Maggiorini M, 2010, PROG CARDIOVASC DIS, V52, P500, DOI 10.1016/j.pcad.2010.03.001; Medex, TRAV HIGH ALT; Moraga FA, 2008, WILD ENVIRON MED, V19, P287, DOI 10.1580/06-WEME-BR-084.1; Peacock AJ, 1998, BRIT MED J, V317, P1063; Pollard AJ., 2003, HIGH ALTITUDE MED HD; Ri-Li G, 2003, ANN INTERN MED, V139, P253, DOI 10.7326/0003-4819-139-4-200308190-00007; RIED LD, 1994, J WILDERNESS MED, V5, P34; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; ROSS RT, 1985, LANCET, V1, P990; Schommer K, 2010, HIGH ALT MED BIOL, V11, P19, DOI 10.1089/ham.2009.1019; SINGH I, 1969, NEW ENGL J MED, V280, P175, DOI 10.1056/NEJM196901232800402; Southard A, 2007, HIGH ALT MED BIOL, V8, P124, DOI 10.1089/ham.2006.1014; Subudhi AW, 2010, STROKE, V41, P641, DOI 10.1161/STROKEAHA.109.574749; Wagner DR, 2007, HIGH ALT MED BIOL, V8, P27, DOI 10.1089/ham.2006.0814; West JB, 2003, HIGH ALT MED BIOL, V4, P389, DOI 10.1089/152702903769192340; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Wilson MH, 2011, J CEREB BLOOD FLOW M; Wu TY, 2009, HIGH ALT MED BIOL, V10, P221, DOI 10.1089/ham.2009.1012	35	41	46	2	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2011	343								d4943	10.1136/bmj.d4943	http://dx.doi.org/10.1136/bmj.d4943			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	811KK	21844157	Green Submitted			2022-12-28	WOS:000294208300001
J	Rosling, A; Cox, F; Cruz-Martinez, K; Ihrmark, K; Grelet, GA; Lindahl, BD; Menkis, A; James, TY				Rosling, Anna; Cox, Filipa; Cruz-Martinez, Karelyn; Ihrmark, Katarina; Grelet, Gwen-Aelle; Lindahl, Bjorn D.; Menkis, Audrius; James, Timothy Y.			Archaeorhizomycetes: Unearthing an Ancient Class of Ubiquitous Soil Fungi	SCIENCE			English	Article							ECTOMYCORRHIZAL; DIVERSITY; COMMUNITIES; EVOLUTION; TREE; BIODIVERSITY; ASCOMYCOTA	Estimates suggest that only one-tenth of the true fungal diversity has been described. Among numerous fungal lineages known only from environmental DNA sequences, Soil Clone Group 1 is the most ubiquitous. These globally distributed fungi may dominate below-ground fungal communities, but their placement in the fungal tree of life has been uncertain. Here, we report cultures of this group and describe the class, Archaeorhizomycetes, phylogenetically placed within subphylum Taphrinomycotina in the Ascomycota. Archaeorhizomycetes comprises hundreds of cryptically reproducing filamentous species that do not form recognizable mycorrhizal structures and have saprotrophic potential, yet are omnipresent in roots and rhizosphere soil and show ecosystem and host root habitat specificity.	[Rosling, Anna; Cruz-Martinez, Karelyn; Ihrmark, Katarina; Lindahl, Bjorn D.; Menkis, Audrius] SLU, Uppsala BioCtr, Dept Forest Mycol & Pathol, S-75007 Uppsala, Sweden; [Rosling, Anna] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Cox, Filipa] Univ London Imperial Coll Sci Technol & Med, Richmond TW9 3DS, Surrey, England; [Cox, Filipa] Royal Bot Gardens, Richmond TW9 3DS, Surrey, England; [Grelet, Gwen-Aelle] Univ Aberdeen, Aberdeen AB24 3UU, Scotland; [James, Timothy Y.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Grelet, Gwen-Aelle] James Hutton Inst, Aberdeen AB24 3UU, Scotland	Swedish University of Agricultural Sciences; Indiana University System; Indiana University Bloomington; Imperial College London; Royal Botanic Gardens, Kew; University of Aberdeen; University of Michigan System; University of Michigan; James Hutton Institute	Rosling, A (corresponding author), SLU, Uppsala BioCtr, Dept Forest Mycol & Pathol, Box 7026, S-75007 Uppsala, Sweden.	anna.rosling@slu.se; tyjames@umich.edu	Finlay, Roger D/B-4731-2009; Rosling, Anna/D-1984-2012; Lindahl, Björn D./AAH-4538-2019; Menkis, Audrius/AAE-5639-2020	Finlay, Roger D/0000-0002-3652-2930; Cox, Filipa/0000-0003-1405-7481; Rosling, Anna/0000-0002-7003-5941; Menkis, Audrius/0000-0002-6545-8907	Carl Trygger Foundation; FORMAS; Natural Environment Research Council UK [NE/C003128/1]; NERC [NE/H014098/1] Funding Source: UKRI; Natural Environment Research Council [NE/C003128/1, NE/H014098/1] Funding Source: researchfish	Carl Trygger Foundation; FORMAS(Swedish Research Council Formas); Natural Environment Research Council UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding from Carl Trygger Foundation, FORMAS, and Natural Environment Research Council UK (NE/C003128/1). We thank A. Taylor and R. Landweert for isolating Archaeorhizomyces finlayi. We thank S. Redhead for advice on the taxonomy and A. Piper for help with the Latin translation. The culture of A. finlayi is available at CBS (CBS 128710) and DNA sequences for Archaeorhizomyces have been deposited at the National Center for Biotechnology Information under accession numbers JF836020 to JF836030 and FN811925 (table S3).	Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Cox F, 2010, ECOL LETT, V13, P1103, DOI 10.1111/j.1461-0248.2010.01494.x; Deslippe JR, 2011, GLOBAL CHANGE BIOL, V17, P1625, DOI 10.1111/j.1365-2486.2010.02318.x; Grelet GA, 2010, NEW PHYTOL, V188, P210, DOI 10.1111/j.1469-8137.2010.03353.x; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Kjoller R, 2009, FOREST ECOL MANAG, V257, P2217, DOI 10.1016/j.foreco.2009.02.038; Landvik S, 2003, MYCOL RES, V107, P1021, DOI 10.1017/S0953756203008219; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Liu Y, 2009, MOL BIOL EVOL, V26, P27, DOI 10.1093/molbev/msn221; Menkis A, 2005, MYCORRHIZA, V16, P33, DOI 10.1007/s00572-005-0011-z; Porter TM, 2008, MOL PHYLOGENET EVOL, V46, P635, DOI 10.1016/j.ympev.2007.10.002; REDHEAD SA, 1979, MYCOLOGIA, V71, P1248, DOI 10.2307/3759112; Rincon A, 2010, FOREST ECOL MANAG, V260, P361, DOI 10.1016/j.foreco.2010.04.028; Rosling A, 2003, NEW PHYTOL, V159, P775, DOI 10.1046/j.1469-8137.2003.00829.x; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0; Sugiyama J, 2006, MYCOLOGIA, V98, P996, DOI 10.3852/mycologia.98.6.996; Tedersoo L, 2009, ENVIRON MICROBIOL, V11, P3166, DOI 10.1111/j.1462-2920.2009.02020.x; Urban A, 2008, MYCORRHIZA, V18, P339, DOI 10.1007/s00572-008-0189-y; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; White TJ., 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Zwickl D, 2006, THESIS U TEXAS AUSTI	28	193	205	0	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2011	333	6044					876	879		10.1126/science.1206958	http://dx.doi.org/10.1126/science.1206958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	806DJ	21836015				2022-12-28	WOS:000293785400040
J	Bienfang, DC; McKenna, MJ; Papaliodis, GN; Gonzalez, RG; Stemmer-Rachamimov, A				Bienfang, Don C.; McKenna, Michael J.; Papaliodis, George N.; Gonzalez, R. Gilberto; Stemmer-Rachamimov, Anat			Case 24-2011: A 36-Year-Old Man with Headache, Memory Loss, and Confusion Anatomical Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACOID PIGMENT EPITHELIOPATHY; RETINAL ARTERIOLAR OCCLUSIONS; OF-THE-LITERATURE; SUSAC-SYNDROME; LYME-DISEASE; HEARING-LOSS; NEUROLOGIC ABNORMALITIES; WHIPPLES DISEASE; MICROANGIOPATHY; ENCEPHALOPATHY		[Bienfang, Don C.] Brigham & Womens Hosp, Div Neuroophthalmol, Boston, MA 02115 USA; [McKenna, Michael J.] Massachusetts Eye & Ear Infirm, Otol & Neurotol Serv, Boston, MA 02114 USA; [Papaliodis, George N.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Stemmer-Rachamimov, Anat] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bienfang, Don C.; Papaliodis, George N.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [McKenna, Michael J.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Stemmer-Rachamimov, Anat] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bienfang, DC (corresponding author), Brigham & Womens Hosp, Div Neuroophthalmol, 75 Francis St, Boston, MA 02115 USA.							BOGOUSSLAVSKY J, 1989, J NEUROL NEUROSUR PS, V52, P43, DOI 10.1136/jnnp.52.1.43; CHURG J, 1951, AM J PATHOL, V27, P277; COGAN DG, 1945, ARCH OPHTHALMOL-CHIC, V33, P144; CURY D, 1956, ARCH OPHTHALMOL-CHIC, V55, P261; DEREMEE RA, 1980, MAYO CLIN PROC, V55, P492; Do TH, 2004, AM J NEURORADIOL, V25, P382; Dobbins 3rd WO, 1987, WHIPPLES DIS; FLEMING JL, 1988, MAYO CLIN PROC, V63, P539, DOI 10.1016/S0025-6196(12)64884-8; Galetta SL., 1998, WALSH HOYTS CLIN NEU, V5, P3725; GASS JDM, 1968, ARCH OPHTHALMOL-CHIC, V80, P177; HAYNES BF, 1981, ARTHRITIS RHEUM, V24, P501, DOI 10.1002/art.1780240308; HAYNES BF, 1980, MEDICINE, V59, P426, DOI 10.1097/00005792-198011000-00003; HEISKALA H, 1988, J NEUROL SCI, V86, P239, DOI 10.1016/0022-510X(88)90102-5; KNOX DL, 1968, JOHNS HOPKINS MED J, V123, P175; LOGIGIAN EL, 1990, NEW ENGL J MED, V323, P1438, DOI 10.1056/NEJM199011223232102; MONTEIRO MLR, 1985, NEUROLOGY, V35, P1113, DOI 10.1212/WNL.35.8.1113; MURPHY CR, 1986, Z MIKROSK ANAT FORSC, V100, P121; O'Halloran HS, 1998, OPHTHALMOLOGY, V105, P1038, DOI 10.1016/S0161-6420(98)96005-5; Papo T, 1998, MEDICINE, V77, P3, DOI 10.1097/00005792-199801000-00002; Petty GW, 1998, MEDICINE, V77, P12, DOI 10.1097/00005792-199801000-00003; REIK L, 1979, MEDICINE, V58, P281, DOI 10.1097/00005792-197907000-00001; REIK L, 1986, AM J MED, V81, P73, DOI 10.1016/0002-9343(86)90185-3; RENIE WA, 1983, RETINA-J RET VIT DIS, V3, P243, DOI 10.1097/00006982-198300340-00001; Rennebohm RM, 2007, J NEUROL SCI, V257, P215, DOI 10.1016/j.jns.2007.01.031; SAVINO PJ, 1974, AM J OPHTHALMOL, V77, P659, DOI 10.1016/0002-9394(74)90527-3; Susac JO, 2003, NEUROLOGY, V61, P1783, DOI 10.1212/01.WNL.0000103880.29693.48; SUSAC JO, 1979, NEUROLOGY, V29, P313, DOI 10.1212/WNL.29.3.313; Susac JO, 2007, J NEUROL SCI, V257, P270, DOI 10.1016/j.jns.2007.01.036	28	16	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					549	559		10.1056/NEJMcpc1011324	http://dx.doi.org/10.1056/NEJMcpc1011324			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805MW	21830970				2022-12-28	WOS:000293732100012
J	Surovy, AM; Hunger, RE				Surovy, Andre M.; Hunger, Robert E.			Warts of the Fingertips	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Surovy, Andre M.; Hunger, Robert E.] Univ Bern, Bern, Switzerland	University of Bern	Surovy, AM (corresponding author), Univ Bern, Bern, Switzerland.	surovy@gmx.ch							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					548	548		10.1056/NEJMicm1009053	http://dx.doi.org/10.1056/NEJMicm1009053			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805MW	21830969				2022-12-28	WOS:000293732100010
J	Kanady, JS; Tsui, EY; Day, MW; Agapie, T				Kanady, Jacob S.; Tsui, Emily Y.; Day, Michael W.; Agapie, Theodor			A Synthetic Model of the Mn3Ca Subsite of the Oxygen-Evolving Complex in Photosystem II	SCIENCE			English	Article							WATER-OXIDIZING COMPLEX; CRYSTAL-STRUCTURE; MANGANESE COMPLEX; MN4CA CLUSTER; OXIDATION; RESOLUTION; CHEMISTRY; DIOXYGEN; COBALT; MN	Within photosynthetic organisms, the oxygen-evolving complex (OEC) of photosystem II generates dioxygen from water using a catalytic Mn4CaOn cluster (n varies with the mechanism and nature of the intermediate). We report here the rational synthesis of a [Mn3CaO4](6+) cubane that structurally models the trimanganese-calcium-cubane subsite of the OEC. Structural and electrochemical comparison between Mn3CaO4 and a related Mn4O4 cubane alongside characterization of an intermediate calcium-manganese multinuclear complex reveals potential roles of calcium in facilitating high oxidation states at manganese and in the assembly of the biological cluster.	[Kanady, Jacob S.; Tsui, Emily Y.; Day, Michael W.; Agapie, Theodor] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Agapie, T (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd,MC 127-72, Pasadena, CA 91125 USA.	agapie@caltech.edu		Tsui, Emily/0000-0001-6419-3954	California Institute of Technology; Rose Hill Foundation; NSF	California Institute of Technology; Rose Hill Foundation; NSF(National Science Foundation (NSF))	We thank California Institute of Technology, the Searle Scholars Program (T.A.), the Rose Hill Foundation (J.S.K.), and the NSF Graduate Research Fellowship Program (E.Y.T.) for funding. We also thank L. M. Henling for assistance with crystallography. The Bruker KAPPA APEXII x-ray diffractometer was purchased via an NSF Chemistry Research Instrumentation and Facilities: Departmental Multi-User Instrumentation award to Caltech (CHE-0639094). Crystallographic data have been deposited at the Cambridge Crystallographic Database Centre, and copies can be obtained on request, free of charge, by quoting the publication citation and the deposition numbers 817379 (3), 817683 (4), and 817924 (5).	ARJOMAND M, 1975, J CHEM SOC DALTON, P1055, DOI 10.1039/dt9750001055; Armstrong FA, 2008, PHILOS T R SOC B, V363, P1263, DOI 10.1098/rstb.2007.2223; Barber J, 2008, PHILOS T R SOC B, V363, P1129, DOI 10.1098/rstb.2007.2208; Bartlett JE, 2008, PHILOS T R SOC B, V363, P1253, DOI 10.1098/rstb.2007.2222; Cady CW, 2008, COORDIN CHEM REV, V252, P444, DOI 10.1016/j.ccr.2007.06.002; CHEN CG, 1995, BIOCHEMISTRY-US, V34, P13511, DOI 10.1021/bi00041a031; CHRISTOU G, 1989, ACCOUNTS CHEM RES, V22, P328, DOI 10.1021/ar00165a006; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dau H, 2008, PHILOS T R SOC B, V363, P1237, DOI 10.1098/rstb.2007.2220; Dismukes GC, 2009, ACCOUNTS CHEM RES, V42, P1935, DOI 10.1021/ar900249x; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fukuzumi S, 2010, NAT CHEM, V2, P756, DOI [10.1038/NCHEM.731, 10.1038/nchem.731]; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hewitt IJ, 2006, CHEM COMMUN, P2650, DOI 10.1039/b518026k; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Kanan MW, 2010, J AM CHEM SOC, V132, P13692, DOI 10.1021/ja1023767; Kotzabasaki V, 2011, INORG CHEM COMMUN, V14, P213, DOI 10.1016/j.inoche.2010.10.025; LEVASON W, 1974, COORDIN CHEM REV, V12, P151, DOI 10.1016/S0010-8545(00)82026-3; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; McEvoy JP, 2005, PHOTOCH PHOTOBIO SCI, V4, P940, DOI 10.1039/b506755c; Messinger J, 2004, PHYS CHEM CHEM PHYS, V6, P4764, DOI 10.1039/b406437b; Mishra A, 2005, CHEM COMMUN, P54, DOI 10.1039/b413680b; Mishra A, 2007, CHEM COMMUN, P1538, DOI 10.1039/b701355h; Mukhopadhyay S, 2004, CHEM REV, V104, P3981, DOI 10.1021/cr0206014; Mullins CS, 2008, COORDIN CHEM REV, V252, P416, DOI 10.1016/j.ccr.2007.07.021; Najafpour MM, 2010, ANGEW CHEM INT EDIT, V49, P2233, DOI 10.1002/anie.200906745; Nayak S, 2011, DALTON T, V40, P2699, DOI 10.1039/c0dt01463j; Park YJ, 2011, J AM CHEM SOC, V133, P9258, DOI 10.1021/ja203458d; Peloquin JM, 2000, J AM CHEM SOC, V122, P10926, DOI 10.1021/ja002104f; Symes MD, 2011, J AM CHEM SOC, V133, P5174, DOI 10.1021/ja110908v; TAMURA N, 1989, BIOCHIM BIOPHYS ACTA, V976, P173, DOI 10.1016/S0005-2728(89)80227-0; Tsui EY, 2011, CHEM COMMUN, V47, P4189, DOI 10.1039/c0cc05608a; Tsui EY, 2011, ANGEW CHEM INT EDIT, V50, P1668, DOI 10.1002/anie.201005232; Tyryshkin AM, 2006, BIOCHEMISTRY-US, V45, P12876, DOI 10.1021/bi061495t; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Yagi M, 2001, CHEM REV, V101, P21, DOI 10.1021/cr980108l; Yano J, 2008, INORG CHEM, V47, P1711, DOI 10.1021/ic7016837; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	40	423	427	5	305	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2011	333	6043					733	736		10.1126/science.1206036	http://dx.doi.org/10.1126/science.1206036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817047				2022-12-28	WOS:000293512100036
J	Delamothe, T				Delamothe, Tony			ON THE CONTRARY Very like a fish	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com						Angell M, 2011, NEW YORK REV BO 0623; Angell M, 2011, NEW YORK REV BO 0714; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Tallis R., 2011, APING MANKIND NEUROM; Taylor J.B., 2008, JB TAYLORS STROKE IN; Taylor JillBolte., 2009, MY STROKE INSIGHT BR; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x	7	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 3	2011	343								d4918	10.1136/bmj.d4918	http://dx.doi.org/10.1136/bmj.d4918			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805NN	21816746				2022-12-28	WOS:000293734700009
J	Lutz, W; Samir, KC				Lutz, Wolfgang; Samir, K. C.			Global Human Capital: Integrating Education and Population	SCIENCE			English	Review							ECONOMIC-DEVELOPMENT; MORTALITY DECLINE; FERTILITY; DEMOGRAPHY; TRENDS; ATTAINMENT; DEMOCRACY; GROWTH	Almost universally, women with higher levels of education have fewer children. Better education is associated with lower mortality, better health, and different migration patterns. Hence, the global population outlook depends greatly on further progress in education, particularly of young women. By 2050, the highest and lowest education scenarios-assuming identical education-specific fertility rates-result in world population sizes of 8.9 and 10.0 billion, respectively. Better education also matters for human development, including health, economic growth, and democracy. Existing methods of multi-state demography can quantitatively integrate education into standard demographic analysis, thus adding the "quality" dimension.	[Lutz, Wolfgang; Samir, K. C.] Wittgenstein Ctr Demog & Global Human Capital, A-1090 Vienna, Austria; [Lutz, Wolfgang; Samir, K. C.] Int Inst Appl Syst Anal IIASA, World Populat Program, A-2361 Laxenburg, Austria; [Lutz, Wolfgang] Austrian Acad Sci, Vienna Inst Demog, A-1040 Vienna, Austria; [Lutz, Wolfgang] Vienna Univ Econ & Business, Dept Appl Stat, A-1090 Vienna, Austria; [Lutz, Wolfgang] Vienna Univ Econ & Business, Res Inst Human Capital & Dev, A-1090 Vienna, Austria	International Institute for Applied Systems Analysis (IIASA); Austrian Academy of Sciences; Vienna University of Economics & Business; Vienna University of Economics & Business	Lutz, W (corresponding author), Wittgenstein Ctr Demog & Global Human Capital, A-1090 Vienna, Austria.	lutz@iiasa.ac.at		Lutz, Wolfgang/0000-0001-7975-8145	European Research Council [ERC-2008-AdG 230195-FutureSoc]	European Research Council(European Research Council (ERC)European Commission)	Funding for this work was made possible by an Advanced Grant of the European Research Council, "Forecasting Societies Adaptive Capacities to Climate Change," grant agreement ERC-2008-AdG 230195-FutureSoc.	Barro R. J., 2003, EC GROWTH; Barro RJ, 2001, OXFORD ECON PAP, V53, P541, DOI 10.1093/oep/53.3.541; Becker G. S., 1987, HUMAN CAPITAL THEORE, DOI DOI 10.7208/CHICAGO/9780226041223.001.0001; Becker Gary S., 1991, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; BENHABIB J, 1994, J MONETARY ECON, V34, P143, DOI 10.1016/0304-3932(94)90047-7; Bongaarts J., 2010, VIENNA YB POPULATION, V2010, P31, DOI DOI 10.1553/POPULATIONYEARBOOK2010S31; CALDWELL JC, 1979, POP STUD-J DEMOG, V33, P395, DOI 10.2307/2173888; CLELAND J, 1988, POP STUD-J DEMOG, V42, P419, DOI 10.1080/0032472031000143566; Cohen D, 2007, J ECON GROWTH, V12, P51, DOI 10.1007/s10887-007-9011-5; Cohen JE, 2008, NATURE, V456, P572, DOI 10.1038/456572a; de la Fuente A, 2006, J EUR ECON ASSOC, V4, P1, DOI 10.1162/jeea.2006.4.1.1; Hanushek EA, 2008, J ECON LIT, V46, P607, DOI 10.1257/jel.46.3.607; HOBCRAFT JN, 1984, POP STUD-J DEMOG, V38, P193, DOI 10.2307/2174073; KC S., 2010, DEMOGR RES, V22, P383, DOI [10.4054/DemRes.2010.22.14, DOI 10.4054/DEMRES.2010.22.15]; KC S., 2010, VIENNA YRBK POPUL RE, V2010, P201; Keyfitz N, 1985, APPL MATH DEMOGRAPHY; Kravdal O, 2002, DEMOGRAPHY, V39, P233, DOI 10.2307/3088337; LIPSET SM, 1959, AM POLIT SCI REV, V53, P69, DOI 10.2307/1951731; Lutz, 2010, VIENNA YEARB POPUL R, V8, P175, DOI DOI 10.1553/populationyearbook2010s175; Lutz W, 1998, POPUL DEV REV, V24, P42, DOI 10.2307/2808050; Lutz W., 1994, POPULATION DEV ENV U, DOI 10.1007/978-3-662-03061-5; Lutz W., 2007, VIENNA YB POPULATION, V5, P193, DOI DOI 10.1553/POPULATIONYEARBOOK2007S193; Lutz W., 2010, VIENNA YB POPULATION, P8, DOI [10.1553/populationyearbook 2010s9, DOI 10.1553/POPULATIONYEARBOOK2010S9, 10.1553/populationyearbook2010-9, DOI 10.1553/POPULATIONYEARBOOK2010-9]; Lutz W, 2008, SCIENCE, V319, P1047, DOI 10.1126/science.1151753; Lutz W, 2010, POPUL DEV REV, V36, P253, DOI 10.1111/j.1728-4457.2010.00329.x; Lutz W, 2009, PHILOS T R SOC B, V364, P3031, DOI 10.1098/rstb.2009.0156; Lutz W, 2009, POPUL DEV REV, V35, P357, DOI 10.1111/j.1728-4457.2009.00282.x; Mackenbach JP, 1999, AM J PUBLIC HEALTH, V89, P1800, DOI 10.2105/AJPH.89.12.1800; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; Mensch B., 1985, CHILD MORTALITY DIFF; Osili UO, 2008, J DEV ECON, V87, P57, DOI 10.1016/j.jdeveco.2007.10.003; Preston S., 2000, DEMOGRAPHY MEASURING; Rogers A., 1982, MULTIDIMENSIONAL MAT; SCHULTZ TP, 1993, AM ECON REV, V83, P337; Skirbekk V, 2008, DEMOGR RES, V18, P145, DOI 10.4054/DemRes.2008.18.5; [United Nations Department of Economics and Social Affairs Population division], 2009, WORLD POP PROSP 2008; Yi Z., 1998, POPULATION DEV REV S, V24, P59	37	158	164	9	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					587	592		10.1126/science.1206964	http://dx.doi.org/10.1126/science.1206964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	798PI	21798940				2022-12-28	WOS:000293222400050
J	Paige, JS; Wu, KY; Jaffrey, SR				Paige, Jeremy S.; Wu, Karen Y.; Jaffrey, Samie R.			RNA Mimics of Green Fluorescent Protein	SCIENCE			English	Article							LIVING CELLS; POLYMERASE; INHIBITORS; LIGANDS; DYES	Green fluorescent protein (GFP) and its derivatives have transformed the use and analysis of proteins for diverse applications. Like proteins, RNA has complex roles in cellular function and is increasingly used for various applications, but a comparable approach for fluorescently tagging RNA is lacking. Here, we describe the generation of RNA aptamers that bind fluorophores resembling the fluorophore in GFP. These RNA-fluorophore complexes create a palette that spans the visible spectrum. An RNA-fluorophore complex, termed Spinach, resembles enhanced GFP and emits a green fluorescence comparable in brightness with fluorescent proteins. Spinach is markedly resistant to photobleaching, and Spinach fusion RNAs can be imaged in living cells. These RNA mimics of GFP provide an approach for genetic encoding of fluorescent RNAs.	[Paige, Jeremy S.; Wu, Karen Y.; Jaffrey, Samie R.] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10065 USA; [Jaffrey, Samie R.] Cornell Univ, Triinst Program Chem Biol, Weill Med Coll, New York, NY 10065 USA	Cornell University; Cornell University	Jaffrey, SR (corresponding author), Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10065 USA.	srj2003@med.cornell.edu		Jaffrey, Samie/0000-0003-3615-6958	McKnight Neuroscience Technology Innovation Award; Weill Cornell Medical College; National Institute of Neurological Disorders and Stroke [NS064516, T32CA062948]; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064516] Funding Source: NIH RePORTER	McKnight Neuroscience Technology Innovation Award; Weill Cornell Medical College; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. S. Cohen, A. Deglincerti, J. D. Warren, and S. C. Blanchard (Weill Cornell Medical College) and D. S. Tan (Sloan-Kettering Institute) for useful comments and suggestions; D. Engelke (University of Michigan) for providing plasmids containing the 5S sequence; and F. Dardel (Universite Paris Descartes) for providing plasmids containing the tRNA scaffold sequence. This work was supported by the McKnight Neuroscience Technology Innovation Award, Weill Cornell Medical College, and National Institute of Neurological Disorders and Stroke grant NS064516 (S.R.J.) and training grant T32CA062948 (J.S.P.).	Babendure JR, 2003, J AM CHEM SOC, V125, P14716, DOI 10.1021/ja037994o; Bell AF, 2000, BIOCHEMISTRY-US, V39, P4423, DOI 10.1021/bi992675o; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Constantin TP, 2008, ORG LETT, V10, P1561, DOI 10.1021/ol702920e; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; LIAO JC, 1994, P NATL ACAD SCI USA, V91, P2659, DOI 10.1073/pnas.91.7.2659; Meech SR, 2009, CHEM SOC REV, V38, P2922, DOI 10.1039/b820168b; Murdoch K, 2002, EUR J CELL BIOL, V81, P549, DOI 10.1078/0171-9335-00271; Niwa H, 1996, P NATL ACAD SCI USA, V93, P13617, DOI 10.1073/pnas.93.24.13617; Paul CP, 2003, MOL THER, V7, P237, DOI 10.1016/S1525-0016(02)00038-2; Ponchon L, 2007, NAT METHODS, V4, P571, DOI 10.1038/NMETH1058; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Tyagi S, 2009, NAT METHODS, V6, P331, DOI [10.1038/NMETH.1321, 10.1038/nmeth.1321]; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003; Wu LP, 2003, EUKARYOT CELL, V2, P256, DOI 10.1128/EC.2.2.256-264.2003; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	23	827	870	29	576	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2011	333	6042					642	646		10.1126/science.1207339	http://dx.doi.org/10.1126/science.1207339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798953	Green Accepted			2022-12-28	WOS:000293222400065
J	Moreau, K; Ravikumar, B; Renna, M; Puri, C; Rubinsztein, DC				Moreau, Kevin; Ravikumar, Brinda; Renna, Maurizio; Puri, Claudia; Rubinsztein, David C.			Autophagosome Precursor Maturation Requires Homotypic Fusion	CELL			English	Article							ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; MAMMALIAN-CELLS; V-SNARES; COMPLEX; PROTEIN; MECHANISMS; GOLGI; TRAFFICKING; PHAGOPHORE	Autophagy is a catabolic process in which lysosomes degrade intracytoplasmic contents transported in double-membraned autophagosomes. Autophagosomes are formed by the elongation and fusion of phagophores, which can be derived from preautophagosomal structures coming from the plasma membrane and other sites like the endoplasmic reticulum and mitochondria. The mechanisms by which preautophagosomal structures elongate their membranes and mature toward fully formed autophagosomes still remain unknown. Here, we show that the maturation of the early Atg16L1 precursors requires homotypic fusion, which is essential for subsequent autophagosome formation. Atg16L1 precursor homotypic fusion depends on the SNARE protein VAMP7 together with partner SNAREs. Atg16L1 precursor homotypic fusion is a critical event in the early phases of autophagy that couples membrane acquisition and autophagosome biogenesis, as this step regulates the size of the vesicles, which in turn appears to influence their subsequent maturation into LC3-positive autophagosomes.	[Moreau, Kevin; Ravikumar, Brinda; Renna, Maurizio; Puri, Claudia; Rubinsztein, David C.] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 20Y, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Rubinsztein, DC (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Wellcome MRC Bldg,Hills Rd, Cambridge CB2 20Y, England.	dcr1000@hermes.cam.ac.uk	Rubinsztein, David C/C-3472-2011		Wellcome Trust; MRC; Cancer Research UK; Medical Research Council [G0600194] Funding Source: researchfish; MRC [G0600194] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful for funding from a Wellcome Trust Senior Clinical Research Fellowship (D.C.R.), an MRC Programme grant (D.C.R.), and Cancer Research UK (C.P.). We thank Tamotsu Yoshimori, Ramnik Xavier, Nicholas Ktistakis, Thierry Galli, Marc Coppolino, and Andrew Peden for reagents, Maike Lichtenberg for helpful assistance, and Paul Luzio and Lena Wartosch for helpful comments on the manuscript.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Barysch SV, 2010, NAT PROTOC, V5, P1127, DOI 10.1038/nprot.2010.84; Bethani I, 2009, TRAFFIC, V10, P1543, DOI 10.1111/j.1600-0854.2009.00959.x; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chaineau M, 2008, J BIOL CHEM, V283, P34365, DOI 10.1074/jbc.M804587200; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; Gordon DE, 2009, EMBO REP, V10, P851, DOI 10.1038/embor.2009.96; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Pocard T, 2007, J CELL SCI, V120, P3309, DOI 10.1242/jcs.007948; Proux-Gillardeaux V, 2005, TRAFFIC, V6, P366, DOI 10.1111/j.1600-0854.2005.00288.x; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Puri C, 2009, J BIOL CHEM, V284, P34998, DOI 10.1074/jbc.M109.012328; Randhawa VK, 2004, MOL BIOL CELL, V15, P5565, DOI 10.1091/mbc.E04-03-0266; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Renna M, 2011, J CELL SCI, V124, P469, DOI 10.1242/jcs.076489; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sarkar S, 2009, AUTOPHAGY, V5, P307, DOI 10.4161/auto.5.3.7664; Skalski M, 2005, BIOCHEM BIOPH RES CO, V335, P1199, DOI 10.1016/j.bbrc.2005.07.195; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yen WL, 2010, J CELL BIOL, V188, P101, DOI 10.1083/jcb.200904075; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180	44	283	290	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 22	2011	146	2					303	317		10.1016/j.cell.2011.06.023	http://dx.doi.org/10.1016/j.cell.2011.06.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	795XS	21784250	hybrid, Green Published			2022-12-28	WOS:000293013000012
J	Bhala, N; Taggar, JS; Rajasekhar, P; Banerjee, A				Bhala, Neeraj; Taggar, Jaspal S.; Rajasekhar, Praveen; Banerjee, Amitava			Anticipating and managing bleeding complications in patients with coronary stents who are receiving dual antiplatelet treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ELEVATION MYOCARDIAL-INFARCTION; CLINICAL-TRIALS; INTERVENTION; CLOPIDOGREL; THERAPY; RISK; METAANALYSIS; ACCESS; ANGIOGRAPHY; THROMBOSIS		[Bhala, Neeraj] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Bhala, Neeraj] Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England; [Bhala, Neeraj] John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford OX3 9DU, England; [Taggar, Jaspal S.] Univ Nottingham, Queens Med Ctr, Div Primary Care, Nottingham NG7 2RD, England; [Rajasekhar, Praveen] S Tyneside Dist Hosp, S Shields, England; [Banerjee, Amitava] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England	University of Oxford; University of Oxford; University of Oxford; University of Nottingham; University of Birmingham	Bhala, N (corresponding author), Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England.	nijbhala@doctors.org.uk	Banerjee, Amitava/D-4381-2014	Banerjee, Amitava/0000-0001-8741-3411; Taggar, Jaspal/0000-0002-5031-0977; Bhala, Neeraj/0000-0003-2502-1177	Medical Research Council [G0701732] Funding Source: Medline; MRC [G0701732] Funding Source: UKRI; National Institute for Health Research [CL-2010-09-002] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Agostoni P, 2004, J AM COLL CARDIOL, V44, P349, DOI 10.1016/j.jacc.2004.04.034; Archbold RA, 2004, BRIT MED J, V329, P443, DOI 10.1136/bmj.329.7463.443; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bavry AA, 2008, LANCET, V371, P2134, DOI 10.1016/S0140-6736(08)60922-8; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; From AM, 2010, EUROINTERVENTION, V6, P269, DOI 10.4244/; Greenhalgh J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004587.pub2; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Ludman P., 2009, BCIS AUDIT RETURNS A; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Meads C, 2000, Health Technol Assess, V4, P1; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mehran R, 2010, J AM COLL CARDIOL, V55, P2556, DOI 10.1016/j.jacc.2009.09.076; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4; MULLER DWM, 1992, AM J CARDIOL, V69, P63, DOI 10.1016/0002-9149(92)90677-Q; Naik H, 2009, JACC-CARDIOVASC INTE, V2, P739, DOI 10.1016/j.jcin.2009.05.020; [National Institute for Health Clinical Excellence], 2008, DRUG EL STENTS TREAT, V152; Neuner M, 2011, EMERGENCY MED; Salman RAS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2586; Serebruany VL, 2008, FUND CLIN PHARMACOL, V22, P315, DOI 10.1111/j.1472-8206.2008.00582.x; Sorensen R, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-6; Subherwal S, 2009, CIRCULATION, V119, P1873, DOI 10.1161/CIRCULATIONAHA.108.828541; Verheugt FWA, 2011, JACC-CARDIOVASC INTE, V4, P191, DOI 10.1016/j.jcin.2010.10.011; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wong EML, 2006, INT J CLIN PRACT, V60, P582, DOI 10.1111/j.1368-5031.2006.00824.x	30	6	7	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2011	343								d4264	10.1136/bmj.d4264	http://dx.doi.org/10.1136/bmj.d4264			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	797ZJ	21778196				2022-12-28	WOS:000293168900002
J	Patel, MR; Mahaffey, KW; Garg, J; Pan, GH; Singer, DE; Hacke, W; Breithardt, G; Halperin, JL; Hankey, GJ; Piccini, JP; Becker, RC; Nessel, CC; Paolini, JF; Berkowitz, SD; Fox, KAA; Califf, RM				Patel, Manesh R.; Mahaffey, Kenneth W.; Garg, Jyotsna; Pan, Guohua; Singer, Daniel E.; Hacke, Werner; Breithardt, Guenter; Halperin, Jonathan L.; Hankey, Graeme J.; Piccini, Jonathan P.; Becker, Richard C.; Nessel, Christopher C.; Paolini, John F.; Berkowitz, Scott D.; Fox, Keith A. A.; Califf, Robert M.		ROCKET AF Investigators	Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTITHROMBOTIC THERAPY; STROKE PREVENTION; NON-INFERIORITY; THROMBOPROPHYLAXIS; PHARMACODYNAMICS; PHARMACOKINETICS; ANTICOAGULATION; DABIGATRAN; ENOXAPARIN; EFFICACY	Background The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor Xa inhibitor, may provide more consistent and predictable anticoagulation than warfarin. Methods In a double-blind trial, we randomly assigned 14,264 patients with nonvalvular atrial fibrillation who were at increased risk for stroke to receive either rivaroxaban (at a daily dose of 20 mg) or dose-adjusted warfarin. The per-protocol, as-treated primary analysis was designed to determine whether rivaroxaban was noninferior to warfarin for the primary end point of stroke or systemic embolism. Results In the primary analysis, the primary end point occurred in 188 patients in the rivaroxaban group (1.7% per year) and in 241 in the warfarin group (2.2% per year) (hazard ratio in the rivaroxaban group, 0.79; 95% confidence interval [CI], 0.66 to 0.96; P < 0.001 for noninferiority). In the intention-to-treat analysis, the primary end point occurred in 269 patients in the rivaroxaban group (2.1% per year) and in 306 patients in the warfarin group (2.4% per year) (hazard ratio, 0.88; 95% CI, 0.74 to 1.03; P < 0.001 for noninferiority; P = 0.12 for superiority). Major and nonmajor clinically relevant bleeding occurred in 1475 patients in the rivaroxaban group (14.9% per year) and in 1449 in the warfarin group (14.5% per year) (hazard ratio, 1.03; 95% CI, 0.96 to 1.11; P = 0.44), with significant reductions in intracranial hemorrhage (0.5% vs. 0.7%, P = 0.02) and fatal bleeding (0.2% vs. 0.5%, P = 0.003) in the rivaroxaban group. Conclusions In patients with atrial fibrillation, rivaroxaban was noninferior to warfarin for the prevention of stroke or systemic embolism. There was no significant between-group difference in the risk of major bleeding, although intracranial and fatal bleeding occurred less frequently in the rivaroxaban group. (Funded by Johnson & Johnson and Bayer; ROCKET AF ClinicalTrials. gov number, NCT00403767.)	[Patel, Manesh R.; Mahaffey, Kenneth W.; Garg, Jyotsna; Piccini, Jonathan P.; Becker, Richard C.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27705 USA; [Califf, Robert M.] Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27705 USA; [Pan, Guohua; Nessel, Christopher C.] Johnson & Johnson Pharmaceut Res & Dev, Raritan, NJ USA; [Paolini, John F.; Berkowitz, Scott D.] Bayer HealthCare Pharmaceut, Montville, NJ USA; [Singer, Daniel E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Singer, Daniel E.] Harvard Univ, Sch Med, Boston, MA USA; [Hacke, Werner] Heidelberg Univ, Heidelberg, Germany; [Breithardt, Guenter] Hosp Univ Munster, Munster, Germany; [Halperin, Jonathan L.] Mt Sinai Med Ctr, Cardiovasc Inst, New York, NY 10029 USA; [Hankey, Graeme J.] Royal Perth Hosp, Perth, WA, Australia; [Fox, Keith A. A.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Fox, Keith A. A.] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland	Duke University; Duke University; Johnson & Johnson; Johnson & Johnson USA; Bayer AG; Bayer Healthcare Pharmaceuticals; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Ruprecht Karls University Heidelberg; University of Munster; Icahn School of Medicine at Mount Sinai; Royal Perth Hospital; University of Western Australia; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Patel, MR (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Rm 0311 Terrace Level,2400 Pratt St, Durham, NC 27705 USA.	manesh.patel@duke.edu	Janota, Tomas/S-7725-2017; Sinkiewicz, Wladyslaw/G-5169-2014; Macleod, Malcolm Robert/B-2052-2010; Walters, Darren/A-7069-2011; Reshetko, Olga/I-7011-2013; Zadionchenko, Vladimir/A-7445-2016; Fox, keith A A/I-3742-2013; Heidbuchel, Hein/C-2331-2019; Patel, Manesh/AAC-5385-2019; De Caterina, Raffaele/K-3857-2016; Parsons, Mark W./G-3750-2014; Libis, Roman/O-9193-2015; bladin, chris/B-9136-2013; Linhart, Ales/O-2375-2017; Yarokhno, Natalya/R-4854-2017; Berkowitz, Scott Darrell/AAS-9397-2021; Mazurov, Vadim I/J-9643-2014; Hankey, Graeme J/H-4968-2014; Yusof, Zurkurnai/AAA-5893-2021; Urina-Triana, Miguel A/H-2605-2016; Ramshev, Konstantin/GYU-1641-2022; Kubica, Jacek/D-6906-2014; Arkhipov, Mikhail V/Q-2316-2015; Marchev, Sotir/AAH-6529-2020; Halperin, Jonathan/AAJ-4721-2020; Boldueva, Svetlana/AAH-3862-2019; Pardo-Oviedo, Juan Mauricio/F-9140-2016; Prabhakaran, Dorairaj/B-4147-2011; Hacke, Werner/ABE-8661-2020	Janota, Tomas/0000-0001-5659-3747; Macleod, Malcolm Robert/0000-0001-9187-9839; Reshetko, Olga/0000-0003-3107-7636; Zadionchenko, Vladimir/0000-0003-2377-5266; Heidbuchel, Hein/0000-0001-9301-8127; De Caterina, Raffaele/0000-0003-1637-574X; Libis, Roman/0000-0003-0130-990X; Linhart, Ales/0000-0002-3372-7850; Yarokhno, Natalya/0000-0003-2055-648X; Berkowitz, Scott Darrell/0000-0002-9428-4408; Mazurov, Vadim I/0000-0002-0797-2051; Hankey, Graeme J/0000-0002-6044-7328; Urina-Triana, Miguel A/0000-0001-6003-4622; Ramshev, Konstantin/0000-0002-6978-6641; Kubica, Jacek/0000-0001-8250-754X; Arkhipov, Mikhail V/0000-0002-7924-7668; Marchev, Sotir/0000-0001-9250-510X; Halperin, Jonathan/0000-0002-8318-5471; Boldueva, Svetlana/0000-0002-1898-084X; Pardo-Oviedo, Juan Mauricio/0000-0003-0084-3449; Prabhakaran, Dorairaj/0000-0002-3172-834X; Yena, Larisa/0000-0001-9633-1848; Fox, Keith/0000-0002-0140-2752; Kaste, Markku/0000-0001-6557-6412; Lanas, Fernando/0000-0003-3595-9759; DEMIN, Aleksandr/0000-0003-1052-1451; GALINIER, Michel/0000-0003-1735-3390; Marabotti, Claudio/0000-0003-1233-692X; HEDDLE, WILLIAM/0000-0001-8167-2826	Johnson Johnson; Bayer	Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Bayer(Bayer AG)	Funded by Johnson & Johnson and Bayer; ROCKET AF ClinicalTrials. gov number, NCT00403767.	Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; Albers GW, 1996, ARCH INTERN MED, V156, P2311, DOI 10.1001/archinte.156.20.2311; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Brittain E, 2005, STAT MED, V24, P1, DOI 10.1002/sim.1934; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Food and Drug Administration HHS, 2010, GUID IND NO IN PRESS; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Kubitza D, 2005, EUR J CLIN PHARMACOL, V61, P873, DOI 10.1007/s00228-005-0043-5; Kubitza D, 2008, CURR MED RES OPIN, V24, P2757, DOI 10.1185/03007990802361499 ; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Piaggio G, 2006, JAMA-J AM MED ASSOC, V296, P1842; Piccini JP, 2009, J AM COLL CARDIOL, V54, P1280, DOI 10.1016/j.jacc.2009.04.091; *ROCKET AF STUD IN, 2010, AM HEART J, V159; Rose AJ, 2011, CIRC-CARDIOVASC QUAL, V4, P22, DOI 10.1161/CIRCOUTCOMES.110.957738; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Sanchez MM, 2006, STAT MED, V25, P1169, DOI 10.1002/sim.2244; Singer DE, 2004, CHEST, V126, p429S, DOI 10.1378/chest.126.3_suppl.429S; Soulakova JN, 2009, STAT MED, V28, P260, DOI 10.1002/sim.3462; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	26	5613	5927	7	415	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 8	2011	365	10					883	891		10.1056/NEJMoa1009638	http://dx.doi.org/10.1056/NEJMoa1009638			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816JX	21830957	Green Published			2022-12-28	WOS:000294595600004
J	Stransky, N; Egloff, AM; Tward, AD; Kostic, AD; Cibulskis, K; Sivachenko, A; Kryukov, GV; Lawrence, MS; Sougnez, C; McKenna, A; Shefler, E; Ramos, AH; Stojanov, P; Carter, SL; Voet, D; Cortes, ML; Auclair, D; Berger, MF; Saksena, G; Guiducci, C; Onofrio, RC; Parkin, M; Romkes, M; Weissfeld, JL; Seethala, RR; Wang, L; Rangel-Escareno, C; Fernandez-Lopez, JC; Hidalgo-Miranda, A; Melendez-Zajgla, J; Winckler, W; Ardlie, K; Gabriel, SB; Meyerson, M; Lander, ES; Getz, G; Golub, TR; Garraway, LA; Grandis, JR				Stransky, Nicolas; Egloff, Ann Marie; Tward, Aaron D.; Kostic, Aleksandar D.; Cibulskis, Kristian; Sivachenko, Andrey; Kryukov, Gregory V.; Lawrence, Michael S.; Sougnez, Carrie; McKenna, Aaron; Shefler, Erica; Ramos, Alex H.; Stojanov, Petar; Carter, Scott L.; Voet, Douglas; Cortes, Maria L.; Auclair, Daniel; Berger, Michael F.; Saksena, Gordon; Guiducci, Candace; Onofrio, Robert C.; Parkin, Melissa; Romkes, Marjorie; Weissfeld, Joel L.; Seethala, Raja R.; Wang, Lin; Rangel-Escareno, Claudia; Carlos Fernandez-Lopez, Juan; Hidalgo-Miranda, Alfredo; Melendez-Zajgla, Jorge; Winckler, Wendy; Ardlie, Kristin; Gabriel, Stacey B.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Golub, Todd R.; Garraway, Levi A.; Grandis, Jennifer R.			The Mutational Landscape of Head and Neck Squamous Cell Carcinoma	SCIENCE			English	Article							TUMOR-SUPPRESSOR; STEM-CELLS; E-CADHERIN; CANCER; NOTCH; SKIN; DIFFERENTIATION; GENOME; KERATINOCYTES; INACTIVATION	Head and neck squamous cell carcinoma (HNSCC) is a common, morbid, and frequently lethal malignancy. To uncover its mutational spectrum, we analyzed whole-exome sequencing data from 74 tumor-normal pairs. The majority exhibited a mutational profile consistent with tobacco exposure; human papillomavirus was detectable by sequencing DNA from infected tumors. In addition to identifying previously known HNSCC genes (TP53, CDKN2A, PTEN, PIK3CA, and HRAS), our analysis revealed many genes not previously implicated in this malignancy. At least 30% of cases harbored mutations in genes that regulate squamous differentiation (for example, NOTCH1, IRF6, and TP63), implicating its dysregulation as a major driver of HNSCC carcinogenesis. More generally, the results indicate the ability of large-scale sequencing to reveal fundamental tumorigenic mechanisms.	[Stransky, Nicolas; Tward, Aaron D.; Kostic, Aleksandar D.; Cibulskis, Kristian; Sivachenko, Andrey; Kryukov, Gregory V.; Lawrence, Michael S.; Sougnez, Carrie; McKenna, Aaron; Shefler, Erica; Ramos, Alex H.; Stojanov, Petar; Carter, Scott L.; Voet, Douglas; Cortes, Maria L.; Auclair, Daniel; Berger, Michael F.; Saksena, Gordon; Guiducci, Candace; Onofrio, Robert C.; Parkin, Melissa; Winckler, Wendy; Ardlie, Kristin; Gabriel, Stacey B.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Golub, Todd R.; Garraway, Levi A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Egloff, Ann Marie; Grandis, Jennifer R.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15213 USA; [Egloff, Ann Marie; Seethala, Raja R.; Wang, Lin; Grandis, Jennifer R.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Tward, Aaron D.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02114 USA; [Tward, Aaron D.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Kostic, Aleksandar D.; Kryukov, Gregory V.; Meyerson, Matthew; Lander, Eric S.; Golub, Todd R.; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Romkes, Marjorie] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Romkes, Marjorie] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15261 USA; [Weissfeld, Joel L.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15232 USA; [Weissfeld, Joel L.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15232 USA; [Seethala, Raja R.; Wang, Lin] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Rangel-Escareno, Claudia; Carlos Fernandez-Lopez, Juan; Hidalgo-Miranda, Alfredo; Melendez-Zajgla, Jorge] Inst Nacl Med Genom, Mexico City 01900, DF, Mexico; [Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Meyerson, Matthew; Golub, Todd R.; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Cambridge, MA 02142 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Grandis, Jennifer R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Instituto Nacional de Medicina Genomica; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Garraway, LA (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	levi_garraway@dfci.harvard.edu; grandisjr@upmc.edu	Cibulskis, Kristian/AAC-7380-2019; Hidalgo-Miranda, Alfredo/B-2123-2010; Fernandez, Juan Carlos/C-4976-2013; Kryukov, Gregory V/A-9592-2008; Melendez-Zajgla, Jorge/A-5708-2008; Lawrence, Michael/AAC-8202-2020; Rangel-Escareno, Claudia/F-4587-2012; Stojanov, Petar/GQI-4462-2022; Meyerson, Matthew L/E-7123-2012	Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Fernandez, Juan Carlos/0000-0003-3680-4193; Rangel-Escareno, Claudia/0000-0003-1303-0834; Stojanov, Petar/0000-0001-7815-776X; Kostic, Aleksandar/0000-0002-0837-4360; Kryukov, Gregory/0000-0002-6131-9483; Cibulskis, Kristian/0000-0003-1343-1582; Meyerson, Matthew/0000-0002-9133-8108	Carlos Slim Health Institute; International Cancer Genome Consortium; National Human Genome Research Institute; National Cancer Institute; Starr Cancer Consortium; Novartis Institutes for BioMedical Research; Howard Hughes Medical Institute; American Cancer Society; NIH; NATIONAL CANCER INSTITUTE [P50CA097190, R01CA077308, R01CA098372] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	Carlos Slim Health Institute; International Cancer Genome Consortium; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Starr Cancer Consortium; Novartis Institutes for BioMedical Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the Broad Institute Sequencing Platform for the generation of sequencing data, the staff of the Biological Samples Platform and the Genetic Analysis Platform at the Broad Institute, and J. Aster for helpful discussions. This work was conducted as part of the Slim Initiative for Genomic Medicine, a joint U.S.-Mexico project funded by the Carlos Slim Health Institute, and is part of a global effort in collaboration with the International Cancer Genome Consortium. The work was also supported by grants from the National Human Genome Research Institute (S.B.G., E.S.L.), the National Cancer Institute (M.M., S.B.G., L.A.G., J.R.G., A.M.E.), the Starr Cancer Consortium (L.A.G.), the Novartis Institutes for BioMedical Research (N.S.), the Howard Hughes Medical Institute (T.R.G.), the American Cancer Society (J.R.G.), and the NIH Director's New Innovator Award (L.A.G.). L.A.G. and M.M. are paid consultants for and equity holders in Foundation Medicine, a genomics-based oncology diagnostics company, and are also paid consultants for Novartis. M.F.B. is a paid consultant for Foundation Medicine. E.S.L. is an equity holder in Foundation Medicine. The compressed binary Sequence Alignment/Map files (BAM) and SNP array data are available in dbGaP under accession no. phs000370.v1.p1.	Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chidgey M, 2001, J CELL BIOL, V155, P821, DOI 10.1083/jcb.200105009; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Extance A, 2010, NAT REV DRUG DISCOV, V9, P749, DOI 10.1038/nrd3288; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gupta S, 2009, INT J CANCER, V125, P2159, DOI 10.1002/ijc.24533; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Kovall RA, 2010, CURR TOP DEV BIOL, V92, P31, DOI 10.1016/S0070-2153(10)92002-4; Lee SY, 2009, CANCER SCI, V100, P920, DOI 10.1111/j.1349-7006.2009.01130.x; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Luke Y, 2008, J CELL SCI, V121, P1887, DOI 10.1242/jcs.019075; Moretti F, 2010, J CLIN INVEST, V120, P1570, DOI 10.1172/JCI40267; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Okuyama R, 2007, ONCOGENE, V26, P4478, DOI 10.1038/sj.onc.1210235; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; Tinkle CL, 2004, P NATL ACAD SCI USA, V101, P552, DOI 10.1073/pnas.0307437100; Tu CL, 2008, J BIOL CHEM, V283, P3519, DOI 10.1074/jbc.M708318200; Westra WH, 2008, CLIN CANCER RES, V14, P366, DOI 10.1158/1078-0432.CCR-07-1402; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Yugawa T, 2010, CANCER RES, V70, P4034, DOI 10.1158/0008-5472.CAN-09-4063	33	1768	1795	3	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 26	2011	333	6046					1157	1160		10.1126/science.1208130	http://dx.doi.org/10.1126/science.1208130			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811VM	21798893	Green Submitted, Green Accepted			2022-12-28	WOS:000294244300052
J	Hayashi, K; Ohta, H; Kurimoto, K; Aramaki, S; Saitou, M				Hayashi, Katsuhiko; Ohta, Hiroshi; Kurimoto, Kazuki; Aramaki, Shinya; Saitou, Mitinori			Reconstitution of the Mouse Germ Cell Specification Pathway in Culture by Pluripotent Stem Cells	CELL			English	Article							GROUND-STATE; MICE; GENERATION; EPIBLAST; LINEAGE; EMBRYOS; TRANSPLANTATION; ESTABLISHMENT; BLIMP1; TESTIS	The generation of properly functioning gametes in vitro requires reconstitution of the multistepped pathway of germ cell development. We demonstrate here the generation of primordial germ cell-like cells (PGCLCs) in mice with robust capacity for spermatogenesis. PGCLCs were generated from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) through epiblast-like cells (EpiLCs), a cellular state highly similar to pregastrulating epiblasts but distinct from epiblast stem cells (EpiSCs). Reflecting epiblast development, EpiLC induction from ESCs/iPSCs is a progressive process, and EpiLCs highly competent for the PGC fate are a transient entity. The global transcription profiles, epigenetic reprogramming, and cellular dynamics during PGCLC induction from EpiLCs meticulously capture those associated with PGC specification from the epiblasts. Furthermore, we identify Integrin-beta 3 and SSEA1 as markers that allow the isolation of PGCLCs with spermatogenic capacity from tumorigenic undifferentiated cells. Our findings provide a paradigm for the first step of in vitro gametogenesis.	[Hayashi, Katsuhiko; Ohta, Hiroshi; Kurimoto, Kazuki; Aramaki, Shinya; Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan; [Hayashi, Katsuhiko; Ohta, Hiroshi; Kurimoto, Kazuki; Saitou, Mitinori] CREST, JST, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Saitou, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	saitou@anat2.med.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; JST-CREST; Takeda Science Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [19061001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. Nichols for her advice on the ground state ESC culture. We are grateful to K. Okita and S. Yamanaka for the information on germline transmission of the three iPSC lines. We also thank K. Kabashima, H. Tanizaki, K. Takakura, S. Chuma, and N. Nakatsuji for their support with the FACS analysis; A. Fukunaga for her help with bisulfate sequence analysis; and Y. Toda for his help with the histology. S. A. is a JSPS research fellow. This study was supported, in part, by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by JST-CREST; by the Takeda Science Foundation; and by the Uehara Memorial Foundation.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chuma S, 2005, DEVELOPMENT, V132, P117, DOI 10.1242/dev.01555; Daley GQ, 2007, SCIENCE, V316, P409, DOI 10.1126/science.1138772; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lee J, 2002, DEVELOPMENT, V129, P1807; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Ohta H, 2000, DEV GROWTH DIFFER, V42, P105; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Rathjen J, 1999, J CELL SCI, V112, P601; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M, 2010, REPRODUCTION, V139, P931, DOI 10.1530/REP-10-0043; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	41	828	886	9	155	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 19	2011	146	4					519	532		10.1016/j.cell.2011.06.052	http://dx.doi.org/10.1016/j.cell.2011.06.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	809HY	21820164	Bronze			2022-12-28	WOS:000294043600008
J	Jackson, MG; Carlson, RW				Jackson, Matthew G.; Carlson, Richard W.			An ancient recipe for flood-basalt genesis	NATURE			English	Article							DECCAN TRAP LAVAS; KERGUELEN PLATEAU; GEOCHEMICAL EVOLUTION; CONTINENTAL-CRUST; MANTLE PLUMES; ORIGIN; ND; ISOTOPE; ELEMENT; DIFFERENTIATION	Large outpourings of basaltic lava have punctuated geological time, but the mechanisms responsible for the generation of such extraordinary volumes of melt are not well known(1). Recent geochemical evidence suggests that an early-formed reservoir may have survived in the Earth's mantle for about 4.5 billion years (ref. 2), and melts of this reservoir contributed to the flood basalt emplaced on Baffin Island about 60 million years ago(3-5). However, the volume of this ancient mantle domain and whether it has contributed to other flood basalts is not known. Here we show that basalts from the largest volcanic event in geologic history-the Ontong Java plateau(1,6,7)-also exhibit the isotopic and trace element signatures proposed for the early-Earth reservoir2. Together with the Ontong Java plateau, we suggest that six of the largest volcanic events that erupted in the past 250 million years derive from the oldest terrestrial mantle reservoir. The association of these large volcanic events with an ancient primitive mantle source suggests that its unique geochemical characteristics-it is both hotter (it has greater abundances of the radioactive heat-producing elements) and more fertile than depleted mantle reservoirs-may strongly affect the generation of flood basalts.	[Jackson, Matthew G.] Boston Univ, Dept Earth Sci, Boston, MA 02215 USA; [Carlson, Richard W.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Boston University; Carnegie Institution for Science	Jackson, MG (corresponding author), Boston Univ, Dept Earth Sci, 675Commonwealth Ave, Boston, MA 02215 USA.	jacksonm@bu.edu			Boston University; Ocean Sciences Section of the National Science Foundation	Boston University; Ocean Sciences Section of the National Science Foundation	We thank J. Day, S. Hart, N. Shimizu, S. Shirey, J. Mahoney and M. Kurz for discussions and B. Hanan and G. Fitton for their detailed review comments. M. J. acknowledges Boston University start-up funds and the Ocean Sciences Section of the National Science Foundation that supported this work.	Bouvier A, 2008, EARTH PLANET SC LETT, V273, P48, DOI 10.1016/j.epsl.2008.06.010; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2006, EARTH PLANET SC LETT, V250, P254, DOI 10.1016/j.epsl.2006.07.046; Brandenburg JP, 2008, EARTH PLANET SC LETT, V276, P1, DOI 10.1016/j.epsl.2008.08.027; Burke K, 2011, ANNU REV EARTH PL SC, V39, P1, DOI 10.1146/annurev-earth-040809-152521; Carlson RW, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001342; CARLSON RW, 1991, AUST J EARTH SCI, V38, P525, DOI 10.1080/08120099108727989; Caro G, 2010, GEOCHIM COSMOCHIM AC, V74, P3333, DOI 10.1016/j.gca.2010.02.025; COFFIN MF, 1994, REV GEOPHYS, V32, P1, DOI 10.1029/93RG02508; DEPAOLO DJ, 1980, GEOCHIM COSMOCHIM AC, V44, P1185, DOI 10.1016/0016-7037(80)90072-1; Fedorenko V.A., 1996, INT GEOL REV, V38, P99, DOI DOI 10.1080/00206819709465327; Fitton JG, 2004, GEOL SOC SPEC PUBL, V229, P151, DOI 10.1144/GSL.SP.2004.229.01.10; Frey FA, 2002, J PETROL, V43, P1207, DOI 10.1093/petrology/43.7.1207; Graham DW, 1998, EARTH PLANET SC LETT, V160, P241, DOI 10.1016/S0012-821X(98)00083-1; HART SR, 1984, NATURE, V309, P753, DOI 10.1038/309753a0; Hawkesworth C. J., 1984, GEOLOGICAL SOC S AFR, P341; Heinonen JS, 2010, CHEM GEOL, V277, P227, DOI 10.1016/j.chemgeo.2010.08.004; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; Ingle S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000482; Ingle S, 2002, EARTH PLANET SC LETT, V197, P35, DOI 10.1016/S0012-821X(02)00473-9; Jackson MG, 2010, NATURE, V466, P853, DOI 10.1038/nature09287; JACOBSEN SB, 1979, J GEOPHYS RES, V84, P7411, DOI 10.1029/JB084iB13p07411; Jagoutz E., 1979, LUNAR PLANETARY SCI, V11, P2031; Larsen LM, 2009, J PETROL, V50, P1667, DOI 10.1093/petrology/egp048; LIGHTFOOT P, 1988, EARTH PLANET SC LETT, V91, P89, DOI 10.1016/0012-821X(88)90153-7; LIGHTFOOT PC, 1990, J PETROL, V31, P1165, DOI 10.1093/petrology/31.5.1165; MAHONEY JJ, 1995, CHEM GEOL, V120, P315, DOI 10.1016/0009-2541(94)00144-W; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Nicolaysen K, 2001, GEOLOGY, V29, P235, DOI 10.1130/0091-7613(2001)029<0235:POPGBG>2.0.CO;2; Operto S, 1996, J GEOPHYS RES-SOL EA, V101, P25077, DOI 10.1029/96JB01758; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; PENG ZX, 1994, GEOCHIM COSMOCHIM AC, V58, P267, DOI 10.1016/0016-7037(94)90464-2; PENG ZX, 1995, EARTH PLANET SC LETT, V134, P169, DOI 10.1016/0012-821X(95)00110-X; Starkey NA, 2009, EARTH PLANET SC LETT, V277, P91, DOI 10.1016/j.epsl.2008.10.007; Storey M., 1992, P OCEAN DRILLING PRO, P33, DOI DOI 10.2973/0DP.PR0C.SR.120.1992; Stuart FM, 2003, NATURE, V424, P57, DOI 10.1038/nature01711; Tejada MLG, 2004, GEOL SOC SPEC PUBL, V229, P133, DOI 10.1144/GSL.SP.2004.229.01.09; Tejada MLG, 2002, J PETROL, V43, P449, DOI 10.1093/petrology/43.3.449; Torsvik TH, 2010, NATURE, V466, P352, DOI 10.1038/nature09216; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	40	69	71	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2011	476	7360					316	U77		10.1038/nature10326	http://dx.doi.org/10.1038/nature10326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21796117				2022-12-28	WOS:000294206500034
J	Singer, S; Shortell, SM				Singer, Sara; Shortell, Stephen M.			Implementing Accountable Care Organizations Ten Potential Mistakes and How to Learn From Them	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Shortell, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA; [Singer, Sara] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management,Dept Med, Sch Med,Massachusetts Gen Hosp,Mongan Inst Publ H, Boston, MA 02115 USA	University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital	Shortell, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, 417E Univ Hall, Berkeley, CA 94720 USA.	shortell@berkeley.edu	Singer, Sara/AAS-5317-2021	Singer, Sara/0000-0002-3374-1177				Andreen Debra L, 2010, J Healthc Inf Manag, V24, P57; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; CMS HHS, 2011, FED REGISTER, V76, P19528; Crosson F. J., 2010, PARTNERS HLTH PHYS H; Fisher ES, 2010, JAMA-J AM MED ASSOC, V304, P1715, DOI 10.1001/jama.2010.1513; GARVIN DA, 1993, HARVARD BUS REV, V71, P78; Moore KD, 2011, WORK AHEAD ACTIVITIE; Robinson JC, 2010, ACCOUNTABLE CARE ORG	9	36	37	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2011	306	7					758	759		10.1001/jama.2011.1180	http://dx.doi.org/10.1001/jama.2011.1180			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	807LP	21828308				2022-12-28	WOS:000293900000027
J	Alberts, MJ				Alberts, Mark J.			Review: Stenting increases stroke but decreases periprocedural MI compared with endarterectomy in carotid artery disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Alberts, MJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.							Dodick DW, 2004, MAYO CLIN PROC, V79, P937, DOI 10.4065/79.7.937; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2011	155	4							JC2-10	10.7326/0003-4819-155-4-201108160-02010	http://dx.doi.org/10.7326/0003-4819-155-4-201108160-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V31LM	21844543				2022-12-28	WOS:000208885100009
J	Kucirka, LM; Grams, ME; Lessler, J; Hall, EC; James, N; Massie, AB; Montgomery, RA; Segev, DL				Kucirka, Lauren M.; Grams, Morgan E.; Lessler, Justin; Hall, Erin Carlyle; James, Nathan; Massie, Allan B.; Montgomery, Robert A.; Segev, Dorry L.			Association of Race and Age With Survival Among Patients Undergoing Dialysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; RACIAL-DIFFERENCES; HEMODIALYSIS-PATIENTS; REPLACEMENT THERAPY; AFRICAN-AMERICANS; UNITED-STATES; PRACTICE PATTERNS; DISPARITIES	Context Many studies have reported that black individuals undergoing dialysis survive longer than those who are white. This observation is paradoxical given racial disparities in access to and quality of care, and is inconsistent with observed lower survival among black patients with chronic kidney disease. We hypothesized that age and the competing risk of transplantation modify survival differences by race. Objective To estimate death among dialysis patients by race, accounting for age as an effect modifier and kidney transplantation as a competing risk. Design, Setting, and Participants An observational cohort study of 1 330 007 incident end-stage renal disease patients as captured in the United States Renal Data System between January 1, 1995, and September 28, 2009 (median potential follow-up time, 6.7 years; range, 1 day-14.8 years). Multivariate age-stratified Cox proportional hazards and competing risk models were constructed to examine death in patients who receive dialysis. Main Outcome Measures Death in black vs white patients who receive dialysis. Results Similar to previous studies, black patients undergoing dialysis had a lower death rate compared with white patients (232 361 deaths [57.1% mortality] vs 585 792 deaths [63.5% mortality], respectively; adjusted hazard ratio [aHR], 0.84; 95% confidence interval [CI], 0.83-0.84; P<.001). However, when stratifying by age and treating kidney transplantation as a competing risk, black patients had significantly higher mortality than their white counterparts at ages 18 to 30 years (27.6% mortality vs 14.2%; aHR, 1.93; 95% CI, 1.84-2.03), 31 to 40 years (37.4% mortality vs 26.8%; aHR, 1.46; 95% CI, 1.41-1.50), and 41 to 50 years (44.8% mortality vs 38.0%; aHR, 1.12; 95% CI, 1.10-1.14; P<.001 for interaction terms between race and each aforementioned age category), as opposed to patients aged 51 to 60 years (51.5% vs 50.9%; aHR, 0.93; 95% CI, 0.92-0.94), 61 to 70 years (64.9% vs 67.2%; aHR, 0.87; 95% CI, 0.86-0.88), 71 to 80 years (76.1% vs 79.7%; aHR, 0.85; 95% CI, 0.84-0.86), and older than 80 years (82.4% vs 83.6%; aHR, 0.87; 95% CI, 0.85-0.88). Conclusions Overall, among dialysis patients in the United States, there was a lower risk of death for black patients compared with their white counterparts. However, the commonly cited survival advantage for black dialysis patients applies only to older adults, and those younger than 50 years have a higher risk of death. JAMA. 2011;306(6):620-626 www.jama.com	[Kucirka, Lauren M.; Hall, Erin Carlyle; James, Nathan; Massie, Allan B.; Montgomery, Robert A.; Segev, Dorry L.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Grams, Morgan E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Grams, Morgan E.; Lessler, Justin; Segev, Dorry L.] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Segev, DL (corresponding author), Johns Hopkins Med Inst, 720 Rutland Ave,Ross 771B, Baltimore, MD 21205 USA.	dorry@jhmi.edu		Grams, Morgan/0000-0002-4430-6023; Lessler, Justin/0000-0002-9741-8109	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R21DK085409]; National Institute on Aging [K23AG032885]; American Federation for Aging Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK085409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG032885] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation for Aging Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Segev reports that this work was supported by grant number R21DK085409 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and by a Paul Beeson Career Development Award (cofunded by the National Institute on Aging K23AG032885 and American Federation for Aging Research).	Abbott KC, 2004, KIDNEY INT, V65, P597, DOI 10.1111/j.1523-1755.2004.00385.x; Agodoa L, 2002, AM J KIDNEY DIS, V40, P1337, DOI 10.1053/ajkd.2002.37395; Agodoa L, 2007, SEMIN DIALYSIS, V20, P577, DOI 10.1111/j.1525-139X.2007.00350.x; Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; Ayanian JZ, 1999, NEW ENGL J MED, V341, P1661, DOI 10.1056/NEJM199911253412206; Bleyer AJ, 1996, AM J KIDNEY DIS, V28, P72, DOI 10.1016/S0272-6386(96)90133-X; BLEYER AJ, 1992, ARCH INTERN MED, V152, P879, DOI 10.1001/archinte.152.4.879; BLOEMBERGEN WE, 1994, J AM SOC NEPHROL, V5, P1231; Buckalew VM, 2010, AM J KIDNEY DIS, V55, P1102, DOI 10.1053/j.ajkd.2009.10.062; COWIE CC, 1994, DIABETES CARE, V17, P681, DOI 10.2337/diacare.17.7.681; Eisenstein EL, 2009, AM J MED, V122, P170, DOI 10.1016/j.amjmed.2008.08.025; ELLISON MD, 1993, TRANSPLANT P, V25, P2462; Epstein AM, 2000, NEW ENGL J MED, V343, P1537, DOI 10.1056/NEJM200011233432106; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frankenfield DL, 1999, AM J KIDNEY DIS, V34, P721, DOI 10.1016/S0272-6386(99)70399-9; Gadegbeku C, 2002, J NATL MED ASSOC, V94, p45S; Garg PP, 2001, AM J KIDNEY DIS, V37, P921, DOI 10.1016/S0272-6386(05)80007-1; Hata Y, 1998, TRANSPLANTATION, V65, P208; HELD PJ, 1987, JAMA-J AM MED ASSOC, V257, P645, DOI 10.1001/jama.257.5.645; Hopson S, 2008, AM J KIDNEY DIS, V52, P753, DOI 10.1053/j.ajkd.2008.04.007; Kalantar-Zadeh K, 2007, NAT CLIN PRACT NEPHR, V3, P493, DOI 10.1038/ncpneph0570; Kalantar-Zadeh K, 2010, J BONE MINER RES, V25, P2448, DOI 10.1002/jbmr.177; KJELLSTRAND CM, 1987, NEPHRON, V45, P257, DOI 10.1159/000184160; Leonard MB, 2004, J AM SOC NEPHROL, V15, P2923, DOI 10.1097/01.ASN.0000143475.39388.DE; LOWRIE EG, 1992, KIDNEY INT, V42, pS22; Medina RA, 1996, AM J KIDNEY DIS, V28, P226, DOI 10.1016/S0272-6386(96)90306-6; Mehrotra R, 2008, J AM SOC NEPHROL, V19, P1403, DOI 10.1681/ASN.2007070747; Mesler DE, 1999, AM J MED, V106, P300, DOI 10.1016/S0002-9343(99)00020-0; Morris D, 2005, AM J MED, V118, P671, DOI 10.1016/j.amjmed.2005.02.023; Myers OB, 2010, J AM SOC NEPHROL, V21, P1970, DOI 10.1681/ASN.2010010125; Norris KC, 2005, KIDNEY INT, V68, P914, DOI 10.1111/j.1523-1755.2005.00485.x; Owen WF, 1996, BLOOD PURIFICAT, V14, P278; Owen WF, 1998, JAMA-J AM MED ASSOC, V280, P1764, DOI 10.1001/jama.280.20.1764; Ozminkowski RJ, 1997, AM J KIDNEY DIS, V30, P749, DOI 10.1016/S0272-6386(97)90078-0; Pei YPC, 2000, KIDNEY INT, V58, P1293, DOI 10.1046/j.1523-1755.2000.00285.x; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Powe NR, 2005, MED CLIN N AM, V89, P475, DOI 10.1016/j.mcna.2004.11.004; Price D A, 1997, Adv Ren Replace Ther, V4, P3; PUGH JA, 1994, AM J KIDNEY DIS, V23, P803; Reddan D, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022422.79790.A8; Reddan DN, 2000, SEMIN DIALYSIS, V13, P399, DOI 10.1046/j.1525-139x.2000.00109.x; Robinson BM, 2006, J AM SOC NEPHROL, V17, P2910, DOI 10.1681/ASN.2005101078; Roderick P, 2009, NEPHROL DIAL TRANSPL, V24, P3774, DOI 10.1093/ndt/gfp348; Salem M, 2002, AM J MED SCI, V323, P100, DOI 10.1097/00000441-200202000-00008; SANFILIPPO FP, 1992, JAMA-J AM MED ASSOC, V267, P247, DOI 10.1001/jama.267.2.247; Schold JD, CLIN TRANSPLANT; Segev DL, 2009, J AM SOC NEPHROL, V20, P621, DOI 10.1681/ASN.2008060591; Sehgal AR, 2000, AM J KIDNEY DIS, V35, pS148, DOI 10.1016/S0272-6386(00)70242-3; Streja E, 2011, AM J KIDNEY DIS, V57, P883, DOI 10.1053/j.ajkd.2010.10.050; Tanna MM, 2000, AM J KIDNEY DIS, V36, P1175, DOI 10.1053/ajkd.2000.19832; Unruh M, 2004, KIDNEY INT, V65, P1482, DOI 10.1111/j.1523-1755.2004.00529.x; USRDS, 2010, US REN DAT SYST ANN; Waikar SS, 2007, J AM SOC NEPHROL, V18, P2740, DOI 10.1681/ASN.2006091060; Winkelmayer WC, 2001, KIDNEY INT, V60, P1547, DOI 10.1046/j.1523-1755.2001.00958.x; Young CJ, 2000, NEW ENGL J MED, V343, P1545, DOI 10.1056/NEJM200011233432107	55	180	184	3	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2011	306	6					620	626		10.1001/jama.2011.1127	http://dx.doi.org/10.1001/jama.2011.1127			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	804XD	21828325	Green Accepted, Bronze			2022-12-28	WOS:000293687300023
J	Feng, L; Ayache, M; Huang, JQ; Xu, YL; Lu, MH; Chen, YF; Fainman, Y; Scherer, A				Feng, Liang; Ayache, Maurice; Huang, Jingqing; Xu, Ye-Long; Lu, Ming-Hui; Chen, Yan-Feng; Fainman, Yeshaiahu; Scherer, Axel			Nonreciprocal Light Propagation in a Silicon Photonic Circuit	SCIENCE			English	Article							NON-HERMITIAN HAMILTONIANS; WAVE-GUIDE; LASERS; SYMMETRY	Optical communications and computing require on-chip nonreciprocal light propagation to isolate and stabilize different chip-scale optical components. We have designed and fabricated a metallic-silicon waveguide system in which the optical potential is modulated along the length of the waveguide such that nonreciprocal light propagation is obtained on a silicon photonic chip. Nonreciprocal light transport and one-way photonic mode conversion are demonstrated at the wavelength of 1.55 micrometers in both simulations and experiments. Our system is compatible with conventional complementary metal-oxide-semiconductor processing, providing a way to chip-scale optical isolators for optical communications and computing.	[Feng, Liang; Huang, Jingqing; Scherer, Axel] CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA; [Feng, Liang; Xu, Ye-Long; Lu, Ming-Hui; Chen, Yan-Feng] Nanjing Univ, Nanjing Natl Lab Microstruct, Nanjing 210093, Jiangsu, Peoples R China; [Ayache, Maurice; Fainman, Yeshaiahu] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Feng, Liang; Huang, Jingqing; Scherer, Axel] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA	California Institute of Technology; Nanjing University; University of California System; University of California San Diego; California Institute of Technology	Feng, L (corresponding author), CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA.	lfeng@caltech.edu; yfchen@nju.edu.cn; etcher@caltech.edu	Feng, Liang/H-7367-2014		NSF; NSF ERC Center for Integrated Access Networks [EEC-0812072]; Defense Advanced Research Projects Agency [W911NF-07-1-0277]; National Basic Research Program of China [2007CB613202]; National Nature Science Foundation of China [50632030, 10874080]; Nature Science Foundation of Jiangsu Province [BK2007712]; Cymer Corp.	NSF(National Science Foundation (NSF)); NSF ERC Center for Integrated Access Networks; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Cymer Corp.	Support by NSF and NSF ERC Center for Integrated Access Networks grant EEC-0812072, Defense Advanced Research Projects Agency under the Nanoscale Architecture for Coherent Hyperoptical Sources program grant W911NF-07-1-0277, National Basic Research Program of China grant 2007CB613202, National Nature Science Foundation of China grants 50632030 and 10874080, and Nature Science Foundation of Jiangsu Province grant BK2007712. We thank Nanonics, Ltd., for extensive training and support in near-field scanning optical microscopy. M.A. acknowledges support of a Cymer Corp. graduate fellowship.	Abashin M, 2006, OPT EXPRESS, V14, P1643, DOI 10.1364/OE.14.001643; Amemiya T, 2010, IEEE J QUANTUM ELECT, V46, P1662, DOI 10.1109/JQE.2010.2058093; Bender CM, 2007, REP PROG PHYS, V70, P947, DOI 10.1088/0034-4885/70/6/R03; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Chen R, 2011, NAT PHOTONICS, V5, P170, DOI [10.1038/nphoton.2010.315, 10.1038/NPHOTON.2010.315]; El-Ganainy R, 2007, OPT LETT, V32, P2632, DOI 10.1364/OL.32.002632; Foster MA, 2008, NATURE, V456, P81, DOI 10.1038/nature07430; Gallo K, 2001, APPL PHYS LETT, V79, P314, DOI 10.1063/1.1386407; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; Hochberg M, 2006, NAT MATER, V5, P703, DOI 10.1038/nmat1719; Jackson J. D, 1998, CLASSICAL ELECTRODYN, VThird; Liang B, 2010, NAT MATER, V9, P989, DOI 10.1038/NMAT2881; Liang D, 2010, NAT PHOTONICS, V4, P511, DOI [10.1038/NPHOTON.2010.167, 10.1038/nphoton.2010.167]; Makris KG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103904; Michel J, 2010, NAT PHOTONICS, V4, P527, DOI [10.1038/nphoton.2010.157, 10.1038/NPHOTON.2010.157]; Musslimani ZH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.030402; Nezhad MP, 2010, NAT PHOTONICS, V4, P395, DOI 10.1038/NPHOTON.2010.88; Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819; Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515; Sun XK, 2009, OPT LETT, V34, P1345, DOI 10.1364/OL.34.001345; Sze S.M., 2002, SEMICONDUCTOR DEVICE, V2nd; Wang Z, 2009, NATURE, V461, P772, DOI 10.1038/nature08293; Yu ZF, 2009, NAT PHOTONICS, V3, P91, DOI 10.1038/NPHOTON.2008.273	23	492	497	11	339	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					729	733		10.1126/science.1206038	http://dx.doi.org/10.1126/science.1206038			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817046				2022-12-28	WOS:000293512100035
J	Ramkumar, N; Anderson, KV				Ramkumar, Nitya; Anderson, Kathryn V.			SnapShot: Mouse Primitive Streak	CELL			English	Editorial Material									[Ramkumar, Nitya; Anderson, Kathryn V.] Sloan Kettering Inst, New York, NY 10065 USA; [Ramkumar, Nitya] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Ramkumar, N (corresponding author), Sloan Kettering Inst, New York, NY 10065 USA.			Anderson, Kathryn/0000-0003-1657-2161; Ramkumar, Nitya/0000-0002-4086-4562	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD035455, R37HD035455] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD035455] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; AULEHLA A, 2010, COLD SPRING HARB PER, V2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Lee JD, 2007, DEVELOPMENT, V134, P2007, DOI 10.1242/dev.000885; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Qian LH, 2011, P NATL ACAD SCI USA, V108, P8692, DOI 10.1073/pnas.1100328108; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Wardle FC, 2008, CURR OPIN GENET DEV, V18, P418, DOI 10.1016/j.gde.2008.07.017	10	24	24	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 5	2011	146	3							488.e1	10.1016/j.cell.2011.07.028	http://dx.doi.org/10.1016/j.cell.2011.07.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	803GT	21816280	Bronze			2022-12-28	WOS:000293570500023
J	Simons, K; Mattaj, IW				Simons, Kai; Mattaj, Iain W.			Lennart Philipson (1929-2011)	SCIENCE			English	Biographical-Item									[Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Mattaj, Iain W.] European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Simons, K (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	simons@mpi-cbg.de; mattaj@embl.org		Mattaj, Iain/0000-0002-5537-8284				PHILIPSON L, PUBLICATION LIST, DOI DOI 10.1126/SCIENCE.1114849	1	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2011	333	6043					711	711		10.1126/science.1210990	http://dx.doi.org/10.1126/science.1210990			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	802LH	21817041				2022-12-28	WOS:000293512100030
J	Mateen, FJ; Rubenstein, LS				Mateen, Farrah J.; Rubenstein, Leonard S.			Government Policies in Violation of Human Rights as a Barrier to Professionalism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL PROFESSIONALISM; SOCIETY		[Mateen, Farrah J.; Rubenstein, Leonard S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21231 USA; [Mateen, Farrah J.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD 21231 USA; [Rubenstein, Leonard S.] Johns Hopkins Univ, Ctr Publ Hlth & Human Rights, Baltimore, MD 21231 USA; [Mateen, Farrah J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Rubenstein, LS (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, 615 N Wolfe St,Room E7148, Baltimore, MD 21231 USA.	lrubenst@jhsph.edu		Mateen, Farrah/0000-0002-4293-8115				Bosch X, 2002, BRIT MED J, V325, P236; Cohen JJ, 2007, JAMA-J AM MED ASSOC, V298, P670, DOI 10.1001/jama.298.6.670; Frank MW, 1999, JAMA-J AM MED ASSOC, V282, P485, DOI 10.1001/jama.282.5.485; Harding R, 2010, J PAIN SYMPTOM MANAG, V40, P405, DOI 10.1016/j.jpainsymman.2009.12.025; Human Rights Watch, TIM TORT; Lohman D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-8; Nair, 2010, HARV HUM RIGHTS J, V22, P223; Ridge AL, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-340; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Wynia MK, 1999, NEW ENGL J MED, V341, P1612, DOI 10.1056/NEJM199911183412112	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2011	306	5					541	542		10.1001/jama.2011.1082	http://dx.doi.org/10.1001/jama.2011.1082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800SH	21813432				2022-12-28	WOS:000293386500021
J	Bates, ME; Simmons, JA; Zorikov, TV				Bates, Mary E.; Simmons, James A.; Zorikov, Tengiz V.			Bats Use Echo Harmonic Structure to Distinguish Their Targets from Background Clutter	SCIENCE			English	Article							BIG BROWN BATS; EPTESICUS-FUSCUS; ECHOLOCATING BAT; ACOUSTIC IMAGES; PERCEPTION; DELAY; DISCRIMINATION; INFORMATION; MODULATION; PATTERN	When echolocating big brown bats fly in complex surroundings, echoes arriving from irrelevant objects (clutter) located to the sides of their sonar beam can mask perception of relevant objects located to the front (targets), causing "blind spots." Because the second harmonic is beamed more weakly to the sides than the first harmonic, these clutter echoes have a weaker second harmonic. In psychophysical experiments, we found that electronically misaligning first and second harmonics in echoes (to mimic the misalignment of corresponding neural responses to harmonics in clutter echoes) disrupts the bat's echo-delay perception but also prevents clutter masking. Electronically offsetting harmonics to realign their neural responses restores delay perception but also clutter interference. Thus, bats exploit harmonics to distinguish clutter echoes from target echoes, sacrificing delay acuity to suppress masking.	[Bates, Mary E.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Simmons, James A.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Simmons, James A.] Doshisha Univ, Bionav Res Ctr, Kyoto 6100321, Japan; [Zorikov, Tengiz V.] Inst Cybernet, GE-0186 Tbilisi, Georgia	Brown University; Brown University; Doshisha University	Bates, ME (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Box 1853, Providence, RI 02912 USA.	maryebates@gmail.com			Office of Naval Research (ONR) [N00014-04-1-0415, N00014-09-1-0691, N00014-07-1-0857]; NSF [IOS-0843522]; National Institute of Mental Health [R01-MH069633]; Brown University; RI Space Grant; Brown Institute for Brain Science; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069633] Funding Source: NIH RePORTER	Office of Naval Research (ONR)(Office of Naval Research); NSF(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brown University; RI Space Grant; Brown Institute for Brain Science; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this research came from Office of Naval Research (ONR) grants N00014-04-1-0415 and N00014-09-1-0691, NSF grant IOS-0843522, and National Institute of Mental Health grant R01-MH069633 to J.A.S.; from a Brown University dissertation fellowship to M. E. B.; from ONR-Global grant N00014-07-1-0857 to T.V.Z.; and from the RI Space Grant and from the Brown Institute for Brain Science. We thank A. M. Simmons for editorial advice.	Acoustical Society of America, S1261995 ANSI AC SOC; Bates ME, 2011, J EXP BIOL, V214, P394, DOI 10.1242/jeb.048983; Bates ME, 2010, J ACOUST SOC AM, V128, P936, DOI 10.1121/1.3459823; BODENHAMER RD, 1981, HEARING RES, V5, P317, DOI 10.1016/0378-5955(81)90055-1; BURKARD R, 1994, J ACOUST SOC AM, V96, P801, DOI 10.1121/1.410318; Ghose K, 2003, J ACOUST SOC AM, V114, P1120, DOI 10.1121/1.1589754; HARTLEY DJ, 1989, J ACOUST SOC AM, V85, P1348, DOI 10.1121/1.397466; Hiryu S, 2010, P NATL ACAD SCI USA, V107, P7048, DOI 10.1073/pnas.1000429107; Ma XF, 2008, J NEUROPHYSIOL, V100, P1127, DOI 10.1152/jn.90508.2008; MASTERS WM, 1985, SCIENCE, V228, P1331, DOI 10.1126/science.4001947; MOSS CF, 1994, J ACOUST SOC AM, V95, P2745, DOI 10.1121/1.409843; Muller R, 2000, J ACOUST SOC AM, V108, P836, DOI 10.1121/1.429617; Petrites AE, 2009, J COMP PHYSIOL A, V195, P603, DOI 10.1007/s00359-009-0435-6; Saillant PA, 2007, J ACOUST SOC AM, V121, P3001, DOI 10.1121/1.2714920; Simmons J. A., 2001, Acoustics Research Letters Online, V2, P43, DOI 10.1121/1.1352717; Simmons JA, 2005, ACOUST RES LETT ONL, V6, P238, DOI 10.1121/1.1985957; SIMMONS JA, 1989, COGNITION, V33, P155, DOI 10.1016/0010-0277(89)90009-7; SIMMONS JA, 1973, J ACOUST SOC AM, V54, P157, DOI 10.1121/1.1913559; SIMMONS JA, 1989, J ACOUST SOC AM, V86, P1333, DOI 10.1121/1.398694; SIMMONS JA, 1990, J COMP PHYSIOL A, V167, P589; SIMMONS JA, 1990, J COMP PHYSIOL A, V166, P449; Stamper SA, 2009, J COMP PHYSIOL A, V195, P79, DOI 10.1007/s00359-008-0384-5; Sumer S, 2009, J COMP PHYSIOL A, V195, P463, DOI 10.1007/s00359-009-0424-9; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Surlykke A, 2009, J EXP BIOL, V212, P1011, DOI 10.1242/jeb.024620; Yovel Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000032	26	81	86	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2011	333	6042					627	630		10.1126/science.1202065	http://dx.doi.org/10.1126/science.1202065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798PI	21798949				2022-12-28	WOS:000293222400061
J	Knoepfler, P				Knoepfler, Paul			My year as a stem-cell blogger	NATURE			English	Editorial Material									Univ Calif Davis, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis	Knoepfler, P (corresponding author), Univ Calif Davis, Sch Med, Davis, CA 95616 USA.	knoepfler@ucdavis.edu		Knoepfler, Paul/0000-0001-5444-334X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100782] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM100782] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2011	475	7357					425	425		10.1038/475425a	http://dx.doi.org/10.1038/475425a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	797ZA	21796162	Bronze, Green Accepted			2022-12-28	WOS:000293167900004
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA The press release, relative risks, and the polypill	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 27	2011	343								d4720	10.1136/bmj.d4720	http://dx.doi.org/10.1136/bmj.d4720			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LS	21795314				2022-12-28	WOS:000293441000008
J	Dua, J; Cheung, WH; Russell, S; Dabbagh, Z				Dua, Janet; Cheung, Wui-hang; Russell, Sabina; Dabbagh, Zaid			PICTURE QUIZ Breathlessness and plethora	BRITISH MEDICAL JOURNAL			English	Editorial Material							VENA-CAVA-SYNDROME; MALIGNANT-DISEASE; OBSTRUCTION; SYSTEM; CT		[Dua, Janet; Cheung, Wui-hang; Russell, Sabina; Dabbagh, Zaid] Chase Farm Hosp, London EN2 8JL, England	University of London; University College London; Royal Free London NHS Foundation Trust	Dua, J (corresponding author), Chase Farm Hosp, London EN2 8JL, England.	janetdua3000@yahoo.co.uk						Abdelkafi S, 1997, THORAX, V52, P492, DOI 10.1136/thx.52.5.492; ABNER A, 1993, CHEST S, V103, P394; AHMANN FR, 1984, J CLIN ONCOL, V2, P961, DOI 10.1200/JCO.1984.2.8.961; Boardman P, 2000, CLIN RADIOL, V55, P645, DOI 10.1053/crad.2000.0107; Eren S, 2006, EUR J RADIOL, V59, P93, DOI 10.1016/j.ejrad.2006.01.003; Gauden S J, 1993, Australas Radiol, V37, P363, DOI 10.1111/j.1440-1673.1993.tb00096.x; Kim JY, 1997, EUR RESPIR J, V10, P2902, DOI 10.1183/09031936.97.10122902; Kim YI, 2004, J KOREAN MED SCI, V19, P519, DOI 10.3346/jkms.2004.19.4.519; Lanciego C, 2001, AM J ROENTGENOL, V177, P585, DOI 10.2214/ajr.177.3.1770585; Lichtenstein A, 2005, THORAX, V60, P350, DOI 10.1136/thx.2004.021014; Marcy PY, 2001, SUPPORT CARE CANCER, V9, P103, DOI 10.1007/s005200000173; Minguez C, 2000, J INFECTION, V40, P187, DOI 10.1016/S0163-4453(00)80015-8; Morrissey NJ, 2010, J ENDOVASC THER, V17, P124, DOI 10.1583/09-2940C.1; Nicholson AA, 1997, J VASC INTERV RADIOL, V8, P781, DOI 10.1016/S1051-0443(97)70660-2; O'Sullivan GJ, 2010, J ENDOVASC THER, V17, P115, DOI 10.1583/09-2940.1; Ostler P J, 1997, Clin Oncol (R Coll Radiol), V9, P83, DOI 10.1016/S0936-6555(05)80445-5; PARISH JM, 1981, MAYO CLIN PROC, V56, P407; Plekker D, 2008, RESPIRATION, V76, P69, DOI 10.1159/000108921; Rowell NP, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001316; SCHWARTZ EE, 1986, AM J CLIN ONCOL-CANC, V9, P71, DOI 10.1097/00000421-198602000-00017; Smayra T, 2001, CARDIOVASC INTER RAD, V24, P388, DOI 10.1007/s00270-001-0055-1; Uberoi R, 2006, CARDIOVASC INTER RAD, V29, P319, DOI 10.1007/s00270-005-0284-9; Urruticoechea A, 2004, LUNG CANCER, V43, P209, DOI 10.1016/S0169-5002(03)00361-1; Wilson LD, 2007, NEW ENGL J MED, V356, P1862, DOI 10.1056/NEJMcp067190; YELLIN A, 1990, AM REV RESPIR DIS, V141, P1114, DOI 10.1164/ajrccm/141.5_Pt_1.1114; Yu JB, 2008, J THORAC ONCOL, V3, P811, DOI 10.1097/JTO.0b013e3181804791	26	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 26	2011	343								d4466	10.1136/bmj.d4466	http://dx.doi.org/10.1136/bmj.d4466			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801LP	21791493				2022-12-28	WOS:000293440700007
J	De Bels, D; Corazza, F; Balestra, C				De Bels, David; Corazza, Francis; Balestra, Costantino			Oxygen Sensing, Homeostasis, and Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[De Bels, David; Corazza, Francis] Free Univ Brussels, Hop Univ Brugmann, B-1020 Brussels, Belgium; [Balestra, Costantino] Haute Ecole Paul Henri Spaak, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	De Bels, D (corresponding author), Free Univ Brussels, Hop Univ Brugmann, Pl Van Gehuchten, B-1020 Brussels, Belgium.	david.debels@chu-brugmann.be	Balestra, Costantino/F-2969-2011; Corazza, Francis V/O-1262-2013	Balestra, Costantino/0000-0001-6771-839X; Corazza, Francis V/0000-0001-9487-2712; De Bels, David/0000-0001-9324-5768				Balestra C, 2006, J APPL PHYSIOL, V100, P512, DOI 10.1152/japplphysiol.00964.2005; De Bels D, 2011, MED HYPOTHESES, V76, P467, DOI 10.1016/j.mehy.2010.11.022; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Semenza GL, 2011, NEW ENGL J MED, V365, P968	4	710	740	4	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2011	365	19					1845	1845		10.1056/NEJMra1011165	http://dx.doi.org/10.1056/NEJMra1011165			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844QQ	22070493				2022-12-28	WOS:000296762800026
J	Semenza, GL				Semenza, Gregg L.			MECHANISMS OF DISEASE Oxygen Sensing, Homeostasis, and Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CRITICAL LIMB ISCHEMIA; RECOMBINANT-HUMAN-ERYTHROPOIETIN; PULMONARY ARTERIAL-HYPERTENSION; FACTOR-I; PHASE-I; MYOCARDIAL-INFARCTION; HIGH-ALTITUDE; THERAPEUTIC STRATEGY; REPERFUSION INJURY		[Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Vasc Program, Inst Cell Engn, Baltimore, MD USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Broadway Res Bldg,Suite 671,733 N Broadway, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Balestra, Costantino/F-2969-2011; Corazza, Francis V/O-1262-2013	Balestra, Costantino/0000-0001-6771-839X; Corazza, Francis V/0000-0001-9487-2712; De Bels, David/0000-0001-9324-5768				Abdelrahman M, 2004, SHOCK, V22, P63, DOI 10.1097/01.shk.00001276869.21260.9d; Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Barnhart BC, 2007, CANCER METAST REV, V26, P261, DOI 10.1007/s10555-007-9053-3; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bergeron M, 2000, ANN NEUROL, V48, P285, DOI 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.0.CO;2-8; Bernhardt WM, 2009, P NATL ACAD SCI USA, V106, P21276, DOI 10.1073/pnas.0903978106; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Bosch-Marce M, 2007, CIRC RES, V101, P1310, DOI 10.1161/CIRCRESAHA.107.153346; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Bowers R, 2004, AM J RESP CRIT CARE, V169, P764, DOI 10.1164/rccm.200301-147OC; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Cai Z, 2008, CARDIOVASC RES, V77, P463, DOI 10.1093/cvr/cvm035; Cai ZQ, 2004, CIRCULATION, V109, P2050, DOI 10.1161/01.CIR.0000127954.98131.23; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Compernolle V, 2003, CARDIOVASC RES, V60, P569, DOI 10.1016/j.cardiores.2003.07.003; Dimmeler S, 2010, ARTERIOSCL THROM VAS, V30, P1088, DOI 10.1161/ATVBAHA.109.191668; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Faeh D, 2009, CIRCULATION, V120, P495, DOI 10.1161/CIRCULATIONAHA.108.819250; Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Formenti F, 2011, FASEB J, V25, P2001, DOI 10.1096/fj.10-177378; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Freret T, 2006, EUR J NEUROSCI, V23, P1757, DOI 10.1111/j.1460-9568.2006.04699.x; Gillies RJ, 2007, CANCER METAST REV, V26, P311, DOI 10.1007/s10555-007-9065-z; Gordeuk VR, 2006, SEMIN THROMB HEMOST, V32, P289, DOI 10.1055/s-2006-939441; HABIB GB, 1991, CIRCULATION, V83, P739, DOI 10.1161/01.CIR.83.3.739; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Harten SK, 2010, ANTIOXID REDOX SIGN, V12, P459, DOI 10.1089/ars.2009.2870; Hlatky MA, 2007, AM HEART J, V154, P1035, DOI 10.1016/j.ahj.2007.07.042; Ho TK, 2006, J VASC SURG, V43, P125, DOI 10.1016/j.jvs.2005.08.042; Holscher M, 2011, J BIOL CHEM, V286, P11185, DOI 10.1074/jbc.M110.186809; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; Jia LF, 2010, STROKE, V41, P2071, DOI 10.1161/STROKEAHA.110.586198; Jiang X, 2011, J CLIN INVEST, V121, P2336, DOI 10.1172/JCI46192; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin WG, 2009, CANCER-AM CANCER SOC, V115, P2262, DOI 10.1002/cncr.24232; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Kilian EG, 2010, CIRC J, V74, P916, DOI 10.1253/circj.CJ-09-0594; Kim JW, 2007, CANCER METAST REV, V26, P291, DOI 10.1007/s10555-007-9060-4; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; Lukashev D, 2007, CANCER METAST REV, V26, P273, DOI 10.1007/s10555-007-9054-2; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Melillo G, 2007, CANCER METAST REV, V26, P341, DOI 10.1007/s10555-007-9059-x; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Nagel S, 2010, ANTIOXID REDOX SIGN, V12, P481, DOI 10.1089/ars.2009.2711; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Rajagopalan S, 2007, CIRCULATION, V115, P1234, DOI 10.1161/CIRCULATIONAHA.106.607994; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Resar JR, 2005, CHEST, V128, P787, DOI 10.1378/chest.128.2.787; Rey S, 2011, BLOOD, V117, P4988, DOI 10.1182/blood-2010-11-321190; Rey S, 2009, P NATL ACAD SCI USA, V106, P20399, DOI 10.1073/pnas.0911921106; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; SABIA PJ, 1992, NEW ENGL J MED, V327, P1825, DOI 10.1056/NEJM199212243272601; Sarkar K, 2010, P NATL ACAD SCI USA, V107, P513, DOI 10.1073/pnas.0913116107; Sarkar K, 2009, P NATL ACAD SCI USA, V106, P18769, DOI 10.1073/pnas.0910561106; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; Shimoda LA, 2006, AM J PHYSIOL-LUNG C, V291, pL941, DOI 10.1152/ajplung.00528.2005; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Smith TG, 2006, PLOS MED, V3, P1178, DOI 10.1371/journal.pmed.0030290; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; Thangarajah H, 2010, CELL CYCLE, V9, P75, DOI 10.4161/cc.9.1.10371; van Weel V, 2008, ANN VASC SURG, V22, P582, DOI 10.1016/j.avsg.2008.02.017; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Whitman EM, 2008, AM J PHYSIOL-LUNG C, V294, pL309, DOI 10.1152/ajplung.00091.2007; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200; Yoon D, 2011, AM J PHYSIOL-CELL PH, V300, pC1215, DOI 10.1152/ajpcell.00044.2011; Yoshida T, 2010, FASEB J, V24, P1759, DOI 10.1096/fj.09-145664; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	101	710	740	4	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2011	365	6					537	547		10.1056/NEJMra1011165	http://dx.doi.org/10.1056/NEJMra1011165			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	805MW	22070493				2022-12-28	WOS:000293732100009
